PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Rane, S; Shankaran, S; Natarajan, G				Rane, Sharayu; Shankaran, Seetha; Natarajan, Girija			Parental Perception of Functional Status Following Tracheostomy in Infancy: A Single Center Study	JOURNAL OF PEDIATRICS			English	Article							LOW-BIRTH-WEIGHT; QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; HEALTH-CARE NEEDS; YOUNG-CHILDREN; OUTCOMES; FAMILY; BORN; TRACHEOTOMY; VALIDATION	Objective To examine the functional outcomes of children who underwent a tracheostomy in the initial hospitalization after birth and to determine their correlates. Study design We administered the validated 43-item Functional Status-II (FS-II) questionnaire by Stein and Jessop over the telephone to caregivers of surviving children. The FS-II items generated a total score, age-specific: (1) total; (2) general health (GH); and (3) responsiveness, activity, or interpersonal functioning (IPF) scores in specific age group categories. Results FS-II was administered to 51/62 (82.2%) survivors at a median (range) age of 5 (1-10) years; 27% children were on the ventilator and 43% required devices. About 40% of children had a median of 1 (1-4) hospitalization in the previous 6 months. Scores were >2 SD below means in 55%, 24%, and 55% cases for age-specific T, GH, and R/A/IPF scores respectively. The T and R/A/IPF scales were significantly higher in those with private, rather than public, maternal insurance, as were T and R/A/IPF scores for children >= 4 years, compared with younger children. On regression analysis, FS-II T, GH, and R/A/IPF scores were independently associated with maternal private insurance (P = .02). R/A/IPF scores were also significantly associated with corrected age at FS-II administration. Conclusions One-third of surviving children who underwent tracheostomy during their initial hospitalization remained technology-dependent. The parental FS-II questionnaires revealed low R/A/IPF scores, especially at younger ages and in those with maternal public insurance. Further research on family-level interventions to improve functional outcomes in this population is warranted.	[Rane, Sharayu; Shankaran, Seetha; Natarajan, Girija] Wayne State Univ, Div Neonatal Perinatal Med, Dept Pediat, Childrens Hosp Michigan, Detroit, MI 48201 USA		Natarajan, G (corresponding author), Wayne State Univ, Div Neonatal Perinatal Med, Dept Pediat, Childrens Hosp Michigan, 3901 Beaubien, Detroit, MI 48201 USA.	gnatara@med.wayne.edu	Natarajan, Girija/AAJ-3308-2021				[Anonymous], 2004, PEDIATRICS, V114, P1377; Bakker JPJ, 2002, AM J PHYS MED REHAB, V81, P906, DOI 10.1097/00002060-200212000-00004; Bramlett MD, 2009, MATERN CHILD HLTH J, V13, P151, DOI 10.1007/s10995-008-0339-z; CRONIN CMG, 1995, ARCH PEDIAT ADOL MED, V149, P151, DOI 10.1001/archpedi.1995.02170140033005; Da Costa D, 2009, DEV MED CHILD NEUROL, V51, P536, DOI 10.1111/j.1469-8749.2009.03318.x; DADDS MR, 1995, J PEDIATR PSYCHOL, V20, P527, DOI 10.1093/jpepsy/20.4.527; DIAMOND KE, 1993, J EARLY INTERVENTION, V17, P107, DOI 10.1177/105381519301700203; Edwards JD, 2010, J PEDIATR-US, V157, P955, DOI 10.1016/j.jpeds.2010.06.012; GLASCOE FP, 1995, PEDIATRICS, V95, P829; Glascoe FP, 1997, PEDIATRICS, V99, P522, DOI 10.1542/peds.99.4.522; GROSS RT, 1990, JAMA-J AM MED ASSOC, V263, P3035; Hack M, 2012, PEDIATRICS, V130, P46, DOI 10.1542/peds.2011-3402; Hintz SR, 2005, ARCH DIS CHILD-FETAL, V90, P128, DOI 10.1136/adc.2003.046268; Hogan DP, 2000, CLIN PERINATOL, V27, P433, DOI 10.1016/S0095-5108(05)70030-0; Keenan HT, 2006, PEDIATRICS, V117, P1291, DOI 10.1542/peds.2005-1883; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Knafl Kathleen A, 2007, J Genet Couns, V16, P481; Manco-Johnson M, 2004, HAEMOPHILIA, V10, P34, DOI 10.1046/j.1365-2516.2003.00842.x; Mandy G, 2013, PEDIATR PULM, V48, P245, DOI 10.1002/ppul.22572; MCCORMICK MC, 1986, J DEV BEHAV PEDIATR, V7, P217, DOI 10.1097/00004703-198608000-00001; Miceli PJ, 2000, J PEDIATR PSYCHOL, V25, P353, DOI 10.1093/jpepsy/25.5.353; Missmer SA, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.2.e24; Murphy KR, 2003, PEDIATRICS, V112, pE212, DOI 10.1542/peds.112.3.e212; Newacheck PW, 2009, PEDIATRICS, V123, pE940, DOI 10.1542/peds.2008-2921; Palermo TM, 2008, J PEDIATR PSYCHOL, V33, P983, DOI 10.1093/jpepsy/jsn038; Pereira KD, 2003, ARCH OTOLARYNGOL, V129, P1268, DOI 10.1001/archotol.129.12.1268; Pritchard MA, 2005, J PAEDIATR CHILD H, V41, P191, DOI 10.1111/j.1440-1754.2005.00586.x; ROSS GS, 1982, J COMMUN DISORD, V15, P95, DOI 10.1016/0021-9924(82)90024-7; SINGER LT, 1989, DEV MED CHILD NEUROL, V31, P224; Sisk EA, 2006, LARYNGOSCOPE, V116, P928, DOI 10.1097/01.MLG.0000214897.08822.14; STEIN REK, 1990, MED CARE, V28, P1041, DOI 10.1097/00005650-199011000-00006; Stein REK, 1991, MAUNAL FUNCTIONAL ST; US Congress Office of Technology Assessment, 1987, OTATMH38 US C; US Department of Health and Human Services Health Resources and Services Administration, NAT SURV CHILDR SPEC; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216	35	7	7	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	SEP	2013	163	3					860	866		10.1016/j.jpeds.2013.03.075			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	212LQ	WOS:000323985300050	23660377				2022-02-06	
J	Rushby, JA; Fisher, AC; McDonald, S; Murphy, A; Finnigan, S				Rushby, Jacqueline A.; Fisher, Alana C.; McDonald, Skye; Murphy, Anne; Finnigan, Simon			Autonomic and neural correlates of dysregulated arousal in severe traumatic brain injury	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						EEG alpha power; Skin conductance level; Traumatic brain injury; Arousal	RESTING-STATE AROUSAL; BLUNT HEAD-INJURY; AFFECTIVE RESPONSIVITY; ORIENTING REFLEX; EEG DIFFERENCES; EMPATHY; IMPACT; LEVEL	Severe traumatic brain injury (TBI) in adults is associated with abnormalities in arousal and emotional responsivity, which are observed physiologically, behaviourally and via self-report measures. While an accurate measure of physiological arousal is debated, Barry et al. (2005, 2007, 2008) have consistently shown an inverse relationship between skin conductance level (SCL), and mean alpha power (alpha) during an eyes-closed resting condition (EC), accompanied by an increase in SCL and corresponding decrease in alpha during eyes-open (EO). Thus, alpha may provide a novel index of autonomic arousal. This study aimed to elucidate the neural and autonomic correlates of arousal disturbances in TBI. Participants were 17 adults with TBI (13 males; mean age 46.50) and 22 matched controls (14 males; mean age 41.25). Mean alpha and SCL were recorded across two 2 minute conditions (EC and EO). Paralleling previous research (e.g., Barry et al., 2007), a significant decrease in alpha was found from EC to EO for the sample overall, but this was significantly reduced in TBI participants. Further, TBI participants showed diminished regional differences compared to controls. Lower SCLs across EC-EO were also found in TBI participants compared to controls'. Contrasting expectations, an increase in SCL from EC to EC) was not found. This study showed that examining simple alpha changes provides insight into TBI-related arousal disturbances. Importantly, our findings accord with the nature of TBI, which involves global and region-specific damage. (C) 2013 Elsevier B.V. All rights reserved.	[Rushby, Jacqueline A.; Fisher, Alana C.; McDonald, Skye; Murphy, Anne] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Finnigan, Simon] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld 4072, Australia		Rushby, JA (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	j.rushby@unsw.edu.au; alana.fisher@unsw.edu.au; s.mcdonald@unsw.edu.au; annemurphy7@gmail.com; finnigan@uq.edu.au	McDonald, Skye/G-4118-2014; Finnigan, Simon/F-8034-2010; Rushby, Jacqueline/D-1820-2010; Fisher, Alana/T-1869-2019	McDonald, Skye/0000-0003-0723-6094; Finnigan, Simon/0000-0003-1291-0741; Rushby, Jacqueline/0000-0002-5018-638X; Fisher, Alana/0000-0002-6027-659X	Australian National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [APP1013796]	Author JAR is supported by an Australian National Health and Medical Research Council (NHMRC) Postdoctoral Fellowship (Clinical Training; APP1013796). We are grateful to the Ryde, Westmead and Liverpool Brain Injury Units in Sydney, Australia, for their assistance with recruitment. We are indebted to the people with traumatic brain injuries and their families, as well as our volunteers from the general community, who gave willingly of their time to make this research possible.	Barry RJ, 2005, CLIN NEUROPHYSIOL, V116, P2693, DOI 10.1016/j.clinph.2005.08.008; Barry RJ, 2004, CLIN NEUROPHYSIOL, V115, P402, DOI 10.1016/S1388-2457(03)00343-2; BARRY RJ, 1993, INT J PSYCHOPHYSIOL, V15, P39, DOI 10.1016/0167-8760(93)90093-5; Barry RJ, 2008, BIOL PSYCHOL, V77, P304, DOI 10.1016/j.biopsycho.2007.11.002; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Barry RJ, 2009, CLIN NEUROPHYSIOL, V120, P1806, DOI 10.1016/j.clinph.2009.08.006; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P1469; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; James W., 1884, MIND, V9, P188, DOI 10.1093/mind/os-IX.34.188, os-IX; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lange C, 1887, UEBER GEMUTHSBEWGUNG, V3, P8; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MALMO RB, 1959, PSYCHOL REV, V66, P367, DOI 10.1037/h0047858; McDonald S, 2011, INT J PSYCHOPHYSIOL, V82, P124, DOI 10.1016/j.ijpsycho.2011.01.014; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Reitan R, 1985, HALSTEAD REITAN NEUR; Rushby JA, 2007, BIOL PSYCHOL, V75, P248, DOI 10.1016/j.biopsycho.2007.03.003; Rushby JA, 2009, INT J PSYCHOPHYSIOL, V74, P120, DOI 10.1016/j.ijpsycho.2009.08.003; Sanchez-Navarro JP, 2005, BEHAV NEUROSCI, V119, P87, DOI 10.1037/0735-7044.119.1.87; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Singh RN, 2006, ESSENTIAL PHYS MED R; Tabachnick B. G., 1989, USING MULTIVARIATE S; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Vianna EPM, 2006, INT J PSYCHOPHYSIOL, V61, P70, DOI 10.1016/j.ijpsycho.2005.10.019; WECHLER D, 1997, WECHSLER ADULT INTEL	35	7	7	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	SEP	2013	89	3			SI		460	465		10.1016/j.ijpsycho.2013.05.009			6	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	245AV	WOS:000326432200022	23707301				2022-02-06	
J	Jowers, CT; Taberner, AJ; Dragunow, M; Anderson, IA				Jowers, Casey T.; Taberner, Andrew J.; Dragunow, Mike; Anderson, Iain A.			The cell injury device: A high-throughput platform for traumatic brain injury research	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury (TBI); High throughput screening; Scratch wound assay; Cell migration	GLIAL SCAR; IN-VITRO; MIGRATION; REGENERATION; ASSAY; CNS; ASTROGLIOSIS; EXPRESSION; CULTURE; AXONS	A novel, automated system for delivering controlled scratch-induced trauma to brain cells cultured in multi-well plates was created and characterized. The system is equipped with high-throughput imaging and analysis capabilities, enabling quantitative measurements of cell migration. The scratch-area coefficient of variation of the device was between 3.9% and 8.4%, a significant improvement over traditional manual methods, which provided a scratch-area coefficient of variation of between 10.7% and 19.6%. The device's inexpensive imaging and analysis capabilities were comparable to a well-known system, the Discovery-1 (Molecular Devices), with no significant difference found between the two. When used for drug screening, the gap area of Neuro2a cells after 72 h was significantly larger in samples containing UO126 (20 mu M), averaging 0.89 mm(2) +/- 0.21 mm(2); compared with an average vehicle control gap area of 0.42 mm(2) +/- 0.1 mm(2). A gradient response could also be detected among samples with increasing UO126 concentrations (0-20 mu M), due to decreased migration and/or proliferation of cells into the gap over the time period. Our device provides an inexpensive method for delivering a standardized, closely controlled pressure/scratch to brain cells cultured in multi-well plates. The system provides more consistent patterns of scratch-induced trauma to cultured cells when compared to traditional methods. This device is an effective platform for quantifying the injury response of cells, and has applications in testing the effectiveness of drugs on cell migration and proliferation which might potentially treat traumatic brain injury. (c) 2013 Elsevier B.V. All rights reserved.	[Jowers, Casey T.; Taberner, Andrew J.; Anderson, Iain A.] Univ Auckland, Auckland Bioengn Inst, Auckland 1142, New Zealand; [Jowers, Casey T.; Dragunow, Mike] Univ Auckland, Fac Med & Hlth Sci, Dept Pharmacol & Clin Pharmacol, Auckland 1142, New Zealand; [Jowers, Casey T.; Dragunow, Mike] Univ Auckland, Fac Med & Hlth Sci, Ctr Brain Res, Auckland 1142, New Zealand; [Taberner, Andrew J.; Anderson, Iain A.] Univ Auckland, Dept Engn Sci, Auckland 1142, New Zealand		Jowers, CT (corresponding author), Univ Auckland, Auckland Bioengn Inst, Private Bag 92019, Auckland 1142, New Zealand.	c.jowers@auckland.ac.nz; a.taberner@auckland.ac.nz; m.dragunow@auckland.ac.nz; i.anderson@auckland.ac.nz		Taberner, Andrew/0000-0002-0452-0308	University of Auckland Doctoral Scholarship; Health Research Council; National Research Centre for Growth and Development (Gravida); Hugh Green Foundation	Research supported by University of Auckland Doctoral Scholarship, the Health Research Council, the National Research Centre for Growth and Development (Gravida), and the Hugh Green Foundation. Special thanks to Claire Lill of University of Auckland, Centre for Brain Research Biobank.	[Anonymous], LAN004 LEAP CYNT INC; Cory G, 2011, METHODS MOL BIOL, V769, P25, DOI 10.1007/978-1-61779-207-6_2; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Hulkower Keren I, 2011, Pharmaceutics, V3, P107, DOI 10.3390/pharmaceutics3010107; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Lackler KP, 2000, J PERIODONTOL, V71, P226, DOI 10.1902/jop.2000.71.2.226; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lim JH, 2007, BRAIN RES, V1164, P1, DOI 10.1016/j.brainres.2007.06.020; Lind CRP, 2006, NEUROSCIENCE, V141, P1925, DOI 10.1016/j.neuroscience.2006.05.038; Menon MB, 2009, CELL MOTIL CYTOSKEL, V66, P1041, DOI 10.1002/cm.20418; Parmentier-Batteur S, 2011, J NEUROCHEM, V118, P1016, DOI 10.1111/j.1471-4159.2011.07375.x; SENIUK NA, 1994, J NEUROSCI RES, V37, P278, DOI 10.1002/jnr.490370213; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Stichel CC, 1999, EUR J NEUROSCI, V11, P632, DOI 10.1046/j.1460-9568.1999.00466.x; Stichel CC, 1999, NEUROSCIENCE, V93, P321, DOI 10.1016/S0306-4522(99)00112-8; Wu VW, 1998, J NEUROSCI RES, V51, P675, DOI 10.1002/(SICI)1097-4547(19980315)51:6<675::AID-JNR2>3.3.CO;2-N; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Zordan MD, 2011, CYTOM PART A, V79A, P227, DOI 10.1002/cyto.a.21029	22	7	7	0	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	AUG 15	2013	218	1					1	8		10.1016/j.jneumeth.2013.04.020			8	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	195HM	WOS:000322692900001	23660525				2022-02-06	
J	Dengler, J; Frenzel, C; Vajkoczy, P; Horn, P; Wolf, S				Dengler, Julius; Frenzel, Christin; Vajkoczy, Peter; Horn, Peter; Wolf, Stefan			The Oxygen Reactivity Index and Its Relation to Sensor Technology in Patients with Severe Brain Lesions	NEUROCRITICAL CARE			English	Article						ORx; Licox; Raumedic; Cerebral tissue oxygenation; PbrO(2); Cerebral autoregulation	CEREBRAL PERFUSION-PRESSURE; TISSUE OXYGEN; CEREBROVASCULAR AUTOREGULATION; AGREEMENT; LICOX	The oxygen reactivity index (ORx) has been introduced to assess the status of cerebral autoregulation after traumatic brain injury (TBI) or subarachnoid hemorrhage (SAH). Currently, there is some controversy about whether the ORx depends on the type of PbrO(2)-sensor technology used for its calculation. To examine if the probe technology does matter, we compared the ORx and the resulting optimal cerebral perfusion pressures (CPPopt) of simultaneously implanted Licox (CC1.SB, Integra Neuroscience, France) and Neurovent-PTO (Raumedic, Germany) probes in patients after aneurysmal SAH or severe TBI. Licox and Raumedic probes were implanted side by side in 11 patients after TBI or SAH. ORx and CPPopt were recorded continuously. The equivalence of both probes was examined using Bland-Altman analyses. The mean difference in ORx was 0.1, with Licox producing higher values. The limits of agreement regarding ORx ranged from -0.6 to +0.7. When both probes' ORx values were compared in each patient, no specific pattern in their relationship was seen. The mean difference in CPPopt was 0 mmHg with limits of agreement between -16.5 and +16.4 mmHg. Owing to the rather limited number of patients, we view the results of this study as preliminary. The main result is that Licox and Raumedic showed consistent differences in ORx and CPPopt. Therefore, ORx values of both probes cannot be interchanged and should not be viewed as equivalent. This should be taken into consideration when discussing ORx data generated by different PbrO(2) probe types.	[Dengler, Julius; Frenzel, Christin; Vajkoczy, Peter; Horn, Peter; Wolf, Stefan] Univ Med Berlin, Charite, Dept Neurosurg, CVK, D-13553 Berlin, Germany		Dengler, J (corresponding author), Univ Med Berlin, Charite, Dept Neurosurg, CVK, Augustenburger Pl 1, D-13553 Berlin, Germany.	julius.dengler@charite.de			Department of Neurosurgery of the Charite, Berlin	The authors are not subject to any conflict of interest. The study was exclusively funded by the Department of Neurosurgery of the Charite, Berlin.	[Anonymous], 2011, R PROJECT STAT COMPU; Barth M, 2010, NEUROCRIT CARE, V12, P234, DOI 10.1007/s12028-009-9287-8; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Critchley LAH, 1999, J CLIN MONIT COMPUT, V15, P85, DOI 10.1023/A:1009982611386; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Dengler J, 2011, INTENS CARE MED, V37, P1809, DOI 10.1007/s00134-011-2316-z; Haitsma I, 2008, ACTA NEUROCHIR SUPPL, V102, P197, DOI 10.1007/978-3-211-85578-2_39; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; Huschak G, 2009, J NEUROSURG ANESTH, V21, P155, DOI 10.1097/ANA.0b013e31818f2eac; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Jaeger M, 2010, NEUROCRIT CARE, V13, P163, DOI 10.1007/s12028-010-9348-z; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; Orakcioglu B, 2010, NEUROSURGERY, V67, P1716, DOI 10.1227/NEU.0b013e3181f9bb5b; Purins K, 2005, ACTA NEUROCHIR WIEN, V152, P681; Radolovich DK, 2009, NEUROCRIT CARE, V10, P274, DOI 10.1007/s12028-009-9190-3; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002	19	7	7	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2013	19	1					74	78		10.1007/s12028-012-9686-0			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	187SP	WOS:000322140000012	22396192				2022-02-06	
J	Mawhinney, LJ; Mabourakh, D; Lewis, MC				Mawhinney, Lana J.; Mabourakh, Davita; Lewis, Michael C.			Gender-Specific Differences in the Central Nervous System's Response to Anesthesia	TRANSLATIONAL STROKE RESEARCH			English	Article						Anesthesia; Brain; Central nervous system; Gender differences; Review	MINIMUM ALVEOLAR CONCENTRATION; PLASMA-PROTEIN BINDING; TRAUMATIC BRAIN-INJURY; POSTOPERATIVE COGNITIVE DYSFUNCTION; PROGESTERONE-RECEPTOR EXPRESSION; NITROUS OXIDE ANESTHESIA; LEFT-VENTRICULAR MASS; SEX-DIFFERENCES; BISPECTRAL INDEX; GRAY-MATTER	Males and females are physiologically distinct in their responses to various anesthetic agents. The brain and central nervous system (CNS), the main target of anesthesia, are sexually dimorphic from birth and continue to differentiate throughout life. Accordingly, gender has a substantial impact on the influence of various anesthetic agents in the brain and CNS. Given the vast differences in the male and female CNS, it is surprising to find that females are often excluded from basic and clinical research studies of anesthesia. In animal research, males are typically studied to avoid the complication of breeding, pregnancy, and hormonal changes in females. In clinical studies, females are also excluded for the variations that occur in the reproductive cycle. Being that approximately half of the surgical population is female, the exclusion of females in anesthesia-related research studies leaves a huge knowledge gap in the literature. In this review, we examine the reported sex-specific differences in the central nervous system's response to anesthesia. Furthermore, we suggest that anesthesia researchers perform experiments on both sexes to further evaluate such differences. We believe a key goal of research studying the interaction of the brain and anesthesia should include the search for knowledge of sex-specific mechanisms that will improve anesthetic care and management in both sexes.	[Mawhinney, Lana J.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg,Lois Pope LIFE Ctr, Miami, FL 33136 USA; [Mabourakh, Davita] Univ Miami, Coll Arts & Sci, Miami, FL 33136 USA; [Lewis, Michael C.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA		Mawhinney, LJ (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg,Lois Pope LIFE Ctr, 1095 NW 14th Terrace R-48, Miami, FL 33136 USA.	ljones5@med.miami.edu			The Miami Project to Cure Paralysis; Department of Anesthesiology at the University of Miami Miller School of Medicine	The authors extend a note of appreciation to Eric Shaw and Dr. Dalton Dietrich for the critical review of this manuscript and helpful discussion. The authors regret space limitations that prevented the citation of many noteworthy and relevant studies. The support for the authors' work and laboratories was from The Miami Project to Cure Paralysis and Department of Anesthesiology at the University of Miami Miller School of Medicine.	Adamus M, 2008, EUR J ANAESTH, V25, P589, DOI 10.1017/S026502150800402X; An JX, 2011, J NEUROSURG ANESTH, V23, P12, DOI 10.1097/ANA.0b013e3181f59db4; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; APFELBAUM JL, 1993, ANESTH ANALG, V77, pS10; AQUIRRE C, 1988, EUR J DRUG METAB PH, V13, P23, DOI 10.1007/BF03189924; Bao AM, 2011, FRONT NEUROENDOCRIN, V32, P214, DOI 10.1016/j.yfrne.2011.02.007; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; BEATTIE WS, 1991, CAN J ANAESTH, V38, P298, DOI 10.1007/BF03007618; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; BITRAN D, 1995, J NEUROENDOCRINOL, V7, P171, DOI 10.1111/j.1365-2826.1995.tb00744.x; Blok LJ, 1996, ENDOCR RES, V22, P197, DOI 10.3109/07435809609030508; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; BRAYNE C, 1995, BRIT J PSYCHIAT, V167, P255, DOI 10.1192/bjp.167.2.255; BRODIE BB, 1951, J PHARMACOL EXP THER, V102, P215; Buchanan FF, 2011, BRIT J ANAESTH, V106, P832, DOI 10.1093/bja/aer094; Buchanan FF, 2006, ANESTH ANALG, V102, P291, DOI 10.1213/01.ane.0000181321.55422.C6; Buchanan FF, BR J ANAESTH, V106, P832; Burgoyne PS, 1995, PHILOS T R SOC B, V350, P253, DOI 10.1098/rstb.1995.0159; BURGOYNE PS, 1993, DEVELOPMENT, V117, P341; Cain PA, 2005, CLIN PHYSIOL FUNCT I, V25, P332, DOI 10.1111/j.1475-097X.2005.00632.x; CARL P, 1990, ANAESTHESIA, V45, P189, DOI 10.1111/j.1365-2044.1990.tb14683.x; Carne RP, 2006, J CLIN NEUROSCI, V13, P60, DOI 10.1016/j.jocn.2005.02.013; Chan MTV, 2013, J NEUROSURG ANESTH, V25, P33, DOI 10.1097/ANA.0b013e3182712fba; CHAN MTV, 1995, ANESTHESIOLOGY, V82, P1360, DOI 10.1097/00000542-199506000-00006; Chen ML, 2000, CLIN PHARMACOL THER, V68, P510, DOI 10.1067/mcp.2000.111184; Chen TL, 2000, BRIT J ANAESTH, V84, P771, DOI 10.1093/oxfordjournals.bja.a013592; CHU CYT, 1981, CLIN CHIM ACTA, V112, P235, DOI 10.1016/0009-8981(81)90382-X; Chung AK, 2006, CIRCULATION, V113, P1597, DOI 10.1161/CIRCULATIONAHA.105.574400; Ciccone GK, 1999, BRIT J ANAESTH, V82, P255, DOI 10.1093/bja/82.2.255; Clarke D, 1996, PSYCHOL MED, V26, P829, DOI 10.1017/S0033291700037855; Clewell HJ, 2002, CRIT REV TOXICOL, V32, P329, DOI 10.1080/20024091064264; Culley DJ, 2007, CURR OPIN ANESTHESIO, V20, P408, DOI 10.1097/ACO.0b013e3282efd18b; Culley DJ, 2004, ANESTH ANALG, V99, P1393, DOI 10.1213/01.ANE.0000135408.14319.CC; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; DATTA S, 1989, ANESTH ANALG, V68, P46; Davis C, 2012, INT J NEUROPSYCHOPH, V15, P181, DOI 10.1017/S1461145711001039; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; de Simone G, 2005, AM J CLIN NUTR, V81, P757, DOI 10.1093/ajcn/81.4.757; Dhruva SS, 2011, CIRC-CARDIOVASC QUAL, V4, P165, DOI 10.1161/CIRCOUTCOMES.110.958215; Domino KB, 1999, ANESTHESIOLOGY, V90, P1053, DOI 10.1097/00000542-199904000-00019; DONATI F, 1986, CAN J ANAESTH, V33, P683, DOI 10.1007/BF03014279; Dong YY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034435, 10.1371/journal.pone.0051643, 10.1371/journal.pone.0039386]; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Edwards DJ, 1998, BRIT J ORAL MAX SURG, V36, P333, DOI 10.1016/S0266-4356(98)90643-X; Eger EI, 2003, ANESTHESIOLOGY, V99, P1059, DOI 10.1097/00000542-200311000-00009; EHRHARDT AA, 1979, ANNU REV MED, V30, P417, DOI 10.1146/annurev.me.30.020179.002221; Erden V, 2005, ANESTH ANALG, V101, P1007, DOI 10.1213/01.ane.0000168271.76090.63; Evans PW, 1998, HUM REPROD, V13, P1057, DOI 10.1093/humrep/13.4.1057; Farace E, 2000, Neurosurg Focus, V8, pe6; Farag E, 2006, ANESTH ANALG, V103, P633, DOI 10.1213/01.ane.0000228870.48028.b5; FILIPEK PA, 1994, CEREB CORTEX, V4, P344, DOI 10.1093/cercor/4.4.344; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Fredriksson A, 2004, BEHAV BRAIN RES, V153, P367, DOI 10.1016/j.bbr.2003.12.026; Fredriksson A, 2007, ANESTHESIOLOGY, V107, P427, DOI 10.1097/01.anes.0000278892.62305.9c; Friess E, 1997, AM J PHYSIOL-ENDOC M, V272, pE885, DOI 10.1152/ajpendo.1997.272.5.E885; Gan TJ, 1999, ANESTHESIOLOGY, V90, P1283, DOI 10.1097/00000542-199905000-00010; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI [10.1146/annurev.pharmtox.44.101802.121453, 10.2165/00003088-200948030-00001]; Ghirlanda G, 2004, FEBS LETT, V578, P140, DOI 10.1016/j.febslet.2004.10.087; Giedd JN, 2006, MOL CELL ENDOCRINOL, V254, P154, DOI 10.1016/j.mce.2006.04.016; Giedd JN, 1997, PROG NEURO-PSYCHOPH, V21, P1185, DOI 10.1016/S0278-5846(97)00158-9; Gilman A. Goodman, 1996, GOODMAN GILMANS PHAR; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; GIN T, 1994, ANESTHESIOLOGY, V81, P829, DOI 10.1097/00000542-199410000-00009; Glass PS, 1997, ANESTHESIOLOGY, V86, P836, DOI 10.1097/00000542-199704000-00014; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldfien A., 1998, BASIC CLIN PHARM, P653; Goldstein JM, 1999, AM J PSYCHIAT, V156, P352; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Gorski JC, 1998, CLIN PHARMACOL THER, V64, P133, DOI 10.1016/S0009-9236(98)90146-1; GRANDI AM, 1992, ACTA CARDIOL, V47, P77; GREENBLATT DJ, 1989, CLIN PHARMACOL THER, V45, P356, DOI 10.1038/clpt.1989.41; GREENBLATT DJ, 1984, ANESTHESIOLOGY, V61, P27, DOI 10.1097/00000542-198461010-00006; Hagberg H, 2004, J NEUROCHEM, V90, P1068, DOI 10.1111/j.1471-4159.2004.02547.x; HARAM K, 1983, BRIT J OBSTET GYNAEC, V90, P139, DOI 10.1111/j.1471-0528.1983.tb08898.x; Harmon D, 2000, ANAESTHESIA, V55, P1164, DOI 10.1046/j.1365-2044.2000.01719.x; Harms CA, 1998, J PHYSIOL-LONDON, V507, P619, DOI 10.1111/j.1469-7793.1998.619bt.x; HILL MD, 1988, CLIN PHARMACOKINET, V14, P156, DOI 10.2165/00003088-198814030-00004; Holdcroft A, 1997, ANAESTHESIA, V52, P931, DOI 10.1111/j.1365-2044.1997.265-az0393.x; Howden LM, 2010, AGE SEX COMPOSITION; Hoymork SC, 2003, BRIT J ANAESTH, V91, P773, DOI 10.1093/bja/aeg258; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kashuba ADM, 1998, CLIN PHARMACOKINET, V34, P203, DOI 10.2165/00003088-199834030-00003; Katoh T, 1998, ANESTHESIOLOGY, V88, P18, DOI 10.1097/00000542-199801000-00006; Katoh T, 1999, BRIT J ANAESTH, V82, P561, DOI 10.1093/bja/82.4.561; Kertai MD, 2011, ANESTHESIOLOGY, V114, P545, DOI 10.1097/ALN.0b013e31820c2b57; Kertai MD, 2010, ANESTHESIOLOGY, V112, P1116, DOI 10.1097/ALN.0b013e3181d5e0a3; Kilbride E, 2003, EUR J APPL PHYSIOL, V89, P595, DOI 10.1007/s00421-003-0853-z; Kinirons MT, 1999, CLIN PHARMACOL THER, V66, P224, DOI 10.1016/S0009-9236(99)70029-9; KOTANI K, 1994, INT J OBESITY, V18, P207; Kvolik S, 2005, LIFE SCI, V77, P2369, DOI 10.1016/j.lfs.2004.12.052; Lancel M, 1997, J PHARMACOL EXP THER, V282, P1213; Lancel M, 1996, AM J PHYSIOL-ENDOC M, V271, pE763, DOI 10.1152/ajpendo.1996.271.4.E763; LAUER MS, 1994, AM J CARDIOL, V74, P487, DOI 10.1016/0002-9149(94)90909-1; Le Freche H, 2012, ANESTHESIOLOGY, V116, P779, DOI 10.1097/ALN.0b013e31824be8c7; Legato M J, 2000, J Gend Specif Med, V3, P15; Leslie K, 2010, ANESTH ANALG, V110, P816, DOI 10.1213/ANE.0b013e3181c3bfb2; Li J, 2009, J CEREBR BLOOD F MET, V29, P670, DOI 10.1038/jcbfm.2009.3; Lindholm ML, 2009, ANESTH ANALG, V108, P508, DOI 10.1213/ane.0b013e31818f603c; Liu FD, 2009, STROKE, V40, P1842, DOI 10.1161/STROKEAHA.108.538686; Loepke AW, 2009, ANESTH ANALG, V108, P90, DOI 10.1213/ane.0b013e31818cdb29; Lombardo MV, 2012, J NEUROSCI, V32, P674, DOI 10.1523/JNEUROSCI.4389-11.2012; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Loryan I, 2012, EUR J CLIN PHARMACOL, V68, P397, DOI 10.1007/s00228-011-1132-2; Lovejoy JC, 2009, OBES REV, V10, P154, DOI 10.1111/j.1467-789X.2008.00529.x; Luders E, 2005, NEUROIMAGE, V26, P493, DOI 10.1016/j.neuroimage.2005.02.010; Luders E, 2009, J NEUROSCI, V29, P14265, DOI 10.1523/JNEUROSCI.2261-09.2009; MACLEOD SM, 1979, J CLIN PHARMACOL, V19, P15, DOI 10.1002/j.1552-4604.1979.tb01612.x; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Manber R, 1999, SLEEP, V22, P540; Martell R, 2001, Nurs Times, V97, P28; Matsumoto S, 2000, Nihon Hinyokika Gakkai Zasshi, V91, P501; Matsuoka H, 2001, ANESTHESIOLOGY, V95, P1467, DOI 10.1097/00000542-200112000-00028; Mawhinney LJ, 2012, BRAIN RES, V1431, P23, DOI 10.1016/j.brainres.2011.11.004; MAYNERT EW, 1955, J PHARMACOL EXP THER, V115, P275; McCarthy MM, 2008, J NEUROENDOCRINOL, V20, P777, DOI 10.1111/j.1365-2826.2008.01723.x; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; McClaran SR, 1998, J APPL PHYSIOL, V84, P1872, DOI 10.1152/jappl.1998.84.6.1872; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; MEAD J, 1980, AM REV RESPIR DIS, V121, P339; Miller IN, 2010, MOVEMENT DISORD, V25, P2695, DOI 10.1002/mds.23388; MINERS JO, 1983, BRIT J CLIN PHARMACO, V16, P503, DOI 10.1111/j.1365-2125.1983.tb02207.x; Moller Daryn H, 2003, Curr Opin Anaesthesiol, V16, P379, DOI 10.1097/00001503-200308000-00003; Mong JA, 2002, DEV BRAIN RES, V139, P151, DOI 10.1016/S0165-3806(02)00541-2; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Monk TG, 2005, ANESTH ANALG, V100, P4, DOI 10.1213/01.ANE.0000147519.82841.5E; Morelli C, 2004, J APPL PHYSIOL, V97, P1673, DOI 10.1152/japplphysiol.00541.2004; MORGAN K, 1993, BRIT J PSYCHIAT, V163, P467, DOI 10.1192/bjp.163.4.467; Murphy DGM, 1996, ARCH GEN PSYCHIAT, V53, P585; Myles PS, 2001, BRIT MED J, V322, P710, DOI 10.1136/bmj.322.7288.710; Myles PS, 1997, ANAESTHESIA, V52, P300, DOI 10.1111/j.1365-2044.1997.89-az0091.x; Myles PS, 2000, BRIT J ANAESTH, V84, P6, DOI 10.1093/oxfordjournals.bja.a013383; Nadeson R, 2001, BRIT J ANAESTH, V86, P704, DOI 10.1093/bja/86.5.704; Neufang S, 2009, CEREB CORTEX, V19, P464, DOI 10.1093/cercor/bhn100; Nishiyama M, 1998, J PHYSIOL-LONDON, V510, P455, DOI 10.1111/j.1469-7793.1998.455bk.x; Nopoulos P, 2000, PSYCHIAT RES-NEUROIM, V98, P1, DOI 10.1016/S0925-4927(99)00044-X; NOTARIANNI LJ, 1990, CLIN PHARMACOKINET, V18, P20, DOI 10.2165/00003088-199018010-00002; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; OCHS HR, 1982, DIGEST DIS SCI, V27, P225, DOI 10.1007/BF01296920; PALAHNIUK RJ, 1974, ANESTHESIOLOGY, V41, P82, DOI 10.1097/00000542-197407000-00021; PALVA ES, 1985, MED BIOL, V63, P92; PARKER CJR, 1992, BRIT J ANAESTH, V69, P439, DOI 10.1093/bja/69.5.439; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Paus T, 1996, J COMP NEUROL, V376, P664, DOI 10.1002/(SICI)1096-9861(19961223)376:4<664::AID-CNE12>3.0.CO;2-M; Pederson T, 1978, Int Rev Cytol, V55, P1; PERUCCA E, 1982, CLIN PHARMACOKINET, V7, P336, DOI 10.2165/00003088-198207040-00004; Pesic V, 2009, INT J DEV NEUROSCI, V27, P279, DOI 10.1016/j.ijdevneu.2008.12.005; PFAFF DW, 1983, SCIENCE, V219, P808, DOI 10.1126/science.6297008; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Pleym H, 2003, ACTA ANAESTH SCAND, V47, P241, DOI 10.1034/j.1399-6576.2003.00036.x; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; Puri A, 2012, INDIAN J PHARMACOL, V44, P402, DOI 10.4103/0253-7613.96348; Quadros PS, 2008, ENDOCRINOLOGY, V149, P3054, DOI 10.1210/en.2007-1133; Quadros PS, 2002, ENDOCRINOLOGY, V143, P3727, DOI 10.1210/en.2002-211438; Reckelhoff JF, 1998, AM J HYPERTENS, V11, P97, DOI 10.1016/S0895-7061(97)00360-9; Renolleau S, 2007, J NEUROCHEM, V100, P1062, DOI 10.1111/j.1471-4159.2006.04269.x; Rizzi S, 2008, BRAIN PATHOL, V18, P198, DOI 10.1111/j.1750-3639.2007.00116.x; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rothstein S, 2008, NEUROSCIENCE, V152, P959, DOI 10.1016/j.neuroscience.2008.01.027; Sadekov RA, 2003, ZH NEVROPATOL PSIKH, V103, P10; Sandin RH, 2000, LANCET, V355, P707, DOI 10.1016/S0140-6736(99)11010-9; Sarangapani R, 2003, INHAL TOXICOL, V15, P987, DOI 10.1080/08958370390226350; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Savic I, 2011, CEREB CORTEX, V21, P2525, DOI 10.1093/cercor/bhr032; Schwarz JM, 2008, HORM BEHAV, V54, P662, DOI 10.1016/j.yhbeh.2008.07.004; Schwarz JM, 2008, NEURON, V58, P584, DOI 10.1016/j.neuron.2008.03.008; SCOTT WJ, 1977, J EMBRYOL EXP MORPH, V40, P259; Sebel PS, 2004, ANESTH ANALG, V99, P833, DOI 10.1213/01.ANE.0000130261.90896.6C; SEMPLE P, 1994, BRIT J ANAESTH, V72, P190, DOI 10.1093/bja/72.2.190; SHAFER SQ, 1988, EPILEPSIA, V29, P590, DOI 10.1111/j.1528-1157.1988.tb03767.x; Shulman Lisa M, 2006, Expert Rev Neurother, V6, P407; Slikker W, 2007, TOXICOL SCI, V98, P145, DOI 10.1093/toxsci/kfm084; Smith CE, 1997, ANAESTHESIA, V52, P833, DOI 10.1111/j.1365-2044.1997.195-az0331.x; Soderpalm AHV, 2004, PSYCHONEUROENDOCRINO, V29, P339, DOI 10.1016/S0306-4530(03)00033-7; Soldin OP, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/187103; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Steinmetz J, 2010, ACTA ANAESTH SCAND, V54, P162, DOI 10.1111/j.1399-6576.2009.02098.x; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; SUCCARI M, 1990, CLIN CHIM ACTA, V187, P235, DOI 10.1016/0009-8981(90)90108-5; Suzuki M, 1998, J CLIN MONITOR COMP, V14, P373, DOI 10.1023/A:1009975701184; SUZUKI M, 1985, OBSTET GYNECOL, V66, pS14; Taenzer AH, 2000, ANESTHESIOLOGY, V93, P670, DOI 10.1097/00000542-200009000-00015; Tang Junxia X, 2011, Alzheimers Dement, V7, P521, DOI 10.1016/j.jalz.2010.10.003; Tang JXX, 2011, CURR OPIN ANESTHESIO, V24, P389, DOI 10.1097/ACO.0b013e32834871c5; Tanifuji Y, 1988, Masui, V37, P1240; THORNHILL AR, 1993, DEVELOPMENT, V118, P171; Tontisirin N, 2007, PEDIATRICS, V119, pE610, DOI 10.1542/peds.2006-2110; Torbati D, 1999, CRIT CARE MED, V27, P1878, DOI 10.1097/00003246-199909000-00028; Tuck CH, 1997, ARTERIOSCL THROM VAS, V17, P1822, DOI 10.1161/01.ATV.17.9.1822; Turtzo LC, 2008, CEREBROVASC DIS, V26, P462, DOI 10.1159/000155983; VANLE L, 1991, J REPROD MED, V36, P872; Viberg H, 2008, TOXICOLOGY, V249, P153, DOI 10.1016/j.tox.2008.04.019; Vuyk J, 2001, BRIT J ANAESTH, V86, P183, DOI 10.1093/bja/86.2.183; Wadelius M, 1997, CLIN PHARMACOL THER, V62, P400, DOI 10.1016/S0009-9236(97)90118-1; Wadhwa A, 2003, ANESTHESIOLOGY, V99, P1062, DOI 10.1097/00000542-200311000-00010; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner EC, 2008, J EXP BIOL, V211, P400, DOI 10.1242/jeb.011205; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; WALLE T, 1989, CLIN PHARMACOL THER, V46, P257, DOI 10.1038/clpt.1989.136; WALLE UK, 1994, BRIT J CLIN PHARMACO, V37, P21, DOI 10.1111/j.1365-2125.1994.tb04233.x; Ward DS, 2002, ANESTHESIOLOGY, V97, P1401, DOI 10.1097/00000542-200212000-00011; Wei HF, 2005, BRAIN RES, V1037, P139, DOI 10.1016/j.brainres.2005.01.009; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; WOOD SM, 1981, CLIN OBSTET GYNAECOL, V8, P255; Wright CL, 2009, J NEUROSCI, V29, P13274, DOI 10.1523/JNEUROSCI.3603-09.2009; Wright DW, 2008, BRAIN INJURY, V22, P107, DOI 10.1080/02699050701867399; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Xie ZC, 2006, J GERONTOL A-BIOL, V61, P1300, DOI 10.1093/gerona/61.12.1300; Xie ZC, 2006, EXP GERONTOL, V41, P346, DOI 10.1016/j.exger.2006.01.014; Xue FS, 1998, BRIT J ANAESTH, V80, P720, DOI 10.1093/bja/80.6.720; Xue FS, 1997, ANESTH ANALG, V85, P667, DOI 10.1097/00000539-199709000-00033; YOSHIMI T, 1968, STEROIDS, V11, P527, DOI 10.1016/S0039-128X(68)80066-2; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161; Young C, 2005, BRIT J PHARMACOL, V146, P189, DOI 10.1038/sj.bjp.0706301; Yuan M, 2009, EXP NEUROL, V217, P210, DOI 10.1016/j.expneurol.2009.02.012; Zambricki EA, 2004, COMPARATIVE MED, V54, P49	227	7	7	0	17	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	AUG	2013	4	4					462	475		10.1007/s12975-012-0229-y			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	176GD	WOS:000321290900010	24323342				2022-02-06	
J	Miyahara, T; Dahlin, C; Galli, S; Parsafar, S; Koizumi, H; Kasugai, S				Miyahara, Takayuki; Dahlin, Christer; Galli, Silvia; Parsafar, Shima; Koizumi, Hiroyasu; Kasugai, Shohei			A novel dual material mouthguard for patients with dental implants	DENTAL TRAUMATOLOGY			English	Article						mouthguard; dental implant; contact sports; porous rubber; shock absorber; dental trauma	ABSORPTION; CONCUSSION; PROTECTORS; TRAUMA	Aim: Dental implant-supported reconstructions demonstrate significantly less physiological flexibility for loading and traumatic forces compared with a normal dentition because of their rigid integration with the adjacent bone. Ethylene vinyl acetate (EVA) material has become widely accepted as a mouthguard material; however, many studies indicate the necessity of improving the impact absorption ability by considering the design and developing new materials. The aim of this study was to compare the shock-absorbing ability of a novel dual component material comprising EVA and porous rubber with that of EVA alone. Materials and methods: Three groups of samples were tested: Group 1 = EVA (thickness, 4 mm), Group 2 = type 1 material (2-mm thick porous rubber sheet sandwiched between two sheets of 1-mm thick EVA sheets), and Group 3 = type 2 material (1-mm thick porous rubber sheet sandwiched between EVA sheets with 1 and 2-mm thickness, respectively). Shock absorption was determined by means of a hammer impact testing device equipped with strain gauge, accelerator, and load cell. Results: The value of shock-absorbing ability of group 2 (40.6 +/- 12.5%) was significantly higher than those of group 1 (15.6 +/- 2.1%) and group 3 (21.2 +/- 9.2%). The material with thicker rubber sheet showed significantly higher shock-absorbing ability compared with that of the material with thinner rubber sheet. Conclusions: The novel dual material was superior to conventional EVA material in shock-absorbing ability depending on the thickness of porous rubber, and it may be potentially effective as mouthguard material, in particular, for patients wearing implant-supported constructions.	[Miyahara, Takayuki; Dahlin, Christer; Galli, Silvia; Parsafar, Shima] Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Gothenburg, Sweden; [Miyahara, Takayuki; Kasugai, Shohei] Tokyo Med & Dent Univ, Dept Masticatory Funct Rehabil, Tokyo 1138549, Japan; [Miyahara, Takayuki; Dahlin, Christer; Parsafar, Shima] BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden; [Dahlin, Christer] NAL Med Ctr Hosp, Dept ENT Oral & Maxillofacial Surg, Trollhattan, Sweden; [Parsafar, Shima] Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Koizumi, Hiroyasu] Nihon Univ, Dept Fixed Prosthodont, Sch Dent, Tokyo 102, Japan; [Kasugai, Shohei] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Programme, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo 1138549, Japan		Miyahara, T (corresponding author), Tokyo Med & Dent Univ, Dept Masticatory Funct Rehabil, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	miyahara.irm@tmd.ac.jp	Koizumi, Hiroyasu/AAZ-1660-2021	Koizumi, Hiroyasu/0000-0002-6160-2692	Ministry of Education, Culture, Sports, Science and Technology, JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy, Goteborg, Sweden	We would like to express special thanks to Nobukazu TAKASAWA (for making the samples of sheets for samples and prototype), Masanori SATO and Satoshi KOBAYASHI (for supplying porous rubber 'Saporous'), and Noriyuki INOUE [Business, Research and Intellectual Property Center (NUBIC) Nihon University]. This work was supported by Grant-in-Aid for GCOE Research and Grant-in-Aid for Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy, Goteborg, Sweden.	Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11; ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776; Andrade RA, 2010, DENT TRAUMATOL, V26, P248, DOI 10.1111/j.1600-9657.2010.00884.x; BISHOP BM, 1985, J PROSTHET DENT, V53, P256, DOI 10.1016/0022-3913(85)90123-4; Cohenca N, 2007, J AM DENT ASSOC, V138, P1121, DOI 10.14219/jada.archive.2007.0326; Craig R G, 1967, J Mich State Dent Assoc, V49, P34; Craig RG, 2002, J ORAL REHABIL, V29, P146, DOI 10.1046/j.1365-2842.2002.00831.x; Gardiner D M, 2000, Dent Clin North Am, V44, P53; GOING RE, 1974, J AM DENT ASSOC, V89, P132, DOI 10.14219/jada.archive.1974.0354; Gould TE, 2009, DENT MATER, V25, P1593, DOI 10.1016/j.dental.2009.08.003; Gould TE, 2009, DENT MATER, V25, P771, DOI 10.1016/j.dental.2008.12.005; Jagger R, 2000, INT J PROSTHODONT, V13, P416; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Lunt DR, 2010, DENT TRAUMATOL, V26, P23, DOI 10.1111/j.1600-9657.2009.00848.x; Maeda Masahiko, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P211, DOI 10.2186/jjps.52.211; Maeda Y, 2009, DENT TRAUMATOL, V25, P556, DOI 10.1111/j.1600-9657.2009.00822.x; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Ozcelik TB, 2011, J PROSTHODONT, V20, P16, DOI 10.1111/j.1532-849X.2010.00654.x; PARK JB, 1994, J PROSTHET DENT, V72, P373, DOI 10.1016/0022-3913(94)90556-8; Pjetursson BE, 2008, J ORAL REHABIL, V35, P72, DOI 10.1111/j.1365-2842.2007.01824.x; Takeda T, 2011, DENT TRAUMATOL, V27, P489, DOI 10.1111/j.1600-9657.2011.01029.x; Tiwari U, 2011, DENT TRAUMATOL, V27, P263, DOI 10.1111/j.1600-9657.2011.00998.x; Westerman B, 2002, BRIT J SPORT MED, V36, P51, DOI 10.1136/bjsm.36.1.51; Westerman B, 2002, DENT TRAUMATOL, V18, P24, DOI 10.1034/j.1600-9657.2002.180103.x; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x	26	7	7	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469			DENT TRAUMATOL	Dent. Traumatol.	AUG	2013	29	4					303	306		10.1111/j.1600-9657.2012.01171.x			4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	178GO	WOS:000321433900008	22853626				2022-02-06	
J	Silverberg, ND; Hanks, RA; Tompkins, SC				Silverberg, Noah D.; Hanks, Robin A.; Tompkins, Season C.			Education Quality, Reading Recognition, and Racial Differences in the Neuropsychological Outcome from Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						traumatic brain injury; premorbid functioning; racial differences; neuropsychological testing; psychometrics	AFRICAN-AMERICAN ACCULTURATION; TEST-PERFORMANCE; PREMORBID INTELLIGENCE; INTERPRETIVE METHOD; HALSTEAD-REITAN; SCREENING-TEST; LEVEL; ABILITY; IMPAIRMENT; BATTERY	Ethnically diverse examinees tend to perform lower on neuropsychological tests. The practice of adjusting normative comparisons for the education level and/or race to prevent overpathologizing low scores is problematic. Education quality, as measured by reading recognition, appears to be a more accurate benchmark for premorbid functioning in certain populations. The present study aimed to extend this line of research to traumatic brain injury (TBI). We hypothesized that a measure of reading recognition, the Wechsler Test of Adult Reading (WTAR), would account for racial differences in neuropsychological performance after TBI. Fifty participants (72% African American, 28% Caucasian) with moderate to severe TBI underwent neuropsychological testing at 1-year post-injury. Reading recognition accounted for all the same variance in neuropsychological performance as race and education (together), as well as considerable additional variance. Estimation of premorbid functioning in African Americans with TBI could be refined by considering reading recognition.	[Silverberg, Noah D.] GF Strong Rehab Ctr, Vancouver, BC V5Z 2G9, Canada; [Silverberg, Noah D.] Univ British Columbia, Dept Med, Dept Phys Med & Rehabil, Vancouver, BC, Canada; [Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Tompkins, Season C.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada		Silverberg, ND (corresponding author), GF Strong Rehab Ctr, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca			National Institute on Disability and Rehabilitation Research [H133A080044]; Vancouver Coastal Health Research Institute	This work was supported by the National Institute on Disability and Rehabilitation Research (H133A080044) and Vancouver Coastal Health Research Institute.	Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Byrd DA, 2005, J CLIN EXP NEUROPSYC, V27, P1056, DOI 10.1080/13803390490919353; Byrd DA, 2004, J INT NEUROPSYCH SOC, V10, P401, DOI 10.1017/S1355617704103081; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; Delis D.C., 2000, CALIFORNIA VERBAL LE; Derogatis L.R, 2001, BRIEF SYMPTOM INVENT, V18; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hardin JW, 2007, GEN LINEAR MODEL EXT; Heaton R. K., 2004, REVISED COMPREHENSIV; Kaplan JB, 2003, JAMA-J AM MED ASSOC, V289, P2709, DOI 10.1001/jama.289.20.2709; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P813, DOI 10.1080/13854040701625846; Lewis R, 1979, MANUAL REPEATABLE CO; Manly JJ, 2007, ARCH CLIN NEUROPSYCH, V22, P319, DOI 10.1016/j.acn.2007.01.006; Manly JJ, 2006, MED CARE, V44, pS10, DOI 10.1097/01.mlr.0000245427.22788.be; Manly JJ, 1998, J INT NEUROPSYCH SOC, V4, P291, DOI 10.1017/S1355617798002914; Manly JJ, 1998, NEUROLOGY, V50, P1238, DOI 10.1212/WNL.50.5.1238; Manly JJ, 2005, CLIN NEUROPSYCHOL, V19, P270, DOI 10.1080/13854040590945346; Manly JJ, 2004, APPL NEUROPSYCHOL, V11, P37, DOI 10.1207/s15324826an1101_5; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; Nabors NA, 2000, CRIT ISS NE, P31; Norman MA, 2000, J CLIN EXP NEUROPSYC, V22, P80, DOI 10.1076/1380-3395(200002)22:1;1-8;FT080; Orme DR, 2004, REHABIL PSYCHOL, V49, P250, DOI 10.1037/0090-5550.49.3.250; Reitan R, 1985, HALSTEAD REITAN NEUR; Rohit M, 2007, J INT NEUROPSYCH SOC, V13, P462, DOI 10.1017/S1355617707070506; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P531, DOI 10.1076/clin.17.4.531.27938; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Ryan EL, 2005, J INT NEUROPSYCH SOC, V11, P889, DOI 10.1017/S1355617705051040; Schneider BC, 2011, ARCH CLIN NEUROPSYCH, V26, P624, DOI 10.1093/arclin/acr062; Schretlen DJ, 2005, J INT NEUROPSYCH SOC, V11, P784, DOI 10.1017/S1355617705050939; Schwartz BS, 2004, ENVIRON HEALTH PERSP, V112, P314, DOI 10.1289/ehp.6727; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Testa SM, 2009, J INT NEUROPSYCH SOC, V15, P1012, DOI 10.1017/S1355617709990713; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vanderploeg RD, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P27; WechslerD, 2001, WECHSLER TEST ADULT; Welsh KA, 1995, NEUROLOGY, V45, P2207, DOI 10.1212/WNL.45.12.2207	47	7	7	0	16	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2013	28	5					485	491		10.1093/arclin/act023			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	186CN	WOS:000322019600010	23858087	Bronze, Green Published			2022-02-06	
J	Vieira, RDA; Hora, EC; de Oliveira, DV; Ribeiro, MDD; de Sousa, RMC				Almeida Vieira, Rita de Cassia; Hora, Edilene Curvelo; de Oliveira, Daniel Vieira; de Oliveira Ribeiro, Maria do Carmo; Cardoso de Sousa, Regina Marcia			Quality of life of victims of traumatic brain injury six months after the trauma	REVISTA LATINO-AMERICANA DE ENFERMAGEM			English	Article						Quality of Life; Brain injuries; Trauma Severity Indices; Wounds and Injury		Objective: to describe the quality of life of victims of traumatic brain injury six months after the event and to show the relationship between the results observed and the clinical, sociodemographic and return to productivity data. Method: data were analyzed from 47 victims assisted in a trauma reference hospital in the municipality of Aracaju and monitored in an outpatient neurosurgery clinic. The data were obtained through analysis of the patient records and structured interviews, with the application of the World Health Organization Quality of Life, brief version, questionnaire. Results: the victims presented positive perceptions of their quality of life, and the physical domain presented the highest mean value (68.4 +/- 22.9). Among the sociodemographic characteristics, a statistically significant correlation was found between marital status and the psychological domain. However, the return to productivity was related to all the domains. Conclusion: the return to productivity was an important factor for the quality of life of the victims of traumatic brain injury and should direct the public policies in promoting the health of these victims.	[Almeida Vieira, Rita de Cassia; Cardoso de Sousa, Regina Marcia] Univ Sao Paulo, Escola Enfermagem, BR-05403000 Sao Paulo, Brazil; [Hora, Edilene Curvelo; de Oliveira Ribeiro, Maria do Carmo] Univ Fed Sergipe, Dept Enfermagem, Aracaju, SE, Brazil; [de Oliveira, Daniel Vieira] Hosp Sao Matheus, Sao Paulo, Brazil		Vieira, RDA (corresponding author), Univ Sao Paulo, Escola Enfermagem, Bairro Cerqueira Cesar, Av Dr Eneas de Carvalho Aguiar 419, BR-05403000 Sao Paulo, Brazil.	ritavieira@usp.br	de Oliveira, Daniel Vieira/AAH-1071-2019; Sousa, Regina M/H-1108-2012; Almeida Vieira, Rita de Cassia/E-3262-2013	de Oliveira, Daniel Vieira/0000-0002-6768-3286; Sousa, Regina M/0000-0002-2575-7937; Almeida Vieira, Rita de Cassia/0000-0002-7981-9822; Vieira, Rita de Cassia/0000-0001-9210-4445			Alves ALA, 2009, REV SAUDE PUBL, V43, P154, DOI 10.1590/S0034-89102009000100020; Association for the Advancement of Automotive Medicine (AAAM), 2008, ABBR INJ SCAL AIS 20; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Cruz LN, 2011, QUAL LIFE RES, V20, P1123, DOI 10.1007/s11136-011-9845-3; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Hora Edilene Curvelo, 2005, Rev. Latino-Am. Enfermagem, V13, P93; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Ministerio da Saude. DATASUS, 2008, INF SAUD; Nogueira LD, 2008, REV LAT-AM ENFERM, V16, P314, DOI 10.1590/S0104-11692008000200022; Orley J., 1994, QUALITY LIFE ASSESSM, P41, DOI [10.1007/978-3-642-79123-9_4, DOI 10.1007/978-3-642-79123-9_4]; Pereira CU, 2006, ARQ BRAS NEUROCIR, V25, P8; Serna Edilene Curvelo Hora, 2006, Rev. Latino-Am. Enfermagem, V14, P183; Silva Cleuza Braga da, 2009, Fisioter. Pesqui., V16, P311; Silva Cleuza Braga da, 2008, Fisioter. Pesqui., V15, P6; Sousa RMC, 1996, REV ESC ENF USP, V30, P484, DOI DOI 10.1590/S0080-62341996000300010; Sousa RMC, 2006, REV ESC ENFERM USP, V40, P203, DOI DOI 10.1590/S0080-62342006000200008; Toien K, 2010, J TRAUMA, V69, P1552, DOI 10.1097/TA.0b013e3181e125f3; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165	21	7	9	1	7	UNIV SAO PAULO, ESCOLA DE ENFERMAGEM DE RIBEIRAO PRETO	RIBEIRAO PRETO	AV BANDEIRANTES, 3900, RIBEIRAO PRETO, SP 14040-902  A, BRAZIL	1518-8345			REV LAT-AM ENFERM	Rev. Latino-Am. Enfermagem	JUL-AUG	2013	21	4					868	875					8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	196VD	WOS:000322804600006	23970222	gold			2022-02-06	
J	Alves-de-Moraes, LBDE; Ribeiro-Paes, JT; Longo, BM; Ferrazoli, EG; de Andrade, TGCS				da Cruz e Alves-de-Moraes, Luis Bruno; Ribeiro-Paes, Joao Tadeu; Longo, Beatriz Monteiro; Ferrazoli, Eneas Galdini; Carneiro Spera de Andrade, Telma Goncalves			Effect of the bone marrow cell transplantation on elevated plus-maze performance in hippocampal-injured mice	BEHAVIOURAL BRAIN RESEARCH			English	Article						Hippocampus; Electrolytic lesion; Anxiety; Elevated plus-maze; Cell therapy; Bone marrow cells	MESENCHYMAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ENTORHINAL CORTEX LESION; MEDIAN RAPHE NUCLEUS; STROMAL CELLS; FUNCTIONAL RECOVERY; MONONUCLEAR-CELLS; ADULT MICE	Several reports have shown that the hippocampus plays an important role in different aspects of the emotional control. There is evidence that lesions in this structure cause behavioral disinhibition, with reduction of reactions expressing fear and anxiety. Thus, to portray the aptitude of cell therapy to abrogate injuries of hippocampal tissue, we examined the behavioral effects of bone marrow mononuclear cells (BMMCs) transplantation on C57BL/6 mice that had the hippocampus damaged by electrolytic lesion. For this purpose, mice received, seven days after bilateral electrolytic lesion in the dorsal hippocampus, culture medium or BMMCs expressing the enhanced green fluorescent protein (EGFP) transgene. One week after transplantation, animals were tested in the elevated plus-maze (EPM). On the whole, three assessment sessions in the EPM were carried out, with seven days separating each trial. Thirty-five days after the induction of injury, mice were sacrificed and their brains removed for immunohistochemistry. The behavioral evaluation showed that the hippocampal lesion caused disinhibition, an effect which was slightly lessened, from the second EPM test, in transplanted subjects. On the other hand, immunohistochemical data revealed an insignificant presence of EGFP(+) cells inside the brains of injured mice. In view of such scenario, we hypothesized that the subtle rehabilitation of the altered behavior might be a result from a paracrine effect from the transplanted cells. This might have been caused by the release of bioactive factors capable of boosting endogenous recuperative mechanisms for a partial regaining of the hippocampal functions. (c) 2013 Elsevier B.V. All rights reserved.	[da Cruz e Alves-de-Moraes, Luis Bruno] USP IPT I Butantan, BR-05508900 Sao Paulo, Brazil; [Ribeiro-Paes, Joao Tadeu; Carneiro Spera de Andrade, Telma Goncalves] UNESP Univ Estadual Paulista, FCL, Dept Biol Sci, BR-19806900 Assis, SP, Brazil; [Longo, Beatriz Monteiro; Ferrazoli, Eneas Galdini] Univ Fed Sao Paulo, Dept Physiol, ECB, BR-04023062 Sao Paulo, Brazil		de Andrade, TGCS (corresponding author), UNESP Univ Estadual Paulista, FCL, Dept Biol Sci, Ave Dom Antonio 2100, BR-19806900 Assis, SP, Brazil.	raica@assis.unesp.br	Ribeiro-Paes, Joao Tadeu/AAB-8937-2021; Andrade, Telma G.C.S./H-2649-2012; Alves-de-Moraes, Luis Bruno/P-2624-2016; Ribeiro-Paes, Joao Tadeu/E-9616-2015	Ribeiro-Paes, Joao Tadeu/0000-0002-7645-5891; Andrade, Telma G.C.S./0000-0002-7918-8776; Ribeiro-Paes, Joao Tadeu/0000-0002-7645-5891	Coordination of Improvement of Higher Education Personnel (CAPES, Brazil) through the Post-Graduation in Biotechnology (USP/IPT/I.Butantan)	LBC Alves-de-Moraes was financially supported by the Coordination of Improvement of Higher Education Personnel (CAPES, Brazil) through the Post-Graduation in Biotechnology (USP/IPT/I.Butantan) institutional grant program.	Abrams MB, 2009, RESTOR NEUROL NEUROS, V27, P307, DOI 10.3233/RNN-2009-0480; Amaral D., 2007, HIPPOCAMPUS BOOK; Andrade T G, 1999, Acta Physiol Pharmacol Ther Latinoam, V49, P279; Andrade T. G. C. S., 2000, Journal of Psychopharmacology, V14, pA38; Andrade TGCS, 2001, PHARMACOL BIOCHEM BE, V70, P1, DOI 10.1016/S0091-3057(01)00512-3; Andrade TGCS, 2004, BEHAV BRAIN RES, V153, P55, DOI 10.1016/j.bbr.2003.10.036; Andrews EM, 2008, EXP NEUROL, V211, P588, DOI 10.1016/j.expneurol.2008.02.027; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bai LH, 2007, NEUROCHEM RES, V32, P353, DOI 10.1007/s11064-006-9212-x; Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chiba Y, 2010, NEUROPATHOLOGY, V30, P241, DOI 10.1111/j.1440-1789.2009.01077.x; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Corti S, 2004, BRAIN, V127, P2518, DOI 10.1093/brain/awh273; Csernansky JG, 1998, SCHIZOPHRENIA BULL, V24, P231, DOI 10.1093/oxfordjournals.schbul.a033323; Del Turco D, 2003, HIPPOCAMPUS, V13, P685, DOI 10.1002/hipo.10118; Deller T, 1997, PROG NEUROBIOL, V53, P687, DOI 10.1016/S0301-0082(97)00044-0; ECCLES JC, 1976, NATURWISSENSCHAFTEN, V63, P8, DOI 10.1007/BF00768675; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Good M, 1997, BEHAV NEUROSCI, V111, P487, DOI 10.1037/0735-7044.111.3.487; Gray JA., 2000, NEUROPSYCHOLOGY ANXI; Hellmann MA, 2006, NEUROSCI LETT, V395, P124, DOI 10.1016/j.neulet.2005.10.097; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Hokari M, 2008, J NEUROSCI RES, V86, P1024, DOI 10.1002/jnr.21572; Holmes A, 1998, PHARMACOL BIOCHEM BE, V60, P473, DOI 10.1016/S0091-3057(98)00008-2; Kadish I, 2003, NEUROSCIENCE, V116, P499, DOI 10.1016/S0306-4522(02)00718-2; Kamiya N, 2008, LIFE SCI, V83, P433, DOI 10.1016/j.lfs.2008.07.018; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Levy YS, 2008, CYTOTHERAPY, V10, P340, DOI 10.1080/14653240802021330; Li TF, 2009, EPILEPSY RES, V84, P238, DOI 10.1016/j.eplepsyres.2009.01.002; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Liberato JL, 2006, BRAIN RES, V1124, P19, DOI 10.1016/j.brainres.2006.09.052; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Maren S, 1997, NEUROBIOL LEARN MEM, V67, P142, DOI 10.1006/nlme.1996.3752; Morris R, 2007, HIPPOCAMPUS BOOK, P581, DOI [10.1093/acprof:oso/9780195100273.003.0013, DOI 10.1093/ACPROF:OSO/9780195100273.003.0013]; NADEL L, 1968, PHYSIOL BEHAV, V3, P891, DOI 10.1016/0031-9384(68)90174-1; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Rasmusson I, 2005, EXP CELL RES, V305, P33, DOI 10.1016/j.yexcr.2004.12.013; Reid IC, 1997, SEIZURE, V6, P351, DOI 10.1016/S1059-1311(97)80034-9; Rezayat M, 2005, PHYSIOL BEHAV, V84, P775, DOI 10.1016/j.physbeh.2005.03.002; Rodgers RJ, 1996, PHARMACOL BIOCHEM BE, V54, P41, DOI 10.1016/0091-3057(95)02156-6; Roy V, 2009, PSYCHOPHARMACOLOGY, V203, P131, DOI 10.1007/s00213-008-1378-2; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sattler C, 2011, CELL TRANSPLANT, V20, P1221, DOI 10.3727/096368910X546553; Shichinohe H, 2010, NEUROPATHOLOGY, V30, P113, DOI 10.1111/j.1440-1789.2009.01050.x; SIMONIAN NA, 1995, NEUROBIOL AGING, V16, P305, DOI 10.1016/0197-4580(95)00034-C; Sosa MAG, 2004, NEUROSCIENCE, V127, P881, DOI 10.1016/j.neuroscience.2004.05.058; Squire LR, 1996, HIPPOCAMPUS, V6, P546; Stark C., 2007, HIPPOCAMPUS BOOK, P549; STEWARD O, 1977, BRAIN RES BULL, V2, P41, DOI 10.1016/0361-9230(77)90023-5; STEWARD O, 1973, EXP BRAIN RES, V18, P396, DOI 10.1007/BF00239108; Venturin GT, 2011, LIFE SCI, V89, P229, DOI 10.1016/j.lfs.2011.06.006; Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016; Walker M., 2007, HIPPOCAMPUS BOOK, P769; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wu QY, 2007, NEUROSCI LETT, V417, P281, DOI 10.1016/j.neulet.2007.02.092; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	75	7	8	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUL 1	2013	248						32	40		10.1016/j.bbr.2013.03.042			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	165QF	WOS:000320497700005	23578758				2022-02-06	
J	Le Roux, PD; Oddo, M				Le Roux, Peter D.; Oddo, Mauro			Parenchymal Brain Oxygen Monitoring in the Neurocritical Care Unit	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Brain monitoring; Brain oxygen; Clark electrode; Hypoxia; Neurocritical care; Optical fluorescence; Traumatic brain injury; Subarachnoid hemorrhage	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; TISSUE OXYGEN; INTRACRANIAL-PRESSURE; BLOOD-FLOW; CEREBROVASCULAR AUTOREGULATION; CARBON-DIOXIDE; REGIONAL OXYGENATION; INDUCED NORMOTHERMIA	Patients admitted to the neurocritical care unit (NCCU) often have serious conditions that can be associated with high morbidity and mortality. Pharmacologic agents or neuroprotectants have disappointed in the clinical environment. Current NCCU management therefore is directed toward identification, prevention, and treatment of secondary cerebral insults that evolve over time and are known to aggravate outcome. This strategy is based on a variety of monitoring techniques including use of intraparenchymal monitors. This article reviews parenchymal brain oxygen monitors, including the available technologies, practical aspects of use, the physiologic rationale behind their use, and patient management based on brain oxygen.	[Le Roux, Peter D.] Lankenau Med Ctr, Brain & Spine Ctr, Wynnewood, PA 19096 USA; [Oddo, Mauro] CHU Vaudois, Serv Med Intens Adulte, Med Surg ICU, CH-1011 Lausanne, Switzerland		Le Roux, PD (corresponding author), Lankenau Med Ctr, Brain & Spine Ctr, 100 E Lancaster Ave, Wynnewood, PA 19096 USA.	lerouxp@mlhs.org	Oddo, Mauro/R-3370-2016	Oddo, Mauro/0000-0002-6155-2525			Adamides AA, 2009, J AM COLL SURGEONS, V209, P531, DOI 10.1016/j.jamcollsurg.2009.05.028; Ang BT, 2007, J NEUROL NEUROSUR PS, V78, P298, DOI 10.1136/jnnp.2005.082735; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; ASTRUP J, 1981, STROKE, V12, P726, DOI 10.1161/01.STR.12.6.726; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bailey RL, 2011, NEUR CAR SOC M MONTR; Bardt TF, 1998, ACT NEUR S, V71, P153; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bohman LE, 2011, NEUROCRIT CARE, V14, P361, DOI 10.1007/s12028-011-9526-7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Chen HI, 2008, NEUROSURGERY, V63, P880, DOI 10.1227/01.NEU.0000327882.10629.06; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clausen T, 2004, BRAIN RES, V1019, P113, DOI 10.1016/j.brainres.2004.05.099; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dengler J, 2011, INTENS CARE MED, V37, P1809, DOI 10.1007/s00134-011-2316-z; Diringer MN, 2008, CURR OPIN CRIT CARE, V14, P167, DOI 10.1097/MCC.0b013e3282f57552; Dohmen C, 2007, STROKE, V38, P56, DOI 10.1161/01.STR.0000251642.18522.b6; Doppenberg EMR, 1998, ACT NEUR S, V71, P166; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2641, DOI 10.1097/CCM.0b013e3181847af3; Ekelund A, 2002, ACTA NEUROCHIR, V144, P703, DOI 10.1007/s00701-002-0959-9; Eriksson EA, 2012, CLIN NEUROPHYSIOL, V123, P1255, DOI 10.1016/j.clinph.2011.08.035; Figaji AA, 2010, PEDIATR CRIT CARE ME, V11, P325, DOI 10.1097/PCC.0b013e3181b80a8e; Figaji AA, 2009, CHILD NERV SYST, V25, P1335, DOI 10.1007/s00381-009-0821-y; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Fletcher JJ, 2010, NEUROCRIT CARE, V13, P47, DOI 10.1007/s12028-010-9345-2; Gelabert-Gonzalez M, 2002, ACTA NEUROCHIR, V144, P863, DOI 10.1007/s00701-002-0975-9; Gopinath SP, 1999, NEUROSURGERY, V44, P1273, DOI 10.1097/00006123-199906000-00066; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; Gracias VH, 2004, J TRAUMA, V56, P469, DOI 10.1097/01.TA.0000114274.95423.C0; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Hoffman WE, 1997, BRIT J ANAESTH, V78, P169, DOI 10.1093/bja/78.2.169; Hoffman WE, 2000, NEUROL RES, V22, P620; Hoffman WE, 2000, ANESTH ANALG, V91, P637, DOI 10.1213/00000539-200009000-00026; Hoffman WE, 1996, ANESTH ANALG, V82, P582, DOI 10.1097/00000539-199603000-00027; Jaeger M, 2005, ACTA NEUROCHIR SUPPL, V95, P79; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Johnston AJ, 2003, BRIT J ANAESTH, V91, P781, DOI 10.1093/bja/aeg256; Kett-White R, 2002, J NEUROSURG, V96, P1013, DOI 10.3171/jns.2002.96.6.1013; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Le Roux PD, 2011, NEUROCRIT CARE, V15, P342, DOI 10.1007/s12028-011-9582-z; Ledwith MB, 2010, J NEUROSCI NURS, V42, P280, DOI 10.1097/JNN.0b013e3181ecafd4; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Longhi L, 2002, ACT NEUR S, V81, P315; Longhi L, 2007, INTENS CARE MED, V33, P2136, DOI 10.1007/s00134-007-0845-2; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maloney-Wilensky E, 2010, CHILD NERV SYST, V26, P419, DOI 10.1007/s00381-009-1037-x; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Meixensberger J, 2004, NEUROL RES, V26, P414, DOI 10.1179/016164104225014094; Meixensberger J, 2003, NEUROL RES, V25, P445, DOI 10.1179/016164103101201823; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Muench E, 2007, CRIT CARE MED, V35, P1844, DOI 10.1097/01.CCM.0000275392.08410.DD; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; O'Brien D, 2010, NAT NEUR ANN M LAS V; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Oddo M, 2009, EVIDENCED BASED PRAC, P399; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Oddo M, 2010, NEUROCRIT CARE, V12, P10, DOI 10.1007/s12028-009-9280-2; Oddo M, 2009, STROKE, V40, P1913, DOI 10.1161/STROKEAHA.108.534115; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Orakcioglu B, 2010, NEUROSURGERY, V67, P1716, DOI 10.1227/NEU.0b013e3181f9bb5b; Pascual JL, 2011, J TRAUMA, V70, P535, DOI 10.1097/TA.0b013e31820b59de; Pennings FA, 2003, J NEUROSURG ANESTH, V15, P1, DOI 10.1097/00008506-200301000-00001; Pennings FA, 2008, J NEUROTRAUM, V25, P1173, DOI 10.1089/neu.2007.0402; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Ramakrishna R, 2008, J NEUROSURG, V109, P1075, DOI 10.3171/JNS.2008.109.12.1075; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Rohlwink UK, 2012, NEUROSURGERY, V70, P1220, DOI 10.1227/NEU.0b013e318243fc59; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rosenthal G, 2008, J NEUROSURG, V108, P59, DOI 10.3171/JNS/2008/108/01/0059; Sakowitz OW, 2007, J TRAUMA, V62, P292, DOI 10.1097/01.ta.0000203560.03937.2d; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; Sarrafzadeh AS, 2003, BRIT J NEUROSURG, V17, P340, DOI 10.1080/02688690310001601234; Scheufler KM, 2004, J NEUROSURG ANESTH, V16, P210, DOI 10.1097/00008506-200407000-00005; Scheufler KM, 2002, ANESTH ANALG, V95, P1042, DOI 10.1097/00000539-200210000-00046; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Siegemund M, 1999, INTENS CARE MED, V25, P1044, DOI 10.1007/s001340051011; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Soehle M, 2003, NEUROL RES, V25, P411, DOI 10.1179/016164103101201580; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stewart C, 2008, NEUROSURGERY, V63, P1159, DOI 10.1227/01.NEU.0000333265.19131.7C; Stiefel MF, 2006, NEUROCRIT CARE, V4, P113, DOI 10.1385/NCC:4:2:113; Stiefel MF, 2004, J NEUROSURG, V101, P594, DOI 10.3171/jns.2004.101.4.0594; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stocchetti N, 1998, ACT NEUR S, V71, P162; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; Swanson EW, 2010, NEUROSURGERY, V66, P925, DOI 10.1227/01.NEU.0000368543.59446.A4; Thorat JD, 2008, J CLIN NEUROSCI, V15, P143, DOI 10.1016/j.jocn.2006.08.014; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	122	7	7	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	2013	24	3					427	+		10.1016/j.nec.2013.03.001			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	191NY	WOS:000322421100011	23809036				2022-02-06	
J	Mezue, WC; Ndubuisi, C; Ohaegbulam, SC; Chikani, M; Erechukwu, U				Mezue, W. C.; Ndubuisi, C.; Ohaegbulam, S. C.; Chikani, M.; Erechukwu, U.			Cranial bony decompressions in the management of head injuries: Decompressive craniotomy or craniectomy	NIGERIAN JOURNAL OF CLINICAL PRACTICE			English	Article						Craniectomy; craniotomy; trauma flap; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HYPERTENSION; SURGERY	Objective: Decompressive surgery is one of the available options in dealing with traumatic brain injury (TBI) when clinical and radiological evidence confirm that medical treatment may be insufficient. This can be achieved either by complete removal of the bone or by allowing it to float, but the indications and utility of these are yet to be resolved. This study examines the indications and outcome for both procedures. Materials and Methods: Review of all cases of bony decompression done at the Memfys Hospital for Neurosurgery, Enugu, Nigeria from August 2002 to May 2010. Prospectively recorded data of CT, MRI, operating room, clinics and wards were utilized. Results: There were 38 patients out of whom 35 were males and 3 females. The mean age was 36 years (range 15-80). The causes of the predisposing TBI were road traffic accidents (RTA) (79%), gunshot (10.5%), and assault (7.9%). Decompressive surgery was unilateral in 36 and bi-frontal in 2. Decompressive craniectomy with bone stored in anterior abdominal wall pocket was done in 8 patients and decompressive craniotomy with bone left in situ in 30. Of the latter, bone was unsecured and allowed to float in 13 and the craniotomy was lightly anchored with sutures in 17 patients. Surgery was performed within 24 h in 68.4% of cases. Mortality was 21.1% overall but was up to 25% in the more severely injured patients who had craniectomy. Conclusion: Bony decompression is useful in the management of head trauma. Careful selection of cases and appropriate radiological assessment are important and will guide decision for either craniotomy or craniectomy.	[Mezue, W. C.; Chikani, M.] Univ Nigeria, Teaching Hosp, Dept Surg, Neurosurg Unit, Enugu, Nigeria; [Ndubuisi, C.; Ohaegbulam, S. C.; Erechukwu, U.] Memfys Hosp Neurosurg, Enugu, Nigeria		Mezue, WC (corresponding author), Univ Nigeria, Teaching Hosp, PMB 01129, Enugu, Nigeria.	mezuec@hotmail.com					Adeleye AO, 2010, INDIAN J NEUROTRAUM, V7, P41, DOI 10.1016/S0973-0508(10)80010-3; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson Peter, 1800, Neurosurg Focus, V22, pE14; Hutchinson PJ, 2011, BRIT J NEUROSURG, V25, P441, DOI 10.3109/02688697.2011.583366; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Mezue WC, 2012, PORT HARCOURT MED J, V6, P204; Michel P, 2009, INT J STROKE, V4, P218, DOI 10.1111/j.1747-4949.2009.00283.x; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rosenfeld JV, 2006, NEUROSURGERY, V59, P467, DOI 10.1227/00006123-200608000-00080; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Valadka AB, 2007, NEUROSURGERY, V61, P203, DOI 10.1227/01.NEU.0000255497.26440.01; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E	19	7	8	0	3	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1119-3077			NIGER J CLIN PRACT	Niger. J. Clin. Pract.	JUL-SEP	2013	16	3					343	347		10.4103/1119-3077.113459			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	190YC	WOS:000322378500015	23771458				2022-02-06	
J	Newman, JB; Reesman, JH; Vaughan, CG; Gioia, GA				Newman, Julie B.; Reesman, Jennifer H.; Vaughan, Christopher G.; Gioia, Gerard A.			Assessment of Processing Speed in Children with Mild TBI: A "First Look" at the Validity of Pediatric ImPACT	CLINICAL NEUROPSYCHOLOGIST			English	Article						Concussion; Traumatic brain injury; Child; Cognitive; Neuropsychological	COMPUTER-BASED ASSESSMENT; TRAUMATIC BRAIN-INJURY; CROSS-VALIDATION; CONCUSSION; PERFORMANCE; MANAGEMENT	Deficit in the speed of cognitive processing is a commonly identified neuropsychological change in children recovering from a mild TBI. However, there are few validated child assessment instruments that allow for serial assessment over the course of recovery in this population. Pediatric ImPACT is a novel measure that purports to assess cognitive speed, learning, and efficiency in this population. The current study sought to validate the use of this new measure by comparing it to traditional paper and pencil measures of processing speed. Method: One hundred and sixty-four children (71% male) age 5-12 with mild TBI evaluated in an outpatient concussion clinic were administered Pediatric ImPACT and other neuropsychological test measures as part of a flexible test battery. Results: Performance on the Response Speed Composite of Pediatric ImPACT was more strongly associated with other measures of cognitive processing speed, than with measures of immediate/working memory and learning/memory in this sample of injured children. Conclusions: There is preliminary support for convergent and discriminant validity of Pediatric ImPACT as a measure for use in post-concussion evaluations of processing speed in children.	[Newman, Julie B.; Vaughan, Christopher G.; Gioia, Gerard A.] Childrens Natl Med Ctr, Rockville, MD 20850 USA; [Newman, Julie B.; Vaughan, Christopher G.; Gioia, Gerard A.] George Washington Univ, Sch Med, Washington, DC USA; [Reesman, Jennifer H.] Kennedy Krieger Inst, Baltimore, MD USA; [Reesman, Jennifer H.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA		Newman, JB (corresponding author), Childrens Natl Med Ctr, Div Pediat Neuropsychol, 15245 Shady Grove Rd, Rockville, MD 20850 USA.	jnewman@childrensnational.org	Meijer, Anna/K-5118-2016	Reesman, Jennifer/0000-0002-0884-3323			Barth JT, 1989, MILD HEAD INJURY, P257; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Broglio SP, 2007, J ATHL TRAINING, V42, P504; CogState, 1999, COGSPORT; Cohen C, 1988, STAT POWER ANAL BEHA; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Gioia G., 2013, BRIT J SPORTS MED, V47; Gioia G. A., 2013, PROFESSIONAL MANUAL; Gioia GA, 2009, TOP LANG DISORD, V29, P266, DOI 10.1097/TLD.0b013e3181b5322b; Iverson G. L., 2003, NAT AC NEUR ANN M; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell M, 2000, IMPACT IMMEDIATE POS; Lovell M. R., 2002, IMPACT BEST APPROACH; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Mather N., 2001, WOODCOCK JOHNSON 3 T; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, MILD TRAUMATIC BRAIN; Paniak C, 1997, CLIN NEUROPSYCHOL, V11, P198, DOI 10.1080/13854049708407051; Randolph C, 2005, J ATHL TRAINING, V40, P139; Riccio CA, 2006, ARCH CLIN NEUROPSYCH, V21, P657, DOI 10.1016/j.acn.2006.05.010; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Skoblar BM, 2004, ARCH CLIN NEUROPSYCH, V19, P886; Smith A., 1991, SYMBOL DIGIT MODALIT; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd, P704; Wechsler D, 2003, WECHSLER INTELLIGENC; Zillmer EA, 2003, APPL NEUROPSYCHOL, V10, P23, DOI 10.1207/S15324826AN1001_4	36	7	7	0	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 1	2013	27	5					779	793		10.1080/13854046.2013.789552			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	170OR	WOS:000320863200003	23597006				2022-02-06	
J	Thompson, GH; Lea, ES; Chin, K; Liu, RW; Son-Hing, JP; Gilmore, A				Thompson, George H.; Lea, Ethan S.; Chin, Kenneth; Liu, Raymond W.; Son-Hing, Jochen P.; Gilmore, Allison			Closed Bone Graft Epiphysiodesis for Avascular Necrosis of the Capital Femoral Epiphysis	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							TRAUMATIC HIP DISLOCATION; TERM-FOLLOW-UP; CORE DECOMPRESSION; RISK-FACTORS; OSTEONECROSIS; HEAD; FRACTURES; CHILDREN; NECK; EXPERIENCE	Avascular necrosis (AVN) of the capital femoral epiphysis (CFE) after an unstable slipped capital femoral epiphysis (SCFE), femoral neck fracture or traumatic hip dislocation can result in severe morbidity. Treatment options for immature patients with AVN are limited, including a closed bone graft epiphysiodesis (CBGE). However, it is unclear whether this procedure prevents AVN progression. We investigated whether early MRI screening and CBGE prevented the development of advanced AVN changes in the CFE and the rates of complications with this approach. We prospectively followed all 13 patients (seven boys, six girls) with unstable SCFEs (six patients), femoral neck fractures (five patients), and traumatic hip dislocations (two patients) and evidence of early AVN treated between 1984 and 2012. Mean age at initial injury was 12 years (range, 10-16 years). Nine of the 13 patients had followup of at least 2 years or until conversion to THA (mean, 4.5 years; range, 0.8-8.5 years), including two with unstable SCFEs, the five with femoral neck fractures, and the two with traumatic hip dislocations. All patients had technetium scans and/or MRI within 1 to 2 months of their initial injury (before CBGE) and all had evidence of early (Ficat 0) AVN. Patients were followed clinically and radiographically for AVN progression. Six of the nine hips did not develop typical clinical or radiographic evidence of AVN. These six patients have been followed 6.3 years (range, 4.3-9.1 years) from initial injury and 5.9 years (range, 3.8-8.5 years) from CBGE. The remaining three patients were diagnosed with AVN at periods ranging from 3 to 6 months after CBGE. Early recognition and treatment of AVN with a CBGE may alter the natural history of this complication. Level IV, therapeutic study. See Instructions for Authors for a complete description of levels of evidence.	[Thompson, George H.; Lea, Ethan S.; Chin, Kenneth; Liu, Raymond W.; Son-Hing, Jochen P.; Gilmore, Allison] Case Western Reserve Univ, Div Pediat Orthopaed, Rainbow Babies & Childrens Hosp, Case Med Ctr, Cleveland, OH 44106 USA		Thompson, GH (corresponding author), Case Western Reserve Univ, Div Pediat Orthopaed, Rainbow Babies & Childrens Hosp, Case Med Ctr, 11100 Euclid Ave, Cleveland, OH 44106 USA.	ght@po.cwru.edu					Adamczyk MJ, 2003, J PEDIATR ORTHOPED, V23, P578, DOI 10.1097/01241398-200309000-00003; BAKSI DP, 1991, J BONE JOINT SURG BR, V73, P241, DOI 10.1302/0301-620X.73B2.2005147; Baksi DP, 2009, INT ORTHOP, V33, P41, DOI 10.1007/s00264-007-0455-1; BARQUET A, 1982, ACTA ORTHOP SCAND, V53, P809, DOI 10.3109/17453678208992298; CANALE ST, 1977, J BONE JOINT SURG AM, V59, P431, DOI 10.2106/00004623-197759040-00001; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ficat R. P, 1980, ISCHEMIA NECROSIS BO, P29; FICAT RP, 1985, J BONE JOINT SURG BR, V67, P3, DOI 10.1302/0301-620X.67B1.3155745; Glueck CJ, 2005, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000157539.67567.03; Gordon JE, 2002, J PEDIATR ORTHOPED, V22, P352, DOI 10.1097/00004694-200205000-00017; Hamilton PR, 1998, J PEDIATR ORTHOPED, V18, P691; Herrera-Soto JA, 2009, J AM ACAD ORTHOP SUR, V17, P15, DOI 10.5435/00124635-200901000-00003; Herrera-Soto JA, 2008, J PEDIATR ORTHOPED, V28, P723, DOI 10.1097/BPO.0b013e318186bda3; Joseph Benjamin, 2011, J Pediatr Orthop, V31, pS152, DOI 10.1097/BPO.0b013e318223b423; Kennedy JG, 2001, J PEDIATR ORTHOPED, V21, P189, DOI 10.1097/00004694-200103000-00011; Kim HKW, 2012, J BONE JOINT SURG AM, V94A, P659, DOI 10.2106/JBJS.J.01834; LAM SF, 1971, J BONE JOINT SURG AM, VA 53, P1165, DOI 10.2106/00004623-197153060-00013; Lieberman JR, 2004, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000150312.53937.6f; Lieberman JR, 2004, CLIN ORTHOP RELAT R, P29; LODER RT, 1993, J BONE JOINT SURG AM, V75A, P1134, DOI 10.2106/00004623-199308000-00002; Maeda S, 2001, J PEDIATR ORTHOPED, V21, P664, DOI 10.1097/00004694-200109000-00021; Maniwa S, 2000, ARCH ORTHOP TRAUM SU, V120, P241, DOI 10.1007/s004020050456; Mehlman CT, 2000, CLIN ORTHOP RELAT R, P68; Mont Michael A, 2006, Instr Course Lect, V55, P167; Moon ES, 2006, J ORTHOP TRAUMA, V20, P323, DOI 10.1097/00005131-200605000-00005; Hung NN, 2012, J PEDIATR ORTHOP B, V21, P542, DOI 10.1097/BPB.0b013e328356371b; OFFIERSKI CM, 1981, J BONE JOINT SURG BR, V63, P194, DOI 10.1302/0301-620X.63B2.7217141; Ramachandran M, 2007, J BONE JOINT SURG AM, V89A, P1727, DOI 10.2106/JBJS.F.00964; Rao SB, 1996, J PEDIATR ORTHOPED, V16, P37, DOI 10.1097/01241398-199601000-00008; Rattey T, 1996, J BONE JOINT SURG AM, V78A, P398, DOI 10.2106/00004623-199603000-00011; Sankar WN, 2010, J PEDIATR ORTHOPED, V30, P544, DOI 10.1097/BPO.0b013e3181e4f372; Schmidt TL, 1996, CLIN ORTHOP RELAT R, P61; Steinberg ME, 2001, CLIN ORTHOP RELAT R, P71; STULBERG BN, 1991, CLIN ORTHOP RELAT R, P140; SWIONTKOWSKI MF, 1986, J TRAUMA, V26, P384, DOI 10.1097/00005373-198604000-00013; Togrul E, 2005, INJURY, V36, P123, DOI 10.1016/j.injury.2004.04.010; Tokmakova KP, 2003, J BONE JOINT SURG AM, V85A, P798, DOI 10.2106/00004623-200305000-00004; TRUETA J, 1957, J BONE JOINT SURG BR, V39, P358, DOI 10.1302/0301-620X.39B2.358; Urbaniak J R, 1998, J Am Acad Orthop Surg, V6, P44; URBANIAK JR, 1995, J BONE JOINT SURG AM, V77A, P681, DOI 10.2106/00004623-199505000-00004; Vialle R, 2005, J PEDIATR ORTHOPED, V25, P138, DOI 10.1097/01.bpo.0000151059.85227.ea; WARD WT, 1990, J PEDIATR ORTHOPED, V10, P14; WEINER DS, 1984, J PEDIATR ORTHOPED, V4, P145, DOI 10.1097/01241398-198403000-00001	43	7	9	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JUL	2013	471	7					2199	2205		10.1007/s11999-013-2819-8			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	159SY	WOS:000320067400023	23389802	Green Published			2022-02-06	
J	von Holst, H; Li, XG				von Holst, Hans; Li, Xiaogai			Numerical Impact Simulation of Gradually Increased Kinetic Energy Transfer Has the Potential To Break Up Folded Protein Structures Resulting in Cytotoxic Brain Tissue Edema	JOURNAL OF NEUROTRAUMA			English	Article						cytotoxic brain edema; traumatic brain injury; finite element modeling; kinetic energy; protein folding/unfolding; traumatic brain injury	PRESSURE; AQUAPORIN-4; INJURY; TRAUMA; HEAD	Although the consequences of traumatic brain injury (TBI) and its treatment have been improved, there is still a substantial lack of understanding the mechanisms. Numerical simulation of the impact can throw further lights on site and mechanism of action. A finite element model of the human head and brain tissue was used to simulate TBI. The consequences of gradually increased kinetic energy transfer was analyzed by evaluating the impact intracranial pressure (ICP), strain level, and their potential influences on binding forces in folded protein structures. The gradually increased kinetic energy was found to have the potential to break apart bonds of Van der Waals in all impacts and hydrogen bonds at simulated impacts from 6 m/s and higher, thereby superseding the energy in folded protein structures. Further, impacts below 6 m/s showed none or very slight increase in impact ICP and strain levels, whereas impacts of 6 m/s or higher showed a gradual increase of the impact ICP and strain levels reaching over 1000 KPa and over 30%, respectively. The present simulation study shows that the free kinetic energy transfer, impact ICP, and strain levels all have the potential to initiate cytotoxic brain tissue edema by unfolding protein structures. The definition of mild, moderate, and severe TBI should thus be looked upon as the same condition and separated only by a gradual severity of impact.	[von Holst, Hans] Karolinska Inst, Div Clin Neurosci, Neurosurg Sect, Stockholm, Sweden; [von Holst, Hans; Li, Xiaogai] Royal Inst Technol KTH, Sch Technol & Hlth, Div Neuron Engn, Stockholm, Sweden		von Holst, H (corresponding author), Karolinska Univ Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden.	hans.vonholst@karolinska.se		Li, Xiaogai/0000-0001-8522-4705	KTH (Stockholm, Sweden)	The present study was supported by research funds from the KTH (Stockholm, Sweden).	Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104; Belytschko T., 2000, NONLINEAR FINITE ELE, V26; Berg J.M, 2002, BIOCHEMISTRY-US; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; CHRYSSOMALLIS GS, 1981, BIOCHEMISTRY-US, V20, P3955, DOI 10.1021/bi00517a002; CLERY C, 1995, FEBS LETT, V370, P212, DOI 10.1016/0014-5793(95)00787-A; Fahlstedt M., 2012, 2012 IRCOBI C P INT, P787, DOI DOI 10.1177/1753193412460139; Feigin V. L., 2007, HDB CLIN NEUROEPIDEM, P197; Hillson N, 1999, P NATL ACAD SCI USA, V96, P14848, DOI 10.1073/pnas.96.26.14848; Ho J., 2009, GENERATION PATIENT S; Hummer G, 1998, P NATL ACAD SCI USA, V95, P1552, DOI 10.1073/pnas.95.4.1552; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Jha SK, 2009, P NATL ACAD SCI USA, V106, P12289, DOI 10.1073/pnas.0905744106; Jha SK, 2009, P NATL ACAD SCI USA, V106, P11113, DOI 10.1073/pnas.0812564106; Kleiven, 2002, FINITE ELEMENT MODEL; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Li XG, 2011, ACTA NEUROCHIR, V153, P2057, DOI 10.1007/s00701-011-1078-2; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Mcllwain H., 1985, BIOCH CENTRAL NERVOU; Narayan R.K., 1995, NEUROTRAUMA; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Royer CA, 2002, BBA-PROTEIN STRUCT M, V1595, P201, DOI 10.1016/S0167-4838(01)00344-2; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.pc.44.100193.000513; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018	31	7	7	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	13					1192	1199		10.1089/neu.2012.2730			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	174WB	WOS:000321186400010	23384662				2022-02-06	
J	Bernal, EF; Gil, FJR; Corral, JCM; Prieto, LAM; Robledo, JG				Frutos Bernal, E.; Rubio Gil, F. J.; Martin Corral, J. C.; Marcos Prieto, L. A.; Robledo, J. Gonzalez			Prognostic factors in severe traumatic brain injury	MEDICINA INTENSIVA			Spanish	Article						Severe traumatic brain injury; Risk factors; Mortality	HEAD-INJURY; EPIDEMIOLOGY	Objective: To describe the factors associated to mortality of patients with severe traumatic brain injury (TBI). Design: A retrospective observational study was made of patients with severe TBI covering the period between 1 January 2007 and 31 December 2010. Setting: Virgen de la Vega Hospital, Salamanca (Spain). Patients: All patients hospitalized during the consecutive study period. Main variables of interest: The dependent variable has been the death rate, while the independent variables were divided into two groups: epidemiological and clinical. Results: The mean patient age was the 50.84 years; 75.5% were mates. The average score on the Glasgow Coma Scale (GCS) was 5.09, and the average Injury Severity Score (ISS) was 30.8. Higher mortality was observed in older patients with a higher ISS score. A total of 68.1% of the patients in which intracranial pressure (ICP) was monitored showed intracranial hypertension (ICH). The mortality rate in patients with severe TBI was 36.8%, and was associated mainly to a lower GCS score, the existence of hyperglycemia, coagulopathy, hypoxemia, the presence of mydriasis and shock. The independent mortality indicators in patients with severe TBI were the existence of mydriasis (OR: 32.75), the GCS score (OR: 2.65) and hyperglycemia (OR: 6.08). Conclusions: The existence of mydriasis, the GCS score and hyperglycemia should be taken into account as prognostic factors in TB! patients. (C) 2011 Elsevier Espana, S.L. and SEMICYUC. All rights reserved.	[Frutos Bernal, E.] Univ Salamanca, Dept Estadist, E-37008 Salamanca, Spain; [Rubio Gil, F. J.; Martin Corral, J. C.; Marcos Prieto, L. A.; Robledo, J. Gonzalez] Hosp Virgen de la Vega, Unidad Cuidados Intens, Salamanca, Spain		Bernal, EF (corresponding author), Univ Salamanca, Dept Estadist, E-37008 Salamanca, Spain.	efb@usal.es					*ASS ADV AUT MED, ABBR INJ SCAL 1990 R; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barcena-Orbe A, 2006, NEUROCIRUGIA, V17, P495; Boto GR, 2006, NEUROCIRUGIA, V17, P215; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Garcia-Delgado M., 2004, MED INTENSIVA, V28, P449; Joosse P, 2009, J CLIN NEUROSCI, V16, P925, DOI 10.1016/j.jocn.2008.06.014; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Alvarez JML, 2011, MED INTENSIVA, V35, P337, DOI 10.1016/j.medin.2011.02.006; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Orient-Lopez F, 2004, REV NEUROLOGIA, V39, P901, DOI 10.33588/rn.3910.2004302; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Reviejo K, 2002, MED INTENSIVA, V26, P241; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	24	7	8	0	9	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	JUN-JUL	2013	37	5					327	332		10.1016/j.medin.2012.05.015			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163NB	WOS:000320343100005	22854619				2022-02-06	
J	Jeong, E				Jeong, Eunju			Psychometric Validation of a Music-Based Attention Assessment: Revised for Patients with Traumatic Brain Injury	JOURNAL OF MUSIC THERAPY			English	Article						music; attention; assessment; traumatic brain injury; test development and validation	CLOSED-HEAD INJURY; SELECTIVE ATTENTION; PREFRONTAL CORTEX; TOP-DOWN; SUSTAINED ATTENTION; DIVIDED ATTENTION; TASK; PERFORMANCE; AWARENESS; LOCATION	Background: An estimated 1.5 to 2 million people sustain a traumatic brain injury (TBI) each year in the United States. Impairments in attention following TBI severely limit everyday functioning in a multifaceted manner. A precise assessment is critical in identifying the types of attention impairments and in recommending appropriate tasks to aid in attention rehabilitation. A Music-based Attention Assessment (MAA) was developed to fill this need and revised to reflect variations of attention ability that exist in the general population. Objective: The purpose of the study was to investigate the theoretically-based constructs of the Music-based Attention Assessment-Revised (MAA-R) using a factorial approach and to examine item properties and test reliability in relation to the exploratively-derived factor constructs. Methods: The MAA-R is a 54-item multiple-choice, melodic contour identification test, designed to assess three different types of auditory attention including sustained, selective, and divided attention. The psychometric validation of the MAA-R was conducted with healthy. adults (n = 165) and patients diagnosed with a moderate to severe TBI (n = 22). Results: Exploratory factor analysis identified five factor constructs, including Sustained-Short, Sustained-Med to Long, Selective-Noise, Selective & Divided, and Divided-Long. After item elimination, the final 45-item MAA-R provided evidence of high internal consistency as. computed by split-half reliability coefficients (r = .836) and Cronbach's alpha (alpha = .940). Conclusion: The aggregate findings suggest that the MAA-R is a valid and reliable measure that provides assessment information in regards to the different types of auditory attention deficits frequently observed in patients with TBI. Development and revision issues as well as the use of melodic contours in auditory attention assessment are discussed along with suggestions for future research.	Ewha Womans Univ, Ewha Mus Rehabil Ctr, Seoul 120750, South Korea		Jeong, E (corresponding author), Ewha Womans Univ, Ewha Mus Rehabil Ctr, Helen Bldg 312,Ewhayeodae Gil 52, Seoul 120750, South Korea.	ejeong@ewha.ac.kr	Jeong, Eunju/L-2185-2017	Jeong, Eunju/0000-0002-5064-5419			Adcock RA, 2000, P NATL ACAD SCI USA, V97, P3567, DOI 10.1073/pnas.060588897; Advokat Claire, 2007, J Atten Disord, V10, P253, DOI 10.1177/1087054706292106; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; Asmus E., 1999, MUSIC EDUC J, V86, P19, DOI DOI 10.2307/3399585; Asmus E. P., 1981, RES S PSYCH AC MUS U; Asmus E. P., 2006, MENC HDB RES METHODO, P95; ASMUS EP, 1989, B COUN RES MUSIC ED, P1; ASMUS EP, 1980, J RES MUSIC EDUC, V28, P143, DOI 10.2307/3345231; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Bigand E, 2000, INT J PSYCHOL, V35, P270, DOI 10.1080/002075900750047987; Boxill E.H., 1985, MUSIC THERAPY DEV DI; Boxill E.H., 2007, MUSIC THERAPY DEV DI; Bregman A., 1999, AUDITORY SCENE ANAL, P455; Byo JL, 1997, J RES MUSIC EDUC, V45, P51, DOI 10.2307/3345465; Ceravolo M. G., 2006, EURA MEDICOPHYS, V42, P59; Chun MM, 2011, NEUROPSYCHOLOGIA, V49, P1407, DOI 10.1016/j.neuropsychologia.2011.01.029; Cohen RJ, 2002, PSYCHOL TESTING ASSE; Crawley EJ, 2002, J EXP PSYCHOL HUMAN, V28, P367, DOI 10.1037//0096-1523.28.2.367; Cusack R, 2004, J EXP PSYCHOL HUMAN, V30, P643, DOI 10.1037/0096-1523.30.4.643; Davison LL, 2003, MUSIC PERCEPT, V21, P3, DOI 10.1525/mp.2003.21.1.3; Deutsch D., 1982, PSYCHOL MUSIC, P99; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Gordon E.E., 1998, INTRO RES PSYCHOL MU; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Gunstad J, 2006, ARCH CLIN NEUROPSYCH, V21, P645, DOI 10.1016/j.acn.2006.05.009; Hampton Bitcon Carol, 1976, ALIKE DIFFERENT CLIN; Henson RK, 2005, PSYCHOL REP, V97, P275, DOI 10.2466/pr0.97.1.275-276; Hodges D., 1996, HDB MUSIC PSYCHOL, P203; Hufford BJ, 2005, J CLIN EXP NEUROPSYC, V27, P255, DOI 10.1080/13803390490515478; HUNTER LL, 1989, J MUSIC THER, V26, P79, DOI 10.1093/jmt/26.2.79; Janata P, 2002, COGN AFFECT BEHAV NE, V2, P121, DOI 10.3758/CABN.2.2.121; Jeong E, 2011, J MUSIC THER, V48, P551, DOI 10.1093/jmt/48.4.551; Johnson JA, 2007, J COGNITIVE NEUROSCI, V19, P907, DOI 10.1162/jocn.2007.19.6.907; JONES RE, 1986, J MUSIC THER, V23, P166, DOI 10.1093/jmt/23.3.166; Kaipio ML, 2000, NEUROREPORT, V11, P1463; Kaipio ML, 2001, NEUROREPORT, V12, P1517, DOI 10.1097/00001756-200105250-00043; Kewman D G, 1988, Brain Inj, V2, P131, DOI 10.3109/02699058809150937; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Koelega H., 1996, HDB PERCEPTION ACTIO, V3, P277; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Leung K.K., 2007, J MED EDUC, V11, P234; LIPE A, 1995, J MUSIC THER, V32, P137, DOI 10.1093/jmt/32.3.137; Lipe AW, 2007, J MUSIC THER, V44, P369, DOI 10.1093/jmt/44.4.369; Loose R., 2000, NEUROIMAGE, V11, P2; Macaluso E, 2002, CEREB CORTEX, V12, P357, DOI 10.1093/cercor/12.4.357; Macken WJ, 2003, J EXP PSYCHOL HUMAN, V29, P43, DOI 10.1037/0096-1523.29.1.43; Magee WL, 2007, NEUROREHABILITATION, V22, P319; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MURPHY KR, 1998, PSYCHOL TESTING PRIN; Nicholls MER, 2011, ATTEN PERCEPT PSYCHO, V73, P1604, DOI 10.3758/s13414-011-0114-x; Ortuno F, 2002, NEUROIMAGE, V17, P411, DOI 10.1006/nimg.2002.1168; Osterlind S. J., 2006, MODERN MEASUREMENT T, P53; Panter AT, 1997, J PERS ASSESS, V68, P561, DOI 10.1207/s15327752jpa6803_6; Pare N, 2009, NEUROPSYCHOL REHABIL, V19, P110, DOI 10.1080/09602010802106486; Ponsford J, 2004, SCI PRACT NEUROPSYCH, P59; Ponsford J., 2008, COGNITIVE NEUROREHAB, P507; Radocy, 1987, MEASUREMENT EVALUATI; Reitan R, 1985, HALSTEAD REITAN NEUR; RIDER MS, 1981, J MUSIC THER, V18, P110, DOI 10.1093/jmt/18.3.110; Ries M, 2005, NEUROPSYCHOLOGY, V19, P476, DOI 10.1037/0894-4105.19.4.476; Rios-Lago M, 2007, REV NEUROLOGIA, V44, P291, DOI 10.33588/rn.4405.2006208; Russell B. E., 2007, THESIS U MIAMI; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Satoh M, 2001, COGNITIVE BRAIN RES, V12, P101, DOI 10.1016/S0926-6410(01)00044-1; Schaap P, 2008, SA J IND PSYCHOL, V34, P29; Schmuckler MA, 1999, MUSIC PERCEPT, V16, P295; Snyder JS, 2007, PSYCHOL BULL, V133, P780, DOI 10.1037/0033-2909.133.5.780; Snyder JS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00015; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Solbakk AK, 2002, CLIN ELECTROENCEPHAL, V33, P102, DOI 10.1177/155005940203300306; Stephan KM, 2002, NEUROIMAGE, V15, P345, DOI 10.1006/nimg.2001.0929; Talland G.A., 1965, DERANGED MEMORY; Turgeon M, 2001, ANN NY ACAD SCI, V930, P375, DOI 10.1111/j.1749-6632.2001.tb05746.x; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Wang D, 2005, PERCEPT PSYCHOPHYS, V67, P239, DOI 10.3758/BF03206488; Wechsler, 2008, WECHSLER MEMORY SCAL; YORK E, 1994, J MUSIC THER, V31, P280, DOI 10.1093/jmt/31.4.280; York E, 2000, PSYCHOL MUSIC, V28, P174, DOI [DOI 10.1177/0305735600282006, 10.1177/0305735600282006]; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773	87	7	7	0	9	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-2917	2053-7395		J MUSIC THER	J. Music Ther.	SUM	2013	50	2					66	92		10.1093/jmt/50.2.66			27	Music; Rehabilitation	Social Science Citation Index (SSCI)	Music; Rehabilitation	171CH	WOS:000320902200001	24156188				2022-02-06	
J	Kandasamy, R; Pal, HK; Swamy, M; Abdullah, J				Kandasamy, Regunath; Pal, Hillol Kanti; Swamy, Mummedy; Abdullah, Jafri			Cerebrospinal fluid nitric oxide metabolite levels as a biomarker in severe traumatic brain injury	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						nitric oxide; cerebrospinal fluid; traumatic brain injury; biomarker	HEAD-INJURY; SYNTHASE; INFLAMMATION; CONTUSION	Nitric oxide has a definitive role in the complex pathophysiology of traumatc brain injury (TBI). This prospective cohort study investigated the changes in nitric oxide metabolite (NOx) levels in cerebrospinal fluid (CSF) and their correlation with factors associated with severity and prognosis after severe TBI. NOx levels were measured in CSF obtained via ventriculostomy in 44 adult patients admitted after severe TBI (Glasgow Coma Scale <= 8/15). The overall mean level of CSF NOx in the study population was 7.40 +/- 1.59 mu mol/L. Levels of CSF NOx were found to be significantly higher in subgroups of patients with poorer outcome measured by Glasgow Outcome Scale score (p < 0.042), in patients with high intracranial pressure (ICP) readings (p < 0.027) and in those with higher Marshall computed tomography (CT) grading scores (p < 0.026). Simple logistic regression demonstrated that CSF NOx levels were a significant predictor of ICP (b = 0.493, 95% CI: 1.03, 2.58, p = 0.033). A patient with 1 mu mol/L increase in NOx level had 1.6 times the odds to have an ICP >= 20 mmHg when other confounders were not adjusted. NOx level is also a significant predictor of Marshall CT grading (b = 0.473, 95% CI: 1.02, 2.50, p = 0.037). A patient with 1 mu mol/L increase in NOx level had 1.6 times the odds to have a high Marshall grade when other confounders were not adjusted. It can be concluded that CSF NOx levels may serve as a potentially useful biomarker in severe TBI given its significant association with ICP readings as well as Marshall CT grading.	[Kandasamy, Regunath; Pal, Hillol Kanti; Abdullah, Jafri] Hosp Univ Sains Malaysia, Dept Neurosci, Kubang Kerian 16150, Kelantan, Malaysia; [Swamy, Mummedy] Hosp Univ Sains Malaysia, Dept Chem Pathol, Kubang Kerian 16150, Kelantan, Malaysia		Kandasamy, R (corresponding author), Hosp Univ Sains Malaysia, Dept Neurosci, Kubang Kerian 16150, Kelantan, Malaysia.	regunath@kk.usm.my	Abdullah, J/C-2828-2011	Abdullah, J/0000-0002-0258-7410; Swamy, Mummedy/0000-0002-8084-5534			Bratasz A, 2004, ANTIOXID REDOX SIGN, V6, P613, DOI 10.1089/152308604773934378; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CHAO CC, 1992, J IMMUNOL, V149, P2736; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Dong Z, 2000, J TONGJI MED U, V20, P148; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Gahm C, 2002, NEUROSURGERY, V50, P1319, DOI 10.1097/00006123-200206000-00024; Heneka MT, 1998, J NEUROCHEM, V71, P88; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Lu YC, 1997, MOL CHEM NEUROPATHOL, V30, P125, DOI 10.1007/BF02815154; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Mesenge C, 1996, J NEUROTRAUM, V13, P11, DOI 10.1089/neu.1996.13.11; Rangel-Castilla L, 2007, INTENSIVE CARE MED, P739, DOI [10.1007/978-0-387-49518-7_66, DOI 10.1007/978-0-387-49518-7_66]; Shohami E, 2011, OXID STRESS APPL BAS, P99, DOI 10.1007/978-1-60327-514-9_7; Uzan M, 2001, SURG NEUROL, V56, P350, DOI 10.1016/S0090-3019(01)00633-4	16	7	7	1	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	JUN	2013	123	6					385	391		10.3109/00207454.2012.761983			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146HJ	WOS:000319080600004	23270401				2022-02-06	
J	Li, H; Cai, QX; Shen, PQ; Chen, T; Zhang, ZM; Zhao, L				Li Hai; Cai Qi-xun; Shen Pin-quan; Chen Ting; Zhang Zi-ming; Zhao Li			Posterior interosseous nerve entrapment after Monteggia fracture-dislocation in children	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Monteggia's fracture; Peripheral nerve injuries; Nerve compression syndromes; Pediatrics		Objective: Although most of nerve injuries associated with Monteggia fracture-dislocation in children are neurapraxias and will recover spontaneously after conservative treatment, surgical exploration of the involved nerve is always required in the cases with the entrapment of posterior interosseous nerve (PIN). However, the necessity and time frame for surgical intervention for specific patterns of nerve dysfunction remains controversial. The aim of the report is to observe and understand the pathology of PIN injury associated with Monteggia fracture-dislocation in children, and to propose the possible indication for the exploration of nerve. Methods: Eight cases, six boys and two girls, with Monteggia fracture-dislocation complicated by PIN injury, managed operatively at the authors' Hospital from 2007 to 2008 were retrospectively reviewed. All the patients underwent the attempted closed reduction before they received exploration of PIN, with open reduction and internal fixation or successful closed reduction. Results: The PIN was found to be trapped acutely posterior to the radiocapitellar joint in 4 out of 5 Type III Bado's Monteggia fractures. In the remaining cases, since there were longer time intervals from injury to operation, chronic compressive changes and epineural fibrosis of radial nerve were visualized. After a microsurgical neurolysis performed, the complete recovery in the nerve function was obtained in all the cases during the follow-up. Conclusion: The findings from this study suggest that every case of type III Monteggia fracture-dislocation with decreased or absent function of muscles innervated by PIN and an irreducible radial head in children should be viewed as an indication for immediate surgical exploration of the involved nerve to exclude a potential PIN entrapment.	[Li Hai; Cai Qi-xun; Shen Pin-quan; Chen Ting; Zhang Zi-ming; Zhao Li] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Orthopaed, Shanghai 200092, Peoples R China		Zhao, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Orthopaed, Shanghai 200092, Peoples R China.	orthzl@126.com					Bado J L, 1967, Clin Orthop Relat Res, V50, P71; BEST TN, 1994, J PEDIATR ORTHOPED, V14, P193, DOI 10.1097/01241398-199403000-00012; Boyd H B, 1969, Clin Orthop Relat Res, V66, P94; BRUCE HE, 1974, J BONE JOINT SURG AM, VA 56, P1563, DOI 10.2106/00004623-197456080-00003; Hirachi K, 1998, J HAND SURG-BRIT EUR, V23B, P413, DOI 10.1016/S0266-7681(98)80071-5; HIRAYAMA T, 1988, J BONE JOINT SURG AM, V70A, P1402, DOI 10.2106/00004623-198870090-00021; HOLSTNIELSEN F, 1984, J HAND SURG-AM, V9A, P572, DOI 10.1016/S0363-5023(84)80112-4; MORRIS AH, 1974, J BONE JOINT SURG AM, VA 56, P1744, DOI 10.2106/00004623-197456080-00033; MULLICK S, 1977, J BONE JOINT SURG AM, V59, P543, DOI 10.2106/00004623-197759040-00024; OH SJ, 1976, SOUTHERN MED J, V69, P177, DOI 10.1097/00007611-197602000-00015; OLNEY BW, 1989, J PEDIATR ORTHOPED, V9, P219; Osamura N, 2004, SCAND J PLAST RECONS, V38, P376, DOI 10.1080/02844310410034303; RECKLING FW, 1982, J BONE JOINT SURG AM, V64, P857, DOI 10.2106/00004623-198264060-00007; Ristic S, 2000, CLIN ORTHOP RELAT R, P138; Ruchelsman David E, 2009, Hand (N Y), V4, P167, DOI 10.1007/s11552-008-9152-9; SMITH FM, 1947, SURG GYNECOL OBSTET, V85, P630; SPAR I, 1977, CLIN ORTHOP RELAT R, P207; SPINNER M, 1968, Journal of Bone and Joint Surgery British Volume, V50-B, P809; STEIN F, 1971, J BONE JOINT SURG AM, VA 53, P1432, DOI 10.2106/00004623-197153070-00022; STOLL TM, 1992, J BONE JOINT SURG BR, V74, P436, DOI 10.1302/0301-620X.74B3.1587897; SUNDERLAND S, 1951, BRAIN, V74, P491, DOI 10.1093/brain/74.4.491; TOMPKINS DG, 1971, J BONE JOINT SURG AM, VA 53, P1109, DOI 10.2106/00004623-197153060-00007; YOUNG C, 1990, J BONE JOINT SURG AM, V72A, P1215, DOI 10.2106/00004623-199072080-00014	23	7	7	0	3	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	JUN	2013	16	3					131	135		10.3760/cma.j.issn.1008-1275.2013.03.001			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1HG	WOS:000442015600001	23735545				2022-02-06	
J	Claudet, I; Gurrera, E; Honorat, R; Rekhroukh, H; Casasoprana, A; Grouteau, E				Claudet, I.; Gurrera, E.; Honorat, R.; Rekhroukh, H.; Casasoprana, A.; Grouteau, E.			Home falls in infants before walking acquisition	ARCHIVES DE PEDIATRIE			French	Article							MINOR HEAD TRAUMA; PEDIATRIC INJURIES; CHILDREN YOUNGER; BRAIN-INJURIES; RISK; MANAGEMENT; CHILDHOOD; AGE	Minor head trauma is frequent among infants and leads to numerous visits to emergency departments for neurological assessment to evaluate the value of cerebral CT scan with the risk for traumatic brain injuries (TBI). Objectives. To analyze the epidemiological characteristics of non-walking infants admitted after falling at home and to analyze associated factors for skull fractures and TBI. Patients and methods. Between January 2007 and December 2011, all children aged 9 months or younger and admitted after a home fall to the pediatric emergency unit of a tertiary children's hospital were included. The data collected were age, sex, weight and height, body mass index; geographic origin, referral or direct admission, mode of transportation; month, day and time of admission; causes of the fall, alleged fall height, presence of an eyewitness, type of landing surface; Glasgow Coma Scale (GCS) score, application of the head trauma protocol, location and type of injuries, cerebral CT scan results, length of hospital stay, progression, and neglect or abuse situations. Results. Descriptive analysis: within the study period, 1910 infants were included. Fifty-four percent of children were aged less than 6 months with a slight male prevalence (52%). Falls from parental bed and infant carriers accounted for the most frequent fall circumstances. GCS score on admission was equal to 14 or 15 in 99% of cases. A cerebral CT scan was performed in 34% of children and detected 104 skull fractures and 55 TBI. Infants aged less than 1 month had the highest rate of TBI (8.5%). Eleven percent of patients were hospitalized. A situation of abuse was identified in 51 infants (3%). Univariate analysis-Male children and infants aged less than 3 months had a higher risk of skull fractures (P = 0.03 and P = 0.0003, respectively). In the TBI group, children were younger (3.8 +/- 2.6 months versus 5.4 +/- 2.5 months, P < 0.0001), fell from a higher height (90.2 +/- 29.5 cm versus 70.9 +/- 28.7 cm, P < 0.0001), were more often admitted on a weekend or day off, and had more skull fractures (54% versus 6%, P < 0.001). Multivariate analysis: all variables showing P < 0.2 in the univariate analysis were entered into the model. In the final model, three variables continued to be associated with a risk of TBI: being referred by a physician (OR 4.6 [2.2-9.6],P < 0.0001), being younger than 3 months old (OR 3.1 [1.7-5.7], P = 0.0002), falling from a height greater than 90 cm (OR 3.1 [1.7-5.6], P = 0.0002). Comments. Before walking acquisition, children are particularly vulnerable and have the highest rate of TBI after a vertical fall. In this age group, the rate of abuse is also higher. Given this double risk, numerous cerebral CT scans are performed (35-40% of the target population). This protocol, however, leads to a low proportion of detected TBI (< 10%) compared to the high number of CT scans and an additional risk of irradiation. Conclusion. As no validated predictive score exists and pending the contribution of the S-100B protein assay, the identification of infants at high risk for TBI and justifying neuroimaging is based on the search for predisposing factors and circumstances. (c) 2013 Elsevier Masson SAS. All rights reserved.	[Claudet, I.; Gurrera, E.; Honorat, R.; Rekhroukh, H.; Casasoprana, A.; Grouteau, E.] CHU Toulouse, Hop Enfants, Serv Accueil Urgences Pediat, F-31059 Toulouse, France		Claudet, I (corresponding author), CHU Toulouse, Hop Enfants, Serv Accueil Urgences Pediat, 330 Ave Grande Bretagne,TSA 70034, F-31059 Toulouse, France.	claudet.i@chu-toulouse.fr	CLAUDET, ISABELLE/N-4195-2019; Claudet, Isabelle/G-9457-2016	CLAUDET, ISABELLE/0000-0002-3868-8483; Claudet, Isabelle/0000-0002-3868-8483			Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Blume Heidi K, 2012, Evid Based Med, V17, pe11, DOI 10.1136/ebmed-2012-100574; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Bouvier D, 2011, CLIN BIOCHEM, V44, P927, DOI 10.1016/j.clinbiochem.2011.05.004; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; Da Dalt L, 2007, J PEDIATR-US, V150, P274, DOI 10.1016/j.jpeds.2006.11.060; Docherty E, 2010, EMERG MED J, V27, P207, DOI 10.1136/emj.2008.069179; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Greenberg RA, 2009, PEDIATR EMERG CARE, V25, P66, DOI 10.1097/PEC.0b013e318196e9dc; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Hallen M, 2010, J TRAUMA, V69, P284, DOI 10.1097/TA.0b013e3181ca060b; Haney SB, 2010, PEDIATR EMERG CARE, V26, P914, DOI 10.1097/PEC.0b013e3181fe9139; Hennelly KE, 2013, J PEDIATR-US, V162, P392, DOI 10.1016/j.jpeds.2012.07.018; Ibrahim NG, 2010, J NEUROSURG-PEDIATR, V6, P57, DOI 10.3171/2010.3.PEDS09357; Jehle E, 2012, ANN FR MED URGENCE, V2, P199, DOI 10.1007/s13341-012-0202-4; Khambalia A, 2006, INJURY PREV, V12, P378, DOI 10.1136/ip.2006.012161; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Love PF, 2009, J TRAUMA, V67, pS12, DOI 10.1097/TA.0b013e3181ac7f22; Macgregor DM, 2003, EMERG MED J, V20, P21, DOI 10.1136/emj.20.1.21; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pickett W, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e365; Pitone ML, 2006, PEDIATR EMERG CARE, V22, P470, DOI 10.1097/01.pec.0000226869.41803.50; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Tarantino CA, 1999, PEDIATR EMERG CARE, V15, P5, DOI 10.1097/00006565-199902000-00002; Thompson AK, 2011, ACCIDENT ANAL PREV, V43, P143, DOI 10.1016/j.aap.2010.07.020; Unni P, 2012, AM J EMERG MED, V30, P1457, DOI 10.1016/j.ajem.2011.12.001; Warrington SA, 2001, ARCH DIS CHILD, V85, P104, DOI 10.1136/adc.85.2.104	30	7	7	0	5	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0929-693X	1769-664X		ARCH PEDIATRIE	Arch. Pediatr.	MAY	2013	20	5					484	491		10.1016/j.arcped.2013.02.071			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	148HC	WOS:000319234300005	23562734				2022-02-06	
J	Moore, M				Moore, Megan			Mild Traumatic Brain Injury: Implications for Social Work Research and Practice With Civilian and Military Populations	SOCIAL WORK IN HEALTH CARE			English	Article						traumatic brain injury; mild traumatic brain injury; medical social work; health	POSTTRAUMATIC-STRESS-DISORDER; DEPRESSION FOLLOWING MILD; HEAD-INJURY; POSTCONCUSSION SYNDROME; RANDOMIZED-TRIAL; SUBSTANCE-ABUSE; RISK-FACTORS; ALCOHOL INTERVENTIONS; CLINICAL MANAGEMENT; FOLLOW-UP	Over one million mild traumatic brain injuries (mTBI) are treated in U.S. hospitals each year. In addition, mTBI has affected thousands of soldiers returning from the Iraq and Afghanistan wars. Many individuals experience post-concussive symptoms immediately after mTBI; some experience severe and prolonged symptoms. Symptom etiology is not well understood, and effective psychosocial interventions have not been well developed. Because of the high incidence of mTBI, many social workers in health care settings will come in contact with mTBI patients and need specialized knowledge to provide appropriate services. Social work researchers can contribute to improved services by elucidating symptom course, and developing and testing effective interventions aimed at preventing or alleviating symptoms. This article provides an overview of civilian- and military-related mTBI outcomes and psychosocial interventions. Recommendations for current social work practice and research are made with the goal of improving the care of persons with mTBI.	Univ Washington, Sch Social Work, Seattle, WA 98195 USA		Moore, M (corresponding author), Univ Washington, Sch Social Work, 4101 15th Ave NE Box 354900, Seattle, WA 98195 USA.	mm99@uw.edu					Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, NAT CTR INJ PREV CON; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Dicker RA, 2011, J TRAUMA, V70, P1337, DOI 10.1097/TA.0b013e318216f611; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Finkelstein E., 2006, INCIDENCE EC BURDEN; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Gentilello LM, 2005, J TRAUMA, V59, pS137, DOI 10.1097/01.ta.0000174877.66875.f3; GENTILELLO LM, 1995, JAMA-J AM MED ASSOC, V274, P1043, DOI 10.1001/jama.274.13.1043; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Gerstenbrand F, 2001, BRAIN INJURY, V15, P95; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Greiffenstein M., 2008, CLIN NEUROPSYCHOL, V22, P1; GRONWALL D, 1986, J HEAD TRAUMA REHAB, V1, P53, DOI DOI 10.1097/00001199-198606000-00009; Heskestad B, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-10; Hinkle J L, 1986, J Neurosci Nurs, V18, P268; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JENNETT B, 1975, LANCET, V1, P480; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; LEW HL, 2005, J REHABIL RES DEV, V42, pR8; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Mayo Clinic, 2010, TRAUM BRAIN INJ; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NINDS National Institute of Neurological Disorders and Stroke, 2002, NIH PUBLICATION, V02-2478; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Piek J, 2010, EUR MAN MED, P249, DOI 10.1007/978-3-540-79565-0_8; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Schootman M, 2000, BRAIN INJURY, V14, P373; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Soo C, 2007, COCHRANE DB SYST REV, V3; Sosin DM, 1996, BRAIN INJURY, V10, P47; Speziale B, 2010, J SOC WORK DISABIL R, V9, P289, DOI 10.1080/1536710X.2010.523664; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; TEASDALE G, 1974, LANCET, V2, P81; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; [No title captured]	84	7	7	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0098-1389	1541-034X		SOC WORK HEALTH CARE	Soc. Work Health Care	MAY 1	2013	52	5					498	518		10.1080/00981389.2012.714447			21	Social Work	Social Science Citation Index (SSCI)	Social Work	150GJ	WOS:000319377900006	23701581				2022-02-06	
J	Sussman, ES; Kellner, CP; McDowell, MM; Bruce, SS; Heuts, SG; Zhuang, Z; Bruce, RA; Claassen, J; Connolly, ES				Sussman, Eric S.; Kellner, Christopher P.; McDowell, Michael M.; Bruce, Samuel S.; Heuts, Simon G.; Zhuang, Zong; Bruce, Rachel A.; Claassen, Jan; Connolly, E. Sander, Jr.			Alpha-7 nicotinic acetylcholine receptor agonists in intracerebral hemorrhage: an evaluation of the current evidence for a novel therapeutic agent	NEUROSURGICAL FOCUS			English	Article						intracerebral hemorrhage; nicotinic acetylcholine receptor; alpha-7 agonist	TRAUMATIC BRAIN-INJURY; FACTOR-KAPPA-B; SUBARACHNOID HEMORRHAGE; CEREBRAL EDEMA; MOUSE MODEL; RAT MODEL; INFLAMMATION; INHIBITION; NEUROPROTECTION; MECHANISMS	Intracerebral hemorrhage (ICH) is the most deadly and least treatable subtype of stroke, and at the present time there are no evidence-based therapeutic interventions for patients with this disease. Secondary injury mechanisms are known to cause substantial rates of morbidity and mortality following ICH, and the inflammatory cascade is a major contributor to this post-ICH secondary injury. The alpha-7 nicotinic acetylcholine receptor (alpha 7-nAChR) agonists have a well-established antiinflammatory effect and have been shown to attenuate perihematomal edema volume and to improve functional outcome in experimental ICH. The authors evaluate the current evidence for the use of an alpha 7-nAChR agonist as a novel therapeutic agent in patients with ICH.	[Sussman, Eric S.; Kellner, Christopher P.; McDowell, Michael M.; Bruce, Samuel S.; Heuts, Simon G.; Zhuang, Zong; Bruce, Rachel A.; Connolly, E. Sander, Jr.] Columbia Univ, Dept Neurol Surg, New York, NY USA; [Claassen, Jan] Columbia Univ, Dept Neurol, New York, NY USA		Connolly, ES (corresponding author), Neurol Inst, 710 W 168th St, New York, NY 10032 USA.	esc5@columbia.edu	Claassen, Jan/AAA-5451-2020; Kellner, Christopher Paul/AAA-3280-2022	Kellner, Christopher Paul/0000-0003-4604-8205	Clinical Research Fellowship from the Doris Duke Charitable Foundation	Michael McDowell and Eric Sussman are recipients of a Clinical Research Fellowship from the Doris Duke Charitable Foundation.	Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Ayer RE, 2008, J PINEAL RES, V44, P197, DOI 10.1111/j.1600-079X.2007.00508.x; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Deutsch SI, 2008, CLIN NEUROPHARMACOL, V31, P34, DOI [10.1097/WNF.0B013E31806462BA, 10.1097/wnf.0b013e31806462ba]; Duris K, 2011, STROKE, V42, P3530, DOI 10.1161/STROKEAHA.111.619965; Dziedzic T, 2002, STROKE, V33, P2334, DOI 10.1161/01.STR.0000027211.73567.FA; Fainardi E, 2013, NEURORADIOLOGY, V55, P145, DOI 10.1007/s00234-012-1093-x; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Flaherty ML, 2005, STROKE, V36, P934, DOI 10.1161/01.STR.0000160756.72109.95; Fujii M, 2012, NEUROCHEM INT, V60, P327, DOI 10.1016/j.neuint.2011.12.014; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Hickenbottom SL, 1999, STROKE, V30, P2472, DOI 10.1161/01.STR.30.11.2472; Hijioka M, 2012, NEUROSCIENCE, V222, P10, DOI 10.1016/j.neuroscience.2012.07.024; Hua Y, 2006, NEUROSURGERY, V58, P542, DOI 10.1227/01.NEU.0000197333.55473.AD; KANE PJ, 1992, J NEUROL NEUROSUR PS, V55, P781, DOI 10.1136/jnnp.55.9.781; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kellner CP, 2010, STROKE, V41, pS99, DOI 10.1161/STROKEAHA.110.597476; Kitaoka T, 2002, STROKE, V33, P3012, DOI 10.1161/01.STR.0000037673.17260.1B; Kox M, 2011, SHOCK, V36, P5, DOI 10.1097/SHK.0b013e3182168d56; Krafft PR, 2012, STROKE, V43, P844, DOI 10.1161/STROKEAHA.111.639989; Lee S, 2009, J PINEAL RES, V46, P43, DOI 10.1111/j.1600-079X.2008.00607.x; Li JH, 2011, J NEUROIMMUNOL, V239, P37, DOI 10.1016/j.jneuroim.2011.08.007; Lightfoot AP, 2008, PROGR MED CHEM, V46, P131, DOI 10.1016/S0079-6468(07)00003-3; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Masada T, 2003, ACT NEUR S, V86, P463; Masada T, 2001, J NEUROSURG, V95, P680, DOI 10.3171/jns.2001.95.4.0680; McGrath J, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004722.PUB2; Nolan GP, 1992, CURR OPIN GENET DEV, V2, P211, DOI 10.1016/S0959-437X(05)80276-X; Othman AA, 2011, J CLIN PHARMACOL, V51, P512, DOI 10.1177/0091270010370460; Park HK, 2009, J NEUROL SCI, V279, P43, DOI 10.1016/j.jns.2008.12.020; Park HJ, 2007, EUR J NEUROSCI, V26, P79, DOI 10.1111/j.1460-9568.2007.05636.x; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; PERRY VH, 1993, TRENDS NEUROSCI, V16, P268, DOI 10.1016/0166-2236(93)90180-T; PULLAN RD, 1994, NEW ENGL J MED, V330, P811, DOI 10.1056/NEJM199403243301202; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Sansing LH, 2011, NEUROCRIT CARE, V14, P395, DOI 10.1007/s12028-010-9498-z; Schaden E, 2010, INTENS CARE MED, V36, P1127, DOI 10.1007/s00134-010-1888-3; Seidel MF, 2004, SCAND J RHEUMATOL, V33, P33, DOI 10.1080/03009740410007005; Shaffer CL, 2007, DRUG METAB DISPOS, V35, P1188, DOI 10.1124/dmd.106.014449; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Takada-Takatori Y, 2006, NEUROPHARMACOLOGY, V51, P474, DOI 10.1016/j.neuropharm.2006.04.007; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; van Maanen MA, 2009, ARTHRITIS RHEUM-US, V60, P114, DOI 10.1002/art.24177; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Wagner KR, 1996, STROKE, V27, P490, DOI 10.1161/01.STR.27.3.490; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wang XF, 2011, ENDOCRINOLOGY, V152, P836, DOI 10.1210/en.2010-0855; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Zahuranec DB, 2006, J NEUROL NEUROSUR PS, V77, P340, DOI 10.1136/jnnp.2005.077164; Zhang XJ, 2006, NEUROL INDIA, V54, P402	58	7	7	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2013	34	5							E10	10.3171/2013.2.FOCUS1315			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	138DR	WOS:000318489300011	23634914	Bronze			2022-02-06	
J	Zhang, X; Lu, XM; Huang, LF; Li, X				Zhang, Xin; Lu, Xiao-Min; Huang, Li-Fa; Li, Xu			Prognostic value of leptin: 6-Month outcome in patients with intracerebral hemorrhage	PEPTIDES			English	Article						Leptin; Intracerebral hemorrhage; 6-Month clinical outcome	TRAUMATIC BRAIN-INJURY; CLINICAL-OUTCOMES; GENE-EXPRESSION; ADIPOKINES; STROKE	Leptin has recently been discussed as a novel biomarker for the clinical outcome of critical illness. This study aims to investigate the prognostic value of leptin with regard to long-term clinical outcomes in patients with intracerebral hemorrhage. In 50 healthy controls and 92 patients with acute spontaneous basal ganglia hemorrhage presenting to the emergency department of a large primary care hospital, we measured plasma leptin levels using an enzyme-linked immunosorbent assay in a blinded fashion. Plasma leptin levels on admission were considerably higher in patients than healthy controls. A significant correlation emerged between plasma leptin level and National Institutes of Health Stroke Scale score. A multivariate analysis identified plasma leptin level as an independent predictor for 6-month clinical outcomes including 6-month mortality and unfavorable outcome (Modified Rankin Scale score >2). Using receiver operating characteristic curves, we calculated areas under the curve for 6-month clinical outcomes. The predictive performance of leptin was similar to, but did not obviously improve that of National Institutes of Health Stroke Scale scores, Thus, leptin may help in the prediction of 6-month mortality and unfavorable outcome after intracerebral hemorrhage. (C) 2013 Elsevier Inc. All rights reserved.	[Zhang, Xin; Huang, Li-Fa; Li, Xu] Tradit Chinese Med Hosp Zhejiang Prov, Dept Neurosurg, Hangzhou 310006, Zhejiang, Peoples R China; [Lu, Xiao-Min] First Hangzhou Municipal Peoples Hosp, Dept Surg, Wushan Branch, Hangzhou 310002, Zhejiang, Peoples R China		Zhang, X (corresponding author), Tradit Chinese Med Hosp Zhejiang Prov, Dept Neurosurg, 54 Youdian Rd, Hangzhou 310006, Zhejiang, Peoples R China.	changzhouzhangxin@163.com					Ahima RS, 2006, PROG BRAIN RES, V153, P155, DOI 10.1016/S0079-6123(06)53009-2; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Biesiada G, 2012, J PHYSIOL PHARMACOL, V63, P471; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; Dong XQ, 2010, WORLD NEUROSURG, V74, P286, DOI 10.1016/j.wneu.2010.02.019; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lin C, 2012, PEPTIDES, V35, P166, DOI 10.1016/j.peptides.2012.03.024; Morash B, 1999, ENDOCRINOLOGY, V140, P5995, DOI 10.1210/en.140.12.5995; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Paz G, 2012, ARQ BRAS ENDOCRINOL, V56, P597, DOI 10.1590/S0004-27302012000900001; Rajendran K, 2012, THROMB J, V10, DOI 10.1186/1477-9560-10-13; Soderberg S, 2003, CEREBROVASC DIS, V15, P63, DOI 10.1159/000067128; Soderberg S, 1999, STROKE, V30, P328, DOI 10.1161/01.STR.30.2.328; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Zhao QJ, 2012, CLIN EXP HYPERTENS, V34, P161, DOI 10.3109/10641963.2011.561902	19	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	MAY	2013	43						133	136		10.1016/j.peptides.2013.03.010			4	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	160TV	WOS:000320144300021	23517880				2022-02-06	
J	Kuo, JR; Chang, MH; Wang, CC; Chio, CC; Wang, JJ; Lin, BS				Kuo, Jinn-Rung; Chang, Ming-Hsien; Wang, Che-Chuan; Chio, Chung-Ching; Wang, Jhi-Joung; Lin, Bor-Shyh			Wireless near-infrared spectroscopy system for determining brain hemoglobin levels in laboratory animals	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury; Near-infrared spectroscopy; Oxyhemoglobin; Deoxyhemoglobin; Total hemoglobin; Triphenyltetrazolium chloride	CEREBRAL-BLOOD-FLOW; INJURY; HEMODYNAMICS; RAT; OXYGENATION; TOMOGRAPHY; ISCHEMIA; INFANTS; VOLUME	Traumatic brain injury (TBI) is usually caused by brain shaking or impact. It can affect normal brain function and may even lead to disability or death. However, there are very few studies on the associated physiologic changes in humans or animals. In this study, a non-invasive, wireless multi-channel near-infrared spectroscopy (NIRS) was developed to continuously monitor the concentration change of oxyhemoglobin (HbO(2)), deoxyhemoglobin (HbR), and total hemoglobin (HbT) to elucidate changes in the physiological state of the brain during and after different strength impaction. The triphenyltetrazolium chloride (TTC) staining was also used to monitor changes of infarction volume after different strength impaction. The results indicated that the concentration changes of HbO(2) and HbT, and the changes of infarction volumes were significantly related to the impact strength. In conclusion, the status of TBI can be clinically evaluated by detecting HbO(2) and HbT changes. The system proposed here is stable, accurate, non-invasive, and mostly important wireless which can easily be used for TBI study. (C) 2013 Elsevier B.V. All rights reserved.	[Kuo, Jinn-Rung; Wang, Che-Chuan; Chio, Chung-Ching] Chi Mei Med Ctr, Div Neurosurg, Dept Surg, Tainan, Taiwan; [Chang, Ming-Hsien; Wang, Che-Chuan; Lin, Bor-Shyh] Natl Chiao Tung Univ, Inst Imaging & Biomed Photon, Tainan, Taiwan; [Kuo, Jinn-Rung] Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Kuo, Jinn-Rung; Wang, Jhi-Joung; Lin, Bor-Shyh] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan		Lin, BS (corresponding author), 301 Gaofa 3rd Rd, Tainan 711, Taiwan.	borshyhlin@gmail.com			National Science Council of the Republic of ChinaMinistry of Science and Technology, Taiwan [NSC 101-2221-E-009-039]	The authors would like to acknowledge the financial support of the National Science Council of the Republic of China (Grant No. NSC 101-2221-E-009-039).	ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Boas DA, 2001, NEUROIMAGE, V13, P76, DOI 10.1006/nimg.2000.0674; Bonoczk Peter, 2002, Eur J Ultrasound, V15, P85, DOI 10.1016/S0929-8266(02)00006-X; Crespi F, 2005, J NEUROSCI METH, V145, P11, DOI 10.1016/j.jneumeth.2004.11.016; Crespi F, 1997, NEUROSCI LETT, V230, P77, DOI 10.1016/S0304-3940(97)00479-5; Crespi F, 2007, CURR VASC PHARMACOL, V5, P305, DOI 10.2174/157016107782023398; Culver JP, 2003, J CEREBR BLOOD F MET, V23, P911, DOI 10.1097/01.WCB.0000076703.71231.BB; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Kuo JR, 2011, J TRAUMA, V71, pE87, DOI 10.1097/TA.0b013e31820932e2; Liu LF, 2008, J MED BIOL ENG, V28, P101; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marchal G, 1999, J CEREBR BLOOD F MET, V19, P467, DOI 10.1097/00004647-199905000-00001; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; McIntosh TK, 1996, LAB INVEST, V74, P315; Merzagora AC, 2011, J INNOV OPT HEAL SCI, V4, P251, DOI 10.1142/S1793545811001551; Noble KA, 2010, J PERIANESTH NURS, V25, P242, DOI 10.1016/j.jopan.2010.05.008; Okada E, 2003, APPL OPTICS, V42, P2906, DOI 10.1364/AO.42.002906; Payne SJ, 2011, BIOMED OPT EXPRESS, V2, P966, DOI 10.1364/BOE.2.000979; Pierro ML, 2012, NEUROIMAGE, V63, P1571, DOI 10.1016/j.neuroimage.2012.07.015; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Tsuji M, 1998, PEDIATR RES, V44, P591, DOI 10.1203/00006450-199810000-00020; VANDERZEE P, 1992, ADV EXP MED BIOL, V316, P143; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WYATT JS, 1990, J APPL PHYSIOL, V68, P1086; WYATT JS, 1986, LANCET, V2, P1063, DOI 10.1016/S0140-6736(86)90467-8	34	7	7	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	APR 15	2013	214	2					204	209		10.1016/j.jneumeth.2013.01.025			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	121PQ	WOS:000317257100012	23391759				2022-02-06	
J	Belanger, HG; Barwick, FH; Kip, KE; Kretzmer, T; Vanderploeg, RD				Belanger, Heather G.; Barwick, Fiona H.; Kip, Kevin E.; Kretzmer, Tracy; Vanderploeg, Rodney D.			Postconcussive Symptom Complaints and Potentially Malleable Positive Predictors	CLINICAL NEUROPSYCHOLOGIST			English	Article						TBI; Mild TBI; Resilience; Postconcussion syndrome; Concussion; Postconcussive; Attributions	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; QUALITY-OF-LIFE; SELF-EFFICACY; COGNITIVE-FACTORS; DISABILITY; ETIOLOGY; EXPECTATION; MANAGEMENT; VETERANS	The purpose of this study was to examine the relationship between postconcussion symptom complaint (PCS) severity and positive coping factors (knowledge, self-efficacy, and attributions) in a sample of individuals who have sustained a mild TBI, above and beyond the demographic and psychiatric predictors that have been most commonly examined. Ninety-one people with a history of reported mild TBI were surveyed. Hierarchical regression analyses revealed that demographic variables and psychiatric symptom severity predicted PCS severity. Consistent with our hypotheses, knowledge, self-efficacy, and attributions, when taken together, made an independent and significant contribution to prediction of PCS severity (21% of additional variance). The most potent factor was attribution, or the extent to which one attributes symptoms to mild TBI versus other causes. Those who attribute their symptoms to TBI are more likely to report greater symptom severity overall. Taken together, knowledge, self-efficacy, and attributions contribute independently to PCS severity. Additional research is needed to determine if these factors are amenable to intervention.	[Belanger, Heather G.; Barwick, Fiona H.; Kretzmer, Tracy; Vanderploeg, Rodney D.] James A Haley VA, Dept Mental Hlth & Behav Sci, Tampa, FL USA; [Belanger, Heather G.; Kretzmer, Tracy; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat, Tampa, FL USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Kip, Kevin E.] Univ S Florida, Coll Nursing, Tampa, FL USA		Belanger, HG (corresponding author), James A Haley Vet Hosp, Psychol Serv 116B, Tampa, FL 33612 USA.	Heather.Belanger@va.gov			Department of DefenseUnited States Department of Defense [W81XWH-10-1-0719]; Department of Veterans Affairs, Veterans Health Administration (VHA)US Department of Veterans Affairs; Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs; James A. Haley Veterans' HospitalUS Department of Veterans Affairs	The research reported here was supported by the Department of Defense (W81XWH-10-1-0719), Department of Veterans Affairs, Veterans Health Administration (VHA), and the Defense and Veterans Brain Injury Center (DVBIC). Further support was provided by the James A. Haley Veterans' Hospital. The views expressed herein are those of the authors and do not necessarily reflect the views or the official policy of the Department of Army, Department of Defense, Department of Veterans Affairs, or U.S. Government.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Bentsen SB, 2010, PATIENT EDUC COUNS, V81, P5, DOI 10.1016/j.pec.2009.11.019; Binder LM, 1996, AM J PSYCHIAT, V153, P7; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Eisenberg H.M., 1989, MILD HEAD INJURY, P133; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Larson E. B., 2012, J INT NEUROPSYCH SOC, V10, P1; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Mancuso CA, 2010, J ASTHMA, V47, P883, DOI 10.3109/02770903.2010.492540; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Nicholson K, 2000, NEUROREHABILITATION, V14, P95; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Pandey S., 2010, J SOC SOC WORK RES, V1, P28, DOI [DOI 10.5243/JSSWR.2010.2, 10.5243/jsswr.2010.2]; Pavawalla S., J INT NEURO IN PRESS; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; Peters KD, 2011, J ABNORM PSYCHOL, V120, P168, DOI 10.1037/a0021899; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan KA, 2012, CLIN NEUROPSYCHOL, V26, P1255, DOI 10.1080/13854046.2012.735254; Thompson DP, 2010, DISABIL REHABIL, V32, P1758, DOI 10.3109/09638281003734342; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wood F., 1984, INT J PSYCHIAT MED, V4, P277; Zabora J, 2001, PSYCHOSOMATICS, V42, P241, DOI 10.1176/appi.psy.42.3.241	49	7	7	1	12	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	APR 1	2013	27	3					343	355		10.1080/13854046.2013.774438			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	129JK	WOS:000317835100001	23458513				2022-02-06	
J	Chen, W; Belle, A; Cockrell, C; Ward, KR; Najarian, K				Chen, Wenan; Belle, Ashwin; Cockrell, Charles; Ward, Kevin R.; Najarian, Kayvan			Automated Midline Shift and Intracranial Pressure Estimation based on Brain CT Images	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 74; Biomedical Engineering; Molecular Biology; Neurobiology; Biophysics; Physiology; Anatomy; Brain CT Image Processing; CT; Midline Shift; Intracranial Pressure Pre-screening; Gaussian Mixture Model; Shape Matching; Machine Learning; traumatic brain injury; TBI; imaging; clinical techniques		In this paper we present an automated system based mainly on the computed tomography (CT) images consisting of two main components: the midline shift estimation and intracranial pressure (ICP) pre-screening system. To estimate the midline shift, first an estimation of the ideal midline is performed based on the symmetry of the skull and anatomical features in the brain CT scan. Then, segmentation of the ventricles from the CT scan is performed and used as a guide for the identification of the actual midline through shape matching. These processes mimic the measuring process by physicians and have shown promising results in the evaluation. In the second component, more features are extracted related to ICP, such as the texture information, blood amount from CT scans and other recorded features, such as age, injury severity score to estimate the ICP are also incorporated. Machine learning techniques including feature selection and classification, such as Support Vector Machines (SVMs), are employed to build the prediction model using RapidMiner. The evaluation of the prediction shows potential usefulness of the model. The estimated ideal midline shift and predicted ICP levels may be used as a fast pre-screening step for physicians to make decisions, so as to recommend for or against invasive ICP monitoring.	[Chen, Wenan] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23284 USA; [Chen, Wenan; Cockrell, Charles; Ward, Kevin R.; Najarian, Kayvan] Virginia Commonwealth Univ Reanimat Engn Sci Ctr, Richmond, VA USA; [Belle, Ashwin; Najarian, Kayvan] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA 23284 USA; [Cockrell, Charles] Virginia Commonwealth Univ, Dept Radiol, Richmond, VA 23284 USA; [Ward, Kevin R.] Virginia Commonwealth Univ, Dept Emergency Med, Richmond, VA 23284 USA		Najarian, K (corresponding author), Virginia Commonwealth Univ Reanimat Engn Sci Ctr, Richmond, VA USA.	knajarian@vcu.edu			National Science FoundationNational Science Foundation (NSF) [IIS0758410]	The material is based upon work partially supported by the National Science Foundation under Grant No. IIS0758410. The data was supplied by Carolinas Healthcare System.	Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; Chen WA, 2010, IEEE INT C BIOINFORM, P510, DOI 10.1109/BIBM.2010.5706619; Chen WA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-S1-S4; Chen WN, 2009, 2009 ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, P15; Greenspan H, 2006, IEEE T MED IMAGING, V25, P1233, DOI 10.1109/TMI.2006.880668; Kingsbury N, 2001, APPL COMPUT HARMON A, V10, P234, DOI 10.1006/acha.2000.0343; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Mierswa I., 2006, P 12 ACM SIGKDD INT, DOI DOI 10.1145/1150402.1150531; Moore EE, 2003, TRAUMA; Wenan Chen, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P2552, DOI 10.1109/ICPR.2010.625; Weszaka J.S., 1976, IEEE T SYST MAN CYBE	11	7	7	0	6	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	APR	2013		74							e3871	10.3791/3871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V36QY	WOS:000209227100003	23604268	Green Published			2022-02-06	
J	Hilz, MJ; Koehn, J; Tillmann, A; Riss, S; Marthol, H; Kohrmann, M; Wasmeier, G; Schwab, S; Stemper, B				Hilz, Max J.; Koehn, Julia; Tillmann, Alexandra; Riss, Stephan; Marthol, Harald; Koehrmann, Martin; Wasmeier, Gerald; Schwab, Stefan; Stemper, Brigitte			Autonomic Blockade During Sinusoidal Baroreflex Activation Proves Sympathetic Modulation of Cerebral Blood Flow Velocity	STROKE			English	Article; Proceedings Paper	International Stroke Conference	JAN 31-FEB 03, 2012	New Orleans, LA			atropine; carvedilol; cerebral blood flow; pharmacological autonomic blockade; sinusoidal neck suction; sympathetic nervous system	HEART-RATE-VARIABILITY; POWER SPECTRAL-ANALYSIS; TRAUMATIC BRAIN-INJURY; PRESSURE VARIABILITY; ARTERIAL-PRESSURE; R-R; AUTOREGULATION; STIMULATION; BARORECEPTOR; HUMANS	Background and Purpose-Pharmacological blockade showed sympathetic origin of 0.03 to 0.15 Hz blood pressure (BP) oscillations and parasympathetic origin of 0.15 to 0.5 Hz RR-interval (RRI) oscillations, but has not been used to determine origin of cerebral blood flow velocity (CBFV) oscillations at these frequencies. This study evaluated by pharmacological blockade whether 0.1 Hz CBFV oscillations are related to sympathetic and 0.2 Hz CBFV oscillations to parasympathetic modulation. Methods-In 11 volunteers (24.6 +/- 2.3 years), we monitored RRIs, BP, and proximal middle cerebral artery CBFV, at rest, during 180 s sympathetic BP activation by 0.1 Hz sinusoidal neck suction (NS), and during 180 s parasympathetic RRI activation by 0.2 Hz NS. We repeated recordings after 25 mg carvedilol, and after 0.04 mg/kg atropine. Autoregressive analysis quantified RRI-, BP-, and CBFV-spectral powers at 0.1 Hz and 0.2 Hz. We compared parameters at rest, during 0.1 Hz, or 0.2 Hz NS, with and without carvedilol or atropine (analysis of variance, post hoc testing; significance, P<0.05). Results-Carvedilol significantly increased RRIs and lowered BP, CBFV, and 0.1 Hz RRI-, BP-, and CBFV-powers at baseline (P=0.041 for CBFV-powers), and during 0.1 Hz NS-induced sympathetic activation (P<0.05). At baseline and during 0.2 Hz NS-induced parasympathetic activation, atropine lowered RRIs and 0.2 Hz RRI-powers, but did not change BP, CBFV, and 0.2 Hz BP-and CBFV-powers. Conclusions-Attenuation of both 0.1 Hz CBFV and BP oscillations after carvedilol indicates a direct relation between 0.1 Hz CBFV oscillations and sympathetic modulation. Absent effects of atropine on BP, CBFV, and 0.2 Hz BP and CBFV oscillations suggest that there is no direct parasympathetic influence on 0.2 Hz BP and CBFV modulation. (Stroke. 2013;44:1062-1069.)	[Hilz, Max J.; Koehn, Julia; Marthol, Harald; Koehrmann, Martin; Schwab, Stefan; Stemper, Brigitte] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [Hilz, Max J.] NYU, Dept Neurol, New York, NY 10016 USA; [Hilz, Max J.] NYU, Dept Med, New York, NY 10016 USA; [Hilz, Max J.] NYU, Dept Psychiat, New York, NY 10016 USA; [Tillmann, Alexandra] Klinikum Schwabing, Dept Dermatol, Munich, Germany; [Riss, Stephan] Univ Erlangen Nurnberg, Dept Ophthalmol, D-91054 Erlangen, Germany; [Wasmeier, Gerald] Klin Neustadt Ad Aisch, Dept Cardiol, Neustadt, Germany; [Stemper, Brigitte] Bayer HealthCare Pharmaceut, Berlin, Germany		Hilz, MJ (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, Schwabachanlage 6, D-91054 Erlangen, Germany.	max.hilz@uk-erlangen.de			International Brain Research Foundation, Flanders, NJ; Rolf- and Hubertine-Schiffbauer-Foundation, Hof, Germany; International Brain Research Foundation; Rolf- and Hubertine-Schiffbauer-Foundation	The study was partially funded by the International Brain Research Foundation, Flanders, NJ, and by the Rolf- and Hubertine-Schiffbauer-Foundation, Hof, Germany.; Dr Hilz received project funding from the International Brain Research Foundation, Rolf- and Hubertine-Schiffbauer-Foundation. Dr Stemper is an employee of Bayer HealthCare Pharmaceuticals.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Aminoff, 2002, NEUROMUSCULAR FUNCTI, P1899; Aminoff M, 1993, CLIN AUTONOMIC DISOR, P527; BERNARDI L, 1990, CARDIOVASC RES, V24, P969, DOI 10.1093/cvr/24.12.969; BERNARDI L, 1995, CIRCULATION, V92, P2895, DOI 10.1161/01.CIR.92.10.2895; Bernardi L, 1997, AM J PHYSIOL-HEART C, V273, pH1867, DOI 10.1152/ajpheart.1997.273.4.H1867; BERNARDI L, 1994, CLIN SCI, V87, P649, DOI 10.1042/cs0870649; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Brown CM, 2008, DIABETOLOGIA, V51, P756, DOI 10.1007/s00125-008-0958-3; Brown CM, 2003, EUR J CLIN INVEST, V33, P10, DOI 10.1046/j.1365-2362.2003.01093.x; Brown CM, 2002, CLIN SCI, V102, P623, DOI 10.1042/CS20010242; Brys M, 2003, AM J PHYSIOL-HEART C, V285, pH1048, DOI 10.1152/ajpheart.00062.2003; BURR RL, 1993, J ELECTROCARDIOL, V25, P224, DOI 10.1016/0022-0736(92)90108-C; Camm AJ, 1996, CIRCULATION, V93, P1043; Carlson, 1999, J Cardiovasc Pharmacol Ther, V4, P205, DOI 10.1177/107424849900400402; Cencetti S, 1999, HEART, V82, P365, DOI 10.1136/hrt.82.3.365; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Dutsch M, 2007, NEUROLOGY, V69, P2249, DOI 10.1212/01.wnl.0000286946.06639.a7; Edvinsson L, 1975, Acta Physiol Scand Suppl, V427, P1; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Goellner E, 2009, MED HYPOTHESES, V73, P410, DOI 10.1016/j.mehy.2009.01.055; Hamner JW, 2004, J PHYSIOL-LONDON, V559, P965, DOI 10.1113/jphysiol.2004.066969; Hering E, 1869, SBER AKAD WISS WI MN, V60, P829; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Hilz MJ, 2011, STROKE, V42, P1528, DOI 10.1161/STROKEAHA.110.607721; Hilz MJ, 2004, J NEUROL, V251, P564, DOI 10.1007/s00415-004-0364-9; Hilz MJ, 2000, FORTSCHR NEUROL PSYC, V68, P398, DOI 10.1055/s-2000-11798; Keyl C, 2000, CLIN SCI, V99, P113, DOI 10.1042/CS19990323; Lagi A, 2002, CLIN SCI, V103, P43; Lincoln J, 1995, PHARMACOL THERAPEUT, V68, P473, DOI 10.1016/0163-7258(95)02017-9; LOBATO RD, 1980, J NEUROSURG, V53, P480, DOI 10.3171/jns.1980.53.4.0480; Low PA, 1999, AM J MED SCI, V317, P124, DOI 10.1097/00000441-199902000-00007; Marthol H, 2006, DIABETOLOGIA, V49, P2481, DOI 10.1007/s00125-006-0368-3; Mayer SA, 1876, SB AKAD WISS WIEN MN, V74, P302; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; MORITA Y, 1995, ACTA PHYSIOL SCAND, V154, P121, DOI 10.1111/j.1748-1716.1995.tb09894.x; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Panerai RB, 2001, AM J PHYSIOL-HEART C, V280, pH2162, DOI 10.1152/ajpheart.2001.280.5.H2162; PARATI G, 1995, HYPERTENSION, V25, P1276, DOI 10.1161/01.HYP.25.6.1276; Poletto R, 2011, PHYSIOL BEHAV, V103, P188, DOI 10.1016/j.physbeh.2011.01.019; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; PURDY RE, 1977, STROKE, V8, P82, DOI 10.1161/01.STR.8.1.82; RADAELLI A, 1994, HYPERTENSION, V24, P556, DOI 10.1161/01.HYP.24.5.556; Reiter MJ, 2004, PROG CARDIOVASC DIS, V47, P11, DOI 10.1016/j.pcad.2004.04.004; RIMOLDI O, 1990, AM J PHYSIOL, V258, pH967, DOI 10.1152/ajpheart.1990.258.4.H967; SLEIGHT P, 1995, CLIN SCI, V88, P103, DOI 10.1042/cs0880103; Sohn YH, 1998, YONSEI MED J, V39, P322, DOI 10.3349/ymj.1998.39.4.322; Faleiros ATD, 2006, ARQ NEURO-PSIQUIAT, V64, P572, DOI 10.1590/S0004-282X2006000400006; Treggiari MM, 2003, STROKE, V34, P961, DOI 10.1161/01.STR.0000060893.72098.80; URSINO M, 1991, CRIT REV BIOMED ENG, V18, P255; WAHL M, 1993, ACTA NEUROCHIR, P3; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE	54	7	7	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	APR	2013	44	4					1062	1069		10.1161/STROKEAHA.111.680256			8	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Cardiovascular System & Cardiology	113NE	WOS:000316673900032	23422083	Bronze			2022-02-06	
J	Hoepner, JK; Turkstra, LS				Hoepner, Jerry K.; Turkstra, Lyn S.			Video-based administration of the La Trobe Communication Questionnaire for adults with traumatic brain injury and their communication partners	BRAIN INJURY			English	Article						Assessment; closed head injury; executive functioning; community integration; self-awareness; social reintegration	HEAD-INJURY; AWARENESS QUESTIONNAIRE; CAREGIVER BURDEN; SELF-AWARENESS; LANGUAGE; DEFICITS; ABILITY; RECALL; SKILLS; PERCEPTIONS	Primary objective: To explore the use of direct video-based review for administration of the LaTrobe Communication Questionnaire (LCQ), and explore use of the LCQ as a tool for identifying and prioritizing targets for partner-based intervention. Research design: Between-groups design comparing self-vs partner ratings of social communication behaviours in conversation and qualitative analysis of response patterns and participant feedback. Methods and procedures: Eight adults with moderate-to-severe TBI and their partners engaged in 20-minute videotaped conversations, elicited using a topic-starter task. Each participant with TBI and his or her partner then completed the LCQ while viewing the dyad's videotaped conversation. Self-and partner ratings of the person with TBI were compared to each other and to published LCQ data. Main outcomes and results: Based on direct review of their videotaped conversations, six of eight individuals with TBI rated themselves as having more frequent problem behaviours than did their partners. Overall agreement between individuals with TBI and their partners was 0.70. Conclusions: The present study suggests that direct review of videotaped conversations might avoid some of the limitations associated with recall of previous events, which can be biased toward negative events and confounded by memory impairments in individuals with TBI. Participants stated that the video segment reflected their typical interactions and, thus, behaviours observed in this context could serve as a starting point for intervention planning.	[Hoepner, Jerry K.] Univ Wisconsin, Eau Claire, WI 54702 USA; [Turkstra, Lyn S.] Univ Wisconsin, Madison, WI USA		Hoepner, JK (corresponding author), Univ Wisconsin, CCC SLP, 105 Garfield Ave, Eau Claire, WI 54702 USA.	hoepnejk@uwec.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	University of Wisconsin Foundation; Walker Foundation	The authors report no conflicts of interest. This work was supported in part by funds from the University of Wisconsin Foundation and the Walker Foundation.	Bandura A., 1997, SELF EFFICACY EXERCI; Broadbent DE, 1982, BRIT J CLIN PSYCHOL, V1, P1, DOI DOI 10.1111/J.2044-8260.1982.TB01421.X; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Buggey T, 2012, PSYCHOL SCHOOLS, V49, P52, DOI 10.1002/pits.20618; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Cream A, 2010, J SPEECH LANG HEAR R, V53, P887, DOI 10.1044/1092-4388(2009/09-0080); Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fiske ST, 1980, JOURNAL OF PERSONALI, V39, P889; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Halford WK, 2002, COGNITIVE THER RES, V26, P759, DOI 10.1023/A:1021289400436; Kennedy MRT, 2004, AM J SPEECH-LANG PAT, V13, P142, DOI 10.1044/1058-0360(2004/015); Kennedy MRT, 2003, BRAIN INJURY, V17, P1043, DOI 10.1080/0269905031000110436; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Kennedy MRT, 2006, METAMEMORY FOR NARRA; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; MacDonald MC, 2002, PSYCHOL REV, V109, P35, DOI 10.1037//0033-295X.109.1.35; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; MATT GE, 1992, CLIN PSYCHOL REV, V12, P227, DOI 10.1016/0272-7358(92)90116-P; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McGraw-Hunter M, 2006, BRAIN INJURY, V20, P1061, DOI 10.1080/02699050600912163; Ortiz J, 2012, PSYCHOL SCHOOLS, V49, P23, DOI 10.1002/pits.20615; Prater MA, 2012, PSYCHOL SCHOOLS, V49, P71, DOI 10.1002/pits.20617; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Turner S, 2006, APHASIOLOGY, V20, P616, DOI 10.1080/02687030600687860; Wallace CA, 2000, BRAIN INJURY, V14, P549; World Health Organisation, 2001, INTERNATIONAL CLASSI; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; YLVISAKER M, 1994, TOP LANG DISORD, V15, P37, DOI 10.1097/00011363-199411000-00005; Ylvisaker M., 1998, COLLABORATIVE BRAIN	45	7	7	0	14	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2013	27	4					464	472		10.3109/02699052.2013.765600			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	117LG	WOS:000316954300011	23472853				2022-02-06	
J	Lewis, VJ; Dell, L; Matthews, LR				Lewis, Virginia J.; Dell, Lisa; Matthews, Lynda R.			EVALUATING THE FEASIBILITY OF GOAL ATTAINMENT SCALING AS A REHABILITATION OUTCOME MEASURE FOR VETERANS	JOURNAL OF REHABILITATION MEDICINE			English	Article						activities of daily living; psychosocial; mental health; rehabilitation; vocational rehabilitation; veteran; PTSD	TRAUMATIC BRAIN-INJURY; CHALLENGES; DISABILITY; CARE	Objective: The increasing number of veterans with complex health conditions accessing rehabilitation leads to the need for an outcome measure that identifies success in areas beyond return to work. The current study was designed to assess the feasibility of Goal Attainment Scaling as a routine measure of outcomes of rehabilitation. Methods: Fifteen organisations contracted by the Australian Department of Veterans' Affairs to work with veterans were invited to trial Goal Attainment Scaling. Training was provided to rehabilitation professionals, and existing documentation was modified by the Australian Department of Veterans' Affairs to introduce the Goal Attainment Scaling approach. Results: Analysis of the use of Goal Attainment Scaling supported the feasibility and potential usefulness of the tool in a veteran population. Rehabilitation providers set goals across a range of domains including medical, psychological, social, as well as return to work. The quality of the goals and the outcome measures was generally good. Conclusions: The Goal Attainment Scaling approach was seen to support a client-focussed approach to rehabilitation. Data obtained through the use of Goal Attainment Scaling can be summarised at different levels to be useful for clients, providers, rehabilitation coordinators, and senior executives to monitor and report on the overall success of the different types of rehabilitation provided to veteran clients.	[Lewis, Virginia J.] La Trobe Univ, Australian Inst Primary Care & Ageing, Melbourne, Vic 3086, Australia; [Lewis, Virginia J.; Dell, Lisa] Univ Melbourne, Australian Ctr Posttraumat Mental Hlth, Melbourne, Vic, Australia; [Matthews, Lynda R.] Univ Sydney, Fac Hlth Sci, Work & Hlth Res Team, Ageing Work & Hlth Res Unit, Sydney, NSW 2006, Australia		Lewis, VJ (corresponding author), La Trobe Univ, Australian Inst Primary Care & Ageing, Melbourne, Vic 3086, Australia.	V.lewis@latrobe.edu.au	Matthews, Lynda R/C-7879-2009; Dell, Lisa/ABH-4002-2020	Matthews, Lynda R/0000-0002-9929-9086; Dell, Lisa/0000-0002-6870-5432; Lewis, Virginia/0000-0001-7802-625X	Australian Department of Veterans' AffairsUS Department of Veterans AffairsAustralian Government	The research reported in this paper was funded by the Australian Department of Veterans' Affairs. The views expressed in this article are those of the authors and do not reflect the official policy or position of the Australian Department of Veterans' Affairs. The authors have declared that no competing interests exist.	Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741; Bruce T. J., 2005, EVIDENCE BASED PRACT, P220; Burke HS, 2009, J REHABIL, V75, P5; Cardillo JE., 1994, GOAL ATTAINMENT SCAL; Commonwealth of Australia Department of Veterans' Affairs, 2003, REV VET ENT CLARK RE; Conneeley A. L., 2004, BR J OCCUP THER, V67, P248, DOI DOI 10.1177/030802260406700603; Ertzgaard P, 2011, J REHABIL MED, V43, P8, DOI 10.2340/16501977-0664; Hurn J, 2006, CLIN REHABIL, V20, P756, DOI 10.1177/0269215506070793; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Lewis V, 2011, INT J DISABIL MANAGE, V6, P10; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; Mailloux Z, 2007, AM J OCCUP THER, V61, P254, DOI 10.5014/ajot.61.2.254; McClain Colleen, 2005, Top Stroke Rehabil, V12, P56, DOI 10.1310/ELB1-EGKF-QUQC-VFE9; McLaren C., 2003, AUST OCCUP THER J, P216, DOI DOI 10.1046/1.1440-1630.2003.00379.X; Sandberg MA, 2009, CLIN NEUROPSYCHOL, V23, P1416, DOI 10.1080/13854040903369425; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Turner-Stokes L, 2011, J REHABIL MED, V43, P70, DOI 10.2340/16501977-0656; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Uomoto JM, 2009, REHABIL PSYCHOL, V54, P259, DOI 10.1037/a0016907; WILLER B, 1976, J CLIN PSYCHOL, V32, P687, DOI 10.1002/1097-4679(197607)32:3<687::AID-JCLP2270320343>3.0.CO;2-V; WILLIAMS RC, 1987, CLIN J PAIN, V2, P219	22	7	7	0	21	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2013	45	4					403	409		10.2340/16501977-1131			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	127NO	WOS:000317705900013	23546308	Green Submitted, gold			2022-02-06	
J	Olson-Madden, JH; Brenner, LA; Matarazzo, BB; Signoracci, GM				Olson-Madden, Jennifer H.; Brenner, Lisa A.; Matarazzo, Bridget B.; Signoracci, Gina M.		Expert Consensus Collaborators	Identification and Treatment of TBI and Co-occurring Psychiatric Symptoms Among OEF/OIF/OND Veterans Seeking Mental Health Services Within the State of Colorado: Establishing Consensus for Best Practices	COMMUNITY MENTAL HEALTH JOURNAL			English	Article						Traumatic brain injury; Mental health; Assessment; Intervention; Implementation	TRAUMATIC BRAIN-INJURY; IMPLEMENTATION; RELIABILITY; VALIDITY	This paper highlights the results of a consensus meeting regarding best practices for the assessment and treatment of co-occurring traumatic brain injury (TBI) and mental health (MH) problems among Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn Veterans seeking care in non-Veterans Affairs Colorado community MH settings. Twenty individuals with expertise in TBI screening, assessment, and intervention, as well as the state MH system, convened to establish and review questions and assumptions regarding care for this Veteran population. Unanimous consensus regarding best practices was achieved. Recommendations for improving care for Veterans seeking care in community MH settings are provided.	[Olson-Madden, Jennifer H.; Brenner, Lisa A.; Matarazzo, Bridget B.; Signoracci, Gina M.] MIRECC, VISN 19, Denver, CO 80220 USA; [Olson-Madden, Jennifer H.; Brenner, Lisa A.; Matarazzo, Bridget B.; Signoracci, Gina M.] Univ Colorado, Sch Med, Dept Psychiat, Denver, CO 80262 USA; [Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Neurol, Denver, CO USA; [Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Denver, CO USA		Olson-Madden, JH (corresponding author), MIRECC, VISN 19, 1055 Clermont St, Denver, CO 80220 USA.	jennifer.olson-madden@va.gov	Brenner, Lisa A./AAG-2442-2019; Signoracci, Gina M./Q-3782-2019				[Anonymous], 2010, INT CLASSIFICATION F; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brenner L. A., J HEAD TRAU IN PRESS; Centers for Disease Control and Prevention (CDC), 2011, INJ PREV CONTR TRAUM; Colorado Department of Health Care Policy and Financing, 2009, BHO PRACT STAND EV T; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Department of Health Care Policy and Financing, 2009, BHO CONTR EXH COV ME; Eccles MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-1; Harvey G, 2002, J ADV NURS, V37, P577, DOI 10.1046/j.1365-2648.2002.02126.x; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Kitson A, 1998, QUAL HEALTH CARE, V7, P149, DOI 10.1136/qshc.7.3.149; Lewis H., 2008, COLORADO NEEDS RESOU; McHugh RK, 2010, AM PSYCHOL, V65, P73, DOI 10.1037/a0018121; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Rogers EM., 2003, DIFFUSION INNOVATION, V5; Rubenstein LV, 2006, J GEN INTERN MED, V21, pS58, DOI 10.1111/j.1525-1497.2006.00364.x; Scott RL, 2001, RES SOCIAL WORK PRAC, V11, P373, DOI 10.1177/104973150101100306; Signoracci G. M., FRONTIERS SUICIDE PR; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468	21	7	7	0	6	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0010-3853			COMMUNITY MENT HLT J	Community Ment. Health J.	APR	2013	49	2					220	229		10.1007/s10597-012-9572-4			10	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	136MS	WOS:000318366600012	23325070				2022-02-06	
J	Pais, V; Danaila, L; Pais, E				Pais, Viorel; Danaila, Leon; Pais, Emil			Ultrastructural Patterns of the Activated Cell Death Programs in the Human Brain	ULTRASTRUCTURAL PATHOLOGY			English	Article						Apoptosis; autophagy; autoschizis; brain; paraptosis; programmed necrosis	AUTOPHAGY; AUTOSCHIZIS; INFLAMMATION; APOPTOSIS	The authors analyzed by transmission electron microscopy (TEM) neurosurgical samples obtained from patients with cerebral tumors, neurotrauma, cerebral ischemia, Moyamoya disease, encephalitis, etc. Their observations concern a variety of dying cell types by different programmed death pathways, including apoptosis, paraptosis, autophagy, autoschizis, programmed necrosis, as well as combined and coexisting forms. This ample work pointed out not only the role of TEM in cell death diagnosis, but the biological differences in cell behavior and beneficial or detrimental effects of suicides for homeostasis, survival, or normal functioning of a tissue, like the integrated vascular tissue and brain parenchyma.	[Pais, Viorel] Natl Inst Neurol & Neurovasc Dis, Dept Neurosurg, Bucharest, Romania; Spectral Mol Imaging, Los Angeles, CA USA		Pais, V (corresponding author), Natl Inst Neurol & Neurovasc Dis, Dept Neurosurg, Bucharest, Romania.	viorelpais@hotmail.com	Pais, Emil Sebastian/H-7155-2013	Pais, Emil Sebastian/0000-0002-0245-671X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1S10RR23057]; CNSI at UCLA; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR023057] Funding Source: NIH RePORTER	The authors acknowledge the use of instruments at the Electron Imaging Center for NanoMachines supported by NIH (1S10RR23057 to ZHZ) and CNSI at UCLA.	Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gilloteaux J, 2010, ULTRASTRUCT PATHOL, V34, P140, DOI 10.3109/01913121003662304; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Jamison JM, 2002, BIOCHEM PHARMACOL, V63, P1773, DOI 10.1016/S0006-2952(02)00904-8; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lobysheva NV, 2009, NEUROCHEM INT, V54, P322, DOI 10.1016/j.neuint.2008.12.015; Northington FJ, 2011, ANN NEUROL, V69, P743, DOI 10.1002/ana.22419; Pais V, 2011, ULTRASTRUCTURE DYING; Pais V, 2009, PROGRAMMED CELL DEAT; Pais V, 2012, ULTRASTRUCT PATHOL, V36, P166, DOI 10.3109/01913123.2012.655856; Park SH, 2002, ULTRASTRUCT PATHOL, V26, P287, DOI 10.1080/01913120290104557; Sperandio S, 2010, J CELL BIOCHEM, V111, P1401, DOI 10.1002/jcb.22870; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang WB, 2012, J CELL PHYSIOL, V227, P2196, DOI 10.1002/jcp.22956; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0	16	7	7	0	10	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0191-3123			ULTRASTRUCT PATHOL	Ultrastruct. Pathol.	APR	2013	37	2					110	120		10.3109/01913123.2012.751949			11	Microscopy; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Microscopy; Pathology	124XQ	WOS:000317502400003	23573891				2022-02-06	
J	Stecker, M; Wolfe, J; Stevenson, M				Stecker, Mark; Wolfe, Jacob; Stevenson, Matthew			Neurophysiologic responses of peripheral nerve to anoxia: Effects of hypothermia and age	CLINICAL NEUROPHYSIOLOGY			English	Article						Anoxia; Ischemia; Peripheral nerve; Nerve conduction; Velocity; Hypothermia	TRAUMATIC BRAIN-INJURY; HUMAN MOTOR AXONS; CNS WHITE MATTER; CIRCULATORY ARREST; EXCITABILITY PROPERTIES; PROPAGATION SPEED; EVOKED-POTENTIALS; MYELINATED NERVE; EXTERNAL NA; TEMPERATURE	Objective: Quantify how temperature and age modulate the effects of multiple periods of anoxia on peripheral nerve. Methods: Nerve action potentials (NAP) recorded from rat sciatic nerve in vitro. Effects of multiple cycles of anoxia on the NAP are evaluated as functions of temperature and age. In some experiments, the nerve was held at constant temperature and others the nerve was hypothermic only during anoxia and returned to 36 degrees C with restoration of oxygen. Results: Hypothermia mitigates the effect of anoxia on the NAP, an effect that increases with multiple cycles of anoxia. Preservation of the NAP waveform after 5 cycles of anoxia is best when hypothermia is delivered only during anoxia. Hypothermia reduces the rate at which the NAP disappears during anoxia but has a limited effect on the rate of recovery. With intermittent hypothermia the amplitude of the NAP is best preserved with temperatures of 15-22 degrees C. Velocity and duration are best preserved below 25 degrees C. The loss of the NAP during anoxia is slower in the older nerves. Conclusions: Lower temperatures improve the recovery of the NAP from anoxia and increase the time it takes for the NAP to disappear during anoxia as does increasing age. Significance: Document the effects of hypothermia on the anoxia response as a step toward understanding its nerve protectant effect. (c) 2012 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Stecker, Mark; Stevenson, Matthew] Winthrop Univ Hosp, Mineola, NY 11530 USA; [Wolfe, Jacob] Marshall Univ, Huntington, WV 25701 USA		Stecker, M (corresponding author), Winthrop Univ Hosp, Dept Neurosci, 222 Stn Plaza North,Suite 408, Mineola, NY 11501 USA.	mmstecker@gmail.com		Stecker, Mark/0000-0002-9632-168X			Baylor K, 2009, CRYOBIOLOGY, V59, P12, DOI 10.1016/j.cryobiol.2009.01.006; BOSTOCK H, 1994, BRAIN, V117, P225, DOI 10.1093/brain/117.2.225; COSELLI JS, 1988, ANN THORAC SURG, V45, P638, DOI 10.1016/S0003-4975(10)64766-2; DELBEKE J, 1978, J NEUROL NEUROSUR PS, V41, P65, DOI 10.1136/jnnp.41.1.65; Gerard RW, 1930, AM J PHYSIOL, V92, P498, DOI 10.1152/ajplegacy.1930.92.2.498; Gerard RW, 1932, PHYSIOL REV, V12, P0469, DOI 10.1152/physrev.1932.12.4.469; HARDY WL, 1973, BIOPHYS J, V13, P1071, DOI 10.1016/S0006-3495(73)86046-1; HARDY WL, 1973, BIOPHYS J, V13, P1054, DOI 10.1016/S0006-3495(73)86045-X; HOFTEIG JH, 1982, J NEUROCHEM, V39, P401, DOI 10.1111/j.1471-4159.1982.tb03961.x; Holzer M, 2005, CRIT CARE MED, V33, P414, DOI 10.1097/01.CCM.0000153410.87750.53; Kiernan MC, 2001, BRAIN, V124, P816, DOI 10.1093/brain/124.4.816; Kiernan MC, 2000, BRAIN, V123, P2542, DOI 10.1093/brain/123.12.2542; LOUIS AA, 1986, ELECTROEN CLIN NEURO, V63, P371, DOI 10.1016/0013-4694(86)90022-2; LOW PA, 1986, J PHYSIOL-LONDON, V374, P263, DOI 10.1113/jphysiol.1986.sp016078; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MORIKAWA E, 1992, J CEREBR BLOOD F MET, V12, P380, DOI 10.1038/jcbfm.1992.55; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; SOLOMON RA, 1991, NEUROSURGERY, V29, P732, DOI 10.1227/00006123-199111000-00015; Stecker MM, 2009, CRYOBIOLOGY, V59, P1, DOI 10.1016/j.cryobiol.2009.01.003; Stecker MM, 2001, ANN THORAC SURG, V71, P22, DOI 10.1016/S0003-4975(00)02021-X; Stecker MM, 2001, ANN THORAC SURG, V71, P14, DOI 10.1016/S0003-4975(00)01592-7; STEEN PA, 1980, ANESTHESIOLOGY, V53, P183; STYS PK, 1992, J CEREBR BLOOD F MET, V12, P977, DOI 10.1038/jcbfm.1992.135; STYS PK, 1992, J NEUROPHYSIOL, V67, P236, DOI 10.1152/jn.1992.67.1.236; Suehiro E, 1999, J NEUROTRAUM, V16, P285, DOI 10.1089/neu.1999.16.285; SVENSSON LG, 1993, J THORAC CARDIOV SUR, V106, P19, DOI 10.1016/S0022-5223(19)33737-7; THARION J, 1982, J THORAC CARDIOV SUR, V84, P66; WEIGL P, 1989, ELECTROEN CLIN NEURO, V73, P369, DOI 10.1016/0013-4694(89)90115-6; Yenari M, 2008, STROKE, V39, P2910, DOI 10.1161/STROKEAHA.108.514471; YOKOTA T, 1994, J NEUROL SCI, V124, P220, DOI 10.1016/0022-510X(94)90330-1	30	7	7	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457			CLIN NEUROPHYSIOL	Clin. Neurophysiol.	APR	2013	124	4					801	808		10.1016/j.clinph.2012.09.014			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	115CE	WOS:000316789200024	23084078				2022-02-06	
J	Wang, EW; Huang, JH				Wang, Ernest W.; Huang, Jason H.			Understanding and treating blast traumatic brain injury in the combat theater	NEUROLOGICAL RESEARCH			English	Article						Blast injury; Traumatic brain injury; GCS; Combat neurosurgery; Decompressive craniectomy	DECOMPRESSIVE CRANIECTOMY; INDUCED NEUROTRAUMA; IRAQI FREEDOM; AFGHANISTAN; PATHOLOGY; TBI; EXPOSURE	Objectives: Blast injury is a frequent cause of traumatic brain injury (TBI) in the modern combat theater. We sought to explain the research and treatment associated with this injury. Methods: We reviewed literature on the prevalence of blast TBI (bTBI), blast injury mechanisms, research, and perspectives on the neurosurgical experience treating bTBI. Results: A majority of combat-related casualties in recent wars are due to blast. A majority of survivors of blast injuries are diagnosed with TBI. Blast injury may induce changes in the brain not seen with non-blast-related mechanisms. However, long-term symptoms are not significantly different from non-blast mechanisms. Aggressive decompressive craniectomies are commonly performed in the combat theater. Discussion: Due to the prevalence and debilitating nature of bTBI, understanding injury mechanisms is crucial in treating the injury before symptoms become permanent. Treatment is currently limited to decompressive craniectomies, which are the most effective treatment for a relatively young and fit military population.	[Wang, Ernest W.; Huang, Jason H.] Univ Rochester, Dept Neurosurg, Rochester, NY 14642 USA		Huang, JH (corresponding author), Univ Rochester, Dept Neurosurg, 601 Elmwood Ave,670, Rochester, NY 14642 USA.	Jason_Huang@urmc.rochester.edu	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168			Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Department of Defense, 2010, DEM 2010 PROF MIL CO; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Golding H, 2009, J REHABIL RES DEV, V46, pVII, DOI 10.1682/JRRD.2009.06.0081; Huang JH, 2008, NEUROSURGERY, V62, P1412, DOI 10.1227/01.neu.0000333492.48818.1b; Knudsen SK, 2003, NEUROSCI RES, V46, P377, DOI 10.1016/S0168-0102(03)00101-9; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ritenour AE, 2010, ANN SURG, V251, P1140, DOI 10.1097/SLA.0b013e3181e01270; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Schlifka B, 2007, J TRAUMA, V62, pS103, DOI 10.1097/TA.0b013e318065b4e5; Schneider GH, 2002, ACT NEUR S, V81, P77; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Vanden Brook T, 2012, US TODAY; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whitlock Craig, 2010, WASHINGTON POST; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Yilmaz S, 2007, AM J EMERG MED, V25, P97, DOI 10.1016/j.ajem.2006.04.014	33	7	8	3	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	APR	2013	35	3					285	289		10.1179/1743132812Y.0000000138			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	104QW	WOS:000316010700009	23336263				2022-02-06	
J	Han, EY; Chun, MH; Kim, ST; Lim, DP				Han, Eun Young; Chun, Min Ho; Kim, Sang Tae; Lim, Dong-pyo			Injection Time-Dependent Effect of Adult Human Bone Marrow Stromal Cell Transplantation in a Rat Model of Severe Traumatic Brain Injury	CURRENT STEM CELL RESEARCH & THERAPY			English	Article						Human bone marrow stromal cells; injection timing; traumatic brain injury	MESENCHYMAL STEM-CELLS; PROGENITOR CELLS; ADIPOSE-TISSUE; NEUROGENESIS; THERAPY; SCAR	The object of this study is to evaluate the effects of injecting adult human bone marrow stromal cells (hBMSCs) into rats with severe traumatic brain injury in acute phase and to determine more optimal injection timing between day 1 and day 2 postinjury. The lateral fluid percussion injury model was used. Adult hBMSCs were transplanted into hemisphere to injury sites in the corpus callosum ipsilateral on day 1 (n = 12) or day 7 (n = 8) after injury. A control group (n = 7) underwent only a sham operation without stem cell transplantation. Rats in all groups were analyzed by magnetic resonance spectroscopy (MRS), and by using behavioral, rotarod, and Barnes maze tests on day 1, 7, 14, and 42. Another nine randomly designated rats were sacrificed for immunohistochemical staining. Behavioral test scores increased significantly at all time-points after TBI in the day 7-injected group, compared to the others (p=0.008). GFAP staining was lower on day 42 in day 7-injected rats than in those injected on day 1. But no significant inter-or intra-group differences were observed for other tests. The injection of hBMSCs was found to have limited therapeutic potential with respect to neuroprotection after traumatic brain injury. However, because injection on day 7 after TBI produced greater functional improvements in neurobehavioral tests and more effectively suppressed astroglial activation than an injection on post-injury day 1, we cautiously recommend the injection time of day 7 post injury in hBMSCs transplantation in severe TBI, rather than day 1 post injury but further studies on developing hBMSC-based new therapeutic approaches should be warranted for improving neuroprotection in severe TBI.	[Han, Eun Young] Jeju Natl Univ Hosp, Dept Rehabil Med, Seoul, South Korea; [Chun, Min Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rehabil Med, Seoul, South Korea; [Kim, Sang Tae; Lim, Dong-pyo] Univ Ulsan, Coll Med, ASAN Inst Life Sci, NMR Lab, Seoul, South Korea		Chun, MH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rehabil Med, Seoul, South Korea.	mhchun@amc.seoul.kr			Asan Institute for Life Sciences research [2008-314]	This study was supported by the Asan Institute for Life Sciences research (2008-314).	Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215; Cafferty WBJ, 2007, J NEUROSCI, V27, P2176, DOI 10.1523/JNEUROSCI.5176-06.2007; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Dezawa M, 2005, CURR MOL MED, V5, P723, DOI 10.2174/156652405774641070; Elfenbein GJ, 2005, PEDIATR TRANSPLANT, V9, P37, DOI 10.1111/j.1399-3046.2005.00444.x; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Fruehauf S, 2005, CYTOTHERAPY, V7, P438, DOI 10.1080/14653240500319135; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Goldman SA, 1998, J NEUROBIOL, V36, P267, DOI 10.1002/(SICI)1097-4695(199808)36:2<267::AID-NEU12>3.3.CO;2-N; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Haas S, 2005, CURR OPIN NEUROL, V18, P59, DOI 10.1097/00019052-200502000-00012; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Heile Anna, 2011, Dialogues Clin Neurosci, V13, P279; Humphreys B D, 2006, Minerva Urol Nefrol, V58, P13; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kang SH, 2009, ANN REHABIL MED-ARM, V33, P520; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; Koide Y, 2007, STEM CELLS, V25, P1213, DOI 10.1634/stemcells.2006-0325; Levy YS, 2004, J MOL NEUROSCI, V24, P353, DOI 10.1385/JMN:24:3:353; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Morigi M, 2006, CELL TRANSPLANT, V15, pS111; Moseley TA, 2006, PLAST RECONSTR SURG, V118, p121S, DOI 10.1097/01.prs.0000234609.74811.2e; Nakagami H, 2006, J ATHEROSCLER THROMB, V13, P77, DOI 10.5551/jat.13.77; Pincus DW, 1998, ANN NEUROL, V43, P576, DOI 10.1002/ana.410430505; Roy NS, 2000, NAT MED, V6, P271; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sohur US, 2006, PHILOS T R SOC B, V361, P1477, DOI 10.1098/rstb.2006.1887; Sottile V, 2007, CELL TISSUE RES, V328, P1, DOI 10.1007/s00441-006-0361-7; Sykova E, 2007, CELL DEATH DIFFER, V14, P1336, DOI 10.1038/sj.cdd.4402140; Taupin P, 2006, CURR OPIN MOL THER, V8, P345; Teng L, 2006, ADV EXP MED BIOL, V589, P206; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; Tholpady SS, 2006, CLIN PLAST SURG, V33, P55, DOI 10.1016/j.cps.2005.08.004; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tu ZD, 2010, STEM CELLS DEV, V19, P1803, DOI 10.1089/scd.2009.0418; Ugoya SO, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/141624; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Yang HS, 2006, ANN REHABIL MED-ARM, V30, P333; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004; Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403	48	7	9	0	5	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1574-888X	2212-3946		CURR STEM CELL RES T	Curr. Stem Cell Res. Ther.	MAR	2013	8	2					172	181					10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	129NB	WOS:000317846400008	23363468				2022-02-06	
J	Isom, AM; Gudelsky, GA; Benoit, SC; Richtand, NM				Isom, Amanda M.; Gudelsky, Gary A.; Benoit, Stephen C.; Richtand, Neil M.			Antipsychotic medications, glutamate, and cell death: A hidden, but common medication side effect?	MEDICAL HYPOTHESES			English	Article							HYPOGLYCEMIC NEURONAL DEATH; INTENSIVE-CARE-UNIT; AMINO-ACID; EXTRACELLULAR GLUTAMATE; DIABETES-MELLITUS; RECEPTOR-BINDING; PERMEABILITY TRANSITION; ATYPICAL ANTIPSYCHOTICS; CHRONIC HALOPERIDOL; METABOLIC SYNDROME	We hypothesize the interaction between antipsychotic medications and regulation of extracellular glutamate which has gone largely unnoticed in the medical community has significant clinical importance. Typical antipsychotic medications such as haloperidol elevate extracellular glutamate because they exert antagonist effects on dopamine D-2 and serotonin 5HT(1A) receptors. In contrast, serotonin 5HT(2A) receptor antagonists inhibit glutamate release. Glutamate is potentially excitotoxic through effects on ionotropic receptor channels and may exert synergistic effects with other neurotoxic pathways. In contrast to typical antipsychotic drugs, pharmacological properties of atypical antipsychotic medications at dopamine D-2, serotonin 5HT(1A) and 5HT(2A) receptors limit extracellular glutamate and may theoretically be neuroprotective in certain clinical settings. In this review we discuss three common clinical settings in which typical antipsychotic medications may potentiate neurotoxicity by elevating extracellular glutamate. The most common clinical setting, hypoglycemia during combined use of antipsychotic medications and insulin, presents a theoretical risk for 35 million diabetic patients worldwide using antipsychotic medications. Antipsychotic medication treatment during hypoxic episodes in the intensive care unit and following traumatic brain injury are two other common clinical settings in which this interaction poses theoretical risk. Further study is needed to test hypothesized risk mechanisms, and determine clinical and epidemiological consequences of these exposures. Published by Elsevier Ltd.	[Richtand, Neil M.] Dept Vet Affairs Med Ctr, Psychiat Serv, Cincinnati, OH 45220 USA; [Isom, Amanda M.; Benoit, Stephen C.; Richtand, Neil M.] Univ Cincinnati, Coll Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45267 USA; [Isom, Amanda M.; Gudelsky, Gary A.; Benoit, Stephen C.; Richtand, Neil M.] Univ Cincinnati, Grad Program Neurosci, Cincinnati, OH 45267 USA; [Gudelsky, Gary A.] James Winkle Coll Pharm, Cincinnati, OH 45267 USA		Isom, AM (corresponding author), Univ Cincinnati, Coll Med, 231 Albert Sabin Way,ML 0583, Cincinnati, OH 45267 USA.	isomaa@mail.uc.edu			Department of Veterans Affairs Medical Research ServiceUS Department of Veterans Affairs; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH083192-01]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH083192] Funding Source: NIH RePORTER	Supported by the Department of Veterans Affairs Medical Research Service and the National Institute of Mental Health (R21MH083192-01).	ADAMS F, 1988, J CLIN PSYCHIAT, V49, P22; Aghajanian GK, 2000, BRAIN RES REV, V31, P302, DOI 10.1016/S0165-0173(99)00046-6; Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; *AM PSYCH ASS, 1999, PRACT GUID TREATM PA; AUER R, 1985, ACTA NEUROPATHOL, V67, P279, DOI 10.1007/BF00687813; Auer RN, 2004, METAB BRAIN DIS, V19, P169, DOI 10.1023/B:MEBR.0000043967.78763.5b; AUER RN, 1993, BAILLIERE CLIN ENDOC, V7, P611, DOI 10.1016/S0950-351X(05)80210-1; Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; BARDGETT ME, 1993, EUR J PHARMACOL, V230, P245, DOI 10.1016/0014-2999(93)90557-X; Behrendt CE, 2000, CHEST, V118, P1100, DOI 10.1378/chest.118.4.1100; Berends AC, 2005, CNS DRUG REV, V11, P379; Bromet EJ, 1999, BIOL PSYCHIAT, V46, P871, DOI 10.1016/S0006-3223(99)00153-5; BUTCHER SP, 1987, J NEUROCHEM, V48, P722, DOI 10.1111/j.1471-4159.1987.tb05576.x; Camacho A, 2006, ARCH MED RES, V37, P11, DOI 10.1016/j.arcmed.2005.05.014; CAREY ME, 1981, J NEUROSURG, V54, P370, DOI 10.3171/jns.1981.54.3.0370; Cassidy F, 1999, AM J PSYCHIAT, V156, P1417; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; DALY DA, 1993, NEUROSCI LETT, V152, P61, DOI 10.1016/0304-3940(93)90483-2; Dani JA, 2004, NEURON, V42, P522, DOI 10.1016/j.neuron.2004.05.008; Dixon L, 2000, SCHIZOPHRENIA BULL, V26, P903, DOI 10.1093/oxfordjournals.schbul.a033504; Donnelly LA, 2005, DIABETIC MED, V22, P749, DOI 10.1111/j.1464-5491.2005.01501.x; Ely EW, 2004, CRIT CARE MED, V32, P106, DOI 10.1097/01.CCM.0000098033.94737.84; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FITZGERALD LW, 1995, J NEUROSCI, V15, P2453, DOI 10.1523/JNEUROSCI.15-03-02453.1995; Fleminger S, 2003, BMJ-BRIT MED J, V327, P4, DOI 10.1136/bmj.327.7405.4; Freedman R, 2005, NEW ENGL J MED, V353, P1286, DOI 10.1056/NEJMe058200; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; Fumagalli F, 2008, MOL PHARMACOL, V73, P1484, DOI 10.1124/mol.107.043786; Gardoni F, 2008, EUR NEUROPSYCHOPHARM, V18, P531, DOI 10.1016/j.euroneuro.2007.10.004; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; Goldstein LB, 2002, NEUROREHAB NEURAL RE, V16, P321, DOI 10.1177/154596830201600402; GOLDSTEIN LB, 1995, J NEUROL NEUROSUR PS, V58, P753, DOI 10.1136/jnnp.58.6.753; Gough Stephen C L, 2005, J Psychopharmacol, V19, P47, DOI 10.1177/0269881105058380; Grant BF, 2005, J CLIN PSYCHIAT, V66, P1205, DOI 10.4088/JCP.v66n1001; Hatzipetros T, 2006, BRAIN RES, V1076, P60, DOI 10.1016/j.brainres.2006.01.015; HEPBURN DA, 1993, DIABETIC MED, V10, P231, DOI 10.1111/j.1464-5491.1993.tb00050.x; Hernandez-Fonseca K, 2008, J NEUROSCI RES, V86, P1768, DOI 10.1002/jnr.21634; Isaev NK, 2007, BIOCHEMISTRY-MOSCOW+, V72, P471, DOI 10.1134/S0006297907050021; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Jakob SM, 1997, INTENS CARE MED, V23, P1165, DOI 10.1007/s001340050474; Kapur S, 2000, ARCH GEN PSYCHIAT, V57, P553, DOI 10.1001/archpsyc.57.6.553; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Konradi C, 2003, PHARMACOL THERAPEUT, V97, P153, DOI 10.1016/S0163-7258(02)00328-5; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lawler CP, 1999, NEUROPSYCHOPHARMACOL, V20, P612, DOI 10.1016/S0893-133X(98)00099-2; Leveque JC, 2000, J NEUROSCI, V20, P4011; Lohr JB, 2003, CNS DRUGS, V17, P47, DOI 10.2165/00023210-200317010-00004; Maciel EN, 2001, J NEUROCHEM, V79, P1237, DOI 10.1046/j.1471-4159.2001.00670.x; Madl JE, 1999, NEUROSCIENCE, V94, P417, DOI 10.1016/S0306-4522(99)00340-1; McIntyre Roger S, 2005, Ann Clin Psychiatry, V17, P83, DOI 10.1080/10401230590932380; Meller R, 2002, J NEUROSCI RES, V67, P399, DOI 10.1002/jnr.10126; Meltzer HY, 1999, NEUROPSYCHOPHARMACOL, V21, pS106, DOI 10.1016/S0893-133X(99)00046-9; Meyer JM, 2009, ACTA PSYCHIAT SCAND, V119, P4, DOI 10.1111/j.1600-0447.2008.01317.x; Muller DJ, 2006, PHARMACOGENOMICS, V7, P863, DOI 10.2217/14622416.7.6.863; Mukherjee S, 1996, COMPR PSYCHIAT, V37, P68, DOI 10.1016/S0010-440X(96)90054-1; Nagy J, 2004, CNS NEUROL DISORD-DR, V3, P169, DOI 10.2174/1568007043337409; Newman-Tancredi A, 1998, EUR J PHARMACOL, V355, P245, DOI 10.1016/S0014-2999(98)00483-X; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; PHILLIS JW, 1989, NEUROSCI LETT, V106, P147, DOI 10.1016/0304-3940(89)90217-6; Pietraszek M, 2002, N-S ARCH PHARMACOL, V366, P417, DOI 10.1007/s00210-002-0619-x; Pramyothin P, 2010, CURR OPIN ENDOCRINOL, V17, P460, DOI 10.1097/MED.0b013e32833de61c; Rao R, 2009, PEDIATR RES, V66, P642, DOI 10.1203/PDR.0b013e3181bbce69; Rao VLR, 2001, BRAIN RES, V911, P96; Regenold WT, 2002, J AFFECT DISORDERS, V70, P19, DOI 10.1016/S0165-0327(01)00456-6; Reynolds GP, 2010, PHARMACOL THERAPEUT, V125, P169, DOI 10.1016/j.pharmthera.2009.10.010; Richtand NM, 2007, NEUROPSYCHOPHARMACOL, V32, P1715, DOI 10.1038/sj.npp.1301305; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Ruzickova M, 2003, CAN J PSYCHIAT, V48, P458, DOI 10.1177/070674370304800705; SANDBERG M, 1986, J NEUROCHEM, V47, P178; SANDERS KM, 1991, J CLIN PSYCHOPHARM, V11, P146, DOI 10.1097/00004714-199104000-00021; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Schmitt A, 2003, NEUROCHEM RES, V28, P235, DOI 10.1023/A:1022325116309; Schwenkreis P, 2004, WORLD J BIOL PSYCHIA, V5, P73, DOI 10.1080/15622970410029915; SEE RE, 1994, EUR J PHARMACOL, V263, P269, DOI 10.1016/0014-2999(94)90722-6; SEEMAN P, 1976, NATURE, V261, P717, DOI 10.1038/261717a0; Segnitz N, 2011, PSYCHOPHARMACOLOGY, V217, P127, DOI 10.1007/s00213-011-2262-z; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; SILVERSTEIN FS, 1990, ANN NEUROL, V28, P516, DOI 10.1002/ana.410280408; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2003, J NEUROSCI, V23, P10681; Trotti D, 1997, EUR J NEUROSCI, V9, P1236, DOI 10.1111/j.1460-9568.1997.tb01478.x; Wang SJ, 2005, SYNAPSE, V55, P156, DOI 10.1002/syn.20104; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB; YAMAMOTO BK, 1994, J CLIN PSYCHIAT, V55, P8; YAMAMOTO BK, 1992, J NEUROCHEM, V58, P1736, DOI 10.1111/j.1471-4159.1992.tb10048.x; YAMAMOTO BK, 1994, J NEUROSCI, V14, P4159; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	98	7	7	0	12	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	MAR	2013	80	3					252	258		10.1016/j.mehy.2012.11.042			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	102GZ	WOS:000315834400010	23265349				2022-02-06	
J	Lee, DH; Lee, JY; Oh, BM; Phi, JH; Kim, SK; Bang, MS; Kim, SU; Wang, KC				Lee, Do-Hun; Lee, Ji Yeoun; Oh, Byung-Mo; Phi, Ji Hoon; Kim, Seung-Ki; Bang, Moon Suk; Kim, Seung U.; Wang, Kyu-Chang			Functional recovery after injury of motor cortex in rats: effects of rehabilitation and stem cell transplantation in a traumatic brain injury model of cortical resection	CHILDS NERVOUS SYSTEM			English	Article						Cortical resection; Rehabilitation; Exogenous neural stem cell transplantation; Combination therapy; Motor-evoked potential	INTRACEREBRAL HEMORRHAGE; ENVIRONMENTAL ENRICHMENT; EVOKED-POTENTIALS; STROKE MODEL; NEUROGENESIS; DIFFERENTIATION; THERAPY; ALTERS; GROWTH; PRECURSORS	Experimental studies and clinical trials designed to help patients recover from various brain injuries, such as stroke or trauma, have been attempted. Rehabilitation has shown reliable, positive clinical outcome in patients with various brain injuries. Transplantation of exogenous neural stem cells (NSCs) to repair the injured brain is a potential tool to help patient recovery. This study aimed to evaluate the therapeutic efficacy of a combination therapy consisting of rehabilitation and NSC transplantation compared to using only one modality. A model of motor cortex resection in rats was used to create brain injury in order to obtain consistent and prolonged functional deficits. The therapeutic results were evaluated using three methods during an 8-week period with a behavioral test, motor-evoked potential (MEP) measurement, and measurement of the degree of endogenous NSC production. All three treatment groups showed the effects of treatment in the behavioral test, although the NSC transplantation alone group (CN) exhibited slightly worse results than the rehabilitation alone group (CR) or the combination therapy group (CNR). The latency on MEP was shortened to a similar extent in all three groups compared to the untreated group (CO). However, the enhancement of endogenous NSC proliferation was dramatically reduced in the CN group compared not only to the CR and CNR groups but also to the CO group. The CR and CNR groups seemed to prolong the duration of endogenous NSC proliferation compared to the untreated group. A combination of rehabilitation and NSC transplantation appears to induce treatment outcomes that are similar to rehabilitation alone. Further studies are needed to evaluate the electrophysiological outcome of recovery and the possible effect of prolonging endogenous NSC proliferation in response to NSC transplantation and rehabilitation.	[Lee, Do-Hun; Lee, Ji Yeoun; Phi, Ji Hoon; Kim, Seung-Ki; Wang, Kyu-Chang] Seoul Natl Univ, Childrens Hosp, Div Pediat Neurosurg, Seoul 110769, South Korea; [Oh, Byung-Mo; Bang, Moon Suk] Seoul Natl Univ, Coll Med, Dept Rehabil Med, Seoul 110769, South Korea; [Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, UBC Hosp, Vancouver, BC V6T 1W5, Canada; [Kim, Seung U.] Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea		Wang, KC (corresponding author), Seoul Natl Univ, Childrens Hosp, Div Pediat Neurosurg, 101 Daehakro, Seoul 110769, South Korea.	kcwang@snu.ac.kr		Oh, Byung-Mo/0000-0001-9353-7541	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A090191]	This study was supported by a grant of the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A090191).	Arida RM, 2011, AM J PHYS MED REHAB, V90, P452, DOI 10.1097/PHM.0b013e3182063a9c; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Booth BW, 2008, P NATL ACAD SCI USA, V105, P14891, DOI 10.1073/pnas.0803214105; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Cuadrado ML, 1999, CEREBROVASC DIS, V9, P337, DOI 10.1159/000016009; Cumming TB, 2011, INT PSYCHOGERIATR, P1; Dahlqvist P, 1999, NEUROSCIENCE, V93, P527, DOI 10.1016/S0306-4522(99)00183-9; de Haan P, 2001, Anesthesiol Clin North Am, V19, P923; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; Ding YH, 2005, ACTA NEUROPATHOL, V109, P237, DOI 10.1007/s00401-004-0943-y; Dong J, 2012, CELL TISSUE BANK, V13, P623, DOI 10.1007/s10561-011-9283-z; Emerick AJ, 2003, J NEUROSCI, V23, P4826; Gonzalez CLR, 2004, EUR J NEUROSCI, V20, P3442, DOI 10.1111/j.1460-9568.2004.03751.x; Guo JS, 2007, NEUROREPORT, V18, P863, DOI 10.1097/WNR.0b013e32811d6d36; Hunt J, 2010, J NEUROSCI, V30, P2888, DOI 10.1523/JNEUROSCI.5991-09.2010; Jang DK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/238409; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Kim Seung U., 2008, V438, P103, DOI 10.1007/978-1-59745-133-8_10; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Lee DH, 2009, CHILD NERV SYST, V25, P1547, DOI 10.1007/s00381-009-0973-9; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee SH, 2008, J NEUROL SCI, V269, P54, DOI 10.1016/j.jns.2007.12.028; Lindvall O, 2004, STROKE, V35, P2691, DOI 10.1161/01.STR.0000143323.84008.f4; Liu YP, 2009, ACTA NEUROPATHOL, V117, P469, DOI 10.1007/s00401-009-0516-1; Locatelli F, 2009, CELL MOL LIFE SCI, V66, P757, DOI 10.1007/s00018-008-8346-1; Luft AR, 2004, JAMA-J AM MED ASSOC, V292, P1853, DOI 10.1001/jama.292.15.1853; Macrae IM, 2011, BRIT J PHARMACOL, V164, P1062, DOI 10.1111/j.1476-5381.2011.01398.x; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Piron L, 2005, ARCH PHYS MED REHAB, V86, P1874, DOI 10.1016/j.apmr.2005.03.007; Riecker A, 2010, HUM BRAIN MAPP, V31, P1017, DOI 10.1002/hbm.20914; Rowntree S, 1997, EUR J NEUROSCI, V9, P2432, DOI 10.1111/j.1460-9568.1997.tb01660.x; Takamatsu Y, 2010, BRAIN RES, V1355, P165, DOI 10.1016/j.brainres.2010.07.070; Taub E, 1999, J REHABIL RES DEV, V36, P237; Tomaszewski W, 2011, MED SCI MONITOR, V17, pCR510, DOI 10.12659/MSM.881938; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427	43	7	7	0	44	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2013	29	3					403	411		10.1007/s00381-012-1969-4			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	086VT	WOS:000314717400010	23180314				2022-02-06	
J	Muthuraju, S; Pati, S; Rafiqul, M; Abdullah, JM; Jaafar, H				Muthuraju, Sangu; Pati, Soumya; Rafiqul, Mohammad; Abdullah, Jafri Malin; Jaafar, Hasnan			Effect of normabaric hyperoxia treatment on neuronal damage following fluid percussion injury in the striatum of mice: A morphological approach	JOURNAL OF BIOSCIENCES			English	Article						Fluid percussion injury; neuronal damage; normabaric hyperoxia; striatum; traumatic brain injury	TRAUMATIC BRAIN-INJURY; APOPTOTIC CELL-DEATH; CEREBRAL BLOOD-FLOW; INTRACRANIAL-PRESSURE; HEAD-INJURY; COGNITIVE DEFICITS; RATS; IMPROVEMENT; METABOLISM; ISCHEMIA	Traumatic brain injury (TBI) causes significant mortality in most developing countries worldwide. At present, it is imperative to identify a treatment to address the devastating post-TBI consequences. Therefore, the present study has been performed to assess the specific effect of immediate exposure to normabaric hyperoxia (NBO) after fluid percussion injury (FPI) in the striatum of mice. To execute FPI, mice were anesthetised and sorted into (i) a TBI group, (ii) a sham group without injury and (iii) a TBI group treated with immediate exposure to NBO for 3 h. Afterwards, brains were harvested for morphological assessment. The results revealed no changes in morphological and neuronal damage in the sham group as compared to the TBI group. Conversely, the TBI group showed severe morphological changes as well as neuronal damage as compared to the TBI group exposed to NBO for 3 h. Interestingly, our findings also suggested that NBO treatment could diminish the neuronal damage in the striatum of mice after FPI. Neuronal damage was evaluated at different points of injury and the neighbouring areas using morphology, neuronal apoptotic cell death and pan-neuronal markers to determine the complete neuronal structure. In conclusion, immediate exposure to NBO following FPI could be a potential therapeutic approach to reduce neuronal damage in the TBI model.	[Muthuraju, Sangu; Pati, Soumya; Rafiqul, Mohammad; Abdullah, Jafri Malin] Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kota Baharu 16150, Kelantan, Malaysia; [Jaafar, Hasnan] Univ Sains Malaysia, Sch Med Sci, Dept Pathol, Kota Baharu 16150, Kelantan, Malaysia		Abdullah, JM (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kota Baharu 16150, Kelantan, Malaysia.	brainsciences@gmail.com	SANGU, MUTHURAJU/AAY-8060-2020; SANGU, MUTHURAJU/C-3200-2011; MUTHURAJU, SANGU/B-2742-2018; Abdullah, J/C-2828-2011	SANGU, MUTHURAJU/0000-0002-7949-2110; MUTHURAJU, SANGU/0000-0002-7949-2110; Abdullah, J/0000-0002-0258-7410			Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; CHOPP M, 1991, ACTA NEUROPATHOL, V83, P66, DOI 10.1007/BF00294432; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Conti AC, 1998, J NEUROSCI, V18, P5663; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; El Massioui N, 2007, NEUROSCIENCE, V147, P906, DOI 10.1016/j.neuroscience.2007.05.015; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Haruddin FA, 2010, ORIENT NEURON NEXUS, V1, P13; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Johnston AJ, 2003, BRIT J ANAESTH, V90, P774, DOI 10.1093/bja/aeg104; Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Luo Chun, 2002, Chin J Traumatol, V5, P24; Maier CM, 2002, NEUROSCIENTIST, V8, P323, DOI 10.1177/107385840200800408; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Muthuraju S, 2012, BASAL GANGLIA, V2, P143, DOI 10.1016/j.baga.2012.06.004; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; Qian L, 1996, ACTA NEUROCHIR, V138, P90, DOI 10.1007/BF01411731; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Tymianski Michael, 1996, Neurosurgery (Baltimore), V38, P1176, DOI 10.1097/00006123-199606000-00028; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Voulalas PJ, 2005, J NEUROSCI, V25, P3763, DOI 10.1523/JNEUROSCI.4574-04.2005; Xu JY, 2010, BLOOD, V115, P2709, DOI 10.1182/blood-2009-05-223776; Zauner A, 1996, ACT NEUR S, V67, P40	37	7	8	0	1	INDIAN ACAD SCIENCES	BANGALORE	C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA	0250-5991	0973-7138		J BIOSCIENCES	J. Biosci.	MAR	2013	38	1					93	103		10.1007/s12038-012-9290-7			11	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	087GK	WOS:000314749100013	23385817				2022-02-06	
J	Sharma, S; de Mestral, C; Hsiao, M; Gomez, D; Haas, B; Rutka, J; Nathens, AB				Sharma, Sunjay; de Mestral, Charles; Hsiao, Marvin; Gomez, David; Haas, Barbara; Rutka, James; Nathens, Avery B.			Benchmarking trauma center performance in traumatic brain injury: The limitations of mortality outcomes	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Meeting of the Congress-of-Neurological-Surgeons	OCT, 2011	Washington, DC	Congress Neurol Surg		Traumatic brain injury; benchmarking; performance; trauma center; head injury	IMPROVEMENT; QUALITY; CARE	BACKGROUND: Trauma centers (TCs) generally use mortality to gauge performance. However, differences in mortality outcomes might reflect different approaches or philosophies toward end-of-life care. We postulate that discharge home (DH) as a proxy for functional outcome may be a more useful measure of quality and may have significant implications on the assessment of TC performance and external benchmarking efforts. METHODS: Data were derived from the National Trauma Data Bank (2007-2009). We included patients (18 years or older) with isolated, severe blunt head injuries who were admitted to Level I and Level II TCs. Observed-to-expected (O/E) mortality ratios were calculated and used to rank TC performance by mortality and then DH. Concordance between performance measures was calculated using a weighted kappa statistic. RESULTS: In total, 19,705 patients in 240 TCs were identified. Crude mortality ranged from 4% to 60%, whereas rates of DH ranged from 3% to 66%. When O/E ratios for mortality were evaluated, five centers were identified as high performers. Of these five centers, only two were also high performers for DH. The concordance of outlier status and correlation across O/E ratios between mortality and DH high performers was 0.16 (poor). CONCLUSION: Centers that are characterized as high performers when evaluating mortality are not high performers for functional outcome as evaluated by DH. DH may provide an alternative way of assessing quality of care delivered to patients with traumatic brain injury. (J Trauma Acute Care Surg. 2013;74: 890-894. Copyright (c) 2013 by Lippincott Williams & Wilkins)	[Sharma, Sunjay; Rutka, James] Univ Toronto, Div Neurosurg, Dept Surg, Toronto, ON M5S 1A1, Canada; [de Mestral, Charles; Hsiao, Marvin; Gomez, David; Haas, Barbara; Nathens, Avery B.] Univ Toronto, Div Gen Surg, Dept Surg, Toronto, ON M5S 1A1, Canada		Sharma, S (corresponding author), St Michaels Hosp, Queen 3N-076 30 Bond St, Toronto, ON M5B 1W8, Canada.	sunjay.sharma@gmail.com	Sharma, Sunjay/AAR-7129-2021	Sharma, Sunjay/0000-0001-7826-9075; Gomez, David/0000-0002-0926-2547			Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Haas B, 2011, ANN SURG, V253, P144, DOI 10.1097/SLA.0b013e3181f9be97; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Khuri SF, 2002, ARCH SURG-CHICAGO, V137, P20, DOI 10.1001/archsurg.137.1.20; King TS, 2001, STAT MED, V20, P2131, DOI 10.1002/sim.845; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Rocker GM, 2006, CAN J ANAESTH, V53, P814, DOI 10.1007/BF03022799; Thurman D, 2001, HEAD TRAUMA BASIC PR, P494; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786	12	7	8	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2013	74	3					890	894		10.1097/TA.0b013e3182827253			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	108UO	WOS:000316321900035	23425753				2022-02-06	
J	Tsai, YD; Liliang, PC; Cho, CL; Chen, JS; Lu, K; Liang, CL; Wang, KW				Tsai, Yu-Duan; Liliang, Po-Chou; Cho, Chung-Lung; Chen, Jui-Sheng; Lu, Kang; Liang, Cheng-Loong; Wang, Kuo Wei			Delayed neurovascular inflammation after mild traumatic brain injury in rats	BRAIN INJURY			English	Article						Neurovascular inflammation; mild traumatic brain injury; ICAM-1	ENDOTHELIAL ADHESION MOLECULES; CEREBRAL-ARTERY OCCLUSION; MOTOR; MICE	Introduction: Experimental traumatic brain injury (TBI) elicits acute local inflammatory responses, including up-regulation of adhesion molecules and neutrophils in the injured brain. However, in clinical experiences there were at least three types of TBI, which included mild, moderate and severe types, and there would be different neuroinflammatory responses. This study investigated the inflammatory responses after mild TBI in rats. Methods: Adult male Sprague-Dawley rats (n = 40) were group-housed and injured using an impact method. Motor function was assessed 1-4 days after the injury by using a grip test (Grip strength meter; Singa). Blood samples collected from the rats before the injury and after the injury and the Intercellular adhesion molecule-1 (ICAM-1) level were measured. Results: The ICAM-1 expression from pre-injury to post-injury showed a significantly greater gradual elevation in the rats in the mild-injury group than in the moderate-injury group. The neurological function evaluated with grip test showed no deterioration of neurological function in the mild-injury group but gradual deterioration in the moderate-injury group. Conclusion: These findings showed a delayed inflammatory reaction in the mild-injury group without progressive deterioration of neurological function. Therefore, in the moderate-injury group, no progression phase was observed.	[Tsai, Yu-Duan; Chen, Jui-Sheng; Lu, Kang; Liang, Cheng-Loong; Wang, Kuo Wei] I Shou Univ, E Da Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Cho, Chung-Lung] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan		Wang, KW (corresponding author), I Shou Univ, E Da Hosp, Dept Neurosurg, 1 E Da Rd, Yan Chau Shiang 824, Kaohsiung Count, Taiwan.	q1207@ms8.hinet.net			research program of E-Da hospital [EDAHP-99027]	The authors report no conflicts of interest. The study was supported by research grants from the research program of E-Da hospital. (EDAHP-99027).	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Bardenheuer HJ, 1999, CARDIOVASC RES, V41, P511; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; Blanco-Colio LM, 2003, KIDNEY INT, V63, P12, DOI 10.1046/j.1523-1755.2003.00744.x; CARLOS TM, 1994, BLOOD, V84, P2068; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gupta AK, 1995, J CEREB BLOOD FLOW M, V15, pS33; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; MATSUO Y, 1994, BRAIN RES, V656, P344, DOI 10.1016/0006-8993(94)91478-8; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; PANTER SS, 1992, J NEUROTRAUM, V9, P47, DOI 10.1089/neu.1992.9.47; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SMITH CW, 1993, CAN J PHYSIOL PHARM, V71, P76, DOI 10.1139/y93-012; Tang T, 1996, J CLIN INVEST, V97, P2485, DOI 10.1172/JCI118695; Weber JR, 1995, J NEUROIMMUNOL, V63, P63; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561	21	7	9	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2013	27	3					361	365		10.3109/02699052.2012.750738			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	096OG	WOS:000315413400014	23438356				2022-02-06	
J	Vonder Haar, C; Friend, DM; Mudd, DB; Smith, JS				Vonder Haar, Cole; Friend, Danielle M.; Mudd, David B.; Smith, Jeffrey S.			Successive bilateral frontal controlled cortical impact injuries show behavioral savings	BEHAVIOURAL BRAIN RESEARCH			English	Article						TBI; Recovery of function; Repeated injury; Plasticity	TRAUMATIC BRAIN-INJURY; TACTILE DISCRIMINATION; COGNITIVE IMPAIRMENT; FUNCTIONAL RECOVERY; VISUAL-CORTEX; ONE-STAGE; LESIONS; RAT; SERIAL; MODEL	Traumatic brain injuries (TBIs) affect millions of people each year. Research investigating repeated or serial damage in the form of lesions indicates that behavioral deficits are reduced in animals given sequential lesions separated by a sufficient period of recovery. In the lesion literature, this phenomenon is known as the serial lesion effect (SLE). Although the SLE phenomenon is established in the lesion literature, it has not been thoroughly investigated under current models of brain injury. In the current study, a controlled cortical impact of the bilateral frontal cortex was performed in either a single procedure or a serial procedure separated by two weeks. Rats were tested on the Morris water maze, bilateral tactile adhesive removal task, rotarod and Barnes maze task to determine behavioral deficits. Histology was performed to determine lesion size and astrocyte and microglial response. A serial lesion effect was demonstrated across a majority of the behavioral tasks. However, histological analyses did not suggest a clear mechanistic link to the behavioral phenomena. This is the first study to demonstrate the SLE in a model of TBI, suggesting that behavioral deficits may actually be reduced in repeated head injuries, given an adequate time window between injuries. (C) 2012 Elsevier B.V. All rights reserved.	[Vonder Haar, Cole] So Illinois Univ, Dept Psychol, Ctr Integrated Res Cognit & Neural Sci, Restorat Neurosci Lab, Carbondale, IL 62901 USA; [Friend, Danielle M.] Univ Utah, Interdept Program Neurosci, Salt Lake City, UT USA; [Mudd, David B.; Smith, Jeffrey S.] Saginaw Valley State Univ, Dept Hlth Sci, Brain Res Lab, University Ctr, MI 48710 USA		Smith, JS (corresponding author), Saginaw Valley State Univ, Dept Hlth Sci, Brain Res Lab, University Ctr, MI 48710 USA.	jsmith12@svsu.edu		Smith, Jeffrey/0000-0001-5499-4475; Vonder Haar, Cole/0000-0001-7949-2068	Butine Fund for Faculty Development at the University of Portland	The authors would like to thank Amy Anderton, Kyle Fink, Sarah Peruzzaro, Ashley Murphy and the other members of the Brain Research Laboratory for their various contributions to this project. Funding was provided by a grant from the Butine Fund for Faculty Development at the University of Portland.	ADAMETZ JH, 1959, J NEUROSURG, V16, P85, DOI 10.3171/jns.1959.16.1.0085; Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Ashman TA, 2006, MT SINAI J MED, V73, P999; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BELL J, 1981, BRAIN RES, V219, P451, DOI 10.1016/0006-8993(81)90309-7; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Bury SD, 2002, J NEUROSCI, V22, P8597; CDC, 2010, INJ PREV CONTR TRAUM; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; DECASTRO JM, 1988, BEHAV NEUROSCI, V102, P843, DOI 10.1037/0735-7044.102.6.843; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DRU D, 1975, BRAIN RES, V88, P353, DOI 10.1016/0006-8993(75)90398-4; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; FASS B, 1980, PHYSIOL BEHAV, V25, P683, DOI 10.1016/0031-9384(80)90370-4; FINGER S, 1971, J COMP PHYSIOL PSYCH, V77, P221, DOI 10.1037/h0031648; GLENDENNING RL, 1972, J COMP PHYSIOL PSYCH, V80, P216, DOI 10.1037/h0033140; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hirota K, 1996, BRIT J ANAESTH, V77, P441, DOI 10.1093/bja/77.4.441; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); KOLB B, 1991, BEHAV BRAIN RES, V43, P51, DOI 10.1016/S0166-4328(05)80051-8; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; NONNEMAN AJ, 1979, PHYSIOL BEHAV, V22, P895, DOI 10.1016/0031-9384(79)90334-2; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; REYES R, 1973, BEHAV BIOL, V8, P807, DOI 10.1016/S0091-6773(73)80123-3; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; SABEL BA, 1984, J NEUROSCI RES, V12, P429, DOI 10.1002/jnr.490120227; Schallert T, 2000, J CEREBR BLOOD F MET, V20, P1513, DOI 10.1097/00004647-200011000-00001; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; SPEAR PD, 1975, BRAIN RES, V94, P337, DOI 10.1016/0006-8993(75)90066-9; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Walbran BB, 1975, PHYSIOL BEHAV, V17, P13	42	7	7	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328			BEHAV BRAIN RES	Behav. Brain Res.	MAR 1	2013	240						153	159		10.1016/j.bbr.2012.11.029			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	152PC	WOS:000319542600020	23201357				2022-02-06	
J	Mirzaie, B; Mohajeri-Tehrani, MR; Annabestani, Z; Shahrzad, MK; Mohseni, S; Heshmat, R; Afshani, HR; Meybodi, HRA; Larijani, B				Mirzaie, Bita; Mohajeri-Tehrani, Mohammad Reza; Annabestani, Zohreh; Shahrzad, Mohammad Karim; Mohseni, Shahrzad; Heshmat, Ramin; Afshani, Hamid Reza; Meybodi, Hamid Reza Aghaei; Larijani, Bagher			Traumatic brain injury and adrenal insufficiency: morning cortisol and cosyntropin stimulation tests	ARCHIVES OF MEDICAL SCIENCE			English	Article						traumatic brain injury; adrenal insufficiency; cosyntropin test	1 MU-G; CORTICOSTEROID INSUFFICIENCY; PITUITARY DISEASE; ILL PATIENTS; DEFICIENCY	Introduction: Adrenal insufficiency (Al) has a great impact on the prognosis of patients with traumatic brain injury. There is a lack of consensus regarding the diagnostic criteria of Al. In these patients with acute stress we compared fasting cortisol, low and high dose cosyntropin stimulation tests to assess adrenal function in patients with moderate to severe traumatic brain injury. Material and methods: This multicenter, cross-sectional study recruited 50 consecutive patients (aged between 15 and 70 years old) with moderate to severe traumatic brain injury who survived more than 5 days after the event. The patients' adrenal function was assessed using the fasting cortisol, 1 and 250-mu g ACTH stimulation tests. Results: More cases of Al were detected by the 1-mu g ACTH stimulation test compared to those detected by the basal serum cortisol level and 250-mu g ACTH stimulation test. The x test showed no agreement between these tests. The incidence of Al in the first 10 days after traumatic brain injury varied from 34% to 82% according to the various definitions of Al. The incidence of hypotension and need for vasopressors was higher in the patients diagnosed by the 250-mu g ACTH stimulation test (p < 0.0001). Conclusions: The incidence of secondary Al in moderate to severe traumatic brain injury seems to be high. A combination of stimulation test (either 250 or 1 mu g) and basal cortisol level may improve diagnostic ability compared to either test alone. Hence performing both tests for the assessment of adrenal function in patients with traumatic brain injury is recommended.	[Mirzaie, Bita; Mohajeri-Tehrani, Mohammad Reza; Annabestani, Zohreh; Shahrzad, Mohammad Karim; Mohseni, Shahrzad; Heshmat, Ramin; Meybodi, Hamid Reza Aghaei; Larijani, Bagher] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran; [Afshani, Hamid Reza] Iranian Endocrine Soc, Tehran, Iran		Mohajeri-Tehrani, MR (corresponding author), Shariati Hosp, EMRC, 5th Floor,North Kargar Ave, Tehran, Iran.	emrc@tums.ac.ir	larijani, Bagher/ABE-3315-2020; Heshmat, Ramin/S-7435-2017; Aghaei Meybodi, Hamid Reza/AAY-7383-2021	larijani, Bagher/0000-0001-5386-7597; Aghaei Meybodi, Hamid Reza/0000-0003-1754-3450; Shahrzad, Mohammad Karim/0000-0002-8872-0859			Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bruns J. Jr., 2003, EPILEPSIA, V10, P2, DOI DOI 10.1046/J.1528-1157.44.S10.3.X; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; JENSEN MD, 1986, ANN INTERN MED, V105, P200, DOI 10.7326/0003-4819-105-2-200; Kozyra EF, 2005, ANN PHARMACOTHER, V39, P691, DOI 10.1345/aph.1E139; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Mayenknecht J, 1998, J CLIN ENDOCR METAB, V83, P1558, DOI 10.1210/jc.83.5.1558; Nieman LK, EVALUATION RESPONSE; Oelkers W, 1999, J CLIN ENDOCR METAB, V84, P2973, DOI 10.1210/jc.84.8.2973; Powner DJ, 2008, CURR OPIN CRIT CARE, V14, P163, DOI 10.1097/MCC.0b013e3282f57528; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Stawerska R, 2005, ARCH MED SCI, V1, P218; Streeten DHP, 1996, J CLIN ENDOCR METAB, V81, P285, DOI 10.1210/jc.81.1.285; SUGIURA M, 1986, DIABETES RES CLIN EX, V3, P111; TEASDALE G, 1983, LANCET, V2, P678; Yeung SCJ, 1998, ENDOCR REV, V19, P144, DOI 10.1210/er.19.2.144; YOSHIDA T, 1983, ACTA ENDOCRINOL-COP, V104, P397, DOI 10.1530/acta.0.1040397	20	7	8	0	6	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	WENEDOW ST 9-1, POZNAN, 61-614, POLAND	1734-1922	1896-9151		ARCH MED SCI	Arch. Med. Sci.	FEB	2013	9	1					68	73		10.5114/aoms.2012.30833			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102FJ	WOS:000315829900011	23515961	Green Submitted, gold, Green Published			2022-02-06	
J	Rao, VK; Haridas, A; Nguyen, TT; Lulla, R; Wainwright, MS; Goldstein, JL				Rao, Vamshi K.; Haridas, Abilash; Nguyen, Thanh T.; Lulla, Rishi; Wainwright, Mark S.; Goldstein, Joshua L.			Symptomatic Cerebral Vasospasm Following Resection of a Medulloblastoma in a Child	NEUROCRITICAL CARE			English	Article						Vasospasm; Medulloblastoma; Transcranial doppler; Pediatric	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; TRANSCRANIAL DOPPLER; REMOVAL; TUMOR; PATHOGENESIS; HEMORRHAGE; ANEURYSMS	Vasospasm may occur following intracranial tumor resection but is uncommon following resection of tumors in the posterior fossa. Case report. Here, we report an unusual pediatric case of symptomatic cerebral vasospasm following resection of a posterior fossa medulloblastoma in a 10-year-old child. CT angiogram and serial Transcranial Doppler (TCD) studies confirmed the presence of vasospasm and response to hemodynamic augmentation therapy, resulting in favorable outcome. This case illustrates an unusual complication of posterior fossa tumor resection, and the potential utility of TCD studies in the detection and management of vasospasm in pediatric neurocritical care.	[Rao, Vamshi K.; Nguyen, Thanh T.; Wainwright, Mark S.; Goldstein, Joshua L.] Northwestern Univ, Feinberg Sch Med, Div Neurol, Dept Pediat,Ann & Robert H Lurie Childrens Hosp C, Chicago, IL 60611 USA; [Haridas, Abilash] Northwestern Univ, Feinberg Sch Med, Dept Neurosurg, Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Lulla, Rishi] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol & Stem Cell Transplant, Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA		Goldstein, JL (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Neurol, Dept Pediat,Ann & Robert H Lurie Childrens Hosp C, 225 E Chicago Ave, Chicago, IL 60611 USA.	jgoldstein@luriechildrens.org	Rao, Vamshi/AAK-3259-2020	Rao, Vamshi/0000-0002-0130-2292; Lulla, Rishi/0000-0003-4109-2207			Almubaslat M, 2007, SURG NEUROL, V68, P322, DOI 10.1016/j.surneu.2006.10.026; Aryan HE, 2006, J CLIN NEUROSCI, V13, P188, DOI 10.1016/j.jocn.2005.07.006; Beijani GK, 1997, NEUROCHIRURGIE, V43, P164; Bejjani GK, 1999, SURG NEUROL, V52, P577, DOI 10.1016/S0090-3019(99)00108-1; CAMP PE, 1980, NEUROSURGERY, V7, P382, DOI 10.1227/00006123-198010000-00012; Carpenter J, 2008, NEUROCRIT CARE, V8, P276, DOI 10.1007/s12028-007-9005-3; Cervoni L, 1996, ITAL J NEUROL SCI, V17, P291, DOI 10.1007/BF01997789; Chang SD, 1999, SURG NEUROL, V51, P521, DOI 10.1016/S0090-3019(97)00313-3; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; DEALMEIDA GM, 1985, SURG NEUROL, V23, P38, DOI 10.1016/0090-3019(85)90157-0; ECKER A, 1951, J NEUROSURG, V8, P660, DOI 10.3171/jns.1951.8.6.0660; Figaji AA, 2009, SURG NEUROL, V72, P389, DOI 10.1016/j.surneu.2009.02.012; Hansen W F, 1996, J Matern Fetal Med, V5, P194; Jacob JT, 2011, NEUROCRIT CARE, V14, P86, DOI 10.1007/s12028-010-9464-9; Kasliwal MK, 2008, NEUROL INDIA, V56, P81; Lee TT, 1998, PEDIATR NEUROSURG, V29, P300, DOI 10.1159/000028741; Lowe LH, 2005, PEDIATR RADIOL, V35, P54, DOI 10.1007/s00247-004-1257-x; MAWK JR, 1979, J NEUROSURG, V50, P229, DOI 10.3171/jns.1979.50.2.0229; Nishioka H, 2001, BRIT J NEUROSURG, V15, P44, DOI 10.1080/02688690020024391; O'Brien NF, 2010, INTENS CARE MED, V36, P680, DOI 10.1007/s00134-009-1747-2; Ojha BK, 2005, SURG NEUROL, V64, P174, DOI 10.1016/j.surneu.2004.11.030; OSTERGAARD JR, 1983, J NEUROSURG, V58, P832, DOI 10.3171/jns.1983.58.6.0832; Ries S, 1997, J NEUROL, V244, P51; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; Velat GJ, 2011, WORLD NEUROSURG, V76, P446, DOI 10.1016/j.wneu.2011.02.030	25	7	7	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2013	18	1					84	88		10.1007/s12028-012-9769-y			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	086SY	WOS:000314708500015	22911499				2022-02-06	
J	Weaver, CM; Joseph, D; Dongon, SN; Fairweather, A; Ruzek, JI				Weaver, Christopher M.; Joseph, David; Dongon, Shara N.; Fairweather, Amy; Ruzek, Josef I.			Enhancing Services Response to Crisis Incidents Involving Veterans: A Role for Law Enforcement and Mental Health Collaboration	PSYCHOLOGICAL SERVICES			English	Article						veterans; offending; police; PTSD; crisis	POSTTRAUMATIC-STRESS-DISORDER; POLICE OFFICERS; INTERVENTION; IRAQ; COMBAT; RISK; WAR; AGGRESSION; DIVERSION; HOSTILITY	When crisis situations involving veterans occur, responding police officers find themselves playing an important role in the spectrum of health and mental health services for those veterans. Crisis response training can help officers respond in a manner that increases safety and optimizes outcomes for all people involved. Yet, current crisis response police training models are only accessible to select officers. Nor do they emphasize the unique challenges and strengths that impact veterans who experience acute symptoms of mental illness. In the current study, we report the results from the first generation of training, collaboratively designed to enhance officers' (a) knowledge of relevant topics, including posttraumatic stress disorder and traumatic brain injury, (b) attitudes about veterans, and (c) and skills helpful in identifying and deescalating veterans and referring them to treatment Officers completed in-class evaluations (N = 314), and a subsample (n = 53) completed 3-month follow-up evaluations. Pre- versus posttest comparisons indicated significant improvements in total score, and individually in knowledge, attitudes, and skills. Consistent with previous literature, the specific in-class gains were not retained on follow-up. However, responding officers widely endorsed use of de-escalation techniques during, and a positive impact of the training on, their interactions with veterans in the 3 months following the training. Implications for future training and policy are discussed.	[Weaver, Christopher M.; Dongon, Shara N.] Palo Alto Univ, Clin Psychol PhD Program, Palo Alto, CA 94143 USA; [Weaver, Christopher M.] Vet Affairs Palo Alto Hlth Care Syst, Natl Ctr Postraumat Stress Disorder, Palo Alto, CA USA; [Joseph, David] US Dept Vet Affairs, No Calif Hlth Care Syst, Oakland, CA USA; [Fairweather, Amy] Swords Plowshares, Coalit Iraq & Afghanistan Vet, San Francisco, CA USA; [Ruzek, Josef I.] Vet Affairs Palo Alto Hlth Care Syst, Natl Ctr PTSD, Palo Alto, CA USA		Weaver, CM (corresponding author), Palo Alto Univ, Forens Psychol Program, 1791 Arastradero Rd, Palo Alto, CA 94143 USA.	cweaver@paloaltou.edu					[Anonymous], 2009, DEPRESS ANXIETY, V26, P493, DOI 10.1002/da.20581; Augustin D, 2011, PSYCHOL SERV, V8, P166, DOI 10.1037/a0024104; Beckham JC, 2000, AGGRESS VIOLENT BEH, V5, P451, DOI 10.1016/S1359-1789(98)00018-4; Compton MT, 2008, PSYCHIAT SERV, V59, P1049, DOI 10.1176/appi.ps.59.9.1049; Deane MW, 1999, PSYCHIATR SERV, V50, P99, DOI 10.1176/ps.50.1.99; Ericsson KA, 2004, ACAD MED, V79, pS70, DOI 10.1097/00001888-200410001-00022; Greenberg GA, 2009, PSYCHIAT QUART, V80, P41, DOI 10.1007/s11126-009-9092-8; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Humphreys K, 2010, PSYCHOL SERV, V7, P275, DOI 10.1037/a0020390; Ilgen MA, 2010, ARCH GEN PSYCHIAT, V67, P1152, DOI 10.1001/archgenpsychiatry.2010.129; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kitchen M, 2012, CLIN TEACH, V9, P3, DOI 10.1111/j.1743-498X.2011.00493.x; McGuire AB, 2011, BEHAV SCI LAW, V29, P81, DOI 10.1002/bsl.941; Oliva JR, 2008, J AM ACAD PSYCHIATRY, V36, P38; Reeves RR, 2005, J PSYCHOSOC NURS MEN, V43, P18, DOI 10.3928/02793695-20050701-06; Russell R. T., 2009, N E J CRIM CIV CONF, V35, P357; Steadman HJ, 2000, PSYCHIATR SERV, V51, P645, DOI 10.1176/appi.ps.51.5.645; Steadman HJ, 2001, PSYCHIATR SERV, V52, P219, DOI 10.1176/appi.ps.52.2.219; Strauss G, 2005, COMMUNITY MENT HLT J, V41, P223, DOI 10.1007/s10597-005-2658-5; Taft CT, 2007, J ABNORM PSYCHOL, V116, P498, DOI 10.1037/0021-843X.116.3.498; Teller JLS, 2006, PSYCHIAT SERV, V57, P232, DOI 10.1176/appi.ps.57.2.232; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tuerk PW, 2009, AM J PSYCHIAT, V166, P762, DOI 10.1176/appi.ajp.2009.08091315; Watson AC, 2011, INT J LAW PSYCHIAT, V34, P287, DOI 10.1016/j.ijlp.2011.07.008; Wilson JK, 2011, PSYCHOL SERV, V8, P319, DOI 10.1037/a0025330	26	7	7	0	24	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	FEB	2013	10	1					66	72		10.1037/a0029651			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	090TI	WOS:000315002500007	23088401				2022-02-06	
J	Artman, LK; McMahon, BT				Artman, Laura; McMahon, Brian			Functional limitations in TBI and their relationship to job maintenance following work re-entry	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Traumatic brain injury; job maintenance; functional limitations; indicators; employment		Using data from the Job Accommodation Network Information System (JANIS), the utility of self- reported functional limitations was examined in relationship to job maintenance for individuals with traumatic brain injury (TBI) who had returned to work. It was found that memory loss and attention/concentration concerns were the most common functional limitations reported. To further establish which limitations were associated with job maintenance, a binary logistic regression was applied. Results suggested that the presence of medical symptoms and emotional dysregulation were reliably and inversely associated with job maintenance. Implications are provided for further research as well as the practice of rehabilitation counseling.	[Artman, Laura; McMahon, Brian] Virginia Commonwealth Univ, Richmond, VA 23284 USA		Artman, LK (corresponding author), Virginia Commonwealth Univ, Richmond, VA 23284 USA.	lartman@vcu.edu					[Anonymous], G POW VERS 3 0 10 CO; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Bricout JC, 2000, SOC WORK RES, V24, P87, DOI 10.1093/swr/24.2.87; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Correia S, 2001, ARCH CLIN NEUROPSYCH, V16, P477, DOI 10.1016/S0887-6177(00)00059-7; Crepeau F, 1997, NEUROPSYCHOL REHABIL, V7, P147, DOI 10.1080/713755525; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Deutsch PM, 2006, NEUROREHABILITATION, V21, P305; Dodson M.B., 2007, OT PRACTICE, V12, pCE; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Fraser R, 2006, J VOCAT REHABIL, V25, P141; Garson G.D., 2009, LOGISTIC REGRESSION; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Golden C.J., 2004, PSYCHOPATHOLOGY WORK, P225; Gurka JA, 1999, J HEAD TRAUMA REHAB, V14, P247, DOI 10.1097/00001199-199906000-00005; Hendricks D.J., 2005, DISABILITY STUDIES Q, DOI [10.18061/dsq.v25i4.623, DOI 10.18061/DSQ.V25I4.623]; HERSHENSON DB, 1981, REHABIL COUNS BULL, V25, P91; Hershenson DB, 1996, REHABIL COUNS BULL, V40, P2; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; Isaki E, 2000, BRAIN INJURY, V14, P441; Job Accommodation Network, 2011, ACC COMPL SER EMPL B; Kai A., 2008, J U OCCUPATIONAL HLT, V4, P403; Kendall E., 2003, AUSTR J CAREER DEV, V12, P25; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; LeBlanc JM, 2000, J HEAD TRAUMA REHAB, V15, P1022, DOI 10.1097/00001199-200008000-00005; Leung K L, 2005, Work, V25, P333; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; McMahon Brian T, 2005, Work, V25, P67; Millington M., 1997, J APPL REHABILITATIO, V28, P36; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Possl O, 2001, BRAIN INJURY, V15, P15; Power PW, 2003, BRAIN INJURY, V17, P1021, DOI 10.1080/0269905031000110526; Roberts CB, 2004, INT J REHABIL RES, V27, P145, DOI 10.1097/01.mrr.0000127142.43208.3b; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Verne D, 2006, STUD NEUROPSYCH DEV, P527; Watt N., 2003, S AFRICAN J PSYCHOL, V3, P27	48	7	7	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2013	39	1					13	21		10.3233/JVR-130638			9	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V72GC	WOS:000211629300002					2022-02-06	
J	Flaherty, BF; Loya, J; Alexander, MD; Pandit, R; Ha, BY; Torres, RA; Schroeder, AR				Flaherty, Brian F.; Loya, Joshua; Alexander, Matthew D.; Pandit, Rajul; Ha, Bo Yoon; Torres, Roland A.; Schroeder, Alan R.			Utility of Clinical and Radiographic Findings in the Management of Traumatic Epidural Hematoma	PEDIATRIC NEUROSURGERY			English	Article						Computed tomography; Cranial therapy; Craniotomy; Epidural hematoma; Head injury; Pediatric trauma; Radiography; Repeat imaging; X-ray	EXTRADURAL HEMATOMAS; COMPUTED-TOMOGRAPHY; HEAD TRAUMA; BRAIN-INJURY; CONSERVATIVE MANAGEMENT; PEDIATRIC-PATIENTS; CHILDREN; MODERATE; FOSSA; AGE	Background: There are currently no clear guidelines for the management and radiological monitoring of pediatric patients with epidural hematomas (EDH). We aim to compare clinical and radiographic characteristics of pediatric EDH patients managed with observation alone versus surgical evacuation and to describe results of repeat head imaging in both groups. Methods: We performed a retrospective observational study of pediatric patients diagnosed with traumatic EDH at a level II trauma center. Results: Forty-seven cases of EDH were analyzed. Sixty-two percent were managed by observation alone. Patients undergoing surgery were more likely to have an altered mental status (17 vs. 72%, p < 0.001), but there were no other significant clinical differences between the groups. The mean initial EDH thickness and volume were 8.0 mm and 8.6 ml in the observed group and 15.5 mm and 35 ml in the surgery group, respectively (p < 0.001 for both comparisons). Eighty-six percent of the observed and all surgery patients underwent repeat CT imaging. The initial repeat CT scan results led to surgery in 1 patient who was initially treated with observation. Conclusions: Most pediatric patients with EDH can be managed with observation. Mental status and radiographic findings should guide the need for surgical intervention. Multiple repeat CT scans have minimal utility in changing management. (C) 2014 S. Karger AG, Basel	[Flaherty, Brian F.; Loya, Joshua; Schroeder, Alan R.] Stanford Sch Med, Stanford, CA USA; [Alexander, Matthew D.; Pandit, Rajul; Ha, Bo Yoon; Schroeder, Alan R.] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA; [Torres, Roland A.] Alaska Native Med Ctr, Anchorage, AK USA		Flaherty, BF (corresponding author), 3689 S Vineyard Ct, Salt Lake City, UT 84106 USA.	flaherty.bf@gmail.com	Flaherty, Brian/ABA-2534-2020	Flaherty, Brian/0000-0002-3486-606X			Balmer B, 2006, CHILD NERV SYST, V22, P363, DOI 10.1007/s00381-005-1254-x; Bejjani GK, 1996, PEDIATR NEUROSURG, V25, P302, DOI 10.1159/000121144; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Bullock M Ross, 2006, Neurosurgery, V58, pS7; BULLOCK R, 1985, NEUROSURGERY, V16, P602, DOI 10.1227/00006123-198505000-00003; CHEN TY, 1993, NEUROSURGERY, V32, P176, DOI 10.1227/00006123-199302000-00004; Cordobes F, 1981, J COMPUT ASSIST TOMO, V5, P596; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Duthie G, 2009, BRIT J NEUROSURG, V23, P596, DOI 10.3109/02688690902978157; ERICSON K, 1981, ACTA RADIOL DIAGN, V22, P513, DOI 10.1177/028418518102200501; FORD LE, 1963, J NEUROSURG, V20, P760, DOI 10.3171/jns.1963.20.9.0760; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; HOOPER R, 1959, BRIT J SURG, V47, P71, DOI 10.1002/bjs.18004720114; Irie F, 2011, J TRAUMA, V71, P847, DOI 10.1097/TA.0b013e3182032c9a; Jamous MA, 2009, PEDIATR NEUROSURG, V45, P181, DOI 10.1159/000218200; Jang JW, 2011, BRIT J NEUROSURG, V25, P55, DOI 10.3109/02688697.2010.520759; KNUCKEY NW, 1989, J NEUROSURG, V70, P392, DOI 10.3171/jns.1989.70.3.0392; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; Maggi G, 1998, J Neurosurg Sci, V42, P95; MOHANTY A, 1995, PEDIATR NEUROSURG, V23, P57, DOI 10.1159/000120936; Munro D, 1941, ANN SURG, V113, P192, DOI 10.1097/00000658-194102000-00003; Paiva WS, 2010, ARQ NEURO-PSIQUIAT, V68, P888, DOI 10.1590/S0004-282X2010000600011; PANG D, 1983, J NEUROSURG, V59, P958, DOI 10.3171/jns.1983.59.6.0958; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Rocchi G, 2005, J CHILD NEUROL, V20, P569, DOI 10.1177/08830738050200070501; Sencer A, 2012, J NEUROSURG-PEDIATR, V9, P139, DOI 10.3171/2011.11.PEDS11177; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; WEAVER D, 1981, J NEUROSURG, V54, P248, DOI 10.3171/jns.1981.54.2.0248	30	7	9	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2013	49	4					208	214		10.1159/000363143			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AQ3ZJ	WOS:000342731700003	25096980				2022-02-06	
J	Hirshson, CI; Gordon, WA; Singh, A; Ambrose, A; Spielman, L; Dams-O'Connor, K; Cantor, J; Dijkers, M				Hirshson, Chari I.; Gordon, Wayne A.; Singh, Ayushi; Ambrose, Anne; Spielman, Lisa; Dams-O'Connor, Kristen; Cantor, Joshua; Dijkers, Marcel			Mortality of elderly individuals with TBI in the first 5 years following injury	NEUROREHABILITATION			English	Article						Traumatic brain injury; aging; mortality; long-term outcomes	TRAUMATIC BRAIN-INJURY; LONG-TERM SURVIVAL; COMORBIDITY SCORES; LIFE EXPECTANCY; AGE; DEATH; OLDER; EPIDEMIOLOGY; PREDICTOR; TRENDS	INTRODUCTION: Although there has been a decline in the incidence of TBI in the general population, the rate of TBI in older adults has increased. Increased age has been long recognized as a predictor of worse outcomes after TBI. Despite the growing number of TBI in the elderly, our understanding of the long-term consequences of TBI is quite limited. METHODS: Chart review; individuals 55 years and older, who completed inpatient acute rehabilitation during the period 2003-2009 and who died one to four years after injury, were compared to matched patients who did not die. RESULTS: There were a significantly higher proportion of deceased subjects with a diagnosis of Abnormality of Gait (53%), respiratory medications at admission (32%) and discharge (17%). Deceased participants were more likely to be prescribed diabetes medication at discharge (35%) while controls were more likely to be prescribed cholesterol-lowering medications (27%) at admission. Deceased patients were discharged with significantly more medications, CONCLUSIONS: The results suggest the need for medical and lifestyle interventions for selected elderly TBI patients. The factors related to death following TBI in the elderly are in need of more research.	[Hirshson, Chari I.; Gordon, Wayne A.; Singh, Ayushi; Ambrose, Anne; Spielman, Lisa; Dams-O'Connor, Kristen; Cantor, Joshua; Dijkers, Marcel] Mt Sinai Sch Med, New York, NY USA		Hirshson, CI (corresponding author), 1 Gustave L Levy Pl,Box 1240, New York, NY 10028 USA.	charihirshson@gmail.com	Ambrose, Anne Felicia/ABE-4161-2020; Heinemann, Allen W/K-6283-2012; Ambrose, Anne Felicia/AAQ-9668-2021	Heinemann, Allen W/0000-0003-2782-7326; Dijkers, Marcel/0000-0002-8362-5596	National Institute on Disability and Rehabilitation Research (NIDRR) [H133P100016, H133B040033]; Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [1R49CE001171-01]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001171] Funding Source: NIH RePORTER	This research was funded through grant(s) no. H133P100016, H133B040033, National Institute on Disability and Rehabilitation Research (NIDRR); 1R49CE001171-01, Centers for Disease Control and Prevention (CDC).	[Anonymous], 2011, PHYS DESK REFERENCE; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Battistella FD, 1998, J TRAUMA, V44, P618, DOI 10.1097/00005373-199804000-00010; CARTER RE, 1993, PARAPLEGIA, V31, P150, DOI 10.1038/sc.1993.28; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; CORKIN S, 1984, ARCH NEUROL-CHICAGO, V41, P975, DOI 10.1001/archneur.1984.04050200081022; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; DEVIVO MJ, 1993, ARCH PHYS MED REHAB, V74, P248; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Faul M, 2010, TRAUMATIC BRAIN INJU; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hirshson C. I., 2011, ARCH PHYS MED REHABI, V93, pe30; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JENNETT B, 1975, LANCET, V1, P480; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; Mosenthal A. C., 2004, J TRAUMA, V52, P907; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Schneeweiss S, 2000, INT J EPIDEMIOL, V29, P891, DOI 10.1093/ije/29.5.891; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Starfleld B, 2005, ANN FAM MED, V3, P215, DOI 10.1370/afm.307; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Verghese J, 2006, J AM GERIATR SOC, V54, P255, DOI 10.1111/j.1532-5415.2005.00580.x; Verghese J, 2004, AGE AGEING, V33, P628, DOI 10.1093/ageing/afh210; Verghese J, 2002, NEW ENGL J MED, V347, P1761, DOI 10.1056/NEJMoa020441; WEISS GH, 1982, ARCH NEUROL-CHICAGO, V39, P741, DOI 10.1001/archneur.1982.00510240003001	50	7	7	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	32	2					225	232		10.3233/NRE-130840			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	115ZT	WOS:000316851900004	23535784				2022-02-06	
B	Horn, LJ; Siebert, B; Patel, N; Zasler, ND		Zasler, ND; Katz, DI; Zafonte, RD		Horn, Lawrence J.; Siebert, Benjamin; Patel, Neil; Zasler, Nathan D.			Post-Traumatic Headache	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							TENSION-TYPE HEADACHE; TRAUMATIC BRAIN-INJURY; GREATER OCCIPITAL NERVE; TRIGEMINAL NUCLEUS CAUDALIS; MYOFASCIAL TRIGGER POINTS; EVIDENCE-BASED GUIDELINES; DOUBLE-BLIND; CERVICOGENIC HEADACHE; SPREADING DEPRESSION; US SOLDIERS		[Horn, Lawrence J.; Siebert, Benjamin; Patel, Neil] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Rehabil Inst Michigan, Detroit, MI 48202 USA; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan D.] Sheltering Arms Hosp, iWalk Program, Richmond, VA USA; [Zasler, Nathan D.] VCU Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA		Horn, LJ (corresponding author), Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Rehabil Inst Michigan, Detroit, MI 48202 USA.						Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Aoki KR, 2003, HEADACHE, V43, pS9; Arendt-Nielsen L, 2000, Prog Brain Res, V129, P343; Ashina M, 2000, NEUROLOGY, V55, P1335, DOI 10.1212/WNL.55.9.1335; Ashina M, 2000, BRAIN, V123, P1830, DOI 10.1093/brain/123.9.1830; Ashina M, 2003, CEPHALALGIA, V23, P109, DOI 10.1046/j.1468-2982.2003.00520.x; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Bartsch T, 2003, BRAIN, V126, P1801, DOI 10.1093/brain/awg190; Bekkelund SI, 2003, HEADACHE, V43, P59, DOI 10.1046/j.1526-4610.2003.03010.x; Belcastro V, 2011, J HEADACHE PAIN, V12, P289, DOI 10.1007/s10194-011-0318-4; Bendtsen L, 2000, CEPHALALGIA, V20, P486, DOI 10.1046/j.1468-2982.2000.00070.x; Bendtsen L, 2007, EUR J NEUROL, V14, P187, DOI 10.1111/j.1468-1331.2006.01607.x; Berglund A, 2001, J CLIN EPIDEMIOL, V54, P851, DOI 10.1016/S0895-4356(00)00369-3; Bettucci Diego, 2006, J Headache Pain, V7, P34, DOI 10.1007/s10194-005-0251-5; BICKERSTAFF ER, 1961, LANCET, V1, P15; Bijlenga P, 2007, J NEUROL NEUROSUR PS, V78, P430, DOI 10.1136/jnnp.2006.099242; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bogduk N, 2008, WOLFFS HEADACHE, P551; BOLINE PD, 1995, J MANIP PHYSIOL THER, V18, P148; BOVIM G, 1992, HEADACHE, V32, P175, DOI 10.1111/j.1526-4610.1992.hed3204175.x; Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; Bryans R, 2011, J MANIP PHYSIOL THER, V34, P274, DOI 10.1016/j.jmpt.2011.04.008; Burstein R, 2004, HEADACHE CURRENTS, V1, P25; Cartlidge N E, 1981, HEAD INJURY; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chaudhry IA, 2009, MIDDLE EAST AFR J OP, V16, P57, DOI 10.4103/0974-9233.53862; Chawla J., MIGRAINE HEADACHE; Christensen MB, 2005, CEPHALALGIA, V25, P1061, DOI 10.1111/j.1468-2982.2005.00962.x; CODERRE TJ, 1993, PAIN, V52, P259, DOI 10.1016/0304-3959(93)90161-H; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Couch J R, 2009, Eur J Neurol, V16, P12, DOI 10.1111/j.1468-1331.2008.02362.x; Cumberbatch MJ, 1997, EUR J PHARMACOL, V328, P37, DOI 10.1016/S0014-2999(97)83024-5; Curter FM, PATHOPHYSIOLOGY CLIN; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; de Leeuw R, 2005, HEADACHE, V45, P1365, DOI 10.1111/j.1526-4610.2005.00269.x; Desmoulin GT, 2009, J TRAUMA, V67, P1113, DOI 10.1097/TA.0b013e3181bb8e84; Devoghel JC, 1981, ACTA ANAESTHESIOLGIC, V32, P101; DIAMOND S, 1971, HEADACHE, V11, P110, DOI 10.1111/j.1526-4610.1971.hed1103110.x; Diener HC, 2004, CEPHALALGIA, V24, P947, DOI 10.1111/j.1468-2982.2004.00783.x; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; DOENICKE A, 1988, LANCET, V1, P1309; DOUKAS AG, 1995, ULTRASOUND MED BIOL, V21, P961, DOI 10.1016/0301-5629(95)00027-O; Elliot S, 2004, J HEADACHE PAIN, V5, P12, DOI DOI 10.1007/s10194-004-0062-0; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Evans RW, 2002, HEADACHE, V42, P383, DOI 10.1046/j.1526-4610.2002.02113.x; Evers S, 2002, CEPHALALGIA, V22, P699, DOI 10.1046/j.1468-2982.2002.00390.x; Fernandez-De-Las-Penas C, 2007, CEPHALALGIA, V27, P383, DOI 10.1111/j.1468-2982.2007.01295.x; Fernandez-de-las-Penas C, 2006, MANUAL THER, V11, P225, DOI 10.1016/j.math.2006.07.003; Forssell H, 1999, PAIN, V83, P549, DOI 10.1016/S0304-3959(99)00160-8; Fredriksen TA, 2008, CEPHALALGIA, V28, P39, DOI 10.1111/j.1468-2982.2008.01619.x; Fumal A, 2008, LANCET NEUROL, V7, P70, DOI 10.1016/S1474-4422(07)70325-3; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Goadsby PJ, 1997, PAIN, V73, P23, DOI 10.1016/S0304-3959(97)00074-2; Goadsby PJ, 2006, WALL MELZACKS TXB PA, V5th, P851; Goldstein J, 2006, HEADACHE, V46, P444, DOI 10.1111/j.1526-4610.2006.00376.x; Govind J, 2003, J NEUROL NEUROSUR PS, V74, P88, DOI 10.1136/jnnp.74.1.88; Gross AR, 2004, SPINE, V29, P1541, DOI 10.1097/01.BRS.0000131218.35875.ED; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hecht JS, 2004, J HEAD TRAUMA REHAB, V19, P58, DOI 10.1097/00001199-200401000-00006; Heckmann JG, 2003, LANCET, V362, P1958, DOI 10.1016/S0140-6736(03)15013-1; HENINGER GR, 1987, PSYCHOPHARMACOLOGY 3, P535; Heo K, 2010, YONSEI MED J, V51, P219, DOI 10.3349/ymj.2010.51.2.219; Hersh Elliot V, 2008, Oral Maxillofac Surg Clin North Am, V20, P197, DOI 10.1016/j.coms.2007.12.005; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hogan QH, 1996, ANESTHESIOLOGY, V84, P1341, DOI 10.1097/00000542-199606000-00010; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holroyd KA, 2003, HEADACHE, V43, P999, DOI 10.1046/j.1526-4610.2003.03193.x; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; ISHIWATA Y, 1988, J NEUROSURG, V68, P58, DOI 10.3171/jns.1988.68.1.0058; JACOME DE, 1986, HEADACHE, V26, P515, DOI 10.1111/j.1526-4610.1986.hed2610515.x; Jasper JF, 2008, PAIN PHYSICIAN, V11, P187; Jenkins B, 2011, HEADACHE, V51, P1254, DOI 10.1111/j.1526-4610.2011.01966.x; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; Johnstone CSH, 2006, NEUROMODULATION, V9, P41, DOI 10.1111/j.1525-1403.2006.00041.x; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; Jull G, 2002, SPINE, V27, P1835, DOI 10.1097/00007632-200209010-00004; Kapural L, 2005, ANESTH ANALG, V101, P171, DOI 10.1213/01.ANE.0000156207.73396.8E; KNIGHT Y, 2005, HEADACHE CURRENTS, V2, P108; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; La Touche R, 2011, CLIN J PAIN, V27, P48, DOI 10.1097/AJP.0b013e3181edc157; Lake AE, 2002, NEUROLOGY, V59, pS8, DOI 10.1212/WNL.59.5_suppl_2.S8; Lampl C, 2006, CEPHALALGIA, V26, P1203, DOI 10.1111/j.1468-2982.2006.01193.x; Leao AAP, 1944, J NEUROPHYSIOL, V7, P391, DOI 10.1152/jn.1944.7.6.391; Lenaerts ME, 2008, CEPHALALGIA, V28, P12, DOI 10.1111/j.1468-2982.2008.01608.x; Lenaerts M.E., 2008, WOLFFS HEADACHE OTHE, P293; Lenssinck MLB, 2004, PAIN, V112, P381, DOI 10.1016/j.pain.2004.09.026; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Linder Steven L, 2007, Curr Pain Headache Rep, V11, P396, DOI 10.1007/s11916-007-0223-3; Lipton RB, 2004, CEPHALALGIA, V24, P321, DOI 10.1111/j.1468-2982.2003.00690.x; Lipton RB, 2002, NEUROLOGY, V58, pS27, DOI 10.1212/WNL.58.9_suppl_6.S27; Lipton RB, 2008, WOLFFS HEADACHE OTHE, P153; Matchar D.B., 2000, NEUROLOGY; Matharu MS, 2001, NEUROLOGY, V56, P273, DOI 10.1212/WNL.56.2.273; Melchart D, 2005, BMJ-BRIT MED J, V331, P376, DOI 10.1136/bmj.38512.405440.8F; MENSE S, 1993, PAIN, V54, P241, DOI 10.1016/0304-3959(93)90027-M; Michel SJ, 2004, RADIOLOGY, V232, P449, DOI 10.1148/radiol.2322021556; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; Misra UK, 2004, POSTGRAD MED J, V80, P720, DOI 10.1136/pgmj.2003.012393; Mokri B, 2010, HEADACHE, V50, P1206, DOI 10.1111/j.1526-4610.2010.01715.x; Mork H, 2003, EUR J PAIN, V7, P145, DOI 10.1016/S1090-3801(02)00096-4; MOSKOWITZ MA, 1993, J NEUROSCI, V13, P1167, DOI 10.1523/jneurosci.13-03-01167.1993; Neely ET, 2009, HEADACHE, V49, P1089, DOI 10.1111/j.1526-4610.2009.001460.x; Nicholson RA, 2007, HEADACHE, V47, P413, DOI 10.1111/j.1526-4610.2006.00716.x; Obelieniene D, 1998, CEPHALALGIA, V18, P559, DOI 10.1046/j.1468-2982.1998.1808559.x; Olesen J, 2006, CEPHALALGIA, V26, P742, DOI 10.1111/j.1468-2982.2006.01172.x; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; Packard RC, 1996, HEADACHE Q-CURR TREA, V7, P139; Packman E, 2005, HEADACHE, V45, P1163, DOI 10.1111/j.1526-4610.2005.00239.x; Putzki N, 2005, CEPHALALGIA, V25, P395, DOI 10.1111/j.1468-2982.2004.00860.x; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; RASKIN NH, 1980, NEUROLOGY, V30, P203, DOI 10.1212/WNL.30.2.203; Russell IJ, 2006, WALL MELZACKS TXB PA, P669; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Saper J, 2006, HEADACHE, V46, P264, DOI 10.1111/j.1526-4610.2006.00334.x; SAXENA PR, 1989, TRENDS PHARMACOL SCI, V10, P200, DOI 10.1016/0165-6147(89)90238-1; Schelfaut D, 2011, EUR J EMERG MED; Scher Ann I, 2002, Curr Pain Headache Rep, V6, P486, DOI 10.1007/s11916-002-0068-8; Schiapparelli P, 2010, NEUROL SCI, V31, P137, DOI 10.1007/s10072-010-0307-4; SCHOENEN J, 1995, CEPHALALGIA, V15, P165, DOI 10.1046/j.1468-2982.1995.015003165.x; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; SELBY G, 1960, J NEUROL NEUROSUR PS, V23, P23, DOI 10.1136/jnnp.23.1.23; Shah JP, 2005, J APPL PHYSIOL, V99, P1977, DOI 10.1152/japplphysiol.00419.2005; Shah RV, 2004, ARCH PHYS MED REHAB, V85, P1013, DOI 10.1016/j.apmr.2003.07.017; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 2005, MAYO CLIN PROC, V80, P1126, DOI 10.4065/80.9.1126; Silberstein SD, 2005, CEPHALALGIA, V25, P460, DOI 10.1111/j.1468-2982.2005.00878.x; Silberstein SD, 2008, WOLFFS HEADACHE OTHE, P177; Silberstein SD, 2008, WOLFFS HEADACHE OTHE, P330; SILVERMAN K, 1992, NEW ENGL J MED, V327, P1109, DOI 10.1056/NEJM199210153271601; Siow HC, 2005, HEADACHE, V45, P358, DOI 10.1111/j.1526-4610.2005.05074.x; Sivori LA, 2010, J ORAL MAXIL SURG, V68, P2041, DOI 10.1016/j.joms.2010.05.041; Sjaastad O, 1998, HEADACHE, V38, P442, DOI 10.1046/j.1526-4610.1998.3806442.x; SLUDER G, 1927, NASAL NEUROLOGY HEAD; Sluder G., 1909, NY MED J, V90, P293; Smetana GW, 2000, ARCH INTERN MED, V160, P2729, DOI 10.1001/archinte.160.18.2729; Storer R. James, 2003, Neurology, V60, pA238; Theeler BJ, 2008, HEADACHE, V48, P876, DOI 10.1111/j.1526-4610.2008.01159.x; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Travell J.G., 1992, MYOFASCIAL PAIN DYSF, V1; Turkdogan D, 2006, HEADACHE, V46, P461, DOI 10.1111/j.1526-4610.2006.00377.x; TURKEWITZ LJ, 1992, HEADACHE, V32, P504, DOI 10.1111/j.1526-4610.1992.hed3210504.x; van Suijlekom HA, 1998, FUNCT NEUROL, V13, P297; VIJAYAN N, 1977, HEADACHE, V17, P19, DOI 10.1111/j.1526-4610.1977.hed1701019.x; Waeber C, 2003, NEUROLOGY, V61, pS9, DOI 10.1212/WNL.61.8_suppl_4.S9; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warner JS, 2000, ARCH NEUROL-CHICAGO, V57, P1778, DOI 10.1001/archneur.57.12.1778; Weiner RL, 1999, NEUROMODULATION, V2, P217, DOI 10.1046/j.1525-1403.1999.00217.x; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; Windsor Robert E, 2004, Pain Physician, V7, P283; Wolff HG., 1948, HEADACHE OTHER HEAD; Yamada SM, 2007, HEADACHE, V47, P289, DOI 10.1111/j.1526-4610.2006.00698.x; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x; Young WB, 2010, CURR PAIN HEADACHE R, V14, P404, DOI 10.1007/s11916-010-0130-x; Zafonte RD, 1999, J HEAD TRAUMA REHAB, V14, P22, DOI 10.1097/00001199-199902000-00005; Zasler N, 2002, PAIN MANAGEMENT PRAC, P313	167	7	7	0	2	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							932	953					22	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100056					2022-02-06	
B	McAllister, TW		Zasler, ND; Katz, DI; Zafonte, RD		McAllister, Thomas W.			Emotional and Behavioral Sequelae of Traumatic Brain Injury	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD-INJURY; AMYLOID PRECURSOR PROTEIN; PSYCHIATRIC-DISORDERS; ALZHEIMERS-DISEASE; MAJOR DEPRESSION; AXIS-I; POSTCONCUSSIVE SYMPTOMS; IMPAIRED AWARENESS; MILD		Dartmouth, Geisel Sch Med, Dept Psychiat, Sect Neuropsychiat, Lebanon, NH 03766 USA		McAllister, TW (corresponding author), Dartmouth, Geisel Sch Med, Dept Psychiat, Sect Neuropsychiat, Lebanon, NH 03766 USA.						Akbarian S, 1996, ARCH GEN PSYCHIAT, V53, P425; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; ANDREASEN NC, 1994, SCIENCE, V266, P294, DOI 10.1126/science.7939669; Arciniegas D B, 2000, Semin Clin Neuropsychiatry, V5, P290, DOI 10.1053/scnp.2000.9554; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Arciniegas DB, 2005, CNS SPECTRUMS, V10, P1, DOI 10.1017/S1092852900026602; Arciniegas DB, 2003, INT REV PSYCHIATR, V15, P328, DOI 10.1080/09540260310001606719; Arnsten AFT, 1998, TRENDS COGN SCI, V2, P436, DOI 10.1016/S1364-6613(98)01240-6; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; BOURDON KH, 1992, PUBLIC HEALTH REP, V107, P663; BOYESON M G, 1984, Society for Neuroscience Abstracts, V10, P68; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Brody A L, 2001, Semin Clin Neuropsychiatry, V6, P102, DOI 10.1053/scnp.2001.21837; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; BUCHANAN RW, 1993, AM J PSYCHIAT, V150, P59; BUCHSBAUM MS, 1992, ARCH GEN PSYCHIAT, V49, P935; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Charney DS, 1998, J CLIN PSYCHIAT, V59, P11; Chau David T, 2004, Curr Psychiatry Rep, V6, P391, DOI 10.1007/s11920-004-0026-8; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cripe LI, 1987, COGNITIVE REHABILITA, V5, P18; Cuesta M, 1996, AM J PSYCHIAT, V153, P270; CUESTA MJ, 1995, AM J PSYCHIAT, V152, P1380; CUESTA MJ, 1994, SCHIZOPHRENIA BULL, V20, P359, DOI 10.1093/schbul/20.2.359; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; DAVID A, 1995, BRIT J PSYCHIAT, V167, P621, DOI 10.1192/bjp.167.5.621; DAVISON K, 1969, BRIT J PSYCHIAT, V114, P113; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; DREVETS WC, 1992, PSYCHOPHARMACOL BULL, V28, P261; Drevets WC, 2000, PROG BRAIN RES, V126, P413; EDNA TH, 1982, ACTA CHIR SCAND, V148, P209; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FAHY TJ, 1967, LANCET, V2, P475; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FEENEY DM, 1983, PSYCHOPHARMACOLOGY, V79, P67, DOI 10.1007/BF00433018; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Flashman LA, 2011, TXB TRAUMATIC BRAIN, P307; FLORHENRY P, 1969, EPILEPSIA, V10, P363, DOI 10.1111/j.1528-1157.1969.tb03853.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORD B, 1976, MED J AUSTRALIA, V1, P603, DOI 10.5694/j.1326-5377.1976.tb140904.x; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; GENTILINI M, 1989, MILD HEAD INJURY, P163; Gioia G.A., 2000, BRIEF BEHAV RATING I; Gioia GA, 2005, PSYCHOL ASSESS RESOU; GOETHE KE, 1984, PSYCHIAT ANN, V14, P540, DOI 10.3928/0048-5713-19840701-11; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Gronwall D, 1989, MILD HEAD INJURY, P153; GUDMUNDS.G, 1966, ACTA NEUROL SCAND, VS 43, P9; Guillamondegui OD, 2011, AHRQ PUBLICATION; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JERNIGAN TL, 1991, ARCH GEN PSYCHIAT, V48, P881; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; KROHN W, 1961, Acta Psychiatr Scand Suppl, V36, P215; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Liotti M, 2001, J CLIN EXP NEUROPSYC, V23, P121, DOI 10.1076/jcen.23.1.121.1223; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; Lovell Mark R., 1994, P133; LYSAKER P, 1994, J NERV MENT DIS, V182, P656, DOI 10.1097/00005053-199411000-00010; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; McAllister, 1998, Semin Clin Neuropsychiatry, V3, P211; McAllister T W, 2000, Semin Clin Neuropsychiatry, V5, P275, DOI 10.1053/scnp.2000.9557; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McAllister TW, 2002, NEUROREHABILITATION, V17, P263; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MCEVOY JP, 1989, J NERV MENT DIS, V177, P43, DOI 10.1097/00005053-198901000-00007; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCKENNA PJ, 1985, AM J PSYCHIAT, V142, P895; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; MILLER H, 1965, LANCET, V1, P225; Miller N. S., 2005, TXB TRAUMATIC BRAIN, P509; Mohamed S, 1999, J NERV MENT DIS, V187, P525, DOI 10.1097/00005053-199909000-00001; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; OTA Y, 1969, LATE EFFECTS HEAD IN, P110; Ovsiew Fred, 2002, Semin Clin Neuropsychiatry, V7, P54, DOI 10.1053/scnp.2002.30373; PAPPIUS HM, 1981, ANN NEUROL, V9, P484, DOI 10.1002/ana.410090511; Perry EK, 2004, PROG BRAIN RES, V145, P287, DOI 10.1016/S0079-6123(03)45020-6; PRASAD MR, 1992, J NEUROTRAUM, V9, P269, DOI 10.1089/neu.1992.9.269; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rapoport M, 2010, PSYCHIAT ANN, V40, P581, DOI 10.3928/00485713-20101015-08; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; Robinson Robert G., 1994, P219; Romhanyi R, 1990, J NEUROTRAUM, V9, P164; ROSS DA, 1989, J NEUROSURG, V71, P498, DOI 10.3171/jns.1989.71.4.0498; RUFF R M, 1990, Brain Injury, V4, P339, DOI 10.3109/02699059009026187; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SHERWIN I, 1982, ARCH NEUROL-CHICAGO, V39, P621, DOI 10.1001/archneur.1982.00510220019004; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; Shytle RD, 2002, DEPRESS ANXIETY, V16, P89, DOI 10.1002/da.10035; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Smeets WJAJ, 2000, BRAIN RES REV, V33, P308, DOI 10.1016/S0165-0173(00)00034-5; Smith C., 2011, TXB TRAUMATIC BRAIN, P23; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; SPARADEO FR, 1990, J HEAD TRAUMA REHAB, V5, P108; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; STARKSTEIN SE, 1987, ARCH NEUROL-CHICAGO, V44, P1069, DOI 10.1001/archneur.1987.00520220065019; STARKSTEIN SE, 1988, J NERV MENT DIS, V176, P87, DOI 10.1097/00005053-198802000-00004; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stevens JR, 1997, SCHIZOPHRENIA BULL, V23, P373, DOI 10.1093/schbul/23.3.373; SUTTON RL, 1992, RESTOR NEUROL NEUROS, V4, P1, DOI 10.3233/RNN-1992-4101; SWAYZE VW, 1992, BIOL PSYCHIAT, V31, P221, DOI 10.1016/0006-3223(92)90046-3; TAMMINGA CA, 1992, ARCH GEN PSYCHIAT, V49, P522; TAMMINGA CA, 1997, AM PSYCHIAT PRESS TX, P855; Tandian D, 1990, J NEUROTRAUM, V9, P174; Tariot PN, 2002, ADV DRUG DELIVER REV, V54, P1567, DOI 10.1016/S0169-409X(02)00153-9; Tariot PN, 1999, J CLIN PSYCHIAT, V60, P29; TOONE BK, 1982, BRIT J PSYCHIAT, V140, P244, DOI 10.1192/bjp.140.3.244; Trimble M R, 1991, Adv Neurol, V55, P143; TRIMBLE MR, 1985, CLIN NEUROPHARMACOL, V8, P211, DOI 10.1097/00002826-198509000-00002; Trimble MR, 1982, TEMPORAL LOBE EPILEP, P98; TSUIKI K, 1995, J NEUROCHEM, V64, P1319; TUCKER GJ, 1986, J NERV MENT DIS, V174, P348, DOI 10.1097/00005053-198606000-00007; TURETSKY B, 1995, ARCH GEN PSYCHIAT, V52, P1061; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Uryu K, 2004, NEUROBIOL AGING S1, V25, pP2; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; WALDMAN AJ, 1992, SOUTHERN MED J, V85, P907, DOI 10.1097/00007611-199209000-00012; WARDEN DL, 2005, TXB TRAUMATIC BRAIN, P231; Wei WH, 2005, ARCH PHYS MED REHAB, V86, P905, DOI 10.1016/j.apmr.2004.09.026; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; YOUNG DA, 1993, SCHIZOPHR RES, V10, P117, DOI 10.1016/0920-9964(93)90046-L; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	189	7	7	0	5	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							1034	1052					19	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100062					2022-02-06	
J	Smouha, E				Smouha, Eric			Inner ear disorders	NEUROREHABILITATION			English	Article						Acoustic neuroma; benign paroxysmal positional vertigo; dizziness; imbalance; inner ear; labyrinthitis; Meniere's disease; migraine; nystagmus; superior canal dehiscence syndrome; vertigo; vestibular neuritis; vestibulo-ocular reflex	PAROXYSMAL POSITIONAL VERTIGO; GENTAMICIN; THERAPY	OBJECTIVES: To present a framework for the diagnosis and treatment of inner ear disorders, with an emphasis on problems common to neuro-rehabilitation. INTRODUCTION: Disorders of the inner ear can cause hearing loss, tinnitus, vertigo and imbalance. Hearing loss can be conductive, sensorineural, or mixed; conductive hearing loss arises from the ear canal or middle ear, while sensorineural hearing loss arises from the inner ear or auditory nerve. Vertigo is a hallucination of motion, and is the cardinal symptom of vestibular system disease. It should be differentiated from other causes of dizziness: gait imbalance, disequilibrium, lightheadedness (pre-syncope). Vertigo can be caused by problems in the inner ear or central nervous system. METHODS: The diagnosis of inner ear disorders begins with a targeted physical examination. The initial work-up of hearing loss is made by audiometry, and vertigo by electronystagmography (ENG). Supplemental tests and MRI are obtained when clinically indicated. RESULTS: The clinical pattern and duration of vertigo are the most important clinical features in the diagnosis. Common inner ear causes of vertigo include: vestibular neuritis (sudden, unilateral vestibular loss), Meniere's disease (episodic vertigo), benign paroxysmal positional vertigo (BPPV), and bilateral vestibular loss. Common central nervous system causes of vertigo include: post concussion syndrome, cervical vertigo, vestibular migraine, cerebrovascular disease, and acoustic neuroma. CONCLUSION: A basic knowledge of vestibular physiology, coupled with a understanding of common vestibular syndromes, will lead to correct diagnosis and treatment in most cases.	Mt Sinai Sch Med, Dept Otolaryngol Head & Neck Surg, New York, NY 10029 USA		Smouha, E (corresponding author), Mt Sinai Sch Med, Dept Otolaryngol Head & Neck Surg, Box 1189,1 Gustave L Levy Pl, New York, NY 10029 USA.	eric.smouha@mssm.edu					Baloh RW, 2002, CURR OPIN NEUROL, V15, P17, DOI 10.1097/00019052-200202000-00004; BECK C, 1978, ARCH OHREN NASEN KEH, V221, P149, DOI 10.1007/BF00455886; BRANDT T, 1980, ARCH OTOLARYNGOL, V106, P484; Bretlau P, 1982, Adv Otorhinolaryngol, V28, P139; Carey J. P., 2005, OTOLARYNGOLOGY HEAD; Chia SH, 2004, OTOL NEUROTOL, V25, P544, DOI 10.1097/00129492-200407000-00023; Cohen HS, 2005, OTOL NEUROTOL, V26, P1034, DOI 10.1097/01.mao.0000185044.31276.59; EPLEY JM, 1992, OTOLARYNG HEAD NECK, V107, P399, DOI 10.1177/019459989210700310; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; Minor LB, 2000, AM J OTOL, V21, P9; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; SILVERSTEIN H, 1990, OTOLARYNG HEAD NECK, V102, P374, DOI 10.1177/019459989010200412; Smouha E E, 1995, Ear Nose Throat J, V74, P649; Smouha EE, 1997, LARYNGOSCOPE, V107, P187, DOI 10.1097/00005537-199702000-00009; Tyler Mitchell, 2003, J Integr Neurosci, V2, P159, DOI 10.1142/S0219635203000263; Wanamaker HH, 1998, AM J OTOL, V19, P170	18	7	8	1	26	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2013	32	3					455	462		10.3233/NRE-130868			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	135DM	WOS:000318266200004	23648600				2022-02-06	
J	Sullivan, KA; Elliott, CD; Lange, RT; Anderson, DS				Sullivan, Karen A.; Elliott, Cameron D.; Lange, Rael T.; Anderson, Deborah S.			A Known-Groups Evaluation of the Response Bias Scale in a Neuropsychological Setting	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						inadequate effort; malingering; MMPI-2; neuropsychological assessment; Response Bias Scale	MMPI-2 VALIDITY SCALES; HENRY-HEILBRONNER INDEX; MALINGERED NEUROCOGNITIVE DYSFUNCTION; TRAUMATIC BRAIN-INJURY; OVER-REPORTING SCALES; FAKE BAD SCALE; CLASSIFICATION ACCURACY; MEMORY TEST; RBS; VALIDATION	We evaluated the Minnesota Multiphasic Personality Inventory-Second Edition (MMPI-2) Response Bias Scale (RBS). Archival data from 83 individuals who were referred for neuropsychological assessment with no formal diagnosis (n=10), following a known or suspected traumatic brain injury (n=36), with a psychiatric diagnosis (n=20), or with a history of both trauma and a psychiatric condition (n=17) were retrieved. The criteria for malingered neurocognitive dysfunction (MNCD) were applied, and two groups of participants were formed: poor effort (n=15) and genuine responders (n=68). Consistent with previous studies, the difference in scores between groups was greatest for the RBS (d=2.44), followed by two established MMPI-2 validity scales, F (d=0.25) and K (d=0.23), and strong significant correlations were found between RBS and F (rs=.48) and RBS and K (r=.41). When MNCD group membership was predicted using logistic regression, the RBS failed to add incrementally to F. In a separate regression to predict group membership, K added significantly to the RBS. Receiver-operating curve analysis revealed a nonsignificant area under the curve statistic, and at the ideal cutoff in this sample of >12, specificity was moderate (.79), sensitivity was low (.47), and positive and negative predictive power values at a 13% base rate were .25 and .91, respectively. Although the results of this study require replication because of a number of limitations, this study has made an important first attempt to report RBS classification accuracy statistics for predicting poor effort at a range of base rates.	[Sullivan, Karen A.; Elliott, Cameron D.] Queensland Univ Technol, Sch Psychol & Counseling, Clin Neuropsychol Res Grp, Brisbane, Qld 4059, Australia; [Sullivan, Karen A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia; [Lange, Rael T.] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada		Sullivan, KA (corresponding author), Queensland Univ Technol, Sch Psychol & Counseling, Victoria Pk Rd,O Block B Wing Room 523, Brisbane, Qld 4059, Australia.	karen.sullivan@qut.edu.au	Anderson, Debra/I-9637-2012		School of Psychology and Counseling, Queensland University of Technology	Funding for this project was provided by the School of Psychology and Counseling, Queensland University of Technology. The research protocol was assessed and approved by the Queensland University of Technology Human Research Ethics Committee (QUT Ref. No. 0900001042) and by occupational workplace health and safety officers.	Allen L., 1997, CARB 1997 MANUAL COM; Axelrod B. N., 1999, J FORENSIC NEUROPSYC, V1, P15; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Berry D., 2008, CLIN ASSESSMENT MALI, P237; Bianchini KJ, 2008, ASSESSMENT, V15, P435, DOI 10.1177/1073191108317341; Butcher J.N., 2001, MINNESOTA MULTIPHASI; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Dionysus KE, 2011, ARCH CLIN NEUROPSYCH, V26, P81, DOI 10.1093/arclin/acq096; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P473, DOI 10.1093/arclin/acq052; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Green P., 2003, GREENS WORD MEMORY T; Green P, 2004, GREENS MED SYMPTOM V; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Iverson G. L., 2010, HDB FORENSIC NEUROPS, P91; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Larrabee G. J., 2008, J INT NEUROPSYCH SOC, V14, P122; Larrabee G. J., 2005, FORENSIC NEUROPSYCHO, P116; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P167, DOI 10.1080/13854040801968443; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; McDermott BE, 2007, PSYCHIAT CLIN N AM, V30, P645, DOI 10.1016/j.psc.2007.07.007; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Nelson NW, 2007, J CLIN EXP NEUROPSYC, V29, P67, DOI 10.1080/13803390500488546; Purdon SE, 2011, CLIN NEUROPSYCHOL, V25, P829, DOI 10.1080/13854046.2011.585141; Rogers R., 2008, CLIN ASSESSMENT MALI, P391; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smart CM, 2008, J INT NEUROPSYCH SOC, V14, P842, DOI 10.1017/S1355617708081034; Sullivan K., 2006, J FORENSIC NEUROPSYC, V4, P49, DOI [10.1300/J151v04n04_04, DOI 10.1300/J151V04N04_04]; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Warrington E, 1984, RECOGNITION MEMORY T, V1; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015	36	7	7	0	5	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282			APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JAN 1	2013	20	1					20	32		10.1080/09084282.2012.670149			13	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	109PH	WOS:000316380000004	23373681	Green Submitted			2022-02-06	
J	Teasdale, TW; Frosig, AJ				Teasdale, Thomas William; Frosig, Anna Julie			Cognitive ability and educational level in relation to concussion: a population study of young men	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HEAD-INJURY; INTELLIGENCE; MANAGEMENT; DYSFUNCTION; CHILDREN; ALCOHOL; PLAYERS; HEALTH	Objectives: To investigate the association of concussion with cognitive ability (CA) and educational level (EL). Design: Epidemiological-cross-linkage of national computer registers. Setting: Denmark. Participants: 130 420 young men appearing before the Danish draft board during the period 2006-2010. Primary and secondary outcome measures: CA test scores, EL and occurrence of concussion during the period 2004-2009, treated either in an A&E unit or upon admission to a hospital ward. Results: The 3067 men who had suffered a concussion had lower CAs (mean=96.5, SD=15, 95% CI 95.0 to 97.0) than the total cohort and they were lower for 1452 who were admitted to a hospital ward (mean CA=95.8, SD=15, 95% CI 95.1 to 96.6) than for 1615 who were treated only at an A&E unit (mean CA=97.1, SD=15, 95% CI 96.3 to 98.0). Multiple logistic regressions revealed that the effects for EL were stronger than those for CA. Among 127 353 men not sustaining a concussion, 48% attended a 'gymnasium' (sixth-form college), among men treated for a concussion at an A&E unit, this falls to 36% and among men hospitalised for a concussion to 30%. Transfer to a gymnasium, if it happens, almost invariably does so before the 18th birthday. Among 701 men suffering a concussion and admitted to a hospital department after this date, only 26% (n=182) were previously transferred to a gymnasium. Among the 804 men treated at an A&E unit after their 18th birthday, 33% (n=265) had done so. These two percentages are significantly below the corresponding non-concussed population (48%). Conclusions: Taken together, the results suggest that lower CA and, in particular, lower EL are risk factors for sustaining a concussion, the risk increasing with the severity of the injury.	[Teasdale, Thomas William; Frosig, Anna Julie] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark		Teasdale, TW (corresponding author), Univ Copenhagen, Dept Psychol, Copenhagen, Denmark.	tom.teasdale@psy.ku.dk	Meijer, Anna/K-5118-2016				Andersen TF, 1999, DAN MED BULL, V46, P263; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Demellweek Colin, 2002, Pediatr Rehabil, V5, P81, DOI 10.1080/136384902320807194; Engberg Aase Worsaa, 2007, Ugeskr Laeger, V169, P3856; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Gottfredson LS, 2004, J PERS SOC PSYCHOL, V86, P174, DOI 10.1037/0022-3514.86.1.174; Gregory R.J., 2011, PSYCHOL TESTING HIST; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hollis SJ, 2011, BRIT J SPORT MED, V45, P997, DOI 10.1136/bjsm.2010.079707; Howell D.C., 2007, STAT METHODS PSYCHOL; Kelly JP, 1997, NEUROLOGY, V48, P581; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Makdissi M, 2010, AUST FAM PHYSICIAN, V39, P12; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; MORTENSEN EL, 1989, SCAND J PSYCHOL, V30, P315, DOI 10.1111/j.1467-9450.1989.tb01094.x; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Teasdale TW, 2011, SCAND J PSYCHOL, V52, P126, DOI 10.1111/j.1467-9450.2010.00862.x; Teasdale TW, 2009, SCAND J PSYCHOL, V50, P633, DOI 10.1111/j.1467-9450.2009.00789.x; Teasdale TW, 1997, BRIT MED J, V315, P569; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397	32	7	7	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2013	3	3							e002321	10.1136/bmjopen-2012-002321			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	301VP	WOS:000330560500042	23474792	gold, Green Published			2022-02-06	
J	Teng, TL; Liang, CC; Shih, CJ; Nguyen, MT				Teng, Tso-Liang; Liang, Cho-Chung; Shih, Chien-Jong; Manh-Trung Nguyen			Design of car hood of sandwich structures for pedestrian safety	INTERNATIONAL JOURNAL OF VEHICLE DESIGN			English	Article						pedestrian; hood; sandwich structures; head injury; headform; EEVC/WG17		Vehicle safety factors should simultaneously consider occupant and pedestrian safety, given that pedestrians are the third largest category of traffic fatalities. Most pedestrian deaths occur due to traumatic brain injury, resulting from the hard impact of the human head against the vehicle's stiff hood or windshield. Therefore, how to design a pedestrian-friendly vehicle and propose a new hood structure is a matter of urgency for minimising pedestrian head injuries. In this study, three kinds of sandwich hood structures are proposed for reducing pedestrian head injuries, including carbon fibre-reinforced polycarbonate, carbon fibre-reinforced foam and aluminium-reinforced polycarbonate. In assessing the friendliness of vehicle hoods, this study adopts the EEVC/WG17 regulations on headforms for hood tests. The finite element method is used to simulate the impact between the vehicle's hood and the headform impactor. The software used in simulation is LS-DYNA. The results predicted by the headform-hood tests show that the hood structure with aluminium-reinforced polycarbonate material provides enough absorption capability to protect pedestrians from the impacts of accidents. It is also stiff enough to keep pedestrians' heads away from the inner parts of the engine cavity. The analysis models and sandwich materials proposed herein contribute to efforts to design vehicle hood structures and pave the way for developing pedestrian protection technologies.	[Teng, Tso-Liang] Hsiuping Univ Sci & Technol, Dept Mech Engn, Taichung 412, Taiwan; [Liang, Cho-Chung; Manh-Trung Nguyen] Da Yeh Univ, Inst Mech & Automat Engn, Changhua 515, Taiwan; [Shih, Chien-Jong] Tam Kang Univ, Dept Mech & Electromech Engn, Taipei 251, Taiwan		Teng, TL (corresponding author), Hsiuping Univ Sci & Technol, Dept Mech Engn, Taichung 412, Taiwan.	tlteng@mail.hust.edu.tw; ccliang@mail.dyu.edu.tw; cjs@mail.tku.edu.tw; rumanji129@yahoo.com.vn					Col D., 1998, MSC US C IT; EEVC Working Group 17, 2002, IMPR TEST METH EV PE; FREDRIKSSON R, 2001, 17 ESV C AMST NETH; Gopalakrishnan V, 2007, J RHEOL, V51, P623, DOI 10.1122/1.2736413; Gundberg T., 2002, FOAM CORE MAT MARINE; Han Y. H., 2003, 2003011232 SAE; Ikeda K., 2003, 2003012793 SAE; Maki T, 2002, JSAE REV, V23, P353, DOI 10.1016/S0389-4304(02)00188-1; Masoumi A, 2011, SAFETY SCI, V49, P1371, DOI 10.1016/j.ssci.2011.05.008; Simms C. K., 2008, PERSPECTIVES DESIGN, P39; Teng TL, 2008, J MECH SCI TECHNOL, V22, P1660, DOI 10.1007/s12206-008-0512-8; Thacker JG, 1998, FINITE ELEM ANAL DES, V30, P279, DOI 10.1016/S0168-874X(98)00043-2; Vaidya AS, 2008, MAT SCI ENG A-STRUCT, V472, P52, DOI 10.1016/j.msea.2007.03.064; Zanella A, 2003, P SOC PHOTO-OPT INS, V4763, P106, DOI 10.1117/12.508679	14	7	7	4	32	INDERSCIENCE ENTERPRISES LTD	GENEVA	WORLD TRADE CENTER BLDG, 29 ROUTE DE PRE-BOIS, CASE POSTALE 856, CH-1215 GENEVA, SWITZERLAND	0143-3369	1741-5314		INT J VEHICLE DES	Int. J. Veh. Des.		2013	63	2-3					185	198		10.1504/IJVD.2013.056142			14	Engineering, Mechanical; Transportation Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Transportation	214WN	WOS:000324168200004					2022-02-06	
J	Pealing, L; Perel, P; Prieto-Merino, D; Roberts, I				Pealing, Louise; Perel, Pablo; Prieto-Merino, David; Roberts, Ian		CRASH-2 Trial Collaborators	Risk Factors for Vascular Occlusive Events and Death Due to Bleeding in Trauma Patients; an Analysis of the CRASH-2 Cohort	PLOS ONE			English	Article							SYSTEMIC INFLAMMATION; MYOCARDIAL-INFARCTION; BRAIN-INJURY; THROMBOSIS; THROMBOEMBOLISM	Background: Vascular occlusive events can complicate recovery following trauma. We examined risk factors for venous and arterial vascular occlusive events in trauma patients and the extent to which the risk of vascular occlusive events varies with the severity of bleeding. Methods and Findings: We conducted a cohort analysis using data from a large international, double-blind, randomised, placebo-controlled trial (The CRASH-2 trial) [1]. We studied the association between patient demographic and physiological parameters at hospital admission and the risk of vascular occlusive events. To assess the extent to which risk of vascular occlusive events varies with severity of bleeding, we constructed a prognostic model for the risk of death due to bleeding and assessed the relationship between risk of death due to bleeding and risk of vascular occlusive events. There were 20,127 trauma patients with outcome data including 204 (1.01%) patients with a venous event (pulmonary embolism or deep vein thrombosis) and 200 (0.99%) with an arterial event (myocardial infarction or stroke). There were 81 deaths due to vascular occlusive events. Increasing age, decreasing systolic blood pressure, increased respiratory rates, longer central capillary refill times, higher heart rates and lower Glasgow Coma Scores (all p<0.02) were strong risk factors for venous and arterial vascular occlusive events. Patients with more severe bleeding as assessed by predicted risk of haemorrhage death had a greatly increased risk for all types of vascular occlusive event (all p<0.001). Conclusions: Patients with severe traumatic bleeding are at greatly increased risk of venous and arterial vascular occlusive events. Older age and blunt trauma are also risk factors for vascular occlusive events. Effective treatment of bleeding may reduce venous and arterial vascular occlusive complications in trauma patients.	[Pealing, Louise; Perel, Pablo; Prieto-Merino, David; Roberts, Ian; CRASH-2 Trial Collaborators] Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England		Pealing, L (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, Keppel St, London WC1E 7HT, England.	louise.pealing@lshtm.ac.uk		Prieto-Merino, David/0000-0001-5001-0061; /0000-0002-2342-301X	National Institute for Health ResearchNational Institute for Health Research (NIHR) [IPF 11-05, 06/303/20] Funding Source: researchfish; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) Funding Source: Medline; Department of HealthEuropean Commission [06/303/20, IPF 11-05, HTA/06/303/20] Funding Source: Medline		Carter Angela M, 2005, Diab Vasc Dis Res, V2, P113, DOI 10.3132/dvdr.2005.018; Chien LC, 2007, J TRAUMA, V62, P928, DOI 10.1097/01.ta.0000215411.92950.72; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Devereaux PJ, 2005, CAN MED ASSOC J, V173, P627, DOI 10.1503/cmaj.050011; Gearhart MM, 2000, SURGERY, V128, P631, DOI 10.1067/msy.2000.108224; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; Hirsh J, 2004, CHEST, V126, p172S, DOI 10.1378/chest.126.3_suppl.172S; Ismailov RM, 2005, INT J CARDIOL, V105, P141, DOI 10.1016/j.ijcard.2004.11.025; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Knudson M Margaret, 2004, Curr Opin Crit Care, V10, P539, DOI 10.1097/01.ccx.0000144941.09650.9f; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Lakatta Edward G, 2002, Heart Fail Rev, V7, P29; Landesberg G, 2009, CIRCULATION, V119, P2936, DOI 10.1161/CIRCULATIONAHA.108.828228; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Lima A, 2009, CRIT CARE MED, V37, P934, DOI 10.1097/CCM.0b013e31819869db; Lucas AR, 2006, CIRCULATION, V113, P728, DOI 10.1161/CIRCULATIONAHA.105.601492; Mann NC, 2001, J TRAUMA, V50, P1111, DOI 10.1097/00005373-200106000-00022; Martinelli I, 2010, CRIT CARE MED, V38, pS3, DOI 10.1097/CCM.0b013e3181c9cbd9; McCartney JS, 1934, AM J PATHOL, V10, P709; Moosikasuwan JB, 2000, J AM COLL SURGEONS, V190, P665, DOI 10.1016/S1072-7515(00)00263-5; Mulvihill NT, 2002, HEART, V87, P201, DOI 10.1136/heart.87.3.201; Namas R, 2009, ACUTE INFLAMMATORY R; Namas R, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.05.025; NAPOLITANO LM, 1995, J TRAUMA, V39, P651, DOI 10.1097/00005373-199510000-00006; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; OMALLEY KF, 1990, J TRAUMA, V30, P748, DOI 10.1097/00005373-199006000-00018; Park MS, 2009, J TRAUMA, V67, P266, DOI 10.1097/TA.0b013e3181ae6f1c; Piotrowski JJ, 1996, AM J SURG, V172, P210, DOI 10.1016/S0002-9610(96)00154-7; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Selby R, 2009, THROMB RES, V124, P281, DOI 10.1016/j.thromres.2008.10.002; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Syrovets T, 2012, J LEUKOC BIOL; Toker S, 2011, THROMBOSIS, V2011; Tolonen H, 2005, INT J EPIDEMIOL, V34; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; WHELTON PK, 1994, LANCET, V344, P101, DOI 10.1016/S0140-6736(94)91285-8; World Bank, WORLD DEV IND; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	45	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50603	10.1371/journal.pone.0050603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	WOS:000312201900014	23251374	Green Accepted, Green Published, Green Submitted, gold			2022-02-06	
J	Adetchessi, AT; Pech-Gourg, G; Metellus, P; Fuentes, S				Adetchessi, A. T.; Pech-Gourg, G.; Metellus, P.; Fuentes, S.			Fracture of macroporous hydroxyapatite prosthesis	NEUROCHIRURGIE			French	Article						Cranioplasty; Macroporous hydroxyapatite; Skull fracture	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; CERAMIC IMPLANTS; BONE DEFECTS; CRANIOPLASTY; EXPERIENCE	Different prosthesis implants are offered to perform a cranioplasty after a decompressive craniectomy when autologous bone graft cannot be used. The authors report the case of a 25-year-old man who benefited a unilateral decompressive craniectomy after a severe head trauma. Seven months later, a cranioplasty using custom macroporous hydroxyapatite prosthesis was performed. The postoperative course was marked by a generalized seizure leading to a traumatic head injury. The CT-scan showed a comminutive fracture of the prosthesis and an extradural hematoma. The patient underwent a removal of the fractured prosthesis and an evacuation of the extradural clot. The postoperative course was uneventful with a Glasgow outcome scale score at 5. A second cranioplasty using a polyether ether ketone (PEEK) implant was performed. Among cranioplasty prosthesis solutions, hydroxyapatite implants seem to have similar property to the bone. However, its weak mechanic resistance is an actual problem in patients susceptible to present generalized seizures with consecutive head impact. Hence, in patients with decompressive craniectomy who are exposed to potential brain injury, we favor the use of more resistant implant as PEEK prosthesis. (C) 2012 Published by Elsevier Masson SAS.	[Adetchessi, A. T.; Pech-Gourg, G.; Metellus, P.; Fuentes, S.] Hop Timone Adulte, Serv Neurochirurg, F-13385 Marseille 5, France		Adetchessi, AT (corresponding author), Hop Timone Adulte, Serv Neurochirurg, 264 Rue St Pierre, F-13385 Marseille 5, France.	agona.adetchessi@ap-hm.fr					Balossier A, 2011, NEUROCHIRURGIE, V57, P21, DOI 10.1016/j.neuchi.2010.08.003; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Chistolini P, 1999, J MATER SCI-MATER M, V10, P739, DOI 10.1023/A:1008939524807; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Hardy H, 2012, NEUROCHIRURGIE, V58, P25, DOI 10.1016/j.neuchi.2011.09.006; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Ono I, 1999, PLAST RECONSTR SURG, V104, P339, DOI 10.1097/00006534-199908000-00003; Pompili A, 1998, J NEUROSURG, V89, P236, DOI 10.3171/jns.1998.89.2.0236; Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348	16	7	7	0	8	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	DEC	2012	58	6					382	385		10.1016/j.neuchi.2012.06.001			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	049IR	WOS:000311976600010	22898300				2022-02-06	
J	Bralic, M; Stemberga, V				Bralic, Marina; Stemberga, Valter			Calpain Expression in the Brain Cortex after Traumatic Brain Injury	COLLEGIUM ANTROPOLOGICUM			English	Article						calpain; neuronal damage; traumatic brain injury; post-mortem study	SPECTRIN BREAKDOWN PRODUCTS; CEREBROSPINAL-FLUID; DISEASE	Traumatic brain injury (TBI) is the leading cause of death and disability worldwide. Calpains, a family of cysteine proteases have been implicated in cells death following TBI. Using immunohistochemistry calpain expression was analyzed in post mortem brain tissue obtained from patients who died after TBI, and findings were compared with the brain tissue from patients who died from sudden cardiac arrest. In the injured cortex an increase in calpain expression was observed in all resident brain cells: neurons, glial and endothelial cells in comparison to the control group (all p<0.001). Calpain expression was analyzed in different post-traumatic intervals, from day 0 until 10 days post-injury, in order to establish a time course of expression in the brain cortex after TBI. Expression was detected in the cortex 5 hours after the accident, peaked at 72 hours, and substantially reduced by 10 days after TBI. Calpain expression in the cortex significantly changed during the time from TBI to death (p<0.001), and the most prominent expression was detected in the cortex 3 days after TBI. Our results indicate that prolonged calpain expression in resident brain cells (neurons, glial and endothelial cells) plays an important role in neuronal degeneration following TBI.	[Bralic, Marina] Univ Rijeka, Rijeka Univ Hosp Ctr, Dept Neurol, Rijeka 51000, Croatia; [Stemberga, Valter] Univ Rijeka, Sch Med, Dept Forens Med & Criminalist, Rijeka 51000, Croatia		Bralic, M (corresponding author), Univ Rijeka, Rijeka Univ Hosp Ctr, Dept Neurol, Cambierieva 17, Rijeka 51000, Croatia.	marina.bralic@yahoo.com		Bralic, Marina/0000-0003-4206-2405			Bloise E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-320; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Girotto D, 2011, COLLEGIUM ANTROPOL, V35, P255; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Peng S, 2011, MOL BIOL REP, V38, P905, DOI 10.1007/s11033-010-0183-2; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Pirjavec A, 2012, COLLEGIUM ANTROPOL, V36, P339; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Tradewell ML, 2010, NEUROREPORT, V21, P976, DOI 10.1097/WNR.0b013e32833ddd45; Varjacic M, 2010, COLLEGIUM ANTROPOL, V34, P157; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x	17	7	7	0	0	COLLEGIUM ANTROPOLOGICUM	ZAGREB	INST ANTHROPOLOGICAL RESEARCH, GAJEVA 32, PO BOX 290, HR-10000 ZAGREB, CROATIA	0350-6134			COLLEGIUM ANTROPOL	Coll. Anthropol.	DEC	2012	36	4					1319	1323					5	Anthropology	Social Science Citation Index (SSCI)	Anthropology	076ZY	WOS:000313998900033	23390828				2022-02-06	
J	Brotfain, E; Leibowitz, A; Dar, DE; Krausz, MM; Shapira, Y; Koyfman, L; Klein, M; Hess, S; Zlotnik, A				Brotfain, Evgeni; Leibowitz, Akiva; Dar, Dalit E.; Krausz, Michael M.; Shapira, Yoram; Koyfman, Leonid; Klein, Moti; Hess, Shmuel; Zlotnik, Alexander			SEVERE TRAUMATIC BRAIN INJURY AND CONTROLLED HEMORRHAGE IN RATS: QUEST FOR THE OPTIMAL MEAN ARTERIAL BLOOD PRESSURE AFTER WHOLE FRESH DONOR BLOOD RESUSCITATION	SHOCK			English	Article						Traumatic brain injury; hemorrhage; neurological outcomes; resuscitation	HEAD-INJURY; SHOCK; HYPOTENSION; FLUID; TRANSFUSION; HYPOXIA; DEATH; CONSEQUENCES; RECOVERY; THERAPY	Treatment of combined traumatic brain injury and hypovolemic shock poses a particular challenge due to the possible conflicting consequences. While restoring diminished volume is the treatment goal for hypovolemia, maintaining and adequate cerebral perfusion pressure and avoidance of secondary damage remain a treatment goal for the injured brain. Various treatment modalities have been proposed, but the optimal resuscitation fluid and goals have not yet been clearly defined. In this study, we investigate the physiological and neurological outcomes in a rat model of combined traumatic brain injury and hypovolemic shock, submitted to treatment with varying amounts of fresh blood. Forty-eight male Lewis rats were divided into control and treatment groups. Traumatic brain injury was inflicted by a free-falling rod on the exposed cranium. Hypovolemia was induced by controlled hemorrhage of 30% blood volume. Treatment groups were treated by fresh whole blood with varying volumes, reaching resuscitation goals of a mean arterial blood pressure (MAP) of 80, 100, and 120 mmHg at 15 min. Mean arterial blood pressure was assessed at 60 min and neurological outcomes and mortality in the subsequent 48 h. At 60 min, MAP was highest for the group resuscitated most aggressively. Neurological outcomes and mortality inversely correlated with the aggressiveness of resuscitation. In this study, we find that mild resuscitation with goals of restoring MAP to 80 mmHg (which is lower than baseline) provided best results when considering hemodynamic stability, survival, and neurological outcomes. An aggressive resuscitation may be detrimental, inducing processes that eventually cause a significant decrease in survival.	[Brotfain, Evgeni; Leibowitz, Akiva; Shapira, Yoram; Koyfman, Leonid; Klein, Moti; Hess, Shmuel; Zlotnik, Alexander] Ben Gurion Univ Negev, Dept Anesthesiol & Crit Care, Soroka Med Ctr, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Dar, Dalit E.] Rambam Med Ctr, Lab Shock & Trauma Res, Haifa, Israel; [Dar, Dalit E.] Rambam Med Ctr, Dept Surg A, Haifa, Israel; [Dar, Dalit E.] Technion Israel Inst Technol, Haifa, Israel; [Krausz, Michael M.] Hillel Yaffe Med Ctr, Hadera, Israel		Leibowitz, A (corresponding author), Ben Gurion Univ Negev, Dept Anesthesiol & Crit Care, Soroka Med Ctr, POB 151, IL-84105 Beer Shiva, Israel.	akival@bgu.ac.il	klein, moti/AAR-6552-2021; Leibowitz, Akiva/F-1397-2012	Leibowitz, Akiva/0000-0003-4244-1915			American College of Surgeons Committee on Trauma, 2008, ATLS ADV TRAUM LIF S; Cabrales P, 2007, SHOCK, V27, P380, DOI 10.1097/01.shk.0000239782.71516.ba; CAPONE AC, 1995, J AM COLL SURGEONS, V180, P49; Carrillo P, 1998, J TRAUMA, V45, P239, DOI 10.1097/00005373-199808000-00007; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Dar DE, 2010, SHOCK, V34, P75, DOI 10.1097/SHK.0b013e3181ce2cbc; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; FALK JL, 1995, CRIT CARE MED, V23, P4, DOI 10.1097/00003246-199501000-00003; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Feldman Z, 1997, J TRAUMA, V43, P667, DOI 10.1097/00005373-199710000-00017; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Kerby JD, 2007, SHOCK, V27, P652, DOI 10.1097/01.shk.0000248584.10400.dc; Krausz Michael M, 2006, World J Emerg Surg, V1, P14, DOI 10.1186/1749-7922-1-14; Krausz MM, 2000, SHOCK, V13, P230, DOI 10.1097/00024382-200003000-00010; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Moore FA, 1997, ARCH SURG-CHICAGO, V132, P620; MOORE FA, 1997, ARCH SURG-CHICAGO, V132, P624; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Popovsky MA, 2006, TRANSFUS APHER SCI, V34, P243, DOI 10.1016/j.transci.2006.01.005; Prough DS, 1997, J TRAUMA, V42, pS10, DOI 10.1097/00005373-199705001-00003; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; YUAN XQ, 1992, SURG GYNECOL OBSTET, V174, P305; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731	36	7	8	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1073-2322			SHOCK	Shock	DEC	2012	38	6					630	634		10.1097/SHK.0b013e318272d59f			5	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	040QV	WOS:000311338900009	23143053				2022-02-06	
J	Chesnut, RM; Temkin, N; Carney, N; Dikmen, S; Pridgeon, J; Barber, J; Celix, JM; Chaddock, K; Cherner, M; Hendrix, T; Lujan, S; Machamer, J; Petroni, G; Rondina, C; Videtta, W				Chesnut, Randall M.; Temkin, Nancy; Carney, Nancy; Dikmen, Sureyya; Pridgeon, Jim; Barber, Jason; Celix, Juanita M.; Chaddock, Kelley; Cherner, Marianna; Hendrix, Terence; Lujan, Silvia; Machamer, Joan; Petroni, Gustavo; Rondina, Carlos; Videtta, Walter			Traumatic Brain Injury in Latin America: Lifespan Analysis Randomized Control Trial Protocol	NEUROSURGERY			English	Article						Craniocerebral trauma; Clinical research protocol; Intracranial pressure; Randomized controlled trial	SCALE; FLUENCY; NORMS	BACKGROUND: Although in the developed world the intracranial pressure (ICP) monitor is considered the standard of care for patients with severe traumatic brain injury (TBI), its usefulness to direct treatment decisions has never been tested rigorously. OBJECTIVE: The primary focus was to conduct a high-quality, randomized, controlled trial to determine whether ICP monitoring used to direct TBI treatment improves patient outcomes. By providing education, equipment, and structure, the project will enhance the research capacity of the collaborating investigators and will foster the collaborations established during earlier studies. METHODS: Study centers were selected that routinely treated ICP based on clinical examination and computed tomography imaging using internal protocols. We randomized patients to either an ICP monitor group or an imaging and clinical examination group. Treatment decisions for the ICP monitor group are guided by ICP monitoring based on established guidelines. Treatment decisions for the imaging and clinical examination group are made using a single protocol derived from those previously being used at those centers. EXPECTED OUTCOMES: There are 2 study hypotheses: (1) patients with severe TBI whose acute care treatment is managed using ICP monitors will have improved outcomes and 2) incorporating ICP monitoring in the care of patients with severe TBI will minimize complications and decrease length of intensive care unit stay. DISCUSSION: This clinical trial tests the effectiveness of a management protocol based on technology considered pivotal to brain trauma treatment in the developed world: the ICP monitor. A randomized, controlled trial of ICP monitoring has never been performeda critical gap in the evidence base that supports the role of ICP monitoring in TBI care. As such, the results of this randomized, controlled trial will have global implications regardless of the level of development of the trauma system.	[Chesnut, Randall M.; Temkin, Nancy; Dikmen, Sureyya; Pridgeon, Jim; Barber, Jason; Celix, Juanita M.; Chaddock, Kelley; Hendrix, Terence] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA; [Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Dept Orthopaed & Sports Med, Seattle, WA 98104 USA; [Temkin, Nancy] Univ Washington, Harborview Med Ctr, Dept Biostat, Seattle, WA 98104 USA; [Dikmen, Sureyya; Machamer, Joan] Univ Washington, Harborview Med Ctr, Dept Rehabil Med, Seattle, WA 98104 USA; [Carney, Nancy] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Cherner, Marianna] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Hendrix, Terence] Univ Calif San Diego, HIV Neurobehav Res Programs, La Jolla, CA 92093 USA; [Lujan, Silvia; Petroni, Gustavo; Rondina, Carlos] Hosp Emergencias, Santa Fe, Argentina; [Videtta, Walter] Hosp Nacl, Buenos Aires, DF, Argentina		Chesnut, RM (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol Surg, 325 9th Ave,Box 359766, Seattle, WA 98104 USA.	chesnutr@uw.edu		Chesnut, Randall/0000-0001-6377-3666	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS058302]; Integra Life Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS058302, R01NS080648] Funding Source: NIH RePORTER	NIH/NINDS R01 NS058302; Integra Life Sciences; Mr Richard Adler with Adler Giersch PS and Mr Michael Nelson and Mr Fred Langer with Langer Engle, PLLC. Dr Chesnut has an endowment from the Integra Foundation. The other authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Artiola i Fortuny L, 2000, MANUAL NOMAS PROCEDI; Benedict R., 1997, BRIEF VISUOSPATIAL M; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; Bullock R, 1998, GUIDELINES MANAGEMEN; Cherner M, 2007, ARCH CLIN NEUROPSYCH, V22, P343, DOI 10.1016/j.acn.2007.01.009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Heaton R. K., 2004, REVISED COMPREHENSIV; Heaton RK., 2002, CLIN INTERPRETATION; Klove H., 1963, GROOVED PEGBOARD; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Woods SP, 2005, J INT NEUROPSYCH SOC, V11, P408, DOI 10.1017/S1355617705050460	22	7	7	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	DEC	2012	71	6					1055	1063		10.1227/NEU.0b013e31827276b7			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	040RC	WOS:000311339600016	22986600	Green Accepted, Bronze			2022-02-06	
J	Hufford, BJ; Williams, MK; Malec, JF; Cravotta, D				Hufford, Bradley J.; Williams, Mark K.; Malec, James F.; Cravotta, David			Use of behavioural contracting to increase adherence with rehabilitation treatments on an inpatient brain injury unit: A case report	BRAIN INJURY			English	Article						Brain injury; awareness; agitation; behavioural contracting	SELF-AWARENESS; DEFICITS; SCALE; PEOPLE	Background: This systematic, single-subject case study presents a 37-year old male with a severe traumatic brain injury who exhibited agitation and poor adherence with rehabilitation treatment on an inpatient traumatic brain injury unit. Attempts to address presumed awareness issues were unsuccessful. Medication trials also failed to produce an observable response in the patient's behaviour. Case study: A behavioural contract was presented by staff that specified positive behaviours the patient needed to demonstrate in order to reach his goal of being discharged from the hospital. Immediately, patient agitation ratings decreased and soon normalized. Statistical analysis of single subject times series data using the method of Nonoverlap of all Pairs results in a ratio of 0.875, indicating a moderate effect size for the intervention. Conclusions: The patient was able to comply with all requests and, with supports, was able to be safely discharged from the hospital ahead of schedule. Factors that could have contributed to this outcome and potential limitations are discussed.	[Hufford, Bradley J.] Rehabil Hosp Indiana, Dept Clin Neuropsychol, Indianapolis, IN 46254 USA; [Hufford, Bradley J.; Malec, James F.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA		Hufford, BJ (corresponding author), Rehabil Hosp Indiana, Dept Clin Neuropsychol, 4141 Shore Dr, Indianapolis, IN 46254 USA.	bhufford@rhin.com					Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Ducharme JM, 1999, BRAIN INJURY, V13, P645, DOI 10.1080/026990599121232; Ducharme JM, 2000, CLIN PSYCHOL REV, V20, P405, DOI 10.1016/S0272-7358(98)00102-0; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleming JM, 1996, BRAIN INJURY, V10, P1; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Manchester D, 1997, BRAIN INJURY, V11, P271; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Parker RI, 2009, BEHAV THER, V40, P357, DOI 10.1016/j.beth.2008.10.006; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg MM, 1998, J HEAD TRAUMA REHAB, V13, P62, DOI 10.1097/00001199-199810000-00008; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Tyson SF, 2009, CLIN REHABIL, V23, P824, DOI 10.1177/0269215509335018; Wood RL, 2011, J HEAD TRAUMA REHAB, V26, P202, DOI 10.1097/HTR.0b013e318217b46d; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 1998, COLLABORATIVE BRAIN	22	7	8	0	11	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1743	1749		10.3109/02699052.2012.698791			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700021	22755512				2022-02-06	
J	King, PR; Wray, LO				King, Paul R.; Wray, Laura O.			Managing Behavioral Health Needs of Veterans with Traumatic brain injury (TBI) in Primary Care	JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS			English	Article						Traumatic brain injury (TBI); Integrated primary care; Veterans	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; PERSISTENT POSTCONCUSSIVE SYMPTOMS; OPERATIONS ENDURING FREEDOM; POST-CONCUSSION SYNDROME; US SERVICE MEMBERS; SUBSTANCE-ABUSE; CHRONIC PAIN; HEAD-INJURY; PSYCHIATRIC-DISORDERS	Traumatic brain injury (TBI) is a frequent occurrence in the United States, and has been given particular attention in the veteran population. Recent accounts have estimated TBI incidence rates as high as 20 % among US veterans who served in Afghanistan or Iraq, and many of these veterans experience a host of co-morbid concerns, including psychiatric complaints (such as depression and post-traumatic stress disorder), sleep disturbance, and substance abuse which may warrant referral to behavioral health specialists working in primary care settings. This paper reviews many common behavioral health concerns co-morbid with TBI, and suggests areas in which behavioral health specialists may assess, intervene, and help to facilitate holistic patient care beyond the acute phase of injury. The primary focus is on sequelae common to mild and moderate TBI which may more readily present in primary care clinics.	[King, Paul R.; Wray, Laura O.] VA Western New York Healthcare Syst, Ctr Integrated Healthcare 116N, Buffalo, NY 14215 USA; [Wray, Laura O.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Med, Div Geriatr Gerontol, Buffalo, NY 14260 USA		King, PR (corresponding author), VA Western New York Healthcare Syst, Ctr Integrated Healthcare 116N, 3495 Bailey Ave, Buffalo, NY 14215 USA.	Paul.King2@va.gov					Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Allen R., 2011, N AM BRAIN INJ SOC 9; American Psychiatric Association, 2012, NEUR DIS DUE TRAUM B; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; [Anonymous], 2010, PRACT REC TREATM VET; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; Ashman TA, 2004, BRAIN INJURY, V18, P191, DOI 10.1080/0269905031000149506; Babor T.F., 2001, AUDIT THE ALCOHOL US; Barth, 2009, MANAGEMENT CONCUSSIO; Barton B., 2011, N AM BRAIN INJ SOC 9; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, BRAIN INJURY, V23, P991, DOI 10.3109/02699050903379362; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Brown S, 2011, BRAIN INJURY, V25, P453, DOI 10.3109/02699052.2011.556581; Bryan CJ, 2009, PROF PSYCHOL-RES PR, V40, P148, DOI 10.1037/a0011141; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carlson K, 2009, ASSESSMENT TREATMENT; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Centers for Disease Control and Prevention, 2010, HEADS FACTS PHYS MIL; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2006, J HEAD TRAUMA REHAB, V21, P408, DOI 10.1097/00001199-200609000-00007; Cigrang JA, 2011, PSYCHOL SERV, V8, P104, DOI 10.1037/a0022740; Clark ME, 2003, J REHABIL RES DEV, V40, P381, DOI 10.1682/JRRD.2003.09.0381; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Cobb Sarah, 2004, J Sch Nurs, V20, P262; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Curtiss G, 2000, J HEAD TRAUMA REHAB, V15, P1113, DOI 10.1097/00001199-200010000-00005; Daggett V, 2009, J NEUROSCI NURS, V41, P59, DOI 10.1097/JNN.0b013e31819a7133; Dausch BM, 2009, REHABIL PSYCHOL, V54, P279, DOI 10.1037/a0016809; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Diaz F G, 1995, Med Law, V14, P131; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Drubach D A, 1993, Md Med J, V42, P989; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferguson SD, 2009, J PERS DISORD, V23, P230, DOI 10.1521/pedi.2009.23.3.230; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; FULLER MG, 1994, J NEUROPSYCH CLIN N, V6, P143; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Greve KW, 2001, BRAIN INJURY, V15, P255; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Gutierrez PM, 2008, ARCH SUICIDE RES, V12, P336, DOI 10.1080/13811110802324961; Hampton T, 2011, JAMA-J AM MED ASSOC, V306, P477, DOI 10.1001/jama.2011.1092; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Haskell SG, 2006, J WOMENS HEALTH, V15, P862, DOI 10.1089/jwh.2006.15.862; Heltemes KJ, 2011, MIL MED, V176, P147, DOI 10.7205/MILMED-D-10-00191; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hourani LL, 2008, 2008 DEP DEF SURV HL; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; Kerr K, 2011, BRAIN INJURY, V25, P729, DOI 10.3109/02699052.2011.580315; King P. R., 2011, 119 AM PSYCH ASS CON; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kivlahan D., 2009, VA DOD CLIN PRACTICE; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lin DL, 2004, J ORTHOP TRAUMA, V18, pS48, DOI 10.1097/00005131-200409001-00008; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Maiuro R. D., 1987, J INTERPERS VIOLENCE, V2, P166, DOI [10.1177/088626087002002003, DOI 10.1177/088626087002002003]; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Murrey GJ, 2007, AM J DRUG ALCOHOL AB, V33, P327, DOI 10.1080/00952990601175110; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Alliance for Caregiving, 2010, REP STUD FIND CAR VE; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Perlick DA, 2011, PROF PSYCHOL-RES PR, V42, P70, DOI 10.1037/a0022319; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Possemato K, 2011, J CLIN PSYCHOL MED S, V18, P268, DOI 10.1007/s10880-011-9237-4; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schnurr PP, 2013, J GEN INTERN MED, V28, P32, DOI 10.1007/s11606-012-2166-6; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; SCHREIBER S, 1993, PAIN, V54, P107, DOI 10.1016/0304-3959(93)90105-X; Schutte C, 2010, INT J NEUROSCI, V120, P551, DOI 10.3109/00207454.2010.494789; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Shemesh E, 2011, J CLIN PSYCHIAT, V72, P168, DOI 10.4088/JCP.09m05116blu; Sherman MD, 2003, PROF PSYCHOL-RES PR, V34, P42, DOI 10.1037/0735-7028.34.1.42; SHERMAN MD, 2008, SAFE PROGRAM SUPPORT; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Smith PC, 2009, J GEN INTERN MED, V24, P783, DOI 10.1007/s11606-009-0928-6; Steer, 1993, MANUAL BECK ANXIETY; Summerall EL, 2010, PSYCHIAT ANN, V40, P563, DOI 10.3928/00485713-20101022-07; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Votruba KL, 2008, J HEAD TRAUMA REHAB, V23, P65, DOI 10.1097/01.HTR.0000314525.93381.69; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Walker RL, 2010, J PAIN, V11, P297, DOI 10.1016/j.jpain.2009.12.001; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WARE JE, 1993, SF 36 HLTH SURV MAN; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Weathers F.W., 1993, 9 ANN C ISTSS; Wehman P, 2000, NEUROREHABILITATION, V15, P71; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f; World Health Organization, 2004, ICD 10 INT STAT CLAS; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	176	7	7	0	26	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9583	1573-3572		J CLIN PSYCHOL MED S	J. Clin. Psychol. Med. Settings	DEC	2012	19	4					376	392		10.1007/s10880-012-9345-9			17	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	057RS	WOS:000312582300004	23184276				2022-02-06	
J	Tormenti, M; Krieger, D; Puccio, AM; McNeil, MR; Schneider, W; Okonkwo, DO				Tormenti, Matthew; Krieger, Donald; Puccio, Ava M.; McNeil, Malcolm R.; Schneider, Walter; Okonkwo, David O.			Magnetoencephalographic virtual recording: a novel diagnostic tool for concussion	NEUROSURGICAL FOCUS			English	Article						concussion; mild traumatic brain injury; magnetoencephalography	TRAUMATIC BRAIN-INJURY; IMAGING APPROACH; HEAD TRAUMA; MILD; MEG	Object. Heightened recognition of the prevalence and significance of head injury in sports and in combat veterans has brought increased attention to the physiological and behavioral consequences of concussion. Current clinical practice is in part dependent on patient self-report as the basis for medical decisions and treatment. Magnetoencephalography (MEG) shows promise in the assessment of the pathophysiological derangements in concussion. The authors have developed a novel MEG-based neuroimaging strategy to provide objective, noninvasive, diagnostic information in neurological disorders. In the current study the authors demonstrate a novel task protocol and then assess MEG virtual recordings obtained during task performance as a diagnostic tool for concussion. Methods. Ten individuals (5 control volunteers and 5 patients with a history of concussion) were enrolled in this pilot study. All participants underwent an MEG evaluation during performance of a language/spatial task. Each individual produced 960 responses to 320 sentence stimuli; 0.3 sec of MEG data from each word presentation and each response were analyzed: the data from each participant were classified using a rule constructed from the data obtained from the other 9 participants. Results. Analysis of response times showed significant differences (p < 10(-4)) between concussed and normal groups, demonstrating the sensitivity of the task. The MEG measures enabled the correct classification of 8 of 10 individuals as concussed versus nonconcussed (p = 0.055). Analysis of single-trial data classified 70% of trials correctly (p < 10(-10)). Concussed patients showed increased activation in the occipitoparietal and temporal regions during evaluation. Conclusions. These pilot findings are the first evidence of the utility of MEG virtual recording in diagnosing concussion. With further refinements, MEG virtual recordings may represent a noninvasive test to diagnose concussion and monitor its resolution. (http://thejns.org/doi/abs/10.3171/2012.10.FOCUS12282)	[Tormenti, Matthew; Krieger, Donald; Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [McNeil, Malcolm R.] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA 15260 USA; [Schneider, Walter] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA		Krieger, D (corresponding author), UPMC Presbyterian, Dept Neurol Surg, Suite B400,200 Lothrop St, Pittsburgh, PA 15213 USA.	kriegerd@upmc.edu		Krieger, Donald/0000-0002-9789-9731	Pittsburgh Foundation	This work was supported by Copeland funding from the Pittsburgh Foundation. The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.	Centers for Disease Control, HEADS FACTS PHYS MIL; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McNeil MR, 1978, REVISED TOKEN TEST; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Xia H, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2392722	14	7	7	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	DEC	2012	33	6							E9	10.3171/2012.10.FOCUS12282			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	048GI	WOS:000311898500010	23199432	Bronze			2022-02-06	
J	van Iersel, FM; Slooter, AJC; Vroegop, R; Wolters, AE; Tiemessen, CAM; Rosken, RHJ; van der Hoeven, JG; Peelen, LM; Hoedemaekers, CWE				van Iersel, Freya M.; Slooter, Arjen J. C.; Vroegop, Renee; Wolters, Annemiek E.; Tiemessen, Charlotte A. M.; Rosken, Rik H. J.; van der Hoeven, Johannes G.; Peelen, Linda M.; Hoedemaekers, Cornelia W. E.			Risk factors for hypoglycaemia in neurocritical care patients	INTENSIVE CARE MEDICINE			English	Article						Hypoglycaemia; Insulin; Intensive care units; Nervous system diseases; Risk factors	INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; GLUCOSE CONTROL; PREDISPOSING FACTORS; NEUROLOGIC PATIENTS; CEREBRAL GLUCOSE; GLYCEMIC CONTROL; ISCHEMIC-STROKE	To identify risk factors for hypoglycaemia in neurocritical care patients receiving intensive insulin therapy (IIT). We performed a nested case-control study. All first episodes of hypoglycaemia (glucose < 80 mg/dL, < 4.4 mmol/L) in neurocritical care patients between 1 March 2006 and 31 December 2007 were identified. Patients were treated according to the local IIT protocol, with target blood glucose levels between 4.5 and 6.0 mmol/L (81.0-108.0 mg/dL). The first hypoglycaemic event of every patient (index moment) was used to match to a control patient. Possible risk factors preceding the index moment were scored using hospital records and analysed with conditional logistic regression. Of 786 neurocritical care patients, 449 developed hypoglycaemia (57.1 %). Independent risk factors for hypoglycaemia were lowering nutrition 6 h before the index moment without insulin dose reduction (odds ratio (OR) 5.25, 95 % confidence interval (95 % CI) 1.32-20.88), mechanical ventilation (OR 2.59, 95 % CI 1.56-4.29), lowering the dosage of norepinephrine 3 h before the index moment (OR 2.44, 95 % CI 1.07-5.55), a hyperglycaemic event (> 10 mmol/L, > 180.0 mg/dL) in the 24 h preceding the index moment (OR 2.40, 95 % CI 1.26-4.58), gastric residual in the 6 h preceding the index moment without insulin dose reduction (OR 1.76, 95 % CI 1.05-2.96) and dosage of insulin at the index moment (OR 0.83, 95 % CI 0.76-0.90). Hypoglycaemia occurs in a considerable proportion of neurocritical care patients. We recommend the identification of these risk factors in these patients to avoid the occurrence of hypoglycaemia.	[van Iersel, Freya M.; Slooter, Arjen J. C.; Vroegop, Renee; Wolters, Annemiek E.; Tiemessen, Charlotte A. M.; Rosken, Rik H. J.] Univ Med Ctr, Dept Intens Care Med, NL-3508 GA Utrecht, Netherlands; [van der Hoeven, Johannes G.; Hoedemaekers, Cornelia W. E.] Radboud Univ Nijmegen Med Ctr, Dept Intens Care Med, Nijmegen, Netherlands; [Peelen, Linda M.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands		van Iersel, FM (corresponding author), Univ Med Ctr, Dept Intens Care Med, POB 85500,Room F06-149, NL-3508 GA Utrecht, Netherlands.	fmvaniersel@gmail.com	Hoedemaekers, C.W.E./L-4375-2015; van der Hoeven, J.G./H-8048-2014				Antonelli M, 2010, INTENS CARE MED, V36, P196, DOI 10.1007/s00134-009-1742-7; Arabi YM, 2009, CRIT CARE MED, V37, P2536, DOI 10.1097/CCM.0b013e3181a381ad; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta Federico, 2007, J Neurosurg Anesthesiol, V19, P156, DOI 10.1097/ANA.0b013e3180338e69; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Bruno A, 2008, STROKE, V39, P384, DOI 10.1161/STROKEAHA.107.493544; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Eslami S, 2010, INTENS CARE MED, V36, P1556, DOI 10.1007/s00134-010-1924-3; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Green DM, 2010, NEUROCRIT CARE, V13, P299, DOI 10.1007/s12028-010-9417-3; Hermanides J, 2010, CRIT CARE MED, V38, P838, DOI 10.1097/CCM.0b013e3181cc4be9; Hoedemaekers CWE, 2008, CRIT CARE MED, V36, P3062, DOI 10.1097/CCM.0b013e318186ffe6; Johnston KC, 2009, STROKE, V40, P3804, DOI 10.1161/STROKEAHA.109.561498; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kreisel SH, 2009, CEREBROVASC DIS, V27, P167, DOI 10.1159/000185608; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Mechanick JI, 2007, CURR OPIN CLIN NUTR, V10, P193, DOI 10.1097/MCO.0b013e32802b7016; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Meyfroidt G, 2010, CRIT CARE MED, V38, P1021, DOI 10.1097/CCM.0b013e3181cf710e; Naidech AM, 2010, NEUROCRIT CARE, V12, P181, DOI 10.1007/s12028-009-9311-z; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Oksanen T, 2007, INTENS CARE MED, V33, P2093, DOI 10.1007/s00134-007-0876-8; ROBERTSHAW M, 1989, BRIT J CLIN PHARMACO, V28, P275, DOI 10.1111/j.1365-2125.1989.tb05427.x; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Schlenk F, 2009, NEUROCRIT CARE, V11, P56, DOI 10.1007/s12028-009-9222-z; Schmutzhard E, 2011, NEUROCRIT CARE, V15, P281, DOI 10.1007/s12028-011-9601-0; Shan L, 2011, J TRAUMA, V71, P1460, DOI 10.1097/TA.0b013e3182250515; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Su YY, 2009, J NEUROL, V256, P1427, DOI 10.1007/s00415-009-5129-z; Thiele RH, 2009, ANESTHESIOLOGY, V110, P603, DOI 10.1097/ALN.0b013e318198006a; Tiemessen CAM, 2011, J NEUROSURG ANESTH, V23, P206, DOI 10.1097/ANA.0b013e31821aa6f2; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vriesendorp TM, 2006, CRIT CARE MED, V34, P96, DOI 10.1097/01.CCM.0000194536.89694.06	37	7	7	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	DEC	2012	38	12					1999	2006		10.1007/s00134-012-2681-2			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036KU	WOS:000311025600011	22907674				2022-02-06	
J	Zhang, J; Tao, DQ; Zhao, H; Yin, ZY				Zhang Jing; Tao Dai-qin; Zhao Hui; Yin Zhi-yong			Expression of Hsp70 and Caspase-3 in rabbits after severe traumatic brain injury	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Forensic sciences; Craniocerebral trauma; Caspase-3; HSP70 Heat-shock proteins; Immunohistochemistry		Objective: To investigate the expression of Caspase-3 and Hsp70 in rabbits after severe traumatic brain injury (TBI) and to explore the feasibility of its application in estimation of injury time in forensic medicine. Methods: A rabbit model of heavy TBI was developed by high velocity impact on the parietal bone with an iron stick. Totally 8 healthy adult New Zealand white rabbits were randomly divided into control group (n=2) and injury group (n=6). Four hours after injury, tissue specimens from the parietal lobe, temporal lobe, occipital lobe, cerebellum and brainstem were harvested to detect the expression of Hsp70 and Caspase-3 by immunohistochemistry. Besides, the gray values of cells positive for Hsp70 and Caspase-3 were analyzed with an image analyzer. Results: Immunohistochemistry staining demonstrated a low level of Caspase-3 and Hsp70 expression in normal control group. While in injury group, both the Caspase-3 and Hsp70 expression was significantly elevated (P<0.05). Positive cells gathered around the lesion focus. Occipital lobe and cerebellum had fewer positive cells while temporal and brainstem had the fewest. Conclusion: The expression of Caspase-3 and Hsp70 at an early stage following severe TBI is characteristic and can be applied to estimate the time of injury.	[Zhang Jing; Tao Dai-qin] Chongqing Publ Secur Bur, Chongqing 401147, Peoples R China; [Zhao Hui; Yin Zhi-yong] Third Mil Med Univ, Chongqing Key Lab Vehicle Crash Bioimpact & Traff, Inst Surg Res, Dept 4,Daping Hosp, Chongqing 400042, Peoples R China		Yin, ZY (corresponding author), Third Mil Med Univ, Chongqing Key Lab Vehicle Crash Bioimpact & Traff, Inst Surg Res, Dept 4,Daping Hosp, Chongqing 400042, Peoples R China.	zyyin@cta.cq.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31170908, 31271006, 81072504, 30800243]; Natural Science Foundation of Chongqing of ChinaNatural Science Foundation of Chongqing [CSTC.2009AB0208]; Key Projects Foundation of the Ministry of Public Security [2009 ZDYJCQSJ007]	The paper was supported by the National Natural Science Foundation of China (31170908, 31271006, 81072504 and 30800243), the Natural Science Foundation of Chongqing of China (CSTC.2009AB0208) and the Key Projects Foundation of the Ministry of Public Security (2009 ZDYJCQSJ007).	CharriautMarlangue C, 1996, TRENDS NEUROSCI, V19, P109, DOI 10.1016/S0166-2236(96)80039-7; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; He LM, 2005, CHIN J NEUROMEDICINE, V4, P874; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Paschen W, 2004, J NEUROCHEM, V88, P983, DOI 10.1046/j.1471-4159.2003.02218.x; Tao Lu-yang, 2004, Fa Yi Xue Za Zhi, V20, P9; [吴思荣 WU Sirong], 2007, [苏州大学学报. 医学版, Suzhou University Journal of Medical Science], V27, P49; Zhang JY, 2007, J BIOMECH, V40, P2341, DOI 10.1016/j.jbiomech.2006.10.021	11	7	7	0	2	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	DEC	2012	15	6					338	341		10.3760/cma.j.issn.1008-1275.2012.06.004			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1GM	WOS:000442002300004	23186922				2022-02-06	
J	Gau, BS; Yang, HL; Huang, SJ; Lou, MF				Gau, Bih-Shya; Yang, Hsiao-Ling; Huang, Sheng-Jean; Lou, Meei-Fang			The use of complementary and alternative medicine for patients with traumatic brain injury in Taiwan	BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article						Complementary and alternative medicine (CAM); Belief in complementary and alternative medicine; Traumatic brain injury (TBI)	CANCER-PATIENTS; OLDER-ADULTS; THERAPIES	Background: The use of complementary and alternative medicine (CAM) continues to increase in Taiwan. This study examined the use of CAM and beliefs about CAM as expressed by patients with traumatic brain injury (TBI) in Taiwan. Methods: TBI patients and their accompanying relatives were interviewed by using a structured questionnaire at an outpatient clinic in a medical center in northern Taiwan. Results: A total of 101 patients with TBI participated in the study. Sixty-four (63%) patients had used at least one form of CAM after sustaining TBI. CAM users had used an average of 2.72 forms of CAM after sustaining TBI. The most frequently used CAM category was traditional Chinese medicine (37; 57.8%), followed by folk and religious therapies (30; 46.9%), and dietary supplements (30; 46.9%). The majority of the patients (45; 70.3%) did not report CAM use because they felt it was unnecessary to do so. Patients who used CAM had a significantly stronger positive belief in CAM than those who did not (t = -2.72; P = .008). After using CAM, most of the patients (54; 85%) perceived moderate satisfaction (2.89 +/- 0.44), according to a 4-point Likert scale. Conclusion: Although the use of CAM is common for TBI patients receiving conventional medical health care in Taiwan, most patients did not inform health care personnel about their CAM use. TBI patients perceive combined use of CAM and conventional medicine as beneficial for their overall health.	[Gau, Bih-Shya; Yang, Hsiao-Ling; Lou, Meei-Fang] Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei 10764, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ, Coll Med, Dept Med, Taipei 10764, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan		Lou, MF (corresponding author), Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei 10764, Taiwan.	mfalou@ntu.edu.tw	Gau, Bih-Shya/S-3627-2016	Gau, Bih-Shya/0000-0002-0137-4149; LOU, MEEI-FANG/0000-0001-6574-8050; Yang, Hsiao-Ling/0000-0003-0445-2824			Akyol AD, 2011, J CLIN NURS, V20, P1035, DOI 10.1111/j.1365-2702.2010.03498.x; Anderson EZ, 2009, TOP GERIATR REHABIL, V25, P320; Bishop FL, 2007, J HEALTH PSYCHOL, V12, P851, DOI 10.1177/1359105307082447; Ceylan S, 2002, COMPLEMENT THER MED, V10, P94, DOI 10.1054/ctim.2002.0527; Chang HY, 2007, J ADV NURS, V58, P307, DOI 10.1111/j.1365-2648.2007.04291.x; Chen H. M., 2005, TAIPEI CITY MED J, V2, P278; Cheung CK, 2007, J ALTERN COMPLEM MED, V13, P997, DOI 10.1089/acm.2007.0527; CHIANG HH, 1996, J NURSING, V43, P42; Delgoda R, 2004, W INDIAN MED J, V53, P400; Harris P, 2003, COMPLEMENT THER MED, V11, P249, DOI 10.1016/S0965-2299(03)00126-2; Hsin LS, 1996, CHINESE J FAMILY MED, V6, P127; Huang HM, 2010, J NURS HEALTHC RES, V6, P289; Huang KC, 1995, CHIN J FAM MED, V5, P64; Lu JH, 2010, CANCER NURS, V33, P320, DOI 10.1097/NCC.0b013e3181d1c7ee; National Center for Complementary and Alternative Medicine (NCCAM), 2010, US COMPL ALT MED US; Oshikoya KA, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-66; Salamonsen A, 2012, SCAND J CARING SCI, DOI [10.1111/j.1471-6712.2012.01002, DOI 10.1111/J.1471-6712.2012.01002]; Sirisupluxana P, 2009, NURS HEALTH SCI, V11, P64, DOI 10.1111/j.1442-2018.2009.00432.x; SUEN YI, 2005, J NURS, V52, P29; Ting CY, 2003, TAIWAN J PUBLIC HLTH, V22, P155; Tseng Y.-H., 2005, CHUNG SHAN MED J, V16, P59; Von Gruenigen VE, 2001, INT J GYNECOL CANCER, V11, P205, DOI 10.1046/j.1525-1438.2001.01011.x; Yamashita H, 2002, COMPLEMENT THER MED, V10, P84, DOI 10.1054/ctim.2002.0519	23	7	7	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1472-6882			BMC COMPLEM ALTERN M	BMC Complement. Altern. Med.	NOV 6	2012	12								211	10.1186/1472-6882-12-211			6	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Integrative & Complementary Medicine	054FP	WOS:000312329700001	23131030	Green Published, gold			2022-02-06	
J	Asselin, G; Ward, C; Penning, JH; Ramanujam, S; Neri, R				Asselin, Glennys; Ward, Constance; Penning, Julius H.; Ramanujam, Savithri; Neri, Rebecca			Therapeutic Horse Back Riding of a Spinal Cord Injured Veteran: A Case Study	REHABILITATION NURSING			English	Article						horseback riding; spinal cord injured; therapeutic		Purpose To determine an incomplete spinal cord injured veteran's experience following participation in a therapeutic horseback riding program. Methods Following the establishment of a nationwide therapeutic riding program for America's wounded service veterans in 2007, a Certified Rehabilitation Registered Nurse from the Michael E. DeBakey Veteran Affairs Medical Center worked with an incomplete spinal cord injured veteran who participated in the Horses for Heroes program. Results This program resulted in many benefits for the veteran, including an increase in balance, muscle strength, and self-esteem. Discussion A physical, psychological, and psychosocial benefit of therapeutic horseback riding is shown to have positive results for the spinal cord injured. Therapeutic riding is an emerging field where the horse is used as a tool for physical therapy, emotional growth, and learning. Conclusion Veterans returning from the Iraq/Afghanistan war with traumatic brain injuries, blast injuries, depression, traumatic amputations, and spinal cord injuries may benefit from this nurse-assisted therapy involving the horse.	[Asselin, Glennys] Spinal Cord Injury Unit, Needville, TX 77461 USA; [Ramanujam, Savithri] Spinal Cord Injury Unit, Houston, TX 77030 USA; [Neri, Rebecca] Med Care Line, Houston, TX 77030 USA		Ward, C (corresponding author), 10202 Brookshore Lane, Pearland, TX 77584 USA.	glennysreins@hotmail.com; Constance.ward@va.gov; Jpenning07@att.net; Savithri.Ramanujam@va.gov; RebeccaE.neri@va.gov					American Hippotherapy Association, 2007, HIPP TREATM STRAT; American Spinal Injury Association, 2010, AM SPIN INJ ASS ASIA; Benda W, 2003, J ALTERN COMPLEM MED, V9, P817, DOI 10.1089/107555303771952163; Brodie SJ, 1999, J CLIN NURS, V8, P329, DOI 10.1046/j.1365-2702.1999.00255.x; Chavez A., 2007, NEWSLETTER, P1; Engel B. T., 2007, ENHANCING HUMAN OCCU; Fosdick K. L., 2010, THERAPEUTIC RIDING; Hammer A., 2007, PHYSIOTHERAPY THEORY, V21, P51; Kiley K. C., 2007, FEATURED COLUMN; Lechner HE, 2003, SPINAL CORD, V41, P502, DOI 10.1038/sj.sc.3101492; Meregillano Gary, 2004, Phys Med Rehabil Clin N Am, V15, P843; Miller J., 2004, J SO AGR ED RES, V54, P113; Paralyzed Veterans of America, 2007, EXP TREATM SPIN CORD; Scott N., 2005, SPECIAL NEEDS SPECIA; SIRE, 2008, SIRE VOL MAN	15	7	9	1	46	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	NOV-DEC	2012	37	6					270	276		10.1002/rnj.027			7	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	050DX	WOS:000312034300002	23212951				2022-02-06	
J	Cai, Q; Wang, HW; Hua, SY; Tan, JZ; Zhou, T; Li, CS				Cai Qing; Wang Hong-wu; Hua Sheng-yu; Tan Jun-zhen; Zhou Tao; Li Chun-shen			Neutroprotective efficacy of sodium tanshinone B on hippocampus neuron in a rat model of focal cerebral ischemia	CHINESE JOURNAL OF INTEGRATIVE MEDICINE			English	Article						ischemia/reperfusion injury; N-methyl-D-aspartic acid receptor; hippocampus; Ca2+; sodium tanshinone	TRAUMATIC BRAIN-INJURY; MOLECULAR-MECHANISMS; ARTERY OCCLUSION; IN-VITRO; STROKE; DEATH; NEUROTOXICITY; SULFONATE; THERAPY; CELLS	To investigate the protective effects of sodium tanshinone B (STB) on brain damage following focal ischemia-reperfusion (I/R) injury through interfering with N-methyl-D-aspartic acid receptor (NMDAR) and excitatory and inhibitory amino acids, and evaluate the potential mechanisms of the neuroprotective activity of STB. Transient forebrain ischemia was induced by middle cerebral artery occlusion (MCAO). The rats were randomized into a sham operated group, a model group (I/R) and three STB different dose groups. Rats were pretreated with STB at the doses of 4, 8, 16 mg/kg (STB1, STB2, STB3) for 3 days before MCAO. The expression of NMDAR1 was detected by immunohistochemistry and Western blotting. The concentrations of glutamate and gamma-aminobutyric acid (GABA) were analyzed using high performance liquid chromatography. STB treatment reduced neurological defect scores, cerebral infarction volume and brain water content. The levels of NMDAR1 were significantly higher in the l/R and STB1 groups than that of the sham and the STB3 groups (P < 0.01). Optical density of NMDAR1 was significantly increased in cornu ammonis (CA)1 region of the l/R group (P < 0.05). STB treatment reduced NMDAR1 optical density in the CA1 region (P < 0.01). The levels of glutamate were significantly lower in the hippocampus in the STB3 group than that of the l/R, STB1 and STB2 groups (P < 0.01). Preconditioning with STB appears to be a simple and promising strategy to reduce or even prevent cerebral l/R injury and has potential for future clinical application.	[Cai Qing; Tan Jun-zhen; Zhou Tao; Li Chun-shen] Tianjin Univ Tradit Chinese Med, Dept Physiol, Tianjin 300193, Peoples R China; [Wang Hong-wu] Tianjin Univ Tradit Chinese Med, Coll Tradit Chinese Med, Tianjin 300193, Peoples R China; [Hua Sheng-yu] Tianjin Univ Tradit Chinese Med, Dept Expt, Tianjin 300193, Peoples R China		Cai, Q (corresponding author), Tianjin Univ Tradit Chinese Med, Dept Physiol, Tianjin 300193, Peoples R China.	qingcai@tjutcm.edu.cn			Science Development Foundation of Tianjin Institute of Education [20070301]; Tianjin Natural Science Foundation of China [11JCYBJC13400]	Supported by Science Development Foundation of Tianjin Institute of Education (No. 20070301) and Tianjin Natural Science Foundation of China (No. 11JCYBJC13400)	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Ban JY, 2008, J PHARMACOL SCI, V106, P68, DOI 10.1254/jphs.FP0071206; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bano D, 2007, STROKE, V38, P674, DOI 10.1161/01.STR.0000256294.46009.29; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Birmingham K, 2002, NAT MED, V8, P5, DOI 10.1038/nm0102-5a; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Dromerick AW, 2000, STROKE, V31, P2984, DOI 10.1161/01.STR.31.12.2984; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Gassen M, 2003, J NEURAL TRANSM, V110, P171, DOI 10.1007/s00702-002-0784-6; Hou ST, 2002, INT REV CYTOL, V221, P93; Huang YF, 2009, J ETHNOPHARMACOL, V125, P436, DOI 10.1016/j.jep.2009.07.020; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; KAWAMURA S, 1991, ACTA NEUROCHIR, V109, P126, DOI 10.1007/BF01403007; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kirino H, 1982, BRAIN RES, V239, P57; KUNKEL DD, 1986, J NEUROSCI, V6, P541; Liu JQ, 2009, AM J PHYSIOL-HEART C, V297, pH1217, DOI 10.1152/ajpheart.00477.2009; Liu ShiXu, 2008, Journal of China Pharmaceutical University, V39, P338; Lo EH, 2005, STROKE, V36, P189, DOI 10.1161/01.STR.0000153069.96296.fd; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Myers WA, 2000, J COMP NEUROL, V418, P373; Peruche B, 1993, PROG NEUROPSYCHOPHAR, V17, P21; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Sarraf-Yazdi S, 1998, ANESTH ANALG, V87, P72, DOI 10.1097/00000539-199807000-00016; Siironen J, 2007, STROKE, V38, P2858, DOI 10.1161/STROKEAHA.107.485441; SOMOGYI P, 1983, J NEUROSCI, V3, P1450; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takahashi K, 2002, BIOCHEM PHARMACOL, V64, P745, DOI 10.1016/S0006-2952(02)01250-9	32	7	7	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1672-0415			CHIN J INTEGR MED	Chin. J. Integr. Med.	NOV	2012	18	11					837	845		10.1007/s11655-012-1266-9			9	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	025VR	WOS:000310224500006	23086488				2022-02-06	
J	Chaturvedi, LS; Zhang, P; Basson, MD				Chaturvedi, Lakshmi S.; Zhang, Ping; Basson, Marc D.			Effects of extracellular pressure and alcohol on the microglial response to inflammatory stimulation	AMERICAN JOURNAL OF SURGERY			English	Article						Proinflammatory cytokines; Microglial cells; MCP-1; IL-6; Mechanotransduction	TRAUMATIC BRAIN-INJURY; CANCER-CELL-PROLIFERATION; CYTOKINE PRODUCTION; ACTIVATION; MORTALITY; NEUROINFLAMMATION; PHAGOCYTOSIS; MODERATE; CNS	BACKGROUND: Traumatic brain injury induces a neuroinflammatory response frequently associated with increased intracranial pressure. The aim of this study was to investigate the effects of alcohol and increased extracellular pressure on murine BV-2 microglial proliferation and cytokine responses to lipopolysaccharide (LPS) stimulation. METHODS: BV-2 cells were cultured under 0 or 30 mm Hg increased extracellular pressure without or with ethanol (100 mmol/L) or LPS (10 ng/mL) for 24 hours. Cell proliferation was assessed using MTS assay and secretion of the proinflammatory cytokines tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, and monocyte chemotactic protein (MCP)-1 by enzyme-linked immunosorbent assay. RESULTS: Increased pressure and LPS stimulation each promoted proliferation. Ethanol pretreatment blocked these effects. Basal TNF-alpha and IL-6 secretion was at the limits of delectability. Basal MCP-1 production was stimulated by pressure, which was blocked by ethanol. Even this low LPS dose stimulated microglial secretion of TNF-alpha, IL-6, and MCP-1. Pressure inhibited LPS-stimulated production of these proinflammatory cytokines, while ethanol pretreatment blocked LPS-stimulated cytokine production. The combination of pressure and ethanol further reduced TNF-alpha, IL-6, and MCP-1 secretion by LPS-stimulated microglial cells. CONCLUSION: Alcohol's anti-inflammatory effects may contribute to the reduced mortality from traumatic brain injury that some have described in acutely intoxicated patients, while pressure down-regulation of inflammatory cytokine release could create a negative feedback that ameliorates inflammation in traumatic brain injury. (C) 2012 Elsevier Inc. All rights reserved.	[Chaturvedi, Lakshmi S.; Zhang, Ping; Basson, Marc D.] Michigan State Univ, Dept Surg, Lansing, MI 48824 USA; [Chaturvedi, Lakshmi S.] Wayne State Univ, Dept Anesthesiol, Detroit, MI USA; [Chaturvedi, Lakshmi S.; Basson, Marc D.] John D Dingell VA Med Ctr, Detroit, MI USA		Basson, MD (corresponding author), Michigan State Univ, Dept Surg, Lansing, MI 48824 USA.	marc.basson@hc.msu.edu			VA Merit Grant; National Institutes of Health (Bethesda, MD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 DK067257, R01 DK060771]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AA019676]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK067257, R01DK060771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA019676] Funding Source: NIH RePORTER	This study was supported in part by a VA Merit Grant and by grant R01 DK067257, and R01 DK060771 from the National Institutes of Health (Bethesda, MD) (to Dr Basson) and grant R01 AA019676 from the National Institutes of Health (to Dr Zhang).	Arbabi S, 1999, J IMMUNOL, V162, P7441; Berry C, 2011, AM SURGEON, V77, P1416; Berry C, 2010, AM SURGEON, V76, P1067; Bhalla S, 2009, AM J SURG, V198, P611, DOI 10.1016/j.amjsurg.2009.07.006; Boyadjieva NI, 2010, ALCOHOL CLIN EXP RES, V34, P1835, DOI 10.1111/j.1530-0277.2010.01271.x; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Cao Q, 2011, NEUROSCIENCE, V192, P140, DOI 10.1016/j.neuroscience.2011.06.060; Downey C, 2011, AM J SURG, V202, P520, DOI 10.1016/j.amjsurg.2011.06.019; IBA T, 1991, MICROVASC RES, V42, P245, DOI 10.1016/0026-2862(91)90059-K; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lee H, 2004, J NEUROIMMUNOL, V156, P88, DOI 10.1016/j.jneuroim.2004.07.008; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Qin LY, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-10; Rehm J, 2003, ALCOHOL RES HEALTH, V27, P39; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Shiratsuch H, 2005, AM J SURG, V190, P757, DOI 10.1016/j.amjsurg.2005.07.016; Walsh MF, 2004, CELL PROLIFERAT, V37, P427, DOI 10.1111/j.1365-2184.2004.00324.x; Woiciechowsky C, 2005, ACT NEUR S, V95, P373; Yu GX, 2011, SURGERY, V150, P887, DOI 10.1016/j.surg.2011.04.002	24	7	11	0	13	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610			AM J SURG	Am. J. Surg.	NOV	2012	204	5					602	606		10.1016/j.amjsurg.2012.07.010			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	045YZ	WOS:000311734000015	23140827	Green Accepted			2022-02-06	
J	Lequerica, A; Bushnik, T; Wright, J; Kolakowsky-Hayner, SA; Hammond, FM; Dijkers, MP; Cantor, J				Lequerica, Anthony; Bushnik, Tamara; Wright, Jerry; Kolakowsky-Hayner, Stephanie A.; Hammond, Flora M.; Dijkers, Marcel P.; Cantor, Joshua			Psychometric Properties of the Multidimensional Assessment of Fatigue Scale in Traumatic Brain Injury: An NIDRR Traumatic Brain Injury Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; fatigue; measurement	POSTTRAUMATIC AMNESIA; SLEEPINESS; SEVERITY; MODERATE	Objective: To investigate the psychometric properties of the Multidimensional Assessment of Fatigue (MAF) scale in a traumatic brain injury (TBI) sample. Design: Prospective survey study. Setting: Community. Participants: One hundred sixty-seven individuals with TBI admitted for inpatient rehabilitation, enrolled into the TBI Model Systems national database, and followed up at either the first or second year postinjury. Interventions: Not applicable. Main Outcome Measure(s): Multidimensional Assessment of Fatigue. Results: The initial analysis, using items 1 to 14, which are based on a 10-point rating scale, found that only 1 item ("walking") misfit the overall construct of fatigue in this TBI population. However, this 10-point rating scale was found to have disordered thresholds. When ratings were collapsed into 4 response categories, all MAF items used to calculate the Global Fatigue Index formed a unidimensional scale. Conclusion(s): Findings generally support the unidimensionality of the MAF when used in a TBI population but call into question the use of a 10-point rating scale for items 1 to 14. Further study is needed to investigate the use of a 4-category rating scale across all items and the fit of the "walking" item for a measure of fatigue among individuals with TBI.	[Lequerica, Anthony] Kessler Fdn Res Ctr, W Orange, NJ 07042 USA; [Lequerica, Anthony] Univ Med & Dent New Jersey, Newark, NJ 07103 USA; [Bushnik, Tamara] NYU Langone Sch Med, Rusk Inst Rehabil Med, New York, NY USA; [Wright, Jerry; Kolakowsky-Hayner, Stephanie A.] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN USA; [Dijkers, Marcel P.; Cantor, Joshua] Mt Sinai Sch Med, New York, NY USA		Lequerica, A (corresponding author), Kessler Fdn Res Ctr, 1199 Pleasant Valley Way, W Orange, NJ 07042 USA.	alequerica@kesslerfoundation.org	Heinemann, Allen W/K-6283-2012; Kolakowsky-Hayner, Stephanie A./I-9858-2019	Heinemann, Allen W/0000-0003-2782-7326; Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Dijkers, Marcel/0000-0002-8362-5596; Bushnik, Tamara/0000-0003-3328-257X	National Institution on Disability and Rehabilitation Research (NIDRR) [H133A070037, H133A070038, H133A070042, H133A070033-09]	This study was funded by grants from the National Institution on Disability and Rehabilitation Research (NIDRR): H133A070037, H133A070038, H133A070042, H133A070033-09. The authors thank the research participants, research assistants, and all project staff for their assistance in the success of this endeavor. In addition, they would like to acknowledge the continued support of our project officers and program director at NIDRR.	Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Bond TG, 2007, APPL RASCH MODEL FUN, P340; Bormann J, 2001, J Assoc Nurses AIDS Care, V12, P75, DOI 10.1016/S1055-3290(06)60146-5; Cantor J. B., 2012, J HEAD TRAU IN PRESS; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Dijkers MPJM, 2008, J HEAD TRAUMA REHAB, V23, P3, DOI 10.1097/01.HTR.0000308716.80590.6b; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; Fairbrother N, 2008, PSYCHOL ASSESSMENT, V20, P150, DOI 10.1037/1040-3590.20.2.150; Jensen MP, 2007, ARCH PHYS MED REHAB, V88, P638, DOI 10.1016/j.apmr.2007.02.002; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; LEZAK MD, 1978, AM J PHYS MED REHAB, V57, P9; Linacre J. M., 2012, WINSTEPS RASCH MEASU; LINACRE JM, 1998, RASCH MEASUREMENT T, V0012, P00636; Lozano LM, 2008, METHODOLOGY-EUR, V4, P73, DOI [10.1027/1614-2241.4.2.73, DOI 10.1027/1614-2241.4.2.73]; Meek PM, 2000, NURS RES, V49, P181, DOI 10.1097/00006199-200007000-00001; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Nunally J.C., 1994, PSYCHOMETRIC THEORY, V3rd ed.; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; PAWLIKOWSKA T, 1994, BRIT MED J, V308, P763, DOI 10.1136/bmj.308.6931.763; Piper B.F., 1989, KEY ASPECTS COMFORT, P199; Rasch G., 1960, PROBABILISTIC MODELS; Shahid A, 2010, J PSYCHOSOM RES, V69, P81, DOI 10.1016/j.jpsychores.2010.04.001; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Singareddy R, 2010, J CLIN SLEEP MED, V6, P405; Smith RM, 2004, INTRO RASCH MEASUREM; TACK BB, 1991, THESIS U CALIFORNIA; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Waljas M, 2012, BRAIN INJURY, V26, P972, DOI 10.3109/02699052.2012.660511; Winstead-Fry P, 1998, J Nurs Meas, V6, P111; Wright B, 1994, MEASUREMENT T, V8, P370; Wright B. D., 2000, RASCH MEASUREMENT T, V14, P753	33	7	7	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					E28	E35		10.1097/HTR.0b013e31826fe574			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200003	23131968				2022-02-06	
J	Lin, CC; Yu, JH; Lin, CC; Li, WC; Weng, YM; Chen, SY				Lin, Chi-Chun; Yu, Jiun-Hao; Lin, Chih-Chuan; Li, Wen-Cheng; Weng, Yi-Ming; Chen, Shou-Yen			Postintubation hemodynamic effects of intravenous lidocaine in severe traumatic brain injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							ENDOTRACHEAL INTUBATION; PRESSURE; HYPERTENSION	Background: The risks of intravenous (IV) lidocaine before rapid sequence induction (RSI) have become a great concern. No study has investigated the hemodynamic effects of IV lidocaine during endotracheal intubation in patients with severe traumatic brain injury. Objective: We investigated whether the use of IV lidocaine before RSI was associated with postintubation hemodynamic changes in patients with severe traumatic brain injury. Methods: In this retrospective cohort study, adults who presented with isolated traumatic brain injury and definite intracranial hemorrhage were included. Patients who presented with other major injuries received prehospital intubation, had initial mean arterial pressure (MAP) less than 70 mm Hg, and/or had incomplete medical records were excluded. Results: A total of 101 patients (82.2% men; mean age, 48.6 +/- 19.6 years) were enrolled. Forty-six patients received IV lidocaine in addition to RSI before intubation (group 1), and 55 received RSI without IV lidocaine before intubation (group 2). There were no significant intergroup differences in baseline characteristics, the number of RSI doses, or the RSI dose used, with the exception of sex, diagnosis of subarachnoid hemorrhage, and diagnosis of subdural hemorrhage. Our results demonstrated no significant intergroup differences in MAP changes or the proportion of patients with hypotension (MAP <70 mm Hg) after intubation. Intravenous lidocaine remained unrelated to significant hypotension after adjusting for variables by logistic regression analysis. Conclusion: Intravenous lidocaine in addition to RSI before endotracheal intubation was not associated with significant hemodynamic changes in patients with severe traumatic brain injury. (C) 2012 Elsevier Inc. All rights reserved.	[Weng, Yi-Ming] Chang Gung Mem Hosp, Dept Emergency Med, Tao Yuan 333, Taiwan; Chang Gung Univ, Coll Med, Tao Yuan 333, Taiwan		Weng, YM (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, Tao Yuan 333, Taiwan.	wengym33@gmail.com					Asfar S N, 1990, Acta Anaesthesiol Belg, V41, P17; Bedford R. F., 1980, INTRACRANIAL PRESSUR, P595; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Castillo J, 2004, STROKE, V35, P520, DOI 10.1161/01.STR.0000109769.22917.B0; DONEGAN MF, 1980, ANESTHESIOLOGY, V52, P516, DOI 10.1097/00000542-198006000-00014; Feng C K, 1996, Acta Anaesthesiol Sin, V34, P61; FORBES AM, 1970, BRIT J ANAESTH, V42, P618, DOI 10.1093/bja/42.7.618; HAMILL JF, 1981, ANESTHESIOLOGY, V55, P578, DOI 10.1097/00000542-198111000-00016; Kuzak Nick, 2006, CJEM, V8, P80; Lev Roneet, 1994, Journal of Emergency Medicine, V12, P499, DOI 10.1016/0736-4679(94)90347-6; Lin CC, 2008, AM J EMERG MED, V26, P845, DOI 10.1016/j.ajem.2007.11.027; Robinson N, 2001, EMERG MED J, V18, P453, DOI 10.1136/emj.18.6.453; Samaha T, 1996, ANN FR ANESTH, V15, P36, DOI 10.1016/0750-7658(96)89400-7; TAM S, 1987, ANESTH ANALG, V66, P1036; Wang Yi-Ming, 2003, Acta Anaesthesiol Sin, V41, P71; WHITE PF, 1982, ANESTHESIOLOGY, V57, P242, DOI 10.1097/00000542-198209000-00019; YANO M, 1986, ANESTHESIOLOGY, V64, P651, DOI 10.1097/00000542-198605000-00019	17	7	7	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	NOV	2012	30	9					1782	1787		10.1016/j.ajem.2012.02.013			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	049QD	WOS:000311997600018	22633717				2022-02-06	
J	Berry, JN; Sharrett-Field, LJ; Butler, TR; Prendergast, MA				Berry, J. N.; Sharrett-Field, L. J.; Butler, T. R.; Prendergast, M. A.			TEMPORAL DEPENDENCE OF CYSTEINE PROTEASE ACTIVATION FOLLOWING EXCITOTOXIC HIPPOCAMPAL INJURY	NEUROSCIENCE			English	Article						NMDA receptors; excitotoxicity; synaptophysin; cysteine protease; calpain	TRAUMATIC BRAIN-INJURY; D-ASPARTATE RECEPTORS; SLICE CULTURES; CELL-DEATH; GLUTAMATE EXCITOTOXICITY; INDUCED NEUROTOXICITY; SYNAPTIC PROTEINS; NERVOUS-SYSTEM; ENDONUCLEASE-G; NMDA RECEPTOR	Excitotoxic insults can lead to intracellular signaling cascades that contribute to cell death, in part by activation of proteases, phospholipases, and endonucleases. Cysteine proteases, such as calpains, are calcium (Ca2+)-activated enzymes which degrade cytoskeletal proteins, including microtubule-associated proteins, tubulin, and spectrin, among others. The current study used the organotypic hippocampal slice culture model to examine whether pharmacologic inhibition of cysteine protease activity inhibits N-methyl-D-aspartate- (NMDA-) induced excitotoxic (20 mu M NMDA) cell death and changes in synaptophysin immunoreactivity. Significant NMDA-induced cytotoxicity (as measured by propidium iodide [PI] uptake) was found in the CA1 region of the hippocampus at all timepoints examined (24, 72, 120 h), an effect significantly attenuated by co-exposure to the selective NMDA receptor antagonist DL-2-Amino-5-phosphonopentanoic acid (APV), but not MDL-28170, a potent cysteine protease inhibitor. Results indicated sparing of NMDA-induced loss of the synaptic vesicular protein synaptophysin in all regions of the hippocampus by MDL-28170, though only at early timepoints after injury. These results suggest Ca2+-dependent recruitment of cysteine proteases within 24 h of excitotoxic insult, but activation of alternative cellular degrading mechanisms after 24 h. Further, these data suggest that synaptophysin may be a substrate for calpains and related proteases. (C) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Berry, J. N.; Sharrett-Field, L. J.; Butler, T. R.; Prendergast, M. A.] Spinal Cord & Brain Injury Res Ctr, Dept Psychol, Lexington, KY 40536 USA		Prendergast, MA (corresponding author), Spinal Cord & Brain Injury Res Ctr, Dept Psychol, 8449 Biomed & Biol Sci Res Bldg,741 S Limestone S, Lexington, KY 40536 USA.	prender@uky.edu		Butler, Tracy/0000-0002-3849-7951	 [DA 016176];  [AA013388]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R56AA013388, R01AA013388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA016176] Funding Source: NIH RePORTER	The authors acknowledge the support of DA 016176 and AA013388, as well as, the assistance provided by Dr. James W. Geddes.	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; BAHR BA, 1995, J PHARMACOL EXP THER, V273, P902; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Bergmann M, 1997, EXP BRAIN RES, V117, P80, DOI 10.1007/s002210050201; Bevers MB, 2010, EXP NEUROL, V224, P170, DOI 10.1016/j.expneurol.2010.03.007; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; Butler TR, 2010, NEUROSCIENCE, V165, P525, DOI 10.1016/j.neuroscience.2009.10.018; Chaitanya GV, 2008, NEUROCHEM RES, V33, P2178, DOI 10.1007/s11064-007-9567-7; Choi Dennis W., 1995, Trends in Neurosciences, V18, P58, DOI 10.1016/0166-2236(95)93870-4; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Del Rio P, 2008, NEUROCHEM RES, V33, P1475, DOI 10.1007/s11064-008-9612-1; DRISCOLL BF, 1993, J NEUROCHEM, V61, P1795, DOI 10.1111/j.1471-4159.1993.tb09818.x; Gafni J, 2009, J BIOL CHEM, V284, P25441, DOI 10.1074/jbc.M109.038174; Geddes JW, 2010, EXP NEUROL, V226, P6, DOI 10.1016/j.expneurol.2010.07.025; Gellerman DM, 1997, J NEUROCHEM, V69, P131; Gibson DA, 2003, ALCOHOL CLIN EXP RES, V27, P1099, DOI 10.1097/01.ALC.0000075824.10502.DD; Granic I, 2010, NEUROPHARMACOLOGY, V59, P334, DOI 10.1016/j.neuropharm.2010.07.013; Gutierrez R, 1999, BRAIN RES, V815, P304, DOI 10.1016/S0006-8993(98)01101-9; Henne WM, 2006, CELL MOL NEUROBIOL, V26, P321, DOI 10.1007/s10571-006-9031-2; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; Horikawa HPM, 2002, MOL CELL NEUROSCI, V21, P454, DOI 10.1006/mcne.2002.1191; Hou ST, 2009, J NEUROCHEM, V111, P870, DOI 10.1111/j.1471-4159.2009.06375.x; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Kim HW, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-123; Lee JH, 2008, J NEUROCHEM, V106, P1066, DOI 10.1111/j.1471-4159.2008.05444.x; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Martens U, 2001, ANAT EMBRYOL, V203, P491, DOI 10.1007/s004290100174; Marti TM, 2004, CELL MOL LIFE SCI, V61, P336, DOI 10.1007/s00018-003-3223-4; MASLIAH E, 1993, BRAIN PATHOL, V3, P77, DOI 10.1111/j.1750-3639.1993.tb00728.x; Mayer S, 2002, ALCOHOL CLIN EXP RES, V26, P655, DOI 10.1097/00000374-200205000-00009; MEHDI S, 1991, TRENDS BIOCHEM SCI, V16, P150, DOI 10.1016/0968-0004(91)90058-4; Mulholland PJ, 2004, NEUROSCIENCE, V125, P671, DOI 10.1016/j.neuroscience.2004.02.007; Mulholland PJ, 2003, NEUROSCI RES, V46, P369, DOI 10.1016/S0168-0102(03)00102-0; Nimmrich V, 2010, BRIT J PHARMACOL, V159, P1523, DOI 10.1111/j.1476-5381.2010.00652.x; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Prendergast MA, 2004, NEUROSCIENCE, V124, P869, DOI 10.1016/j.neuroscience.2003.12.013; Prendergast MA, 2001, NEUROSCIENCE, V102, P75, DOI 10.1016/S0306-4522(00)00450-4; Rami A, 1997, NEUROSCI RES, V27, P93, DOI 10.1016/S0168-0102(96)01123-6; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SIMAN R, 1989, J NEUROSCI, V9, P1579; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1111/j.1365-2613.2000.00169.x; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Wilkins LH, 2006, ALCOHOL CLIN EXP RES, V30, P1768, DOI 10.1111/j.1530-0277.2006.00210.x; Zimmer J, 2000, AMINO ACIDS, V19, P7, DOI 10.1007/s007260070029	51	7	8	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	OCT 11	2012	222						147	158		10.1016/j.neuroscience.2012.07.033			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	010HM	WOS:000309085500015	22842515	Green Accepted			2022-02-06	
J	Gopinathan, NR; Chouhan, D; Akkina, N; Behera, P				Gopinathan, Nirmal Raj; Chouhan, Devendra; Akkina, Narendranadh; Behera, Prateek			Case Report: Bilateral Femoral Neck Fractures in a Child and a Rare Complication of Slipped Capital Epiphysis After Internal Fixation	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							HIP-FRACTURES; FEMUR	Bilateral traumatic femoral neck fractures are uncommon in children. The most commonly reported complications are nonunion, avascular necrosis of the femoral head, and chondrolysis. Slipped capital femoral epiphysis (SCFE) associated with nonunion after percutaneous partially threaded cancellous screw (PTCS) fixation of the fracture is an unreported complication. We describe a 10-year-old boy who had bilateral femoral neck fractures secondary to a fall from a height. The patient was treated with percutaneous PTCS fixation on both sides and achieved union on the right side in 3 months, however, a nonunion and SCFE developed on the left side 5 months after the initial surgery. Management of the nonunion and SCFE with PTCS and nonvascularized fibula graft led to union. Eighteen months after the initial injury, the patient achieved a pain and limp-free gait. A literature review shows avascular necrosis, posttraumatic coxa vara, premature physeal closure, nonunion, chondrolysis, infection, and implant failure as complications of operative management of femoral neck fractures. SCFE has not been previously reported. This case highlights the need for close followup of adolescent patients with PTCS fixation for femoral neck fractures.	[Gopinathan, Nirmal Raj; Chouhan, Devendra; Akkina, Narendranadh; Behera, Prateek] Postgrad Inst Med Educ & Res, Dept Orthoped, Chandigarh 160012, India		Akkina, N (corresponding author), Postgrad Inst Med Educ & Res, Dept Orthoped, Chandigarh 160012, India.	drnarendraa@gmail.com	Behera, Prateek/AAG-2902-2019; Gopinathan, Nirmal Raj/AAU-9951-2021	Behera, Prateek/0000-0001-6731-7211; Gopinathan, Nirmal Raj/0000-0003-0208-5653			Azam MQ, 2009, INDIAN J ORTHOP, V43, P253, DOI 10.4103/0019-5413.53455; Blanco J S, 1999, Am J Orthop (Belle Mead NJ), V28, P187; Blasier RW, 2006, ROCKWOOD WILKINS FRA, P861; Boardman MJ, 2009, J AM ACAD ORTHOP SUR, V17, P162, DOI 10.5435/00124635-200903000-00005; Chadha M, 2001, ACTA ORTHOP SCAND, V72, P94, DOI 10.1080/000164701753606770; Chen CE, 1998, ARCH ORTHOP TRAUM SU, V118, P164, DOI 10.1007/s004020050339; Colonna PC, 1928, ANN SURG, V88, P902, DOI 10.1097/00000658-192811000-00012; Flynn JM, 2002, J BONE JOINT SURG BR, V84B, P108, DOI 10.1302/0301-620X.84B1.11972; FORLIN E, 1992, J PEDIATR ORTHOPED, V12, P503, DOI 10.1097/01241398-199207000-00017; Gilban Hussa M, 2005, West Afr J Med, V24, P348; Herring J.A., 2008, TACHDJIANS PEDIAT OR, V4th; KLEIN A, 1951, AM J ROENTGENOL, V66, P361; Kumar P, 2006, J ORTHOP, V3, pe5; Loder RT, 1996, CLIN ORTHOP RELAT R, P8; Mirdad T, 2002, INJURY, V33, P823, DOI 10.1016/S0020-1383(02)00013-X; Moon ES, 2006, J ORTHOP TRAUMA, V20, P323, DOI 10.1097/00005131-200605000-00005; Nagi O N, 1992, J Orthop Trauma, V6, P306, DOI 10.1097/00005131-199209000-00007; Schroder J, 2001, Swiss Surg, V7, P222, DOI 10.1024/1023-9332.7.5.222; Su YL, 2011, INJURY, V42, P140, DOI 10.1016/j.injury.2010.05.008; Togrul E, 2005, INJURY, V36, P123, DOI 10.1016/j.injury.2004.04.010; Upadhyay A, 2004, INJURY, V35, P1073, DOI 10.1016/S0020-1383(03)00190-6	21	7	14	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	OCT	2012	470	10					2941	2945		10.1007/s11999-012-2458-5			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	005GA	WOS:000308737300038	22767419	Green Published			2022-02-06	
J	Mayr, R; Troyer, S; Kastenberger, T; Krappinger, D; Rosenberger, R; Obwegeser, A; El Attal, R				Mayr, R.; Troyer, S.; Kastenberger, T.; Krappinger, D.; Rosenberger, R.; Obwegeser, A.; El Attal, R.			The impact of coagulopathy on the outcome of traumatic epidural hematoma	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Traumatic brain injury; Epidural hematoma; Outcome; Multiple injuries; Coagulopathy; Progressive hemorrhage	DISSEMINATED INTRAVASCULAR COAGULATION; EXTRADURAL HEMATOMA; BRAIN-INJURY; HEAD TRAUMA; ABNORMALITIES; FIBRINOLYSIS; HEMORRHAGE; DIAGNOSIS; VOLUME	To evaluate the impact of trauma-associated coagulation disorders on the neurological outcome in patients with traumatic epidural hematoma undergoing surgical or non-surgical treatment. A retrospective analysis was performed using prospectively collected data in a consecutive patient series from a level 1 trauma center. Eighty-five patients with traumatic epidural hematoma were identified out of 1,633 patients admitted to our emergency room with traumatic head injuries between October 2004 and December 2008. The following prospectively assessed parameters were analyzed: Glasgow Coma Scale, coagulopathy, presence of skull fractures, additional injuries, the Injury Severity Score, hematoma volume and thickness at admission, hematoma volume progression over time and neurologic symptoms. Furthermore, patients were grouped based on whether they had undergone surgical or non-surgical treatment of the epidural hematoma. Clinical outcome was determined according to the Glasgow Outcome Score (GOS) at hospital discharge. Patients with coagulopathy showed significantly lower GOS values compared to patients with intact blood coagulation. Initial and progressive hematoma volumes did not influence neurological outcome. Patients with multiple injuries did not show a worse outcome compared to those with isolated epidural hematoma. There was no difference in patient's outcome after surgical or non-surgical treatment. Poor outcome after traumatic epidural hematoma was associated with coagulopathy. Progression of epidural hematoma volume was not associated with coagulopathy or with poor neurological outcome. Prospective studies are needed to confirm these results.	[Mayr, R.; Troyer, S.; Kastenberger, T.; Krappinger, D.; Rosenberger, R.; El Attal, R.] Innsbruck Med Univ, Dept Trauma Surg, A-6020 Innsbruck, Austria; [Obwegeser, A.] Innsbruck Med Univ, Dept Neurosurg, A-6020 Innsbruck, Austria		El Attal, R (corresponding author), Innsbruck Med Univ, Dept Trauma Surg, Anichstr 35, A-6020 Innsbruck, Austria.	rene.attal@uki.at		Attal, Rene/0000-0002-5313-2985			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BREDBACKA S, 1992, J NEUROSURG ANESTH, V4, P128, DOI 10.1097/00008506-199204000-00008; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; COOK RJ, 1988, ACTA NEUROCHIR, V95, P90, DOI 10.1007/BF01790766; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; Fabbri A, 2010, J NEUROL NEUROSUR PS, V81, P1275, DOI 10.1136/jnnp.2009.197467; GALLAGHE.JP, 1968, J NEUROSURG, V29, P1, DOI 10.3171/jns.1968.29.1.0001; Gando S, 2001, SEMIN THROMB HEMOST, V27, P585, DOI 10.1055/s-2001-18864; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GUPTA SK, 1992, CLIN NEUROL NEUROSUR, V94, P127, DOI 10.1016/0303-8467(92)90069-F; Heinzelmann M, 1996, INJURY, V27, P345, DOI 10.1016/0020-1383(95)00223-5; Irie F, 2011, J TRAUMA, V71, P847, DOI 10.1097/TA.0b013e3182032c9a; JENNETT B, 1975, LANCET, V1, P480; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maggi G, 1998, J Neurosurg Sci, V42, P95; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P363, DOI 10.1007/BF00327488; PHONPRASERT C, 1980, J TRAUMA, V20, P679, DOI 10.1097/00005373-198008000-00008; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; SAWADA Y, 1984, J NEUROL NEUROSUR PS, V47, P1125, DOI 10.1136/jnnp.47.10.1125; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tauber H, 2011, BRIT J ANAESTH, V107, P378, DOI 10.1093/bja/aer158; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; Uzan M, 1998, J Neurosurg Sci, V42, P89; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; VANDERSANDE JJ, 1981, J NEUROSURG, V54, P21, DOI 10.3171/jns.1981.54.1.0021; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wu JJ, 1999, J TRAUMA, V47, P39, DOI 10.1097/00005373-199907000-00009	43	7	7	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	OCT	2012	132	10					1445	1450		10.1007/s00402-012-1559-7			6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	010CE	WOS:000309071200011	22678529				2022-02-06	
J	Mazzio, E; Soliman, KFA				Mazzio, E.; Soliman, K. F. A.			Whole genome expression profile in neuroblastoma cells exposed to 1-methyl-4-phenylpyridine	NEUROTOXICOLOGY			English	Article						MPP; Neuro 2a; Parkinson's disease; Whole genome; Glycolysis; Complex I	GLUTAMATE OXALOACETATE TRANSAMINASE; DAVID BIOINFORMATICS RESOURCES; MITOCHONDRIAL LON PROTEASE; TRAUMATIC BRAIN-INJURY; LARGE GENE LISTS; PARKINSONS-DISEASE; COMPLEX-I; OXIDATIVE-PHOSPHORYLATION; DOPAMINE TRANSPORTER; GAMMA-CYSTATHIONASE	Mitochondrial dysfunction and subsequent energy failure is a contributing factor to degeneration of the substantia nigra pars compacta associated with Parkinson's disease (PD). In this study, we investigate molecular events triggered by cell exposure to the mitochondrial toxin 1-methyl-4-phenylpyridine (MPP+) using whole genome-expression microarray, Western Blot and metabolic studies. The data show that MPP+ (500 mu M) obstructs mitochondrial respiration/oxidative phosphorylation (OXPHOS) in mouse neuroblastoma Neuro-2a cells, juxtaposing accelerated glucose consumption and production of lactic acid. While additional glucose concentrations restored viability in the presence of MPP+ (500 mu M), the loss of OXPHOS was sustained, suggesting that compensatory anaerobic metabolic systems were fulfilling required energy needs. Under these conditions, MPP+ initiated significant changes to the transcription of 439 genes of which 287 DAVID IDs were identified and subsequent functional annotation clusters identified. Prominent changes were as follows; MPP+ initiated loss of mRNA for mitochondrial encoded 3-hydroxybutyratedehydrogenase, type2(Bdh2), tv1, NADH dehydrogenase 4,5 genes, cytochrome b and NADH dehydrogenase (ubiquinone) flavoprotein 3, concomitant to rise in a mitochondrial fission gene; ganglioside-induced differentiation-associated-protein 1 (GDAP1). The negative changes to OXPHOS components were accompanied by protective forces within the mitochondria espousing elevated ratio of anti/pro-apoptotic processes. These included a loss of apoptotic Bcl-2/adenovirus Et B 19-kDa-interacting protein (BNIP3) and family with sequence similarity 162, member A (FAM162a) and rise of heat shock protein 1 and Lon peptidase 1. There were no changes indicative of free radical damage (e.g. SOD, GSH-Px), rather MPP+ initiated significant elevation in G protein signaling components (which trigger catabolic processes) and anaerobic metabolic systems involving carboxylic acid/transamination reactions (e.g. glutamate oxaloacetate transaminase 1 (GOT1), glutamic pyruvate-alanine transaminase 2 (GPT2), cystathionase and redox proteins such as cytochrome b5 reductase 1 and ferredoxin reductase. Counter-intuitively, the data show reduction of mRNA in glycolytic processes [DAVID enrichment score 9.96 p value 1.90E-19], some corroborated by Western Blot, bringing in to question the sources of lactate observed in the presence of MPP+. Examining this aspect, the data show that diverse carboxylic acids (succinate, oxaloacetate and a-ketoglutarate) are capable of contributing to the lactate pool in addition to phosph(enolpyruvate) or pyruvate in the absence of glucose by this cell line. In conclusion, these findings show that MPP+ negatively affects the transcriptome involved with complex I, but initiated an elevation of G protein signaling and anaerobic metabolic systems involved with nitrogen/carboxylic acid metabolism. Future research will be required to elucidate the survival pathways that drive anaerobic substrate level phosphorylation, and define functional ramification to the loss of mitochondrial FAM162a and BNIP3 proteins. (C) 2012 Elsevier Inc. All rights reserved.	[Mazzio, E.; Soliman, K. F. A.] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA		Soliman, KFA (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Room 104,Dyson Pharm Bldg,1520 ML King Blvd, Tallahassee, FL 32307 USA.	karam.soliman@famu.edu			National Center for Research Resources NIH NCRR RCMI program [G12RR 03020]; National Institute of Minority Health and Health Disparities, NIH [8G12MD007582-28, 1P20 MD006738-01]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [G12RR003020] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [P20MD006738, G12MD007582] Funding Source: NIH RePORTER	This project was supported by the National Center for Research Resources NIH NCRR RCMI program (G12RR 03020) and the National Institute of Minority Health and Health Disparities, NIH (8G12MD007582-28 and 1P20 MD006738-01).	Absi E, 2000, J PINEAL RES, V29, P40, DOI 10.1034/j.1600-079X.2000.290106.x; Akashi S, 2011, BIOL PHARM BULL, V34, P243, DOI 10.1248/bpb.34.243; Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Asgari S, 2011, PHYSIOL MEAS, V32, P1639, DOI 10.1088/0967-3334/32/10/011; Bayot A, 2008, BIOCHIMIE, V90, P260, DOI 10.1016/j.biochi.2007.10.010; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Bouhouche A, 2007, CAN J NEUROL SCI, V34, P421, DOI 10.1017/S0317167100007290; Boyalla SS, 2011, J NEUROSCI RES, V89, P2068, DOI 10.1002/jnr.22669; Burch D, 2005, LANCET, V365, P622; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1387, DOI 10.1038/jcbfm.2011.4; Campos F, 2011, CLIN SCI, V121, P11, DOI 10.1042/CS20100427; Cassereau J, 2011, EXP NEUROL, V227, P31, DOI 10.1016/j.expneurol.2010.09.006; Cassereau J, 2009, NEUROGENETICS, V10, P145, DOI 10.1007/s10048-008-0166-9; Chalmers-Redman RME, 1999, BIOCHEM BIOPH RES CO, V257, P440, DOI 10.1006/bbrc.1999.0487; Chen J, 2012, ASIAN PAC J TROP MED, V5, P67, DOI 10.1016/S1995-7645(11)60248-4; Chowdhury U, 2009, CANCER METAST REV, V28, P225, DOI 10.1007/s10555-009-9183-x; Clark DW, 2008, CURR CANCER DRUG TAR, V8, P421, DOI 10.2174/156800908785133196; Conn KJ, 2001, NEUROSCI LETT, V306, P145, DOI 10.1016/S0304-3940(01)01888-2; Cooper AJL, 2011, AMINO ACIDS, V41, P7, DOI 10.1007/s00726-010-0552-0; Darpolor MM, 2011, NMR BIOMED, V24, P506, DOI 10.1002/nbm.1616; DELZOMPO M, 1993, BRIT J PHARMACOL, V109, P411; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; DIMONTE D, 1988, BIOCHEM BIOPH RES CO, V153, P734, DOI 10.1016/S0006-291X(88)81156-2; Ebadi M, 2001, BIOL SIGNAL RECEPT, V10, P224; Evans SM, 2001, TOXICOL IN VITRO, V15, P579, DOI 10.1016/S0887-2333(01)00064-9; Fishovitz J, 2011, ACS CHEM BIOL, V6, P781, DOI 10.1021/cb100408w; Gallagher FA, 2011, MAGN RESON MED, V66, P18, DOI 10.1002/mrm.22851; Girish V, 2004, Indian J Cancer, V41, P47; Goebel G, 2012, BRIT J CANCER, V106, P189, DOI 10.1038/bjc.2011.510; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hu S, 2011, CELL METAB, V14, P131, DOI 10.1016/j.cmet.2011.04.012; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hyun DH, 2005, J NEUROSCI RES, V82, P232, DOI 10.1002/jnr.20638; Ifergan I, 2011, ANN NEUROL, V70, P751, DOI 10.1002/ana.22519; Jin HO, 2009, IUBMB LIFE, V61, P1153, DOI 10.1002/iub.271; Karathanou A, 2011, J NEUROSURG SCI, V55, P173; Kim JY, 2006, FEBS LETT, V580, P3270, DOI 10.1016/j.febslet.2006.05.001; Koga K, 2006, EUR J NEUROSCI, V23, P1077, DOI 10.1111/j.1460-9568.2006.04610.x; Kotake Y, 2003, CURR MED CHEM, V10, P2507, DOI 10.2174/0929867033456558; Kubo T, 2002, J NEUROCHEM, V82, P1129, DOI 10.1046/j.1471-4159.2002.01060.x; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Lee MJ, 2004, MOL CELL BIOL, V24, P3918, DOI 10.1128/MCB.24.9.3918-3927.2004; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Levy OA, 2009, APOPTOSIS, V14, P478, DOI 10.1007/s10495-008-0309-3; Lin Tsu-Kung, 2009, Chang Gung Med J, V32, P589; Lin YQ, 2009, ANAL CHEM, V81, P2067, DOI 10.1021/ac801946s; Ling J, 2011, GYNECOL ENDOCRINOL, V27, P63, DOI 10.3109/09513590.2010.487594; Liu JR, 2010, AM J PHYSIOL-ENDOC M, V298, pE565, DOI 10.1152/ajpendo.00467.2009; Martin JA, 2007, CELL MOL BIOL NOIS S, V53; Maruoka N, 2007, J NEURAL TRANSM, V114, P1155, DOI 10.1007/s00702-007-0720-x; Mazzio E, 2003, NEUROTOXICOLOGY, V24, P137, DOI 10.1016/S0161-813X(02)00110-9; Mazzio E, 2003, BRAIN RES, V962, P48, DOI 10.1016/S0006-8993(02)03695-8; Mazzio EA, 2004, BIOCHEM PHARMACOL, V67, P1167, DOI 10.1016/j.bcp.2003.11.016; Mazzio EA, 2010, CELL BIOL TOXICOL, V26, P527, DOI 10.1007/s10565-010-9161-7; Mazzio EA, 2010, CELL BIOL TOXICOL, V26, P177, DOI 10.1007/s10565-009-9138-6; Mhawech-Fauceglia P, 2009, J CLIN PATHOL, V62, P710, DOI 10.1136/jcp.2009.066159; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; Mizuno Y, 1989, Rinsho Shinkeigaku, V29, P1494; MIZUNO Y, 1987, NEUROSCI LETT, V81, P204, DOI 10.1016/0304-3940(87)90366-1; Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Nagatsu T, 2002, J NEURAL TRANSM, V109, P731, DOI 10.1007/s007020200061; Nagatsu T, 1997, NEUROSCI RES, V29, P99, DOI 10.1016/S0168-0102(97)00083-7; Nakamura T, 2010, APOPTOSIS, V15, P1354, DOI 10.1007/s10495-010-0476-x; Naldini A, 2012, J CELL PHYSIOL, V227, P587, DOI 10.1002/jcp.22761; Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011; Nishioka K, 2010, PARKINSONISM RELAT D, V16, P686, DOI 10.1016/j.parkreldis.2010.09.007; Ogasawara Y, 2002, J BIOCHEM BIOPH METH, V51, P139, DOI 10.1016/S0165-022X(02)00010-6; Ogasawara Y, 1997, BBA-GEN SUBJECTS, V1334, P33, DOI 10.1016/S0304-4165(96)00072-4; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Omerhozic I, 2011, ACTA CLIN CROAT, V50, P13; Pedrola L, 2005, HUM MOL GENET, V14, P1087, DOI 10.1093/hmg/ddi121; Pedrola L, 2008, J CELL MOL MED, V12, P679, DOI 10.1111/j.1582-4934.2007.00158.x; Pinti M, 2011, MITOCHONDRION, V11, P200, DOI 10.1016/j.mito.2010.09.010; Qu Y, 2009, STROKE, V40, P2843, DOI 10.1161/STROKEAHA.109.553644; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Rink C, 2011, ANTIOXID REDOX SIGN, V14, P1777, DOI 10.1089/ars.2011.3930; ROLLEMA H, 1988, J PHARMACOL EXP THER, V245, P858; Ruckert IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022932; Serganova I, 2011, CLIN CANCER RES, V17, P6250, DOI 10.1158/1078-0432.CCR-11-0397; Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3; Song AR, 2011, IMMUNOPHARM IMMUNOT, V33, P454, DOI 10.3109/08923973.2010.534100; Stein Marco, 2012, Acta Neurochir Suppl, V114, P333, DOI 10.1007/978-3-7091-0956-4_64; Steyn SJ, 2005, J BIOCHEM BIOPH METH, V62, P25, DOI 10.1016/j.jbbm.2004.07.002; Storch A, 1999, NEUROCHEM INT, V35, P393, DOI 10.1016/S0197-0186(99)00083-2; Storch A, 2002, BIOCHEM PHARMACOL, V63, P909, DOI 10.1016/S0006-2952(01)00922-4; SUZUKI K, 1990, NEUROCHEM RES, V15, P705, DOI 10.1007/BF00973651; Swarnkar S, 2012, ARCH TOXICOL; Thomas RL, 2011, AUTOPHAGY, V7, P775, DOI 10.4161/auto.7.7.15536; Tofaris GK, 2005, MOVEMENT DISORD, V20, pS37, DOI 10.1002/mds.20538; Wagatsuma A, 2011, MOL CELL BIOCHEM, V349, P139, DOI 10.1007/s11010-010-0668-2; Wang Ping, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P214; Wang Z, 2011, CANCER BIOTHER RADIO, V26, P279, DOI 10.1089/cbr.2010.0898; Wennemers M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2934; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Xu P, 2011, GENE DEV, V25, P310, DOI 10.1101/gad.1984311; Yokobori S, 2011, NEUROL MED-CHIR, V51, P265, DOI 10.2176/nmc.51.265; Zhao YL, 2011, FOOD CHEM TOXICOL, V49, P1705, DOI 10.1016/j.fct.2011.04.011; Zhao Y, 2012, J CELL PHYSIOL, V227, P639, DOI 10.1002/jcp.22768; Zhu JH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.46; Zweckberger K, 2011, NEUROL RES, V33, P875, DOI 10.1179/1743132811Y.0000000017	106	7	7	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	OCT	2012	33	5					1156	1169		10.1016/j.neuro.2012.06.009			14	Neurosciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	028BA	WOS:000310396600020	22776087	Green Accepted			2022-02-06	
J	Mijzen, EJ; Jacobs, B; Aslan, A; Rodgers, MGG				Mijzen, Elsbeth J.; Jacobs, Bram; Aslan, Adnan; Rodgers, Michael G. G.			Propofol Infusion Syndrome Heralded by ECG Changes	NEUROCRITICAL CARE			English	Article						Propofol; Traumatic brain injury; Sedation; Propofol infusion syndrome; Electrocardiography	SEVERE HEAD-INJURY; MANAGEMENT; PATHOPHYSIOLOGY; METABOLISM; ACIDOSIS; CHILDREN; FAILURE; PATIENT; UPDATE; DEATH	Propofol infusion syndrome (PRIS) is well known, often associated with, lethal complication of sedation with propofol. PRIS seems to be associated with young age, traumatic brain injury (TBI), higher cumulative doses of propofol, and the concomitant use of catecholamines. Known manifestations of PRIS are metabolic acidosis, rhabdomyolysis, and cardiac failure. While fatal PRIS can occur suddenly and rapidly, there is no sensitive test or early warning sign, and the only preventive measure is to limit propofol dosage and its duration. A case report was used for investigation purposes of this study. We report the case study of a young patient with severe TBI, receiving propofol sedation because of high intracranial pressure. Seven days after the trauma, the patient developed metabolic acidosis and refractory circulatory shock, probably caused by PRIS. Reversal of T-waves was seen on the electrocardiogram (ECG) 29 h before circulation failure occurred. In the absence of other signs of cardiac dysfunction or ischemia, these reversed T-waves probably represent an early warning sign of developing PRIS. From the findings of this study, we conclude that meticulous observation and analysis of the ECG during propofol sedation might result in earlier recognition of developing PRIS.	[Mijzen, Elsbeth J.; Aslan, Adnan; Rodgers, Michael G. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Intens Care, NL-9700 RB Groningen, Netherlands; [Jacobs, Bram] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 RB Groningen, Netherlands		Mijzen, EJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Intens Care, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	ejmijzen@gmail.com					Ahlen K, 2006, EUR J ANAESTH, V23, P990, DOI 10.1017/S0265021506001281; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Bray RJ, 1998, PAEDIATR ANAESTH, V8, P491; Cremer OL, 2001, LANCET, V357, P117, DOI 10.1016/S0140-6736(00)03547-9; Davenport A, 2010, HEMODIAL INT, V14, pS27, DOI 10.1111/j.1542-4758.2010.00487.x; Fong JJ, 2008, CRIT CARE MED, V36, P2281, DOI 10.1097/CCM.0b013e318180c1eb; Fudickar A, 2009, MINERVA ANESTESIOL, V75, P339; Iyer VN, 2009, CRIT CARE MED, V37, P3024, DOI 10.1097/CCM.0b013e3181b08ac7; Johnston AJ, 2003, BRIT J ANAESTH, V91, P781, DOI 10.1093/bja/aeg256; Kam PCA, 2007, ANAESTHESIA, V62, P690, DOI 10.1111/j.1365-2044.2007.05055.x; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Marinella MA, 1996, CHEST, V109, P292, DOI 10.1378/chest.109.1.292; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; Otterspoor LC, 2008, CURR OPIN ANESTHESIO, V21, P544, DOI 10.1097/ACO.0b013e32830f44fb; PARKE TJ, 1992, BRIT MED J, V305, P613, DOI 10.1136/bmj.305.6854.613; Perrier ND, 2000, CRIT CARE MED, V28, P3071, DOI 10.1097/00003246-200008000-00066; Roberts RJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8145; Smith H, 2009, NEUROCRIT CARE, V10, P166, DOI 10.1007/s12028-008-9163-y; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x; Vernooy K, 2006, HEART RHYTHM, V3, P131, DOI 10.1016/j.hrthm.2005.11.005; Wolf A, 2001, LANCET, V357, P606, DOI 10.1016/S0140-6736(00)04064-2; Wong JM, 2010, AM J THER, V17, P487, DOI 10.1097/MJT.0b013e3181ed837a	24	7	7	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	OCT	2012	17	2					260	264		10.1007/s12028-012-9743-8			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	002QU	WOS:000308548800018	22847396				2022-02-06	
J	Yoon, YS; Yu, KP; Kim, H; Kim, HI; Kwak, SH; Kim, BO				Yoon, Yong-Soon; Yu, Ki Pi; Kim, Hyojoon; Kim, Hyoung-ihl; Kwak, Soo Hyun; Kim, Bong Ok			The Effect of Electric Cortical Stimulation after Focal Traumatic Brain Injury in Rats	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Cortical stimulation; Traumatic brain injury; Rehabilitation; Motor recovery		Objective To evaluate the effects of electric cortical stimulation in the experimentally induced focal traumatic brain injury (TBI) rat model on motor recovery and plasticity of the injured brain. Method Twenty male Sprague-Dawlev rats were pre-trained on a single pellet reaching task (SPRT) and on a Rotarod task (RRT) for 14 days. Then, the TBI model was induced by a weight drop device (40 g in weight, 25 cm in height) on the dominant motor cortex, and the electrode was implanted over the perilesional cortical surface. All rats were divided into two groups as follows: Electrical stimulation (ES) group with anodal continuous stimulation (50 Hz and 194 mu s duration) or Sham-operated control (SOC) group with no electrical stimulation. The rats were trained SPRT and RRT for 14 days for rehabilitation and measured Garcia's neurologic examination. Histopathological and immunostaining evaluations were performed after the experiment. Results There were no differences in the slice number in the histological analysis. Garcia's neurologic scores & SPRT were significantly increased In the ES group (p < 0.05), yet, there was no difference in RRT in both groups. The ES group showed more expression of c-Fos around the brain injured area than the SOC group. Conclusion Electric cortical stimulation with rehabilitation is considered to be one of the trial methods for motor recovery in TBI. However, more studies should be conducted for the TBI model in order to establish better stimulation methods.	[Yoon, Yong-Soon; Yu, Ki Pi; Kim, Hyoung-ihl; Kwak, Soo Hyun] Presbyterian Med Ctr, Dept Rehabil Med, Sewon St 68, Jeonju 560750, South Korea; [Kim, Hyojoon] Presbyterian Med Ctr, Dept NeuroSurg, Jeonju 560750, South Korea; [Kim, Bong Ok] Chungnam Natl Univ, Sch Med, Dept Rehabil Med, Daejeon 301721, South Korea		Kwak, SH (corresponding author), Presbyterian Med Ctr, Dept Rehabil Med, Sewon St 68, Jeonju 560750, South Korea.	littlemicky@hanmail.net		Kim, Hyoung-Ihl/0000-0001-7914-3968	Korea of Healthcare Technology R&D Project, Ministry for Health & Welfare & Family Affairs, Republic of Korea [A091220]	This study was supported by a grant of the Korea of Healthcare Technology R&D Project, Ministry for Health & Welfare & Family Affairs, Republic of Korea (A091220).	Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Alonso-Alonso Miguel, 2007, Cerebrovasc Dis, V24 Suppl 1, P157, DOI 10.1159/000107392; Braddom RL, 2006, PHYS MED REHABILITAT, P1133; Brown JA, 2003, NEUROL RES, V25, P815, DOI 10.1179/016164103771953907; Brown JA, 2006, NEUROSURGERY, V58, P464, DOI 10.1227/01.NEU.0000197100.63931.04; Choi YB, 2004, BRAIN RES, V1019, P47, DOI 10.1016/j.brainres.2004.05.079; Cogiamanian F, 2009, TEXTBOOK OF THERAPEUTIC CORTICAL STIMULATION, P45; DUBNER R, 1992, TRENDS NEUROSCI, V15, P96, DOI 10.1016/0166-2236(92)90019-5; Ducker TB, 1976, HDB CLIN NEUROLOGY, P9; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gharbawie OA, 2005, BEHAV BRAIN RES, V156, P125, DOI 10.1016/j.bbr.2004.05.015; Gonzalez CLR, 2003, EUR J NEUROSCI, V18, P1950, DOI 10.1046/j.1460-9568.2003.02928.x; Harris-Love ML, 2006, ARCH PHYS MED REHAB, V87, pS84, DOI 10.1016/j.apmr.2006.08.330; Harvey RL, 2007, TOP STROKE REHABIL, V14, P54, DOI 10.1310/tsr1406-54; Hunter AJ, 1998, TRENDS PHARMACOL SCI, V19, P59, DOI 10.1016/S0165-6147(97)01157-7; KATAYAMA Y, 1994, STEREOT FUNCT NEUROS, V62, P295, DOI 10.1159/000098635; Kim DY, 2007, NEUROSCI RES, V58, P164, DOI 10.1016/j.neures.2007.02.016; Kim HS, 2006, ANN REHABIL MED-ARM, V30, P135; Kleim JA, 2003, NEUROL RES, V25, P789, DOI 10.1179/016164103771953862; Kreisel SH, 2007, CEREBROVASC DIS, V23, P243, DOI 10.1159/000098323; Moon SK, 2009, NEUROSCI LETT, V460, P152, DOI 10.1016/j.neulet.2009.05.029; Moon SK, 2007, LAB ANIM RES, V23, P25; Park HK, 1999, CRIT REV NEUROSURG, V9, P44, DOI 10.1007/s003290050108; Pascual-Leone A, 2006, PROG BRAIN RES, V157, P315, DOI 10.1016/S0079-6123(06)57019-0; Paxinos G, 2007, RAT BRAIN STEREOTAXI, P30; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Sawaki L, 2006, STROKE, V37, P246, DOI 10.1161/01.STR.0000195130.16843.ac; Schallert T, 1997, ADV NEUROL, V73, P229; Teskey GC, 2003, NEUROL RES, V25, P794, DOI 10.1179/016164103771953871; Tsubokawa T, 1991, Acta Neurochir Suppl (Wien), V52, P137; Vergara-Aragon P, 2003, J NEUROSCI, V23, P579, DOI 10.1523/JNEUROSCI.23-02-00579.2003; Walsh V, 2006, BEHAV NEUROL, V17, P131, DOI 10.1155/2006/164397; Whishaw IQ, 1998, BEHAV BRAIN RES, V96, P79, DOI 10.1016/S0166-4328(97)00200-3; WHISHAW IQ, 1983, PHYSIOL BEHAV, V30, P471, DOI 10.1016/0031-9384(83)90154-3; Yang CY, 2008, ANN REHABIL MED-ARM, V32, P375	38	7	7	0	1	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	OCT	2012	36	5					596	608		10.5535/arm.2012.36.5.596			13	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VC5EG	WOS:000433810400002	23185723	gold, Green Submitted, Green Published			2022-02-06	
J	Wang, Q; Ishikawa, T; Michiue, T; Zhu, BL; Guan, DW; Maeda, H				Wang, Qi; Ishikawa, Takaki; Michiue, Tomomi; Zhu, Bao-Li; Guan, Da-Wei; Maeda, Hitoshi			Quantitative immunohistochemical analysis of human brain basic fibroblast growth factor, glial fibrillary acidic protein and single-stranded DNA expressions following traumatic brain injury	FORENSIC SCIENCE INTERNATIONAL			English	Article						Basic fibroblast growth factor; Glial fibrillary acidic protein; Single-stranded DNA; Human traumatic brain injury; Immunohistochemistry	HIGH INTRACRANIAL-PRESSURE; CELL-DEATH; CEREBRAL EDEMA; HEAD-INJURY; FACTOR BFGF; DAMAGE; HEMORRHAGE; APOPTOSIS; RATS; TIME	Previous studies demonstrated the healing process after traumatic brain injury (TBI), usually at the site or in the area adjacent to the injury, in connection with wound timing. However, the whole brain condition after TBI has not been elucidated clearly. In the present study, we investigated immunohistochemistry of the basic fibroblast growth factor (bFGF), glial fibrillary acidic protein (GFAP) and single-stranded DNA (ssDNA) in the parietal lobe and hippocampus distant from the primary injury site in forensic autopsy cases of TBI (n = 174). Characteristic findings were detected with regard to brain compression signs and survival time (ST). Peracute deaths (n = 22) had a lower GFAP positivity in the parietal white matter. Fatalities without a brain compression sign (parahippocampal herniation/Duret hemorrhage; n = 53) had a lower brain weight without glial loss; however, GFAP positivity in the parietal white matter was decreased during ST of <12 h, and glial bFGF positivity was increased at each site in deaths after 12 h to 3 days, followed by a delayed neuronal loss after 3 days. Fatalities with a brain compression sign (n = 78) showed a higher brain weight, and gradual glial and neuronal losses with an early increase of glial bFGF positivity in the parietal cerebral cortex (ST <0.5 h). This was followed by an increase of glial bFGF positivity in other sites (ST, 6-24 h), and final decreases of glial bFGF and GFAP positivities with increased neuronal ssDNA positivity in the parietal lobe and hippocampus (ST >3 days), which were detected in earlier deaths despite decompressive craniectomy (ST, 12-60 h; n = 21). These observations suggest that the combined use of bFGF, GFAP and ssDNA immunohistochemistry can be used to evaluate the severity of damage and response of brain after TBI. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Wang, Qi] Osaka City Univ, Sch Med, Dept Legal Med, Abeno Ku, Osaka 5458585, Japan; [Wang, Qi; Ishikawa, Takaki; Michiue, Tomomi; Maeda, Hitoshi] MLCPI SC, Osaka, Japan; [Zhu, Bao-Li; Guan, Da-Wei] China Med Univ, Sch Forens Med, Dept Forens Pathol, Shenyang, Peoples R China		Wang, Q (corresponding author), Osaka City Univ, Sch Med, Dept Legal Med, Abeno Ku, Asahi Machi 1-4-3, Osaka 5458585, Japan.	m2041106@med.osaka-cu.ac.jp	Ishikawa, Takaki/AAP-7005-2020		Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [21790612, 22590642]	This study was in part supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology, Japan (Grant Nos. 21790612 and 22590642).	Alzheimer C, 2002, ADV EXP MED BIOL, V513, P335; Ay I, 2001, MOL BRAIN RES, V87, P71, DOI 10.1016/S0169-328X(00)00285-0; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Bratzke H, 2004, FORENSIC SCI INT, V144, P157, DOI 10.1016/j.forsciint.2004.04.050; Byard Roger W, 2009, Leg Med (Tokyo), V11 Suppl 1, pS128, DOI 10.1016/j.legalmed.2009.02.001; Castejon O. J., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P21; Chen J, 1997, J NEUROCHEM, V69, P232; Deguchi Y, 2002, J NEUROCHEM, V83, P381, DOI 10.1046/j.1471-4159.2002.01129.x; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Graham D.I., 2002, GREENFIELDS NEUROPAT; GRAHAM DI, 1987, NEUROPATH APPL NEURO, V13, P209, DOI 10.1111/j.1365-2990.1987.tb00184.x; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Hausmann R, 2001, INT J LEGAL MED, V114, P338, DOI 10.1007/s004140000199; Hellal F, 2004, NEUROSCI LETT, V357, P21, DOI 10.1016/j.neulet.2003.12.036; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; KLATZO I, 1994, ACTA NEUROCHIR, P3; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; LOUIS JC, 1993, EUR J NEUROSCI, V5, P1610, DOI 10.1111/j.1460-9568.1993.tb00230.x; Macmillan CSA, 2002, INTENS CARE MED, V28, P1012, DOI 10.1007/s00134-002-1382-7; Maleszewski J, 2007, J HISTOCHEM CYTOCHEM, V55, P597, DOI 10.1369/jhc.6A7152.2007; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; Michiue T, 2008, FORENSIC SCI INT, V178, P185, DOI 10.1016/j.forsciint.2008.03.019; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; Parizel PM, 2002, INTENS CARE MED, V28, P85, DOI 10.1007/s00134-001-1160-y; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Saukko P, 2004, KNIGHTS FORENSIC PAT; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Takamiya M, 2007, J NEUROTRAUM, V24, P1833, DOI 10.1089/neu.2007.0336; Tamatani M, 1998, CELL DEATH DIFFER, V5, P911, DOI 10.1038/sj.cdd.4400439; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Walter Till, 2009, Leg Med (Tokyo), V11 Suppl 1, pS56, DOI 10.1016/j.legalmed.2009.01.112; Wang Q., 2012, FORENSIC SCI INT; Wang Q, 2011, FORENSIC SCI INT, V211, P19, DOI 10.1016/j.forsciint.2011.03.037; Zador Z, 2007, PROG BRAIN RES, V161, P185, DOI 10.1016/S0079-6123(06)61012-1	42	7	9	1	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	SEP 10	2012	221	1-3					142	151		10.1016/j.forsciint.2012.04.025			10	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	981KR	WOS:000306967300034	22607979				2022-02-06	
J	Allen, DN; Thaler, NS; Ringdahl, EN; Barney, SJ; Mayfield, J				Allen, Daniel N.; Thaler, Nicholas S.; Ringdahl, Erik N.; Barney, Sally J.; Mayfield, Joan			Comprehensive Trail Making Test Performance in Children and Adolescents With Traumatic Brain Injury	PSYCHOLOGICAL ASSESSMENT			English	Article						traumatic brain injury; Trail Making Test; validity; children; adolescents	NEUROPSYCHOLOGICAL TEST BATTERY; VERBAL-LEARNING TEST; CATEGORY TEST; CRITERION VALIDITY; CONSTRUCT; DISCREPANCIES; SENSITIVITY; ABILITY; VERSION; TASK	The sensitivity of the Trail Making Test to brain damage has been well-established over many years, making it one of the most commonly used tests in clinical neuropsychological evaluations. The current study examined the validity of scores from a newer version of the Trail Making Test, the Comprehensive Trail Making Test (CTMT), in children and adolescents with traumatic brain injury (TBI). Participants included 242 children and adolescents, 121 with sustained TBI and 121 normal control participants, who were matched to the individuals with TBI on age and sex. Receiver operating characteristic analysis indicated that the CTMT composite index provided the best overall classification, with a correct classification rate of 79%. Differences between the TBI and control groups remained stable across age. These findings indicate that the CTMT is sensitive to TBI and overall demonstrates classification rates that are comparable with some other versions of the Trail Making Test. Whether the CTMT will exhibit similar classification accuracy in adults with TBI and for other neurological disorders awaits further investigation.	[Allen, Daniel N.; Thaler, Nicholas S.; Ringdahl, Erik N.; Barney, Sally J.] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, 4505 Maryland Pkway, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; Allen DN, 2009, CHILD NEUROPSYCHOL, V15, P543, DOI 10.1080/09297040902748234; Armitage S. G., 1946, PSYCHOL MONOGRAPHS, V60; Armstrong CM, 2008, ARCH CLIN NEUROPSYCH, V23, P351, DOI 10.1016/j.acn.2007.11.004; Atkinson TM, 2008, J PSYCHOEDUC ASSESS, V26, P42, DOI 10.1177/0734282907301592; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bauman Johnson WL, 2010, ARCH CLIN NEUROPSYCH, V25, P601, DOI 10.1093/arclin/acq049; Bello DT, 2008, ARCH CLIN NEUROPSYCH, V23, P329, DOI 10.1016/j.acn.2007.12.002; Brown RR, 1942, J GEN PSYCHOL, V27, P71, DOI 10.1080/00221309.1942.10545185; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; Demakis GJ, 2004, J CLIN EXP NEUROPSYC, V26, P441, DOI 10.1080/13803390490510149; Donders J, 2005, J INT NEUROPSYCH SOC, V11, P386, DOI 10.1017/S1355617705050435; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Fowler P C, 1987, Arch Clin Neuropsychol, V2, P81, DOI 10.1016/0887-6177(87)90035-7; GOLDSTEIN G, 1966, PERCEPT MOTOR SKILL, V22, P347, DOI 10.2466/pms.1966.22.2.347; GOLDSTEIN G, 1972, PERCEPT MOTOR SKILL, V34, P603, DOI 10.2466/pms.1972.34.2.603; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hosmer D.W., 2000, APPL LOGISTIC REGRES, P375, DOI [10.1002/0471722146, DOI 10.1002/0471722146]; Krug D, 1995, INT J NEUROSCI, V83, P131, DOI 10.3109/00207459508986332; Langenecker SA, 2007, J CLIN EXP NEUROPSYC, V29, P842, DOI 10.1080/13803390601147611; Leckliter Ingrid N, 1992, Clin Neuropsychol, V6, P201, DOI 10.1080/13854049208401856; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P529, DOI 10.1076/1380-3395(200008)22:4;1-0;FT529; Leiter RG., 1949, PSYCHOL SERVICE CTR, V1, P11; Levin HS., 1982, NEUROBEHAVIORAL CONS; MITTELMEIER C, 1989, INT J CLIN NEUROPSYC, V11, P163; MOEHLE KA, 1990, INT J CLIN NEUROPSYC, V12, P107; Mok N, 2008, APPL NEUROPSYCHOL, V15, P123, DOI 10.1080/09084280802083962; NICI J, 1986, J CONSULT CLIN PSYCH, V54, P542, DOI 10.1037/0022-006X.54.4.542; Park BS, 2009, APPL NEUROPSYCHOL, V16, P1, DOI 10.1080/09084280802636371; Partington J, 1949, PSYCHOL SERVICE CTR, V1, P46; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Putnam S.H., 1990, CLIN NEUROPSYCHOL, V4, P199, DOI [https://doi.org/10.1080/13854049008401906, DOI 10.1080/13854049008401906]; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Reitan RM, 2004, ARCH CLIN NEUROPSYCH, V19, P281, DOI 10.1016/S0887-6177(03)00042-8; REITAN RM, 1985, J CLIN PSYCHOL, V41, P643, DOI 10.1002/1097-4679(198509)41:5<643::AID-JCLP2270410510>3.0.CO;2-A; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Riccio CA, 2011, ARCH CLIN NEUROPSYCH, V26, P235, DOI 10.1093/arclin/acq105; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Smith SR, 2008, CLIN NEUROPSYCHOL, V22, P507, DOI 10.1080/13854040701399269; Soukup V M, 1998, Appl Neuropsychol, V5, P65, DOI 10.1207/s15324826an0502_2; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Sweet JJ, 2011, CLIN NEUROPSYCHOL, V25, P12, DOI 10.1080/13854046.2010.544165; Swets J. A., 1996, SCI PSYCH S; TEASDALE G, 1974, LANCET, V2, P81; WILLIAMS J, 1995, ARCH CLIN NEUROPSYCH, V10, P211, DOI 10.1016/0887-6177(94)00041-N; Wolfson, 1992, HALSTEAD REITAN NEUR; WUENSCH K. L., 2011, USING SPSS OBTAIN CO	56	7	7	0	20	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	SEP	2012	24	3					556	564		10.1037/a0026263			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	999AI	WOS:000308281100003	22103551				2022-02-06	
J	Berger, TW; Song, D; Chan, RHM; Shin, D; Marmarelis, VZ; Hampson, RE; Sweatt, AJ; Heck, CN; Liu, CY; Wills, J; LaCoss, J; Granacki, JJ; Gerhardt, GA; Deadwyler, SA				Berger, Theodore W.; Song, Dong; Chan, Rosa H. M.; Shin, Dae; Marmarelis, Vasilis Z.; Hampson, Robert E.; Sweatt, Andrew J.; Heck, Christi N.; Liu, Charles Y.; Wills, Jack; LaCoss, Jeff; Granacki, John J.; Gerhardt, Greg A.; Deadwyler, Sam A.			Role of the Hippocampus in Memory Formation	IEEE PULSE			English	Article							MEDIAL TEMPORAL-LOBE; TRAUMATIC BRAIN-INJURY; SYNAPTIC TRANSMISSION; RECOGNITION MEMORY; ENSEMBLE ACTIVITY; NEURAL ENSEMBLE; PERFORMANCE; ITEM; STIMULATION; INFORMATION		[Berger, Theodore W.; Song, Dong; Chan, Rosa H. M.; Shin, Dae; Marmarelis, Vasilis Z.] Univ So Calif, Ctr Neural Engn, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Hampson, Robert E.; Sweatt, Andrew J.; Deadwyler, Sam A.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC USA; [Heck, Christi N.] Univ So Calif, Keck Hosp, Adult Comprehens Epilepsy Program, Dept Neurol, Los Angeles, CA 90089 USA; [Liu, Charles Y.] USC, LAC USC Med Ctr, Adult Comprehens Epilepsy Program, Dept Neurol Surg,Keck Hosp, Los Angeles, CA USA; [Liu, Charles Y.] Rancho Los Amigos Natl Rehabil Ctr, Downey, CA USA; [Wills, Jack; LaCoss, Jeff; Granacki, John J.] Univ So Calif, Inst Informat Sci, Viterbi Sch Engn, Los Angeles, CA 90089 USA; [Gerhardt, Greg A.] Univ Kentucky, Ctr Microelectrode Technol, Lexington, KY 40506 USA		Berger, TW (corresponding author), Univ So Calif, Ctr Neural Engn, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA 90089 USA.	berger@bmsr.usc.edu; dsong@usc.edu; homchan@usc.edu; vzm@bmsrs.usc.edu; rhampson@wfuhmc.edu; asweatt@wfubmc.edu; check@usc.edu; cliu@usc.edu; jackw@isi.edu; jlacoss@isi.edu; granacki@usc.edu; gregg@uky.edu; sdeadwyl@wfubmc.edu		Hampson, Robert/0000-0002-8648-9462; Song, Dong/0000-0002-6179-1120; CHAN, Rosa/0000-0003-4808-2490	DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [N66601-09-C-2080, N66601-09-C-2081]; NIH/NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41-EB001978]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01DA07625];  [NSF EEC-0310723]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB001978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA007625] Funding Source: NIH RePORTER	This work was supported in part by DARPA contracts to S. A. D. N66601-09-C-2080 and to T. W. B. N66601-09-C-2081 (Prog. Dir: COL G. Ling), and grants NSF EEC-0310723 to USC (T. W. B.), NIH/NIBIB grant P41-EB001978 to the Biomedical Simulations Resource at USC (to V.Z.M.) and NIH R01DA07625 (to S. A. D.). The views, opinions, and/or findings contained in this article are those of the authors and should not be interpreted as representing the official views or policies, either expressed or implied, of the DARPA or the Department of Defense. The authors appreciate the efforts of Dr. L. Porrino, Dr. J. Daunais, Dr. R. Espana, Dr. I. Opris, Dr. J. Simeral, Dr. M. Hsiao, and the technical expertise of D. C. Collins, V. Collins, C. Dyson, G. McLeod, M. Moran, and M. Riley.	Berger TW, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046017; Berger TW, 2010, P IEEE, V98, P356, DOI 10.1109/JPROC.2009.2038804; Boettiger CA, 2005, J NEUROSCI, V25, P2723, DOI 10.1523/JNEUROSCI.3697-04.2005; Buckner RL, 2000, ACTA PSYCHOL, V105, P127, DOI 10.1016/S0001-6918(00)00057-3; Canals S, 2008, MAGN RESON IMAGING, V26, P978, DOI 10.1016/j.mri.2008.02.018; Carey ME, 1996, J TRAUMA, V40, pS165, DOI 10.1097/00005373-199603001-00036; Cavanaugh J, 2006, J NEUROSCI, V26, P11347, DOI 10.1523/JNEUROSCI.2376-06.2006; Chapin JK, 2004, NAT NEUROSCI, V7, P452, DOI 10.1038/nn1234; COAN EJ, 1987, NEUROSCI LETT, V80, P111, DOI 10.1016/0304-3940(87)90505-2; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Deadwyler SA, 1996, J NEUROSCI, V16, P354; DEADWYLER SA, 1995, SCIENCE, V270, P1316, DOI 10.1126/science.270.5240.1316; Deadwyler SA, 1997, ANNU REV NEUROSCI, V20, P217, DOI 10.1146/annurev.neuro.20.1.217; Deadwyler SA, 2007, J NEUROSCI, V27, P14239, DOI 10.1523/JNEUROSCI.3878-07.2007; Dulay MF, 2009, J NEUROSURG, V110, P1300, DOI 10.3171/2008.2.JNS17666; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Eichenbaum H, 2009, PHILOS T R SOC B, V364, P1183, DOI 10.1098/rstb.2008.0306; Gold JJ, 2006, P NATL ACAD SCI USA, V103, P9351, DOI 10.1073/pnas.0602716103; Hampson RE, 2010, BEHAV BRAIN RES, V212, P1, DOI 10.1016/j.bbr.2010.03.011; Hampson R. E., 2008, NEURAL POPULATION EN, P74; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Hampson RE, 2004, P NATL ACAD SCI USA, V101, P3184, DOI 10.1073/pnas.0400162101; Hampson RE, 2011, NEUROMETHODS, V54, P215, DOI 10.1007/978-1-60327-202-5_9; Hampson RE, 2011, NEUROPHARMACOLOGY, V60, P944, DOI 10.1016/j.neuropharm.2011.01.039; Hampson RE, 2011, PSYCHOPHARMACOLOGY, V213, P105, DOI 10.1007/s00213-010-2017-2; Hsiao MC, 2008, IEEE ENG MED BIO, P5535, DOI 10.1109/IEMBS.2008.4650468; Komorowski RW, 2009, J NEUROSCI, V29, P9918, DOI 10.1523/JNEUROSCI.1378-09.2009; Lebedev MA, 2004, PLOS BIOL, V2, P1919, DOI 10.1371/journal.pbio.0020365; Lega BC, 2010, NEUROBIOL DIS, V38, P354, DOI 10.1016/j.nbd.2009.07.007; Lipton P. A., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/258467; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Narayanan NS, 2009, J NEUROPHYSIOL, V101, P2859, DOI 10.1152/jn.90615.2008; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Paz R, 2004, PLOS BIOL, V2, P264, DOI 10.1371/journal.pbio.0020045; Ross RS, 2006, J NEUROSCI, V26, P4852, DOI 10.1523/JNEUROSCI.0659-06.2006; Smith NJ, 2009, NEURON, V63, P146, DOI 10.1016/j.neuron.2009.07.007; Song D., 2009, STAT SIGNAL PROCESSI; Song D, 2007, P ANN INT IEEE EMBS, P4727, DOI 10.1109/IEMBS.2007.4353395; Song D, 2007, IEEE T BIO-MED ENG, V54, P1053, DOI 10.1109/TBME.2007.891948; Song Dong, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P6129; Song D, 2009, NEURAL NETWORKS, V22, P1340, DOI 10.1016/j.neunet.2009.05.004; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003	49	7	7	0	24	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2154-2287	2154-2317		IEEE PULSE	IEEE Pulse	SEP-OCT	2012	3	5					17	22		10.1109/MPUL.2012.2205775			6	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	014SJ	WOS:000309395700005	23014702				2022-02-06	
J	Cavus, SY; Dilbaz, N; Darcin, AE; Eren, F; Kaya, H; Kaya, O				Cavus, Sercin Yalcin; Dilbaz, Nesrin; Darcin, Asli Enez; Eren, Fatma; Kaya, Hasan; Kaya, Ozlem			Alterations in Serum BDNF Levels in Early Alcohol Withdrawal and Comparison with Healthy Controls	KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY			English	Article						Brain-Derived Neurotrophic Factor (BDNF); alcohol dependence; alcohol withdrawal	NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR LEVELS; TRAUMATIC BRAIN-INJURY; RAT HIPPOCAMPUS; CHRONIC ETHANOL; EXPRESSION; DEPENDENCE; NEUROGENESIS; MICE	Alterations in serum BDNF levels in early alcohol withdrawal and comparison with healthy controls Objective: A protective effect of BDNF against ethanol induced cell damage has been suggested, and this effect may contribute to the development of alcohol dependence. Although the mechanisms involved in chronic alcohol treatment-induced neurotoxic actions have not yet been clearly identified, recent studies have hypothesized that prolonged alcohol intake may affect the synthesis of neurotrophins, which are a family of proteins that play a crucial role in cognitive functions, including learning and memory. One of these neurotrophins, BDNF, has a significant role in neuronal development, plasticity, and learning, There are also various study results showing a modulatory role of BONE in the development and maintenance of addictive behaviour. In this study, we aimed to determine the changes of serum BONE levels in alcoholic patients at the first and seventh days of withdrawal and compare that to those of healthy controls in order to determine the role of BDNF in alcohol dependence. Method: A total of 31 male patients suffering from alcohol dependence according to the DSM-IV-TR were admitted for alcohol detoxification treatment and 29 healthy control subjects were enrolled in the study. Patients suffering from psychiatric diagnoses apart from alcohol and nicotine dependence were excluded from the study. Further exclusion criteria were substance abuse other than alcohol or nicotine, severe neurological diseases like cerebral ischemia or haemorrhage, epilepsy, cardiovascular and renal diseases, former delirium tremens, and use of psychopharmacological medication. Alcoholic patients were treated with diazepam in order to prevent alcohol withdrawal symptoms. The dose of diazepam was tapered gradually by monitoring alcohol withdrawal severity (minimum: 30 mg, maximum: 40 mg on day 1) during alcohol withdrawal. The severity of withdrawal symptoms was evaluated by the Clinical Institute Withdrawal Assessment-Alcohol, Revised (CIWA-AR) every eight hours. Blood samples of the patient group were collected on the first and seventh day of alcohol withdrawal, and centrifuged and stored at -70 degrees C immediately after collection. Serum BDNF levels were measured using a sandwich enzyme-linked immunosorbent assay (ELISA). The study was approved by the local ethics committee and all participants gave written informed consent prior to enrollment in the study. Results: Serum BDNF levels were significantly lower in the alcoholic patients compared with control subjects. (52.9 +/- 19.0 ng/ml and 65.3 +/- 15.9ng/ml, respectively, p=0.018) Furthermore, BDNF levels were found to be significantly decreased on the seventh day of withdrawal compared to that at baseline. (from 52.9 19.0 ng/ml to 33.5 +/- 8.8 ng/ml, p <= 0.001). The BDNF levels did not significantly correlate with clinical characteristics such usage, amount of alcohol consumption in the last month, duration of intake, or family history. Conclusion: This study suggests chronic drinking leads to a reduction in BDNF levels compared to those of healthy controls, implying that BDNF may have a role in the development of alcohol dependence and there is no elevation to that of control BDNF levels in the early alcohol withdrawal period. Further research will be necessary in order to identify the pathophysiological mechanisms and causalities that regulate BDNF plasma levels following alcohol intoxication and withdrawal. These studies should consider both early and late withdrawal periods and should be conducted in large samples in order to identify the association between the disorder and peripheral BDNF levels.	[Darcin, Asli Enez] Kayseri Training & Res Hosp, Psychiat Serv, Kayseri, Turkey; [Cavus, Sercin Yalcin] Madalyon Psychiat Ctr, Ankara, Turkey; [Dilbaz, Nesrin] Uskudar Univ, Neuropsychiat Hosp, Istanbul, Turkey; [Eren, Fatma] Erzurum Reg Training & Res Hosp, Psychiat Serv, Erzurum, Turkey; [Kaya, Hasan] Merzifon State Hosp, Psychiat Serv, Amasya, Turkey; [Kaya, Ozlem] Ankara Numune Training & Res Hosp, Psychiat Serv, Ankara, Turkey		Darcin, AE (corresponding author), Kayseri Training & Res Hosp, Psychiat Serv, Kayseri, Turkey.	aenez5280@yahoo.com.tr	Dilbaz, Nesrin/AAA-2447-2022; Dilbaz, Nesrin/ABH-2210-2021; kaya, hasan/AAC-7235-2022				Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Chul BL, 2009, ALCOHOL, V43, P265, DOI 10.1016/j.alcohol.2009.04.003; Costa MA, 2011, ALCOHOL CLIN EXP RES, V35, P1966, DOI 10.1111/j.1530-0277.2011.01548.x; Crews FT, 2004, ALCOHOL CLIN EXP RES, V28, P350, DOI 10.1097/01.ALC.0000113416.65546.01; Crews FT, 2003, ALCOHOL RES HEALTH, V27, P197; D'Sa C, 2012, ALCOHOL, V46, P253, DOI 10.1016/j.alcohol.2011.12.001; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; He J, 2005, EUR J NEUROSCI, V21, P2711, DOI 10.1111/j.1460-9568.2005.04120.x; Heberlein A, 2010, PROG NEURO-PSYCHOPH, V34, P1060, DOI 10.1016/j.pnpbp.2010.05.025; Hensler JG, 2003, J NEUROCHEM, V85, P1139, DOI 10.1046/j.1471-4159.2003.01748.x; Huang MC, 2008, ALCOHOL ALCOHOLISM, V43, P241, DOI 10.1093/alcalc/agm172; Jockers-Scherubl MC, 2007, NEUROSCI LETT, V419, P78, DOI 10.1016/j.neulet.2007.03.051; Joe KH, 2007, ALCOHOL CLIN EXP RES, V31, P1833, DOI 10.1111/j.1530-0277.2007.00507.x; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; Luo J, 1998, BRAIN RES REV, V27, P157, DOI 10.1016/S0165-0173(98)00009-5; MACLENNAN AJ, 1995, NEUROSCI LETT, V197, P105; McGough NNH, 2004, J NEUROSCI, V24, P10542, DOI 10.1523/JNEUROSCI.3714-04.2004; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Tapia-Arancibia L, 2001, J NEUROSCI RES, V63, P200, DOI 10.1002/1097-4547(20010115)63:2<200::AID-JNR1012>3.0.CO;2-Q; Thoenen H, 2007, SCIENCE, V419, P78; WALKER DW, 1993, ALCOHOL CLIN EXP RES, V17, P12, DOI 10.1111/j.1530-0277.1993.tb00719.x; Yoon SJ, 2006, ALCOHOL CLIN EXP RES, V30, P1060, DOI 10.1111/j.1530-0277.2006.00120.x; Zanardini R, 2011, ALCOHOL CLIN EXP RES, V35, P1529, DOI 10.1111/j.1530-0277.2011.01489.x	27	7	7	0	6	KURE ILETISIM GRUBU A S	ISTANBUL	SIRACEVIZLER CAD 43/3 SISLI, ISTANBUL, 34381, TURKEY	1017-7833			KLIN PSIKOFARMAKOL B	Klin. Psikofarmakol. Bul.	SEP	2012	22	3					210	215		10.5455/bcp.20120731055756			6	Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Psychiatry	044CW	WOS:000311598000002					2022-02-06	
J	Chhor, V; Schang, AL; Favrais, G; Fleiss, B; Gressens, P				Chhor, V.; Schang, A. -L.; Favrais, G.; Fleiss, B.; Gressens, P.			Long-term cerebral effects of perinatal inflammation	ARCHIVES DE PEDIATRIE			French	Article							TRAUMATIC BRAIN-INJURY; PROGRAMMED CELL-DEATH; BIRTH-WEIGHT INFANTS; WHITE-MATTER INJURY; SYSTEMIC INFLAMMATION; DEVELOPMENTAL REGULATION; MICROGLIAL ACTIVATION; HYPOXIA-ISCHEMIA; IMMATURE BRAIN; PRETERM	Perinatal inflammation can lead to fetal/neonatal inflammatory syndrome, a risk factor for brain lesions, especially in the white matter. Perinatal inflammation is associated with increased incidence of cerebral palsy in humans and animal models and there is a strong relationship with increased incidence of autism and schizophrenia in humans. Perinatal inflammation causes acute microglial and astroglial activation, blood-brain barrier dysfunction, and disrupts oligodendrocyte maturation leading to hypomyelination. Inflammation also sensitizes the brain to additional perinatal insults, including hypoxia-ischemia. Furthermore, long after the primary cause of inflammation has resolved, gliosis may also persist and predispose to neurodegenerative diseases including Alzheimer's and Parkinson's disease, but this relation is still hypothetical. Finding of acute and chronic changes in brain structure and function due to perinatal inflammation highlights the need for treatments. As gliosis appears to be involved in the acute and chronic effects of perinatal inflammation, modulating the glial phenotype may be an effective strategy to prevent damage to the brain. (c) 2012 Published by Elsevier Masson SAS.	[Chhor, V.; Schang, A. -L.; Fleiss, B.; Gressens, P.] Hop Robert Debre, Inserm U676, F-75019 Paris, France; [Chhor, V.; Schang, A. -L.; Fleiss, B.; Gressens, P.] Univ Paris 07, Fac Med Denis Diderot, F-75205 Paris 13, France; [Chhor, V.; Schang, A. -L.; Fleiss, B.; Gressens, P.] PremUP, F-75006 Paris, France; [Favrais, G.] Univ Tours, Hop Clocheville, CHRU Tours, F-37000 Tours, France; [Fleiss, B.; Gressens, P.] Imperial Coll, Ctr Developing Brain, London W12 OHS, Royaume Uni, England		Gressens, P (corresponding author), Hop Robert Debre, Inserm U676, 48 Blvd Serurier, F-75019 Paris, France.	pierre.gressens@inserm.fr	gressens, pierre/M-7557-2017; Fleiss, Bobbi/F-9899-2011; Favrais, Geraldine/P-5060-2019; Schang, Anne-Laure/A-1450-2017	gressens, pierre/0000-0002-0909-4221; Fleiss, Bobbi/0000-0001-7828-673X; Favrais, Geraldine/0000-0002-0301-2053; Schang, Anne-Laure/0000-0003-1712-8505			Aden U, 2010, BRAIN BEHAV IMMUN, V24, P747, DOI 10.1016/j.bbi.2009.10.010; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Brochu ME, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-55; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; Choi Ehn-Kyoung, 2011, Lab Anim Res, V27, P77, DOI 10.5625/lar.2011.27.2.77; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Dean JM, 2011, ANN NEUROL, V70, P846, DOI 10.1002/ana.22480; Debillon T, 2000, PEDIATR RES, V47, P736, DOI 10.1203/00006450-200006000-00009; Dommergues MA, 2000, ANN NEUROL, V47, P54, DOI 10.1002/1531-8249(200001)47:1<54::AID-ANA10>3.0.CO;2-Y; Eklind S, 2001, EUR J NEUROSCI, V13, P1101, DOI 10.1046/j.0953-816x.2001.01474.x; Ellis S, 2005, FASEB J, V19, P1519, DOI 10.1096/fj.04-3569fje; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P25, DOI 10.1023/A:1015337611258; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Fontaine RH, 2008, P NATL ACAD SCI USA, V105, P16779, DOI 10.1073/pnas.0803004105; Galic MA, 2008, J NEUROSCI, V28, P6904, DOI 10.1523/JNEUROSCI.1901-08.2008; GILLES FH, 1977, ANN NEUROL, V2, P49, DOI 10.1002/ana.410020108; Girard S, 2010, J IMMUNOL, V184, P3997, DOI 10.4049/jimmunol.0903349; Glass HC, 2008, PEDIATRICS, V122, P299, DOI 10.1542/peds.2007-2184; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Hansen-Pupp I, 2008, PEDIATR RES, V64, P183, DOI 10.1203/PDR.0b013e318176144d; Hendson L, 2011, J PEDIATR-US, V158, P397, DOI 10.1016/j.jpeds.2010.09.010; Hintz SR, 2005, PEDIATRICS, V115, P696, DOI 10.1542/peds.2004-0569; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Huang ZH, 2009, BRAIN RES, V1301, P100, DOI 10.1016/j.brainres.2009.09.006; Juurlink BHJ, 1997, NEUROSCI BIOBEHAV R, V21, P151, DOI 10.1016/S0149-7634(96)00005-X; Kannan S, 2011, DEV NEUROSCI-BASEL, V33, P231, DOI 10.1159/000328125; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Leviton A, 2011, CYTOKINE, V53, P66, DOI 10.1016/j.cyto.2010.09.003; Lin CY, 2010, ANN NEUROL, V68, P204, DOI 10.1002/ana.22049; Martin CR, 2010, J PEDIATR-US, V157, P751, DOI 10.1016/j.jpeds.2010.05.042; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2009, PSYCHOPHARMACOLOGY, V206, P587, DOI 10.1007/s00213-009-1504-9; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Moreno B, 2011, ANN NEUROL, V70, P932, DOI 10.1002/ana.22550; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nelson KB, 1998, ANN NEUROL, V44, P665, DOI 10.1002/ana.410440413; Nijboer CHA, 2008, J NEUROSCI, V28, P3324, DOI 10.1523/JNEUROSCI.4769-07.2008; Normann E, 2009, PEDIATR RES, V65, P430, DOI 10.1203/PDR.0b013e31819984ce; Pang Y, 2003, DEV BRAIN RES, V140, P205, DOI 10.1016/S0165-3806(02)00606-5; Pang Y, 2010, NEUROSCIENCE, V166, P464, DOI 10.1016/j.neuroscience.2009.12.040; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Romero E, 2010, MOL PSYCHIATR, V15, P372, DOI 10.1038/mp.2008.44; Rousset CI, 2006, PEDIATR RES, V59, P428, DOI 10.1203/01.pdr.0000199905.08848.55; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Shatrov JG, 2010, OBSTET GYNECOL, V116, P387, DOI 10.1097/AOG.0b013e3181e90046; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stolp HB, 2005, EUR J NEUROSCI, V22, P2805, DOI 10.1111/j.1460-9568.2005.04483.x; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Venturi L, 2009, J NEUROTRAUM, V26, P1547, DOI [10.1089/neu.2008.0723, 10.1089/neu.2008-0723]; Wang XY, 2009, J CHILD NEUROL, V24, P1171, DOI 10.1177/0883073809338068; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P406, DOI 10.1016/S0002-9378(97)70206-0; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	57	7	7	0	7	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0929-693X	1769-664X		ARCH PEDIATRIE	Arch. Pediatr.	SEP	2012	19	9					946	952		10.1016/j.arcped.2012.06.013			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	002FD	WOS:000308516500010	22885003				2022-02-06	
J	Crownover, J; Galang, GNF; Wagner, A				Crownover, James; Galang, Gary Noel F.; Wagner, Amy			Rehabilitation Considerations for Traumatic Brain Injury in the Geriatric Population: Epidemiology, Neurobiology, Prognosis, and Management	CURRENT GERIATRICS REPORTS			English	Article						Traumatic brain injury; Elderly; Geriatrics; Etiology; Pathophysiology; Dopamine; Glutamate; Neuroprotection; Neuroendocrine disorders; Hypogonadism; Sex hormones; Estrogen; Progesterone; Neurodegeneration; Alzheimer's disease; Parkinson's disease; Functional outcomes; Neuropharmacology; Anticholinergics; Antihistaminics; Antipsychotics; Antiepileptics; Fall prevention; Neurostimulants; Rehabilitation	CONTROLLED CORTICAL IMPACT; ELDERLY-PATIENTS; OLDER-ADULTS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; BLOOD-GLUCOSE; VITAL SIGNS; FALLS; OUTCOMES; RISK	Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in the United States, and the incidence has been increasing within the geriatric age group as the population ages. There are many factors that are unique to this subgroup, including normal aging processes, differences in pathophysiology, and inherent medical comorbidities that affect their outcomes, treatment, and therefore, the allocation of medical and social services. The geriatric population has age-appropriate strength, coordination and balance deficits that make them predisposed to falls and subsequent TBI. The aging brain often has premorbid atrophy and increased susceptibility to the inflammatory, excitatory, and vascular processes that facilitate neurologic damage during the acute phases after injury. The aged also can have premorbid neurodegenerative and medical comorbidities that also affect their rehabilitation course, recovery, and outcomes once a TBI has occurred. Pharmacological strategies to maximize rehabilitation and recovery require specific considerations of the potential for adverse effects and contraindications specific to common comorbidities in the aged population. The management of geriatric TBI requires a coordinated effort between physicians and other healthcare providers with focus on risk factor modification, medical optimization, and successful return to the community by setting goals that emphasize level of function and quality of life.	[Crownover, James; Galang, Gary Noel F.] UPMC Mercy Hosp, Dept Phys Med & Rehabil, 1400 Locust St, Pittsburgh, PA 15212 USA; [Wagner, Amy] Safar Ctr Resuscitat Res, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA		Wagner, A (corresponding author), Safar Ctr Resuscitat Res, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu					Alban JP, 2004, AM J PHYS MED REHAB, V83, P131, DOI 10.1097/01.phm.0000112308.68586.1d; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; Boles JA, 2012, NATL NEUROTRAUMA S; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; BULLOCK R, 1994, J NEUROSURG, V80, P595; Butterfield DA, 2001, CURR MED CHEM, V8, P815, DOI 10.2174/0929867013373048; Campbell AJ, 1999, J AM GERIATR SOC, V47, P850, DOI 10.1111/j.1532-5415.1999.tb03843.x; Carter M, 2011, J NEUROTRAUM, V28, pA14; CHOI DW, 1987, J NEUROSCI, V7, P369; Chourdakis M, 2012, JPEN-PARENTER ENTER, V36, P108, DOI 10.1177/0148607110397878; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cumming RG, 1999, J AM GERIATR SOC, V47, P1397, DOI 10.1111/j.1532-5415.1999.tb01556.x; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; Dick FD, 2007, OCCUP ENVIRON MED, V64, P666, DOI 10.1136/oem.2006.027003; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Durham LK, 2004, PSYCHOPHARMACOLOGY, V174, P525, DOI 10.1007/s00213-003-1562-3; Dziedzic Tomasz, 2006, Am J Alzheimers Dis Other Demen, V21, P258, DOI 10.1177/1533317506289260; Epocrates Online Drugs, 2011, CIT FLUOX ESC PAR SE; Erol A, 2007, BIOESSAYS, V29, P811, DOI 10.1002/bies.20618; FACTOR SA, 1988, MOVEMENT DISORD, V3, P30, DOI 10.1002/mds.870030105; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Frieden TR, TRAUMATIC BRAIN INJU; Garg R, 2006, STROKE, V37, P267, DOI 10.1161/01.STR.0000195175.29487.30; Garwood CL, 2008, ANN PHARMACOTHER, V42, P523, DOI 10.1345/aph.1K498; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Iaboni A, 2012, AM J GERIATR PSYCHIA; Inouye SK, 2009, NEW ENGL J MED, V360, P2390, DOI 10.1056/NEJMp0900963; Itoh T, 2012, BRAIN STRUCT FUNCT; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; Lavretsky H, 2008, INT J GERIATR PSYCH, V23, P55, DOI 10.1002/gps.1837; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lee J, 2008, BRAIN, V131, P1574, DOI 10.1093/brain/awn085; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Lord S. R., 2006, AGE AGEING, V35, ps2; Love S, 1999, BRAIN PATHOL, V9, P119; Marks JD, 2000, DEV BRAIN RES, V124, P101, DOI 10.1016/S0165-3806(00)00096-1; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Mauri M, 2006, FUNCT NEUROL, V21, P223; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Mellergard P, 2012, J NEUROTRAUM, V29, P112, DOI 10.1089/neu.2010.1732; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Moreau OK, 2012, J NEUROTRAUM, V29, P81, DOI 10.1089/neu.2011.2048; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Murphy GM, 2004, ARCH GEN PSYCHIAT, V61, P1163, DOI 10.1001/archpsyc.61.11.1163; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Pit SW, 2007, MED J AUSTRALIA, V187, P23, DOI 10.5694/j.1326-5377.2007.tb01110.x; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Ramanathan D, 2012, J NEUROTRAUM, V29, P1; Robertson M.C., 2009, COCHRANE DATABASE SY; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Ross DE, 2001, BRAIN INJURY, V25, P1271; ROTHWELL NJ, 1993, CEREBROVAS BRAIN MET, V5, P178; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith GS, 2011, AM J GERIAT PSYCHIAT, V19, P1016, DOI 10.1097/JGP.0b013e318227f83f; Steadman J, 2003, J AM GERIATR SOC, V51, P847, DOI 10.1046/j.1365-2389.2003.51268.x; Steffens DC, 2002, AM J GERIAT PSYCHIAT, V10, P185, DOI 10.1176/appi.ajgp.10.2.185; Stenvall M, 2006, ARCH GERONTOL GERIAT, V43, P389, DOI 10.1016/j.archger.2006.01.004; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, J NEUROTRAUM; Thurman D. J., TRAUMATIC BRAIN INJU; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Trollor JN, 2011, ASS SYSTEMIC INFLAMM; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Willmott C, 2009, J REHABIL MED, V41, P585, DOI 10.2340/16501977-0369; Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Zou HC, 2011, J NEUROTRAUM, V28, pA104	102	7	7	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2196-7865			CURR GERIATR REP	Curr. Geriatr. Rep.	SEP	2012	1	3					149	158		10.1007/s13670-012-0021-6			10	Geriatrics & Gerontology	Emerging Sources Citation Index (ESCI)	Geriatrics & Gerontology	V3S8Y	WOS:000218556700004		Bronze			2022-02-06	
J	Malenfant, S; Goulet, C; Nadeau, L; Hamel, D; Emery, CA				Malenfant, Simon; Goulet, Claude; Nadeau, Luc; Hamel, Denis; Emery, Carolyn A.			The incidence of behaviours associated with body checking among youth ice hockey players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Ice hockey; Behaviours; Physical contacts; Body checking; Prevention; Athletic injury	INJURY; CONCUSSIONS; RISK	Objectives: To determine if a difference exists between the incidence and intensity of the physical contacts of Pee Wee (aged 11-12 years) ice hockey players according to whether the players participate in a league in which body checking is permitted (Calgary, Canada) compared to a league in which body checking is not permitted (Quebec City, Canada). Design: Cohort study conducted in Quebec City and Calgary during the 2007-2008 Pee Wee ice hockey season. Methods: Ten games were randomly selected for each city (n = 20) and analysed. Games were videotaped and subsequently analysed with a validated observation system allowing quantification of the intensity of the various physical contacts. Incidence rate ratios (RR) based on multivariate Poisson regression were used to compare the physical contacts between provinces. All analyses were controlling for game period, score difference, and zone on the playing surface. Results: A total of 2418 physical contacts with the trunk and 757 other physical contacts were observed. Very light intensity trunk physical contacts were more frequent in Quebec City (adjusted incidence RR [ARR]: 0.68; 95% CI: 0.48-0.97). Very high intensity trunk physical contacts were more frequent in Calgary (ARR: 12.72; 95% CI: 4.48-36.14). Hooking (ARR: 0.89; 95% CI: 0.84-0.95) and slashing (ARR: 0.91; 95% CI: 0.85-0.97) were more frequent in Quebec City. Conclusions: Results suggest that players' behaviours are different in leagues where body checking is permitted compared to leagues where it is not permitted. Policy allowing body checking in Pee Wee ice hockey increases the frequency and intensity of physical contacts. (c) 2012 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Malenfant, Simon; Goulet, Claude; Nadeau, Luc] Univ Laval, Dept Phys Educ, Fac Educ, Quebec City, PQ G1V 0A6, Canada; [Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Roger Jackson Ctr Hlth & Wellness Res, Sport Med Ctr, Calgary, AB, Canada; [Hamel, Denis] Quebec Publ Hlth Inst, Quebec City, PQ, Canada		Goulet, C (corresponding author), Univ Laval, Dept Phys Educ, Fac Educ, Pavillon Educ Phys & Sports,2300 Rue Terrasse,Loc, Quebec City, PQ G1V 0A6, Canada.	claude.goulet@fse.ulaval.ca	Emery, Carolyn/AAI-2761-2020; Malenfant, Simon/AAQ-5587-2020	Nadeau, Luc/0000-0002-8732-0212; Malenfant, Simon/0000-0002-3911-3702	ministere de l'Education, du Loisir et du Sport du Quebec [Quebec Ministry of Education, Leisure, and Sport]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Max Bell Foundation	This study was financially supported by the ministere de l'Education, du Loisir et du Sport du Quebec [Quebec Ministry of Education, Leisure, and Sport], the Canadian Institutes of Health Research, and the Max Bell Foundation. We also wish to thank the study coordinators and research assistants for their assistance in completing this research. Without the support of players, parents, coaches and administrators in Hockey Calgary and Hockey Quebec, this work would not have been possible.	[Anonymous], 2010, HOCK CAN ANN REP; Bernard D, 1993, SAFETY ICE HOCKEY, V2; COLBURN K, 1986, SOCIOL QUART, V27, P63, DOI 10.1111/j.1533-8525.1986.tb00249.x; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Dionne JP, 2000, SAFETY ICE HOCKEY, V3; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Hockey Canada, 2009, BACKGR CHECK; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Nadeau L, 2008, EUR J SPORT SCI, V8, P379, DOI 10.1080/17461390802284456; Regnier G, 1989, SAFETY ICE HOCKEY; ROBIDOUX M, 2006, ARTIFICIAL ICE HOCKE; Trudel P, 1993, SAFETY ICE HOCKEY, V2	16	7	7	0	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	SEP	2012	15	5					463	467		10.1016/j.jsams.2012.03.003			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	003RA	WOS:000308627800014	22497722				2022-02-06	
J	McDonald, S; Anderson, V; Ponsford, J; Tate, R; Togher, L; Morgan, A; Fleming, J; Ownsworth, T; Douglas, J; Murdoch, B				McDonald, Skye; Anderson, Vicki; Ponsford, Jennie; Tate, Robyn; Togher, Leanne; Morgan, Angela; Fleming, Jennifer; Ownsworth, Tamara; Douglas, Jacinta; Murdoch, Bruce			Moving Ahead: A New Centre of Research Excellence in Brain Recovery, Focusing on Psychosocial Reintegration Following Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; rehabilitation; psychosocial function	COGNITIVE-BEHAVIORAL THERAPY; AWARENESS DEFICITS; HEAD-INJURY; REHABILITATION; COMMUNICATION; RECOGNITION; IRRITABILITY; ASSOCIATION; IMPAIRMENT; ADJUSTMENT	Severe traumatic brain injury (TBI) is the most common cause of brain injury in the Western world and leads to physical, cognitive and emotional deficits that reduce independence. Changes to psychosocial function are the most disruptive, resulting in vocational difficulties, family stress and deteriorating relationships, and are a major target for remediation. But rehabilitation is expensive and its evidence base is limited. Thus, new collaborative initiatives are needed. This article details the development of 'Moving Ahead', a model for a Centre of Research Excellence (CRE) for Traumatic Brain Injury Rehabilitation. This CRE offers severalmajor innovations. First, it provides an integrated, multi-faceted approach to addressing psychosocial difficulties embracing different clinical standpoints (e.g., psychological, speech pathology, occupational therapy) and levels of investigation (e.g., basic science to community function) across the lifespan. It is based upon a close relationship with clinicians to ensure transfer of research to practice and, conversely, to ensure that research is clinically meaningful. It provides an integrated platform with which to support and train new researchers in the field via scholarships, postdoctoral fellowships, websites, meetings, mentoring and across-site training, and thus build workforce capacity for individuals with TBI and their families. It has input from the international community to contextualise research more broadly and ensure scientific rigour. Finally, it provides collaboration across sites to facilitate research and data collection.	[McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Anderson, Vicki; Morgan, Angela] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Ponsford, Jennie] Monash Univ, Melbourne, Vic 3004, Australia; [Tate, Robyn; Togher, Leanne] Univ Sydney, Sydney, NSW 2006, Australia; [Fleming, Jennifer; Murdoch, Bruce] Univ Queensland, Brisbane, Qld, Australia; [Ownsworth, Tamara] Griffith Univ, Brisbane, Qld 4111, Australia; [Douglas, Jacinta] La Trobe Univ, Melbourne, Vic, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	Togher, Leanne/AAC-7083-2019; Ownsworth, Tamara/ABB-6961-2021; Murdoch, Bruce E/C-1397-2012; McDonald, Skye/G-4118-2014; Morgan, Angela/J-5235-2017	Ownsworth, Tamara/0000-0003-1835-7094; McDonald, Skye/0000-0003-0723-6094; Douglas, Jacinta/0000-0003-0940-6624; Morgan, Angela/0000-0003-1147-7405; Togher, Leanne/0000-0002-4518-6748			Access Economics , 2009, EC COST SPIN CORD IN; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Behn N., BRAIN INJUR IN PRESS; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Burke B. L., 2004, J COGN PSYCHOTHER, V18, P309, DOI [10.1891/jcop.18.4.309.64002, DOI 10.1891/JC0P.18.4.309.64002]; Cahill LM, 2002, BRAIN INJURY, V16, P415, DOI 10.1080/02699050110119871; Caldwell E, 2008, AUST OCCUP THER J, V55, P79, DOI 10.1111/j.1440-1630.2007.00669.x; Chambless, 1993, TASK FORCE PROMOTION; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lane-Brown A.T., 2008, COCHRANE DATABASE SY; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; McGinn LK, 2001, CLIN PSYCHOL-SCI PR, V8, P23, DOI 10.1093/clipsy/8.1.23; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Metcalfe C, 2001, PHYSIOTHERAPY, V87, P433, DOI [10.1016/S0031-9406(05)65462-4, DOI 10.1016/S0031-9406(05)65462-4]; Miller W.R., 2002, MOTIVATIONAL INTERVI; Murdoch BE, 2012, EUR J NEUROL, V19, P340, DOI 10.1111/j.1468-1331.2011.03524.x; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Perdices M., 2006, BRAIN IMPAIR, V7, P119, DOI DOI 10.1375/BRIM.7.2.119; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Rapee R.M., 2006, COOL KIDS CHILD ADOL; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Soo C., 2012, DEV SOCIAL NEUROSCIE; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Tate R.L., 2009, BRAIN IMPAIR, V10, P228; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Togher L, 2012, DISABIL REHABIL, V34, P1562, DOI 10.3109/09638288.2012.656788; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Westra HA, 2006, COGNITIVE THER RES, V30, P481, DOI 10.1007/s10608-006-9016-y; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Woods D., LONG TERM M IN PRESS; Woods DT, 2011, DEV NEUROREHABIL, V14, P274, DOI 10.3109/17518423.2011.586371; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Young JM, 2002, BRIT MED J, V324, P950, DOI 10.1136/bmj.324.7343.950; [No title captured]	68	7	7	0	28	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2012	13	2					256	270		10.1017/BrImp.2012.21			15	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	019FC	WOS:000309721500006		Green Published, Bronze			2022-02-06	
J	Tweedly, L; Ponsford, J; Lee, N				Tweedly, Laura; Ponsford, Jennie; Lee, Nicole			Investigation of the Effectiveness of Brief Interventions to Reduce Alcohol Consumption Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol; brain injury; closed head injury; intervention study; randomized controlled trial; substance use; treatment outcome	COGNITIVE-BEHAVIORAL INTERVENTIONS; RANDOMIZED CONTROLLED-TRIAL; SUBSTANCE-ABUSE; CHANGE QUESTIONNAIRE; DRINKING; READINESS; EFFICACY; METAANALYSIS; PATTERNS; VALIDITY	Objective: To examine the relative effectiveness of brief interventions comprising an information booklet with and without a brief motivational interview and an informal discussion in reducing alcohol use following traumatic brain injury. Participants: Sample of 60 participants with traumatic brain injury (mean age = 35 years) with preinjury history of alcohol use. Research Design: Randomized controlled trial, using block randomization, stratified for gender. Methods and Procedures: Following collection of demographic information and alcohol consumption data using the Time Line Follow-Back, participants were randomly allocated to 1 of 3 groups (informal discussion, information only, or motivational interview) and given appropriate treatment. Follow-up assessments were completed by an independent researcher 6 months later. Results: Nonparametric significance testing was used to compare differences in frequency and quantity of alcohol consumption at preintervention (6-9 months postinjury) and follow-up (12-15 months postinjury) sessions. There was a positive trend showing participants in both the intervention groups to be drinking less frequently and consuming fewer alcoholic drinks than those in the informal discussion (control) group. However, group differences did not reach statistical significance. Conclusions: Further randomized controlled trials with larger samples are needed to establish whether brief educational and motivational interview interventions targeting alcohol use are efficacious in the traumatic brain injury population.	[Tweedly, Laura; Ponsford, Jennie] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [Ponsford, Jennie] Epworth Healthcare, Monash Epworth Rehabil Ctr, Melbourne, Vic, Australia; [Lee, Nicole] Flinders Univ S Australia, Natl Ctr Educ & Training Addict, Adelaide, SA 5001, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia.	Jennie.ponsford@monash.edu					Allen J, 1997, ADDICTION, V92, P1671; Allen J, 1998, ALCOHOL CLIN EXP RES, V22, P1300; BABOR TF, 1986, BRIT J ADDICT, V81, P23; Baker A, 2005, ADDICTION, V100, P367, DOI 10.1111/j.1360-0443.2005.01002.x; Baker A, 2001, ADDICTION, V96, P1279, DOI 10.1046/j.1360-0443.2001.96912797.x; BIEN TH, 1993, ADDICTION, V88, P315, DOI 10.1111/j.1360-0443.1993.tb00820.x; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; Bombardier CH, 1997, REHABIL PSYCHOL, V42, P259; Bombardier CH, 2000, J HEAD TRAUMA REHAB, V15, P696, DOI 10.1097/00001199-200002000-00008; Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; CORRIGAN JD, 1995, BRAIN INJURY, V9, P221, DOI 10.3109/02699059509008195; Corrigan JD, 2005, PSYCHOL ADDICT BEHAV, V19, P131, DOI 10.1037/0893-164X.19.2.131; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Donovan DM, 1999, ALCOHOL CLIN EXP RES, V23, P564, DOI 10.1111/j.1530-0277.1999.tb04154.x; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Drummond DC, 1999, ADDICTION, V94, P39; Dunn C, 2001, ADDICTION, V96, P1725, DOI 10.1046/j.1360-0443.2001.961217253.x; Emmen MJ, 2005, ALCOHOL ALCOHOLISM, V40, P219, DOI 10.1093/alcalc/agh137; Guth S, 2008, J STUD ALCOHOL DRUGS, V69, P243, DOI 10.15288/jsad.2008.69.243; HEATHER N, 1993, ADDICTION, V88, P1667, DOI 10.1111/j.1360-0443.1993.tb02042.x; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; Kaner EFS, 2009, DRUG ALCOHOL REV, V28, P301, DOI 10.1111/j.1465-3362.2009.00071.x; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; KREUTZER JS, 1991, J HEAD TRAUMA REHAB, V6, P12; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Kypri K, 2007, ADDICTION, V102, P62, DOI 10.1111/j.1360-0443.2006.01632.x; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Lundahl B, 2009, J CLIN PSYCHOL, V65, P1232, DOI 10.1002/jclp.20638; Lundahl BW, 2010, RES SOCIAL WORK PRAC, V20, P137, DOI 10.1177/1049731509347850; Miller W.R., 2002, MOTIVATIONAL INTERVI; Miller WR, 2009, BEHAV COGN PSYCHOTH, V37, P129, DOI 10.1017/S1352465809005128; Moyer A, 2002, ADDICTION, V97, P279, DOI 10.1046/j.1360-0443.2002.00018.x; National Institute on Alcohol Abuse and Alcoholism, 1998, J MENT HEALTH, V7, P589, DOI DOI 10.1080/09638239817743; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Ohio Valley Center for Brain Injury Prevention and Rehabilitation, 1996, US MAN FAST MOR REL; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Project Match Res Grp, 1998, J STUD ALCOHOL, V59, P631; Rollnick, 2000, READINESS CHANGE QUE; ROLLNICK S, 1992, BRIT J ADDICT, V87, P743; Rollnick S, 2002, MOTIVATIONAL INTERVI; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Saunders JB, 2004, ALCOHOL CLIN EXP RES, V28, P322, DOI 10.1097/01.ALC.0000113418.12889.08; Searles JS, 2000, PSYCHOL ADDICT BEHAV, V14, P277, DOI 10.1037/0893-164X.14.3.277; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sobell LC, 2000, HDB PSYCHIAT MEASURE, P477; Sobell LC, 1992, MEASURING ALCOHOL CO, P41, DOI 10.1007/978-1-4612-0357-5_3; Soderstrom CA, 2007, J TRAUMA, V62, P1102, DOI 10.1097/TA.0b013e31804bdb26; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; VANZOMERAN AH, 1994, CLIN NEUROPSYCHOLOGY; Vasilaki EI, 2006, ALCOHOL ALCOHOLISM, V41, P328, DOI 10.1093/alcalc/agl016; Vungkhanching M, 2007, J HEAD TRAUMA REHAB, V22, P167, DOI 10.1097/01.HTR.0000271117.19652.98	57	7	7	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2012	27	5					331	341		10.1097/HTR.0b013e318262200a			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	004OQ	WOS:000308691400087	22955098				2022-02-06	
J	Woods, GW; Freedman, D; Greenspan, S				Woods, George W.; Freedman, David; Greenspan, Stephen			Neurobehavioral assessment in forensic practice	INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY			English	Article						Assessment; Neurocognition; Neurodevelopmental; Multigenerational social history; Best practices	TRAUMATIC BRAIN-INJURY; COGNITIVE FLEXIBILITY; SPECTRUM DISORDERS; MOTOR INHIBITION; BIPOLAR DISORDER; MENTAL-ILLNESS; CHILDREN; SCHIZOPHRENIA; RELATIVES; PREVALENCE	There is a growing awareness among mental health practitioners that many mental disorders previously believed to be primarily behavioral in nature, reflecting character and environment, are actually grounded in brain mal-development or brain disorder. This growing awareness, influenced by the advent of new diagnostic procedures and measures, is also found among forensic practitioners. In this paper, we describe some of the elements involved in conducting a neurobehavioral assessment of cognitive functioning, particularly in capital cases, organizing this material in terms of the professional disciplines - social work, mitigation investigation, psychological, and medical - with which these methods are mainly identified. The paper concludes with a brief discussion of how to integrate the multiple areas of expertise to create an accurate understanding of the neurobehavioral functioning and capacity of the subject. This is the basis from which civil and criminal forensic opinions must emanate. (C) 2012 Elsevier Ltd. All rights reserved.	[Woods, George W.] Morehouse Sch Med, Atlanta, GA 30310 USA; [Freedman, David] Columbia Univ, New York, NY 10027 USA; [Greenspan, Stephen] Univ Colorado, Boulder, CO 80309 USA		Woods, GW (corresponding author), Morehouse Sch Med, Atlanta, GA 30310 USA.	gwoods@georgewoodsmd.com			NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH013043] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32 MH013043] Funding Source: Medline		Adnams CM, 2007, ALCOHOL, V41, P403, DOI 10.1016/j.alcohol.2007.07.005; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; ANDREW JM, 1981, CRIM JUSTICE BEHAV, V8, P131, DOI 10.1177/009385488100800201; ASARNOW RF, 1994, SCHIZOPHRENIA BULL, V20, P647, DOI 10.1093/schbul/20.4.647; Barkley, 2012, EXECUTIVE FUNCTIONS; Barkley RA., 2012, EXECUTIVE FUNCTIONS; Bell C. C., 2012, CLIN PSYCHIAT N 0412, V40; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Bozikas VP, 2006, COMPR PSYCHIAT, V47, P136, DOI 10.1016/j.comppsych.2005.05.002; Bradford LD, 2002, PHARMACOGENOMICS, V3, P229, DOI 10.1517/14622416.3.2.229; Butcher JN, 2004, J CLIN PSYCHOL, V60, P331, DOI 10.1002/jclp.10267; Butcher JN, 2000, PSYCHOL ASSESSMENT, V12, P6, DOI 10.1037/1040-3590.12.1.6; Caruso KA, 2003, J AM ACAD PSYCHIATRY, V31, P444; Chamberlain SR, 2007, AM J PSYCHIAT, V164, P335, DOI 10.1176/appi.ajp.164.2.335; Chamberlain SR, 2006, AM J PSYCHIAT, V163, P1282, DOI 10.1176/appi.ajp.163.7.1282; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; Coley H. A., 2012, POLICY GUIDANCE ASSE; Constantino JN, 2006, AM J PSYCHIAT, V163, P294, DOI 10.1176/appi.ajp.163.2.294; Cummings J., 2003, NEUROPSYCHIATRY BEHA; DAHLOF LG, 1978, PHYSIOL BEHAV, V20, P193, DOI 10.1016/0031-9384(78)90072-0; Danielyan A, 2009, PSYCHIAT CLIN N AM, V32, P719, DOI 10.1016/j.psc.2009.08.004; DEVINSKY O, 2004, NEUROLOGY COGNITIVE; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; Ernst T, 2002, NEUROLOGY, V59, P1343, DOI 10.1212/01.WNL.0000031811.45569.B0; Freedman D, 2011, INT J DEV NEUROSCI, V29, P237, DOI 10.1016/j.ijdevneu.2010.11.003; GarciaRill E, 1997, MED HYPOTHESES, V49, P379, DOI 10.1016/S0306-9877(97)90083-9; Geffken GR, 1998, PSYCHIAT CLIN N AM, V21, P473, DOI 10.1016/S0193-953X(05)70017-4; Geller DA, 2006, PSYCHIAT CLIN N AM, V29, P353, DOI 10.1016/j.psc.2006.02.012; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; Greenspan S., 1996, MANUAL DIAGNOSIS PRO, P127; Groth-Marnat G, 2006, J CLIN PSYCHOL, V62, P73, DOI 10.1002/jclp.20201; Groth-Marnat G, 2000, NEUROPSYCHOLOGICAL A; Guo JJ, 2006, J CLIN PSYCHIAT, V67, P1055, DOI 10.4088/JCP.v67n0707; Hall H, 1993, DISORDERS EXECUTIVE; Haney Craig, 2008, HOFSTRA L REV, V36, P835; Heilman KM, 1979, CLIN NEUROPSYCHOLOGY; Heinrichs RW, 2005, AM PSYCHOL, V60, P229, DOI 10.1037/0003-066X.60.3.229; Holdman Scharlette, 2008, HOFSTRA LAW REV, V36, P886; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jea A, 2008, CHILD NERV SYST, V24, P685, DOI 10.1007/s00381-008-0626-4; Joseph R, 1999, PSYCHIATRY, V62, P138, DOI 10.1080/00332747.1999.11024862; Kennedy CR, 2006, NEW ENGL J MED, V354, P2131, DOI 10.1056/NEJMoa054915; Keshaven MS, 2003, SCHIZOPHR RES, V59, P85, DOI 10.1016/S0920-9964(01)00400-5; Lambert MV, 2002, J NEUROPSYCH CLIN N, V14, P141, DOI 10.1176/appi.neuropsych.14.2.141; Langdon R, 2011, BRIT J CLIN PSYCHOL, V50, P145, DOI 10.1348/014466510X500837; Lee KH, 2006, AM J PSYCHIAT, V163, P1926, DOI 10.1176/appi.ajp.163.11.1926; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lichter DC, 2001, FRONTAL-SUBCORTICAL CIRCUITS IN PSYCHIATRIC AND NEUROLOGICAL DISORDERS, P260; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacDonald AW, 2005, AM J PSYCHIAT, V162, P475, DOI 10.1176/appi.ajp.162.3.475; MacDonald DA, 2002, PSYCHOL REP, V91, P785, DOI 10.2466/PR0.91.7.785-792; Maj M, 2003, AM J PSYCHIAT, V160, P2134, DOI 10.1176/appi.ajp.160.12.2134; MARUFF P, 1994, ARCH NEUROL-CHICAGO, V51, P689, DOI 10.1001/archneur.1994.00540190069017; Mattson SN, 1998, NEUROPSYCHOLOGY, V12, P146, DOI 10.1037/0894-4105.12.1.146; McMurtrie J., 2012, LAW PSYCHIAT; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Miller B.L., 2007, HUMAN FRONTAL LOBES, V2nd; Miller SP, 2007, NEW ENGL J MED, V357, P1928, DOI 10.1056/NEJMoa067393; Monteleone P, 2009, PSYCHIAT CLIN N AM, V32, P775, DOI 10.1016/j.psc.2009.08.003; Mullick M, 2001, PSYCHIATR SERV, V52, P488, DOI 10.1176/appi.ps.52.4.488; Murphy FC, 2001, PSYCHOL MED, V31, P679, DOI 10.1017/S0033291701003804; Nopoulos P, 2001, J NEUROIMAGING, V11, P418, DOI 10.1111/j.1552-6569.2001.tb00072.x; Perlis RH, 2007, PSYCHIAT CLIN N AM, V30, P125, DOI 10.1016/j.psc.2006.12.004; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Raja PV, 2004, CNS SPECTRUMS, V9, P763, DOI 10.1017/S1092852900022409; Rasmusson AM, 2010, EXP BIOL MED, V235, P1150, DOI 10.1258/ebm.2010.009334; REESE NB, 1995, PROG NEUROBIOL, V47, P105, DOI 10.1016/0301-0082(95)00023-O; Reschly DJ, 2009, APPL NEUROPSYCHOL, V16, P124, DOI 10.1080/09084280902864469; Riecker A, 2007, J NEUROL, V254, P528, DOI 10.1007/s00415-006-0152-9; Rivkees Scott A., 2007, DIS THYROID CHILDHOO; Rotimi CN, 2010, NEW ENGL J MED, V363, P1551, DOI 10.1056/NEJMra0911564; Schiffman SS, 1997, JAMA-J AM MED ASSOC, V278, P1357, DOI 10.1001/jama.278.16.1357; Schulze TG, 2006, ARCH GEN PSYCHIAT, V63, P1368, DOI 10.1001/archpsyc.63.12.1368; SCHWARZ ED, 1994, PSYCHIAT CLIN N AM, V17, P311; SCOTT TF, 1993, J NEUROPSYCH CLIN N, V5, P287; Shin LM, 2009, ARCH GEN PSYCHIAT, V66, P1099, DOI 10.1001/archgenpsychiatry.2009.138; Shonkoff J. B., 2000, NEURONS NEIGHBORHOOD; Spitzer C, 2009, PSYCHOSOM MED, V71, P1012, DOI 10.1097/PSY.0b013e3181bc76b5; Steadman HJ, 2009, PSYCHIAT SERV, V60, P761, DOI 10.1176/ps.2009.60.6.761; Suen HK, 2009, APPL NEUROPSYCHOL, V16, P214, DOI 10.1080/09084280903098786; Szoke A, 2006, PSYCHIAT RES, V144, P131, DOI 10.1016/j.psychres.2005.11.013; Trandafir A, 2006, SCHIZOPHR RES, V81, P217, DOI 10.1016/j.schres.2005.09.005; VOLAVKA J, 1992, J FORENSIC SCI, V37, P237; Wayland Kathleen, 2008, HOFSTRA L REV, V36, P923; Winsler A, 2000, J CHILD PSYCHOL PSYC, V41, P875, DOI 10.1017/S0021963099006228; Wiseman MB, 1999, J NEUROPSYCH CLIN N, V11, P222; Woods G. W., 2011, J PSYCHIAT LAW, V39, P9; Zonana H, 2010, J AM ACAD PSYCHIATRY, V38, P499	89	7	8	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0160-2527	1873-6386		INT J LAW PSYCHIAT	Int. J. Law Psychiatr.	SEP-DEC	2012	35	5-6			SI		432	439		10.1016/j.ijlp.2012.09.014			8	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	067SR	WOS:000313315900014	23059206	Green Accepted			2022-02-06	
J	Zeng, X; Pan, S; Hu, Z				Zeng, Xianwei; Pan, Shun; Hu, Zhenbo			Geriatric Traumatic Brain Injury in China	CURRENT GERIATRICS REPORTS			English	Article						Traumatic brain injury; Geriatric; Trauma; Injury; Epidemiology; Outcomes	HEAD-INJURIES; OLDER-ADULTS; RISK-FACTORS; AGE; EPIDEMIOLOGY; MORTALITY; OUTCOMES; ACCIDENTS; GENDER	Traumatic brain injury (TBI) is one of the major causes of morbidity and mortality in China. The elderly population has the higher rates of TBI-related hospitalization and death. Traffic accidents are the major cause for TBI in all age groups except in the group of 75 years and older, in which stumbles occurred in nearly half of those who suffered TBI. Older age is known to negatively influence outcome after TBI. To date, investigators have identified a panel of prognostic factors that include initial Glasgow Coma Scale score, comorbidities, cerebrospinal fluid leakage, associated extracranial lesions, and other factors such as cerebral perfusion pressure on recovery after injury. However, these aspects remain understudied in elderly patients with TBI. In the absence of complete clinical data, predicting outcomes and providing good care of the elderly population with TBI remain limited. To address this significant public health issue, a refocusing of research efforts is justified to prevent TBI in this population and to develop unique care strategies for achieving better clinical outcomes of the patients with TBI.	[Zeng, Xianwei; Pan, Shun; Hu, Zhenbo] Weifang Med Univ, Affiliated Hosp, Dept Neurosurg, 465 Yuhe Rd, Shandong 261031, Peoples R China		Zeng, X (corresponding author), Weifang Med Univ, Affiliated Hosp, Dept Neurosurg, 465 Yuhe Rd, Shandong 261031, Peoples R China.	zengxwei@163.com					Crandall M, 2011, ARCH SURG-CHICAGO, V146, P442, DOI 10.1001/archsurg.2011.34; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Fei L, 2001, Chin J Traumatol, V4, P28; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Harden CL, 2003, NEUROLOGY, V61, P451, DOI 10.1212/01.WNL.0000081228.48016.44; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Kennedy RL, 2002, J TRAUMA, V52, P660, DOI 10.1097/00005373-200204000-00008; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Ma JP, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub2; MILLER J D, 1989, Neurosurgical Review, V12, P441; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Qu Xiao-dong, 2011, Chinese Medical Sciences Journal, V26, P98; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; Stein DG, 2011, PM&R, V3, pS100, DOI 10.1016/j.pmrj.2011.03.010; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Suzuki T, 2003, EXP NEUROL, V184, P1017, DOI 10.1016/S0014-4886(03)00389-3; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Zhao YD, 2001, WORLD J SURG, V25, P1202	30	7	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2196-7865			CURR GERIATR REP	Curr. Geriatr. Rep.	SEP	2012	1	3					167	170		10.1007/s13670-012-0018-1			4	Geriatrics & Gerontology	Emerging Sources Citation Index (ESCI)	Geriatrics & Gerontology	V3S8Y	WOS:000218556700006	24014155	Green Published, hybrid			2022-02-06	
J	Corrigan, JD; Bogner, J; Pretz, C; Mellick, D; Kreider, S; Whiteneck, GG; Harrison-Felix, C; Dijkers, MP; Heinemann, AW				Corrigan, John D.; Bogner, Jennifer; Pretz, Christopher; Mellick, Dave; Kreider, Scott; Whiteneck, Gale G.; Harrison-Felix, Cynthia; Dijkers, Marcel P.; Heinemann, Allen W.			Use of Neighborhood Characteristics to Improve Prediction of Psychosocial Outcomes: A Traumatic Brain Injury Model Systems Investigation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Rehabilitation; Social environment; Treatment outcome	TERM REHABILITATION OUTCOMES; PARTICIPATION ASSESSMENT; ENVIRONMENTAL-FACTORS; LIFE SATISFACTION; CHILDREN	Objective: To determine whether use of neighborhood characteristics derived from U.S. Census Bureau information contributes to the prediction of outcomes after traumatic brain injury (TBI) beyond the variance accounted for by individual characteristics. Design: Cross-sectional analysis of follow-up interviews conducted 1, 2, and 5 years postinjury. Setting: Twelve Traumatic Brain Injury Model Systems (TBIMS) centers. Participants: Patients 16 years of age and older with moderate or severe TBI enrolled in the TBIMS National Database (N = 472). Interventions: None. Main Outcome Measures: Satisfaction With Life Scale and Participation Assessment with Recombined Tools-Objective. Results: Individual characteristics alone accounted for 26% and 48% of variance in life satisfaction and participation, respectively; neighborhood characteristics alone accounted for 6% and 9% of variance, respectively. Models combining both types of characteristics included significant neighborhood and individual predictors for participation but not life satisfaction; however, for participation, prediction only improved beyond that found for individual characteristics alone by 1.2%. Conclusions: The results did not support the hypotheses that characteristics of a person's neighborhood would increase out-come prediction beyond that which can be accomplished based on characteristics of the individual alone. Though neighborhood characteristics were statistically significant in prediction models, the improvement in percent of variance accounted for was negligible. Refinements in conceptualization and methodology are suggested for continued exploration of the contribution of neighborhood characteristics to TBI outcomes.	[Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Pretz, Christopher; Mellick, Dave; Kreider, Scott; Whiteneck, Gale G.; Harrison-Felix, Cynthia] Craig Hosp, Res Dept, Englewood, CO USA; [Dijkers, Marcel P.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Heinemann, Allen W.] Inst Rehabil, Chicago, IL USA		Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA.	corrigan.l@osu.edu	Bogner, Jennifer/E-2773-2011; Heinemann, Allen W./AAI-2790-2021; Heinemann, Allen W/K-6283-2012; Corrigan, John D./E-2921-2011	Heinemann, Allen W./0000-0003-2782-7326; Heinemann, Allen W/0000-0003-2782-7326; Dijkers, Marcel/0000-0002-8362-5596	National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, U.S. Department of Education, Traumatic Brain Injury Model Systems [H133A070029, H133A070022, H133A070033, H133A080045]	Supported by the National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, U.S. Department of Education, Traumatic Brain Injury Model Systems (grant nos. H133A070029, H133A070022, H133A070033 and H133A080045).	Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Gordon WA, 1998, LIVING LIFE TBI RTC; *I MED, 1997, EN AM ASS ROL REH SC; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kleinbaum DG, 1998, APPL REGRESSION ANAL, V3rd; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; National Institute on Disability and Rehabilitation Research, 2006, FED REGISTER, V71, P8166; Oliver M., 1990, POLITICS DISABLEMENT; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; United States Census Bureau, 2011, PART STAT AR PROGR; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; World Health Organization, 2007, INT CLASS FUNCT DIS; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	31	7	7	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2012	93	8					1350	1358		10.1016/j.apmr.2012.04.028			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	983XJ	WOS:000307151700009	22840834				2022-02-06	
J	Fernandez-Rodriguez, E; Bernabeu, I; Andujar-Plata, P; Casanueva, FF				Fernandez-Rodriguez, Eva; Bernabeu, Ignacio; Andujar-Plata, Paula; Casanueva, Felipe F.			Subclinical hypopituitarism	BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article						hypopituitarism; pituitary insufficiency; partial GH deficiency; partial ACTH deficiency	GROWTH-HORMONE DEFICIENCY; TRAUMATIC BRAIN-INJURY; CORONARY-HEART-DISEASE; GH-RELEASING HORMONE; ADULT PATIENTS; CARDIOVASCULAR RISK; PREMATURE MORTALITY; BODY-COMPOSITION; VARYING DEGREES; DIAGNOSIS	The presence of subclinical or minor pituitary hormone deficiencies could be recognised in clinical practice and might represent intermediate situations among normal pituitary hormone secretion and clinical hypopituitarism. However, this entity has not been correctly identified and associated clinical impairment and even more, long-term consequences regarding to morbidity and mortality, strongly related to clinical hypopituitarism, has not been correctly settled. Furthermore, best test or methods for diagnosis and the cut off to define these intermediate situates are also unknown. With this purpose, long-term controlled studies are needed to define correctly this entity, the appropriate methods for diagnosis and the potential benefits of substitutive hormone therapy in detected cases. The present review will focus on the available evidence concerning the prevalence, clinical features and diagnosis of subclinical hypopituitarism. (C) 2011 Elsevier Ltd. All rights reserved.	[Fernandez-Rodriguez, Eva; Bernabeu, Ignacio; Andujar-Plata, Paula; Casanueva, Felipe F.] Univ Santiago de Compostela, Div Endocrinol, Complejo Hosp Univ Santiago de Compostela CHUS, SERGAS,Dept Medicina, La Coruna 15706, Spain; [Casanueva, Felipe F.] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Fisiopatol Obes & Nut, Santiago De Compostela 15706, Spain		Casanueva, FF (corresponding author), Hosp Clin Univ, Div Endocrinol, Travesia Choupana S-N, La Coruna 15706, Spain.	felipe.casanueva@usc.es	Bernabeu, Ignacio/P-2049-2014	Bernabeu, Ignacio/0000-0001-8421-7394			Abs R, 2006, EUR J ENDOCRINOL, V155, P79, DOI 10.1530/eje.1.02179; ADAN L, 1994, J CLIN ENDOCR METAB, V78, P353, DOI 10.1210/jc.78.2.353; Agha A, 2004, CLIN ENDOCRINOL, V60, P688, DOI 10.1111/j.1365-2265.2004.02035.x; Appelman-Dijkstra NM, 2011, J CLIN ENDOCR METAB, V96, P2330, DOI 10.1210/jc.2011-0306; Ascoli Paola, 2006, Pituitary, V9, P335, DOI 10.1007/s11102-006-0416-5; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Attanasio AF, 2010, J CLIN ENDOCR METAB, V95, P74, DOI 10.1210/jc.2009-1326; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; BESHYAH SA, 1995, CLIN SCI, V89, P321, DOI 10.1042/cs0890321; Bhandare N, 2007, INT J RADIAT ONCOL, V68, P1131, DOI 10.1016/j.ijrobp.2007.01.029; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Bulow B, 1997, CLIN ENDOCRINOL, V46, P75, DOI 10.1046/j.1365-2265.1997.d01-1749.x; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1919, DOI 10.1210/jc.84.6.1919; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1277, DOI 10.1210/jc.84.4.1277; Colao A, 2006, J CLIN ENDOCR METAB, V91, P2191, DOI 10.1210/jc.2005-2566; DEBOER H, 1992, J CLIN ENDOCR METAB, V75, P833, DOI 10.1210/jc.75.3.833; DEBOER H, 1994, METABOLISM, V43, P199, DOI 10.1016/0026-0495(94)90245-3; Dekkers O M, 2008, Ned Tijdschr Geneeskd, V152, P792; Endert E, 2005, NETH J MED, V63, P435; Erfurth E M, 2000, Pituitary, V3, P77, DOI 10.1023/A:1009901707125; Fernandez-Rodriguez E, 2011, NEUROENDOCRINOLOGY, V93, P181, DOI 10.1159/000324087; Gandhi P G, 2002, J Postgrad Med, V48, P280; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; JACKSON IMD, 1982, NEW ENGL J MED, V306, P145, DOI 10.1056/NEJM198201213060305; Kaji H, 2007, ENDOCR J, V54, P239, DOI 10.1507/endocrj.K06-129; Koppeschaar Hans P F, 2004, Pituitary, V7, P15, DOI 10.1023/B:PITU.0000044629.10484.40; Laureti S, 2002, J Postgrad Med, V48, P251; Lindholm J, 2006, CLIN ENDOCRINOL, V65, P51, DOI 10.1111/j.1365-2265.2006.02545.x; MARKUSSIS V, 1992, LANCET, V340, P1188, DOI 10.1016/0140-6736(92)92892-J; Mauras N, 2005, J CLIN ENDOCR METAB, V90, P3946, DOI 10.1210/jc.2005-0208; MEROLA B, 1993, J CLIN ENDOCR METAB, V77, P1658, DOI 10.1210/jcem.77.6.8263155; Mitchell H, 1999, ARCH DIS CHILD, V80, P443, DOI 10.1136/adc.80.5.443; Murray RD, 2006, J CLIN ENDOCR METAB, V91, P432, DOI 10.1210/jc.2005-0897; Murray RD, 2005, CLIN ENDOCRINOL, V62, P182, DOI 10.1111/j.1365-2265.2005.02194.x; Murray RD, 2004, J CLIN ENDOCR METAB, V89, P1586, DOI 10.1210/jc.2003-030761; Murray RD, 2007, J CLIN ENDOCR METAB, V92, P1705, DOI 10.1210/jc.2006-2055; Murray RD, 2010, CLIN ENDOCRINOL, V73, P508, DOI 10.1111/j.1365-2265.2009.03754.x; Ochs N, 2008, ANN INTERN MED, V148, P832, DOI 10.7326/0003-4819-148-11-200806030-00225; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Rahim A, 1996, CLIN ENDOCRINOL, V45, P557; Razvi S, 2008, J CLIN ENDOCR METAB, V93, P2998, DOI 10.1210/jc.2008-0167; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Rosen T, 1997, EUR J ENDOCRINOL, V137, P240, DOI 10.1530/eje.0.1370240; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; SHAHI M, 1992, BRIT HEART J, V67, P92; Shalet SM, 2003, J CLIN ENDOCR METAB, V88, P4124, DOI 10.1210/jc.2003-030126; Shalet SM, 2010, CLIN ENDOCRINOL, V73, P432, DOI 10.1111/j.1365-2265.2010.03809.x; SMAIL PJ, 1979, ARCH DIS CHILD, V54, P475, DOI 10.1136/adc.54.6.475; SMALL M, 1986, POSTGRAD MED J, V62, P445, DOI 10.1136/pgmj.62.728.445; Streeten DHP, 1999, J CLIN ENDOCR METAB, V84, P835, DOI 10.1210/jc.84.3.835; TAPHOORN MJB, 1995, J NEURO-ONCOL, V25, P97, DOI 10.1007/BF01057753; Tauber M, 2003, J CLIN ENDOCR METAB, V88, P5101, DOI 10.1210/jc.2003-030392; Thaler LM, 1998, J CLIN ENDOCR METAB, V83, P2726, DOI 10.1210/jc.83.8.2726; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Toogood AA, 2008, ENDOCRIN METAB CLIN, V37, P235, DOI 10.1016/j.ecl.2007.10.004; Vahl N, 2000, J CLIN ENDOCR METAB, V85, P1874, DOI 10.1210/jc.85.5.1874; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101; Zargar AH, 1997, BRIT J OBSTET GYNAEC, V104, P629, DOI 10.1111/j.1471-0528.1997.tb11548.x; ZIMMERMAN TS, 1967, AM J MED, V42, P146, DOI 10.1016/0002-9343(67)90012-5	64	7	7	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1521-690X	1532-1908		BEST PRACT RES CL EN	Best Pract. Res. Clin. Endoc. Metab.	AUG	2012	26	4					461	469		10.1016/j.beem.2011.10.007			9	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	994FY	WOS:000307917500007	22863388				2022-02-06	
J	Kao, C; Forbes, JA; Jermakowicz, WJ; Sun, DA; Davis, B; Zhu, JP; Lagrange, AH; Konrad, PE				Kao, Chris; Forbes, Jonathan A.; Jermakowicz, Walter J.; Sun, David A.; Davis, Brandon; Zhu, Jiepei; Lagrange, Andre H.; Konrad, Peter E.			Suppression of thalamocortical oscillations following traumatic brain injury in rats Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; coma; thalamocortical slice; slow cortical oscillation; recovery; rat	IN-VITRO; NEURONS; SLICES; RESPONSES; ISCHEMIA; RECOVERY; STROKE; MICE; EEG	Object. Traumatic brain injury (TBI) often causes an encephalopathic state, corresponding amplitude suppression, and disorganization of electroencephalographic activity. Clinical recovery in patients who have suffered TBI varies, and identification of patients with a poor likelihood of functional recovery is not always straightforward. The authors sought to investigate temporal patterns of electrophysiological recovery of neuronal networks in an animal model of TBI. Because thalamocortical circuit function is a critical determinant of arousal state, as well as electroencephalography organization, these studies were performed using a thalamocortical brain slice preparation. Methods. Adult rats received a moderate parietal fluid-percussion injury and were allowed to survive for 1 hour, 2 days, 7 days, or 15 days prior to in vitro electrophysiological recording. Thalamocortical brain slices, 450-mu m thick, were prepared using a cutting angle that preserved reciprocal connections between the somatosensory cortex and the ventrobasal thalamic complex. Results. Extracellular recordings in the cortex of uninjured control brain slices revealed spontaneous slow cortical oscillations (SCOs) that are blocked by (2R)-amino-5-phosphonovaleric acid (50 mu M) and augmented in low [Mg2+]o. These oscillations have been shown to involve simultaneous bursts of activity in both the cortex and thalamus and are used here as a metric of thalamocortical circuit integrity. They were absent in 84% of slices recorded at 1 hour postinjury, and activity slowly recovered to approximate control levels by Day 15. The authors next used electrically evoked SCO-like potentials to determine neuronal excitability and found that the maximum depression occurred slightly later, on Day 2 following TBI, with only 28% of slices showing evoked activity. In addition, stimulus intensities needed to create evoked SCO activity were elevated at 1 hour, 2 days, and 7 days following TBI, and eventually returned to control levels by Day 15. The SCO frequency remained low throughout the 15 days following TBI (40% of control by Day 15). Conclusions. The suppression of cortical oscillatory activity following TBI observed in the rat model suggests an injury-induced functional disruption of thalamocortical networks that gradually recovers to baseline at approximately 15 days postinjury. The authors speculate that understanding the processes underlying disrupted thalamocortical circuit function may provide important insights into the biological basis of altered consciousness following severe head injury. Moreover, understanding the physiological basis for this process may allow us to develop new therapies to enhance the rate and extent of neurological recovery following TBI. (http://thejns.org/doi/abs/10.3171/2012.4.JNS111170)	[Kao, Chris] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Med Ctr N, Nashville, TN 37232 USA; [Jermakowicz, Walter J.] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; [Lagrange, Andre H.] Tennessee Valley Vet Adm, Dept Neurol, Nashville, TN USA; [Lagrange, Andre H.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Sun, David A.] Norton Neurosci Inst, Dept Neurosurg, Louisville, KY USA; [Zhu, Jiepei] Virginia Commonwealth Univ, Dept Anesthesiol, Richmond, VA USA		Kao, C (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Med Ctr N, Room T-4224, Nashville, TN 37232 USA.	chris.kao@vanderbilt.edu	Jermakowicz, Walter/AAC-5467-2019; Lagrange, Andre/B-1227-2008	Jermakowicz, Walter/0000-0001-6517-208X; Konrad, Peter/0000-0003-4223-0819; Lagrange, Andre/0000-0003-0147-7778	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024975] Funding Source: NIH RePORTER		AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Alves OL, 2005, J NEUROTRAUM, V22, P733, DOI 10.1089/neu.2005.22.733; Arrieta-Cruz I, 2009, ANN NY ACAD SCI, V1157, P24, DOI 10.1111/j.1749-6632.2008.04118.x; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Clauss RP, 2004, ARZNEIMITTELFORSCH, V54, P641; Conti AC, 1998, J NEUROSCI, V18, P5663; COULTER DA, 1993, BRAIN RES, V631, P137, DOI 10.1016/0006-8993(93)91199-3; Dawson LA, 2000, BRAIN RES BULL, V53, P767, DOI 10.1016/S0361-9230(00)00363-4; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Hall SD, 2010, CLIN NEUROPHYSIOL, V121, P549, DOI 10.1016/j.clinph.2009.11.084; Hartings JA, 2003, J NEUROSCI, V23, P5264; Jermakowicz WJ, 2007, BRAIN RES REV, V55, P264, DOI 10.1016/j.brainresrev.2007.06.003; Kao C, 2011, NEUROMODULATION, V14, P104, DOI 10.1111/j.1525-1403.2011.00337.x; Kao CQ, 2004, J NEUROTRAUM, V21, P259, DOI 10.1089/089771504322972059; Kao CQ, 1997, J NEUROPHYSIOL, V77, P2661, DOI 10.1152/jn.1997.77.5.2661; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Littlejohns L, 2005, AACN ADV CRIT CARE, V16, P501, DOI 10.1097/00044067-200510000-00007; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; Luhmann HJ, 1996, PROG NEUROBIOL, V48, P131, DOI 10.1016/0301-0082(95)00042-9; NILSSON GE, 1991, AM J PHYSIOL, V261, pR32, DOI 10.1152/ajpregu.1991.261.1.R32; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Povlishock J T, 2000, Clin Neurosurg, V46, P113; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; RUMPL E, 1979, ELECTROEN CLIN NEURO, V46, P487, DOI 10.1016/0013-4694(79)90002-6; Schiff ND, 2008, NATURE, V452, P120, DOI 10.1038/nature06818; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; Tanaka Y, 2008, J NEUROSCI METH, V171, P118, DOI 10.1016/j.jneumeth.2008.02.021; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	32	7	7	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	AUG	2012	117	2					316	323		10.3171/2012.4.JNS111170			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	978ST	WOS:000306766800024	22631688				2022-02-06	
J	Oliveira, RARA; Araujo, S; Falcao, ALE; Soares, SMTP; Kosour, C; Dragosavac, D; Cintra, EA; Cardoso, APD; Thiesen, RA				Oliveira, Rosmari A. R. A.; Araujo, Sebastiao; Falcao, Antonio L. E.; Soares, Silvia M. T. P.; Kosour, Carolina; Dragosavac, Desanka; Cintra, Eliane A.; Cardoso, Ana Paula D.; Thiesen, Rosana A.			Glasgow outcome scale at hospital discharge as a prognostic index in patients with severe traumatic brain injury	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						brain Injuries; Glasgow coma scale; Glasgow outcome scale; prognosis	SEVERE HEAD-INJURY; MORTALITY	Objective: Evaluate the Glasgow outcome scale (GOS) at discharge (GOS-HD) as a prognostic indicator in patients with traumatic brain injury (TBI). Method: Retrospective data were collected of 45 patients, with Glasgow coma scale <= 8, age 25 +/- 10 years, 36 men, from medical records. Later, at home visit, two measures were scored: GOS-HD (according to information from family members) and GOS LATE (12 months after TBI). Results: At discharge, the ERG showed: vegetative state (VS) in 2 (4%), severe disability (SD) in 27 (60%), moderate disability (MD) in 15 (33%) and good recovery (GR) in 1 (2%). After 12 months: death in 5 (11%), VS in 1 (2%), SD in 7 (16%), MD in 9 (20%) and GR in 23 (51%). Variables associated with poor outcome were: worse GOS-HD (p=0.03), neurosurgical procedures (p=0.008) and the kind of brain injury (p=0.009). Conclusion: The GOS-HD was indicator of prognosis in patients with severe TBI.	[Oliveira, Rosmari A. R. A.; Soares, Silvia M. T. P.] Pontificia Univ Catolica Campinas, Fac Physiotherapy, Campinas, SP, Brazil; [Araujo, Sebastiao; Falcao, Antonio L. E.; Dragosavac, Desanka; Cardoso, Ana Paula D.] State Univ Campinas UNICAMP, Dept Surg, Campinas, SP, Brazil; [Cintra, Eliane A.] Univ Estadual Campinas, Hosp Clin, Intens Care Unit, Campinas, SP, Brazil		Oliveira, RARA (corresponding author), Rua Alfredo Vieira Alves 33 Residencial Shangrila, BR-13098608 Campinas, SP, Brazil.	rrosmari@terra.com.br					Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; ARREOLARISA C, 1995, J TRAUMA, V39, P457; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Boto GR, 2004, NEUROCIRUGIA, V15, P233; Brandt AR, 1999, CONDUTAS PACIENTE GR, P855; Camargo ABM, 1995, VELHOS NOVOS MALES S, P256; Chesnut RM, 1998, SURG NEUROL, V50, P187, DOI 10.1016/S0090-3019(98)00075-5; Dantas VP, 2001, ARQ NEURO-PSIQUIAT, V59, P895, DOI 10.1590/S0004-282X2001000600011; Falcao ALE, 2000, ARQ NEURO-PSIQUIAT, V58, P877, DOI 10.1590/S0004-282X2000000500013; FALCAO ALE, 1995, ARQ NEURO-PSIQUIAT, V53, P390, DOI 10.1590/S0004-282X1995000300004; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; HEIDEN JS, 1983, PHYS THER, V63, P1946, DOI 10.1093/ptj/63.12.1946; Hellawell DJ, 2000, SCAND J REHABIL MED, V32, P25; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; Mantovani M, 2001, TRAUMA DOENCA SECULO, P2851; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Prat R, 1998, ACTA NEUROCHIR, V140, P1257, DOI 10.1007/s007010050247; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	31	7	9	0	10	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	AUG	2012	70	8					604	608		10.1590/S0004-282X2012000800009			5	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	991QP	WOS:000307716600009	22899032	Green Submitted, gold			2022-02-06	
J	Stein, DM; Hu, PF; Chen, HGH; Yang, SM; Stansbury, LG; Scalea, TM				Stein, Deborah M.; Hu, Peter F.; Chen, Hegang H.; Yang, Shiming; Stansbury, Lynn G.; Scalea, Thomas M.			Computational gene mapping to analyze continuous automated physiologic monitoring data in neuro-trauma intensive care	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Structured machine learning; machine learning; microarray analysis; electronic monitoring; vital signs monitoring	INTRACRANIAL HYPERTENSION; EXPRESSION; PRESSURE; INJURY	BACKGROUND: We asked whether the advanced machine learning applications used in microarray gene profiling could assess critical thresholds in the massive databases generated by continuous electronic physiologic vital signs (VS) monitoring in the neurotrauma intensive care unit. METHODS: We used Class Prediction Analysis to predict binary outcomes (life/death, good/bad Extended Glasgow Outcome Score, etc.) based on data accrued within 12, 24, 48, and 72 hours after admission to the neuro-trauma intensive care unit. Univariate analyses selected "features," discriminator VS segments or "genes," in each individual's data set. Prediction models using these selected features were then constructed using six different statistical modeling techniques to predict outcome for other individuals in the sample cohort based on the selected features of each individual then cross-validated with a leave-one-out method. RESULTS: We gleaned complete sets of 588 VS monitoring segment features for each of four periods and outcomes from 52 of 60 patients with severe traumatic brain injury who met study inclusion criteria. Overall, intracranial pressures and blood pressures over time (e.g., intracranial pressure >20 mm Hg for 20 minutes) provided the best discrimination for outcomes. Modeling performed best in the first 12 hours of care and for mortality. The mean number of selected features included 76 predicting 14-day hospital stay in that period, 11 predicting mortality, and 4 predicting 3-month Extended Glasgow Outcome Score. Four of the six techniques constructed models that correctly identified mortality by 12 hours 75% of the time or higher. CONCLUSION: Our results suggest that valid prediction models after severe traumatic brain injury can be constructed using gene mapping techniques to analyze large data sets from conventional electronic monitoring data, but that this methodology needs validation in larger data sets, and that additional unstructured learning techniques may also prove useful. (J Trauma Acute Care Surg. 2012; 73: 419-425. Copyright (c) 2012 by Lippincott Williams & Wilkins) LEVEL OF EVIDENCE: Prognostic study, level III.	[Stein, Deborah M.; Hu, Peter F.; Chen, Hegang H.; Yang, Shiming; Stansbury, Lynn G.; Scalea, Thomas M.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Shock Trauma & Anesthesia Res Ctr, Baltimore, MD 21201 USA		Stansbury, LG (corresponding author), Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Shock Trauma & Anesthesia Res Ctr, Baltimore, MD 21201 USA.	lynn.stansbury@gmail.com	Yang, Shiming/I-3695-2015	Yang, Shiming/0000-0003-0338-4268; Stein, Deborah/0000-0003-3683-3963			Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Functional Genomics Data Society, MIN INF MICR EXP MIA; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kahraman S, 2011, J TRAUMA, V70, P547, DOI 10.1097/TA.0b013e31820c768a; Kahraman S, 2010, J NEUROSURG ANESTH, V22, P296, DOI 10.1097/ANA.0b013e3181e25fc3; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Simon R, 2003, J NATL CANCER I, V95, P14, DOI 10.1093/jnci/95.1.14; Simon R, 2003, DESIGN ANAL DNA MICR; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Stork D.G., 2001, PATTERN CLASSIFICATI; Vapnik V. N., 1998, STAT LEARNING THEORY; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345	19	7	7	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2012	73	2					419	424		10.1097/TA.0b013e31825ff59a			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	992VG	WOS:000307807400030	22846949				2022-02-06	
J	Rasmussen, R; Wetterslev, J; Stavngaard, T; Skjoth-Rasmussen, J; Grande, PO; Olsen, NV; Romner, B				Rasmussen, Rune; Wetterslev, Jorn; Stavngaard, Trine; Skjoth-Rasmussen, Jane; Grande, Per Olof; Olsen, Niels Vidiendal; Romner, Bertil			The effects of continuous prostacyclin infusion on regional blood flow and cerebral vasospasm following subarachnoid haemorrhage: study protocol for a randomised controlled trial	TRIALS			English	Article						Subarachnoid haemorrhage; Prostacyclin; Epoprostenol; Vasospasm; Delayed ischaemic neurological deficit	LOW-DOSE PROSTACYCLIN; TRAUMATIC BRAIN-INJURY; ARTERIAL SPASM; MICRODIALYSIS; PERFUSION; ISCHEMIA	Background: One of the main causes of mortality and morbidity following subarachnoid haemorrhage (SAH) is the development of cerebral vasospasm, a frequent complication arising in the weeks after the initial bleeding. Despite extensive research, to date no effective treatment of vasospasm exists. Prostacyclin is a potent vasodilator and inhibitor of platelet aggregation. In vitro models have shown a relaxing effect of prostacyclin after induced contraction in cerebral arteries, and a recent pilot trial showed a positive effect on cerebral vasospasm in a clinical setting. No randomised, clinical trials have been conducted, investigating the possible pharmacodynamic effects of prostacyclin on the human brain following SAH. Methods: This trial is a single-centre, randomised, placebo-controlled, parallel group, blinded, clinical, pilot trial. A total of 90 patients with SAH will be randomised to one of three intervention arms: epoprostenol 1 ng/kg/min, epoprostenol 2 ng/kg/min or placebo in addition to standard treatment. Trial medication will start day 5 after SAH and continue to day 10. The primary outcome measure is changes in regional cerebral blood flow from baseline in the arterial territories of the anterior cerebral artery, medial cerebral artery and the posterior cerebral artery, measured by CT perfusion scan. The secondary outcomes will be vasospasm measured by CT angiography, ischaemic parameters measured by brain microdialysis, flow velocities in the medial cerebral artery, clinical parameters and outcome (Glasgow Outcome Scale) at 3 months.	[Rasmussen, Rune; Skjoth-Rasmussen, Jane; Romner, Bertil] Copenhagen Univ Hosp, Dept Neurosurg, Copenhagen, Denmark; [Wetterslev, Jorn] Copenhagen Univ Hosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Rigshosp, Copenhagen, Denmark; [Stavngaard, Trine] Copenhagen Univ Hosp, Dept Radiol, Copenhagen, Denmark; [Grande, Per Olof] Univ Lund Hosp, Dept Anaesthesia & Intens Care, S-22185 Lund, Sweden; [Olsen, Niels Vidiendal] Copenhagen Univ Hosp, Dept Neuroanesthesiol, Copenhagen, Denmark		Rasmussen, R (corresponding author), Copenhagen Univ Hosp, Dept Neurosurg, 9 Blegdamsvej, Copenhagen, Denmark.	rune333@gmail.com	Wetterslev, Jorn/ABF-1251-2020	Wetterslev, Jorn/0000-0001-7778-1771; Olsen, Niels Vidiendal/0000-0001-7724-3981			Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; BOULLIN DJ, 1979, BRIT J CLIN PHARMACO, V7, P139, DOI 10.1111/j.1365-2125.1979.tb00914.x; BRANDT L, 1981, J NEUROSURG, V55, P877, DOI 10.3171/jns.1981.55.6.0877; DORSCH NWC, 1995, BRIT J NEUROSURG, V9, P403, DOI 10.1080/02688699550041403; Grande PO, 2010, CEPHALALGIA, V30, P890, DOI 10.1177/0333102409352909; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; Hansen-Schwartz J, 2004, NEUROCRIT CARE, V1, P235, DOI 10.1385/NCC:1:2:235; Johnston SC, 1998, NEUROLOGY, V50, P1413, DOI 10.1212/WNL.50.5.1413; Koskinen LOD, 2009, ACTA NEUROCHIR, V151, P595, DOI 10.1007/s00701-009-0295-4; Lundblad C, 2008, J CEREBR BLOOD F MET, V28, P367, DOI 10.1038/sj.jcbfm.9600533; Macdonald RL, 2006, NEUROSURG REV, V29, P179, DOI 10.1007/s10143-005-0013-5; Mees SMD, 2008, STROKE, V39, P2186, DOI 10.1161/STROKEAHA.107.509257; Moller AD, 2001, CRIT CARE MED, V29, P351; MONCADA S, 1977, LANCET, V1, P18; NOSKO M, 1988, NEUROSURGERY, V22, P45, DOI 10.1227/00006123-198801000-00007; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; PAUL KS, 1982, J NEUROSURG, V57, P334, DOI 10.3171/jns.1982.57.3.0334; Reinstrup P, 2011, NEUROCRIT CARE, V14, P441, DOI 10.1007/s12028-010-9486-3; Saver JL, 2007, STROKE, V38, P3055, DOI 10.1161/STROKEAHA.107.488536; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123	21	7	7	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JUL 2	2012	13								102	10.1186/1745-6215-13-102			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	032SA	WOS:000310738200002	22747768	Green Published, gold			2022-02-06	
J	Davidson, GH; Maier, RV; Arbabi, S; Goldin, AB; Rivara, FP				Davidson, Giana H.; Maier, Ronald V.; Arbabi, Saman; Goldin, Adam B.; Rivara, Frederick P.			Impact of operative intervention delay on pediatric trauma outcomes	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Pediatric trauma; traumatic brain injury; craniotomy; solid organ injury; outcomes	INJURY SEVERITY SCORE; SPLENIC INJURIES; HEAD-INJURY; CARE; MANAGEMENT; ASSOCIATION; DIAGNOSIS; SCALE	BACKGROUND: Establishing quality indicators is an essential step in improving mortality and disability among pediatric patients with trauma. We hypothesized that timing of craniotomy, intracranial pressure (ICP) monitoring for traumatic brain injury, and abdominal operation for solid organ injury correlates with a reduced risk of death, shorter stay, and reduced risk of requiring assistance at discharge. METHODS: This was a retrospective cohort study of 99,513 pediatric patients with trauma, using the National Trauma Data Bank. RESULTS: For patients who had an ICP monitor placed within 4 hours compared with those whose ICP monitor was delayed, there was no difference in mortality; however, there was a shorter stay in the hospital (relative risk [RR], 0.84; 95% confidence interval (CI), 0.72-0.97) and in the intensive care unit (ICU) (RR, 0.76; 95% CI, 0.66-0.86) in those that survived to discharge. Patients who had craniotomy within 4 hours had higher mortality (RR, 1.98; 95% CI, 1.11-3.51) compared with those that were delayed. After excluding those that died, there was a shorter overall stay (RR, 0.69; 95% CI, 0.59-0.81) and ICU stay (RR, 0.69; 95% CI, 0.57-0.83). Similar length of stay results were seen in pediatric patients with solid organ injuries. Excluding those that died, length of stay (RR, 0.58; 95% CI, 0.47-0.73) and ICU stay (RR, 0.52; 95% CI, 0.37-0.74) were shorter. CONCLUSION: Early intervention in those who survive their initial operation is associated with shorter ICU and hospital stay for traumatic brain and solid organ injuries. (J Trauma Acute Care Surg. 2012; 73: 162-167. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Davidson, Giana H.; Maier, Ronald V.; Arbabi, Saman; Goldin, Adam B.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Harborview Med Ctr, Seattle, WA 98195 USA; [Davidson, Giana H.; Maier, Ronald V.; Arbabi, Saman; Goldin, Adam B.] Univ Washington, Dept Surg, Harborview Med Ctr, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Harborview Med Ctr, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Harborview Med Ctr, Seattle, WA 98195 USA; [Goldin, Adam B.] Seattle Childrens Hosp, Dept Gen & Thorac Surg, Seattle, WA USA		Davidson, GH (corresponding author), Univ Washington, Med Ctr, Box 356410,1959 NE Pacific St, Seattle, WA 98195 USA.	ghd@u.washington.edu			National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1T32HD057822-01AZ]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER	This work was supported by the National Institute of Child Health and Human Development grant 1T32HD057822-01AZ that was awarded to the Pediatric Injury Research Training Program.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Birkmeyer JD, 1998, SURGERY, V124, P917, DOI 10.1067/msy.1998.90268; Borse N, 2009, FAM COMMUNITY HEALTH, V32, P189, DOI 10.1097/01.FCH.0000347986.44810.59; Bowman SM, 2005, JAMA-J AM MED ASSOC, V294, P2611, DOI 10.1001/jama.294.20.2611; Dean NC, 2006, CHEST, V130, P794, DOI 10.1378/chest.130.3.794; Dougherty D, 2005, MED CARE, V43, P58; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Eastman AB, 1999, J TRAUMA, V46, P579; Figaji AA, 2006, SAMJ S AFR MED J, V96, P969; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Hedges JR, 2009, J EMERG MED, V37, P115, DOI 10.1016/j.jemermed.2008.07.001; Hoff WS, 2002, J TRAUMA, V53, P602, DOI 10.1097/00005373-200209000-00038; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Knudson MM, 2007, J TRAUMA, V63, pS140, DOI 10.1097/TA.0b013e31815acd2f; Letton RW, 2010, J TRAUMA, V68, P790, DOI 10.1097/TA.0b013e3181d27957; Mooney DP, 2004, J TRAUMA, V56, P328, DOI 10.1097/01.TA.0000053737.16542.FB; Mooney DP, 1998, J PEDIATR SURG, V33, P1076, DOI 10.1016/S0022-3468(98)90534-6; Nathens A, 2009, NATL TRAUMA DATA BAN; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Rivara FP, 2007, J TRAUMA, V63, pS155, DOI 10.1097/TA.0b013e31815acd92; Rivara FP, 2007, J TRAUMA, V63, pS52, DOI 10.1097/TA.0b013e31815aca0a; Rutledge R, 1997, J TRAUMA, V42, P477, DOI 10.1097/00005373-199703000-00016; Rutledge R, 1996, J TRAUMA, V40, P944, DOI 10.1097/00005373-199606000-00013; Sampalis JS, 1999, J TRAUMA, V46, P565, DOI 10.1097/00005373-199904000-00004; Stelfox HT, 2010, CRIT CARE MED, V38, P1187, DOI 10.1097/CCM.0b013e3181d455fe; Stylianos S, 2006, J AM COLL SURGEONS, V202, P247, DOI 10.1016/j.jamcollsurg.2005.10.012; Stylianos S, 2005, CURR OPIN PEDIATR, V17, P402, DOI 10.1097/01.mop.0000163693.96101.84; Tataria M, 2007, J TRAUMA, V63, P608, DOI 10.1097/TA.0b013e318142d2c2; Wessen D, 1998, J PEDIATR SURG, V33, P1079	30	7	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2012	73	1					162	167		10.1097/TA.0b013e31825699b4			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	979JU	WOS:000306814100024	22743386	Green Accepted			2022-02-06	
J	Hopman, K; Tate, RL; McCluskey, A				Hopman, Kate; Tate, Robyn L.; McCluskey, Annie			Community-Based Rehabilitation Following Brain Injury: Comparison of a Transitional Living Program and a Home-Based Program	BRAIN IMPAIRMENT			English	Article						Traumatic brain injury; community rehabilitation; community reintegration; transitional living; program evaluation; cohort study	ASSESSING SUPPORT NEEDS; NEUROREHABILITATION PROGRAM; COGNITIVE REHABILITATION; POSTACUTE REHABILITATION; RANDOMIZED-TRIAL; INTEGRATION; SCALE; PEOPLE; CARE; INDIVIDUALS	Background and aims: Community-based rehabilitation programs for people with a brain injury are diverse. Comparative program evaluation is required to identify optimal type, intensity and duration of programs. The aim of this study was to compare the effectiveness of two community-based rehabilitation programs using a set of standardised outcome measures. Methods: The study used a quantitative, multicentre, longitudinal design. Persons with severe traumatic brain injury (TBI, n = 39) and acquired brain impairment (n = 2) were recruited from two residential, transitional living programs (TLU; n = 21) and two home-based community rehabilitation programs (CR; n = 20). Participants were assessed via interview at program entry, 2 months and 6 months later using a broad range of standardised measures. The quantity and types of intervention provided to study participants were recorded. Results: No significant differences were identified between the TLU and CR groups at baseline or 6-month follow-up. Two significant group-by-time interactions were identified on the Community Integration Questionnaire (CIQ). First, the CR group had significantly greater changes in productivity (p = .003; d = 1.0) compared to the TLU group over time; by contrast, the TLU group showed significantly greater improvements in social integration (p = .007; d = .86). The TLU participants received up to five times more intervention than the CR participants. This finding is significant considering the similar levels of improvement in function made by both TLU and CR participants. Conclusions: Both TLU and CR groups improved on a range of measures. The TLU group however, received significantly more face-to-face interventions. Further examination of the relationship between participant contextual factors, such as coping style and self-esteem, and impairments such as challenging behaviour and decreased self-awareness, of people attending TLU and CR programs is required.	[Tate, Robyn L.] Univ Sydney, Sydney Med Sch, No Clin Sch, Rehabil Studies Unit, Ryde, NSW 1680, Australia; [Hopman, Kate] Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia; [McCluskey, Annie] Univ Sydney, Fac Hlth Sci, Ryde, NSW 1680, Australia		Tate, RL (corresponding author), Univ Sydney, Sydney Med Sch, No Clin Sch, Rehabil Studies Unit, POB 6, Ryde, NSW 1680, Australia.	rtate@med.usyd.edu.au					Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bowen A, 1999, NEUROREHABILITATION, V13, P147; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cohen J., 2013, STAT POWER ANAL BEHA; Glenn MB, 2004, J HEAD TRAUMA REHAB, V19, P482, DOI 10.1097/00001199-200411000-00005; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Hashimoto K, 2006, J REHABIL MED, V38, P20, DOI 10.1080/16501970510038473; HERBERT R, 1988, AGE AGEING, V17, P293; Knight RG, 1997, J CLIN EXP NEUROPSYC, V19, P7, DOI 10.1080/01688639708403832; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Malec JF, 2002, ARCH PHYS MED REHAB, V83, P1759, DOI 10.1053/apmr.2002.36072; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Moseley AM, 2002, AUST J PHYSIOTHER, V48, P43, DOI 10.1016/S0004-9514(14)60281-6; Olver J., 1996, INT PERSPECT TRAUMAT, P359; Pace GM, 1999, BRAIN INJURY, V13, P535; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258; SIMPSON G, 2004, BRAIN IMPAIR, V5, DOI DOI 10.1375/BRIM.5.1.67.35401; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Soo C, 2007, J HEAD TRAUMA REHAB, V22, P288, DOI 10.1097/01.HTR.0000290973.01872.4c; Soo C, 2010, ARCH PHYS MED REHAB, V91, P905, DOI 10.1016/j.apmr.2009.11.033; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Turner-Stokes L., 2005, MULTIDISCIPLINARY RE; Wheeler S. D., 2004, EFFECTIVENESS COMMUN; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P5; WILLIAMS JH, 1991, GERONTOLOGIST, V31, P84, DOI 10.1093/geront/31.1.84; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; World Health Organization, 2007, INT CLASS FUNCT DIS	42	7	7	0	20	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	JUL	2012	13	1			SI		44	61		10.1017/BrImp.2012.6			18	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	964VQ	WOS:000305725200005					2022-02-06	
J	Kim, HN; Park, YJ; Kim, GL; Park, YW				Kim, Hyong-Nyun; Park, Yoo-Jung; Kim, Gab-Lae; Park, Yong-Wook			Closed Antegrade Intramedullary Pinning for Reduction and Fixation of Metatarsal Fractures	JOURNAL OF FOOT & ANKLE SURGERY			English	Article						bone healing; fracture; Kirschner wire; radiograph; surgery; trauma	NECK FRACTURES; METACARPAL FRACTURES; MANAGEMENT; INJURIES; TOES	The purpose of this study was to present the results of the metatarsal fractures treated with a closed antegrade intramedullary pinning technique. The records of 35 consecutive patients with metatarsal fractures operated on from August 2005 to June 2010 by the authors were retrospectively reviewed. Four patients were not contactable and 1 patient refused to participate. Accordingly, the study cohort was composed of 30 patients (24 male, 6 female) with 46 metatarsal head, neck, or shaft fractures. Inclusion criteria were metatarsal head, neck, or shaft fractures with a displacement of more than 3 to 4 mm or an angulation of more than 10 degrees in the sagittal plane. Fractures combined with Lisfranc injury or metatarsal base fractures were excluded, as were bicortical comminuted fractures or long oblique fractures. Times to bone union, limitations of motion at affected metatarsophalangeal joints, and residual pain were evaluated at 6 weeks after surgery and at final follow-up. American Orthropedic Foot and Ankle Society scale was evaluated at final follow-up. Fracture union was obtained at an average of 7.1 (range 6 to 10) weeks. Two patients had moderate limitation of metatarsophalangeal joint at 6 weeks but recovered to full range at final follow-up. Average American Orthropedic Foot and Ankle Society score at final follow-up was 96.7 (range 83 to 100) points. Closed antegrade intramedullary pinning was found to be a useful method for treating displaced metatarsal fractures and to allow immediate joint motion and partial weightbearing in a stiff-soled shoe. (C) 2012 by the American College of Foot and Ankle Surgeons. All rights reserved.	[Kim, Gab-Lae; Park, Yong-Wook] Hallym Univ, Coll Med, Dept Orthoped Surg, Kangnam Sacred Heart Hosp, Seoul 150950, South Korea; [Park, Yoo-Jung] Yonsei Univ, Coll Med, Dept Orthoped Surg, Seoul, South Korea; [Kim, Hyong-Nyun] Yangju Mil Hosp, Dept Orthoped Surg, Yangju, South Korea		Park, YW (corresponding author), Hallym Univ, Coll Med, Dept Orthoped Surg, Kangnam Sacred Heart Hosp, 948-1,Dalim 1Dong, Seoul 150950, South Korea.	aofas@chollian.net		Kim, Hyong Nyun/0000-0001-5934-0665			Aguado HJ, 2003, J PEDIATR ORTHOP B, V12, P350; Alepuz ES, 1996, FOOT ANKLE INT, V17, P200, DOI 10.1177/107110079601700403; ANDERSON LD, 1977, CLIN ORTHOP RELAT R, P18; Armagan OE, 2001, ORTHOP CLIN N AM, V32, P1, DOI 10.1016/S0030-5898(05)70189-9; Buddecke Donald E, 2010, Clin Podiatr Med Surg, V27, P601, DOI 10.1016/j.cpm.2010.07.001; Cakir H, 2011, ARCH ORTHOP TRAUM SU, V131, P241, DOI 10.1007/s00402-010-1164-6; Calder JDF, 2000, INJURY, V31, P47, DOI 10.1016/S0020-1383(99)00201-6; Donahue MP, 2004, FOOT ANKLE INT, V25, P438, DOI 10.1177/107110070402500615; DUTKOWSKY J, 1989, FOOT ANKLE, V10, P43, DOI 10.1177/107110078901000109; Early JS, 2006, FRACTURES ADULTS, P2370; GONZALEZ MH, 1995, J HAND SURG-AM, V20A, P382, DOI 10.1016/S0363-5023(05)80091-7; Gonzalez MH, 1996, CLIN ORTHOP RELAT R, P47; Itadera E, 2008, J HAND SURG-ASIAN-PA, V13, P139, DOI 10.1142/S0218810408003980; Joplin RJ, 1958, FRACTURES OTHER INJU, P604; KITAOKA HB, 1994, FOOT ANKLE INT, V15, P349, DOI 10.1177/107110079401500701; LIGIER JN, 1983, CHIR PEDIATR, V24, P383; MCDONALD RJ, 1986, J AM PODIAT MED ASSN, V76, P283, DOI 10.7547/87507315-76-5-283; Mereddy Praveen K R, 2007, J Foot Ankle Surg, V46, P320, DOI 10.1053/j.jfas.2007.02.003; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; Miller JC, 2008, J FOOT ANKLE SURG, V47, P46, DOI 10.1053/j.jfas.2007.09.003; Ozer Hamza, 2006, J Foot Ankle Surg, V45, P190, DOI 10.1053/j.jfas.2006.02.009; Pan Yong-wei, 2006, Zhonghua Wai Ke Za Zhi, V44, P1689; Rammelt Stefan, 2004, Injury, V35 Suppl 2, pSB77; SAMMARCO GJ, 1995, ORTHOP CLIN N AM, V26, P265; Sanders RW P.S., 2007, SURG FOOT ANKLE, P2216; Shereff MJ, 2001, INSTR COURSE LECT, V39, P133; Singer G, 2008, J BONE JOINT SURG AM, V90A, P772, DOI 10.2106/JBJS.G.00547; SMITH GH, 1983, J AM POD ASSOC, V73, P25, DOI 10.7547/87507315-73-1-25; SPECTOR FC, 1984, J AM POD ASSOC, V74, P259, DOI 10.7547/87507315-74-6-259; Ursei Monica, 2006, Acta Orthop Belg, V72, P131; Urteaga A J, 1995, Clin Podiatr Med Surg, V12, P759; Verzin EJ, 2000, FOOT ANKLE INT, V21, P868, DOI 10.1177/107110070002101014	32	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1067-2516	1542-2224		J FOOT ANKLE SURG	J. Foot Ankle Surg.	JUL-AUG	2012	51	4					445	449		10.1053/j.jfas.2012.04.009			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	963EJ	WOS:000305602600009	22608998				2022-02-06	
J	Potts, MA; Stewart, EW; Griesser, MJ; Harris, JD; Gelfius, CD; Klamar, K				Potts, Michelle A.; Stewart, Eric W.; Griesser, Michael J.; Harris, Joshua D.; Gelfius, Carl D.; Klamar, Karl			Exceptional Neurologic Recovery in a Teenage Football Player After Second Impact Syndrome With a Thin Subdural Hematoma	PM&R			English	Article							REPETITIVE HEAD-INJURY; 2ND-IMPACT SYNDROME; CONCUSSION; SPORTS		[Potts, Michelle A.; Gelfius, Carl D.; Klamar, Karl] Nationwide Childrens Hosp, Div Phys Med & Rehabil, Columbus, OH 43205 USA; [Stewart, Eric W.; Gelfius, Carl D.; Klamar, Karl] Ohio State Univ, Med Ctr, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Griesser, Michael J.; Harris, Joshua D.] Ohio State Univ, Med Ctr, Dept Orthopaed Surg, Columbus, OH 43210 USA		Potts, MA (corresponding author), Nationwide Childrens Hosp, Div Phys Med & Rehabil, 700 Childrens Dr, Columbus, OH 43205 USA.	Michelle.Potts@nationwidechildrens.org	Gelfius, Carl/F-9742-2013; Griesser, Michael/J-6042-2019; Harris, Joshua D/L-6280-2015	Harris, Joshua D/0000-0002-7606-2473			Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Schneider RC., 1973, HEAD NECK INJURIES F; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020	8	7	7	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482			PM&R	PM&R	JUL	2012	4	7					530	532		10.1016/j.pmrj.2012.01.015			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	981RR	WOS:000306987800012	22516435				2022-02-06	
J	Saunders, J; Craig, M; Parent, D				Saunders, James; Craig, Matthew; Parent, Daniel			Moving Deformable Barrier Test Procedure for Evaluating Small Overlap/Oblique Crashes	SAE INTERNATIONAL JOURNAL OF COMMERCIAL VEHICLES			English	Article								In September 2009 the National Highway Traffic Safety Administration (NHTSA) published a report that investigated the incidence of fatalities to belted non-ejected occupants in frontal crashes involving late-model vehicles. The report concluded that after exceedingly severe crashes, the largest number of fatalities occurred in crashes involving poor structural engagement between the vehicle and its collision partner, present in crashes characterized as corner impacts, oblique crashes, impacts with narrow objects, and heavy vehicle underrides. By contrast, few if any of these 122 fatal crashes were full-frontal or offset-frontal impacts with good structural engagement, excepting crashes that were of extreme severity or the occupants that were exceptionally vulnerable. The intent of this research program is to develop a test protocol that replicates real-world injury potential in small overlap impacts (SOI) and oblique offset impacts (Oblique) in motor vehicle crashes. Previous work towards this goal has led to the development of a Research Moving Deformable Barrier-to-Vehicle (RMDBtV) test protocol, which is further evaluated in this paper. While there were some inherent differences in the Vehicle-to-Vehicle (VtV) and RMDBtV test results, the overall agreement of vehicle and occupant responses proved promising enough to perform another VtV to RMDBtV comparison. As in the previous study, the first step is to compare the RMDBtV to VtV test for the same vehicle. This comparison focuses on the target vehicle crash metrics (pulse shape, average deceleration, slope of the velocity timehistory, total change in velocity, exterior crush profile, and interior intrusion) as well as occupant kinematics and injury assessment values. The second step of this research program is to assess the performance of new vehicles in the SOI RMDBtV and the Oblique RMDBtV test procedures. This research will provide insight on the ability of these two test procedures to replicate vehicle and occupant response as seen in the field. This paper presents the results of 7 different 2010-2011 model year vehicles tested in both the SOI and the Oblique test procedures. In these tests the overlap and RMDB closing speed was held constant for both procedures. The vehicle response demonstrated a decreasing trend of delta-V and longitudinal acceleration with increasing vehicle mass, but the trend did not hold for lateral acceleration. Aside from the lightest vehicle showing the largest magnitude of intrusion, there was no apparent trend of vehicle mass with intrusion. The occupant kinematics demonstrated head contact locations that are common in the field, torso loading of the restraint system and steering wheel, and a distribution of injury assessment values that is representative of the field injury risk.	[Saunders, James; Craig, Matthew; Parent, Daniel] NHTSA, Washington, DC 20590 USA		Saunders, J (corresponding author), NHTSA, Washington, DC 20590 USA.						Bean J. D., 2009, FATALITIES FRONTAL C, V811, P202; Dibb Alan T, 2006, Stapp Car Crash J, V50, P567; Halloway D., 2011, 2011010543 SAE, DOI [10.4271/2011-01-0543, DOI 10.4271/2011-01-0543]; Kuppa S., 2001, 17 ESV C 456; Martin P.G., 2011, 22 ESV C PAP 11 0234; Mueller B. C., 2011, P 55 STAPP CAR CRASH; Najm Eigen, 2009, 811114 DOT HS; National Highway Traffic Safety Administration, 2005, GESAC0504 US DEP TRA; Ridella S., 2011, 22 ESV C PAP 11 0312; Rudd R., 2011, 22 ESV C PAP 11 0384; Rupp JD, 2010, J BIOMECH, V43, P527, DOI 10.1016/j.jbiomech.2009.09.038; Saunders J., 22 ESV C PAP 11 0343; Saunders J., 2007, 2007011181 SAE, DOI [10.4271/2007-01-1181, DOI 10.4271/2007-01-1181]; Shams T., 2005, 19 ESV C PAP 05 0455; Shaw G, 2009, STAPP CAR CRASH JO, V53, P1; Takhounts E. G., 2011, 22 ESV C PAP 11 0263; Trella T., 2000, 2000010637 SAE, DOI [10.4271/2000-01-0637, DOI 10.4271/2000-01-0637]	17	7	8	0	0	SAE INT	WARRENDALE	400 COMMONWEALTH DR, WARRENDALE, PA 15096 USA	1946-391X	1946-3928		SAE INT J COMMER VEH	SAE Int. J. Commer. Veh.	JUL	2012	5	1					172	195		10.4271/2012-01-0577			24	Transportation Science & Technology	Emerging Sources Citation Index (ESCI)	Transportation	V8J5M	WOS:000421693700016					2022-02-06	
J	Timmons, SD; Toms, SA				Timmons, Shelly D.; Toms, Steven A.			Comparative effectiveness research in neurotrauma	NEUROSURGICAL FOCUS			English	Article						comparative effectiveness research; neurotrauma; evidence-based medicine; traumatic brain injury	TRAUMATIC BRAIN-INJURY; GUIDELINES	Comparative effectiveness research (CER) is emerging as a commonly applied technique to determine the usefulness of medical interventions. Such research aims to compare various treatments for specific disease entities for overall effectiveness and potential for harm. According to the Centers for Disease Control, an estimated 1.7 million patients sustain a traumatic brain injury (TBI) annually in the US. In this review the authors examine the existence of CER reports in the area of neurotrauma to date and consider the context in which clinical research and evidence-based guidelines have and will continue to inform such analyses, with special attention to TBI. (http://thejns.org/doi/abs/10.3171/2012.6.FOCUS1296)	[Timmons, Shelly D.; Toms, Steven A.] Geisinger Hlth Syst, Dept Neurosurg, Danville, PA 17822 USA		Timmons, SD (corresponding author), Geisinger Hlth Syst, Dept Neurosurg, 100 Acad Ave N, Danville, PA 17822 USA.	stimmons@mac.com					Aarabi Bizhan, 2001, Journal of Trauma Injury Infection and Critical Care, V51, pS1; American Association for the Surgery of Trauma, 2003, J Trauma, V54, pS235; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Bullock M Ross, 2006, Neurosurgery, V58, pS47; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Committee on Comparative Effectiveness Research Prioritization Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Gabriel EJ, 2000, GUIDELINES PREHOSPIT; Knuth T, 2006, GUIDELINES FIELD MAN; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Marion Donald W, 2006, Prog Neurol Surg, V19, P171, DOI 10.1159/000095191; Marion DW, 2006, NEUROSURGERY, V58, P655; Marko NF, 2012, NEUROSURGERY, V70, P425, DOI 10.1227/NEU.0b013e3182320a9e; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Office of the Federal Register, 2012, FED REG        0223, V77; Panczykowski DM, 2011, J NEUROSURG, V115, P541, DOI 10.3171/2011.4.JNS101672; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Sarkar B, 2011, J TRAUMA, V71, P1447, DOI 10.1097/TA.0b013e3182325d32; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Timmons SD, 2010, CRIT CARE MED, V38, pS431, DOI 10.1097/CCM.0b013e3181ec57ab; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Watts Dorraine D, 2004, Prehosp Emerg Care, V8, P254; WILKINS RH, 1964, J NEUROSURG, V21, P240, DOI 10.3171/jns.1964.21.3.0240	36	7	8	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	JUL	2012	33	1							E3	10.3171/2012.6.FOCUS1296			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	968PX	WOS:000305997400004	22746235				2022-02-06	
J	Doddamani, RS; Gupta, SK; Singla, N; Mohindra, S; Singh, P				Doddamani, Ramesh S.; Gupta, Sunil K.; Singla, Navneet; Mohindra, Sandeep; Singh, Paramjeet			Role of repeat CT scans in the management of traumatic brain injury	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Change in management; Intracranial lesions; Traumatic brain injury; Serial CT scans		Background: In trauma practice, there are no guidelines on the necessity or value of repeat CT scan. The purpose of the present study was to determine the role of serial CTs in demonstrating changes in intracranial lesions and the influence on management. Methods: In this study, 201 patients of traumatic brain injury were followed with serial CT scans for a maximum of up to 5 scans. The presence of different types of intracranial lesions at each CT scan as well as the evolution of lesions was recorded. The development of new lesions was noted. The management decisions at the time of each CT was detailed. Results: Progression of lesion was seen most often in patients with mixed lesions (21.8%). New lesions were seen in 5.5% of patients at CT-2 and in 5.8% at CT-3. Out of total 201 patients, 47 (23%) had change in management. 26 (55%) decisions of change in management were based upon clinical deterioration and 21 (45%) upon radiological changes only. A higher incidence of surgical intervention was seen in patients who had the first CT scan within 6 h of initial trauma. However, a few patients in whom the first CT scan was 6 h after trauma as well as some patients in whom CT scan was repeated as a routine without any clinical deterioration also had a change in their management. Conclusions: Repeat CT scans resulted in management changes even in patients with no clinical deterioration and thus may be of value in detecting changes at an early stage. Copyright (C) 2012, Neurotrauma Society of India. All rights reserved.	[Doddamani, Ramesh S.; Gupta, Sunil K.; Singla, Navneet; Mohindra, Sandeep] Post Grad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India; [Singh, Paramjeet] Post Grad Inst Med Educ & Res, Dept Radio Diag, Chandigarh 160012, India		Gupta, SK (corresponding author), Post Grad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India.	drguptasunil@gmail.com					Brown CV, J TRAUMA; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; COOPER PR, 1979, NEUROSURGERY, V5, P566, DOI 10.1227/00006123-197911000-00004; COPE DN, 1988, ARCH PHYS MED REHAB, V69, P483; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; POLMAN CH, 1986, NEUROSURGERY, V19, P446, DOI 10.1227/00006123-198609000-00019; ROBERSON FC, 1979, SURG NEUROL, V12, P161; SAKAI H, 1988, J NEUROSURG, V68, P566, DOI 10.3171/jns.1988.68.4.0566; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; SMITH HK, 1991, NEUROSURGERY, V29, P258, DOI 10.1227/00006123-199108000-00016; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; Stein SC, DELAYED BRAIN INJURY; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109; YAMAKI T, 1990, ACTA NEUROCHIR, V103, P112, DOI 10.1007/BF01407516	24	7	7	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2012	9	1					33	39		10.1016/j.ijnt.2012.04.007			7	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M3E	WOS:000218385700006					2022-02-06	
J	Lou, MQ; Xue, F; Chen, LJ; Xue, YJ; Wang, K				Lou, Meiqing; Xue, Fei; Chen, Lujia; Xue, Yajun; Wang, Ke			Is high PEEP ventilation strategy safe for acute respiratory distress syndrome after severe traumatic brain injury?	BRAIN INJURY			English	Article						Acute lung injury; acute respiratory distress syndrome; positive end-expiratory pressure; severe traumatic brain injury; severe head injury	ACUTE LUNG INJURY; SEVERE HEAD-INJURY; END-EXPIRATORY PRESSURE	Primary objective: To investigate the safety and efficacy of high positive end-expiratory pressure (PEEP) ventilation strategy for acute respiratory distress syndrome (ARDS) after traumatic brain injury. Research design: A case report and discussion based on literature review. Methods and procedures: This article reports the case of a 17-year-old male patient who developed ARDS after severe traumatic brain injury. PEEP was applied and adjusted to appropriate levels on the basis of information obtained from continuous monitoring of cerebral and systemic haemodynamics. Data from medical charts, surgical notes and radiographic findings were reviewed and analysed. Main outcomes and results: With the application of high PEEP ventilation, the patient survived ARDS following severe traumatic brain injury and achieved a favourable neurological outcome. A titration of PEEP levels from 5-15 cm H2O in the patient resulted in acceptable changes of cerebral and systemic haemodynamics, including an increase of intracranial pressure (ICP) from 15 to 18mmHg and a decrease of cerebral perfusion pressure (CPP) from 78 to 72mmHg. Conclusions: With close monitoring of cerebral and systemic haemodynamics, PEEP can be safely applied and titrated to an optimal level in the management of ARDS following traumatic brain injury.	[Lou, Meiqing; Xue, Fei; Chen, Lujia; Xue, Yajun; Wang, Ke] Tongji Univ, Dept Neurosurg, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China		Wang, K (corresponding author), Tongji Univ, Dept Neurosurg, Shanghai Peoples Hosp 10, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.	trizzt@gmail.com		Chen, Lu-Jia/0000-0002-7656-9063			Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; COOPER KR, 1985, J NEUROSURG, V63, P552, DOI 10.3171/jns.1985.63.4.0552; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Saharan S, 2010, INDIAN J PEDIATR, V77, P1296, DOI 10.1007/s12098-010-0169-z	14	7	12	0	10	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2012	26	6					887	890		10.3109/02699052.2012.660514			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	943EO	WOS:000304103500011	22583180				2022-02-06	
J	Yan, H; Zhang, HW; Wu, QL; Zhang, GB; Liu, K; Zhi, DS; Hu, ZB; Zeng, XW				Yan Hua; Zhang Hong-wei; Wu Qiao-li; Zhang Guo-bin; Liu Kui; Zhi Da-shi; Hu Zhen-bo; Zeng Xian-wei			Increased leakage of brain antigens after traumatic brain injury and effect of immune tolerance induced by cells on traumatic brain injury	CHINESE MEDICAL JOURNAL			English	Article						traumatic brain injury; stem cell; antigen; dendritic cell; immune tolerance	IMMATURE DENDRITIC CELLS; INDUCTION; TUMOR	Background Although traumatic brain injury can lead to opening the blood-brain barrier and leaking of blood substances (including water) into brain tissue, few studies of brain antigens leaking into the blood and the pathways have been reported. Brain antigens result in damage to brain tissues by stimulating the immune system to produce anti-brain antibodies, but no treatment has been reported to reduce the production of anti-brain antibodies and protect the brain tissue. The aim of the study is to confirm the relationship between immune injury and arachnoid granulations following traumatic brain injury, and provide some new methods to inhibit the immune injury. Methods In part one, methylene blue was injected into the rabbits' cisterna magna after traumatic brain injury, and concentrations of methylene blue and tumor necrosis factor (TNF)-alpha in blood were detected to determine the permeability of arachnoid granulations. In part two, umbilical cord mesenchymal stem cells and immature dendritic cells were injected into veins, and concentrations of interleukin 1 (IL-1), IL-10, interferon (IFN)-gamma, transforming growth factor (TGF)-beta, anti-brain antibodies (ABAb), and IL-12 were measured by ELISA on days 1, 3, 7, 14 and 21 after injury, and the numbers of leukocytes in the blood were counted. Twenty-one days after injury, expression of glutamate in brain tissue was determined by immunohistochemical staining, and neuronal degeneration was detected by H&E staining. Results In part one, blood concentrations of methylene blue and TNF-alpha in the traumatic brain injury group were higher than in the control group (P<0.05). Concentrations of methylene blue and TNF-alpha in the trauma cerebrospinal fluid (CSF) injected group were higher than in the control cerebrospinal fluid injected group (P<0.05). In part two, concentrations of IL-1, IFN-gamma, ABAb, IL-12, expression of glutamate (Glu), neuronal degeneration and number of peripheral blood leukocytes were lower in the group with cell treatment compared to the control group. IL-10 and TGF-beta were elevated compared to the control group. Conclusions Traumatic brain injury can lead to stronger arachnoid granulations (AGs) permeability; umbilical cord mesenchymal stem cells and immature dendritic cells can induce immune tolerance and reduce inflammation and anti-brain antibodies to protect the brain tissue. Chin Med J 2012;125(9):1618-1626	[Zeng Xian-wei] Weifang Med Coll, Affiliated Hosp, Dept Neurosurg, Weifang 261053, Shandong, Peoples R China; [Hu Zhen-bo] Weifang Med Coll, Affiliated Hosp, Dept Stem Cell Res & Transplantat Ctr, Weifang 261053, Shandong, Peoples R China; [Yan Hua; Wu Qiao-li; Zhang Guo-bin; Zhi Da-shi] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin 300070, Peoples R China; [Zhang Hong-wei] Tianjin Med Univ, Second Hosp, Dept Neurosurg, Tianjin 300070, Peoples R China; [Liu Kui] Tianjin Peoples Hosp, Dept Neurosurg, Tianjin 300070, Peoples R China		Zeng, XW (corresponding author), Weifang Med Coll, Affiliated Hosp, Dept Neurosurg, Weifang 261053, Shandong, Peoples R China.	zengxwei@163.com			Tianjin Public Health Bureau [07KG3, 10KG208]; Tianjin Municipal Science and Technology Commission [08ZCGYSF01600]; Shandong Province Science and Technology Development Plan [2011GSF11829]	YAN Hua and ZHANG Hong-wei contributed equally to this study. This study was supported by grants from Tianjin Public Health Bureau (No. 07KG3, 10KG208), Tianjin Municipal Science and Technology Commission (No. 08ZCGYSF01600) and Shandong Province Science and Technology Development Plan (2011GSF11829).	Aldinucci A, 2010, J IMMUNOL, V185, P5102, DOI 10.4049/jimmunol.1001332; Choi YS, 2012, IMMUNOL INVEST, V41, P214, DOI 10.3109/08820139.2011.619022; Conegero CI, 2003, ARQ NEURO-PSIQUIAT, V61, P561, DOI 10.1590/S0004-282X2003000400007; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; Grzybowski DM, 2006, INVEST OPHTH VIS SCI, V47, P3664, DOI 10.1167/iovs.05-0929; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Holman David W, 2005, Cerebrospinal Fluid Res, V2, P9, DOI 10.1186/1743-8454-2-9; Huang XQ, 2007, CHIN J NEUROL CHIN, V6, P165; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Lutz MB, 2009, EUR J IMMUNOL, V39, P2325, DOI 10.1002/eji.200939548; MANN JD, 1979, J NEUROSURG, V50, P343, DOI 10.3171/jns.1979.50.3.0343; Meng L, 2006, J CHINESE PHYS, V8, P865; PENG QA, 1993, J PHOTOCH PHOTOBIO B, V20, P63, DOI 10.1016/1011-1344(93)80132-S; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ren Ya-na, 2007, Zhonghua Xue Ye Xue Za Zhi, V28, P298; Ren YN, 2008, CHIN J EXP HEMATOL C, V16, P650; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Shlomchik MJ, 2009, CURR OPIN IMMUNOL, V21, P626, DOI 10.1016/j.coi.2009.08.005; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Tipnis S, 2010, IMMUNOL CELL BIOL, V88, P795, DOI 10.1038/icb.2010.47; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; [闫华 YAN Hua], 2010, [中华神经外科杂志, Chinese Journal of Neurosurgery], V26, P155; Yu P, 2009, IMMUNOLOGY, V127, P500, DOI 10.1111/j.1365-2567.2009.03057.x; [张洪伟 ZHANG Hongwei], 2011, [中华神经外科杂志, Chinese Journal of Neurosurgery], V27, P624; 谢如锋, 2005, [中国生物制品学杂志, Chinese Journal of Biologicals], V18, P424; 孟雷, 2006, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V32, P258	31	7	11	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0366-6999	2542-5641		CHINESE MED J-PEKING	Chin. Med. J.	MAY 5	2012	125	9					1618	1626		10.3760/cma.j.issn.0366-6999.2012.09.018			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942DM	WOS:000304022500018	22800832				2022-02-06	
J	Degos, V; Lescot, T; Icke, C; Le Manach, Y; Fero, K; Sanchez, P; Hadiji, B; Zouaoui, A; Boch, AL; Abdennour, L; Apfel, CC; Puybasset, L				Degos, Vincent; Lescot, Thomas; Icke, Christian; Le Manach, Yannick; Fero, Katherin; Sanchez, Paola; Hadiji, Bassem; Zouaoui, Abederrezak; Boch, Anne-Laure; Abdennour, Lamine; Apfel, Christian C.; Puybasset, Louis			Computed Tomography-Estimated Specific Gravity at Hospital Admission Predicts 6-Month Outcome in Mild-to-Moderate Traumatic Brain Injury Patients Admitted to the Intensive Care Unit	ANESTHESIA AND ANALGESIA			English	Article							CLOSED-HEAD INJURY; SERUM S-100B; DENSITY; VOLUME; CONTUSIONS; EDEMA; AREAS; MODEL; MICE	BACKGROUND: It is clear that patients with a severe traumatic brain injury (TBI) develop secondary, potentially lethal neurological deterioration. However, it is difficult to predict which patients with mild-to-moderate TBI (MM-TBI), even after intensive care unit (ICU) admission, will experience poor outcome at 6 months. Standard computed tomography (CT) imaging scans provide information that can be used to estimate specific gravity (eSG). We have previously demonstrated that higher eSG measurements in the standard CT reading were associated with poor outcomes after severe TBI. The aim of this study was to determine whether eSG of the intracranial content predicts 6-month outcome in MM-TBI. METHODS: We analyzed admission clinical and CT scan data (including eSG) of 66 patients with MM-TBI subsequently admitted to our neurosurgical ICU. Primary outcome was defined as a Glasgow Outcome Scale score of 1 to 3 after 6 months. Discriminating power (area under the receiver operating characteristic curve [ROC-AUC], 95% confidence interval) of eSG to predict 6-month poor outcome was calculated. The correlation of eSG with the main ICU characteristics was then compared. RESULTS: Univariate and stepwise multivariate analyses showed an independent association between eSG and 6-month poor outcome (P = 0.001). ROC-AUC of eSG for the prediction of 6-month outcomes was 0.87 (confidence interval: 0.77-0.96). Admission eSG values were correlated with the main ICU characteristics, specifically 14-day mortality (P = 0.004), length of mechanical ventilation (P = 0.01), length of ICU stay (P = 0.045), and ICU procedures such as intracranial pressure monitoring (P < 0.001). CONCLUSIONS: In this MM-TBI cohort admitted to the ICU, eSG of routine CT scans was correlated with mortality, ICU severity, and predicted 6-month poor outcome. An external validation with studies that include the spectrum of TBI severities is warranted to confirm our results. (Anesth Analg 2012;114:1026-33)	[Degos, Vincent; Fero, Katherin; Apfel, Christian C.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94115 USA; [Degos, Vincent; Lescot, Thomas; Icke, Christian; Le Manach, Yannick; Sanchez, Paola; Hadiji, Bassem; Abdennour, Lamine; Puybasset, Louis] Grp Hosp Pitie Salpetriere, Dept Anesthesiol & Crit Care, F-75634 Paris, France; [Zouaoui, Abederrezak] Grp Hosp Pitie Salpetriere, Dept Neuroradiol, F-75634 Paris, France; [Boch, Anne-Laure] Grp Hosp Pitie Salpetriere, Dept Neurosurg, F-75634 Paris, France		Degos, V (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, 1600 Divisadero St, San Francisco, CA 94115 USA.	degosv@anesthesia.ucsf.edu	Le Manach, Yannick/AAE-5700-2019	Le Manach, Yannick/0000-0003-0474-8545; Fero, Katherine/0000-0002-2155-960X	Assistance Publique des Hopitaux de Paris; nonprofit organization Fondation des Gueules Cassees, Paris, France	Supported by Assistance Publique des Hopitaux de Paris and the nonprofit organization Fondation des Gueules Cassees, Paris, France.	Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; BULLOCK R, 1985, J NEUROSURG, V63, P64, DOI 10.3171/jns.1985.63.1.0064; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Degos V, 2008, NEUROCRIT CARE, V9, P338, DOI 10.1007/s12028-008-9131-6; Degos V, 2006, ANESTH ANALG, V103, P1229, DOI 10.1213/01.ane.0000237401.22688.22; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hoelper BM, 2000, ACTA NEUROCHIR SUPPL, V76, P21; Inaba K, 2007, AM SURGEON, V73, P1023; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Kofke WA, 2011, J NEUROSURG ANESTH, V23, P177, DOI 10.1097/ANA.0b013e318222b5f2; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Lescot T, 2005, INTENS CARE MED, V31, P1042, DOI 10.1007/s00134-005-2709-y; Lescot T, 2008, CURR OPIN CRIT CARE, V14, P129, DOI 10.1097/MCC.0b013e3282f63c51; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MULL RT, 1984, AM J ROENTGENOL, V143, P1101, DOI 10.2214/ajr.143.5.1101; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; PHELPS ME, 1975, RADIOLOGY, V117, P585, DOI 10.1148/117.3.585; Stapert S, 2005, EUR NEUROL, V53, P22, DOI 10.1159/000083678; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013	32	7	7	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	MAY	2012	114	5					1026	1033		10.1213/ANE.0b013e318249fe7a			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	931PI	WOS:000303231400017	22366842				2022-02-06	
J	Falavigna, A; Teles, AR; Velho, MC; Medeiros, GS; Canabarro, CT; de Braga, GL; Barazzetti, DO; Vedana, VM; Kleber, FD				Falavigna, Asdrubal; Teles, Alisson Roberto; Velho, Maira Cristina; Medeiros, Gregory Saraiva; Canabarro, Carolina Travi; de Braga, Gustavo Lisboa; Barazzetti, Daniel Ongaratto; Vedana, Viviane Maria; Kleber, Fabricio Diniz			Impact of an injury prevention program on teenagers' knowledge and attitudes: results of the Pense Bem-Caxias do Sul Project Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						injury prevention; spinal cord injury; traumatic brain injury; education; Pense Bem Project; ThinkFirst; trauma	TRAFFIC ACCIDENTS; BEHAVIOR; SAFETY; VIDEO; RISK; CITY	Object. Trauma is the leading cause of mortality and morbidity in children, young people, and working-age adults. Because of the high incidence of intentional and unintentional injuries in young people, it is necessary to implement injury-prevention programs and measure the efficacy of these initiatives. The authors evaluated the effectiveness of an injury-prevention program in high school students in a city in southern Brazil. Methods. In a randomized controlled study, 1049 high school students were divided into a control group and intervention group. The study was conducted in the following 3 stages: a questionnaire was applied I week before the educational intervention (PO), shortly after the intervention (P1), and 5 months later (P3). In the control group, a questionnaire based on the Pense Bern Project was applied at the 3 time stages, without any intervention between the stages. Results. The postintervention analysis evidenced a slight change in knowledge about unintentional spinal cord and brain injuries. Regarding attitudes, the only significant improvement after the intervention lecture was in the use of helmets, which remained high 5 months later. A substantial number of students only partially agreed with using safety behaviors. The only significant postintervention change was the major agreement to check swimming pool depth before entering the water (P0 89% and P1 97.8%, p < 0.001; P2 92.8%, p = 0.005). Conclusions. An educational intervention based on a single lecture improved students' knowledge of traumatic brain and spinal cord injuries, but this type of intervention did not modify most attitudes toward injury prevention.	[Falavigna, Asdrubal] Univ Caxias do Sul, Dept Neurol & Neurosurg, BR-95040290 Caxias Do Sul, RS, Brazil; [Teles, Alisson Roberto] Hosp Sao Jose, Dept Neurosurg, Complexo Hosp Santa Casa de Misericordia Porto Al, Porto Alegre, RS, Brazil; [Velho, Maira Cristina] Hosp Beneficencia Portuguesa, Dept Neurosurg, Porto Alegre, RS, Brazil; [Medeiros, Gregory Saraiva; Canabarro, Carolina Travi; de Braga, Gustavo Lisboa; Barazzetti, Daniel Ongaratto] Univ Caxias do Sul LAMNN, UCS, Acad Multidisciplinar Neurol & Neurocirurgia, Caxias Do Sul, Brazil; [Kleber, Fabricio Diniz] Hosp Clin Porto Alegre, Dept Neurol, Porto Alegre, RS, Brazil		Falavigna, A (corresponding author), Univ Caxias do Sul, Dept Neurol & Neurosurg, Rua Gen Arcy de Rocha Nobrega 401-602, BR-95040290 Caxias Do Sul, RS, Brazil.	asdrubalmd@gmail.com	Medeiros, Gregory/AAL-8194-2021; Teles, Alisson R./U-5661-2018; Medeiros, Gregory S/F-1675-2013; Falavigna, Asdrubal/H-5123-2012	Teles, Alisson R./0000-0003-2169-8156; Falavigna, Asdrubal/0000-0002-0016-3198			BAKER SP, 1984, INJURY FACT BOOK; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Eichel JD, 2001, J SCHOOL HEALTH, V71, P180, DOI 10.1111/j.1746-1561.2001.tb07312.x; Fitzpatrick P, 2006, INJURY PREV, V12, P404, DOI 10.1136/ip.2006.013177; Hingson R, 1991, J TRAFFIC MED, V18, P123; JONAH BA, 1986, ACCIDENT ANAL PREV, V18, P255, DOI 10.1016/0001-4575(86)90041-2; Jorge Maria Helena Prado de Mello, 2004, Rev. bras. epidemiol., V7, P228; Josse JM, 2006, INT J CIRCUMPOL HEAL, V65, P385; Laraque D, 1995, B NEW YORK ACAD MED, V72, P16; Minayo MCS, 1994, CAD SAUDE PUBLICA, V10, P7, DOI [10. 1590/ S0102- 311X1994000500002, DOI 10.1590/S0102-311X1994000500002]; Mock C, 2007, SURG CLIN N AM, V87, P1, DOI 10.1016/j.suc.2006.09.017; Monneuse OJY, 2008, J AM COLL SURGEONS, V207, P179, DOI 10.1016/j.jamcollsurg.2008.01.021; Morrison L, 2002, INJ PREV, V8, P111, DOI 10.1136/ip.8.2.111; Salvarani CP, 2009, SURG NEUROL, V72, P6, DOI 10.1016/j.surneu.2007.10.008; SCHALL E, 1994, AM J PREV MED, V10, P30, DOI 10.1016/S0749-3797(18)30549-X; Sethi D, INJURIES VIOLENCE EU; Shope JT, 2006, INJURY PREV, V12, P9, DOI 10.1136/ip.2006.011874; Vasconcellos EA, 1999, ACCIDENT ANAL PREV, V31, P319, DOI 10.1016/S0001-4575(98)00065-7; Wesner ML, 2003, CAN J PUBLIC HEALTH, V94, P115, DOI 10.1007/BF03404583; *WHO, NEW PUBL SHOW INJ KI; Williams AF, 2006, INJURY PREV, V12, P4, DOI 10.1136/ip.2006.011783; Wright M, 1995, Inj Prev, V1, P81, DOI 10.1136/ip.1.2.81	22	7	7	0	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707			J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAY	2012	9	5					562	568		10.3171/2011.12.PEDS11169			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	929TQ	WOS:000303089000017	22546036				2022-02-06	
J	Goksu, E; Ucar, T; Akyuz, M; Yilmaz, M; Kazan, S				Goksu, Ethem; Ucar, Tanju; Akyuz, Mahmut; Yilmaz, Murat; Kazan, Saim			Effects of decompressive surgery in patients with severe traumatic brain injury and bilateral non-reactive dilated pupils	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Decompressive surgery; traumatic brain injury; nonreactive dilated pupil	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; COMA SCALE SCORE; INTRACRANIAL HYPERTENSION; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; CRANIECTOMY; MANAGEMENT; HYPERVENTILATION; MANNITOL	BACKGROUND We investigated Glasgow Coma Scale (GCS) scores, intracranial pressure (ICP) and cerebral perfusion pressure (CPP) changes, and long-term clinical outcomes in patients with severe traumatic brain injury (STBI) associated with bilateral non-reactive dilated pupils (BNDP) who underwent decompressive surgery (DS). METHODS The study group consisted of 28 patients (11 females, 17 males) with BNDP from among 147 patients who underwent DS due to STBI in our department. RESULTS The mean GCS score was 4.96 +/- 1.20 at admission and 4 preoperatively. Mean ICP in non-surviving patients after DS was higher (p<0.05). ICP decrease after DS was also higher in surviving patients than in non-surviving patients (p<0.05). The overall mortality rate was 61.02%. A GCS motor score >2 at admission was associated with lower mortality (p<0.05). Four of the surviving patients (14.28%) had a functional outcome (Glasgow Outcome Score: 4 and 5) at one year after hospital discharge. CONCLUSION Outcome in patients with BNDP after STBI may not always be fatal or poor. Rapid DS may increase the chance of functional survival, especially in patients with admission GCS score of 6 or 7.	[Goksu, Ethem; Ucar, Tanju; Akyuz, Mahmut; Kazan, Saim] Akdeniz Univ, Fac Med, Dept Neurosurg, TR-07070 Antalya, Turkey; [Yilmaz, Murat] Akdeniz Univ, Fac Med, Dept Anaesthesiol & Reanimat, TR-07070 Antalya, Turkey		Goksu, E (corresponding author), Akdeniz Univ, Fac Med, Dept Neurosurg, TR-07070 Antalya, Turkey.	ethemgoksu@mynet.com	Yilmaz, Murat/I-6629-2017; Kazan, Saim/G-1782-2016				Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Cruz J, 2002, NEUROSURGERY, V51, P628, DOI 10.1097/00006123-200209000-00006; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; GERL A, 1980, Zentralblatt fuer Neurochirurgie, V41, P125; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; JOURDAN C, 1993, NEUROCHIRURGIE, V39, P304; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kazan S, 1997, ACTA NEUROCHIR, V139, P295, DOI 10.1007/BF01808824; Koh MS, 2000, SURG NEUROL, V53, P225, DOI 10.1016/S0090-3019(00)00163-4; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marmarou A, 1996, ACT NEUR S, V66, P118; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McKinely BA, 1999, J TRAUMA, V46, P271, DOI 10.1097/00005373-199902000-00013; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Pasquale MD, 1996, J TRAUMA, V41, P726, DOI 10.1097/00005373-199610000-00022; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; Young JS, 2000, J NEUROSURG, V92, P191	40	7	7	0	8	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAY	2012	18	3					231	238		10.5505/tjtes.2012.79059			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	958VM	WOS:000305269000007	22864715	Bronze			2022-02-06	
J	Blissitt, PA				Blissitt, Patricia A.			Controversies in the Management of Adults With Severe Traumatic Brain Injury	AACN ADVANCED CRITICAL CARE			English	Article						controversies; critical care nursing; evidence-based practice; management; severe traumatic brain injury	REFRACTORY INTRACRANIAL HYPERTENSION; HYPERTONIC SALINE; DECOMPRESSIVE CRANIECTOMY; THERAPEUTIC HYPOTHERMIA; VENOUS THROMBOEMBOLISM; CEREBRAL OXYGENATION; HEAD-INJURY; PRESSURE; MANNITOL; TRANSFUSION	Despite progress in the management of adults with severe traumatic brain injury, several controversies persist. Among the unresolved issues of greatest concern to neurocritical care clinicians and scientists are the following: (1) the best use of technological advances and the data obtained from multimodality monitoring; (2) the use of mannitol and hypertonic saline in the management of increased intracranial pressure; (3) the use of decompressive craniectomy and barbiturate coma in refractory increased intracranial pressure; (4) therapeutic hypothermia as a neuroprotectant; (5) anemia and the role of blood transfusion; and (6) venous thromboembolism prophylaxis in severe traumatic brain injury. Each of these strategies for managing severe traumatic brain injury, including the postulated mechanism(s) of action and beneficial effects of each intervention, adverse effects, the state of the science, and critical care nursing implications, is discussed.	[Blissitt, Patricia A.] Harborview Med Ctr, 325 Ninth Ave, Seattle, WA 98104 USA; [Blissitt, Patricia A.] Univ Washington, Clin Fac, Sch Nursing, Seattle, WA 98195 USA		Blissitt, PA (corresponding author), Harborview Med Ctr, 325 Ninth Ave, Seattle, WA 98104 USA.	pbliss@u.washington.edu					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; Andrefsky JC, 1999, J NEUROSURG, V90, P644, DOI 10.3171/jns.1999.90.4.0644; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Appelboom G, 2012, WORLD NEUROSURG; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Bassin SL, 2008, CRIT CARE, V12, DOI 10.1186/cc7020; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2007.9991; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS21; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Chen HI, 2008, NEUROSURGERY, V63, P880, DOI 10.1227/01.NEU.0000327882.10629.06; Chesnut RM, 2007, SURG CLIN N AM, V87, P119, DOI 10.1016/j.suc.2006.09.018; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Diedler J, 2010, NEUROCRIT CARE, V12, P313, DOI 10.1007/s12028-010-9350-5; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490; Finkelstein Robert A, 2010, J Intensive Care Med, V25, P205, DOI 10.1177/0885066610366919; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Hartl R, 1997, ACT NEUR S, V70, P126; Hays AN, 2011, NEUROCRIT CARE, V14, P222, DOI 10.1007/s12028-010-9477-4; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Honeybul S, 2011, J NEUROSURG SCI, V55, P343; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Huang SJ, 2006, SURG NEUROL, V65, P539, DOI 10.1016/j.surneu.2005.11.019; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Komotar RJ, 2011, NEUROSURGERY, V69, pN22, DOI 10.1227/01.neu.0000400020.24025.21; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Nau R, 2000, CLIN PHARMACOKINET, V38, P23, DOI 10.2165/00003088-200038010-00002; Netzer G, 2008, CRIT CARE MED, V36, P1383, DOI 10.1097/CCM.0b013e31816a10a3; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Patanwala AE, 2010, AM J HEALTH-SYST PH, V67, P1920, DOI 10.2146/ajhp090523; Perez-Barcena J, 2008, CRIT CARE, V12, DOI 10.1186/cc6999; Perez-Perez AJ, 2002, AM J NEPHROL, V22, P573, DOI 10.1159/000065279; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Sakowitz OW, 2007, J TRAUMA, V62, P292, DOI 10.1097/01.ta.0000203560.03937.2d; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Salottolo K, 2011, J TRAUMA, V70, P19, DOI 10.1097/TA.0b013e318207c54d; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Shang EK, 2011, VASC ENDOVASC SURG, V45, P290, DOI 10.1177/1538574410395038; Sinclair HL, 2010, CRIT CARE, V14, DOI 10.1186/cc8220; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Sorani MD, 2008, J NEUROTRAUM, V25, P291, DOI 10.1089/neu.2007.0411; Stevens AM, 2008, ANN PHARMACOTHER, V42, P516, DOI 10.1345/aph.1K555; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Strijkers RHW, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5916; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub3; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Torre-Healy A, 2012, NEUROCRIT CARE, V17, P117, DOI 10.1007/s12028-011-9649-x; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; Visweswaran P, 1997, J AM SOC NEPHROL, V8, P1028; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Wartenberg KE, 2007, CRIT CARE CLIN, V23, P507, DOI 10.1016/j.ccc.2007.06.002; Wen L, 2011, BRAIN INJURY, V25, P1318, DOI 10.3109/02699052.2011.608214; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Winter CD, 2005, SURG-J R COLL SURG E, V3, P329, DOI 10.1016/S1479-666X(05)80112-X; Ziai WC, 2007, J NEUROL SCI, V261, P157, DOI 10.1016/j.jns.2007.04.048; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	101	7	7	0	0	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1559-7768	1559-7776		AACN ADV CRIT CARE	AACN Adv. Crit. Care	APR-JUN	2012	23	2					186	203		10.1097/NCI.0b013e31824db4f3			18	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	VF8SQ	WOS:000443786100009	22543492				2022-02-06	
J	Friess, SH; Naim, MY; Kilbaugh, TJ; Ralston, J; Margulies, SS				Friess, S. H.; Naim, M. Y.; Kilbaugh, T. J.; Ralston, J.; Margulies, S. S.			Premedication with meloxicam exacerbates intracranial haemorrhage in an immature swine model of non-impact inertial head injury	LABORATORY ANIMALS			English	Article						Swine; refinement; meloxicam; bleeding; brain injury	TRAUMATIC AXONAL INJURY; NEONATAL PIG; PHARMACOKINETICS; PIGLETS	Meloxicam is a cyclo-oxygenase-2 (COX-2) preferential non-steroidal anti-inflammatory drug with very effective analgesic and anti-inflammatory effects in swine. Previous reports in piglets have demonstrated that meloxicam also inhibits COX-1 and reduces production of thromboxane significantly. We use preinjury analgesia in our immature swine (3-5-day-old piglets) model of brain injury using rapid head rotations without impact. In 23 consecutive subjects we found that premedication with meloxicam (n = 6) produced a significantly higher mortality rate (5/6 or 83%) than buprenorphine (n = 17, 1/17 or 6%, P < 0.02). On gross neuropathological examination of the meloxicam-treated swine, we observed massive subdural and subarachnoid bleeding which were not present in buprenorphine-premedicated animals. To our knowledge there are no previous reports in swine of increased bleeding or platelet inhibition associated with meloxicam administration and further research is needed to define mechanisms of action in piglets. We caution the use of meloxicam in swine when inhibition of platelet aggregation might adversely affect refinement of experimental research protocols, such as in stroke, trauma and cardiac arrest models.	[Ralston, J.; Margulies, S. S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Friess, S. H.; Naim, M. Y.; Kilbaugh, T. J.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA		Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu		Kilbaugh, Todd/0000-0002-4959-3092	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08-NS064051, R01 NS39679]; Thrasher Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS069545, K08NS064051, R01NS039679] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health K08-NS064051 (SHF); Thrasher Research Foundation New Investigator Award (MYN); and National Institutes of Health R01 NS39679 (SSM).	Brideau C, 2001, AM J VET RES, V62, P1755, DOI 10.2460/ajvr.2001.62.1755; Busch U, 1998, DRUG METAB DISPOS, V26, P576; Fosse TK, 2008, J VET PHARMACOL THER, V31, P246, DOI 10.1111/j.1365-2885.2008.00958.x; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Friton GM, 2006, VET REC, V159, P552, DOI 10.1136/vr.159.17.552; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Reyes L, 2002, PHARMACOL BIOCHEM BE, V73, P521, DOI 10.1016/S0091-3057(02)00820-1; Rinder HM, 2002, J CLIN PHARMACOL, V42, P881, DOI 10.1177/009127002401102795	11	7	7	0	7	ROYAL SOC MEDICINE PRESS LTD	LONDON	1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND	0023-6772			LAB ANIM-UK	Lab. Anim.	APR	2012	46	2					164	166		10.1258/la.2011.011084			3	Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences; Zoology	949MP	WOS:000304580600012	22238292	Green Accepted			2022-02-06	
J	Schibler, A; Humphreys, S				Schibler, Andreas; Humphreys, Susan			Increased brain tissue oxygen tension in children with traumatic brain injury using temperature-corrected guided ventilation during prophylactic hypothermia	CRITICAL CARE AND RESUSCITATION			English	Article							SEVERE HEAD-INJURY; ALPHA-STAT; PH-STAT; SUBARACHNOID HEMORRHAGE; THERAPEUTIC HYPOTHERMIA; PRESSURE; CARE; MANAGEMENT; REACTIVITY	Objective: To investigate whether ventilatory management using a temperature-corrected (pH-stat) or uncorrected (alpha-stat) blood gas analysis strategy improves brain tissue oxygen tension (PbrO(2)) in children prophylactically treated with moderate hypothermia for traumatic brain injury. Design, setting and participants: Double crossover study conducted in the intensive care unit of a tertiary children's hospital. Nine children aged 3-14 years with severe traumatic brain injury were randomly allocated twice to a 6-hour period of either alpha- or pH-stat management while being kept hypothermic at 32.5 degrees C. Main outcome measures: PbrO(2), intracranial pressure (ICP) and PbrO(2)/PaO2. Results: PbrO(2) was significantly higher during pH-stat management (alpha-stat, 23.2 mmHg [95% Cl, 22.4-24.0 mmHg] v pH-stat, 28.7 mmHg [95% Cl, 27.9-29.5 mmHg]; P<0.001). PbrO(2)/PaO2 was significantly higher during pH-stat (alpha-stat, 0.190 [95% Cl, 0.187-0.193] v pH-stat, 0.251 [95% Cl, 0.246-0.259]; P < 0.05). ICP was non-significantly higher during pH-stat (alpha-stat, 8.8 mmHg [95% Cl, 8.1-9.5 mmHg] v ph-stat, 10.2 mmHg [95% Cl, 9.6-10.8]). Conclusion: PbrO(2) may be improved using a pH-stat blood gas management strategy in prophylactic hypothermia for paediatric patients with traumatic brain injury without any clinically relevant increase in ICP.	[Schibler, Andreas; Humphreys, Susan] Univ Queensland, Mater Childrens Hosp, Paediat Crit Care Res Grp, Paediat Intens Care Unit, Brisbane, Qld 4101, Australia		Schibler, A (corresponding author), Univ Queensland, Mater Childrens Hosp, Paediat Crit Care Res Grp, Paediat Intens Care Unit, Brisbane, Qld 4101, Australia.	andreas.schibler@mater.org.au	Humphreys, Susan/N-9746-2017; Schibler, Andreas/C-3503-2012; Schibler, Andreas/D-8876-2015	Humphreys, Susan/0000-0003-0286-2088; Schibler, Andreas/0000-0002-0791-5938			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS28; Adelson PD, 2003, PEDIAT CRIT CARE M S, V4, pS45; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Critchley GR, 2003, NEUROL RES, V25, P451, DOI 10.1179/016164103101201841; du Plessis AJ, 1997, J THORAC CARDIOV SUR, V114, P991, DOI 10.1016/S0022-5223(97)70013-8; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Hutchison JS, 2010, DEV NEUROSCI-BASEL, V32, P406, DOI 10.1159/000323260; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Johnston AJ, 2003, BRIT J ANAESTH, V90, P774, DOI 10.1093/bja/aeg104; Kochanek PM, 2009, PEDIATR CRIT CARE ME, V10, P517, DOI 10.1097/PCC.0b013e3181ab88cd; Kollmar R, 2009, NEUROCRIT CARE, V10, P173, DOI 10.1007/s12028-008-9162-z; Laussen PC, 2002, PAEDIATR ANAESTH, V12, P199, DOI 10.1046/j.1460-9592.2002.00779.x; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Meixensberger J, 2003, NEUROL RES, V25, P445, DOI 10.1179/016164103101201823; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Shann F, 2003, LANCET, V362, P1950, DOI 10.1016/S0140-6736(03)15083-0; Steiner LA, 2003, ANESTH ANALG, V97, P572, DOI 10.1213/01.ANE.0000070234.17226.B0; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; Timmons SD, 2010, CRIT CARE MED, V38, pS431, DOI 10.1097/CCM.0b013e3181ec57ab; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Vigue B, 2000, INTENS CARE MED, V26, P722, DOI 10.1007/s001340051238	28	7	7	0	1	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	MAR	2012	14	1					20	24					5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904PL	WOS:000301210300005	22404057				2022-02-06	
J	Thompson, JWG; Hagedorn, D				Thompson, James W. G.; Hagedorn, David			Multimodal Analysis: New Approaches to the Concussion Conundrum	JOURNAL OF CLINICAL SPORT PSYCHOLOGY			English	Article						electrocardiography; electroencephalography; sport; concussion; traumatic brain injury; heart rate variability	TRAUMATIC BRAIN-INJURY; HEART-RATE-VARIABILITY; COLLEGIATE FOOTBALL PLAYERS; SPORT-RELATED CONCUSSION; EVENT-RELATED POTENTIALS; CEREBRAL CONCUSSION; POSTURAL CONTROL; PRESSURE VARIABILITY; SPECTRAL-ANALYSIS; BLOOD-PRESSURE	Sports-related concussions are complex injuries with biomechanical and biochemical etiology that present with central and autonomic nervous system dysfunction. Current methods for assessing concussions and basing return-to-play decisions rely on symptom resolution, rating scales, and neuropsychological testing, all of which are indirect measures of injury severity and detect functional capabilities but do not directly measure injury location or severity. In addition, these downstream measures are susceptible to false negatives because compensatory mechanism, such as unmasking and redundancies in brain circuitry can return functional capabilities before injury resolution. The multifactorial nature of concussion necessitates rapid, inexpensive, and easily applied multimodal analysis methods that can offer greater sensitivity and specificity. This article discusses how new approaches utilizing electrophysiology (e.g., QEEG, ERP, ECG, HRV), quantified balance measures, and biochemistry are necessary to advance the science of concussion assessment, treatment, recovery projections, and return-to-play decisions. These additional assessment tools offer a more direct window into the severity and location of the injury, real-time measures of brain function, and the ability to measure the multiple body systems negatively affected by concussion.	[Thompson, James W. G.] Evoke Neurosci Inc, New York, NY 10010 USA; [Hagedorn, David] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA		Thompson, JWG (corresponding author), Evoke Neurosci Inc, New York, NY 10010 USA.						Adrian ED, 1932, J PHYSIOL-LONDON, V74, P115, DOI 10.1113/jphysiol.1932.sp002832; Amann C.M., 2000, CLIN FAMILY MED, V2, P110; [Anonymous], 1994, J Clin Neurophysiol, V11, P40; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Barth JT, 2001, J ATHL TRAINING, V36, P253; Barwick F., 2011, CLIN NEUROPHYSIOL; Berezovchuk L V, 2008, Klin Khir, P40; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Booher MA, 2003, CLIN J SPORT MED, V13, P93, DOI 10.1097/00042752-200303000-00005; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Burnside S., 2004, SPORTSNET MAGAZ 1004; Camm AJ, 1996, EUR HEART J, V17, P354; Cao C, 2008, IEEE T NEUR SYS REH, V16, P327, DOI 10.1109/TNSRE.2008.918422; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cevese A, 2001, J PHYSIOL-LONDON, V531, P235, DOI 10.1111/j.1469-7793.2001.0235j.x; Chen Xi-Ping, 2006, Neurosci Bull, V22, P165; CORKIN S, 1989, J NEUROSCI, V9, P3876; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Cushing H, 1901, B JOHNS HOPKINS HOSP, V12, P290; Dambinova S.A., 2006, 24 ANN NAT NEUR SOC; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Evoke Neuroscience, 2009, QUANTITATIVE BALANCE; Finkelstein E., 2006, INCIDENCE EC BURDEN; Furgala Agata, 2007, Folia Med Cracov, V48, P35; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Gosselin N, 2010, PHYSICIAN SPORTSMED, V38, P27, DOI 10.3810/psm.2010.10.1805; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Grippo AJ, 2009, STRESS, V12, P1, DOI 10.1080/10253890802046281; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2004, AM J MED SPORTS, V6, P13; Hallett M, 2001, BRAIN RES REV, V36, P169, DOI 10.1016/S0165-0173(01)00092-3; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Jansen E C, 1978, Ugeskr Laeger, V140, P2715; Jennings JR, 2009, NEUROIMAGE, V47, P914, DOI 10.1016/j.neuroimage.2009.04.072; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; Kahraman S, 2010, J NEUROSURG ANESTH, V22, P296, DOI 10.1097/ANA.0b013e3181e25fc3; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Katz-Leurer M, 2010, BRAIN INJURY, V24, P110, DOI 10.3109/02699050903508234; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; King ML, 1997, BRAIN INJURY, V11, P445; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kropotov J.D., 2009, INDEPENDENT COMPONEN; Kropotov J. D., 2009, QUANTITATIVE EEG EVE; Kropotov JD, 2009, NEUROREPORT, V20, P1592, DOI 10.1097/WNR.0b013e3283309cbd; Kushner DS, 2001, AM FAM PHYSICIAN, V64, P1007; Kuss O, 2008, J ELECTROCARDIOL, V41, P287, DOI 10.1016/j.jelectrocard.2008.02.014; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; LEHRER PM, 1989, PSYCHOPHYSIOLOGY, V26, P668, DOI 10.1111/j.1469-8986.1989.tb03169.x; Leon-Carrion J, 2009, CLIN NEUROPHYSIOL, V120, P1039, DOI 10.1016/j.clinph.2009.01.021; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Lin DC, 2010, CHAOS, V20, DOI 10.1063/1.3427639; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lorensen T.D., 2004, J NEUROTHERAPY, V8, P53; LOWENSOHN RI, 1977, LANCET, V1, P626; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMahon CG, 2011, SHOCK, V35, P53, DOI 10.1097/SHK.0b013e3181e687c6; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Nagai M, 2010, J AM SOC HYPERTENS, V4, P174, DOI 10.1016/j.jash.2010.05.001; Neki N S, 2004, J Assoc Physicians India, V52, P223; Nichols DS, 1997, PHYS THER, V77, P553, DOI 10.1093/ptj/77.5.553; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Oliaro S, 2001, J ATHL TRAINING, V36, P257; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Plymale J, 2010, PEDIATR CARDIOL, V31, P1064, DOI 10.1007/s00246-010-9766-x; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Ponomarev V A, 2010, Fiziol Cheloveka, V36, P5; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Randolph C, 2005, J ATHL TRAINING, V40, P139; Ravnskov U, 2009, ANN CLIN LAB SCI, V39, P3; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Rossini PM, 2004, BRAIN, V127, P99, DOI 10.1093/brain/awh012; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Sherlin L, 2010, APPL PSYCHOPHYS BIOF, V35, P219, DOI 10.1007/s10484-010-9132-z; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; SLEIGHT P, 1995, CLIN SCI, V88, P103, DOI 10.1042/cs0880103; Slobounov S, 2005, NEUROSCI LETT, V383, P251, DOI 10.1016/j.neulet.2005.04.039; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P185, DOI 10.1016/S1388-2457(01)00737-4; Slobounov S, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P1, DOI 10.1007/0-387-32565-4_1; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Sterman M. B., 2001, Journal of Neurotherapy, V4, P73; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Tereshchenko E P, 2010, Fiziol Cheloveka, V36, P5; Thatcher R. W., 2003, Journal of Neurotherapy, V7, P87, DOI 10.1300/J184v07n03_05; Thatcher R.W., 2009, EEG EVALUATION TRAUM; Thatcher RW, 2001, CLIN NEUROPHYSIOL, V112, P1729, DOI 10.1016/S1388-2457(01)00609-5; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Thompson J., 2006, FDN SPORT RELATED BR, P342; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Vaschillo E, 2002, APPL PSYCHOPHYS BIOF, V27, P1, DOI 10.1023/A:1014587304314; WARD AA, 1948, J NEUROPHYSIOL, V11, P13, DOI 10.1152/jn.1948.11.1.13; Wijnen VJM, 2006, CLIN NEUROPHYSIOL, V117, P1794, DOI 10.1016/j.clinph.2006.03.006; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42	128	7	7	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1932-9261	1932-927X		J CLIN SPORT PSYCHOL	J. Clin. Sport Psychol.	MAR	2012	6	1					22	46		10.1123/jcsp.6.1.22			25	Psychology, Applied	Emerging Sources Citation Index (ESCI)	Psychology	V22SD	WOS:000215040600003					2022-02-06	
J	Liu, J; Yang, XY; Jiang, LY; Wang, CX; Yang, MG				Liu, Jian; Yang, Xiaoyu; Jiang, Lianying; Wang, Chunxin; Yang, Maoguang			Neural plasticity after spinal cord injury	NEURAL REGENERATION RESEARCH			English	Article						spinal cord injury; plasticity; synapse; functional exercise; neurotrophic factor; cell transplantation; tissue transplantation; reviews	TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; ADULT-RAT; FUNCTIONAL RECOVERY; SYNAPTIC CONNECTIVITY; ENRICHED ENVIRONMENT; CORTICAL PLASTICITY; CORTICOSPINAL TRACT; NEURONS; NEUROGENESIS	Plasticity changes of uninjured nerves can result in a novel neural circuit after spinal cord injury, which can restore sensory and motor functions to different degrees. Although processes of neural plasticity have been studied, the mechanism and treatment to effectively improve neural plasticity changes remain controversial. The present study reviewed studies regarding plasticity of the central nervous system and methods for promoting plasticity to improve repair of injured central nerves. The results showed that synaptic reorganization, axonal sprouting, and neurogenesis are critical factors for neural circuit reconstruction. Directed functional exercise, neurotrophic factor and transplantation of nerve-derived and non-nerve-derived tissues and cells can effectively ameliorate functional disturbances caused by spinal cord injury and improve quality of life for patients.	[Liu, Jian; Yang, Xiaoyu; Jiang, Lianying; Wang, Chunxin; Yang, Maoguang] Jilin Univ, Dept Orthoped, China Japan Union Hosp, Changchun 130033, Jilin Province, Peoples R China		Yang, XY (corresponding author), Jilin Univ, Dept Orthoped, China Japan Union Hosp, Changchun 130033, Jilin Province, Peoples R China.	yangxiaoyu88@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30972153, 30872609]	This study was supported by the National Natural Science Foundation of China (Goat model of ischemic injury in corticospinal tract projection path and axonal guidance of MPA-1B migration in the spinal cord), No. 30972153; the National Natural Science Foundation of China (Spinal cord ischemia/reperfusion injury and proteomics), No. 30872609.	Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Bareyre FM, 2002, J NEUROSCI, V22, P7097; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Benowitz LI, 1999, P NATL ACAD SCI USA, V96, P13486, DOI 10.1073/pnas.96.23.13486; Blesch A, 2001, J COMP NEUROL, V436, P399, DOI 10.1002/cne.1076; Celnik PA, 2004, RESTOR NEUROL NEUROS, V22, P261; Chi LY, 2006, STEM CELLS, V24, P34, DOI 10.1634/stemcells.2005-0076; Darian-Smith C, 2009, NEUROSCIENTIST, V15, P149, DOI 10.1177/1073858408331372; Engesser-Cesar C, 2005, J NEUROTRAUM, V22, P157, DOI 10.1089/neu.2005.22.157; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Fouad K, 2008, NEUROL RES, V30, P17, DOI 10.1179/016164107X251781; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Gonzenbach RR, 2008, CELL MOL LIFE SCI, V65, P161, DOI 10.1007/s00018-007-7170-3; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Han XG, 2011, NEUROSCI LETT, V487, P255, DOI 10.1016/j.neulet.2010.09.007; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; HENDERSON CE, 1993, RESTOR NEUROL NEUROS, V5, P15, DOI 10.3233/RNN-1993-5105; HESS G, 1994, J NEUROPHYSIOL, V71, P2543, DOI 10.1152/jn.1994.71.6.2543; Hickmott PW, 2006, NEUROSCIENTIST, V12, P16, DOI 10.1177/1073858405282417; Hou SW, 2008, STROKE, V39, P2837, DOI 10.1161/STROKEAHA.107.510982; Huang HH, 2009, PHYS THER, V89, P1126, DOI 10.2522/ptj.20080111; Jeffery ND, 2001, NEUROSCIENCE, V104, P513, DOI 10.1016/S0306-4522(01)00068-9; JONES TA, 1994, J NEUROSCI, V14, P2140; Ketschek Andrea, 2011, Commun Integr Biol, V4, P55, DOI 10.4161/cib.4.1.13647; Kim BG, 2006, EXP NEUROL, V198, P401, DOI 10.1016/j.expneurol.2005.12.010; Kim BG, 2008, J COMP NEUROL, V508, P473, DOI 10.1002/cne.21686; Koelsch A, 2010, J NEUROCHEM, V113, P143, DOI 10.1111/j.1471-4159.2010.06593.x; Komitova M, 2005, EUR J NEUROSCI, V21, P2397, DOI 10.1111/j.1460-9568.2005.04072.x; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; Lu KW, 2002, J NEUROTRAUM, V19, P1081, DOI 10.1089/089771502760341983; Lu P, 2001, J COMP NEUROL, V436, P456, DOI 10.1002/cne.1080; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Marin R, 2003, PHYSIOL BEHAV, V80, P167, DOI 10.1016/j.physbeh.2003.06.001; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Nielsen J, 2009, J NEUROSCI, V29, P11360, DOI 10.1523/JNEUROSCI.3239-09.2009; Nishimura Y, 2009, NEUROSCIENTIST, V15, P436, DOI 10.1177/1073858408331375; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Ohori Y, 2006, J NEUROSCI, V26, P11948, DOI 10.1523/JNEUROSCI.3127-06.2006; Park WB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-119; Ploughman M, 2007, EUR J NEUROSCI, V25, P3453, DOI 10.1111/j.1460-9568.2007.05591.x; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vessal M, 2007, EUR J NEUROSCI, V26, P2777, DOI 10.1111/j.1460-9568.2007.05871.x; Vogelin E, 2006, EXP NEUROL, V199, P348, DOI 10.1016/j.expneurol.2005.12.029; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005; Zhou LJ, 2003, J NEUROSCI, V23, P1424, DOI 10.1523/JNEUROSCI.23-04-01424.2003	58	7	8	4	10	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	FEB	2012	7	5					386	391		10.3969/j.issn.1673-5374.2012.05.010			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	907EX	WOS:000301401700010	25774179				2022-02-06	
J	Moinard, C; Butel, MJ; Bureau, MF; Choisy, C; Waligora-Dupriet, AJ; Moulis, J; Marc, J; Cynober, L; Charrueau, C				Moinard, Christophe; Butel, Marie-Jose; Bureau, Michel Francis; Choisy, Caroline; Waligora-Dupriet, Anne-Judith; Moulis, Julie; Marc, Julie; Cynober, Luc; Charrueau, Christine			In Vivo Bioluminescent Imaging of a New Model of Infectious Complications in Head-Injury Rats	JOURNAL OF NEUROTRAUMA			English	Article						bioluminescence; Escherichia coli; head trauma; optical imaging; sepsis	TRAUMATIC BRAIN-INJURY; FLUID PERCUSSION; SEPSIS; EXPRESSION; EFFICACY; MUSCLE; STATE	Infectious complications are responsible for 10-25% of mortality in head-injured patients. In the present work we developed a model of infectious complications in head-injury rats using Escherichia coli (E. coli) with a stable copy of the lux operon, and monitored the infection in vivo by optical imaging. Rats were randomized into three groups: AL (healthy rats), HI (head-injury rats), and HI-EC (HI rats + single enteral bolus of E. co/i, 1.3 x 10(9)/rat given 2 days after HI). Infection was evaluated with a camera at 2 and 6 h after E. coli challenge. Blood and organs were sampled to assess biological parameters. HI was associated with body weight loss, muscle atrophy, and plasma amino acid disturbances, in particular glutamine depletion (AL 919 37 versus HI 647 25 and HI-EC 717 20 mu mol IL; p<0.05). In the HI-EC rats, the luminescence signal was observed at T + 2 (mean [range]: 34,778 cpm [1617-2,918,810]), and was significantly decreased at T + 6 (0 cpm [0-847,922]; p<0.05). Bacterial challenge was associated with a specific body weight loss and a decrease in gastrocnemius protein content, in alanine (AL 512 41 versus HI-EC 395 29 mu mol/L; p<0.05), and in sulfur plasma amino acids. In conclusion, we propose a controlled model of HI with infectious complications characterized by specific metabolic alterations. Combined with the in vivo monitoring of the infection by bioluminescence, this model offers a valuable tool to evaluate specific strategies for HI patients.	[Charrueau, Christine] Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Pharm Galen, Platforme Univ Paris Descartes PIPAS,EA 4466, F-75270 Paris 06, France; [Moinard, Christophe; Choisy, Caroline; Moulis, Julie; Marc, Julie; Cynober, Luc] Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Biol Nutr, EA 4466, F-75270 Paris 06, France; [Butel, Marie-Jose; Waligora-Dupriet, Anne-Judith] Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Microbiol, EA 4065, F-75270 Paris 06, France; [Bureau, Michel Francis] Platforme Univ Paris Descartes PIPAS, CNRS, Lab Imagerie Opt Petit Anim LIOPA, INSERM,U 1022,UMR 8151, Paris, France; [Cynober, Luc] Cochin & Hotel Dieu, Serv Biochim Bisite, Paris, France		Charrueau, C (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Pharm Galen, Platforme Univ Paris Descartes PIPAS,EA 4466, 4 Ave Observ, F-75270 Paris 06, France.	christine.charrueau@parisdescartes.fr	Cynober, Luc/ABB-2368-2020		Nestle Clinical Nutrition (Noisiel, France)Nestle SA; Ministry of Research and TechnologyMinistry of Research and Technology of the Republic of Indonesia (RISTEK)	This work was supported in part by an unrestricted grant from Nestle Clinical Nutrition (Noisiel, France), and by a grant from the Ministry of Research and Technology.	Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Breuille D, 1999, INFECT IMMUN, V67, P1079, DOI 10.1128/IAI.67.3.1079-1085.1999; Breuille D, 1998, CLIN SCI, V94, P413, DOI 10.1042/cs0940413; Bureau MF, 2010, BBA-GEN SUBJECTS, V1800, P537, DOI 10.1016/j.bbagen.2010.02.003; Charrueau C, 2011, HANDBOOK OF BEHAVIOR, FOOD AND NUTRITION, P1585, DOI 10.1007/978-0-387-92271-3_103; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; Contag Pamela Reilly, 2008, V415, P101, DOI 10.1007/978-1-59745-570-1_6; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; FINK MP, 1990, J SURG RES, V49, P186, DOI 10.1016/0022-4804(90)90260-9; FLEURY P, 1951, Ann Biol Clin (Paris), V9, P453; FRACKMAN S, 1990, J BACTERIOL, V172, P5767, DOI 10.1128/jb.172.10.5767-5773.1990; Hamani D, 2007, INTENS CARE MED, V33, P1076, DOI 10.1007/s00134-007-0624-0; HASSELGREN PO, 1989, METABOLISM, V38, P634, DOI 10.1016/0026-0495(89)90100-5; Heard SO, 1998, CRIT CARE MED, V26, P748, DOI 10.1097/00003246-199804000-00027; Jawhara S, 2004, ANTIMICROB AGENTS CH, V48, P3436, DOI 10.1128/AAC.48.9.3436-3441.2004; Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003; MacFie J, 2006, BRIT J SURG, V93, P87, DOI 10.1002/bjs.5184; Malmezat T, 2000, AM J PHYSIOL-ENDOC M, V279, pE1391; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Moinard C, 2008, J NEUROTRAUM, V25, P124, DOI 10.1089/neu.2007.0391; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; Sharma PK, 2010, SURGERY, V147, P89, DOI 10.1016/j.surg.2009.05.016; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; Wu JC, 2001, MOL THER, V4, P297, DOI 10.1006/mthe.2001.0460; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P380, DOI 10.1128/AAC.49.1.380-387.2005	28	7	7	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					335	342		10.1089/neu.2011.1862			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300012	21806472				2022-02-06	
J	Hawkins, BE; Frederickson, CJ; DeWitt, DS; Prough, DS				Hawkins, Bridget E.; Frederickson, Christopher J.; DeWitt, Douglas S.; Prough, Donald S.			Fluorophilia: Fluorophore-containing compounds adhere non-specifically to injured neurons	BRAIN RESEARCH			English	Article						Neuronal degeneration; Traumatic brain injury; Fluorescent indicator; Newport Green; Fluoro-Jade; TSQ	CEREBRAL-ARTERY OCCLUSION; INTRACELLULAR FREE ZINC; TRAUMATIC BRAIN-INJURY; DENTATE HILAR NEURONS; JADE-C; FLUID PERCUSSION; CELL-DEATH; ISCHEMIA; VULNERABILITY; DEGENERATION	Ionic (free) zinc (Zn2+) is implicated in apoptotic neuronal degeneration and death. In our attempt to examine the effects of Zn2+ in neurodegeneration following brain injury, we serendipitously discovered that injured neurons bind fluorescein moieties, either alone or as part of an indicator dye, in histologic sections. This phenomenon, that we have termed "fluorophilia", is analogous to the ability of degenerating neuronal somata and axons to bind silver ions (argyrophilia - the basis of silver degeneration stains). To provide evidence that fluorophilia occurs in sections of brain tissue, we used a wide variety of indicators such as Fluoro-Jade (FJ), a slightly modified fluorescein sold as a marker for degenerating neurons; Newport Green, a fluorescein-containing Zn2+ probe; Rhod-5N, a rhodamine-containing Ca2+ probe; and plain fluorescein. All yielded remarkably similar staining of degenerating neurons in the traumatic brain-injured tissue with the absence of staining in our sham-injured brains. Staining of presumptive injured neurons by these agents was not modified when Zn2+ in the brain section was removed by prior chelation with EDTA or TPEN, whereas staining by a non-fluorescein containing Zn2+ probe, N-(6-methoxy-8-quinolyl)-p-toluenesulfonamide (TSQ), was suppressed by prior chelation. Thus, certain fluorophore-containing compounds nonspecifically stain degenerating neuronal tissue in histologic sections and may not reflect the presence of Zn2+. This may be of concern to researchers using indicator dyes to detect metals in brain tissue sections. Further experiments may be advised to clarify whether Zn2+-binding dyes bind more specifically in intact neurons in culture or organotypic slices. (C) 2011 Elsevier B.V. All rights reserved.	[Hawkins, Bridget E.; DeWitt, Douglas S.; Prough, Donald S.] Univ Texas Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, Galveston, TX 77555 USA; [Frederickson, Christopher J.] NeuroBioTex Inc, Galveston, TX 77550 USA		Hawkins, BE (corresponding author), UTMB Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA.	behawkin@utmb.edu; zincdoc@gmail.com; ddewitt@utmb.edu; dsprough@utmb.edu	Hawkins, Bridget/H-4933-2015; Prough, Donald S/G-5793-2013	Hawkins, Bridget/0000-0002-1887-3657; Prough, Donald S/0000-0001-7994-532X	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS042849, NS041682]; Moody Center for Traumatic Brain and Spinal Cord Injury Research/Mission Connect; NIEHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [5T32ES007254-18]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32ES007254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R43NS041682, R44NS041682, R01NS042849] Funding Source: NIH RePORTER	This study was supported in part by NINDS grant nos. NS042849 (Dr. Donald S. Prough, PI) and NS041682 (Dr. Christopher J. Frederickson, PI) and Moody Center for Traumatic Brain and Spinal Cord Injury Research/Mission Connect (Dr. Douglas S. DeWitt, PI). Bridget E. Hawkins' work was supported by a predoctoral fellowship under NIEHS grant no. 5T32ES007254-18 ("Molecular Mechanisms for Environmental Injury," Dr. Bill T. Ameredes, PI). We thank Robin Williams and Leonard J. Giblin III, M.D., Ph.D. for their technical assistance with the pilocarpine animals. We would also like to thank Bridget Capra, R.N. and Kristine Eidson for preliminary studies involving the traumatically brain-injured animals.	Bian GL, 2007, BRAIN RES, V1150, P55, DOI 10.1016/j.brainres.2007.02.078; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; BUSCH H, 1979, CANCER RES, V39, P857; Calderone A, 2004, J NEUROSCI, V24, P9903, DOI 10.1523/JNEUROSCI.1713-04.2004; Canzoniero LMT, 1997, NEUROBIOL DIS, V4, P275, DOI 10.1006/nbdi.1997.0160; Capasso M, 2005, J ALZHEIMERS DIS, V8, P93; Cheng CL, 1998, J NEUROCHEM, V71, P2401; Chidlow G, 2009, EXP EYE RES, V88, P426, DOI 10.1016/j.exer.2008.10.015; Choi DW, 1996, COLD SPRING HARB SYM, V61, P385; Cizkova D, 1996, ARCH ITAL BIOL, V134, P279; CLIFTON G L, 1989, Journal of Neurotrauma, V6, P71, DOI 10.1089/neu.1989.6.71; Diener HC, 2008, STROKE, V39, P1774, DOI 10.1161/STROKEAHA.107.506378; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Duckworth EAM, 2005, BRAIN RES, V1042, P29, DOI 10.1016/j.brainres.2005.02.021; Duckworth EAM, 2006, BRAIN RES, V1088, P167, DOI 10.1016/j.brainres.2006.02.103; Elangovan T, 2008, Indian J Dent Res, V19, P141; FINK ROBERT P., 1967, BRAIN RES, V4, P369, DOI 10.1016/0006-8993(67)90166-7; FREDERICKSON CJ, 1990, PROG BRAIN RES, V83, P71; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; FRIEDE RL, 1966, ACTA NEUROPATHOL, V6, P1, DOI 10.1007/BF00691077; GHATAK NR, 1986, J NEUROPATH EXP NEUR, V45, P385, DOI 10.1097/00005072-198607000-00001; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; IIZUKA H, 1989, STROKE, V20, P1516, DOI 10.1161/01.STR.20.11.1516; Jagt TAV, 2009, NEUROSCIENCE, V159, P104, DOI 10.1016/j.neuroscience.2008.11.052; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Kim YH, 1999, NEUROSCIENCE, V89, P175, DOI 10.1016/S0306-4522(98)00313-3; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Levenson CW, 2005, PHYSIOL BEHAV, V86, P399, DOI 10.1016/j.physbeh.2005.08.010; Li Y, 2010, BRAIN RES, V1330, P131, DOI 10.1016/j.brainres.2010.03.034; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MCLARDY T, 1964, NATURE, V201, P92, DOI 10.1038/201092a0; Medvedeva YV, 2009, J NEUROSCI, V29, P1105, DOI 10.1523/JNEUROSCI.4604-08.2009; Pillai KR, 2005, IN VIVO, V19, P807; Riljak V, 2005, Prague Med Rep, V106, P75; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2001, METHOD DETECTING NEU; SLOMIANKA L, 1992, NEUROSCIENCE, V48, P325, DOI 10.1016/0306-4522(92)90494-M; Stork C.J., 2006, J NEUROSCI METHODS; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; Uchihara T, 2007, ACTA NEUROPATHOL, V113, P483, DOI 10.1007/s00401-007-0200-2; Ye XM, 2001, BRAIN RES PROTOC, V8, P104, DOI 10.1016/S1385-299X(01)00086-1	50	7	7	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 13	2012	1432						28	35		10.1016/j.brainres.2011.11.009			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899HI	WOS:000300806600004	22137653	Green Accepted			2022-02-06	
J	Bargerhuff, ME; Cole, DJ; Teeters, L				Bargerhuff, Mary Ellen; Cole, Donna J.; Teeters, Laura			Using a transdisciplinary model to address inequities in field placements for teacher candidates with disabilities	INTERNATIONAL JOURNAL OF INCLUSIVE EDUCATION			English	Article						disability; higher education; inclusive education; special education	STUDENTS; PROGRAMS; TEAM	This paper examines the contradiction between articulated university policy on diversity/inclusion and actual practice with regard to field placements for teacher candidates with disabilities. Analysis of a unique case study involving a teacher candidate with traumatic brain injury illustrates the inequities of the traditional concern conference method to addressing problems in the field. Authors propose a transdisciplinary team model as a more inclusive approach to capitalising on the strengths of teacher candidates.	[Cole, Donna J.] Wright State Univ, Coll Educ & Human Serv, Off Partnerships & Field Experiences, Dayton, OH 45435 USA; [Bargerhuff, Mary Ellen] Wright State Univ, Dept Teacher Educ, Coll Educ & Human Serv, Dayton, OH 45435 USA		Bargerhuff, ME (corresponding author), Wright State Univ, Dept Teacher Educ, Coll Educ & Human Serv, Dayton, OH 45435 USA.	mary.bargerhuff@wright.edu					Acedo C., 2008, PROSPECTS, V38, P5, DOI DOI 10.1007/S11125-008-9064-Z; Anderson RC, 2006, REV EDUC PEDAGOG CUL, V28, P367, DOI 10.1080/10714410600873258; AOTA (American Occupational Therapy Association), 1997, OCC THER SERV CHILDR; Armstrong F, 1999, INT J INCLUSIVE EDUC, V3, DOI [10.1080/136031199285200, DOI 10.1080/136031199285200]; Atkins W., 2001, ACCOMMODATING STUDEN; Barnes C, 2005, WORK EMPLOY SOC, V19, P527, DOI 10.1177/0950017005055669; Barnes C, 2007, BRIT J SOCIOL EDUC, V28, P135, DOI 10.1080/01425690600996832; Broderick A., 2006, VITAL QUESTIONS FACI, P133; CAMPBELL PH, 1987, J ASSOC PERS SEVERE, V12, P107, DOI 10.1177/154079698701200204; Carpenter S.L., 1998, PROFESSIONAL SCH COU, V2, P1; Chapman L, 1999, SUPP LEARN, V14, P104, DOI [10.1111/1467-9604.00113, DOI 10.1111/1467-9604.00113]; Cook Sharon A., 2001, CANADIAN J ED, V26, P419; Danielson C., 1996, ENHANCING PROFESSION; Darling-Hammond L., 1995, PHI DELTA KAPPAN, V76, P579; Dorevanis G., 2002, LRE MANDATE HAS IT B; Downing J., 1990, J EDUC PSYCHOL CONS, V1, P259; Duquette C., 2000, TEACHERS TEACHING TH, V6, P215; Educational Testing Service, 2003, PATHW CLASSR OBS SYS; Gale T., 2000, J EDUC TEACHING, V26, P127; Gerke R.E., 1994, DREAM TEAM MULTILEVE; Gilbert S., 1996, RIGHTS VERSUS RESPON; Harrison S., 1999, 19 C AM COUNC RUR SP; HEWARD WL, **DROPPED REF**; Hurst D, 2000, ED STAT Q, V2, P55; Knight D., 1996, TEACHER ED, V31, P313, DOI [10.1080/08878739609555124, DOI 10.1080/08878739609555124]; Merrick N., 2006, TIMES ED SUPPLE 1124, P6; Mertens D.M., 1995, RES METHODS SPECIAL; Obiakor F., 1995, DEMANDS CHALLENGES B; Ogletree BT, 2001, INTERV SCH CLIN, V36, P138, DOI 10.1177/105345120103600302; Oliver M., 1996, UNDERSTANDING DISABI; ORELOVE F, 1996, ED CHILDREN MULTIPLE; PAPALIA-BERARDI A., 2002, TEACH EDUC SPEC EDUC, V25, P23, DOI DOI 10.1177/088840640202500104; Paul PV, 1996, THEOR PRACT, V35, P4, DOI 10.1080/00405849609543695; Peters S, 2009, TEACH TEACH EDUC, V25, P551, DOI 10.1016/j.tate.2009.02.006; Riddick B., 2003, INT J INCLUSIVE EDUC, V7, P389, DOI [10.1080/1360311032000110945, DOI 10.1080/1360311032000110945]; RYAN J, 2004, INT J INCLUSIVE EDUC, V8, P73, DOI 10.1080/1360311032000139421; Shaw M., 2006, TIMES ED SUPPLE 0113, P4; Simon JA, 2001, TOP LANG DISORD, V21, P1; Slee R., 2001, INT J INCLUSIVE EDUC, V5, P167; Slee R, 2008, INT STUD SOCIOL EDUC, V18, P99, DOI 10.1080/09620210802351342; Tesch, 1993, ETHNOGRAPHY QUALITAT; VALAS H, 2001, SCAND J EDUC RES, V45, P101, DOI DOI 10.1080/00313830120052705; Valle J. W., 2004, EQUITY EXCELLENCE ED, V37, P4; Welch M, 1996, J EDUC PSYCHOL CONS, V7, P223, DOI 10.1207/s1532768xjepc0703_3; Westling D. L., 2000, TEACHING STUDENTS SE; Williams S.J., 1998, ACCOMMODATING DISABI	46	7	7	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1360-3116			INT J INCLUSIVE EDUC	Int. J. Incl. Educ.		2012	16	2					185	206		10.1080/13603111003721098			22	Education & Educational Research	Social Science Citation Index (SSCI)	Education & Educational Research	914KT	WOS:000301949400005					2022-02-06	
S	Bettermann, K; Slocomb, JE		Dambinova, SA; Hayes, RL; Wang, KKW		Bettermann, Kerstin; Slocomb, Julia E.			Clinical Relevance of Biomarkers for Traumatic Brain Injury	BIOMARKERS FOR TRAUMATIC BRAIN INJURY	RSC Drug Discovery Series		English	Article; Book Chapter							NEURON-SPECIFIC ENOLASE; MYELIN BASIC-PROTEIN; FIBRILLARY ACIDIC PROTEIN; CREATINE-KINASE BB; CEREBROSPINAL-FLUID LEVELS; BIOCHEMICAL SERUM MARKERS; AMYLOID-BETA DYNAMICS; OUTCOME PREDICTION; SURROGATE MARKERS; S100B		[Bettermann, Kerstin; Slocomb, Julia E.] Penn State Coll Med, Dept Neurol, Hershey, PA 17033 USA		Bettermann, K (corresponding author), Penn State Coll Med, Dept Neurol, 500 Univ Dr, Hershey, PA 17033 USA.	kbettermann@hmc.psu.edu					[Anonymous], 1998, CHEM REV, V98, P1; Armstrong CL, 2010, HANDBOOK OF MEDICAL NEUROPSYCHOLOGY: APPLICATIONS OF COGNITIVE NEUROSCIENCE, P1, DOI 10.1007/978-1-4419-1364-7; Barr TL, 2011, BIOL RES NURS, V13, P140, DOI 10.1177/1099800410385671; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bhardwaj A., 2010, HDB NEUROCRITICAL CA, P307; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Blyth B. J., 2011, J NEUROTRAUMA; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Deierborg T, 2010, NEUROSCIENCE, V171, P1386, DOI 10.1016/j.neuroscience.2010.09.045; Emmerling MR, 2000, ANN NY ACAD SCI, V903, P118, DOI 10.1111/j.1749-6632.2000.tb06357.x; Faul X. L., 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Golan JD, 2007, J TRAUMA, V63, P365, DOI 10.1097/TA.0b013e31811ec178; Greenberg MS., 2010, HDB NEUROSURGERY, V7th; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Jonsson H, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-24; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Lamers KJB, 2003, BRAIN RES BULL, V61, P261, DOI 10.1016/S0361-9230(03)00089-3; Lemstra AW, 2000, NEUROLOGY, V55, P514, DOI 10.1212/WNL.55.4.514; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; MATIASGUIU J, 1986, ACTA NEUROL SCAND, V73, P203; MATIASGUIU J, 1986, ACTA NEUROL SCAND, V73, P461, DOI 10.1111/j.1600-0404.1986.tb04585.x; MATIASGUIU J, 1986, CLIN CHEM, V32, P915; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Missler U, 1999, CLIN CHEM, V45, P138; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Norton J. A., 2008, SURGERY, P461; NOSEWORTHY TW, 1985, CRIT CARE MED, V13, P743, DOI 10.1097/00003246-198509000-00010; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelsers MMAL, 2005, CLIN CHEM LAB MED, V43, P802, DOI 10.1515/CCLM.2005.135; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raby CA, 1998, J NEUROCHEM, V71, P2505; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Siman R, 2005, J CEREBR BLOOD F MET, V25, P1433, DOI 10.1038/sj.jcbfm.9600138; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Siman R, 2008, BRAIN RES, V1213, P1, DOI 10.1016/j.brainres.2008.03.034; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Streeter J, 2011, PROC SPIE, V8029, DOI 10.1117/12.885615; Van Geel WJA, 2005, J IMMUNOL METHODS, V296, P179, DOI 10.1016/j.jim.2004.11.015; van Geel WJA, 2002, CLIN CHIM ACTA, V326, P151, DOI 10.1016/S0009-8981(02)00330-3; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Zhou Y. W., 2002, J FORENSIC MED, V18, P146; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005	81	7	7	1	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF, CAMBS, ENGLAND	2041-3203	2041-3211	978-1-84973-389-2; 978-1-84973-474-5	RSC DRUG DISCOV	RSC Drug Discov.		2012	24						1	18		10.1039/9781849734745-00001	10.1039/9781849734745		18	Chemistry, Medicinal; Pharmacology & Pharmacy	Book Citation Index – Science (BKCI-S)	Pharmacology & Pharmacy	BJQ29	WOS:000329653900003					2022-02-06	
J	Cantore, L; Norwood, K; Patrick, P				Cantore, Lisa; Norwood, Kenneth; Patrick, Peter			Medical aspects of pediatric rehabilitation after moderate to severe traumatic brain injury	NEUROREHABILITATION			English	Article						Pediatric brain injury; autonomic instability; brain injury; deep vein thrombosis; depression; fractures; gastrostomy; headaches; heterotopic bone ossification; neurocongitive disorders; neuro-endocrine disorders; nutrition; pain; injury; pediatric rehabilitation; pressure ulcers; seizures; sleeping disorders; spasticity; tracheostomy; visual deficits	SLEEP DISORDERS; HEAD-INJURY; PAIN; TBI; MANAGEMENT; SPASTICITY; CHILDHOOD; DYSTONIA; SEQUELAE; CHILDREN	Recovery from severe traumatic brain injury (TBI) is prolonged, complicated and challenging. Medical rehabilitation is the bridge from acute medical care and stabilization to community reintegration. The process of caring for the recovering brain introduces unknown challenges of neural plasticity with demands to restore and to also move the child and family back to the developmental trajectory they once knew. While the ongoing focus is to maintain and advance medical stability, co-morbid conditions are addressed, and a plan for ongoing health is established. While no one manuscript can cover all of the medical aspects, this article will present in a "systems review" manner the most challenging and demanding medical conditions that children may confront following severe brain injury.	[Cantore, Lisa; Norwood, Kenneth; Patrick, Peter] Univ Virginia, Childrens Hosp, Charlottesville, VA USA; [Cantore, Lisa; Norwood, Kenneth; Patrick, Peter] Kluge Childrens Rehabil Ctr, Charlottesville, VA USA		Cantore, L (corresponding author), 2270 Ivy Rd, Charlottesville, VA 22903 USA.	lmc8c@virginia.edu					Acerini CL, 2007, HORM RES, V68, P14, DOI 10.1159/000110465; ALHADY MRA, 1990, J LARYNGOL OTOL, V104, P927, DOI 10.1017/S0022215100114410; Allison Christine L, 2008, Optometry, V79, P78, DOI 10.1016/j.optm.2007.02.023; Annegers F, 1998, NEW ENGLAND J M 0101, P20; [Anonymous], 1989, CHEST AM COLL PHYS, V96, P178; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Bourjeily G, 2002, CLIN PULM MED, V9, P273; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; CITTAPIETROLUNGO TJ, 1993, ARCH PHYS MED REHAB, V74, P905; Cochrane LA, 2006, PAEDIATR RESPIR REV, V7, P169, DOI 10.1016/j.prrv.2006.06.005; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dones I, 2006, J Neurosurg Sci, V50, P101; Fehlings Darcy, 2005, Paediatr Child Health, V10, P379; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Gettig Kelly, 2009, J Trauma Nurs, V16, P169, DOI 10.1097/JTN.0b013e3181b9dfa4; Guettard E, 2009, DEV NEUROREHABIL, V12, P128, DOI 10.1080/17518420902927994; Ivanhoe CB, 2004, J HEAD TRAUMA REHAB, V19, P29, DOI 10.1097/00001199-200401000-00004; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; KIRKPATRICK M, 1989, ARCH DIS CHILD, V64, P124, DOI 10.1136/adc.64.1.124; Kita M, 2000, DRUGS, V59, P487, DOI 10.2165/00003495-200059030-00006; Kottner J, 2010, INT J NURS STUD, V47, P1330, DOI 10.1016/j.ijnurstu.2010.07.006; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Levy M, 2005, NEUROREHABILITATION, V20, P279; Mavrogenis AF, 2011, ORTHOPEDICS, V34, DOI 10.3928/01477447-20110124-08; McKesson health Soluations LLC, 2010, INTERQUAL LEVEL CARE, P71; Morgan A, 2004, J HEAD TRAUMA REHAB, V19, P226, DOI 10.1097/00001199-200405000-00004; Mounts J, 2011, CLIN PEDIATR, V50, P183, DOI 10.1177/0009922810384725; Munjal SK, 2010, J TRAUMA, V68, P13, DOI 10.1097/TA.0b013e3181c9f274; Munjal SK, 2010, BRAIN INJURY, V24, P525, DOI 10.3109/02699050903516872; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Phillips K, 2011, INTERVENTIONS MANAGI; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; RICHTER KJ, 1995, J HEAD TRAUMA REHAB, V10, P7, DOI 10.1097/00001199-199512000-00004; Sabel B A, 2000, Curr Opin Ophthalmol, V11, P430, DOI 10.1097/00055735-200012000-00008; Sandoval JA, 2007, AM VENOUS FORUM, P837; Sanger TD, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e89; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Suddaby EC, 2008, DERMATOL NURS, V18, P155; Truitt AK, 2005, J PEDIATR SURG, V40, P124, DOI 10.1016/j.jpedsurg.2004.09.017; Valadka AB, 2007, NEUROSURGERY, V61, P203, DOI 10.1227/01.NEU.0000255497.26440.01	47	7	8	1	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	30	3					225	234		10.3233/NRE-2012-0749			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	948CD	WOS:000304480300010	22635128				2022-02-06	
J	Chawla, N; Kafescioglu, N				Chawla, Neelu; Kafescioglu, Nilufer			Evidence-Based Couple Therapy for Chronic Illnesses: Enriching the Emotional Quality of Relationships With Emotionally Focused Therapy	JOURNAL OF FAMILY PSYCHOTHERAPY			English	Article						chronic illnesses; CVD; emotionally focused therapy; traumatic brain injury		Chronic illness affects couples' relationship dynamics, as well as individual functioning. A chronic illness may present a significant amount of stress for both the patient and partner. This article discusses the application of an empirically supported couples' therapy approach, emotionally focused therapy, to address relationship distress and individual functioning in the context of chronic illness. Two case examples show how couples can learn to enrich the emotional quality of their relationship; express their innermost feelings of fear, sadness, and loneliness to each other to expand their emotional experiences; and meet each others' needs for safety, comfort, and security, despite the limitations and challenges presented by chronic illnesses.	[Chawla, Neelu] Purdue Univ, Dept Human Dev & Family Studies, 1200 West State St,HDFS Fowler Mem House, W Lafayette, IN 47907 USA; [Kafescioglu, Nilufer] Dogus Univ, Dept Psychol, Istanbul, Turkey		Chawla, N (corresponding author), Purdue Univ, Dept Human Dev & Family Studies, 1200 West State St,HDFS Fowler Mem House, W Lafayette, IN 47907 USA.	nchawla@purdue.edu	Kafescioglu, Nilufer/AAH-4367-2020				Arefjord K, 1998, PSYCHOL REP, V83, P1203, DOI 10.2466/PR0.83.7.1203-1216; Bankier B, 2002, PSYCHOTHER PSYCHOSOM, V71, P133, DOI 10.1159/000056280; BARNETT RC, 1991, HEALTH PSYCHOL, V10, P94, DOI 10.1037/0278-6133.10.2.94; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bowlby J, 1973, ATTACHMENT LOSS SEPA, V2; Bowlby J., 1982, ATTACHMENT LOSS ATTA, V1; BURMAN B, 1992, PSYCHOL BULL, V112, P39, DOI 10.1037/0033-2909.112.1.39; Carnelley KB, 1996, PERS RELATIONSHIP, V3, P257, DOI 10.1111/j.1475-6811.1996.tb00116.x; Cloutier PR, 2002, J MARITAL FAM THER, V28, P391, DOI 10.1111/j.1752-0606.2002.tb00364.x; COYNE JC, 1991, J PERS SOC PSYCHOL, V61, P404, DOI 10.1037/0022-3514.61.3.404; Denollet J, 2010, AM J CARDIOL, V105, P1555, DOI 10.1016/j.amjcard.2010.01.015; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Franks MM, 2006, J FAM PSYCHOL, V20, P311, DOI 10.1037/0893-3200.20.2.311; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Giese-Davis J, 2002, J CONSULT CLIN PSYCH, V70, P916, DOI 10.1037//0022-006X.70.4.916; GORDON HS, 1995, ARCH INTERN MED, V155, P2465, DOI 10.1001/archinte.155.22.2465; Helgeson VS, 1996, HEALTH PSYCHOL, V15, P135, DOI 10.1037/0278-6133.15.2.135; Johnson S. M., 2004, PRACTICE EMOTIONALLY, V2nd; Johnson SM, 1999, CLIN PSYCHOL-SCI PR, V6, P67, DOI 10.1093/clipsy/6.1.67; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Leathem J, 1996, BRAIN INJURY, V10, P27; Martins LDO, 2007, LECT NOTES ARTIF INT, V4571, P784; Mikulincer M, 2005, PERS RELATIONSHIP, V12, P149, DOI 10.1111/j.1350-4126.2005.00108.x; O'Farrell P, 2000, HEART LUNG, V29, P97; Pennebaker J. W., 1988, J CONSULT CLIN PSYCH, V56, P781; Pennebaker J.W., 1995, EMOTION DISCLOSURE H; PENNEBAKER JW, 1993, BEHAV RES THER, V31, P539, DOI 10.1016/0005-7967(93)90105-4; Rankin-Esquer LA, 2000, COGN BEHAV PRACT, V7, P212, DOI 10.1016/S1077-7229(00)80034-6; Ren XS, 1997, SOC SCI MED, V44, P241, DOI 10.1016/S0277-9536(96)00158-X; Robles TF, 2003, PHYSIOL BEHAV, V79, P409, DOI 10.1016/S0031-9384(03)00160-4; ROSS CE, 1990, J MARRIAGE FAM, V52, P1059, DOI 10.2307/353319; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Schmaling K. B., 2000, PSYCHOL COUPLES ILLN; Shields CG, 2000, AGING MENT HEALTH, V4, P223, DOI 10.1080/713649921; STIELL K, 2007, J SYSTEMIC THERAPIES, V26, P59; Weihs K, 2002, FAM SYST HEALTH, V20, P7, DOI [10.1037/h0089481, DOI 10.1037/H0089481]	37	7	7	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0897-5353	1540-4080		J FAM PSYCHOTHER	J. Fam. Psychother.		2012	23	1					42	53		10.1080/08975353.2012.654080			12	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	V63AE	WOS:000211005500003					2022-02-06	
J	Dawson, EC; Montgomery, CP; Frim, D; Koogler, T				Dawson, Emily C.; Montgomery, Christopher P.; Frim, David; Koogler, Tracy			Is Repeat Head Computed Tomography Necessary in Children Admitted with Mild Head Injury and Normal Neurological Exam?	PEDIATRIC NEUROSURGERY			English	Article						Children; Mild head injuries; Repeat head computed tomography; Radiation	TRAUMATIC BRAIN-INJURY; INTRACRANIAL INJURY; MODERATE; UTILITY; CT	Background: Children admitted following mild head injury (MHI) often undergo repeat head computed tomography (HCT) to identify progression of injury, although there is little evidence to support this practice. Methods: From January 2007 to December 2009, we retrospectively reviewed the medical records of patients aged 2 months to 18 years admitted with a diagnosis of MHI to a Level I Pediatric Trauma Center. Data including Glasgow Coma Scale, loss of consciousness, length of stay (LOS), and number and results of HCTs were analyzed. Results: A total of 507 patients were admitted with MHI and normal neurological exam; 389 had a normal and 118 had an abnormal initial HCT. The median LOS in the normal HCT group was 17.68 h (5.47-109.68) and in the abnormal HCT group 36.63 h (10.15-192.40). The median number of HCTs in the normal HCT group was 1 (1-2) and in the abnormal HCT group 2 (1-5). Conclusions: Children admitted with MHI, abnormal initial HCT and normal neurological exam had longer LOS and more HCTs compared with children with normal initial HCTs. No patient in either group had any change in their management based on HCT. Therefore, repeat HCT may be unnecessary for patients with MHI and normal neurological exam. Copyright (C) 2013 S. Karger AG, Basel	[Dawson, Emily C.; Montgomery, Christopher P.; Koogler, Tracy] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Frim, David] Univ Chicago, Dept Surg & Pediat, Chicago, IL 60637 USA		Dawson, EC (corresponding author), Univ Chicago, Pediat Crit Care Sect, 5841 S Maryland MC 1145, Chicago, IL 60637 USA.	edawson@uchicago.edu		Montgomery, Christopher/0000-0001-7247-0683	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [K08AI076596] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [K08 AI076596] Funding Source: Medline		ASHKENAZI E, 1990, J TRAUMA, V30, P613, DOI 10.1097/00005373-199005000-00015; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Figg RE, 2006, PEDIATR SURG INT, V22, P215, DOI 10.1007/s00383-005-1560-0; Hollingsworth W, 2007, PED CRITICAL CARE ME, V8, p348 356; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lucas da Silva PS, 2008, J TRAUMA, V65, p1293 1297; Schnellinger MG, 2010, CLIN PEDIATR, V49, P569, DOI 10.1177/0009922809352375; Sirif ZC, 2006, J TRAUMA, V61, p862 867; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Sosin DM, 1996, BRAIN INJURY, V10, P47; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	17	7	7	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.		2012	48	4					221	224		10.1159/000346697			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	220PI	WOS:000324596900004	23548857				2022-02-06	
B	Elliott, TR; Parker, M		Talley, RC; Crews, JE		Elliott, Timothy R.; Parker, Michael			Family Caregivers and Health Care Providers: Developing Partnerships for a Continuum of Care and Support	MULTIPLE DIMENSIONS OF CAREGIVING AND DISABILITY: RESEARCH, PRACTICE, POLICY	Caregiving-Research Practice Policy		English	Article; Book Chapter							PROBLEM-SOLVING ABILITIES; TRAUMATIC BRAIN-INJURY; SPINAL-CORD INJURIES; PHYSICAL HEALTH; PUBLIC-HEALTH; RISK-FACTOR; INTERVENTION; PREDICTORS; DISABILITIES; ADOLESCENTS		[Elliott, Timothy R.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77845 USA; [Parker, Michael] Univ Alabama, Sch Social Work, Tuscaloosa, AL 35487 USA		Elliott, TR (corresponding author), Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77845 USA.	telliott@tamu.edu; mwparker@sw.ua.edu	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714			Allman RM, 2004, J GEN INTERN MED, V19, P1118, DOI 10.1111/j.1525-1497.2004.30239.x; Baker PS, 2003, J AM GERIATR SOC, V51, P1610, DOI 10.1046/j.1532-5415.2003.51512.x; Berkman B., 2006, HDB AGING SOCIAL WOR, P391; Berry J. W., REHABILITAT IN PRESS; Billings DW, 2000, J PERS SOC PSYCHOL, V79, P131, DOI 10.1037/0022-3514.79.1.131; Bond J. T., 1998, 1997 NATL STUDY CARE; Braddock D, 1999, MENT RETARD, V37, P155, DOI 10.1352/0047-6765(1999)037<0155:AADDDA>2.0.CO;2; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; CARTER R, 2008, PREVENTING CHRONIC D, V5, P1; Chwalisz K, 1996, Appl Neuropsychol, V3, P28, DOI 10.1207/s15324826an0301_5; Donelan K, 2002, HEALTH AFFAIR, V21, P222, DOI 10.1377/hlthaff.21.4.222; Donelan K, 2001, WOMEN HEALTH ISS, V11, P185, DOI 10.1016/S1049-3867(01)00080-9; Elliott T, 2003, HDB CLIN HLTH PSYCHO, P61; Elliott T., 2003, C COND CTR DIS CONTR; Elliott TR, 2008, BEHAV RES THER, V46, P1220, DOI 10.1016/j.brat.2008.08.004; Elliott TR, 2011, HEALTH SERV RES, V46, P1803, DOI 10.1111/j.1475-6773.2011.01284.x; Elliott TR, 2009, J CLIN PSYCHOL, V65, P406, DOI 10.1002/jclp.20527; Elliott Timothy R, 2008, NeuroRehabilitation, V23, P439; Elliott TR, 2002, J CLIN PSYCHOL MED S, V9, P65, DOI 10.1023/A:1014931924809; Elliott TR, 2001, J COUNS PSYCHOL, V48, P223, DOI 10.1037//0022-0167.48.2.223; Elliott TR, 2000, HDB HOPE THEORY MEAS, P373; Fiscella K, 1997, FAM PROCESS, V36, P25, DOI 10.1111/j.1545-5300.1997.00025.x; Fiske V., 1991, J FAM PSYCHOL, V5, P4, DOI 10.1037/0893-3200.5.1.4; Fox S, 2004, OLDER AM INTERNET; Glueckauf RL, 2002, REHABIL PSYCHOL, V47, P49, DOI 10.1037/0090-5550.47.1.49; Grant JS, 2006, ARCH PHYS MED REHAB, V87, P343, DOI 10.1016/j.apmr.2005.09.019; Grant JS, 2002, STROKE, V33, P2060, DOI 10.1161/01.STR.0000020711.38824.E3; Hooker K, 1998, J GERONTOL B-PSYCHOL, V53, pP73, DOI 10.1093/geronb/53B.2.P73; Hufford BJ, 1999, REHABIL PSYCHOL, V44, P176, DOI 10.1037/0090-5550.44.2.176; King LA, 2000, J RES PERS, V34, P509, DOI 10.1006/jrpe.2000.2285; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Knussen C, 2005, PSYCHOL HEALTH, V20, P207, DOI 10.1080/08870440512331334013; Kramer B., 1997, GERONTOLOGIST, V33, P240; Levine C, 2010, HEALTH AFFAIR, V29, P116, DOI 10.1377/hlthaff.2009.0520; Lollar DJ, 2003, ANNU REV PUBL HEALTH, V24, P195, DOI 10.1146/annurev.publhealth.24.100901.140844; Long MP, 1998, REHABIL PSYCHOL, V43, P101, DOI 10.1037/0090-5550.43.2.101; MaloneBeach E E, 1995, Int Psychogeriatr, V7, P25, DOI 10.1017/S1041610295001827; Martin J., 2003, GERIATRIC CARE MANAG, V13, P3; Mechanic D, 1998, MILBANK Q, V76, P281, DOI 10.1111/1468-0009.00089; Metropolitan Life Insurance Company, 2004, MIL METLIFE STUD LON; Moen P., 2000, WORLDS DIFFERENCE IN; National Alliance for Caregiving American Association of Retired Persons, 2009, CAR US; Navaie-Waliser M, 2002, AM J PUBLIC HEALTH, V92, P409, DOI 10.2105/AJPH.92.3.409; NOVACK TA, 1991, ARCH PHYS MED REHAB, V72, P521; Parish SL, 2003, MENT RETARD, V41, P174, DOI 10.1352/0047-6765(2003)41<174:FSITUS>2.0.CO;2; Park CL, 1997, J PERS, V65, P421, DOI 10.1111/j.1467-6494.1997.tb00960.x; Parker AW, 2002, MIL PSYCHOL, V14, P257; Parker M., 2002, J GERONTOL SOC, V35, P35, DOI [DOI 10.1300/J083V35N04_, DOI 10.1300/J083V35N04_04]; Parker M., 2002, PARENT CARE PREPARAT; Parker M. W., 2003, 1 NAT GER SOC WORK C; Parker M. W., 2003, J GERONTOLOGICAL SOC, V40, P101, DOI [10.1300/J083v40n01_07, DOI 10.1300/J083V40N01_07]; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; QUITTNER AL, 1990, J PERS SOC PSYCHOL, V59, P1266, DOI 10.1037/0022-3514.59.6.1266; Reinhard SC, 2011, HEALTH AFFAIR, V30, P447, DOI 10.1377/hlthaff.2011.0099; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Roberts J, 1995, Can J Nurs Res, V27, P111; Roff L., 2003, GERIATRIC CARE MANAG, V13, P23; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Schulz R., 2000, HDB DEMENTIA CAREGIV; Shewchuk R, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P553, DOI 10.1037/10361-026; Shewchuk RM, 1998, HEALTH PSYCHOL, V17, P125, DOI 10.1037/0278-6133.17.2.125; SOSKOLNE V, 2000, AIDS BEHAV, V4, P221, DOI DOI 10.1023/A:1009572816986; Talley RC, 2007, AM J PUBLIC HEALTH, V97, P224, DOI 10.2105/AJPH.2004.059337; THOMPSON SC, 1995, PERS RELATIONSHIP, V2, P125, DOI 10.1111/j.1475-6811.1995.tb00081.x; Vitaliano PP, 2004, CURR DIR PSYCHOL SCI, V13, P13, DOI 10.1111/j.0963-7214.2004.01301004.x; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; WAGNER DL, 1994, EDUC GERONTOL, V20, P645, DOI 10.1080/0360127940200704; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; WILLIAMSON GM, 1995, J APPL SOC PSYCHOL, V25, P93, DOI 10.1111/j.1559-1816.1995.tb01586.x; Wisensale SK, 2002, GERONTOLOGIST, V42, P421; Ybema JF, 2002, PERS RELATIONSHIP, V9, P73, DOI 10.1111/1475-6811.00005; Ybema JF, 2001, PERS SOC PSYCHOL B, V27, P3, DOI 10.1177/0146167201271001	76	7	7	0	4	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4614-3383-5	CAREGIVING-RES PRACT			2012							135	152		10.1007/978-1-4614-3384-2_9	10.1007/978-1-4614-3384-2		18	Health Policy & Services; Social Work	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Health Care Sciences & Services; Social Work	BGN70	WOS:000323583000010					2022-02-06	
J	Gomes, AM; Spencer-Smith, MM; Jacobs, RK; Coleman, L; Anderson, VA				Gomes, Alison M.; Spencer-Smith, Megan M.; Jacobs, Rani K.; Coleman, Lee; Anderson, Vicki A.			Attention and social functioning in children with malformations of cortical development and stroke	CHILD NEUROPSYCHOLOGY			English	Article						Developmental lesions; Cortical malformations; Childhood stroke; Attention; Social function	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; BEHAVIOR; AUTISM; EMOTIONALITY; DISORDER; OUTCOMES	Attention and social functioning and their interrelationships have not been routinely examined in children with early brain insult (EBI). This study aimed to describe attention and social functioning in children with two types of EBI: malformations of cortical development (MCD) and stroke. Children diagnosed with MCD (n = 14, 6 males) or stroke (n = 14, 8 males) aged 8 to 14 years (M = 12 years 11 months) completed neuropsychological assessments to examine attention processes. Primary care-givers completed a questionnaire to assess executive components of children's attention and teachers completed a questionnaire to measure children's social functioning. Brain scans (MRI or CT) were coded by a pediatric neuroradiologist. Higher rates of impairments in attention and social function were found in children with EBI compared with normative expectations. Children with MCD experienced more global and clinically significant levels of impairment than children with stroke; though impairments were present in both groups. A strong association between executive components of attention and social function was observed. In addition, complex attention processes were associated with social function. The findings emphasize the reciprocity between attention, behavior and social outcomes, and the vulnerability of social function following EBI.	[Gomes, Alison M.] Monash Univ, Sch Psychol Psychiat & Psychol Med, Dept Psychol, Clayton, Vic 3800, Australia; [Gomes, Alison M.; Spencer-Smith, Megan M.; Jacobs, Rani K.; Anderson, Vicki A.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Spencer-Smith, Megan M.; Jacobs, Rani K.; Anderson, Vicki A.] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Coleman, Lee; Anderson, Vicki A.] Royal Childrens Hosp, Dept Radiol, Melbourne, Vic, Australia; [Anderson, Vicki A.] Univ Melbourne, Dept Psychol, Melbourne, Vic, Australia		Gomes, AM (corresponding author), Monash Univ, Sch Psychol Psychiat & Psychol Med, Dept Psychol, Bldg 17, Clayton, Vic 3800, Australia.	alison.gomes@monash.edu.au		Spencer-Smith, Megan/0000-0002-1047-0829			Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Anderson P. J., 2008, EXECUTIVE FUNCTIONS, P3; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2010, STUD NEUROPSYCHOL NE, P123; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; EISENBERG N, 1994, CHILD DEV, V65, P109, DOI 10.1111/j.1467-8624.1994.tb00738.x; EISENBERG N, 1995, CHILD DEV, V66, P1360, DOI 10.1111/j.1467-8624.1995.tb00940.x; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Everts R, 2008, CHILD NEUROPSYCHOL, V14, P323, DOI 10.1080/09297040701792383; Gioia G.A., 2000, BRIEF BEHAV RATING I; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Greenham M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00022; Happe F, 2006, BRAIN COGNITION, V61, P25, DOI 10.1016/j.bandc.2006.03.004; Hartel C, 2004, EUR J NEUROL, V11, P431, DOI 10.1111/j.1468-1331.2004.00861.x; Hayman-Abello SE, 2003, J INT NEUROPSYCH SOC, V9, P887, DOI 10.1017/S1355617703960097; Kenworthy L, 2009, CHILD NEUROPSYCHOL, V15, P425, DOI 10.1080/09297040802646983; Klimkeit EI, 2004, CHILD NEUROPSYCHOL, V10, P201, DOI 10.1080/713657846; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; Leventer RJ, 1999, NEUROLOGY, V53, P715, DOI 10.1212/WNL.53.4.715; Manly T., 1999, TEST EVERYDAY ATTENT; Max JE, 2004, J INT NEUROPSYCH SOC, V10, P976, DOI 10.1017/S1355617704107066; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Pellicano E, 2007, DEV PSYCHOL, V43, P974, DOI 10.1037/0012-1649.43.4.974; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rebok GW, 1997, CHILD NEUROPSYCHOL, V3, P28, DOI 10.1080/09297049708401366; Roberts G, 2008, J PAEDIATR CHILD H, V44, P276, DOI 10.1111/j.1440-1754.2007.01251.x; Ruff H. A., 1996, ATTENTION EARLY DEV; Spencer-Smith M, 2011, DEV NEUROPSYCHOL, V36, P353, DOI 10.1080/87565641.2010.549983; Spencer-Smith M, 2009, DEV MED CHILD NEUROL, V51, P909, DOI 10.1111/j.1469-8749.2009.03309.x; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Walker H.M., 1988, WALKER MCCONNELL SCA; Wechsler D., 1999, WASI WECHSLER ABBREV; Westmacott R, 2010, DEV MED CHILD NEUROL, V52, P386, DOI 10.1111/j.1469-8749.2009.03403.x; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535	36	7	7	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2012	18	4					392	403		10.1080/09297049.2011.613810			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	964ND	WOS:000305701500005	21961832				2022-02-06	
J	Guloglu, R; Sarici, IS; Bademler, S; Emirikci, S; Issever, H; Yanar, H; Ertekin, C				Guloglu, Recep; Sarici, Inanc Samil; Bademler, Suleyman; Emirikci, Selman; Issever, Halim; Yanar, Hakan; Ertekin, Cemalettin			Falling television related child injuries in Turkey: 10-year experience	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Children; furniture type; pediatric Glasgow coma scale; pediatric trauma score; television; injury	UNITED-STATES; TRENDS	BACKGROUND We reviewed retrospectively TV-related injuries to determine the risk factors, type of injuries, and operative intervention(s) required in children injured by falling TVs. METHODS This was a retrospective descriptive study, conducted on 42 pediatric patients who were admitted to Istanbul University, Istanbul Medical Faculty, Emergency Surgery Department. Case notes included all demographic and injury details, TV and TV-related furniture type, mechanism of injury, Pediatric Trauma Score (PTS), Pediatric Glasgow Coma Scale (PGCS), length of hospital stay, need for intensive care unit assessments, and management plans. RESULTS More than 65% of the children were aged 1 to 3 years. The injury rate was higher for boys (66.7%) than girls (33.3%). Of the 42 patients identified, 17 (40.5%) sustained only head injuries, with almost half of these having a definite traumatic brain injury; 6(14.3%) had only thoracic injury, and 4 (9.5%) had only limb injury. The PGCS ranged from 3 to 15, with a mean of 7. The PTS ranged from -6 to 12, with a mean of 9. Five children (11.9%), all aged 2 years or younger, died in the hospital as a result of the TV-related injury, all sustaining head and thorax injuries, which are reflected in a significantly lower PTS and lower PGCS on admission compared with older children. TV falls on to children often occur because of unstable supports, with dressers and shelves being the most common. The most common mechanism of injury (71.4%) among all age groups was fall/tipping of furniture. Pulling the furniture onto oneself (19%) was the second most frequent mechanism of injury. CONCLUSION Injuries related to TV falls can lead to significant morbidity and mortality in children. As they are preventable injuries, restricted activity and improved supervision of children around the TV can potentially lead to fewer incidences.	[Guloglu, Recep; Sarici, Inanc Samil; Bademler, Suleyman; Emirikci, Selman; Yanar, Hakan; Ertekin, Cemalettin] Istanbul Univ, Istanbul Fac Med, Dept Gen Surg, Trauma & Emergency Surg Serv, Istanbul, Turkey; [Issever, Halim] Istanbul Univ, Istanbul Fac Med, Dept Publ Hlth, Istanbul, Turkey		Sarici, IS (corresponding author), A-6 Blok Da 54, Istanbul, Turkey.	isamilsarici@hotmail.com	Sarici, Inanc Samil/V-8868-2017; Yanar, Hakan/AAY-9163-2020; Issever, Halim/AAV-1006-2020; Guloglu, Recep/AAY-9132-2020; Ertekin, Cemalettin/AAY-9962-2020; Bademler, Suleyman/AAY-4675-2020				Bernard PA, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.3.e32; Brenner RA, 1999, PEDIATRICS, V103, P968, DOI 10.1542/peds.103.5.968; DiScala C, 2001, ARCH PEDIAT ADOL MED, V155, P145, DOI 10.1001/archpedi.155.2.145; Gottesman BL, 2009, CLIN PEDIATR, V48, P851, DOI 10.1177/0009922809334352; Jea A, 2003, PEDIATR NEUROSURG, V38, P191, DOI 10.1159/000069098; MARGANITT B, 1992, PEDIATRICS, V89, P608; Murray KJ, 2009, INJURY PREV, V15, P240, DOI 10.1136/ip.2009.021550; Ota FS, 2006, ACAD EMERG MED, V13, P700, DOI 10.1197/j.aem.2006.01.021; Ozkaya C, 2011, TURKIYE AILE AILENIN, P217; Rutkoski JD, 2011, J SURG RES, V166, P199, DOI 10.1016/j.jss.2010.05.051; Scheidler MG, 2002, J PEDIATR SURG, V37, P572, DOI 10.1053/jpsu.2002.31612; TARAS HL, 1990, AM J DIS CHILD, V144, P357, DOI 10.1001/archpedi.1990.02150270107036; TONGE BJ, 1990, AUST NZ J PSYCHIAT, V24, P552, DOI 10.3109/00048679009062912	13	7	7	0	7	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	JAN	2012	18	1					61	64		10.5505/tjtes.2012.54775			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	895UI	WOS:000300521700012	22290052	Bronze			2022-02-06	
J	Leung, J; Harvey, LA; Moseley, AM; Tse, C; Bryant, J; Wyndham, S; Barry, S				Leung, Joan; Harvey, Lisa A.; Moseley, Anne M.; Tse, Charis; Bryant, Jane; Wyndham, Shirley; Barry, Siobhan			Electrical stimulation and splinting were not clearly more effective than splinting alone for contracture management after acquired brain injury: a randomised trial	JOURNAL OF PHYSIOTHERAPY			English	Article						Randomised controlled trial; Acquired brain injury; Contracture; Splinting; Electrical stimulation	ANKLE DORSIFLEXION; WRIST CONTRACTURE; UPPER EXTREMITY; STROKE PATIENTS; MOTOR RECOVERY; DAILY STRETCH; PEOPLE; SPASTICITY; MOBILITY; WEAKNESS	Question: Is electrical stimulation and splinting more effective than splinting alone for the management of wrist contracture following acquired brain injury? Design: A multi-centre randomised trial with concealed allocation, assessor blinding, and intention-to-treat analysis. Participants: Thirty-six adults with first stroke or traumatic brain injury and mild to moderate wrist flexion contractures. Intervention: The experimental group received electrical stimulation to the wrist and finger extensor muscles for 1 hour a day over 4 weeks while the control group did not. Both groups wore a splint for 12 hours a day during this 4-week period. Outcome measures: The primary outcome was passive wrist extension measured with a 3 Nm torque and with the fingers in extension. Secondary outcomes included passive wrist extension, wrist and finger extensor strength, wrist flexor spasticity, motor control of the hand, and Global Perceived Effect of Treatment, and perception of treatment credibility. Outcome measures were taken at baseline, at the end of the intervention period (4 weeks), and after a 2-week follow-up period (6 weeks). Results: At 4 and 6 weeks, the mean between-group difference (95% CI) for passive wrist extension was 7 degrees (-2 to 15) and -3 degrees (-13 to 7), respectively. Secondary outcomes were statistically non-significant or were of borderline statistical significance. Conclusion: It is not clear whether electrical stimulation and splinting is more effective than splinting alone for the management of wrist contracture after acquired brain injury. Therapists confidence in the efficacy of electrical stimulation for contracture management is not yet justified. Trial registration: ACTRN12609000495224. [Leung J, Harvey LA, Moseley AM, Tse C, Bryant J, Wyndham S, Barry S (2012) Electrical stimulation and splinting were not clearly more effective than splinting alone for contracture management after acquired brain injury: a randomised trial. Journal of Physiotherapy 58: 231-240]	[Leung, Joan] Royal Rehabil Ctr Sydney, Brain Injury Unit, Dept Physiotherapy, Ryde, NSW 2112, Australia; [Harvey, Lisa A.] Univ Sydney, Sydney Med Sch No, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Moseley, Anne M.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Moseley, Anne M.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Bryant, Jane] Balmain Hosp, Balmain, Australia		Leung, J (corresponding author), Royal Rehabil Ctr Sydney, Brain Injury Unit, Dept Physiotherapy, 59 Charles St, Ryde, NSW 2112, Australia.	joan.leung@royalrehab.com.au	Leung, Joan/AAC-8623-2019	Leung, Joan/0000-0003-0888-558X; Harvey, Lisa A/0000-0002-4365-0236	Motor Accidents Authority (NSW) Grants	Motor Accidents Authority (NSW) Grants.	Ada L, 2006, DISABIL REHABIL, V28, P891, DOI 10.1080/09638280500535165; Ada L, 2005, ARCH PHYS MED REHAB, V86, P230, DOI 10.1016/j.apmr.2004.02.031; Ada L, 2003, BRAIN, V126, P724, DOI 10.1093/brain/awg066; Alon G, 2008, AM J PHYS MED REHAB, V87, P627, DOI 10.1097/PHM.0b013e31817fabc1; Bakhtiary AH, 2008, CLIN REHABIL, V22, P418, DOI 10.1177/0269215507084008; Ben M, 2005, AUST J PHYSIOTHER, V51, P251, DOI 10.1016/S0004-9514(05)70006-4; BOHANNON RW, 1987, PHYS THER, V67, P931, DOI 10.1093/ptj/67.6.931; Bolton DAE, 2004, J NEUROL SCI, V223, P121, DOI 10.1016/j.jns.2004.05.005; BOTTE MJ, 1988, CLIN ORTHOP RELAT R, P7; BOWMAN BR, 1985, ANN BIOMED ENG, V13, P59, DOI 10.1007/BF02371250; BOWMAN BR, 1979, ARCH PHYS MED REHAB, V60, P497; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Chan MKL, 2009, NEUROREHAB NEURAL RE, V23, P357, DOI 10.1177/1545968308326428; Cheng JS, 2010, ARCH PHYS MED REHAB, V91, P505, DOI 10.1016/j.apmr.2009.11.022; de Jong LD, 2006, CLIN REHABIL, V20, P656, DOI 10.1191/0269215506cre1007oa; de Kroon JR, 2002, CLIN REHABIL, V16, P350, DOI 10.1191/0269215502cr504oa; Dean CM, 2000, AUST J PHYSIOTHER, V46, P35, DOI 10.1016/S0004-9514(14)60312-3; Fergusson D, 2007, CLIN ORTHOP RELAT R, P22, DOI 10.1097/01.BLO.0b013e3180308456; Glinsky J, 2007, PHYSIOTHER RES INT, V12, P175, DOI 10.1002/pri.375; Gustafsson L, 2006, CLIN REHABIL, V20, P277, DOI 10.1191/0269215506cr944oa; Harburn K, 1993, PHYS MED REHABIL, V7, P113; Harvey L, 1994, J Hand Ther, V7, P251; Harvey LA, 2000, ARCH PHYS MED REHAB, V81, P1340, DOI 10.1053/apmr.2000.9168; Harvey LA, 2003, AUST J PHYSIOTHER, V49, P176, DOI 10.1016/S0004-9514(14)60237-3; Harvey L, 2006, AUST J PHYSIOTHER, V52, P251, DOI 10.1016/S0004-9514(06)70004-6; Horsley SA, 2007, AUST J PHYSIOTHER, V53, P239, DOI 10.1016/S0004-9514(07)70004-1; Katalinic OM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007455.pub2; Kwah LK, 2012, J PHYSIOTHER, V58, P41, DOI 10.1016/S1836-9553(12)70071-1; Lannin NA, 2003, ARCH PHYS MED REHAB, V84, P297, DOI 10.1053/apmr.2003.50031; Lannin NA, 2007, STROKE, V38, P111, DOI 10.1161/01.STR.0000251722.77088.12; Moseley AM, 1997, PHYS THER, V77, P240, DOI 10.1093/ptj/77.3.240; Ng SSM, 2007, STROKE, V38, P2953, DOI 10.1161/STROKEAHA.107.490318; Patrick E, 2006, CLIN REHABIL, V20, P173, DOI 10.1191/0269215506cr922oa; Powell J, 1999, STROKE, V30, P1384, DOI 10.1161/01.STR.30.7.1384; Schneider L S, 1996, Int Psychogeriatr, V8, P277, DOI 10.1017/S1041610296002645; TARDIEU G, 1954, REV NEUROL, V91, P143; Yan TB, 2005, STROKE, V36, P80, DOI 10.1161/01.STR.0000149623.24906.63	37	7	7	0	18	AUSTRALIAN PHYSIOTHERAPY ASSOC	ST KILDA	LEVEL 3, 201  FITZROY ST, ST KILDA, 3182, AUSTRALIA	1836-9553	1836-9561		J PHYSIOTHER	J. Physiother.		2012	58	4					231	240		10.1016/S1836-9553(12)70124-8			10	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	054PS	WOS:000312356300003	23177225	gold			2022-02-06	
J	Martins, AT; Faisca, L; Esteves, F; Simao, C; Justo, MG; Muresan, A; Reis, A				Martins, Ana Teresa; Faisca, Luis; Esteves, Francisco; Simao, Claudia; Justo, Mariline Gomes; Muresan, Angelica; Reis, Alexandra			Changes in social emotion recognition following traumatic frontal lobe injury	NEURAL REGENERATION RESEARCH			English	Article						traumatic brain injury; facial emotion recognition; social emotions	BRAIN-INJURY; ASPERGER-SYNDROME; NORMAL ADULTS; AMYGDALA; MIND; NEUROLOGY; LESIONS; EYES	Changes in social and emotional behaviour have been consistently observed in patients with traumatic brain injury. These changes are associated with emotion recognition deficits which represent one of the major barriers to a successful familiar and social reintegration. In the present study, 32 patients with traumatic brain injury, involving the frontal lobe, and 41 age- and education-matched healthy controls were analyzed. A Go/No-Go task was designed, where each participant had to recognize faces representing three social emotions (arrogance, guilt and jealousy). Results suggested that ability to recognize two social emotions (arrogance and jealousy) was significantly reduced in patients with traumatic brain injury, indicating frontal lesion can reduce emotion recognition ability. In addition, the analysis of the results for hemispheric lesion location (right, left or bilateral) suggested the bilateral lesion sub-group showed a lower accuracy on all social emotions.	[Martins, Ana Teresa; Faisca, Luis; Muresan, Angelica; Reis, Alexandra] Univ Algarve, Dept Psychol, P-8000000 Faro, Algarve, Portugal; [Esteves, Francisco; Simao, Claudia; Justo, Mariline Gomes] Lisbon Univ Inst, CIS ISCTE IUL, Lisbon, Portugal		Martins, AT (corresponding author), Univ Algarve, Dept Psychol, P-8000000 Faro, Algarve, Portugal.	atmartins@ualg.pt	Reis, Alexandra A I/A-3888-2013; GNC, GNC/B-5716-2013; Martins, Ana Teresa/A-8885-2013; Faisca, Luis/A-4633-2013; Esteves, Francisco/I-1206-2012; Simao, Claudia/K-1871-2015	Reis, Alexandra A I/0000-0001-5598-0999; Martins, Ana Teresa/0000-0002-3304-6051; Faisca, Luis/0000-0003-4859-8817; Esteves, Francisco/0000-0002-5403-0091; Simao, Claudia/0000-0002-7723-752X			Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; Adolphs R, 2006, PROG BRAIN RES, V156, P363, DOI 10.1016/S0079-6123(06)56020-0; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Ardila A, 2008, BRAIN COGNITION, V68, P92, DOI 10.1016/j.bandc.2008.03.003; Back E, 2009, VIS COGN, V17, P1271, DOI 10.1080/13506280802479998; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; BUCK R, 1992, J PERS SOC PSYCHOL, V63, P962, DOI 10.1037/0022-3514.63.6.962; Buck R, 1984, COMMUNICATION EMOTIO; Damasio AR, 1995, DESCARTES ERROR REAS; Emery NJ, 2001, BEHAV NEUROSCI, V115, P515, DOI 10.1037/0735-7044.115.3.515; Eslinger PJ, 2002, CURR OPIN NEUROL, V15, P91, DOI 10.1097/00019052-200202000-00014; Gainotti G, 2001, J NEUROL, V248, P743, DOI 10.1007/s004150170088; HEIMER L, 1991, PROG BRAIN RES, V87, P109; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Leventhal H, 1982, AFFECT COGNITION; Martins A, 2007, STIMULI VALIDATION P; McDonald S., 2005, BRAIN IMPAIR, V6, P58, DOI [DOI 10.1375/BRIM.6.1.56.65481, 10.1375/brim.6.1.56.65481]; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Muller F, 2009, CORTEX, V45, P1; Norman W, 1986, CONSCIOUSNESS SELF R; Ochsner KN, 2007, SOCIAL PSYCHOL HDB B; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; ROSS ED, 1994, NEUROPSY NEUROPSY BE, V7, P1; Shamay-Tsoory SG, 2008, J AUTISM DEV DISORD, V38, P1451, DOI 10.1007/s10803-007-0515-9; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shaw P, 2005, J COGNITIVE NEUROSCI, V17, P1410, DOI 10.1162/0898929054985491; Tamietto M, 2007, NEUROPSYCHOLOGIA, V45, P836, DOI 10.1016/j.neuropsychologia.2006.08.012; Taylor, 2008, SOCIAL COGNITION BRA; TUCKER DM, 1981, PSYCHOL BULL, V89, P19, DOI 10.1037/0033-2909.89.1.19; Zaborszky L, 1997, NEUROSCIENCE, V79, P1051, DOI 10.1016/S0306-4522(97)00049-3	36	7	8	2	22	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JAN	2012	7	2					101	108		10.3969/j.issn.1673-5374.2012.02.004			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	887GO	WOS:000299915100004	25767483				2022-02-06	
J	Miller, JB; Axelrod, BN; Rapport, LJ; Hanks, RA; Bashem, JR; Schutte, C				Miller, Justin B.; Axelrod, Bradley N.; Rapport, Lisa J.; Hanks, Robin A.; Bashem, Jesse R.; Schutte, Christian			Substitution of California Verbal Learning Test, Second Edition for Verbal Paired Associates on the Wechsler Memory Scale, Fourth Edition	CLINICAL NEUROPSYCHOLOGIST			English	Article						Memory; List learning; Substitution; Paired associates; Wechsler; California Verbal Learning Test; second edition; CVLT-II	TRAUMATIC BRAIN-INJURY	Two common measures used to evaluate verbal learning and memory are the Verbal Paired Associates (VPA) subtest from the Wechsler Memory Scales (WMS) and the second edition of the California Verbal Learning Test (CVLT-II). For the fourth edition of the WMS, scores from the CVLT-II can be substituted for VPA; the present study sought to examine the validity of the substitution. For each substitution, paired-samples t tests were conducted between original VPA scaled scores and scaled scores obtained from the CVLT-II substitution to evaluate comparability. Similar comparisons were made at the index score level. At the index score level, substitution resulted in significantly lower scores for the AMI (p = .03; r = .13) but not for the IMI (p = .29) or DMI (p = .09). For the subtest scores, substituted scaled scores for VPA were not significantly different from original scores for the immediate recall condition (p = .20) but were significantly lower at delayed recall (p = .01). These findings offer partial support for the substitution. For both the immediate and delayed conditions, the substitution produced generally lower subtest scores compared to original VPA subtest scores.	[Miller, Justin B.; Rapport, Lisa J.; Bashem, Jesse R.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [Axelrod, Bradley N.; Schutte, Christian] John D Dingell Dept Vet Affairs Med Ctr, Psychol Sect, Detroit, MI USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA		Miller, JB (corresponding author), Univ Calif Los Angeles, UCLA Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA.	justin.b.miller@gmail.com		Rapport, Lisa/0000-0001-8014-9523; Miller, Justin B./0000-0002-4439-6604	National Institute on Disability and Rehabilitation Research Department of Education [H133A080044]; Del Harder Foundation; Wayne State University Graduate School	Justin B. Miller is now at the Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles. This research was supported by a grant from the National Institute on Disability and Rehabilitation Research Department of Education (H133A080044), the Del Harder Foundation, and the Wayne State University Graduate School. The contents of this study do not necessarily represent the policies of the funding agencies.	Delis D.C., 2000, CALIFORNIA VERBAL LE; Green P., 2005, MED SYMPTOM VALIDITY; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Holdnack J.A., 2010, WAIS 4 CLIN USE INTE, P237, DOI [10.1016/B978-0-12-375035-8.10009-6, DOI 10.1016/B978-0-12-375035-8.10009-6]; Miller JB, 2012, J CLIN EXP NEUROPSYC, V34, P531, DOI 10.1080/13803395.2012.665437; Miller JB, 2011, CLIN NEUROPSYCHOL, V25, P160, DOI 10.1080/13854046.2010.533197; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D., 2008, TECHNICAL INTERPRETI; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 2008, WECHSLER MEMORY SCAL	12	7	7	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	4					599	608		10.1080/13854046.2012.677478			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	945XW	WOS:000304311100004	22462576				2022-02-06	
B	Pella, RD; Hill, BD; Singh, AN; Hayes, JS; Gouvier, WD		Reynolds, CR; Horton, AM		Pella, Russell D.; Hill, B. D.; Singh, Ashvind N.; Hayes, Jill S.; Gouvier, Wm Drew			Noncredible Performance in Mild Traumatic Brain Injury	DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION			English	Article; Book Chapter							VERBAL-LEARNING TEST; POSTTRAUMATIC-STRESS-DISORDER; SYMPTOM VALIDITY TEST; CLOSED-HEAD-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; ADULT INTELLIGENCE SCALE; RELIABLE DIGIT SPAN; CARD SORTING TEST; RESPONSE BIAS; FORENSIC NEUROPSYCHOLOGY		[Pella, Russell D.; Gouvier, Wm Drew] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA; [Singh, Ashvind N.] Metropolitan State Hosp, Norwalk, CA 91325 USA; [Hill, B. D.] Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Providence, RI USA; [Pella, Russell D.] S Texas Vet Hlth Care Syst, San Antonio, TX USA		Gouvier, WD (corresponding author), Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA.	wgouvie@lsu.edu		Hill, Benjamin/0000-0002-5797-5082			Achenbach TM., 2003, MANUAL ASEBA ADULT F; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 1847, GAZETTE MED PARIS FR, V2, P209; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Arnold G., 2007, ASSESSMENT FEIGNED C, P178; Association of the United States Army, 2008, NCO REPORT, V17, P1; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Babin PR, 2002, J REHABIL, V68, P4; Backhaus SL, 2004, CLIN NEUROPSYCHOL, V18, P591, DOI 10.1080/13854040490888558; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Bigler ED, 2006, ARCH CLIN NEUROPSYCH, V21, P503, DOI 10.1016/j.acn.2006.03.008; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Boone, 2007, ASSESSMENT FEIGNED C, P152; Boone K., 2002, B TEST MANUAL; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone K. B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 1999, CLIN NEUROPSYCHOL, V13, P414; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Bordini EJ, 2002, NEUROREHABILITATION, V17, P93; Brennan A. B., 2008, CLIN NEUROPSYCHOL, V2, P1; Brennan AM, 2006, APPL NEUROPSYCHOL, V13, P1, DOI 10.1207/s15324826an1301_1; Brennan R.L., 2001, GEN THEORY; Briere J., 2001, DETAILED ASSESSMENT; Bury AS, 2002, PSYCHOL ASSESSMENT, V14, P472, DOI 10.1037//1040-3590.14.4.472; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Cato MA, 2002, CLIN NEUROPSYCHOL, V16, P524, DOI 10.1076/clin.16.4.524.13901; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Cercy S. P., 1997, CLIN ASSESSMENT MALI, P85; Chafetz MD, 2007, ARCH CLIN NEUROPSYCH, V22, P1, DOI 10.1016/j.acn.2006.10.003; CONDER R, 1992, MANUAL COMPUTERIZED; Dawes R, 2002, HEURISTICS BIASES PS, P716; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Demakis GJ, 2001, PSYCHOL ASSESSMENT, V13, P240, DOI 10.1037//1040-3590.13.2.240; Department of Veterans Affairs, 2008, FED REG         0103, V73, P1; Doubleday EK, 2002, J NEUROL NEUROSUR PS, V72, P602, DOI 10.1136/jnnp.72.5.602; Drane DL, 2006, EPILEPSIA, V47, P1879, DOI 10.1111/j.1528-1167.2006.00611.x; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Edens JF, 1998, J PERS ASSESS, V71, P379, DOI 10.1207/s15327752jpa7103_7; Elhai JD, 2002, J PERS ASSESS, V79, P531, DOI 10.1207/S15327752JPA7903_08; Engel CC, 2006, CNS SPECTRUMS, V11, P225, DOI 10.1017/S1092852900014395; Essig SM, 2001, ARCH CLIN NEUROPSYCH, V16, P271, DOI 10.1016/S0887-6177(99)00065-7; Etherton Joseph L, 2006, Spine J, V6, P61, DOI 10.1016/j.spinee.2005.05.382; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; FAUST D, 1989, PSYCHIATRY, V52, P197, DOI 10.1080/00332747.1989.11024443; Faust D, 1998, CRIT ISS NE, P1; Faust D, 2007, APPL NEUROPSYCHOL, V14, P26, DOI 10.1080/09084280701280411; FELDT LS, 1961, PSYCHOMETRIKA, V26, P307, DOI 10.1007/BF02289799; Finkelstein E., 2006, INCIDENCE EC BURDEN; FISHBAIN DA, 1994, APS J, V3, P264, DOI 10.1016/S1058-9139(05)80274-8; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; Frederick R. I., 1997, VALIDITY INDICATOR P; Frederick R. I., 1991, PSYCHOL ASSESSMENT J, V3, P596, DOI DOI 10.1037/1040-3590.3.4.596; Friedman R, 2007, POLARIZING CASE EXPO; Frueh BC, 2000, CLIN PSYCHOL REV, V20, P853, DOI 10.1016/S0272-7358(99)00015-X; Frueh BC, 2005, BRIT J PSYCHIAT, V186, P467, DOI 10.1192/bjp.186.6.467; Frueh BC, 2003, PSYCHIATR SERV, V54, P84, DOI 10.1176/appi.ps.54.1.84; Gavin H, 1843, FEIGNED FACTITIOUS D; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gioia GA IP, 2000, BEHAV RATING INVENTO; Girard Nancy J, 2008, AORN J, V87, P15, DOI 10.1016/j.aorn.2007.12.004; Glassmire DM, 2003, J CLIN EXP NEUROPSYC, V25, P465, DOI 10.1076/jcen.25.4.465.13875; Gouvier WD, 2001, NEUROREHABILITATION, V16, P215; Gouvier WD, 2004, ARCH CLIN NEUROPSYCH, V19, P153, DOI 10.1016/j.acn.2002.09.001; Gouvier WD, 2003, NEURO S B C, P405; Gouvier WD, 1999, STUD NEUROPSYCHOL DE, P27; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GRAF P, 1984, J EXP PSYCHOL LEARN, V10, P164, DOI 10.1037/0278-7393.10.1.164; Graue LO, 2007, CLIN NEUROPSYCHOL, V21, P929, DOI 10.1080/13854040600932137; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Green P., 2008, GREENS NONVERBAL MED; Green P, 2004, GREENS MED SYMPTOM V; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greiffenstein MF, 2002, PSYCHOL ASSESSMENT, V14, P202, DOI 10.1037//1040-3590.14.2.202; GREIFFENSTEIN MF, 2007, ASSESSMENT MALINGERE, P100; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve K. W., 2007, ASSESSMENT MALINGERE, P171; Greve KW, 2007, ASSESSMENT, V14, P12, DOI 10.1177/1073191106295095; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Griffin GAE, 1997, J CLIN PSYCHOL, V53, P757, DOI 10.1002/(SICI)1097-4679(199711)53:7<757::AID-JCLP14>3.0.CO;2-K; Gunstad J, 2001, CLIN NEUROPSYCHOL, V15, P397, DOI 10.1076/clin.15.3.397.10271; Guriel-Tennant J, 2006, J FORENSIC PSYCHI PS, V17, P577, DOI 10.1080/14789940600895838; HAMILTON JC, 2001, CHEST PAIN, P443; Hausknecht JP, 2007, J APPL PSYCHOL, V92, P373, DOI 10.1037/0021-9010.92.2.373; Hebben N., 2002, ESSENTIALS NEUROPSYC; Heilbronner R., 2008, NEUROPSYCHOLOGY COUR; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Hepp U, 2006, BRIT J PSYCHIAT, V188, P278, DOI 10.1192/bjp.bp.104.008102; Hill BD, 2008, ARCH CLIN NEUROPSYCH, V23, P823, DOI 10.1016/j.acn.2008.07.003; Hilsabeck RC, 2005, ARCH CLIN NEUROPSYCH, V20, P1025, DOI 10.1016/j.acn.2005.05.003; Hilsabeck RC, 1998, J CLIN EXP NEUROPSYC, V20, P328, DOI 10.1076/jcen.20.3.328.813; Hilsabeck RC, 2001, ARCH CLIN NEUROPSYCH, V16, P669, DOI 10.1016/S0887-6177(00)00077-9; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Iverson G. L., 1991, THESIS W VIRGINIA U; Iverson GL, 2000, J CLIN EXP NEUROPSYC, V22, P191, DOI 10.1076/1380-3395(200004)22:2;1-1;FT191; Iverson GL, 2003, HANDBOOK OF FORENSIC NEUROPSYCHOLOGY, P137; IVERSON GL, 1994, ARCH CLIN NEUROPSYCH, V9, P437, DOI 10.1016/0887-6177(94)90006-X; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Jelicic M, 2007, INT J NEUROSCI, V117, P1185, DOI 10.1080/00207450600934697; Ju D, 2000, Appl Neuropsychol, V7, P201, DOI 10.1207/S15324826AN0704_1; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; Kirmayer LJ, 2007, PSYCHOSOM MED, V69, P832, DOI 10.1097/PSY.0b013e31815b002c; Labarge AS, 2003, ARCH CLIN NEUROPSYCH, V18, P165, DOI 10.1016/S0887-6177(01)00193-7; Lamb D.G., 1994, PSYCHOL ASSESSMENT, V6, P8, DOI [https://doi.org/10.1037/1040-3590.6.1.8, DOI 10.1037/1040-3590.6.1.8]; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee G. J., 2007, CLIN NEUROPSYCHOL, V22, P1; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LEESHALEY PR, 1990, PSYCHOL REP, V66, P1355, DOI 10.2466/PR0.66.4.1355-1360; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LeesHaley PR, 1996, PSYCHOL REP, V79, P811, DOI 10.2466/pr0.1996.79.3.811; LEWIN K, 1946, MANUAL CHILD PSYCHOL, P791, DOI DOI 10.1037/10756-016; Lewin K, 1931, J GEN PSYCHOL, V5, P141, DOI 10.1080/00221309.1931.9918387; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LoPiccolo CJ, 1999, ANN MED, V31, P166, DOI 10.3109/07853899909115975; Lu P. H., 2007, ASSESSMENT FEIGNED C, P128; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Martin RC, 1996, J CLIN EXP NEUROPSYC, V18, P265, DOI 10.1080/01688639608408281; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Mayou R, 2005, AM J PSYCHIAT, V162, P847, DOI 10.1176/appi.ajp.162.5.847; McDermott BE, 2007, PSYCHIAT CLIN N AM, V30, P645, DOI 10.1016/j.psc.2007.07.007; MEEHL PE, 1990, PSYCHOL REP, V66, P195, DOI 10.2466/PR0.66.1.195-244; Meyers J E, 2001, Appl Neuropsychol, V8, P234, DOI 10.1207/09084280152829084; Meyers J E, 1999, Appl Neuropsychol, V6, P208, DOI 10.1207/s15324826an0604_3; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Miller H.A., 2001, MILLER FORENSIC ASSE; Millis S. R., 2004, PRINCIPLES PRACTICE, P1077; Millis S. R., 2008, TXB CLIN NEUROPSYCHO, P891; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Millon T., 1997, MILLON CLIN MULTIAXI, V2nd ed.; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morey, 1991, PERSONALITY ASSESSME; Niccolls R., 1991, MULTIDIGIT MEMORY TE; Nisbett R., 1980, HUMAN INFERENCE STRA; O'Bryant SE, 2006, CLIN NEUROPSYCHOL, V20, P533, DOI 10.1080/13854040590967568; O'Donohue W. T., 2003, HDB FORENSIC PSYCHOL; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Ord J.S., 2007, CLIN NEUROPSYCHOL, V22, P1; Orey SA, 2000, ARCH CLIN NEUROPSYCH, V15, P335, DOI 10.1016/S0887-6177(99)00024-4; PANKRATZ L, 1975, J CONSULT CLIN PSYCH, V43, P421, DOI 10.1037/h0076722; PANKRATZ L, 1979, J CONSULT CLIN PSYCH, V47, P409, DOI 10.1037/0022-006X.47.2.409; Pankratz L., 1997, CLIN ASSESSMENT MALI; PAUL DS, 1992, INT J CLIN NEUROPSYC, V14, P1; Phelps MA, 2004, ACAD EMERG MED, V11, P692, DOI 10.1197/j.aem.2003.08.022; Popper Karl., 2002, LOGIC SCI DISCOVERY; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Preacher KJ, 2005, PSYCHOL METHODS, V10, P178, DOI 10.1037/1082-989X.10.2.178; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Pritchard, 1996, DETECTING MALINGERIN; Puente A. E., 1991, NEUROPSYCHOLOGY LAW, P39; Resnick P. J., 1984, BEHAV SCI LAW, V2, P20; RESNICK PJ, 1997, CLIN ASSESSMENT MALI; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; REYNOLDS C, 2001, CLIN ASSESSMENT SCAL; Reynolds CR, 1998, CRIT ISS NE, P261; Reynolds CR., 2004, MANUAL BEHAV ASSESSM; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R, 1996, J PERS ASSESS, V67, P629, DOI 10.1207/s15327752jpa6703_15; Rogers R., 1992, STRUCTURED INTERVIEW; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; Ross SR, 2006, CLIN NEUROPSYCHOL, V20, P798, DOI 10.1080/13854040500328477; Russell EW, 2005, ARCH CLIN NEUROPSYCH, V20, P785, DOI 10.1016/j.acn.2005.05.001; Sbordone RJ, 2000, ARCH CLIN NEUROPSYCH, V15, P465; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Slick D., 1997, VSVT VICTORIA SYMPTO; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Sohlberg M., 2001, COGNITIVE REHABILITA; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Stone DC, 2006, CLIN NEUROPSYCHOL, V20, P766, DOI 10.1080/13854040500428459; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Strauss SE, 2005, EVIDENCE BASED MED P; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet JJ, 2000, CLIN NEUROPSYCHOL, V14, P18, DOI 10.1076/1385-4046(200002)14:1;1-8;FT018; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P481, DOI 10.1076/clin.16.4.481.13914; SZASZ TS, 1956, ARCH NEURO PSYCHIATR, V76, P432, DOI 10.1001/archneurpsyc.1956.02330280090009; Taylor S, 2007, J ANXIETY DISORD, V21, P22, DOI 10.1016/j.janxdis.2006.03.016; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tombaugh T. N., 1995, TEST MEMORY MALINGER; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; United States of America, 2008, BUDGET US GOVT FISCA; US Government Accountability Office, 2008, VA HLTH CAR MILD TRA; Vallabhajosula B, 2001, J AM ACAD PSYCHIATRY, V29, P207; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Victor TL, 2004, PROF PSYCHOL-RES PR, V35, P373, DOI 10.1037/0735-7028.35.4.373; Vilar-Lopez R, 2007, ARCH CLIN NEUROPSYCH, V22, P379, DOI 10.1016/j.acn.2007.01.012; Vitacco M. J., 2002, FORENSIC PSYCHOL CLA, P83; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wetter MW, 1996, PSYCHOL ASSESSMENT, V8, P39; WETTER MW, 1995, PROF PSYCHOL-RES PR, V26, P474, DOI 10.1037/0735-7028.26.5.474; Whitney KA, 2008, APPL NEUROPSYCHOL, V15, P287, DOI 10.1080/09084280802325215; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; WILLIAMS JM, 1987, COGNITIVE BEHAV RATI; World Health Organization, 1999, ICIHD 2 INT CLASS FU; World Health Organization, 2007, INT CLASS FUNCT DIS; Youngjohn, 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]; Youngjohn JR, 1999, ARCH CLIN NEUROPSYCH, V14, P511, DOI 10.1016/S0887-6177(98)00049-3; [No title captured]; [No title captured]	239	7	7	0	6	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4614-0441-5				2012							121	150		10.1007/978-1-4614-0442-2_3	10.1007/978-1-4614-0442-2		30	Psychology, Clinical; Neurosciences	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology	BAD69	WOS:000303852000003					2022-02-06	
J	Saldert, C; Bergman, M; Holstensson, J; Jonsson, S; Nygren, K; Vennman, F; Ferm, U				Saldert, Charlotta; Bergman, Malin; Holstensson, Josefin; Jonsson, Sara; Nygren, Klara; Vennman, Frida; Ferm, Ulrika			Combining methods in the assessment and analysis of communication in aphasia: Benefits and shortcomings of different approaches	JOURNAL OF INTERACTIONAL RESEARCH IN COMMUNICATION DISORDERS			English	Article						APHASIA; ASSESSMENT; COMMUNICATION DISORDER; INTERACTION ANALYSIS; SPOUSES	TRAUMATIC BRAIN-INJURY; CONVERSATION PARTNERS; TRAINING VOLUNTEERS; ADULTS; PEOPLE; CAREGIVER; SPEECH; CHILD	In this case study the benefit of using analysis of conversational interaction in clinical assessment of communication is explored. A diagnostic test revealed a severe global aphasia in a man. However, according to a questionnaire filled out by the wife, her husband had some functional communication. The description of the consequences of aphasia in this man was further modified and enriched by analyses of conversational interaction between the man and his spouse. The Measure of Participation in Conversation and the Measure of Skill in Supported Conversation show that the couple has strategies that facilitate communication. Activity-based Communication Analysis provides information about how the strategies are used and about the influence of different factors brought into the interaction by the situation and the individuals involved. Thus, although time consuming, analysis of natural conversations provide valid information that is of importance in assessment of communication and implementation of intervention that can have an impact on everyday life in persons with aphasia and their conversation partners.	[Saldert, Charlotta; Bergman, Malin; Holstensson, Josefin; Jonsson, Sara; Nygren, Klara; Vennman, Frida] Univ Gothenburg, Div Speech & Language Pathol, Inst Neurosci & Physiol, Gothenburg, Sweden; [Saldert, Charlotta] Univ Gothenburg, GPCC, Gothenburg, Sweden; [Ferm, Ulrika] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Reg Rehabil Ctr, DART Ctr AAC & AT, Gothenburg, Sweden		Saldert, C (corresponding author), Univ Gothenburg, Div Speech & Language Pathol, Inst Neurosci & Physiol, Gothenburg, Sweden.	charlotta.saldert@neuro.gu.se	Saldert, Charlotta/ABH-1746-2020	Saldert, Charlotta/0000-0001-8808-3610			Ahlsen E., 1995, 15 SCAND C LING OSL, P1; Ahlsen E., 1995, GOTHENBURG PAPERS TH, P77; Allwood J, 2000, ABDUCTION BELIEF CON, P47; Allwood J, 1976, MONOGRAPHS LINGUISTI, V2; Atkinson M., 1984, STRUCTURES SOCIAL IN; Barlow DH, 2004, BEHAV THER, V35, P205, DOI 10.1016/S0005-7894(04)80036-4; Brady MC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000425.pub3; Cheepen C, 1988, PREDICTABILITY INFOR; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Ferm U, 2005, AUGMENT ALTERN COMM, V21, P19, DOI 10.1080/07434610412331270507; Ferm U, 2012, J INTELLECT DEV DIS, V37, P11, DOI 10.3109/13668250.2011.649718; Fox S, 2009, APHASIOLOGY, V23, P951, DOI 10.1080/02687030802669526; Frattali C. M., 1995, AM SPEECH LANGUAGE H; Glueckauf RL, 2003, NEUROREHABILITATION, V18, P281; Goodglass H., 1972, ASSESSMENT APHASIA R; GOODWIN C, 1995, RES LANG SOC INTERAC, V28, P233, DOI 10.1207/s15327973rlsi2803_4; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Legg C, 2005, APHASIOLOGY, V19, P559, DOI 10.1080/02687030544000029; Lindstrom E, 1995, NING NEUROLINGVISTIS; Linehan M. M., 1997, EMPATHY RECONSIDERED, P353, DOI DOI 10.1037/10226-016; Lock S., 2001, SPPARC SUPPORTING PA; Nivre J., 2004, GOTEBORG TRANSCRIPTI; Oelschlaeger ML, 2000, J COMMUN DISORD, V33, P205, DOI 10.1016/S0021-9924(00)00019-8; Perkins L, 1999, APHASIOLOGY, V13, P259, DOI 10.1080/026870399402091; Perkins L., 1997, CONVERSATION ANAL PE; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Rayner H, 2003, INT J LANG COMM DIS, V38, P149, DOI 10.1080/1368282021000060308; Rydeman B., 2010, THESIS; Saldert C, 2010, J INTERACT RES COM D, V1, P169, DOI 10.1558/jircd.v1i2.169; Schegloff Emanuel A., 1982, ANAL DISCOURSE TEXT, P71; SMITH L, 1985, BRIT J DISORD COMMUN, V20, P31; Sorin-Peters R, 2004, APHASIOLOGY, V18, P951, DOI 10.1080/02687030444000453; Spreen O., 2003, ASSESSMENT APHASIA; Thunberg G, 2007, CLIN LINGUIST PHONET, V21, P457, DOI 10.1080/02699200701314963; Todman J, 2003, J PRAGMATICS, V35, P523, DOI 10.1016/S0378-2166(02)00130-3; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Wilkinson R., 2003, CONVERSATION BRAIN D, P59; Wilkinson R, 2010, J INTERACT RES COM D, V1, P45, DOI 10.1558/jircd.v1i1.45; Worrall L. E., 2000, NEUROGENIC COMMUNICA, P162	41	7	7	0	0	EQUINOX PUBLISHING LTD	SHEFFIELD	415, THE WORKSTATION, 15 PATERNOSTER ROW, SHEFFIELD, S1 2BX, ENGLAND	2040-5111	2040-512X		J INTERACT RES COM D	J. Interact. Res. Commun. Disord.		2012	3	2					141	169		10.1558/jircd.v3i2.141			29	Linguistics	Emerging Sources Citation Index (ESCI)	Linguistics	V2W7Q	WOS:000217981300002					2022-02-06	
J	Williams, C; Wood, RL				Williams, Claire; Wood, Rodger L.			Affective modulation of the startle reflex following traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Emotion; Startle reflex; Information Processing; Attention	SELF-ASSESSMENT MANNEQUIN; EMOTION RECOGNITION; SELECTIVE ATTENTION; FACIAL EXPRESSION; SOCIAL-PERCEPTION; HEAD-INJURY; EYEBLINK; DEPRESSION; DEFICITS; PROBE	Diminished emotional recognition, expression, and responsivity are frequent legacies of traumatic brain injury (TBI) that can have an adverse impact on relationships and psychosocial recovery. However, assessment of emotion responsivity is often difficult because many patients lack insight into their altered personality. To overcome this obstacle, we used a physiological measure of emotion responsivity, the startle reflex, to examine how this can vary according to the affective valence of stimuli by comparing a TBI group with a matched control group. The study also examined whether weaknesses of attention and speed of information processing could account for differences in startle modulation across groups. Sixty-four TBI patients and controls completed the startle reflex procedure. Participants were presented with pictures that differed in affective valence, and measures were taken of eyeblink startle responses to an acoustic probe. Subjective ratings of affect and arousal for each picture were obtained, and TBI patients completed measures of attention and information processing. Results revealed that the TBI group did not show the pattern of startle modulation observed in the control group. Whilst pleasant pictures produced the usual attenuation of the startle response, startle responses to unpleasant pictures were significantly lower in the TBI group than in controls. No significant correlations emerged between startle responses and performance on neuropsychological measures in the TBI group. The TBI group also rated unpleasant pictures as significantly less arousing than did controls. The results provide partial support for a growing body of evidence that has proposed impaired emotion responsivity following TBI.	[Williams, Claire; Wood, Rodger L.] Swansea Univ, Dept Psychol, Coll Human & Hlth Sci, Brain Injury Res Grp, Swansea SA2 8PP, W Glam, Wales		Williams, C (corresponding author), Swansea Univ, Dept Psychol, Coll Human & Hlth Sci, Brain Injury Res Grp, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	claire.williams@swansea.ac.uk		Williams, Claire/0000-0002-0791-744X	Brain Injury Rehabilitation Trust, UK	The information in this manuscript and the manuscript itself are new and original, are not currently under review by any other publication, and have never been published either electronically or in print. Financial disclosures: Funding for this research was obtained, in part, from the Brain Injury Rehabilitation Trust, UK. The funding source had no direct involvement in the conduct of the research or preparation of the article.	Allen NB, 1999, BIOL PSYCHIAT, V46, P542, DOI 10.1016/S0006-3223(99)00025-6; Amodio DM, 2011, EMOTION, V11, P47, DOI 10.1037/a0021238; Angrilli A, 1996, BRAIN, V119, P1991, DOI 10.1093/brain/119.6.1991; Angrilli A, 2008, NEUROPSYCHOLOGIA, V46, P1179, DOI 10.1016/j.neuropsychologia.2007.10.018; Anthony B. J, 1985, ADV PSYCHOPHYSIOLOGY; ANTHONY BJ, 1985, BIOL PSYCHOL, V21, P43, DOI 10.1016/0301-0511(85)90052-3; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Backs RW, 2005, EXP AGING RES, V31, P421, DOI 10.1080/03610730500206808; BALABAN MT, 1985, INFANT BEHAV DEV, V8, P443, DOI 10.1016/0163-6383(85)90008-6; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; BRADLEY MM, 1990, PSYCHOPHYSIOLOGY, V27, P513, DOI 10.1111/j.1469-8986.1990.tb01966.x; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Buchanan TW, 2004, BEHAV NEUROSCI, V118, P429, DOI 10.1037/0735-7044.118.2.429; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Codispoti M, 2001, PSYCHOPHYSIOLOGY, V38, P474, DOI 10.1017/S004857720198028X; Cook III E. W., 1999, STARTLE MODIFICATION; CORR PJ, 1995, PERS INDIV DIFFER, V19, P543, DOI 10.1016/0191-8869(95)00059-F; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Danziger N, 2006, BRAIN, V129, P2494, DOI 10.1093/brain/awl155; Dichter GS, 2004, PSYCHOPHYSIOLOGY, V41, P433, DOI 10.1111/j.1469-8986.00162.x; DIMBERG U, 1990, PSYCHOPHYSIOLOGY, V27, P481, DOI 10.1111/j.1469-8986.1990.tb01962.x; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Feldner MT, 2006, J BEHAV THER EXP PSY, V37, P171, DOI 10.1016/j.jbtep.2005.06.002; Filion DL, 1998, BIOL PSYCHOL, V47, P1, DOI 10.1016/S0301-0511(97)00020-3; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Greenwald M. K., 1989, J PSYCHOPHYSIOL; Gyurak A, 2009, COGN AFFECT BEHAV NE, V9, P144, DOI 10.3758/CABN.9.2.144; Hamm AO, 1997, PSYCHOPHYSIOLOGY, V34, P97, DOI 10.1111/j.1469-8986.1997.tb02420.x; HAZLETT EA, 1995, PSYCHOPHYSIOLOGY, V32, pS39; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Jennings PD, 1996, PSYCHOPHYSIOLOGY, V33, P148, DOI 10.1111/j.1469-8986.1996.tb02118.x; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kaviani H, 2004, J AFFECT DISORDERS, V83, P21, DOI 10.1016/j.jad.2004.04.007; Kucharska-Pietura K, 2003, NEUROPSYCHOLOGIA, V41, P1082, DOI 10.1016/S0028-3932(02)00294-4; Lang P. J., 1999, A4 U FLOR CTR RES PS; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lang PJ, 2008, A8 U FLOR CTR RES PS; Levenston GK, 2000, J ABNORM PSYCHOL, V109, P373, DOI 10.1037//0021-843X.109.3.373; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S., 2009, NEUROPSYCHOL REHABIL, V7, P1; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; McDonald S, 2010, J CLIN EXP NEUROPSYC, V32, P855, DOI 10.1080/13803391003596405; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Mneimne M, 2008, EMOTION, V8, P552, DOI 10.1037/a0012827; Molina V, 2010, EUR ARCH PSY CLIN N, V260, P609, DOI 10.1007/s00406-010-0102-5; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; PATRICK CJ, 1993, J ABNORM PSYCHOL, V102, P82, DOI 10.1037/0021-843X.102.1.82; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Rissling AJ, 2005, PSYCHOPHYSIOLOGY, V42, P440, DOI 10.1111/j.1469-8986.2005.00296.x; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; SCHELL AM, 1995, PSYCHOPHYSIOLOGY, V32, P266, DOI 10.1111/j.1469-8986.1995.tb02955.x; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; SILVERSTEIN LD, 1981, PSYCHOPHYSIOLOGY, V18, P240, DOI 10.1111/j.1469-8986.1981.tb03026.x; SIMONS RF, 1985, PSYCHOPHYSIOLOGY, V22, P44, DOI 10.1111/j.1469-8986.1985.tb01558.x; Soussignan R, 2005, NEUROCASE, V11, P114, DOI 10.1080/13554790590922513; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TEASDALE G, 1974, LANCET, V2, P81; Tulsky D., 1997, WAIS 3 WMS 3 TECHNIC; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VRANA SR, 1988, J ABNORM PSYCHOL, V97, P487, DOI 10.1037/0021-843X.97.4.487; Wechsler, 1997, WECHSLER ADULT INTEL; Wilbarger JL, 2009, NEUROPSYCHOLOGIA, V47, P1323, DOI 10.1016/j.neuropsychologia.2009.01.025; Williams C., 2012, J HEAD TRAUMA UNPUB; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518; Yartz AR, 2002, BIOL PSYCHOL, V59, P55, DOI 10.1016/S0301-0511(01)00121-1; Zahn TP, 1999, NEUROPSYCHOLOGIA, V37, P1227, DOI 10.1016/S0028-3932(99)00020-2	86	7	7	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2012	34	9					948	961		10.1080/13803395.2012.703641			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	030YB	WOS:000310604900006	22873359				2022-02-06	
J	Matlung, SE; Bilo, RAC; Kubat, B; van Rijn, RR				Matlung, S. E.; Bilo, R. A. C.; Kubat, B.; van Rijn, R. R.			Multicystic encephalomalacia as an end-stage finding in abusive head trauma	FORENSIC SCIENCE MEDICINE AND PATHOLOGY			English	Article						Multicystic encephalomalacia; Abusive head trauma; Blunt cerebral injury; Shaking; Impact	BRAIN-DAMAGE; YOUNG-CHILDREN; INFANTS; INJURY; CONTROVERSIES	Abusive head trauma (AHT) is one of the most severe forms of physical child abuse. If a child initially survives severe AHT the neurological outcome can be poor. In recent years several children were seen who developed multicystic encephalomalacia (MCE) after documented severe AHT. A search of the Netherlands Forensic Institute database in The Hague was performed. Inclusion criteria were cases of AHT between 1999 and 2010 where the child was under the age of 1 year old at the time of trauma. Trauma mechanism and radiological information were collected. Five children, three boys and two girls (mean age 57 days, range 8-142 days) who developed cystic encephalomalacia after inflicted traumatic brain injury were included. Survival ranged from 27 to 993 days. In all cases judicial autopsy was performed. All cases came before court and in each case child abuse was considered to be proven. In two cases the perpetrator confessed, during police interrogation, to shaking of the child only. Although a known serious outcome, this is one of the few reports on MCE as a result of AHT. In all cases the diagnosis was confirmed at autopsy.	[van Rijn, R. R.] Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Zuid Oost, Netherlands; [Matlung, S. E.] Univ Amsterdam, Fac Sci, Amsterdam, Netherlands; [Bilo, R. A. C.; van Rijn, R. R.] Netherlands Forens Inst, Sect Forens Pediat, Dept Forens Med, The Hague, Netherlands		van Rijn, RR (corresponding author), Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Zuid Oost, Netherlands.	r.r.vanrijn@amc.uva.nl	van Rijn, Rick/H-5526-2019	van Rijn, Rick/0000-0002-8876-6515			Butefisch C, 1996, Semin Pediatr Neurol, V3, P236, DOI 10.1016/S1071-9091(96)80017-9; CAFFEY J, 1974, PEDIATRICS, V54, P396; Case ME, 2008, BRAIN PATHOL, V18, P571, DOI 10.1111/j.1750-3639.2008.00204.x; Coppoletta JM, 1933, AM J PATHOL, V9, P55; Fernando S, 2008, PEDIATR RADIOL, V38, P827, DOI 10.1007/s00247-007-0729-1; Garten L, 2007, J CHILD NEUROL, V22, P645, DOI 10.1177/0883073807302618; GUTIERREZ LG, 2010, NEURORADIOLOGY; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Lonergan GJ, 2003, RADIOGRAPHICS, V23, P811, DOI 10.1148/rg.234035030; MarinPadilla M, 1997, J NEUROPATH EXP NEUR, V56, P219, DOI 10.1097/00005072-199703000-00001; Oehmichen M, 2008, ACTA NEUROPATHOL, V116, P317, DOI 10.1007/s00401-008-0356-4; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; Sie LTL, 2000, NEUROPEDIATRICS, V31, P128, DOI 10.1055/s-2000-7496; Stoodley N, 2006, BRIT J RADIOL, V79, P550, DOI 10.1259/bjr/23921951; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; Trenchs V, 2007, PEDIATR NEUROSURG, V43, P352, DOI 10.1159/000106382; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1	18	7	9	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1547-769X			FORENSIC SCI MED PAT	Forensic Sci. Med. Pathol.	DEC	2011	7	4					355	363		10.1007/s12024-011-9236-7			9	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	871HN	WOS:000298728700010	21519862	hybrid, Green Published			2022-02-06	
J	Micklewright, JL; Yutsis, M; Smigielski, JS; Brown, AW; Bergquist, TF				Micklewright, Jackie L.; Yutsis, Maya; Smigielski, Jeffrey S.; Brown, Allen W.; Bergquist, Thomas F.			Point of Entry and Functional Outcomes After Comprehensive Day Treatment Participation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Rehabilitation Psychology Conference	FEB 25-28, 2010	Tucson, AZ			Brain injuries; Outcome assessment (health care); Rehabilitation	TRAUMATIC BRAIN-INJURY; REHABILITATION; IMPACT	Objectives: To explore the relationship between point of entry into a comprehensive day treatment (CDT) program and outcomes after acquired brain injury (ABI). We hypothesized that participants entering our program 0 to 6 months postinjury would demonstrate greater declines in neurobehavioral sequelae and improvements in residential/vocational independence than those entering >6 to 12 and >12 to 24 months postinjury. Design: Retrospective examination of admission, discharge, and 1-year follow-up data from a CDT program. Setting: A large Midwestern academic medical center. Participants: Adult CDT participants with traumatic brain injuries (TBI) (n=54) or cerebrovascular accidents (CVAs) (n=29). Interventions: A CDT rehabilitation program. Main Outcome Measures: Portland Adaptability Inventory/Mayo-Portland Adaptability Inventory (percent change scores between admission and discharge) and the Independent Living and Vocational Independence Scales. Results: Time since injury was categorically coded into the 3 aforementioned point of entry groups. A 2 (injury type) X 3 (point of entry) between subjects analysis of covariance revealed a significant main effect for the point of entry (P<.001). Post hoc tests indicated that individuals entering the program 0 to 6 months postinjury demonstrated significantly greater treatment gains than those entering 6 to 12 or 12 to 24 months postinjury. Within group chi-square analyses revealed that a significantly higher percentage of the early entry participants were living and working independently at discharge and 1-year follow-up. Conclusions: Entry into a CDT program (0-6mo postinjury) is associated with significantly greater declines in neurobehavioral sequelae and improvements in residential and vocational independence in participants with TBI or CVA. Sustainable modest treatment gains were also observed in the late entry groups, suggesting that these individuals also benefit significantly from CDT program participation.	[Micklewright, Jackie L.; Yutsis, Maya; Smigielski, Jeffrey S.; Bergquist, Thomas F.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; [Smigielski, Jeffrey S.; Brown, Allen W.; Bergquist, Thomas F.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA		Bergquist, TF (corresponding author), Mayo Clin, Dept Psychiat & Psychol, 200 1st St SW, Rochester, MN 55905 USA.	bergquist.thomas@mayo.edu		Brown, Allen W./0000-0001-7228-3351			Andrewes D., 2001, NEUROPSYCHOLOGY THEO; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Malec JF., MANUAL MAYO PORTLAND; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; TREXLER LE, 1994, P CONS C DEV MULT ST; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; WOOD RLL, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P3	17	7	7	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2011	92	12					1974	1978		10.1016/j.apmr.2011.07.199			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	858WZ	WOS:000297835200007	22133244				2022-02-06	
J	Schulte, S; Schiffer, T; Sperlich, B; Kleinoder, H; Holmberg, HC				Schulte, Stefanie; Schiffer, Thorsten; Sperlich, Billy; Kleinoeder, Heinz; Holmberg, Hans Christer			Serum Concentrations of S100B are not Affected by Cycling to Exhaustion With or Without Vibration	JOURNAL OF HUMAN KINETICS			English	Article						biomarker; neurotrophin; hormone; endurance; serum	NEURON-SPECIFIC ENOLASE; BRAIN-DAMAGE; SEROTONERGIC NEURONS; BIOCHEMICAL MARKERS; CEREBROSPINAL-FLUID; ELITE PLAYERS; S-100B; S100-BETA; INCREASES; PROTEIN	The calcium-binding protein S100B is produced primarily by astrocytes and exerts concentration-dependent paracrine and autocrine effects on neurons and glia. The numerous findings of a correlation between S100B and traumatic brain injury (TBI) have resulted in the employment of this protein as a clinical biomarker for such injury. Our present aim was to determine whether cycling with (V) or without (NV) vibration alters serum concentrations of S100B. Twelve healthy, male non-smokers (age: 25.3 +/- 1.6 yrs, body mass: 74.2 +/- 5.9 kg, body height: 181.0 +/- 3.7 cm, VO2peak: 56.9 +/- 5.1 ml.min(-1).kg(-1) (means +/- SD)) completed in random order two separate trials to exhaustion on a vibrating bicycle (amplitude 4 mm and frequency 20 Hz) connected to an ergometer. The initial workload of 100 W was elevated by 50 W every 5 min and the mean maximal period of exercise was 25:27 +/- 1:30 min. The S100B in venous blood taken at rest, immediately after the test, and 30, 60 and 240 min post-exercise exhibited no significant differences (p>0.05), suggesting that cycling with and without vibration does not influence this parameter.	[Schulte, Stefanie; Schiffer, Thorsten] German Sport Univ Cologne, Inst Motor Control & Movement Tech, D-50933 Cologne, Germany; [Sperlich, Billy; Kleinoeder, Heinz] German Sport Univ Cologne, Inst Training Sci & Sport Informat, D-50933 Cologne, Germany; [Holmberg, Hans Christer] Mid Sweden Univ, Swedish Winter Sports Res Ctr, Dept Hlth Sci, Ostersund, Sweden		Schulte, S (corresponding author), German Sport Univ Cologne, Inst Motor Control & Movement Tech, Sportpk Mungersdorf 6, D-50933 Cologne, Germany.	schulte@dshs-koeln.de		Holmberg, Hans-Christer/0000-0002-3814-6246			Agawa H, 2008, INT J SPORTS MED, V29, P867, DOI 10.1055/s-2008-1038490; Billy S, 2009, J EXERCISE PHYSL, V12, P40; Bosco C, 2000, EUR J APPL PHYSIOL, V81, P449, DOI 10.1007/s004210050067; Dietrich MO, 2003, CAN J APPL PHYSIOL, V28, P710, DOI 10.1139/h03-054; Griffin MJ, 1996, HDB HUMAN VIBRATION, P15; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; KARPOVA N I, 1973, Gigiena i Sanitariya, V38, P36; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Kvorning T, 2006, EUR J APPL PHYSIOL, V96, P615, DOI 10.1007/s00421-006-0139-3; Manislield NJ, 2005, HUMAN RESPONSE VIBRA, P14; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Mester J, 2006, J BIOMECH, V39, P1056, DOI 10.1016/j.jbiomech.2005.02.015; Nishi M, 2000, BRAIN RES, V868, P113, DOI 10.1016/S0006-8993(00)02201-0; Nishiyama H, 2002, NEUROSCI LETT, V321, P49, DOI 10.1016/S0304-3940(01)02549-6; NOVOTNY S, 1959, Prac Lek, V11, P511; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Stalnacke BM, 2008, BIOMARK INSIGHTS, V3, P87; Struder HK, 2001, INT J SPORTS MED, V22, P482, DOI 10.1055/s-2001-17606; Suhr F, 2007, J APPL PHYSIOL, V103, P474, DOI 10.1152/japplphysiol.01160.2006; ZIMMER DB, 1987, AM J PHYSIOL, V252, pC285, DOI 10.1152/ajpcell.1987.252.3.C285	27	7	7	0	3	ACAD PHYSICAL EDUCATION-KATOWICE	KATOWICE	UL MIKOLOWSKA 72A, KATOWICE, 40-065, POLAND	1640-5544			J HUM KINET	J. Hum. Kinet.	DEC	2011	30						59	63		10.2478/v10078-011-0073-2			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	885FX	WOS:000299765000007	23487156	gold, Green Published			2022-02-06	
J	Marz-Weiss, P; Kunz, D; Bimmler, D; Berkemeier, C; Ozbek, S; Dimitriades-Schmutz, B; Haybaeck, J; Otten, U; Graf, R				Maerz-Weiss, Pia; Kunz, Dieter; Bimmler, Daniel; Berkemeier, Caroline; Oezbek, Suat; Dimitriades-Schmutz, Beatrice; Haybaeck, Johannes; Otten, Uwe; Graf, Rolf			Expression of Pancreatitis-Associated Protein after Traumatic Brain Injury: A Mechanism Potentially Contributing to Neuroprotection in Human Brain	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Apoptosis; Traumatic brain injury; PAP I/reg2; Oxidative stress; Human brain; Central neurons; Neuroprotective action	ASTROCYTE-TARGETED EXPRESSION; RECEPTOR/IL-6 FUSION PROTEIN; INTERLEUKIN-6 IL-6; CYTOKINE; EXOCRINE; NEURONS; FAMILY; DEGENERATION; REGENERATION; SURVIVAL	Neuronal cell death after severe traumatic brain injury (TBI) is caused by a complex interplay of pathological mechanisms including excitotoxicity, oxidative stress, mitochondrial dysfunction, extensive neuroinflammation, and ischemia-reperfusion injury. Pancreatitis-associated protein I (PAP I/reg2) was reported to be a survival factor for peripheral neurons, particularly sensory and motor neurons. In rat brains, by experimental TBI as well as by kainic acid induced brain seizure, PAP I and PAP III were found to be up-regulated in central neurons. In this study, we performed immunohistochemical staining in postmortem human brain from patients who died after severe TBI to demonstrate PAP expression on protein level in cerebellar Purkinje cells, pyramidal and granular neurons in cerebral cortex, and cortical neurons in the fore- and mid-brain. In primary cultures of rat brain cortical, hippocampal, and cerebellar neurons, we found neuroprotective effects for PAP I on H2O2-induced oxidative stress. Moreover, serum K+-deprivation induces apoptotic cell death in 55% of cerebellar granule neurons (CGN), whereas upon treatment with PAP I only 32% of CGN are apoptotic. Using Western blot analyses, we compared protein phosphorylation in neuronal signaling pathways activated by PAP I versus Interleukin-6 (IL-6). We found a rapid activation of Akt-kinase phosphorylation by PAP I with a peak at 15 min, whereas IL-6 induces Akt-phosphorylation lasting longer than 30 min. Phosphorylation of MAP-42/44 kinases is stimulated in a comparable fashion. Both, IL-6 and PAP I increase phosphorylation of NF kappa B for activation of gene transcription, whereas only IL-6 recruits STAT3 phosphorylation, indicating that STAT3 is not a target of PAP I transcription activation in brain neurons. Application of the Akt-inhibitor Wortmanin reveals only a partial inhibition of PAP I-dependent protection of CGN from H2O2-induced oxidative stress. Based on our findings, we suggest that PAP I is a long lasting neurotrophic signal for central neurons. The neuroprotective effects parallel those that have been described for effects of PAP I in ciliary neurotrophic factor (CNTF)-mediated survival of sensory and motor neurons. PAP I may act in autocrine and/or paracrine fashion and thus may contribute to endogenous protective mechanisms relevant under harmful conditions like oxidative stress, brain injury, or neurodegeneration.	[Kunz, Dieter; Berkemeier, Caroline; Dimitriades-Schmutz, Beatrice; Otten, Uwe] Univ Basel, Inst Physiol, CH-4056 Basel, Switzerland; [Maerz-Weiss, Pia] Hoffmann LaRoche Ltd, Translat Res, CH-4070 Basel, Switzerland; [Bimmler, Daniel; Graf, Rolf] Univ Zurich Hosp, Dept Surg, Pancreatitis Res Lab, CH-8091 Zurich, Switzerland; [Oezbek, Suat] Heidelberg Univ, Inst Mol Evolut & Genom, D-69120 Heidelberg, Germany; [Haybaeck, Johannes] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Haybaeck, Johannes] Med Univ Graz, Inst Pathol, A-8036 Graz, Austria		Kunz, D (corresponding author), Univ Basel, Inst Physiol, Pestalozzistr 20, CH-4056 Basel, Switzerland.	dieter.kunz@unibas.ch; uwe.otten@unibas.ch	Ozbek, Suat/D-3701-2014	Ozbek, Suat/0000-0003-2569-3942; Graf, Rolf/0000-0001-7449-7302	Swiss National FoundationSwiss National Science Foundation (SNSF) [3100BO-100730]; Stiftungs-Forderstipendium of the University of Basel; Amelie Waring Stiftung, Zurich	This study was supported by Swiss National Foundation Grant 3100BO-100730 (to U.O.) and by Stiftungs-Forderstipendium of the University of Basel (to P. M.). Further support was received from the Amelie Waring Stiftung, Zurich (to R. G). We are grateful to S. P. Hunt for supply with Reg-2 antibody.	Ampo KI, 2009, J NEUROTRAUM, V26, P1683, DOI [10.1089/neu.2008.0847, 10.1089/neu.2008-0847]; Averill S, 2002, J NEUROSCI, V22, P7493; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cao ZX, 2006, J NEUROSCI, V26, P5565, DOI 10.1523/JNEUROSCI.0815-06.2006; DELAMONTE SM, 1990, J CLIN INVEST, V86, P1004, DOI 10.1172/JCI114762; DRICKAMER K, 1995, CURR OPIN STRUC BIOL, V5, P589, DOI 10.1016/0959-440X(95)80048-4; Duplan L, 2001, NEUROBIOL AGING, V22, P79, DOI 10.1016/S0197-4580(00)00182-2; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Graf R, 2002, J SURG RES, V105, P136, DOI 10.1006/jsre.2002.6387; Graf R, 2001, J BIOL CHEM, V276, P21028, DOI 10.1074/jbc.M010717200; Graf R, 2006, J SURG RES, V133, P113, DOI 10.1016/j.jss.2005.09.030; He SQ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-23; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Kawahara S, 2011, NEUROSCIENCE, V175, P273, DOI 10.1016/j.neuroscience.2010.11.020; Kunz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-90; Li L, 2009, PANCREATOLOGY, V9, P99, DOI 10.1159/000178880; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marz P, 1999, EUR J NEUROSCI, V11, P2995, DOI 10.1046/j.1460-9568.1999.00755.x; Marz P, 1997, EUR J NEUROSCI, V9, P2765, DOI 10.1111/j.1460-9568.1997.tb01705.x; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Namikawa K, 2005, BIOCHEM BIOPH RES CO, V332, P126, DOI 10.1016/j.bbrc.2005.04.105; Namikawa K, 2006, J NEUROSCI, V26, P7460, DOI 10.1523/JNEUROSCI.0023-06.2006; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Peng YP, 2005, NEUROSCI LETT, V374, P192, DOI 10.1016/j.neulet.2004.10.069; Penkowa M, 2003, J NEUROSCI RES, V73, P481, DOI 10.1002/jnr.10681; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Pizzi M, 2004, MOL CELL NEUROSCI, V25, P301, DOI 10.1016/j.mcn.2003.10.022; Rose-John S, 2007, EXPERT OPIN THER TAR, V11, P613, DOI 10.1517/14728222.11.5.613; Schiesser M, 2001, PANCREAS, V22, P186, DOI 10.1097/00006676-200103000-00012; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Sun Y, 2002, BIOCHEM BIOPH RES CO, V295, P532, DOI 10.1016/S0006-291X(02)00706-4; Valerio A, 2002, MOL CELL NEUROSCI, V21, P602, DOI 10.1006/mcne.2002.1208; Yamashita T, 2005, J NEUROCHEM, V94, P459, DOI 10.1111/j.1471-4159.2005.03227.x; Zhang PL, 2006, MOL CELL NEUROSCI, V31, P387, DOI 10.1016/j.mcn.2005.10.014; Zhang YW, 2003, WORLD J GASTROENTERO, V9, P2635	37	7	8	0	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	NOV	2011	31	8					1141	1149		10.1007/s10571-011-9715-0			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	836DU	WOS:000296090300003	21643999	Green Submitted			2022-02-06	
J	Muller, B; Evangelopoulos, DS; Bias, K; Wildisen, A; Zimmermann, H; Exadaktylos, AK				Mueller, B.; Evangelopoulos, D. S.; Bias, K.; Wildisen, A.; Zimmermann, H.; Exadaktylos, A. K.			Can S-100B serum protein help to save cranial CT resources in a peripheral trauma centre? A study and consensus paper	EMERGENCY MEDICINE JOURNAL			English	Article							MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; DIFFERENT ASSAYS; S100B PROTEIN; BRAIN-INJURY; MARKER; LEVEL	Background Cranial CT (CCT) is the gold standard to rule out traumatic brain injury. The serum level of the protein S-100B has recently been proposed as promising marker of traumatic brain injury. We prospectively investigated whether it might be a reliable tool for CCT triage in mild brain injury at a peripheral trauma centre with limited CT resources. Methods Patients with mild head injury and a Glasgow Coma Score of 13-15 admitted to the emergency department of a peripheral trauma centre were enrolled. Blood samples for S-100B analysis were obtained after clinical evaluation. The cut-off level for positive S-100B was 0.105 mu g/l. All patients underwent CCT. The relationship between clinical findings, CCT results and S-100B levels was evaluated. Results 233 patients were enrolled. Median time between injury and sampling was 137 min. CCT was positive in 22 (9%) patients. Of these, 19 (8%) had positive serum S-100B levels. Overall, S-100B had a specificity of 12.2% and a sensitivity of 86.4%, with a positive predictive value of 12.8% and a negative predictive value of 85.7% as a selection tool for CCT triage in patients with mild head injury. Conclusion The S-100B serum level showed a high sensitivity and negative predictive value in the screening of patients with mild head injury. The use of serum S-100B as a biomarker for CCT triage may improve patient screening and decrease the number of CCT scans performed. This would reduce unnecessary radiation exposure and free up capacity in the emergency rooms of peripheral hospitals to enable them to cope better with multiple admissions.	[Evangelopoulos, D. S.; Zimmermann, H.; Exadaktylos, A. K.] Inselspital Bern, Dept Emergency Med, CH-3010 Bern, Switzerland; [Mueller, B.; Bias, K.; Wildisen, A.] Reg Hosp Sursee, Dept Surg, Luzern, Switzerland		Evangelopoulos, DS (corresponding author), Inselspital Bern, Dept Emergency Med, CH-3010 Bern, Switzerland.	ds.evangelopoulos@gmail.com					Ambrozic J, 2008, EMERG MED J, V25, P90, DOI 10.1136/emj.2006.044222; Benneker LM, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-13; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; DIMOPOULOU I, 2003, RESTOR NEUROL NEUROS, V21, P159; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; GOODACRE SW, EMERG MED J; Hallen M, 2008, CLIN CHEM LAB MED, V46, P1025, DOI 10.1515/CCLM.2008.190; Herrmann M, 2001, NEUROSURGERY, V49, P1272, DOI 10.1097/00006123-200111000-00058; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Lomas JP, 2005, EMERG MED J, V22, P889, DOI 10.1136/emj.2005.031732; Michetti F, 2002, CLIN CHEM, V48, P2097; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Munoz-Sanchez MA, 2009, BRAIN INJURY, V23, P39, DOI 10.1080/02699050802590346; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Pickering A, 2008, EMERG MED J, V25, P88, DOI 10.1136/emj.2007.046631; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schaller B, 2010, EMERG MED J, V27, P537, DOI 10.1136/emj.2009.073031; Smit LHM, 2005, INT J BIOL MARKER, V20, P34, DOI 10.1177/172460080502000106; Stein SC, 2000, NEW ENGL J MED, V343, P1570; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Unden J, 2009, SCAND J CLIN LAB INV, V69, P13, DOI 10.1080/00365510802651833; WALLING AD, IS CT SCANNING INDIC	29	7	10	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205			EMERG MED J	Emerg. Med. J.	NOV	2011	28	11					938	940		10.1136/emj.2010.095372			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	834SL	WOS:000295984200008	20961930				2022-02-06	
J	Chang, VH; Lombard, LA; Greher, MR				Chang, Victor H.; Lombard, Lisa A.; Greher, Michael R.			Mild Traumatic Brain Injury in the Occupational Setting	PM&R			English	Article							POSTCONCUSSION-LIKE SYMPTOMS; HEAD-INJURY; CHRONIC PAIN; PERFORMANCE; RECOVERY; WORK; MANAGEMENT; DIAGNOSIS	The evaluation and management of mild traumatic brain injury (mTBI) in the occupational setting may pose significant challenges for even the most-seasoned practitioner. Providers must simultaneously address the clinical management of mTBI and be familiar with the systematic and administrative requirements related to the management of injured workers with mTBI who are covered by workers' compensation insurance, including causation, return to work, and the potential of permanent impairment. Given the primarily subjective nature of many mTBI symptoms, an injured worker with a delayed recovery may raise the question, if not suspicion, of symptom magnification and secondary gain. This review discusses the evaluation and treatment of the injured worker with mTBI, and focuses on the medicolegal issues that are present in the workers' compensation system, especially the role of neuropsychological evaluations. Although significant differences exist regarding classification schema, for the purposes of this discussion, mTBI is used to encompass the terms concussion, postconcussive syndrome, and persistent postconcussive syndrome. PM R 2011;3:S387-S395	[Chang, Victor H.] Univ Colorado, Dept Phys Med & Rehabil, Sch Med, Aurora, CO 80045 USA; [Lombard, Lisa A.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Greher, Michael R.] Univ Colorado, Dept Neurosurg, Sch Med, Aurora, CO 80045 USA		Chang, VH (corresponding author), Univ Colorado, Dept Phys Med & Rehabil, Sch Med, Mailstop F-493,12631 E 17th Ave,Rm 2513, Aurora, CO 80045 USA.	victor.chang@ucdenver.edu					Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boone K. B., 2007, ASSESSMENT FEIGNED C; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Frenchman K. A., 2005, J CLIN EXPT NEUROPSY, V27, P334; Greiffenstein M, 2009, CLIN NEUROPSYCHOL, V23, P286, DOI 10.1080/13854040802104873; Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kim H, 2006, NEUROREHABILITATION, V21, P269; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; KRAUS JF, 1985, J OCCUP ENVIRON MED, V27, P757; Kristman VL, 2008, BRAIN INJURY, V22, P51, DOI 10.1080/02699050701849991; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Macmillan M, 2010, NEUROPSYCHOL REHABIL, V20, P641, DOI 10.1080/09602011003760527; Martelli M.F., 2007, BRAIN INJURY MED PRI, P1183; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Powell GE, 2008, J NEUROL NEUROSUR PS, V79, P237, DOI 10.1136/jnnp.2007.131722; Richards PM, 2010, PSYCHOL INJ LAW, V3, P3, DOI 10.1007/s12207-010-9065-0; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sweet JJ, 2011, CLIN NEUROPSYCHOL, V25, P12, DOI 10.1080/13854046.2010.544165; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008	42	7	7	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2011	3	10		3			S387	S395		10.1016/j.pmrj.2011.08.007			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	966YK	WOS:000305873100006	22035681				2022-02-06	
J	D'Anci, KE; Allen, PJ; Kanarek, RB				D'Anci, Kristen E.; Allen, Patricia J.; Kanarek, Robin B.			A Potential Role for Creatine in Drug Abuse?	MOLECULAR NEUROBIOLOGY			English	Article						Creatine; Nutrition; Drug abuse; Depression; Stress; Magnetic resonance spectroscopy; Post-traumatic stress disorder; Traumatic brain injury	MAGNETIC-RESONANCE-SPECTROSCOPY; BRAIN ENERGY-METABOLISM; HUNTINGTONS-DISEASE; MITOCHONDRIAL DYSFUNCTION; PSYCHIATRIC-DISORDERS; ORAL SUPPLEMENTATION; DEPRESSED-PATIENTS; MONOHYDRATE; KINASE; USERS	Supplemental creatine has been promoted for its positive health effects and is best known for its use by athletes to increase muscle mass. In addition to its role in physical performance, creatine supplementation has protective effects on the brain in models of neuronal damage and also alters mood state and cognitive performance. Creatine is found in high protein foods, such as fish or meat, and is also produced endogenously from the biosynthesis of arginine, glycine, and methionine. Changes in brain creatine levels, as measured using magnetic resonance spectroscopy, are seen in individuals exposed to drugs of abuse and depressed individuals. These changes in brain creatine indicate that energy metabolism differs in these populations relative to healthy individuals. Recent work shows that creatine supplementation has the ability to function in a manner similar to antidepressant drugs and can offset negative consequences of stress. These observations are important in relation to addictive behaviors as addiction is influenced by psychological factors such as psychosocial stress and depression. The significance of altered brain levels of creatine in drug-exposed individuals and the role of creatine supplementation in models of drug abuse have yet to be explored and represent gaps in the current understanding of brain energetics and addiction.	[D'Anci, Kristen E.; Allen, Patricia J.; Kanarek, Robin B.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA		D'Anci, KE (corresponding author), Tufts Univ, Dept Psychol, 490 Boston Ave, Medford, MA 02155 USA.	Kristen.danci@tufts.edu		Allen, Patricia/0000-0001-8753-9938			Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Adriani W, 2007, NEUROTOXICOL TERATOL, V29, P116, DOI 10.1016/j.ntt.2006.11.010; AGREN H, 1988, J NEURAL TRANSM, V74, P55, DOI 10.1007/BF01243575; Allen PJ, 2010, NEUROPSYCHOPHARMACOL, V35, P534, DOI 10.1038/npp.2009.160; Amital D, 2006, J CLIN PSYCHIAT, V67, P836, DOI 10.4088/JCP.v67n0521c; Andres RH, 2005, CELL TRANSPLANT, V14, P537, DOI 10.3727/000000005783982756; Andres RH, 2005, J NEUROCHEM, V95, P33, DOI 10.1111/j.1471-4159.2005.03337.x; Andres RH, 2005, NEUROSCIENCE, V133, P701, DOI 10.1016/j.neuroscience.2005.03.004; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Beard E, 2010, J NEUROCHEM, V115, P297, DOI 10.1111/j.1471-4159.2010.06935.x; Bender A, 2006, NEUROLOGY, V67, P1262, DOI 10.1212/01.wnl.0000238518.34389.12; Bender A, 2005, J NEUROL, V252, P36, DOI 10.1007/s00415-005-0595-4; Brosnan JT, 2007, ANNU REV NUTR, V27, P241, DOI 10.1146/annurev.nutr.27.061406.093621; Brustovetsky N, 2001, J NEUROCHEM, V76, P425, DOI 10.1046/j.1471-4159.2001.00052.x; Buttner A, 2011, NEUROPATH APPL NEURO, V37, P118, DOI 10.1111/j.1365-2990.2010.01131.x; Chang L, 1999, AM J PSYCHIAT, V156, P716; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Dager SR, 2004, ARCH GEN PSYCHIAT, V61, P450, DOI 10.1001/archpsyc.61.5.450; Daumann J, 2004, NEUROSCI LETT, V362, P113, DOI 10.1016/j.neulet.2004.03.004; Dechent P, 1999, AM J PHYSIOL-REG I, V277, pR698, DOI 10.1152/ajpregu.1999.277.3.R698; Ducray AD, 2007, J NEUROSCI RES, V85, P1863, DOI 10.1002/jnr.21337; Ernst T, 2000, NEUROLOGY, V54, P1344, DOI 10.1212/WNL.54.6.1344; Gold MS, 2009, BIOL PSYCHIAT, V66, P118, DOI 10.1016/j.biopsych.2009.02.021; Gualano B, 2010, AMINO ACIDS, V38, P31, DOI 10.1007/s00726-009-0263-6; Hermann D, 2007, BIOL PSYCHIAT, V61, P1281, DOI 10.1016/j.biopsych.2006.08.027; Hersch SM, 2006, NEUROLOGY, V66, P250, DOI 10.1212/01.wnl.0000194318.74946.b6; Iosifescu DV, 2008, BIOL PSYCHIAT, V63, P1127, DOI 10.1016/j.biopsych.2007.11.020; KATO T, 1992, J AFFECT DISORDERS, V26, P223, DOI 10.1016/0165-0327(92)90099-R; KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3; Kim J, 2010, BBA-MOL BASIS DIS, V1802, P673, DOI 10.1016/j.bbadis.2010.05.001; KUZHIKANDATHIL EV, 1994, J NEUROSCI RES, V39, P70, DOI 10.1002/jnr.490390110; Licata SC, 2010, ANN NY ACAD SCI, V1187, P148, DOI 10.1111/j.1749-6632.2009.05143.x; Lyoo IK, 2003, PSYCHIAT RES-NEUROIM, V123, P87, DOI 10.1016/S0925-4927(03)00046-5; Lyoo IK, 2002, BIOL PSYCHIAT, V51, P195, DOI 10.1016/S0006-3223(01)01313-0; Matthews RT, 1998, J NEUROSCI, V18, P156; Matthews RT, 1999, EXP NEUROL, V157, P142, DOI 10.1006/exnr.1999.7049; McLeish MJ, 2005, CRIT REV BIOCHEM MOL, V40, P1, DOI 10.1080/10409230590918577; Moore CM, 1997, AM J PSYCHIAT, V154, P116; Mudd SH, 2007, AM J CLIN NUTR, V85, P19, DOI 10.1093/ajcn/85.1.19; NASH SR, 1994, RECEPTOR CHANNEL, V2, P165; NIKLASSON F, 1984, BIOL PSYCHIAT, V19, P1183; O'Neill J, 2001, ALCOHOL CLIN EXP RES, V25, P1673; O'Neill J, 2001, ADDICT BIOL, V6, P347, DOI 10.1080/13556210020077073; Ohtsuki S, 2002, J CEREBR BLOOD F MET, V22, P1327, DOI 10.1097/01.WCB.0000033966.83623.7D; Pan JW, 2007, AM J PHYSIOL-REG I, V292, pR1745, DOI 10.1152/ajpregu.00717.2006; Reneman L, 2001, BIOL PSYCHIAT, V50, P550, DOI 10.1016/S0006-3223(01)01177-5; Renshaw PF, 2001, AM J PSYCHIAT, V158, P2048, DOI 10.1176/appi.ajp.158.12.2048; Rezin GT, 2009, NEUROCHEM RES, V34, P1021, DOI 10.1007/s11064-008-9865-8; Roitman S, 2007, BIPOLAR DISORD, V9, P754, DOI 10.1111/j.1399-5618.2007.00532.x; Roy BD, 2002, CAN J PHYSIOL PHARM, V80, P1008, DOI 10.1139/Y02-129; Sakellaris G, 2006, J TRAUMA, V61, P322, DOI 10.1097/01.ta.0000230269.46108.d5; Sakellaris G, 2008, ACTA PAEDIATR, V97, P31, DOI 10.1111/j.1651-2227.2007.00529.x; Salo R, 2007, BIOL PSYCHIAT, V61, P1272, DOI 10.1016/j.biopsych.2006.07.031; Scheff SW, 2004, NEUROCHEM RES, V29, P469, DOI 10.1023/B:NERE.0000013753.22615.59; Segal M, 2007, EUR NEUROPSYCHOPHARM, V17, P194, DOI 10.1016/j.euroneuro.2006.08.010; Sestili P, 2006, FREE RADICAL BIO MED, V40, P837, DOI 10.1016/j.freeradbiomed.2005.10.035; Shao L, 2008, ANN MED, V40, P281, DOI 10.1080/07853890801923753; Silva Ana P, 2010, Curr Drug Abuse Rev, V3, P239; Smith LM, 2001, PEDIATRICS, V107, P227, DOI 10.1542/peds.107.2.227; Stack EC, 2008, ANN NY ACAD SCI, V1147, P79, DOI 10.1196/annals.1427.008; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Volz HP, 1998, EUR ARCH PSY CLIN N, V248, P289, DOI 10.1007/s004060050052; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wilken B, 1998, PEDIATR RES, V43, P8, DOI 10.1203/00006450-199801000-00002; WYSS M, 1994, MOL CELL BIOCHEM, V133, P51, DOI 10.1007/BF01267947; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yang SL, 2009, PSYCHIAT RES-NEUROIM, V174, P171, DOI 10.1016/j.pscychresns.2009.05.004; Zhang SF, 2011, NEURODEGENER DIS, V8, P194, DOI 10.1159/000321681; Zhu S, 2004, J NEUROSCI, V24, P5909, DOI 10.1523/JNEUROSCI.1278-04.2004	69	7	7	0	13	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648			MOL NEUROBIOL	Mol. Neurobiol.	OCT	2011	44	2					136	141		10.1007/s12035-011-8176-2			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825LQ	WOS:000295277600002	21399936				2022-02-06	
J	Joshua, SP; Agrawal, D; Sharma, BS; Mahapatra, AK				Joshua, Shejoy P.; Agrawal, Deepak; Sharma, B. S.; Mahapatra, A. K.			Papilloedema as a non-invasive marker for raised intra-cranial pressure following decompressive craniectomy for severe head injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Raised ICP; Papilloedema; Decompressive craniectomy; Severe head injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HYDROCEPHALUS; TOMOGRAPHY	Background: Decompressive craniectomy is an extremely useful surgical procedure for decreasing intra cranial pressure following severe head injury. However, there is anecdotal evidence to suggest that some of these patients may continue to have raised intracranial pressure in spite of an apparently adequate Decompressive craniectomy. Aims and objectives: (1) To assess whether fundoscopic findings accurately reflect changes in ICP in severe head injury. (2) To study the temporal course of fundoscopic findings in patients with severe head injury following decompressive craniectomy and to correlate fundoscopy findings with ventriculomegaly (if any) on serial Computerized tomography in these patients. Materials and methods: In this prospective study from November 2008 to March 2009,32 patients severe head injury (GCS <= 8) admitted at the Department of Neurosurgery, JPN Apex Trauma Center, All India Institute of Medical Sciences, New Delhi who underwent a wide (> 80 cubic cm) decompressive craniectomy with a lax duraplasty for severe head injury were subjected to fundoscopic examinations on the 1st, 3rd, 5th, 7th and 14th post operative days along with serial C.T. imaging studies to check for ventriculomegaly. Ventriculomegaly was defined as dilatation of temporal horn > 2 mm along with ballooning of III ventricle and/or presence of pen-ventricular lucency. Seven severe head injury patients who were conservatively managed with continuous ICP monitoring were also subjected to serial fundoscopic examinations. Results: 32 patients who underwent decompressive craniectomy for severe head injury were evaluated during the study period. The age group of the patients ranged from 12 to 75 years. The mean GCS on admission was 6/15 (range 3/15-8/15). There were 12 cases of acute traumatic subdural hemorrhage and 20 cases of intracerebral contusion (frontal/temporal regions). Fundoscopic examination showed papilloedema in 81% (n = 26) on the first post operative day, 66% (n = 21) on the third post operative day, 28% (n = 9) on the fifth post operative day, 13% (n = 4) on the seventh post operative day and 6% (n = 2) at 14 days post-operatively. In 4(13%) patients papilloedema reappeared on fundoscopy after one week of surgery. Of these, only 1 (3%) patient had ventriculomegaly on CT scans. Lumbar drain was placed in 2 of these patients and resulted in prompt resolution of papilloedema. In the 7 patients who were managed conservatively and had ICP monitoring, serial fundoscopic examination were found to accurately reflect the ICP readings in all cases. No papilloedema was seen in any of the patients when ICP was below 20 mm of Hg and papilloedema appeared in all cases where the ICP was >= 20 mm of Hg. Conclusion: Fundoscopy is an extremely useful non-invasive tool to assess changes in intracranial pressure in severe head injury. Reappearance of papilloedema in the postoperative period even in the absence of ventriculomegaly indicates raised ICP and should be treated aggressively. (C) 2011 Elsevier B.V. All rights reserved.	[Joshua, Shejoy P.; Agrawal, Deepak; Sharma, B. S.; Mahapatra, A. K.] All India Inst Med Sci, Dept Neurosurg, JPN Apex Trauma Ctr, New Delhi 110029, India		Agrawal, D (corresponding author), All India Inst Med Sci, Dept Neurosurg, JPN Apex Trauma Ctr, New Delhi 110029, India.	drdeepak@gmail.com	/AAG-3032-2021	/0000-0002-5499-0746; Joshua, Shejoy/0000-0002-3758-2732			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Agarwal AK, 2000, J INDIAN ACAD CLIN M, V1, P271; Balan C, 2009, ROM NEUROSURG, V16, P20; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Beaumont A, 1999, CRIT REV NEUROSURG, V9, P207, DOI 10.1007/s003290050135; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; DALVI AI, 2010, NORMAL PRESSURE HYDR; Dandy WE, 1914, AM J DIS CHILD, V8, P406; Figg RE, 2006, PEDIATR SURG INT, V22, P215, DOI 10.1007/s00383-005-1560-0; Geeraerts T, 2008, CRIT CARE, V12, DOI [10.1186/cc6893, 10.1186/cc7006]; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; HAWKINS TD, 1976, CLIN RADIOL, V27, P279, DOI 10.1016/S0009-9260(76)80069-4; KANSKI JJ, 2005, CLIN OPHTHALMOLOGY S, P598; Marion DW, 2006, NEUROSURGERY, V58, P655; Mizumaki Y, 2003, NEUROL SURG TOKYO, V31, P201; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046; PHILIPPON J, 1976, NEUROCHIRURGIE, V22, P111; SELHORST JB, 1985, NEUROSURGERY, V16, P357, DOI 10.1227/00006123-198503000-00013; WALSH H, 2007, ESSENTIALS CLIN NEUR, P122; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Yatsushige H, 2010, ACTA NEUROCHIR SUPPL, V106, P265, DOI 10.1007/978-3-211-98811-4_50	22	7	8	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2011	113	8					635	638		10.1016/j.clineuro.2011.05.012			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	820EI	WOS:000294887900007	21676532				2022-02-06	
J	Belikova, NA; Glumac, AL; Kapralova, V; Cheikhi, A; Tyurina, YY; Vagni, VA; Kochanek, PM; Kagan, VE; Bayir, H				Belikova, Natalia A.; Glumac, Ashley L.; Kapralova, Valentyna; Cheikhi, Amin; Tyurina, Yulia Y.; Vagni, Vincent A.; Kochanek, Patrick M.; Kagan, Valerian E.; Bayir, Huelya			A high-throughput screening assay of ascorbate in brain samples	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Vitamin C; Ascorbic acid; Nitroxides; Controlled cortical impact; Hemorrhagic shock; Head trauma	DOPAMINE-BETA-HYDROXYLATION; VITAMIN-C; OXIDATIVE STRESS; INJURY; ALBUMIN; PROBES; ACID; RESUSCITATION; PLASMA; MODEL	Ascorbate is a vital reductant/free radical scavenger in the CNS, whose content defines - to a large extent - the redox status and the antioxidant reserves. Quick, reliable and specific methods for its measurement in brain samples are highly desirable. We have developed a new high-throughput screening assay for measurements of ascorbate using a fluorescence plate-reader. This assay is based on a direct reaction of ascorbate with a nitroxide radical conjugated with a fluorogenic acridine moiety, 4-((9-acridinecarbonyl)-amino)-2,2,6,6-tetramethylpiperidine-1-oxyl radical (AC-TEMPO), yielding fluorescent hydroxylamine product (AC-TEMPO-H). The reaction was monitored over time using fluorescence and electron spin resonance techniques. The appearance of fluorescent AC-TEMPO-H was linear within the range of 3.75-75 mu M AscH(-) in the sample (0.5-10 mu M AscH(-) in the well). Assay was validated with high performance liquid chromatography method. The concentration of ascorbate in murine tissue samples, including brain samples after traumatic brain injury and hemorrhagic shock, was measured. (C) 2011 Elsevier B.V. All rights reserved.	[Belikova, Natalia A.; Glumac, Ashley L.; Kapralova, Valentyna; Cheikhi, Amin; Tyurina, Yulia Y.; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Vagni, Vincent A.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15201 USA; [Belikova, Natalia A.; Glumac, Ashley L.; Kapralova, Valentyna; Cheikhi, Amin; Tyurina, Yulia Y.; Kagan, Valerian E.; Bayir, Huelya] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15219 USA		Bayir, H (corresponding author), Univ Pittsburgh, Dept Crit Care Med, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	bayihx@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Tyurina, Yulia/0000-0003-0287-2091; Kagan, Valerian E./0000-0002-7245-1885	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS061817, NS30318, HL70755, U19 AI068021, HD057587]; NIOSHUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [OH008282]; US ArmyUnited States Department of Defense [W81XWH-09-0187]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD057587] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL070755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTHUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [R01OH008282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, R01NS061817, P01NS030318, P20NS030318] Funding Source: NIH RePORTER	Supported by grants from NIH (NS061817, NS30318, HL70755, U19 AI068021, and HD057587); NIOSH (OH008282) and the US Army (W81XWH-09-0187). We thank Drs. Li Ma and Carleton J. Hsia of SynZyme Technologies for providing PNA.	Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Borisenko GG, 2004, J BIOL CHEM, V279, P23453, DOI 10.1074/jbc.M400119200; BORS W, 1997, VITAMIN C HLTH DIS; BRADLEY DW, 1973, CLIN CHIM ACTA, V44, P47, DOI 10.1016/0009-8981(73)90158-7; CAREY RN, 2006, EP15A2 FACB, P64; CHESTER D, 2008, CLIN BIOCH REV S1, pS23; COMSTOCK GW, 1995, CANCER EPIDEM BIOMAR, V4, P505; Crookes BA, 2004, J TRAUMA, V57, P547, DOI 10.1097/01.TA.0000135162.85859.4C; DILIBERTO EJ, 1981, J BIOL CHEM, V256, P3385; DILIBERTO EJ, 1991, AM J CLIN NUTR, V54, pS1163, DOI 10.1093/ajcn/54.6.1163s; Exo JL, 2009, J NEUROTRAUM, V26, P2403, DOI 10.1089/neu.2009.0980; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; KAGAN VE, 1994, BIOCHEMISTRY-US, V33, P9651, DOI 10.1021/bi00198a034; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Li HQ, 2002, FREE RADICAL BIO MED, V32, P712, DOI 10.1016/S0891-5849(02)00762-1; Likhtenstein GI, 2007, PHOTOCHEM PHOTOBIOL, V83, P871, DOI 10.1111/j.1751-1097.2007.00141.x; Lozinsky E, 2001, BBA-GEN SUBJECTS, V1526, P53, DOI 10.1016/S0304-4165(01)00100-3; Lozinsky E, 1999, J BIOCHEM BIOPH METH, V38, P29, DOI 10.1016/S0165-022X(98)00029-3; Sato S, 2009, SPECTROCHIM ACTA A, V71, P2030, DOI 10.1016/j.saa.2008.07.045; Soh N, 2001, ANALYST, V126, P564, DOI 10.1039/b101600h; Vethanayagam JGG, 1999, FREE RADICAL BIO MED, V26, P1591, DOI 10.1016/S0891-5849(99)00031-3; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Vislisel JM, 2007, ANAL BIOCHEM, V365, P31, DOI 10.1016/j.ab.2007.03.002; WASHKO PW, 1992, ANAL BIOCHEM, V204, P1, DOI 10.1016/0003-2697(92)90131-P	25	7	7	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	SEP 30	2011	201	1					185	190		10.1016/j.jneumeth.2011.08.001			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	828LY	WOS:000295503700023	21855575	Green Accepted			2022-02-06	
J	Agrawal, D; Sahoo, S; Satyarthee, GD; Gupta, D; Sinha, S; Misra, MC				Agrawal, Deepak; Sahoo, Siddhartha; Satyarthee, G. D.; Gupta, Deepak; Sinha, Sumit; Misra, M. C.			Initial experience with mobile computed tomogram in neurosurgery intensive care unit in a level 1 trauma center in India	NEUROLOGY INDIA			English	Article						Head injury; intensive care unit; mobile computed tomogram		Neurosurgical patients, in particular patients with severe head injury require frequent computed tomogram (CT) of the head, usually at short notice. A mobile CT may prove to be invaluable for these patients. This report reviews the initial experience with a mobile CT at tertiary trauma center. A total of 1292 head CT scans were done during 9 months study period with an average of 4.78 CT scans for day. Of the 563 patients in whom the detailed prospective data was available, 456 (81) patients were on ventilator, 450 (80) patients were on sedation, and 37 (6.5) patients were on ionotropic support at the time of doing CT scan. The mean Glasgow Coma Scale score at the time of CT was 8.1 (range 3-15). The average time to do a CT scan (from time of request to transmission into picture archiving and communication system) was 12.6 min (range 7.8-47 min). Image quality was judged to be excellent by all the neurosurgical faculty in the intensive care unit. During the study period, the main CT scanner broke down four times (for variable time periods) and the mobile CT scanner could manage the load of severe head injured patients in the casualty without any problems. The mobile CT machine itself broke down 36 times and the mean response time was 12.5 h (range 1-144 h) during each breakdown point. This experience suggests that mobile CT is extremely useful in the management of patients with severe traumatic brain injury and can be recommended for any high-volume neurosurgery department in the country.	[Agrawal, Deepak; Sahoo, Siddhartha; Satyarthee, G. D.; Gupta, Deepak; Sinha, Sumit; Misra, M. C.] All India Inst Med Sci, JPN Apex Trauma Ctr, New Delhi 110029, India		Agrawal, D (corresponding author), All India Inst Med Sci, JPN Apex Trauma Ctr, New Delhi 110029, India.	drdeepak@gmail.com	/AAG-3032-2021	/0000-0002-5499-0746			Butler WE, 1998, NEUROSURGERY, V42, P1304, DOI 10.1097/00006123-199806000-00064; Gunnarsson T, 2000, J NEUROSURG, V93, P432, DOI 10.3171/jns.2000.93.3.0432; Masaryk Thomas, 2008, Radiol Manage, V30, P50; Mirvis SE, 1999, SURG CLIN N AM, V79, P1317, DOI 10.1016/S0039-6109(05)70080-3; Stevens GC, 2009, J RADIOL PROT, V29, P483, DOI 10.1088/0952-4746/29/4/002; 2008, HLTH DEVICES, V37, P325	6	7	7	0	2	MEDKNOW PUBLICATIONS	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0028-3886			NEUROL INDIA	Neurol. India	SEP-OCT	2011	59	5					91	94		10.4103/0028-3886.86551			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	846TE	WOS:000296925300017	22019661				2022-02-06	
J	Carbonneau, H; Martineau, E; Andre, M; Dawson, D				Carbonneau, Helene; Martineau, Eric; Andre, Melanie; Dawson, Deirdre			Enhancing Leisure Experiences Post Traumatic Brain Injury: A Pilot Study	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; leisure education meaning; integration	QUALITY-OF-LIFE; SATISFACTION; ADULTS; REHABILITATION; PARTICIPATION; HEALTH; AWARENESS; DEFICITS	Up to 90% of people with severe traumatic brain injury (TBI) report dissatisfaction with the status of their leisure participation and/or social integration. Yet, there are virtually no studies that have investigated the benefits of interventions that target leisure specifically for this population. The purpose of this study was to determine whether the Leisure Education Program (Carbonneau, Fontaine, & Lussier, 2006) designed to assist people with stroke to engage in meaningful leisure activities, build leisure self-efficacy and promote general wellbeing would have similar benefits for survivors of TBI. We recruited three community-dwelling survivors of TBI to participate in a 10-week leisure program. All three participants reported some benefit in leisure satisfaction and self-efficacy. This extended to improvements in general wellbeing and health-related quality of life for two of the three. These findings suggest that further investigations into the benefits of leisure education for adults with TBI should be conducted.	[Carbonneau, Helene; Martineau, Eric] Univ Quebec Trois Rivieres, Trois Rivieres, PQ G9A 5H7, Canada; [Dawson, Deirdre] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5S 1A1, Canada; [Dawson, Deirdre] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5S 1A1, Canada; [Andre, Melanie; Dawson, Deirdre] Kunin Lunenfield Appl Res Unit, Toronto, ON, Canada		Carbonneau, H (corresponding author), Univ Quebec Trois Rivieres, 3351 Boul Forges,CP 500, Trois Rivieres, PQ G9A 5H7, Canada.	helene.carbonneau@UQTR.ca	Dawson, Deirdre R/I-8882-2014	Dawson, Deirdre R/0000-0001-7517-6121	Ontario Neurotrauma Foundation (ONF); ONF-REPAR; Quebec Rehabilitation Research Network (REPAR)	This study was conducted by a postdoctoral fellow (HC) funded through a grant to D. Dawson from the Ontario Neurotrauma Foundation (ONF) in collaboration with the Quebec Rehabilitation Research Network (REPAR) and student research assistants funded through a grant from the ONF-REPAR to D. Dawson and H. Lefebvre. The authors would especially like to thank the participants for their involvement in the study.	Agostino J. N., 1981, ACTIVITIES ADAPTATIO, V1, P5; ASTROM M, 1992, STROKE, V23, P527, DOI 10.1161/01.STR.23.4.527; BANDURA A, 1982, J BEHAV THER EXP PSY, V13, P195, DOI 10.1016/0005-7916(82)90004-0; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Bravo G, 1996, CAN J AGING, V15, P112, DOI 10.1017/S0714980800013325; Cantin R., 2004, J READAPTATION MED, V24, P118; Carbonneau H., 2006, PROGRAMME ED LOISIR; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; COLEMAN D, 1993, J LEISURE RES, V25, P111, DOI 10.1080/00222216.1993.11969913; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; Desrosiers J, 2007, ARCH PHYS MED REHAB, V88, P1095, DOI 10.1016/j.apmr.2007.06.017; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Drummond A, 1995, CLIN REHABIL, V9, P283, DOI DOI 10.1177/026921559500900402; Dupuy H J, 1978, AM PUBL HLTH ASS M L; Ecker C., 2001, FTATPL1020001 FED HI; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Fazio A.F., 1977, VITAL HLTH STAT, V2, P1; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Iso-Ahola S. E., 1983, Leisure Studies, V2, P45, DOI 10.1080/02614368300390041; ISOAHOLA SE, 1982, ANN TOURISM RES, V9, P256, DOI 10.1016/0160-7383(82)90049-4; Iwasaki Y, 2001, CAN J PUBLIC HEALTH, V92, P214, DOI 10.1007/BF03404309; Jackson E. L., 1988, Leisure Sciences, V10, P203, DOI 10.1080/01490408809512190; JUMISKO E, 2007, THESIS LULEA U TECHN; Kelly J. R., 1987, Leisure Sciences, V9, P189, DOI 10.1080/01490408709512159; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Lefebvre H, 2004, PARTICIPATION SOCIAL; Leitner M. J., 1985, ACTIVITY ADAPTATION, V7, P125; Lloyd Kathleen, 2003, URBAN POLICY RES, V21, P339, DOI DOI 10.1080/0811114032000147395; LoBello SC, 2003, J REHABIL RES DEV, V40, P293, DOI 10.1682/JRRD.2003.07.0293; Malec J. F., 2003, MANUAL MAYO PORTLAND; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2005, REHABILITATION TRAUM, P176; Malley D, 2008, NEUROREHABILITATION, V23, P329; McColl MA, 2007, BRAIN IMPAIR, V8, P238, DOI DOI 10.1375/BRIM.8.3.238; McDowell I., 1996, MEASURING HLTH GUIDE; Nour K., 2002, THERAP RECREATION J, V34, P48; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Paille P, 2003, ANAL QUALITATIVE SCI; Parker CJ, 2001, CLIN REHABIL, V15, P42, DOI 10.1191/026921501666968247; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; PETERSON CA, 2000, THERAPEUTIC RECREATI; Powell J., 2008, ARCH PHYS MED REHAB, V89, pe25; Prvu J., 1999, 9 CAN C LEIS RES AC; Quintard B., 2002, Annales de Readaptation et de Medecine Physique, V45, P456, DOI 10.1016/S0168-6054(02)00296-9; Ragheb M. G., 1993, Leisure Studies, V12, P61, DOI 10.1080/02614369300390051; RAGHEB MG, 1982, J LEISURE RES, V14, P295, DOI 10.1080/00222216.1982.11969527; RIDDICK CC, 1984, J LEISURE RES, V16, P136, DOI 10.1080/00222216.1984.11969581; Rousseau J., 1995, LOISIRS SOC, V8, P93; Shannon CS, 2008, LEISURE SCI, V30, P1, DOI 10.1080/01490408509512105; SNEEGAS JJ, 1986, J LEISURE RES, V18, P248, DOI 10.1080/00222216.1986.11969663; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Sumison T, 2009, PREPARING PROFESSION, P51; Tham K, 2001, AM J OCCUP THER, V55, P46, DOI 10.5014/ajot.55.1.46; Trombly CA, 1998, AM J OCCUP THER, V52, P810, DOI 10.5014/ajot.52.10.810; Watkins M, 2007, LEISURE SCI, V29, P287, DOI 10.1080/01490400701259985; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; Wise J. B., 2002, Therapeutic Recreation Journal, V36, P335; [No title captured], DOI DOI 10.1375/BRIM.7.2.107	64	7	7	1	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2011	12	2			SI		140	151		10.1375/brim.12.2.140			12	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	837BH	WOS:000296165600007					2022-02-06	
J	de Moura, JC; Rangel, BLR; Creoncio, SCE; Pernambuco, JRB				de Moura, Jose Carlos; Ramos Rangel, Bruno Lazaro; Evangelista Creoncio, Sheila Cristiane; Barros Pernambuco, Jose Ricardo			Clinical and epidemiological profile of head trauma at the Urgencias e Traumas Hospital in the city of Petrolina, Pernambuco	BRAZILIAN NEUROSURGERY-ARQUIVOS BRASILEIROS DE NEUROCIRURGIA			Portuguese	Article						Brain injuries; accidents; traffic; trauma; nervous system	SAO-PAULO; INJURY	Objective: In Brazil, among the set of injuries resulting from external causes, the head trauma (HT) stands out in terms of magnitude, both in dead and wounded. This study aims to evaluate epidemiologically the cases of traumatic brain injury occurred in the Sao Francisco Valley analyzing them in age, sex, origin, trauma etiology, conduct and additional tests. Method: The medical records of patients victims of head injury admitted to the Urgencias e Traumas Hospital, between December 2008 and June 2009 were studied in a descriptive and analytical with a quantitative approach. A total of 101 medical records were evaluated. Conclusion: The most common etiology of HT were motorcycle accidents, followed by fall. Male is the most affected gender and most affected age group was 21 to 40 years. Regarding the classification of severity of HT, 53.47% were classified as mild, 25.73% were classified as moderate and 20.80% classified as severe, indicating the prevalence of mild HT, but with a significant percentage of severe cases.				jcdemoura@uol.com.br					Alho EJL, 2008, J BRAS NEUROCIRURG, V19, P31; BRAGA FM, 2008, ARQ CATARINENSE MED, V37, P35; de Andrade AF, 2009, REV ASSOC MED BRAS, V55, P75, DOI 10.1590/S0104-42302009000100020; Oliveira Nelson Luiz Batista de, 2003, Rev. Latino-Am. Enfermagem, V11, P749, DOI 10.1590/S0104-11692003000600008; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Fonseca A., 2002, J TARDE         0717; Franciozi Carlos Eduardo da Silveira, 2008, Acta ortop. bras., V16, P261, DOI 10.1590/S1413-78522008000500001; Gawryszewski VP, 2009, REV SAUDE PUBL, V43, P275, DOI 10.1590/S0034-89102009000200008; Koizumi MS, 2000, ARQ NEURO-PSIQUIAT, V58, P81, DOI 10.1590/S0004-282X2000000100013; Kraus J. F., 1996, NEUROLOGY AND TRAUMA, V2, P3, DOI DOI 10.1055/s-2008-1041052; Macedo KC, 2006, THESIS; Melo JRT, 2004, ARQ NEURO-PSIQUIAT, V62, P711, DOI 10.1590/S0004-282X2004000400027; Melo JRT, 2005, ARQ BRAS NEUROCIR, V24, P94; Morais DF, 2006, ARQ BRAS NEUROCIR, V25, P125; Organizacion Mundial de la Salud, PUBL CIENT TECN, V599; Pereira CU, 2004, ARQ BRAS NEUROCIR, V23, P157; Pereira CU, 2004, J BRAS NEUROCIRURG, V15, P18; Pereira CU, 2006, ARQ BRAS NEUROCIR, V25, P8; Pereira CU, 2005, ARQ BRAS NEUROCIR, V24, P58; Pereira CU, 2005, J BRAS NEUROCIRURG, V16, P25; Santos ME, ACTA MED PORT, V16, P71; Soares DFPP, 2006, CUIDADO SAUDE MARI S, V5, P77	23	7	7	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0103-5355	2359-5922		BRAZ NEUROSURG	Braz. Neurosurg.	SEP	2011	30	3					99	104					6	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	VC6OK	WOS:000434518100003					2022-02-06	
J	Hijab, S; Havalad, S; Snyder, AK				Hijab, Samina; Havalad, Suresh; Snyder, Ann K.			The Role of Organic Osmolytes in the Response of Cultured Astrocytes to Hyperosmolarity	AMERICAN JOURNAL OF THERAPEUTICS			English	Article						idiogenic osmoles; organic osmolytes; hyperosmolarity	CELL-VOLUME REGULATION; TRAUMATIC BRAIN-INJURY; HYPERTONIC SALINE; APOPTOSIS; SALT	Idiogenic osmoles are volume-regulatory organic solutes that accumulate within a cell in response to hyperosmolar conditions such as those found in diabetic ketoacidosis or hypernatremic dehydration in infants. Intracellular metabolites known to play this role include certain amino acids and taurine, polyols, and trimethylamines. In this study, in vitro astrocyte cultures prepared from the cerebral cortices of 1-day-old Sprague-Dawley rats were exposed to graded conditions of hypernatremia (325-375 mOsm/kg), a range that can be observed in vivo, for 24, 48, and 72 hours. Cell survival and generation of idiogenic osmoles were determined. Next, we assessed the ability of selected exogenous osmoles to protect the cultured cells from the effects of hypernatremia. Significant cell loss occurred after 48 to 72 hours of exposure and was proportional to the degree of hyperosmolarity. Addition of myoinositol (1 mM) to the cultures reduced cell loss resulting from hypernatremia by approximately 50%. In agreement with previous studies, intracellular levels of myoinositol and taurine correlated with the degree of in vitro hypernatremic exposure and play a significant role in increasing survival of astrocytes subjected to hypertonic insult.	[Hijab, Samina; Havalad, Suresh] Advocate Lutheran Gen Hosp, Div Pediat Crit Care, Park Ridge, IL 60068 USA; [Snyder, Ann K.] Rosalind Franklin Univ Med & Sci, Dept Cellular & Mol Pharmacol, N Chicago, IL USA		Hijab, S (corresponding author), Advocate Lutheran Gen Hosp, Div Pediat Crit Care, 1675 Dempster St, Park Ridge, IL 60068 USA.	Suresh.Havalad.md@advocatehealth.com			Advocate Lutheran General Children's Hospital	We acknowledge the assistance of Pastor R Couceyro, PhD, in the HPLC/mass spectrometry studies and the support of the Pediatric Critical Care Fellowship Program of Advocate Lutheran General Children's Hospital.	Alfieri RR, 2002, J PHYSIOL-LONDON, V540, P499, DOI 10.1113/jphysiol.2001.013395; Beetsch JW, 1998, AM J PHYSIOL-CELL PH, V274, pC866, DOI 10.1152/ajpcell.1998.274.4.C866; BERMAN T, 1966, J BIOL CHEM, V241, P800; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; HEILIG CW, 1989, AM J PHYSIOL, V257, pF1108, DOI 10.1152/ajprenal.1989.257.6.F1108; Horio M, 2001, NEPHROL DIAL TRANSPL, V16, P483, DOI 10.1093/ndt/16.3.483; Ibsen L, 1996, AM J PHYSIOL-RENAL, V271, pF877, DOI 10.1152/ajprenal.1996.271.4.F877; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; LIEN YHH, 1990, J CLIN INVEST, V85, P1427, DOI 10.1172/JCI114587; MACKNIGHT ADC, 1994, J EXP ZOOL, V268, P80, DOI 10.1002/jez.1402680203; NACHLAS MM, 1960, ANAL BIOCHEM, V1, P317, DOI 10.1016/0003-2697(60)90029-4; POLLOCK AS, 1980, AM J PHYSIOL, V239, pF195, DOI 10.1152/ajprenal.1980.239.3.F195; Ransom B, 2003, TRENDS NEUROSCI, V26, P520, DOI 10.1016/j.tins.2003.08.006; SNYDER AK, 1992, ALCOHOL CLIN EXP RES, V16, P295, DOI 10.1111/j.1530-0277.1992.tb01380.x; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Strange K, 2004, ADV PHYSIOL EDUC, V28, P155, DOI 10.1152/advan.00034.2004; TRACHTMAN H, 1991, PEDIATR NEPHROL, V5, P743, DOI 10.1007/BF00857889; Wade CE, 2002, CRIT CARE, V6, P397; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; WOLFF SD, 1989, AM J PHYSIOL, V256, pF954, DOI 10.1152/ajprenal.1989.256.5.F954	22	7	8	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1075-2765	1536-3686		AM J THER	Am. J. Ther.	SEP	2011	18	5					366	370		10.1097/MJT.0b013e3181cd816f			5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	819DK	WOS:000294805400019	20093923				2022-02-06	
J	Karathanou, A; Paterakis, K; Pakopoulou, M; Tasiou, A; Hadjigeorgiou, G; Chovas, A; Paraforos, G; Fountas, K; Komnos, A				Karathanou, A.; Paterakis, K.; Pakopoulou, M.; Tasiou, A.; Hadjigeorgiou, G.; Chovas, A.; Paraforos, G.; Fountas, K.; Komnos, A.			Biochemical markers analyzed using microdialysis and traumatic brain injury outcomes	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Brain Injuries; Lactate; Pyruvate	CEREBRAL MICRODIALYSIS; SUBARACHNOID HEMORRHAGE; OXYGENATION; METABOLISM; DELIVERY; LACTATE; TISSUE	Aim. Traumatic brain injury is a leading cause of disability and mortality among young people. Multiparametric cerebral bedside monitoring is a safe and promising technique for preventing secondary brain damage. The objective of this study was to investigate the usefulness of cerebral microdialysis in predicting the outcomes of patients with traumatic brain injury. Methods. Thirty-eight patients (33 males) were included in the study. The GCS on admission was <= 8. The outcome was assessed using the GOS over six months of follow-up. Results. Among the patients included, 18 had a favorable outcome (GOS=4.5) and the remaining 20 had an unfavorable outcome. LIP ratio and glycerol concentration were statistically significantly higher in the patients with unfavorable prognosis. Conclusion. Biochemical parameters analysed using microdialysis could serve as predictor indexes of clinical outcome several months after the injury.	[Karathanou, A.] Achillopoulio Gen Hosp, Intens Care Unit, Volos, Greece; [Paterakis, K.; Pakopoulou, M.; Tasiou, A.; Fountas, K.] Univ Hosp, Dept Neurosurg, Larisa, Greece; [Hadjigeorgiou, G.] Univ Hosp, Dept Neurol, Larisa, Greece; [Chovas, A.; Paraforos, G.; Komnos, A.] Gen Hosp, Intens Care Unit, Larisa, Greece		Komnos, A (corresponding author), Axenidou 9, Larisa 41222, Greece.	komnosap@otenet.gr	Paterakis, Konstantinos/AAH-4554-2019		"Enorasis" Pharmaceuticals	We would like to thank Dr. Krommydas George for statistical advice and editing and "Enorasis" Pharmaceuticals for financial support of this work.	Cesarini KG, 2002, ACTA NEUROCHIR, V144, P1121, DOI 10.1007/s00701-002-1011-9; Chiang MF, 2006, ACTA NEUROCHIR, V148, P615, DOI 10.1007/s00701-006-0771-z; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Low D, 2009, J NEUROTRAUM, V26, P1177, DOI [10.1089/neu.2008.0841, 10.1089/neu.2008-0841]; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; Nordstrom CH, 2009, CHILDS NERV IN PRESS; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF	15	7	7	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616	1827-1855		J NEUROSURG SCI	J. Neurosurg. Sci.	SEP	2011	55	3					173	177					5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	837TH	WOS:000296225600002	21968581				2022-02-06	
J	Lynch, CA; Houry, DE; Dai, DJ; Wright, DW				Lynch, Catherine A.; Houry, Debra E.; Dai, Dajun; Wright, David W.			Evidence-based Community Consultation for Traumatic Brain Injury	ACADEMIC EMERGENCY MEDICINE			English	Article							INFORMED-CONSENT; EXCEPTION; ATTITUDES	Objectives: The objective was to determine if geospatial techniques can be used to inform targeted community consultation (CC) and public disclosure (PD) for a clinical trial requiring emergency exception from informed consent (EFIC). Methods: Data from January 2007 to December 2009 were extracted from a Level I trauma center's trauma database using the National Trauma Registry of the American College of Surgeon (NTRACS). Injury details, demographics, geographic codes, and clinical data necessary to match core elements of the clinical trial inclusion criteria (Glasgow Coma Scale [GCS] 3-12 and blunt head injury) were collected on all patients. Patients' home zip codes were geocoded to compare with population density and clustering analysis. Results: Over a 2-year period, 179 patients presented with moderate to severe traumatic brain injury (TBI). Mapping the rate and frequency of TBI patients presenting to the trauma center delineated at-risk populations for moderate to severe head injury. Four zip codes had higher incidences of TBI than the rest, with one zip code having a very high rate of 80 per 100,000 population. Conclusions: Geospatial techniques and hospital data records can be used to characterize potential subjects and delineate a high-risk population to inform directed CC and public disclosure strategies. ACADEMIC EMERGENCY MEDICINE 2011; 18: 972-976 (C) 2011 by the Society for Academic Emergency Medicine	[Lynch, Catherine A.; Houry, Debra E.; Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA; [Dai, Dajun] Georgia State Univ, Dept Geosci, Atlanta, GA 30303 USA		Lynch, CA (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA.	calynch@emory.edu	Wright, David/F-1209-2013	Wright, David/0000-0002-7145-9105; Staton, Catherine/0000-0002-6468-2894			BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Burton Thomas M, 2006, Wall St J (East Ed), pA12; Dai DJ, 2010, HEALTH PLACE, V16, P1038, DOI 10.1016/j.healthplace.2010.06.012; Grubesic T.H., 2008, SOCIOECON PLAN SCI, V42, P129, DOI [DOI 10.1016/j.seps.2006.09.001, DOI 10.1016/J.SEPS.2006.09.001]; MARKARIAN M, 2007, J REG MANAG, V34, P42; McClure KB, 2003, ACAD EMERG MED, V10, P352, DOI 10.1111/j.1553-2712.2003.tb01348.x; McGee G, 2005, ACAD EMERG MED, V12, P1019, DOI 10.1197/j.aem.2005.07.023; Nichol G, 2004, RESUSCITATION, V62, P3, DOI 10.1016/j.resuscitation.2004.02.013; Triner W, 2007, ACAD EMERG MED, V14, P187, DOI 10.1197/j.aem.2006.08.019	9	7	7	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	SEP	2011	18	9					972	976		10.1111/j.1553-2712.2011.01153.x			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	818OZ	WOS:000294764200012	21854486				2022-02-06	
J	Oluwole, OSA				Oluwole, O. S. A.			Incidence and Risk Factors of Early Post-traumatic Seizures in Nigerians	BRAIN INJURY			English	Article						post-traumatic; trauma; brain; injury; seizures; epilepsy; african	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; EPIDEMIOLOGY; POPULATION; EPILEPSY; ADULTS; ETIOLOGY; SWEDEN	Objectives: To determine the incidence and risk factors of early post-traumatic seizures (PTS) in Nigerian subjects. Methods: Subjects were recruited consecutively, classified as mild, moderate or severe traumatic brain injury (TBI), and followed for 168 hrs for development of seizures. Results: There were 266 subjects, 213 (80%) males and 53 (20%) females, with mean age 31 years (sd 18, range 1-80, median 30). Causes of TBI were motor traffic accident (MTA) related in 217 (82%), falls in 25 (9%), struck by objects in 15 (5%), firearms in 4 (2%), sports and recreation in 3 (1%), and failed suicide in 2 (1%). Cumulative incidence of early PTS was 119% (95% CI 80-156). Risk factors were age <= 12 years, severity of TBI, history of seizures, and TBI at weekend, but gender and GCS were not. Skeletomotor palsy was independently associated with early PTS. Conclusions: Incidence of early PTS is high in this population, probably due to the relatively high proportion of severe TBI. Risk factors are TBI severity, young age, history of seizures, and TBI at weekends. The best preventive strategy is reduction of MTA, which causes over 80% of TBI. Prophylactic anti-seizure therapy may benefit subjects with severe TBI and skeletomotor deficits.	Univ Ibadan, Neurol Unit, Coll Med, Ibadan, Nigeria		Oluwole, OSA (corresponding author), Univ Ibadan, Neurol Unit, Coll Med, Ibadan, Nigeria.	osaoluwole@hotmail.com					Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; Lee ST, 1997, CAN J NEUROL SCI, V24, P40, DOI 10.1017/S0317167100021077; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Odebode OT, 2008, NIGER J CLIN PRACT, V11, P193; Odebode TO, 2006, J TRAUMA, V61, P388, DOI 10.1097/01.ta.0000224140.26660.5c; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; R Development Core Team, 2010, R LANG ENV STAT COMP; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; VICTOR M, 2001, ADAMS VICTORS PRINCI; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; [No title captured]; [No title captured]	37	7	7	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2011	25	10					980	988		10.3109/02699052.2011.589798			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	801TZ	WOS:000293464800008	21812585				2022-02-06	
J	Oud, L				Oud, Lavi			Community-acquired meningitis due to Staphylococcus capitis in the absence of neurologic trauma, surgery, or implants	HEART & LUNG			English	Article						Coagulase-negative staphylococci; Staphylococcus capitis; Meningitis	COAGULASE-NEGATIVE STAPHYLOCOCCI; BACTERIAL-MENINGITIS; BLOOD CULTURES; ADULTS; SEPSIS; IDENTIFICATION; EPIDEMIOLOGY; HYPOGLYCEMIA; DEFINITIONS; INFECTION	Community-acquired meningitis due to coagulase-negative staphylococci in adults has been rarely reported and generally develops in patients with ventricular shunts or after neurosurgery or neurotrauma. Staphylococcus capitis is a rare cause of adult meningitis. We describe a patient with community-acquired meningitis due to S. capitis, in the absence of traditional risk factors, with atypical presentation.	Texas Tech Univ, Dept Internal Med, Div Pulm & Crit Care Med, Hlth Sci Ctr, Odessa, TX 79763 USA		Oud, L (corresponding author), Texas Tech Univ, Dept Internal Med, Div Pulm & Crit Care Med, Hlth Sci Ctr, 701W 5th St, Odessa, TX 79763 USA.	lavi.oud@ttuhsc.edu					Ackermann RJ, 1996, J AM GERIATR SOC, V44, P927, DOI 10.1111/j.1532-5415.1996.tb01862.x; Al-Sanori Tarek Mohammad, 1996, Mikrobiolohichnyi Zhurnal, V58, P64; BANNERMAN TL, 1991, INT J SYST BACTERIOL, V41, P144, DOI 10.1099/00207713-41-1-144; Beekmann SE, 2005, INFECT CONT HOSP EP, V26, P559, DOI 10.1086/502584; BERKMAN P, 1985, J AM GERIATR SOC, V33, P644, DOI 10.1111/j.1532-5415.1985.tb06322.x; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chang WN, 2007, JPN J INFECT DIS, V60, P262; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Frid P, 2009, ORAL SURG ORAL MED O, V107, P641, DOI 10.1016/j.tripleo.2009.01.020; GUIOT HFL, 1994, EUR J CLIN MICROBIOL, V13, P772, DOI 10.1007/BF02276065; HAWLEY HB, 1973, AM J DIS CHILD, V126, P261, DOI 10.1001/archpedi.1973.02110190231025; Huang CR, 2005, INFECTION, V33, P56, DOI 10.1007/s15010-005-4083-7; KHATIB R, 1995, J CLIN MICROBIOL, V33, P816, DOI 10.1128/JCM.33.4.816-820.1995; KLOOS WE, 1975, INT J SYST BACTERIOL, V25, P62, DOI 10.1099/00207713-25-1-62; Laguna-Del Estal P, 2009, REV NEUROL, V48, P2; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lu CH, 2002, CLIN NEUROL NEUROSUR, V104, P352, DOI 10.1016/S0303-8467(02)00052-5; Nalmas S, 2008, HEART LUNG, V37, P380, DOI 10.1016/j.hrtlng.2007.09.005; NOUEL O, 1981, ARCH INTERN MED, V141, P1477, DOI 10.1001/archinte.141.11.1477; Ohara-Nemoto Y, 2008, J MED MICROBIOL, V57, P95, DOI 10.1099/jmm.0.47561-0; PAL N, 1989, INDIAN J MED RES-A, V89, P300; Roland PS, 2002, LARYNGOSCOPE, V112, P1166, DOI 10.1097/00005537-200207000-00005; Rybak MJ, 2006, CLIN INFECT DIS, V42, pS35, DOI 10.1086/491712; SCHEETZ A, 1990, J AM GERIATR SOC, V38, P490; Seo SK, 2000, AM J MED, V109, P697, DOI 10.1016/S0002-9343(00)00596-9; Sivadon V, 2005, J CLIN MICROBIOL, V43, P2952, DOI 10.1128/JCM.43.6.2952-2954.2005; Tunkel AR, 2010, MANDELL DOUGLAS BENN, P1189; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116	28	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0147-9563	1527-3288		HEART LUNG	Heart Lung	SEP-OCT	2011	40	5					467	471		10.1016/j.hrtlng.2010.09.002			5	Cardiac & Cardiovascular Systems; Nursing; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Nursing; Respiratory System	819AG	WOS:000294797200012	21411150				2022-02-06	
J	Paiva, WS; Soares, MS; Amorim, RLO; de Andrade, AF; Matushita, H; Teixeira, MJ				Paiva, Wellingson S.; Soares, Matheus S.; Amorim, Robson L. O.; Ferreira de Andrade, A.; Matushita, Hamilton; Teixeira, Manoel J.			TRAUMATIC BRAIN INJURY AND SHAKEN BABY SYNDROME	ACTA MEDICA PORTUGUESA			English	Article							HEAD-INJURY; SUBDURAL HEMORRHAGES; MENTAL-RETARDATION; IMPACT SYNDROME; YOUNG-CHILDREN; INFANTS; SHAKING; DAMAGE	Shaken baby syndrome is a serious form of physical child abuse, which is frequently overlooked. It is defined as vigorous manual shaking of an infant who is being held by the extremities or shoulders, leading to whiplashinduced intracranial and intraocular bleeding and no external signs of head trauma. This syndrome is seen most commonly in children under 2 years, mainly in children under 6 months. This article summarizes issues related to clinical presentation, diagnosis, risk factors, and interventions for healthcare professionals.	[Paiva, Wellingson S.; Soares, Matheus S.; Amorim, Robson L. O.; Ferreira de Andrade, A.; Matushita, Hamilton; Teixeira, Manoel J.] Univ Sao Paulo, Sch Med, Div Neurosurg, Sao Paulo, Brazil		Paiva, WS (corresponding author), Univ Sao Paulo, Sch Med, Div Neurosurg, Sao Paulo, Brazil.		Matushita, Hamilton/E-9095-2012; Paiva, Wellingson S/G-5517-2013; Teixeira, Manoel J/E-3110-2012; Amorim, Robson/AAK-1368-2021	Paiva, Wellingson S/0000-0002-5165-7040; Amorim, Robson/0000-0003-2391-7519			Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bellemare S, 2007, AM J EMERG MED, V25, P1080, DOI 10.1016/j.ajem.2007.06.007; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Biousse V, 2002, AM J OPHTHALMOL, V133, P249, DOI 10.1016/S0002-9394(01)01366-6; Blumenthal I, 2002, POSTGRAD MED J, V78, P732, DOI 10.1136/pmj.78.926.732; Bonnier C, 2002, BRAIN PATHOL, V12, P320; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1946, AM J ROENTGENOL, V56, P163; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Carbaugh Suzanne Franklin, 2004, Adv Neonatal Care, V4, P105, DOI 10.1016/S1536-0903(04)00031-1; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Comittee on Child Abuse and Neglect, 1997, DEL MED J, V69, P365; Coody D, 1994, J Pediatr Health Care, V8, P50, DOI 10.1016/S0891-5245(07)80003-4; Datta S, 2005, ARCH DIS CHILD, V90, P947, DOI 10.1136/adc.2002.021154; de Andrade AF, 2001, WORLD J SURG, V25, P1186; DE ANDRADE AF, 2010, GUIDELINES BRAZILIAN; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kairys SW, 2001, PEDIATRICS, V108, P206; Mungan NK, 2007, CURR OPIN OPHTHALMOL, V18, P392, DOI 10.1097/ICU.0b013e3282a167f0; SPAIDE RF, 1990, AM FAM PHYSICIAN, V41, P1145; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011	25	7	8	0	5	ORDEM MEDICOS	LISBON	AV ALMIRANTE GAGO COUTINHO, 151, LISBON, 1749-084, PORTUGAL	1646-0758			ACTA MEDICA PORT	Acta Medica Port.	SEP-OCT	2011	 24	5					805	808					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	893ON	WOS:000300365300017	22525633				2022-02-06	
J	Jones, CA; Turkstra, LS				Jones, Corinne A.; Turkstra, Lyn S.			Selling the story: Narratives and charisma in adults with TBI	BRAIN INJURY			English	Article						Traumatic brain injury; conversation; communication; social behaviour; charisma	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; DISCOURSE PRODUCTION; STUDENT-RATINGS; ELICITATION TASK; SELF-AWARENESS; HAND GESTURES; ABILITIES; CHILDREN; SPEECH	Objective: To examine storytelling performance behaviours in adults with traumatic brain injury (TBI) and relate these behaviours to perceived charisma and desirability as a conversation partner. Design and methods: Seven adult males with traumatic brain injury (TBI) told their accident narratives to a male confederate. Ten male undergraduate students rated 1-minute video clips from the beginning of each narrative using the Charismatic Leadership Communication Scale (CLCS). Raters also indicated whether or not they would like to engage in conversation with each participant. Results: Of the performative behaviours analysed, gestures alone significantly influenced CLCS ratings and reported likelihood of engaging in future conversation with the participant. Post-hoc analysis revealed that speech rate was significantly correlated with all of the preceding measures. There was a significant correlation between self- and other-ratings of charisma. Conclusions: The findings suggest that aspects of non-verbal performance, namely gesture use and speech rate, influence how charismatic an individual is perceived to be and how likely someone is to engage in conversation with that person. Variability in these performance behaviours may contribute to the variation in social outcomes seen in the TBI population.	[Turkstra, Lyn S.] Univ Wisconsin, Dept Commun Disorders, Madison, WI 53706 USA		Turkstra, LS (corresponding author), Univ Wisconsin, Dept Commun Disorders, Madison, WI 53706 USA.	lsturkstra@wisc.edu	Jones, Corinne/K-7775-2019; Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	Wisconsin Alumni Research Foundation; Walker Foundation; NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [T32DC005359]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [T32DC005359] Funding Source: NIH RePORTER	This study was supported in part by funds from the Wisconsin Alumni Research Foundation, the Walker Foundation and NIDCD Grant T32DC005359. The authors report no conflicts of interest.	ABRAMI PC, 1982, REV EDUC RES, V52, P446, DOI 10.3102/00346543052003446; AMBADY N, 1992, PSYCHOL BULL, V111, P256, DOI 10.1037/0033-2909.111.2.256; APPLE W, 1979, J PERS SOC PSYCHOL, V37, P715, DOI 10.1037/0022-3514.37.5.715; Bass B.M., 1985, LEADERSHIP PERFORMAN; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; BROWN BL, 1973, J ACOUST SOC AM, V54, P29, DOI 10.1121/1.1913571; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Champion TB, 1999, TOP LANG DISORD, V19, P52, DOI 10.1097/00011363-199905000-00006; Cherney L. R., 1998, ANAL DISCOURSE COMMU, P1; COELHO C A, 1991, Brain Injury, V5, P381, DOI 10.3109/02699059109008111; Coelho C. A., 1999, BRAIN DAM B; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Emerson R.M., 2011, WRITING ETHNOGRAPHIC, VSecond, P21, DOI [10.7208/chicago/9780226206868.001.0001, DOI 10.7208/CHICAGO/9780226206868.001.0001]; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Grahe JE, 2002, PERS SOC PSYCHOL B, V28, P1407, DOI 10.1177/014616702236872; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Holladay S. J., 1993, MANAGEMENT COMMUNICA, V6, P405, DOI DOI 10.1177/0893318993006004003; HUNT KW, 1970, MONOGR SOC RES CHILD, V35, P1; Jones C, 2007, BEHAV RES THER, V45, P151, DOI 10.1016/j.brat.2006.02.004; Jordan FM, 1996, BRAIN INJURY, V10, P91, DOI 10.1080/026990596124575; Kertesz A., 1982, W APHASIA BATTERY; KIERNAN PJ, 2003, MODELS CONVERSATION; Krause JC, 2002, J ACOUST SOC AM, V112, P2165, DOI 10.1121/1.1509432; Krauss RM, 1996, ADV EXP SOC PSYCHOL, V28, P389, DOI 10.1016/S0065-2601(08)60241-5; Labov W, 1997, J NARRAT LIFE HIST, V7, P395, DOI 10.1075/jnlh.7.1-4.49som; Labov W., 1972, LANGUAGE INNER CITY; Labov W., 1967, ESSAYS VERBAL VISUAL, P12; Langellier, 1989, TEXT PERFORM Q, V9, P243, DOI DOI 10.1080/10462938909365938; Levine KJ, 2010, COMMUN MONOGR, V77, P576, DOI 10.1080/03637751.2010.499368; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LILES BZ, 1993, J SPEECH HEAR RES, V36, P868, DOI 10.1044/jshr.3605.868; MacWhinney B., 2000, CHILDES PROJECT; Maricchiolo F, 2009, LANG COGNITIVE PROC, V24, P239, DOI 10.1080/01690960802159929; MARSH HW, 1982, J EDUC PSYCHOL, V74, P126, DOI 10.1037/0022-0663.74.1.126; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; Medved MI, 2008, QUAL HEALTH RES, V18, P469, DOI 10.1177/1049732308315731; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; MILLER N, 1976, J PERS SOC PSYCHOL, V34, P615, DOI 10.1037//0022-3514.34.4.615; MILLS MT, 2011, LANGUAGE SP IN PRESS; NAFTULIN DH, 1973, J MED EDUC, V48, P630; Newman RM, 2006, J SPEECH LANG HEAR R, V49, P1022, DOI 10.1044/1092-4388(2006/073); Norton R., 1983, COMMUNICATOR STYLE T; *OXF ENGL DICT, 1989, CHAR; PERRY RP, 1979, J EDUC PSYCHOL, V71, P107, DOI 10.1037/0022-0663.71.1.107; Peterson C., 1983, DEV PSYCHOLINGUISTIC; PICHENY MA, 1986, J SPEECH HEAR RES, V29, P434, DOI 10.1044/jshr.2904.434; Prigatano GP, 1999, REHABIL PSYCHOL, V44, P145, DOI 10.1037/0090-5550.44.2.145; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Randolph C., 1998, REPEATABLE BATTERY A; Riessman C, 1993, NARRATIVE ANAL QUALI; RIPICH DN, 1988, J LEARN DISABIL, V21, P165, DOI 10.1177/002221948802100309; Sedikides C., 1999, REPRESENTATIVE RES S, V23, P1; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; STEWART MA, 1982, J LANG SOC PSYCHOL, V1, P91, DOI DOI 10.1177/0261927X8200100201; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; TOGHER L, 1999, BRAIN DAM B, P113; Togher L., 2000, BRAIN DAM B, P1; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Turkstra L, 2003, LANG SPEECH HEAR SER, V34, P117, DOI 10.1044/0161-1461(2003/010); Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; WARE JE, 1975, J MED EDUC, V50, P149; WARE JE, 1977, EDUC PSYCHOL MEAS, V37, P627, DOI 10.1177/001316447703700306; Weber M, 1964, THEORY SOCIAL EC ORG; WILLIAMS RG, 1977, AM EDUC RES J, V14, P449, DOI 10.3102/00028312014004449; WILLIAMS RG, 1976, J EDUC PSYCHOL, V68, P48, DOI 10.1037/0022-0663.68.1.48; WINTER L, 2005, SOCIAL COGNITION KEY, P299; WOLFSON N, 1982, CHP CONVERSATIONAL H; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951; Yuan J., 2006, 9 INT C SPOK LANG PR	87	7	8	1	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2011	25	9					844	857		10.3109/02699052.2011.585507			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	790CY	WOS:000292567300005	21714624	Green Accepted			2022-02-06	
J	Abney, TM; Feng, Y; Pless, R; Okamoto, RJ; Genin, GM; Bayly, PV				Abney, Teresa M.; Feng, Yuan; Pless, Robert; Okamoto, Ruth J.; Genin, Guy M.; Bayly, Philip V.			Principal Component Analysis of Dynamic Relative Displacement Fields Estimated from MR Images	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; HEAD; MOTION; DEFORMATION; IMPACT; ACCELERATION; BIOMECHANICS; CYLINDER; STRAIN	Non-destructive measurement of acceleration-induced displacement fields within a closed object is a fundamental challenge. Inferences of how the brain deforms following skull impact have thus relied largely on indirect estimates and course-resolution cadaver studies. We developed a magnetic resonance technique to quantitatively identify the modes of displacement of an accelerating soft object relative to an object enclosing it, and applied it to study acceleration-induced brain deformation in human volunteers. We show that, contrary to the prevailing hypotheses of the field, the dominant mode of interaction between the brain and skull in mild head acceleration is one of sliding arrested by meninges.	[Abney, Teresa M.; Feng, Yuan; Okamoto, Ruth J.; Genin, Guy M.; Bayly, Philip V.] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA; [Abney, Teresa M.; Genin, Guy M.] Washington Univ, Ctr Mat Innovat, St Louis, MO USA; [Pless, Robert] Washington Univ, Dept Comp Sci & Engn, St Louis, MO USA; [Bayly, Philip V.] Washington Univ, Dept Biomed Engn, St Louis, MO USA		Abney, TM (corresponding author), Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA.	baylyp@seas.wustl.edu	Pless, Robert B/I-4698-2013; Feng, Yuan/C-7417-2011	Feng, Yuan/0000-0003-1902-3408; Okamoto, Ruth/0000-0002-3085-3878; Bayly, Philip/0000-0003-4303-0704	NIFDepartment of Science & Technology (India) [NS055951, HL079165]; NSFNational Science Foundation (NSF) [0538541]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K25HL079165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	This work was supported in part by the NIF through grants NS055951 and HL079165, and by the NSF through grant 0538541 and a graduate fellowship to TMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXEL L, 1989, RADIOLOGY, V171, P841, DOI 10.1148/radiology.171.3.2717762; BAILY BN, 1989, MILD HEAD INJURY, P308; Bayly PV, 2008, J MECH PHYS SOLIDS, V56, P2036, DOI 10.1016/j.jmps.2007.10.012; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bayly PV, 2004, J BIOMECH ENG-T ASME, V126, P523, DOI 10.1115/1.1785811; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hardy Warren N., 2001, INVESTIGATION HEAD I; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; JACOBS N, 2008, FULLY AUTOMATIC GEOL, P1; Ji Songbai, 2004, Stapp Car Crash J, V48, P227; Ji SB, 2007, J BIOMECH, V40, P92, DOI 10.1016/j.jbiomech.2005.11.009; Ji SB, 2009, MED IMAGE ANAL, V13, P659, DOI 10.1016/j.media.2009.05.007; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Massouros PG, 2008, P ROY SOC A-MATH PHY, V464, P207, DOI 10.1098/rspa.2007.0081; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; SIROVICH L, 1987, J OPT SOC AM A, V4, P519, DOI 10.1364/JOSAA.4.000519; SOEDEL W, 2004, VIBRATIONS SHELLS PL, V14, P366; Spaethling JM, 2007, PROG BRAIN RES, V161, P27, DOI 10.1016/S0079-6123(06)61003-0; Takhounts EG, 2008, STAPP CAR C, V52, P1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	27	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22063	10.1371/journal.pone.0022063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	WOS:000292811300038	21811560	gold, Green Published, Green Submitted			2022-02-06	
J	Bakhtiary, M; Marzban, M; Mehdizadeh, M; Joghataei, MT; Khoei, S; Tondar, M; Mahabadi, VP; Laribi, B; Ebrahimi, A; Hashemian, SJ; Modiry, N; Mehrabi, S				Bakhtiary, Mehrdad; Marzban, Mohsen; Mehdizadeh, Mehdi; Joghataei, Mohammad Taghi; Khoei, Samideh; Tondar, Mandi; Mahabadi, Vahid Pirhajati; Laribi, Bahareh; Ebrahimi, Asghar; Hashemian, Seyed Jafar; Modiry, Navid; Mehrabi, Soraya			Combination of Stem Cell Mobilized by Granulocyte-Colony Stimulating Factor and Human Umbilical Cord Matrix Stem Cell: Therapy of Traumatic Brain Injury in Rats	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Combine Therapy; G-CSF; Stem Cell; TBI; Wharton's jelly	MARROW STROMAL CELLS; FOCAL CEREBRAL-ISCHEMIA; BONE-MARROW; ADULT RATS; PERIPHERAL-BLOOD; FUNCTIONAL RECOVERY; TRANSPLANTATION; STROKE; PROLIFERATION; MODEL	Objective(s) Clinical studies of treating traumatic brain injury (TBI) with autologous adult stem cells led us to examine the impression of a combination therapy. This was performed by intravenous injection of human umbilical cord matrix stem cell (hUCMSC-Wharton's jelly stem cell) with bone marrow cell mobilized by granulocytecolony stimulating factor (G-CSF) in rats injured with cortical compact device. Materials and Methods Adult male Wistar. rats (n= 50) were injured with controlled cortical impact device and divided into five groups. All injections were performed 1 day after injury into the tail veins of rats. Neurological functional evaluation of animals was performed before and after injury using modified neurological severity scores (mNSS). Animals were sacrificed 42 days after TBI and brain sections were stained by Brdu immunohistochemistry. Results Statistically significant improvement in functional outcome was observed in treatment groups when compared with control (P< 0.01). mNSS showed no significant differences among the hUCMSC and G-CSF treated groups at any time point (end of trial). Rats with hUCMSC + G-CSF treatment had a significant improvement on mNSS at 5 and 6 week compared to other treatment group (P< 0.01). Conclusion Histological analysis in G-CSF+ hUCMSC treated traumatic rats exhibited significant increase in numbers of Brdu immunoreactive cells in their traumatic core compared with other labeled group.	[Bakhtiary, Mehrdad; Marzban, Mohsen; Mehdizadeh, Mehdi; Joghataei, Mohammad Taghi; Khoei, Samideh] Univ Tehran Med Sci, Cellular & Mol Res Ctr, Tehran, Iran; [Bakhtiary, Mehrdad; Marzban, Mohsen; Mehdizadeh, Mehdi; Joghataei, Mohammad Taghi; Tondar, Mandi; Mahabadi, Vahid Pirhajati; Hashemian, Seyed Jafar; Modiry, Navid] Univ Tehran Med Sci, Dept Anat, Tehran, Iran; [Ebrahimi, Asghar] Milano Bicocca Univ, Dept Biosci & Biotechnol, Milan, Italy; [Khoei, Samideh] Univ Tehran Med Sci, Dept Med Phys, Tehran, Iran; [Laribi, Bahareh] Univ Tehran Med Sci, Dept Immunol, Tehran, Iran; [Mehrabi, Soraya] Univ Tehran Med Sci, Dept Physiol, Tehran, Iran		Marzban, M (corresponding author), Univ Tehran Med Sci, Cellular & Mol Res Ctr, Tehran, Iran.	mohsen136051@yahoo.com	Khoei, Samideh/T-2591-2019; Marzban, Mohsen/B-1746-2019; mehdizadeh, mehdi/O-5737-2018	Marzban, Mohsen/0000-0001-5558-2392; Khoei, Samideh/0000-0001-9357-0229; mehdizadeh, mehdi/0000-0002-9268-7318; Joghataei, Mohammad Taghi/0000-0003-0492-8239	Tehran University of Medical Sciences, IranTehran University of Medical Sciences	This study was supported in part by Tehran University of Medical Sciences, Iran. We thank Masoomeh Bakhshayesh technician of Cellular & Molecular Research Center for valuable comments during the project.	BODINE DM, 1994, BLOOD, V84, P1482; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; DEMETRI GD, 1991, BLOOD, V78, P2791; Ding DC, 2007, NEUROBIOL DIS, V27, P339, DOI 10.1016/j.nbd.2007.06.010; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fukumoto Y, 1997, BRIT J HAEMATOL, V97, P666, DOI 10.1046/j.1365-2141.1997.842724.x; Heard SO, 1998, CRIT CARE MED, V26, P748, DOI 10.1097/00003246-199804000-00027; Jiang W, 2001, STROKE, V32, P1201, DOI 10.1161/01.STR.32.5.1201; Jomura S, 2007, STEM CELLS, V25, P98, DOI 10.1634/stemcells.2006-0055; KARIM F, 2005, J NEUROSCI, V25, P1169; Komine-Kobayashi M, 2006, J CEREBR BLOOD F MET, V26, P402, DOI 10.1038/sj.jcbfm.9600195; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2003, J HEAD TRAUMA REHAB, V18, P357, DOI 10.1097/00001199-200307000-00006; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Medicetty S, 2004, EXP NEUROL, V190, P32, DOI 10.1016/j.expneurol.2004.06.023; MEMBERG SP, 1995, MOL CELL NEUROSCI, V6, P323, DOI 10.1006/mcne.1995.1025; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rice A, 1992, J Hematother, V1, P19, DOI 10.1089/scd.1.1992.1.19; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Six I, 2003, EUR J PHARMACOL, V458, P327, DOI 10.1016/S0014-2999(02)02785-1; Stumm RK, 2002, J NEUROSCI, V22, P5865; Sugimori H, 2001, NEUROSCI LETT, V300, P13, DOI 10.1016/S0304-3940(01)01549-X; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; WEAVER CH, 1993, BLOOD, V82, P1981; Weiss ML, 2003, EXP NEUROL, V182, P288, DOI 10.1016/S0014-4886(03)00128-6; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	37	7	9	0	0	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866			IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	JUL-AUG	2011	14	4					327	339					13	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	803UZ	WOS:000293608600004	23492840				2022-02-06	
J	Muncert, ES; Bickford, SA; Guzic, BL; Demuth, BR; Bapat, AR; Roberts, JB				Muncert, Eric S.; Bickford, Steven A.; Guzic, Brenda L.; Demuth, Barbara R.; Bapat, Ashok R.; Roberts, Jay B.			Enhancing the Quality of Life and Preserving Independence for Target Needs Populations Through Integration of Assistive Technology Devices	TELEMEDICINE AND E-HEALTH			English	Article						technology; military medicine; home health monitoring		Telehealth Test Bed-Quality of Life Studies is a research study investigating, testing, evaluating, and demonstrating technologies that have the potential to improve the quality of life for target populations, such as warriors in transition, veterans, individuals with physical and mental disabilities, and adults age 65 and older, who may require assistive technology devices to aid in maintaining or improving their quality of life. Thousands of soldiers who fought in Operation Iraqi Freedom and Operation Enduring Freedom have been wounded in action or have sustained injuries from noncombat accidents. Many of these injuries affecting military populations, as well as the general public, have resulted in amputations, traumatic brain injuries, and other physical or mental impairments. Depending on the severity of the injury, assistive technologies may be temporarily needed, or as a long-term solution, to regain and maintain normal daily functions. Saint Francis University's Center of Excellence for Remote and Medically Under-Served Areas developed an evaluation matrix comparing assistive technologies to identify devices that will improve or maintain the quality of life for these target populations. The integration of telehealth and telerehabilitation applications into patients' daily lives was examined to help improve home rehabilitation via access to healthcare specialties in rural and medically underserved settings. Researchers identified and tested assistive technology devices to be included in a self-sufficient living environment. The continuation of this research involves recruiting individuals to test and evaluate the functions of these commercially available technologies and to complete data collection surveys and questionnaires. The results are useful in selecting devices that will enhance or extend the quality of life of the target populations.	[Muncert, Eric S.; Bickford, Steven A.; Guzic, Brenda L.; Demuth, Barbara R.; Bapat, Ashok R.; Roberts, Jay B.] St Francis Univ, Ctr Excellence Remote & Med Under Served Areas, Loretto, PA 15940 USA		Muncert, ES (corresponding author), St Francis Univ, Ctr Excellence Remote & Med Under Served Areas, 117 Evergreen Dr, Loretto, PA 15940 USA.	emuncert@cermusa.francis.edu			U.S. Army Medical Research and Materiel Command Telemedicine and Advanced Technology Research Center, Fort Detrick, MarylandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-06-2-0018]	This project was supported by and administered via the U.S. Army Medical Research and Materiel Command Telemedicine and Advanced Technology Research Center, Fort Detrick, Maryland-Contract Number W81XWH-06-2-0018.	Ambrosio F, 2007, J REHABIL RES DEV, V44, P693, DOI 10.1682/JRRD.2006.02.0016; American Telemedicine Association, TEL DEF; ARTHUR D, ONE 3 US TROOPS SUFF; BATAVIA A I, 1990, Journal of Rehabilitation Research and Development, V27, P425, DOI 10.1682/JRRD.1990.10.0425; COHN E, 2009, TELEREHABILITATION R; *DIS, 54 4 MILL AM REP SOM; *EM HLTH, 2007, OCC THER REST LIV WO; *INT CORP, 2010, WHATS NAM; *NAT I AG, US POP AG 65 YEARS O; SUTTON L, 2009, US TODAY        0304; *TEMPL U I DIS, WHAT ASS TECHN; *US BUR CENS, 2010, NEWSR; US ARMY 2008 POSTURE	13	7	7	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED E-HEALTH	Telemed. e-Health	JUL-AUG	2011	17	6					478	483		10.1089/tmj.2010.0206			6	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	794CD	WOS:000292872100015	21631385				2022-02-06	
J	Reid, S; Held, JM; Lawrence, S				Reid, Sheila; Held, Jean M.; Lawrence, Suzanne			Reliability and Validity of the Shaw Gait Assessment Tool for Temporospatial Gait Assessment in People With Hemiparesis	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Adult; Gait; Hemiplegia; Rehabilitation; Reproducibility of results	BRAIN-INJURY; STOPWATCH; SPEED	Reid S, Held JM, Lawrence S. Reliability and validity of the Shaw gait assessment tool for temporospatial gait assessment in people with hemiparesis. Arch Phys Med Rehabil 2011;92:1060-5. Objective: To assess the intra-/interrater reliability and the validity of the free web-based Shaw Gait Assessment Tool (with visual and numerical output) for assessing speed, cadence, step length, and limb advance time in people with hemiplegic gait. Design: Intra-/interrater reliability and concurrent validity with 2 raters using the Shaw Gait Assessment Tool and 1 rater using a multimemory stopwatch. Setting: Busy outpatient rehabilitation gym at a tertiary care medical center. Participants: Convenience sample of adults with hemiplegic gait after cerebrovascular accident or traumatic brain injury. Interventions: Not applicable. Main Outcome Measures: Intraclass correlation coefficients (ICCs) and Pearson product-moment correlation coefficients. Results: ICCs for intrarater reliability ranged from 0.94 (95% CI, 0.88-0.97) to 0.98 (95% CI, 0.96-0.99), (P<.001), and for interrater reliability from 0.95 (95% CI, 0.88-0.98) to 0.99 (95% CI, 0.99-0.99), (P<.001). The Shaw Gait Assessment Tool correlated with the stopwatch for all measured gait parameters with Pearson product-moment correlation coefficients (range, r=0.95 to r= 0.99, P<.001). Conclusions: The Shaw Gait Assessment Tool is a free, easy-to-use tool that gives reliable and valid results for 4 temporospatial parameters of hemiplegic gait.	[Reid, Sheila; Lawrence, Suzanne] Fletcher Allen Hlth Care, Rehabil Therapies, Colchester, VT 05446 USA; [Held, Jean M.] Univ Vermont, Dept Rehabil & Movement Sci, Burlington, VT USA		Reid, S (corresponding author), Fletcher Allen Hlth Care, Rehabil Therapies, C-O Ste 102,Room 111,Med Off Bldg,792 Coll Pkwy, Colchester, VT 05446 USA.	Sheila.reid@vtmednet.org					Bohannon R W, 1991, Int J Rehabil Res, V14, P246, DOI 10.1097/00004356-199109000-00010; GAUDET G, 1990, Physiotherapy Canada, V42, P12; Gok H, 2003, CLIN REHABIL, V17, P137, DOI 10.1191/0269215503cr605oa; Handa T, 2007, J PHYS THER SCI, V19, P213, DOI 10.1589/jpts.19.213; Hillier SL, 1997, BRAIN INJURY, V11, P661; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; KREBS DE, 1985, PHYS THER, V65, P1027, DOI 10.1093/ptj/65.7.1027; McGinley JL, 2003, PHYS THER, V83, P146, DOI 10.1093/ptj/83.2.146; Mumma C M, 1986, Rehabil Nurs, V11, P19; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Reid S, 2005, ARCH PHYS MED REHAB, V86, P1014, DOI 10.1016/j.apmr.2004.09.019; Riley M, 1999, S AFR J PHYSIOTHER, V55, P8; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; Toro B, 2003, ARCH PHYS MED REHAB, V84, P1878, DOI 10.1016/S0003-9993(03)00482-9; Wall J.C., 1997, PHYSIOTHERAPY, V83, P109, DOI DOI 10.1016/S0031-9406(05)67156-8; Wall JC, 2000, J ORTHOP SPORT PHYS, V30, P410, DOI 10.2519/jospt.2000.30.7.410; WHITTLE MW, 2007, GAIT ANAL INTRO, P15597; Youdas JW, 2000, J ORTHOP SPORT PHYS, V30, P279, DOI 10.2519/jospt.2000.30.5.279; QUERY ADVISOR	20	7	7	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2011	92	7					1060	1065		10.1016/j.apmr.2011.02.014			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	790UU	WOS:000292615900006	21704785				2022-02-06	
J	Ranjan, N; Nair, KPS; Romanoski, C; Singh, R; Venketswara, G				Ranjan, Nishant; Nair, Krishnan Padmakumari Sivaraman; Romanoski, Charles; Singh, Rajiv; Venketswara, Guruprasad			Tics after traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; MRI; Tics; Tourette syndrome; movement disorder	TOURETTE-SYNDROME; DISORDERS	Background: Tics are involuntary non-rhythmic, stereotyped muscle contractions which can be suppressed temporarily. Tics usually start during childhood as part of Tourette syndrome. Adult onset tics are infrequent. This study reports on an adult man who developed tics 1 year after severe traumatic brain injury (TBI). Methods: Case report and review of literature. Results: A 19-year-old man sustained TBI following a road traffic accident. He did not have tics or features of obsessive compulsive disorder before the brain injury. A year after injury he developed motor and vocal tics. Magnetic resonance image of the brain showed lesions in the basal ganglia. A search of databases Medline, EMBASE and CINHAL found only four publications on tics in adults with TBI. None of these reported cases had lesions in the basal ganglia. Conclusion: Tics are a rare complication of TBI. People with early onset post-traumatic tics may have had a previously unrecognized, mild tic disorder or a genetic predisposition for tics, which was unmasked by the TBI. In contrast, late post-traumatic tics could be due to delayed effects of injury on neural circuits connecting the frontal cortex and basal ganglia.	[Ranjan, Nishant; Nair, Krishnan Padmakumari Sivaraman; Romanoski, Charles; Singh, Rajiv; Venketswara, Guruprasad] Sheffield Teaching Hosp NHS Trust, Sheffield, S Yorkshire, England		Nair, KPS (corresponding author), No Gen Hosp, Princess Royal Spinal Injuries & Neurorehabil Ctr, Herries Rd, Sheffield S5 7AU, S Yorkshire, England.	siva.nair@sth.nhs.uk	Nair, Krishnan/AAE-3474-2020	Nair, Krishnan/0000-0002-4004-2315; singh, rajiv/0000-0002-3173-9591			Albin RL, 2006, TRENDS NEUROSCI, V29, P175, DOI 10.1016/j.tins.2006.01.001; Berardelli A, 2003, J NEUROL, V250, P781, DOI 10.1007/s00415-003-1102-4; Bloch MH, 2005, NEUROLOGY, V65, P1253, DOI 10.1212/01.wnl.0000180957.98702.69; Chouinard S, 2000, J NEUROL NEUROSUR PS, V68, P738, DOI 10.1136/jnnp.68.6.738; GAUL JJ, 1994, MOVEMENT DISORD, V9, P121; Gomis M, 2008, MOVEMENT DISORD, V23, P765, DOI 10.1002/mds.21955; Krauss JK, 2002, NEUROSURGERY, V50, P927, DOI 10.1097/00006123-200205000-00003; Krauss JK, 1997, MOVEMENT DISORD, V12, P776, DOI 10.1002/mds.870120527; MEJA NI, 2005, REV BRAS PSIQUIATR, V27, P11; Shprecher D, 2009, MOVEMENT DISORD, V24, P15, DOI 10.1002/mds.22378; Siemers E, 1990, Mov Disord, V5, P183; SINGER C, 1989, MOVEMENT DISORD, V4, P342, DOI 10.1002/mds.870040409	12	7	7	1	7	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2011	25	6					629	633		10.3109/02699052.2011.572944			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	758FF	WOS:000290146300010	21534741				2022-02-06	
J	Ratnaike, TE; Hastie, H; Gregson, B; Mitchell, P				Ratnaike, Thiloka Erandathi; Hastie, Helen; Gregson, Barbara; Mitchell, Patrick			The geometry of brain contusion: relationship between site of contusion and direction of injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Head injury; brain injury; contusions	HEAD	Up to a fifth of Accident and Emergency admissions are head-injury related. Alcohol is involved in a large proportion of adult head injuries and although the incidence of death due to head injury (HI) is relatively low, long-term sequelae including cognitive disturbance are frequent. Contrecoup contusions (CCs) have been observed commonly in closed head injuries and may be an independent factor in long-term neuro-disability. The mechanisms of their formation are still under debate. The aim of this study was to define the relationship between the direction of the blow to the head and the location of brain contusion after HI. The location of scalp injuries was used as a surrogate for the direction of the blow to the head. Between January 2007 and March 2009, 358 cases of HI were treated at the Newcastle Neurosurgery Unit. Of these, 129 had contusions. Of these, 100 scans were available. The site of scalp injury could be identified in 98 cases and these were used for the study. Sixty-six percent of scalp injuries were to the back of the head. Most contusions (77%) were contracoup affecting the frontal and temporal lobes. Sixty percent of the injuries were inflicted by a fall from a standing position striking the back of the head on a paved surface, most commonly in the context of assaults or fighting.	[Mitchell, Patrick] Newcastle Univ, Royal Victoria Infirm, Dept Neurosurg, Inst Neurosci, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England		Mitchell, P (corresponding author), Newcastle Univ, Royal Victoria Infirm, Dept Neurosurg, Inst Neurosci, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	patrick.mitchell@ncl.ac.uk		Gregson, Barbara/0000-0003-4868-9137			Bauer M, 2004, J Clin Forensic Med, V11, P65, DOI 10.1016/j.jcfm.2003.10.003; FUJIWARA S, 1989, FORENSIC SCI INT, V43, P159, DOI 10.1016/0379-0738(89)90132-1; Ishikawa R, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1327; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kaye AH, 2000, LANCET, V356, P1540, DOI 10.1016/S0140-6736(00)03121-4; KING AI, 2003, IS HEAD INJ CAUS LIN; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; National Collaborating Centre for Acute Care (UK), 2007, HEAD INJ TRIAG ASS I	8	7	7	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	JUN	2011	25	3					410	413		10.3109/02688697.2010.548879			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	769QR	WOS:000291033800025	21344980				2022-02-06	
J	d'Aloja, E; De Giorgio, F; Ausania, F; Cascini, F				d'Aloja, Ernesto; De Giorgio, Fabio; Ausania, Francesco; Cascini, Fidelia			A Case of Suicidal Suffocation Simulating Homicide	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; autopsy; plastic bag; asphyxia; autoerotic; elderly; suicide	PLASTIC BAG SUFFOCATION; ASPHYXIAL SUICIDE; UNITED-STATES; INHALATION; HELIUM; INCAPRETTAMENTO; STRANGULATION; CHLOROFORM; DEATHS	This case concerns an unusual suicidal plastic bag suffocation. An elderly white man was found dead and partially disrobed in his apartment lying supine on a sofa with a plastic bag closed by a rope over the head and the upper and lower extremities tightly tied with two other ropes, the end of both arranged into slipknots (self-rescue mechanism). Police investigations found no pornography in the apartment, and circumstantial data alleged no psychiatric disorders or suicidal intentions. The autopsy excluded signs of struggle and sexual intercourse as well as any type of injury or physical illness. Chemical analyses on the peripheral blood excluded acute drugs and/or alcohol intoxication. A differential diagnosis of the manner of death was performed, including scenarios of accidental autoerotic asphyxiation, homicide during either sexual activity or ritualistic, elderly suicide. The collected data most strongly supported the hypothesis of a suicidal asphyxiation simulating homicide to devolve a life insurance to the victim's sons because of economic difficulties.	[De Giorgio, Fabio; Ausania, Francesco; Cascini, Fidelia] Catholic Univ, Sch Med, Inst Legal Med, I-00168 Rome, Italy; [d'Aloja, Ernesto] Univ Cagliari, Inst Legal Med, I-09124 Cagliari, Italy		Cascini, F (corresponding author), Catholic Univ, Sch Med, Inst Legal Med, Largo F Vito 1, I-00168 Rome, Italy.	f.cascini@rm.unicatt.it	d'Aloja, Ernesto/P-4539-2017; Cascini, Fidelia/AAY-8431-2020; Ausania, Fabio/V-1550-2019; De Giorgio, Fabio/AAB-7163-2022	d'Aloja, Ernesto/0000-0003-4456-6252; Cascini, Fidelia/0000-0001-6499-0734; De Giorgio, Fabio/0000-0001-7433-0924			Auwaerter V, 2007, FORENSIC SCI INT, V170, P139, DOI 10.1016/j.forsciint.2007.03.027; AVIS SP, 1994, J FORENSIC SCI, V39, P253; BALDING LE, 1995, AM J FOREN MED PATH, V16, P229, DOI 10.1097/00000433-199509000-00008; Bullock MJ, 2000, J FORENSIC SCI, V45, P608; Burgess, 1983, AUTOEROTIC FATALITIE; Byard Roger W, 2006, J Clin Forensic Med, V13, P9, DOI 10.1016/j.jcfm.2005.05.005; Drago DA, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.5.e59; Fineschi V, 1998, AM J FOREN MED PATH, V19, P87, DOI 10.1097/00000433-199803000-00017; Haddix TL, 1996, AM J FOREN MED PATH, V17, P308, DOI 10.1097/00000433-199612000-00006; HUNT AC, 1962, BRIT MED J, P378, DOI 10.1136/bmj.1.5275.378; IKEDA N, 1988, MED SCI LAW, V28, P131, DOI 10.1177/002580248802800210; JAFFE FA, 1994, AM J FOREN MED PATH, V15, P203, DOI 10.1097/00000433-199409000-00004; JOHNSTONE JM, 1960, BRIT MED J, V2, P1714, DOI 10.1136/bmj.2.5214.1714; Jones LS, 2000, AM J FOREN MED PATH, V21, P401, DOI 10.1097/00000433-200012000-00021; Knight B., 1996, FORENSIC PATHOLOGY; KRAUS JF, 1985, PUBLIC HEALTH REP, V100, P231; MARTINEZ AL, 1993, MED SCI LAW, V33, P71, DOI 10.1177/002580249303300114; MCGEE MB, 1987, J FORENSIC SCI, V32, P1453; NASHELSKY MB, 1995, J FORENSIC SCI, V40, P134; Ogden RD, 2002, AM J FOREN MED PATH, V23, P234, DOI 10.1097/00000433-200209000-00005; Pollanen MS, 2003, AM J FOREN MED PATH, V24, P51, DOI 10.1097/00000433-200303000-00010; Schon CA, 2007, AM J FOREN MED PATH, V28, P364, DOI 10.1097/PAF.0b013e31815b4c69; UVA JL, 1995, J FORENSIC SCI, V40, P574; Watanabe T, 1998, FORENSIC SCI INT, V96, P47, DOI 10.1016/S0379-0738(98)00112-1; WINEK CL, 1970, LANCET, V1, P365	25	7	7	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	MAY	2011	56	3					810	812		10.1111/j.1556-4029.2011.01719.x			3	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Legal Medicine	754YD	WOS:000289892900045	21361945				2022-02-06	
J	Honeybul, S; Ho, KM; Lind, CRP; Gillett, GR				Honeybul, Stephen; Ho, Kwok M.; Lind, Christopher R. P.; Gillett, Grant R.			Surgical intervention for severe head injury: ethical considerations when performing life-saving but non-restorative surgery	ACTA NEUROCHIRURGICA			English	Article						Decompressive craniectomy; Outcome; Ethics	TRAUMATIC BRAIN-INJURY; EARLY DECOMPRESSIVE CRANIECTOMY; CEREBRAL-ARTERY INFARCTION; MULTICENTER; MANAGEMENT; HEMICRANIECTOMY; HYPERTENSION; VALIDATION; TRIAL; LIFE	The aim of this study was to compare the predicted outcome with observed outcome in those patients who have had a unilateral decompressive craniectomy following evacuation of an intracranial mass lesion and to consider some of the ethical issues that need to be addressed when performing life-saving but non-restorative surgery. By using the web-based outcome prediction model developed by the CRASH trial collaborators predicted and observed outcomes were compared for those patients who had had a unilateral decompression after evacuation of a mass lesion in the two major neurotrauma hospitals in Western Australia between 2004 and 2008. Three cases were selected with differing outcome predictions. For the three selected cases the predicted risk of an unfavourable outcome at 6 months was 65.8%, 78.9% and 91.3%, respectively. For the 11 patients in this cohort with an outcome prediction between 61% and 70%, the observed outcome at 18 months (GOS) was: 5 had a good outcome, 4 were moderately disabled, and 3 were severely disabled. For the ten patients with an outcome prediction between 90-100%, observed outcome confirmed: one patient was moderately disabled, four patients were severely disabled, one patient was in a permanent vegetative state, and four patients had died. As the index of injury severity (as adjudged by the CRASH outcome prediction model) increases, clinical decision making and discussion with surrogates must reflect the evidence provided by observed outcome, prior to life-saving but potentially non-restorative decompressive surgery.	[Honeybul, Stephen; Lind, Christopher R. P.] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; [Ho, Kwok M.] Royal Perth Hosp, Dept Intens Care Med, Perth, WA, Australia; [Gillett, Grant R.] Univ Otago, Dunedin Hosp, Dunedin, New Zealand; [Gillett, Grant R.] Univ Otago, Otago Bioeth Ctr, Dunedin, New Zealand; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Lind, Christopher R. P.] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010; Lind, Christopher/K-3629-2012	Ho, Kwok M./0000-0002-6705-6004; Lind, Christopher/0000-0001-9991-1725			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; GILLETT GR, 2001, NZ MED J, V27, P188; Gillett G, 2006, QUT LAW REV, V6, P243; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holtkamp M, 2001, J NEUROL NEUROSUR PS, V70, P226, DOI 10.1136/jnnp.70.2.226; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kelly AG, 2010, NEUROLOGY, V75, P682, DOI 10.1212/WNL.0b013e3181eee273; Koh MS, 2000, SURG NEUROL, V53, P225, DOI 10.1016/S0090-3019(00)00163-4; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Meier U, 2005, ACT NEUR S, V95, P55; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235	28	7	7	0	7	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAY	2011	153	5					1105	1110		10.1007/s00701-011-0974-9			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	750BQ	WOS:000289519500019	21347576				2022-02-06	
J	Mahmoud, AO; Ayanniyi, AA; Salman, MF				Mahmoud, Abdulraheem Olarongbe; Ayanniyi, Abdulkabir Ayansiji; Salman, Medinat Folorunso			Observations of teachers in llorin, Nigeria on their practices of corporal punishment that are potentially injurious to their pupils' eyes	ANNALS OF AFRICAN MEDICINE			English	Article						Corporal punishment; eye injuries in childhood; school discipline	ATTITUDES; CHILDREN	Objective: To document the observations of elementary school teachers (ESTs) in Ilorin, Nigeria on their practice of some types of corporal punishment (CP) that could result in eye injuries among their pupils. Materials and Methods: A short battery of questions that explored ESTs' observations on attitudes to, and knowledge of some commonly used CP practices was self-administered on 172 consenting teachers from six sampled schools. The potentials for their pupils to sustain eye injuries while receiving such CP practices were inferred from the usage of items with sharp and protruding ends to administer CP, and the application of CP onto pupils' body parts that are in close proximity to the eye such as the head and face. Results: Only 50 of the 172 ESTs favored the practice of CP of pupils by their teachers. Analyses of several potentially moderating variables on this response such as ESTs' ages, years of EST teaching experience, school, and class or grade that EST teaches did not prove significant. Over three-quarters of ESTs (80.2%) had ever observed that pupils were being disciplined by ESTs with a cane. About a fifth of them had also observed that ESTs applied CP to the head (19.8%) and the face (16.3%) of pupils. Conclusion: Findings suggest that ESTs' commonly employed CP practices have significant injurious potential to their pupils' eyes. It is recommended that CP be abolished in elementary schools, and instead alternative nonabusive methods of disciplining erring pupils by teachers be introduced.	[Mahmoud, Abdulraheem Olarongbe] Univ Ilorin, Dept Ophthalmol, Ilorin, Nigeria; [Ayanniyi, Abdulkabir Ayansiji] Univ Abuja, Dept Ophthalmol, Abuja, Nigeria; [Salman, Medinat Folorunso] Univ Ilorin, Sci Educ, Ilorin, Nigeria		Ayanniyi, AA (corresponding author), Univ Abuja, Coll Hlth Sci, Dept Ophthalmol, PMB 117, Abuja, Nigeria.	ayanniyikabir@yahoo.com					Abolfotouh Mostafa A, 2009, J Forensic Nurs, V5, P5, DOI 10.1111/j.1939-3938.2009.01025.x; Adeoye A O, 2002, Niger J Med, V11, P26; American academy of pediatrics, 2006, PEDIATRICS, V106, P343; Ateah Christine A, 2003, J Pediatr Health Care, V17, P126, DOI 10.1067/mph.2003.18; Ayanniyi A A, 2009, Afr J Med Med Sci, V38, P193; Calzada JI, 2003, AM J OPHTHALMOL, V135, P719, DOI 10.1016/S0002-9394(02)01890-1; Corporal punishment in schools: A position paper of the Society for Adolescent Medicine, 1992, J ADOLESCENT HEALTH, V13, P240; Ekpunobi AN, 2003, STAT INFORM BASIC ED; Gofin R, 2004, ISRAEL J PSYCHIAT, V41, P90; Greydanus DE, 2003, J ADOLESCENT HEALTH, V32, P385, DOI 10.1016/S1054-139X(03)00042-9; Horn IB, 2004, J NATL MED ASSOC, V96, P1162; Jaffee SR, 2004, DEV PSYCHOL, V40, P1047, DOI 10.1037/0012-1649.40.6.1047; Kenny MC, 2004, CHILD ABUSE NEGLECT, V28, P1311, DOI 10.1016/j.chiabu.2004.06.010; Mahmoud A. O., 2007, Sahel Medical Journal, V10, P79; Mahmoud AO, 2006, TROP J HLTH SCI, V13, P35; Mohr Wanda K, 2002, J Sch Nurs, V18, P346; Nwomeh BC, 2003, AFR J TRAUMA, V1, P7; Nwosu S N, 1995, West Afr J Med, V14, P137; Paolucci EO, 2004, J PSYCHOL, V138, P197, DOI 10.3200/JRLP.138.3.197-222; Shumba A, 2001, CHILD ABUSE NEGLECT, V25, P265, DOI 10.1016/S0145-2134(00)00244-1; Smith DE, 2003, ADOLESCENCE, V38, P369; Socolar R, 2004, AMBUL PEDIATR, V4, P166, DOI 10.1367/A03-071R1.1; Taylor J, 2004, J ADV NURS, V46, P311, DOI 10.1111/j.1365-2648.2004.02993.x; Zolotor AJ, 2010, CHILD ABUSE REV, V19, P229, DOI 10.1002/car.1131	24	7	7	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1596-3519	0975-5764		ANN AFR MED	Ann. Afr. Med.	APR-JUN	2011	10	2					150	154		10.4103/1596-3519.82075			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V3P4B	WOS:000218466000015	21691023				2022-02-06	
J	Dunham, CM; Chirichella, TJ				Dunham, C. Michael; Chirichella, Thomas J.			Attenuated hypocholesterolemia following severe trauma signals risk for late ventilator-associated pneumonia, ventilator dependency, and death: a retrospective study of consecutive patients	LIPIDS IN HEALTH AND DISEASE			English	Article							INFLAMMATORY RESPONSE; SERUM-CHOLESTEROL; BRAIN-INJURY; INFECTION; SURGERY; LIPOPROTEIN; PREDICTORS; GUIDELINES; MORTALITY; DIAGNOSIS	Background: Post-traumatic ventilator-associated pneumonia (VAP) is a substantial clinical problem that increases hospital costs and typically adds to the duration of mechanical ventilation. We evaluated the impact of VAP on ventilator days. We also assessed 48-hour total blood cholesterol (TC) and other potential risk factors for the development of VAP. Methods: We performed a retrospective study of consecutive trauma patients requiring emergency tracheal intubation and evaluated TC, age, gender, ethanol status, smoker status, injury mechanism, chest injury, brain injury, Injury Severity Score (ISS), shock, day-one hypoxemia, and RBC transfusion as potential risks for VAP. Results: The 152 patients had ISS 28.1, brain injury 68.4%, VAP 50.0%, ventilator days 14.3, and death 9.9%. Ventilator days were increased with late VAP (p < 0.0001). TC was 110.7 mg/dL with expected TC 197.5 mg/dL. TC was lower with chest injury, shock, and RBC transfusion but, higher with brain injury (p <= 0.01). TC decreased as ISS increased (p = 0.01). However, one patient subset (ISS >= 20-&-TC >= 90 mg/dL) had a relative increase in TC despite an increase in ISS. ISS >= 20-&-TC >= 90 mg/dL, but not ISS alone, was the only independent predictor of late VAP (OR 3.0; p = 0.002). ISS >= 20-&-TC >= 90 mg/dL and day-one hypoxemia were the only independent predictors for increased ventilator days (p = 0.01). ISS >= 20-&-TC >= 90 mg/dL, but not ISS alone, was the only predictor of death (OR 3.8; p = 0.03). Conclusions: Severe traumatic injury produced substantial hypocholesterolemia that is greater with chest injury, shock, and RBC transfusion, but less with brain injury. Total blood cholesterol tended to decrease with increasing injury severity. However, attenuated hypocholesterolemia (ISS >= 20-&-TC >= 90 mg/dL) represents a unique response that can occur with critical injury. Attenuated hypocholesterolemia signals early risk for late VAP, ventilator dependency, and death.	[Dunham, C. Michael; Chirichella, Thomas J.] St Elizabeth Hlth Ctr, Trauma Crit Serv, Youngstown, OH 44501 USA		Dunham, CM (corresponding author), St Elizabeth Hlth Ctr, Trauma Crit Serv, 1044 Belmont Ave, Youngstown, OH 44501 USA.	dunham.michael@sbcglobal.net		Dunham, C. Michael/0000-0002-7842-9750			ALVAREZ C, 1986, CLIN CHEM, V32, P142; Anderson GD, 1998, ANN PHARMACOTHER, V32, P554, DOI 10.1345/aph.17332; Arnett DK, 2005, CIRCULATION, V112, P3884, DOI 10.1161/CIRCULATIONAHA.105.549857; Bakalar B, 2003, WIEN KLIN WOCHENSCHR, V115, P775, DOI 10.1007/BF03040502; Cavalcanti M, 2006, CRIT CARE MED, V34, P1067, DOI 10.1097/01.CCM.0000206471.44161.A0; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; Cohen MJ, 2009, J TRAUMA, V67, P1176, DOI 10.1097/TA.0b013e3181c1c1bc; Croce MA, 2003, J TRAUMA, V54, P724, DOI 10.1097/01.TA.0000054643.54218.C5; Delgado-Rodriguez M, 2002, ARCH SURG-CHICAGO, V137, P805, DOI 10.1001/archsurg.137.7.805; Dunham CM, 2003, CRIT CARE, V7, pR145, DOI 10.1186/cc2382; DUNHAM CM, 1994, CRIT CARE MED, V22, P667, DOI 10.1097/00003246-199404000-00024; Eckert MJ, 2006, J TRAUMA, V60, P104, DOI 10.1097/01.ta.0000197376.98296.7c; Elliott DC, 1996, ANN SURG, V224, P672, DOI 10.1097/00000658-199611000-00011; ERTEL W, 1995, J TRAUMA, V39, P879, DOI 10.1097/00005373-199511000-00011; Giannoudis PV, 2004, J BONE JOINT SURG BR, V86B, P313, DOI 10.1302/0301-620X.86B3.15035; Giovannini I, 1999, INTENS CARE MED, V25, P748, DOI 10.1007/s001340050940; Gordon BR, 2001, CRIT CARE MED, V29, P1563, DOI 10.1097/00003246-200108000-00011; Gui D, 1996, INTENS CARE MED, V22, P790, DOI 10.1007/s001340050168; Kallel H, 2005, J TRAUMA, V59, P705, DOI 10.1097/01.ta.0000177749.09844.c6; Kohl BA, 2006, CURR OPIN CRIT CARE, V12, P325, DOI 10.1097/01.ccx.0000235210.85073.fc; Lansford Todd, 2007, Surg Infect (Larchmt), V8, P505, DOI 10.1089/sur.2006.001; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Magnotti Louis J, 2004, Surg Infect (Larchmt), V5, P237, DOI 10.1089/sur.2004.5.237; Meisner M, 2006, CRIT CARE, V10, DOI 10.1186/cc3910; Miller PR, 2006, J TRAUMA, V60, P98, DOI 10.1097/01.ta.0000196379.74305.e4; Minei JP, 2006, J TRAUMA, V60, P1106, DOI 10.1097/01.ta.0000220424.34835.f1; Mintzer S, 2009, ANN NEUROL, V65, P448, DOI 10.1002/ana.21615; Muscedere J, 2008, J CRIT CARE, V23, P138, DOI 10.1016/j.jcrc.2007.12.008; Palma S, 2007, BRIT J SURG, V94, P369, DOI 10.1002/bjs.5626; Pikuleva IA, 2006, PHARMACOL THERAPEUT, V112, P761, DOI 10.1016/j.pharmthera.2006.05.014; Rea-Neto A, 2008, CRIT CARE, V12, DOI 10.1186/cc6877; Shephard RJ, 1998, CAN J PHYSIOL PHARM, V76, P469, DOI 10.1139/cjpp-76-5-469; Spriet I, 2009, INTENS CARE MED, V35, P603, DOI 10.1007/s00134-008-1383-2; Stachon A, 2000, CLIN CHEM, V46, P1114; Talmor M, 1999, ARCH SURG-CHICAGO, V134, P81, DOI 10.1001/archsurg.134.1.81; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; WOLFRAM G, 1980, KLIN WOCHENSCHR, V58, P1327, DOI 10.1007/BF01477730; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	38	7	9	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1476-511X			LIPIDS HEALTH DIS	Lipids Health Dis.	MAR 3	2011	10								42	10.1186/1476-511X-10-42			8	Biochemistry & Molecular Biology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Nutrition & Dietetics	735ED	WOS:000288395300003	21371328	Green Published, gold			2022-02-06	
J	Casson, IR; Viano, DC; Powell, JW; Pellman, EJ				Casson, Ira R.; Viano, David C.; Powell, John W.; Pellman, Elliot J.			Concussions Involving 7 or More Days Out in the National Football League	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; traumatic brain concussion; concussion surveillance; epidemiology; sport concussion; postconcussion syndrome; concussion guidelines	PROFESSIONAL FOOTBALL; INJURIES; GAME	Background: Positions, signs, symptoms, and medical management of National Football League players with concussions involving 7 or more days out (7+) from play were compared for two 6-year study periods (2002-2007 vs 1996-2001). Hypothesis: More players were held out 7+ days in the 2002-2007 period without significant difference in concussion signs and symptoms. Study Design: Cohort. Methods: From 1996 through 2007, National Football League team physicians reported concussion signs and symptoms, medical action taken, and follow-up management. Results: During the 2002-2007 period, 143 (16.7%) and 33 (3.86%) concussed players were out 7+ days and 21+ days, respectively, compared with 73 (8.2%) and 7 (0.79%) in the 1996-2001 period, a significant difference ( z = 5.39, P < .01). The positions with the highest fraction of 7+ days out were the quarterback (24.5% vs 16.1%), linebacker (19.7% vs 4.6%), and wide receiver (19.5% vs 8.2%) in the later versus earlier period. The player positions with the highest odds for being out 7+ days were quarterback (odds ratio = 1.80 vs 4.02), linebacker (odds ratio = 1.28 vs 0.65), and wide receiver (odds ratio = 1.25 vs 1.15). The highest incidence of 7+ days out occurred after passing plays (32.2% vs 37.0%), followed by kickoffs (18.9% vs 21.9%). The majority of players with 7+ days out were removed from the game on the day of injury (74.8% vs 72.6%); a smaller fraction were returned to play on the day of injury in the later 6 years (3.5% vs 6.8%). Conclusions: The positions with the highest odds for being out 7+ days with concussion were quarterbacks, linebackers, and wide receivers. In the more recent 6-year period, more players were managed conservatively by being held out 7+ days, even though the signs and symptoms of their concussions were similar to those in the earlier period.	[Casson, Ira R.] Long Isl Jewish Med Ctr, Dept Neurol, New Hyde Pk, NY 11042 USA; [Casson, Ira R.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Viano, David C.] ProBiomech LLC, 265 Warrington Rd, Bloomfield, NJ 48304 USA; [Powell, John W.] Michigan State Univ, Dept Kinesiol & Radiol, E Lansing, MI USA; [Pellman, Elliot J.] ProHEALTH Care Associates LLP, New York, NY USA; [Pellman, Elliot J.] Mt Sinai Sch Med, Dept Med & Orthopaed, New York, NY USA		Viano, DC (corresponding author), ProBiomech LLC, 265 Warrington Rd, Bloomfield, NJ 48304 USA.	dviano@comcast.net					Casson IR, 2008, NEUROL CLIN, V26, P217, DOI 10.1016/j.ncl.2007.11.005; Casson IR, 2008, NEUROSURGERY, V62, P204, DOI 10.1227/01.NEU.0000311079.65895.3E; Casson IR, 2011, SPORTS HEALTH, V3, P11, DOI 10.1177/1941738110391413; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, VIn: Vol 12, P386; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 1997, NEUROLOGY, V48, P581; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2	14	7	7	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAR-APR	2011	3	2					130	144		10.1177/1941738110397876			15	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V19RZ	WOS:000214837400002	23016000	Green Published			2022-02-06	
J	Farag, E; Manno, EM; Kurz, A				Farag, E.; Manno, E. M.; Kurz, A.			Use of hypothermia for traumatic brain injury: point of view	MINERVA ANESTESIOLOGICA			English	Article						Hypothermia; Traumatic brain injury; Wounds and injuries	THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; PIAL ARTERIOLES; CARDIAC-ARREST; MECHANISMS; TRIAL; MICROCIRCULATION; MULTICENTER; PREVENTION; INDUCTION	Traumatic brain injury (TBI) is one of the major causes of disability in modern society. The World Health Organization has predicted that, by 2020, traffic accidents will represent the greatest burden of global disease and injury. Brain injury after trauma occurs in two stages. Primary injury is directly associated with the biomechanical effects of the trauma, whereas secondary injury occurs later and can be attributed to processes that develop within the brain. Currently, there is no consensus for the use of hypothermia in the treatment of secondary injury after TBI. Until the results of ongoing studies are published, maintaining normothermia and avoiding hyperthermia should be used in managing patient with TBI. (Minerva Anestesiol 2011;77:366-70)	[Farag, E.; Manno, E. M.] Cleveland Clin, Cerebrovasc Ctr, Cleveland, OH 44195 USA		Farag, E (corresponding author), Cleveland Clin, Cerebrovasc Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA.	farage@ccf.org					Adelson PD, 2009, J NEUROTRAUM, V26, P429, DOI 10.1089/neu.2008.0571; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; Alzaga AG, 2006, RESUSCITATION, V70, P369, DOI 10.1016/j.resuscitation.2006.01.017; Arrich J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub2; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Castren M, 2009, ACTA ANAESTH SCAND, V53, P280, DOI 10.1111/j.1399-6576.2008.01881.x; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Clifton GL, 2009, J NEUROTRAUM, V26, P393, DOI 10.1089/neu.2008.0556; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Irikura K, 1998, J CEREBR BLOOD F MET, V18, P1294, DOI 10.1097/00004647-199812000-00003; Kishi K, 2000, ANESTH ANALG, V91, P140, DOI 10.1097/00000539-200007000-00026; Laffey JG, 2002, NEW ENGL J MED, V347, P43, DOI 10.1056/NEJMra012457; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marshall LF, 2001, J NEUROSURG, V95, P733, DOI 10.3171/jns.2001.95.5.0733; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Nielsen N, 2009, ACTA ANAESTH SCAND, V53, P926, DOI 10.1111/j.1399-6576.2009.02021.x; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2003, INTENS CARE MED, V29, P1202, DOI 10.1007/s00134-003-1787-y; POLDERMAN KH, 2009, CRIT CARE MED; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Povlishock JT, 1999, ACT NEUR S, V73, P15; Sahuquillo J, 2009, INTENS CARE MED, V35, P890, DOI 10.1007/s00134-008-1357-4; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Sutcliffe IT, 2001, J CEREBR BLOOD F MET, V21, P1310, DOI 10.1097/00004647-200111000-00007; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub4; Thoresen M, 2001, PEDIATR RES, V50, P405, DOI 10.1203/00006450-200109000-00017; Tooley JR, 2003, ANN NEUROL, V53, P65, DOI 10.1002/ana.10402; Weisinger JR, 1998, LANCET, V352, P391, DOI 10.1016/S0140-6736(97)10535-9	41	7	10	0	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393			MINERVA ANESTESIOL	Minerva Anestesiol.	MAR	2011	77	3					366	370					5	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	751CA	WOS:000289593900017	21283076				2022-02-06	
J	Omerhozic, I; Dizdarevic, K; Rotim, K; Hajdarpasic, E; Niksic, M; Bejtic-Custovic, E; Selimovic, E; Custovic, M				Omerhozic, Ibrahim; Dizdarevic, Kemal; Rotim, Kresimir; Hajdarpasic, Edin; Niksic, Maida; Bejtic-Custovic, Enisa; Selimovic, Emina; Custovic, Mirsada			CEREBRAL MICRODIALYSIS: PERIOPERATIVE MONITORING AND TREATMENT OF SEVERE NEUROSURGICAL PATIENT	ACTA CLINICA CROATICA			English	Article						Microdialysis; Brain injury; Subarachnoid hemorrhage; Intracranial hemorrhage, traumatic; Postoperative care	TRAUMATIC BRAIN-INJURY; NORMOBARIC HYPEROXIA; METABOLISM; CONSENSUS; PRESSURE; LACTATE	The early signs of brain ischemia are key indicators of secondary brain injury and their recognition on time can ultimately save life. Direct recording of cerebral ischemia is possible using the method of cerebral microdialysis (CM). This paper presents results of the five-year experience in applying this method at University Department of Neurosurgery, Sarajevo University Clinical Center in Sarajevo. In this observational prospective clinical study, the treatment and outcome of 51 patients with subarachnoid hemorrhage (SAH) and traumatic intracranial hemorrhage (tICH) undergoing neurosurgery and consequently treated conservatively at Neurosurgical Intensive Care Unit (NICU) were analyzed. All patients were followed up by unified monitoring at NICU and additionally by the CM method. Between December 2006 and September 2010, CM monitoring was performed in 51 patients: 18 patients with SAH and 33 patients with tICH. In all patients, samples were obtained on 367 occasions, yielding a total of 3314 samples for biochemical parameters (mean 64.98 per patient, range 42-114 samples). Positive correlation was found between glucose level and outcome at one-year follow up (when glucose level was lower, the patient Glasgow Outcome Scale (GOS) score was worse). The correlation coefficient for glycerol was negative (r=-0.81), and so was for the lactate/pyruvate ratio. There was a significant difference in patient outcome in favor of the group of patients monitored by use of CM in terms of poor and good outcome graded according to GOS score 12 months after the injury compared with the group of patients not monitored with CM (P<0.028). According to our experience, we believe that CM enables early initiation of appropriate therapeutic strategies to overcome cerebral ischemia and secondary brain damage, eventually leading to better patient outcome.	[Omerhozic, Ibrahim] Univ Sarajevo, Ctr Clin, Neurosurg Intens Care Unit, Univ Dept Neurosurg, Sarajevo 71000, Bosnia & Herceg; [Rotim, Kresimir] Sestre Milosrdnice Univ Hosp, Univ Dept Neurosurg, Zagreb, Croatia; [Niksic, Maida] Univ Sarajevo, Ctr Clin, Dept Radiol, Sarajevo 71000, Bosnia & Herceg; [Bejtic-Custovic, Enisa] Univ Sarajevo, Ctr Clin, Dept Anesthesiol & Resuscitat, Sarajevo 71000, Bosnia & Herceg		Omerhozic, I (corresponding author), Univ Sarajevo, Ctr Clin, Neurosurg Intens Care Unit, Univ Dept Neurosurg, Bolnicka 25, Sarajevo 71000, Bosnia & Herceg.	genijana@bih.net.ba	Omerhodzic, Ibrahim/AAL-7976-2020	Omerhodzic, Ibrahim/0000-0001-5143-8801			Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Chefer Vladimir I, 2009, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0701s47; DENDUKURI N, 2005, 21 MCGILL U HLTH CTR; Dizdairevic K, 2007, PROCEEDINGS OF THE 13TH EUROPEAN CONGRESS OF NEUROSURGERY, P505; DIZDAREVIC K, 2007, THESIS U SARAJEVO SA; Dizdarevic Kemal, 2006, Med Arh, V60, P13; Gautschi OP, 2009, ANASTH INTENSIV NOTF, V44, P268, DOI 10.1055/s-0029-1222434; HUTCHINSON PJ, 2002, J NEUROL NEUROSUR S1, V73, pi3; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Komotar RJ, 2009, NEUROSURGERY, V64, P397, DOI 10.1227/01.NEU.0000338946.42939.C7; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Marion DW, 2006, NEUROSURGERY, V58, P655; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mocco J, 2006, NEUROSURGERY, V59, P529, DOI 10.1227/01.NEU.0000228680.22550.A2; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; NORDSTROM CH, 2009, S CER MICR ZAGR CROA, P3; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Olesen J, 2006, J NEUROL NEUROSUR PS, V77; OMERHODZIC I, 2006, MAT SOCIO MED, V18, P41; OMERHODZIC I, 2010, PREDICTIVE VALUE CER, P182; OMERHODZIC I, 2010, 2 C SURG FED BOSN HE, P235; OMERHODZIC I, 2008, NEUROL CROAT S3, V57, P160; Samuelsson C, 2009, ACTA NEUROCHIR, V151, P437, DOI 10.1007/s00701-009-0265-x; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wartenberg KE, 2007, CRIT CARE CLIN, V23, P507, DOI 10.1016/j.ccc.2007.06.002	30	7	8	0	1	SESTRE MILOSRDNICE UNIV HOSPITAL	ZAGREB	VINOGRADSKA C 29, ZAGREB, HR-10000, CROATIA	0353-9466	1333-9451		ACTA CLIN CROAT	Acta Clin. Croat.	MAR	2011	50	1					13	20					8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835ZW	WOS:000296076800003	22034779				2022-02-06	
J	Wei, G; Lu, XCM; Shear, DA; Yang, XF; Tortella, FC				Wei, Guo; Lu, Xi-Chun M.; Shear, Deborah A.; Yang, Xiaofang; Tortella, Frank C.			Neuroprotection of Selective Brain Cooling After Penetrating Ballistic-like Brain Injury in Rats	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article								Induced hypothermia has been reported to provide neuroprotection against traumatic brain injury. We recently developed a novel method of selective brain cooling (SBC) and demonstrated its safety and neuroprotection efficacy in a rat model of ischemic brain injury. The primary focus of the current study was to evaluate the potential neuroprotective efficacy of SBC in a rat model of penetrating ballistic-like brain injury (PBBI) with a particular focus on the acute cerebral pathophysiology, neurofunction, and cognition. SBC (34 degrees C) was induced immediately after PBBI, and maintained for 2 hours, followed by a spontaneous re-warming. Intracranial pressure (ICP) and regional cerebral blood flow were monitored continuously for 3 hours, and the ICP was measured again at 24 hours postinjury. Brain swelling, blood-brain barrier permeability, intracerebral hemorrhage, lesion size, and neurological status were assessed at 24 hours postinjury. Cognitive abilities were evaluated in a Morris water maze task at 12-16 days postinjury. Results showed that SBC significantly attenuated PBBI-induced elevation of ICP (PBBI = 33.2 +/- 10.4; PBBI + SBC = 18.8 +/- 6.7 mmHg) and reduced brain swelling, blood-brain barrier leakage, intracerebral hemorrhage, and lesion volume by 40%-45% for each matrix, and significantly improved neurologic function. However, these acute neuroprotective benefits of SBC did not translate into improved cognitive performance in the Morris water maze task. These results indicate that 34 degrees C SBC is effective in protecting against acute brain damage and related neurological dysfunction. Further studies are required to establish the optimal treatment conditions (i.e., duration of cooling and/or combined therapeutic approaches) needed to achieve significant neurocognitive benefits.	[Wei, Guo; Lu, Xi-Chun M.; Shear, Deborah A.; Yang, Xiaofang; Tortella, Frank C.] Walter Reed Army Inst Res, Dept Appl Neurobiol, Silver Spring, MD 20910 USA		Wei, G (corresponding author), Walter Reed Army Inst Res, Dept Appl Neurobiol, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	guo.wei@us.army.mil			U.S. Army Medical Research and Materiel Command, Combat Casualty Care Research ProgramU.S. Army Medical Research & Materiel Command (USAMRMC)	This work was supported by core funding provided by the U.S. Army Medical Research and Materiel Command, Combat Casualty Care Research Program.	Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cheng H, 2006, ACTA NEUROCHIR, V148, P559, DOI 10.1007/s00701-006-0735-3; Clark DL, 2007, J CEREBR BLOOD F MET, V27, P115, DOI 10.1038/sj.jcbfm.9600327; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Clifton Guy L, 2004, Curr Opin Crit Care, V10, P116, DOI 10.1097/00075198-200404000-00007; Covaciu L, 2008, RESUSCITATION, V76, P83, DOI 10.1016/j.resuscitation.2007.07.002; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Doll H, 2009, J NEUROTRAUM, V26, P235, DOI 10.1089/neu.2008.0741; Einer-Jensen N, 2000, EXP BRAIN RES, V130, P244, DOI 10.1007/s002219900230; Fingas M, 2007, EXP NEUROL, V208, P277, DOI 10.1016/j.expneurol.2007.08.018; GALR C, 2002, CLIN NEUROL NEUROSUR, V104, P318; Harris BA, 2007, BRIT J ANAESTH, V98, P93, DOI 10.1093/bja/ael308; Hayashi S, 2005, ACT NEUR S, V95, P269; Hemmen TM, 2007, STROKE, V38, P794, DOI 10.1161/01.STR.0000247920.15708.fa; Hemphill JC, 2005, NEUROCRIT CARE, V3, P260, DOI 10.1385/NCC:3:3:260; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Lu XCM, 2009, J CEREBR BLOOD F MET, V29, P1924, DOI 10.1038/jcbfm.2009.109; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Masaoka Hiroyuki, 2000, Keio Journal of Medicine, V49, pA159; MELLERGARD P, 1992, NEUROSURGERY, V31, P671; Milhaud D, 2005, J NEUROSURG ANESTH, V17, P49; Murakami Y, 2009, J NEUROTRAUM, V26, pA22; NATALE JE, 1989, STROKE, V20, P770, DOI 10.1161/01.STR.20.6.770; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Romlin B, 2007, ACTA ANAESTH SCAND, V51, P198, DOI 10.1111/j.1399-6576.2006.01181.x; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Shear DA, 2009, PHARMACOL BIOCHEM BE, V94, P56, DOI 10.1016/j.pbb.2009.07.006; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Tieu BH, 2007, WORLD J SURG, V31, P1055, DOI 10.1007/s00268-006-0653-9; Tortella FC, 1999, J PHARMACOL EXP THER, V291, P399; TOWFIGHI J, 1994, ACTA NEUROPATHOL, V87, P598; Trubel H, 2004, INTENS CARE MED, V30, P1829, DOI 10.1007/s00134-004-2350-1; Ueda Y, 2003, J NEUROSURG, V99, P899, DOI 10.3171/jns.2003.99.5.0899; Vespa P, 2002, ACTA NEUROCHIR SUPPL, V81, P355; Wang YJ, 2007, EUR J APPL PHYSIOL, V101, P31, DOI 10.1007/s00421-007-0451-6; Wei G, 2008, J NEUROTRAUM, V25, P888; Wei G, 2008, J NEUROTRAUM, V25, P549, DOI 10.1089/neu.2007.0498; Wei HH, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-19; Williams AJ, 2005, PHARMACOL BIOCHEM BE, V81, P182, DOI 10.1016/j.pbb.2005.03.011; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Zhao CS, 2005, BEHAV BRAIN RES, V158, P211, DOI 10.1016/j.bbr.2004.09.001	61	7	7	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	MAR 1	2011	1	1					33	42		10.1089/ther.2010.0007			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V38PS	WOS:000209355900002	24716886				2022-02-06	
J	Younis, R; Younis, M; Hamidi, S; Musmar, M; Mawson, AR				Younis, Rafif; Younis, Mustafa; Hamidi, Samer; Musmar, Mohamed; Mawson, Anthony R.			Causes of traumatic brain injury in patients admitted to Rafidia, Al-Ittihad and the specialized Arab hospitals, Palestine, 2006-2007	BRAIN INJURY			English	Article						Assault; Palestine; traumatic brain injury (TBI); motor vehicle crash; falls	HEAD-INJURY; EPIDEMIOLOGY	Primary objective: The eruption of Al-Aqsa Intifada created a war situation in Palestine, increasing the number of firearms injuries caused by occupying Israeli forces as well as disabling head injuries. No data were available to the Palestinian Ministry of Health and other health organizations on traumatic brain injury (TBI) in Palestine. This study, therefore, sought to determine the causes and outcomes of TBI in patients who were admitted to three hospitals in Nablus, Palestine. Research design: Retrospective review of medical records and contacts with patients and/or caregivers. Methods and procedures: The medical records of patients who were diagnosed with TBI (n=312) and admitted to any one of the three hospitals in 2006 and 2007 were reviewed. Data were also obtained from follow-up home visits and telephone calls with consenting patients and/or caregivers. Main outcomes and results: The major causes of TBI were assault (33%), falls (32.1%), road traffic crashes (29.8%) and impacts from heavy objects (3.2%). Gunshot wounds are a major cause of head injury in Palestine. Conclusions: The study shows that assault with firearms is the most frequent cause of TBI in this population and that patients with head injuries due to assault have poorer outcomes at discharge than those injured in other ways.	[Mawson, Anthony R.] Univ Mississippi, Med Ctr, Dept Pediat, Div Genet & Epidemiol, Jackson, MS 39216 USA; [Mawson, Anthony R.] Chalfont LLC, Jackson, MS 39211 USA; [Younis, Rafif] Directorate Educ, Sch Hlth Div, Nablus, Israel; [Younis, Mustafa] Jackson State Univ, Jackson, MS USA; [Hamidi, Samer] Hamadan Bin Mohammad E Univ, Sch Hlth & Environm Studies, Dubai, U Arab Emirates; [Musmar, Mohamed] An Najah Univ, Fac Pharm, Nablus, Israel		Mawson, AR (corresponding author), Chalfont LLC, 5359 Briarfield Rd, Jackson, MS 39211 USA.	amawsn@gmail.com		Hamidi, Samer/0000-0002-6766-3728			*AG HLTH CAR POL R, 1999, AHCPR PUBL; Agran PF, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.3.e45; Al-Kashmiri A, 2006, TRAUMA, V8, P189, DOI 10.1177/1460408606071144; ALISSA A, 2003, MIDDLE E J EMERGENCY, V3, P5; ALTUKHI MH, 1998, ANN SAUDI MED J, V8, pA310; *BRAIN RES INF NET, TRAUM BRAIN INJ; Bull MJ, 2001, PEDIATRICS, V107, P1188, DOI 10.1542/peds.107.5.1188; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; Centers for Disease Control and Prevention, LEAD CAUS NONF INJ R; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Faul M, 2010, TRAUMATIC BRAIN INJU; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; JAMOUS L, 1994, THESIS JORDAN U SCI; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Mahajna A, 2002, LANCET, V359, P1795, DOI 10.1016/S0140-6736(02)08708-1; MEZUE WC, 1998, PAN ARAB J NEUROSURG, V2, P49; MOSENTHAL AC, 1995, J TRAUMA, V38, P753, DOI 10.1097/00005373-199505000-00013; Nawaz A, 2005, J PEDIATR SURG, V40, P1248, DOI 10.1016/j.jpedsurg.2005.05.006; *PAL CENTR BUR STA, PAL CHILDR ISS STAT; *PAL CENTR BUR STA, 1997, SUMM FIN RES DEM STA; *PAL MIN HLTH, 2006, STAT CAS PAL 2000 20; PEDRETTI LW, 2001, OCCUPATIONAL THERAPY, P671; Powell EC, 2002, PEDIATRICS, V110, P792, DOI 10.1542/peds.110.4.792; SHAHBAZ M, 2003, MIDDLE E J EMERGENCY, V2, P6; Sikron F, 2004, ISR MED ASSOC J, V6, P332; Stella J, 2001, ANZ J SURG, V71, P665, DOI 10.1046/j.1445-1433.2001.02229.x; WASSERTHEIL-SMOLLER S, 1982, Neuroepidemiology, V1, P154, DOI 10.1159/000110697	30	7	7	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2011	25	3					282	291		10.3109/02699052.2010.546823			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	734UP	WOS:000288365400004	21299371				2022-02-06	
J	Martinez, M; Brezun, JM; Xerri, C				Martinez, Marina; Brezun, Jean-Michel; Xerri, Christian			Sensorimotor Experience Influences Recovery of Forelimb Abilities but Not Tissue Loss after Focal Cortical Compression in Adult Rats	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PRIMARY SOMATOSENSORY CORTEX; ENRICHED ENVIRONMENT; SPINAL-CORD; CEREBRAL-CORTEX; VESTIBULAR COMPENSATION; BEHAVIORAL RECOVERY; CUTANEOUS INPUTS; MOTOR; LOCOMOTION	Sensorimotor activity has been shown to play a key role in functional outcome after extensive brain damage. This study was aimed at assessing the influence of sensorimotor experience through subject-environment interactions on the time course of both lesion and gliosis volumes as well as on the recovery of forelimb sensorimotor abilities following focal cortical injury. The lesion consisted of a cortical compression targeting the forepaw representational area within the primary somatosensory cortex of adult rats. After the cortical lesion, rats were randomly subjected to various postlesion conditions: unilateral C5-C6 dorsal root transection depriving the contralateral cortex from forepaw somatosensory inputs, standard housing or an enriched environment promoting sensorimotor experience and social interactions. Behavioral tests were used to assess forelimb placement during locomotion, forelimb-use asymmetry, and forepaw tactile sensitivity. For each group, the time course of tissue loss was described and the gliosis volume over the first postoperative month was evaluated using an unbiased stereological method. Consistent with previous studies, recovery of behavioral abilities was found to depend on post-injury experience. Indeed, increased sensorimotor activity initiated early in an enriched environment induced a rapid and more complete behavioral recovery compared with standard housing. In contrast, severe deprivation of peripheral sensory inputs led to a delayed and only partial sensorimotor recovery. The dorsal rhizotomy was found to increase the perilesional gliosis in comparison to standard or enriched environments. These findings provide further evidence that early sensory experience has a beneficial influence on the onset and time course of functional recovery after focal brain injury.	[Martinez, Marina; Brezun, Jean-Michel; Xerri, Christian] Univ Provence, CNRS, UMR 6149, IFR 131, Marseilles, France		Martinez, M (corresponding author), Univ Provence, CNRS, UMR 6149, IFR 131, Pole 3 C, Marseilles, France.	christian.xerri@univ-provence.fr		Martinez, Marina/0000-0002-3294-3017	Ministere de l'Enseignement Superieur et de la RechercheEstonian Research CouncilEuropean Commission; CNRSCentre National de la Recherche Scientifique (CNRS)European Commission	This work was supported by grants from Ministere de l'Enseignement Superieur et de la Recherche and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auriat AM, 2006, BRAIN RES, V1109, P183, DOI 10.1016/j.brainres.2006.06.035; Barbay S, 2006, EXP BRAIN RES, V169, P106, DOI 10.1007/s00221-005-0129-4; Bland ST, 2000, STROKE, V31, P1144, DOI 10.1161/01.STR.31.5.1144; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3625, DOI 10.1152/jn.00496.2003; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3640, DOI 10.1152/jn.00497.2003; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; CASTRO AJ, 1977, PHYSIOL BEHAV, V18, P605, DOI 10.1016/0031-9384(77)90059-2; Chen JR, 2004, J NEUROTRAUM, V21, P1640, DOI 10.1089/0897715042441729; Chen JR, 2003, J NEUROTRAUM, V20, P767, DOI 10.1089/089771503767869999; Coq JO, 1999, EXP BRAIN RES, V129, P518, DOI 10.1007/s002210050922; Coyle DE, 1998, GLIA, V23, P75; DOETSCH GS, 1990, EXP NEUROL, V108, P162, DOI 10.1016/0014-4886(90)90024-M; Frigon A, 2006, BIOL CYBERN, V95, P607, DOI 10.1007/s00422-006-0129-x; GOLDBERGER ME, 1974, J COMP NEUROL, V158, P37, DOI 10.1002/cne.901580104; GRABOWSKI M, 1995, EXP NEUROL, V133, P96, DOI 10.1006/exnr.1995.1011; HELGREN ME, 1993, EXP NEUROL, V123, P17, DOI 10.1006/exnr.1993.1137; Hsu JE, 2006, EXP NEUROL, V201, P479, DOI 10.1016/j.expneurol.2006.05.003; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Ibrahim AG, 2009, EXP NEUROL, V215, P142, DOI 10.1016/j.expneurol.2008.09.023; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Jenkins WM, 1987, PROG BRAIN RES <D>, V71, P249; Johansson BB, 1996, EXP NEUROL, V139, P322, DOI 10.1006/exnr.1996.0106; Keiner S, 2008, GLIA, V56, P516, DOI 10.1002/glia.20632; Knieling M, 2009, NEUROSCIENCE, V163, P759, DOI 10.1016/j.neuroscience.2009.07.004; Komitova M, 2006, EXP NEUROL, V199, P113, DOI 10.1016/j.expneurol.2005.12.007; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kundrotiene J, 2002, J NEUROTRAUM, V19, P69, DOI 10.1089/089771502753460259; Lippert-Gruener M, 2007, EXP NEUROL, V203, P82, DOI 10.1016/j.expneurol.2006.07.025; Liu L, 1998, GLIA, V23, P221, DOI 10.1002/(SICI)1098-1136(199807)23:3<221::AID-GLIA5>3.3.CO;2-Z; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Marin R, 2003, PHYSIOL BEHAV, V80, P167, DOI 10.1016/j.physbeh.2003.06.001; Martinez M, 2010, EXP NEUROL, V221, P186, DOI 10.1016/j.expneurol.2009.10.022; Martinez M, 2009, EUR J NEUROSCI, V30, P2356, DOI 10.1111/j.1460-9568.2009.07019.x; Martinez M, 2009, J NEUROTRAUM, V26, P1043, DOI 10.1089/neu.2008.0717; Metz GA, 2005, BEHAV BRAIN RES, V162, P71, DOI 10.1016/j.bbr.2005.03.002; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Napieralski JA, 1998, EXP NEUROL, V154, P80, DOI 10.1006/exnr.1998.6893; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Risedal A, 2002, BRAIN RES BULL, V58, P315, DOI 10.1016/S0361-9230(02)00796-7; ROSE FD, 1987, BEHAV BRAIN RES, V24, P195, DOI 10.1016/0166-4328(87)90057-X; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHALLERT T, 1983, PHARMACOL BIOCHEM BE, V18, P753, DOI 10.1016/0091-3057(83)90019-9; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Soblosky JS, 1997, J NEUROSCI METH, V78, P75, DOI 10.1016/S0165-0270(97)00131-3; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; Vessal M, 2010, J NEUROSCI, V30, P8613, DOI 10.1523/JNEUROSCI.5272-09.2010; Watanabe S, 2001, STROKE, V32, P2615, DOI 10.1161/hs1101.097384; Webb AA, 2003, EUR J NEUROSCI, V18, P412, DOI 10.1046/j.1460-9568.2003.02768.x; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119, DOI 10.1152/jn.1998.79.4.2119; ZennouAzogui Y, 1996, BEHAV BRAIN RES, V74, P65, DOI 10.1016/0166-4328(95)00142-5; ZENNOUAZOGUI Y, 1995, RESTOR NEUROL NEUROS, V7, P235, DOI 10.3233/RNN-1994-7406	56	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16726	10.1371/journal.pone.0016726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	WOS:000287392700022	21359230	Green Submitted, gold, Green Published			2022-02-06	
J	Nelson, C; St Cyr, K; Weiser, M; Gifford, S; Gallimore, J; Morningstar, A				Nelson, Charles; St Cyr, Kate; Weiser, Margaret; Gifford, Shannon; Gallimore, Jane; Morningstar, Andrew			Knowledge Gained From the Brief Traumatic Brain Injury Screen-Implications for Treating Canadian Military Personnel	MILITARY MEDICINE			English	Article							PERFORMANCE; IRAQ; TBI; AFGHANISTAN; SYMPTOMS; VETERANS; SOLDIERS; PATTERNS; ALCOHOL; ABUSE	Objective: To compare physical and mental health outcomes of Canadian military personnel with probable mild traumatic brain injury (mTBI) to outcomes of those without and to report implications for collaboration and treatment. Methods: One hundred forty-seven soldiers attending the Operational Stress Injury Clinic at Parkwood Hospital, London, Ontario, were screened for mTBI and completed several other measures of mental and physical health. Scores from these measures were compared across two groups (positive vs. negative screens for mTBI) using an independent samples t-test. Results: Thirty-four of 147 participants screened positively for mTBI. Soldiers with probable mTBI were more likely to have poorer physical health but were less likely to engage in problem drinking than those who screened negatively for mTBI. Conclusions: In this initial study, we found that the wide range of physical and mental health difficulties experienced by Canadian military personnel with probable mTBI necessitates an interdisciplinary collaborative care model.	[Nelson, Charles; St Cyr, Kate; Gifford, Shannon; Gallimore, Jane] Parkwood Hosp, Operat Stress Injury Clin, London, ON N6C 5J1, Canada; [Weiser, Margaret] Parkwood Hosp, Acquired Brain Injury Program, London, ON N6C 5J1, Canada; [Morningstar, Andrew] Univ Western Ontario, Fac Hlth Sci, Bachelor Hlth Sci Program, London, ON N6A 5B9, Canada		Nelson, C (corresponding author), Parkwood Hosp, Operat Stress Injury Clin, Hobbins Bldg,3rd Floor,Room H3012,801 Commissione, London, ON N6C 5J1, Canada.						Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Babor TF, 2001, AUDIT ALCOHOL USE DI; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; BRADSHAW D, 2007, TRAUMATIC BRAIN INJU; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gosling J, 1999, BRAIN INJURY, V13, P785; Grattan LM, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P266; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoofien D, 2001, BRAIN INJURY, V15, P189; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; *NAT CTR POSTTR ST, PTSD CHECKL PCL CIV; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Richman J, 2006, J OCCUP ENVIRON MED, V48, P303, DOI 10.1097/01.jom.0000183482.41957.c3; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwab KA, 2006, NEUROLOGY, V66, pA235; SOLOMON Z, 1987, J PSYCHOSOM RES, V31, P463, DOI 10.1016/0022-3999(87)90004-3; Tate DG, 2004, ARCH PHYS MED REHAB, V85, P1837, DOI 10.1016/j.apmr.2004.02.022; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thompson JM, 2008, CAN FAM PHYSICIAN, V54, P1549; THOMPSON JM, 2008, PERSISTENT SYMPTOMS, P26; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware Jr JE, SF 36 HLTH SURV UPD; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Yates PJ, 2003, NEUROPSYCHOL REHABIL, V13, P291, DOI 10.1080/09602010244000408	42	7	7	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	FEB	2011	176	2					156	160		10.7205/MILMED-D-10-00252			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825BL	WOS:000295245800010	21366077	Bronze			2022-02-06	
J	Ohta, S; Iwashita, Y; Kakinoki, R; Noguchi, T; Nakamura, T				Ohta, Souichi; Iwashita, Yasushi; Kakinoki, Ryosuke; Noguchi, Takashi; Nakamura, Takashi			Effects of Continuous Intravenous Infusion of MCI-186 on Functional Recovery after Spinal Cord Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						antioxidants; locomotor function; recovery; rat; spinal cord injury	FREE-RADICAL SCAVENGER; LIPID-PEROXIDATION; ENHANCED RECOVERY; METHYLPREDNISOLONE; BRAIN; NEUROPROTECTION; EDARAVONE; PATHOLOGY; ISCHEMIA; YM-14673	We investigated the effects of a free radical scavenger, MCI-186 (edaravone), on neuroprotection in the rat post-traumatic spinal cord using various doses and routes of administration. The injury was produced with a weightdrop device. Lipid peroxide formation in the spinal cord was measured using the thiobarbituric acid test for malonyldialdehyde (MDA). In the first experiment, MDA production in the untreated post-traumatic spinal cord reached peak values at 1 h post-trauma, and gradually decreased to control levels in 7 days. In the second experiment, rats received twice-daily injections (0, 1, 3, 5, 10, or 20 mg/kg) for 3 days. We found that 3 mg/kg was most effective functionally and histologically. In the third experiment, rats received a 3 mg/kg bolus+continuous infusion (0, 1.5, 2.4, or 3.0 mg/kg/h) for 1, 2, 4, and 8 h. We found that a 3 mg/kg bolus+infusion of 3.0 mg/kg/h was most effective for the inhibition of MDA production. In the fourth experiment, a 3 mg/kg bolus given once immediately after injury and twice daily for 3 days, a 3 mg/kg bolus+3.0 mg/kg/h for 1 day, or a 3 mg/kg bolus+3.0 mg/kg/h for 3 days were administered. The continuous infusion for 1 day showed significant improvement functionally and histologically, but continuous infusion at the same rate for another 2 days did not show any further improvement. To effectively reduce secondary neuronal damage, strong inhibition of free radical chain reactions at the early stage, particularly within the first 24 h post-trauma, is important.	[Ohta, Souichi] Kyoto Univ, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan; [Iwashita, Yasushi] Natl Hosp Org Utano Hosp, Dept Orthopaed Surg, Kyoto, Japan		Ohta, S (corresponding author), Kyoto Univ, Dept Orthopaed Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	sota@kuhp.kyoto-u.ac.jp					Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; ANDO K, 1997, JPN PHARM THER S, V25, pS1723; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BEHRMANN DL, 1993, EXP NEUROL, V119, P258, DOI 10.1006/exnr.1993.1028; BEHRMANN DL, 1994, EXP NEUROL, V126, P61, DOI 10.1006/exnr.1994.1042; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; BRAUGHLER JM, 1982, J NEUROSURG, V56, P838, DOI 10.3171/jns.1982.56.6.0838; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; DEMOPOULOS HB, 1982, CAN J PHYSIOL PHARM, V60, P1415, DOI 10.1139/y82-210; FRIED LC, 1971, J NEUROSURG, V35, P709, DOI 10.3171/jns.1971.35.6.0709; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HALL ED, 1992, J NEUROTRAUM, V9, pS165; HALL ED, 1981, EXP NEUROL, V73, P321, DOI 10.1016/0014-4886(81)90067-4; Hall ED, 1995, J NEUROL SCI, V134, P79, DOI 10.1016/0022-510X(95)00211-J; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Kawai H, 1997, J PHARMACOL EXP THER, V281, P921; KOMATSU T, 1996, DRUG METAB PHARMACOK, V11, P463; Kubo K, 2009, BRAIN RES, V1279, P139, DOI 10.1016/j.brainres.2009.04.045; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Mattson MP, 1998, TRENDS NEUROSCI, V21, P53, DOI 10.1016/S0166-2236(97)01188-0; MUROTA SI, 1990, ANN NY ACAD SCI, V598, P182, DOI 10.1111/j.1749-6632.1990.tb42289.x; NISHI H, 1989, STROKE, V20, P1236, DOI 10.1161/01.STR.20.9.1236; Ohta S, 2005, SPINE, V30, P1154, DOI 10.1097/01.brs.0000162402.79482.fd; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Shibata H, 1998, JPN J CLIN PHARM THE, V29, P863; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Takamatsu Y., 1997, JPN PHARM THER S, V25, pS1793; TAKAMATSU Y, 1997, JPN PHARMACOL THER, V25, pS1785; Tanahashi N, 2002, INTERNAL MED, V41, P337, DOI 10.2169/internalmedicine.41.337; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; WATANABE T, 1988, PROSTAG LEUKOTR ESS, V33, P81, DOI 10.1016/0952-3278(88)90127-5; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Yamamoto Y, 1996, REDOX REP, V2, P333, DOI 10.1080/13510002.1996.11747069	35	7	7	0	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	2011	28	2					289	298		10.1089/neu.2010.1477			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	719UE	WOS:000287234700012	21142437				2022-02-06	
J	Perlick, DA; Straits-Troster, K; Dyck, DG; Norell, DM; Strauss, JL; Henderson, C; Close, J; Berger, N; Bonuck, ER; Taber, KH; Kalvin, C; Dolber, T; Cristian, A				Perlick, Deborah A.; Straits-Troester, Kristy; Dyck, Dennis G.; Norell, Diane M.; Strauss, Jennifer L.; Henderson, Claire; Close, Joy; Berger, Noelle; Bonuck, Elizabeth R.; Taber, Katherine H.; Kalvin, Carla; Dolber, Trygve; Cristian, Adrian			Multifamily Group Treatment for Veterans With Traumatic Brain Injury	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article						multifamily group; combat veterans; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; MULTIPLE-FAMILY GROUPS; SERVICE MEMBERS; THERAPY; SCHIZOPHRENIA; IMPACT; CAREGIVERS; IRAQ; CARE	A common clinical problem encountered by clinicians treating veterans who incurred traumatic brain injury (TBI) while serving in Afghanistan in support of Operation Enduring Freedom (OEF) or in Iraq in support of Operation Iraqi Freedom (OIF) is lack of knowledge about TBI on the part of the veterans' family members. Insufficient information can exacerbate marital or family conflict and lead to psychological distress and social isolation for the veteran and family, and suboptimal illness management for the veteran. To address this problem, we adapted Multifamily Group Treatment (MFGT), an evidence-based practice for treatment of serious mental illness (SMI), for treatment of OEF/OIF veterans with TBI and their families. We have implemented the adapted treatment (MFG-TBI) in four groups of veterans and families (N = 20 veterans and 20 family members) across two sites: the Durham VA Medical Center (VAMC) in North Carolina and the JJ Peters VAMC in the Bronx, New York. Adaptations focused on contents and format of the educational components, specification of a protocol for conjugal couples, and the addition of an ecomap to identify support systems during the joining (i.e. assessment) phase, a shorter (9 months) intervention duration, and a more active clinician role including use of motivational enhancement, intersession support, and coordination with other service providers. Biweekly group sessions were supervised and rated for adherence. We illustrate how MFG-TBI both educates and builds problem-solving skills with clinical examples. Suggestions for effective use of problem-solving skills with this population are offered.	[Perlick, Deborah A.; Berger, Noelle; Bonuck, Elizabeth R.; Kalvin, Carla; Dolber, Trygve] Vet Affairs Med Ctr, JJ Peters Dept, Bronx, NY USA; [Perlick, Deborah A.; Kalvin, Carla; Dolber, Trygve] VISN 3 Mental Illness Res Educ & Clin Ctr, Bronx, NY USA; [Straits-Troester, Kristy; Strauss, Jennifer L.; Close, Joy] Dept Vet Affairs Med Ctr, Durham, NC USA; [Straits-Troester, Kristy; Strauss, Jennifer L.; Close, Joy] VISN 6 Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Straits-Troester, Kristy; Strauss, Jennifer L.; Close, Joy] Duke Univ, Durham, NC 27706 USA; [Dyck, Dennis G.; Norell, Diane M.] Washington State Univ, Pullman, WA 99164 USA; [Henderson, Claire] Kings Coll London, Inst Psychiat, London, England; [Taber, Katherine H.] Dept Vet Affairs Med Ctr, Salisbury, NC USA; [Taber, Katherine H.] VISN 6 Mental Illness Res Educ & Clin Ctr, Salisbury, NC USA; [Taber, Katherine H.] Virginia Coll Osteopath Med, Blacksburg, VA USA; [Cristian, Adrian] Dept Vet Affairs Med Ctr, Bronx, NY USA		Perlick, DA (corresponding author), JJ Peters VAMC, Bronx, NY 10468 USA.	deborah.perlick@va.gov	Henderson, Claire/E-4664-2010; Taber, Katherine H/B-8260-2011	Henderson, Claire/0000-0002-6998-5659; Taber, Katherine H/0000-0001-7382-6151			Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Cozza SJ, 2010, J TRAUMA STRESS, V23, P112, DOI 10.1002/jts.20488; Dyck DG, 2000, PSYCHIAT SERV, V51, P513, DOI 10.1176/appi.ps.51.4.513; Dyck DG, 2002, PSYCHIAT SERV, V53, P749, DOI 10.1176/appi.ps.53.6.749; Eaton KM, 2008, MIL MED, V173, P1051, DOI 10.7205/MILMED.173.11.1051; Erbes CR, 2008, J CLIN PSYCHOL, V64, P972, DOI 10.1002/jclp.20521; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Glynn SM, 1999, J CONSULT CLIN PSYCH, V67, P243, DOI 10.1037/0022-006X.67.2.243; HARTMAN A, 1978, SOC CASEWORK-JCSW, V59, P465, DOI 10.1177/104438947805900803; Hazel NA, 2004, PSYCHIAT SERV, V55, P35, DOI 10.1176/appi.ps.55.1.35; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jacobson N. S., 1996, INTEGRATIVE COUPLE T; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 2010, J HEAD TRAUMA REHABI; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; McDonell MG, 2003, FAM PROCESS, V42, P91, DOI 10.1111/j.1545-5300.2003.00091.x; McFarlane W.R., 2002, MULTIFAMILY GROUPS T; Miller W.R., 2002, MOTIVATIONAL INTERVI; Monson CM, 2008, J CLIN PSYCHOL, V64, P958, DOI 10.1002/jclp.20511; Mueser K. T., 1999, BEHAV FAMILY THERAPY; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Perlick DA, 2001, PSYCHIAT SERV, V52, P1613, DOI 10.1176/appi.ps.52.12.1613; Rodgers ML, 2007, AM J PHYS MED REHAB, V86, P482, DOI 10.1097/PHM.0b013e31805c00a1; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; Sherman MD, 2005, PROF PSYCHOL-RES PR, V36, P626, DOI 10.1037/0735-7028.36.6.626; Sherman MD, 2008, PROF PSYCHOL-RES PR, V39, P443, DOI 10.1037/0735-7028.39.4.443; Sherman MD, 2009, PROF PSYCHOL-RES PR, V40, P593, DOI 10.1037/a0016333; STRAITSTROSTER K, J SOCIAL IS IN PRESS; US Department of Health and Human Services, 1999, MENT HLTH REP SURG G	31	7	7	0	14	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028	1939-1323		PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	FEB	2011	42	1			SI		70	78		10.1037/a0022319			9	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	733TE	WOS:000288285100010					2022-02-06	
J	Thompson, HJ; Kagan, SH				Thompson, Hilaire J.; Kagan, Sarah H.			Clinical management of fever by nurses: doing what works	JOURNAL OF ADVANCED NURSING			English	Article						acute care; adult patients; case study; elevated temperature; evidence-based fever management; fever; nursing	TRAUMATIC BRAIN-INJURY; INFECTIOUS-DISEASES SOCIETY; INTENSIVE-CARE-UNIT; LENGTH-OF-STAY; 2008 UPDATE; HYPERTHERMIA; GUIDELINES; KNOWLEDGE; STROKE; COMPLICATIONS	P>Aims. The specific aims were to (1) define fever from the nurse's perspective; (2) describe fever management decision-making by nurses and (3) describe barriers to evidence-based practice across various settings. Background. Publication of practice guidelines, which address fever management, has not yielded improvements in nursing care. This may be related to differences in ways nurses define and approach fever. Method. The collective case study approach was used to guide the process of data collection and analysis. Data were collected during 2006-7. Transcripts were coded using the constant comparative method until themes were identified. Cross-case comparison was conducted. The nursing process was used as an analytical filter for refinement and presentation of the findings. Findings. Nurses across settings defined fever as a (single) elevated temperature that exceeded some established protocol. Regardless of practice setting, interventions chosen by nurses were frequently based on trial and error or individual conventions -'what works'- rather than evidence-based practice. Some nurses' accounts indicated use of interventions that were clearly contraindicated by the literature. Participants working on dedicated neuroscience units articulated specific differences in patient care more than those working on mixed units. Conclusions. By defining a set temperature for intervention, protocols may serve as a barrier to critical clinical judgment. We recommend that protocols be developed in an interdisciplinary manner to foster local adaptation of best practices. This could further best practice by encouraging individual nurses to think of protocols not as a recipe, but rather as a guide when individualizing patient care. There is value of specialty knowledge in narrowing the translational gap, offering institutions evidence for planning and structuring the organization of care.	[Thompson, Hilaire J.] Univ Washington, Seattle, WA 98195 USA; [Kagan, Sarah H.] Univ Penn, Philadelphia, PA 19104 USA		Thompson, HJ (corresponding author), Univ Washington, Seattle, WA 98195 USA.	hilairet@uw.edu			Integra Foundation/Neuroscience Nurses Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32NR007106, 1KL2RR025015]; John A. Hartford Foundation [06-202]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007106] Funding Source: NIH RePORTER	This work was supported in part by grants from the Integra Foundation/Neuroscience Nurses Foundation, the National Institutes of Health (T32NR007106; 1KL2RR025015) and the John A. Hartford Foundation Building Geriatric Academic Nursing Capacity Program (06-202).	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; ALEXANDER SE, 2007, CARE PATIENT ANEURYS; Axelrod P, 2000, CLIN INFECT DIS, V31, pS224, DOI 10.1086/317516; Bruderlein U, 2006, Anasthesiol Intensivmed Notfallmed Schmerzther, V41, pE8, DOI 10.1055/s-2006-925295; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cairns Chris J S, 2002, Curr Opin Crit Care, V8, P106, DOI 10.1097/00075198-200204000-00003; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Cooper KE, 2002, J APPL PHYSIOL, V92, P1717, DOI 10.1152/japplphysiol.01051.2001; COOPER KE, 1995, FEVER ANTIPYRESIS RO; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Edwards H E, 2001, Nurs Health Sci, V3, P119, DOI 10.1046/j.1442-2018.2001.00083.x; Edwards H, 2007, J ADV NURS, V57, P257, DOI 10.1111/j.1365-2648.2006.04077.x; Emmoth U, 1997, Vard Nord Utveckl Forsk, V17, P4; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Grossman D, 1995, Medsurg Nurs, V4, P193; GUBA EG, 1981, ECTJ-EDUC COMMUN TEC, V29, P75; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; High KP, 2009, J AM GERIATR SOC, V57, P375, DOI [10.1086/595683, 10.1111/j.1532-5415.2009.02175.x]; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Johnston NJ, 2006, RESUSCITATION, V70, P254, DOI 10.1016/j.resuscitation.2006.02.010; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kirkness CJ, 2008, NEUROCRIT CARE, V8, P380, DOI 10.1007/s12028-007-9034-y; Laupland KB, 2009, CRIT CARE MED, V37, pS273, DOI 10.1097/CCM.0b013e3181aa6117; Lee AJ, 1997, HEALTH SERV RES, V32, P197; Mcilvoy Laura, 2007, J Neurosci Nurs, V39, P324; Miles M.B., 1994, QUALITATIVE DATA ANA, P245; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; O'Grady NP, 2008, CRIT CARE MED, V36, P1330, DOI 10.1097/CCM.0b013e318169eda9; Oeyen S, 2007, CRIT CARE MED, V35, P2219, DOI 10.1097/01.CCM.0000281461.96109.4B; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Reaven Nancy L, 2009, J Intensive Care Med, V24, P131, DOI 10.1177/0885066608330211; Rosenberg JP, 2007, J ADV NURS, V60, P447, DOI 10.1111/j.1365-2648.2007.04385.x; Schulman Carl I, 2005, Surg Infect (Larchmt), V6, P369; Segatore M, 1992, J Neurosci Nurs, V24, P104; Sinuff T, 2007, CRIT CARE MED, V35, P2083, DOI 10.1097/01.ccm.0000281446.15342.74; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Thompson Hilaire J, 2007, Intensive Crit Care Nurs, V23, P91, DOI 10.1016/j.iccn.2006.11.005; Thompson Hilaire J, 2007, J Neurosci Nurs, V39, P196; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Walsh AM, 2005, J ADV NURS, V49, P453, DOI 10.1111/j.1365-2648.2004.03318.x; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; World Health Organization, 2008, The global burden of disease: 2004 update; Yin RK., 2014, CASE STUDY RES DESIG, V5	45	7	8	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-2402	1365-2648		J ADV NURS	J. Adv. Nurs.	FEB	2011	67	2					359	370		10.1111/j.1365-2648.2010.05506.x			12	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	706IK	WOS:000286211400013	21044137	Green Accepted			2022-02-06	
J	Aguerrevere, LE; Greve, KW; Bianchini, KJ; Ord, JS				Aguerrevere, Luis E.; Greve, Kevin W.; Bianchini, Kevin J.; Ord, Jonathan S.			Classification accuracy of the Millon Clinical Multiaxial Inventory-III modifier indices in the detection of malingering in traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Millon Clinical Multiaxial Inventory; Malingering; Assessment; Validity	MMPI-2 VALIDITY SCALES; FAKE-BAD SCALE; NEUROCOGNITIVE DYSFUNCTION; MCMI-II; PERSONALITY-DISORDER; HEAD-INJURY; PSYCHOPATHOLOGY; INDIVIDUALS; BIAS	The present study used criterion groups validation to determine the ability of the Millon Clinical Multiaxial Inventory-III (MCMI-III) modifier indices to detect malingering in traumatic brain injury (TBI). Patients with TBI who met criteria for malingered neurocognitive dysfunction (MND) were compared to those who showed no indications of malingering. Data were collected from 108 TBI patients referred for neuropsychological evaluation. Base rate (BR) scores were used for MCMI-III modifier indices: Disclosure, Desirability, and Debasement. Malingering classification was based on the Slick, Sherman, and Iverson (1999) criteria for MND. TBI patients were placed in one of three groups: MND (n = 55), not-MND (n = 26), or Indeterminate (n = 26).The not-MND group had lower modifier index scores than the MND group. At scores associated with a 4% false-positive (FP) error rate, sensitivity was 47% for Disclosure, 51% for Desirability, and 55% for Debasement. Examination of joint classification analysis demonstrated 54% sensitivity at cutoffs associated with 0% FP error rate. Results suggested that scores from all MCMI-III modifier indices are useful for identifying intentional symptom exaggeration in TBI. Debasement was the most sensitive of the three indices. Clinical implications are discussed.	[Aguerrevere, Luis E.; Greve, Kevin W.; Bianchini, Kevin J.; Ord, Jonathan S.] Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; [Aguerrevere, Luis E.; Greve, Kevin W.; Bianchini, Kevin J.; Ord, Jonathan S.] Jefferson Neurobehav Grp, Metairie, LA USA		Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu	Aguerrevere, Luis/P-5684-2019	Aguerrevere, Luis/0000-0001-9160-1044			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bagby R. M., 1991, J COUNSELING CLIN PS, V3, P496; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; BINDER LM, 1993, PORTLAND DIGIT RECOG; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Daubert SD, 2000, PSYCHOL ASSESSMENT, V12, P418, DOI 10.1037/1040-3590.12.4.418; Etherton Joseph L, 2006, Spine J, V6, P61, DOI 10.1016/j.spinee.2005.05.382; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Gouvier WD, 1998, CRIT ISS NE, P55; Green P, 1996, MANUAL COMPUTERIZED; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; GROSSMAN LS, 1995, J PERS ASSESS, V64, P384, DOI 10.1207/s15327752jpa6402_17; Heilbronner RL, 1997, CLIN NEUROPSYCHOL, V11, P445, DOI 10.1080/13854049708400477; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; Larrabee G.J., 2007, ASSESSMENT MALINGERE; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; Lemeshow S, 2000, APPL LOGISTIC REGRES; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Millis S. R., 2004, PRINCIPLES PRACTICE, P1077; MILLON T, 1994, MILLON CLIN MULTIAXI, V3; MILLON T, 1997, MILLON CLIN MULTIAXI, V3; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; RETZLAFF P, 1991, J PERS ASSESS, V56, P466, DOI 10.1207/s15327752jpa5603_8; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Ruocco AC, 2008, CLIN NEUROPSYCHOL, V22, P547, DOI 10.1080/13854040701336444; Ruocco AC, 2007, J NEUROPSYCH CLIN N, V19, P27, DOI 10.1176/appi.neuropsych.19.1.27; Schoenberg MR, 2004, J PERS ASSESS, V82, P273, DOI 10.1207/s15327752jpa8203_03; Schoenberg MR, 2003, PSYCHOL ASSESSMENT, V15, P198, DOI 10.1037/1040-3590.15.2.198; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	42	7	7	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	5					497	504	PII 935216472	10.1080/13803395.2010.535503			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	773AQ	WOS:000291279800001	21424973				2022-02-06	
J	Murphy, CFB; Fillippini, R; Palma, D; Zalcman, TE; Lima, JP; Schochat, E				Borges Murphy, Cristina Ferraz; Fillippini, Renata; Palma, Debora; Zalcman, Tatiane Eisencraft; Lima, Janaina Patricio; Schochat, Eliane			Auditory training and cognitive functioning in adult with traumatic brain injury	CLINICS			English	Article									[Borges Murphy, Cristina Ferraz; Fillippini, Renata; Palma, Debora; Zalcman, Tatiane Eisencraft; Lima, Janaina Patricio; Schochat, Eliane] Univ Sao Paulo, Fonoaudiol & Terapia Ocupac Fac Med, Dept Fisioterapia, Sao Paulo, Brazil		Murphy, CFB (corresponding author), Univ Sao Paulo, Fonoaudiol & Terapia Ocupac Fac Med, Dept Fisioterapia, Sao Paulo, Brazil.	crist78@yahoo.com	Schochat, Eliane/B-5460-2014; Murphy, Cristina F/C-4104-2012; Filippini, Renata/F-5875-2012	Schochat, Eliane/0000-0002-1775-7603; Filippini, Renata/0000-0002-3306-6941; Murphy, Cristina/0000-0002-2732-2283			Alonso Renata, 2009, Braz. j. otorhinolaryngol., V75, P726; Chermak Gail D., 2002, Seminars in Hearing, V23, P297, DOI 10.1055/s-2002-35878; FRASCA MFS, 2005, THESIS U SAO PAULO; JERGER S, 1982, CENTRAL AUDITORY LAN, V30; Keith R W, 1995, J Am Acad Audiol, V6, P286; Musiek Frank E., 1998, Seminars in Hearing, V19, P357, DOI 10.1055/s-0028-1082983; Musiek Frank E, 2004, J Am Acad Audiol, V15, P117, DOI 10.3766/jaaa.15.2.3; Vitiello APP, 2007, ARQ NEURO-PSIQUIAT, V65, P299, DOI 10.1590/S0004-282X2007000200021; Wright BA, 2007, EXP BRAIN RES, V180, P727, DOI 10.1007/s00221-007-0898-z; ZALCMAN TE, 2008, REV SOC BRAS FONOAUD, V12, P310	10	7	11	0	3	HOSPITAL CLINICAS, UNIV SAO PAULO	SAO PAULO	FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL	1807-5932			CLINICS	Clinics		2011	66	4					713	715		10.1590/S1807-59322011000400030			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MT	WOS:000291312100030	21655770	Green Submitted, Green Published, gold			2022-02-06	
J	Chermak, GD; Musiek, FE				Chermak, Gail D.; Musiek, Frank E.			Neurological Substrate of Central Auditory Processing Deficits in Children	CURRENT PEDIATRIC REVIEWS			English	Article						Central auditory nervous system; central auditory processing deficits; central auditory processing disorder; children; neuroaudiology; neurological	EVENT-RELATED POTENTIALS; LANDAU-KLEFFNER-SYNDROME; TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; EVOKED-POTENTIALS; INTERHEMISPHERIC-TRANSFER; CORPUS-CALLOSUM; DEVELOPMENTAL DYSLEXIA; FOLLOW-UP; DYSFUNCTION	Central auditory processing deficits and central auditory processing disorder (CAPD) has been linked to a number of different etiological bases. Reports document CAPD in children stemming from neurological abnormalities, including seizure disorders, neoplasms, degenerative processes, traumatic brain injury, cerebrovascular accidents, metabolic disorders, and genetic disorders across a variety of sites of lesion at all levels of the central auditory nervous system (CANS). Also documented is the efficiency of central auditory behavioral tests and electrophysiological procedures in evaluating pediatric patients with known or suspected neurological involvement. All regions of the CANS can be assessed using auditory evoked potentials, electoacoustic procedures, and central auditory behavioral tests after a careful assessment of the peripheral auditory system. Multidisciplinary evaluation is crucial to both diagnosis and intervention given the potential for multiple system involvement, complex clinical profiles, and frequent co-morbidities in children with neurological problems. The patterns of performance deficits seen in children with documented CANS lesions are comparable to those patterns seen in adult patients with documented CANS lesions. Moreover, central auditory test battery deficit patterns seen in children with auditory-related complaints but with no identifiable lesions of the CANS mirror those patterns seen in pediatric and adult populations with circumscribed disorders of the CANS, and these deficit patterns correlate with neuroimaging results. These common patterns indicate that lesion studies of adult (or pediatric) patients can serve to approximate a 'gold standard' for CAPD in children with no identifiable CANS lesion. Whether the source of CANS dysfunction is benign or the result of neurological lesion or compromise, the underlying source of the resulting CAPD is neurobiological, originating in the central nervous system.	[Chermak, Gail D.] Washington State Univ, Dept Speech & Hearing Sci, Pullman, WA 99164 USA; [Musiek, Frank E.] Univ Connecticut, Dept Commun Sci, Storrs, CT USA		Chermak, GD (corresponding author), Washington State Univ, Dept Speech & Hearing Sci, Pullman, WA 99164 USA.	Chermak@wsu.edu					Addis L, 2002, GENES BRAIN BEH, V9, P545; American Academy of Audiology, 2010, GUID DIAGN TREATM MA; American Speech-Language-Hearing Association, 2005, CENTR AUD PROC DIS; [Anonymous], 1997, CHILD NEUROPSYCHOL, V1, P47; Bamiou DE, 2006, NEUROLOGY, V67, P614, DOI 10.1212/01.wnl.0000230197.40410.db; Bamiou DE, 2004, ANN NEUROL, V56, P503, DOI 10.1002/ana.20227; Bamiou DE, 2001, ARCH DIS CHILD, V85, P361, DOI 10.1136/adc.85.5.361; Bamiou DE, 2007, ARCH PEDIAT ADOL MED, V161, P463, DOI 10.1001/archpedi.161.5.463; Banai K, 2007, INT J AUDIOL, V46, P524, DOI 10.1080/14992020701383035; Baran J, 1999, CONT PERSPECTIVES HE, P375; Baran J., 1984, SEMIN HEAR, V5, P231, DOI [10.1055/s-0028-1095748, DOI 10.1055/S-0028-1095748]; Bellis TJ, 2001, J SPEECH LANG HEAR R, V44, P246, DOI 10.1044/1092-4388(2001/021); Benavidez DA, 1999, CORTEX, V35, P315, DOI 10.1016/S0010-9452(08)70803-7; Bishop D, 2009, ANN NY ACAD SCI, V1156, P1, DOI 10.1111/j.1749-6632.2009.04419.x; BLAETTNER U, 1989, BRAIN, V112, P177, DOI 10.1093/brain/112.1.177; BLANCAFORT JB, 1995, CHILD NERV SYST, V11, P400, DOI 10.1007/BF00717405; Boatman DF, 2008, EPILEPSIA, V49, P1018, DOI 10.1111/j.1528-1167.2007.01519.x; BOCCA E, 1954, ACTA OTO-LARYNGOL, V44, P219, DOI 10.3109/00016485409128700; Boscariol M, 2010, BRAIN DEV-JPN, V32, P299, DOI 10.1016/j.braindev.2009.04.002; Boscariol M, 2009, ARQ NEURO-PSIQUIAT, V67, P499, DOI 10.1590/S0004-282X2009000300023; Bouma PAD, 1997, NEUROLOGY, V48, P430, DOI 10.1212/WNL.48.2.430; Brizzolara D, 2002, NEUROPSYCHOLOGIA, V40, P620, DOI 10.1016/S0028-3932(01)00158-0; Bulgheroni S, 2004, NEUROPSYCHOLOGY, V18, P748, DOI 10.1037/0894-4105.18.4.748; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Champoux F, 2007, EUR J NEUROSCI, V25, P291, DOI 10.1111/j.1460-9568.2006.05260.x; Chermak G, 2008, HEAR J, V61, P36; CHERMAK GD, 2007, HDB CENTRAL AUDITORY, V2, P3; Chermak GD, 2007, HDB CENTRAL AUDITORY, V2; Chermak GD, 2009, ASHA LEAD, V14, P16, DOI [DOI 10.1044/LEADER.FTR3.14152009.16, 10.1044/leader.FTR3.14152009.16]; CHIAPPA KH, 1982, NEW ENGL J MED, V306, P1140, DOI 10.1056/NEJM198205133061904; DAVIS SL, 1985, ARCH NEUROL-CHICAGO, V42, P156, DOI 10.1001/archneur.1985.04060020070019; Flood GM, 2005, BRAIN INJURY, V19, P1019, DOI 10.1080/02699050500110223; Galaburda A M, 1978, Trans Am Neurol Assoc, V103, P262; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Giedd JN, 1996, DEV BRAIN RES, V91, P274; GOLDIE WD, 1987, J CHILD NEUROL, V2, P272, DOI 10.1177/088307388700200407; Grindle CR, 2010, LARYNGOSCOPE, V120, P1671, DOI 10.1002/lary.20986; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; HALL JW, 1983, OTOLARYNG HEAD NECK, V91, P50, DOI 10.1177/019459988309100110; Hattiangadi N, 2005, BRAIN LANG, V92, P12, DOI 10.1016/j.bandl.2004.05.003; Heinslus T, 1998, NEUROLOGY, V50, P341; Holmes Gregory L., 1993, Current Opinion in Pediatrics, V5, P653, DOI 10.1097/00008480-199312000-00003; HUGDAHL K, 1994, J CLIN EXP NEUROPSYC, V16, P84, DOI 10.1080/01688639408402619; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Isaacs E, 1996, NEUROPSYCHOLOGIA, V34, P127, DOI 10.1016/0028-3932(95)00089-5; JERGER J, 1974, ARCH OTOLARYNGOL, V99, P351; Jerger James, 2002, J Am Acad Audiol, V13, P438; JERGER S, 1988, AM J OTOL, V9, P63; JERGER S, 1989, EAR HEARING, V10, P167, DOI 10.1097/00003446-198906000-00005; KALMANCHEY R, 1991, Acta Paediatrica Hungarica, V31, P83; Kalmanchey Rozalia, 1997, Indian Journal of Pediatrics, V64, P639, DOI 10.1007/BF02726117; Kolb B., 2008, FUNDAMENTALS HUMAN N; Kovas Y, 2006, TRENDS COGN SCI, V10, P198, DOI 10.1016/j.tics.2006.03.001; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lessard N, 2002, BRAIN, V125, P1039, DOI 10.1093/brain/awf096; MENDELSOHN DB, 1992, NEURORADIOLOGY, V34, P384, DOI 10.1007/BF00596495; Metz- Lutz MN, 2013, DICHOTIC LISTENING P; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P79, DOI 10.1016/S0887-6177(00)00105-0; Moller A. R, 2000, HEARING ITS PHYSL PA; Moncrieff Deborah, 2004, J Am Acad Audiol, V15, P518, DOI 10.3766/jaaa.15.7.6; Morell RJ, 2007, HUM GENET, V122, P103, DOI 10.1007/s00439-007-0384-5; Moser A. B., 2001, METABOLIC MOL BASES; Musiek F, 2007, AUDITORY EVOKED POTE, P291; Musiek F E, 1992, J Am Acad Audiol, V3, P5; Musiek F.E., 2007, AUDITORY SYSTEM ANAT; Musiek F E, 1994, NEUROAUDIOLOGY CASE; MUSIEK FE, 1990, AUDIOLOGY, V29, P304; MUSIEK FE, 1980, ARCH OTOLARYNGOL, V106, P610; Musiek FE, 1999, CONT PERSPECTIVES HE, P243; Musiek FE, 1985, COMMUN DISORD Q, V9, P43, DOI DOI 10.1177/152574018500900105; MUSIEK FE, 1984, SEMIN HEAR, V5, P219; MUSIEK FE, 2007, HDB CENTRAL AUDITORY, V1; Musiek Frank E, 2005, Am J Audiol, V14, P128, DOI 10.1044/1059-0889(2005/014); NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Pandya DN., 1986, 2 HEMISPHERES ONE BR, P47; PAPANICOLAOU AC, 1990, ARCH NEUROL-CHICAGO, V47, P562, DOI 10.1001/archneur.1990.00530050086016; PAQUIER PF, 1992, ARCH NEUROL-CHICAGO, V49, P354, DOI 10.1001/archneur.1992.00530280034019; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Plaza M, 2001, BRAIN COGNITION, V46, P235, DOI 10.1016/S0278-2626(01)80074-9; Price C, 2005, TRENDS COGN SCI, V9, P271, DOI 10.1016/j.tics.2005.03.009; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; ROTTEVEEL JJ, 1985, CHILD NERV SYST, V1, P172, DOI 10.1007/BF00735734; SCHERG M, 1986, ELECTROEN CLIN NEURO, V65, P344, DOI 10.1016/0168-5597(86)90014-6; Scott SK, 2004, J ACOUST SOC AM, V115, P813, DOI 10.1121/1.1639336; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; Staden U, 1998, NEUROPEDIATRICS, V29, P242, DOI 10.1055/s-2007-973569; Turkdogan D, 2003, BRAIN DEV-JPN, V25, P396, DOI 10.1016/S0387-7604(03)00016-0; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Willcutt EG, 2007, AM J MED GENET B, V144B, P709, DOI 10.1002/ajmg.b.30310; Wioland N, 2001, CLIN NEUROPHYSIOL, V112, P319, DOI 10.1016/S1388-2457(00)00528-9; Yakovlev PI, 1967, REGIONAL DEV BRAIN E, P3	93	7	7	0	0	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1573-3963	1875-6336		CURR PEDIATR REV	Curr. Pediatr. Rev.		2011	7	3					241	251		10.2174/157339611796548393			11	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VC6NF	WOS:000434514800012					2022-02-06	
J	Cummings, L				Cummings, Louise			Pragmatic disorders and their social impact	PRAGMATICS AND SOCIETY			English	Article						autistic spectrum disorder (ASD); mental illness; occupational functioning; pragmatic disorder; right-hemisphere damage (RHD); schizophrenia; social adjustment; traumatic brain injury; Gricean maxims	TRAUMATIC BRAIN-INJURY; AUTISM SPECTRUM DISORDERS; RIGHT-HEMISPHERE; CHRONIC-SCHIZOPHRENIA; LANGUAGE IMPAIRMENT; FUNCTIONAL OUTCOMES; ASPERGER-SYNDROME; COMMUNICATION; CHILDREN; ADOLESCENTS	Pragmatic disorders in children and adults have been the focus of clinical investigations for approximately 40 years. In that time, clinicians and researchers have established a diverse range of pragmatic phenomena that are disrupted in these disorders. Pragmatic deficits include problems with the use and understanding of speech acts, the processing of non-literal language, failure to adhere to Gricean maxims in conversation and discourse deficits. These deficits are found in several clinical populations including individuals with autistic spectrum disorders, schizophrenia, traumatic brain injury and right-hemisphere damage. However, what is less often investigated is the social impact of pragmatic disorders on the children and adults who are affected by them. In this paper, I examine what is known about pragmatic disorders in these clinical groups. I then consider the wider social consequences of these disorders, where consequences are broadly construed to include factors that act as indicators of social adjustment.	[Cummings, Louise] Nottingham Trent Univ, Nottingham NG11 8NS, England		Cummings, L (corresponding author), Nottingham Trent Univ, Sch Arts & Humanities, Clifton Campus,Clifton Lane, Nottingham NG11 8NS, England.	louise.cummings@ntu.ac.uk		Cummings, Louise/0000-0002-8947-8195			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bauminger N, 2000, CHILD DEV, V71, P447, DOI 10.1111/1467-8624.00156; Bazin N, 2000, SCHIZOPHR RES, V45, P93, DOI 10.1016/S0920-9964(99)00167-X; Blake ML, 2006, AM J SPEECH-LANG PAT, V15, P255, DOI 10.1044/1058-0360(2006/024); Bora E, 2006, PSYCHIAT RES, V145, P95, DOI 10.1016/j.psychres.2005.11.003; Bowie CR, 2008, SCHIZOPHR RES, V103, P240, DOI 10.1016/j.schres.2008.05.006; BRUNDAGE S, 1996, CLIN APHASIOLOGY, V24, P215; BRYAN KL, 1988, BRIT J DISORD COMMUN, V23, P111; Capps I, 2000, J ABNORM CHILD PSYCH, V28, P193; Cheang HS, 2006, CLIN LINGUIST PHONET, V20, P447, DOI 10.1080/02699200500135684; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; CUMMINGS L, 2005, PRAGMATICS MULTIDISC; Cummings L., 2009, CLIN PRAGMATICS; Cummings L, 2007, LANG COMMUN, V27, P396, DOI 10.1016/j.langcom.2007.06.001; Cummings Louise, 2007, SEMINARS SPEECH LANG, V28, P98; Cummings Louise, 2008, CLIN LINGUISTICS; Cummings Louise, 2011, HDB PRAGMAT IN PRESS; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; Dickinson D, 2007, SCHIZOPHRENIA BULL, V33, P1213, DOI 10.1093/schbul/sbl067; Diehl JJ, 2006, J ABNORM CHILD PSYCH, V34, P87, DOI 10.1007/s10802-005-9003-x; Docherty NM, 2003, J ABNORM PSYCHOL, V112, P469, DOI 10.1037/0021-843X.112.3.469; Emerich DM, 2003, J AUTISM DEV DISORD, V33, P253, DOI 10.1023/A:1024498232284; Esbensen AJ, 2010, AJIDD-AM J INTELLECT, V115, P277, DOI 10.1352/1944-7558-115.4.277; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Frith R C, 1996, Cogn Neuropsychiatry, V1, P305, DOI 10.1080/135468096396460; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GILLBERG C, 1989, DEV MED CHILD NEUROL, V31, P520; GORWOOD P, 1995, AM J PSYCHIAT, V152, P208; Hale CM, 2005, AUTISM, V9, P157, DOI 10.1177/1362361305051395; Hedley D, 2006, AUTISM, V10, P139, DOI 10.1177/1362361306062020; Heerey EA, 2005, J ABNORM CHILD PSYCH, V33, P55, DOI 10.1007/s10802-005-0934-z; Hird K, 2003, CLIN LINGUIST PHONET, V17, P309, DOI 10.1080/0269920031000080037; Hofvander B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-35; Humphrey N, 2008, AUTISM, V12, P23, DOI 10.1177/1362361307085267; Klonoff PS, 1990, NEUROPSYCHOLOGY, V4, P147, DOI 10.1037/0894-4105.4.3.147; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Lippert-Gruner M, 2002, J REHABIL MED, V34, P211, DOI 10.1080/165019702760279198; MacLennan D. L., 2002, PREMIER OUTLOOK, V3, P38; Marini A, 2005, BRAIN LANG, V93, P46, DOI 10.1016/j.bandl.2004.08.002; Martin I, 2004, J AUTISM DEV DISORD, V34, P311, DOI 10.1023/B:JADD.0000029553.52889.15; McDonald, 2000, METAPHOR SYMBOL, V15, P85, DOI DOI 10.1080/10926488.2000.9678866; McDonald S, 2000, BRAIN LANG, V75, P82, DOI 10.1006/brln.2000.2342; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S., 1992, BRAIN INJURY, V6, P293; McGrath JJ, 2006, SCHIZOPHRENIA BULL, V32, P195, DOI 10.1093/schbul/sbi052; Meilijson SR, 2004, J SPEECH LANG HEAR R, V47, P695, DOI 10.1044/1092-4388(2004/053); Mitchell RLC, 2005, BRAIN, V128, P963, DOI 10.1093/brain/awh466; Myers Penelope S., 1979, CLIN APHASIOLOGY C P, P38; O'Brien G, 2004, AUTISM, V8, P125, DOI 10.1177/1362361304042718; Papagno C, 2006, NEUROPSYCHOLOGY, V20, P598, DOI 10.1037/0894-4105.20.5.598; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Skuse DH, 2000, PEDIATR RES, V47, P9, DOI 10.1203/00006450-200001000-00006; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Surian L, 1996, Cogn Neuropsychiatry, V1, P55, DOI 10.1080/135468096396703; Tenyi T, 2002, PSYCHOPATHOLOGY, V35, P25, DOI 10.1159/000056212; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Tompkins Connie A., 1998, Seminars in Speech and Language, V19, P303, DOI 10.1055/s-2008-1064052; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; van Roekel E, 2010, J AUTISM DEV DISORD, V40, P63, DOI 10.1007/s10803-009-0832-2; Volden J, 2004, INT J LANG COMM DIS, V39, P171, DOI 10.1080/13682820410001663252; Whitehouse AJO, 2009, INT J LANG COMM DIS, V44, P511, DOI 10.1080/13682820802708098; Ziatas K, 2003, DEV PSYCHOPATHOL, V15, P73, DOI 10.1017/S0954579403000051; [No title captured]	66	7	7	1	18	JOHN BENJAMINS PUBLISHING CO	AMSTERDAM	PO BOX 36224, 1020 ME AMSTERDAM, NETHERLANDS	1878-9714	1878-9722		PRAGMAT SOC	Pragmat. Soc.		2011	2	1					17	36		10.1075/ps.2.1.02cum			20	Linguistics; Language & Linguistics	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Linguistics	V29XW	WOS:000208782100002		Green Submitted			2022-02-06	
S	Evrard, SG; Brusco, A		Nixon, RA; Yuan, A		Evrard, Sergio G.; Brusco, Alicia			Ethanol Effects on the Cytoskeleton of Nerve Tissue Cells	CYTOSKELETON OF THE NERVOUS SYSTEM	Advances in Neurobiology		English	Article; Book Chapter						Alcohol; Alcoholism; Alcohol-related neurodevelopmental disorders; Cytoskeleton; Dark neuron; Ethanol; Fetal alcohol spectrum disorders; Fetal alcohol syndrome; Glial fibrillary acidic protein; Intermediate filaments; MAP-2	ACIDIC PROTEIN-IMMUNOREACTIVITY; MICROTUBULE-ASSOCIATED PROTEINS; ALCOHOL-INDUCED ALTERATIONS; GEL PHASE-TRANSITION; DARK NEURONS; RAT-BRAIN; OXIDATIVE STRESS; GENE-EXPRESSION; TAU-PROTEIN; HIPPOCAMPAL NEUROGENESIS	Ethanol (EtOH) is the most ancient drug and one of those most used and abused by human beings. Although its effects are better known and are best studied on the cytoskeleton of hepatocytes (due to the EtOH role in the etiology of liver cirrhosis), its effects on nerve tissue cells' cytoskeleton are beginning to be elucidated. We review in this chapter the known mechanisms by which EtOH affects microtubules, intermediate filaments, and microfilaments. EtOH disrupts the cytoskeleton in many different and still incompletely known ways (spontaneous chemical reactions with derivatives of EtOH metabolism, changes in the expression level of cytoskeletal proteins, functional modification of proteins with regulatory actions on cytoskeleton assembly or disassembly, etc.). EtOH's deleterious effects, by acting on neuronal and glial cytoskeleton during embryonic and/or fetal development, are a critical factor in the induction of alcohol-related neurodevelopmental disorders (ARND) and fetal alcohol syndrome (FAS). Its cytoskeletal actions during adulthood are also critical in the induction of different neuropsychiatric disorders (such as alcoholic dementia). However, existing evidence points to the fact that EtOH disruption of cytoskeleton in neurons is shared with the effects of other noxious stimuli (hypoxia-asphyxia, traumatic brain injuries, electrical discharges, neurotoxicants, other drugs of abuse, neurodegenerative disorders, etc.). We propose here that a presently forgotten and disregarded (but classically described) form of chronic neuronal disease (Zellschrumpfung) is an ancient morphological evidence of neuronal cytoskeletal involvement in the action of those many noxious stimuli. Taking into account all the existing present and historical evidence, we may conclude that the damage to the cytoskeleton is a common final pathway for neuronal damage.	[Evrard, Sergio G.; Brusco, Alicia] Univ Buenos Aires, Fac Med, Inst Biol Celular Neurociencias Prof Eduardo De R, Buenos Aires, DF, Argentina; [Evrard, Sergio G.] Hosp Neuropsiquiatr Braulio A Moyano, Buenos Aires, DF, Argentina		Brusco, A (corresponding author), Univ Buenos Aires, Fac Med, Inst Biol Celular Neurociencias Prof Eduardo De R, Paraguay 2155 3Er Piso,C1121ABG, Buenos Aires, DF, Argentina.	sgevrard@yahoo.com.ar; hbrusco@fmed.uba.ar		Evrard, Sergio Gustavo/0000-0003-1521-256X			Adickes E D, 1983, Pediatr Pathol, V1, P369; ADICKES ED, 1986, ALCOHOL ALCOHOLISM, V21, P347; Ahluwala B, 2000, ALCOHOL ALCOHOLISM, V35, P452, DOI 10.1093/alcalc/35.5.452; Albano E, 2006, P NUTR SOC, V65, P278, DOI 10.1079/PNS2006496; AZMITIA EC, 1995, BRAIN RES, V677, P181, DOI 10.1016/0006-8993(95)00051-Q; Azmitia EC, 2001, BRAIN RES BULL, V56, P413, DOI 10.1016/S0361-9230(01)00614-1; Azorin I, 2004, ALCOHOL ALCOHOLISM, V39, P203, DOI 10.1093/alcalc/agh043; Bakeeva LE, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1335, DOI 10.1023/A:1013374410540; Banan A, 2000, J PHARMACOL EXP THER, V294, P997; BELLOMO G, 1992, ANN NY ACAD SCI, V663, P97, DOI 10.1111/j.1749-6632.1992.tb38653.x; BENITEZ I, 1996, ALCMEON, V5, P117; Berlucchi G, 2009, EXP BRAIN RES, V192, P307, DOI 10.1007/s00221-008-1611-6; Bidel S, 2005, WORLD J GASTROENTERO, V11, P4032, DOI 10.3748/wjg.v11.i26.4032; BIELSCHOWSKY M, 1932, CYTOLOGY CELLULAR PA, P145; BLEULER E, 1967, TRATADO PSIQUIATRIA, P764; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cahill A, 2002, ALCOHOL CLIN EXP RES, V26, P907, DOI 10.1111/j.1530-0277.2002.tb02621.x; Cajal S.R., 1899, TEXTURA SISTEMA NERV, V1; CAJAL SR, 1899, TEXTURA SISTEMA NERV, V2; CAJAL SR, 1913, DEGENERACION REGENER; CAMMERMEYER JAN, 1961, ACTA NEUROPATHOL, V1, P245; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; CRAGG BG, 1976, J ANAT, V121, P331; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; CULLEN KM, 1995, NEUROPATH APPL NEURO, V21, P312, DOI 10.1111/j.1365-2990.1995.tb01065.x; CULLEN KM, 1995, METAB BRAIN DIS, V10, P81, DOI 10.1007/BF01991785; Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005; de la Monte SM, 2001, ALCOHOL CLIN EXP RES, V25, P898, DOI 10.1097/00000374-200106000-00016; Dehmelt L, 2005, GENOME BIOL, V6; Deitrich RA, 2004, J STUD ALCOHOL, V65, P557, DOI 10.15288/jsa.2004.65.557; Delacourte A, 2005, FOLIA NEUROPATHOL, V43, P244; DEMOOR J, 1898, ANN SOC ROY SCI MED, V7, P205; Demoor J., 1896, ARCH BIOL BRUXELLES, V14, P723; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Depaz I, 2003, ALCOHOL CLIN EXP RES, V27, P1481, DOI 10.1097/01.ALC.0000086060.18032.59; Depaz IM, 2006, BRAIN RES, V1081, P59, DOI 10.1016/j.brainres.2006.01.126; Depaz IM, 2005, J NEUROSCI RES, V81, P253, DOI 10.1002/jnr.20563; Di Stefano G, 2006, REJUV RES, V9, P94; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; EBELS EJ, 1975, ACTA NEUROPATHOL, V33, P271, DOI 10.1007/BF00688399; Evrard SG, 2006, EXP NEUROL, V200, P438, DOI 10.1016/j.expneurol.2006.03.001; Evrard SG, 2003, DEV BRAIN RES, V147, P119, DOI 10.1016/j.devbrainres.2003.09.004; EVRARD SG, 2008, THESIS U BUENOS AIRE, P367; Fan L, 2001, J NEUROCHEM, V76, P1275, DOI 10.1046/j.1471-4159.2001.00176.x; FLAX MH, 1964, AM J PATHOL, V44, P441; FLETCHER TL, 1993, ALCOHOL CLIN EXP RES, V17, P993, DOI 10.1111/j.1530-0277.1993.tb05654.x; FRENCH SW, 1987, ANN NY ACAD SCI, V492, P262, DOI 10.1111/j.1749-6632.1987.tb48680.x; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; GALLOWAY PG, 1987, J NEUROPATH EXP NEUR, V46, P185, DOI 10.1097/00005072-198703000-00006; Gallyas F, 2006, ACTA NEUROPATHOL, V111, P229, DOI 10.1007/s00401-006-0034-3; Gallyas F, 2004, BIOL CELL, V96, P313, DOI 10.1016/j.biolcel.2004.01.009; GALLYAS F, 1990, ACTA NEUROPATHOL, V79, P620, DOI 10.1007/BF00294239; GALLYAS F, 1992, ACTA NEUROPATHOL, V83, P504, DOI 10.1007/BF00310027; Garrett S, 2003, CURR BIOL, V13, pR810, DOI 10.1016/j.cub.2003.09.052; Georges PC, 2008, MOL NEUROBIOL, V38, P270, DOI 10.1007/s12035-008-8046-8; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Goetz M, 1998, TRENDS NEUROSCI, V21, P135, DOI 10.1016/S0166-2236(98)01228-4; GOODLETT CR, 1993, DEV BRAIN RES, V72, P85, DOI 10.1016/0165-3806(93)90162-4; Hajnal A, 1997, BRAIN RES BULL, V43, P235, DOI 10.1016/S0361-9230(97)00015-4; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; Hasegawa M, 2006, NEUROPATHOLOGY, V26, P484, DOI 10.1111/j.1440-1789.2006.00666.x; HASSLER JA, 1986, EXPERIENTIA, V42, P575, DOI 10.1007/BF01946710; HASSLER JA, 1986, J CRAN GENET DEV BIO, P129; He J, 2005, EUR J NEUROSCI, V21, P2711, DOI 10.1111/j.1460-9568.2005.04120.x; Heras RDL, 2007, BRAIN RES, V1128, P12, DOI 10.1016/j.brainres.2006.10.017; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; Hipolito L, 2007, CURR DRUG METAB, V8, P716, DOI 10.2174/138920007782109797; HIRANO A, 1994, NEUROPATH APPL NEURO, V20, P3, DOI 10.1111/j.1365-2990.1994.tb00951.x; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Hoche Alfred E, 1991, HIST PSYCHIATR, V2, P334; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; HOFFMAN PN, 1988, P NATL ACAD SCI USA, V85, P4530, DOI 10.1073/pnas.85.12.4530; Hoyme HE, 2005, PEDIATRICS, V115, P39, DOI 10.1542/peds.2004-0259; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huss M., 1852, CHRONISCHE ALKOHOLSK; IIZUKA H, 1989, STROKE, V20, P1516, DOI 10.1161/01.STR.20.11.1516; Ishida K, 2004, NEUROSCIENCE, V125, P633, DOI 10.1016/j.neuroscience.2004.02.002; ISLAM N, 1994, ACTA MED OKAYAMA, V48, P123; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JAKOB C, 1938, REV ASOC MED ARG, V52, P326; Jortner B.S., 2005, J MED CBR DEF, V3, P1; Jortner BS, 2006, NEUROTOXICOLOGY, V27, P628, DOI 10.1016/j.neuro.2006.03.002; Joseph RA, 2008, HEPATOLOGY, V47, P1745, DOI 10.1002/hep.22014; Kannarkat GT, 2006, J HEPATOL, V44, P963, DOI 10.1016/j.jhep.2005.07.007; Kapaki E, 2005, INT J GERIATR PSYCH, V20, P722, DOI 10.1002/gps.1351; Kellermayer R, 2006, CELL BIOL INT, V30, P175, DOI 10.1016/j.cellbi.2005.11.002; KOCH OR, 1977, MEDICINA-BUENOS AIRE, V37, P351; KOCH OR, 1977, MEDICINA-BUENOS AIRE, V37, P21; Koh CG, 2006, NEUROSIGNALS, V15, P228, DOI 10.1159/000101527; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; KORSAKOW SS, 1890, ARCH PSYCHIAT NERVEN, V21, P669; Kovesdi E, 2007, BRAIN RES, V1147, P272, DOI 10.1016/j.brainres.2007.02.011; KRIEG WJS, 1946, J COMP NEUROL, V84, P277, DOI 10.1002/cne.900840302; KRIEG WJS, 1946, J COMP NEUROL, V84, P221, DOI 10.1002/cne.900840205; Kuhn DM, 1999, J BIOL CHEM, V274, P29726, DOI 10.1074/jbc.274.42.29726; Kuhn DM, 1997, J NEUROSCI, V17, P7245; LAAS R, 1994, NEUROPATH APPL NEURO, V20, P12, DOI 10.1111/j.1365-2990.1994.tb00952.x; LANE BP, 1966, AM J PATHOL, V49, P593; Lodish H., 2007, MOL CELL BIOL, Vsixth; Loidl CF, 1997, MOL CHEM NEUROPATHOL, V31, P301; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MAGNAN V, 1871, ETUDE EXPT CLIN ALCO; Marchiafava E., 1903, RIV PATOL NERV MENT, V8, P544; Matsushita S, 2008, ALCOHOL CLIN EXP RES, V32, P1091, DOI 10.1111/j.1530-0277.2008.00671.x; Mayer DJ, 1999, P NATL ACAD SCI USA, V96, P7731, DOI 10.1073/pnas.96.14.7731; MCKINNON G, 1987, BRAIN RES, V416, P90, DOI 10.1016/0006-8993(87)91500-9; MCLANE JA, 1987, ALCOHOL, V4, P385, DOI 10.1016/0741-8329(87)90071-1; Miguel-Hidalgo JJ, 2002, BIOL PSYCHIAT, V52, P1121, DOI 10.1016/S0006-3223(02)01439-7; MILLER MW, 1993, J COMP NEUROL, V337, P253, DOI 10.1002/cne.903370206; MILLER MW, 1986, SCIENCE, V233, P1308, DOI 10.1126/science.3749878; Mooney SM, 2004, CEREB CORTEX, V14, P1071, DOI 10.1093/cercor/bhh066; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Morikawa Y, 1999, ALCOHOL CLIN EXP RES, V23, P575, DOI 10.1097/00000374-199904001-00001; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; MOYANO BA, 1933, THESIS U BUENOS AIRE; Mukaetova-Ladinska EB, 2004, NEUROPATH APPL NEURO, V30, P615, DOI 10.1111/j.1365-2990.2004.00574.x; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; NI Y, 1992, CELL BIOL TOXICOL, V8, P1, DOI 10.1007/BF00119291; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; Noraberg J, 1998, NEUROREPORT, V9, P3177, DOI 10.1097/00001756-199810050-00010; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Onizuka K, 1996, EXP NEUROL, V137, P324, DOI 10.1006/exnr.1996.0033; Ooigawa H, 2006, ACTA NEUROPATHOL, V112, P471, DOI 10.1007/s00401-006-0108-2; ORLANDO JC, 1952, NEUROPSIQUIATRIA, V3, P97; Papadopoulos MC, 1999, CLIN SCI, V96, P461, DOI 10.1042/CS19980327; Parnavelas JG, 1999, EXP NEUROL, V156, P418, DOI 10.1006/exnr.1999.7044; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Pinheiro TJT, 2006, CHEM PHYS LIPIDS, V141, P66, DOI 10.1016/j.chemphyslip.2006.02.022; POLTORAK M, 1990, PHARMACOL BIOCHEM BE, V35, P693, DOI 10.1016/0091-3057(90)90309-6; Putzke J, 1998, MOL BRAIN RES, V62, P196, DOI 10.1016/S0169-328X(98)00253-8; Rafalowska J, 2006, FOLIA NEUROPATHOL, V44, P162; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, P NATL ACAD SCI USA, V92, P11323, DOI 10.1073/pnas.92.25.11323; Ramos AJ, 2000, BRAIN RES, V883, P1, DOI 10.1016/S0006-8993(00)02862-6; Ramos AJ, 2002, ANN NY ACAD SCI, V965, P343; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Reiter-Funk CK, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-16; RENAUPIQUERAS J, 1989, J HISTOCHEM CYTOCHEM, V37, P229, DOI 10.1177/37.2.2642942; Rintala J, 2000, ALCOHOL ALCOHOLISM, V35, P458, DOI 10.1093/alcalc/35.5.458; Rintala J, 2001, ALCOHOL, V23, P1, DOI 10.1016/S0741-8329(00)00116-6; ROBSON SJ, 1989, CELL MOTIL CYTOSKEL, V12, P273, DOI 10.1002/cm.970120408; Rovasio RA, 2002, ALCOHOL CLIN EXP RES, V26, P1286, DOI 10.1097/01.ALC>0000026102.7386.65; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Satriotomo I, 2000, BRAIN RES, V879, P55, DOI 10.1016/S0006-8993(00)02729-3; Saunders DE, 1997, ALCOHOL, V14, P519, DOI 10.1016/S0741-8329(97)00043-8; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schroeder E, 2003, NEUROBIOL AGING, V24, P135, DOI 10.1016/S0197-4580(02)00063-5; Shepard BD, 2008, HEPATOLOGY, V48, P1671, DOI 10.1002/hep.22481; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Slaugenhaupt SA, 2002, CURR OPIN GENET DEV, V12, P307, DOI 10.1016/S0959-437X(02)00303-9; SMITH SL, 1989, J CLIN INVEST, V84, P337, DOI 10.1172/JCI114159; Soto C, 2008, ARCH NEUROL-CHICAGO, V65, P184, DOI 10.1001/archneurol.2007.56; Spielmeyer W, 1922, HISTOPATHOLOGIE NERV, P493; Stevenson JR, 2009, NEUROPSYCHOPHARMACOL, V34, P1209, DOI 10.1038/npp.2008.90; Strnad R, 2008, BBA-MOL BASIS DIS, V1782, P764, DOI 10.1016/j.bbadis.2008.08.008; Tagliaferro P, 2002, ANN NY ACAD SCI, V965, P334; Tagliaferro P, 2006, BRAIN RES, V1085, P163, DOI 10.1016/j.brainres.2005.12.089; Tajuddin NF, 2003, ALCOHOL, V29, P157, DOI 10.1016/S0741-8329(03)00024-7; TAN SE, 1993, ALCOHOL, V10, P391, DOI 10.1016/0741-8329(93)90026-K; Tateno M, 2005, ALCOHOL CLIN EXP RES, V29, p225S, DOI 10.1097/01.alc.0000190658.56149.d4; TINBERG HM, 1981, BIOCHEM BIOPH RES CO, V102, P867, DOI 10.1016/0006-291X(81)91618-1; TINBERG HM, 1980, BIOCHEM BIOPH RES CO, V94, P940, DOI 10.1016/0006-291X(80)91325-X; Tomas M, 2005, NEUROBIOL DIS, V20, P773, DOI 10.1016/j.nbd.2005.05.012; Tomas M, 2003, J NEUROCHEM, V87, P220, DOI 10.1046/j.1471-4159.2003.01993.x; Triarhou LC, 2006, EUR NEUROL, V56, P176, DOI 10.1159/000096424; Triarhou LC, 2006, EUR NEUROL, V56, P189, DOI 10.1159/000096425; TUMA DJ, 1987, ANN NY ACAD SCI, V492, P277, DOI 10.1111/j.1749-6632.1987.tb48681.x; TUMA DJ, 1991, ANN NY ACAD SCI, V625, P786, DOI 10.1111/j.1749-6632.1991.tb33920.x; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Valles S, 1996, J NEUROCHEM, V67, P2425; Valles S, 1997, J NEUROCHEM, V69, P2484; Victorov IV, 2000, BRAIN RES PROTOC, V5, P135, DOI 10.1016/S1385-299X(00)00004-0; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Weber M.K., 2004, FETAL ALCOHOL SYNDRO; Weber MM, 2000, HIST PSYCHIATR, V11, P235, DOI 10.1177/0957154X0001104301; WERNICKE C, 1881, LEHRBUCH GEHIRNKRANK, V1, P229; WESSELY Z, 1981, STAIN TECHNOL, V56, P169, DOI 10.3109/10520298109067305; Whitaker-Azmitia PM, 1997, BRAIN RES, V776, P51, DOI 10.1016/S0006-8993(97)01002-0; WILLIAMSON D, 1993, BLOOD REV, V7, P146, DOI 10.1016/0268-960X(93)90002-L; Yang WC, 2005, DEV BRAIN RES, V156, P127, DOI 10.1016/j.devbrainres.2005.02.004; Yoon Y, 1998, AM J PHYSIOL-GASTR L, V274, pG757, DOI 10.1152/ajpgi.1998.274.4.G757; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zsombok A, 2005, J NEUROSCI METH, V142, P145, DOI 10.1016/j.jneumeth.2004.08.005; [No title captured]	193	7	7	0	3	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	2190-5215		978-1-4419-6786-2	ADV NEUROBIOL	Adv. Neurobiol.		2011	3						697	758		10.1007/978-1-4419-6787-9_29	10.1007/978-1-4419-6787-9		62	Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Life Sciences & Biomedicine - Other Topics; Neurosciences & Neurology	BTS28	WOS:000287955100029					2022-02-06	
J	Fraas, MR				Fraas, Michael R.			Enhancing Quality of Life for Survivors of Stroke Through Phenomenology	TOPICS IN STROKE REHABILITATION			English	Article						comprehensive-holistic treatment; coping; quality of life; stroke; stroke education	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; IMPACT; MISCONCEPTIONS; PERCEPTIONS; ADJUSTMENT; DEPRESSION; NARRATIVES; HISTORIES; AWARENESS	Kaufman argued for the need to implement a phenomenological approach to explore the boundaries of authority and responsibility associated with modern Western medicine. Twenty-two years later, survivors of stroke and their families continue to experience a poor quality of life (QOL) due to unmet health care expectations. Therefore, the need to establish a phenomenological approach to examine the issues impacting the QOL of survivors of stroke is as important as ever. This article will examine 3 issues germane to the QOL of survivors of stroke that can be addressed through phenomenological methodology: (1) comprehensive-holistic treatment; (2) active, problem-based coping strategies; and (3) education for the general public and health care personnel. Existential responses from survivors of stroke and recent findings from narrative-based research will help to highlight these important issues.	Elmhurst Coll, Dept Commun Arts & Sci, Elmhurst, IL USA		Fraas, MR (corresponding author), Elmhurst Coll, Dept Commun Arts & Sci, Elmhurst, IL USA.						Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Code C, 1999, INT J LANG COMM DIS, V34, P193, DOI 10.1080/136828299247531; Cohen O, 2005, J HUMANIST PSYCHOL, V45, P333, DOI 10.1177/0022167805277107; Crossley ML, 2000, THEOR PSYCHOL, V10, P527, DOI 10.1177/0959354300104005; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Curtiss G, 2000, J HEAD TRAUMA REHAB, V15, P1113, DOI 10.1097/00001199-200010000-00005; Dewar BK, 2007, NEUROPSYCHOL REHABIL, V17, P602, DOI 10.1080/09602010601051610; Ellis-Hill CS, 2000, CLIN REHABIL, V14, P279, DOI 10.1191/026921500671231410; Faircloth CA, 2004, SOCIOL HEALTH ILL, V26, P242, DOI 10.1111/j.1467-9566.2004.00388.x; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fraas MR, 2007, DISABIL REHABIL, V29, P1449, DOI 10.1080/09638280601102311; Fraas MR, 2009, AM J SPEECH-LANG PAT, V18, P315, DOI 10.1044/1058-0360(2009/08-0008); Franceschini M, 2010, EUR J PHYS REHAB MED, V46, P389; GREENHALGH T, 2003, NARRATIVE BASED HLTH; Hare R, 2006, FAM PRACT, V23, P131, DOI 10.1093/fampra/cmi098; Hinckley JJ, 2006, TOP STROKE REHABIL, V13, P25, DOI 10.1310/FLJ3-04DQ-MG8W-89EU; HINCKLEY JJ, 2008, NARRATIVE BASED PRAC; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Kalpakjian CZ, 2002, BRAIN INJURY, V16, P501, DOI 10.1080/02699050110119123; KAUFMAN S, 1988, J AGING STUD, V2, P217, DOI 10.1016/0890-4065(88)90002-3; KAUFMAN S R, 1988, Medical Anthropology Quarterly, V2, P338, DOI 10.1525/maq.1988.2.4.02a00040; KAUFMAN SR, 1988, QUALITATIVE GERONTOL, P82; Kotila M, 1998, STROKE, V29, P368, DOI 10.1161/01.STR.29.2.368; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Montbriand MJ, 2004, WESTERN J NURS RES, V26, P242, DOI 10.1177/0193945903259630; Mukherjee D, 2006, TOP STROKE REHABIL, V13, P26, DOI 10.1310/tsr1304-26; *NIH, STROK; Pinker S, 2007, PHILOS LITERATURE, V31, P162, DOI 10.1353/phl.2007.0016; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Rochette A, 2006, INT J REHABIL RES, V29, P247, DOI 10.1097/01.mrr.0000230051.24228.c8; Tervo RC, 2004, CLIN REHABIL, V18, P908, DOI 10.1191/0269215504cr820oa; Thorne A, 2003, AUTOBIOGRAPHICAL MEMORY AND THE CONSTRUCTION OF A NARRATIVE SELF: DEVELOPMENTAL AND CULTURAL PERSPECTIVES, P169; White JH, 2007, ARCH PHYS MED REHAB, V88, P1140, DOI 10.1016/j.apmr.2007.06.003; Wolters G, 2010, NEUROPSYCHOL REHABIL, V20, P587, DOI 10.1080/09602011003683836	39	7	7	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1074-9357	1945-5119		TOP STROKE REHABIL	Top. Stroke Rehabil.	JAN-FEB	2011	18	1					40	46		10.1310/tsr1801-40			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	728XJ	WOS:000287907500007	21371979				2022-02-06	
J	French, LM; Parkinson, GW; Massetti, S				French, Louis M.; Parkinson, Glenn W.; Massetti, Silvia			Care Coordination in Military Traumatic Brain Injury	SOCIAL WORK IN HEALTH CARE			English	Article						traumatic brain injury; care management; civilian social workers	SOLDIERS; BLAST; TBI	Traumatic brain injury (TBI)-an injury to the brain that may or may not create lasting impairment for the survivor-has been recognized as a major public health problem by the Centers for Disease Control (Langlois, Rutland-Brown, & Thomas, 2006). Ongoing conflicts in Iraq and Afghanistan have highlighted the problem for the military (Warden, 2006). Many soldiers are exposed to severe impact to the head resulting in TBI. As those with TBI transition to their home locality, civilian social workers and other providers will be involved in their care. This article examines the medical and emotional implications of mild TBI and offers suggestions for care of those affected, both the service member and his/her family.	[French, Louis M.; Massetti, Silvia] Walter Reed Army Med Ctr, Dept Orthopaed & Rehabil, Washington, DC 20307 USA; [French, Louis M.; Parkinson, Glenn W.] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA; [French, Louis M.; Massetti, Silvia] Natl Naval Med Ctr, Bethesda, MD USA; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Parkinson, Glenn W.] Walter Reed Army Med Ctr, Dept Neurol, Washington, DC 20307 USA		French, LM (corresponding author), Walter Reed Army Med Ctr, Dept Orthopaed & Rehabil, 6900 Georgia Ave NW,Bldg 2,Room 2J41, Washington, DC 20307 USA.	louis.french@us.army.mil	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604			Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cozza SJ, 2010, J TRAUMA STRESS, V23, P112, DOI 10.1002/jts.20488; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Dominguez Marie A, 2008, US Army Med Dep J, P8; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hohl A, 2009, ARQ BRAS ENDOCRINOL, V53, P908, DOI 10.1590/S0004-27302009000800003; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Martin EM, 2010, NEUROREHABILITATION, V26, P279, DOI 10.3233/NRE-2010-0563; OLKIN R, 1999, PSYCHOTHERAPISTS SHO; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wain H, 2005, PSYCHIAT QUART, V76, P351, DOI 10.1007/s11126-005-4971-0; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WEINSTEIN EA, 1961, PSYCHIATR, V24, P69	19	7	7	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0098-1389	1541-034X		SOC WORK HEALTH CARE	Soc. Work Health Care		2011	50	7			SI		501	514		10.1080/00981389.2011.582007			14	Social Work	Social Science Citation Index (SSCI)	Social Work	888PI	WOS:000300015600003	21846251				2022-02-06	
J	Katz-Leurer, M; Rotem, H; Keren, O; Meyer, S				Katz-Leurer, Michal; Rotem, Hemda; Keren, Ofer; Meyer, Shirley			The effect of variable gait modes on walking parameters among children post severe traumatic brain injury and typically developed controls	NEUROREHABILITATION			English	Article						Traumatic brain injury; walking speed; balance; step variability	OLDER-ADULTS; STRIDE VARIABILITY; MOTOR; MOBILITY; LENGTH; RECOVERY; VALIDITY; WALKWAY; DISEASE; BALANCE	The goal of the present study was to assess the effect of various walking modes on dynamic gait characteristics and to evaluate the possible differences in the adaptation reactions between children post severe traumatic brain injury (TBI) and typically developed (TD) controls. Methods: Thirteen children post severe TBI, mean of 3.5 years post trauma, independent walkers, with a walking velocity > 1.1 m/sec, and 15 TD controls participated in this study. Ages were 7-13 years. Gait speed, step time and length and step time and length variability were assessed by an electronic walkway. The children completed three cycles on the walkway for each of the following situations: comfortable walking, walking as fast as possible, as slow as possible and walking on a straight line. Results: Despite a similar walking performance while walking at a "regular" speed, children post severe TBI exhibit a significantly reduced range of walking speeds (73-154 cm/sec), about half, as compared to TD children (54-193 cm/sec) across the study assignments. In addition, while "walking on a straight line" children post TBI walk slower, with increased step variability as compared to their peers. Conclusion: Children post severe traumatic brain injury may achieve independent walking at a comparable rate to typically developed controls; however their impairments will be exacerbated as the demands increase. Since a variety of walking speeds is crucial for independent daily living at any age and for children in particular, and since adequate balance is an inherent element of walking, these issues need repeated assessments and the children should receive appropriate treatment.	[Katz-Leurer, Michal] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Phys Therapy Dept, IL-69978 Ramat Aviv, Israel; [Katz-Leurer, Michal; Rotem, Hemda; Keren, Ofer; Meyer, Shirley] Alyn Hosp, Pediat & Adolescent Rehabil Ctr Jerusalem, Jerusalem, Israel		Katz-Leurer, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Phys Therapy Dept, IL-69978 Ramat Aviv, Israel.	michalkz@post.tau.ac.il					[Anonymous], 1995, GAIT POSTURE; BASFORD JR, 2003, ARCH PHYS MED REHAB, V84, P249; Bilney B, 2003, GAIT POSTURE, V17, P68, DOI 10.1016/S0966-6362(02)00053-X; Brisswalter J, 1996, Can J Appl Physiol, V21, P471; Cirstea CM, 2006, STROKE, V37, P1237, DOI 10.1161/01.STR.0000217417.89347.63; Danion F, 2003, GAIT POSTURE, V18, P69, DOI 10.1016/S0966-6362(03)00030-4; Dubost V, 2006, HUM MOVEMENT SCI, V25, P372, DOI 10.1016/j.humov.2006.03.004; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Hausdorff JM, 2005, J NEUROENG REHABIL, V20, P2; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; MacKay-Lyons M, 1998, PHYS THER, V78, P1083, DOI 10.1093/ptj/78.10.1083; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Nakamura T, 1996, GERONTOLOGY, V42, P108, DOI 10.1159/000213780; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; PERRY J, 1992, GAIT ANAL NORMAL PAT, P434; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sekiya N, 1997, J ORTHOP SPORT PHYS, V26, P266, DOI 10.2519/jospt.1997.26.5.266; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Thorpe DE, 2005, ARCH PHYS MED REHAB, V86, P2342, DOI 10.1016/j.apmr.2005.07.301; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; VanderSchaaf PJ, 1997, PEDIATR NEUROL, V16, P306, DOI 10.1016/S0887-8994(97)00025-8; YAMASAKI M, 1991, EUR J APPL PHYSIOL O, V62, P99, DOI 10.1007/BF00626763	28	7	7	1	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2011	29	1					45	51		10.3233/NRE-2011-0676			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	814JR	WOS:000294447000006	21876295				2022-02-06	
J	Khodaee, M; Fetters, MD; Gorenflo, DW				Khodaee, Morteza; Fetters, Michael D.; Gorenflo, Daniel W.			Football (Soccer) Safety Equipment Use and Parental Attitudes Toward Safety Equipment in a Community Youth Sports Program	RESEARCH IN SPORTS MEDICINE			English	Article						soccer; safety equipment; parental attitudes; survey research; prevention	INJURIES; MOUTHGUARDS; CONCUSSIONS; PREVENTION	While a growing number of children are playing football (soccer), there are limited data on prevalence of injuries, actual use of football safety equipment (SE), and parental attitudes about football SE. We distributed a self-administered survey by mail to parents of all players enrolled in a community recreation youth football program. Parents of 865 children responded. Overall, 32 (3.7%) children were reported as having injuries requiring medical/dental evaluation. Upper/lower extremities were the most commonly injured sites. Shinguards (SGs) were the only equipment commonly used. While there was high parental support for SG use (97.4%) and moderate support for mouthguards (MGs; 53.8%), there was less support for other SE. Many parents were unfamiliar with available SE, but they were mostly willing to pay for it. In a community youth sports program, reports of football injuries were low as was the use of football SE other than SGs.	[Khodaee, Morteza] Univ Colorado, Dept Family Med, AF Williams Clin, Denver, CO 80238 USA; [Fetters, Michael D.; Gorenflo, Daniel W.] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA		Khodaee, M (corresponding author), Univ Colorado, Dept Family Med, AF Williams Clin, 3055 Roslyn St, Denver, CO 80238 USA.	morteza.khodaee@ucdenver.edu			AAFP/F-AAFP Grant Awards Council (JGAC) [N005998, G0411RS]	We express our warm thanks to Mr. Larry Dishman, coordinator of team sports, and the administration and staff of the Ann Arbor Community Education & Recreation. This study would never have been possible without the generosity of our study participants. This study was supported by the American Academy of Family Physician Foundation and the Joint AAFP/F-AAFP Grant Awards Council (JGAC), Grant # N005998, Sponsor # G0411RS. The authors have no personal or professional relationship with any company or manufacturer that might benefit from the results of this study.	*AAP, 2000, PEDIATRICS, V105, P659; *AC SPORTS DENT, 1999, POS STAT ATHL MOUTHG; Adams AL, 2006, ACAD EMERG MED, V13, P571, DOI 10.1197/j.aem.2005.12.015; *AM AC PED DENT, 2010, POL PREV SPORTS REL; *AM MED ASS, 2010, PAR PACK POINTS PAR; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Burt CW, 2001, ANN EMERG MED, V37, P301, DOI 10.1067/mem.2001.111707; Delaney J Scott, 2005, Clin J Sport Med, V15, P216, DOI 10.1097/01.jsm.0000168077.74497.a4; Delaney JS, 2005, CLIN J SPORT MED, V15, P212; Diab N, 1997, Pediatr Dent, V19, P455; *FIFA, 2010, LAWS GAM; FIFA, 2006, BIG COUNT; Fuller CW, 2006, CLIN J SPORT MED, V16, P97, DOI 10.1097/00042752-200603000-00003; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Lieger O, 2006, DENT TRAUMATOL, V22, P1, DOI 10.1111/j.1600-9657.2006.00328.x; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; *NCAA, 2010, NCAA SPORTS MED HDB; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; Pribble JM, 2004, INJURY PREV, V10, P159, DOI 10.1136/ip.2003.004754; Truman BI, 2002, AM J PREV MED, V23, P21, DOI 10.1016/S0749-3797(02)00449-X; Washington RL, 2004, PEDIATRICS, V113, P619; Wong P, 2005, BRIT J SPORT MED, V39, P473, DOI 10.1136/bjsm.2004.015511	24	7	7	2	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.		2011	19	2			SI		129	143	PII 936109827	10.1080/15438627.2011.556907			15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	750XP	WOS:000289581800005	21480059				2022-02-06	
J	Kwon, HG; Jang, SH				Kwon, Hyeok Gyu; Jang, Sung Ho			Optic radiation injury following traumatic epidural hematoma: Diffusion tensor imaging study	NEUROREHABILITATION			English	Article						Optic radiation; epidural hematoma; head trauma; brain injury; hemianopia; diffusion tensor imaging	TEMPORAL-LOBE RESECTION; HOMONYMOUS HEMIANOPIA; AXONAL INJURY; MAGNETIC-RESONANCE; TRACTOGRAPHY; TRACKING; STROKE; BRAIN	Little is known about optic radiation (OR) injury in patients with traumatic brain injury (TBI). We report on a patient who showed an OR injury on diffusion tensor imaging (DTI) following traumatic epidural hematoma (EDH). A 38 year-old man with TBI and 7 age-matched normal subjects were enrolled in this study. The patient had fallen down stairs while in an alcohol intoxicated state. He underwent a craniotomy following diagnosis of traumatic EDH in the left temporo-parietal lobe on brain CT. He complained of right bilateral homonymous hemianopsia, which was confirmed on the Humphrey visual field test. No lesion on the left OR was observed during brain MRI. We were not able to reconstruct the fiber tractography for the left OR in this patient. We found that the left OR had been injured most severely around the midportion between the lateral geniculate body and occipital pole. We determined that DTI would be a useful technique for detection of an OR injury in patients with TBI. Therefore, we believe that DTI should be performed along with conventional brain MRI for patients with visual field defects following TBI.	[Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Kwon, Hyeok Gyu] Daegu Univ, Grad Sch Rehabil Sci, Dept Phys Therapy, Taegu, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net					BOSLEY TM, 1985, NEUROLOGY, V35, P470, DOI 10.1212/WNL.35.4.470; Bruce BB, 2006, J NEUROL NEUROSUR PS, V77, P986, DOI 10.1136/jnnp.2006.088799; Chen ZQ, 2010, J MAGN RESON IMAGING, V31, P1054, DOI 10.1002/jmri.22142; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; ELISEVICH KV, 1984, SURG NEUROL, V22, P565, DOI 10.1016/0090-3019(84)90433-6; Glass HC, 2010, AM J NEURORADIOL, V31, P1424, DOI 10.3174/ajnr.A2110; Hassan A, 2002, CLIN EXP OPHTHALMOL, V30, P273, DOI 10.1046/j.1442-9071.2002.00534.x; Hofer S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00015; Hong JH, 2009, BRAIN RES BULL, V80, P30, DOI 10.1016/j.brainresbull.2009.05.021; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; KAN S, 1978, NEURORADIOLOGY, V16, P299, DOI 10.1007/BF00395280; Kwak SY, 2010, EUR NEUROL, V63, P149, DOI 10.1159/000281108; Mahmutyazicioglu Kamran, 2005, Diagn Interv Radiol, V11, P19; Marriott Elizabeth, 2007, Semin Ophthalmol, V22, P3, DOI 10.1080/08820530601182543; Mizrachi IBB, 2005, J NEURO-OPHTHALMOL, V25, P193, DOI 10.1097/01.wno.0000179357.20858.22; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Powell HWR, 2005, NEUROLOGY, V65, P596, DOI 10.1212/01.wnl.0000172858.20354.73; Segal L, 2009, J NEURO-OPHTHALMOL, V29, P308, DOI 10.1097/WNO.0b013e3181c1cefd; Seghier ML, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-17; Shinoura N, 2010, ACTA NEUROCHIR, V152, P637, DOI 10.1007/s00701-009-0582-0; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Taoka T, 2008, AM J NEURORADIOL, V29, P1329, DOI 10.3174/ajnr.A1101; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114; Yoshida M, 2006, J NEURO-OPHTHALMOL, V26, P11, DOI 10.1097/01.wno.0000205620.60510.01; Zhang XJ, 2006, J NEURO-OPHTHALMOL, V26, P180, DOI 10.1097/01.wno.0000235587.41040.39	27	7	8	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2011	28	4					383	387		10.3233/NRE-2011-0667			5	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	795VL	WOS:000293004900009	21725172				2022-02-06	
J	Meyers, J; Reinsch-Boothby, L; Miller, R; Rohling, M; Axelrod, B				Meyers, John; Reinsch-Boothby, Lorrie; Miller, Ronald; Rohling, Martin; Axelrod, Bradley			Does the Source of a Forensic Referral Affect Neuropsychological Test Performance on a Standardized Battery of Tests?	CLINICAL NEUROPSYCHOLOGIST			English	Article						Meyers Neuropsychological Battery; MNB; Forensic; Plaintiff; Defense	TRAUMATIC BRAIN-INJURY; CLINICAL NEUROPSYCHOLOGISTS; HEAD-INJURY; MMPI-2; SCALE; INTELLIGENCE; VALIDATION; SAMPLE; INDEX	The current study examines the differences in neuropsychological test performance between individuals who were referred for evaluation by either plaintiff or defense attorneys. Comparisons were made using a standardized battery of tests, with the same tests being administered to both groups of individuals along with the MMPI-2. The results of the study showed no significant difference in domain-level performance, or on the psychological measures administered for plaintiff vs defense referrals who passed symptom validity tests (SVTs). Similarly, although those failing SVTs produced markedly lower test performance and reported more psychological symptoms in comparison to those passing SVTs, there were no differences between plaintiff or defense referrals on test performance for those failing SVTs.	[Meyers, John; Reinsch-Boothby, Lorrie] Meyers Neuropsychol Serv, Mililani, HI 96789 USA; [Miller, Ronald] Brigham Young Univ, Dept Psychol, Laie, HI USA; [Rohling, Martin] Univ Alabama, Dept Psychol, Mobile, AL USA; [Axelrod, Bradley] John D Dingell Dept Vet Affairs, Psychol Sect, Detroir, MI USA		Meyers, J (corresponding author), Meyers Neuropsychol Serv, 162,94-553 Alapoai St, Mililani, HI 96789 USA.	jmeyersneuro@yahoo.com					BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; BROWN MB, 1974, TECHNOMETRICS, V16, P129, DOI 10.2307/1267501; Bruning JL, 1977, COMPUTATIONAL HDB ST, V2nd; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; COHEN J, 1988, STAT POWER ANAL BEHA, pR21; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; FOX DD, 1995, J CLIN PSYCHOL, V51, P42, DOI 10.1002/1097-4679(199501)51:1<42::AID-JCLP2270510108>3.0.CO;2-Z; Friedman A.F., 2001, PSYCHOL ASSESSMENT M, V2nd ed.; Graham J.R., 1990, MMPI 2 ASSESSING PER; Greene RL, 2000, MMPI 2 INTERPRETIVE; Greiffenstein M., 2008, CLIN NEUROPSYCHOL, V22, P1; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P813, DOI 10.1080/13854040701625846; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 2003, J FORENSIC NEUROPSYC, V3, P167, DOI DOI 10.1300/J151V03N01_01; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Meyers J E, 2001, Appl Neuropsychol, V8, P234, DOI 10.1207/09084280152829084; Meyers J E, 2000, Appl Neuropsychol, V7, P133, DOI 10.1207/S15324826AN0703_3; Meyers J E, 1999, Appl Neuropsychol, V6, P208, DOI 10.1207/s15324826an0604_3; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P157, DOI 10.1016/S0887-6177(00)00107-4; MEYERS JE, 2007, ASSESSMENT NONCREDIB; MEYERS JE, 2003, MANUAL MEYERS NEROPS; Meyers JE, 1998, APPL NEUROPSYCHOL, V5, P120, DOI 10.1207/s15324826an0503_2; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Moore D, 2009, INTRO PRACTICE STAT; OLEJNIK SF, 1987, J EDUC STAT, V12, P45; Pilgrim B M, 1999, Appl Neuropsychol, V6, P243, DOI 10.1207/s15324826an0604_7; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sweet JJ, 2000, CLIN NEUROPSYCHOL, V14, P18, DOI 10.1076/1385-4046(200002)14:1;1-8;FT018; Urbina S, 1997, PSYCHOL TESTING; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	41	7	7	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	3					477	487	PII 935830540	10.1080/13854046.2011.554442			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	751RU	WOS:000289636100010	21491350				2022-02-06	
J	Sodickson, A; Okanobo, H; Ledbetter, S				Sodickson, Aaron; Okanobo, Heitor; Ledbetter, Stephen			Spiral head CT in the evaluation of acute intracranial pathology: a pictorial essay	EMERGENCY RADIOLOGY			English	Article						Spiral head CT; Helical head CT; Multiplanar reformations; Head trauma; Intracranial hemorrhage; Calvarial fracture	TRAUMATIC SUBARACHNOID HEMORRHAGE; CORONAL REFORMATIONS; COMPUTED-TOMOGRAPHY; DIAGNOSIS; BRAIN; MDCT; INJURY	The purpose of this pictorial essay is to review the benefits of spiral head computed tomography (CT) with routine multiplanar reformations in the evaluation of acute intracranial pathology. This technique is particularly useful in trauma patients for detection of skull base or calvarial fractures, thin tentorial subdural hematomas, or for more specific characterization of intracranial hemorrhage. The benefits of multiplanar reformations have been described for a variety of other diagnoses in the chest, abdomen, extremities, and spine, and their routine use continues to grow with the widespread availability of multi-slice CT scanners. In this article, we describe spiral head CT technique with multiplanar reformations as an alternative to the routinely used sequential technique. Subtle findings and lesions aligned predominantly in the axial plane can often be visualized to better advantage with multiplanar reformations. We also address technical factors for optimizing spiral technique.	[Sodickson, Aaron; Okanobo, Heitor; Ledbetter, Stephen] Brigham & Womens Hosp, Harvard Med Sch, Dept Radiol, 75 Francis St, Boston, MA 02115 USA		Sodickson, A (corresponding author), Brigham & Womens Hosp, Harvard Med Sch, Dept Radiol, 75 Francis St, Boston, MA 02115 USA.	asodickson@partners.org		Sodickson, Aaron/0000-0003-1275-681X			Aschoff AJ, 2006, EUR RADIOL S7, V16, P54; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Fanucci E, 2007, EMERG RADIOL, V13, P251, DOI 10.1007/s10140-006-0554-0; GENTRY LR, 1994, RADIOLOGY, V191, P1; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hernalsteen D, 2007, EUR RADIOL, V17, P975, DOI 10.1007/s00330-006-0360-9; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Jaffe TA, 2006, RADIOLOGY, V238, P135, DOI 10.1148/radiol.2381050489; Jayashankar A, 2008, EMERG RADIOL, V15, P29, DOI 10.1007/s10140-007-0670-5; Kim HC, 2008, BRIT J RADIOL, V81, P859, DOI 10.1259/bjr/19297777; LAINE FJ, 1995, AM J ROENTGENOL, V165, P967, DOI 10.2214/ajr.165.4.7677003; Lucey BC, 2005, AM J ROENTGENOL, V185, P1435, DOI 10.2214/AJR.04.1396; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Mirvis SE, 2007, EUR RADIOL, V17, P1411, DOI 10.1007/s00330-006-0553-2; NEW PFJ, 1980, RADIOLOGY, V136, P665, DOI 10.1148/radiology.136.3.7403545; Ptak T, 2003, RADIOLOGY, V229, P902, DOI 10.1148/radiol.2293021651; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Sliker CW, 2008, RADIOGRAPHICS, V28, P1689, DOI 10.1148/rg.286085521; Smirniotopoulos JG, 2007, RADIOGRAPHICS, V27, P525, DOI 10.1148/rg.272065155; Strub WM, 2007, AM J NEURORADIOL, V28, P1679, DOI 10.3174/ajnr.A0653; Turner BG, 2004, AM J ROENTGENOL, V183, P751, DOI 10.2214/ajr.183.3.1830751; Wei SC, 2010, AM J NEURORADIOL, V31, P334, DOI 10.3174/ajnr.A1824; Zacharia TT, 2010, EMERG RADIOL, V17, P97, DOI 10.1007/s10140-009-0842-6; Zangos S, 2007, ACAD RADIOL, V14, P19, DOI 10.1016/j.acra.2006.09.050	25	7	7	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1070-3004	1438-1435		EMERG RADIOL	Emerg. Radiol.	JAN	2011	18	1					81	91		10.1007/s10140-010-0914-7			11	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	V1Y1B	WOS:000217340200015	20941635				2022-02-06	
J	Steurer, MA; Berger, TM				Steurer, M. A.; Berger, T. M.			Infusion therapy for neonates, infants and children	ANAESTHESIST			German	Article						Acid-base equilibrium; Electrolytes; Glucose; Maintenance; Deficit	HOSPITAL-ACQUIRED HYPONATREMIA; INTRAVENOUS MAINTENANCE FLUID; TRANSEPIDERMAL WATER-LOSS; HYPERTONIC SALINE; ISOTONIC SALINE; IATROGENIC HYPONATREMIA; ENDOTHELIAL GLYCOCALYX; INTRACRANIAL-PRESSURE; EXTRACELLULAR FLUID; METABOLIC-ACIDOSIS	Intravenous administration of fluids, electrolytes and glucose are the most common interventions in hospitalized pediatric patients. Parenteral fluid administration can be life-saving, however, if used incorrectly it also carries substantial risks. Perioperatively, adequate hydration, prevention of electrolyte imbalances and maintenance of normoglycemia are the main goals of parenteral fluid therapy. Conceptionally, the distinction between maintenance requirements, deficits and ongoing loss is helpful. Although the pathophysiological basis for parenteral fluid therapy was clarified in the first half of the 20th century, some aspects still remain controversial. In newborn infants, rational parenteral fluid therapy must take into account large insensible fluid losses, adaptive changes of renal function in the first days of life and the fact that neonates do not tolerate prolonged periods of fasting. In older infants the occurrence of iatrogenic hyponatremia with the use of hypotonic solutions has led to a critical reappraisal of the validity of the Holliday-Segar method for calculating maintenance fluid requirements in the postoperative period. Pragmatically, only isotonic solutions should be used in clinical situations which are known to be associated with increases in antidiuretic hormone (ADH) secretion. In this context, it is important to realize that in contrast to lactated Ringer's solution, the use of normal saline can lead to hyperchloremic acidosis in a dose-dependent fashion. Although there is no convincing evidence that colloids are better than crystalloids, there are clinical situations where the use of the more expensive colloids seems justified. It may be reasonable to choose a solution for fluid replacement which has a composition comparable to the composition of the fluid which must be replaced. Although hypertonic saline can reduce an elevated intracranial pressure, this therapy cannot be recommended as a routine procedure because there is currently no evidence that this intervention improves long-term outcome in pediatric patients with traumatic brain injury.	[Steurer, M. A.; Berger, T. M.] Kinderspital Luzern, CH-6000 Luzern, Switzerland		Berger, TM (corresponding author), Kinderspital Luzern, CH-6000 Luzern, Switzerland.	thomas.berger@ksl.ch					Adamson RH, 2004, J PHYSIOL-LONDON, V557, P889, DOI 10.1113/jphysiol.2003.058255; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; Agren J, 1998, ACTA PAEDIATR, V87, P1185; Agren J, 2003, PEDIATR RES, V53, P558, DOI 10.1203/01.PDR.0000055777.25933.98; ARIEFF AI, 1992, BRIT MED J, V304, P1218, DOI 10.1136/bmj.304.6836.1218; Ayus JC, 2008, AM J PHYSIOL-RENAL, V295, pF619, DOI 10.1152/ajprenal.00502.2007; Bernard C., 1878, LECONS PHENOMENES VI; Blackfan KD, 1918, AM J DIS CHILD, V15, P19; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Bunn F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001319.pub2; Cartlidge P, 2000, Semin Neonatol, V5, P273, DOI 10.1053/siny.2000.0013; Chappell D, 2008, ANESTHESIOLOGY, V109, P723, DOI 10.1097/ALN.0b013e3181863117; Chappell D, 2007, ANESTHESIOLOGY, V107, P776, DOI 10.1097/01.anes.0000286984.39328.96; Choong K, 2006, ARCH DIS CHILD, V91, P828, DOI 10.1136/adc.2005.088690; Custer J.W., 2008, HARRIET LANE HDB; DARROW DC, 1946, J CLIN INVEST, V25, P324, DOI 10.1172/JCI101712; Darrow DC, 1938, J PEDIATR-US, V13, P670, DOI 10.1016/S0022-3476(38)80158-X; Finberg L, 2004, PEDIATRICS, V114, P1741, DOI 10.1542/peds.2004-1998; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Friedman AL, 2005, KIDNEY INT, V67, P380, DOI 10.1111/j.1523-1755.2005.00092.x; Gamble JL, 1925, J CLIN INVEST, V1, P403, DOI 10.1172/JCI100021; Gamble JL, 1923, J BIOL CHEM, V57, P633; Halberthal M, 2001, BRIT MED J, V322, P780, DOI 10.1136/bmj.322.7289.780; Hanna S, 2003, ACTA PAEDIATR, V92, P430, DOI 10.1111/j.1651-2227.2003.tb00573.x; Hartnoll G, 2000, ARCH DIS CHILD-FETAL, V82, pF19, DOI 10.1136/fn.82.1.F19; Hatherill M, 2004, PEDIATRICS, V114, P1368, DOI 10.1542/peds.2004-1350; Hay WW, 2008, NEONATOLOGY, V94, P245, DOI 10.1159/000151643; HAYCOCK GB, 1993, PEDIATR NEPHROL, V7, P871, DOI 10.1007/BF01213376; Holliday MA, 2000, PEDIATR NEPHROL, V15, P317, DOI 10.1007/s004670000437; HOLLIDAY MA, 1957, PEDIATRICS, V19, P823; Holliday MA, 2005, PEDIATRICS, V115, P193, DOI 10.1542/peds.2004-1769; Holliday MA, 1999, PEDIATR NEPHROL, V13, P292, DOI 10.1007/s004670050611; Holliday MA, 2003, PEDIATRICS, V111, P424; Hoorn EJ, 2004, PEDIATRICS, V113, P1279, DOI 10.1542/peds.113.5.1279; KARELITZ S, 1931, AM J DIS CHILD, V42, P871; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Lang W, 2005, J APPL PHYSIOL, V98, P62, DOI 10.1152/japplphysiol.00292.2004; Latta T., 1832, LANCET, V18, P274, DOI DOI 10.1016/S0140-6736(02)80289-6; LEE JH, 1994, NEW ENGL J MED, V331, P439, DOI 10.1056/NEJM199408183310704; LORENZ JM, 1995, PEDIATRICS, V96, P484; Modi N, 2000, EARLY HUM DEV, V59, P201, DOI 10.1016/S0378-3782(00)00097-9; Modi Neena, 2003, Semin Neonatol, V8, P301, DOI 10.1016/S1084-2756(03)00043-5; Montanana PA, 2008, PEDIATR CRIT CARE ME, V9, P589, DOI 10.1097/PCC.0b013e31818d3192; Moritz ML, 2004, PEDIATRICS, V113, P1395, DOI 10.1542/peds.113.5.1395; Murat I, 2008, PEDIATR ANESTH, V18, P363, DOI 10.1111/j.1460-9592.2008.02505.x; Neville KA, 2006, ARCH DIS CHILD, V91, P226, DOI 10.1136/adc.2005.084103; Neville KA, 2010, J PEDIATR-US, V156, P313, DOI 10.1016/j.jpeds.2009.07.059; O'Dell E, 2007, CRIT CARE MED, V35, P2390, DOI 10.1097/01.CCM.0000284588.17760.99; OSTLUND EVC, 1993, PEDIATR NEPHROL, V7, P41; Perel P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub3; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Playfor S, 2003, ARCH DIS CHILD, V88, P646, DOI 10.1136/adc.88.7.646-a; Rehm M, 2004, ANESTHESIOLOGY, V100, P1211, DOI 10.1097/00000542-200405000-00025; Roberts KB, 2004, PEDIATRICS, V114, P1743, DOI 10.1542/peds.2004-1241; Rutter N, 2000, Semin Neonatol, V5, P281, DOI 10.1053/siny.2000.0014; Scheingraber S, 1999, ANESTHESIOLOGY, V90, P1265, DOI 10.1097/00000542-199905000-00007; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Starling E H, 1896, J Physiol, V19, P312; Steele A, 1997, ANN INTERN MED, V126, P20, DOI 10.7326/0003-4819-126-1-199701010-00003; Stephens Robert, 2003, Curr Opin Anaesthesiol, V16, P385, DOI 10.1097/00001503-200308000-00004; STEWART PA, 1978, RESP PHYSIOL, V33, P9, DOI 10.1016/0034-5687(78)90079-8; Story DA, 2004, BRIT J ANAESTH, V92, P54, DOI 10.1093/bja/aeh018; Sumpelmann R, 2010, PEDIATR ANESTH, V20, P977, DOI 10.1111/j.1460-9592.2010.03428.x; Taylor D, 2006, INTENS CARE MED, V32, P295, DOI 10.1007/s00134-005-0009-1; Walker PA, 2009, J TRAUMA, V67, pS120, DOI 10.1097/TA.0b013e3181ad323a; Waters JH, 1999, CRIT CARE MED, V27, P2142, DOI 10.1097/00003246-199910000-00011; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820; Witt L, 2010, BRIT J ANAESTH, V105, P635, DOI 10.1093/bja/aeq204; Zander R, 2009, ANAESTHESIST, V58, P405, DOI 10.1007/s00101-009-1524-1	70	7	8	1	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	JAN	2011	60	1					10	22		10.1007/s00101-010-1824-5			13	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	711QF	WOS:000286605800003	21181098				2022-02-06	
B	Togher, L		Guendouzi, J; Loncke, F; Williams, MJ		Togher, Leanne			Cognitive Communication Disorders After Traumatic Brain Injury	HANDBOOK OF PSYCHOLINGUISTIC AND COGNITIVE PROCESSES: PERSPECTIVES IN COMMUNICATION DISORDERS			English	Article; Book Chapter							CLOSED-HEAD-INJURY; PRAGMATIC LANGUAGE-SKILLS; SOCIAL-SKILLS; EMOTION PERCEPTION; DISCOURSE ABILITIES; NARRATIVE DISCOURSE; TREATMENT EFFICACY; ADULTS; DEFICITS; CONVERSATION		Univ Sydney, Sydney, NSW 2006, Australia		Togher, L (corresponding author), Univ Sydney, Sydney, NSW 2006, Australia.		Togher, Leanne/AAC-7083-2019	Togher, Leanne/0000-0002-4518-6748			Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Body R., 2006, BRAIN IMPAIR, V7, P212, DOI DOI 10.1375/BRIM.7.3.212; Body R., 1999, BRAIN DAM B; Booth S, 1999, INT J LANG COMM DIS, V34, P291, DOI 10.1080/136828299247423; Booth S, 1999, APHASIOLOGY, V13, P283, DOI 10.1080/026870399402109; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Bourgeois M., 2001, AUGMENTATIVE ALTERNA, V17, P196, DOI DOI 10.1080/714043383; Bowers D., 1991, FLORIDA AFFECT BATTE; BRAUNLINGMCMORROW D, 1986, J REHABIL, V52, P39; BROTHERTON FA, 1988, ARCH PHYS MED REHAB, V69, P827; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burgio LD, 2001, GERONTOLOGIST, V41, P449, DOI 10.1093/geront/41.4.449; Byng S., 2000, ACQUIRED NEUROLOGICA; Cannizzaro MS, 2002, BRAIN INJURY, V16, P1065, DOI 10.1080/02699050210155230; Carnevale GJ, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199602000-00005; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Damico J. S., 1985, COMMUNICATION SKILLS, P165; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Ehrlich J, 1989, Brain Inj, V3, P193, DOI 10.3109/02699058909004552; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; FARRELL AD, 1985, BEHAV ASSESS, V7, P155; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; Frattali C M, 1993, Disabil Rehabil, V15, P1; GAJAR A, 1984, J APPL BEHAV ANAL, V17, P353, DOI 10.1901/jaba.1984.17-353; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; GOLDSTEIN K, 1942, AFTER EFFECTS BRAIN; GRAFMAN J, 1987, NEUROBEHAVIORAL RECO, P44; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Grice H. P., 1975, SYNTAX SEMANTICS, P41; Grimes JE., 1975, THREAD DISCOURSE; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Halliday M., 2004, INTRO FUNCTIONAL GRA; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hasan Ruqaiya, 1985, LANGUAGE CONTEXT TEX; HELFFENSTEIN DA, 1982, INT J CLIN NEUROPSYC, V4, P139; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Holland A., 1982, CLIN APH P C, P345; Holland D, 1998, BRAIN INJURY, V12, P993, DOI 10.1080/026990598121918; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; HYMES D, 1986, DIRECTIONS SOCIOLING, P35; JOHNSON DA, 1987, BRIT J CLIN PSYCHOL, V26, P289, DOI 10.1111/j.2044-8260.1987.tb01362.x; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); KENNEDY MRT, 1991, COMMUNICATION DISORD, P123; Labov W., 1969, STUD GEN, V23, P30; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; Levinson Stephen., 1983, PRAGMATICS; LEWIS FD, 1988, BEHAV THER, V19, P203, DOI 10.1016/S0005-7894(88)80043-1; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; Luria A.R., 1970, TRAUMATIC APHASIA; Lyon JG, 1997, APHASIOLOGY, V11, P693, DOI 10.1080/02687039708249416; MANDLER JM, 1977, COGNITIVE PSYCHOL, V9, P111, DOI 10.1016/0010-0285(77)90006-8; MARSH NV, 1999, BRAIN DAM B, P175; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; McDonald, 2000, METAPHOR SYMBOL, V15, P85, DOI DOI 10.1080/10926488.2000.9678866; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McDonald Skye, 2007, IRONY LANGUAGE THOUG, P217; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; MILTON SB, 1984, CLIN APHASIOLOGY C P; NEWHOFF M, 1981, CLIN APHASIOLOGY, V11, P234; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pearce S, 1998, BRAIN COGNITION, V38, P150, DOI 10.1006/brcg.1998.1018; Penn C, 1988, Brain Inj, V2, P3, DOI 10.3109/02699058809150928; Phillips ML, 2003, BRIT J PSYCHIAT, V182, P190, DOI 10.1192/bjp.182.3.190; Pound C., 2000, APHASIA THERAPIES LI; Prigatano G. P., 1985, LANG SCI, V7, P217, DOI [10.1016/S0388-0001(85)80020-6, DOI 10.1016/S0388-0001(85)80020-6]; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Ripich D. N., 1999, CLIN GERONTOLOGIST, V21, P37, DOI DOI 10.1300/J018V21N01; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Schank R, 1977, SCRIPTS PLANS GOALS; SCHLOSS PJ, 1985, APPL RES MENT RETARD, V6, P269, DOI 10.1016/0270-3092(85)90001-3; SIMMONS N, 1987, CLIN APHASIOLOGY, V17, P106; Simmons-Mackie N, 1999, APHASIOLOGY, V13, P807, DOI 10.1080/026870399401894; SMITH L, 1986, B COLLEGE SPEECH THE, V409, P10; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1999, APHASIOLOGY, V13, P709, DOI 10.1080/026870399401821; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 1996, DISABIL REHABIL, V18, P559, DOI 10.3109/09638289609166317; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; TOGHER L, 1998, COMMUNITY POLI UNPUB; TOGHER L, 2001, COMMUNICATION TRAINI; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; ULATOWSKA HK, 1989, SEMINARS SPEECH LANG, V110, P298; Van Dijk T A., 1977, TEXT CONTEXT EXPLORA; VENTOLA E, 1979, J PRAGMATICS, V3, P267, DOI 10.1016/0378-2166(79)90034-1; VENTOLA E, 1987, STRUCTURE SOCIAL INT; WALLANDER JL, 1985, BEHAV ASSESS, V7, P137; Wilkinson R, 1998, Int J Lang Commun Disord, V33 Suppl, P144; World Health Organization, 2007, INT CLASS FUNCT DIS; Worrall L, 2000, APHASIOLOGY, V14, P911, DOI 10.1080/02687030050127711; Worrall L. E., 2000, NEUROGENIC COMMUNICA, P162; Ylvisaker M., 1994, LANGUAGE INTERVENTIO, P546; Ylvisaker M., 1993, STAFF DEV CLIN INTER, P57; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P303	123	7	7	0	7	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-0-203-84800-5; 978-1-84872-910-0				2011							603	624					22	Linguistics; Psychology, Experimental	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Linguistics; Psychology	BUI08	WOS:000289414500030					2022-02-06	
J	Woods, DL; Herron, TJ; Yund, EW; Hink, RF; Kishiyama, MM; Reed, B				Woods, David L.; Herron, T. J.; Yund, E. W.; Hink, R. F.; Kishiyama, M. M.; Reed, Bruce			Computerized analysis of error patterns in digit span recall	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Verbal; Memory; Short-term; Working; Malingering; Wechsler Adult Intelligence Scale; Adaptive; Digit span; Traumatic brain injury; Concussion	ADULT INTELLIGENCE SCALE; TRAUMATIC BRAIN-INJURY; SHORT-TERM-MEMORY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; WAIS-III; CLASSIFICATION ACCURACY; PERFORMANCE PATTERNS; IMMEDIATE RECALL; WORKING-MEMORY; ORDER	We analyzed error patterns during digit span (DS) testing in four experiments. In Experiment 1, error patterns analyzed from a community sample of 427 subjects revealed strong primacy and recency effects. Subjects with shorter DSs showed an increased incidence of transposition errors in comparison with other error types and a greater incidence of multiple errors on incorrect trials. Experiment 2 investigated 46 young subjects in three test sessions. The results replicated those of Experiment 1 and demonstrated that error patterns of individual subjects were consistent across repeated test administrations. Experiment 3 investigated 40 subjects from Experiment 2 who feigned symptoms of traumatic brain injury (TBI) with 80% of malingering subjects producing digit spans in the abnormal range. A digit span malingering index (DSMI) was developed to detect atypical error patterns in malingering subjects. Overall, 59% of malingering subjects with abnormal digit spans showed DSMIs in the abnormal range and DSMI values correlated significantly with the magnitude of malingering. Experiment 4 compared 29 patients with TBI with a new group of 38 control subjects. The TBI group showed significant reductions in digit span. Overall, 32% of the TBI patients showed DS abnormalities and 11% showed abnormal DSMIs. Computerized error-pattern analysis improves the sensitivity of DS assessment and can assist in the detection of malingering.	[Woods, David L.] VANCHCS, Neurol Serv 127E, Human Cognit Neurophysiol Lab, Martinez, CA 95553 USA; [Woods, David L.; Reed, Bruce] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Center Neurosci, Davis, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Reed, Bruce] VANCHCS, Alzheimers Dis Ctr, Martinez, CA 95553 USA		Woods, DL (corresponding author), VANCHCS, Neurol Serv 127E, Human Cognit Neurophysiol Lab, 150 Muir Rd, Martinez, CA 95553 USA.	dlwoods@ucdavis.edu		Herron, Timothy/0000-0002-4297-014X; Woods, David/0000-0002-8804-3587; Yund, E./0000-0002-6833-0052	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES014038] Funding Source: NIH RePORTER; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES014038, R01 ES014038] Funding Source: Medline		AARONSON D, 1968, J EXP PSYCHOL, V76, P129, DOI 10.1037/h0025290; Ardila A, 2007, ARCH CLIN NEUROPSYCH, V22, P1003, DOI 10.1016/j.acn.2007.08.004; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; BENTON AL, 1962, CONFIN NEUROL, V22, P141; Bianchini KJ, 2003, CLIN NEUROPSYCHOL, V17, P574, DOI 10.1076/clin.17.4.574.27946; BJORK EL, 1974, J VERB LEARN VERB BE, V13, P80, DOI 10.1016/S0022-5371(74)80033-2; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Bunting MF, 2008, MEM COGNITION, V36, P799, DOI 10.3758/MC.36.4.799; BURGESS N, 1992, J MEM LANG, V31, P429, DOI 10.1016/0749-596X(92)90022-P; Burkart M, 1998, DEMENT GERIATR COGN, V9, P130, DOI 10.1159/000017036; Cameron P.J., 1999, PERMUTATION GROUPS; CAPITANI E, 1992, CORTEX, V28, P315, DOI 10.1016/S0010-9452(13)80143-8; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; CONRAD R, 1965, J VERB LEARN VERB BE, V4, P161, DOI 10.1016/S0022-5371(65)80015-9; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Estes W.K., 1972, CODING PROCESS HUM, P161; Fisher HL, 2005, J CLIN EXP NEUROPSYC, V27, P840, DOI 10.1080/13803390490919065; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; FUCHS AH, 1969, J EXP PSYCHOL, V82, P14, DOI 10.1037/h0028046; GIBSON AJ, 1981, BRIT J CLIN PSYCHOL, V20, P179, DOI 10.1111/j.2044-8260.1981.tb00516.x; Gillam RB, 1998, J SPEECH LANG HEAR R, V41, P913, DOI 10.1044/jslhr.4104.913; GILLAM RB, 1995, J SPEECH HEAR RES, V38, P393, DOI 10.1044/jshr.3802.393; Green P., 1997, WORD MEMORY TEST MAN; Greiffenstein MF, 2008, CLIN NEUROPSYCHOL, V22, P565, DOI 10.1080/13854040701377810; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2007, ASSESSMENT, V14, P12, DOI 10.1177/1073191106295095; Gusfield Dan, 1997, ACM SIGACT NEWS, V1st; HEALY AF, 1974, J VERB LEARN VERB BE, V13, P644, DOI 10.1016/S0022-5371(74)80052-6; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Helland T, 2004, J CLIN EXP NEUROPSYC, V26, P31, DOI 10.1076/jcen.26.1.31.23935; Henson RNA, 1998, COGNITIVE PSYCHOL, V36, P73, DOI 10.1006/cogp.1998.0685; IVERSON GL, 1991, LAW HUMAN BEHAV, V15, P667, DOI 10.1007/BF01065859; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; JURDEN FH, 1993, J GENET PSYCHOL, V154, P249, DOI 10.1080/00221325.1993.9914738; Kemtes KA, 2008, J CLIN EXP NEUROPSYC, V30, P661, DOI 10.1080/13803390701641414; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kessels RPC, 2008, ASSESSMENT, V15, P426, DOI 10.1177/1073191108315611; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; Lamar M, 2007, NEUROPSYCHOLOGIA, V45, P245, DOI 10.1016/j.neuropsychologia.2006.07.009; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LEE CL, 1977, J VERB LEARN VERB BE, V16, P395, DOI 10.1016/S0022-5371(77)80036-4; MASSMAN PJ, 1993, DEV NEUROPSYCHOL, V9, P1, DOI 10.1080/87565649309540540; MCNICOL D, 1971, AUST J PSYCHOL, V23, P77, DOI 10.1080/00049537108254600; Miller LJ, 2004, CLIN NEUROPSYCHOL, V18, P327, DOI 10.1080/13854040490501592; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; OCARROLL RE, 1986, BRIT J CLIN PSYCHOL, V25, P157, DOI 10.1111/j.2044-8260.1986.tb00690.x; Page MPA, 1998, PSYCHOL REV, V105, P761, DOI 10.1037/0033-295X.105.4.761-781; Pebler P., 2011, PRESENTATION SOFTWAR; Richardson JTE, 2007, CORTEX, V43, P635, DOI 10.1016/S0010-9452(08)70493-3; RUNDUS D, 1970, J VERB LEARN VERB BE, V9, P99, DOI 10.1016/S0022-5371(70)80015-9; Ruocco AC, 2008, CLIN NEUROPSYCHOL, V22, P547, DOI 10.1080/13854040701336444; Schwarz LR, 2006, CLIN NEUROPSYCHOL, V20, P741, DOI 10.1080/13854040590967054; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Shum DHK, 2004, ARCH CLIN NEUROPSYCH, V19, P817, DOI 10.1016/j.acn.2003.10.002; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Vagnini VL, 2006, CLIN NEUROPSYCHOL, V20, P289, DOI 10.1080/13854040590947470; Warschausky S, 1996, ARCH CLIN NEUROPSYCH, V11, P147, DOI 10.1016/0887-6177(95)00004-6; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; West L. K., 2010, J NEUROPSYCHOLOGY; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P263, DOI 10.1093/arclin/acp034; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149	76	7	7	1	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	7					721	734		10.1080/13803395.2010.550602			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	882HE	WOS:000299553600001	21957866				2022-02-06	
J	Yarvis, JS				Yarvis, Jeffrey S.			A Civilian Social Worker's Guide to the Treatment of War-Induced PTSD	SOCIAL WORK IN HEALTH CARE			English	Article						post-traumatic stress disorder; wounds of war; PTSD treatment approaches	POSTTRAUMATIC-STRESS-DISORDER; MALE VIETNAM VETERANS; NATIONAL COMORBIDITY SURVEY; TRAUMATIC BRAIN-INJURY; DELAYED-ONSET PTSD; PEACEKEEPING VETERANS; LONGITUDINAL ANALYSIS; MILITARY PERSONNEL; MAJOR DEPRESSION; CARE UTILIZATION	Post-traumatic stress disorder has been designated as one of the signature wounds of the Iraq/Afghanistan war. Approximately 15% of returning service members have been diagnosed with PTSD and the numbers increase daily. As such, civilian social workers and other mental health professionals need to understand the diagnosis and how best to help those struggling with the disorder. This article will explore the etiology and treatment approaches used in management for those with PTSD.	Uniformed Serv Univ Hlth Sci, Dept Family Med, Ft Belvoir, VA 22060 USA		Yarvis, JS (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Family Med, 6915 Inlet Cove Dr, Ft Belvoir, VA 22060 USA.	Jeffrey.Yarvis@amedd.army.mil					Ballenger JC, 2004, J CLIN PSYCHIAT, V65, P55; Beckham JC, 1997, ADDICT BEHAV, V22, P637, DOI 10.1016/S0306-4603(96)00071-8; Blanchard EB, 1998, J ANXIETY DISORD, V12, P21, DOI 10.1016/S0887-6185(97)00047-9; Bolton EE, 2003, J TRAUMA STRESS, V16, P203, DOI 10.1023/A:1023754820991; BOSCARINO JA, 1995, J TRAUMA STRESS, V8, P317, DOI 10.1007/BF02109567; BOSCARINO JA, 2006, ENCY STRESS; Bramsen I, 2000, AM J PSYCHIAT, V157, P1115, DOI 10.1176/appi.ajp.157.7.1115; Breslau N, 2000, BIOL PSYCHIAT, V48, P902, DOI 10.1016/S0006-3223(00)00933-1; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Bryant RA, 2003, J CONSULT CLIN PSYCH, V71, P706, DOI 10.1037/0022-006X.71.4.706; Buckley TC, 2004, MIL MED, V169, P536, DOI 10.7205/MILMED.169.7.536; Buckley TC, 1996, J ABNORM PSYCHOL, V105, P617, DOI 10.1037/0021-843X.105.4.617; Cabrera OA, 2007, AM J PREV MED, V33, P77, DOI 10.1016/j.amepre.2007.03.019; Davis LL, 2006, CNS DRUGS, V20, P465, DOI 10.2165/00023210-200620060-00003; *DEP VET AFF HLTH, 2003, OFF QUAL PERF PUBL; Devilly GJ, 2002, J CLIN PSYCHOL, V58, P1119, DOI 10.1002/jclp.10041; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; EHLERS A, 2006, CLIN PSYCHOL, V13; Engdahl B, 1997, AM J PSYCHIAT, V154, P1576, DOI 10.1176/ajp.154.11.1576; Foa E.B., 2001, INT ENCY SOCIAL BEHA, P12363, DOI DOI 10.1016/B0-08-043076-7/01338-3; FOA EB, 1995, BEHAV THER, V26, P487, DOI 10.1016/S0005-7894(05)80096-6; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Foa EB, 1998, TREATING TRAUMA RAPE; FOA EB, 1999, CLIN PRAC, P23; Fontana A, 1998, PSYCHIATR SERV, V49, P658, DOI 10.1176/ps.49.5.658; Forbes D, 2003, J NERV MENT DIS, V191, P93, DOI 10.1097/01.NMD.0000051903.60517.98; Freeman TW, 2003, SOUTH MED J, V96, P240, DOI 10.1097/01.SMJ.0000054421.36880.6E; Gahm GA, 2008, MIL MED, V173, P17, DOI 10.7205/MILMED.173.1.17; Gray MJ, 2004, J CONSULT CLIN PSYCH, V72, P909, DOI 10.1037/0022-006X.72.5.909; Gray MJ, 2004, PSYCHIAT QUART, V75, P321, DOI 10.1023/B:PSAQ.0000043508.52428.6e; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; HELZER JE, 1987, NEW ENGL J MED, V317, P1630, DOI 10.1056/NEJM198712243172604; Himmelfarb N, 2006, J TRAUMA STRESS, V19, P837, DOI 10.1002/jts.20163; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Institute of Medicine, 2007, TREAT POSTTR STRESS; JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916; Keane T. M., 2004, ASSESSING PSYCHOL TR, P262; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 1997, PSYCHOL MED, V27, P861, DOI 10.1017/S0033291797004807; King DW, 1996, J CONSULT CLIN PSYCH, V64, P520, DOI 10.1037/0022-006X.64.3.520; King LA, 1998, J PERS SOC PSYCHOL, V74, P420, DOI 10.1037/0022-3514.74.2.420; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Koenen KC, 2006, J CONSULT CLIN PSYCH, V74, P186, DOI 10.1037/0022-006X.74.1.186; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Lapp KG, 2005, MIL MED, V170, P787, DOI 10.7205/MILMED.170.9.787; Ledgerwood DM, 2006, J TRAUMA STRESS, V19, P411, DOI 10.1002/jts.20123; Litz BT, 1997, AM J PSYCHIAT, V154, P178; Maguen S, 2006, MIL MED, V171, P454, DOI 10.7205/MILMED.171.5.454; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; MCNALLY RJ, 1995, AM J PSYCHIAT, V152, P936; McWilliams LA, 2005, J ANXIETY DISORD, V19, P626, DOI 10.1016/j.janxdis.2004.06.003; Mehlum L, 2002, J TRAUMA STRESS, V15, P17, DOI 10.1023/A:1014375026332; Mellman TA, 2003, PSYCHIAT SERV, V54, P1618, DOI 10.1176/appi.ps.54.12.1618; Novaco RW, 2002, J TRAUMA STRESS, V15, P123, DOI 10.1023/A:1014855924072; Orth U, 2006, J CONSULT CLIN PSYCH, V74, P698, DOI 10.1037/0022-006X.74.4.698; Ouimette P, 2003, J CONSULT CLIN PSYCH, V71, P410, DOI 10.1037/0022-006X.71.2.410; Ouimette P., 2002, TRAUMA SUBSTANCE ABU; Prigerson HG, 2001, J NERV MENT DIS, V189, P99, DOI 10.1097/00005053-200102000-00005; RESICK PA, 1992, J CONSULT CLIN PSYCH, V60, P748, DOI 10.1037/0022-006X.60.5.748; RESICK PA, 2005, ANN M ASS BEHAV COGN; Richardson JD, 2006, J CLIN PSYCHIAT, V67, P1240, DOI 10.4088/JCP.v67n0810; Riggs DS, 1998, J TRAUMA STRESS, V11, P87, DOI 10.1023/A:1024409200155; Rizzo AA, 2009, VIRTUAL REALITY EXPO; Rosen GM, 2006, J PERS ASSESS, V86, P329, DOI 10.1207/s15327752jpa8603_08; Ruscio AM, 2002, J TRAUMA STRESS, V15, P351, DOI 10.1023/A:1020125006371; Samper RE, 2004, J TRAUMA STRESS, V17, P311, DOI 10.1023/B:JOTS.0000038479.30903.ed; Sareen J, 2005, J NERV MENT DIS, V193, P450, DOI 10.1097/01.nmd.0000168263.89652.6b; Sautter F, 2006, J PSYCHOPATHOL BEHAV, V28, P123, DOI 10.1007/s10862-006-7490-x; Schnurr P. P., 2004, TRAUMA HLTH PHYS HLT; Schnurr PP, 2006, J CONSULT CLIN PSYCH, V74, P707, DOI 10.1037/0022-006X.74.4.707; SCHNURR PP, 2000, J CONSULT CLIN PSYCH, V67, P236; SHEAR K, 2006, COGNITIVE BEHAV THER, P290; Smith Mark W, 2005, Ment Health Serv Res, V7, P89, DOI 10.1007/s11020-005-3780-2; Stapleton JA, 2006, MIL MED, V171, P562, DOI 10.7205/MILMED.171.6.562; Stein MB, 2000, GEN HOSP PSYCHIAT, V22, P261, DOI 10.1016/S0163-8343(00)00080-3; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; Stein MB, 2002, AM J PSYCHIAT, V159, P1777, DOI 10.1176/appi.ajp.159.10.1777; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Ward J., 2002, TORONTO STAR; Weathers F.W., 1993, ANN CONV INT SOC TRA; WEISS DS, 1992, J TRAUMA STRESS, V5, P365, DOI 10.1002/jts.2490050304; Wolfe J, 1999, J CONSULT CLIN PSYCH, V67, P520, DOI 10.1037/0022-006X.67.4.520; Yaeger D, 2006, J GEN INTERN MED, V21, pS65, DOI 10.1111/j.1525-1497.2006.00377.x; Yarvis JS, 2008, J WORKPLACE BEHAV HE, V23, P395, DOI 10.1080/15555240802547801; YARVIS JS, 2005, STRESS TRAUMA CRISIS, V8, P195, DOI DOI 10.1080/15434610590956949; Zlotnick C, 2002, COMPR PSYCHIAT, V43, P413, DOI 10.1053/comp.2002.35900	90	7	7	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	0098-1389			SOC WORK HEALTH CARE	Soc. Work Health Care		2011	50	1					51	72		10.1080/00981389.2010.518856			22	Social Work	Social Science Citation Index (SSCI)	Social Work	726GJ	WOS:000287707600005	21240771				2022-02-06	
J	Yoshihara, H; VanderHeiden, TF; Harasaki, Y; Beauchamp, KM; Stahel, PF				Yoshihara, Hiroyuki; VanderHeiden, Todd F.; Harasaki, Yasuaki; Beauchamp, Kathryn M.; Stahel, Philip F.			Fatal outcome after brain stem infarction related to bilateral vertebral artery occlusion - case report of a detrimental complication of cervical spine trauma	PATIENT SAFETY IN SURGERY			English	Article								Background: Vertebral artery injury (VAI) after blunt cervical trauma occurs more frequently than historically believed. The symptoms due to vertebral artery (VA) occlusion usually manifest within the first 24 hours after trauma. Misdiagnosed VAI or delay in diagnosis has been reported to cause acute deterioration of previously conscious and neurologically intact patients. Case presentation: A 67 year-old male was involved in a motor vehicle crash (MVC) sustaining multiple injuries. Initial evaluation by the emergency medical response team revealed that he was alert, oriented, and neurologically intact. He was transferred to the local hospital where cervical spine computed tomography (CT) revealed several abnormalities. Distraction and subluxation was present at C5-C6 and a comminuted fracture of the left lateral mass of C6 with violation of the transverse foramen was noted. Unavailability of a spine specialist prompted the patient's transfer to an area medical center equipped with spine care capabilities. After arrival, the patient became unresponsive and neurological deficits were noted. His continued deterioration prompted yet another transfer to our Level 1 regional trauma center. A repeat cervical spine CT at our institution revealed significantly worsened subluxation at C5-C6. CT angiogram also revealed complete occlusion of bilateral VA. The following day, a repeat CT of the head revealed brain stem infarction due to bilateral VA occlusion. Shortly following, the patient was diagnosed with brain death and care was withdrawn. Conclusion: Brain stem infarction secondary to bilateral VA occlusion following cervical spine trauma resulted in fatal outcome. Prompt imaging evaluation is necessary to assess for VAI in cervical trauma cases with facet joint subluxation/dislocation or transverse foramen fracture so that treatment is not delayed. Additionally, multiple transportation events are risk factors for worsening when unstable cervical injuries are present. Close attention to proper immobilization and neck position depending on the mechanism of injury is mandatory.	[Yoshihara, Hiroyuki; VanderHeiden, Todd F.; Stahel, Philip F.] Univ Colorado, Denver Hlth Med Ctr, Sch Med, Dept Orthopaed Surg, 777 Bannock St, Denver, CO 80204 USA; [Harasaki, Yasuaki; Beauchamp, Kathryn M.] Univ Colorado, Denver Hlth Med Ctr, Sch Med, Dept Neurosurg, Denver, CO 80204 USA		Yoshihara, H (corresponding author), Univ Colorado, Denver Hlth Med Ctr, Sch Med, Dept Orthopaed Surg, 777 Bannock St, Denver, CO 80204 USA.	hiroyoshihara55@yahoo.co.jp	Yoshihara, Hiroyuki/P-8444-2014				Biffl WL, 2002, J TRAUMA, V53, P850, DOI 10.1097/00005373-200211000-00008; Biffl WL, 2000, ANN SURG, V231, P672, DOI 10.1097/00000658-200005000-00007; Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; CARPENTER S, 1961, J NEUROSURG, V18, P849, DOI 10.3171/jns.1961.18.6.0849; Cheatham ML, 1998, AM SURGEON, V64, P900; FRIEDMAN D, 1995, AM J ROENTGENOL, V164, P443, DOI 10.2214/ajr.164.2.7839986; Giacobetti FB, 1997, SPINE, V22, P188, DOI 10.1097/00007632-199701150-00011; GOLUEKE P, 1987, J TRAUMA, V27, P856, DOI 10.1097/00005373-198708000-00003; Harrop JS, 2001, SPINE, V26, P340, DOI 10.1097/00007632-200102150-00008; Hauswald M, 1998, ACAD EMERG MED, V5, P214, DOI 10.1111/j.1553-2712.1998.tb02615.x; Hollingworth W, 2003, EUR J RADIOL, V48, P88, DOI 10.1016/S0720-048X(03)00200-6; Inamasu J, 2006, SURG NEUROL, V65, P238, DOI 10.1016/j.surneu.2005.06.043; Kloen P, 1999, ARCH ORTHOP TRAUM SU, V119, P478, DOI 10.1007/s004020050027; LOUW JA, 1990, J BONE JOINT SURG BR, V72, P679, DOI 10.1302/0301-620X.72B4.2380226; LYNESS SS, 1978, ORTHOP CLIN N AM, V9, P1029; MARKS RL, 1973, ARCH NEUROL-CHICAGO, V28, P412, DOI 10.1001/archneur.1973.00490240072014; MARSHALL LF, 1987, J NEUROSURG, V66, P400, DOI 10.3171/jns.1987.66.3.0400; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Ozveren F, 1999, NEUROL MED-CHIR, V39, P28, DOI 10.2176/nmc.39.28; PARENT AD, 1992, NEUROSURGERY, V31, P501, DOI 10.1227/00006123-199209000-00012; Prabhu V, 1996, J TRAUMA, V40, P130, DOI 10.1097/00005373-199601000-00027; Schneider RC, 1972, NEUROLOGY, V19, P312; SIMEONE FA, 1968, J NEUROSURG, V29, P540, DOI 10.3171/jns.1968.29.5.0540; SIX EG, 1981, J NEUROSURG, V54, P814, DOI 10.3171/jns.1981.54.6.0814; Taylor MW, 2002, J TRAUMA, V52, P1186, DOI 10.1097/00005373-200206000-00027; Wirbel R, 1996, SPINE, V21, P1375, DOI 10.1097/00007632-199606010-00020	26	7	9	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1754-9493			PATIENT SAF SURG	Patient Saf. Surg.		2011	5								18	10.1186/1754-9493-5-18			5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	V13PC	WOS:000214424300018	21756312	Green Published, gold			2022-02-06	
J	Brody, A; Kashuk, JL; Moore, EE; Beauchamp, K; Barnett, C; Biffl, WL; Burlew, CC; Johnson, JL; Sauaia, A				Brody, Aaron; Kashuk, Jeffry L.; Moore, Ernest E.; Beauchamp, Kathryn; Barnett, Carlton; Biffl, Walter L.; Burlew, C. Clay; Johnson, Jeffrey L.; Sauaia, Angela			Fatal gunshot wounds to the head: a critical appraisal of organ donation rates	AMERICAN JOURNAL OF SURGERY			English	Article; Proceedings Paper	62nd Annual Meeting of the Southwestern-Surgical-Congress	MAR 21-24, 2010	Tucson, AZ	SW Surg Congress		Penetrating head injury; Gunshot wound; Organ transplantation; Organ donation; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; UNITED-STATES; WAITING-LIST; POTENTIAL DONORS; SPANISH MODEL; MORTALITY; TRANSPLANTATION; PROCUREMENT; MANAGEMENT; MEDICINE	BACKGROUND: Patients sustaining fatal gunshot wounds to the head are often young, without associated comorbidities, and are potentially ideal transplantation candidates. METHODS: A 5-year review of a level I trauma center's prospective database was performed for all patients sustaining fatal gunshot wounds to the head. Demographic, physiologic, anatomic, and laboratory variables were collected. RESULTS: Sixty-eight patients were identified, of whom 10 (14.7%) were organ donors. Of 25 admitted to the intensive care unit who eventually did not become donors, 15 (60%) were due to lack of consent. CONCLUSIONS: Despite frequent intensive care unit admissions, organ donation is infrequent following fatal gunshot wounds to the head, primarily because of lack of consent. Improved communication with next of kin could improve organ recovery and reduce futile care in this group. (C) 2010 Elsevier Inc. All rights reserved.	[Brody, Aaron] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI 48201 USA; [Kashuk, Jeffry L.] Penn State Hershey Med Ctr, Dept Surg, Div Trauma Crit Care & Acute Care Surg, Hershey, PA USA; [Moore, Ernest E.; Beauchamp, Kathryn; Barnett, Carlton; Biffl, Walter L.; Burlew, C. Clay; Johnson, Jeffrey L.] Rocky Mt Reg Trauma Ctr, Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Sauaia, Angela] Univ Colorado, Dept Surg, Denver, CO 80202 USA		Brody, A (corresponding author), Wayne State Univ, Sch Med, Dept Emergency Med, 540 E Canfield, Detroit, MI 48201 USA.	abrody@dmc.org					Aaronson KD, 1999, J AM COLL CARDIOL, V33, P1189, DOI 10.1016/S0735-1097(98)00697-4; Aubrey P, 2008, TRANSPL P, V40, P1008, DOI 10.1016/j.transproceed.2008.03.059; Austin MT, 2007, ARCH SURG-CHICAGO, V142, P1079, DOI 10.1001/archsurg.142.11.1079; Bresnahan MJ, 2010, BIOETHICS, V24, P54, DOI 10.1111/j.1467-8519.2008.00690.x; Croezen DH, 2001, CLIN TRANSPLANT, V15, P11, DOI 10.1034/j.1399-0012.2001.00002.x; DuBose Joseph, 2008, J Intensive Care Med, V23, P367, DOI 10.1177/0885066608324208; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Hartman M, 2009, HEALTH AFFAIR, V28, P246, DOI 10.1377/hlthaff.28.1.246; Kemp CD, 2008, J TRAUMA, V64, P1573, DOI 10.1097/TA.0b013e318068fc2f; Klassen AC, 1996, ANN INTERN MED, V125, P70, DOI 10.7326/0003-4819-125-1-199607010-00011; Kluge EH, 1997, CAN MED ASSOC J, V157, P160; Kompanje EJO, 2006, INTENS CARE MED, V32, P217, DOI 10.1007/s00134-005-0001-9; Lanken P N, 1997, New Horiz, V5, P38; Lopez-Navidad A, 2002, TRANSPLANT P, V34, P20, DOI 10.1016/S0041-1345(01)02826-3; MACKENZIE DJ, 1993, AM SURGEON, V59, P764; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P289; Mascia L, 2009, MINERVA ANESTESIOL, V75, P125; Matesanz R, 2002, J NEPHROL, V15, P22; Michael GE, 2009, ACAD EMERG MED, V16, P850, DOI 10.1111/j.1553-2712.2009.00472.x; Procaccio F, 2001, Minerva Anestesiol, V67, P71; Punch JD, 2007, AM J TRANSPLANT, V7, P1327, DOI 10.1111/j.1600-6143.2007.01779.x; Quigley M, 2008, J MED ETHICS, V34, P223, DOI 10.1136/jme.2007.023127; REILLY PM, 1997, INTERNET J THORAC CA; Salim A, 2005, J TRAUMA, V58, P991, DOI 10.1097/01.TA.0000168708.78049.32; Sisko A, 2009, HEALTH AFFAIR, V28, pW346, DOI 10.1377/hlthaff.28.2.w346; Sung RS, 2008, AM J TRANSPLANT, V8, P922, DOI 10.1111/j.1600-6143.2008.02171.x; Venuta F, 2003, J HEART LUNG TRANSPL, V22, P828, DOI 10.1016/S1053-2498(02)00634-4; Wendler D, 2001, JAMA-J AM MED ASSOC, V285, P329, DOI 10.1001/jama.285.3.329; DONATE LIFE AM DONOR	29	7	8	0	2	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610			AM J SURG	Am. J. Surg.	DEC	2010	200	6					728	733		10.1016/j.amjsurg.2010.09.002			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	708EO	WOS:000286344900018	21146012				2022-02-06	
J	Chadwick, DL; Castillo, EM; Kuelbs, C; Cox, SA; Lindsay, SP				Chadwick, David L.; Castillo, Edward M.; Kuelbs, Cynthia; Cox, Susan A.; Lindsay, Suzanne P.			Missed and missing cases of abusive injuries: The magnitude and the measurement of the problem	CHILD ABUSE & NEGLECT			English	Article						Case fatality rate; Inflicted physical injury; Unintentional injury; Disparity; Missed injury; Missing injury; Unrecognized injury	TRAUMATIC BRAIN-INJURY; SUSPECTED CHILD-ABUSE; HEAD-INJURY; YOUNG-CHILDREN; BATTERED-CHILD; INFANTS; MALTREATMENT; POPULATION; S100B; COST	Objective: The authors' objective is to describe the disparity between the case-fatality rates for inflicted versus unintentional injuries of children, and to emphasize its utility as a way of estimating the effectiveness of the ascertainment of inflicted injuries of children. Method: Determination, comparison, and explanation of the case-fatality-rate disparity in four injury databases were derived from hospitalized injury cases. Results: The CFR disparity is 6-14-fold in the 4 injury databases. The CFR disparity varies strongly and inversely with the observed incidence of inflicted injuries in the databases. Conclusions: A large disparity between the case fatality rates (CFRs) of inflicted and unintentional injuries exists in a number of injury databases. Inflicted injuries have much higher CFRs than unintentional injuries. The disparity can be accounted for by "missed" (incorrectly diagnosed) and "missing" (unseen) cases. Practice implications: Present diagnostic criteria for physically abusive (inflicted) injuries are forensically-driven and too conservative for public health purposes. New public-health-oriented case definitions for "inflicted injury" are needed. Programs to reduce injury recidivism in young children should be a part of overall injury prevention. (C) 2010 Elsevier Ltd. All rights reserved.	[Chadwick, David L.; Kuelbs, Cynthia] Rady Childrens Hosp San Diego, Chadwick Ctr Children & Families, San Diego, CA USA; [Castillo, Edward M.] Univ Calif San Diego, Sch Med, Dept Emergency Med, San Diego, CA 92103 USA; [Cox, Susan A.] Rady Childrens Hosp San Diego, Childrens Trauma Ctr, San Diego, CA USA; [Lindsay, Suzanne P.] San Diego State Univ, Grad Sch Publ Hlth, Inst Publ Hlth, San Diego, CA 92182 USA		Chadwick, DL (corresponding author), Rady Childrens Hosp San Diego, Chadwick Ctr Children & Families, 4816 Rushville Lane, San Diego, CA USA.						*AM COLL SURG, 2004, NAT TRAUM DAT; AYOUB C, 1979, AM J DIS CHILD, V133, P910, DOI 10.1001/archpedi.1979.02130090038006; Barr RG, 2009, CAN MED ASSOC J, V180, P727, DOI 10.1503/cmaj.081419; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Block RW, 2006, J PEDIATR-US, V148, P711, DOI 10.1016/j.jpeds.2006.01.033; Campbell KA, 2007, PEDIATRICS, V120, P295, DOI 10.1542/peds.2007-0437; Chang DC, 2004, J TRAUMA, V57, P1189, DOI 10.1097/01.TA.0000145076.05111.E1; COOPER A, 1988, J TRAUMA, V28, P1483, DOI 10.1097/00005373-198810000-00015; *DEP PUBL HLTH STA, 2008, EPICENTER; Dubowitz H, 2009, PEDIATRICS, V123, P858, DOI 10.1542/peds.2008-1376; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Ettaro L, 2004, CHILD ABUSE NEGLECT, V28, P1099, DOI 10.1016/j.chiabu.2004.06.006; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; FELDMAN K, 1997, BATTERED CHILD, P1997; Flaherty EG, 2006, CHILD ABUSE NEGLECT, V30, P341, DOI 10.1016/j.chiabu.2006.02.008; GARCIA VF, 1990, J TRAUMA, V30, P695, DOI 10.1097/00005373-199006000-00007; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; HAMPTON RL, 1985, AM J PUBLIC HEALTH, V75, P56, DOI 10.2105/AJPH.75.1.56; HARPER FV, 1963, PEDIATRICS, V31, P899; Irazuzta JE, 1997, CHILD ABUSE NEGLECT, V21, P751, DOI 10.1016/S0145-2134(97)00036-7; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jones R, 2008, PEDIATRICS, V122, P259, DOI 10.1542/peds.2007-2312; Kairys SW, 2002, PEDIATRICS, V110, P644; Kaufmann CR, 1998, J TRAUMA, V45, P325, DOI 10.1097/00005373-199808000-00019; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; Libby AM, 2003, PEDIATRICS, V112, P58, DOI 10.1542/peds.112.1.58; MacMillan HL, 2003, CHILD ABUSE NEGLECT, V27, P1397, DOI 10.1016/j.chiabu.2003.06.003; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; PECLET MH, 1990, J PEDIATR SURG, V25, P85, DOI 10.1016/S0022-3468(05)80169-1; Schmitt BD., 1980, BATTERED CHILD, P128; Sege RD, 2008, ARCH DIS CHILD, V93, P822, DOI 10.1136/adc.2006.100545; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; SILVERMAN FN, 1953, AM J ROENTGENOL, V69, P413; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; TARDIEU A, 1860, ANN HYG PUBLIQUE MED, V13, P361, DOI DOI 10.3917/EP.039.0174; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; Trokel M, 2006, PEDIATRICS, V117, P722, DOI 10.1542/peds.2004-2731; *US DEP HHS, 2003, 3582 ICPSR CDCP US D; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Vulliamy AP, 2000, CHILD ABUSE NEGLECT, V24, P1461, DOI 10.1016/S0145-2134(00)00199-X; ZELLMAN GL, 1992, CHILD ABUSE NEGLECT, V16, P57, DOI 10.1016/0145-2134(92)90008-F	42	7	7	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134			CHILD ABUSE NEGLECT	Child Abuse Negl.	DEC	2010	34	12					943	950		10.1016/j.chiabu.2010.08.001			8	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	704FX	WOS:000286037600006	21047687				2022-02-06	
J	Kuo, LT; Huang, APH; Yang, CC; Tsai, SY; Tu, YK; Huang, SJ				Kuo, Lu-Ting; Huang, Abel Po-Hao; Yang, Chi-Cheng; Tsai, Shao-Yu; Tu, Yong-Kwang; Huang, Sheng-Jean			Clinical Outcome of Mild Head Injury with Isolated Oculomotor Nerve Palsy	JOURNAL OF NEUROTRAUMA			English	Article						head trauma; oculomotor nerve palsy; outcome measures; traumatic brain injury	STRUCTURED INTERVIEWS; INITIAL SIGN; TRAUMA	Isolated oculomotor nerve palsy after mild head injury is rare. Only a few case reports have described the clinical presentation of these patients, and clinical and functional outcome have not been discussed in depth. The outcome of 10 patients with mild head injury in whom imaging studies ruled out other possible causes of oculomotor palsy was assessed during follow-up using the Glasgow Outcome Scale-Extended (GOSE). We suggest that limited eye movement is a major factor that negatively affects functional status after mild head injury.	[Tsai, Shao-Yu; Tu, Yong-Kwang; Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Div Neurosurg, Dept Surg, Taipei 100, Taiwan; [Kuo, Lu-Ting] Natl Taiwan Univ Hosp, Div Neurosurg, Dept Surg, Yunlin, Taiwan; [Huang, Abel Po-Hao] Chang Gung Univ, Dept Occupat Therapy, Tao Yuan, Taiwan; [Yang, Chi-Cheng] Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei, Taiwan		Huang, SJ (corresponding author), Natl Taiwan Univ Hosp, Div Neurosurg, Dept Surg, 7 Chung San S Rd, Taipei 100, Taiwan.	sjhuang@ntu.edu.tw	Kuo, Lu-Ting/AAU-3205-2021	Kuo, Lu-Ting/0000-0002-1405-8700; HUANG, ABEL PO-HAO/0000-0002-5689-6761; Tu, Yong-kwang/0000-0003-2113-1176; TSAI, SHAO-YU/0000-0002-2874-5202			Balcer LJ, 1996, AM J OPHTHALMOL, V122, P437, DOI 10.1016/S0002-9394(14)72078-1; BURDE RM, 1980, BRAIN RES, V198, P434, DOI 10.1016/0006-8993(80)90757-X; Chen CC, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.016311; Chua H. C., 2000, SMJ Singapore Medical Journal, V41, P458; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; EYSTER EF, 1972, J AMER MED ASSOC, V220, P1083, DOI 10.1001/jama.220.8.1083; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; ING EB, 1992, J PEDIATR OPHTHALMOL, V29, P331; JACOBSON DM, 1988, J CLIN NEURO-OPHTHAL, V8, P263; Kaido T, 2006, J CLIN NEUROSCI, V13, P852, DOI 10.1016/j.jocn.2005.08.020; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; KSIAZEK SM, 1994, AM J OPHTHALMOL, V118, P97, DOI 10.1016/S0002-9394(14)72848-X; Levy RL, 2005, NEUROLOGY, V65, P169, DOI 10.1212/01.wnl.0000167288.10702.03; Miller NR, 1996, CURR OPIN NEUROL, V9, P21, DOI 10.1097/00019052-199602000-00005; Muthu P, 2001, EMERG MED J, V18, P310, DOI 10.1136/emj.18.4.310; NAGASEKI Y, 1989, ACTA NEUROCHIR, V97, P117, DOI 10.1007/BF01772821; Neetens A, 1981, Bull Soc Belge Ophtalmol, V193, P161; Park UC, 2008, EYE, V22, P691, DOI 10.1038/sj.eye.6702720; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; REDING MJ, 1988, STROKE, V19, P1354, DOI 10.1161/01.STR.19.11.1354; ROPER-HALL G, 1975, American Orthoptic Journal, V25, P122; SAAD N, 1992, AUST NZ J OPHTHALMOL, V20, P121, DOI 10.1111/j.1442-9071.1992.tb00723.x; TOKUNO T, 1995, NEUROL SURG TOKYO, V23, P497; WALTER KA, 1994, NEUROLOGY, V44, P148, DOI 10.1212/WNL.44.1.148; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	26	7	9	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2010	27	11					1959	1964		10.1089/neu.2010.1407			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	682BZ	WOS:000284375500003	20799883				2022-02-06	
J	Kim, YW; Kim, HS; An, YS; Im, SH				Kim, Yong Wook; Kim, Hyoung Seop; An, Young-Sil; Im, Sang Hee			Voxel-based statistical analysis of cerebral glucose metabolism in patients with permanent vegetative state after acquired brain injury	CHINESE MEDICAL JOURNAL			English	Article						cerebral glucose metabolism; permanent vegetative state; acquired brain injury	MINIMALLY CONSCIOUS STATE; COMA RECOVERY SCALE; CONNECTIVITY; MECHANISMS; PRECUNEUS; DIAGNOSIS; CRITERIA	Background Permanent vegetative state is defined as the impaired level of consciousness longer than 12 months after traumatic causes and 3 months after non-traumatic causes of brain injury. Although many studies assessed the cerebral metabolism in patients with acute and persistent vegetative state after brain injury, few studies investigated the cerebral metabolism in patients with permanent vegetative state. In this study, we performed the voxel-based analysis of cerebral glucose metabolism and investigated the relationship between regional cerebral glucose metabolism and the severity of impaired consciousness in patients with permanent vegetative state after acquired brain injury. Methods We compared the regional cerebral glucose metabolism as demonstrated by F-18 fluorodeoxyglucose positron emission tomography from 12 patients with permanent vegetative state after acquired brain injury with those from 12 control subjects. Additionally, covariance analysis was performed to identify regions where decreased changes in regional cerebral glucose metabolism significantly correlated with a decrease of level of consciousness measured by JFK-coma recovery scale. Statistical analysis was performed using statistical parametric mapping. Results Compared with controls, patients with permanent vegetative state demonstrated decreased cerebral glucose metabolism in the left precuneus, both posterior cingulate cortices, the left superior parietal lobule (P-corrected < 0.001), and increased cerebral glucose metabolism in the both cerebellum and the right supramarginal cortices (P-corrected < 0.001). In the covariance analysis, a decrease in the level of consciousness was significantly correlated with decreased cerebral glucose metabolism in the both posterior cingulate cortices (P-uncorrected < 0.005). Conclusion Our findings suggest that the posteromedial parietal cortex, which are part of neural network for consciousness, may be relevant structure for pathophysiological mechanism in patients with permanent vegetative state after acquired brain injury. Chin Mod J 2010;123(20):2853-2857	[Kim, Yong Wook] Yonsei Univ, Coll Med, Dept & Res Inst Rehabil, Seoul, South Korea; [Kim, Hyoung Seop] Ilsan Hosp, Natl Hlth Insurance Corp, Dept Phys Med & Rehabil, Gyonggi Do, South Korea; [An, Young-Sil] Ajou Univ, Sch Med, Dept Nucl Med, Suwon 441749, South Korea; [Im, Sang Hee] Cheju Natl Univ, Sch Med, Dept Rehabil Med, Cheju, South Korea		Im, SH (corresponding author), Jeju Natl Univ Hosp, Dept Rehabil Med, Ara 1 Dong 1753-3, Cheju 690716, South Korea.	dongin32@yahoo.com		IM, Sang Hee/0000-0001-5128-5526; KIM, YONGWOOK/0000-0002-5234-2454; An, Young-Sil/0000-0003-0777-6226			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Fins JJ, 2007, ARCH NEUROL-CHICAGO, V64, P1400, DOI 10.1001/archneur.64.10.1400; Fiset P, 1999, J NEUROSCI, V19, P5506; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, NEUROREHABILITATION, V19, P335; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; LEVY DE, 1987, ANN NEUROL, V22, P673, DOI 10.1002/ana.410220602; Rainville P, 1999, J COGNITIVE NEUROSCI, V11, P110, DOI 10.1162/089892999563175; Rudolf J, 2002, EUR J NEUROL, V9, P671, DOI 10.1046/j.1468-1331.2002.00468.x; Rudolf J, 1999, J NEUROSURG ANESTH, V11, P17, DOI 10.1097/00008506-199901000-00004; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; TOMRNASINO C, 1995, J NEUROSURG ANESTHES, V7, P109; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313	23	7	7	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	OCT 20	2010	123	20					2853	2857		10.3760/cma.j.issn.0366-6999.2010.20.020			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	673WF	WOS:000283694200020	21034596				2022-02-06	
J	Shinkai-Ouchi, F; Yamakawa, Y; Hara, H; Tobiume, M; Nishijima, M; Hanada, K; Hagiwara, K				Shinkai-Ouchi, Fumiko; Yamakawa, Yoshio; Hara, Hideyuki; Tobiume, Minoru; Nishijima, Masahiro; Hanada, Kentaro; Hagiwara, Ken'ichi			Identification and structural analysis of C-terminally truncated collapsin response mediator protein-2 in a murine model of prion diseases	PROTEOME SCIENCE			English	Article							FIBRILLARY ACIDIC PROTEIN; TRAUMATIC BRAIN-INJURY; POSTTRANSLATIONAL MODIFICATIONS; EXPRESSION PROFILES; NEURITE OUTGROWTH; CALPAIN CLEAVAGE; INFECTED MICE; MOUSE-BRAIN; GROWTH CONE; MU-CALPAIN	Background: Prion diseases are fatal neurodegenerative disorders that accompany an accumulation of the disease-associated form(s) of prion protein (PrPSc) in the central nervous system. The neuropathological changes in the brain begin with focal deposits of PrPSc, followed by pathomorphological abnormalities of axon terminal degeneration, synaptic loss, atrophy of dendritic trees, and eventual neuronal cell death in the lesions. However, the underlying molecular basis for these neuropathogenic abnormalities is not fully understood. Results: In a proteomic analysis of soluble proteins in the brains of mice challenged intracerebrally with scrapie prion (Obihiro I strain), we found that the amount of the full-length form of collapsin response mediator protein-2 (CRMP-2; 61 kDa) decreased in the late stages of the disease, while the amount of its truncated form (56 kDa) increased to comparable levels observed for the full-length form. Detailed analysis by liquid chromatography-electrospray ionization-tandem mass spectrometry showed that the 56-kDa form (named CRMP-2-Delta C) lacked the sequence from serine(518) to the C-terminus, including the C-terminal phosphorylation sites important for the regulation of axonal growth and axon-dendrite specification in developing neurons. The invariable size of the mRNA transcript in Northern blot analysis suggested that the truncation was due to post-translational proteolysis. By overexpression of CRMP-2-Delta C in primary cultured neurons, we observed the augmentation of the development of neurite branch tips to the same levels as for CRMP-2(T514A/T555A), a non-phosphorylated mimic of the full-length protein. This suggests that the increased level of CRMP-2-Delta C in the brain modulates the integrity of neurons, and may be involved in the pathogenesis of the neuronal abnormalities observed in the late stages of the disease. Conclusions: We identified the presence of CRMP-2-Delta C in the brain of a murine model of prion disease. Of note, C-terminal truncations of CRMP-2 have been recently observed in models for neurodegenerative disorders such as ischemia, traumatic brain injury, and Wallerian degeneration. While the structural identity of CRMP-2-Delta C in those models remains unknown, the present study should provide clues to the molecular pathology of degenerating neurons in prion diseases in connection with other neurodegenerative disorders.	[Shinkai-Ouchi, Fumiko; Yamakawa, Yoshio; Hara, Hideyuki; Nishijima, Masahiro; Hanada, Kentaro; Hagiwara, Ken'ichi] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan; [Tobiume, Minoru] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Nishijima, Masahiro] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan		Hagiwara, K (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	hagiwark@nih.go.jp	Shinkai-ouchi, Fumiko/E-3207-2010	Shinkai-ouchi, Fumiko/0000-0002-0095-941X; Hagiwara, Ken'ichi/0000-0002-1948-6034	MHLW, Japan [20330701]; MEXT, JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [17659024]	We thank Prof. M. Horiuchi (University of Hokkaido) for the anti-PrP antibody 44B1. This work was supported by Grants-in-aid for BSE Research from MHLW, Japan (20330701, YY and KH) and for Exploratory Research from MEXT, Japan (17659024, KH).	Auvergnon N, 2009, BRAIN RES, V1261, P1, DOI 10.1016/j.brainres.2009.01.006; Breci LA, 2003, ANAL CHEM, V75, P1963, DOI 10.1021/ac026359i; Bretin S, 2005, J COMP NEUROL, V486, P1, DOI 10.1002/cne.20465; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brown AR, 2005, BIOCHEM BIOPH RES CO, V334, P86, DOI 10.1016/j.bbrc.2005.06.060; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Byk T, 1998, EUR J BIOCHEM, V254, P14, DOI 10.1046/j.1432-1327.1998.2540014.x; Chich JF, 2007, BBA-PROTEINS PROTEOM, V1774, P154, DOI 10.1016/j.bbapap.2006.10.016; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; DIEDRICH J, 1987, MICROB PATHOGENESIS, V2, P435, DOI 10.1016/0882-4010(87)90050-7; *EXPASY PROT SERV, COMP PL MW TOOL; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gray BC, 2006, BIOCHEM SOC T, V34, P51, DOI 10.1042/BST0340051; Greenwood AD, 2005, J MOL BIOL, V349, P487, DOI 10.1016/j.jmb.2005.03.076; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; HOGAN RN, 1987, J NEUROPATH EXP NEUR, V46, P461, DOI 10.1097/00005072-198707000-00005; Inoue Y, 2005, JPN J INFECT DIS, V58, P78; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Jiang SX, 2007, EUR J NEUROSCI, V26, P801, DOI 10.1111/j.1460-9568.2007.05715.x; Kamata T, 1998, MOL BRAIN RES, V54, P219, DOI 10.1016/S0169-328X(97)00332-X; Katano T, 2006, PROTEOMICS, V6, P6085, DOI 10.1002/pmic.200600300; Kim CL, 2004, VIROLOGY, V320, P40, DOI 10.1016/j.virol.2003.10.026; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kumar Y, 2004, PROTEOMICS, V4, P1672, DOI 10.1002/pmic.200300778; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Mironov A, 2003, J NEUROSCI, V23, P7183, DOI 10.1523/JNEUROSCI.23-18-07183.2003; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB., 2004, PRION BIOL DIS, V2; Quinn CC, 2003, J NEUROSCI, V23, P2815; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Rogemond V, 2008, J BIOL CHEM, V283, P14751, DOI 10.1074/jbc.M708480200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHINAGAWA M, 1985, MICROBIOL IMMUNOL, V29, P543, DOI 10.1111/j.1348-0421.1985.tb00856.x; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Touma E, 2007, EUR J NEUROSCI, V26, P3368, DOI 10.1111/j.1460-9568.2007.05943.x; *U CA PROT PROSP P, MASS SPECTR FAC; Wang LH, 1996, J NEUROSCI, V16, P6197; Xiang W, 2007, J NEUROCHEM, V102, P834, DOI 10.1111/j.1471-4159.2007.04566.x; Yanagisawa Y, 2006, J PATHOL, V209, P464, DOI 10.1002/path.2012; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yuasa-Kawada J, 2003, EUR J NEUROSCI, V17, P2329, DOI 10.1046/j.1460-9568.2003.02664.x; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhu K, 2005, ANAL CHEM, V77, P2745, DOI 10.1021/ac048494w; ZHUO S, 1993, J BIOL CHEM, V268, P17754	52	7	8	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1477-5956			PROTEOME SCI	Proteome Sci.	OCT 20	2010	8								53	10.1186/1477-5956-8-53			12	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	678UI	WOS:000284106500001	20961402	gold, Green Published			2022-02-06	
J	Liu, Y; Xia, JZ; Wu, AH; Wang, YJ				Liu Yuan; Xia Jun-zhe; Wu An-hua; Wang Yun-jie			Burr-hole craniotomy treating chronic subdural hematoma: a report of 398 cases	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Hematoma, subdural, chronic; Craniotomy; Tomography; X-ray computed; Risk factors; Neurologic manifestations; Brain injuries; Age factors; Sex		Objective: To investigate the treatment of chronic subdural hematoma (CSDH) with burr-hole craniotomy in our hospital. Methods: From January 2004 to December 2009, 398 patients with CSDH, 338 males and 60 females (male/female=5.63/1), received burr-hole craniotomy in our hospital. The median age was 60 years with the mean age of (58.1 +/- 18.1) years, (65.0 +/- 14.5) years for females and (57.0 +/- 18.2) years for males. Trauma history was determined in 275 patients (69.1%). Burr-hole craniotomy was performed under local anesthesia in 368 patients and general anesthesia in 30 patients. CSDH was classified into 3 groups according to the density on CT scan. Clinical data concerning etiologies, symptoms and signs, concomitant diseases, diagnosis, therapies and outcomes were investigated retrospectively. Patients' neurological status on admission and at discharge was also classified to judge the outcomes. Results: Generally, trauma history showed few differences between those over 60 years old and under 60 years old, but showed obvious differences when gender was taken into account. Totally 123 male patients (60.0% of 204 cases) suffering from head injuries were under 60 years, whereas 35 female patients (85.4% of 41 cases) with trauma histories were over 60 years. The duration from trauma to appearance of clinical symptoms was (84.0 +/- 61.7) days (range, 0-1493 days). Traumatic accident was the leading etiology, other accompanying diseases such as cerebral vascular disease, hypertension, etc, were also predisposing factors. Commonly, the elderly presented with hemiplegia/hemidysesthesia/hemiataxia and the young with headache. Most CSDH patients (95.6%) treated with burr-hole craniotomy successfully recovered. However, postoperative complications occurred in 17 cases, including recurrence of CSDH in 15 cases, subdural abscess in 1 case and pneumonia in 3 cases. Conclusion: Burr-hole craniotomy is an easy, efficient and reliable way to treat CSDH.	[Liu Yuan; Xia Jun-zhe; Wu An-hua; Wang Yun-jie] China Med Univ, Affiliated Hosp 1, Dept Neurosurg, Shenyang 110001, Liaoning, Peoples R China		Wang, YJ (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Neurosurg, Shenyang 110001, Liaoning, Peoples R China.	wyj024@vip.sina.com.cn					AOKI N, 1990, J NEUROSURG, V73, P201, DOI 10.3171/jns.1990.73.2.0201; Ernestus RI, 1997, SURG NEUROL, V48, P220, DOI 10.1016/S0090-3019(97)80031-6; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; GIUFFRE R, 1992, NEUROCHIRURGIA, V35, P103; Greenberg MS, 2010, HDB NEUROSURGERY, P899; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Lanksch W, 1978, ZENTRALBL CHIR, V103, P501; Lega BC, 2009, J NEUROSURG; MARKWALDER TM, 1981, J NEUROSURG, V54, P637, DOI 10.3171/jns.1981.54.5.0637; Murakami H, 2002, J NEUROSURG, V96, P877, DOI 10.3171/jns.2002.96.5.0877; Ramnarayan R, 2008, CLIN NEUROL NEUROSUR, V110, P774, DOI 10.1016/j.clineuro.2008.04.013; RICHTER HP, 1984, ACTA NEUROCHIR, V71, P179, DOI 10.1007/BF01401313; Sambasivan M, 1997, SURG NEUROL, V47, P418, DOI 10.1016/S0090-3019(97)00188-2; Yoshino Y, 2000, SURG NEUROL, V53, P601, DOI 10.1016/S0090-3019(00)00240-8	14	7	7	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	OCT	2010	13	5					265	269		10.3760/cma.j.issn.1008-1275.2010.05.002			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1AS	WOS:000441916900002	20880450				2022-02-06	
J	Ruggeri, RM; Smedile, G; Granata, F; Longo, M; Cannavo, S; Sarlis, NJ; Trimarchi, F; Benvenga, S				Ruggeri, Rosaria M.; Smedile, Giovanni; Granata, Francesca; Longo, Marcello; Cannavo, Salvatore; Sarlis, Nicholas J.; Trimarchi, Francesco; Benvenga, Salvatore			Spontaneous recovery from isolated post-traumatic central hypogonadism in a woman	HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM			English	Article						Gonadotropin deficiency; Infertility; Oligo-amenorrhoea; Post-head trauma hypopituitarism	TRAUMATIC BRAIN-INJURY; PITUITARY INSUFFICIENCY; ACUTE-PHASE; HYPOPITUITARISM; DYSFUNCTION; PREVALENCE	OBJECTIVE. Hypopituitarism is a recognized complication of Traumatic Brain Injury (TBI). Resolution of established anterior pituitary hormones deficiency is rare. CASE REPORT. A woman was initially presented at the age of 22 years with amenorrhoea. Two years earlier she had been involved in a car accident with consequent TBI. At our evaluation, serum oestradiol (E-2) was low (3 pmol/l), Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH) were borderline low [1.7 and 2.5 mIU/l, normal range (NR) for 20-35 yr old women being 1.4-13 and 2.5-13, respectively] with poor response to Gonadotropin Releasing Hormone (GnRH) (Delta LH = 2.4 and, Delta FSH = 4.0 mIU/l), while serum Prolactin (PRL) was elevated (951 mIU/l; NR: 102-496). No other pituitary hormone deficiencies were observed. Magnetic resonance imaging (MRI) showed a partially empty sella and very thin stalk. Ten years later a new endocrine evaluation was performed. On day 4 of her menstrual cycle, serum values of PRL (196 mIU/l), FSH (4.7 mIU/l), LH (4.8 mIU/l) and E2 (103 pmol/l) were within normal limits for women aged 20-35. Six months after this evaluation (that is, 12 years after trauma), the patient became pregnant and delivered a healthy baby. CONCLUSIONS. Our case shows that spontaneous resolution of post-head trauma anterior hypopituitarism occur even many years after head injury. Medicolegal implications are self-evident.	[Ruggeri, Rosaria M.; Smedile, Giovanni; Cannavo, Salvatore; Trimarchi, Francesco; Benvenga, Salvatore] Univ Messina, Clin Expt Dept Med & Pharmacol, Endocrinol Sect, Messina, Italy; [Granata, Francesca; Longo, Marcello] Univ Messina, Dept Radiol Sci, Messina, Italy; [Sarlis, Nicholas J.] Sanofi Aventis US, Oncol US, Dept Med Affairs, Bridgewater, NJ USA		Ruggeri, RM (corresponding author), Policlin Univ G Martino, Dipartimento Clin Sperimentale Med & Farmacol, Unitat Endocrinol, 4 Piano, I-98125 Messina, Italy.	rmruggeri@unime.it	Granata, Francesca/K-5842-2016; Sarlis, Nicholas/AAN-9444-2020; Longo, Marcello/K-5854-2016; Ruggeri, Rosaria Maddalena/AAB-7364-2019; Cannavo, Salvatore/D-7608-2013	Granata, Francesca/0000-0002-6939-1009; Longo, Marcello/0000-0003-1117-1772; Ruggeri, Rosaria Maddalena/0000-0001-8899-684X; Cannavo, Salvatore/0000-0001-8779-7283			Agha A, 2005, AM J PHYS MED REHAB, V84, P381, DOI 10.1097/01.PHM.0000156898.47097.93; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Benvenga S, 1997, J ENDOCRINOL INVEST, V20, P675, DOI 10.1007/BF03348031; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Benvenga Salvatore, 2005, Pituitary, V8, P193, DOI 10.1007/s11102-006-6040-6; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Falsetti L, 2002, J CLIN ENDOCR METAB, V87, P500, DOI 10.1210/jc.87.2.500; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; LEE SC, 1994, BRAIN INJURY, V8, P571; Raivio T, 2007, NEW ENGL J MED, V357, P863, DOI 10.1056/NEJMoa066494; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Sesmilo Gemma, 2007, Hormones (Athens), V6, P132; SPEROFF L, 2005, CLIN GYNECOLOGIC END, P438; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; WOOLF PD, 1986, CLIN ENDOCRINOL, V25, P265, DOI 10.1111/j.1365-2265.1986.tb01691.x	21	7	8	0	1	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	1109-3099	2520-8721		HORM-INT J ENDOCRINO	Horm.-Int. J. Endocrinol. Metab.	OCT-DEC	2010	9	4					332	337		10.14310/horm.2002.1285			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	679IV	WOS:000284156000007	21112865	Bronze			2022-02-06	
J	Ibey, RJ; Chung, R; Benjamin, N; Littlejohn, S; Sarginson, A; Salbach, NM; Kirkwood, G; Wright, V				Ibey, Robyn J.; Chung, Rochelle; Benjamin, Nicole; Littlejohn, Shannon; Sarginson, Andrea; Salbach, Nancy Margaret; Kirkwood, Gail; Wright, Virginia			Development of a Challenge Assessment Tool for High-Functioning Children With an Acquired Brain Injury	PEDIATRIC PHYSICAL THERAPY			English	Article						activities of daily living; adolescents; children; health status indicators; locomotion; motor skills; outcome measures; postural balance; running; task performance and analysis; traumatic brain injury/rehabilitation; walking		Purpose: To develop a performance-based challenge assessment to evaluate gross motor abilities of high-functioning youth with an acquired brain injury (ABI). Methods: Potential items were identified from the literature. A panel of 4 expert physical therapists selected items on the basis of 3 criteria: safety to test, feasibility to administer, and importance to perform. Item reduction was completed using ratings from a physical therapist web survey. The Acquired Brain Injury-Challenge Assessment (ABI-CA) was created and pilot tested with youth with an ABI. Results: Seventy-eight items were identified and reduced to 47 items following expert panel discussion. Web-survey item reduction by 75 pediatric physical therapists yielded a 24-item ABI-CA that was administered to 6 youth with an ABI, aged 8 to 17 years. The ABI-CA mean score was 50.7/81.0 (SD = 17.4). Conclusion: The ABI-CA was feasible to administer and demonstrated gross motor activity challenges beyond the Gross Motor Function Measure. Response option refinement and measure validation are required prior to clinical/research use. (Pediatr Phys Ther 2010;22:268-276)	[Wright, Virginia] Bloorview Res Inst, Toronto, ON M4G 1R8, Canada; [Ibey, Robyn J.; Chung, Rochelle; Benjamin, Nicole; Littlejohn, Shannon; Sarginson, Andrea; Salbach, Nancy Margaret; Wright, Virginia] Univ Toronto, Fac Med, Dept Phys Therapy, Toronto, ON, Canada; [Kirkwood, Gail] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada		Wright, V (corresponding author), Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	vwright@hollandbloorview.ca		Wright, F Virginia/0000-0002-9713-4536	Bloorview Research Institute; Canadian Institutes of Health Research Strategic Training InitiativeCanadian Institutes of Health Research (CIHR)	This work was supported by Bloorview Research Institute. The senior author, Virginia Wright, is jointly supported by Bloorview Research Institute and a Career Development Award (2007 to 2011) through the Canadian Child Health Clinician Scientist Program (CCHCSP), a Canadian Institutes of Health Research Strategic Training Initiative. This research was completed by the first 5 authors as partial fulfillment of the requirements for an MScPT degree at the University of Toronto.	BOYCE WF, 1995, PHYS THER, V75, P603, DOI 10.1093/ptj/75.7.603; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Deitz Jean C, 2007, Phys Occup Ther Pediatr, V27, P87, DOI 10.1300/J006v27n04_06; Dillman DA., 2007, MAIL INTERNET SURVEY; Duger T, 1999, Pediatr Rehabil, V3, P125; Dumas Helene M., 2002, Physical & Occupational Therapy in Pediatrics, V22, P73, DOI 10.1300/J006v22n03_06; Finley R, SURVEYMONKEY COM; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gordon AM, 2007, DEV MED CHILD NEUROL, V49, P830, DOI 10.1111/j.1469-8749.2007.00830.x; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Kisner C., 2007, THERAPEUTIC EXERCISE; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Linder-Lucht M, 2007, PEDIATRICS, V120, P880, DOI 10.1542/peds.2006-2258; Malina RM., 2004, GROWTH MATURATION PH, V2nd ed; Moody K D, 2007, Dev Neurorehabil, V10, P205, DOI 10.1080/13638490601104496; National Trauma Registry, 2007, 2007 INJ HOSP HIGHL; OSullivan S., 2007, PHYS REHABILITATION, VFifth; Quinn B, 2000, BRAIN INJURY, V14, P1063; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Russell DJ, 2000, PHYS THER, V80, P873, DOI 10.1093/ptj/80.9.873; Thomas-Stonell N, 2006, Pediatr Rehabil, V9, P14, DOI 10.1080/13638490500050097; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wright MJ, 2005, PHYS THER, V85, P782, DOI 10.1093/ptj/85.8.782; Wright V, 2009, DEV MED CHILD NEUROL, V51, P25; Wright V, 2009, DEV MED CHILD NEU S2, V51, P61	32	7	7	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-5669	1538-005X		PEDIATR PHYS THER	Pediatr. Phys. Ther.	FAL	2010	22	3					268	276		10.1097/PEP.0b013e3181ea8ff6			9	Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Rehabilitation	V21SE	WOS:000208226500006	20699774				2022-02-06	
J	Polito, MZ; Thompson, JWG; DeFina, PA				Polito, Mary Zemyan; Thompson, James W. G.; DeFina, Philip A.			A review of the International Brain Research Foundation novel approach to mild traumatic brain injury presented at the International Conference on Behavioral Health and Traumatic Brain Injury	JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS			English	Article						Cognitive functions; neuroscience; predictors; post-traumatic stress disorder (PTSD); traumatic brain injury	TRANSCRANIAL MAGNETIC STIMULATION; INCREASED INTRACRANIAL PRESSURE; HYPERBARIC-OXYGEN; IMPROVEMENT; CONCUSSION; METABOLISM	"The International Conference on Behavioral Health and Traumatic Brain Injury" held at St. Joseph's Regional Medical Center in Paterson, NJ., from October 12 to 15, 2008, included a presentation on the novel assessment and treatment approach to mild traumatic brain injury (mTBI) by Philip A. DeFina, PhD, of the International Brain Research Foundation (IBRF). Because of the urgent need to treat a large number of our troops who are diagnosed with mTBI and post-traumatic stress disorder (PTSD), the conference was held to create a report for Congress titled "Recommendations to Improve the Care of Wounded Warriors NOW. March 12, 2009." This article summarizes and adds greater detail to Dr. DeFina's presentation on the current standard and novel ways to approach assessment and treatment of mTBI and PTSD. Pilot data derived from collaborative studies through the IBRF have led to the development of clinical and research protocols utilizing currently accepted, valid, and reliable neuroimaging technologies combined in novel ways to develop "neuromarkers." These neuromarkers are being evaluated in the context of an "Integrity-Deficit Matrix" model to demonstrate their ability to improve diagnostic accuracy, guide treatment programs, and possibly predict outcomes for patients suffering from traumatic brain injury.	[Polito, Mary Zemyan; Thompson, James W. G.; DeFina, Philip A.] Duquesne Univ, Pittsburgh, PA 15219 USA		Polito, MZ (corresponding author), 120 Main St, Johnstown, PA 15905 USA.	mzp@atlanticbb.net			International Brain Research Foundation (IBRF)	The International Brain Research Foundation (IBRF) is a global organization that supports medical research that focuses on brain health. The IBRF specializes in research areas related to brain injury, neurodevelopmental disorders, and neurodegenerative diseases. The IBRF invites scientists and clinicians specializing in these disorders to join as collaborators. The IBRF can be contacted through their website at www.IBRFinc.org.	Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123; *BRAIN INJ ASS AM, 2009, FACTS BRAIN INJ; CANTRILL SV, 2003, M ACEP SCI ASS BOST; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coe J E, 1966, Am Surg, V32, P493; CONTRERAS FL, 1998, J NEUROSURG, V68, P137; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; *DEF VET BRAIN INJ, 2008, TRAUM BRAIN INJ AW P; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; Gunkelman J., 2006, BIOFEEDBACK, V34, P95; GUNKELMAN J, 2008, OV EEG QEEG; Harch P. G., 2004, TXB HYPERBARIC MED, P471; Harch PG, 1996, TXB HYPERBARIC MED, P480; Harch PG, 2007, OXYGEN REVOLUTION; Harch PG, 1999, TXB HYPERBARIC MED, P318; HARCH PG, 1994, UNDERSEA HYPERB ME S, V21, P30; HAYAKAWA T, 1971, J NEUROL NEUROSUR PS, V34, P580, DOI 10.1136/jnnp.34.5.580; HOLBACH KH, 1977, J NEUROL, V217, P17, DOI 10.1007/BF00316313; HOVDA DA, 2007, WHAT IS SO MILD MILD; Liepert J, 2005, ACT NEUR S, V93, P71; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; MILLER JD, 1970, J NEUROL NEUROSUR PS, V33, P745, DOI 10.1136/jnnp.33.6.745; MILLER JD, 1971, ARCH NEUROL-CHICAGO, V24, P210, DOI 10.1001/archneur.1971.00480330038003; MILLER JD, 1973, EUR NEUROL, V10, P1, DOI 10.1159/000114256; NEUBAUER RA, 1992, CLIN NUCL MED, V17, P477, DOI 10.1097/00003072-199206000-00010; Neubauer RA, 1998, NEUROL RES, V20, pS33; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; OKADA YC, 1988, VISUALIZATION BRAIN, P245; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thompson JWG, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P341, DOI 10.1007/0-387-32565-4_15; Tinius T. P., 2000, J NEUROTHER, V4, P27, DOI [DOI 10.1300/J184v04n02_05, 10.1300/J184v04n02_05]; *US DEP VET AFF, 2009, TRAUM BRAIN INJ TBI; World Health Organization, 2008, HELM ROAD SAF MAN; YUFU K, 1993, NEUROCHEM RES, V18, P1033, DOI 10.1007/BF00966765	38	7	7	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1041-2972	1745-7599		J AM ACAD NURSE PRAC	J. Am. Acad. Nurse Pract.	SEP	2010	22	9					504	509		10.1111/j.1745-7599.2010.00540.x			6	Health Care Sciences & Services; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Nursing	647ZX	WOS:000281660700009	20854643				2022-02-06	
J	Siemionow, M; Mendiola, A				Siemionow, Maria; Mendiola, Amanda			Methods of Assessment of Cortical Plasticity in Patients Following Amputation, Replantation, and Composite Tissue Allograft Transplantation	ANNALS OF PLASTIC SURGERY			English	Article						cortical plasticity; amputation; hand transplantation; replantation	UPPER-LIMB AMPUTATION; HUMAN MOTOR CORTEX; SOMATOSENSORY CORTEX; THUMB RECONSTRUCTION; SENSORIMOTOR CORTEX; FUNCTIONAL MRI; REORGANIZATION; HAND; PAIN	The brain is always adapting to new inputs from the environment. New noninvasive techniques are available to scrupulously study cortical plasticity. Several studies have proven that these modifications of neural pathways occur because of denervation from injury such as amputation. Changes that occur rapidly are likely because of unmasking of established synapses that are latent, whereas changes that occur over long periods of time are more likely because of establishment of new neural connections. Cortical reorganization that occurs from traumatic amputation has been shown to be reversible with replantation and transplantation. With the new field of composite tissue transplantation, such as hand or face, it is critical to be aware of these changes to choose potential patients and to modify their rehabilitation, on the basis of our understanding of the cortical reorganization that occurs over time.	[Siemionow, Maria] Cleveland Clin Fdn, Dept Plast & Reconstruct Surg, Cleveland, OH 44195 USA; [Mendiola, Amanda] Akron Gen Med Ctr, Dept Surg, Akron, OH USA		Siemionow, M (corresponding author), Cleveland Clin, Dept Plast & Reconstruct Surg, 9500 Euclid Ave,A-60, Cleveland, OH 44195 USA.	siemiom@ccf.org					BARKER AT, 2002, HDB TRANSCRANIAL MAG, P3; Birbaumer N, 1997, J NEUROSCI, V17, P5503; Bjorkman A, 2007, SCAND J PLAST RECONS, V41, P70, DOI 10.1080/02844310601140956; Borsook D, 1998, NEUROREPORT, V9, P1013, DOI 10.1097/00001756-199804200-00011; Chen CJ, 2006, AM J NEURORADIOL, V27, P1617; COHEN LG, 1991, BRAIN, V114, P615, DOI 10.1093/brain/114.1.615; COHEN LG, 2002, HDB TRANSCRANIAL MAG, P346; COHEN MS, 1994, TRENDS NEUROSCI, V17, P268, DOI 10.1016/0166-2236(94)90055-8; Cruz VT, 2003, NEUROREHABILITATION, V18, P299; Garraghty PE, 1996, J COMP NEUROL, V367, P319, DOI 10.1002/(SICI)1096-9861(19960401)367:2<319::AID-CNE12>3.0.CO;2-L; Giraux P, 2001, NAT NEUROSCI, V4, P691, DOI 10.1038/89472; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Kim SG, 2006, FUNCTIONAL MRI: BASIC PRINCIPLES AND CLINICAL APPLICATIONS, P3, DOI 10.1007/0-387-34665-1_1; Lotze M, 1999, NAT NEUROSCI, V2, P501, DOI 10.1038/9145; Manduch M, 2002, NEUROLOGY, V59, P1278, DOI 10.1212/WNL.59.8.1278; Ni Z, 2010, J NEUROPHYSIOL, V103, P65, DOI 10.1152/jn.00732.2009; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Piza-Katzer H, 2007, ACTA NEUROCHIR SUPPL, V100, P113; RAMACHANDRAN VS, 1992, NEUROREPORT, V3, P583, DOI 10.1097/00001756-199207000-00009; Roricht S, 2001, ANN NEUROL, V50, P240, DOI 10.1002/ana.1091; Schwenkreis P, 2000, NEUROSCI LETT, V293, P143, DOI 10.1016/S0304-3940(00)01517-2; Stippich C, 2007, MED RADIOL DIAGN IMA, P1, DOI 10.1007/978-3-540-49976-3_1; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R	23	7	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-7043			ANN PLAS SURG	Ann. Plast. Surg.	SEP	2010	65	3					344	348		10.1097/SAP.0b013e3181e944d9			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	642BZ	WOS:000281179600016	20733372				2022-02-06	
J	Garcia-Molina, A; Guitart, MB; Roig-Rovira, T				Garcia-Molina, Alberto; Bernabeu Guitart, Montserrat; Roig-Rovira, Teresa			Traumatic brain injury and daily life: The role of executive function	PSICOTHEMA			Spanish	Article							ECOLOGICAL VALIDITY; INSTRUMENTAL ACTIVITIES; PERFORMING ACTIVITIES; COGNITIVE STRUCTURE; SELF-AWARENESS; ASSOCIATION; COMPETENCE; PREDICTORS; DEFICITS; SCHIZOPHRENIA	Traumatic brain injury and daily life: The role of executive function. Executive functions are critical in our daily life. People with traumatic brain injury (TBI) often have difficulty functioning appropriately in everyday life. The objective of this study was to investigate the relationship between executive function and functional capacity after TBI. The sample consisted of 43 moderate or severe TBI patients (mean age: 32 years, SD=13.9). All participants were tested with a battery of executive function measures (Trail Making Test-B, Wisconsin Card Sorting Test, Letter-Number Sequencing of the WAIS-III, Stroop Color-Word Interference Test, and Controlled Oral Word Association Test). Patients' everyday functioning was examined with the Patient Competency Rating Scale (PCRS). PCRS was correlated significantly, although moderately, with Trail Making Test-B, Letter-Number Sequencing, and Controlled Oral Word Association Test. These findings suggest that executive function measures used in clinical practice reveal some degree of ecological validity, providing relevant information for predicting daily-life functioning after moderate to severe TBI.	[Garcia-Molina, Alberto] Univ Autonoma Barcelona, Inst Univ Neurorehabil Guttmann, Badalona 08916, Spain		Garcia-Molina, A (corresponding author), Univ Autonoma Barcelona, Inst Univ Neurorehabil Guttmann, Badalona 08916, Spain.	agarciam@guttmann.com					Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Artiola i Fortuny L, 1999, MANUAL NORMAS PROCED; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; Biringer E, 2005, EUR ARCH PSY CLIN N, V255, P373, DOI 10.1007/s00406-005-0577-7; Birnboim S, 2004, MULT SCLER J, V10, P67, DOI 10.1191/1352458504ms980oa; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; Carlson MC, 1999, J GERONTOL B-PSYCHOL, V54, pS262, DOI 10.1093/geronb/54B.5.S262; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; DAVIDSON PS, 2007, J CLIN EXP NEUROPSYC, V11, P1; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Garcia-Molina A, 2007, ANALES PSIQUIATRIA, V23, P217; GARCIAMOLINA A, 2008, REHABILITACION, V42, P67, DOI DOI 10.1016/S0048-7120(08)73616-8; Godbout L, 2005, BRAIN INJURY, V19, P337, DOI 10.1080/02699050400005093; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; Goldberg E, 2000, J CLIN EXP NEUROPSYC, V22, P56, DOI 10.1076/1380-3395(200002)22:1;1-8;FT056; Golden C.J., 1994, STROOP TEST COLORES; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Grafman G., 2002, PRINCIPLES FRONTAL L, P292; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Heaton R.K., 1997, WCST TEST CLASIFICAC; HEILBRONNER RL, 1993, J CLIN EXP NEUROPSYC, V15, P67; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Johnson JK, 2007, J GERONTOL A-BIOL, V62, P1134, DOI 10.1093/gerona/62.10.1134; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Kravariti E, 2005, SCHIZOPHR RES, V74, P221, DOI 10.1016/j.schres.2004.06.008; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McClure MM, 2007, SCHIZOPHR RES, V89, P330, DOI 10.1016/j.schres.2006.07.024; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, ACT NEUR S, V93, P39; Reason J., 1990, HUMAN ERROR INTERNET, DOI DOI 10.1017/CBO9781139062367; Reitan R.M., 1993, HALSTEADREITAN NEURO; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Sbordone RJ, 1999, STUD NEUROPSYCHOL DE, P227; Stablum F, 2004, BRAIN COGNITION, V56, P328, DOI 10.1016/j.bandc.2004.08.048; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Symonds C P, 1937, Proc R Soc Med, V30, P1081; TEASDALE G, 1974, LANCET, V2, P81; Tirapu J, 1997, ANALES SISTEMA SANIT, V20, P101; WECHSLER D, 1999, ESCALA INTELIGENCIA, V3; Wilson, 1993, APPL PREV PSYCHOL, V2, P209, DOI DOI 10.1016/S0962-1849(05)80091-5; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Zinn S, 2007, ARCH PHYS MED REHAB, V88, P173, DOI 10.1016/j.apmr.2006.11.015; [No title captured]	59	7	7	0	11	COLEGIO OFICIAL DE PSICOLOGOS DE ASTURIAS	OVIEDO	ILDEFONSO S. DEL RIO, 4-1 B, 33001 OVIEDO, SPAIN	0214-9915	1886-144X		PSICOTHEMA	Psicothema	AUG	2010	22	3					430	435					6	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	625WG	WOS:000279926900012	20667271				2022-02-06	
J	Fitzgerald, CE				Fitzgerald, Cynthia E.			Improving nurse practitioner assessment of woman veterans	JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS			English	Article						Women's health; veterans; nurse practitioners; health assessment	FEMALE VETERANS; MENTAL-HEALTH; GULF-WAR; WOMEN; AFGHANISTAN; DEPLOYMENT; INJURY; TRAUMA; IRAQ	Purpose: To provide nurse practitioners (NPs) with brief screening tools that can be used to identify postmilitary healthcare concerns common among women veterans. Data sources: Existing screening tools for posttraumatic stress disorder, traumatic brain injury, and military sexual trauma. Conclusions: Women represent more than 10% of military veterans who have served in combat settings during the current wars in Afghanistan and Iraq. As a result of their military service, women veterans may present in community healthcare settings with one or more of a variety of functional health problems, posttraumatic stress disorder, depression, anxiety, or other evidence of significant physical or psychiatric stress. Their families may be temporarily or permanently unstable as a result of the disruption caused by their military service, deployment, or health status. Implications for practice: NPs who are aware of the unique healthcare needs of women veterans returning from combat will be better prepared to assess and intervene when these patients present with symptoms or health consequences of military service. Simple, straightforward assessments can determine the extent to which women veteran patients require intervention during wartime and/or referral.	Washington State Univ, Coll Nursing, Spokane, WA 99202 USA		Fitzgerald, CE (corresponding author), Washington State Univ, Coll Nursing, 103 Spokane Falls Blvd, Spokane, WA 99202 USA.	cefitzgerald@wsu.edu					*DEF VET BRAIN INJ, 2006, 3 QUEST DBVIC TBI SC; Dobie DJ, 2004, ARCH INTERN MED, V164, P394, DOI 10.1001/archinte.164.4.394; Frayne SM, 1999, J WOMEN HEALTH GEN-B, V8, P835, DOI 10.1089/152460999319156; FRAYNE SM, 2006, J GEN INTERNAL MED, V21, P40; Friedl KE, 2005, J WOMENS HEALTH, V14, P764, DOI 10.1089/jwh.2005.14.764; Kimerling R, 2008, PSYCHIAT SERV, V59, P635, DOI 10.1176/appi.ps.59.6.635; Kimerling R, 2007, AM J PUBLIC HEALTH, V97, P2160, DOI 10.2105/AJPH.2006.092999; Klein E, 2003, CAN J PSYCHIAT, V48, P28, DOI 10.1177/070674370304800106; KUREA E, 2006, NEURORADIOLOGY, V48, P661; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; McIntyre LM, 1999, J GEN INTERN MED, V14, P186, DOI 10.1046/j.1525-1497.1999.00311.x; Murdoch M, 2006, J GEN INTERN MED, V21, pS5, DOI 10.1111/j.1525-1497.2006.00368.x; *NAT CTR PTSD, 2008, FACT SHEET MIL SEX T; OUIMETTE P, J ANXIETY DISORDERS, V22, P337; Pierce PF, 1998, J APPL SOC PSYCHOL, V28, P1286, DOI 10.1111/j.1559-1816.1998.tb01677.x; *PLANN NAT CTR VET, 2008, VA BEN HLTH CAR UT; *PLANN NAT CTR VET, 2007, WOM VET PAST PRES FU; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Stafford, 2004, IRAQ WAR CLIN GUIDE, P66; Taber KH, 2007, J NEUROPSYCH CLIN N, V19, P100; Tanielian T., 2008, INVISIBLE WOUNDS WAR; U. S. Bureau of Census, 2008, 2008 STAT ABSTR NAT; Vinokur AD, 1999, J ORGAN BEHAV, V20, P865; Vogt DS, 2005, J TRAUMA STRESS, V18, P115, DOI 10.1002/jts.20018; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Zinzow HM, 2007, TRAUMA VIOLENCE ABUS, V8, P384, DOI 10.1177/1524838007307295	29	7	7	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1041-2972	1745-7599		J AM ACAD NURSE PRAC	J. Am. Acad. Nurse Pract.	JUL	2010	22	7					339	345		10.1111/j.1745-7599.2010.00520.x			7	Health Care Sciences & Services; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Nursing	615VR	WOS:000279166600003	20590954				2022-02-06	
J	Chang, TP; Nager, AL				Chang, Todd P.; Nager, Alan L.			Pediatric Traumatic Brain Injury: The Utility of Beta-Natriuretic Peptide	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Beta-natriuretic peptide; Pediatric traumatic brain injury; Pediatric head trauma	CONGESTIVE-HEART-FAILURE; SUBARACHNOID HEMORRHAGE; COMPUTED-TOMOGRAPHY; SERUM BIOMARKERS; CHILDREN; CT; DISEASE; BODY	Background: According to the literature, serum beta-natriuretic peptide ( BNP) levels have been shown to increase in adult trauma patients, specifically for those with traumatic brain injury and in those with intracranial hemorrhage. It has been suggested that BNP levels may be an ideal serum marker for traumatic brain injury. It may save time and radiation if the levels correlated with head computed tomography ( CT) scan findings, especially for pediatric patients who have higher radiation risks. We hypothesized that serum BNP levels would be elevated in patients with intracranial bleeding on head CT. Method: Serum BNP levels were drawn from 95 consecutive "Level I status" pediatric trauma patients immediately on presentation to the emergency department. These patients had high impact mechanisms, were altered, or were physiologically unstable. The findings of head CTs were recorded. Patients were subsequently divided into a negative bleed or positive bleed group. Clinical data such as Glasgow Coma Scale, loss of consciousness, and hospital course were collected. Results were compared using Wilcoxon rank sum test and Spearman correlation coefficients. Results: BNP levels did not increase significantly in the positive bleed group ( n = 21) compared with the negative bleed group ( n = 74) ( p = 0.48). BNP levels did not correlate with loss of consciousness, Glasgow Coma Scale, Injury Severity Score, or hospital stay. Conclusion: BNP levels drawn at the time of the emergency department visit do not seem to be a predictor for intracranial hemorrhage in pediatric trauma patients. A head CT still remains the best diagnostic study for diagnosing intracranial hemorrhage.	[Chang, Todd P.; Nager, Alan L.] Childrens Hosp Los Angeles, Div Emergency Med & Transport Med, Los Angeles, CA 90027 USA		Chang, TP (corresponding author), Childrens Hosp Los Angeles, Div Emergency Med & Transport Med, 4650 Sunset Blvd,Mailstop 113, Los Angeles, CA 90027 USA.	tochang@chla.usc.edu		Chang, Todd/0000-0002-4508-2551	NIH NCRR GCRCUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [MO1 RR-46]	Supported by the NIH NCRR GCRC Grant MO1 RR-46.	Beaudin M, 2007, J PEDIATR SURG, V42, P849, DOI 10.1016/j.jpedsurg.2006.12.038; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Berendes E, 1997, LANCET, V349, P245, DOI 10.1016/S0140-6736(96)08093-2; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cowie MR, 2003, EUR HEART J, V24, P1710, DOI 10.1016/S0195-668X(03)00476-7; Jindal A, 2002, WORLD J SURG, V26, P13; Kia M, 2006, AM J SURG, V191, P353, DOI 10.1016/j.amjsurg.2005.10.033; Kirchhoff C, 2006, J NEUROTRAUM, V23, P943, DOI 10.1089/neu.2006.23.943; Koulouri S, 2004, PEDIATR CARDIOL, V25, P341, DOI 10.1007/s00246-003-0578-0; Maher KO, 2008, PEDIATRICS, V121, pE1484, DOI 10.1542/peds.2007-1856; Martin C, 2008, CURR OPIN PEDIATR, V20, P294, DOI 10.1097/MOP.0b013e3282ff0dfa; Mazonakis M, 2007, EUR RADIOL, V17, P1352, DOI 10.1007/s00330-006-0417-9; Paterson A, 2001, AM J ROENTGENOL, V176, P297, DOI 10.2214/ajr.176.2.1760297; Rossano JW, 2008, J HEART LUNG TRANSPL, V27, P649, DOI 10.1016/j.healun.2008.03.008; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Stewart D, 2007, J TRAUMA, V63, P747, DOI 10.1097/01.ta.0000240458.46050.38; Sviri GE, 2006, ACTA NEUROCHIR, V148, P529, DOI 10.1007/s00701-005-0666-4; Sviri GE, 2000, STROKE, V31, P118, DOI 10.1161/01.STR.31.1.118; Willis AP, 2008, CLIN RADIOL, V63, P165, DOI 10.1016/j.crad.2007.05.027	22	7	8	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2010	68	6					1401	1405		10.1097/TA.0b013e3181bb9a87			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	610ES	WOS:000278714600025	20068481				2022-02-06	
J	Merritta, C; Cherian, B; Macaden, AS; John, JA				Merritta, Catherine; Cherian, Binu; Macaden, Ashish S.; John, Judy Ann			Measurement of physical performance and objective fatigability in people with mild-to-moderate traumatic brain injury	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						cognitive examination; fatigue; physical performance; traumatic brain injury	WALKING SPEED; FATIGUE; RELIABILITY; VALIDITY; RECOVERY	The aims of this study were to objectively measure the physical performance and physical endurance of patients with traumatic brain injury with minimization of cognitive and psychological fatigue, and to compare the physical performance of brain injured patients with that of healthy controls. This was a nonrandomized partially blinded controlled study. The study setting was the Outpatient Multidisciplinary Brain Injury Clinic in the Department of Physical Medicine and Rehabilitation of a tertiary care university teaching hospital. Participants included an experimental group that comprised independently ambulant men (age 18-55 years) with mild-to-moderate traumatic brain injury (n=24) who complained of greater fatigue than before their injury and an age-matched and sex-matched control group (n=24). The intervention included the Six-Minute Walk Test. The primary outcome measures were the Six-Minute Walk Distance, the Fatigue Severity Scale, Addenbrooke's Cognitive Examination, and the Fatigue Visual Numeric Scale; the secondary outcome measures were the Physiological Cost Index of Walking and the Borg Scale of Perceived Exertion. The Six-Minute Walk Distance of the experimental group (452.33 +/- 68.816) when compared with that of the control group (518.08 +/- 92.114) was reduced by 12.7 and 30.5%, respectively, when compared with the predicted Six-Minute Walking Distance (650.04 +/- 79.142) for the same age and sex. The mean Fatigue Severity Scale values were 2.51 and 1.62 for the experimental and control groups, respectively. The mean Addenbrooke's Cognitive Examination Score for the patients was 85.5 +/- 7.265. In conclusion, the Six-Minute Walk Test is useful in segregating physical fatigue from cognitive and psychological aspects of fatigue when cognitive and psychological dimensions are known. The Six-Minute Walk Test can be used as a tool for exercise intensity prescription in men with mild-to-moderate brain injury, to avoid the deleterious effects of fatigue. International Journal of Rehabilitation Research 33:109-114 (C) 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Merritta, Catherine; Cherian, Binu; Macaden, Ashish S.; John, Judy Ann] Christian Med Coll & Hosp, Dept Phys Med & Rehabil, Vellore 632004, Tamil Nadu, India		Cherian, B (corresponding author), Christian Med Coll & Hosp, Dept Phys Med & Rehabil, Vellore 632004, Tamil Nadu, India.	binucherian@cmcvellore.ac.in					Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; Enright PL, 2004, RESP CARE, V48, P783; Gaber TAZK, 2008, BRAIN INJURY, V22, P589, DOI 10.1080/02699050802132461; Krupp LB, 1996, CURR OPIN NEUROL, V9, P456, DOI 10.1097/00019052-199612000-00011; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; RACHEL CG, 2005, ARCH PHYS MED REHAB, V86, P2041; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; *SPSS INC CHIC, 1989, SPSS 11 0 WIND REL 1; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	22	7	7	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	JUN	2010	33	2					109	114		10.1097/MRR.0b013e32832e6b37			6	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	602CS	WOS:000278116700003	19593157				2022-02-06	
J	Vinchon, M; Desurmont, M; Soto-Ares, G; De Foort-Dhellemmes, S				Vinchon, Matthieu; Desurmont, Marie; Soto-Ares, Gustavo; De Foort-Dhellemmes, Sabine			Natural history of traumatic meningeal bleeding in infants: semiquantitative analysis of serial CT scans in corroborated cases	CHILDS NERVOUS SYSTEM			English	Article						Traumatic head injury; Infant; Shaken baby syndrome; Accidental head trauma; CT scanner; Subdural hematoma; Pathophysiology	NONACCIDENTAL HEAD-INJURY; SUBDURAL HEMATOMAS; CHILD-ABUSE; INTRACRANIAL HEMORRHAGE; CEREBROSPINAL-FLUID; BRAIN-INJURY; EVOLUTION; CHANNELS; PATHWAY; DURA	The natural history of posttraumatic meningeal bleeding in infants is poorly documented, and the differences between inflicted head injury (IHI) and accidental trauma (AT) are debated. Autopsy findings have suggested that anoxia also plays a role in bleeding; however, these findings may not reflect what occurs in live trauma patients. We studied the natural history of traumatic meningeal bleeding in infants using serial computed tomography (CT) scans in corroborated IHI and AT. From our prospective series, we selected corroborated cases (confessed IHI or AT having occurred in public), who underwent at least three CT scans in the acute phase. We performed a semiquantitative analysis of meningeal bleeding using a four-tier scale (absent, faint, frank, and thick) derived from the Fisher grading for aneurysmal bleeding in four regions of interest (convexity, falx cerebri, sagittal sinus, and tentorium cerebelli). We studied 20 cases: ten IHI and ten AT. Bleeding was maximal at the convexity initially, then increased along the falx and sagittal sinus, and then along the tentorium. Decrease and disappearance of blood was variable according to the site and the initial quantity of blood. We found no difference between IHI and AT. Our findings suggest that the primary site of meningeal bleeding in infantile head trauma is the convexity of the brain; blood cells then migrate toward the midline following the flow of cerebrospinal fluid circulation and inferiorly following gravity. The pattern of bleeding in traumatic cases appears similar in IHI and AT but different from anoxic lesions.	[Vinchon, Matthieu] Lille Univ Hosp, Dept Pediat Neurosurg, F-59037 Lille, France; [Desurmont, Marie] Lille Univ Hosp, Dept Legal Med, F-59037 Lille, France; [Soto-Ares, Gustavo] Lille Univ Hosp, Dept Neuroradiol, F-59037 Lille, France; [De Foort-Dhellemmes, Sabine] Lille Univ Hosp, Dept Neuroophthalmol, F-59037 Lille, France		Vinchon, M (corresponding author), Lille Univ Hosp, Dept Pediat Neurosurg, F-59037 Lille, France.	m-vinchon@chru-lille.fr		Vinchon, Matthieu/0000-0002-9122-6165			Barkovich AJ, 2000, PEDIAT NEUROIMAGING, P157; Barlow KM, 1999, ACTA PAEDIATR, V88, P734; Biron D, 2005, CHILD ABUSE NEGLECT, V29, P1347, DOI 10.1016/j.chiabu.2005.05.003; Byard RW, 2007, PEDIATR DEVEL PATHOL, V10, P348, DOI 10.2350/06-08-0154.1; Case ME, 2008, BRAIN PATHOL, V18, P571, DOI 10.1111/j.1750-3639.2008.00204.x; Duhaime AC, 1996, PEDIATR NEUROSURG, V25, P116, DOI 10.1159/000121108; FELDMAN KW, 1995, CHILD ABUSE NEGLECT, V19, P307, DOI 10.1016/S0145-2134(94)00130-8; Feldman KW, 1997, CHILD ABUSE NEGLECT, V21, P199, DOI 10.1016/S0145-2134(96)00145-7; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fox RJ, 1996, NEUROSURGERY, V39, P84, DOI 10.1097/00006123-199607000-00017; Friede RL, 1989, DEV NEUROPATHOLOGY, P198; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Hart BL, 1996, AM J FOREN MED PATH, V17, P217, DOI 10.1097/00000433-199609000-00008; HARWOODNASH DC, 1992, AM J NEURORADIOL, V13, P569; KUROIWA T, 1993, J NEUROSURG, V78, P126, DOI 10.3171/jns.1993.78.1.0126; Leestma, 2006, J AM PHYS SURG, V11, P14; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; MODIC MT, 1981, RADIOLOGY, V141, P93, DOI 10.1148/radiology.141.1.7291548; Papasian NC, 2000, PEDIATR NEUROSURG, V33, P188, DOI 10.1159/000055951; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Raul JS, 2008, INT J LEGAL MED, V122, P327; Rooks VJ, 2008, AM J NEURORADIOL, V29, P1082, DOI 10.3174/ajnr.A1004; Roth S, 2007, INT J LEGAL MED, V121, P223, DOI 10.1007/s00414-006-0129-3; SATO Y, 1989, RADIOLOGY, V173, P653, DOI 10.1148/radiology.173.3.2813768; Squier W, 2009, CHILD NERV SYST, V25, P925, DOI 10.1007/s00381-009-0888-5; Squier W, 2009, FORENSIC SCI INT, V187, P6, DOI 10.1016/j.forsciint.2009.02.005; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; STARLING SP, 1995, PEDIATRICS, V95, P259; Stoodley N, 2002, LANCET, V360, P271, DOI 10.1016/S0140-6736(02)09563-6; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Vinchon M, 2004, J NEUROSURG, V101, P44, DOI 10.3171/ped.2004.101.2.0044; Vinchon M, 2002, PEDIATR NEUROSURG, V37, P245, DOI 10.1159/000066216; Vinchon M, 2001, J NEUROSURG, V95, P249, DOI 10.3171/jns.2001.95.2.0249; Wells RG, 2002, ARCH PEDIAT ADOL MED, V156, P252, DOI 10.1001/archpedi.156.3.252; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9; YAMASHIMA T, 1986, BRAIN RES, V384, P68, DOI 10.1016/0006-8993(86)91220-5	38	7	7	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	JUN	2010	26	6					755	762		10.1007/s00381-009-1047-8			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	595FE	WOS:000277595300009	19946689				2022-02-06	
J	Dadlani, R; Ghosal, N; Bagdi, N; Venkatesh, PK; Hegde, AS				Dadlani, Ravi; Ghosal, Nandita; Bagdi, Naman; Venkatesh, Prasanna K.; Hegde, Alangar Sathya			Chronic brain abscess secondary to a retained wooden foreign body: Diagnostic and management dilemmas	INDIAN JOURNAL OF PEDIATRICS			English	Article						Wooden foreign body; Chronic brain abscess; Pediatric head injury; Antibiotic therapy	COMPUTED-TOMOGRAPHY; INTRACRANIAL WOOD; BODIES; INJURY; ORBIT	A four-year-old child presented with recent onset generalized tonic clonic seizures. She was operated for a suspected intracranial tuberculoma and was found to harbor an intra-parenchymal retained wooden foreign body with a chronic abscess. The foreign body had entered the brain parenchyma after a minor head injury, sustained three years earlier. She was asymptomatic for the intervening three years. The initial diagnosis was missed by several physicians. A retained wooden fragment via a transtemporal apparently closed head injury is an extremely rare event. The present study reveals the diagnostic and therapeutic challenges and stresses the importance of high degree of suspicion to diagnose retained intracranial foreign bodies and the need for early surgical exploration, to avoid chronic and potentially life threatening neurological complications.	[Dadlani, Ravi; Venkatesh, Prasanna K.; Hegde, Alangar Sathya] Sri Sathya Sai Inst Higher Med Sci, Dept Neurosurg, EPIP Area, Bangalore 560066, Karnataka, India; [Ghosal, Nandita] Sri Sathya Sai Inst Higher Med Sci, Dept Pathol, Bangalore 560066, Karnataka, India; [Bagdi, Naman] Sri Sathya Sai Inst Higher Med Sci, Dept Radiol, Bangalore 560066, Karnataka, India		Dadlani, R (corresponding author), Sri Sathya Sai Inst Higher Med Sci, Dept Neurosurg, EPIP Area, Bangalore 560066, Karnataka, India.	dr_ravi@doctor.com					ARSENL C, 1967, ACTA NEUROCHIR, V16, P201, DOI 10.1007/BF01793126; Aulino JM, 2005, AM J NEURORADIOL, V26, P1855; Frazier JL, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/6/E8; GLATT HJ, 1990, OPHTHALMIC PLAST REC, V6, P108, DOI 10.1097/00002341-199006000-00005; HANSEN JE, 1988, J NEUROSURG, V68, P752, DOI 10.3171/jns.1988.68.5.0752; Ishikawa E, 2000, NEUROL MED-CHIR, V40, P458, DOI 10.2176/nmc.40.458; MILLER CF, 1977, SURG NEUROL, V7, P95; Nishio Y, 2004, ACTA NEUROCHIR, V146, P847, DOI 10.1007/s00701-004-0283-7; Santoreneos S, 1997, J CLIN NEUROSCI, V4, P255, DOI 10.1016/S0967-5868(97)90084-9; SPECHT CS, 1992, SURV OPHTHALMOL, V36, P341, DOI 10.1016/0039-6257(92)90110-F; Tsaloumas MD, 1998, BRIT MED J, V316, P1363, DOI 10.1136/bmj.316.7141.1363	11	7	8	0	1	ALL INDIA INST MEDICAL SCIENCES	NEW DELHI	ANSARI NAGAR, NEW DELHI 110 029, INDIA	0019-5456			INDIAN J PEDIATR	Indian J. Pediatr.	MAY	2010	77	5					575	576		10.1007/s12098-010-0073-6			2	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	613GT	WOS:000278968100018	20454935				2022-02-06	
J	Frink, M; Zeckey, C; Haasper, C; Krettek, C; Hildebrand, F				Frink, M.; Zeckey, C.; Haasper, C.; Krettek, C.; Hildebrand, F.			Injury severity and pattern at the scene	UNFALLCHIRURG			German	Article						Accident mechanism; Injury pattern; Injury severity; Triage	PELVIC FRACTURE; TRAUMA TRIAGE; ORGAN INJURY; FIELD TRIAGE; MAJOR TRAUMA; BRAIN-INJURY; MECHANISM; CRITERION; MORTALITY; ROLLOVER	The mechanism of injury is the major cause for trauma team activation and emergency room resuscitation of trauma victims. To date, it remains unclear to what extent the injury mechanism influences injury pattern and severity. A comprehensive systematic literature search based on Medline was carried out. Only a limited number of studies are available which investigated the influence of injury mechanisms on injury patterns and severity. There are no specific mechanisms for traumatic brain and spine injuries. Injuries to the chest and abdomen most frequently resulted from motor vehicle accidents involving passengers sitting on the side of the impact. Steering wheel deformity correlated with the injury severity. Pelvic fractures occurred most frequently due to motor vehicle accidents. The highest mortality resulted from pedestrians being struck by a vehicle and additional loss of life in the same vehicle compartment. The systematic literature research showed inconsistent results regarding the influence of trauma mechanisms on the resulting injury. Therefore, a treatment algorithm for trauma patients should be independent of the mechanism which is represented in several training programs (e.g. ATLSA (R) and PHTLSA (R)). However, the mechanism of injury may increase the alertness of the trauma team with respect to injury distribution and severity.	[Frink, M.; Zeckey, C.; Haasper, C.; Krettek, C.; Hildebrand, F.] Hannover Med Sch, Unfallchirurg Klin, D-30625 Hannover, Germany		Frink, M (corresponding author), Hannover Med Sch, Unfallchirurg Klin, Carl Neuberg Str 1, D-30625 Hannover, Germany.	michaelfrink@web.de	Hildebrand, Frank/J-3176-2017; Haasper, Carl/H-3089-2019	Haasper, Carl/0000-0003-1209-4721; Krettek, Christian/0000-0001-9807-0020			Arbogast KB, 2007, J TRAUMA, V62, P1473, DOI 10.1097/01.ta.0000231965.20704.16; Bilston LE, 2007, SPINE, V32, P2339, DOI 10.1097/BRS.0b013e3181558886; Blackmore CC, 2006, J TRAUMA, V61, P346, DOI 10.1097/01.ta.0000226151.88369.c9; Bond RJ, 1997, J TRAUMA, V43, P283, DOI 10.1097/00005373-199708000-00013; Brasel KJ, 2005, J TRAUMA, V59, P1057, DOI 10.1097/01.ta.0000187798.37920.4c; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Champion HR, 2009, J TRAUMA, V67, P350, DOI 10.1097/TA.0b013e3181aabdc7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clarke JR, 2002, J TRAUMA, V52, P420, DOI 10.1097/00005373-200203000-00002; Conroy C, 2007, J TRAUMA, V62, P1462, DOI 10.1097/01.ta.0000221271.76676.2e; DALAL SA, 1989, J TRAUMA, V29, P981, DOI 10.1097/00005373-198907000-00012; Domeier R M, 1999, Prehosp Emerg Care, V3, P332, DOI 10.1080/10903129908958964; Engum SA, 2000, J PEDIATR SURG, V35, P82, DOI 10.1016/S0022-3468(00)80082-2; Ersson A, 1999, Eur J Emerg Med, V6, P341; Haan JM, 2009, AM SURGEON, V75, P1109; Haasper C, 2006, UNFALLCHIRURG, V109, P1025, DOI 10.1007/s00113-006-1186-2; Haider AH, 2009, J SURG RES, V153, P138, DOI 10.1016/j.jss.2008.04.011; Heckman SR, 2005, J PEDIATR SURG, V40, P98, DOI 10.1016/j.jpedsurg.2004.09.004; Helling TS, 1999, J TRAUMA, V46, P453, DOI 10.1097/00005373-199903000-00019; HOFF WS, 1992, J TRAUMA, V33, P408, DOI 10.1097/00005373-199209000-00012; Hutchings L, 2009, J TRAUMA, V67, P681, DOI 10.1097/TA.0b013e3181a5f0ed; Kato H, 2008, J TRAUMA, V65, P373, DOI 10.1097/TA.0b013e31817db11d; KNUDSON P, 1988, J TRAUMA, V28, P602, DOI 10.1097/00005373-198805000-00006; Kong LB, 1996, J AM COLL SURGEONS, V182, P17; LONG WB, 1986, AM J SURG, V151, P581, DOI 10.1016/0002-9610(86)90553-2; LOWE DK, 1986, AM J SURG, V152, P6, DOI 10.1016/0002-9610(86)90128-5; Lunsjo K, 2007, J TRAUMA, V62, P687, DOI 10.1097/01.ta.0000203591.96003.ee; Parreira JG, 2000, INJURY, V31, P677	30	7	7	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	MAY	2010	113	5					360	+		10.1007/s00113-010-1776-x			5	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	592HT	WOS:000277369900004	20376617				2022-02-06	
J	Gao, H; Gao, Y; Li, XH; Shen, AG; Yan, MJ				Gao, Heng; Gao, Ying; Li, Xiaohong; Shen, Aiguo; Yan, Meijuan			Spatiotemporal Patterns of Dexamethasone-Induced Ras Protein 1 Expression in the Central Nervous System of Rats with Experimental Autoimmune Encephalomyelitis	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Dexamethasone-induced Ras protein 1 (Dexras 1); Neuronal nitric oxide synthase (nNOS); Carboxy-terminal PDZ ligand of nNOS (CAPON); Neurons; Oligodendrocytes	NITRIC-OXIDE SYNTHASE; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; DEMYELINATING DISEASES; DEXRAS1; TRANSMISSION; TRANSECTION; INHIBITION; PLASTICITY	Dexamethasone-induced Ras protein 1 (Dexras 1), a brain-enriched member of Ras subfamily of guanosine triphosphatases, as a novel physiologic nitric oxide (NO) effector, anchor neuronal nitric oxide synthase (nNOS) that could form a ternary complex with carboxy-terminal PDZ ligand of nNOS (CAPON) and nNOS, to specific targets to enhance NO signaling. The present study was to explore the expression pattern of Dexras 1 in the development of experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis. Western blot and immunochemistry analysis showed that the gene and protein expression of Dexras 1 in the central nervous system (CNS) of rats increased significantly during the process of EAE compared with control groups (p < 0.01) and maintain a high level in the remission period. The protein expressions of nNOS and CAPON in hippocampus were approximately paralleled Dexras 1. Immunofluorescence revealed that both neurons and glial cells expressed the Dexras 1 in EAE CNS. Importantly, the damaged CNS in EAE-affected rats showed the codistribution between Dexras 1 and caspase 3, indicating the role of Dexras 1 played in the apoptotic process in EAE. Furthermore, colocalizations of Dexras 1 were observed in neurons and glial cells in CNS with nNOS or CAPON, supporting the ternary complex in this model. Thus, these findings suggest the postulation that Dexras 1 might participate into CNS neuronal cell death and demyelination in the whole process of EAE through regulating the NO signaling by binding to nNOS and CAPON.	[Shen, Aiguo; Yan, Meijuan] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China; [Gao, Heng; Gao, Ying; Li, Xiaohong; Shen, Aiguo; Yan, Meijuan] Nantong Univ, Affiliated Jiangyin Hosp, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu Prov, Peoples R China; [Gao, Heng] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China		Shen, AG (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, 19 Qi Xiu Rd, Nantong 226001, Jiangsu, Peoples R China.	ymz8888@gmail.com; shag@ntu.edu.cn	yan, mei/AAA-1379-2022		National Natural Scientific Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30300099, 30770488, 30772242, 30872320]; Natural Scientific Foundation of Jiangsu Province [BK2009156, BK2006547]; College and University Natural Scientific Research Program of Jiangsu Province [08KJB320011]; Technology Guidance Plan for Social Development Grant of Jiangsu Province [BS2004526]; Health Project of Jiangsu Province [H200632]	This work was supported by the National Natural Scientific Foundation of China (30300099, 30770488, 30772242, and 30872320), Natural Scientific Foundation of Jiangsu Province (BK2009156 and BK2006547), College and University Natural Scientific Research Program of Jiangsu Province (08KJB320011), Technology Guidance Plan for Social Development Grant of Jiangsu Province (BS2004526), Health Project of Jiangsu Province (H200632).	Akiyama H, 2000, ALZ DIS ASSOC DIS, V14, pS47, DOI 10.1097/00002093-200000001-00008; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; Borgs M, 1996, HEPATOLOGY, V23, P1564, DOI 10.1053/jhep.1996.v23.pm0008675178; BREDT DS, 1994, NEURON, V13, P301, DOI 10.1016/0896-6273(94)90348-4; BUISSON A, 1992, BRIT J PHARMACOL, V106, P766, DOI 10.1111/j.1476-5381.1992.tb14410.x; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Curtis J, 1999, J NEUROSCI RES, V58, P88, DOI 10.1002/(SICI)1097-4547(19991001)58:1<88::AID-JNR9>3.0.CO;2-R; Dawson T M, 1993, NIDA Res Monogr, V136, P258; Dawson VL, 1996, J NEUROSCI, V16, P2479; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; FAWCETT JW, 1992, TRENDS NEUROSCI, V15, P5, DOI 10.1016/0166-2236(92)90338-9; Gilg AG, 2000, J NEUROPATH EXP NEUR, V59, P1063, DOI 10.1093/jnen/59.12.1063; Giri S, 2002, FASEB J, V16, DOI 10.1096/fj.01-0798com; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Inglis FM, 1998, J NEUROSCI, V18, P10493; KOPROWSKI H, 1993, P NATL ACAD SCI USA, V90, P3024, DOI 10.1073/pnas.90.7.3024; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; NAGAFUJI T, 1992, NEUROSCI LETT, V147, P159, DOI 10.1016/0304-3940(92)90584-T; NISHIKAWA T, 1993, STROKE, V24, P1717, DOI 10.1161/01.STR.24.11.1717; NOWICKI JP, 1991, EUR J PHARMACOL, V204, P339, DOI 10.1016/0014-2999(91)90862-K; OPDENAKKER G, 1994, IMMUNOL TODAY, V15, P103, DOI 10.1016/0167-5699(94)90151-1; Satake K, 2000, MOL BRAIN RES, V85, P114, DOI 10.1016/S0169-328X(00)00253-9; Sato T, 1997, J NEUROCHEM, V68, P1312; Shen AG, 2008, J CHEM NEUROANAT, V35, P85, DOI 10.1016/j.jchemneu.2007.07.004; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Stover JF, 1997, EUR J CLIN INVEST, V27, P1038, DOI 10.1046/j.1365-2362.1997.2250774.x; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; TRIFILETTI RR, 1992, EUR J PHARMACOL, V218, P197, DOI 10.1016/0014-2999(92)90168-4; Vodovotz Y, 1996, J EXP MED, V184, P1425, DOI 10.1084/jem.184.4.1425; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Waxman SG, 1998, NEW ENGL J MED, V338, P323, DOI 10.1056/NEJM199801293380510; WILLENBORG DO, 1979, J IMMUNOL, V123, P1145; Wolosker H, 1996, FEBS LETT, V392, P274, DOI 10.1016/0014-5793(96)00829-0; ZHANG J, 1992, P NATL ACAD SCI USA, V89, P9382, DOI 10.1073/pnas.89.20.9382	41	7	8	1	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAY	2010	41	1					198	209		10.1007/s12031-009-9322-4			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	573IH	WOS:000275905400026	20084551				2022-02-06	
J	Mahesh, R; Pandey, DK; Katiyar, S; Kukade, G; Viyogi, S; Rudra, A				Mahesh, Radhakrishnan; Pandey, Dilip Kumar; Katiyar, Shruti; Kukade, Gaurav; Viyogi, Shruti; Rudra, Anjuman			Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats	INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Anti-depressants; Anxiety; Depression; Traumatic brain injury	OLFACTORY BULBECTOMIZED RATS; PSYCHIATRIC-DISORDERS; EMOTIONAL BEHAVIOR; HEAD-INJURY; ANTIDEPRESSANTS; SEROTONIN; HIPPOCAMPUS; ANXIETY; LESIONS; METAANALYSIS	Disruption of normal neuronal networks and neurotransmitters like serotonin and norepinephrine levels in post traumatic brain injury (TBI) are observed to be the primary causative agent for depression/anxiety. This communication reports the efficacy of various classes' anti-depressants in the treatment of depression/anxiety following TBI in rats. Chronic treatment with anti-depressants (escitalopram and venlafaxine) leads to improvement in the depressive/anxiogenic -like behaviour in the TBI rat and corroborates the notion of the involvement of serotonin and norepinephrine in the behavioural consequences of post-TBI. Chronic treatments with escitalopram and venlafaxine significantly reversed the effect of TBI as compared to vehicle-treated TBI group. The results showed a quantitative battery of neuro-behavioural functional assessments that correlates with neuronal damage following traumatic brain injury.	[Mahesh, Radhakrishnan; Pandey, Dilip Kumar; Katiyar, Shruti; Kukade, Gaurav; Viyogi, Shruti; Rudra, Anjuman] Birla Inst Technol & Sci, Dept Pharm, Pilani 333031, Rajasthan, India		Pandey, DK (corresponding author), Birla Inst Technol & Sci, Dept Pharm, FD 3, Pilani 333031, Rajasthan, India.	pandeysdl1408@gmail.com			CSIR, New DelhiCouncil of Scientific & Industrial Research (CSIR) - India	The authors thank CSIR, New Delhi for supporting the work.	ARJAN B, 2002, J PSYCHOPHARMACOL, V16, P39; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BOULENGER JP, 2006, CURR MED RES OPIN, V22, P11; BRADY JV, 1955, J COMP PHYSIOL PSYCH, V48, P412, DOI 10.1037/h0046406; BROEKKAMP CL, 1986, EUR J PHARMACOL, V126, P223, DOI 10.1016/0014-2999(86)90051-8; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; FILE SE, 1978, BRIT J PHARMACOL, V62, P19, DOI 10.1111/j.1476-5381.1978.tb07001.x; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Hemels MEH, 2002, ANN PHARMACOTHER, V36, P1375, DOI 10.1345/aph.1A331; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; ICHIMARU Y, 1995, JPN J PHARMACOL, V68, P65, DOI 10.1254/jjp.68.65; Izumi J, 1997, PHARMACOL BIOCHEM BE, V57, P883, DOI 10.1016/S0091-3057(96)00455-8; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JOSEPH AB, 1995, J HEAD TRAUMA REHAB, V10, P90, DOI 10.1097/00001199-199504000-00010; Kelly JP, 1997, PHARMACOL THERAPEUT, V74, P299, DOI 10.1016/S0163-7258(97)00004-1; Khouzam HR, 1998, GEN HOSP PSYCHIAT, V20, P62, DOI 10.1016/S0163-8343(97)00097-2; KING FA, 1958, J NERV MENT DIS, V126, P57, DOI 10.1097/00005053-195801000-00006; Kontinen VK, 1999, PAIN, V80, P341, DOI 10.1016/S0304-3959(98)00230-9; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Marmarou A, 1990, Adv Neurol, V52, P233; MAYEUX R, 1988, MOVEMENT DISORD, V3, P237, DOI 10.1002/mds.870030308; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; McManus P, 2000, MED J AUSTRALIA, V173, P458, DOI 10.5694/j.1326-5377.2000.tb139294.x; MICHAEL A, 1988, J ANXIETY DISORDER, V4, P353; Moller HJ, 2000, J CLIN PSYCHIAT, V61, P24; Ortiz Lobo A, 2005, Aten Primaria, V35, P152, DOI 10.1157/13071941; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; RAITT JR, 1961, J PHARM CHEMOTHER, V17, P473; Ramamoorthy R, 2008, BEHAV PHARMACOL, V19, P29, DOI 10.1097/FBP.0b013e3282f3cfd4; RICHELSON E, 1984, EUR J PHARMACOL, V104, P277, DOI 10.1016/0014-2999(84)90403-5; ROSS CA, 1991, INT PSYCHOGERIATR, V3, P325; Sairanen M, 2007, NEUROSCIENCE, V144, P368, DOI 10.1016/j.neuroscience.2006.08.069; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHIBATA S, 1984, PHARMACOL BIOCHEM BE, V21, P225, DOI 10.1016/0091-3057(84)90219-3; Slotkin TA, 1999, J PHARMACOL EXP THER, V289, P334; Suarez M, 2002, LIFE SCI, V71, P1125, DOI 10.1016/S0024-3205(02)01830-1; Thase ME, 2005, J CLIN PSYCHIAT, V66, P974, DOI 10.4088/JCP.v66n0803; THASE ME, 2006, J CLIN PSYCHOPHARM, V26, P42; TREIT D, 1981, PHARMACOL BIOCHEM BE, V15, P619, DOI 10.1016/0091-3057(81)90219-7; van Marwijk HWJ, 2001, PHARM WORLD SCI, V23, P46, DOI 10.1023/A:1011294305606; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; VANRIEZEN H, 1990, PHARMACOL THERAPEUT, V47, P21, DOI 10.1016/0163-7258(90)90043-2; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Vouimba RM, 2006, STRESS, V9, P29, DOI 10.1080/10253890600610973; Wang DY, 2007, BEHAV BRAIN RES, V178, P262, DOI 10.1016/j.bbr.2007.01.003	48	7	8	0	2	NATL INST SCIENCE COMMUNICATION-NISCAIR	NEW DELHI	DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI 110 012, INDIA	0019-5189	0975-1009		INDIAN J EXP BIOL	Indian J. Exp. Biol.	MAY	2010	48	5					466	473					8	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	592MR	WOS:000277383800005	20795363				2022-02-06	
J	Oh, CK; Yoon, SH				Oh, Chang Keun; Yoon, Soo Han			The significance of incomplete skull fracture in the birth injury	MEDICAL HYPOTHESES			English	Article							HEAD-INJURY	Vaginal delivery is accomplished by the force of the labor overcoming the resistance forces of birth canal. During this process, the fetal head passes through the birth canal and the skull receives pressure on the lateral aspect, resulting in molding, the convex shaping of the cranium. Also, the infant's skull is compressed by the mother's pelvic bony structures. These forces may lead to skull fractures and brain injuries. The hypothesis by the authors is that many skull fractures of the newborn present as incomplete fractures. The bony skull of the newborn is histologically primary bone tissue and which is incomplete in its ossification process. During birth the pressure forces upon the newborn's skull is gradual in one direction, rather than a sudden impact, and therefore it is thought that the skull fracture would be an incomplete fracture. However, it is very hard to ascertain the presence of incomplete fractures especially in incompletely ossified skulls with plain X-ray studies, and therefore it is possible that the real incidence of skull fractures in the newborn are higher than reported in the current and past literature. It is also probable that the external forces upon the skull that are sufficient to cause skull fractures, would also lead to significant brain injury more frequently than actually observed, and subsequently contribute to development of many brain disease later in children. The authors of this study propose that very close examination should be conducted to find incomplete fracture, and increased efforts should be made to establish the presence of possible accompanied brain injuries in babies with incomplete skull fracture. The definitive diagnosis and treatment, as well as close follow up of patients with brain injury will assist the clinician in determining the causes of neurological diseases especially in those with previously unknown etiologies, which may be due to birth injuries. Assistance may be also afforded in the early treatment and prevention of such conditions. (C) 2009 Elsevier Ltd. All rights reserved.	[Oh, Chang Keun; Yoon, Soo Han] Ajou Univ, Sch Med, Dept Neurosurg, Suwon 443721, South Korea		Yoon, SH (corresponding author), Ajou Univ, Sch Med, Dept Neurosurg, Suwon 443721, South Korea.	ee802000@yahoo.co.kr					Alexander JM, 2006, OBSTET GYNECOL, V108, P885, DOI 10.1097/01.AOG.0000237116.72011.f3; [Anonymous], 2008, PEDIATR ANESTH, V18, P11, DOI 10.1111/j.1460-9592.2007.02405.x; BENARI Y, 1986, EUR J OBSTET GYN R B, V22, P249, DOI 10.1016/0028-2243(86)90073-0; Bhat B. Vishnu, 1994, Indian Journal of Pediatrics, V61, P401, DOI 10.1007/BF02751901; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Browning JG, 2005, EMERG MED J, V22, P33, DOI 10.1136/emj.2004.016196; CUNNINGHAM FG, 2005, DIS INJURIES FETUS N, P684; Demissie K, 2004, BRIT MED J, V329, P24, DOI 10.1136/bmj.329.7456.24; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Gogos KA, 2003, PEDIATR RADIOL, V33, P236, DOI 10.1007/s00247-002-0861-x; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gurney JG, 1996, EPIDEMIOLOGY, V7, P485, DOI 10.1097/00001648-199609000-00006; Harpold TL, 1998, NEUROSURG CLIN N AM, V9, P141; Heise RH, 1996, OBSTET GYNECOL, V87, P851; Huda W, 1997, RADIOLOGY, V203, P417, DOI 10.1148/radiology.203.2.9114097; Hughes CA, 1999, ARCH OTOLARYNGOL, V125, P193, DOI 10.1001/archotol.125.2.193; JUNQUEIRA LC, 2005, BONE BASIC HISTOLOGY, P137; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301; Pollina J, 2001, PEDIATR NEUROSURG, V35, P113, DOI 10.1159/000050403; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Raimondi A. J., 1986, HEAD INJURIES NEWBOR, P233; TERVILA L, 1975, ANN CHIR GYNAECOL FE, V64, P118	23	7	7	0	3	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	MAY	2010	74	5					898	900		10.1016/j.mehy.2009.11.014			3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	599BY	WOS:000277886400034	20005051				2022-02-06	
J	Scheurich, A; Urban, PP; Koch-Khoury, N; Fellgiebel, A				Scheurich, Armin; Urban, Peter P.; Koch-Khoury, Nassrin; Fellgiebel, Andreas			CSF phospho-tau is independent of age, cognitive status and gender of neurological patients	JOURNAL OF NEUROLOGY			English	Article						Biochemical markers; Cerebrospinal fluid; Dementia; Neurodegeneration; Neurological diseases	CEREBROSPINAL-FLUID TAU; CREUTZFELDT-JAKOB-DISEASE; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; CORTICOBASAL DEGENERATION; DIFFERENTIAL-DIAGNOSIS; AXONAL DEGENERATION; MULTIPLE-SCLEROSIS; LEWY BODIES; PROTEIN	CSF phospho-tau (p-tau(181)) levels have shown good diagnostic utility in differential diagnosis of Alzheimer disease (AD). Unlike total-tau (t-tau), age related changes of this promising biomarker are sparsely studied. The aim of the study was to determine whether p-tau(181) is dependent on age, cognitive status or gender in patients with different neurological diseases who underwent diagnostic lumbar puncture and who had no clinical evidence of neurodegenerative diseases. CSF levels of p-tau(181) and total-tau (t-tau) of 46 neurologic patients (age range 22-89 years; 22 male, 24 female) were analyzed. Clinical diagnoses were cerebral ischaemia (n = 6), multiple sclerosis (n = 13), epileptic seizures (n = 3), polyneuropathy (n = 9) and other neurological diagnoses (n = 15). Cognitive performance was assessed by the German version of the CERAD battery. The mean level of p-tau(181) was in accordance with previous findings in neurological patients (42.8 +/- A 15.3 pg/ml) and did not differ between neurological diseases. In contrast to t-tau (r = 0.38; P = 0.009), p-tau(181) did not correlate significantly to age (r = 0.15; P = 0.308). No influence of cognitive status or gender on p-tau(181) levels could be detected. The study corroborates the independence of p-tau(181) from age, cognitive status, gender and a wide spectrum of neurological diseases. The findings suggest that neither age related neurodegenerative processes nor ischaemic or inflammatory processes are accompanied by tau protein phosphorylation. In contrast, the data support the view that p-tau(181) seems to be a sign of the highly AD-specific pattern of tau phosphorylation during formation of neurofibrillary tangles.	[Scheurich, Armin; Koch-Khoury, Nassrin; Fellgiebel, Andreas] Johannes Gutenberg Univ Mainz, Dept Psychiat & Psychotherapy, D-55131 Mainz, Germany; [Urban, Peter P.] Asklepios Hosp Barmbek, Dept Neurol, D-22291 Hamburg, Germany		Scheurich, A (corresponding author), Johannes Gutenberg Univ Mainz, Dept Psychiat & Psychotherapy, Untere Zahlbacher Str 8, D-55131 Mainz, Germany.	scheurich@psychiatrie.klinik.uni-mainz.de	Fellgiebel, Andreas/F-4428-2012				Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bartosik-Psujek H, 2006, J NEURAL TRANSM, V113, P339, DOI 10.1007/s00702-005-0327-z; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; Blomberg M, 2001, DEMENT GERIATR COGN, V12, P127, DOI 10.1159/000051246; Fellgiebel A, 2009, J GERIATR PSYCH NEUR, V22, P3, DOI 10.1177/0891988708327810; Hampel H, 2004, ARCH GEN PSYCHIAT, V61, P95, DOI 10.1001/archpsyc.61.1.95; Hampel H, 2004, J NEURAL TRANSM, V111, P247, DOI 10.1007/s00702-003-0065-z; Hampel H, 2003, BRAIN RES BULL, V61, P243, DOI 10.1016/S0361-9230(03)00087-X; Hampel H, 2001, ANN NEUROL, V49, P545, DOI 10.1002/ana.111; Hein K, 2008, NEUROSCI LETT, V436, P72, DOI 10.1016/j.neulet.2008.02.064; Hesse C, 2001, NEUROSCI LETT, V297, P187, DOI 10.1016/S0304-3940(00)01697-9; Hesse Camilla, 2000, Journal of Alzheimer's Disease, V2, P199; Ibach B, 2006, NEUROBIOL AGING, V27, P1202, DOI 10.1016/j.neurobiolaging.2005.06.005; Janca A, 1996, COMPR PSYCHIAT, V37, P180, DOI 10.1016/S0010-440X(96)90034-6; Le Bastard N, 2010, NEUROBIOL AGING, V31, P1867, DOI 10.1016/j.neurobiolaging.2008.10.017; Maddalena A, 2003, ARCH NEUROL-CHICAGO, V60, P1202, DOI 10.1001/archneur.60.9.1202; Maruyama M, 2001, EXP NEUROL, V172, P433, DOI 10.1006/exnr.2001.7814; MILLER AKH, 1980, NEUROPATH APPL NEURO, V6, P119, DOI 10.1111/j.1365-2990.1980.tb00283.x; Mitani K, 1998, J NEUROL, V245, P44; Mollenhauer B, 2006, CLIN CHEM LAB MED, V44, P192, DOI 10.1515/CCLM.2006.035; MONSCH AU, 2002, CERAD CONSORTIUM EST; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Otto M, 2002, NEUROLOGY, V58, P192, DOI 10.1212/WNL.58.2.192; Palmio J, 2009, SEIZURE-EUR J EPILEP, V18, P474, DOI 10.1016/j.seizure.2009.04.006; Parnetti L, 2008, BIOL PSYCHIAT, V64, P850, DOI 10.1016/j.biopsych.2008.02.016; Riemenschneider M, 2003, MOL PSYCHIATR, V8, P343, DOI 10.1038/sj.mp.4001220; Sjogren M, 2001, CLIN CHEM, V47, P1776; Tumani H, 2008, EXPERT REV MOL DIAGN, V8, P479, DOI 10.1586/14737159.8.4.479; Urakami K, 1999, NEUROSCI LETT, V259, P127, DOI 10.1016/S0304-3940(98)00923-9; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Wittchen H. U., 1997, DIA X INTERVIEW; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x	34	7	8	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	APR	2010	257	4					609	614		10.1007/s00415-009-5382-1			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577WO	WOS:000276254900017	19921301				2022-02-06	
J	Harting, MT; Smith, CT; Radhakrishnan, RS; Aroom, KR; Dash, PK; Gill, B; Cox, CS				Harting, Matthew T.; Smith, Carter T.; Radhakrishnan, Ravi S.; Aroom, Kevin R.; Dash, Pramod K.; Gill, Brijesh; Cox, Charles S., Jr.			Regional Differences in Cerebral Edema After Traumatic Brain Injury Identified by Impedance Analysis	JOURNAL OF SURGICAL RESEARCH			English	Article						traumatic brain injury; brain edema; trauma; electrical properties; impedance	CLOSED HEAD-INJURY; ACUTE RESPONSES; ANIMAL-MODELS; WATER-CONTENT; TISSUE; TOPOGRAPHY; PREDICTION; DISEASE; MILD; RATS	Objective. Cerebral edema is a common and potentially devastating sequel of traumatic brain injury. We developed and validated a system capable of tissue impedance analysis, which was found to correlate with cerebral edema. Methods. Constant sinusoidal current (50 mu A), at frequencies from 500 to 5000 Hz, was applied across a bipolar electrode unit superficially placed in a rat brain after traumatic brain injury. Rats were randomized to three groups: severe controlled cortical injury (CCI), mild CCI, or sham injury. At 60 h post-CCI, cerebral voltage and phase angle were measured at each frequency at the site of injury, at the penumbral region, at the ipsilateral frontal region, and in the contralateral hemisphere. Impedance measurements were also obtained in vivo. The electrical properties of varied injuries and specified locations were compared using a repeated measures analysis of variance (RMANOVA), were correlated with regional tissue water percentage using regression analyses, and were combined to generate polar coordinates. Results. The measured voltage was significantly different at the site of injury (P < 0.0001), in the penumbra (P = 0.002), and in the contralateral hemisphere (P = 0.005) when severe, mild, and sham CCI rats were compared. Severely injured rats had statistically different voltage measurements when the various sites were compared (P = 0.002). The ex vivo measurements correlated with in vivo measurements. Further, the impedance measurements correlated with measured tissue water percentage at the site of injury (R(2) = 0.69; P < 0.0001). The creation of a polar coordinate graph, incorporating voltage and phase angle measurements, enabled the identification of impedance areas unique to normal, mild edema, and severe edema measurements in the rat brain. Conclusions. Electrical measurements and tissue water percentages quantified regional and severity differences in rat brain edema after CCI. Impedance was inversely proportional to the tissue water percentage. Thus, impedance measurement can be used to quantify severity of cerebral edema in real time at specific sites. (C) 2010 Elsevier Inc. All rights reserved.	[Harting, Matthew T.; Smith, Carter T.; Radhakrishnan, Ravi S.; Aroom, Kevin R.; Gill, Brijesh; Cox, Charles S., Jr.] Univ Texas Med Sch Houston, Dept Surg, Div Pediat Surg, Houston, TX 77030 USA; [Radhakrishnan, Ravi S.; Cox, Charles S., Jr.] Univ Texas Med Sch Houston, Ctr Microvasc & Lymphat Studies, Dept Surg, Houston, TX 77030 USA; [Dash, Pramod K.] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Dash, Pramod K.] Univ Texas Med Sch Houston, Vivian L Smith Ctr Neurol Res, Houston, TX 77030 USA		Cox, CS (corresponding author), Univ Texas Med Sch Houston, Dept Pediat Surg, 6431 Fannin St,MSB 5-228, Houston, TX 77030 USA.	charles.s.cox@uth.tmc.edu		Aroom, Kevin/0000-0003-1504-0585; Harting, Matthew/0000-0002-8929-8311; Dash, Pramod/0000-0001-6746-1002	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM008792-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER	This study was supported by NIH grant T32 GM008792-06.	Baskaya MFK, 1996, NEUROSURGERY, V38, P140; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Cihangiroglu M, 2002, NEUROL RES, V24, P7, DOI 10.1179/016164102101199440; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Grasso G, 2002, NEUROSURGERY, V50, P1064, DOI 10.1097/00006123-200205000-00023; Kimelberg HK, 2004, NEUROSCIENCE, V129, P851, DOI 10.1016/j.neuroscience.2004.07.033; KLEIN HC, 1993, NEUROPATH APPL NEURO, V19, P57, DOI 10.1111/j.1365-2990.1993.tb00405.x; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lingwood BE, 2003, BRAIN RES, V969, P160, DOI 10.1016/S0006-8993(03)02295-9; Liu LX, 2006, NEUROL RES, V28, P31, DOI 10.1179/016164106X91843; Lythgoe MF, 2003, BRIT MED BULL, V65, P235, DOI 10.1093/bmb/65.1.235; Marion D, 2006, J BIOMOL NMR, V36, P45, DOI 10.1007/s10858-006-9066-1; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; MARMAROU A, 1982, J NEUROSURG, V56, P246, DOI 10.3171/jns.1982.56.2.0246; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; Radhakrishnan RS, 2007, J SURG RES, V138, P106, DOI 10.1016/j.jss.2006.06.009; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shochat M, 2006, INTENS CARE MED, V32, P1214, DOI 10.1007/s00134-006-0237-z; Siemionow V, 2000, J NEUROSCI METH, V96, P113, DOI 10.1016/S0165-0270(99)00188-0; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; TORNHEIM PA, 1984, J NEUROSURG, V60, P473, DOI 10.3171/jns.1984.60.3.0473; TORNHEIM PA, 1981, J NEUROSURG, V55, P407, DOI 10.3171/jns.1981.55.3.0407; TORNHEIM PA, 1985, BRAIN RES, V337, P81, DOI 10.1016/0006-8993(85)91611-7; Ueda Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2136386; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; van der Weerd L, 2004, METHOD ENZYMOL, V386, P149; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; VANDENBRINK WA, 1990, ACT NEUR S, V51, P261; VANHARREVELD A, 1956, AM J PHYSIOL, V187, P180, DOI 10.1152/ajplegacy.1956.187.1.180; Walker DC, 2005, PHYSIOL MEAS, V26, P251, DOI 10.1088/0967-3334/26/3/010; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	32	7	8	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	MAR	2010	159	1					557	564		10.1016/j.jss.2008.10.014			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	601NJ	WOS:000278066600019	19181334	Green Accepted			2022-02-06	
J	Poulos, CJ				Poulos, Christopher J.			EVALUATING INPATIENT PUBLIC REHABILITATION IN AUSTRALIA USING A UTILIZATION REVIEW TOOL DEVELOPED IN NORTH AMERICA	JOURNAL OF REHABILITATION MEDICINE			English	Article						rehabilitation; inpatient; utilization review; therapy; intensity; efficiency	TRAUMATIC BRAIN-INJURY; THERAPY INTENSITY; STROKE; CARE; SUBACUTE; OUTCOMES	Objective: To evaluate inpatient rehabilitation in public facilities in Australia against a utilization review tool used in the USA. Design: Prospective cohort study. Subjects: Patients identified in the acute wards of a regional referral hospital and subsequently transferred to a public inpatient rehabilitation facility. Methods: The InterQual utilization review criteria were applied to days of stay in the rehabilitation wards. Reasons for variance and actual therapy time were recorded. Results: Data on 267 patient episodes (7359 days) are available. Only 48% of patient days met utilization review criteria, with reasons for variance including insufficient therapy, awaiting discharge to long-term care or to home and being more appropriate for acute medical care. Therapy time data (available on 208 patient episodes) show that therapy was received on 50% of calendar days and for an average of 37 min per weekday (56 min for stroke patients). Allied health staffing levels were below recommended levels, but consistent with other Australian public hospital rehabilitation facilities. Conclusion: Patients in these facilities seem to be receiving less therapy than their American counterparts; however, therapists often viewed their rehabilitation as appropriate. Findings also suggest inefficiencies in care delivery. Utilization review may help in the assessment of level of care appropriateness in the rehabilitation setting.	[Poulos, Christopher J.] Univ Wollongong, Warrawong, NSW, Australia; [Poulos, Christopher J.] S Eastern Sydney Illawarra Area Hlth Serv, Warrawong, NSW, Australia		Poulos, CJ (corresponding author), Port Kembla Hosp, POB 21, Warrawong, NSW 2502, Australia.	chris.poulos@sesiahs.health.nsw.gov.au			HCF Health and Medical Research Foundation; Centre for Health Service Development; University of Wollongong	This research was funded by the HCF Health and Medical Research Foundation. Professor Kathy Eagar and Dr Christopher Magee from the Centre for Health Service Development, University of Wollongong, and Anne Lees, Joanne Morrell and other staff from the involved hospitals, assisted in this work.	Allied Health in Rehabilitation Consultative Committee, 2007, GUID ALL HLTH RES RE; *AUSTR FAC REH MED, 2005, AD REH MED SERV PUBL; Baggerly J, 1995, Rehabil Nurs, V20, P161; Braitberg G, 2007, MED J AUSTRALIA, V187, P624, DOI 10.5694/j.1326-5377.2007.tb01448.x; Cameron PA, 2006, MED J AUSTRALIA, V184, P203, DOI 10.5694/j.1326-5377.2006.tb00200.x; Chen CC, 2002, ARCH PHYS MED REHAB, V83, P1514, DOI 10.1053/apmr.2002.35107; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Flintoft VF, 1998, CAN MED ASSOC J, V158, P1289; Hellweg S, 2008, BRAIN INJURY, V22, P365, DOI 10.1080/02699050801998250; Jette DU, 2005, ARCH PHYS MED REHAB, V86, P373, DOI 10.1016/j.apmr.2004.10.018; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Kwakkel G, 2006, DISABIL REHABIL, V28, P823, DOI 10.1080/09638280500534861; *MED INP REH CRIT, 2009, STAND ASS MED APPR C; New PW, 2008, MED J AUSTRALIA, V189, P340, DOI 10.5694/j.1326-5377.2008.tb02058.x; Page SJ, 2006, TOP STROKE REHABIL, V13, pVIII; Poulos Christopher J, 2007, Aust New Zealand Health Policy, V4, P3, DOI 10.1186/1743-8462-4-3; Poulos CJ, 2007, AUST HEALTH REV, V31, pS129, DOI 10.1071/AH07S129; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Simmonds F, 2008, AUST HEALTH REV, V32, P85, DOI 10.1071/AH080085; Slade A, 2002, J REHABIL MED, V34, P260, DOI 10.1080/165019702760390347; Smith CB, 1996, MED CARE, V34, P85, DOI 10.1097/00005650-199601000-00007; Teasell Robert, 2005, Top Stroke Rehabil, V12, P46; *UN DAT SYST MED R, 1997, GUID UN DAT SET MED; Weinrich M, 2004, NEUROREHAB NEURAL RE, V18, P12, DOI 10.1177/0888439003262041; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	25	7	7	0	3	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAR	2010	42	3					246	253		10.2340/16501977-0506			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	572TA	WOS:000275854800009	20411220	gold, Green Published			2022-02-06	
J	Shah, MI				Shah, Manish I.			Prehospital Management of Pediatric Trauma	CLINICAL PEDIATRIC EMERGENCY MEDICINE			English	Article						pediatric trauma; intravenous access; intraosseous access; cervical spine immobilization; traumatic brain injury; prehospital care; airway; emergency medical services	EMERGENCY MEDICAL-SERVICES; ENDOTRACHEAL INTUBATION; INTRAVENOUS ACCESS; FLUID THERAPY; CARE; CHILDREN; SURVIVAL; INJURY; TIME; RISK	A limited body of literature about pediatric prehospital trauma care exists to date. Topics that have been studied include delaying transport to initiate treatment on-scene, the use of advanced life support or basic life support resources, identifying high-risk pediatric trauma patients, optimal airway management, obtaining intravenous or intraosseous access, immobilization of the cervical spine, optimal management of traumatic brain injury, and the assessment and management of pain. Translating the best available evidence into clinical practice is important to providing quality prehospital pediatric trauma care. This article will review the literature regarding the risks and benefits of various aspects of pediatric trauma care in the prehospital setting.	[Shah, Manish I.] Baylor Coll Med, Dept Pediat, Sect Emergency Med, Houston, TX USA		Shah, MI (corresponding author), Texas Childrens Hosp, 6621 Fannin St,MC 1-1481, Houston, TX 77030 USA.	mxshah@texaschildrens.org					American College of Surgeons, 2008, ADV TRAUM LIF SUPP D; Atabaki SM, 2006, CLIN PEDIATR EMERG M, V7, P94, DOI 10.1016/j.cpem.2006.03.003; Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Baxt C, 2004, J PEDIATR SURG, V39, P979, DOI 10.1016/j.jpedsurg.2004.02.031; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Carr BG, 2008, PREHOSP EMERG CARE, V12, P327, DOI 10.1080/10903120802096928; Carr BG, 2006, PREHOSP EMERG CARE, V10, P198, DOI 10.1080/10903120500541324; COLLINS M, 2004, CURR OPIN ORTHOP, V15, P100; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Cudnik MT, 2008, PREHOSP EMERG CARE, V12, P459, DOI 10.1080/10903120802290745; Cudnik MT, 2007, PREHOSP EMERG CARE, V11, P224, DOI 10.1080/10903120701205208; Ehrlich PF, 2004, J PEDIATR SURG, V39, P1376, DOI 10.1016/j.jpedsurg.2004.05.010; Engum SA, 2000, J PEDIATR SURG, V35, P82, DOI 10.1016/S0022-3468(00)80082-2; FUCHS S, 1991, ANN EMERG MED, V20, P371, DOI 10.1016/S0196-0644(05)81657-9; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; GUY J, 1993, J PEDIATR SURG, V28, P158, DOI 10.1016/S0022-3468(05)80263-5; HALLER JA, 1983, J TRAUMA, V23, P691, DOI 10.1097/00005373-198308000-00002; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Institute of Medicine of the National Academies, 2006, EM MED SERV C; Krug S, 2005, PEDIATRICS, V115, P1089, DOI 10.1542/peds.2005-0403; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Lewis FR, 1989, PREHOSP DISASTER MED, V4, P129; Liberman M, 2000, J TRAUMA, V49, P584, DOI 10.1097/00005373-200010000-00003; LILLIS KA, 1992, ANN EMERG MED, V21, P1430, DOI 10.1016/S0196-0644(05)80054-X; Lzsak E, 2008, PREHOSP EMERG CARE, V12, P182, DOI 10.1080/10903120801907471; NCCSIR, 2000, 18 ANN REP; Newgard CD, 2007, PEDIATR EMERG CARE, V23, P450, DOI 10.1097/01.pec.0000280508.90665.df; Newgard CD, 2009, PREHOSP EMERG CARE, V13, P420, DOI 10.1080/10903120903144882; ORNATO JP, 1990, ANN EMERG MED, V19, P1469, DOI 10.1016/S0196-0644(05)82623-X; RAMENOFSKY ML, 1989, J PEDIATR SURG, V24, P153, DOI 10.1016/S0022-3468(89)80236-2; Sadow KB, 2001, CLIN PEDIAT EMERG ME, V2, P23; SAMPALIS JS, 1993, J TRAUMA, V34, P252, DOI 10.1097/00005373-199302000-00014; Shah MN, 2008, PREHOSP EMERG CARE, V12, P269, DOI 10.1080/10903120802100167; Suominen P, 1998, J PEDIATR SURG, V33, P1388, DOI 10.1016/S0022-3468(98)90014-8; TEACH SJ, 1995, PEDIATR EMERG CARE, V11, P5, DOI 10.1097/00006565-199502000-00002; TRUNKEY DD, 1984, J TRAUMA, V24, P86, DOI 10.1097/00005373-198401000-00017; Viccellio P, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e20; WEARS RL, 1990, ANN EMERG MED, V19, P163, DOI 10.1016/S0196-0644(05)81802-5; Zempsky WT, 2004, PEDIATRICS, V114, P1348, DOI 10.1542/peds.2004-1752	42	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1522-8401	1558-2310		CLIN PEDIATR EMERG M	Clin. Pediatr. Emerg. Med.	MAR	2010	11	1					10	17		10.1016/j.cpem.2009.12.003			8	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	V5F4L	WOS:000219559000003					2022-02-06	
J	Alain-Pascal, BBN; Wei, HJ; Chen, X; Zhang, JN				Alain-Pascal, Biteghe-Bi-Nzeng; Wei Hui-jie; Chen Xin; Zhang Jian-ning			Evaluation of stress hormones in traumatic brain injury patients with gastrointestinal bleeding	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Brain injuries; Gastrointestinal hemorrhage; Adrenocorticotropic hormone; Gastrins	RISK-FACTORS; HEAD; RESPONSES; ULCER; AXIS	Objective: To evaluate the local risk factors of traumatic brain injury (TBI) patients developing gastrointestinal (GI) bleeding during the early hospitalization in neurosurgery intensive care unit (NICU). Method: From September 2005 to February 2006, 41 patients admitted to NICU and 13 healthy volunteers were involved in our study. Blood samples at 24 hours, 2-3 days and 5-7 days were obtained from each patient via arterial line at 8 a. m. tomeasure the concentrations of serumadrenocorticotropic hormone (ACTH), total cortisol and gastrin. The collected serum was immersed in an ice bath and tested by the Immulite 1000 systems. Data were analyzed by SPSS 11.5. Results: Within 24 hours following TBI, the concentrations of total cortisol, ACTH and gastrin increased proportionally to the severity of injury, especially significant in the experimental group (P<0.05). The concentrations of ACTHand gastrinwerehigher in theGI bleeding positive group than in theGI bleeding negative group, (F=1.413, P=0.253) for ACTHand (F=9.371, P=0.006) for gastrin. GI bleeding had a positive correlation with gastrin concentration (r=0. 312, P<0.05) and a negative correlation with serum hemoglobin (Hb) (r=-0.420, P<0.01). The clinical incidence ofGI bleedingwas 24.39%(10/41) in the experimental group. Within 24 hours, GI bleeding had a strong correlation with gastrin concentration (OR=26.643, P<0.05) and hematocrit (Hct) (OR=5.385, P<0.05). HighACTHconcentration (> 100pg/ml) increased the frequency of GI bleeding. For patients with severe TBI and treated with routine antacids, the incidence of GI bleeding was 40.91% (9/22) and the mortality rate was 20%(2/10). Conclusions: Low Glasgow coma scale scores, low Hb, high concentrations of gastrin andACTH (> 100 pg/ml) are risk factors and can be predictive values for post-traumaticGI bleeding. Severe TBI patients have high risks of GI bleeding with high mortality.	[Alain-Pascal, Biteghe-Bi-Nzeng; Wei Hui-jie; Chen Xin; Zhang Jian-ning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com			Tianjin Science and Techonology Development Plan [05YFGDSF02500]	This study was supported by the Tianjin Science and Techonology Development Plan (No. 05YFGDSF02500).	BAIGRIE RJ, 1992, BRIT J SURG, V79, P757, DOI 10.1002/bjs.1800790813; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Borm K, 2003, EUR J ENDOCRINOL, V149, P535, DOI 10.1530/eje.0.1490535; Cavaliere F, 2004, CURR DRUG TARGETS, V5, P411, DOI 10.2174/1389450043345362; Cernak I, 1999, BRAIN INJURY, V13, P1005; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; COLICE GL, 1984, AM REV RESPIR DIS, V130, P941; COOK DJ, 1994, NEW ENGL J MED, V330, P377, DOI 10.1056/NEJM199402103300601; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; GLASER F, 1995, ANN SURG, V221, P372; KAMADA T, 1977, J TRAUMA, V17, P44, DOI 10.1097/00005373-197701000-00006; KARCH SB, 1972, J NEUROSURG, V37, P27, DOI 10.3171/jns.1972.37.1.0027; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; METZ CA, 1993, CRIT CARE MED, V21, P1844, DOI 10.1097/00003246-199312000-00010; Pittella JEH, 2003, J FORENSIC SCI, V48, P626; PRUITT BA, 1970, ANN SURG, V172, P523, DOI 10.1097/00000658-197010000-00001; Roe SY, 1998, EUR J NEUROSCI, V10, P553, DOI 10.1046/j.1460-9568.1998.00064.x; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; Shohami E, 1995, J NEUROTRAUM, V12, P1069, DOI 10.1089/neu.1995.12.1069; SHUMAN RB, 1987, ANN INTERN MED, V106, P562, DOI 10.7326/0003-4819-106-4-562; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; Van den Berghe G, 2000, EUR J ENDOCRINOL, V143, P1, DOI 10.1530/eje.0.1430001; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011	25	7	8	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	FEB	2010	13	1					25	31		10.3760/cma.j.issn.1008-1275.2010.01.005			7	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF0YP	WOS:000441895200005	20109364				2022-02-06	
J	Fickenscher, KA; Dean, JS; Mena, DC; Green, BA; Lowe, LH				Fickenscher, Kristin A.; Dean, Julianne S.; Mena, David C.; Green, Brian A.; Lowe, Lisa H.			Occult Cranial Injuries Found with Neuroimaging in Clinically Asymptomatic Young Children Due to Abusive Compared to Accidental Head Trauma	SOUTHERN MEDICAL JOURNAL			English	Article						asymptomatic; child abuse; neuroradiology	VICTIMS	Objective: To compare occult brain injuries on neuroimaging in clinically asymptomatic children under 20 months due to abusive versus accidental head trauma. Subjects and Methods: A retrospective review of 58 children under 20 months who underwent neuroimaging for possible abusive trauma was performed. The data collected were demographics, neurological signs/symptoms, imaging findings, and disposition (abusive or accidental). Results: The disposition of 31 subjects was abusive trauma and 27 were accidental. At presentation, 8/31(25.8%) children with abusive injury and 15/27(55.6%) with accidental injury were neurologically asymptomatic. Neuroimaging was abnormal in 6 of 8 (75.0%) asymptomatic children with abusive injury, and 13/15 (86.7%) children with accidental trauma. No significant (P = 0.59) difference in frequency of abnormal neuroimaging was seen between the asymptomatic abusive and accidental trauma groups. Conclusions: Although victims of abusive trauma under 20 months of age are less often neurologically asymptomatic compared to accidental trauma victims, neuroimaging revealed a high rate of occult traumatic brain injury in both groups.	[Lowe, Lisa H.] Childrens Mercy Hosp & Clin, Dept Radiol, Kansas City, MO 64152 USA; Univ Missouri, Dept Radiol, Kansas City, MO 64110 USA; Univ Missouri, Dept Radiol, Columbia, MO USA		Lowe, LH (corresponding author), Childrens Mercy Hosp & Clin, Dept Radiol, 2401 Gillham Rd, Kansas City, MO 64152 USA.	lhlowe@cmh.edu					Barnes RE, 2000, BIOETHICS, V14, P16, DOI 10.1111/1467-8519.00178; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Berger RP, 2004, CHILD ABUSE NEGLECT, V28, P739, DOI 10.1016/j.chiabu.2004.01.007; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; DUUS BR, 1994, ANN EMERG MED, V23, P1279, DOI 10.1016/S0196-0644(94)70352-3; Fernando S, 2008, PEDIATR RADIOL, V38, P827, DOI 10.1007/s00247-007-0729-1; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Judkins AR, 2004, AM J FOREN MED PATH, V25, P29, DOI 10.1097/01.paf.0000113811.85110.54; Laskey AL, 2004, J PEDIATR-US, V144, P719, DOI 10.1016/j.jpeds.2004.02.023; LEVIN AV, 2001, OCULAR MANIFESTATION; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382	15	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0038-4348	1541-8243		SOUTH MED J	South.Med.J.	FEB	2010	103	2					121	125		10.1097/SMJ.0b013e3181c9944e			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	604OS	WOS:000278289000009	20065898				2022-02-06	
J	Jackson, BF				Jackson, Benjamin F.			Orbital Trauma, Bradycardia, and Vomiting: Trapdoor Fracture and the Oculocardiac Reflex A Case Report	PEDIATRIC EMERGENCY CARE			English	Article						orbital trauma; trapdoor fracture; oculocardiac reflex	TRIGEMINOCARDIAC REFLEX; EYE INJURY	The presentation of vomiting and bradycardia after closed head trauma should invariably prompt concern for significant intracranial injury, yet other less common causes for the clinical picture do exist. This case reports one such scenario in which fracture to the patient's inferior orbital wall resulted in the rare though potentially life-threatening oculocardiac reflex, a vagally mediated phenomenon with possible respiratory, cardiovascular, and gastric motility effects.	Med Univ S Carolina, Div Emergency Med, Dept Pediat, Charleston, SC 29425 USA		Jackson, BF (corresponding author), Med Univ S Carolina, Div Emergency Med, Dept Pediat, 135 Rutledge Ave,POB 250566, Charleston, SC 29425 USA.	jacksobf@musc.edu					Agrawal A, 2008, CLIN NEUROL NEUROSUR, V110, P321, DOI 10.1016/j.clineuro.2008.01.013; Baek Se Hyun, 2003, Korean J Ophthalmol, V17, P44; Bauer DF, 2005, SURG NEUROL, V63, P143, DOI 10.1016/j.surneu.2004.03.022; Brady SM, 2001, AM J EMERG MED, V19, P147, DOI 10.1053/ajem.2001.21315; Brophy M, 2006, PEDIATRICS, V117, pE1263, DOI 10.1542/peds.2005-1950; Burnstine MA, 2002, OPHTHALMOLOGY, V109, P1207, DOI 10.1016/S0161-6420(02)01057-6; Chang Eli L, 2004, Curr Opin Ophthalmol, V15, P411, DOI 10.1097/01.icu.0000137854.37950.fb; Doniger SJ, 2006, PEDIATR CLIN N AM, V53, P85, DOI 10.1016/j.pcl.2005.10.004; DONLON JV, 2005, MILLERS ANESTHESIA, P1883; Egbert JE, 2000, OPHTHALMOLOGY, V107, P1875, DOI 10.1016/S0161-6420(00)00334-1; Grant JH, 2002, PLAST RECONSTR SURG, V109, P482, DOI 10.1097/00006534-200202000-00011; Kwon JH, 2005, ARCH OTOLARYNGOL, V131, P723, DOI 10.1001/archotol.131.8.723; LANG S, 1991, CAN J ANAESTH, V38, P757, DOI 10.1007/BF03008454; Mathison DJ, 2008, CLIN PEDIATR EMERG M, V9, P106, DOI 10.1016/j.cpem.2008.03.002; McGwin G, 2005, ARCH OPHTHALMOL-CHIC, V123, P662, DOI 10.1001/archopht.123.5.662; Meng QL, 2008, CLIN NEUROL NEUROSUR, V110, P662, DOI 10.1016/j.clineuro.2008.03.018; Nash EA, 1998, ARCH OPHTHALMOL-CHIC, V116, P1222, DOI 10.1001/archopht.116.9.1222; Ogata H, 2004, EUR J PLAST SURG, V27, P12; Prevent Blindness America, SCOP EYE INJ PROBL; Schaller B, 2004, J NEUROL, V251, P658, DOI 10.1007/s00415-004-0458-4; Sires BS, 1998, ARCH OPHTHALMOL-CHIC, V116, P955; Yoon KC, 2003, J KOREAN MED SCI, V18, P881, DOI 10.3346/jkms.2003.18.6.881	22	7	9	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	FEB	2010	26	2					143	145		10.1097/PEC.0b013e3181ce30d8			3	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	559CZ	WOS:000274799500016	20145507				2022-02-06	
J	Pesl, T; Havranek, P				Pesl, T.; Havranek, P.			Monteggia Lesions in the Growing Skeleton: Principles of Therapy	ACTA CHIRURGIAE ORTHOPAEDICAE ET TRAUMATOLOGIAE CECHOSLOVACA			Czech	Article						Monteggia lesion; radius; ulna; fracture; physeal injury; child	EQUIVALENT LESIONS; FRACTURES; CHILDREN	PURPOSE OF THE STUDY In this retrospective study we analyse the methods of Monteggia lesion (ML) treatment in children used in our department. Based on the results we propose several general principals for the therapy of this complex injury to the forearm in a growing skeleton. MATERIAL The group included patients with the diagnosis of acute ML treated at our department in the 2003-2007 period. No patients in whom therapy was started later than two weeks after injury were included. METHODS We assessed injuries according to the Bado classification system modified by Olney for young age, and also by the system based on ML stability assessment previously published by us. We evaluated the type of ulnar fracture and lesions affecting the radio-humero-ulnar joint, and the therapeutic method used. The treatment outcome was evaluated by the criteria proposed by Letts et al. for the elbow joint in children (minimal follow-up of one year). RESULTS In the five-year period, we treated 36 children with acute ML. The most frequent were patients with Bado type I equivalent lesion (61 %) and those with unstable ML (53 %). We treated 39 % of the patients conservatively and 61% by osteosynthesis. The;osteosynthesis of one bone was performed in 30 % (radius, 11 % ulna, 19 %) and of both bones in 31 % of the cases. The outcome assessed by the Letts score was excellent in 80 %, good in 17 % of the patients and poor in only one patient (3 %). DISCUSSION There is general consensus in the literature that childhood ML, if early and correctly diagnosed and correctly treated, has a good prognosis in most of the cases, in contrast to adult ML. However, the views on therapy vary from closed reduction under general anaesthesia to routine surgical exploration of the radio-humero-ulnar joint with open reduction of dislocation of the radial head and temporary radio-humeral arthrodesis. However, a unified therapeutic approach to an immature skeleton has not been proposed yet. CONCLUSIONS In the treatment of a growing skeleton, the reduction and stabilisation of an ulnar fracture is of primary concern. Only then is the management of injury to the radio-humero-ulnar joint reasonable. Any ML should always be considered on the whole. In most cases, a stable lesion is indicated for conservative treatment and an unstable one for surgical stabilisation. A potentially unstable lesion should first be managed conservatively and, if this fails, by surgical stabilisation.	[Pesl, T.; Havranek, P.] Fak Thomayerova Nemocnice, Kliln Detske Chirurg & Traumatol 3, LF UK, Prague 14059 4, Czech Republic		Pesl, T (corresponding author), Fak Thomayerova Nemocnice, Kliln Detske Chirurg & Traumatol 3, LF UK, Videnska 800, Prague 14059 4, Czech Republic.	tomas.pesl@ftn.cz					ANGERMANN P, 2000, MIKROCHIR PLAST CHIR, V32, P260; Bado J L, 1967, Clin Orthop Relat Res, V50, P71; BRUCE HE, 1974, J BONE JOINT SURG AM, VA 56, P1563, DOI 10.2106/00004623-197456080-00003; FOWLES JV, 1983, J BONE JOINT SURG AM, V65, P1276, DOI 10.2106/00004623-198365090-00008; GAL P, 2001, URAZOVA CHIRURGIE, V9, P1; Givon U, 1997, CLIN ORTHOP RELAT R, P208; Guven M, 2008, ACTA ORTHOP TRAUMATO, V42, P90; HAVRANEK P, 2001, ACTA CHIR ORTHOP TR, V68, P73; LETTS M, 1985, J BONE JOINT SURG BR, V67, P724, DOI 10.1302/0301-620X.67B5.4055869; Li Ming, 2003, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V17, P192; Macintyre NR, 2009, ACTA CHIR ORTHOP TR, V76, P7; ONLEY BW, 1989, J PEDIATR ORTHOPED, V9, P219; PEIRO A, 1977, J BONE JOINT SURG AM, V59, P92, DOI 10.2106/00004623-197759010-00017; Perren SM, 2008, ACTA CHIR ORTHOP TR, V75, P241; Pesl T, 2005, Acta Chir Orthop Traumatol Cech, V72, P164; Ring D, 1996, J BONE JOINT SURG BR, V78B, P734, DOI 10.1302/0301-620X.78B5.0780734; Schmidt CM, 2008, UNFALLCHIRURG, V111, P350, DOI 10.1007/s00113-007-1328-1; Tan JW, 2008, INJURY, V39, P451, DOI 10.1016/j.injury.2007.07.010; VINZ H, 1991, ZBL CHIR, V116, P143; von Laer L, 2004, PEDIAT FRACTURES DIS; Wang S T, 1996, Zhonghua Yi Xue Za Zhi (Taipei), V58, P355; WILEY JJ, 1985, J BONE JOINT SURG BR, V67, P728, DOI 10.1302/0301-620X.67B5.4055870	22	7	13	0	3	GALEN SRO	PRAGUE 5	NA BELIDLE 34, PRAGUE 5, 150 00, CZECH REPUBLIC	0001-5415			ACTA CHIR ORTHOP TR	Acta Chir. Orthop. Traumatol. Cechoslov.	FEB	2010	77	1					32	38					7	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	567XS	WOS:000275482700005	20214858				2022-02-06	
B	Catroppa, C; Anderson, V		Anderson, V; Jacobs, R; Anderson, PJ		Catroppa, Cathy; Anderson, Vicki			Intervention approaches for executive dysfunction following brain injury in childhood	EXECUTIVE FUNCTIONS AND THE FRONTAL LOBES: A LIFESPAN PERSPECTIVE	Studies on Neuropsychology Neurology and Cognition		English	Article; Book Chapter							CLOSED-HEAD-INJURY; FRONTAL LOBES; COGNITIVE REHABILITATION; INTELLECTUAL DISABILITY; BEHAVIORAL SUPPORTS; YOUNG-CHILDREN; WHITE-MATTER; MEMORY; DEFICITS; TBI		[Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Dept Psychol, Royal Childrens Hosp, Sch Behav Sci, Melbourne, Vic, Australia		Catroppa, C (corresponding author), Univ Melbourne, Dept Psychol, Royal Childrens Hosp, Sch Behav Sci, Melbourne, Vic, Australia.		Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; ARANOW HU, 1987, J HEAD TRAUMA REHAB, V2, P24; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Beaulieu CL, 2002, SURG CLIN N AM, V82, P393, DOI 10.1016/S0039-6109(02)00009-9; Benson D.F., 1986, FRONTAL LOBES; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; Brett A W, 1998, Pediatr Rehabil, V2, P27; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; CATROPPA C, IMPLEMENTAT IN PRESS; Chen CC, 2004, AM J OCCUP THER, V58, P44, DOI 10.5014/ajot.58.1.44; CICERONE K, 1990, NEUROPSYCHOLOGY EVER, P271; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Cronin AF, 2001, AM J OCCUP THER, V55, P377, DOI 10.5014/ajot.55.4.377; CROWLEY JA, 1991, J PEDIATR PSYCHOL, V16, P611, DOI 10.1093/jpepsy/16.5.611; Davis CH, 1997, AM J PHYS MED REHAB, V76, P213, DOI 10.1097/00002060-199705000-00011; DAVIS MJ, 1995, J DENTISTRY CHIL MAR, P93; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Dennis M., 1989, CLIN NEUROPSYCHOLOGY; Diller L., 1981, HDB CLIN NEUROPSYCHO, V1, P702; Dumas HM, 2002, AM J PHYS MED REHAB, V81, P661, DOI 10.1097/00002060-200209000-00005; Dykeman B, 2003, J INSTRUCTIONAL PSYC, P225; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; FENNELL EB, 1992, ADV CHILD NEUROPSYCH, V1; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Garth J, 1997, Pediatr Rehabil, V1, P99; Gavidia-Payne S, 2002, J INTELLECT DEV DIS, V27, P31, DOI 10.1080/13668250120119626; GIALLO R, TREATMENT A IN PRESS; GLANG A, 1992, J HEAD TRAUMA REHAB, V7, P93; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; Goldstein FC, 1992, COGNITIVE DISORDERS; GRAHAM AJH, 1982, NEUROLOGY, V12, P557; Gray JM, 1992, NEUROPSYCHOL REHABIL, V2, P97, DOI DOI 10.1080/09602019208401399; Guare R., 2004, EXECUTIVE SKILLS CHI; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Harris JR, 1996, J COMMUN DISORD, V29, P79, DOI 10.1016/0021-9924(94)00035-2; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; Hostler SL, 1999, J HEAD TRAUMA REHAB, V14, P384, DOI 10.1097/00001199-199908000-00007; HUDPETH W, 1990, J EDUC PSYCHOL, V82, P881; Hudson AM, 2003, J INTELL DISABIL RES, V47, P238, DOI 10.1046/j.1365-2788.2003.00486.x; HYND GW, 1988, PAEDIAT NEUROPSYCHOL; JACOBS R, 2003, THESIS U MELBOURNE A; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jennett B, 1981, MANAGEMENT HEAD INJU; Johnson M H, 1990, J Cogn Neurosci, V2, P81, DOI 10.1162/jocn.1990.2.2.81; Johnson M. H., 1997, DEV COGNITIVE NEUROS; Johnson MH, 2003, BIOL PSYCHIAT, V54, P1312, DOI 10.1016/S0006-3223(03)00426-8; Johnson MH, 2000, CHILD DEV, V71, P75, DOI 10.1111/1467-8624.00120; Kazdin A. E., 1984, BEHAV MODIFICATION A; Kelly T., 2000, CLIN NEUROPSYCHOL, V1, P38; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Kolb B., 1999, COGNITIVE NEUROREHAB, P9; KOLB B, 1996, FUNDAMENTALS HUMAN N; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Kraus JF, 1987, HEAD INJURY, V2, P1; Lashley K., 1929, BRAIN MECH INTELLIGE; Laurence S., 1978, RECOVERY BRAIN DAMAG, P369; *LEARN CO, 1987, THINK QUICK; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; LEVIN HS, 1982, NEUROBEHAVIOURAL CON; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; LEVINE MJ, 1988, COGNITIVE REHABILITA, V6, P14; Luria AR, 1963, RESTORATION FUNCTION; Mateer C A, 1999, Semin Clin Neuropsychiatry, V4, P50; Mateer CA, 1996, J LEARN DISABIL, V29, P618, DOI 10.1177/002221949602900606; Mateer CA, 1999, COGNITIVE NEUROREHAB; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; MAZUREK AJ, 1994, J ACCID EMERG MED, V11, P9; MILLER JD, 1991, NEUROPSYCHOLOGY, V5, P235; MILLER JD, 1992, NEUROPSYCHOLOGY, V5, P235; MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663; MILNER B, 1984, TRENDS NEUROSCI, V7, P403, DOI 10.1016/S0166-2236(84)80143-5; Mottram Lisa, 2004, Pediatr Rehabil, V7, P133, DOI 10.1080/1363849042000202286; Munk H, 1881, GESAMMELTE JAHREN, P1877; Napolitano E, 2005, MED SCI MONITOR, V11, pRA212; PAAKKO E, 1992, CANCER, V70, P2728, DOI 10.1002/1097-0142(19921201)70:11<2728::AID-CNCR2820701126>3.0.CO;2-7; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Penkman Louise, 2004, Pediatr Rehabil, V7, P111, DOI 10.1080/13638490310001649417; Pentland L, 1998, NEUROPSYCHOL REHABIL, V8, P301, DOI 10.1080/713755572; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; PRUNETI CA, 1988, RES COMMUN PSYCH PSY, V13, P193; ROBERTSON I, 1990, APHASIOLOGY, V4, P381, DOI 10.1080/02687039008249090; Rosenblueth, 1949, SUPERSENSITIVITY DEN; ROTHI LJ, 1983, J CLIN NEUROPSYCHOL, V5, P73, DOI 10.1080/01688638308401152; RUFF R M, 1990, Brain Injury, V4, P339, DOI 10.3109/02699059009026187; Sanders M R, 1999, Clin Child Fam Psychol Rev, V2, P71, DOI 10.1023/A:1021843613840; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; Schwartz MF, 2006, COGN NEUROPSYCHOL, V23, P202, DOI 10.1080/02643290500202623; Selznick L, 2000, BEHAV INTERVENT, V15, P243, DOI 10.1002/1099-078X(200007/09)15:3<243::AID-BIN59>3.3.CO;2-T; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; SHALLICE T, 1978, CORTEX, V14, P294, DOI 10.1016/S0010-9452(78)80055-0; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Sinnakaruppan I, 2001, INT J REHABIL RES, V24, P35, DOI 10.1097/00004356-200103000-00005; Smidts DP, 2004, DEV NEUROPSYCHOL, V26, P385, DOI 10.1207/s15326942dn2601_2; Sohlberg M, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; STERLING L, 1994, STUDENTS ACQUIRED BR; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; STUSS DT, 1992, BRAIN COGNITION, V20, P8, DOI 10.1016/0278-2626(92)90059-U; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; STUSS DT, 1994, BRAIN INJURY REHABIL; Suzman KB, 1997, J BEHAV THER EXP PSY, V28, P203, DOI 10.1016/S0005-7916(97)00023-2; Swaine BR, 2000, AM J PHYS MED REHAB, V79, P412, DOI 10.1097/00002060-200009000-00002; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; THATCHER RW, 1991, DEV NEUROPSYCHOL, V7, P397, DOI 10.1080/87565649109540500; Thomson J. B., 1995, J INT NEUROPSYCH SOC, V1, P149; THOMSON JB, 2000, NEUROPSYCHOLOGICAL M, P233; Todd JA, 1996, NEUROPSYCHOL REHABIL, V6, P81, DOI 10.1080/713755500; TUEL S M, 1992, Brain Injury, V6, P363, DOI 10.3109/02699059209034951; Vakil E, 2004, CHILD NEUROPSYCHOL, V10, P57, DOI 10.1080/09297040490911078; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; Walsh K. W., 1978, NEUROPSYCHOLOGY CLIN; WELSH MC, 1988, DEV NEUROPSYCHOL, V4, P199, DOI 10.1080/87565648809540405; WEYANDT LL, 1994, DEV NEUROPSYCHOL, V10, P27, DOI 10.1080/87565649409540564; Wilson BA, 1996, ACTA NEUROL BELG, V96, P51; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 1996, MEMORY, V4, P465, DOI 10.1080/741940776; Wilson BA, 2000, NEUROPSYCHOL REV, V10, P233, DOI 10.1023/A:1026464827874; WILSON BA, 1992, CLIN MANAGEMENT MEMO; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876; WOOD RL, 1988, J LEARN DISABIL, V21, P327, DOI 10.1177/002221948802100603; Wright Ingram, 2004, Pediatr Rehabil, V7, P85, DOI 10.1080/13638490410001668758; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M., 1985, HEAD INJURY REHABILI; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, Vxiv; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891; [No title captured]	154	7	7	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND			978-1-13687-354-6	STUD NEUROPSYCHOL NE			2010							439	469					31	Psychology, Biological; Psychology, Developmental; Psychology; Psychology, Experimental	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology	BVE09	WOS:000291249500021					2022-02-06	
B	Constantinidou, F; Thomas, RD		Ashley, MJ		Constantinidou, Fofi; Thomas, Robin D.			Principles of Cognitive Rehabilitation in Traumatic Brain Injury: An Integrative Neuroscience Approach	TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION			English	Article; Book Chapter							WORKING-MEMORY CAPACITY; CLOSED-HEAD-INJURY; IMPLICIT MEMORY; SHORT-TERM; INDIVIDUAL-DIFFERENCES; CONCEPTUAL KNOWLEDGE; IMAGERY MNEMONICS; STIMULUS MODALITY; EXEMPLAR MODELS; VISUAL-STIMULI		[Constantinidou, Fofi] Univ Cyprus, Dept Psychol, Nicosia, Cyprus; [Thomas, Robin D.] Miami Univ, Dept Psychol, Oxford, OH 45056 USA		Constantinidou, F (corresponding author), Univ Cyprus, Dept Psychol, Nicosia, Cyprus.						ADAMOVICH BB, 1985, COGNITIVE REHABILITA; Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Ashby FG, 2001, TRENDS COGN SCI, V5, P204, DOI 10.1016/S1364-6613(00)01624-7; Ashby FG, 2005, TRENDS COGN SCI, V9, P83, DOI 10.1016/j.tics.2004.12.003; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Ashby FG, 2000, CURR DIR PSYCHOL SCI, V9, P10, DOI 10.1111/1467-8721.00049; Ashley M. J., 2004, TRAUMATIC BRAIN INJU, P367; Atkinson R. C., 1968, PSYCHOL LEARN MOTIV, V2, P89, DOI [10.1016/S0079-7421(08)60422-3., DOI 10.1016/S0079-7421(08)60422-3]; Awh E, 2000, J EXP PSYCHOL HUMAN, V26, P834, DOI 10.1037/0096-1523.26.2.834; Baddeley A, 2002, NEUROPSYCHOLOGIA, V40, P1737, DOI 10.1016/S0028-3932(01)00146-4; BADDELEY A, 1988, J MEM LANG, V27, P586, DOI 10.1016/0749-596X(88)90028-9; Baddeley A.D., 1986, WORKING MEMORY; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baddeley Alan, 1995, P755; Beauregard M, 1998, NEUROREPORT, V9, P1867, DOI 10.1097/00001756-199806010-00037; BECKER DP, 1988, WESTERN J MED, V148, P670; Beilock SL, 2005, PSYCHOL SCI, V16, P101, DOI 10.1111/j.0956-7976.2005.00789.x; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BIEDERMAN I, 1991, COGNITIVE PSYCHOL, V23, P393, DOI 10.1016/0010-0285(91)90014-F; BISIACH E, 1978, CORTEX, V14, P129, DOI 10.1016/S0010-9452(78)80016-1; Bracy O. L., 1986, COGN REHABIL, V4, P11; Braisby N, 1999, J CHILD LANG, V26, P23, DOI 10.1017/S0305000998003638; BROOKS D N, 1975, Cortex, V11, P329; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Caetano C., 1997, NEUROPSYCHOL REHABIL, P63; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Caramazza A, 2003, TRENDS COGN SCI, V7, P354, DOI 10.1016/S1364-6613(03)00159-1; Caramazza A, 2006, COGN NEUROPSYCHOL, V23, P13, DOI 10.1080/02643290542000021; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Caramazza A, 1996, NATURE, V380, P485, DOI 10.1038/380485a0; CAVE CB, 1992, J EXP PSYCHOL LEARN, V18, P509, DOI 10.1037/0278-7393.18.3.509; Christensen AL, 1999, NEUROPSYCHOL REV, V9, P71, DOI 10.1023/A:1025655707095; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Colflesh GJH, 2007, PSYCHON B REV, V14, P699, DOI 10.3758/BF03196824; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Constantinidou F, 2004, BRAIN LANG, V89, P216, DOI 10.1016/S0093-934X(03)00399-7; Constantinidou F, 1999, J MED SPEECH-LANG PA, V7, P283; Constantinidou F, 1996, J GEN PSYCHOL, V123, P173, DOI 10.1080/00221309.1996.9921270; CONSTANTINIDOU F, 1995, J HEAD TRAUMA REHAB, V10, P90, DOI 10.1097/00001199-199508000-00009; Constantinidou F., 1998, HEARSAY, V12, P20; Constantinidou F., 2004, TRAUMATIC BRAIN INJU, P337; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Cree GS, 2003, J EXP PSYCHOL GEN, V132, P163, DOI 10.1037/0096-3445.132.2.163; CROSSON B, 1984, J CLIN NEUROPSYCHOL, V6, P287, DOI 10.1080/01688638408401219; CROSSON B, 1993, CLIN NEUROPSYCHOL, V7, P250, DOI 10.1080/13854049308401897; CROVITZ HF, 1979, CORTEX, V15, P225, DOI 10.1016/S0010-9452(79)80027-1; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; DeCaro MS, 2008, COGNITION, V107, P284, DOI 10.1016/j.cognition.2007.07.001; EICH JM, 1982, PSYCHOL REV, V89, P627, DOI 10.1037/0033-295X.89.6.627; Eimer M, 1997, BIOL PSYCHOL, V44, P143, DOI 10.1016/S0301-0511(96)05217-9; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Farah M. J., 1990, VISUAL AGNOSIA DISOR; FARAH MJ, 1991, J EXP PSYCHOL GEN, V120, P339, DOI 10.1037/0096-3445.120.4.339; FARAH MJ, 1988, PSYCHOL REV, V95, P307, DOI 10.1037/0033-295X.95.3.307; FARAH MJ, 1991, NEUROPSYCHOLOGIA, V29, P949, DOI 10.1016/0028-3932(91)90059-H; FINGER S, 1988, BRAIN INJURY RECOVER; Fodor J.A., 1983, MODULARITY MIND; Fromkin V., 1992, INTRO LANGUAGE; GABRIELI JDE, 1995, PSYCHOL SCI, V6, P76, DOI 10.1111/j.1467-9280.1995.tb00310.x; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; GAZZANIGA MS, 1998, COGNITIVE NEUROSCIEN; Glinsky E. L., 1992, J HEAD TRAUMA REHAB, V7, P1; GLOSSER G, 1990, J CLIN EXP NEUROPSYC, V12, P485, DOI 10.1080/01688639008400995; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; GRAF P, 1984, J VERB LEARN VERB BE, V23, P553, DOI 10.1016/S0022-5371(84)90346-3; GRAF P, 1990, J EXP PSYCHOL LEARN, V16, P978, DOI 10.1037/0278-7393.16.6.978; GRAF P, 1982, SCIENCE, V218, P1243, DOI 10.1126/science.7146909; GRAF P, 1984, J EXP PSYCHOL LEARN, V10, P164, DOI 10.1037/0278-7393.10.1.164; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Hall E. D., 1998, BRAIN INJURY SOURCE, V2, P18; Heitz R. P., 2005, HDB UNDERSTANDING ME, P61; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillis AE, 2007, NEUROLOGY, V69, P200, DOI 10.1212/01.wnl.0000265600.69385.6f; Holyoak K.J., 1995, INVITATION COGNITIVE, P267; Hovda D. A., 1998, BRAIN INJURY SOURCE, V2, P22; Humphreys G. W., 2001, BEHAV BRAIN SCI, V24, P476; Humphreys GW, 1999, PSYCHOL RES-PSYCH FO, V62, P118, DOI 10.1007/s004260050046; Humphreys GW, 2001, BEHAV BRAIN SCI, V24, P453, DOI 10.1017/S0140525X01004150; JACOBY LL, 1982, CAN J PSYCHOL, V36, P300, DOI 10.1037/h0080638; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; JACOBY LL, 1987, J EXP PSYCHOL LEARN, V13, P456, DOI 10.1037/0278-7393.13.3.456; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Joseph John, 2001, JOURNEY VULNERABLE B; KAHNEMAN D, 1972, COGNITIVE PSYCHOL, V3, P430, DOI 10.1016/0010-0285(72)90016-3; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Katz D, 1992, J HEAD TRAUMA REHAB, V72, P1, DOI [10.1097/00001199-200501000-00008, DOI 10.1097/00001199-200501000-00008]; Klein G.A., 1993, DECISION MAKING ACTI, P138, DOI DOI 10.1002/BDM.3960080307]; KNIGHT RT, 1980, ELECTROEN CLIN NEURO, V50, P112, DOI 10.1016/0013-4694(80)90328-4; KNOWLTON BJ, 1993, SCIENCE, V262, P1747, DOI 10.1126/science.8259522; KOSSLYN SM, 1992, WET MIND NEW COGNITI; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; LADAVAS E, 1993, NEUROPSYCHOLOGIA, V31, P1307, DOI 10.1016/0028-3932(93)90100-E; Laiacona M, 2003, NEUROCASE, V9, P221, DOI 10.1076/neur.9.3.221.15562; Lamberts K, 2002, BRAIN DAM B, P291; Lamberts K, 2001, BEHAV BRAIN SCI, V24, P484, DOI 10.1017/S0140525X01304156; Levin H. S., 1989, J EXP PSYCHOL, V12, P95; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1992, SCAND J REHABIL MED, P14; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Luria AR, 1963, RESTORATION FUNCTION; MADDOX WT, 1993, PERCEPT PSYCHOPHYS, V53, P49, DOI 10.3758/BF03211715; Maddox WT, 2004, BEHAV PROCESS, V66, P309, DOI 10.1016/j.beproc.2004.03.011; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; MALEC JF, 1996, NEUROLOGY TRAUMA, P231; Markowitsch Hans J., 1995, P765; Mateer C. A., 1999, REHABILITATION ADULT, P254; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; MILNER B, 1966, AMNESIA, P109; MONTGOMERY GK, 1995, BRAIN INJURY, V9, P453, DOI 10.3109/02699059509008205; National Institutes of Health, 1998, NIH CONSENUS STATEME, V16, P1; Nosofsky R. M., 1992, MULTIDIMENSIONAL MOD, P363; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; ODONNELL JP, 1988, J GEN PSYCHOL, V115, P355, DOI 10.1080/00221309.1988.9710572; OLTON DS, 1980, PHYSIOL PSYCHOL, V8, P239; Paivio A., 1976, RECALL RECOGNITION, P103; Paivio A., 1971, IMAGERY VERBAL PROCE; PAPAGNO C, 1991, J MEM LANG, V30, P331, DOI 10.1016/0749-596X(91)90040-Q; PARENTE R., 1996, RETRAINING COGNITION; Parente R., 1989, J HEAD TRAUMA REHAB, V4, P55; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI., 1994, IMAGES MIND; Posner MI, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P410, DOI 10.1017/CBO9780511546396.018; Posner Michael I., 1995, P615; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Redick TS, 2006, APPL COGNITIVE PSYCH, V20, P713, DOI 10.1002/acp.1224; RICHARDSON JTE, 1985, COGNITIVE NEUROPSYCH, V2, P149, DOI 10.1080/02643298508252864; RICHARDSON JTE, 1979, BRIT J SOC CLIN PSYC, V18, P319, DOI 10.1111/j.2044-8260.1979.tb00342.x; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Roediger HL, 1987, MEMORY COGNITIVE PRO, P349; ROSCH E, 1976, J EXP PSYCHOL HUMAN, V2, P491, DOI 10.1037/0096-1523.2.4.491; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; Rumelhart DE., 1986, PARALLEL DISTRIBUTED, P318, DOI 10.7551/mitpress/5236.001.0001; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Sander AM, 2007, AM J SPEECH-LANG PAT, V16, P316, DOI 10.1044/1058-0360(2007/036); SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; SCHACTER D L, 1990, P543; Schacter D. L., 1994, MEMORY SYSTEMS 1994; SCHACTER DL, 1985, ANN NY ACAD SCI, V444, P41, DOI 10.1111/j.1749-6632.1985.tb37578.x; SCHACTER DL, 1992, AM PSYCHOL, V47, P559, DOI 10.1037/0003-066X.47.4.559; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SHIMAMURA AP, 1984, J EXP PSYCHOL GEN, V113, P556, DOI 10.1037/0096-3445.113.4.556; Shimamura Arthur P., 1995, P803; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; SPIKMAN JM, 1995, J CLIN EXP NEUROPSYC, V17, P29, DOI 10.1080/13803399508406578; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 1995, P NATL ACAD SCI USA, V92, P12470, DOI 10.1073/pnas.92.26.12470; Squire LR., 1987, MEMORY BRAIN; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Thomas RD, 1998, J EXP PSYCHOL LEARN, V24, P119, DOI 10.1037/0278-7393.24.1.119; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Tranel D, 2003, COGN NEUROPSYCHOL, V20, P409, DOI 10.1080/02643290244000248; TULVING E, 1982, J EXP PSYCHOL LEARN, V8, P336, DOI 10.1037/0278-7393.8.4.336; TULVING E, 1991, J EXP PSYCHOL LEARN, V17, P595, DOI 10.1037/0278-7393.17.4.595; Tulving Endel, 1995, P839; Unsworth N, 2007, PSYCHOL BULL, V133, P1038, DOI 10.1037/0033-2909.133.6.1038; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Viano D. C., 1988, BIOMECHANICS HEAD IN; VOLPE BT, 1979, NATURE, V282, P722, DOI 10.1038/282722a0; WALLACE MA, 1994, CARN S COGN, P359; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273; WAUGH NC, 1965, PSYCHOL REV, V72, P89, DOI 10.1037/h0021797; WILSON B, 1987, REHABILITATION MEMOR; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Younger BA, 1999, CHILD DEV, V70, P291, DOI 10.1111/1467-8624.00022; [No title captured]	195	7	7	0	0	CRC PRESS-TAYLOR & FRANCIS GROUP	BOCA RATON	6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA			978-1-4398-4982-8; 978-1-4200-7194-8				2010							549	582		10.1201/9781439849828-c18	10.1201/9781439849828		34	Clinical Neurology; Rehabilitation	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Rehabilitation	BF7QW	WOS:000384329900019					2022-02-06	
J	Garcia-Molina, A; Gomez, A; Rodriguez, P; Sanchez-Carrion, R; Zumarraga, L; Ensenat, A; Bernabeu, M; Tormos, JM; Roig-Rovita, T				Garcia-Molina, A.; Gomez, A.; Rodriguez, P.; Sanchez-Carrion, R.; Zumarraga, L.; Ensenat, A.; Bernabeu, M.; Tormos, J. M.; Roig-Rovita, T.			Clinical program of cognitive telerrehabilitation for traumatic brain injury	TRAUMA-SPAIN			Spanish	Article						Traumatic brain injury; rehabilitation; telemedicine; activities of daily living		Objetive: The purpose of this study was to validate clinically the cognitive rehabilitation services based on telemedicine systems (PREVIRNEC platform) for persons with moderate or severe traumatic brain injury (TBI). Patients and Methods. Eighty patients with moderate or severe TBI; mean age: 36 years; the mean Glasgow Coma Scale score at injury was 6,8 (SD=3,6). Cognitive rehabilitation took place in 50 sessions during 10 weeks. Differences between pre-and post-treatment neuropsychological test scores were used to measure patient's improvements in the domains of attention, memory and executive functions. Patient's everyday competence after rehabilitation was examined with the Patient Competency Rating Scale (PCRS). Results. Patients were divided in two group based in PCRS scores (patients with and without adequate everyday competence). There was observed a significant difference between both groups on number of task performed on higher rang of right responses in attention and executive rehabilitation tasks (p=0,026 and p=0,040, respectively). Conclusions. The cognitive rehabilitation program based on telemedicine systems (PREVIRNEC platform) improves attention, memory, and executive functions and the patient's everyday competence.	[Garcia-Molina, A.; Gomez, A.; Rodriguez, P.; Sanchez-Carrion, R.; Zumarraga, L.; Ensenat, A.; Bernabeu, M.; Tormos, J. M.; Roig-Rovita, T.] Inst Univ Neurorehabil Guttmann UAB, Cami Can Ruti S-N, Badalona 08916, Spain		Garcia-Molina, A (corresponding author), Inst Univ Neurorehabil Guttmann UAB, Cami Can Ruti S-N, Badalona 08916, Spain.	agarciam.investigacio@guttmann.com		Tormos Munoz, Jose Maria/0000-0002-8764-2289			Artiola i Fortuny L, 1999, MANUAL NORMAS PROCED; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Golden C.J., 1994, TEST COLORES PALABRA; Heaton .R, 1997, TEST CLASIFICACION T; Institut Guttmann, 2003, CONS RESP MOD AS PLA; Levin HS., 1982, NEUROBEHAVIORAL CONS; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Rey A., 1964, EXAMEN CLIN PSYCHOL; Ricker JH, 2002, J HEAD TRAUMA REHAB, V17, P242, DOI 10.1097/00001199-200206000-00005; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Torsney K, 2003, NEUROREHABILITATION, V18, P183; Wechsler D., 1999, ESCALA INTELIGENCIA; Wolfson, 1993, HALSTEAD REITAN NEUR; [No title captured]	17	7	9	0	0	FUNDACION MAPFRE	MADRID	PASEO DE RECOLETOS, 23, MADRID, 28004, SPAIN	1888-6116			TRAUMA-SPAIN	Trauma-Spain	JAN-MAR	2010	21	1					58	63					6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V6G0J	WOS:000420250400010					2022-02-06	
J	Hazer, DB; Berker, M; Narin, F; Ileri-Gurel, E; Basak, AT; Seringec, N; Kaymaz, F; Dikmenoglu, N; Tuncel, M				Hazer, Derya Burcu; Berker, Mustafa; Narin, Firat; Ileri-Gurel, Esin; Basak, Ahmet Tulgar; Seringec, Nurten; Kaymaz, Figen; Dikmenoglu, Neslihan; Tuncel, Murvet			Effects of pravastatin on cellular ultrastructure and hemorheology in rats after traumatic head injury	CLINICAL HEMORHEOLOGY AND MICROCIRCULATION			English	Article						pravastatin; brain injury; erythrocyte aggregation; erythrocyte deformability; cellular ultrastructure; plasma viscosity	CONTROLLED CORTICAL IMPACT; NITRIC-OXIDE SYNTHASE; SPINAL-CORD-INJURY; BRAIN-INJURY; HYPERCHOLESTEROLEMIC PATIENTS; SUBARACHNOID HEMORRHAGE; ATORVASTATIN REDUCTION; SIMVASTATIN; STATINS; THERAPY	Pravastatin has neuroprotective effects against aging but its role in brain injury remains unclear. This study evaluated the effects of pravastatin on the ultrastructural changes and hemorheological parameters in rats after traumatic brain injury (TBI) of right parietal cortical contusion by a controlled weight-dropping method. There were three groups: (I) Sham operated group; (II) TBI + vehicle (saline) group; and (III) TBI + pravastatin group. Right parietal craniectomy was performed in all groups. In TBI + pravastatin group, pravastatin was administered orally at a dose of 1 mg/kg every day for 7 days starting at 24 hours after the injury. Plasma viscosity, erythrocyte deformability and erythrocyte aggregation were measured from blood samples of all rats on 2nd, 7th and 15th days. At the same time electron microscopic study was done on designated days for groups II and III. Treatment with pravastatin markedly increased aggregation amplitude and gamma Isc max values and significantly decreased erythrocyte deformability but did not change plasma viscosity in 2 weeks time. Ultrastructural parameters such as perinuclear edema, mitochondrial swelling and intraneuronal vacuoles were detected in lower degree in the statin group when compared to the saline group, especially decreased demyelinization and endothelial detachment was prominent. As a result, the hyperviscosity state with increased erythrocyte aggregation and decreased erythrocyte deformability induced by pravastatin in this study was accompanied by an improvement of the ultrastructural findings in TBI. This hyperviscosity state may be a compensatory mechanism to increase the oxygenation of the injured tissue by inducing the release of antiaggregant and vasodilatory substances by increasing shear stress. Therefore, we suggest that prolonged pravastatin usage may exert affirmative effects on traumatic brain injury conditions by increasing blood viscosity.	[Hazer, Derya Burcu] Cankiri State Hosp, Dept Neurosurg, TR-18100 Cankiri, Turkey; [Berker, Mustafa; Narin, Firat; Basak, Ahmet Tulgar] Hacettepe Univ, Fac Med, Dept Neurosurg, TR-06100 Ankara, Turkey; [Ileri-Gurel, Esin; Seringec, Nurten; Dikmenoglu, Neslihan] Hacettepe Univ, Fac Med, Dept Physiol, TR-06100 Ankara, Turkey; [Kaymaz, Figen] Hacettepe Univ, Fac Med, Dept Histol, TR-06100 Ankara, Turkey; [Tuncel, Murvet] Hacettepe Univ, Fac Med, Dept Anat, TR-06100 Ankara, Turkey		Hazer, DB (corresponding author), Cankiri State Hosp, Dept Neurosurg, TR-18100 Cankiri, Turkey.	burcuhazer@hotmail.com	ILERI-GUREL, Esin/I-8356-2013; Hayran, Murvet/H-5747-2013	ILERI-GUREL, Esin/0000-0001-9610-416X; Hayran, Murvet/0000-0001-6058-6304; Seringec Akkececi, Nurten/0000-0003-1915-2330; hazer, derya burcu/0000-0003-1881-1146; DIKMENOGLU FALKMARKEN, NESLIHAN HACER/0000-0002-0411-6540			Amin-Hanjani S, 2001, STROKE, V32, P980, DOI 10.1161/01.STR.32.4.980; BEIGEL Y, 1991, J INTERN MED, V230, P23, DOI 10.1111/j.1365-2796.1991.tb00402.x; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; CHENG SQ, 2005, J NEUROSURG, V103, P695; Coccia R, 2007, CLIN THER, V29, P1706, DOI 10.1016/j.clinthera.2007.08.010; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DUJOVNE CA, 2003, NUTR METAB CARDIOVAS, V13, P87; Eto M, 2003, ENDOTHELIUM-J ENDOTH, V10, P35, DOI 10.1080/10623320303359; Fei Z, 2001, J CLIN NEUROSCI, V8, P250, DOI 10.1054/jocn.2000.0760; Forconi S, 2009, CLIN HEMORHEOL MICRO, V42, P1, DOI 10.3233/CH-2009-1186; Frontczak-Baniewicz M, 2003, ACTA NEUROBIOL EXP, V63, P65; Gorgulu AK, 2001, NEUROSURGERY, V49, P1434; Joukhadar C, 2001, THROMB HAEMOSTASIS, V85, P47, DOI 10.1055/s-0037-1612902; Kaptanoglu E, 2000, J NEUROSURG, V93, P77, DOI 10.3171/spi.2000.93.1.0077; Kaptanoglu E, 2002, J NEUROSURG ANESTH, V14, P114, DOI 10.1097/00008506-200204000-00005; Kohno M, 1997, METABOLISM, V46, P287, DOI 10.1016/S0026-0495(97)90255-9; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; LOMINADZE D, 2009, ACTA PHYSL OXF, V198, P1; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROSURG, V101, P822, DOI 10.3171/jns.2004.101.5.0822; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Maeda T, 2003, ENDOCRINOLOGY, V144, P681, DOI 10.1210/en.2002-220682; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; McGirt MJ, 2002, STROKE, V33, P2950, DOI 10.1161/01.STR.0000038986.68044.39; Miossec P, 1999, DIABETIC MED, V16, P424, DOI 10.1046/j.1464-5491.1999.00083.x; Morikawa Shigeru, 2002, J Atheroscler Thromb, V9, P178; Muravyov AV, 2004, CLIN HEMORHEOL MICRO, V31, P251; Nemeth N, 2006, CLIN HEMORHEOL MICRO, V35, P59; Vazquez BYS, 2010, CLIN HEMORHEOL MICRO, V44, P55, DOI [10.3233/CH-2010-1252, 10.3233/CH-2010-1261]; Seyfried D, 2004, J NEUROSURG, V101, P104, DOI 10.3171/jns.2004.101.1.0104; Singhal AB, 2005, NEUROLOGY, V64, P1008, DOI 10.1212/01.WNL.0000154523.21633.0E; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; Turkoglu OF, 2008, J CLIN NEUROSCI, V15, P60, DOI 10.1016/j.jocn.2007.03.005; Turkoglu OF, 2009, SURG NEUROL, V72, P146, DOI 10.1016/j.surneu.2008.07.004; Vaz R, 1998, ACTA NEUROCHIR, V140, P76, DOI 10.1007/s007010050061; Vaz R, 1997, ACTA NEUROCHIR, V139, P215, DOI 10.1007/BF01844754; Wierzbicki AS, 1998, LANCET, V351, P569, DOI 10.1016/S0140-6736(05)78556-1	38	7	7	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1386-0291	1875-8622		CLIN HEMORHEOL MICRO	Clin. Hemorheol. Microcirc.		2010	46	1					1	11		10.3233/CH-2010-1328			11	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	651KX	WOS:000281927700001	20852358				2022-02-06	
J	Heydari, M; Jani, S				Heydari, Mahdi; Jani, Saeid			An ellipsoidal model for studying response of head impacts	ACTA OF BIOENGINEERING AND BIOMECHANICS			English	Article						ellipsoidal model; head impact; shell stiffness; Hertzian contact stiffness	FINITE-ELEMENT MODELS; FILLED SPHERICAL SHELL; TRAUMATIC BRAIN-INJURY	The objective of this study was to propose a new analytical model for studying response of head impacts. Head is modeled by fluid-filled ellipsoidal shell of inconstant thickness impacted by a solid elastic sphere. Modeling the head as an ellipsoid is more realistic than modeling it as a sphere, the previous model existing in the literature [3]-[8]. In this model, the effect of Hertzian contact stiffness and local shell stiffness are combined to derive explicit equations for impact duration, the peak force transmitted to head, and the head injury criterion. One of the advantages of the model presented is sensitivity to the site of impact. A comparison between the present analytical results with the analytical data from spherical model [8] has been done to verify the validation of the present model.	[Jani, Saeid] Off Golpayegan Univ Technol, Dept Mech Engn, Tehran, Iran; [Heydari, Mahdi] Sharif Univ Technol, Dept Mech Engn, Tehran, Iran		Jani, S (corresponding author), Off Golpayegan Univ Technol, Dept Mech Engn, Azadi Ave, Tehran, Iran.	jani@gut.ac.ir		Heydari, Mahdi/0000-0003-0177-1029			Anzelius A, 1943, ACTA PATH MICROBIO S, V48, P153; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; ENGIN AE, 1969, J BIOMECH, V2, P325, DOI 10.1016/0021-9290(69)90089-X; Goldsmith W., 1966, P HEAD INJURY C, P350; GOLDSMITH W, 1960, IMPACT THEORY PHYS B, P88; Gray A., 1997, MODERN DIFFERENTIAL; GUTTINGER W, 1950, Z NATURFORSCH A, V5, P622; Hertz H., 1882, Z REINE ANGEW MATH, V92, P156; Johnson EAC, 2005, J BIOMECH, V38, P39, DOI 10.1016/j.jbiomech.2004.03.018; KENNER VH, 1972, INT J MECH SCI, V14, P557, DOI 10.1016/0020-7403(72)90056-2; KHALIL TB, 1982, P 26 STAPP CAR CRASH, P87; POSTON A, 2000, STATIC ADULT HUMAN P, P72; Raul JS, 2008, INT J LEGAL MED, V122, P359, DOI 10.1007/s00414-008-0248-0; REISSNER E, 1946, J MATH PHYS CAMB, V25, P279, DOI 10.1002/sapm1946251279; SAUREN AAH, 1993, P 1993 INT IRCOBI C, P1; Thurman DJ, 2001, HEAD TRAUMA, P327; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; Young PG, 2003, J SOUND VIB, V267, P1107, DOI 10.1016/S0022-460X(03)00200-1; Young PG, 1998, P 1998 IRCOBI C BIOM, V26, P391	20	7	7	1	6	WROCLAW UNIV TECHNOLOGY, FAC COMPUTER SCIENCE & MANAGEMENT	WROCLAW	WYBRZEZE WYSPIANSKIEGO 27, WROCLAW, 50-370, POLAND	1509-409X			ACTA BIOENG BIOMECH	Acta Bioeng. Biomech.		2010	12	1					47	53					7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	631HM	WOS:000280337400008	20653325				2022-02-06	
J	Nance, ML; Kallan, MJ; Arbogast, KB; Park, MS; Durbin, DR; Winston, FK				Nance, Michael L.; Kallan, Michael J.; Arbogast, Kristy B.; Park, Myung S.; Durbin, Dennis R.; Winston, Flaura K.			Factors Associated With Clinically Significant Head Injury in Children Involved in Motor Vehicle Crashes	TRAFFIC INJURY PREVENTION			English	Article						Head injury; Pediatric; Motor vehicle	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; SURVEILLANCE; COMPARTMENT; INTRUSIONS; MECHANISMS; COLLISIONS; MORTALITY; SEVERITY; TRIAGE	Objective: Head injury is the most common cause of death for child occupants in motor vehicle crashes (MVCs). The morbidity associated with nonlethal MVC-related head injuries is of great clinical consequence as well. The purpose of this study was to identify the frequency of, and risk factors for, clinically significant head injury (CSHI) in child occupants in MVCs. Methods: A large, child-specific crash surveillance system linking insurance claims data to telephone survey data was utilized. Qualifying crashes involved model year 1990 or newer vehicles in crashes with one or more child occupants (age 4 to 15 years) occurring in 15 U.S. states. Data were accrued between March 2000 and December 2007. A probability sample of crashes was selected for telephone survey with the driver of the insured vehicle. A clinically significant head injury, as reported by the child's parent using a validated survey, included concussions, skull fractures, and intracranial hemorrhages. Multivariate logistic regression was used to identify factors associated with a CSHI. Results: During the period of study, completed interviews were obtained on 19,075 children aged 4-15, representing 318,527 children involved in 219,511 crashes. The overall rate of CSHI in child occupants was 1.08 percent. Factors associated with an increased risk of head injury included rollover (odds ratio [OR] = 8.60, 95% confidence interval [CI] 6.40-11.57) and near-side impact crashes (OR = 2.39, 95% CI 1.73-3.30) vs. frontal impact; lack of restraint (OR = 3.13, 95% CI 2.26-4.33) vs. restrained; and driver age 25 years (OR = 1.43, 95% CI 1.12-1.81) vs. driver age epsilon 25 years. Some factors varied based on occupant age, and younger child age had a protective effect on the risk for head injury. Conclusion: The risk of CSHI for 4- to 15-year-old child occupants was 1.08 percent. Several demographic and crash factors were associated with CSHI in child occupants. This information may help inform design safety initiatives.	[Nance, Michael L.] Childrens Hosp Philadelphia, Dept Surg, Philadelphia, PA 19104 USA; [Nance, Michael L.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Kallan, Michael J.] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Arbogast, Kristy B.; Durbin, Dennis R.; Winston, Flaura K.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Arbogast, Kristy B.; Durbin, Dennis R.; Winston, Flaura K.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Park, Myung S.] Mayo Clin, Div Trauma Crit Care & Gen Surg, Rochester, MN USA		Nance, ML (corresponding author), Childrens Hosp Philadelphia, Dept Surg, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	nance@email.chop.edu	Durbin, Dennis/AAD-7829-2022	Arbogast, Kristy/0000-0002-1694-4562	State Farm Insurance Companies; State Farm Mutual Automobile Insurance Company	This work was funded by State Farm Insurance Companies. The authors acknowledge the commitment and financial support of State Farm Mutual Automobile Insurance Company for the creation and ongoing maintenance of the Partners for Child Passenger Safety (PCPS) program, the source of data for this study. The authors also thank the many State Farm policyholders who consented to participate in PCPS. The results presented in this report are the interpretation solely of the author(s) and are not necessarily the views of State Farm.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; AGRAN PF, 1992, ACCIDENT ANAL PREV, V24, P349, DOI 10.1016/0001-4575(92)90047-M; Arbogast KB, 2001, J TRAUMA, V51, P469, DOI 10.1097/00005373-200109000-00008; Arbogast Kristy B, 2004, Stapp Car Crash J, V48, P479; *ASS ADV AUT MED, 1998, ABBR INJ SCAL AIS 19; Ballesteros MF, 2003, INJURY PREV, V9, P173, DOI 10.1136/ip.9.2.173; Bina M, 2006, ACCIDENT ANAL PREV, V38, P472, DOI 10.1016/j.aap.2005.11.003; Brown JK, 2006, J PEDIATR SURG, V41, P362, DOI 10.1016/j.jpedsurg.2005.11.014; Durbin DR, 1999, ARCH PEDIAT ADOL MED, V153, P404; Durbin DR, 2001, ACCIDENT ANAL PREV, V33, P407, DOI 10.1016/S0001-4575(00)00054-3; Ferguson S A, 2000, Inj Prev, V6, P24, DOI 10.1136/ip.6.1.24; Gururaj G., 2005, TRAUMATIC BRAIN INJU; Henry MC, 1996, ACAD EMERG MED, V3, P992, DOI 10.1111/j.1553-2712.1996.tb03340.x; Howard A, 2004, J TRAUMA, V56, P1276, DOI 10.1097/01.TA.0000078883.74947.EB; Hyder AA, 2009, B WORLD HEALTH ORGAN, V87, P345, DOI 10.2471/BLT.08.055798; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; McGwin G, 2003, J TRAUMA, V54, P655, DOI 10.1097/01.TA.0000055548.84109.C2; McGwin G, 1999, ACCIDENT ANAL PREV, V31, P181; McKnight A J, 2000, Annu Proc Assoc Adv Automot Med, V44, P321; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; *NAT CTR INJ PREV, 2004, FAT NONF INJ REP; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Scheidler MG, 2000, J TRAUMA, V49, P864, DOI 10.1097/00005373-200011000-00012; SIEGEL JH, 1993, J TRAUMA, V34, P736, DOI 10.1097/00005373-199305000-00017; Stefanopoulos N, 2003, INJURY, V34, P487, DOI 10.1016/S0020-1383(02)00345-5; Thompson EC, 2003, ARCH SURG-CHICAGO, V138, P142, DOI 10.1001/archsurg.138.2.142; *WHO, 2009, WHO REP CHILD INJ PR; Williams AF, 2003, INJ PREV, V9, P25, DOI 10.1136/ip.9.1.25; Winston FK, 2000, PEDIATRICS, V105, P1179, DOI 10.1542/peds.105.6.1179	29	7	7	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1538-9588			TRAFFIC INJ PREV	Traffic Inj. Prev.		2010	11	6					600	605	PII 930472639	10.1080/15389588.2010.513072			6	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	689CM	WOS:000284904900010	21128190				2022-02-06	
J	Singhania, P; Andankar, MG; Pathak, HR				Singhania, Piyush; Andankar, Mukund G.; Pathak, Hemant R.			Urodynamic Evaluation of Urinary Disturbances following Traumatic Brain Injury	UROLOGIA INTERNATIONALIS			English	Article						Bladder dysfunction; Lower urinary tract symptoms; Neurogenic bladder; Urodynamic study; Head injury	CEREBROVASCULAR ACCIDENT; STANDARDIZATION; TERMINOLOGY	Objectives: To identify the incidence and the type of voiding dysfunction by doing urodynamic studies (UDS) in head injury patients. The purpose of this paper is to present our findings and promote research in this field. Patients and Methods: A prospective study was conducted recruiting patients sustaining head injuries with positive CT scan findings. Clinical and radiological evaluation was done. Patients then underwent standardized UDS. The urodynamic findings were correlated with outcome and analyzed. Results: Three out of 11 patients (27.3%) had unstable bladder with multiple involuntary contractions in the filling phase. All of them had significant contusions in the right frontal region and 2 of them had subarachnoid hemorrhage. All of these patients had normal proprioception, voluntary detrusor contractions and nil post-void residue. Two out of the 3 patients had catheter in situ and 1 patient had complaints of frequency and urgency. At 1 year of follow-up, all 3 patients had a normal voiding pattern and the upper tracts were normal on ultrasound in all patients. Conclusions: Voiding dysfunction is a significant problem in patients with head injury. Bladder hyperreflexia is seen in patients with injuries above the pontine micturition center. The voiding abnormality has good prognosis and resolves spontaneously. Treatment in the acute phase may require anticholinergics for a few months. Copyright (C) 2010 S. Karger AG, Basel	[Singhania, Piyush; Andankar, Mukund G.; Pathak, Hemant R.] BYL Nair Charitable Hosp, Dept Urol, Bombay, Maharashtra, India		Singhania, P (corresponding author), BYL Nair Charitable Hosp, Dept Urol, Flat 203,CitiHill View Apartments,Plot 13,Sector, Nerul, Navi Mumbai, India.	piyushsnghn@yahoo.co.in					Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; BADLANI GH, 1991, NEUROUROL URODYNAM, V10, P119, DOI 10.1002/nau.1930100113; Burney TL, 1996, UROL CLIN N AM, V23, P483, DOI 10.1016/S0094-0143(05)70327-X; *CDCP, 2001, TRAUM BRAIN INJ; CHANCELLOR MB, 2002, CAMPBELLS UROLOGY, V3, P1922; Khorsandi M, 1998, UROL INT, V61, P142, DOI 10.1159/000030310; Stohrer M, 1999, NEUROUROL URODYNAM, V18, P139; THURMAN DJ, 1994, GUIDELINES SURVEILLA	8	7	8	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0042-1138			UROL INT	Urol.Int.		2010	84	1					89	93		10.1159/000273473			5	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	557UM	WOS:000274695600016	20173376				2022-02-06	
J	Vance, DE; Struzick, T; Farr, K				Vance, David E.; Struzick, Tom; Farr, Kenneth			Spaced Retrieval Technique-A Cognitive Tool for Social Workers and Their Clients	JOURNAL OF GERONTOLOGICAL SOCIAL WORK			English	Article						HIV; Alzheimer's disease; dementia; everyday functioning; instrumental activities of living; mnemonic; Spaced Retrieval; traumatic brain injury		Social workers frequently work with clients who have cognitive deficits that impair their ability to perform instrumental activities of daily living and reduce their quality of life. Borrowing from the cognitive aging literature, the Spaced Retrieval Technique can be used by social workers to help their clients retain information needed for more autonomous functioning. This technique consists of recalling information over progressively longer periods of time until the information is successfully consolidated into long-term memory. The retained information may include adhering to medication regimens, keeping doctor's appointments, and remembering to pay bills. This technique is established and employed in early Alzheimer's disease, traumatic brain injury, and HIV. Implications for social work practice are posited.	[Vance, David E.; Farr, Kenneth] Univ Alabama Birmingham, Sch Nursing, 1701 Univ Blvd,Room 456, Birmingham, AL 35294 USA; [Struzick, Tom] Univ Alabama Birmingham, CHRD Core Ctr Study Community Hlth, Sch Publ Hlth, Birmingham, AL 35294 USA		Vance, DE (corresponding author), Univ Alabama Birmingham, Sch Nursing, 1701 Univ Blvd,Room 456, Birmingham, AL 35294 USA.	devance@uab.edu	Vance, David/AAE-6047-2020	Vance, David/0000-0002-0498-6263			Anstey Kaarin J, 2004, Aust Fam Physician, V33, P783; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Ball K. K., 2004, PRINCIPLES PRACTICE, P795; Boccardi M, 2006, MECH AGEING DEV, V127, P166, DOI 10.1016/j.mad.2005.09.027; Bourgeois MS, 2003, J COMMUN DISORD, V36, P361, DOI 10.1016/S0021-9924(03)00051-0; Cherry KE, 2005, EXP AGING RES, V31, P261, DOI 10.1080/03610730590948186; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hirono N, 1997, DEMENT GERIATR COGN, V8, P210, DOI 10.1159/000106633; Hochhalter AK, 2005, EXP AGING RES, V31, P101, DOI 10.1080/03610730590914976; Insel K, 2006, J GERONTOL B-PSYCHOL, V61, pP102, DOI 10.1093/geronb/61.2.P102; John PS, 2003, J GERIATR PSYCH NEUR, V16, P80, DOI 10.1177/0891988703016002003; Lekeu F, 2002, ACTA NEUROL BELG, V102, P114; McGuire LC, 2006, AM J GERIAT PSYCHIAT, V14, P36, DOI 10.1097/01.JGP.0000192502.10692.d6; Morrow KL, 2006, J COMMUN DISORD, V39, P2, DOI 10.1016/j.jcomdis.2005.05.001; Neundorfer M. M., 2004, Journal of HIV/AIDS & Social Services, V3, P79, DOI 10.1300/J187v03n01_07; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; Sykes, 1978, PRACTICAL ASPECTS ME, P625; Tabert MH, 2002, NEUROLOGY, V58, P758, DOI 10.1212/WNL.58.5.758; Turkstra LS, 2005, J MED SPEECH-LANG PA, V13, P205; Vance DE, 2006, ACT ADAPT AGING, V30, P61, DOI 10.1300/J016v30n03_04; Vance DE, 2007, J GERONTOL NURS, V33, P46, DOI 10.3928/00989134-20070901-08; Vance DE, 2008, J NEUROSCI NURS, V40, P241, DOI 10.1097/01376517-200808000-00008; Wan H, 2005, CURRENT POPULATION R; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463	24	7	8	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1540-4048	0163-4372		J GERONTOL SOC WORK	J. Gerontol. Soc. Work		2010	53	2					148	158		10.1080/01634370903409745			11	Geriatrics & Gerontology; Gerontology; Social Work	Emerging Sources Citation Index (ESCI)	Geriatrics & Gerontology; Social Work	V96KS	WOS:000213263700003	20094934				2022-02-06	
J	Walker, PA; Jimenez, F; Cox, CS				Walker, Peter A.; Jimenez, Fernando; Cox, Charles S., Jr.			Progenitor cell therapy for traumatic brain injury: effect of serum osmolarity on cell viability and cytokine production	REGENERATIVE MEDICINE			English	Article						cytokines; inflammation; mesenchymal stem cells; osmolarity	POSTTRAUMATIC INTRACRANIAL HYPERTENSION; HYPERTONIC SALINE RESUSCITATION; HEAD-INJURY; STEM-CELLS; LACTATED RINGERS; STRESS; BLOOD; TRANSPLANTATION; HYPOTENSION; CHILDREN	Introduction: The potential translation of mesenchymal stem cell (MSC) therapy into a multimodal protocol for traumatic brain injury requires evaluation of viability and cytokine production in a hyperosmolar environment. Optimization of MSC therapy requires delivery to the target area without significant loss of cellular function or viability. No model evaluating the potential efficacy of MSC therapy at varying osmolarities currently exists. Methods: Rat MSCs were characterized with flow cytometric immunophenotyping. MSCs (passage 3) were placed in culture with multipotent adult progenitor cell media at varying osmolarities (250, 270, 290, 310, 330, 350 and 370 mOsm) potentially found with hypertonic saline infusion. After culture for 24 h, cellular viability was measured using flow cytometry (n = 6). Next, brain tissue supernatant was harvested from both normal rat brains and injured brains 6 h after cortical injury. Subsequently, MSCs were placed in culture with multipotent adult progenitor cell media 20% normal brain or injured brain supernatant (at the aforementioned osmolarities) and allowed to remain in culture for 24 h (n = 11). At this point, media supernatant cytokine levels were measured using a multiplex cytokine assay system. Results: MSCs showed no clinically significant difference in viability at 24 h. MSCs cultured with 20% injured brain supernatant showed an decrease in proinflammatory cytokine production (IL-1 alpha and IL-1 beta) with increasing osmolarity. No difference in anti-inflammatory cytokine production (IL-4 and IL-10) was observed. Conclusion: Progenitor cell therapy for traumatic brain injury may require survival and activity in a hyperosmolar environment. Culture of MSCs in such conditions shows no clinically significant effect on cell viability. In addition, MSC efficacy could potentially be enhanced via a decrease in proinflammatory cytokine production. Overall, a multimodal traumatic brain injury treatment protocol based upon MSC infusion and hypertonic saline therapy would not negatively affect progenitor cell efficacy and could be considered for multicenter clinical trials.	[Walker, Peter A.; Jimenez, Fernando; Cox, Charles S., Jr.] Univ Texas Med Sch Houston, Dept Pediat Surg, Houston, TX 77030 USA		Cox, CS (corresponding author), Univ Texas Med Sch Houston, Dept Pediat Surg, 6431 Fannin St,MSB 5-234, Houston, TX 77030 USA.	charles.s.cox@uth.tmc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM 08 79201, M01 RR 02558 R21]; Texas Higher Education Coordinating Board; Children's Memorial Hermann Hospital Foundation; Brown Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD042659] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR002558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER	The authors are supported by grants NIH T32 GM 08 79201, M01 RR 02558 R21, Texas Higher Education Coordinating Board, Children's Memorial Hermann Hospital Foundation and The Brown Foundation. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.; No writing assistance was utilized in the production of this manuscript.	Adams SD, 2008, J TRAUMA, V65, P170, DOI 10.1097/TA.0b013e31805824ca; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; *AM ASS NEUR SURG, 2007, J NEUROTRAUM, V24, pS14; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gastaldello K, 2008, PERITON DIALYSIS INT, V28, P655; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Harting MT, 2008, CYTOTHERAPY, V10, P243, DOI 10.1080/14653240801950000; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kim JM, 2007, BRAIN RES, V1183, P43, DOI 10.1016/j.brainres.2007.09.005; Lee JW, 2009, FREE RADICAL RES, V43, P262, DOI 10.1080/10715760802691471; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Maeno E, 2006, FEBS LETT, V580, P6513, DOI 10.1016/j.febslet.2006.10.074; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; *NIH, 2008, COMB THER TRAUM BRAI; Otto NM, 2008, CRIT CARE, V12, DOI 10.1186/cc6989; Penolazzi L, 2008, CELL BIOL INT, V32, P320, DOI 10.1016/j.cellbi.2007.08.030; Pinto FCG, 2006, J TRAUMA, V60, P758, DOI 10.1097/01.ta.0000214581.89316.73; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RIOS EC, 2009, CLIN EXP PHARM PHYSL; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Walker PA, 2009, J TRAUMA, V67, pS120, DOI 10.1097/TA.0b013e3181ad323a	35	7	7	0	5	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1746-0751	1746-076X		REGEN MED	Regen. Med.	JAN	2010	5	1					65	71		10.2217/RME.09.73			7	Cell & Tissue Engineering; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Engineering	544AM	WOS:000273623600012	20017695	Green Accepted			2022-02-06	
J	Kim, JS; Kim, OL; Seo, WS; Koo, BH; Joo, Y; Bai, DS				Kim, Jin-Sung; Kim, Oh-Lyong; Seo, Wan-Seok; Koo, Bon-Hoon; Joo, Yeol; Bai, Dai-Seg			Memory Dysfunctions after Mild and Moderate Traumatic Brain Injury : Comparison between Patients with and without Frontal Lobe Injury	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Frontal lobe injury; Memory; Severity	CLOSED-HEAD-INJURY; LEARNING-TASKS; DEFICITS; RETRIEVAL; MODALITY; RECALL; CORTEX	Objective : The purpose of this study was to assess memory dysfunction in patients with mild and moderate traumatic brain injury (TBI) with and without frontal lobe injury (FLI) Methods : The subjects were 110 TBI patients, who had recovered from the acute clinical phase, and comprised 20 (18 2%) mild TBI (MTBI) patients with FLI, 16 (14 5%) MTBI patients without FLI, 51 (46 4%) moderate TBI (MOTBI) patients with FLI and 23 (20 9%) MTBI patients without FLI All patients were administrated the Korean version of the Memory Assessment Scale (K-MAS) Results : Almost all the Summary Scale scores on the K-MAS failed to show any differences between TBI patients with and without FLI, but differences did emerge by types at severities TBI patients with FLI showed higher Global Memory ability than TBI patients without FLI if their TBI was only mild, but when their TBI was more severe, this finding was reversed, and TBI patients with FLI showed lower Verbal and Global Memory abilities than TBI patients Without FLI Conclusion : Different kinds of assessment tools a;e needed for the measurement of memory abilities in TBI patients with FLI, and that the selection of the appropriate tool depends oil the severity of the TBI	[Kim, Oh-Lyong] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea; [Kim, Jin-Sung; Seo, Wan-Seok; Koo, Bon-Hoon; Joo, Yeol; Bai, Dai-Seg] Yeungnam Univ, Coll Med, Dept Psychiat, Taegu 705717, South Korea		Kim, OL (corresponding author), Yeungnam Univ, Coll Med, Dept Neurosurg, 317-1 Daemyeong,5 Dong, Taegu 705717, South Korea.				Yeungnam University	This research was supported by the Yeungnam University research grants in 2007.	AHARONPERETZ J, 2001, HUMAN FRONTAL LOBES, P540; ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; Bennett T. L., 2008, NEUROPSYCHOLOGY HDB, P533; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; BROOKS D N, 1975, Cortex, V11, P329; Cimino C.R., 1994, CLIN GUIDE NEUROPSYC, P69; Constantinidou F, 1996, J GEN PSYCHOL, V123, P173, DOI 10.1080/00221309.1996.9921270; CONSTANTINIDOU F, 1995, J HEAD TRAUMA REHAB, V10, P90, DOI 10.1097/00001199-199508000-00009; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; Daum I, 2000, BEHAV NEUROL, V12, P161, DOI 10.1155/2000/327304; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Demery JA, 2002, J CLIN EXP NEUROPSYC, V24, P818, DOI 10.1076/jcen.24.6.818.8400; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; FREDERIKSEN N, 1986, AM PSYCHOL, V41, P445; FUSTER JM, 1985, HUM NEUROBIOL, V4, P169; Fuster JM., 1980, PREFRONTAL CORTEX; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GEFFEN GM, 1994, BRAIN INJURY, V8, P405, DOI 10.3109/02699059409150992; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Haut M W, 1990, Arch Clin Neuropsychol, V5, P299, DOI 10.1016/0887-6177(90)90028-N; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; LEE HS, 2001, KOREAN VERSION MEMOR; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1989, HDB NEUROPSYCHOLOGY, V3, P183; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Mangels JA, 1997, NEUROPSYCHOLOGY, V11, P207, DOI 10.1037/0894-4105.11.2.207; Mangels JA, 1996, NEUROPSYCHOLOGY, V10, P32, DOI 10.1037/0894-4105.10.1.32; Mayes A., 1988, HUMAN ORGANIC MEMORY; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Miller B.L., 2007, HUMAN FRONTAL LOBES, V2nd; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Moscovitch M, 1995, ANN NY ACAD SCI, V769, P119, DOI 10.1111/j.1749-6632.1995.tb38135.x; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Selby M. J., 2000, NEUROPSYCHOLOGICAL A, P48; Shallice T., 1991, FRONTAL LOBE FUNCTIO; SHIMAMURA AP, 1996, ANN NY ACAD SCI, V760, P151; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; Squire LR., 1987, MEMORY BRAIN; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [https://doi.org/10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355]; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vakil E, 1996, NEUROPSY NEUROPSY BE, V9, P176; Vakil E, 1997, NEUROPSYCHOLOGY, V11, P545, DOI 10.1037/0894-4105.11.4.545; Vakil E, 2003, J CLIN EXP NEUROPSYC, V25, P274, DOI 10.1076/jcen.25.2.274.13637; Vakil E, 2001, J CLIN EXP NEUROPSYC, V23, P207, DOI 10.1076/jcen.23.2.207.1209; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; WILLIAMS JM, 1991, MEMORY ASSESSMENT SC	50	7	8	1	4	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	NOV	2009	46	5					459	467		10.3340/jkns.2009.46.5.459			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	530GN	WOS:000272577300006	20041056	Green Published, gold			2022-02-06	
J	Kamishina, H; Cheeseman, JA; Clemmons, RM				Kamishina, Hiroaki; Cheeseman, Jennifer A.; Clemmons, Roger M.			The effects of canine bone marrow stromal cells on neuritogenesis from dorsal root ganglion neurons in vitro	VETERINARY RESEARCH COMMUNICATIONS			English	Article; Proceedings Paper	37th Annual Meeting of the Society-for-Neuroscience	NOV 03-07, 2007	San Diego, CA	Soc Neurosci		Bone marrow stromal cell; Neurite; Canine; Central nervous system	MESENCHYMAL STEM-CELLS; SPINAL-CORD-INJURY; NERVE GROWTH-FACTOR; COLONY-STIMULATING FACTOR; TRAUMATIC BRAIN-INJURY; NEURITE OUTGROWTH; NEUROTROPHIC FACTORS; MATRIX METALLOPROTEINASES; PREFERENTIAL OUTGROWTH; CORTICOSPINAL NEURONS	The present in vitro study was designed to evaluate whether canine bone marrow stromal cells (BMSCs) promote neurite outgrowth from dorsal root ganglion (DRG) neurons. Bone marrow aspirates were collected from iliac crests of three young adult dogs. DRG neurons were cultured on BMSCs, fibroblasts, or laminin substrates. DRG neurons were also cultured in BMSC- or fibroblast-conditioned media. DRG neurons grown on BMSCs extended longer neurites and developed a much more elaborate conformation of branching neurites compared to those on fibroblasts or laminin. Quantitative analysis revealed that these effects were associated with the emergence of increased numbers of primary and branching neurites. The effect appears to be dependent upon cell-cell interactions rather than by elaboration of diffusible molecules. With more extensive investigations into the basic biology of canine BMSCs, their ability for promoting neurite outgrowth may be translated into a novel therapeutic strategy for dogs with a variety of neurological disorders.	[Kamishina, Hiroaki] Iwate Univ, Fac Agr, Dept Vet Clin Med, Morioka, Iwate 020, Japan; [Kamishina, Hiroaki; Cheeseman, Jennifer A.; Clemmons, Roger M.] Univ Florida, Dept Small Anim Clin Sci, Coll Vet Med, Gainesville, FL 32610 USA		Kamishina, H (corresponding author), Iwate Univ, Fac Agr, Dept Vet Clin Med, 3-18-8 Ueda, Morioka, Iwate 020, Japan.	Kamicna@iwate-u.ac.jp					Akiyama Y, 2002, J NEUROSCI, V22, P6623; Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010; Arnhold S, 2006, EUR J CELL BIOL, V85, P551, DOI 10.1016/j.ejcb.2006.01.015; Auffray I, 1996, BLOOD, V88, P1608, DOI 10.1182/blood.V88.5.1608.bloodjournal8851608; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bartunek J, 2007, AM J PHYSIOL-HEART C, V292, pH1095, DOI 10.1152/ajpheart.01009.2005; Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007; Chakrabortty S, 2000, J NEUROCYTOL, V29, P707, DOI 10.1023/A:1010930819854; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Cogle CR, 2004, LANCET, V363, P1432, DOI 10.1016/S0140-6736(04)16102-3; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Deng J, 2006, STEM CELLS, V24, P1054, DOI 10.1634/stemcells.2005-0370; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Dormady SP, 2001, J HEMATOTH STEM CELL, V10, P125, DOI 10.1089/152581601750098372; FALLON JR, 1985, J NEUROSCI, V5, P3169; FALLON JR, 1985, J CELL BIOL, V100, P198, DOI 10.1083/jcb.100.1.198; FOSANG AJ, 1992, J BIOL CHEM, V267, P19470; Garcia R, 2004, BIOCHEM BIOPH RES CO, V316, P753, DOI 10.1016/j.bbrc.2004.02.111; Goss JR, 1998, EXP NEUROL, V149, P301, DOI 10.1006/exnr.1997.6712; Grayson WL, 2004, BIOTECHNOL PROGR, V20, P905, DOI 10.1021/bp034296z; Hammond ENL, 1999, NEUROREPORT, V10, P2671, DOI 10.1097/00001756-199908200-00043; Hasegawa N, 2006, J PERIODONTOL, V77, P1003, DOI 10.1902/jop.2006.050341; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5; Kamishina H, 2006, AM J VET RES, V67, P1921, DOI 10.2460/ajvr.67.11.1921; Kimura K, 2004, J NEUROCYTOL, V33, P465, DOI 10.1023/B:NEUR.0000046576.70319.3a; Kohno KI, 2005, J CELL PHYSIOL, V205, P253, DOI 10.1002/jcp.20394; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lu P, 2001, J COMP NEUROL, V436, P456, DOI 10.1002/cne.1080; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Oblander SA, 2007, MOL CELL NEUROSCI, V34, P481, DOI 10.1016/j.mcn.2006.12.002; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; ORR DJ, 1988, J CELL SCI, V91, P555; Park HC, 2005, TISSUE ENG, V11, P913, DOI 10.1089/ten.2005.11.913; Passi A, 1999, FEBS LETT, V456, P93, DOI 10.1016/S0014-5793(99)00929-1; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Price RD, 2006, J BIOMOL SCREEN, V11, P155, DOI 10.1177/1087057105283344; Puch S, 2001, J CELL SCI, V114, P1567; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schense JC, 2000, NAT BIOTECHNOL, V18, P415, DOI 10.1038/74473; Smith PM, 2006, BRAIN PATHOL, V16, P99, DOI 10.1111/j.1750-3639.2006.00001.x; SMITH RA, 1987, J NEUROSCI RES, V17, P265, DOI 10.1002/jnr.490170310; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Song S, 2004, EXP NEUROL, V185, P191, DOI 10.1016/j.expneurol.2003.09.003; Volk SW, 2005, AM J VET RES, V66, P1729, DOI 10.2460/ajvr.2005.66.1729; Wang YM, 2006, BRAIN RES, V1115, P186, DOI 10.1016/j.brainres.2006.07.060; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wright KT, 2007, BIOCHEM BIOPH RES CO, V354, P559, DOI 10.1016/j.bbrc.2007.01.013; Wu QY, 2007, NEUROSCI LETT, V417, P281, DOI 10.1016/j.neulet.2007.02.092; Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	66	7	7	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0165-7380			VET RES COMMUN	Vet. Res. Commun.	OCT	2009	33	7					645	657		10.1007/s11259-009-9213-8			13	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Veterinary Sciences	495JC	WOS:000269886200006	19255866				2022-02-06	
J	Kan, CH; Saffari, M; Khoo, TH				Kan, Choon Hong; Saffari, Mohd; Khoo, Teik Hooi			Prognostic Factors of Severe Traumatic Brain Injury Outcome in Children Aged 2-16 Years at A Major Neurosurgical Referral Centre	MALAYSIAN JOURNAL OF MEDICAL SCIENCES			English	Article						severe traumatic brain injury (TBI); children; prognostic factors; Pediatric Cerebral Performance Categories Score; neurosciences		Background: Traumatic Brain Injury (TBI) in children has been poorly studied, and the literature is limited. We evaluated 146 children with severe TBI ( coma score less than 8) in an attempt to establish the prognostic factors of severe TBI in children. Methods: The severity of TBI was assessed via modified Glasgow Coma Score for those more than 3 years old and via Children Coma Score for those under 3 years old. Clinical presentations, laboratory parameters and features of Computerised Tomography brain scans were analyzed. Outcomes were assessed at 6 months with the Pediatric Cerebral Performance Categories Scale; the outcomes were categorised as good or poor outcomes. Correlations with outcome were evaluated using univariate and multivariate logistic models. Results: A low coma score upon admission was independently associated with poor outcome. The presence of diabetes insipidus within 3 days post-TBI (OR: 1.9), hyperglycaemia (OR: 1.2), prolonged PT ratio (OR: 2.3) and leukocytosis (OR: 1.1) were associated with poorer outcome. Conclusion: Knowledge of these prognostic factors helps neurosurgeons and neurocritical care specialists to manage and improve outcome in severe TBI in children.	[Kan, Choon Hong; Saffari, Mohd; Khoo, Teik Hooi] Hosp Kuala Lumpur, Dept Neurosurg, Kuala Lumpur 50586, Malaysia; [Kan, Choon Hong; Saffari, Mohd] Hosp Univ Sains Malaysia, Dept Neurosci, Kelantan, Malaysia; [Khoo, Teik Hooi] Hosp Pulau Pinang, Dept Anaesthesiol, George Town 10990, Malaysia		Kan, CH (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kubang Kerian 16150, Kelantan, Malaysia.	kanchoonhong@yahoo.co.uk					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS49; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; ASTRUP T, 1965, THROMB DIATH HAEMOST, V14, P401; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Boughey JC, 2004, AM SURGEON, V70, P500; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiaretti A, 1998, CHILD NERV SYST, V14, P455, DOI 10.1007/s003810050259; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Francel PC, 1996, NEUROLOGICAL SURG, P1730; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Keller M S, 2001, Semin Pediatr Surg, V10, P12, DOI 10.1053/spsu.2001.19381; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Lee K. K., 2006, SMJ Singapore Medical Journal, V47, P31; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MEERT KL, 1995, CRIT CARE MED, V23, P822, DOI 10.1097/00003246-199505000-00008; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; PARISH RA, 1988, J TRAUMA, V28, P517, DOI 10.1097/00005373-198804000-00017; Rovlias A, 2001, SURG NEUROL, V55, P190, DOI 10.1016/S0090-3019(01)00414-1; Saborio P, 2000, Pediatr Rev, V21, P122, DOI 10.1542/pir.21-4-122; Suresh HS, 2003, NEUROL INDIA, V51, P16; Tomberg T, 1996, ACTA NEUROCHIR, V138, P543, DOI 10.1007/BF01411174; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300	40	7	10	0	0	UNIV SAINS MALAYSIA, SCH MEDICAL SCIENCES	KELANTAN	HEALTH CAMPUS, 16150 KUBANG KERIAN, KELANTAN, 00000, MALAYSIA	1394-195X	2180-4303		MALAYS J MED SCI	Malays. J. Med. Sci.	OCT-DEC	2009	16	4					25	33					9	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	V6M2V	WOS:000420412800004	22135509				2022-02-06	
J	Limbrick, DD; Behdad, A; Derdeyn, CP; Custer, PL; Zipfel, GJ; Santiago, P				Limbrick, David D., Jr.; Behdad, Amir; Derdeyn, Colin P.; Custer, Phillip L.; Zipfel, Gregory J.; Santiago, Paul			Traumatic enucleation with avulsion of the ophthalmic artery resulting in aneurysm-like subarachnoid hemorrhage Case report	JOURNAL OF NEUROSURGERY			English	Article						avulsion; enucleation; hydrocephalus; ophthalmic artery; optic nerve; Pantoea agglomerans; subarachnoid hemorrhage	OPTIC-NERVE; LUXATION; INJURY; EYE	Traumatic, nonaneurysmal subarachnoid hemorrhage (SAH) is common after closed head injury and most often results from ruptured cortical microvessels. Here, the authors present the case of a 60-year-old woman who fell and struck her head, causing traumatic enucleation and avulsion of both the optic nerve and ophthalmic artery. The arterial avulsion caused a Fisher Grade 3 SAH. During her stay in the intensive care unit, hydrocephalus and vasospasm developed, clinical conditions commonly observed after aneurysmal SAH. Epileptiform activity also developed, although this may have been related to concurrent Pantoea agglomerans ventriculitis. It is reasonable to suggest that intracerebral arterial avulsion with profuse arterial bleeding may be more likely than traditional traumatic SAH to result in clinical events similar to that of aneurysmal SAH. Special consideration should be given to the acute care of patients with intracranial arterial avulsions (conservative management vs surgical exploration or endovascular treatment), as well as long-term follow-up for vascular or other neurosurgical complications. (DOI: 10.3171/2009.2.17687)	[Limbrick, David D., Jr.; Behdad, Amir; Derdeyn, Colin P.; Zipfel, Gregory J.; Santiago, Paul] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA; [Derdeyn, Colin P.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Custer, Phillip L.] Washington Univ, Sch Med, Dept Ophthalmol, St Louis, MO 63110 USA		Limbrick, DD (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, St Louis Childrens Hosp, 1 Childrens Pl,Suite 4S20, St Louis, MO 63110 USA.	limbrickd@nsurg.wustl.edu		Derdeyn, Colin/0000-0002-5932-2683			Alp B, 2001, Eur J Emerg Med, V8, P331, DOI 10.1097/00063110-200112000-00016; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Bajaj Mandeep S., 2000, Orbit, V19, P165, DOI 10.1076/orbi.19.3.165.2661; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Cruz AT, 2007, J CLIN MICROBIOL, V45, P1989, DOI 10.1128/JCM.00632-07; DAVIDSON SI, 1962, ACTA PSYCHOTHER, V10, P286; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; GORIN M, 1964, ARCH OPHTHALMOL-CHIC, V72, P225; Kiratli H, 1999, ACTA OPHTHALMOL SCAN, V77, P340, DOI 10.1034/j.1600-0420.1999.770319.x; Lelli GJ, 2007, OPHTHAL PLAST RECONS, V23, P158, DOI 10.1097/IOP.0b013e31803045b4; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; MIDDLETON TH, 1987, NEUROSURGERY, V21, P89, DOI 10.1227/00006123-198707000-00020; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; SUZUKI N, 1988, SHINKEI GEKA, V16, P1293; Thomas S, 2000, ACTA NEUROCHIR SUPPL, V76, P203	16	7	7	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	OCT	2009	111	4					653	657		10.3171/2009.2.17687			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	503PL	WOS:000270550000005	19374504				2022-02-06	
J	Luccichenti, G; Sabatini, U				Luccichenti, Giacomo; Sabatini, Umberto			Colouring rehabilitation with functional neuroimaging	FUNCTIONAL NEUROLOGY			English	Article						advanced techniques; magnetic resonance imaging; recovery; rehabilitation	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; PROTON-MAGNETIC-RESONANCE; SUBCORTICAL STROKE; CORTICAL REORGANIZATION; MULTIPLE-SCLEROSIS; MOTOR RECOVERY; CORTEX; FMRI; THERAPY	Neuroimaging is becoming an increasingly important means of detecting changes in biochemical, microstructural and functional patterns occurring during rehabilitation. In magnetic resonance imaging (MRI), "advanced techniques", such as functional MRI, relaxometry, diffusion tensor imaging and spectroscopy, are making it possible to investigate these changes in vivo, together with brain function. This review highlights how advances in the field of MRI can shed light on the relationship between cerebral reorganisation after focal damage and functional recovery, providing insights that might be translated into clinical benefits for patients.	[Luccichenti, Giacomo; Sabatini, Umberto] IRCCS Santa Lucia Fdn, Dept Radiol, I-00179 Rome, Italy		Sabatini, U (corresponding author), IRCCS Santa Lucia Fdn, Dept Radiol, Via Ardeatina 306, I-00179 Rome, Italy.	u.sabatini@hsantalucia.it	Sabatini, Umberto/K-4659-2016	Sabatini, Umberto/0000-0001-5321-8626			Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Askim T, 2009, NEUROREHAB NEURAL RE, V23, P295, DOI 10.1177/1545968308322840; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Calautti C, 2003, NEUROIMAGE, V19, P1650, DOI 10.1016/S1053-8119(03)00205-2; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Cherubini A, 2007, NEUROIMAGE, V34, P1331, DOI 10.1016/j.neuroimage.2006.11.024; Cramer SC, 2007, EXP BRAIN RES, V177, P233, DOI 10.1007/s00221-006-0662-9; Crosson B, 2009, BRAIN LANG, V111, P73, DOI 10.1016/j.bandl.2009.08.001; Dechaumont-Palacin S, 2008, NEUROREHAB NEURAL RE, V22, P154, DOI 10.1177/1545968307307118; DeGutis JM, 2007, J COGNITIVE NEUROSCI, V19, P1790, DOI 10.1162/jocn.2007.19.11.1790; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; Hamzei F, 2006, NEUROIMAGE, V31, P710, DOI 10.1016/j.neuroimage.2005.12.035; Han BS, 2008, NEUROREHABILITATION, V23, P171; Han BS, 2007, NEUROREHABILITATION, V22, P151; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; HEELMANN V, 2009, INT J REHABIL R 1203; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Jang SH, 2007, NEUROREHABILITATION, V22, P141; Johansen-Berg H, 2002, BRAIN, V125, P2731, DOI 10.1093/brain/awf282; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kokotilo KJ, 2009, J NEUROL PHYS THER, V33, P45, DOI 10.1097/NPT.0b013e31819824f0; Kokotilo KJ, 2010, NEUROREHAB NEURAL RE, V24, P78, DOI 10.1177/1545968309345269; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; Loubinoux I, 2007, CEREB CORTEX, V17, P2980, DOI 10.1093/cercor/bhm023; Lucignani G, 2007, FUNCT NEUROL, V22, P181; Luft AR, 2008, STROKE, V39, P3341, DOI 10.1161/STROKEAHA.108.527531; Meinzer M, 2008, NEUROIMAGE, V39, P2038, DOI 10.1016/j.neuroimage.2007.10.008; Mezzapesa DM, 2008, HUM BRAIN MAPP, V29, P562, DOI 10.1002/hbm.20418; Naganawa S, 2004, AM J NEURORADIOL, V25, P1553; Nowak DA, 2008, ARCH NEUROL-CHICAGO, V65, P741, DOI 10.1001/archneur.65.6.741; Pelletier J, 2009, Int MS J, V16, P26; Reddy H, 2000, BRAIN, V123, P2314, DOI 10.1093/brain/123.11.2314; Rocca MA, 2003, NEUROIMAGE, V18, P847, DOI 10.1016/S1053-8119(03)00043-0; Rocca MA, 2003, STROKE, V34, P665, DOI 10.1161/01.STR.0000057977.06681.11; Schaechter JD, 2002, NEUROREHAB NEURAL RE, V16, P326, DOI 10.1177/154596830201600403; Schaechter JD, 2006, BRAIN, V129, P2722, DOI 10.1093/brain/awl214; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Thimm M, 2009, CORTEX, V45, P850, DOI 10.1016/j.cortex.2008.10.007; Ward NS, 2005, POSTGRAD MED J, V81, P510, DOI 10.1136/pgmj.2004.030809; Winship IR, 2009, NEUROSCIENTIST, V15, P507, DOI 10.1177/1073858409333076; Yoo WK, 2008, NEUROIMAGE, V39, P1886, DOI 10.1016/j.neuroimage.2007.10.035	48	7	7	0	3	C I C-EDIZIONI INT SRL	ROME	CORSO TRIESTE, 42, 00198 ROME, ITALY	0393-5264	1971-3274		FUNCT NEUROL	Funct. Neurol.	OCT-DEC	2009	24	4					189	193					5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	649ET	WOS:000281751200005	20412724				2022-02-06	
J	Panesar, SS; Rao, C; Vecht, JA; Mirza, SB; Netuveli, G; Morris, R; Rosenthal, J; Darzi, A; Athanasiou, T				Panesar, Sukhmeet S.; Rao, Christopher; Vecht, Joshua A.; Mirza, Saqeb B.; Netuveli, Gopalakrishnan; Morris, Richard; Rosenthal, Joe; Darzi, Ara; Athanasiou, Thanos			Development of the Veritas plot and its application in cardiac surgery: an evidence-synthesis graphic tool for the clinician to assess multiple meta-analyses reporting on a common outcome	CANADIAN JOURNAL OF SURGERY			English	Article							CORONARY-ARTERY-BYPASS; RANDOMIZED CONTROLLED-TRIALS; TRAUMATIC BRAIN-INJURY; OFF-PUMP SURGERY; SYSTEMATIC REVIEWS; PUBLICATION BIAS; QUALITY; MORBIDITY; STROKE; DISCREPANCIES	Background: Meta-analyses may be prone to generating misleading results because of a paucity of experimental studies (especially in surgery); publication bias; and heterogeneity in study design, intervention and the patient population of included studies. When investigating a specific clinical or scientific question on which several relevant meta-analyses may have been published, value judgments must be applied to determine which analysis represents the most robust evidence. These value judgments should be specifically acknowledged. We designed the Veritas plot to explicitly explore important elements of quality and to facilitate decision-making by highlighting specific areas in which meta-analyses are found to be deficient. Furthermore, as a graphic tool, it may be more intuitive than when similar data are presented in a tabular or text format. Methods: The Veritas plot is an adaption of the radar plot, a graphic tool for the description of multiattribute data. Key elements of meta-analytical quality such as heterogeneity, publication bias and study design are assessed. Existing qualitative methods such as the Assessment of Multiple Systematic Reviews (AMSTAR) tool have been incorporated in addition to important considerations when interpreting surgical meta-analyses such as the year of publication and population characteristics. To demonstrate the potential of the Veritas plot to inform clinical practice, we apply the Veritas plot to the meta-analytical literature comparing the incidence of 30-day stroke in off-pump coronary artery bypass surgery and conventional coronary artery bypass surgery. Results: We demonstrate that a visually-stimulating and practical evidence-synthesis tool can direct the clinician and scientist to a particular meta-analytical study to inform clinical practice. The Veritas plot is also cumulative and allowed us to assess the quality of evidence over time. Conclusion: We have presented a practical graphic application for scientists and clinicians to identify and interpret variability in meta-analyses. Although further validation of the Veritas plot is required, it may have the potential to contribute to the implementation of evidence-based practice.	[Panesar, Sukhmeet S.; Rao, Christopher; Vecht, Joshua A.; Darzi, Ara; Athanasiou, Thanos] Univ London Imperial Coll Sci Technol & Med, Dept Biosurg & Surg Technol, London, England; [Mirza, Saqeb B.] Royal Natl Orthopaed Hosp NHS Trust, Dept Orthopaed Surg, London, England; [Netuveli, Gopalakrishnan] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London, ON, Canada; [Morris, Richard; Rosenthal, Joe] UCL, Dept Primary Care & Populat Hlth Sci, London WC1E 6BT, England		Athanasiou, T (corresponding author), 111 Gowan Ave, London SW6 6RQ, England.	t.athanasiou@imperial.ac.uk		Rao, Christopher/0000-0003-3244-3888; Morris, Richard/0000-0001-7240-4563			Athanasiou T, 2004, ANN THORAC SURG, V77, P745, DOI 10.1016/j.athoracsur.2003.07.002; Bailar JC, 1997, NEW ENGL J MED, V337, P559, DOI 10.1056/NEJM199708213370810; Berman Nancy G, 2002, BMC Med Res Methodol, V2, P10, DOI 10.1186/1471-2288-2-10; BORZAK S, 1995, ANN INTERN MED, V123, P873, DOI 10.7326/0003-4819-123-11-199512010-00010; Cappelleri JC, 1996, JAMA-J AM MED ASSOC, V276, P1332, DOI 10.1001/jama.276.16.1332; Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028; Christensen E, 2001, J HEPATOL, V34, P342, DOI 10.1016/S0168-8278(00)00002-7; Delaney A, 2005, CRIT CARE, V9, pR575, DOI 10.1186/cc3803; Egger M, 1997, BMJ-BRIT MED J, V315, P1371, DOI 10.1136/bmj.315.7119.1371; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELLIS J, 1995, LANCET, V346, P407, DOI 10.1016/S0140-6736(95)92781-6; EYSENCK HJ, 1978, AM PSYCHOL, V33, P517, DOI 10.1037/0003-066X.33.5.517.a; Furukawa TA, 2000, J CLIN EPIDEMIOL, V53, P1193, DOI 10.1016/S0895-4356(00)00250-X; GALBRAITH RF, 1994, J AM STAT ASSOC, V89, P1232, DOI 10.2307/2290987; Glass, 1976, ED RES, V5, P3, DOI [10.2307/1174772ISSN0536-1036, 10.3102/0013189x005010003, DOI 10.3102/0013189X005010003]; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Howes N, 1997, BRIT J SURG, V84, P1220; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Jadad AR, 1997, CAN MED ASSOC J, V156, P1411; JONES RS, 2003, B AM COLL SURG, V88, P11; Kelly KD, 2001, ANN EMERG MED, V38, P518, DOI 10.1067/mem.2001.115881; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; OXMAN AD, 1994, BMJ-BRIT MED J, V309, P648, DOI 10.1136/bmj.309.6955.648; Panesar SS, 2006, HEART, V92, P1808, DOI 10.1136/hrt.2006.088450; Panesar SS, 2006, J ROY SOC MED, V99, P470, DOI 10.1258/jrsm.99.9.470; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Petitti DB, 2000, METAANALYSIS DECISIO; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; POLLOCK A V, 1989, Theoretical Surgery, V4, P163; POLLOCK AV, 1993, BRIT J SURG, V80, P964, DOI 10.1002/bjs.1800800807; Puhan MA, 2006, J CLIN EPIDEMIOL, V59, P1017, DOI 10.1016/j.jclinepi.2005.12.016; RAO C, 1988, STAT SCI, V1, P109; RAO CR, 1988, STAT SCI, V3, P131; Reston JT, 2003, ANN THORAC SURG, V76, P1510, DOI 10.1016/S0003-4975(03)01195-0; Saary MJ, 2008, J CLIN EPIDEMIOL, V61, P311, DOI 10.1016/j.jclinepi.2007.04.021; Sackett DL, 2007, CLIN ORTHOP RELAT R, P3, DOI 10.1097/BLO.06013e31802fba1e; SACKETT DL, 1995, J CLIN EPIDEMIOL, V48, P61, DOI 10.1016/0895-4356(94)00085-5; Sedrakyan A, 2006, STROKE, V37, P2759, DOI 10.1161/01.STR.0000245081.52877.f2; SHEA B, 2001, ASSESSING QUALITY RE; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Takagi H, 2007, J THORAC CARDIOV SUR, V134, P1059, DOI 10.1016/j.jtcvs.2007.07.006; THOMPSON SG, 1991, LANCET, V338, P1127, DOI 10.1016/0140-6736(91)91975-Z; VILLAR J, 1995, LANCET, V345, P772, DOI 10.1016/S0140-6736(95)90646-0; WACHTER KW, 1988, SCIENCE, V241, P1407, DOI 10.1126/science.3420397; Wijeysundera DN, 2005, J AM COLL CARDIOL, V46, P872, DOI 10.1016/j.jacc.2005.05.064	53	7	12	0	4	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0008-428X	1488-2310		CAN J SURG	Can. J. Surg.	OCT	2009	52	5					E137	E145					9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	500OU	WOS:000270313500017	19865543				2022-02-06	
J	Bramlett, HM; Furones-Alonso, O; Lotocki, G; Rodriguez-Paez, A; Sanchez-Molano, J; Keane, RW				Bramlett, Helen M.; Furones-Alonso, Ofelia; Lotocki, George; Rodriguez-Paez, Alejandra; Sanchez-Molano, Juliana; Keane, Robert W.			Sex differences in XIAP cleavage after traumatic brain injury in the rat	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; X-linked inhibitor of apoptosis; Sex differences	PROGRAMMED CELL-DEATH; CEREBRAL-ISCHEMIA; INHIBITION; ESTROGEN; CASPASE-3; NEURODEGENERATION; ACTIVATION; MECHANISMS; NEURONS; FEMALE	Sex influences histological and behavioral outcomes following traumatic brain injury (TBI), but the underlying sex-dependent pathomechanisms regulating outcome measures remain poorly defined. Here, we investigated the TBI-induced regulation of the X-linked inhibitor of apoptosis protein (XIAP) that, in addition to suppressing cell death by inhibition of caspases, is involved in signaling cascades, including immune regulation and cell migration. Since estrogen has been shown to have anti-apoptotic properties, we specifically examined sex differences and the influence of estrogen on XIAP processing after TBI. Sprague-Dawley male (TBI-M), female (TBI-F), ovariectomized female (TBI-OVX) and ovariectomized females supplemented with estrogen (TBI-OVX+EST) were subjected to moderate (1.7-2.2atm) fluid percussion (FP) injury. Animals were sacrificed 24 h after FP injury; cortical tissue (ipsilateral and contralateral) was dissected and analyzed for XIAP processing by immunoblot analysis (n = 6-7/group) or confocal microscopy (n = 2-3/group). Significant differences in XIAP cleavage products in the ipsilateral cortex were found between groups (p < 0.03). Post hoc analysis showed an increase in XIAP processing in both TBI-F and TBI-OVX+EST compared to TBI-M and TBI-OVX (p < 0.05), indicating that more XIAP is cleaved following injury in intact females and TBI-OVX+EST than in TBI-M and TBI-OVX groups. Colocalization of XIAP within neurons also demonstrated sex-dependent changes. Based on these data, it appears that the processing of XIAP after injury is different between males and females and may be influenced by exogenous estrogen treatment. (C) 2009 Elsevier Ireland Ltd. All rights reserved.	[Bramlett, Helen M.; Furones-Alonso, Ofelia; Lotocki, George; Rodriguez-Paez, Alejandra; Sanchez-Molano, Juliana] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33101 USA; [Keane, Robert W.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA		Bramlett, HM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, 1095 NW 14th Terrace,LPLC 3-18, Miami, FL 33136 USA.	hbramlett@miami.edu			Eli Lilly CoEli Lilly;  [NS042133];  [NS030291]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042133, R01NS043233, P50NS030291] Funding Source: NIH RePORTER	This work was supported by NS042133, NS030291 and Eli Lilly & Co.	Alkayed NJ, 2001, J NEUROSCI, V21, P7543, DOI 10.1523/JNEUROSCI.21-19-07543.2001; Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Bramlett Helen M, 2005, Pathophysiology, V12, P17, DOI 10.1016/j.pathophys.2005.02.009; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; DERIVERO JP, 2009, J CEREB BLOOD F 0429; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Dubal DB, 1999, J NEUROSCI, V19, P6385; Duckett CS, 1998, MOL CELL BIOL, V18, P608, DOI 10.1128/MCB.18.1.608; Fan T, 2003, BRAIN RES, V993, P10, DOI 10.1016/j.brainres.2003.07.006; Fan YF, 2006, NEUROCHEM INT, V48, P50, DOI 10.1016/j.neuint.2005.07.008; Fukuda K, 2000, STROKE, V31, P155, DOI 10.1161/01.STR.31.1.155; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Kairisalo M, 2007, BIOCHEM BIOPH RES CO, V364, P138, DOI 10.1016/j.bbrc.2007.09.115; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Lotocki G, 2003, J CEREBR BLOOD F MET, V23, P1129, DOI 10.1097/01.WCB.0000086938.68719.E0; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rau SW, 2003, J NEUROSCI, V23, P11420; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Silke J, 2001, EMBO J, V20, P3114, DOI 10.1093/emboj/20.12.3114; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; Trapp T, 2003, MOL CELL NEUROSCI, V23, P302, DOI 10.1016/S1044-7431(03)00013-7; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	31	7	7	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 8	2009	461	1					49	53		10.1016/j.neulet.2009.05.071			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475QK	WOS:000268375000011	19500649	Green Accepted			2022-02-06	
J	Fang, D; Ming, QZ; Li, Z; Mei, WX; Ya, K				Fang, Du; Ming, Qian Zhong; Li, Zhu; Mei, Wu Xiao; Ya, Ke			Hypothermia attenuates protective effects of ginkgolides on astrocytes from ischemia/reperfusion injury	NEUROCHEMISTRY INTERNATIONAL			English	Article						Hypothermia; Ginkgolides; Astrocytes; Ischemia and reperfusion injury; Hypoxia-inducible factor-1alpha (HIF-1alpha); Protective role	TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; NEUROPROTECTION; ACTIVATION; EXPRESSION	The neuroprotective roles of both hypothermia and ginkgolides have been well confirmed. We first examined whether hypothermia (32 or 28 degrees C) or ginkgolides have a protective effect on astrocytes against ischemia and reperfusion-induced injury. We demonstrated that ginkgolides, but not hypothermia, have a significantly time- and concentration-dependent protective role in ischemic astrocytes. We then investigated whether co-treatment with hypothermia and ginkgolides has a synergistic role to protect astrocytes against ischemia and reperfusion-induced injury. Cells were incubated with 18.75, 37.5 or 75 mu g/ml of ginkgolides at 37.32 or 28 degrees C for 24,48 or 72 h before exposure to ischemia (24 h) and then reperfusion (24 h). Data showed that the co-treatment induced a significant decrease, rather than an increase as we had expected, in their cellular viabilities and anti-apoptotic abilities as compared with the cells treated by ginkgolides only. Western blot analysis demonstrated that hypothermia (32 or 28 degrees C for 24 h) has no effect on the expression of Hypoxia-inducible factor-1alpha (HIF-1alpha) protein, suggesting that HIF-1alpha is not associated with the adverse effect of hypothermia on ginkgolides. The findings imply the importance of further investigating the effects of hypothermia on the pharmacological role or therapeutic efficacy of drugs commonly used clinically. (C) 2009 Published by Elsevier Ltd.	[Fang, Du; Ming, Qian Zhong; Li, Zhu; Mei, Wu Xiao; Ya, Ke] Nantong Univ, Inst Naut Med, Nantong 226001, Peoples R China; [Fang, Du; Ming, Qian Zhong; Li, Zhu; Mei, Wu Xiao; Ya, Ke] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Peoples R China; [Fang, Du; Mei, Wu Xiao; Ya, Ke] Chinese Univ Hong Kong, Fac Med, Dept Physiol, Shatin, Hong Kong, Peoples R China; [Ming, Qian Zhong; Li, Zhu] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; [Ming, Qian Zhong; Li, Zhu] Hong Kong Polytech Univ, Natl Key Lab Chinese Med & Mol Pharmacol Shenzhen, Kowloon, Hong Kong, Peoples R China		Li, Z (corresponding author), Nantong Univ, Inst Naut Med, Nantong 226001, Peoples R China.	zhulilili65@yahoo.com; yake@cuhk.edu.hk	Ke, Ya/B-3115-2010	Ke, Ya/0000-0001-8166-6653			Ahlemeyer B, 2003, CELL MOL LIFE SCI, V60, P1779, DOI 10.1007/s00018-003-3080-1; Ahlemeyer B, 2003, PHARMACOPSYCHIATRY, V36, pS8; Arrica M, 2007, SEMIN CARDIOTHORAC V, V11, P6, DOI 10.1177/1089253206297409; Balestri F, 2007, NEUROCHEM INT, V50, P517, DOI 10.1016/j.neuint.2006.10.005; Bu XN, 2007, NEUROCHEM INT, V51, P459, DOI 10.1016/j.neuint.2007.04.028; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Fang D, 2008, BBA-MOL BASIS DIS, V1782, P658, DOI 10.1016/j.bbadis.2008.09.007; Gunn A J, 2006, NeuroRx, V3, P154, DOI 10.1016/j.nurx.2006.01.007; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Hoesch RE, 2007, NEUROLOGIST, V13, P331, DOI 10.1097/NRL.0b013e318154bb79; Holzer M, 2005, CRIT CARE MED, V33, P414, DOI 10.1097/01.CCM.0000153410.87750.53; Li Z, 2008, J CELL BIOCHEM, V103, P564, DOI 10.1002/jcb.21427; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Obara M, 2008, NEUROCHEM INT, V52, P905, DOI 10.1016/j.neuint.2007.10.015; Qian ZM, 1999, EXP BRAIN RES, V129, P473, DOI 10.1007/s002210050916; Qian ZM, 2000, CELL MOL BIOL, V46, P541; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Tenn CC, 2007, NEUROSCI LETT, V417, P155, DOI 10.1016/j.neulet.2007.02.073; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Verkhratsky A, 2006, J CELL MOL MED, V10, P826, DOI 10.1111/j.1582-4934.2006.tb00527.x; Wagner KR, 2005, NEUROL RES, V27, P238, DOI 10.1179/016164105X25261; Wei H, 2008, INT J BIOCHEM CELL B, V40, P651, DOI 10.1016/j.biocel.2007.10.013; Zhu L, 2007, BRAIN RES, V1166, P1, DOI 10.1016/j.brainres.2007.07.003; Zhu L, 2007, EXP BRAIN RES, V179, P665, DOI 10.1007/s00221-006-0823-x	24	7	7	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	SEP	2009	55	4					181	186		10.1016/j.neuint.2008.12.009			6	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	468SC	WOS:000267839600001	19121359				2022-02-06	
J	Hodgkinson, A; Gillett, L; Simpson, GK				Hodgkinson, Adeline; Gillett, Lauren; Simpson, Grahame K.			Does Apolipoprotein E Play a Role in Outcome After Severe Traumatic Brain Injury?	BRAIN IMPAIRMENT			English	Article						apolipoprotein E; traumatic brain injury; outcome	E EPSILON-4 ALLELE; HEAD-INJURY; ALZHEIMERS-DISEASE; APOE GENOTYPE; ASSOCIATION; RECOVERY; POLYMORPHISM; E-EPSILON-4; PREDICTS; MODERATE	There is mixed evidence linking adverse outcomes after traumatic brain injury 0 the presence of the epsilon 4 allele of the apolipoprotein gene (APOE). Further, there has been limited investigation of the role of APOE in populations who have sustained severe brain injuries. In this study, 100 individuals aged 16 to 65 years with a severe to extremely severe traumatic brain injury were recruited prospectively from an inpatient rehabilitation unit. APOE genotypes were determined, and demographic and clinical data were collected by blind assessors at 6 months postinjury. Sixty-nine participants who were divided into an acute (less than 12 months postinjury) and chronic (greater than 12 months) groups also completed neuropsychological assessments testing various domains of memory, attention and problem-solving at follow-up. No significant differences in injury severity, cognitive or functional outcome were found between individuals with the epsilon 4 allele and those without at either time postinjury. This finding is consistent with other recent data that has questioned the role of APOE status as a factor in recovery from TBI.	[Hodgkinson, Adeline; Gillett, Lauren; Simpson, Grahame K.] Liverpool Hlth Serv, Brain Injury Rehabil Unit, Liverpool Bc, NSW 1871, Australia		Hodgkinson, A (corresponding author), Liverpool Hlth Serv, Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool Bc, NSW 1871, Australia.	adeline.hodgkinson@sswahs.nsw.gov.au	Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060	Motor Accidents Authority (MAA) of NSW	This study was supported by a grant from the Motor Accidents Authority (MAA) of NSW.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koponen S, 2004, NEUROLOGY, V63, P749, DOI 10.1212/01.WNL.0000134603.57107.2F; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; MILLER EN, 1980, CALIFORNIA COMPUTERI; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Pfaff A, 2004, MANUAL MODIFIED OXFO; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Quinn TJ, 2004, NEUROPATH APPL NEURO, V30, P569, DOI 10.1111/j.1365-2990.2004.00581.x; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Rey A., 1964, EXAMEN CLIN ENPSYCHO; ROSES AD, 1995, EXP NEUROL, V132, P149, DOI 10.1016/0014-4886(95)90019-5; Soininen HS, 1996, TRENDS NEUROSCI, V19, P224, DOI 10.1016/0166-2236(96)10027-8; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Taylor L B, 1969, Clin Neurosurg, V16, P269; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; White F, 2001, NEUROBIOL DIS, V8, P611, DOI 10.1006/nbdi.2001.0401; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO	43	7	7	0	3	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	1443-9646			BRAIN IMPAIR	Brain Impair.	SEP	2009	10	2					162	168		10.1375/brim.10.2.162			7	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	488UR	WOS:000269376200002					2022-02-06	
J	Mate-Kole, CC; Conway, J; Catayong, K; Bieu, R; Sackey, NA; Wood, R; Fellows, R				Mate-Kole, C. Charles; Conway, James; Catayong, Katherine; Bieu, Rachel; Sackey, Naa Amerley; Wood, Rebecca; Fellows, Robert			Validation of the Revised Quick Cognitive Screening Test	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Canadian Colloquium on Dementia	OCT 18-20, 2007	Vancouver, CANADA			Psychometrics; Rehabilitation	ALZHEIMERS-DISEASE; MINI-COG; DEMENTIA; IMPAIRMENT; DIAGNOSIS; SCALE; ADAS; MICROCOG; CARE	Objective: To validate the revised version of the Quick Cognitive Screening Test (QCST). Design: Cross-sectional. Setting: Senior homes; hospital; college campus. Participants: Participants (N=377; 114 men, 263 women) were recruited comprising healthy controls (n=201; 40 men, 161 women), subjects with dementia (n=93; 34 men, 59 women) including Alzheimer disease (n=73) and vascular dementia (n=20); subjects with psychiatric illness (n=35, 15 men, 20 women), specifically schizophrenia or bipolar disorder; and subjects with other neurologic conditions (n=48, 25 men, 23 women) such as traumatic brain injury (n=12) and cerebrovascular disease (n=31). Diagnoses were confirmed by physicians using appropriate criteria. Recruitment was done in the northeastern region. Interventions: Not applicable. Main Outcome Measures: In an effort to examine the reliability and validity of the revised QCST, participants were administered the revised QCST with a number of standardized measures (ie, Alzheimer's Disease Assessment Scale-Cognitive, Mini-Mental State Examination, Tests of Oral Fluency, Trail-Making Test, and Functional Activities Questionnaire). Results: The results revealed that the revised QCST discriminated between healthy controls and the neuropsychiatric participants. Additionally, the revised QCST significantly correlated with other standardized measures, confirming the revised QCST's reliability and validity as a screening instrument for subjects with cognitive deficits. Conclusions: The revised QCST provides the clinician with a short yet reliable screening instrument in detecting cognitive deficits in subjects with dementia and other neurologic conditions.	[Mate-Kole, C. Charles; Conway, James; Catayong, Katherine; Bieu, Rachel; Wood, Rebecca; Fellows, Robert] Cent Connecticut State Univ, Dept Psychol, New Britain, CT 06050 USA; [Catayong, Katherine; Bieu, Rachel] Inst Living, Olin Neuropsychiat Res Ctr, Hartford, CT USA; [Sackey, Naa Amerley] Drexel Univ, Dept Publ Hlth, Philadelphia, PA USA		Mate-Kole, CC (corresponding author), Cent Connecticut State Univ, Dept Psychol, 1615 Stanley St, New Britain, CT 06050 USA.	matekolec@ccsu.edu					Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Anderson DA, 2001, INT J NEUROSCI, V111, P221, DOI 10.3109/00207450108994233; ARDERN M, 1993, INT J GERIATR PSYCH, V8, P929, DOI 10.1002/gps.930081107; ASHLA MM, 2000, COMPREHENSIVE GERIAT, P67; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Borson S, 2003, J AM GERIATR SOC, V51, P1451, DOI 10.1046/j.1532-5415.2003.51465.x; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; BUTLER M, 1991, PROF PSYCHOL-RES PR, V22, P510, DOI 10.1037/0735-7028.22.6.510; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; ELON R, 2000, COMPREHENSIVE GERIAT, P1; Elwood RW, 2001, NEUROPSYCHOL REV, V11, P89, DOI 10.1023/A:1016671201211; FISCHER CE, 2002, CAN PSYCHIAT ASS B, V34, P16; Flicker L, 1997, INT J GERIATR PSYCH, V12, P203, DOI 10.1002/(SICI)1099-1166(199702)12:2<203::AID-GPS603>3.0.CO;2-W; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galvin JE, 2007, ARCH NEUROL-CHICAGO, V64, P725, DOI 10.1001/archneur.64.5.725; GUALTIERI T, 2006, CNS VITAL SIGNS CLIN; GUALTIERI T, 2004, INT NEUR SOC ANN M F; GUALTIERI T, 2005, S DEM SCREEN ALZH AS; Hannesdottir K, 2002, NORD J PSYCHIAT, V56, P201, DOI 10.1080/080394802317607183; HIGGINSON C, 2003, ARCH CLIN NEUROPSYCH, V11, P185; Ihl R, 2000, NEUROPSYCHOBIOLOGY, V41, P102, DOI 10.1159/000026640; Johnson JA, 2003, PSYCHOL REP, V93, P1261; Kalbe E, 2004, INT J GERIATR PSYCH, V19, P136, DOI 10.1002/gps.1042; KATZMAN R, 1983, J NEUROL NEUROSUR PS, V50, P734; KEYS R, 1998, TREATING TRAUMATIC B; LARRABEE GJ, 1996, NEUROPSYCHOLOGICAL A, P102; LEZAK MD, 2004, NEUROPSYCHOLOGICAL A, P3; Lopez Y, 2002, MOL BREEDING, V9, P183, DOI 10.1023/A:1019767825486; Lorentz WJ, 2002, CAN J PSYCHIAT, V47, P723, DOI 10.1177/070674370204700803; MacNeill S. E., 1999, HDB ASSESSMENT CLIN, P417; Manning L, 2001, EUR J PSYCHOL ASSESS, V17, P79, DOI 10.1027//1015-5759.17.2.79; MATEKOLE CC, 1994, ARCH PHYS MED REHAB, V75, P867; MCFIE J, 1975, ASSESSMENT ORGANIC I; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morgan CD, 1997, PSYCHIAT CLIN N AM, V20, P25, DOI 10.1016/S0193-953X(05)70391-9; Olson KR, 2001, J CLIN PSYCHOL, V57, P727, DOI 10.1002/jclp.1045; Parker Chris, 2007, Nurs Older People, V18, P31; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Powlishta KK, 2002, NEUROLOGY, V59, P898, DOI 10.1212/WNL.59.6.898; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Scanlan J, 2001, INT J GERIATR PSYCH, V16, P216, DOI 10.1002/1099-1166(200102)16:2<216::AID-GPS316>3.0.CO;2-B; SCHWARB S, 1988, INT J GERIATR PSYCH, V3, P45, DOI 10.1002/gps.930030107; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; SKINNER HA, 1986, PROF PSYCHOL-RES PR, V17, P44, DOI 10.1037/0735-7028.17.1.44; Teresi JA, 1998, SOC PSYCH PSYCH EPID, V33, P283, DOI 10.1007/s001270050056; Thomas S.A., 2005, AUST OCCUP THER J, V52, P57, DOI DOI 10.1111/J.1440-1630.2005.00456.X; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P29, DOI 10.1076/jcen.21.1.29.939; WARRINGTON E, 1973, CORTEX, V9, P159; Xu GL, 2002, INT J GERIATR PSYCH, V17, P1027, DOI 10.1002/gps.744; [No title captured]	54	7	8	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2009	90	9					1469	1477		10.1016/j.apmr.2009.02.007			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	496AA	WOS:000269938100003	19735773				2022-02-06	
J	Newsome, MR; Scheibel, RS; Seignourel, PJ; Steinberg, JL; Troyanskaya, M; Li, XQ; Levin, HS				Newsome, Mary R.; Scheibel, Randall S.; Seignourel, Paul J.; Steinberg, Joel L.; Troyanskaya, Maya; Li, Xiaoqi; Levin, Harvey S.			Effects of Methylphenidate on Working Memory in Traumatic Brain Injury: A Preliminary fMRI Investigation	BRAIN IMAGING AND BEHAVIOR			English	Article						Traumatic brain injury; Working memory; Functional magnetic resonance imaging (fMRI); Pharmacotherapy; Methylphenidate	FUNCTIONAL MAGNETIC-RESONANCE; COGNITIVE PERFORMANCE; ANTERIOR CINGULATE; PREFRONTAL CORTEX; ATTENTION-DEFICIT; ACTIVATION; DISORDER; LOBE; TASK; LOAD	As part of a preliminary investigation on the effects of methylphenidate on brain activation during a working memory (WM) task in patients with traumatic brain injury (TBI), patients with TBI received 15 mg of methylphenidate (N=4) or placebo (N=5) twice a day for one month in a double-blind, placebo-controlled design. Brain activation was assessed at pre-treatment and on the final treatment day using functional magnetic resonance imaging (fMRI) with an N-back task using faces as stimuli. In a whole brain voxel-wise analysis, methylphenidate, compared to placebo, produced a decrease in brain activation for the 2-load minus 0-load contrast in the anterior cingulate, thalamus, cuneus and cerebellum, regions associated with WM performance. Further, an a priori region of interest analysis with small volume correction found reduced activation in the anterior cingulate. Although based on a small sample size, these preliminary findings suggest methylphenidate may increase processing efficiency associated with cognitive control during WM tasks in patients with TBI.	[Newsome, Mary R.; Scheibel, Randall S.; Troyanskaya, Maya; Li, Xiaoqi; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, Houston, TX 77030 USA; [Seignourel, Paul J.; Steinberg, Joel L.] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77225 USA		Newsome, MR (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, 1709 Dryden,Ste 725,BCM635, Houston, TX 77030 USA.	mnewsome@bcm.edu			 [NS-42772];  [NS-21889]	This research was supported by grants NS-42772 and NS-21889 awarded to Harvey S. Levin. The Michael E. DeBakey Veterans' Affairs Medical Center and the South Central Mental Illness Research, Education and Clinical Center (MIRECC) provided equipment and laboratory space used in the collection and analysis of imaging data. We express gratitude to Andrew Saykin, Erin Bigler, and two anonymous reviewers for helpful comments.	BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DONALDSON W, 1992, J EXP PSYCHOL GEN, V121, P275, DOI 10.1037/0096-3445.121.3.275; Elliott R, 1997, PSYCHOPHARMACOLOGY, V131, P196, DOI 10.1007/s002130050284; Fincham JM, 2006, P NATL ACAD SCI USA, V103, P12941, DOI 10.1073/pnas.0605493103; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Kim BN, 2001, YONSEI MED J, V42, P19, DOI 10.3349/ymj.2001.42.1.19; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LOU HC, 1989, ARCH NEUROL-CHICAGO, V46, P48, DOI 10.1001/archneur.1989.00520370050018; Mattay VS, 2000, NEUROIMAGE, V12, P268, DOI 10.1006/nimg.2000.0610; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Mehta MA, 2000, J NEUROSCI, V20; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Price CJ, 2002, NEUROCASE, V8, P345, DOI 10.1076/neur.8.4.345.16186; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Talairach J., 1988, COPLANAR STEREOTAXIC; TEASDALE G, 1974, LANCET, V2, P81; Tomasi D, 2007, BRAIN RES, V1132, P158, DOI 10.1016/j.brainres.2006.11.030; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Vaidya CJ, 1998, P NATL ACAD SCI USA, V95, P14494, DOI 10.1073/pnas.95.24.14494; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; WILLMOTT C, 2008, J NEUROLOGY NEUR DEC, P5	36	7	7	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557			BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2009	3	3					298	305		10.1007/s11682-009-9072-5			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	510LT	WOS:000271090700008	22005992				2022-02-06	
J	Zlotnik, S; Sachs, D; Rosenblum, S; Shpasser, R; Josman, N				Zlotnik, Sharon; Sachs, Dalia; Rosenblum, Sara; Shpasser, Raluka; Josman, Naomi			Use of the Dynamic Interactional Model in Self-Care and Motor Intervention After Traumatic Brain Injury: Explanatory Case Studies	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						adolescent; brain injuries; cognitive therapy; consciousness; mobility limitation; self-care	REHABILITATION; AWARENESS; DEFICITS; CHILDREN	PURPOSE. The highest proportion of traumatic brain injuries (TBIs) occurs among adolescents. This study examines the effectiveness of a therapeutic protocol for rehabilitation of adolescents with TBI. This protocol is based on Toglia's (1998, 2005) Dynamic Interactional Model and Expanded Awareness Model (Toglia & Kirk, 2000). METHOD. Explanatory case studies presenting 2 adolescents (ages 16-17) with mild to moderate TBI are combined with qualitative and quantitative data assessing self-care, mobility, and graphomotor abilities as well as deficit awareness in these domains. Outcome measures include the FIM (TM), the Canadian Occupational Performance Measure, the Computerized Penmanship Object Evaluation Tool, and the Awareness of Mobility Deficits Questionnaire. Graphic data analysis compared outcome measures before, during, and after intervention, RESULTS. The Dynamic Interactional Model was effective in improving self-care, mobility, and graphomotor abilities and identified awareness of deficits in these domains, CONCLUSION. These research findings contribute to our theoretical knowledge in rehabilitation and promote adopting this approach for rehabilitation of adolescents with TBI.	[Sachs, Dalia; Rosenblum, Sara; Josman, Naomi] Univ Haifa, Dept Occupat Therapy, Fac Social Welf & Hlth Sci, IL-31999 Haifa, Israel; [Shpasser, Raluka] Loewenstein Hosp & Rehabil Ctr, Rehabil Ctr, Childrens Rehabil Unit, Raanana, Israel		Zlotnik, S (corresponding author), Rambam Hlth Care Campus, Haifa, Israel.	naomij@research.haita.ac.il					Averbuch S, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P99; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; CORNIN AF, 2001, A J OCCUPATIONAL THE, V55, P377; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; Hotz G, 2001, J HEAD TRAUMA REHAB, V16, P426, DOI 10.1097/00001199-200110000-00003; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JOSMAN N, 2005, COGNITION OCCUPATION, P261; Law M., 1994, CANADIAN OCCUPATIONA, V2; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; MONTGOMERY CB, 2004, DISS ABSTR INT A, V4, P1246; Olive T, 2002, MEM COGNITION, V30, P594, DOI 10.3758/BF03194960; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Rosenblum S, 2003, PERCEPT MOTOR SKILL, V96, P933, DOI 10.2466/PMS.96.3.933-954; TEASDALE G, 1974, LANCET, V2, P81; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J. P., 2003, WILLARD SPACKMANS OC, P607; Toglia J. P., 1992, COGNITIVE REHABILITA, P104; Toglia JP, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P5; Toglia JP, 2005, COGNITION OCCUPATION, P29; Westmorland M., 1998, CRITICAL REV FORM QU; World Health Organization, 2007, INT CLASS FUNCT DIS; Yin RK, 2003, CASE STUDY RES DESIG	26	7	7	0	8	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	SEP-OCT	2009	63	5					549	558		10.5014/ajot.63.5.549			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	493SG	WOS:000269757700005	19785254				2022-02-06	
J	Pileggi, R; Holland, GR				Pileggi, Roberta; Holland, Graham Rex			The expression of heat shock protein 70 in the dental pulp following trauma	DENTAL TRAUMATOLOGY			English	Article							HEAT-SHOCK PROTEINS; INJURIES	Background/Aim: Traumatic dental injuries vary in severity from mild concussion to avulsion. All organisms respond to stress by inducing the synthesis of a group of proteins known generically as heat shock proteins. The activation of these proteins is an essential cellular mechanism designed to protect against a variety of environmental stresses. It is probable that the production of these proteins is increased in the cells of the traumatized dental pulp, however, this has not as yet been demonstrated. The degree of heat shock proteins expression may be related to the severity of the trauma such that estimating the extent of heat shock proteins expression may provide a practicable way of quantifying these injuries. Materials and Methods: Twenty adult male ferrets were divided into four groups. Each maxillary and mandibular right canine was traumatized with the contralateral canines acting as undamaged controls. The trauma was a simulated concussion injury applied using a uniform force. Animals were killed at 24, 48, 72 and 168 h after the injury. The canines were extracted, sectioned and processed for immunohistochemistry using a mouse monoclonal antibody specific for Hsp70. Results: There was a statistically significant difference in Hsp70 staining between traumatized and non-traumatized teeth only in the group observed 24 h after the trauma. The expression of heat shock proteins form part of the early pulpal response to trauma.	[Pileggi, Roberta] Univ Florida, Dept Endodont, Coll Dent, Hlth Sci Ctr, Gainesville, FL 32610 USA; [Holland, Graham Rex] North Univ, Dept Cariol Restorat Sci & Endodont, Sch Dent, Ann Arbor, MI USA		Pileggi, R (corresponding author), Univ Florida, Dept Endodont, Coll Dent, Hlth Sci Ctr, POB 100436, Gainesville, FL 32610 USA.	rpileggi@dental.ufl.edu					ANDREASEN FM, 1985, DENT TRAUMATOL, V2, P9; ANDREASEN FM, 1993, TXB COLOR ATLAS TRAU, P315; Andreasen JO, 2002, DENT TRAUMATOL, V18, P116, DOI 10.1034/j.1600-9657.2002.00079.x; BERTI R, 2002, J CEREB BLOOD FLOW M, V23, P75; BOLGER AP, 2002, CIRCULATION, V106, P49; Chen Z, 2000, Chin J Dent Res, V3, P50; Dunne James R, 2004, Surg Infect (Larchmt), V5, P395, DOI 10.1089/sur.2004.5.395; Flores MT, 2007, DENT TRAUMATOL, V23, P66, DOI 10.1111/j.1600-9657.2007.00592.x; Giffard RG, 2008, ANESTHESIOLOGY, V109, P339, DOI 10.1097/ALN.0b013e31817f4ce0; Jang HJ, 2008, TRANSPL P, V40, P2581, DOI 10.1016/j.transproceed.2008.08.075; Kawagishi E, 2006, CELL TISSUE RES, V326, P111, DOI 10.1007/s00441-006-0230-4; Ohshima H, 2000, ARCH HISTOL CYTOL, V63, P381, DOI 10.1679/aohc.63.381; Ohshima H, 2001, ARCH HISTOL CYTOL, V64, P425, DOI 10.1679/aohc.64.425; Pileggi R, 1996, ENDOD DENT TRAUMATOL, V12, P16; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Shigehara Satoshi, 2006, Bull Tokyo Dent Coll, V47, P117, DOI 10.2209/tdcpublication.47.117; SILVA CA, 2004, DENT TRAUMATOL, V1, P6; Srivastava P, 2004, METHODS, V32, P1, DOI 10.1016/S1046-2023(03)00178-6; Voegeli TS, 2008, APPL PHYSIOL NUTR ME, V33, P1042, DOI 10.1139/H08-068	19	7	10	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	AUG	2009	25	4					426	428		10.1111/j.1600-9657.2009.00801.x			3	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	469FP	WOS:000267881600011	19519864				2022-02-06	
J	Vyhnanek, F; Duchac, V; Skala, P				Vyhnanek, F.; Duchac, V.; Skala, P.			Damage Control Laparotomy in Blunt Abdominal Injury	ACTA CHIRURGIAE ORTHOPAEDICAE ET TRAUMATOLOGIAE CECHOSLOVACA			Czech	Article						damage control laparotomy; blunt trauma to abdominal organs and retroperitoneum; pelvic fracture	CONTROL SURGERY; MANAGEMENT; TRAUMA	PURPOSE OF THE STUDY Damage control surgery is one of the major advances in surgical techniques used in polytrauma patients in the past 25 years. It is based on a foreshortened pre-operative examination during ongoing resuscitation which includes surgical intervention in an injured patient with severe hypotension due to haemorrhage. In this seven-year retrospective study the authors evaluate the results of damage control laparotomy in patients with injury to the abdominal organs, retroperitoneum and pelvis. MATERIAL AND METHODS The evaluated group included 21 patients with blunt abdominal trauma who underwent damage control laparotomy in the 2001-2007 period. There were 17 men and four women; the age range was 17 to 69 years, with an average of 36 years. Damage control laparotomy was indicated in the patients with blunt abdominal trauma, or with closed or open pelvic fracture, who developed a progressive haemorrhagic shock. RESULTS Between 2001 and 2007, a total of 21 922 patients were admitted to the Trauma Centre and 12 392 operations were performed. However, only in 21 of them (0.1 %) damage control laparotomy was indicated. The procedure was most frequently performed for liver injury (16 patients), which was associated with multiple injury to the other abdominal organs and retroperitoneum in five patients. Further three patients were operated on for haemoperitoneum at continual bleeding due to type C fracture of the pelvis. In the remaining two patients the damage control procedure was chosen to stop persistent bleeding following splenectomy and nephrectomy for traumatic rupture. In these 21 patients blunt trauma was part of polytrauma (ISS > 15). Repeat surgery was carried out within 48 to 96 hours (average, 58 h). Four patients (19 %) died; two due to progressive traumatic haemorrhagic shock and two because of brain oedema after concussion. DISCUSSION Damage control surgery has become a fundamental component of surgical strategy for severe trauma and has been accepted by surgeons although it cannot be evaluated in randomized clinical studies. Survival after damage control laparotomy in serious intra-abdominal injuries involved in polytrauma is reported in relation to the scoring system values (ISS, GCS), but depends, first of all, on blood loss, degree of acidosis and severity of associated injuries, with craniocerebral trauma in the first place. CONCLUSIONS Damage control laparotomy is an effective procedure in the treatment of severe trauma to the abdominal organs and retroperitoneum in critically injured patients. This time-limited, staged surgical intervention is included in resuscitation of patients with hypothermia, metabolic acidosis and coagulopathy. The outcome of damage control surgery is related to not only the severity of injury, but also experience with comprehensive acute care in trauma centres.	[Vyhnanek, F.; Duchac, V.; Skala, P.] Traumatol Ctr FNKV, Prague 10034 10, Czech Republic		Vyhnanek, F (corresponding author), Traumatol Ctr FNKV, Srobarova 50, Prague 10034 10, Czech Republic.	vyhnanek@fnkv.cz					Arvieux C, 2003, ANN CHIR, V128, P150, DOI 10.1016/S0003-3944(02)00029-9; Bashir Masoud M, 2003, Eur J Surg Suppl, P8; Burkhardt M, 2005, UNFALLCHIRURG, V108, P812, DOI 10.1007/s00113-005-0997-x; Chmelova J, 2008, ACTA CHIR ORTHOP TR, V75, P93; Fabian TC, 2007, SURG CLIN N AM, V87, P73, DOI 10.1016/j.suc.2006.09.011; Finlay IG, 2004, BRIT J SURG, V91, P83, DOI 10.1002/bjs.4434; Miller PR, 2007, AM SURGEON, V73, P606; Miller RS, 2005, J TRAUMA, V59, P1365, DOI 10.1097/01.ta.0000196004.49422.af; Pavelka T, 2007, ACTA CHIR ORTHOP TR, V74, P19; Pavelka T, 2009, ACTA CHIR ORTHOP TR, V76, P15; Sagraves Scott G, 2006, J Intensive Care Med, V21, P5, DOI 10.1177/0885066605282790; STONE HH, 1983, ANN SURG, V197, P532, DOI 10.1097/00000658-198305000-00005; Sutton E, 2006, J TRAUMA, V61, P831, DOI 10.1097/01.ta.0000239504.35149.c5; Treska V, 2006, Rozhl Chir, V85, P159; Tugnoli G, 2007, ANN ITAL CHIR, V78, P81; Wyrzykowski AD, 2008, TRAUMA, P851; Xian-kai Huang, 2007, Chin J Traumatol, V10, P279	17	7	7	0	2	GALEN SRO	PRAGUE 5	NA BELIDLE 34, PRAGUE 5, 150 00, CZECH REPUBLIC	0001-5415			ACTA CHIR ORTHOP TR	Acta Chir. Orthop. Traumatol. Cechoslov.	AUG	2009	76	4					310	313					4	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	492VV	WOS:000269691300007	19755055				2022-02-06	
J	de la Cueva-Barrao, L; Noe-Sebastian, E; Sopena-Novales, P; Lopez-Aznar, D; Ferri-Campos, J; Colomer-Font, C; Martinez-Carsi, C; Abreu-Sanchez, P; Uruburu-Garcia, E; Lull-Noguera, N; Robles-Viejo, M; Chirivella-Garrido, J				de la Cueva-Barrao, L.; Noe-Sebastian, E.; Sopena-Novales, P.; Lopez-Aznar, D.; Ferri-Campos, J.; Colomer-Font, C.; Martinez-Carsi, C.; Abreu-Sanchez, P.; Uruburu-Garcia, E.; Lull-Noguera, N.; Robles-Viejo, M.; Chirivella-Garrido, J.			THE CLINICAL RELEVANCE OF FDG-PET IMAGING IN SEVERE TRAUMATIC BRAIN INJURIES	REVISTA DE NEUROLOGIA			Spanish	Article						Disability; Neuropsychology; Outcome; Positron emission tomography; Rehabilitation; Traumatic brain injury	DIFFUSE AXONAL INJURY; HEAD-INJURY; SCALE; REHABILITATION; CONSCIOUSNESS; GLUCOSE; METABOLISM; DISCHARGE; DEFICITS; MODERATE	Aim. To evaluale the usefulness of positron emission tomography (PET) as a predictor of long-term disability after a severe traumatic brain injury (TBI). Patients and methods. Fifty-six patients who had sustained a severe TBI were assessed with a broad halter), of cognitive and functional scales at baseline and 6-months after inclusion in a multidisciplinary rehabilitation program. All patients underwent a FDG-PET at baseline. A physician blind to clinical data performed a semi-quantitative analysis (normal vs altered) of functional neuroimaging (PET), including four cortical and three subcortical areas. The total number of lesions (cortical, subcortical and total) was correlated to the intensity, of the TBI and to clinical data at admission and at follow-up. Results. All patients showed changes in cerebral metabolism. being the thalamus the area most frequently affected. The degree of cerebral hypometabolism showed a significant correlation with TBI severity, functional disability. global outcome and cognitive impairment not only at baseline but also at follow-up). Conclusions. According to our results, FDG-PET may be a useful tool when studying brain dysfunction after severe TBI. FDG-PET findings correlate with the TBI severity, and with the level of patients' disability, as well as with the degree of memory and intelligence impairment. However, clinical variables related to the severity, of the TBI, still are the best predictors of functional outcome after TBI. [REV NEUROL 2009; 49: 58-63]	[de la Cueva-Barrao, L.; Sopena-Novales, P.; Lopez-Aznar, D.; Martinez-Carsi, C.; Abreu-Sanchez, P.; Uruburu-Garcia, E.] Hosp 9 Octubre, Serv PET Med Nucl, Valencia, Spain; [Noe-Sebastian, E.; Ferri-Campos, J.; Colomer-Font, C.; Chirivella-Garrido, J.] Hosp NISA, Serv Dano Cerebral, FIVAN, Valencia, Spain; [Lull-Noguera, N.; Robles-Viejo, M.] Univ Politecn Valencia, ITACA Informat Biomed, E-46071 Valencia, Spain; [Lull-Noguera, N.] Univ CEU Cardenal Herrera, Valencia, Spain		Noe-Sebastian, E (corresponding author), Hosp Valencia Mar, Serv Dano Cerebral, Rio Tajo 1, E-46011 Valencia, Spain.	enoe@comv.es	Sopena-Novales, Pablo/AAA-4427-2019	Sopena-Novales, Pablo/0000-0002-0560-0051; Noe Sebastian, Enrique/0000-0002-2547-8727			Ahmed S, 2000, BRAIN INJURY, V14, P765; Alavi A, 1989, J Neuropsychiatry Clin Neurosci, V1, pS45; Bates D, 2001, J NEUROL NEUROSUR PS, V71, P20; Benedet M., 1998, TEST APRENDIZAJE VER; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Brandstack N, 2006, BRAIN INJURY, V20, P409, DOI 10.1080/02699050500487951; de la Cueva L, 2006, Rev Esp Med Nucl, V25, P89, DOI 10.1157/13086250; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Ferri-Campos J, 2008, REV NEUROLOGIA, V46, P109, DOI 10.33588/rn.4602.2007424; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Hattori N, 2003, J NUCL MED, V44, P1709; HEATON RK, 2001, TEST CLASIFICACION C; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; LULL N, 2006, NEUROLOGIA, V21, P513; Marshall S B, 1988, J Neurosci Nurs, V20, P253; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; SHAH S, 1989, STROKE, V20, P766, DOI 10.1161/01.STR.20.6.766; Slick DJ, 2006, COMPENDIUM NEUROPSYC, P3; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; TEASDALE G, 1974, LANCET, V2, P81; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; WECHSLER D, 1999, ESCALA INTELIGENCIA, V3; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	34	7	7	0	2	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	JUL 16	2009	49	2					58	63		10.33588/rn.4902.2008676			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	471PI	WOS:000268070100002	19598133				2022-02-06	
J	Kilinc, D; Gallo, G; Barbee, KA				Kilinc, Devrim; Gallo, Gianluca; Barbee, Kenneth A.			Interactive image analysis programs for quantifying injury-induced axonal beading and microtubule disruption	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						Axonal injury; Axonal beading; Morphometric analysis; Image analysis	ASSISTED MORPHOMETRIC ANALYSIS; BRAIN-INJURY; NEURONS; NERVE; MORPHOLOGY; DAMAGE; ALGORITHMS; NEUROPATHY; FIBERS; SHAPE	Focal axonal beading and focal disruption of microtubule structure are characteristic to traumatic axonal injury. We have recently reproduced these morphological and structural changes in our in vitro model system [D. Kilinc, G. Gallo, K.A. Barbee, Mechanically induced membrane poration causes axonal beading and localized cytoskeletal damage, Exp. Neurol. 212 (2008) 422-430]. In order to measure bead formation objectively, an observer-independent quantification of beading was necessary. in addition, a quantitative measure for the extent of co-localization of axonal beads and microtubule disruptions was required to establish a causal relationship between focal cytoskeletal damage and bead formation. In this paper we describe Matlab-based, interactive image analysis programs for axonal beading quantification and co-localization analysis. injury-induced increases in the axonal beading could be successfully detected using the bead analysis program. (C) 2009 Elsevier Ireland Ltd. All rights reserved.	[Kilinc, Devrim; Barbee, Kenneth A.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Gallo, Gianluca] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA		Barbee, KA (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, 3141 Chestnut St, Philadelphia, PA 19104 USA.	barbee@drexel.edu	Kilinc, Devrim/E-8733-2011; Chaboyer, Wendy/F-9588-2018; Barbee, Kenneth/F-4333-2014; Kilinc, Devrim/I-4180-2019	Kilinc, Devrim/0000-0003-3321-5203; Kilinc, Devrim/0000-0003-3321-5203	State of Pennsylvania Tobacco Settlement Fund (KAB); National Institutes HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS048090]; Drexel University Neuroengineering Major Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS048090, R01NS048090] Funding Source: NIH RePORTER	This research was supported in part by a grant from the State of Pennsylvania Tobacco Settlement Fund (KAB); by the National Institutes Health (NS048090, GG); and by Drexel University Neuroengineering Major Research Initiative (KAB, DK). The authors thank Hasan Ayaz for helpful discussions. K.A. Barbee and G. Gallo share last authorship on this work.	[Anonymous], 2004, IM PROC TOOLB US GUI; Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Ascoli GA, 2002, NETWORK-COMP NEURAL, V13, P247, DOI 10.1088/0954-898X/13/3/301; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; CALVET MC, 1984, PROG NEUROBIOL, V23, P251, DOI 10.1016/0301-0082(84)90006-6; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gallo G, 1999, J NEUROSCI, V19, P3860; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Gomes-Leal W, 2002, ANAT EMBRYOL, V205, P291, DOI 10.1007/s00429-002-0260-y; Goto Noboru, 2006, Hum Cell, V19, P49, DOI 10.1111/j.1749-0774.2006.00013.x; Jones CL, 2001, METHODS, V24, P347, DOI 10.1006/meth.2001.1205; KILINC D, 2007, EMBC07, P5395; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Klimaschewski L, 2002, J NEUROSCI METH, V113, P63, DOI 10.1016/S0165-0270(01)00473-3; Lehning EJ, 2000, TOXICOL APPL PHARM, V165, P127, DOI 10.1006/taap.2000.8937; LoPachin RM, 2003, TOXICOL APPL PHARM, V193, P29, DOI 10.1016/j.taap.2003.07.005; MASSEROLI M, 1993, COMPUT METH PROG BIO, V41, P89, DOI 10.1016/0169-2607(93)90068-V; McCreery DB, 1997, J NEUROSCI METH, V73, P159, DOI 10.1016/S0165-0270(97)02223-1; McIntosh TK, 1996, LAB INVEST, V74, P315; Ochs S, 1997, PROG NEUROBIOL, V52, P391, DOI 10.1016/S0301-0082(97)00022-1; Petite D, 1997, BRAIN RES, V769, P1, DOI 10.1016/S0006-8993(97)00427-7; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; TORCH S, 1989, PATHOL RES PRACT, V185, P567, DOI 10.1016/S0344-0338(89)80195-5; Urso-Baiarda F, 2006, J NEUROSCI METH, V156, P333, DOI 10.1016/j.jneumeth.2006.02.014; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Weaver CM, 2004, NEURAL COMPUT, V16, P1353, DOI 10.1162/089976604323057425	26	7	7	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	JUL	2009	95	1					62	71		10.1016/j.cmpb.2009.01.002			10	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	447JR	WOS:000266187900006	19285748				2022-02-06	
J	Aniruddha, TJ; Pillai, S; Devi, BI; Sampath, S; Chandramouli, BA				Aniruddha, T. J.; Pillai, Shibu; Devi, B. Indira; Sampath, S.; Chandramouli, B. A.			Role of citicoline in the management of mild head injury	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						mild head injury; citicoline; post concussion symptoms		Mild head injuries can cause functional disabilities resulting in economic loss. Post concussion syndrome is seen in 15-45% of these patients. Cytidine-5`-diphosphocholine (citicoline) is known to improve cognitive dysfunction. This study was undertaken to evaluate the effect of citicoline on the number of working days lost and on post concussion symptoms following mild head injury in adults, in a randomized, prospective, single blind study. Following informed consent, adults with mild head injury (Glasgow coma score of 13-15, <24 hours) were randomized, using a computer generated randomization table, to receive either citicoline (1 gram/day) or placebo for one month. The parameters evaluated at one month were number of working days lost, Glasgow outcome score, presence of post concussion symptoms and the Rivermead head injury follow up questionnaire (RHFQ) scores. The groups were compared using Pearson chi-square test and fisher's exact test. The groups were well matched with respect to age, gender, GCS and mode of injury. There was no difference in the number of working days lost between the groups (P=0.061), Glasgow outcome score (P=0.281), Rivermead head injury follow up questionnaire scores (P=0.667) and the post concussion symptoms (P=0.3) between the groups. Compared to placebo, one gram/ day of citicoline for one month in patients with mild head injury did not reduce either the number of working days lost, or the post concussion symptoms. There was no difference in the quality of life between patients taking citicoline and placebo.	[Aniruddha, T. J.; Pillai, Shibu; Devi, B. Indira; Sampath, S.; Chandramouli, B. A.] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India		Pillai, S (corresponding author), 2301,Oakwood Apartments,1st Cross,8th Main, Bangalore 560034, Karnataka, India.	drshibupillai@gmail.com					Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; LEVIN HS, 1991, J NEUROL SCI, V103, pS39; McAllister Thomas W., 1994, P357; Secades J.J, 2006, EXP CLIN PHARMACOL, V28, P1; TEASDALE G, 1974, LANCET, V2, P81; TENNANT FS, 1987, AM J PSYCHIAT, V144, P813; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105	14	7	7	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2009	6	1					49	52					4	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M0Y	WOS:000218379900008					2022-02-06	
J	Carr, ME; Masullo, LN; Brown, JK; Lewis, PC				Carr, Marcus E., Jr.; Masullo, Lawrence N.; Brown, J. Kendall; Lewis, Paul C.			Creatine Kinase BB Isoenzyme Blood Levels in Trauma Patients With Suspected Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article; Proceedings Paper	Advanced Technology Applications in Combat Casualty Care Conference (ATACCC)	AUG 11-13, 2008	St Pete Beach, FL				HEAD-INJURY; CEREBROSPINAL-FLUID; PROGNOSIS; INDEX	This pilot study sought to determine if creatine kinase isoenzyme BB (CK-BB) levels might serve as a biological marker of injury severity in mild TBI (mTBI). This was a retrospective study of 64 soldiers with suspected mTBI seen in a combat support hospital in Mosul between March and August of 2007. Four of the 64 total samples were positive for CK-BB. One major trauma patient had a negative CK-BB. This yields a sensitivity of 11% and a specificity of 97%. Military Acute Concussion Evaluation (MACE) scores collected also did not appear to reflect extent of injury. Although the low sensitivity of CK-BB from this study does not support its use as an early marker of suspected mTBI, the result is not conclusive given the small sample and the possibility of isoenzyme degradation during transport. Although limited, the data collected on MACE scores warrant additional evaluation of whether this measure is clinically relevant.	[Carr, Marcus E., Jr.] Novo Nordisk Inc, CMR, W Princeton, NJ 08540 USA; [Masullo, Lawrence N.] Carl R Darnall Army Med Ctr, Ft Hood, TX 76544 USA; [Brown, J. Kendall] USAMRIID, Ft Detrick, MD 21702 USA; [Lewis, Paul C.] Brooke Army Med Ctr, Nursing Res Serv, Ft Sam Houston, TX 78234 USA		Carr, ME (corresponding author), Novo Nordisk Inc, CMR, 100 Coll Rd, W Princeton, NJ 08540 USA.						Brosch LR, 2008, J TRAUMA, V64, pS9, DOI 10.1097/TA.0b013e31816093a6; Nordby H K, 1986, Acta Neurochir Suppl (Wien), V36, P142; NORDBY HK, 1984, ACTA NEUROCHIR, V71, P205, DOI 10.1007/BF01401315; NORDBY HK, 1985, ACTA NEUROCHIR, V76, P131, DOI 10.1007/BF01418475; NORDBY HK, 1982, ACTA NEUROCHIR, V65, P93, DOI 10.1007/BF01405445; SCHWARTZ JG, 1989, CLIN CHEM, V35, P651; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; TEASDALE G, 1974, LANCET, V2, P81; TSUNG SH, 1982, J CLIN PATHOL, V35, P200, DOI 10.1136/jcp.35.2.200	9	7	8	0	2	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	JUN	2009	174	6					622	625		10.7205/MILMED-D-02-4708			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	601LD	WOS:000278059900012	19585776	Bronze			2022-02-06	
J	Chun, HJ; Yi, HJ				Chun, Hyoung-Joon; Yi, Hyeong-Joong			Traumatic extracranial. pseudoaneurysm on the peripheral. ophthalmic artery presenting as delayed intraparenchymal hematoma: case report	SURGICAL NEUROLOGY			English	Article						Delayed intraparenchymal hemorrhage; Peripheral ophthalmic artery; Pseudoaneurysm; Skull fracture; Traumatic brain injury	MIDDLE MENINGEAL ARTERY; ANEURYSM	Background: Extracranial pseudoaneurysm is barely noticed after head injury, and therefore, recognizing such sequels is amenable when there is severe initial injury, unexplained intracranial bleeding, or neurologic sequelae. We report such an unexpected case of intraorbital pseudoaneurysm presenting as delayed intraparenchymal hemorrhage. Case Description: A 71-year-old man with traumatic brain injury sustained delayed intraparenchymal hemorrhage after unremarkable surgical evacuation. Suspicious intraorbital mass was shown adjacent to the fracture line of medial orbital wall. Catheter angiogram revealed peripheral, extracranial ophthalmic artery pseudoaneurysm, and endovascular occlusion was attempted. The patient made gradual recovery with radiographic evidence of disappeared pseudosac and resolved intracranial hematoma. Conclusion: Traumatic aneurysm of peripheral ophthalmic artery should be strongly suspected when there is skull fracture at the orbital wall or persistent or delayed intraparenchymal hemorrhage despite proper surgical hematoma evacuation, and in such case, swift endovascular occlusion can be done safely. (C) 2009 Elsevier Inc. All rights reserved.	[Chun, Hyoung-Joon; Yi, Hyeong-Joong] Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul 133792, South Korea		Yi, HJ (corresponding author), Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul 133792, South Korea.	hjyi8499@hanyang.ac.kr	Yi, Hyeong-Joong/AAR-2685-2020				Bozzetto-Ambrosi P, 2006, SURG NEUROL, V66, pS29, DOI 10.1016/j.surneu.2006.08.048; Bruneau M, 2002, SURG NEUROL, V57, P174, DOI 10.1016/S0090-3019(01)00668-1; Dehdashti AR, 2002, NEURORADIOLOGY, V44, P600, DOI 10.1007/s00234-002-0786-y; JOHNSON HC, 1951, J NEUROSURG, V8, P631, DOI 10.3171/jns.1951.8.6.0631; Lasjaunias P, 2001, SURG NEUROANGIOGRAPH, P435; OGAWA A, 1992, NEUROSURGERY, V31, P1102, DOI 10.1227/00006123-199212000-00017; Piche SL, 2005, AM J NEURORADIOL, V26, P1929; RAHMAT H, 1984, J NEUROSURG, V60, P630, DOI 10.3171/jns.1984.60.3.0630; Singh M, 2006, SURG NEUROL, V66, P321, DOI 10.1016/j.surneu.2005.11.029; Srinivasan A, 2006, AM J NEURORADIOL, V27, P882; Tsutsumi M, 2002, SURG NEUROL, V58, P325, DOI 10.1016/S0090-3019(02)00834-0; Yanaka K, 2002, NEUROSURGERY, V51, P1066, DOI 10.1097/00006123-200210000-00038	12	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	JUN	2009	71	6					701	704		10.1016/j.surneu.2007.11.018			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	447XM	WOS:000266225300013	18313737				2022-02-06	
J	Cimera, RE				Cimera, Robert Evert			Supported Employment's Cost-Efficiency to Taxpayers: 2002 to 2007	RESEARCH AND PRACTICE FOR PERSONS WITH SEVERE DISABILITIES			English	Article						supported employment; costs; taxpayer; cost-efficiency	COMPETITIVE EMPLOYMENT; MENTAL-RETARDATION; DISABILITIES; PROGRAMS; ILLINOIS; BENEFITS; OUTCOMES; MODEL	This study explored the cost-efficiency of all 231,204 supported employees funded by vocational rehabilitation throughout the entire United States from 2002 to 2007. Results found that supported employees returned an average monthly net benefit to taxpayers of $251.34 (i.e., an annual net benefit of $3,016.08 per supported employee) and generated a benefit cost ratio of 1.46. Further, economic returns of supported employees were in across nine disabling conditions. Even individuals with the least cost-efficient disability (i.e., traumatic brain injuries) returned to taxpayers a monthly net benefit of $111.62. Finally, this study determined that supported employees with multiple conditions were as cost-efficient as individuals with only one disability (i.e., benefit cost ratios of 1.49 versus 1.46, respectively).	Kent State Univ, Educ Fdn & Special Serv, Kent, OH 44242 USA		Cimera, RE (corresponding author), Kent State Univ, Educ Fdn & Special Serv, POB 5190, Kent, OH 44242 USA.	rcimera@kent.edu					BAER R, 1995, J REHABILITATION ADM, V18, P46; Boardman A. E., 2006, COST BENEFIT ANAL CO; CHO DW, 1980, J REHABIL, V46, P28; Cimera R. E., 2007, RES PRACT PERS SEV D, V32, P1; Cimera R. E., 2000, J VOCATIONAL REHABIL, V14, P51; Cimera RE, 1999, INT REV RES MENT RET, V22, P175, DOI 10.1016/S0074-7750(08)60134-2; Cimera RE, 1998, MENT RETARD, V36, P280, DOI 10.1352/0047-6765(1998)036<0280:AIWSMR>2.0.CO;2; Cimera RE, 2008, J VOCAT REHABIL, V28, P15; Cimera RE, 2009, J VOCAT REHABIL, V30, P1, DOI 10.3233/JVR-2009-0448; Cimera RE, 2007, J VOCAT REHABIL, V26, P153; Cimera RE, 2010, CAREER DEV TRANSIT E, V33, P4, DOI 10.1177/0885728809346959; CONLEY RW, 1989, J APPL BEHAV ANAL, V22, P441, DOI 10.1901/jaba.1989.22-441; CONLEY RW, 1990, SUPPORTED EMPLOYMENT, P271; HEAL LW, 1989, RES DEV DISABIL, V10, P201, DOI 10.1016/0891-4222(89)90007-3; Hill M., 1983, J ASS SEVERELY HANDI, V8, P30; HILL ML, 1987, RES DEV DISABIL, V8, P71, DOI 10.1016/0891-4222(87)90041-2; HILL ML, 1987, J ASSOC PERS SEVERE, V12, P182, DOI 10.1177/154079698701200303; JOHNSTON MV, 1987, REHABILITATION OUTCO, P99; KREGEL J, 1989, J APPL BEHAV ANAL, V22, P407, DOI 10.1901/jaba.1989.22-407; Kregel J., 2000, J VOCATIONAL REHABIL, V14, P153; LAM CS, 1986, REHABIL COUNS BULL, V30, P66; Levin HM, 2000, COST EFFECTIVENESS A; LEWIS DR, 1992, J DISABIL POLICY STU, V3, P67; McCaughrin W.B., 1991, J DEV PHYS DISABIL, V3, P129; MCCAUGHRIN WB, 1993, MENT RETARD, V31, P41; MCCAUGHRIN WB, 1988, THESIS U ILLINOIS UR; NOBLE JH, 1991, J DISABIL POLICY STU, V2, P39; *REH SERV ADM, 2004, RSAPD0404; ROGERS ES, 1995, EVAL PROGRAM PLANN, V18, P105, DOI 10.1016/0149-7189(95)00002-S; RUSCH ER, 2005, RES PRACT PERS SEV D, V29, P237; RUSCH FR, 1993, J REHABIL, V59, P31; SCHNEIDER K, 1981, FUNDING COST ANAL; Tax Form Processing LLC, 2009, SOC SEC TAX WAG LIM; THOMPSON L, 1992, J ASSOC PERS SEVERE, V17, P87, DOI 10.1177/154079699201700203; TINES J, 1990, AM J MENT RETARD, V95, P44; U. S. Department of Health and Human Services, 2009, 2007 HHS POV GUID; WEHMAN P, 1985, MENT RETARD, V23, P274; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; WEHMAN P, 1987, J ASSOC PERS SEVERE, V12, P11, DOI 10.1177/154079698701200103; Zivolich S., 1997, J VOCATIONAL REHABIL, V8, P211, DOI DOI 10.1016/S1052-2263(97)00004-4	40	7	8	0	4	TASH	WASHINGTON	1025 VERMONT AVE,  NW 7TH FLR, WASHINGTON, DC 20005 USA	0274-9483			RES PRACT PERS SEV D	Res. Pract. Pers. Sev. Disabil.	SUM	2009	34	2					13	20		10.2511/rpsd.34.2.13			8	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	619OO	WOS:000279439700002					2022-02-06	
J	Haug, KS; Baylen, BG; Mink, RB				Haug, Kevin S.; Baylen, Barry G.; Mink, Richard B.			Death From Cardiac Failure in a Child With Ruptured Cerebral Arteriovenous Malformation	PEDIATRIC EMERGENCY CARE			English	Article						subarachnoid hemorrhage; intracranial arteriovenous malformation; myocardial ischemia; troponin	ANEURYSMAL SUBARACHNOID HEMORRHAGE; HEAD-INJURY; NEUROCARDIOGENIC INJURY; STUNNED MYOCARDIUM; PULMONARY-EDEMA; ECG-CHANGES; DYSFUNCTION; COMPLICATIONS; PREDICTORS; MORTALITY	We present the case of a 13-year-old boy with a ruptured cerebral arteriovenous malformation who had rapidly progressive cardiac failure leading to death. Serial electrocardiograms, cardiac enzymes, echocardiograms, and pulmonary artery catheter data confirmed severe ventricular dysfunction related to myocardial ischemia and infarction. Cardiac dysfunction after cerebral insult is commonly described in adults with aneurysmal subarachnoid hemorrhage and has been termed "neurogenic stunned myocardium" because of its transient nature in most of patients. In children, cardiovascular dysfunction has been described in a few reports and only after traumatic brain injury. No deaths have been reported. This case report illustrates the potentially lethal consequences of cardiovascular dysfunction in children after ruptured cerebral arteriovenous malformation with subarachnoid hemorrhage. Compromised cardiac function should be considered during the early evaluation and management of these patients and supportive care instituted to limit secondary brain injury from poor perfusion.	[Haug, Kevin S.] Univ Calif Davis, Childrens Hosp, Sacramento, CA 95817 USA; [Haug, Kevin S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Crit Care, Los Angeles, CA 90095 USA; [Baylen, Barry G.] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Cardiol, Dept Pediat, Los Angeles, CA 90095 USA; [Mink, Richard B.] Harbor UCLA Med Ctr, David Geffen Sch Med UCLA, Dept Pediat, Div Pediat Crit Care, Torrance, CA 90509 USA		Haug, KS (corresponding author), Univ Calif Davis, Childrens Hosp, 2516 Stockton Blvd, Sacramento, CA 95817 USA.	kevin.haug@ucdmc.ucdavis.edu					Banki N, 2006, J NEUROSURG, V105, P15, DOI 10.3171/jns.2006.105.1.15; Banki NM, 2005, CIRCULATION, V112, P3314, DOI 10.1161/CIRCULATIONAHA.105.558239; Bjelakovic B, 2006, THESCIENTIFICWORLDJO, V6, P571, DOI 10.1100/tsw.2006.108; Brisman JL, 2006, NEW ENGL J MED, V355, P928, DOI 10.1056/NEJMra052760; Bulsara KR, 2003, J NEUROSURG, V98, P524, DOI 10.3171/jns.2003.98.3.0524; Dash M, 2003, J NEUROSURG ANESTH, V15, P270, DOI 10.1097/00008506-200307000-00017; Divekar A, 2006, PEDIATR CARDIOL, V27, P376, DOI 10.1007/s00246-005-1263-2; Hays A, 2006, NEUROLOGY, V66, P1330, DOI 10.1212/01.wnl.0000210523.22944.9b; Kawahara E, 2003, CIRC J, V67, P753; Kim DH, 2005, NEUROCRIT CARE, V3, P11, DOI 10.1385/NCC:3:1:011; Masuda T, 2002, STROKE, V33, P1671, DOI 10.1161/01.STR.0000016327.74392.02; Naidech AM, 2005, CIRCULATION, V112, P2851, DOI 10.1161/CIRCULATIONAHA.105.533620; Ozdemir D, 2005, PEDIATR EMERG CARE, V21, P658, DOI 10.1097/01.pec.0000181427.25342.e0; PERKIN RM, 1991, CRIT CARE MED, V19, P587, DOI 10.1097/00003246-199104000-00028; Schuiling WJ, 2005, J NEUROL NEUROSUR PS, V76, P1565, DOI 10.1136/jnnp.2004.060913; Tung P, 2004, STROKE, V35, P548, DOI 10.1161/01.STR.0000114874.96688.54; Urbaniak K, 2007, SURG NEUROL, V67, P21, DOI 10.1016/j.surneu.2006.08.065; Yarlagadda S, 2006, NEUROCRIT CARE, V5, P102, DOI 10.1385/NCC:5:2:102; YUKI K, 1991, J NEUROSURG, V75, P308, DOI 10.3171/jns.1991.75.2.0308	19	7	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAY	2009	25	5					342	344		10.1097/PEC.0b013e3181a348ea			3	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	445VG	WOS:000266079000012	19444033				2022-02-06	
J	Smucker, P; Hekmatyar, SK; Bansal, N; Rodgers, RB; Shapiro, SA; Borgens, RB				Smucker, Philip; Hekmatyar, S. K.; Bansal, Navin; Rodgers, Richard B.; Shapiro, Scott A.; Borgens, Richard B.			INTRAVENOUS POLYETHYLENE GLYCOL SUCCESSFULLY TREATS SEVERE ACCELERATION-INDUCED BRAIN INJURY IN RATS AS ASSESSED BY MAGNETIC RESONANCE IMAGING	NEUROSURGERY			English	Article						Apparent diffusion coefficient; Cytotoxic edema; Diffuse axonal injury; Diffusion-weighted imaging; Membrane repair; Polyethylene glycol; Traumatic brain injury	SPINAL-CORD-INJURY; DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; FLUID-PERCUSSION MODEL; CEREBRAL-ISCHEMIA; POSTTRAUMATIC HYPOTHERMIA; MOLECULAR REPAIR; CELLULAR EDEMA; TIME-COURSE; RECOVERY	OBJECTIVE: Polyethylene glycol (PEG) is a nontoxic molecule with known efficacy as a cell membrane sealant, improving histological and behavioral outcomes in trauma models. Diffusion-weighted (DW) magnetic resonance imaging (MRI) is the most sensitive method of detecting in vivo diffuse axonal injury (DAI), where a decreased apparent diffusion coefficient (ADC) of water reflects cytotoxic edema. We use DW-MRI to assess severe DAI in rats treated with a single acute postinjury injection of PEG. METHODS: Rats were divided into uninjured, injured saline-treated, and injured PEG-treated groups. Injury groups received a severe brain injury using an impact-acceleration weight-drop model. Saline or PEG was administered acutely as a single intravenous dose to injured saline-treated and injured PEG-treated groups, respectively. DW-MRI analysis was performed at postinjury day 7 with a 9.4-T magnet. ADC was calculated for cortex, corpus callosum/hippocampus, and thalamus in each group. RESULTS: An expected decrease in ADC, representing cytotoxic edema, was observed in the injured saline-treated group. The injured PEG-treated group demonstrated no decrease in ADC relative to the uninjured rats, and the difference between ADC in saline and PEG-treated groups reached significance for all 3 zones of assessed brain. Differences were seen grossly between injured saline-treated and injured PEG-treated groups on representative color-mapped ADC images. CONCLUSION: A single intravenous dose of PEG dramatically limits sequelae of severe acceleration-induced brain injury-in this case, assessed by cytotoxic edema on DW-MRI-by intervening at the primary injury level of neuronal membrane disruption. This outcome is unprecedented, as no prior treatments for DAI have demonstrated similar efficacy. DAI treatment with intravenous PEG may have future clinical relevance and warrants further investigation.	[Smucker, Philip; Rodgers, Richard B.; Shapiro, Scott A.] Indiana Univ, Sch Med, Dept Neurol Surg, Indianapolis, IN 46202 USA; [Hekmatyar, S. K.; Bansal, Navin] Indiana Univ, Sch Med, Dept Radiol, Div Imaging Sci, Indianapolis, IN 46202 USA; [Borgens, Richard B.] Purdue Univ, Ctr Paralysis Res, Dept Basic Med Sci, Sch Vet Med, Lafayette, IN USA; [Borgens, Richard B.] Purdue Univ, Dept Biomed Engn, Weldon Sch Engn, Lafayette, IN USA		Smucker, P (corresponding author), Indiana Univ, Sch Med, Dept Neurol Surg, 545 Barnhill Dr,Emerson Hall,Suite 139, Indianapolis, IN 46202 USA.	phil@smucker1.com	Hekmatyar, Khan/AAC-3677-2020				Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; BENVENISTE H, 1992, STROKE, V23, P746, DOI 10.1161/01.STR.23.5.746; Borgens RB, 2000, FASEB J, V14, P27, DOI 10.1096/fasebj.14.1.27; Borgens RB, 2002, J EXP BIOL, V205, P1; Borgens RB, 2001, NEUROSURGERY, V49, P370, DOI 10.1097/00006123-200108000-00021; Borgens RB, 2001, J NEUROSCI RES, V66, P1179; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Buki A, 2000, J NEUROSCI, V20, P2825; BUSZA AL, 1992, STROKE, V23, P1602, DOI 10.1161/01.STR.23.11.1602; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; DARDZINSKI BJ, 1993, MAGNET RESON MED, V30, P318, DOI 10.1002/mrm.1910300307; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Donaldson J, 2002, NEUROSURGERY, V50, P147, DOI 10.1097/00006123-200201000-00023; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fruijtier-Polloth C, 2005, TOXICOLOGY, V214, P1, DOI 10.1016/j.tox.2005.06.001; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; HOSSMANN KA, 1995, CEREBROVAS BRAIN MET, V7, P187; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Koob AO, 2006, J NEUROSCI RES, V83, P1558, DOI 10.1002/jnr.20837; Koob AO, 2005, J NEUROTRAUM, V22, P1092, DOI 10.1089/neu.2005.22.1092; Laverty PH, 2004, J NEUROTRAUM, V21, P1767, DOI 10.1089/neu.2004.21.1767; Luo J, 2004, J NEUROTRAUM, V21, P994, DOI 10.1089/0897715041651097; Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Petty MA, 1996, EUR J PHARMACOL, V307, P149, DOI 10.1016/0014-2999(96)00235-X; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; SKLAR EML, 1992, RADIOL CLIN N AM, V30, P353; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; WORKING P, 1997, AM CHEM SOC, P45	48	7	11	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAY	2009	64	5					984	990		10.1227/01.NEU.0000342406.43816.13			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	439XN	WOS:000265661100052	19404158				2022-02-06	
J	Zweckberger, K; Sakowitz, OW; Unterberg, AW; Kiening, KL				Zweckberger, K.; Sakowitz, O. W.; Unterberg, A. W.; Kiening, K. L.			Intracranial pressure-volume relationship. Physiology and pathophysiology	ANAESTHESIST			German	Article						Traumatic brain injury; Intracranial pressure; Continuous intracranial compliance; Elasticity; Pressure-volume index	FLUID PULSE PRESSURE; CEREBRAL PERFUSION-PRESSURE; INDEX; CSF	Posttraumatic increase of intracranial pressure (ICP) is a strong prognostic factor for the outcome of patients after traumatic brain injury. After exhausting all compensatory mechanisms ICP increases exponentially, where ICP(norm)=(CSF production*CSF flow resistance)+venous pressure((sinus sagittalis))=10-15 mmHg. The ICP curve is influenced by the compliance (Delta V/Delta P) and elasticity (Delta P/Delta V) of the brain. Marmarou could demonstrate that the non-linear cranio-spinal pressure-volume relationship describes a logarithmic, mono-exponential, strongly linear relationship between pressure and volume and named this the pressure volume index (PVI=log ICP/Delta V). The pressure volume index describes the volume necessary to increase ICP by a factor of 10. Additionally to PVI the measurement of volume-pressure response (VPR) was introduced. The continuous intracranial compliance could be determined on the principle of pulsatile volume increases as an equivalent of very small intra-cranial volume increases. However, to ascertain functional status of the injured brain a combination of measurements of different parameters, such as tissue oxygen partial pressure (p(ti)O(2)) cerebral blood flow (CBF), microdialysis and electrocorticography (ECoG) is recommended.	[Zweckberger, K.; Sakowitz, O. W.; Unterberg, A. W.; Kiening, K. L.] Univ Heidelberg, Neurochirurg Klin, D-69120 Heidelberg, Germany		Zweckberger, K (corresponding author), Univ Heidelberg, Neurochirurg Klin, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	klaus.zweckberger@med.uni-heidelberg.de		Sakowitz, Oliver/0000-0003-3248-6335			ANILE C, 1987, NEUROSURGERY, V20, P389, DOI 10.1227/00006123-198703000-00006; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; AVEZAAT CJJ, 1986, ACTA NEUROCHIR, V79, P13, DOI 10.1007/BF01403461; AVEZAAT CJJ, 1986, NEUROSURG REV, V9, P113, DOI 10.1007/BF01743061; BORGESON SE, 1989, INTRACRANIAL PRESSUE, P353; BRAY RS, 1986, INTRACRANIAL PRESSUR, V6, P260; Davson H, 1967, PHYSL CEREBROSPINAL, P445; EKSTEDT J, 1978, J NEUROL NEUROSUR PS, V41, P345, DOI 10.1136/jnnp.41.4.345; FUCHS G, 2003, KOMPLIKATIONEN GEFAH; GRAY WJ, 1987, J NEUROSURG, V67, P369, DOI 10.3171/jns.1987.67.3.0369; GRAY WJ, 1987, J NEUROSURG, V67, P377, DOI 10.3171/jns.1987.67.3.0377; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; HASE U, 1978, ACTA NEUROCHIR, V44, P69, DOI 10.1007/BF01401631; KATZMANN R, 1970, NEUROLOGY, V20, P196; Kiening KL, 2003, BRIT J NEUROSURG, V17, P311, DOI 10.1080/02688690310001601199; LANGFITT TW, 1964, J NEUROSURG, V21, P989, DOI 10.3171/jns.1964.21.11.0989; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MAKSYMOWICZ W, 1993, INTRACRANIAL PRESSUR, P829; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MARMAROU A, 1973, THESIS DREXEL U; MILLER JD, 1973, ARCH NEUROL-CHICAGO, V28, P265, DOI 10.1001/archneur.1973.00490220073011; MILLER JD, 1973, BRIT J SURG, V60, P316; PIPER IR, 1990, ACT NEUR S, V51, P387; Raabe A, 1999, ACTA NEUROCHIR, V141, P31, DOI 10.1007/s007010050263; RYDER HW, 1951, J NEUROSURG, V8, P46, DOI 10.3171/jns.1951.8.1.0046; Troupp H, 1975, Zentralbl Neurochir, V36, P11; VANEIJNDHOVEN JHM, 1986, NEUROSURGERY, V19, P507, DOI 10.1227/00006123-198610000-00004; WYLER AR, 1972, J NEUROSURG, V37, P185, DOI 10.3171/jns.1972.37.2.0185	28	7	7	1	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-2417			ANAESTHESIST	Anaesthesist	APR	2009	58	4					392	397		10.1007/s00101-009-1522-3			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	436FB	WOS:000265397000011	19384533				2022-02-06	
J	Gioia, D; Brekke, JS				Gioia, Deborah; Brekke, John S.			Neurocognition, Ecological Validity, and Daily Living in the Community for Individuals with Schizophrenia: A Mixed Methods Study	PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES			English	Article							TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; NEGATIVE SYMPTOMS; SOCIAL COGNITION; STRATEGIES; WORKSHOP; DEFICITS; PEOPLE; ADULTS; SKILLS	The ecological validity of neurocognitive measures concerns translating laboratory-based neuropsychological (NP) findings into relevant predictions about how people will perform in varied real world settings. There have been no studies of the ecological validity of psychosocial or neurocognitive measures in schizophrenia that incorporated direct observation of naturally occurring community behavior. The research questions for this mixed method study were: (1) Are there differences in the daily community functioning of persons with schizophrenia who have high or low cognitive functioning as determined by lab-based assessments? and (2) Can ethnographic methods be used to create descriptions of functioning that are useful for assessing ecological validity? Ten individuals from a larger longitudinal study were randomly selected from two strata that reflected low or high neurocognitive functioning. Individuals completed quantitative measures of psychosocial functioning and were also observed ethnographically for three days by an observer who was blind to their neurocognitive status. A new method developed in this study for characterizing the predominant behavioral living strategies of individuals with schizophrenia found notable differences between high and low NP groups in their community functioning. This study found evidence to support the ecological validity of NP measures and yielded an ethnographically based observational protocol to reliably characterize the predominant individual daily behavioral strategies.	[Gioia, Deborah] Univ Maryland, Sch Social Work, Baltimore, MD 21201 USA; [Brekke, John S.] Univ So Calif, Sch Social Work, Los Angeles, CA 90089 USA		Gioia, D (corresponding author), Univ Maryland, Sch Social Work, 525 W Redwood St, Baltimore, MD 21201 USA.	dgioia@ssw.umaryland.edu			NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [RO3 MH64686-01]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R03MH064686] Funding Source: NIH RePORTER	Research was funded by NIMH RO3 MH64686-01 (Gioia, PI).	ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784; Bellack AS, 2007, SCHIZOPHRENIA BULL, V33, P805, DOI 10.1093/schbul/sbl035; Brekke J, 2005, SCHIZOPHR RES, V80, P213, DOI 10.1016/j.schres.2005.07.008; Brekke JS, 2007, SCHIZOPHRENIA BULL, V33, P1247, DOI 10.1093/schbul/sbl072; BREKKE JS, 1993, SCHIZOPHRENIA BULL, V19, P599, DOI 10.1093/schbul/19.3.599; Bromley E, 2007, SCHIZOPHRENIA BULL, V33, P648, DOI 10.1093/schbul/sbm024; Brown CE, 2006, PSYCHIAT SERV, V57, P573, DOI 10.1176/appi.ps.57.4.573; Buchanan RW, 2005, SCHIZOPHRENIA BULL, V31, P5, DOI 10.1093/schbul/sbi020; Carpenter WT, 2006, AM J PSYCHIAT, V163, P353, DOI 10.1176/appi.ajp.163.3.353; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Creswell J.W., 2017, RES DESIGN QUALITATI; Creswell JW, 2017, DESIGNING CONDUCTING, V3rd; Emerson R.M., 2011, WRITING ETHNOGRAPHIC, VSecond, P21, DOI [10.7208/chicago/9780226206868.001.0001, DOI 10.7208/CHICAGO/9780226206868.001.0001]; Farmer J E, 1995, Appl Neuropsychol, V2, P107, DOI 10.1207/s15324826an0203&4_2; Gioia D, 2006, QUAL HEALTH RES, V16, P1217, DOI 10.1177/1049732306294009; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; GOODMAN SH, 1993, COMMUNITY MENT HLT J, V29, P119, DOI 10.1007/BF00756338; Green M.F., 2000, COGNITION SCHIZOPHRE, P178, DOI DOI 10.1093/OXFORDJOURNALS.SCHBUL.A033380; Green MF, 2005, SCHIZOPHRENIA BULL, V31, P882, DOI 10.1093/schbul/sbi049; Greenwood KE, 2005, SCHIZOPHRENIA BULL, V31, P910, DOI 10.1093/schbul/sbi035; HAMERA E, 2002, PSYCHIATR REHABIL J, V6, P296, DOI DOI 10.1080/10973430208408440; Hudson W.W., 1982, CLIN MEASUREMENT PAC; Kern RS, 2005, AM J PSYCHIAT, V162, P513, DOI 10.1176/appi.ajp.162.3.513; Koren D, 2006, SCHIZOPHRENIA BULL, V32, P310, DOI 10.1093/schbul/sbj035; Medalia A, 2004, SCHIZOPHR RES, V71, P331, DOI 10.1016/j.schres.2004.03.003; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Myin-Germeys I, 2005, PSYCHOL MED, V35, P733, DOI 10.1017/S0033291704004179; Rempfer MV, 2003, PSYCHIAT RES, V117, P103, DOI 10.1016/S0165-1781(02)00318-9; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; Sbordone RJ, 1996, ECOLOGICAL VALIDITY; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Test MA, 2005, PSYCHIAT SERV, V56, P292, DOI 10.1176/appi.ps.56.3.292; TEST MA, 1991, ADV NEUROPSYCBIATRY, V1; Velligan DI, 2002, SCHIZOPHRENIA BULL, V28, P283, DOI 10.1093/oxfordjournals.schbul.a006938; Ventura J., 1993, INT J METHODS PSYCHI, V3, P227	37	7	7	0	2	GUILFORD PUBLICATIONS INC	NEW YORK	72 SPRING STREET, NEW YORK, NY 10012 USA	0033-2747			PSYCHIATRY	Psychiatry-Interpers. Biol. Process.	SPR	2009	72	1					94	107		10.1521/psyc.2009.72.1.94			14	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	429GR	WOS:000264909400007	19366297				2022-02-06	
J	Naqvi, F; Lee, S; Fields, SD				Naqvi, Fatima; Lee, Susan; Fields, Suzanne D.			An evidence-based review of the NICHE guideline for preventing falls in older adults in an acute care setting	GERIATRICS			English	Article						falls; risk factors; fall assessment and management	METAANALYSIS; INJURIES; PEOPLE; INTERVENTION; MOBILITY	Although falling may seem like a simple event, in reality it is a complex medical issue leading to serious injuries including fractures, lacerations, soft tissue and traumatic brain injuries, and even death. The Nurses Improving Care for Health System Elders (NICHE) guideline for falls prevention in acute care unit was formulated by incorporating recommendations from systematic reviews of the literature and advice from expert consensus. Recommendations include pre-fall risk assessment, utilization of a post-fall assessment tool, follow-up monitoring for 48 hours, and implementation of an individualized, multidisciplinary plan of care to address treatable problems that contributed to the fall and to prevent future falls. The guideline also calls for staff education.	[Fields, Suzanne D.] SUNY Stony Brook, Sch Med, Div Geriatr & Gen Internal Med, Stony Brook, NY 11794 USA					Lee, Susan/0000-0003-2705-0705			Capezuti E, 2002, J AM GERIATR SOC, V50, P90, DOI 10.1046/j.1532-5415.2002.50013.x; Chang JT, 2007, J AM GERIATR SOC, V55, pS327, DOI 10.1111/j.1532-5415.2007.01339.x; Coussement J, 2008, J AM GERIATR SOC, V56, P29, DOI 10.1111/j.1532-5415.2007.01508.x; Gates S, 2008, BRIT MED J, V336, P130, DOI 10.1136/bmj.39412.525243.BE; GREYMICELLI D, 2008, PREVENTING FALLS ACU, P161; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; Lubitz J, 2003, NEW ENGL J MED, V349, P1048, DOI 10.1056/NEJMsa020614; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; Mahoney JE, 2000, ARCH INTERN MED, V160, P2788, DOI 10.1001/archinte.160.18.2788; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stevens J. A., 2006, Morbidity and Mortality Weekly Report, V55, P1221; Stevens M, 2001, J AM GERIATR SOC, V49, P1442, DOI 10.1046/j.1532-5415.2001.4911235.x; Tinetti ME, 2008, J AM GERIATR SOC, V56, P1563, DOI 10.1111/j.1532-5415.2008.01800.x; Tinetti ME, 2008, NEW ENGL J MED, V359, P252, DOI 10.1056/NEJMoa0801748; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; Vellas BJ, 1997, AGE AGEING, V26, P189, DOI 10.1093/ageing/26.3.189	17	7	9	0	8	ADVANSTAR COMMUNICATIONS INC	WOODLAND HILLS	6200 CANOGA AVE, 2ND FLR, WOODLAND HILLS, CA 91367 USA	0016-867X			GERIATRICS	Geriatrics	MAR	2009	64	3					10	+					5	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	420CK	WOS:000264265800002	19351218				2022-02-06	
J	Ushewokunze, S; Sgouros, S				Ushewokunze, S.; Sgouros, S.			Brain tissue oxygenation changes in children during the first 24 h following head injury	CHILDS NERVOUS SYSTEM			English	Article; Proceedings Paper	36th Annual Meeting of the International-Society-for-Pediatric-Neurosurgery	OCT 12-16, 2008	Cape Town, SOUTH AFRICA	Int Soc Pediat Neurosurg		Traumatic brain injury; Head injury; Brain tissue oxygen tension	CEREBRAL OXYGENATION; INTRACRANIAL-PRESSURE; EPIDEMIOLOGY; CARE	The aim of this study is to assess the changes of brain tissue oxygen levels in children during the first 24 h following head injury and its correlation with changes of intracranial pressure and clinical outcome. Invasive monitoring of partial brain tissue oxygen tension (PbtO(2)) using the Licox (Integra Neurosciences, Plainsboro, NJ, USA) oxygen probe was performed in children with severe head injury requiring ventilation, during the years 2002-2005. The study focused in the recordings of the first 24 h following injury. There were four patients (three males, one female) with an age range of 2-12 years. All injuries were due to motor vehicle accidents. The Glasgow Coma Score ranged from 5 to 9. All patients had diffuse axonal injuries on Computed Tomography scan. One patient underwent a bilateral decompressive craniectomy. The total duration of monitoring was 567.84 h. During the first 24 h, the mean PbtO(2) was 4.2 mmHg, 12.7 mmHg, 21.8 mmHg, and 25.1 mmHg in each patient. Fifteen episodes of ICP > 20 mmHg were seen in the first 24 h of monitoring. Nine of these episodes were accompanied by a reduction in PbtO(2) levels. The Glasgow Outcome Score at 1 year was good recovery (GOS 3) in three patients and severe disability in one patient. There were no complications from the monitoring. In children with head injury, rise in ICP may be accompanied by fall in PbtO(2). However, low brain oxygen levels during the first 24 h following head injury may not correlate necessarily with poor outcome.	[Ushewokunze, S.; Sgouros, S.] Birmingham Childrens Hosp, Dept Neurosurg, Birmingham B4 6NH, W Midlands, England		Sgouros, S (corresponding author), Birmingham Childrens Hosp, Dept Neurosurg, Steelhouse Lane, Birmingham B4 6NH, W Midlands, England.	s.sgouros@bham.ac.uk	Sgouros, Spyridon/AAH-1361-2020	Sgouros, Spyridon/0000-0003-4615-0808			Figaji AA, 2007, CHILD NERV SYST, V23, P1331, DOI 10.1007/s00381-007-0388-4; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007	15	7	8	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2009	25	3					341	345		10.1007/s00381-008-0752-z			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pediatrics; Surgery	404CL	WOS:000263128200012	19057911				2022-02-06	
J	Baloui, H; Stettler, O; Weiss, S; Nothias, F; von Boxberg, Y				Baloui, Hasna; Stettler, Olivier; Weiss, Stefan; Nothias, Fatiha; von Boxberg, Ysander			Upregulation in Rat Spinal Cord Microglia of the Nonintegrin Laminin Receptor 37 kDa-LRP following Activation by a Traumatic Lesion or Peripheral Injury	JOURNAL OF NEUROTRAUMA			English	Article						dorsal root ganglia; MAP1B (microtubule-associated protein-1B); p38 MAPK; sciatic nerve lesion; spinal cord lesion	ADHESION MOLECULE EXPRESSION; COLONY-STIMULATING FACTOR; CENTRAL-NERVOUS-SYSTEM; CELL-SURFACE RECEPTOR; DORSAL-ROOT GANGLIA; NEUROPATHIC PAIN; BINDING PROTEIN; PRION PROTEIN; REACTIVE MICROGLIOSIS; AXONAL REGENERATION	The molecular mechanisms triggering microglial activation after injury to the central nervous system, involving cell-extracellular matrix interactions and cytokine signaling, are not yet fully understood. Here, we report that resident microglia in spinal cord express low levels of the non-integrin laminin receptor precursor (LRP), also found on certain neurons and glial cells in the peripheral nervous system. 37LRP/p40 and its 67-kDa isoform laminin receptor (LR) were the first high-affinity laminin binding proteins identified. While the role of laminin receptor was later attributed to integrins, LRP/LR gained new interest as receptors for prions, and their interaction with laminin seems important for migration of metastatic cancer cells. Using immunohistochemistry and Western blotting, we demonstrate that traumatic spinal cord injury leads to a strong and rapid increase in LRP levels in relation to activated microglia/macrophages. Associated with laminin re-expression in the lesion epicenter, LRP-positive microglia/macrophages exhibit a rounded, ameboid-like shape characteristic of phagocytic cells, whereas in more distant loci they reveal a hypertrophied cell body and short ramifications. The same morphological difference is observed in vitro for purified microglia cultured with or without laminin. Strong, transient upregulation of LRP by activated spinal cord microglia is also induced by transection of the sciatic nerve that affects the spinal cord circuitry without blood-brain barrier dysruption. LRP expression is maximal by 1 week post-lesion, before becoming restricted to dorsal and ventral horns, sites of major structural reorganization. Our findings strongly suggest the involvement of LRP in lesion-induced activation and migration of microglia.	[Baloui, Hasna; Nothias, Fatiha; von Boxberg, Ysander] Univ Paris 06, NSI UMR7101, F-75005 Paris, France; [Baloui, Hasna; Nothias, Fatiha; von Boxberg, Ysander] CNRS, UMR7101, IFR83, F-75005 Paris, France; [Stettler, Olivier] Ecole Normale Super, CNRS, UMR 8542, Paris, France; [Weiss, Stefan] LMU Munchen, Inst Biochem, Mol Biol Lab, Genzentrum, Munich, Germany		Nothias, F (corresponding author), Univ Paris 06, NSI UMR7101, F-75005 Paris, France.	fatiha.nothias@snv.jussieu.fr		Nothias, Fatiha/0000-0002-2497-2096; von Boxberg, Ysander/0000-0001-5886-6155	CNRSCentre National de la Recherche Scientifique (CNRS)European Commission; UPMC; IRME (Institut de Recherche sur la Moelle Epiniere et l'Encephale); Fondation pour la Recherche Medicale (FRM)Fondation pour la Recherche Medicale; DGA; Demain debout	We wish to thank Dr. M. Mallat for providing the Bv2 cell line and advice, Dr. J.M. Perrin for help with primary glial cell cultures and critiques on the manuscript, and Dr. S. Soares for help on the revised version. This research was supported by CNRS, UPMC, IRME (Institut de Recherche sur la Moelle Epiniere et l'Encephale); Ph.D. fellowships to H. B. by Fondation pour la Recherche Medicale (FRM), DGA, and "Demain debout.''	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Ardini E, 1997, J BIOL CHEM, V272, P2342; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; Ardini E, 2002, CANCER RES, V62, P1321; Baloui H, 2004, EUR J NEUROSCI, V20, P2605, DOI 10.1111/j.1460-9568.2004.03728.x; Berno V, 2005, ENDOCR-RELAT CANCER, V12, P393, DOI 10.1677/erc.1.00870; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Bouhy D, 2006, FASEB J, V20, P1239, DOI 10.1096/fj.05-4382fje; Bouquet C, 2007, MOL CELL NEUROSCI, V36, P235, DOI 10.1016/j.mcn.2007.07.002; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; Canfield SM, 1999, J IMMUNOL, V163, P3430; CHAMAK B, 1991, NEUROSCIENCE, V45, P513, DOI 10.1016/0306-4522(91)90267-R; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Clausse N, 1996, DNA CELL BIOL, V15, P1009, DOI 10.1089/dna.1996.15.1009; Compston A, 1997, J ANAT, V190, P161, DOI 10.1046/j.1469-7580.1997.19020161.x; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Dina OA, 2004, EUR J NEUROSCI, V19, P634, DOI 10.1111/j.1460-9568.2004.03169.x; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; ERIKSSON NP, 1993, EXP BRAIN RES, V96, P19, DOI 10.1007/BF00230435; Fedoroff S, 1997, NEUROSCI BIOBEHAV R, V21, P187, DOI 10.1016/S0149-7634(96)00009-7; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; GRAEBER MB, 1989, NEUROSCI LETT, V103, P241, DOI 10.1016/0304-3940(89)90106-7; Hailer NP, 1997, HIPPOCAMPUS, V7, P341, DOI 10.1002/(SICI)1098-1063(1997)7:3<341::AID-HIPO8>3.0.CO;2-N; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jin SX, 2003, J NEUROSCI, V23, P4017; Jones LL, 2003, J NEUROSCI, V23, P9276; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Kim SY, 2002, NEUROREPORT, V13, P2483, DOI 10.1097/00001756-200212200-00021; Kloss CUA, 1999, J COMP NEUROL, V411, P162, DOI 10.1002/(SICI)1096-9861(19990816)411:1<162::AID-CNE12>3.0.CO;2-W; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LANDOWSKI TH, 1995, BIOCHEMISTRY-US, V34, P11276, DOI 10.1021/bi00035a037; LESOT H, 1983, EMBO J, V2, P861, DOI 10.1002/j.1460-2075.1983.tb01514.x; Liesi P, 2002, EXP NEUROL, V173, P31, DOI 10.1006/exnr.2001.7800; Lindia JA, 2005, J PAIN, V6, P434, DOI 10.1016/j.jpain.2005.02.001; MALINOFF HL, 1983, J CELL BIOL, V96, P1475, DOI 10.1083/jcb.96.5.1475; Milner R, 2002, J NEUROSCI, V22, P1562, DOI 10.1523/JNEUROSCI.22-05-01562.2002; Milner R, 2007, J IMMUNOL, V178, P8158, DOI 10.4049/jimmunol.178.12.8158; Moleres FJ, 2005, BRAIN RES, V1056, P10, DOI 10.1016/j.brainres.2005.06.067; Moleres FJ, 2007, BRAIN RES, V1174, P143, DOI 10.1016/j.brainres.2007.07.069; MONETA ME, 1993, J NEUROIMMUNOL, V45, P203, DOI 10.1016/0165-5728(93)90181-W; Montuori N, 1999, CLIN CANCER RES, V5, P1465; Morel E, 2005, AM J PATHOL, V167, P1033, DOI 10.1016/S0002-9440(10)61192-3; Moya KL, 2000, MICROSC RES TECHNIQ, V50, P58, DOI 10.1002/1097-0029(20000701)50:1<58::AID-JEMT9>3.0.CO;2-5; Nakajima K, 2004, NEUROCHEM INT, V44, P205, DOI 10.1016/S0197-0186(03)00163-3; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; PELLEGRINI R, 1994, INT J CANCER, P116; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; RAO CN, 1989, BIOCHEMISTRY-US, V28, P7476, DOI 10.1021/bi00444a047; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; Salama RHM, 2001, EXP CELL RES, V270, P13, DOI 10.1006/excr.2001.5341; Selleri C, 2006, BLOOD, V108, P2476, DOI 10.1182/blood-2005-11-012625; Simoneau S, 2003, BIOL CHEM, V384, P243, DOI 10.1515/BC.2003.027; Soares S, 2002, EUR J NEUROSCI, V16, P593, DOI 10.1046/j.1460-9568.2002.02126.x; Stettler O, 1999, J NEUROCYTOL, V28, P1035, DOI 10.1023/A:1007044207002; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Takada T, 1997, J BIOCHEM-TOKYO, V122, P453; Takai S, 2007, LIFE SCI, V81, P585, DOI 10.1016/j.lfs.2007.06.018; Takeuchi A, 2001, J NEUROSCI RES, V65, P38, DOI 10.1002/jnr.1125; Tiraihi T, 2004, DEV BRAIN RES, V148, P97, DOI 10.1016/j.devbrainres.2003.11.002; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Vana K, 2007, CELL MOL NEUROBIOL, V27, P107, DOI 10.1007/s10571-006-9121-1; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Boxberg Y, 2006, EUR J NEUROSCI, V24, P1031, DOI 10.1111/j.1460-9568.2006.04994.x; VONBOXBERG Y, 1988, ANAL BIOCHEM, V169, P372; Wang TG, 2006, FASEB J, V20, P906, DOI 10.1096/fj.05-5053com; WOOLF CJ, 1995, J COMP NEUROL, V360, P121, DOI 10.1002/cne.903600109; Xu JT, 2007, EXP NEUROL, V204, P355, DOI 10.1016/j.expneurol.2006.11.016; YOW HK, 1988, P NATL ACAD SCI USA, V85, P6394, DOI 10.1073/pnas.85.17.6394; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003	77	7	7	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2009	26	2					195	207		10.1089/neu.2008.0677			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	410NS	WOS:000263585100003	19196078				2022-02-06	
J	Neudecker, JJ; Skeel, RL				Neudecker, John J.; Skeel, Reid L.			Development of a Novel Malingering Detection Method Involving Multiple Detection Strategies	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	27th Annual Meeting of the National-Academy-of-Neuropsychology	NOV 14-17, 2007	Scottsdale, AZ	Natl Acad Neuropsychol		Neuropsychological assessment; Traumatic brain injury; Malingering	VERBAL-LEARNING TEST; SIMULATED MEMORY IMPAIRMENT; TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE DYSFUNCTION; INCOMPLETE EFFORT; 3RD EDITION; POOR EFFORT; DIGIT SPAN; VALIDATION; PERFORMANCE	This study utilized a novel computer-administered measure designed to assess multiple malingering detection strategies, as well as measure genuine impairment in a brain-injured sample. Ninety-four neurologically normal subjects comprised control and simulator groups. Twenty individuals with moderate to severe head injuries comprised a clinical sample. The summary score from the measure yielded a sensitivity of .81 and a specificity of .89. Total completion time and learning curves were utilized as genuine impairment indicators. Sensitivity (.95) and specificity (.95) were quite high for these dimensions. Results suggest there is utility to combining detection techniques, including indicators of genuine impairment.	[Neudecker, John J.; Skeel, Reid L.] Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA		Neudecker, JJ (corresponding author), Cent Michigan Univ, 720 Wackerly St,Suite 12, Midland, MI 48640 USA.	jneudecker@yahoo.com					Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; BAKER F, 2000, BEHAV MEASUREMENT LE, V7, P2; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Binder L. M., 1991, J CONSULT CLIN PSYCH, V3, P175; BINDER LM, 1996, AM J PSYCHIAT, V153, P5; Bolan B, 2002, J CLIN EXP NEUROPSYC, V24, P154, DOI 10.1076/jcen.24.2.154.1000; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; DELIS D, 1987, CALIFORNIA VERBAL LE; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 1996, MANUAL COMPUTERISED; Green P., 2005, MED SYMPTOM VALIDITY; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GUDJONSSON GH, 1986, BRIT J CLIN PSYCHOL, V25, P35, DOI 10.1111/j.2044-8260.1986.tb00668.x; Haines ME, 2001, CLIN NEUROPSYCHOL, V15, P171, DOI 10.1076/clin.15.2.171.1891; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hilsabeck RC, 2005, ARCH CLIN NEUROPSYCH, V20, P1025, DOI 10.1016/j.acn.2005.05.003; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; King JH, 1998, J CLIN EXP NEUROPSYC, V20, P603, DOI 10.1076/jcen.20.5.603.1124; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Levin H.S., 1989, MILD HEAD INJURY; LEZAK M, 2004, NEUROPSYCHOLOGICAL A; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Millar W J, 1996, Health Rep, V8, P17; MILLIS S, 1997, J INT NEUROPSYCH SOC, V3, P225; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reynolds CR, 1998, CRIT ISS NE, P261; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Schmand B., 1999, AMSTERDAMSE KORTE TE; Silverberg N, 2005, J CLIN EXP NEUROPSYC, V27, P907, DOI 10.1080/13803390490919326; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wogar MA, 1998, BRIT J CLIN PSYCHOL, V37, P327, DOI 10.1111/j.2044-8260.1998.tb01389.x	37	7	7	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2009	24	1					59	70		10.1093/arclin/acp008			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology	428YU	WOS:000264888800007	19395357	Bronze			2022-02-06	
J	Balaban, T; Hyde, N; Colantonio, A				Balaban, Tammy; Hyde, Nellemarie; Colantonio, Angela			The Effects of Traumatic Brain Injury during Adolescence on Career Plans and Outcomes	PHYSICAL & OCCUPATIONAL THERAPY IN PEDIATRICS			English	Article						Career plans; occupational outcome; long-term consequences; adolescent head injury		Traumatic brain injury (TBI) often occurs during the years when individuals are aiming for vocational goals and acquiring skills needed to achieve vocational success. This exploratory study aimed to describe the perceived long-term impact on career outcomes for individuals who were hospitalized with a TBI during adolescence. This study used a retrospective cohort design. A telephone questionnaire was administered 5 years postinjury to a consecutive series of 51 participants aged 15-19 years at time of injury, as well as 46 informants who knew the participants well. Participants and informants described the impact the injury had on career plans and outcomes. The nature of occupation postinjury was compared with preinjury plans, with results indicating many participants altering preinjury career plans following TBI.	[Colantonio, Angela] Univ Toronto, Toronto Rehabil Inst, Toronto, ON M5G 1V7, Canada; [Hyde, Nellemarie] St Elizabeth Hlth Care, Driver Assessment Serv, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Hyde, Nellemarie] St Elizabeth Hlth Care, Driver Training Serv, Toronto, ON, Canada		Colantonio, A (corresponding author), Univ Toronto, Toronto Rehabil Inst, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Easter Seals Research Institute, an Ontario Ministry of Health; Ontario Work Study Program	Funding was received by Easter Seals Research Institute, an Ontario Ministry of Health and Long-Term Care Grant to the Toronto Rehabilitation Institute Foundation, and Ontario Work Study Program to support this research. We thank the participants who made this work possible.	Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; BERGLAND MM, 1991, REHABIL COUNS BULL, V35, P5; Bogan AM, 1997, BRAIN INJURY, V11, P431; *CAN ASS OCC THER, 1997, EN OCC OCC THER PERS; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; CROSSON B, 1987, CLIN NEUROPSYCHOL, V1, P335, DOI DOI 10.1080/13854048708520069; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; DeMatteo CA, 2008, ARCH PHYS MED REHAB, V89, P1803, DOI 10.1016/j.apmr.2008.02.025; DRUMMOND A, 2005, BRIT J OCCUPATIONAL, V68, P324; Erikson E.H., 1997, LIFE CYCLE COMPLETED; Gerberich SG, 1997, NEUROEPIDEMIOLOGY, V16, P1, DOI 10.1159/000109665; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Hollingshead A. B, 1975, 4 FACTOR INDEX UNPUB; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; KIM JA, 1997, OCCUPATIONAL THERAPY, V4, P178; KRIEL RL, 1988, PEDIATR NEUROL, V4, P337, DOI 10.1016/0887-8994(88)90079-3; Marsh NV, 2006, NEUROPSYCHOL REHABIL, V16, P684, DOI 10.1080/09602010500220290; Ocampo S, 1997, OCCUP THER INT, V4, P161; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; RUMNEY P, 2007, HEAD INJURY CHILDREN, P61; Slater E.J., 1989, J ADOLESCENT RES, V4, P371; SLATER EJ, 1988, AM J DIS CHILD, V142, P1048, DOI 10.1001/archpedi.1988.02150100042022; *STAT CAN, 1997, LAB FORC UPD CAT 71; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Viguier D, 2001, BRAIN INJURY, V15, P263	30	7	7	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0194-2638	1541-3144		PHYS OCCUP THER PEDI	Phys. Occup. Ther. Pediatr.		2009	29	4					367	383		10.3109/01942630903245333			17	Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics; Rehabilitation	V19BE	WOS:000208047100004	19916823				2022-02-06	
J	Brenner, LA; Carlson, NE; Harrison-Felix, C; Ashman, T; Hammond, FM; Hirschberg, RE				Brenner, Lisa A.; Carlson, Nichole E.; Harrison-Felix, Cynthia; Ashman, Teresa; Hammond, Flora M.; Hirschberg, Ronald E.			Self-inflicted traumatic brain injury: Characteristics and outcomes	BRAIN INJURY			English	Article						Traumatic brain injury; suicide; self-inflicted; inpatient rehabilation	DISABILITY RATING-SCALE; FUNCTIONAL INDEPENDENCE MEASURE; RISK-FACTORS; SUICIDE-PREVENTION; MODEL SYSTEMS; VIOLENCE; POPULATION; VALIDITY; BEHAVIOR	Objective: To characterize the population of those receiving inpatient rehabilitation who sustained a traumatic brain injury (TBI) secondary to a suicide attempt and identify differences between such individuals and a demographically-matched control group (n = 230) of those whose TBIs were of an unintentional aetiology. Method: Analysed cases were identified from the TBI Model Systems National Database. Based on ICD-9-CM external cause-of-injury codes, 79 participants incurred a TBI secondary to a suicide attempt. An approximate 1 : 3 matched case-control (age, gender, race, injury year) design was chosen to make statistical comparisons. Results: Those who sustained a TBI secondary to a suicide attempt had greater pre-existing psychiatric and psychosocial problems (substance use problems (p = 0.01) prior suicide attempt (p<0.0001), psychiatric hospitalization (p = 0.014) and non-productive activity (p = 0.014)), required more resources during acute and rehabilitative hospitalizations (i.e. charges per day; p = 0.024, p = 0.047) and had greater disability at the time of discharge, even after controlling for injury severity (p = 0.022). Conclusion: Individuals who sustained TBIs secondary to a suicide attempt had increased pre-injury psychiatric and psychosocial problems and poorer outcomes at discharge than those who incurred unintentional injuries. For these individuals, acute and rehabilitation charges per day were higher and could not be accounted for by injury severity.	[Brenner, Lisa A.] Denver VAMC, MIRECC, VA VISN 19, Denver, CO 80223 USA; [Brenner, Lisa A.] Univ Colorado Denver, Sch Med, Dept Psychiat, Denver, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Sch Med, Dept Neurol, Denver, CO USA; [Brenner, Lisa A.; Harrison-Felix, Cynthia] Univ Colorado Denver, Sch Med, Dept Phys Med & Rehabil, Denver, CO USA; [Brenner, Lisa A.; Carlson, Nichole E.; Harrison-Felix, Cynthia] Craig Hosp, Englewood, CO USA; [Carlson, Nichole E.] Univ Colorado Denver, Dept Biostat & Informat, Denver, CO USA; [Ashman, Teresa] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; [Hammond, Flora M.] Carolinas Traumat Brain Injury Rehabil & Res Syst, Charlotte, NC USA; [Hirschberg, Ronald E.] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Hirschberg, Ronald E.] Spaulding Rehabil Hosp, Boston, MA USA		Brenner, LA (corresponding author), Denver VAMC, MIRECC, VA VISN 19, 1055 Clermont St, Denver, CO 80223 USA.	lisa.brenner@va.gov	Ashman, Teresa/B-1621-2013; Brenner, Lisa A./AAG-2442-2019				Ban LH, 2008, J NEUROSURG, V108, P1021, DOI 10.3171/JNS/2008/108/5/1021; Brenner LA, 2008, J HEAD TRAUMA REHAB, V23, P401, DOI 10.1097/01.HTR.0000341436.59627.a5; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Daigle MS, 2005, ACCIDENT ANAL PREV, V37, P625, DOI 10.1016/j.aap.2005.03.004; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Gutierrez-Gonzalez R, 2008, CLIN NEUROL NEUROSUR, V110, P207, DOI 10.1016/j.clineuro.2007.09.014; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Hawton K, 2007, CRISIS, V28, P4, DOI 10.1027/0227-5910.28.S1.4; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; Karlin, 2008, SAFETY PLAN TREATMEN; Kim H, 2008, J TRAUMA, V65, P1287, DOI 10.1097/TA.0b013e31817196f5; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Kruesi MJP, 1999, J AM ACAD CHILD PSY, V38, P250, DOI 10.1097/00004583-199903000-00010; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Mihailovic Z, 2007, AM J FOREN MED PATH, V28, P220, DOI 10.1097/PAF.0b013e3180600fb4; Neese LE, 2000, BRAIN INJURY, V14, P719; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Traumatic Brain Injury Model Systems, TRAUM BRAIN INJ MOD; *UN DAT SYST MED R, 1997, GUID UN DAT SET MED; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Wright J., 2000, CTR OUTCOME MEASUREM	30	7	7	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2009	23	13-14					991	998		10.3109/02699050903379362			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	529YR	WOS:000272556000001	19891537				2022-02-06	
J	Dau, B; Oda, G; Holodniy, M				Dau, Birgitt; Oda, Gina; Holodniy, Mark			Infectious complications in OIF/OEF veterans with traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						Acinetobacter; Afghanistan; brain injury; infection; infectious disease management; Iraq; leishmaniasis; MRSA; sexually transmitted infection; veteran	DEPLOYED US MILITARY; OPERATION-IRAQI-FREEDOM; RESISTANT ACINETOBACTER-BAUMANNII; COMBAT-RELATED INJURIES; ENDURING-FREEDOM; HIV-INFECTION; AFGHANISTAN; PERSONNEL; STRONGYLOIDIASIS; LEISHMANIASIS	Of veterans from the U.S. Global War on Terrorism who have sought care in the Department of Veterans Affairs, approximately 12% have an infectious disease diagnosis. Infections in those veterans with traumatic brain injury (TBI) include infections associated with blast injuries and burns, such as skin and soft tissue infections; infections as a result of retained bullet or shrapnel fragments; pulmonary infections resulting from lung injury, intubation, or resultant tracheostomy; hospital-acquired infections, such as those associated with methicillin-resistant Staphylococcus aureus and other antimicrobial resistant organisms such as Acinetobacter baumannii; and infections from implanted prosthetic devices, such as metal hardware or skull flaps. Longer-term cognitive impairment may result in behaviors that place veterans with TBI at risk for human immunodeficiency virus or hepatitis C virus infections. Finally, chronic infections acquired abroad, such as cutaneous leishmaniasis or Q-fever, may be diagnosed after veterans return to the United States. These infections present challenges in terms of added morbidity and costs associated with complex antimicrobial management; isolation requirements; and surgical procedures, such as those to remove infected retained fragments or prosthetic devices. In this review, providers will become more familiar with the scope and complexity of infectious disease management in veterans with TBI.	[Dau, Birgitt; Holodniy, Mark] VA Palo Alto Hlth Care Syst, Dept Vet Affairs, Palo Alto, CA 94304 USA; [Dau, Birgitt; Holodniy, Mark] Stanford Univ, Div Infect Dis, Stanford, CA 94305 USA; [Oda, Gina; Holodniy, Mark] VA, Off Publ Hlth Surveillance & Res, Washington, DC USA		Holodniy, M (corresponding author), VA Palo Alto Hlth Care Syst, Dept Vet Affairs, 3801 Miranda Ave 132, Palo Alto, CA 94304 USA.	mark.holodniy@va.gov		Holodniy, Mark/0000-0002-6655-7982			Aronson NE, 2006, CLIN INFECT DIS, V43, P1045, DOI 10.1086/507539; Beyer JL, 2007, PSYCHOSOMATICS, V48, P31, DOI 10.1176/appi.psy.48.1.31; BRAY RM, 2005, DEP DEFENSE SURVEY H; Bryant KJ, 2006, SUBST USE MISUSE, V41, P1465, DOI 10.1080/10826080600846250; CALHOUN PS, 2007, VA HLTH SERV RES DEV; Cardo LJ, 2006, TRANSFUSION, V46, P1641, DOI 10.1111/j.1537-2995.2006.00941.x; Carey J, 2005, J TRAVEL MED, V12, P291, DOI 10.2310/7060.2005.12511; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P264; Centers for Disease Control and Prevention, 2004, MMWR MORB MORTAL WKL, V53, P1063; Chen Hsin-Pai, 2005, Journal of Microbiology Immunology and Infection, V38, P127; Ciminera P, 2007, AM J TROP MED HYG, V76, P275, DOI 10.4269/ajtmh.2007.76.275; Davis KA, 2005, EMERG INFECT DIS, V11, P1218, DOI 10.3201/1108.050103; *DEP VET AFF OFF I, 2005, 0500641149 DEP VET A; *DEP VET AFF OFF I, 2006, 0601642126 DEP VET A; Elston DM, 2004, CUTIS, V74, P253; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; GENTA RM, 1987, JAMA-J AM MED ASSOC, V258, P49, DOI 10.1001/jama.258.1.49; Griffith ME, 2008, INFECT CONT HOSP EP, V29, P664, DOI 10.1086/589585; Griffith ME, 2006, INFECT CONT HOSP EP, V27, P659, DOI 10.1086/506596; HAKIM SZ, 1986, ARCH PATHOL LAB MED, V110, P809; HAMERSCHLAG A, 2004, IL10200400713; Hawley JS, 2007, ANTIMICROB AGENTS CH, V51, P376, DOI 10.1128/AAC.00858-06; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Johnson EN, 2007, CLIN INFECT DIS, V45, P409, DOI 10.1086/520029; Kotwal RS, 2005, JAMA-J AM MED ASSOC, V293, P212, DOI 10.1001/jama.293.2.212; Kucan John O, 2005, J Burns Wounds, V4, pe3; Lalliss SJ, 2007, PLAST RECONSTR SURG, V120, P574, DOI 10.1097/01.prs.0000267671.78598.b4; Leininger BE, 2006, J TRAUMA, V61, P1207, DOI 10.1097/01.ta.0000241150.15342.da; MITCHELL AE, 2007, GULF WAR HLTH, V5; Monteville MR, 2006, AM J TROP MED HYG, V75, P762, DOI 10.4269/ajtmh.2006.75.762; Murray CK, 2008, CRIT CARE MED, V36, pS358, DOI 10.1097/CCM.0b013e31817e2ffc; Murray CK, 2008, J TRAUMA, V64, pS232, DOI 10.1097/TA.0b013e318163c3f5; Murray CK, 2006, MIL MED, V171, P821, DOI 10.7205/MILMED.171.9.821; Murray CK, 2006, MIL MED, V171, P826, DOI 10.7205/MILMED.171.9.826; Owens DK, 2007, AM J PUBLIC HEALTH, V97, P2173, DOI 10.2105/AJPH.2007.110700; PERLIN J, 2004, VHA INFORM LETT; Petersen K, 2007, ANN SURG, V245, P803, DOI 10.1097/01.sla.0000251707.32332.c1; Putnam SD, 2006, J TRAVEL MED, V13, P92, DOI 10.1111/j.1708-8305.2006.00020.x; Ressner RA, 2008, J AM COLL SURGEONS, V206, P439, DOI 10.1016/j.jamcollsurg.2007.09.017; ROSELLE G, 2004, ACINETOBACTER BAUMAN, P539; Salmond CH, 2005, J NEUROTRAUM, V22, P613, DOI 10.1089/neu.2005.22.613; SCOTT P, 2007, 45 ANN M INF DIS SOC; Scott P, 2007, CLIN INFECT DIS, V44, P1577, DOI 10.1086/518170; SIEGEL JD, 2006, HEALTHCARE INFECT CO; Thornton SA, 2005, CLIN INFECT DIS, V40, P519, DOI 10.1086/427501; Urban C, 2003, CLIN INFECT DIS, V36, P1268, DOI 10.1086/374847; Weina PJ, 2004, CLIN INFECT DIS, V39, P1674, DOI 10.1086/425747; Wolf SE, 2006, ANN SURG, V243, P786, DOI 10.1097/01.sla.0000219645.88867.b7; Wright J, 2006, MIL MED, V171, P1024, DOI 10.7205/MILMED.171.10.1024; Yun HC, 2008, J TRAUMA, V64, pS163, DOI 10.1097/TA.0b013e318160868c; Zapor MJ, 2005, CURR OPIN INFECT DIS, V18, P395, DOI 10.1097/01.qco.0000182102.50430.2c; 2005, MED SURVEILLANCE MON, V11, P7	52	7	7	0	7	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2009	46	6					673	684		10.1682/JRRD.2008.09.0113			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	531BQ	WOS:000272638100005	20104397	Bronze			2022-02-06	
J	Fong, KNK; Chan, MKL; Ng, PPK; Ng, SSW				Fong, Kenneth N. K.; Chan, Marko K. L.; Ng, Peggie P. K.; Ng, Serena S. W.			Measuring processing speed after traumatic brain injury in the outpatient clinic	NEUROREHABILITATION			English	Article						Traumatic brain injury; simple reaction time; movement time; mental processing speed	CLOSED-HEAD-INJURY; REACTION-TIME; NEUROPSYCHOLOGICAL ASSESSMENT; ATTENTION; DEFICITS; MILD; PERFORMANCE; CONCUSSION; CONSTRUCT; RECOVERY	Objectives: To evaluate processing speed performance in outpatients with moderate-to-severe traumatic brain injury (TBI). Design: Prospective cross-sectional observational study. Participants: Twenty outpatients with traumatic brain injury (TBI) were compared with 20 matched healthy subjects. Measure: Measurement by six instruments in the domains of simple reaction time (SRT), movement time (MT), and mental processing speed at a single time occasion. Results: Significant differences were found in speed but not accuracy of work between outpatients with TBI and healthy subjects. Simple reaction time was sensitive to predicting patients with moderate-to-severe TBI as opposed to healthy counterparts. Conclusion: Outpatient clinics should consider measuring SRT.	[Fong, Kenneth N. K.] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China; [Chan, Marko K. L.; Ng, Peggie P. K.; Ng, Serena S. W.] Kowloon Hosp, Occupat Therapy Dept, Hong Kong, Hong Kong, Peoples R China		Fong, KNK (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.	rsnkfong@polyu.edu.hk	Fong, Kenneth/F-9608-2014	Fong, Kenneth/0000-0001-5909-4847			Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; BRADFORD R, 1992, INTERPRETIVE REASONI; BRAUN CMJ, 1989, INT J CLIN NEUROPSYC, V11, P167; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; CHAMBERLIN CJ, 1989, RES Q EXERCISE SPORT, V60, P256, DOI 10.1080/02701367.1989.10607449; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; Geldmacher DS, 1997, BRAIN INJURY, V11, P59, DOI 10.1080/026990597123818; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Incoccia C, 2004, CORTEX, V40, P111, DOI 10.1016/S0010-9452(08)70924-9; Khan MA, 2006, Q J EXP PSYCHOL, V59, P524, DOI 10.1080/02724980443000809; *LAF INSTR, 1998, MINN MAN DEXT TEST T; *LAF INSTR, 1998, REACT MOV TIM US INS; LEVIN HS, 1988, SCAND J REHABIL MED, P33; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; MAGILL RA, 2004, MOTOR LEARNING CONTR; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Perbal S, 2003, NEUROPSYCHOLOGIA, V41, P1599, DOI 10.1016/S0028-3932(03)00110-6; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rath JF, 2004, ARCH CLIN NEUROPSYCH, V19, P613, DOI 10.1016/j.acn.2003.08.006; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; SANDFORD JA, 1985, CAPTAINS LOG COGNITI; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; *VALP INT CORP, 1993, VALP COMP WORK SAMPL; Zwaagstra R, 1996, J CLIN EXP NEUROPSYC, V18, P383, DOI 10.1080/01688639608408995	34	7	8	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2009	24	2					165	173		10.3233/NRE-2009-0465			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	436OF	WOS:000265422900007	19339755				2022-02-06	
J	Greve, KW; Bianchini, KJ; Etherton, JL; Ord, JS; Curtis, KL				Greve, Kevin W.; Bianchini, Kevin J.; Etherton, Joseph L.; Ord, Jonathan S.; Curtis, Kelly L.			Detecting Malingered Pain-Related Disability: Classification Accuracy of the Portland Digit Recognition Test	CLINICAL NEUROPSYCHOLOGIST			English	Article						Chronic pain; Cognition; Malingering; Known-groups design; Criterion groups validation; Symptom validity test; Response bias	TRAUMATIC BRAIN-INJURY; MMPI-2 VALIDITY SCALES; FAKE BAD SCALE; NEUROCOGNITIVE DYSFUNCTION; INDICATORS; SPECIFICITY; SENSITIVITY; PERFORMANCE; DEPRESSION	This study used criterion groups validation to determine the classification accuracy of the Portland Digit Recognition Test (PDRT) at a range of cutting scores in chronic pain patients undergoing psychological evaluation (n = 318), college student simulators (n = 29), and patients with brain damage (n = 120). PDRT scores decreased and failure rates increased as a function of greater independent evidence of intentional underperformance. There were no differences between patients classified as malingering and college student simulators. The PDRT detected from 33% to nearly 60% of malingering chronic pain patients, depending on the cutoff used. False positive error rates ranged from 3% to 6%. Scores higher than the original cutoffs may be interpreted as indicating negative response bias in patients with pain, increasing the usefulness and facilitating the clinical application of the PDRT in the detection of malingering in pain.	[Greve, Kevin W.; Bianchini, Kevin J.; Ord, Jonathan S.; Curtis, Kelly L.] Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; [Greve, Kevin W.; Bianchini, Kevin J.; Etherton, Joseph L.; Curtis, Kelly L.] Jefferson Neurobehav Grp, Metairie, LA USA; [Etherton, Joseph L.] Texas State Univ San Marcos, San Marcos, TX USA		Greve, KW (corresponding author), Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu			Binder and Kelly	The assistance of Michelle Josey and Chris Pasztor in conducting this study is gratefully acknowledged. The authors would also like to thank Laurence M. Binder for providing us with the specific scores from a subset of the Binder and Kelly ( 1996) sample.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Arbisi PA, 2004, CLIN J PAIN, V20, P383, DOI 10.1097/00002508-200411000-00002; Bianchini K. J., 2004, J FORENSIC NEUROPSYC, V4, P65; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P461, DOI 10.1076/clin.15.4.461.1890; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1996, ASSESSMENT, V3, P403, DOI DOI 10.1177/107319119600300405; BINDER LM, 1993, PORTLAND DIGIT RECOG; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Doane BM, 2005, CLIN NEUROPSYCHOL, V19, P99, DOI 10.1080/13854040490524100; Ericsson M, 2002, DISABIL REHABIL, V24, P334, DOI 10.1080/09638280110096241; Etherton Joseph L, 2006, Spine J, V6, P61, DOI 10.1016/j.spinee.2005.05.382; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fishbain DA, 1999, CLIN J PAIN, V15, P244, DOI 10.1097/00002508-199912000-00002; Frederick RI, 2007, ASSESSMENT, V14, P3, DOI 10.1177/1073191106292009; GERVAIS RO, 2001, J FORENSIC NEUROPSYC, V2, DOI DOI 10.1300/J151V02N02_01; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2008, ARCH CLIN NEUROPSYCH, V23, P341, DOI 10.1016/j.acn.2007.12.001; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2003, ARCH PHYS MED REHAB, V84, P1233, DOI 10.1016/S0003-9993(03)00145-X; GREVE KW, 2007, 35 ANN M INT NEUR SO; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; IVERSON GL, 2001, J FORENSIC NEUROPSYC, V2, P19, DOI DOI 10.1300/J151v02n01_02; Ju D, 2000, Appl Neuropsychol, V7, P201, DOI 10.1207/S15324826AN0704_1; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2007, ASSESSMENT MALINGERE, P44; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Meyers J E, 2000, Appl Neuropsychol, V7, P133, DOI 10.1207/S15324826AN0703_3; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Reynolds CR, 1998, CRIT ISS NE, P261; Rogers R., 1997, CLIN ASSESSMENT MALI; SCHNURR RF, 1995, CLIN J PAIN, V11, P103, DOI 10.1097/00002508-199506000-00004; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tsushima WT, 2001, ASSESSMENT, V8, P205, DOI 10.1177/107319110100800208; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilson KG, 2002, CLIN J PAIN, V18, P77, DOI 10.1097/00002508-200203000-00002	49	7	7	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2009	23	5					850	869	PII 909178944	10.1080/13854040802585055			20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	458JI	WOS:000267013500008	19255913				2022-02-06	
J	Juran, V; Smrcka, M; Svoboda, K; Fadrus, P; Sprlakova, A; Gal, R				Juran, V.; Smrcka, M.; Svoboda, K.; Fadrus, P.; Sprlakova, A.; Gal, R.			Indication of Decompressive Craniectomy in Traumatic Brain Injury	CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE			Czech	Article						decompressive craniectomy; traumatic brain injury; indication; monitoring	SEVERE HEAD-INJURIES; INTRACRANIAL HYPERTENSION; COMPUTERIZED-TOMOGRAPHY; PRACTICAL SCALE; CEREBRAL EDEMA; MANAGEMENT; MULTICENTER; CRANIOTOMY	Backgrounds: Decompressive craniectomy (DC) is a type of neurosurgical operation performed for the purpose of radical reduction of intracranial pressure, which enables sufficient cerebral perfusion and prevents from brain ischaemia. In severe traumatic brain injuries (Glasgow Coma Scale 3-8), the indication depends on the clinical status of the patient, findings of CT scans, on intracranial and perfusion pressure and on perioperativefindings. Aim: To identify the group of patients which most benefit from DC. To evaluate the significance of intracranial monitoring and level of decrease of intracranial pressure after DC. To summarize the main operation diagnoses and review the area of the performed DC. Patient group and methods: The study is based on three-year prospective monitoring of 81 patients undergoing DC after severe brain injury in 2003-2005. Control group was formed by 68 retrospectively analyzed patients who had undergone DC in the years 1996-1998. In both groups we analyzed age, sex, anamnesis, operative diagnosis, performed monitoring, timing of the operation, localization and the area of DC, GCS at the time of indication of DC and GOS 12 months after injury. Results: The group of patients younger than 50 years of age had good recovery (GOS 4-5) in 45% of cases and if these patients had even ICP monitoring, good recovery was present in 70% of cases, which was statistically significant (alpha < 0.05). After DC there was a statistically significant reduction in intracranial pressure from a mean of 31.8 mmHg to 9.2 mmHg 2 hours after the operation, and 11.0 mmHg 24 hours after the operation (p < 0.01), respectively. Most frequent operative diagnoses were: acute subdural haematoma in 56% of cases, and cerebral contusion in 25% of cases. Mean area of performed DC was 157 cm(2). Conclusion: Good recovery in patients with severe traumatic brain injury is conditioned by early indication of DC according to ICP monitoring, by age under 50 years, and by performing sufficiently large decompression.	[Juran, V.; Smrcka, M.; Svoboda, K.; Fadrus, P.] LF MU & FN Brno, Neurol Klin, Brno 62500, Czech Republic; [Sprlakova, A.] LF MU & FN Brno, Radiodiagnost Klin, Brno 62500, Czech Republic; [Gal, R.] LF MU & FN Brno, Klin Anesteziol Resuscitace & Intenzivni Med, Brno 62500, Czech Republic		Juran, V (corresponding author), LF MU & FN Brno, Neurol Klin, Jihlavska 20, Brno 62500, Czech Republic.	vjuran@fnbrno.cz	Juran, Vilem/ABD-9854-2020; Fadrus, Pavel/J-8636-2014; Smrcka, Martin/AAM-8872-2021	Juran, Vilem/0000-0003-1080-3520; Smrcka, Martin/0000-0002-9191-8700			Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Breasted J., 1930, E SMITH SURG PAPYRUS; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Compagnone C, 2005, NEUROSURGERY, V57, P1183; COOPER DJ, DECRA TRIAL EARLY DE; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; FRENCH BN, 1977, SURG NEUROL, V7, P171; GAL R, 2000, ANEST NEODKL PECE, V11, P174; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; JURAN V, 2004, PROGRAMY KVALITY STA; Kocher T., 1901, HIRNERSCHUTTERUNG HI, V3, P262; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Meier U, 2003, ACTA NEUROCHIR SUPPL, V86, P367; Mracek J, 2007, CESK SLOV NEUROL N, V70, P290; Mracek Z, 1977, Rozhl Chir, V56, P597; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Navratil L, 2007, CESK SLOV NEUROL N, V70, P294; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; SMRCKA M, 2001, SCRIPTA MED, V74, P391; SMRCKA M, 2002, PATOFYZIOLOGIE PORAN; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TEASDALE G, 1974, LANCET, V2, P81; Valadka AB, 2007, NEUROSURGERY, V61, P203, DOI 10.1227/01.NEU.0000255497.26440.01; Weiwei H, 2007, CESK SLOV NEUROL N, V70, P388	30	7	7	0	5	CZECH MEDICAL SOC	PRAGUE 2	SOKOLSKA 31, PRAGUE 2 120 26, CZECH REPUBLIC	1210-7859	1802-4041		CESK SLOV NEUROL N	Cesk. Slov. Neurol. Neurochir.		2009	72	5					439	445					7	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	510JF	WOS:000271083700005					2022-02-06	
J	Lew, HL; Gray, M; Poole, JH				Lew, Henry L.; Gray, Max; Poole, John H.			Simultaneous Measurement of Perceptual and Motor Cortical Potentials Implications for Assessing Information Processing in Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Motor Potential; P300; Reaction Time; Processing Speed; Traumatic Brain Injury	EVENT-RELATED POTENTIALS; FINGER MOVEMENTS; CLINICAL UTILITY; REACTION-TIME; HEAD-INJURY; P300; ACTIVATION; ATTENTION; RECOVERY	Objective: Psychomotor slowing is a common manifestation of traumatic brain injury. Previous electrophysiological studies of traumatic brain injury have focused on abnormal attentional and perceptual responses to incoming stimuli. We hypothesize that traumatic brain injury is also associated with abnormal cortical components of motor execution. Design: To test this hypothesis, we analyzed event-related potentials of 22 subjects (11 with a history of severe traumatic brain injury and 11 age-matched healthy subjects) during oddball discrimination tasks. In addition to the usual stimulus-locked averaging of electrophysiological data to reveal cognitive components, such as the P300, we also analyzed subjects' response-locked data to reveal motor potential waveforms. To focus on generalized effects across modality, analyses were performed on composite measures from both auditory and visual event-related potentials. Results: (1) Traumatic brain injury subjects had abnormal P300 responses (with reduced amplitude and prolonged latency) in both sensory modalities. (2) Traumatic brain injury subjects' motor potential waveforms showed significantly reduced amplitude in both sensory modalities. (3) Abnormalities in P300 latency, amplitude, and motor potential amplitude (effect sizes = 1.2-1.5 SID) were greater than behavioral slowing, as measured by reaction times (0.7 SD). (4) P300 latency and motor potential amplitude together accounted for much of the reaction time prolongation (r = 0.73). Conclusions: This study demonstrates the value of concurrently analyzing stimulus-locked and response-locked event-related potential data to evaluate cortical components of perceptual and motor processing. The present findings indicate that patients with traumatic brain injury have impairments in both the perceptual interpretation of incoming stimuli and the execution of motor responses and that both abnormalities contribute to psychomotor slowing in patients with traumatic brain injury.	[Lew, Henry L.] VA Boston Healthcare Syst, Phys Med & Rehabil Serv, Boston, MA USA; [Lew, Henry L.] Harvard Univ, Sch Med, Boston, MA USA; [Gray, Max; Poole, John H.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA		Lew, HL (corresponding author), VA Boston Healthcare Syst, Phys Med & Rehabil Serv, 150 S Huntington Ave, Boston, MA USA.				Department of Veterans Affairs, ARCDUS Department of Veterans Affairs [B3262K]	Supported by Department of Veterans Affairs, ARCD Grant B3262K.	Bennington JY, 1999, INT J PSYCHOPHYSIOL, V34, P171, DOI 10.1016/S0167-8760(99)00070-7; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Di Russo F, 2005, J NEUROTRAUM, V22, P297; Gerloff C, 1998, J CLIN NEUROPHYSIOL, V15, P502, DOI 10.1097/00004691-199811000-00009; Incoccia C, 2004, CORTEX, V40, P111, DOI 10.1016/S0010-9452(08)70924-9; JAHANSHAHI M, 2003, BEREITSCHAFT POTENTI; Lew H, 1997, J Am Acad Audiol, V8, P104; Lew HL, 2007, J CLIN NEUROPHYSIOL, V24, P398, DOI 10.1097/WNP.0b013e318150694b; Lew HL, 2006, J HEAD TRAUMA REHAB, V21, P350, DOI 10.1097/00001199-200607000-00006; Lew HL, 2005, J REHABIL RES DEV, V42, P29, DOI 10.1682/JRRD.2004.05.0056; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 1998, J CLIN NEUROPHYSIOL, V15, P14, DOI 10.1097/00004691-199801000-00004; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Viggiano MP, 1996, J CLIN EXP NEUROPSYC, V18, P631, DOI 10.1080/01688639608408288; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1	21	7	7	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JAN	2009	88	1					1	6		10.1097/PHM.0b013e3181911102			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	388NS	WOS:000262027100001	19096287				2022-02-06	
J	Liao, KH; Chang, CK; Chang, HC; Chang, KC; Chen, CF; Chen, TY; Chou, CW; Chung, WY; Chiang, YH; Hong, KS; Hsiao, SH; Hsu, YH; Huang, HL; Huang, SC; Hung, CC; Kung, SS; Kuo, KN; Li, KH; Lin, JW; Lin, TG; Lin, CM; Su, CF; Tsai, MT; Tsai, SH; Wang, YC; Yang, TY; Yu, KF; Chiu, WT				Liao, Kuo-Hsing; Chang, Cheng-Kuei; Chang, Hong-Chang; Chang, Kun-Chuan; Chen, Chieh-Feng; Chen, Tzu-Yung; Chou, Chi-Wen; Chung, Wen-Yu; Chiang, Yung-Hsiao; Hong, Kuo-Sheng; Hsiao, Sheng-Huang; Hsu, Yu-Hone; Huang, Hsu-Lin; Huang, Sheng-Chien; Hung, Ching-Chang; Kung, Sui-Sum; Kuo, Ken N.; Li, Kun-Hsing; Lin, Jia-Wei; Lin, Tzu-Gan; Lin, Chien-Min; Su, Chuan-Fa; Tsai, Ming-Ta; Tsai, Shin-Han; Wang, Yu-Chih; Yang, Ta-Yu; Yu, Kuo-Fan; Chiu, Wen-Ta			Clinical practice guidelines in severe traumatic brain injury in Taiwan	SURGICAL NEUROLOGY			English	Article						Evidence-based; Guidelines; Management; Severe; Taiwan; Traumatic brain injury; Clinical practice guidelines	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; RAISED INTRACRANIAL-PRESSURE; BLOOD-FLOW; DECOMPRESSIVE CRANIECTOMY; HYPERTONIC SALINE; NEUROLOGIC STATUS; MANAGEMENT; SEDATION; HYPERTENSION	Background: Severe TBIs are major causes of disability and death in accidents. The Brain Trauma Foundation supported the first edition of the Guidelines for the Management of Severe Traumatic Brain Injury in 1995 and revised it in 2000. The recommendations in these guidelines are well accepted in the world. There are still some different views on trauma mechanisms, pathogenesis, and managements in different areas. Individualized guidelines for different countries would be necessary, and Taiwan is no exception. Methods: In November 2005, we organized the severe TBI guidelines committee and selected 9 topics, including ER treatment, ICP monitoring, CPP, fluid therapy, use of sedatives, nutrition, intracranial hypertension, seizure prophylaxis, and second-tier therapy. We have since searched key questions in these topics on Medline. References are classified into 8 levels of evidence: 1++, 1+, 1-, 2++, 2+, 2, 3, and 4 based on the criteria of the SIGN. Results: Recommendations are formed and graded as A, B, C, and D. Grade A means that at least one piece of evidence is rated as 1++, whereas grade B means inclusion of studies rated as 2++. Grade C means inclusion of references rated as 2+, and grade D means levels of evidence rated as 3 or 4. Overall, 42 recommendations are formed. Three of these are rated as grade A, 13 as grade B, 21 as grade C, and 5 as grade D. Conclusions: We have completed the first evidence-based, clinical practice guidelines for severe TBIs. It is hoped that the guidelines will provide concepts and recommendations to promote the quality of care for severe TBIs in Taiwan. (C) 2009 Published by Elsevier Inc.	[Chen, Chieh-Feng; Chiang, Yung-Hsiao; Chiu, Wen-Ta] Taipei Med Univ, Sch Med, Off President, Taipei 110, Taiwan; [Liao, Kuo-Hsing; Hong, Kuo-Sheng; Lin, Jia-Wei; Lin, Chien-Min; Tsai, Shin-Han; Chiu, Wen-Ta] Taipei Med Univ, Wan Fang Med Ctr, Dept Neurosurg, Taipei 116, Taiwan; [Chang, Cheng-Kuei] Mackay Mem Hosp, Dept Neurosurg, Taipei 104, Taiwan; [Chang, Hong-Chang] Mackay Mem Hosp, Taitung Branch, Dept Surg, Taitung Cty 950, Taiwan; [Chang, Kun-Chuan] Cathay Gen Hosp, Dept Neurosurg, Taipei 106, Taiwan; [Chen, Chieh-Feng] Taipei Med Univ, Wan Fang Med Ctr, Evidence Based Med Ctr, Taipei 116, Taiwan; [Chen, Tzu-Yung] Chang Gung Mem Hosp, Dept Neurosurg, Chilung 204, Taiwan; [Chou, Chi-Wen] Changhua Christian Hosp, Dept Neurosurg, Changhua 500, Taiwan; [Chung, Wen-Yu] Taipei Vet Gen Hosp, Dept Neurosurg, Neurol Inst, Taipei 112, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei 110, Taiwan; [Hsiao, Sheng-Huang] Taipei City Hosp, Dept Neurosurg, Taipei 106, Taiwan; [Hsu, Yu-Hone] Far Eastern Hosp, Dept Neurosurg, Taipei Cty 220, Taiwan; [Huang, Hsu-Lin; Li, Kun-Hsing] Chung Ho Mem Hosp, Dept Neurosurg, Kaohsiung 807, Taiwan; [Huang, Sheng-Chien] Natl Taiwan Univ Hosp, Dept Neurosurg, Taipei 100, Taiwan; [Hung, Ching-Chang] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Kung, Sui-Sum] Yuans Gen Hosp, Dept Neurosurg, Kaohsiung 802, Taiwan; [Kuo, Ken N.] Natl Hlth Res Inst, Ctr Hlth Policy Res & Dev, Taipei 115, Taiwan; [Lin, Tzu-Gan] Chang Gung Mem Hosp, Dept Neurosurg, Linkou 333, Taiwan; [Su, Chuan-Fa] Buddhist Tzu Chi Gen Hosp, Dept Neurosurg, Hualien 970, Taiwan; [Tsai, Ming-Ta] Shin Kong Wu Ho Mem Hosp, Dept Neurosurg, Taipei 111, Taiwan; [Chiang, Yung-Hsiao; Hong, Kuo-Sheng; Lin, Jia-Wei; Lin, Chien-Min; Tsai, Shin-Han; Chiu, Wen-Ta] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei Cty 235, Taiwan; [Wang, Yu-Chih] Chung Shan Med Univ Hosp, Dept Neurosurg, Taichung 402, Taiwan; [Yang, Ta-Yu] Chang Bing Show Chwan Mem Hosp, Changhua Cty 505, Taiwan; [Yu, Kuo-Fan] Chi Mei Hosp, Dept Neurosurg, Liuying 736, Taiwan; [Tsai, Shin-Han] Taipei Med Univ, Inst Injury Prevent & Control, Taipei 110, Taiwan		Chiu, WT (corresponding author), Taipei Med Univ, Sch Med, Off President, Taipei 110, Taiwan.	wtchiu@tmu.edu.tw	Kuo, Ken-Nan/E-3845-2010	Chen, Chiehfeng/0000-0002-1595-6553; Hsu, Yu-Hone/0000-0002-1296-6334	Department of Health, Executive Yuan, Taiwan [DOH-TD-B-111-002]; National Health Research Institute, TaiwanNational Health Research Institutes - Taiwan [NHRI-EX98-9707PI, NHRI-CN-HD9503S]; National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 96-2314-B-038-010-MY2]	The formation and supplementation of Taiwan's guidelines were supported by grant DOH-TD-B-111-002 from the Department of Health, Executive Yuan, Taiwan; grant NHRI-EX98-9707PI, NHRI-CN-HD9503S from the National Health Research Institute, Taiwan; and grant NSC 96-2314-B-038-010-MY2 from National Science Council, Taiwan. The quality of this guidelines was assessed with AGREE instrument. The instrument is adapted from the original AGREE instrument (http://www.agreetrustorg/). For more information about the ongoing research with the AGREE instrument, please visit the AGREE Research Trust Web site (http://www.agreetrust.org/projects.htm).	Adelt S, 2003, BIOORG CHEM, V31, P44, DOI 10.1016/S0045-2068(02)00523-0; AITKENHEAD AR, 1989, BRIT J ANAESTH, V63, P196, DOI 10.1093/bja/63.2.196; American College of Surgeons Committee on Trauma, 2004, ADV TRAUM LIF SUPP C; [Anonymous], 2006, ANESTHESIOLOGY, V105, P198; BOUMA GJ, 1995, NEW HORIZ, V3, P581; Brain Trauma Foundation The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P527; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; BRUDER N, 1997, CRIT CARE MED, V25, P1378; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1995, GUIDELINES MANAGEMEN; CHAMBERS IR, 1990, NEUROSURGERY, V26, P421, DOI 10.1227/00006123-199003000-00007; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Chesnut R M, 1995, New Horiz, V3, P581; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiu WT, 2006, SURG NEUROL, V66, pS37, DOI 10.1016/j.surneu.2006.08.028; Chiu WT, 2003, J TRAUMA, V55, P391, DOI 10.1097/01.TA.0000079368.15678.6D; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; CLIFTON GL, 1985, J NEUROSURG, V62, P186, DOI 10.3171/jns.1985.62.2.0186; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; De Deyne C, 1996, Eur J Emerg Med, V3, P69, DOI 10.1097/00063110-199606000-00002; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Edwards P, 2005, LANCET, V365, P1957; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Karabinis A, 2004, CRIT CARE, V8, pR268, DOI 10.1186/cc2896; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kramer GC, 2003, J TRAUMA, V54, pS89, DOI 10.1097/01.TA.0000065609.82142.F1; LANIER WL, 1987, ANESTHESIOLOGY, V66, P39, DOI 10.1097/00000542-198701000-00008; Lee H. L., 1994, Tropical Biomedicine, V11, P31; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marion D W, 1995, New Horiz, V3, P439; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; Marion DW, 1997, CONT NEUROSURG, V19, P1; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; McGraw CP, 1989, INTRACRANIAL PRESSUR, P839; McKeage K, 2003, CNS DRUGS, V17, P235, DOI 10.2165/00023210-200317040-00003; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MIRSKI MA, 1995, CRIT CARE MED, V23, P2038, DOI 10.1097/00003246-199512000-00013; MORSE ML, 1985, CRIT CARE MED, V13, P563, DOI 10.1097/00003246-198507000-00011; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; OTT LG, 1988, DRUG INTEL CLIN PHAR, V22, P763, DOI 10.1177/106002808802201004; Polin RS, 2003, CRIT CARE, V7, P409, DOI 10.1186/cc2370; Procaccio F, 2000, J Neurosurg Sci, V44, P1; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; RAPP RP, 1985, J NEUROSURG, V63, P714; Reithmeier T, 2005, CHILD NERV SYST, V21, P249, DOI 10.1007/s00381-004-1044-x; Robertson C S, 1995, New Horiz, V3, P410; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schierhout G., 2000, COCHRANE DB SYST REV; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; *SCOTT INT GUID NE, 2008, SIGN 50 GUID DEV HDB, P34; Servadei F, 2002, ACT NEUR S, V81, P81; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; [The American Association of Neurological Surgeons The Brain Trauma Foundation], 2000, J NEUROTRAUM, V17, P463; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P493; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231; YOUNG B, 1987, J NEUROSURG, V67, P76, DOI 10.3171/jns.1987.67.1.0076; Young C, 2000, CRIT CARE MED, V28, P854, DOI 10.1097/00003246-200003000-00041; Zornow M H, 1995, New Horiz, V3, P488; ZORNOW MH, 1988, ANESTHESIOLOGY, V69, P180, DOI 10.1097/00000542-198808000-00005	84	7	8	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0090-3019			SURG NEUROL	Surg. Neurol.		2009	72			2			66	74		10.1016/j.surneu.2009.07.004			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	616UA	WOS:000279234100010	19818476				2022-02-06	
J	Lytle, IF; Chung, KC				Lytle, Ian F.; Chung, Kevin C.			Prevention of Recurrent Radioulnar Heterotopic Ossification by Combined Indomethacin and a Dermal/Silicone Sheet Implant: Case Report	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Heterotopic ossification; distal radius; silicone sheet; Integra; dermal substitute	TRAUMATIC BRAIN-INJURY; TOTAL HIP-REPLACEMENT; RADIATION-THERAPY; OPERATIVE TREATMENT; SURGICAL-TREATMENT; ULNAR SYNOSTOSIS; BONE-FORMATION; ELBOW; IRRADIATION; FRACTURES	A 27-year-old, right-handed man developed severe radioulnar synostosis at the distal radius 7 months after open reduction and internal fixation of his distal radius fracture. Heterotopic ossification formed at the radius fracture site, requiring excision of the heterotopic bone and plate removal. A bilayer, dermal substitute and silicone sheet was placed between the radius and ulna in the interosseous space to prevent recurrence of the heterotopic ossification. After surgery, the patient was treated with indomethacin 25 mg orally 3 times daily for 6 weeks. At I year after surgery, he has retained full pronation and near normal supination, Radiographs demonstrate no new heterotopic bone formation. (J Hand Surg 2009;34A:49-53. Copyright (C) 2009 by the American Society for Surgery of the Hand. All rights reserved.)	[Lytle, Ian F.; Chung, Kevin C.] Univ Michigan Hlth Syst, Sect Plast Surg, Dept Surg, Ann Arbor, MI 48109 USA		Chung, KC (corresponding author), Univ Michigan Hlth Syst, Sect Plast Surg, Dept Surg, 2130 Taubman Ctr,SPC 5340,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	kecchung@umich.edu		Chung, Kevin/0000-0002-2822-3164	National Institute of Arthritis and Musculoskeletal and Win DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [K24 AR053120]; Integra Corporation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [K24AR053120] Funding Source: NIH RePORTER	Supported in part by a Midcareer Investigator Award in Patient-Oriented Research (K24 AR053120) from the National Institute of Arthritis and Musculoskeletal and Win Diseases (to Dr. Kevin C (hung). Dr. Chung has received a grant from the Integra Corporation to study wrist arthroplasty procedures.	BREIT R, 1983, CLIN ORTHOP RELAT R, V174, P149; CITTAPIETROLUNGO TJ, 1992, ARCH PHYS MED REHAB, V73, P258; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; FAILLA JM, 1989, J BONE JOINT SURG AM, V71A, P1208, DOI 10.2106/00004623-198971080-00014; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P38; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Henry M, 2004, ANN PLAS SURG, V53, P506, DOI 10.1097/01.sap.0000120296.75440.ed; Ilahi OA, 1998, ORTHOPEDICS, V21, P265; Ippolito E, 1999, J BONE JOINT SURG AM, V81A, P783, DOI 10.2106/00004623-199906000-00005; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Jang SH, 2000, YONSEI MED J, V41, P536, DOI 10.3349/ymj.2000.41.4.536; Jupiter JB, 1998, J BONE JOINT SURG AM, V80A, P248, DOI 10.2106/00004623-199802000-00012; Knelles D, 1997, J BONE JOINT SURG BR, V79B, P596, DOI 10.1302/0301-620X.79B4.6829; MOED BR, 1994, J ORTHOP TRAUMA, V8, P34, DOI 10.1097/00005131-199402000-00008; Moore KD, 1998, J BONE JOINT SURG BR, V80B, P259, DOI 10.1302/0301-620X.80B2.8157; PELLEGRINI VD, 1992, J BONE JOINT SURG AM, V74A, P186, DOI 10.2106/00004623-199274020-00005; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; SPJUT HJ, 1981, AM J SURG PATHOL, V5, P423, DOI 10.1097/00000478-198107000-00002; URIST MR, 1978, ARCH PATHOL LAB MED, V102, P312; Vielpeau C, 1999, CLIN ORTHOP RELAT R, P279; VINCE KG, 1987, J BONE JOINT SURG AM, V69A, P640, DOI 10.2106/00004623-198769050-00002; YONGHING K, 1983, J BONE JOINT SURG BR, V65, P433, DOI 10.1302/0301-620X.65B4.6874714	22	7	7	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	JAN	2009	34A	1					49	53		10.1016/j.jhsa.2008.09.008			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	397SJ	WOS:000262682100009	19121730				2022-02-06	
J	Seeley, HM; Kirker, S; Harkin, C; Dias, C; Richards, H; Pickard, JD; Hutchinson, PJ				Seeley, H. M.; Kirker, S.; Harkin, C.; Dias, C.; Richards, H.; Pickard, J. D.; Hutchinson, P. J.			Head injury rehabilitation: the role of a neurotrauma clinic	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Head injury; neurorehabilitation; outcome; service provision	TRAUMATIC BRAIN-INJURY; YOUNG-PEOPLE; DISABILITY; RETURN; WORK; ADULTS	Survivors of head injury are often left with varying degrees of disability and complex and varied needs, necessitating prolonged periods of rehabilitation and continuing care. Advances have been made in the acute management of these patients, but continuing management in terms of rehabilitation remains deficient with lack of specialist resources and a fragmented service. For head-injured patients, lack of access to appropriate ongoing rehabilitation may have profound effects on outcome and social re-integration. There are also considerable economic implications for planning and provision of services. The aims of this paper are to describe, review and evaluate the role of a Neurotrauma clinic within the Head Injury Service at Addenbrooke's Hospital, Cambridge. The multidisciplinary Neurotrauma clinic commenced in June 2003 following an extensive collaborative research programme to assess current regional head injury service provision and address deficiencies and management issues. Patients of all ages with ongoing problems following varying severity of head injury are followed up at 2 months+post-injury for as long as appropriate. Patients complete an SF-36 and GOSE questionnaire at each clinic appointment and this self-reported data is complemented by neuropsychological assessments, and demographic data entered on a database. The clinic acts as a 'gateway' to access appropriate ongoing rehabilitation and a source of information and support. The routine collection of outcome data enables tracking of individual patient progress and outcome and provides an information resource for further research. The findings highlight deficiencies in rehabilitation both in general service provision and specific patient need. Evidence in support of demand, need and effectiveness of rehabilitation for head injury is particularly relevant within the limited resources of the NHS. Early indications show that a specialist clinic can assist in providing continuity of patient care, in improving coordination of services, and act as a resource for further research on epidemiology, outcome and impact of rehabilitation.	[Seeley, H. M.; Harkin, C.; Richards, H.; Pickard, J. D.; Hutchinson, P. J.] Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 0QQ, England; [Kirker, S.] Addenbrookes Hosp, Dept Rehabil Med, Cambridge CB2 0QQ, England; [Dias, C.] Headway Cambridge, Cambridge, England		Seeley, HM (corresponding author), Addenbrookes Hosp, Dept Neurosurg, Box 167,Hills Rd, Cambridge CB2 0QQ, England.	hms35@medschl.cam.ac.uk		Hutchinson, Peter/0000-0002-2796-1835	Academy of Medical Science/Health Foundation; The Oliver Zangwill Centre; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G0600986, G9439390, G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0001237, G0601025, G0600986] Funding Source: UKRI	PJH is supported by an Academy of Medical Science/Health Foundation Senior Surgical Scientist Fellowship. Collaborations with NCCU (Professor Menon), Headway (A. Gardner) and The Oliver Zangwill Centre (A. Bateman).	[Anonymous], 1956, REPORT COMMITTEE ENQ; BRADLEY L, 2006, BRIT J NEUROSURG, V20, P271; *BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Department of Health, 2005, NAT SERV FRAM LONGT; Desouza M, 2007, DISABIL REHABIL, V29, P671, DOI 10.1080/09638280600926538; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Fleminger S, 2006, J NEUROL NEUROSUR PS, V77, P1105, DOI 10.1136/jnnp.2006.099697; *HOUS COMM HLTH CO, 2000, P COMM EV APP, P307; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; *NAT FUND RES CRIP, 1976, INT DIS; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Pickard JD, 2004, J ROY SOC MED, V97, P384, DOI 10.1258/jrsm.97.8.384; Pransky G, 2005, J OCCUP REHABIL, V15, P453, DOI 10.1007/s10926-005-8027-y; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roy CW, 2002, BRAIN INJURY, V16, P1057, DOI 10.1080/02699050210154231; *ROYAL COLL SURG, 1999, REP WORK PART MAN HE; *ROYAL COLL SURG B, 2003, REH FOLL ACQ BRAIN I; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Seeley HM, 2006, BRIT J NEUROSURG, V20, P9, DOI 10.1080/02688690600601218; Seeley HM, 2001, EMERG MED J, V18, P358, DOI 10.1136/emj.18.5.358; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Tennant A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-21; TENNANT A, 1995, TRAUMATIC BRAIN INJU; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; ZHUN X, 2007, BRAIN INJURY, V21, P681; 1945, REPORT INTERDEPARTME; 1972, REPORT SUBCOMMITTEE	35	7	7	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2009	23	5					530	537	PII 915243410	10.1080/02688690903078874			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	498JX	WOS:000270137100010	19863400				2022-02-06	
J	Tavano, A; Galbiati, S; Recla, M; Formica, F; Giordano, F; Genitori, L; Strazzer, S				Tavano, Alessandro; Galbiati, Susanna; Recla, Monica; Formica, Francesca; Giordano, Flavio; Genitori, Lorenzo; Strazzer, Sandra			Language and cognition in a bilingual child after traumatic brain injury in infancy: Long-term plasticity and vulnerability	BRAIN INJURY			English	Article						Bilingual aphasia; neuroplasticity; traumatic brain injury; recovery	HEAD-INJURY; LESIONS; REORGANIZATION; DEFICITS; MEMORY	Primary objective: This study aimed at investigating the long-term effects of the combination of severity of injury and time of injury in a 6-year-old bilingual Arabic-Italian child who sustained a severe left traumatic brain injury at the age of 7 months. Methods and procedures: Standard neurological, cognitive and neuropsychological assessments were administered at 40 days after surgery and again at 18, 31, 62 and 73 months. Main outcomes and results: The child presented with developmental arrest at 18 and 31 months. Later on, right hemiparetic and oculomotor signs gradually improved to a significant extent, as well as dysexecutive, visuospatial and praxic deficits. At present, persistent language disorders in a fluent speech characterize the child's profile to a similar extent and type in both languages, suggesting common underlying learning strategies which are ineffective for procedurally acquiring language. Conclusions: This case confirms that children who sustain severe left hemisphere traumatic brain injury in infancy present with increased vulnerability to linguistic deficits. Left frontotemporal, cortical-subcortical lesions which occur during very early language development may permanently disrupt the procedural language acquisition network required for first language acquisition.	[Tavano, Alessandro] Sci Inst E Medea, Neurolinguist Unit, I-33037 Pasian Di Prato, UD, Italy; [Galbiati, Susanna; Recla, Monica; Formica, Francesca; Strazzer, Sandra] Sci Inst E Medea, Dept Neurorehabil 3, Bosisio Parini, LC, Italy; [Giordano, Flavio; Genitori, Lorenzo] Anna Meyer Pediat Hosp, Florence, Italy		Tavano, A (corresponding author), Sci Inst E Medea, Neurolinguist Unit, Via Cialdini 29, I-33037 Pasian Di Prato, UD, Italy.	alessandro.tavano@pp.Lnf.it	Galbiati, Susanna/AAH-6883-2019; Strazzer, Sandra/AAH-5712-2019; formica, francesca/AAA-6043-2020; Genitori, Lorenzo/K-9682-2016; Recla, Monica/ABG-1905-2020; Tavano, Alessandro/J-4201-2012	Galbiati, Susanna/0000-0001-7209-4251; Strazzer, Sandra/0000-0001-8414-6565; Recla, Monica/0000-0002-3001-8872; Tavano, Alessandro/0000-0002-2096-5542; formica, francesca/0000-0002-4423-8200; Genitori, Lorenzo/0000-0002-4359-0798	Ministry of Health (Scientific Institute 'E. Medea') [2008 3: 06]	The authors wish to thank Dr Chiara Gagliardi for important hints on the relevance of the 'crowding hypothesis' to early TBI. This work has been supported by a grant from the Ministry of Health (2008 3: 06, Scientific Institute 'E. Medea') awarded to Alessandro Tavano as Principal Investigator.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Chilosi AM, 2008, BRAIN LANG, V106, P211, DOI 10.1016/j.bandl.2007.12.010; Chilosi AM, 2001, J CHILD NEUROL, V16, P309, DOI 10.1177/088307380101600502; Cianchetti C, 1997, TEST VALUTAZIONE LIN; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Griffiths R, 1996, GRIFFITHS MENTAL DEV; Kolk A, 2000, J CHILD NEUROL, V15, P581, DOI 10.1177/088307380001500903; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Lidzba K, 2006, NEUROPSYCHOLOGIA, V44, P1088, DOI 10.1016/j.neuropsychologia.2005.10.022; Liscio M, 2008, DISABIL REHABIL, V30, P275, DOI 10.1080/09638280701257023; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Peru A, 2003, NEUROPSYCHOLOGIA, V41, P634, DOI 10.1016/S0028-3932(02)00203-8; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Vicari S, 2000, CORTEX, V36, P31, DOI 10.1016/S0010-9452(08)70834-7; Wechsler D, 1996, WECHSLER PRESCHOOL P; [No title captured]	21	7	7	1	23	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	2					167	171	PII 908447280	10.1080/02699050802657012			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	403LD	WOS:000263083200011	19191096				2022-02-06	
J	Wilgus, J; Wilgus, B				Wilgus, Jack; Wilgus, Beverly			Face to Face with Phineas Gage	JOURNAL OF THE HISTORY OF THE NEUROSCIENCES			English	Article						Phineas Gage; history; daguerreotype; traumatic brain injury; tamping iron	GAGE,PHINEAS	We present here a reproduction of a daguerreotype of Phineas Gage that came into our possession more than 30 years ago. It is, as far as we know, the only image of this famous patient. We describe how we identified the subject in the image, describe how daguerreotypes are made and set out our comparisons of the image with the Phineas Gage life mask and tamping iron held in the Warren Anatomical Museum, Francis A. Countway Library of Medicine.				phineasgage@brightbytes.com					BIGELOW HJ, 1850, AM J MED SCI, V20, P12; Damasio A., 1994, DESCARTES ERROR EMOT; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; FLEISCHMAN JOHN, 2002, PHINEAS GAGE GRUESOM; Harlow J.M., 1993, PUBLICATIONS MASSACH, V4, P274, DOI [DOI 10.1177/0957154X9300401407, https://doi.org/10.1177/0957154X9300401407]; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Holmes Oliver Wendell, 1864, SOUNDINGS ATLANTIC; Kotowicz Z, 2007, HIST HUM SCI, V20, P115, DOI 10.1177/0952695106075178; Macmillan M, 2000, ODD KIND FAME STORIE; Macmillan M, 2008, PSYCHOLOGIST, V21, P828; Newhall Beaumont, 1968, DAGUERREOTYPE AM; Ratiu PF, 2004, NEW ENGL J MED, V351, pE21, DOI 10.1056/NEJMicm031024	12	7	7	4	24	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0964-704X	1744-5213		J HIST NEUROSCI	J. Hist. Neurosci.		2009	18	3					340	345		10.1080/09647040903018402			6	History & Philosophy Of Science; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	History & Philosophy of Science; Neurosciences & Neurology	481MK	WOS:000268815400013	20183215				2022-02-06	
J	Bektas, F; Eken, C; Soyuncu, S; Kilicaslan, I; Cete, Y				Bektas, Firat; Eken, Cenker; Soyuncu, Secigin; Kilicaslan, Isa; Cete, Yidiray			Artificial neural network in predicting craniocervical junction injury: an alternative approach to trauma patients	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						artificial neural network; craniocervical junction injury; trauma	CERVICAL-SPINE; HEAD; FRACTURES	Objective The aim of this study is to determine the efficiency of artificial intelligence in detecting craniocervical junction injuries by using an artificial neural network (ANN) that may be applicable in future studies of different traumatic injuries. Materials and methods Major head trauma patients with Glasgow Coma Scale <= 8 of all age groups who presented to the Emergency Department were included in the study. All patients underwent brain computerized tomography (CT), craniocervical junction CT, and cervical plain radiography. A feedforward with back propagation ANN and a stepwise forward logistic regression were performed to test the performances of all models. Results A total of 127 patients fulfilling inclusion criteria were included in the study. The mean age of the study patients was 31 +/- 17.7, 77.2% (n=98) of them were male, 13.4% of the patients (n=17) had craniocervical junction pathologies. About 64.7% (n = 11) of these pathologies were detected only by CT; 23.5% (n=4) of them by both craniocervical CT and cervical plain radiography; and 11.8% (n = 2) of them only by cervical plain radiography. A logistic regression model had a sensitivity of 11.8% and specificity of 99.1%. Positive predictive value was 66.7% and negative predictive value was 87.9%. Area under the curve for logistic regression model was 0.794 (P=0.000). ANN had a sensitivity of 82.4% and specificity of 100%. Positive predictive value was 100% and negative predictive value was 97.3%. Area under the curve for ANN model was 0.912 (p= 0.000). Conclusion ANN as an artificial intelligence application seems appropriate for detecting and excluding craniocervical junction injury but it should not replace craniocervical junction CT However, these findings should lead us to test the applicability of ANN on hard-to-diagnose trauma patients or in constructing clinical decision rules. European Journal of Emergency Medicine 15:318-323 (C) 2008 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Bektas, Firat; Eken, Cenker; Soyuncu, Secigin; Kilicaslan, Isa; Cete, Yidiray] Akdeniz Univ, Sch Med, Dept Emergency Med, TR-07059 Antalya, Turkey		Eken, C (corresponding author), Akdeniz Univ, Sch Med, Dept Emergency Med, TR-07059 Antalya, Turkey.	cenkereken@akdeniz.edu.tr	Cete, Yildiray/C-3037-2016; Kilicaslan, Isa/AAG-9330-2020; Soyuncu, Secgin/C-1761-2016; Eken, Cenker/C-1821-2016; Kilicaslan, Isa/AAJ-7469-2020; Bektas, Firat Ahmet/C-1686-2016	Kilicaslan, Isa/0000-0002-0330-2595; Soyuncu, Secgin/0000-0002-5666-9550; Eken, Cenker/0000-0002-2743-5608; Kilicaslan, Isa/0000-0002-0330-2595; Bektas, Firat Ahmet/0000-0002-0885-8509	Akdeniz University HospitalAkdeniz University; Akdeniz University Research FoundationAkdeniz University	The authors thank Dr Stephan Rinnert for editing the syntax of the article and the residents and attending physicians in the ED at Akdeniz University Hospital. This study was supported by the Akdeniz University Research Foundation.	ACHESON MB, 1987, AM J ROENTGENOL, V148, P1179, DOI 10.2214/ajr.148.6.1179; BAYLESS P, 1989, AM J EMERG MED, V7, P139, DOI 10.1016/0735-6757(89)90125-3; GERRELTS BD, 1991, J TRAUMA, V31, P1622, DOI 10.1097/00005373-199112000-00010; HARIS JH, 1987, RADIOLOGY ACUTE SERV; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Hoffman JR, 2001, NEW ENGL J MED, V344, P464; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Keats T E, 2000, Radiology, V215 Suppl, P243; KIRSHENBAUM K J, 1990, Journal of Emergency Medicine, V8, P183, DOI 10.1016/0736-4679(90)90230-S; LINK TM, 1995, RADIOLOGY, V196, P741, DOI 10.1148/radiology.196.3.7644638; MARION D, 2000, DETERMINATION CERVIC; MILLER MD, 1978, AM J ROENTGENOL, V130, P659, DOI 10.2214/ajr.130.4.659; NEIFELD G L, 1988, Journal of Emergency Medicine, V6, P203, DOI 10.1016/0736-4679(88)90327-7; Nunez DB, 1994, EMERG RADIOL, V1, P273, DOI [10.1007/ BF02614949, DOI 10.1007/BF02614949]; Pasquale M, 1998, J TRAUMA, V44, P941, DOI 10.1097/00005373-199806000-00001; PECH P, 1985, RADIOLOGY, V157, P117, DOI 10.1148/radiology.157.1.4034955; Pitts W., 1943, B MATH BIOPHYS, V5, P115, DOI DOI 10.1007/BF02478259; REID DC, 1987, J TRAUMA, V27, P980, DOI 10.1097/00005373-198709000-00005; Roberts FR, 1979, TOP EMERG MED, V1, P63; ROCKSWOLD GL, 1981, MINN MED, V64, P81; Schenarts PJ, 2001, J TRAUMA, V51, P663, DOI 10.1097/00005373-200110000-00007; SCHLEEHAUF K, 1989, ANN EMERG MED, V18, P815, DOI 10.1016/S0196-0644(89)80202-1; STIETWIESER DR, 1983, ANN EMERG MED, V12, P538; VANDEMARK RM, 1990, AM J ROENTGENOL, V155, P465, DOI 10.2214/ajr.155.3.2117342; WILLIAMS J, 1992, ANN EMERG MED, V21, P719, DOI 10.1016/S0196-0644(05)82786-6	26	7	7	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	DEC	2008	15	6					318	323		10.1097/MEJ.0b013e3282fce7af			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	379LV	WOS:000261398600003	19078833				2022-02-06	
J	Bhandari, PS; Sadhotra, LP; Bhargava, P; Bath, AS; Mukherjee, MK; Bhatti, TS; Maurya, S				Bhandari, P. S.; Sadhotra, L. P.; Bhargava, P.; Bath, A. S.; Mukherjee, M. K.; Bhatti, T. S.; Maurya, S.			Multiple nerve transfers for the reanimation of shoulder and elbow functions in irreparable C5, C6 and upper truncal lesions of the brachial plexus	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						brachial plexus injury; C5-C6 injuries; upper truncal lesions; nerve transfers		In irreparable C5, C6 spinal nerve and upper truncal injuries the proximal root stumps are not available for grafting, hence repair is based on nerve transfer or neurotization. Between Feb 2004 and May 2006, 23 patients with irreparable C5, C6 or upper truncal injuries of the Brachial Plexus underwent multiple nerve transfers to restore the shoulder and elbow functions. Most of them (16 patients) sustained injury following motor cycle accidents. The average denervation period was 5.3 months. Shoulder function was restored by transfer of distal part of spinal accessory nerve to suprascapular nerve, and transfer of radial nerve branch to long head of triceps to the anterior branch of axillary nerve. Elbow function was restored by transfers of ulnar and median nerve fascicles to the biceps and brachialis motor branches of musculocutaneous nerve. All patients recovered shoulder abduction and external rotation; 7 scored M4 and 16 scored M3. Range of abduction averaged 123 degrees(range, 80 degrees-170 degrees). Full elbow flexion was restored in all 23 patients; 15 scored M4 and 8 scored M3. Patients with excellent results could lift 5 kgs of weight. Selective nerve transfers close to the target muscle provide an early and good return of functions. There is negligible morbidity in donor nerves. These intraplexal transfers are suitable in all cases of upper brachial plexus injuries.	[Bhandari, P. S.; Sadhotra, L. P.; Bhargava, P.; Bath, A. S.; Mukherjee, M. K.; Bhatti, T. S.; Maurya, S.] Armed Forces Med Coll & Command Hosp SC, Dept Plast & Reconstruct Surg, Pune 40, Maharashtra, India		Bhandari, PS (corresponding author), Command Hosp SC, Reconstruct Surg, Pune 411040, Maharashtra, India.	doctorbhandari@hotmail.com					ALLIEU Y, 1988, CLIN ORTHOP RELAT R, P67; ALNOT JY, 1995, HAND CLIN, V11, P623; Alnot JY, 1998, REV CHIR ORTHOP, V84, P113; Bertelli JA, 2004, J HAND SURG-AM, V29A, P131, DOI 10.1016/j.jhsa.2003.10.013; BRANDT KE, 1993, J HAND SURG-AM, V18A, P726, DOI 10.1016/0363-5023(93)90328-Z; CHUANG DC, 1992, J HAND SURG-AM, V17A, P822, DOI 10.1016/0363-5023(92)90451-T; CHUANG DCC, 1995, PLAST RECONSTR SURG, V96, P122, DOI 10.1097/00006534-199507000-00019; DAI SY, 1990, J HAND SURG-AM, V15A, P36, DOI 10.1016/S0363-5023(09)91102-9; El-Gammal TA, 2002, J RECONSTR MICROSURG, V18, P7, DOI 10.1055/s-2002-19703; Gu YD, 1996, CLIN ORTHOP RELAT R, P119; GU YD, 1989, MICROSURG, V10, P287; Gu YD, 1989, CHIN HAND SURG, V5, P1; Hallock G G., 1998, ANN PLAST SURG, V30, P359; KAWAI H, 1988, CLIN ORTHOP RELAT R, P75; KRAKAUER JD, 1994, J HAND SURG-AM, V19A, P829, DOI 10.1016/0363-5023(94)90196-1; Leechavengvongs S, 2006, J HAND SURG-AM, V31A, P183, DOI 10.1016/j.jhsa.2005.09.019; Leechavengvongs S, 2003, J HAND SURG-AM, V28A, P633, DOI 10.1016/S0363-5023(03)00199-0; Leechavengvongs S, 1998, J HAND SURG-AM, V23A, P711, DOI 10.1016/S0363-5023(98)80059-2; Leffert RD., 1985, BRACHIAL PLEXUS INJU, P189; Lim AYT, 2001, PLAST RECONSTR SURG, V107, P1746, DOI 10.1097/00006534-200106000-00016; Liverneaux PA, 2006, PLAST RECONSTR SURG, V117, P915, DOI 10.1097/01.prs.0000200628.15546.06; LURJE A, 1948, ANN SURG, V127, P317, DOI 10.1097/00000658-194802000-00009; Mackinnon SE, 2005, J HAND SURG-AM, V30A, P978, DOI 10.1016/j.jhsa.2005.05.014; Merrell GA, 2001, J HAND SURG-AM, V26A, P303, DOI 10.1053/jhsu.2001.21518; MINAMI M, 1987, J HAND SURG-AM, V12A, P1114, DOI 10.1016/S0363-5023(87)80128-4; NAGANO A, 1989, J HAND SURG-AM, V14A, P980, DOI 10.1016/S0363-5023(89)80047-4; NARAKAS A, 1978, CLIN ORTHOP RELAT R, P71; Narakas A., 1987, MICRORECONSTRUCTION, P447; NARAKAS AO, 1988, CLIN ORTHOP RELAT R, P43; OBERLIN C, 1994, J HAND SURG-AM, V19A, P232, DOI 10.1016/0363-5023(94)90011-6; Ogino T, 2001, J HAND SURG-AM, V26, P303; Samardzic M, 2002, NEUROSURGERY, V50, P1277, DOI 10.1097/00006123-200206000-00019; Songcharoen P, 1996, J HAND SURG-AM, V21A, P387, DOI 10.1016/S0363-5023(96)80349-2; Sungpet A, 2000, J HAND SURG-BRIT EUR, V25B, P325, DOI 10.1054/jhsb.2000.0367; Terzis JK, 1999, PLAST RECONSTR SURG, V104, P1221, DOI 10.1097/00006534-199910000-00001; Terzis JK, 2000, PLAST RECONSTR SURG, V106, P1097, DOI 10.1097/00006534-200010000-00022; TRAVILL AA, 1962, ANAT REC, V144, P373, DOI 10.1002/ar.1091440408; Tung TH, 2003, J NEUROSURG, V98, P313, DOI 10.3171/jns.2003.98.2.0313; Tung THH, 2003, CLIN PLAST SURG, V30, P269, DOI 10.1016/S0094-1298(02)00094-9; Waikakul S, 1999, J HAND SURG-AM, V24A, P571; Warnor C W., 1998, CAMPBELLS OPERATIVE, P3971; Witoonchart K, 2003, J HAND SURG-AM, V28A, P628, DOI 10.1016/S0363-5023(03)00200-4; Zhao X, 2001, CLIN ORTHOP RELAT R, P244	43	7	7	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2008	5	2					95	104		10.1016/S0973-0508(08)80008-1			10	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M0P	WOS:000218379000008					2022-02-06	
J	Ivins, BJ; Crowley, JS; Johnson, J; Warden, DL; Schwab, KA				Ivins, Brian J.; Crowley, John S.; Johnson, Jeffrey; Warden, Deborah L.; Schwab, Karen A.			Traumatic Brain Injury Risk While Parachuting: Comparison of the Personnel Armor System for Ground Troops Helmet and the Advanced Combat Helmet	MILITARY MEDICINE			English	Article								Military paratroopers are inherently at risk for a variety of injuries when they jump, including traumatic brain injuries (TBIs). U.S. Army paratroopers rely on their ballistic helmets for protection against TBIs when jumping. Currently, two different helmets are available to Army paratroopers, that is, the personnel armor system for ground troops helmet and the advanced combat helmet. This study compared the incidence of self-reported, jump-related TBIs in a small sample of paratroopers (N = 585) using each type of helmet. Data were obtained from surveys of soldiers at Fort Bragg, North Carolina. The overall relative risk of sustaining a TBI while jumping was 2.3 times (95% confidence interval, 1.3-4.3) higher for personnel armor system for ground troops helmet users. Most of the increase in risk was accounted for by the most-minor TBIs (American Academy of Neurology grade I or 2 concussion).	[Ivins, Brian J.; Warden, Deborah L.; Schwab, Karen A.] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA; [Crowley, John S.] USA, Aeromed Res Lab, Ft Rucker, AL 36362 USA; [Johnson, Jeffrey] Irwin Army Community Hosp, Ft Riley, KS 66442 USA		Ivins, BJ (corresponding author), Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA.						Bar-Dayan Y, 1998, MIL MED, V163, P1; Bricknell MCM, 1999, OCCUP MED-OXFORD, V49, P17, DOI 10.1093/occmed/49.1.17; Craig SC, 1997, MIL MED, V162, P162, DOI 10.1093/milmed/162.3.162; DAVISON DJ, 1990, INJURY, V21, P314, DOI 10.1016/0020-1383(90)90050-5; Ekeland A, 1997, INJURY, V28, P219, DOI 10.1016/S0020-1383(96)00185-4; FARROW GB, 1992, AUST NZ J SURG, V62, P209, DOI 10.1111/j.1445-2197.1992.tb05465.x; Gabbe BJ, 2003, BRIT J SPORT MED, V37, P545, DOI 10.1136/bjsm.37.6.545; HALLEL T, 1975, J TRAUMA, V15, P14; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Ivins BJ, 2007, MIL MED, V172, P586, DOI 10.7205/MILMED.172.6.586; Kahn HA, 1989, STAT METHODS EPIDEMI; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 1997, NEUROLOGY, V48, P581; Kotwal RS, 2004, AVIAT SPACE ENVIR MD, V75, P833; McEntire BJ, 2005, 200512 USAARL; *NAT CTR INJ CONTR, 2003, REP C MILD TRAUM BRA; PASCHEL CR, 1990, EVALUATION HEAD INJU; Sosin DM, 1996, BRAIN INJURY, V10, P47; Steinberg P J, 1988, Br J Sports Med, V22, P25	19	7	7	2	4	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	DEC	2008	173	12					1168	1172		10.7205/MILMED.173.12.1168			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V11ZO	WOS:000207569700007	19149333	Bronze			2022-02-06	
J	Rehman, L; Khattak, A; Naseer, A; Musthaq				Rehman, Lal; Khattak, Azmatullah; Naseer, Aamer; Musthaq			Outcome of Acute Traumatic Extradural Hematoma	JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN			English	Article						Extradural hematoma; Glasgow coma scale; Head injury	EPIDURAL HEMATOMAS; BRAIN-INJURY; HEAD-INJURY; COMPUTED-TOMOGRAPHY; MANAGEMENT; CHILDREN; LESIONS	Objective: To assess the surgical outcome of acute extradural hematoma in terms of neurological recovery and survival. Study Design: Case series. Place and Duration of Study: Postgraduate Medical Institute, Neurosurgery Unit, Hayatabad Medical Complex, Peshawar, from January to October 2006. Methodology: All patients admitted and operated for acute traumatic extradural hematoma during the study period were included. Demographic data, history, mode of trauma, examination findings, investigations and outcome were recorded. Glasgow coma scale was used for initial assessment and Glasgow outcome scale was applied to assess outcome in terms of neurological recovery in all patients. The follow-up period was 3 months. Results: A total of 30 patients were operated during the period of 10 months including 22 males and 8 females. Patients were in the age range of 20-30 years comprised 30% of all. Most common causes were road traffic accident (50%), fall from height (33%) and assault (17%). Patients were divided according to the initial Glasgow Coma Score (GCS) after resuscitation. The GCS was 3-8 in 6 patients, 9-12 in 7 patients, 13-15 in 17 patients. Twenty-four patients had good outcome, one patient had moderate disability in the form of left sided weakness, one patient remained in vegetative state, while 3 (10%) patients died. Chi-square test was significant for good outcome in patients with GCS 13-15 (p=0.01) and for death in patients with GCS 3-8 (p=0.01). Conclusion: Extradural hematoma in head injuries affected young males more commonly. The outcome was better when the initial GCS was in the higher range.	[Rehman, Lal; Khattak, Azmatullah; Naseer, Aamer; Musthaq] Rayatabad Med Complex HMC, Dept Neurosurg Surg, Peshawar, Pakistan		Rehman, L (corresponding author), Adam Khan Cloth House, Shop 1,Gul Noor Market, Peshawar, Pakistan.	drlalrehman@yahoo.com					Alliez JR, 2005, NEUROCHIRURGIE, V51, P464, DOI 10.1016/S0028-3770(05)83504-0; ANDREWS BT, 1986, NEUROSURGERY, V19, P408, DOI 10.1227/00006123-198609000-00012; Berker M, 2003, BRIT J NEUROSURG, V17, P226, DOI 10.1080/0268869031000153071; BERNEY J, 1994, CHILD NERV SYST, V10, P509, DOI 10.1007/BF00335073; Caird J, 1999, IRISH MED J, V92, P270; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; Dirim Berna Vidinli, 2005, Diagn Interv Radiol, V11, P14; ERICSON K, 1981, ACTA RADIOL DIAGN, V22, P513, DOI 10.1177/028418518102200501; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; GUTMAN MB, 1992, J NEUROSURG, V77, P9, DOI 10.3171/jns.1992.77.1.0009; HAMID AN, 1998, PAK J NEUROL, V4, P30; Huynh T, 2006, AM SURGEON, V72, P1162; Iqbal Z, 1999, PAK J NEUROL, V5, P36; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; KNUCKEY NW, 1989, J NEUROSURG, V70, P392, DOI 10.3171/jns.1989.70.3.0392; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; PILLAY R, 1995, S AFR MED J, V85, P672; Rocchi G, 2005, J CHILD NEUROL, V20, P569, DOI 10.1177/08830738050200070501; Russell R. C. G., 2004, BAILEY LOVES SHORT P, P594; Shiomi N, 2004, NEUROL SURG TOKYO, V32, P465; Vilalta J, 1992, Rev Esp Anestesiol Reanim, V39, P277; Wester K, 1999, NEUROSURGERY, V44, P495, DOI 10.1097/00006123-199903000-00034; Zee CS, 1998, NEUROIMAG CLIN N AM, V8, P525	24	7	7	0	2	COLL PHYSICIANS & SURGEONS PAKISTAN	KARACHI	SEVENTH CENTRAL ST, DEFENCE HOUSING AUTHORITY, KARACHI, 75500, PAKISTAN	1022-386X			JCPSP-J COLL PHYSICI	JCPSP-J. Coll. Physicians Surg.	DEC	2008	18	12					759	762					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402JM	WOS:000263010000007	19032889				2022-02-06	
J	Vogel, T; Ockert, B; Krotz, M; Linsenmaier, U; Kirchhoff, C; Pfeifer, KJ; Mutschler, W; Mussack, T				Vogel, T.; Ockert, B.; Kroetz, M.; Linsenmaier, U.; Kirchhoff, C.; Pfeifer, K. J.; Mutschler, W.; Mussack, T.			Progredient intracranial bleeding after traumatic brain injury. When is a control CCT necessary?	UNFALLCHIRURG			German	Article						Head injury; Progressive intracranial bleeding (PIB); Cranial computed tomography (CCT); Clinical parameters; CCT control	SERIAL COMPUTED-TOMOGRAPHY; HEAD TRAUMA; PROGRESSIVE HEMORRHAGE; CT-SCAN; MANAGEMENT; PREDICTORS	Background. The aim of the study was to quantify the occurrence of progressive intracranial bleeding (PIB) and to identify concomitant parameters in patients suffering from traumatic brain injury (TBI). Methods. TBI patients were included if initial and serial cranial computed tomography (CCT) scans were conducted within 24 h after trauma. A progression of = 25% was considered as PIB. Patients with progression were compared to those with constant bleeding regarding clinical parameters, time lapse and coagulation status. Results. A total of 98 patients with TBI and intracranial hemorrhaging were analyzed. PIB was detected in 45 patients showing significantly more intracerebral bleeding as well as fractures to the skull (p < 0.05), compared to patients with constant bleeding. No significant differences between the groups regarding demographic and clinical parameters, time interval between trauma and initial CCT, and coagulation status were found. Conclusions. Early progression of intracranial hemorrhaging occurs in nearly every second TBI patient and is recognized frequently in cerebral contusions and after fractures to the skull. Hence, early repeated CT scanning is indicated in all TBI patients suffering from intracranial bleeding.	[Vogel, T.] Klinikum Ruhr Univ Bochum, Klin Orthopad & Unfallchirurg, D-44791 Bochum, Germany; [Ockert, B.; Kirchhoff, C.; Mutschler, W.; Mussack, T.] Klinikum Univ Munchen, Chirurg Klin & Poliklin Innenstadt, Munich, Germany; [Kroetz, M.; Linsenmaier, U.; Pfeifer, K. J.] Klinikum Univ Munchen, Inst Klin Radiol, Munich, Germany		Vogel, T (corresponding author), Klinikum Ruhr Univ Bochum, Klin Orthopad & Unfallchirurg, Gudrunstr 56, D-44791 Bochum, Germany.	t.vogel@klinikum-bochum.de					BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; *DGU APD, 2002, JAHR 2002 TRAUM; Dharap SB, 2005, INJURY, V36, P412, DOI 10.1016/j.injury.2004.06.020; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Falimirski ME, 2003, J TRAUMA, V55, P1, DOI 10.1097/01.TA.0000071295.67263.A2; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kuhne CA, 2003, UNFALLCHIRURG, V106, P380, DOI 10.1007/s00113-003-0579-8; Lehmann U, 1997, UNFALLCHIRURG, V100, P705, DOI 10.1007/s001130050180; MOHANTY SK, 1991, J TRAUMA, V31, P801, DOI 10.1097/00005373-199106000-00010; *NAT I HLTH CLIN E, 2003, CG4 HEAD INJ FULL GU; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Rieger J, 2002, RADIOLOGE, V42, P547, DOI 10.1007/s00117-002-0765-7; Ruchholtz S, 2001, UNFALLCHIRURG, V104, P927, DOI 10.1007/s001130170033; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; VALADKA AB, INJURY CRANIUM	24	7	7	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	NOV	2008	111	11					898	904		10.1007/s00113-008-1502-0			7	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	382GI	WOS:000261593200005	18806975				2022-02-06	
J	Patel, TH; Sprague, S; Lai, Q; Jimenez, DF; Barone, CM; Ding, Y				Patel, Tarak H.; Sprague, Shane; Lai, Qin; Jimenez, David F.; Barone, Constance M.; Ding, Yuchuan			Blood brain barrier (BBB) dysfunction associated with increased expression of tissue and urokinase plasminogen activators following peripheral thermal injury	NEUROSCIENCE LETTERS			English	Article						TPA; UPA; Brain damage; Brain edema; Skin burn	FOCAL CEREBRAL-ISCHEMIA; MATRIX-METALLOPROTEINASE EXPRESSION; CENTRAL-NERVOUS-SYSTEM; GENE KNOCK-OUT; BURN INJURY; EARLY APPEARANCE; MATRIX-METALLOPROTEINASE-9; INHIBITION; MICE; RESUSCITATION	Emerging data suggests the serine proteases, tissue plasminogen activator (tPA), and urokinase plasminogen activator (uPA), may play a detrimental role in traumatic states leading to compromise of the blood brain barrier (131313). The purpose of our study was to define the role of endogenous tPA and uPA on the BBB following peripheral burn injuries. Adult male Sprague-Dawley rats (n = 46) were studied in control and thermal injury groups. Rats were anesthetized and submerged in 100 degrees C water for 6 s producing a third degree burn affecting 60-70% of the total body surface area. BBB dysfunction was then evaluated by measuring the amount of Evans blue and by calculating the water content in the brain. Levels of tPA and uPA mRNA in the brain were determined with real-time polyrnerase chain reaction (PCR) at 3 and 7 h post-injury. Results showed an increase in the brain water content and the presence of Evans blue in the brain tissue of thermally injured rats, temporally associated with an increased expression of endogenous tPA and uPA. Our study demonstrates that peripheral thermal injury does induce an increase in the permeability of the BBB. A possible mechanism may be an increased expression of tPA and uPA. (C) 2008 Elsevier Ireland Ltd. All rights reserved.	[Sprague, Shane; Jimenez, David F.; Barone, Constance M.; Ding, Yuchuan] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA; [Lai, Qin] Wayne State Univ, Sch Educ, Detroit, MI 48202 USA		Ding, Y (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, Mail Code 7843,7703 Floyd Curt Dr, San Antonio, TX 78229 USA.	dingyuchuan@gmail.com			American Heart AssociationAmerican Heart Association; UTHSCSA Neurosurgery Stimulation Fund to Yuchuan Ding	We are grateful to Dr. Yimin Wu and Mr. William Davis for their technical supports, and to Mr. Yandong Zhou for his help in preparation of the manuscript. This work was supported partially by an American Heart Association Grant in Aid and UTHSCSA Neurosurgery Stimulation Fund to Yuchuan Ding.	Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Barone CM, 2000, J BURN CARE REHABIL, V21, P20, DOI 10.1097/00004630-200021010-00005; Barone M, 1997, ACT NEUR S, V70, P265; Berger J, 2007, NEUROL RES, V29, P610, DOI 10.1179/016164107X172158; Burggraf D, 2004, EUR J NEUROSCI, V20, P2903, DOI 10.1111/j.1460-9568.2004.03757.x; CANNON JG, 1992, CRIT CARE MED, V20, P1414, DOI 10.1097/00003246-199210000-00009; DEBANDT JP, 1994, J TRAUMA, V36, P624, DOI 10.1097/00005373-199405000-00004; East E, 2005, AM J PATHOL, V167, P545, DOI 10.1016/S0002-9440(10)62996-3; Fernandez-Monreal M, 2004, MOL CELL NEUROSCI, V25, P594, DOI 10.1016/j.mcn.2003.11.002; Fujimura M, 1999, BRAIN RES, V842, P92, DOI 10.1016/S0006-8993(99)01843-0; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Gelfand V B, 1986, Acta Chir Plast, V28, P103; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Heo JH, 1999, J CEREBR BLOOD F MET, V19, P624, DOI 10.1097/00004647-199906000-00005; Herz J, 2003, J CLIN INVEST, V112, P1483, DOI 10.1172/JCI200320337; Kawai N, 2001, BRAIN RES, V895, P50, DOI 10.1016/S0006-8993(01)02026-1; Kelly BA, 2003, MOL HUM REPROD, V9, P351, DOI 10.1093/molehr/gag043; Lapchak PA, 2000, STROKE, V31, P3034, DOI 10.1161/01.STR.31.12.3034; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; MOHNOT D, 1982, ANN NEUROL, V12, P42, DOI 10.1002/ana.410120108; Mori T, 2001, NEUROREPORT, V12, P4117, DOI 10.1097/00001756-200112210-00051; Nassar T, 2004, BLOOD, V103, P897, DOI 10.1182/blood-2003-05-1685; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reyes R, 2006, NEUROSCI LETT, V407, P11, DOI 10.1016/j.neulet.2006.07.071; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Shin C, 1998, BURNS, V24, P39, DOI 10.1016/S0305-4179(97)00057-0; Sumii T, 2002, STROKE, V33, P831, DOI 10.1161/hs0302.104542; Swann K, 2007, BRAIN RES, V1129, P26, DOI 10.1016/j.brainres.2006.10.061; Teesalu T, 2002, BIOCHEM SOC T, V30, P183, DOI 10.1042/bst0300183; Wagenaar GTA, 2004, FREE RADICAL BIO MED, V36, P782, DOI 10.1016/j.freeradbiomed.2003.12.007; Wagner S, 2003, BRAIN RES, V984, P63, DOI 10.1016/S0006-8993(03)03088-9; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; WARLOW CP, 1969, LANCET, V2, P978; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212	40	7	11	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	OCT 31	2008	444	3					222	226		10.1016/j.neulet.2008.08.020			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	368IR	WOS:000260615300004	18718505				2022-02-06	
J	Diaz, AL				Diaz, Anne L.			Do I Know You? A Case Study of Prosopagnosia (Face Blindness)	JOURNAL OF SCHOOL NURSING			English	Article						prosopagnosia; face blindness; social disability; depression; learning disability	DEVELOPMENTAL PROSOPAGNOSIA	Prosopagnosia, also known as face blindness, can be a congenital disorder or the result of a traumatic brain injury or developmental problems. This disorder interferes with a person's ability to recall faces and thus recognize individuals, even ones with whom he or she is intimate or familiar. Strangers cannot be distinguished from friends, which creates safety issues for the prosopagnosics. Furthermore, social interactions can be painful and ostracism is common as persons previously met cannot be recognized at subsequent meetings. This article presents a case study of a 13-year-old male and his mother who have congenital prosopagnosia. Information obtained from the student and his mother followed four themes: academic/career, safety, interpersonal relationships, and coping strategies. Examples of these themes and related interventions for school nurses are included.	Clark Cty Sch Dist, Sch Nurse, Las Vegas, NV USA		Diaz, AL (corresponding author), Clark Cty Sch Dist, Sch Nurse, Las Vegas, NV USA.						Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Duchaine BC, 2006, CURR OPIN NEUROBIOL, V16, P166, DOI 10.1016/j.conb.2006.03.003; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; GROHOL J, 2006, PROSOPAGNOSIA; GRUETER T, 2007, SCI AM MIND, V18, P68; Jones RD, 2001, J CLIN EXP NEUROPSYC, V23, P265, DOI 10.1076/jcen.23.3.265.1183; Kress T, 2003, BEHAV NEUROL, V14, P109, DOI 10.1155/2003/520476; Le Grand R, 2006, BRAIN COGNITION, V61, P139, DOI 10.1016/j.bandc.2005.11.005; Nelson CA, 2001, INFANT CHILD DEV, V10, P3, DOI 10.1002/icd.239; PASSMORE B, 2007, ER WHATS YOUR NAME A; TESORIERO HW, 2007, WALL STREET J   0705	12	7	7	2	25	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1059-8405	1546-8364		J SCH NURS	J. Sch. Nurs.	OCT	2008	24	5					284	289		10.1177/1059840508322381			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	483SX	WOS:000268989600006	18941152				2022-02-06	
J	Chirdan, LB; Uba, AF; Chirdan, OO				Chirdan, L. B.; Uba, A. F.; Chirdan, O. O.			GASTROINTESTINAL INJURIES FOLLOWING BLUNT ABDOMINAL TRAUMA IN CHILDREN	NIGERIAN JOURNAL OF CLINICAL PRACTICE			English	Article						Gastrointestinal injury; Blunt abdominal trauma; children	SMALL-BOWEL INJURY; TRACT PERFORATION; CHILDHOOD	Purpose: Gastrointestinal (GI) injuries in children following blunt abdominal trauma is rare; early diagnosis and treatment is important for good outcome. The purpose of this report is to describe the management problems encountered in children with GI injuries following blunt abdominal trauma. Patients and Methods: From January 1996 June 2006, 168 children were treated at our centre for abdominal trauma. Twenty three had GI injuries, 19 were due to blunt trauma while four were due to penetrating trauma. We retrospectively reviewed the clinical data of the 19 children that had GI injuries as a result of blunt abdominal trauma to document the presentation, clinical features, diagnosis and outcome. Results: There were 19 patients, 14 were boys, and five were girls. The median age at presentation was nine years (range1.5 15 years). Road traffic accident was responsible for injuries in 10, fall from heights in six and assault in two children. In one child the cause of injury was not recorded. Most children presented late and at presentation over 80% had abdominal signs. Diagnosis was mainly by physical examination supported by plain abdominal x-ray in 15 children. All 19 children had laparotomy. There were a total of 23 injuries. Gastric and duodenal injuries accounted for one each. Most of the injuries were in the jejunum and ileum (10 perforations, two contusions with one mesenteric. haematoma and one mesenteric tear). There was one caecal perforation and six colonic injuries, one of which was associated with intraperitoneal rectal injury. Five children had other associated injuries (three splenic injuries, one renal injury, one bladder contusion associated with long bone fractures and. one severe closed head injury). Treatment included segmental resection with end to end anastomosis, wedge resection with anastomosis, exteriorizations stomas, simpler excision of the perforation and closure in two layers (gastric perforation). The total mortality was four (21.1%), two of them due to associated injuries. Conclusion: Gastrointestinal injuries due to blunt abdominal trauma pose a management challenge. Management based on decisions from serial clinical examinations and simple tests without recourse to advance imaging techniques may suffice.	[Chirdan, L. B.; Uba, A. F.] Univ Jos, Teaching Hosp, Dept Surg, Jos, Nigeria; [Chirdan, O. O.] Univ Jos, Teaching Hosp, Dept Community Hlth, Jos, Nigeria		Chirdan, LB (corresponding author), Univ Jos, Teaching Hosp, Dept Surg, Jos, Nigeria.	lohfab@yahoo.com					Ameh E A, 2004, East Afr Med J, V81, P194; Bensard DD, 1996, J TRAUMA, V41, P476, DOI 10.1097/00005373-199609000-00015; BROWN RA, 1992, BRIT J SURG, V79, P522, DOI 10.1002/bjs.1800790615; Canty TG, 1999, J TRAUMA, V46, P234, DOI 10.1097/00005373-199902000-00005; Ciftci AO, 1998, PEDIATR SURG INT, V13, P259, DOI 10.1007/s003830050311; Galifer RB, 2001, EUR J PEDIATR SURG, V11, P230, DOI 10.1055/s-2001-17157; Holmes JF, 2001, J PEDIATR SURG, V36, P968, DOI 10.1053/jpsu.2001.24719; Jamieson DH, 1996, PEDIATR RADIOL, V26, P188, DOI 10.1007/BF01405296; Jerby BL, 1997, J PEDIATR SURG, V32, P580, DOI 10.1016/S0022-3468(97)90711-9; Moss RL, 1996, J PEDIATR SURG, V31, P1178, DOI 10.1016/S0022-3468(96)90113-X; Nance ML, 1997, J TRAUMA, V43, P618, DOI 10.1097/00005373-199710000-00009; NORDBERG E, 1994, E AFR MED J, V71, P339; SCHIMPL G, 1992, EUR J PEDIATR SURG, V2, P341, DOI 10.1055/s-2008-1063474; SHERCK JP, 1990, J TRAUMA, V30, P1, DOI 10.1097/00005373-199001000-00001; Ulman I, 1996, J TRAUMA, V41, P110, DOI 10.1097/00005373-199607000-00017	15	7	8	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1119-3077			NIGER J CLIN PRACT	Niger. J. Clin. Pract.	SEP	2008	11	3					250	253					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386YK	WOS:000261918300015	19140363				2022-02-06	
J	Nott, MT; Chapparo, C				Nott, Melissa T.; Chapparo, Christine			Measuring information processing in a client with extreme agitation following traumatic brain injury using the Perceive, Recall, Plan and Perform System of Task Analysis	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						assessment; brain injuries; case reports; cognition; information processing	REHABILITATION; AGGRESSION; PERSONALITY; OUTCOMES	Background/Aims: Agitation following traumatic brain injury is characterised by a heightened state of activity with disorganised information processing that interferes with learning and achieving functional goals. This study aimed to identify information processing problems during task performance of a severely agitated adult using the Perceive, Recall, Plan and Perform (PRPP) System of Task Analysis. Second, this study aimed to examine the sensitivity of the PRPP System to changes in task performance over a short period of rehabilitation, and third, to evaluate the guidance provided by the PRPP in directing intervention. Methods: A case study research design was employed. The PRPP System of Task Analysis was used to assess changes in task embedded information processing capacity during occupational therapy intervention with a severely agitated adult in a rehabilitation context. Performance is assessed on three selected tasks over a one-month period. Results: Information processing difficulties during task performance can be clearly identified when observing a severely agitated adult following a traumatic brain injury. Processing skills involving attention, sensory processing and planning were most affected at this stage of rehabilitation. These processing difficulties are linked to established descriptions of agitated behaviour. Fluctuations in performance across three tasks of differing processing complexity were evident, leading to hypothesised relationships between task complexity, environment and novelty with information processing errors. Changes in specific information processing capacity over time were evident based on repeated measures using the PRPP System of Task Analysis. This lends preliminary support for its utility as an outcome measure, and raises hypotheses about the type of therapy required to enhance information processing in people with severe agitation. Conclusions: The PRPP System is sensitive to information processing changes in severely agitated adults when used to reassess performance over short intervals and can provide direct guidance to occupational therapy intervention to improve task embedded information processing by categorising errors under four stages of an information processing model: Perceive, Recall, Plan and Perform.	[Nott, Melissa T.; Chapparo, Christine] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia		Nott, MT (corresponding author), Univ Sydney, Fac Hlth Sci, POB 170, Lidcombe, NSW 1825, Australia.	mnot2529@mail.usyd.edu.au	Nott, Melissa T/M-6778-2018	Nott, Melissa T/0000-0001-7088-5826			ALBERTO PA, 2002, APPL BEHAV ANAL TEAC; BAILEY DM, 1998, RES HLTH PROFESSIONA, P61; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Chapparo C, 2005, PRPP SYSTEM TASK ANA; CHAPPARO C, 1998, PRPP RES TRAINING MA; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; Fry K, 2002, AUSTR OCCUPATIONAL T, V49, P182, DOI 10.1046/j.1440-1630.2002.00337.x; GALSKI T, 1994, ARCH PHYS MED REHAB, V75, P380, DOI 10.1016/0003-9993(94)90158-9; GILES GM, 1989, ARCH PHYS MED REHAB, V70, P156; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Greve KW, 2001, BRAIN INJURY, V15, P255; Hagen C, 1979, REHABILITATION HEAD, P87; HAGEN C, 2001, RELEARNING TIMES, V8, P1; Katz D, 1992, J HEAD TRAUMA REHAB, V72, P1, DOI [10.1097/00001199-200501000-00008, DOI 10.1097/00001199-200501000-00008]; KATZMANN S, 1993, AM J OCCUPATIONAL TH, V28, P259; Kirwan B, 1992, GUIDE TASK ANAL; Lazaro F, 2000, PSYCHIAT B, V24, P264; Miles MB, 1994, EXPANDED SOURCEBOOK; Montgomery P, 1997, Rehabil Nurs, V22, P20; NICHOLLS J, 1993, OPM A IMPROVING PERF; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Plylar P A, 1989, J Neurosci Nurs, V21, P353; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Radomski M. V., 2002, OCCUPATIONAL THERAPY, P855; Ragin C. C., 1992, WHAT IS CASE EXPLORI; Salminen A.L., 2006, AUST OCCUP THER J, V53, DOI [10.1111/j.1440-1630.2006.00540.x, DOI 10.1111/J.1440-1630.2006.00540.X, https://doi.org/10.1111/j.1440-1630.2006.00540.x]; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; SCHACTER DL, 1999, OXFORD HDB MEMORY, P627; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; SLIFER KJ, 1993, ARCH PHYS MED REHAB, V74, P810, DOI 10.1016/0003-9993(93)90006-V; Stake R., 1995, ART CASE STUDY RES; Swan L, 2004, BRAIN INJURY, V18, P143, DOI 10.1080/02699050310001596923; Toglia JP, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P5; WEBB D, 1991, COGNITIVE REHABI MAY, P29; Westling DL, 2004, TEACHING STUDENTS SE; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006; Yamadori A, 1996, COGNITIVE BRAIN RES, V5, P49, DOI 10.1016/S0926-6410(96)00040-7; Yin R.K., 2002, APPL SOCIAL RES METH, V5, DOI DOI 10.1086/421629; YIN RK, 2003, APPL SOCIAL RES METH, V0034	40	7	7	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	SEP	2008	55	3					188	198		10.1111/j.1440-1630.2007.00685.x			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	336YD	WOS:000258401800006	20887461				2022-02-06	
J	Turnipseed, SD; Vierra, D; DeCarlo, D; Panacek, EA				Turnipseed, Samuel D.; Vierra, Dana; DeCarlo, Diana; Panacek, Edward A.			Reporting patterns for "lapses of consciousness" by California emergency physicians	JOURNAL OF EMERGENCY MEDICINE			English	Article						lapses of consciousness; emergency physicians; syncope; seizure; medical impairment; Department of Motor Vehicles	IMPAIRED DRIVERS; SYNCOPE; PATIENT	Physician reporting of lapses of consciousness (LOC) to the Department of Motor Vehicles is a controversial topic in medicine. The objective of this study was to describe current LOC reporting practices by emergency physicians (EPs) in a state with mandatory reporting requirements (California). A questionnaire describing 14 different clinical scenarios involving LOC was distributed to a diverse sample of California EPs. Clinical scenarios included new seizure, hypoglycemia, atrial fibrillation/rapid heart rate, cerebrovascular accident, micturation syncope, vasovagal syncope, hepatic encephallopathy, alcohol intoxication, closed head injury, hyperosmollar coma, methamphetamine psychosis, dementia, hyperventilation syndrome, and hypercalcemia. Emergency physicians were asked how often they would report these LOC-related conditions to the state. Simple summary statistics were calculated. The response rate was 207/340 (61%) of the forms distributed. The average number of years in Emergency Medicine practice among respondents was 12 (range 1-35), and 57% were Emergency Medicine trained. Of the 14 scenarios, only one (new-onset seizure) was reported frequently by EPs (89% reported "nearly always" or "most of the time"). The remaining 13 scenarios were rarely reported (mean of 86% for "occasionally" or "never"). Although reporting of LOC, from any cause, is mandatory in California, only new-onset seizures are frequently reported by California EPs. (C) 2008 Elsevier Inc.	[Turnipseed, Samuel D.; Vierra, Dana; DeCarlo, Diana; Panacek, Edward A.] Univ Calif Davis, Davis Med Ctr, Dept Emergency Med, Sacramento, CA 95817 USA		Turnipseed, SD (corresponding author), Univ Calif Davis, Davis Med Ctr, Dept Emergency Med, 4150 V St,PSSB Suite 2100, Sacramento, CA 95817 USA.						Aschkenasy MT, 2006, J EMERG MED, V30, P29, DOI 10.1016/j.jemermed.2005.04.015; Bansch D, 1998, J AM COLL CARDIOL, V31, P608, DOI 10.1016/S0735-1097(97)00543-3; BENO J, 2000, MEDIGRAM, V25, P41; Berger JT, 2000, J GEN INTERN MED, V15, P667, DOI 10.1046/j.1525-1497.2000.04309.x; Dalrymple J, 2000, BRIT MED J, V320, P94, DOI 10.1136/bmj.320.7227.94; DHALA A, 1995, AM J CARDIOL, V75, P516, DOI 10.1016/S0002-9149(99)80595-5; DRUCKER F, 1995, JAMA-J AM MED ASSOC, V273, P1833, DOI 10.1001/jama.1995.03520470041019; *INF, 2002, 10 LEAD CAUS DEATH U; Lee W, 2002, ANN EMERG MED, V39, P656, DOI 10.1067/mem.2002.121520; Li HG, 2000, AM J CARDIOL, V85, P184, DOI 10.1016/S0002-9149(99)00647-5; *NAT CTR HLTH STAT, DEATHS LEAD CAUS; *NAT CTR INJ PREV, COMM BAS INT RED MOT; Ott B R, 1999, Med Health R I, V82, P428; Reuben DB, 1996, WESTERN J MED, V164, P111; SALINSKY MC, 1992, EPILEPSIA, V33, P469, DOI 10.1111/j.1528-1157.1992.tb01693.x; Selmo K K, 1997, Minn Med, V80, P42; Trappe HJ, 1998, J INTERV CARD ELECTR, V2, P193, DOI 10.1023/A:1009763818159	17	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679			J EMERG MED	J. Emerg. Med.	JUL	2008	35	1					15	21		10.1016/j.jemermed.2007.06.035			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	321HO	WOS:000257295500003	18226871				2022-02-06	
J	Mala, H; Castro, MR; Knippel, J; Kohler, PJ; Lassen, P; Moensen, J				Mala, Hana; Castro, Maria Rodriguez; Knippel, Julia; Kohler, Peter Jes; Lassen, Pia; Moensen, Jesper			Therapeutic effects of a restraint procedure on posttraumatic place learning in fimbria-fornix transected rats	BRAIN RESEARCH			English	Article						restraint procedure; brain injury; recovery; rat; hippocampus; therapy	MEDIAL PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY; MESSENGER-RNA EXPRESSION; ALTERS DENDRITIC MORPHOLOGY; GROWTH-ASSOCIATED GENE; CHRONIC STRESS; SPATIAL MEMORY; IMMOBILIZATION STRESS; NEUROTROPHIC FACTOR; WATER MAZE	Restraint procedures have been shown to influence the neural processes in the brain (dendritic changes or changes in the expression of neurotrophines, etc.) as well as to alter the behavioural performance. While many report deleterious effects of this procedure in normal animals, there are also indications of positive effects in the context of brain injury. In order to address the issue from the perspective of functional posttraumatic recovery, we studied 6 experimental groups of rats-3 groups undergoing a fimbria-fornix transection, and 3 groups remaining neurally intact. Within the lesioned and intact groups, respectively, one group of animals was subjected to an 8-day long restraint procedure (2 h daily) that ended immediately prior to the infliction of trauma; another group was subjected to the same procedure starting immediately after the infliction of trauma; and one group was not subjected to the restraint procedure at all. After a brief period of postoperative pause, the animals were tested on their acquisition of an 8-arm radial maze based place learning task and the effects of the restraint procedure on the task acquisition were evaluated. The results show that within the neurally intact groups, the administration of this procedure had no effect at all. However, the lesioned groups that were subjected to the restraint procedure showed significantly improved acquisition of the studied task compared to the lesioned animals that did not undergo the restraint procedure. The improved task performance suggests a therapeutic effect of this manipulation on the functional recovery after a mechanical trauma. (C) 2008 Elsevier B.V. All rights reserved.	[Mala, Hana; Castro, Maria Rodriguez; Knippel, Julia; Kohler, Peter Jes; Lassen, Pia; Moensen, Jesper] Univ Copenhagen, Dept Psychol, Unit Cognit Neurosci, DK-1353 Copenhagen, Denmark		Moensen, J (corresponding author), Univ Copenhagen, Dept Psychol, Unit Cognit Neurosci, Oester Farimagsgade 5A,Bldg 10, DK-1353 Copenhagen, Denmark.	jesper.mogensen@psy.ku.dk	Kohler, Peter J./H-7725-2019	Kohler, Peter J./0000-0001-5002-3356; Mogensen, Jesper/0000-0003-1959-581X; Rytter, Hana Mala/0000-0002-2910-372X			ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; Abidin I, 2004, INT J NEUROSCI, V114, P683, DOI 10.1080/00207450490430543; Adlard PA, 2004, STRESS HEALTH, V20, P175, DOI 10.1002/smi.1022; ANISMAN H, 1986, ANN NY ACAD SCI, V467, P205, DOI 10.1111/j.1749-6632.1986.tb14630.x; ANISMAN H, 1990, PHARMACOL THERAPEUT, V46, P119, DOI 10.1016/0163-7258(90)90039-5; Bain MJ, 2004, NEUROSCI LETT, V368, P7, DOI 10.1016/j.neulet.2004.04.096; Barbay S, 2006, NEUROREHAB NEURAL RE, V20, P455, DOI 10.1177/1545968306290773; Beck KD, 1999, BRAIN RES, V830, P56, DOI 10.1016/S0006-8993(99)01380-3; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Bisagno V, 2004, PHARMACOL BIOCHEM BE, V78, P541, DOI 10.1016/j.pbb.2004.04.023; BLANC G, 1980, NATURE, V284, P265, DOI 10.1038/284265a0; Bowman RE, 2006, BRAIN RES, V1126, P156, DOI 10.1016/j.brainres.2006.07.047; Bowman RE, 2005, J NEUROENDOCRINOL, V17, P526, DOI 10.1111/j.1365-2826.2005.01335.x; Bowman RE, 2003, HORM BEHAV, V43, P48, DOI 10.1016/S0018-506X(02)00022-3; Bowman RE, 2002, NEUROSCIENCE, V113, P401, DOI 10.1016/S0306-4522(02)00156-2; Bowman RE, 2001, BRAIN RES, V904, P279, DOI 10.1016/S0006-8993(01)02474-X; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Briones TL, 2006, BEHAV BRAIN RES, V168, P261, DOI 10.1016/j.bbr.2005.11.015; Brown SM, 2005, CEREB CORTEX, V15, P1714, DOI 10.1093/cercor/bhi048; Canudas AM, 2005, MOL BRAIN RES, V134, P147, DOI 10.1016/j.molbrainres.2004.11.012; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Caudra G, 1999, BRAIN RES BULL, V48, P303, DOI 10.1016/S0361-9230(98)00179-8; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037/0735-7044.113.5.902; Conrad CD, 2004, PHARMACOL BIOCHEM BE, V78, P569, DOI 10.1016/j.pbb.2004.04.025; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Corbett D, 2006, EXP NEUROL, V202, P133, DOI 10.1016/j.expneurol.2006.05.020; Dagnino-Subiabre A, 2006, BRAIN RES, V1086, P27, DOI 10.1016/j.brainres.2006.02.118; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; de Bruin JPC, 2001, NEUROBIOL LEARN MEM, V75, P164, DOI 10.1006/nlme.2000.3962; DEUTCH AY, 1985, BRAIN RES, V333, P143, DOI 10.1016/0006-8993(85)90134-9; Franklin TB, 2006, PSYCHONEUROENDOCRINO, V31, P38, DOI 10.1016/j.psyneuen.2005.05.008; Ginsberg SD, 2002, J NEUROTRAUM, V19, P99, DOI 10.1089/089771502753460277; Ginsberg SD, 1998, NEUROSCIENCE, V86, P1259, DOI 10.1016/S0306-4522(98)00136-5; Givalois L, 2001, NEUROENDOCRINOLOGY, V74, P148, DOI 10.1159/000054681; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Grasso G, 2004, NEUROSCIENTIST, V10, P93, DOI 10.1177/1073858403259187; GRESCH PJ, 1994, J NEUROCHEM, V63, P575; Harvey BH, 2006, PHYSIOL BEHAV, V87, P881, DOI 10.1016/j.physbeh.2006.01.033; Jackson ME, 2006, EUR J NEUROSCI, V24, P1702, DOI 10.1111/j.1460-9568.2006.05054.x; Kim DH, 2005, NEUROCRIT CARE, V3, P71, DOI 10.1385/NCC:3:1:071; Kitraki E, 2004, ANN NY ACAD SCI, V1018, P323, DOI 10.1196/annals.1296.039; LAHTINEN H, 1993, BRAIN RES BULL, V31, P311, DOI 10.1016/0361-9230(93)90223-X; Lee KJ, 2006, EXP MOL MED, V38, P44, DOI 10.1038/emm.2006.6; Li SL, 2006, NEUROBIOL DIS, V23, P362, DOI 10.1016/j.nbd.2006.03.011; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; Lippert-Gruener M, 2007, EXP NEUROL, V203, P82, DOI 10.1016/j.expneurol.2006.07.025; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; LUINE V, 1994, ANN NY ACAD SCI, V746, P403; Luine Victoria, 1996, Physiology and Behavior, V59, P27, DOI 10.1016/0031-9384(95)02016-0; Luine V, 2002, STRESS, V5, P205, DOI 10.1080/1025389021000010549; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Mala Hana, 2005, Neural Plasticity, V12, P329, DOI 10.1155/NP.2005.329; Marmigere F, 2003, HIPPOCAMPUS, V13, P646, DOI 10.1002/hipo.10109; MHARZI M, 1988, PHYSIOL BEHAV, V42, P575, DOI 10.1016/0031-9384(88)90160-6; MOGENSEN J, 1995, NEUROBIOL LEARN MEM, V64, P17, DOI 10.1006/nlme.1995.1040; Mogensen J, 2005, BRAIN RES BULL, V65, P41, DOI 10.1016/j.brainresbull.2004.11.010; Mogensen J, 2004, PHARMACOL BIOCHEM BE, V77, P381, DOI 10.1016/j.pbb.2003.11.017; Mogensen J, 2004, BRAIN RES BULL, V63, P217, DOI 10.1016/j.brainresbull.2004.02.008; Mogensen J, 2002, NEUROBIOL LEARN MEM, V78, P139, DOI 10.1006/nlme.2001.4055; Mogensen J, 2007, BRAIN RES BULL, V73, P86, DOI 10.1016/j.brainresbull.2007.02.006; Murakami S, 2005, NEUROSCI RES, V53, P129, DOI 10.1016/j.neures.2005.06.008; Nibuya M, 1999, NEUROSCI LETT, V267, P81, DOI 10.1016/S0304-3940(99)00335-3; Orsini C, 2002, PHYSIOL BEHAV, V75, P135, DOI 10.1016/S0031-9384(01)00629-1; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; PUGLISIALLEGRA S, 1991, BRAIN RES, V554, P217, DOI 10.1016/0006-8993(91)90192-X; Radecki DT, 2005, HIPPOCAMPUS, V15, P246, DOI 10.1002/hipo.20048; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Rage F, 2002, NEUROSCIENCE, V112, P309, DOI 10.1016/S0306-4522(02)00072-6; Sandi C, 2003, EUR J NEUROSCI, V17, P2447, DOI 10.1046/j.1460-9568.2003.02675.x; Scaccianoce S, 2004, HIPPOCAMPUS, V14, P275, DOI 10.1002/hipo.10192; Scaccianoce S, 2000, INT J DEV NEUROSCI, V18, P469, DOI 10.1016/S0736-5748(00)00014-9; Shansky Rebecca M, 2006, Behav Brain Funct, V2, P8, DOI 10.1186/1744-9081-2-8; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Smith DG, 2006, BRAIN RES, V1114, P24, DOI 10.1016/j.brainres.2006.07.058; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Trneckova L, 2006, BRAIN RES, V1077, P7, DOI 10.1016/j.brainres.2006.01.029; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Ventura R, 2001, NEUROSCIENCE, V104, P627, DOI 10.1016/S0306-4522(01)00160-9; Vyas A, 2002, J NEUROSCI, V22, P6810; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WORTWEIN G, 1995, INT J NEUROSCI, V82, P71, DOI 10.3109/00207459508994291; Wright RL, 2005, STRESS, V8, P151, DOI 10.1080/10253890500156663	91	7	7	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 27	2008	1217						221	231		10.1016/j.brainres.2008.04.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	326CU	WOS:000257636300023	18501337				2022-02-06	
J	Qin, HP; Mei, GH; Wei, L; Jiang, JY				Qin, Hua-Ping; Mei, Guang-Hai; Wei, Liang; Jiang, Ji-Yao			Effect of profound hypothermia on genomics of hippocampus following complete cerebral ischemia in rats	NEUROLOGICAL RESEARCH			English	Article						cerebral ischemia; profound hypothermia; gene chips; genomics	TRAUMATIC BRAIN-INJURY; MILD HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; CARDIAC-ARREST; TEMPERATURE; HYPOXIA; RELEASE; ADULTS	Objective: To determine differential gene expression of hippocampus in rats following complete cerebral ischemia with treatment of profound hypothermia compared to normothermia. Methods: Six rats got 5 minutes of complete cerebral ischemia with circulatory arrest and randomly divided into two groups: normothermia ischemia group (37 +/- 0.3 degrees C, n=3) and profound hypothermia ischemia group (18 +/- 0.5 degrees C, n=3). Affymetrix U34A rat arrays were applied to detect the difference of gene expression profile in hippocampus between the two groups. Results: Expression profiles of a total of 75 transcripts in the profound hypothermia ischemia group were statistically different from those of the normothermia ischemia group, and 33 of them were significantly up-regulated and other 42 were significantly down-regulated (p < 0.01). Conclusions: Compared with normothermia, profound hypothermia had a significant effect on the gene expression profiles following complete cerebral ischemia, which may be involved in the mechanisms of cerebral protection by profound hypothermia.	[Qin, Hua-Ping; Mei, Guang-Hai; Wei, Liang; Jiang, Ji-Yao] Shanghai Jiao Tong Univ, Dept Neurosurg, Renji Hosp, Sch Med, Shanghai 200127, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Dept Neurosurg, Renji Hosp, Sch Med, Shanghai 200127, Peoples R China.	Jiangjyb@online.sh.cn					ALBERTS MJ, 1995, ANN INTERN MED, V122, P622, DOI 10.7326/0003-4819-122-8-199504150-00013; ALTHAUS U, 1982, ANN SURG, V195, P492, DOI 10.1097/00000658-198204000-00018; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BIGELOW WG, 1950, ANN SURG, V132, P849, DOI 10.1097/00000658-195011000-00001; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; CHURN SB, 1999, STROKE, V21, P758; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; GRIEPP EB, 1992, J CARDIAC SURG, V7, P134, DOI 10.1111/j.1540-8191.1992.tb00790.x; Grocott HP, 2001, PERFUSION-UK, V16, P75, DOI 10.1177/026765910101600111; Hayashi N, 1997, NEUROCHEMISTRY, P97; Holzer M, 2002, NEW ENGL J MED, V346, P549; [江基尧 Jiang Jiyao], 2003, [中华神经外科杂志, Chinese Journal of Neurosurgery], V19, P304; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jiang JY, 2004, NEUROSURGERY, V54, P713, DOI 10.1227/01.NEU.0000109535.58429.49; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Jin KL, 2001, ANN NEUROL, V50, P93, DOI 10.1002/ana.1073; Kaibara T, 1999, J NEUROSURG, V90, P339, DOI 10.3171/jns.1999.90.2.0339; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MITANI A, 1991, BRAIN RES, V562, P159, DOI 10.1016/0006-8993(91)91201-B; MIYAZAWA T, 1993, ACTA NEUROPATHOL, V85, P526; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; Safar PJ, 2002, NEW ENGL J MED, V346, P612, DOI 10.1056/NEJM200202213460811; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; STEEN PA, 1980, ANESTHESIOLOGY, V52, P224, DOI 10.1097/00000542-198003000-00007; Tang Y, 2001, ANN NEUROL, V50, P699, DOI 10.1002/ana.10042; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; WELSH FA, 1990, J CEREBR BLOOD F MET, V10, P557, DOI 10.1038/jcbfm.1990.98; ZARINS CK, 1973, J SURG RES, V14, P97, DOI 10.1016/0022-4804(73)90015-2	31	7	11	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	JUN	2008	30	5					536	541		10.1179/174313208X284250			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	333EZ	WOS:000258137100019	18953745				2022-02-06	
J	Bello, DT; Allen, DN; Mayfield, J				Bello, Danielle T.; Allen, Daniel N.; Mayfield, Joan			Sensitivity of the children's category test level 2 to brain dysfunction	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						category test; children; traumatic brain injury; ADHD; abstraction; problem solving; executive functions	HALSTEAD CATEGORY TEST; TRAUMATIC HEAD-INJURY; DEFICIT HYPERACTIVITY DISORDER; MULTIDIMENSIONAL INSTRUMENT; LATENT STRUCTURE; OLDER CHILDREN; ABILITIES; ATTENTION; VALIDITY; IMPACT	The current study examined the psychometric properties and sensitivity to brain dysfunction of a popular test of abstraction and problem solving ability, the Children's Category Test Level 2 (CCT-2; Boll, 1993). Participants were 113 children with various forms of structural brain damage (n = 82) or with Attention-Deficit/Hyperactivity Disorder (n = 31). Results indicated that while there is some support for the validity of the CCT-2, the test is not particularly sensitive to brain dysfunction. The composite T-score, subtest scores and factor scores did not distinguish children with ADHD from those with structural brain damage and the T-scores of both groups were within the normal range. These results illustrate the importance of validating measures of neurocognitive function with clinical populations as even tests with otherwise excellent psychometric properties may not be sensitive to brain dysfunction. It is recommended that the CCT-2 not be used to draw conclusions regarding the impact of brain damage on abstraction and problem solving abilities. (C) 2007 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	[Bello, Danielle T.; Allen, Daniel N.] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, Box 455030,4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Allen DN, 2006, ARCH CLIN NEUROPSYCH, V21, P711, DOI 10.1016/j.acn.2006.08.003; Allen DN, 1999, J CLIN EXP NEUROPSYC, V21, P237, DOI 10.1076/jcen.21.2.237.926; ALLEN DN, 2006, QUANTIFIED PROCESS A, P259; Assel M. A., 2003, APPL DEV SCI, V7, P27, DOI [10.1207/s1532480xads0701_3, DOI 10.1207/S1532480XADS0701_3, 10.1207/S1532480XADS0701_3, DOI 10.1207/S1532480XADS0701_]; Barkley R.A., 1997, ADHD NATURE SELF CON; BOLL T, 1993, CHILDRENS CATEGORY T; BOLL TJ, 1974, CLIN NEUROPSYCHOLOGY, P91; Carte ET, 1996, J ABNORM CHILD PSYCH, V24, P481, DOI 10.1007/BF01441570; Choca JP, 1997, NEUROPSYCHOL REV, V7, P61, DOI 10.1023/B:NERV.0000005944.98635.16; Dennis M, 2004, DEV NEUROPSYCHOL, V25, P1, DOI 10.1207/s15326942dn2501&2_1; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 1999, J CLIN EXP NEUROPSYC, V21, P279; Donders J, 2001, PSYCHOL ASSESSMENT, V13, P592, DOI 10.1037/1040-3590.13.4.592; Donders J, 1996, ARCH CLIN NEUROPSYCH, V11, P131, DOI 10.1016/0887-6177(95)00005-4; Fischer M, 2005, DEV NEUROPSYCHOL, V27, P107, DOI 10.1207/s15326942dn2701_5; Forrest TJ, 2004, CLIN NEUROPSYCHOL, V18, P334, DOI 10.1080/13854040490501673; Halstead WC, 1947, BRAIN INTELLIGENCE Q; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; Johnson M.B., 1989, WOODCOCK JOHNSON PSY; Johnstone B, 1997, PSYCHOL ASSESSMENT, V9, P28, DOI 10.1037/1040-3590.9.1.28; KELLY MD, 1992, ARCH CLIN NEUROPSYCH, V7, P415, DOI 10.1016/0887-6177(92)90154-F; KLONOFF H, 1969, DEV MED CHILD NEUROL, V11, P198; LURIA AR, 1977, AM PSYCHOL, V32, P959, DOI 10.1037/0003-066X.32.11.959; Nesbit-Greene K, 2002, J CLIN EXP NEUROPSYC, V24, P194, DOI 10.1076/jcen.24.2.194.996; Osmon DC, 2006, J CLIN EXP NEUROPSYC, V28, P84, DOI 10.1080/13803390490918129; REED HBC, 1965, J CONSULT PSYCHOL, V29, P247, DOI 10.1037/h0022145; REEDER KP, 1992, ARCH CLIN NEUROPSYCH, V7, P53, DOI 10.1016/0887-6177(92)90018-I; REITAN RM, 1964, FRONTAL GRANULAR COR; Seidman LJ, 2005, DEV NEUROPSYCHOL, V27, P79, DOI 10.1207/s15326942dn2701_4; SELZ M, 1979, J CONSULT CLIN PSYCH, V47, P258, DOI 10.1037/0022-006X.47.2.258; STRANG JD, 1983, J CLIN CHILD PSYCHOL, V12, P33, DOI 10.1080/15374418309533110; TAYLOR JM, 1984, J CLIN NEUROPSYCHOL, V6, P341, DOI 10.1080/01688638408401224; TEASDALE G, 1974, LANCET, V2, P81; WECHSLER D, 1991, WECHSLER INTELIGENCE; Weyandt LL, 2005, DEV NEUROPSYCHOL, V27, P1, DOI 10.1207/s15326942dn2701_1	36	7	7	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2008	23	3					329	339		10.1016/j.acn.2007.12.002			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	310VT	WOS:000256559500008	18280106	Bronze			2022-02-06	
J	Kreitschmann-Andermahr, I; Poll, EM; Reineke, A; Langejurgen, Y; Yagmur, E; Gilsbach, JM; Saller, B				Kreitschmann-Andermahr, I.; Poll, E. M.; Reineke, A.; Langejuergen, Y.; Yagmur, E.; Gilsbach, J. M.; Saller, B.			Diagnosing neuroendocrine dysfunction in patients after aneurysmal subarachnoid hemorrhage in clinical practice - Does basal hormone screening make sense?	EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES			English	Article						hypopituitarism; neuroendocrine dysfunction; subarachnoid hemorrhage; growth hormone deficiency; adrenocorticotroph deficiency	TRAUMATIC BRAIN-INJURY; INSULIN-TOLERANCE-TEST; GH DEFICIENCY; PITUITARY DEFICIENCY; HYPOPITUITARISM; PREVALENCE; SURGERY; TIME	Recent studies indicate that neuroendocrine dysfunction is a more frequent sequel of aneurysmal subarachnoid hemorrhage (SAH), than has so far been recognized. However, from the available data it remains unclear whether certain subgroups of SAH patients carry a higher risk to sustain endocrine sequelae due to the hemorrhage than others and should be specifically followed-up in terms of hormone assessment. To investigate whether a basal hormone screening is a practical method in clinical routine to single out patients in whom endocrine function testing is warranted, we established a screening protocol, based on the findings from a cohort of 40 SAH patients (study group) who had all been investigated by basal hormone parameters as well as standardized endocrinological function testing, within the framework of a previously published clinical study. We then applied this protocol to 45 newly investigated SAH-patients (screening group). According to the thus established protocol, 20 of the 45 screened patients (44.4%) were recommended further investigations, 12 of whom agreed to undergo dynamic endocrine function testing. Altogether, the percentage of test-confirmed neuroendocrine dysfunction was only 13.3 % (6/45) in the Screening group as compared to 55 % in the study group. Low IGF-I (2 SD below normal) did not serve to predict growth hormone deficiency, whereas low 9 am serum cortisol was of limited value to single out ACTH-deficiency in SAH-patients. In summary we conclude that basal hormone screening is not sufficient to identify SAH patients with impaired hypothalamo-pituitary function, at least not in the context of clinical routine practice.	[Kreitschmann-Andermahr, I.; Poll, E. M.; Reineke, A.; Langejuergen, Y.; Gilsbach, J. M.] Rhein Westfal TH Aachen, Univ Hosp, Dept Neurosurg, D-52074 Aachen, Germany; [Yagmur, E.] Rhein Westfal TH Aachen, Univ Hosp, Inst Clin Chem & Pathobiochem, Aachen, Germany; [Saller, B.] Univ Hosp Essen, Dept Endocrinol, Essen, Germany		Kreitschmann-Andermahr, I (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Dept Neurosurg, Pauwelsstr 30, D-52074 Aachen, Germany.	ikreitschmann-andermahr@ukaachen.de	Poll, Eva/A-1321-2009				Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2003, CLIN ENDOCRINOL, V59, P56, DOI 10.1046/j.1365-2265.2003.01794.x; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Courtney CH, 2000, CLIN ENDOCRINOL, V53, P431, DOI 10.1046/j.1365-2265.2000.01106.x; CROMPTON MR, 1963, BRAIN, V86, P301, DOI 10.1093/brain/86.2.301; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Darzy KH, 2003, J CLIN ENDOCR METAB, V88, P95, DOI 10.1210/jc.2002-021094; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; HIJDRA A, 1988, STROKE, V19, P1250, DOI 10.1161/01.STR.19.10.1250; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Hutter BO, 1999, ACT NEUR S, V72, P157; JENNETT B, 1975, LANCET, V1, P480; JONES SL, 1994, CLIN ENDOCRINOL, V41, P123, DOI 10.1111/j.1365-2265.1994.tb03793.x; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2003, J NEUROL NEUROSUR PS, V74, P1133, DOI 10.1136/jnnp.74.8.1133; Kreitschmann-Andermahr Ilonka, 2005, Pituitary, V8, P219, DOI 10.1007/s11102-006-6044-2; LEROITH D, 1992, ANN INTERN MED, V116, P854, DOI 10.7326/0003-4819-116-10-854; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; Savastano S, 2006, J ENDOCRINOL INVEST, V29, P536, DOI 10.1007/BF03344144; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P553, DOI 10.1530/eje.1.02258; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schuiling WJ, 2005, STROKE, V36, P578, DOI 10.1161/01.STR.0000154862.33213.73	29	7	7	0	0	JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH	STUTTGART	RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY	0947-7349			EXP CLIN ENDOCR DIAB	Exp. Clin. Endocrinol. Diabet.	MAY	2008	116	5					276	281		10.1055/s-2007-1004552			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	310MK	WOS:000256533500005	18589891				2022-02-06	
J	Brown, JM; Udomphorn, Y; Suz, P; Vavilala, MS				Brown, Jonathon M.; Udomphorn, Yuthana; Suz, Pilar; Vavilala, Monica S.			Antipyretic treatment of noninfectious fever in children with severe traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						pediatric traumatic brain injury; head trauma; fever; pyrexia; antipyretic treatment	INTENSIVE-CARE-UNIT; LENGTH-OF-STAY; BODY-TEMPERATURE; ACETAMINOPHEN; HYPERTHERMIA; STROKE; PROGNOSIS; THERAPY	Objective The purpose of this study was to describe the treatment of noninfectious fever in children with severe traumatic brain injury (TBI). Materials and methods We conducted a retrospective study to compare type of and response to antipyretic treatment strategies in children less than or equal to 17 years and Glasgow Coma Scale (GCS) score less than 9. Results The average admission GCS score was 4. Forty children (35 boys, 5 girls), age 7.8 +/- 5.2 years, had noninfectious fever. Seventy percent (28 of 40) received acetaminophen only, and 30% (12 of 40) received acetaminophen plus either ibuprofen or physical cooling. Time to next febrile episode was longer in patients receiving combination therapy than those receiving monotherapy (p=0.03). Fever refractory to treatment dose or strategy occurred in more than 40% of the patients. Conclusions Early combination antipyretic therapy may be needed to effectively maintain normothermia in children with severe TBI.	[Vavilala, Monica S.] Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA; [Brown, Jonathon M.] Drexel Univ, Coll Med, Med Sci Program, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Brown, Jonathon M.; Udomphorn, Yuthana; Vavilala, Monica S.] Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; [Suz, Pilar; Vavilala, Monica S.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; [Suz, Pilar] Univ Texas Houston, Sch Med, Dept Anesthesiol, Houston, TX 77030 USA		Vavilala, MS (corresponding author), Harborview Med Ctr, Dept Anesthesiol, 325 9th Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@u.washington.edu					AMEER B, 1977, ANN INTERN MED, V87, P202, DOI 10.7326/0003-4819-87-2-202; AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; Bazan NG, 2002, NATURE, V420, P135, DOI 10.1038/420135a; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; CHILDERS MK, 1994, BRAIN INJURY, V8, P335, DOI 10.3109/02699059409150984; Clinchot DM, 1997, AM J PHYS MED REHAB, V76, P323, DOI 10.1097/00002060-199707000-00012; CUNHA BA, 1988, HEART LUNG, V17, P608; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; Dippel DWJ, 2001, STROKE, V32, P1607, DOI 10.1161/01.STR.32.7.1607; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; Hinz J, 2007, J NEUROSURG ANESTH, V19, P130, DOI 10.1097/ANA.0b013e318032a208; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kinoshita K, 2002, J NEUROSURG, V97, P945, DOI 10.3171/jns.2002.97.4.0945; Mayer SA, 2001, NEUROLOGY, V56, P292, DOI 10.1212/WNL.56.3.292; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Rang HP, 2003, PHARMACOLOGY, V5th; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Scolnik D, 2002, PEDIATRICS, V110, P553, DOI 10.1542/peds.110.3.553; SIBERRY GK, 2000, HARRIET LANE HDB; SIMILA S, 1975, EUR J PEDIATR, V121, P15, DOI 10.1007/BF00464391; STEELE RW, 1972, AM J DIS CHILD, V123, P204, DOI 10.1001/archpedi.1972.02110090074006; Suz P, 2006, J NEUROSURG ANESTH, V18, P5, DOI 10.1097/01.ana.0000189079.26212.37; Taketomo CK., 1999, PEDIAT DOSAGE HDB, V6; TEMPLE AR, 1978, PEDIATRICS, V62, P873; Thompson Hilaire J, 2007, J Neurosci Nurs, V39, P151	29	7	7	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	APR	2008	24	4					477	483		10.1007/s00381-007-0517-0			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	267RA	WOS:000253525700010	17917733				2022-02-06	
J	Li, AL; Zhi, DS; Wang, Q; Huang, HL				Li Ai-lin; Zhi Da-shi; Wang Qiong; Huang Hui-ling			Extracellular glycerol in patients with severe traumatic brain injury	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Traumatic brain injury; Glycerol; Microdialysis		Objective: To study the factors affecting extracellular glycerol (Gly) in patients with severe traumatic brain injury (STBI). Methods: Perilesional extracellular Gly and cerebral blood flow (CBF) in 53 patients with STBI were consecutively monitored. Simultaneously, the intracranial pressure (ICP) and cerebral perfusion pressure (CCP) were monitored. The hourly minimum of CCP and CBF and the hourly maximum of ICP levels were matched with the hourly Gly. Gly values were divided into several groups according to regional ICP (< 15 mm Hg or > 15 mm Hg), CCP (< 70 mm Hg or > 70 mm Hg), CBF (<50 AU or 50-150 AU) and the outcomes (death or persistent vegetative state group, severe or moderate disability group, and good recovery group). Results: In comparison with the severe or moderate disability group, the Gly concentration of the death or persistent vegetative state group increased significantly, but CBF and CCP decreased significantly. In comparison with the good recovery group, the Gly concentration of the severe or moderate disability group increased significantly, but CBF and CCP decreased significantly. The Gly concentrations in patients with ICP>15 mm Hg, CCP<70 mm Hg and CBF<50 AU were respectively higher than those of patients with ICP < 15 mm Hg, CCP>70 mm Hg and 50 AU <CBF<150 AU. In patients with diffuse axial injury, the mean Gly concentration was (201.17 +/- 55.00) mu mol/L, which was significantly higher than that of the patients with epidural hematoma (n=7, 73.26 +/- 8.37, P<0.05) or subdural hematoma (n=9, 114.67 +/- 62.88, P<0.05), but it did not increase significantly when compared with those in patients with contusion (n=24, 167.48 +/- 52.63). Conclusion: Gly can be taken as a marker for degradation of membrane phospholipids and ischemia, which reflects the severity of primary or secondary insult.	[Li Ai-lin; Zhi Da-shi; Wang Qiong; Huang Hui-ling] Huanhu Hosp, Dept Neurosurg, Tianjin 300060, Peoples R China		Zhi, DS (corresponding author), Huanhu Hosp, Dept Neurosurg, Tianjin 300060, Peoples R China.	tnhnicc@public.tpt.tj.cn					Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CHAN PH, 1982, J NEUROCHEM, V38, P525, DOI 10.1111/j.1471-4159.1982.tb08659.x; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; FAROOQUI AA, 1994, INT REV NEUROBIOL, V36, P267, DOI 10.1016/S0074-7742(08)60306-2; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; Heiss WD, 2003, ACTA NEUROCHIR SUPPL, V86, P237; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Konig K, 2001, J NEUROSURG, V94, P621, DOI 10.3171/jns.2001.94.4.0621; Nguyen NHT, 2003, J NEUROCHEM, V85, P831, DOI 10.1046/j.1471-4159.2003.01762.x; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; WINN HR, 1977, SURG NEUROL, V8, P41	13	7	9	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	APR	2008	11	2					84	88		10.1016/S1008-1275(08)60018-8			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF0VI	WOS:000441864600004	18377710	hybrid			2022-02-06	
J	Ryan, MAK; Lloyd, DW; Conlin, AMS; Gumbs, GR; Keenan, HT				Ryan, Margaret A. K.; Lloyd, David W.; Conlin, Ava M. S.; Gumbs, Gia R.; Keenan, Heather T.			Evaluating the epidemiology of inflicted traumatic brain injury in infants of US military families	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							SHAKEN BABY SYNDROME; CHILD MALTREATMENT; MENTAL-RETARDATION; CRANIAL INJURIES; YOUNG-CHILDREN; HEAD-INJURY; IMPACT; ABUSE; SHAKING; SOLDIERS	Background: Evaluating the incidence of inflicted traumatic brain injuries (inflicted TBI) in young children, and encompassing shaken baby syndrome (SBS) and related injuries, is ail epidemiologic challenge. Data available regarding military families in the U.S. may complement other national surveillance efforts. Methods: A protocol was developed to assess the epidemiology of inflicted TBI among infants of U.S. military families, integrating data from the Department of Defense Birth and Infant Health Registry, healthcare utilization databases, child abuse reporting systems, and military personnel databases. The in-progress protocol, and its inherent strengths and limitations, are described here. Discussion: The primary strengths of data from U.S. military families are related to the full characterization of the denominator, such that analyses are person-time and population based. Unique data are available to describe the full population of military parents, including occupational, geographic, and socioeconomic factors, as well as deployment-related potential stressors. The limitations of military data are similar to many other child abuse surveillance systems in that cases are underreported and not fully characterized. Linking abuse reports and medical utilization data to population data, however, will allow unique analyses of "probable" and "possible" cases of inflicted TBI in infants of military families. Conclusions: Data from the U.S. military, when appropriately linked and analyzed, provide opportunities to evaluate important risk factors for inflicted TBI in infants. Although epidemiologic challenges may make incidence rates using military data noncomparable to rates using other data sources, multivariate analyses can evaluate critical and unique risk factors, as well as the effectiveness of prevention initiatives.	[Ryan, Margaret A. K.; Conlin, Ava M. S.; Gumbs, Gia R.] NHRC, Dept Def, Ctr Dev Hlth Res, San Diego, CA 92106 USA; [Lloyd, David W.] Mil Community & Family Policy, Off Under Secretary Def Personnel & Readiness, Dept Def, Family Advocacy Program, Washington, DC USA; [Keenan, Heather T.] Univ Utah, Dept Pediat, Salt Lake City, UT USA		Ryan, MAK (corresponding author), NHRC, Dept Def, Ctr Dev Hlth Res, 140 Sylvester Rd, San Diego, CA 92106 USA.	rnargaret.ryan@med.navy.mil					ALEXANDER R, 1990, AM J DIS CHILD, V144, P724, DOI 10.1001/archpedi.1990.02150300124032; Brown CE, 2005, PUBLIC HEALTH, V119, P721, DOI 10.1016/j.puhe.2004.10.009; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Chamberlain H, 2003, MIL MED, V168, P257, DOI 10.1093/milmed/168.3.257; Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; GESSNER RR, 1995, ARCH PEDIAT ADOL MED, V149, P467; Gibbs DA, 2007, JAMA-J AM MED ASSOC, V298, P528, DOI 10.1001/jama.298.5.528; Gilliland MGF, 1996, J FORENSIC SCI, V41, P114; Herman-Giddens Marcia E, 2005, N C Med J, V66, P380; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kairys SW, 2001, PEDIATRICS, V108, P206; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Merrill LL, 2004, CHILD MALTREATMENT, V9, P18, DOI 10.1177/1077559503260852; Raiha NK, 1997, CHILD ABUSE NEGLECT, V21, P759, DOI 10.1016/S0145-2134(97)00037-9; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Rentz ED, 2007, AM J EPIDEMIOL, V165, P1199, DOI 10.1093/aje/kwm008; Rentz ED, 2006, TRAUMA VIOLENCE ABUS, V7, P93, DOI 10.1177/1524838005285916; Rosen LN, 1998, CHILD ABUSE NEGLECT, V22, P197, DOI 10.1016/S0145-2134(97)00171-3; Rosen LN, 1996, CHILD ABUSE NEGLECT, V20, P1149, DOI 10.1016/S0145-2134(96)00112-3; Ryan MAK, 2001, TERATOLOGY, V64, pS26, DOI 10.1002/tera.1081; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; WILKINSON WS, 1989, ARCH OPHTHALMOL-CHIC, V107, P1472, DOI 10.1001/archopht.1989.01070020546037; Young SYN, 2006, ARCH PEDIAT ADOL MED, V160, P1207, DOI 10.1001/archpedi.160.12.1207	28	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0749-3797			AM J PREV MED	Am. J. Prev. Med.	APR	2008	34	4		S			S143	S147		10.1016/j.amepre.2007.12.020			5	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine	279TT	WOS:000254378300009	18374265				2022-02-06	
J	Shapiro, ED				Shapiro, Eugene D.			Using case-control studies to assess the prevention of inflicted traumatic brain injury	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							RANDOMIZED CLINICAL-TRIALS; BIAS; EFFICACY; VACCINE	Because the incidence of inflicted traumatic brain injury (inflicted TBI) is low, even in populations at increased risk, very large samples are necessary to have adequate statistical power to conduct a randomized clinical trial of the effectiveness of a potential intervention to prevent inflicted TBI. This requirement for large samples, in addition to the logistic demands of prospective clinical trials, makes it prohibitively expensive to conduct such Studies. Case-control studies provide a statistically efficient and logistically and economically feasible alternative approach to evaluating such interventions. However, because these are observational studies, they are susceptible to bias. Approaches are presented to conducting and analyzing case-control studies to evaluate interventions to prevent inflicted TBI while assessing and minimizing possible bias.	[Shapiro, Eugene D.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Shapiro, Eugene D.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA		Shapiro, ED (corresponding author), Yale Univ, Sch Med, Dept Pediat, POB 208064,333 Cedar St, New Haven, CT 06520 USA.	Engene.Shapiro@yale.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024139, K24RR022477] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000142] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K24 RR022477, UL1 RR024139, K24 RR022477-07, RR022477] Funding Source: Medline		CLEMENS JD, 1984, REV INFECT DIS, V6, P589; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; CORNFIELD J, 1951, J NATL CANCER I, V11, P1269; FEINSTEIN AR, 1986, J CHRON DIS, V39, P495, DOI 10.1016/0021-9681(86)90194-3; FEINSTEIN AR, 1978, CLIN RES, V26, P241; MANTEL N, 1959, J NATL CANCER I, V22, P719; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; SCHLESSELMAN IJ, 1982, CASE CONTROL STUIDES; Shapiro ED, 2004, PEDIATR INFECT DIS J, V23, P127, DOI 10.1097/01.inf.0000109248.32907.1d; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; SIBER ALM, 1986, LANCET, V1, P638; [No title captured]	13	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0749-3797			AM J PREV MED	Am. J. Prev. Med.	APR	2008	34	4		S			S153	S156		10.1016/j.amepre.2008.01.022			4	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	279TT	WOS:000254378300011	18374267	Green Accepted			2022-02-06	
J	de Faria, JWV; Nishioka, SDA; Arbex, GL; Alarcao, GG; de Freitas, WA				de Faria, Jose Weber Vieira; Nishioka, Sergio de Andrade; Arbex, Guilherme Leonel; Alarcao, Gustavo Gil; de Freitas, Wender Arbosa			Occurrence of severe and moderate traumatic brain injury in patients attended in a Brazilian teaching hospital - Epidemiology and dosage of alcoholemy	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						alcohol; traumatic brain injury	HEAD-INJURY; DRIVERS; ABUSE; INTOXICATION; PREVALENCE; OUTCOMES; TESTS	This study aimed at observing aspects of epidemiology in order to investigate the use of alcohol in patients older than 18 with severe and moderate traumatic brain injury, which were attended in the Clinics Hospital of the University of Uberlandia. Positive alcoholemy was found in 39.3% of the patients. Of the 33 positive exams alcoholemy was found higher than 60 mg/dL in 28 (84.6%). There was not significant relation between alcoholemy levels and trauma severity. The major prevalence occurred on Saturdays nights. The most frequent types of external causes were transportation accidents (64.74) followed by accidental falls (17.27%) and physical aggression (16.55%). 93.9% of the patients with positive alcoholemy were men aged 20-29. 24.2% of the ones with positive alcoholemy died yet no significant difference was found in the study of the ones with negative alcoholemy (n=51) (p=0.93); RR= 0.9; IC95%=0.40-2.08.	Univ Fed Uberlandia, Clin Hosp, Belo Horizonte, MG, Brazil; [de Faria, Jose Weber Vieira; Arbex, Guilherme Leonel] Univ Fed Uberlandia, Dept Chirurg, Uberlandia, MG, Brazil; [de Faria, Jose Weber Vieira; Arbex, Guilherme Leonel] Univ Fed Uberlandia, Neurosurg Serv, Uberlandia, MG, Brazil; [Nishioka, Sergio de Andrade] Univ Fed Uberlandia, Med Clin, Uberlandia, MG, Brazil; Univ Fed Uberlandia, Fac Med, Uberlandia, MG, Brazil; [Alarcao, Gustavo Gil] State Univ Sao Paulo, Fac Med, Sao Paulo, Brazil; [de Freitas, Wender Arbosa] Univ Triangulo Mineiro, Fac Med, Uberaba, MG, Brazil		Arbex, GL (corresponding author), Rua Francisco Vicente Ferreira 170-300-R, BR-38408102 Uberlandia, MG, Brazil.	leonelarbex@yahoo.com					BALLIN JC, 1986, JAMA-J AM MED ASSOC, V255, P522; BARSS P, 1998, INJURY PREVENTION IN, V5, P158; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bombardier CH, 1997, ARCH PHYS MED REHAB, V78, P592, DOI 10.1016/S0003-9993(97)90424-X; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; CHERPITEL CJ, 1995, ANN EMERG MED, V26, P158, DOI 10.1016/S0196-0644(95)70146-X; Colli BO, 1997, ARQ NEURO-PSIQUIAT, V55, P91, DOI 10.1590/S0004-282X1997000100015; COLQUITT M, 1987, NEW ENGL J MED, V317, P1262, DOI 10.1056/NEJM198711123172005; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; Gazal-Carvalho C, 2002, REV SAUDE PUBL, V36, P47, DOI 10.1590/S0034-89102002000100008; Hartshorne NJ, 1997, AM J FOREN MED PATH, V18, P258, DOI 10.1097/00000433-199709000-00006; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; JENNETT B, 1979, BRIT MED J, V2, P955, DOI 10.1136/bmj.2.6196.955; KIRBY JM, 1992, SOUTHERN MED J, V85, P800, DOI 10.1097/00007611-199208000-00003; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; MAULL KI, 1984, JAMA-J AM MED ASSOC, V252, P1880, DOI 10.1001/jama.252.14.1880; OSTROM M, 1992, ACCIDENT ANAL PREV, V24, P539, DOI 10.1016/0001-4575(92)90062-N; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; SKINNER HA, 1984, ANN INTERN MED, V101, P847, DOI 10.7326/0003-4819-101-6-847; Turizo RA, 1985, MORTALIDAD TRAUMA EN, P291; Turner AP, 2003, ARCH PHYS MED REHAB, V84, P358, DOI 10.1053/apmr.2003.50107; WINTEMUTE GJ, 1990, ACCIDENT ANAL PREV, V22, P291, DOI 10.1016/0001-4575(90)90020-L	26	7	8	0	2	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X			ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	MAR	2008	66	1					69	73		10.1590/S0004-282X2008000100016			5	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	282PQ	WOS:000254580100016	18392418	gold, Green Submitted, Green Published			2022-02-06	
J	Flanagan, SR; Kwasnica, C; Brown, AW; Elovic, EP; Kothari, S				Flanagan, Steven R.; Kwasnica, Christina; Brown, Allen W.; Elovic, Elie P.; Kothari, Sunil			Congenital and acquired brain injury. 2. Medical rehabilitation in acute and subacute settings	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; comorbidity; muscle spasticity; psychomotor agitation; rehabilitation	DEEP VENOUS THROMBOSIS; SEVERE HEAD-INJURY; HETEROTOPIC OSSIFICATION; INTRATHECAL BACLOFEN; MOLECULAR-WEIGHT; CRITICALLY-ILL; MANAGEMENT; THROMBOEMBOLISM; DYSAUTONOMIA; RECOVERY	This self-directed learning module reviews common clinical problems and issues pertaining to early management of persons with traumatic brain injury (TBI). It is part of the study guide on brain injury medicine in the Self-Directed Physiatric Education Program for practitioners and trainees in physical medicine and rehabilitation. Acute TBI is frequently complicated by agitation, dystonia, and numerous orthopedic and neurologic comorbidities, often causing a decrement in function, which requires careful assessment and treatment. Individuals with acute brain injury typically receive rehabilitation in a setting determined by numerous factors, including medical stability and tolerance to rehabilitation interventions. Overall Article Objectives: To describe (a) common traumatic brain injury-related comorbidities and treatment strategies, (b) potential causes of declining patient performance, and (c) appropriate settings for rehabilitation interventions.	[Flanagan, Steven R.] Mt Sinai Hosp, New York, NY 10029 USA; [Kwasnica, Christina] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Elovic, Elie P.] Kessler Med Rehabil Res & Educ Ctr, W Orange, NJ USA; [Kothari, Sunil] Inst Rehabil & Res, Houston, TX USA		Flanagan, SR (corresponding author), Mt Sinai Hosp, Box 1240B,1 Gustave Levy Pl, New York, NY 10029 USA.	steve.flanagan@mssm.edu		Flanagan, Steven/0000-0001-9005-5897; Brown, Allen W./0000-0001-7228-3351			[Anonymous], 2006, FED REG; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; Cohen IL, 2002, CRIT CARE MED, V30, pS97, DOI 10.1097/00003246-200201002-00001; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; ELOVIC E, 2001, PHYS MED REHABIL STA, V15, P327; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FLEMINGER S, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003299; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GARLAND DE, 1991, CLIN ORTHOP RELA FEB, P5; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; GOLDSTEIN LB, 1995, NEUROLOGY, V45, P865, DOI 10.1212/WNL.45.5.865; Hsieh Joseph C, 2006, Neurosurg Focus, V21, pe5; Iorio A, 2000, ARCH INTERN MED, V160, P2327, DOI 10.1001/archinte.160.15.2327; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Liu LL, 2003, DRUGS, V63, P755, DOI 10.2165/00003495-200363080-00003; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Mayer NH, 2004, J HEAD TRAUMA REHAB, V19, P119, DOI 10.1097/00001199-200403000-00005; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; *MEDPAC, 2006, REP C MED PAYM POL, P225; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 2004, J HEAD TRAUMA REHAB, V19, P101, DOI 10.1097/00001199-200403000-00003; Meythaler JM, 2003, ARCH PHYS MED REHAB, V84, P285, DOI 10.1053/apmr.2003.50116; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P1, DOI 10.1016/S0003-9993(96)90210-5; MYSIW WJ, 2007, BRAIN INJURY MED PRI, P283; Naraghi FF, 1996, ORTHOPEDICS, V19, P145; Paddock SM, 2007, MED CARE, V45, P123, DOI 10.1097/01.mlr.0000250863.65686.bc; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Rogers Frederick, 2007, J Intensive Care Med, V22, P26, DOI 10.1177/0885066606295291; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; SILVER JM, 2004, TXB TRAUMATIC BRAIN, P259; SPIELMAN G, 1983, ARCH PHYS MED REHAB, V64, P539; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; Wen PY, 2006, J NEURO-ONCOL, V80, P313, DOI 10.1007/s11060-006-9193-2; World Health Organization, 2007, INT CLASS FUNCT DIS; Yablon SA, 2004, NEUROLOGY, V63, P485, DOI 10.1212/01.WNL.0000133009.24727.9F; Yablon SA, 1996, NEUROLOGY, V47, P939, DOI 10.1212/WNL.47.4.939; Zafonte R, 2004, J HEAD TRAUMA REHAB, V19, P89, DOI 10.1097/00001199-200403000-00002	46	7	7	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2008	89	3		1			S9	S14		10.1016/j.apmr.2007.12.010			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	276TX	WOS:000254167100003	18295656				2022-02-06	
J	Davies, AL; Kramer, JLK; Hayes, KC				Davies, A. L.; Kramer, J. L. K.; Hayes, K. C.			Carbon monoxide-releasing molecule tricarbonyldichlororuthenium (II) dimer induces con centration-dependent alterations in the electrophysiological properties of axons in mammalian spinal cord	NEUROSCIENCE			English	Article						spinal cord injury; double sucrose gap; guinea pig	HEME OXYGENASE-2 GENE; CNS WHITE-MATTER; OXIDATIVE STRESS; NITRIC-OXIDE; CONDUCTION BLOCK; INJURY; INDUCTION; MECHANISMS; DELETION; SURVIVAL	Traumatic spinal cord injury (SCI) typically involves intraparenchymal hemorrhage and a cascade of inflammatory and cytotoxic processes leading to tissue necrosis and apoptosis. A consequence of the hemorrhage is the accumulation of deoxygenated heme proximal and distal to the epicenter of the lesion. The heme oxygenase (HO) system is an endogenous heme degradation system and is upregulated following neurotrauma. The breakdown of heme via HO activity yields the byproducts carbon monoxide (CO), biliverdin, and iron. CO has documented neuromodulatory properties; however, the effects of elevated concentrations of CO on axonal conduction in the spinal cord have not previously been studied. The present study tested the hypothesis that CO causes alterations in the electrophysiological properties of axons within the isolated guinea-pig spinal cord. Ex vivo spinal cord preparations were exposed to 100, 500, and 1000 mu M concentrations of the carbon monoxide-releasing molecule (CORM) 2 for 30 min in a double sucrose gap electrophysiological recording system and the compound action potential (CAP) and membrane potential (CMP) were recorded continuously during pretreatment, CORM-2 treatment, and washout (30 min) with Krebs' solution. CAP amplitude and area were significantly (P<0.05) reduced following treatment with 500 and 1000 mu M CORM-2 and did not recover during washout. No effect on CMP was observed, however, stimulus-peak latency did increase significantly (P<0.05) following CORM-2 treatment at these concentrations, and a decrease in the amplitude of the second CAP elicited by paired-pulse stimulation was also evident at interpulse intervals of 2 and 4 ms. These results are consistent with a CO-induced alteration in axonal conduction, possibly attributable to modified Na+ channel conductance. They also identify a new mechanism by which post-traumatic hemorrhage contributes to the neurological deficits observed following SCI. (c) 2008 IBRO. Published by Elsevier Ltd. All rights reserved.	[Davies, A. L.; Kramer, J. L. K.; Hayes, K. C.] Lawson Hlth Res Inst, London, ON N6C 5J1, Canada; [Davies, A. L.; Kramer, J. L. K.; Hayes, K. C.] Univ Western Ontario, Neurosci Program, London, ON, Canada		Hayes, KC (corresponding author), Lawson Hlth Res Inst, 801 Commissioners Rd E, London, ON N6C 5J1, Canada.	kchayes@uwo.ca					Ashki N, 2006, J NEUROTRAUM, V23, P1779, DOI 10.1089/neu.2006.23.1779; Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; Bishop A, 2003, CURR DRUG METAB, V4, P171, DOI 10.2174/1389200033489514; Carratu M R, 1995, Arch Toxicol Suppl, V17, P295; Chen J, 2004, BIOCHEM BIOPH RES CO, V318, P88, DOI 10.1016/j.bbrc.2004.03.187; DAVIES AL, 2006, ABSTR SOC NEUR; DAVIES AL, 2007, ABSTR SOC NEUR; Davies AL, 2006, J NEUROTRAUM, V23, P1261, DOI 10.1089/neu.2006.23.1261; Fern R, 1998, J NEUROPHYSIOL, V79, P95, DOI 10.1152/jn.1998.79.1.95; Freitas A, 2006, BRIT J PHARMACOL, V149, P345, DOI 10.1038/sj.bjp.0706882; Goldstein L, 2003, J NEUROSCI RES, V73, P113, DOI 10.1002/jnr.10633; Hartsfield CL, 2002, ANTIOXID REDOX SIGN, V4, P301, DOI 10.1089/152308602753666352; Hayes KC, 1997, J NEUROTRAUM, V14, P235, DOI 10.1089/neu.1997.14.235; HAYES KC, 2006, SPINAL CORD, V42, P383; Jing CR, 2005, J NEUROSCI RES, V82, P802, DOI 10.1002/jnr.20681; Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Lin Y, 2007, J CEREBR BLOOD F MET, V27, P1010, DOI 10.1038/sj.jcbfm.9600412; Liu Y, 2002, J NEUROTRAUM, V19, P479, DOI 10.1089/08977150252932424; Maines MD, 2005, ANTIOXID REDOX SIGN, V7, P1761, DOI 10.1089/ars.2005.7.1761; Mautes AEM, 2000, EXP NEUROL, V166, P254, DOI 10.1006/exnr.2000.7520; Mautes AEM, 2000, BRAIN RES, V883, P233, DOI 10.1016/S0006-8993(00)02846-8; Mautes AEM, 1998, BRAIN RES, V795, P17, DOI 10.1016/S0006-8993(98)00230-3; Megias J, 2007, BRIT J PHARMACOL, V150, P977, DOI 10.1038/sj.bjp.0707184; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Panahian N, 2001, J NEUROCHEM, V76, P539, DOI 10.1046/j.1471-4159.2001.00023.x; Qu Y, 2005, J CEREBR BLOOD F MET, V25, P1466, DOI 10.1038/sj.jcbfm.9600143; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Regan RF, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-34; Rogers B, 2003, FREE RADICAL BIO MED, V35, P872, DOI 10.1016/S0891-5849(03)00431-3; Sener RN, 2003, AM J NEURORADIOL, V24, P1475; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Shi RY, 1997, EXP NEUROL, V148, P495, DOI 10.1006/exnr.1997.6706; Shrager P, 1998, J NEUROPHYSIOL, V79, P529, DOI 10.1152/jn.1998.79.2.529; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; Tekkok SB, 2004, NEUROCHEM RES, V29, P2163; Thom S R, 1997, Res Rep Health Eff Inst, P1; Thom SR, 1997, CHEM RES TOXICOL, V10, P1023, DOI 10.1021/tx970041h; Tofighi R, 2006, BRAIN RES, V1098, P1, DOI 10.1016/j.brainres.2006.04.095; Varadi J, 2007, LIFE SCI, V80, P1619, DOI 10.1016/j.lfs.2007.01.047; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Xi GH, 1998, J NEUROSURG, V89, P991, DOI 10.3171/jns.1998.89.6.0991; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	51	7	7	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	FEB 19	2008	151	4					1104	1111		10.1016/j.neuroscience.2007.12.002			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	264PS	WOS:000253301500017	18248914				2022-02-06	
J	Guler, I; Tunca, A; Gulbandilar, E				Guler, Inan; Tunca, Ayse; Gulbandilar, Eyyup			Detection of traumatic brain injuries using fuzzy logic algorithm	EXPERT SYSTEMS WITH APPLICATIONS			English	Article						fuzzy logic; traumatic brain injuries; electroencephalogram; trauma scores; Glasgow coma scores	EVOKED-POTENTIALS; EEG; ANESTHESIA; SYSTEM; COMA; CONSCIOUSNESS; SIGNALS; DEPTH; SCALE	The aim of this study was to develop a diagnostic system for detecting the severity of traumatic brain injuries using fuzzy logic. Twenty-six traumatic brain injury patients in different age and gender were taken in the study. Electroencephalography, Trauma and Glasgow coma scores were used for evaluating the system. The results were compared with the findings of neurologists. We found a significant relationship between the findings of neurologists and systems output for normal, mild and severe electroencephalography tracing data. Getting this system in routine use will facilitate to make a rapid decision for the degree of trauma with electroencephalography. (C) 2006 Elsevier Ltd. All rights reserved.	[Guler, Inan] Gazi Univ, Fac Tech Educ, Dept Elect & Comp Educ, TR-06500 Ankara, Turkey; [Tunca, Ayse] Dept Neurol, Dirimsel Outpatient Clin, Ankara 06520, Turkey; [Gulbandilar, Eyyup] Dumlupinar Univ, Fac Engn, Dept Comp Engn, Kutahya, Turkey		Guler, I (corresponding author), Gazi Univ, Fac Tech Educ, Dept Elect & Comp Educ, TR-06500 Ankara, Turkey.	iguler@gazi.edu.tr; etunca@e-kolay.net; egul50@dumlupinar.edu.tr	GAler, A°nan/AAF-4652-2020; Guler, Inan/AAB-9023-2019; Gulbandilar, Eyyup/H-1746-2015	Gulbandilar, Eyyup/0000-0001-5559-5281			Abrahams JM, 2002, NEUROSURGERY, V51, P264, DOI 10.1097/00006123-200207000-00044; Allen R, 2001, ARTIF INTELL MED, V21, P185, DOI 10.1016/S0933-3657(00)00084-1; Amin AP, 2000, SURGERY, V127, P245, DOI 10.1067/msy.2000.104296; Center B, 1998, ARTIF INTELL REV, V12, P213, DOI 10.1023/A:1006577431288; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; Elkfafi M, 1997, IEE P-CONTR THEOR AP, V144, P354, DOI 10.1049/ip-cta:19971169; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Guerit JM, 1999, NEUROPHYSIOL CLIN, V29, P301, DOI 10.1016/S0987-7053(99)90044-8; Guerit JM, 2000, ACTA NEUROL BELG, V100, P229; Guler I, 2005, J NEUROSCI METH, V148, P113, DOI 10.1016/j.jneumeth.2005.04.013; Guler I, 2002, COMPUT BIOL MED, V32, P435, DOI 10.1016/S0010-4825(02)00021-5; Huupponen E, 2002, ARTIF INTELL MED, V24, P133, DOI 10.1016/S0933-3657(01)00098-7; James CJ, 1998, P ANN INT IEEE EMBS, V20, P2175, DOI 10.1109/IEMBS.1998.747041; KITTEL WA, 1992, P 35 MIDW S, V1, P699; Lopez F, 2006, MED HYPOTHESES, V66, P121, DOI 10.1016/j.mehy.2005.07.015; Muthuswamy J, 1999, IEEE T BIO-MED ENG, V46, P291, DOI 10.1109/10.748982; Pointinger H, 2002, BRAIN INJURY, V16, P799, DOI 10.1080/02699050210131911; Quinonez D, 1998, ELECTROEN CLIN NEURO, V106, P108, DOI 10.1016/S0013-4694(97)00112-0; Robets J.H., 1993, HDB OPERATIONS RES M, P27, DOI [10.1016/S0927-0507(05)80025-8, DOI 10.1016/S0927-0507(05)80025-8]; Subasi A, 2006, EXPERT SYST APPL, V31, P320, DOI 10.1016/j.eswa.2005.09.027; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thatcher RW, 2001, CLIN NEUROPHYSIOL, V112, P1729, DOI 10.1016/S1388-2457(01)00609-5; Wellman HM, 2004, ACCIDENT ANAL PREV, V36, P165, DOI 10.1016/S0001-4575(02)00146-X; YAGER RR, 1994, FUZZY SETS NEURAL NE; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P312, DOI 10.1109/10.914794; Zouridakis G, 1997, IEEE T BIO-MED ENG, V44, P673, DOI 10.1109/10.605424	28	7	7	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0957-4174	1873-6793		EXPERT SYST APPL	Expert Syst. Appl.	FEB	2008	34	2					1312	1317		10.1016/j.eswa.2006.12.009			6	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Operations Research & Management Science	263TH	WOS:000253238900053					2022-02-06	
J	Barber, RC; Chang, LYE; Lemaire, SM; Burris, A; Purdue, GF; Hunt, JL; Arnoldo, BD; Horton, JW				Barber, Robert C.; Chang, Ling-Yu E.; Lemaire, Susan M.; Burris, Agnes; Purdue, Gary F.; Hunt, John L.; Arnoldo, Brett D.; Horton, Jureta W.			Epistatic interactions are critical to gene-association studies: PAI-1 and risk for mortality after burn injury	JOURNAL OF BURN CARE & RESEARCH			English	Article; Proceedings Paper	39th Annual Meeting of the American-Burn-Association	MAR 22-25, 2007	San Diego, CA	Amer Burn Assoc			TUMOR-NECROSIS-FACTOR; INTERLEUKIN-6 PROMOTER POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; INHIBITOR TYPE-1 GENE; PLASMINOGEN-ACTIVATOR; SEVERE SEPSIS; POPULATION STRATIFICATION; COMMON VARIANTS; TLR4; DISEASE	Replication of statistically significant associations between single nucleotide polymorphisms (SNPs) and disease phenotypes has been problematic. One reason for conflicting observations may be failure to consider confounding factors, including gene- gene (epistatic) interactions. Our experience with the insertion/deletion polymorphism at -688 in the promoter region of plasminogen activator inhibitor (PAI-1) seems to support this contention and may foreshadow problems for genome-wide association scans, which tend to use unadjusted analytical methodologies. One hundred forty-nine patients with;>= 15% total body surface area (TBSA) burns, without significant nonburn-related trauma (injury severity score <= 16), traumatic or anoxic brain injury or spinal cord injury who survived > 48 hours postadmission were enrolled under a protocol approved by the UT Southwestern and Parkland Hospital IBRs. Clinical data were collected prospectively and candidate polymorphisms in PAI-1 (-688), toll-like receptor 4 (+896), CD14 (-159), tumor necrosis factor-alpha (-308), and interleukin-6 (-174) were genotyped. The PAI-1 SNP was significantly associated (P-value for trend = 0.036) with risk for death when evaluated in isolation by unadjusted analysis. However, after adjustment for potential confounders using multiple logistic regression, only age, full-thickness burn size, and CD14 genotype (as previously reported) were associated with increased mortality. Genetic association analyses should be adjusted for interactions between multiple SNPs, injury or disease characteristics, and demographic variables. Increasingly sophisticated analytical methods will be required as gene-mapping studies transition from a candidate-gene based approach to genome-wide association scans.	[Barber, Robert C.; Chang, Ling-Yu E.; Lemaire, Susan M.; Burris, Agnes; Purdue, Gary F.; Hunt, John L.; Arnoldo, Brett D.; Horton, Jureta W.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA		Barber, RC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM021681] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5P50GM021681-41] Funding Source: Medline		Abraham LJ, 1999, J LEUKOCYTE BIOL, V66, P562, DOI 10.1002/jlb.66.4.562; Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Arnalich F, 2002, CLIN EXP IMMUNOL, V127, P331, DOI 10.1046/j.1365-2249.2002.01743.x; Arslan E, 2000, BURNS, V26, P521, DOI 10.1016/S0305-4179(00)00024-3; Barber RC, 2004, J MED GENET, V41, P808, DOI 10.1136/jmg.2004.021600; Barber RC, 2007, SHOCK, V27, P232, DOI 10.1097/01.shk.0000239770.10528.9a; BIEMOND BJ, 1995, CLIN SCI, V88, P587, DOI 10.1042/cs0880587; Brull DJ, 2001, ARTERIOSCL THROM VAS, V21, P1458, DOI 10.1161/hq0901.094280; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; CARRELL RW, 1991, NATURE, V353, P576, DOI 10.1038/353576a0; Chapes SK, 2001, J LEUKOCYTE BIOL, V69, P381; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; DROST AC, 1993, J TRAUMA, V35, P335, DOI 10.1097/00005373-199309000-00001; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; ENDO S, 1993, BURNS, V19, P124, DOI 10.1016/0305-4179(93)90033-5; Ferrand PE, 2002, MOL HUM REPROD, V8, P1031, DOI 10.1093/molehr/8.11.1031; Fishman D, 1998, EUR CYTOKINE NETW, V9, P364; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gambaro G, 2000, LANCET, V355, P308, DOI 10.1016/S0140-6736(99)07202-5; Glueck CJ, 2000, METABOLISM, V49, P845, DOI 10.1053/meta.2000.6749; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; Hermans PWM, 1999, LANCET, V354, P556, DOI 10.1016/S0140-6736(99)02220-5; Hermans PWM, 2005, CLIN INFECT DIS, V41, pS453, DOI 10.1086/431996; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hirschhorn JN, 2002, AM J HUM GENET, V71, P360; Ingalls RR, 2000, J ENDOTOXIN RES, V6, P411, DOI 10.1177/09680519000060050301; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kitchens RL, 2001, J CLIN INVEST, V108, P485, DOI 10.1172/JCI200113139; Kroeger KM, 2000, CYTOKINE, V12, P110, DOI 10.1006/cyto.1999.0529; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; Leveque G, 2003, INFECT IMMUN, V71, P1116, DOI 10.1128/IAI.71.3.1116-1124.2003; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; MARANO MA, 1990, SURG GYNECOL OBSTET, V170, P32; Menges T, 2001, LANCET, V357, P1096, DOI 10.1016/S0140-6736(00)04311-7; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; O'Keefe GE, 2002, J TRAUMA, V52, P817, DOI 10.1097/00005373-200205000-00001; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rannala B, 2001, Am J Pharmacogenomics, V1, P203, DOI 10.2165/00129785-200101030-00005; Russell JA, 2003, CRIT CARE MED, V31, pS243, DOI 10.1097/01.CCM.0000057870.61079.3E; Schluter B, 2002, CRIT CARE MED, V30, P32, DOI 10.1097/00003246-200201000-00005; Schwartz DA, 2002, INT J HYG ENVIR HEAL, V205, P221, DOI 10.1078/1438-4639-00117; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Tilg H, 1997, IMMUNOL TODAY, V18, P428, DOI 10.1016/S0167-5699(97)01103-1; Wang Y, 2003, HEPATOLOGY, V37, P65, DOI 10.1053/jhep.2003.50017; 1999, NAT GENET, V22, P1	52	7	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1559-047X			J BURN CARE RES	J. Burn Care Res.	JAN-FEB	2008	29	1					168	175		10.1097/BCR.0b013e31815f59f4			8	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Dermatology; Surgery	252OE	WOS:000252455000027	18182917				2022-02-06	
J	Ergun, A; Oder, W				Ergun, A.; Oder, W.			Oral diadochokinesis and velocity of narrative speech: A prognostic parameter for the outcome of diffuse axonal injury in severe head trauma	BRAIN INJURY			English	Article						traumatic brain injury; dysarthria; oral diadochokinesis; diffuse axonal injury	BRAIN-INJURY; ELECTROMAGNETIC ARTICULOGRAPHY; DYSARTHRIA; COMMUNICATION	Aim: To investigate dysarthria in severe traumatic brain injury following an acceleration/deceleration trauma and to correlate results with the severity of head trauma. Methods: Oral diadochokinesis by testing alternating (/pa/, /ta/and/ka/) and sequential motion rates (/pataka/and/tana/) and contextual speech, which comprises narrative speech and text reading, were examined in 15 patients in the chronic stage after severe closed head trauma with diffuse axonal injury. A possible influence of the severity of brain injury, expressed by the duration of post-traumatic amnesia, was examined. Results: Oral diadochokinesis of alternating motion rates and velocity of narrative speech were significantly reduced in traumatic brain injury. Both parameters correlated highly significantly with each other and correlated with the severity of brain injury described by the duration of post-traumatic amnesia. Reading speed was not comparable with narrative speech. Reading speed did not correlate with diffuse axonal injury but was strongly influenced by parameters that also influenced mental abilities. Conclusion: Oral diadochokinetic abilities of alternating motion rates and velocity of narrative speech represent a possible additional prognostic parameter for the outcome of traumatic brain injury in diffuse axonal injury.	[Ergun, A.; Oder, W.] AUVA, Rehabil Ctr Head Trauma Patient Meidling, A-1120 Vienna, Austria		Ergun, A (corresponding author), AUVA, Rehabil Ctr Head Trauma Patients, Koeglergasse 2A, A-1120 Vienna, Austria.	Alice.ergun@auva.at					Bartle CJ, 2006, BRAIN INJURY, V20, P529, DOI 10.1080/02699050500487613; BREITBACHSNOWDO.H, 2003, UNTERSUCHUNG NEUROLO; Drummond SS, 2004, BRAIN INJURY, V18, P41, DOI 10.1080/0269905031000149461; DUFFY JR, 2005, MOTOR SPEECH DISORDE, P14; Goozee J V, 2001, Logoped Phoniatr Vocol, V26, P51; Goozee JV, 2002, FOLIA PHONIATR LOGO, V54, P177, DOI 10.1159/000063191; Guo YE, 2008, BRAIN INJURY, V22, P83, DOI 10.1080/02699050701824150; Jaeger M, 2000, FOLIA PHONIATR LOGO, V52, P187, DOI 10.1159/000021533; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kuruvilla M, 2007, BRAIN INJURY, V21, P601, DOI 10.1080/02699050701427525; ROBERTSON SJ, 1995, DYSARTHRIA PROFILE; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Wang YT, 2005, FOLIA PHONIATR LOGO, V57, P59, DOI 10.1159/000083569; Wang YT, 2005, J COMMUN DISORD, V38, P231, DOI 10.1016/j.jcomdis.2004.12.001; Wurzer W, 1992, POSTTRAUMATISCHE ORG; ZIEGLER W, 1993, NEUROPSYCHOLOGISCHE, P187	16	7	8	0	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2008	22	10					773	779		10.1080/02699050802372182			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	347MJ	WOS:000259145400007	18787987				2022-02-06	
J	Greve, KW; Lotz, KL; Bianchini, KJ				Greve, Kevin W.; Lotz, Kenni L.; Bianchini, Kevin J.			Observed Versus Estimated IQ as an Index of Malingering in Traumatic Brain Injury: Classification Accuracy in Known Groups	APPLIED NEUROPSYCHOLOGY			English	Article						Barona index; intelligence; malingering; neuropsychological assessment; response bias; traumatic brain injury; Wechsler scales	WAIS-R; NEUROCOGNITIVE DYSFUNCTION; SCORES	This study examined the classification accuracy of observed WAIS-III VIQ, PIQ. and FSIQ minus Barona-estimate differential scores in the detection of Malingered Neurocognitive Dysfunction (MND) in Traumatic Brain Injury (TBI) using a known-groups design. Two hundred eleven TBI patients were assigned to one of three groups: Not-MND (n = 87), Indeterminate (it = 68), and MND (n = 56). A General Clinical Sample of 93 no-incentive patients (e.g., CVA, memory disorder) was also included to better study specificity. The VIQ differential accurately differentiated MND from Not-MND TBI patients regardless of injury severity. The PIQ differential was only accurate in mild TBI and did not add incremental validity to the VIQ differential. This study indicates that VIQ declines of greater than 24 points arc rare except in very severe TBI. Particularly in mild TBI. such differentials likely indicate intentional suppression of WAIS-III performance consistent with MND. Clinical application is discussed.	[Greve, Kevin W.; Lotz, Kenni L.] Jefferson Neurobehav Grp, Metairie, LA USA; [Greve, Kevin W.; Lotz, Kenni L.; Bianchini, Kevin J.] Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA		Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; BINDER LM, 1993, PORTLAND DIGIT RECOG; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Demakis GJ, 2001, PSYCHOL ASSESSMENT, V13, P240, DOI 10.1037//1040-3590.13.2.240; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Heaton SK, 1993, WISCONSIN CARD SORTI; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; Millis S. R., 2004, PRINCIPLES PRACTICE, P1077; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; *PSYCH CORP, WECHSL TEST AD READ; Schoenberg MR, 2006, ARCH CLIN NEUROPSYCH, V21, P469, DOI 10.1016/j.acn.2006.06.006; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME	29	7	7	0	1	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2008	15	3					161	169		10.1080/09084280802324085			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	362TG	WOS:000260219400001	18726736				2022-02-06	
J	Johnson, EA; Daugherty, KS; Gallagher, SJ; Moran, AV; DeFord, SM				Johnson, Erik A.; Daugherty, Kelly S.; Gallagher, Sarah J.; Moran, Anita V.; DeFord, S. Michelle			Glutamate receptor pathology is present in the hippocampus following repeated sub-lethal soman exposure in the absence of spatial memory deficits	NEUROTOXICOLOGY			English	Article						soman; GD; NMDA receptor; AMPA receptor; glutamate; Morris water mazes; sub-lethal; spatial memory; GluR2; NMDAR1; NMDAR2a; NMDAR2b	TRAUMATIC BRAIN-INJURY; MICROTUBULE-ASSOCIATED PROTEIN-2; PRENATAL ETHANOL EXPOSURE; LONG-TERM POTENTIATION; AGENT-INDUCED SEIZURE; 3 DIFFERENT SUBUNITS; NMDA RECEPTORS; COGNITIVE IMPAIRMENT; CEREBRAL-ISCHEMIA; GUINEA-PIGS	Much is still unknown about the long-term effects of repeated, sub-lethal exposure to organophosphorus (OP) nerve agents, such as soman (GD), on learning and memory tasks and related protein expression in the hippocampus. In the present study, guinea pigs were exposed to sub-lethal doses of GD for 10 days and cognitive performance assessed using the Morris water maze (MWM) up to 88 days post-exposure to investigate spatial learning. Additionally, hippocampal lysates were probed for cytoskeletal, synaptic and glutamate receptor proteins using Western blot analyses. No significant difference in MWM performance was observed between repeated sub-lethal GD exposed and saline control groups. However, Western blot analyses revealed significant changes in glutamate receptor protein immunoreactivity for subunits GluR2, NMDAR1, NMDAR2a and NMDAR2b in the hippocampi of GD-exposed guinea pigs. Levels of GluR2, NMDAR2a and NMDAR2b increased by 3 months post-initial exposure and returned to control levels by 6 months while NMDAR1 decreased by 6 months. No significant differences in neurofilament medium (NFM), neurofilament light (NFL) or synaptophysin densitometry were detected and alpha-II-spectrin proteolytic breakdown was also absent. These results reveal that repeated, sub-lethal exposure to GD affects glutamate receptor subunit expression but does not affect cytoskeletal protein immunoreactivity or the proteolytic state in the hippocampus. Though these changes do not affect spatial memory, they may contribute to other cognitive deficits previously observed following sub-lethal OP exposure. Published by Elsevier Inc.	[Johnson, Erik A.] USA, Med Res Inst Chem Def, Div Comparat Med, Comparat Pathol Branch, Aberdeen Proving Ground, MD 21010 USA; [Johnson, Erik A.; Daugherty, Kelly S.; Gallagher, Sarah J.; Moran, Anita V.; DeFord, S. Michelle] USA, Anal Toxicol Div, Neurobehav Toxicol Branch, Aberdeen Proving Ground, MD 21010 USA; [DeFord, S. Michelle] SE Massachusetts Univ, Dept Psychol, N Dartmouth, MA 02747 USA		Johnson, EA (corresponding author), USA, Med Res Inst Chem Def, Div Comparat Med, Comparat Pathol Branch, 3100 Ricketts Pt Rd, Aberdeen Proving Ground, MD 21010 USA.	erik.a.johnsonl@us.anny.mil					Atchison CR, 2004, TOXICOL MECH METHOD, V14, P183, DOI 10.1080/15376520490429166; Back T, 2004, J NEUROL, V251, P388, DOI 10.1007/s00415-004-0399-y; Baille V, 2001, PHARMACOL BIOCHEM BE, V69, P561, DOI 10.1016/S0091-3057(01)00549-4; BALLOUGH GPH, 1995, J NEUROSCI METH, V61, P23, DOI 10.1016/0165-0270(95)00019-Q; Briones TL, 2006, BEHAV BRAIN RES, V168, P261, DOI 10.1016/j.bbr.2005.11.015; Bruschettini M, 2006, PEDIATR RES, V60, P50, DOI 10.1203/01.pdr.0000220349.41675.92; BURCHFIEL JL, 1976, TOXICOL APPL PHARM, V35, P365, DOI 10.1016/0041-008X(76)90296-9; Byrnes ML, 2004, NEUROTOXICOL TERATOL, V26, P543, DOI 10.1016/j.ntt.2004.04.005; Carpentier P, 2001, NEUROTOXICOLOGY, V22, P13, DOI 10.1016/S0161-813X(00)00016-4; Carter TL, 2004, EXP NEUROL, V187, P299, DOI 10.1016/j.expneurol.2003.12.010; Cebers G, 1999, J NEUROCHEM, V72, P2181, DOI 10.1046/j.1471-4159.1999.0722181.x; Cebers G, 2001, NEUROCHEM INT, V39, P151, DOI 10.1016/S0197-0186(01)00014-6; Chazot PL, 1997, J NEUROCHEM, V69, P2138; CHURCHILL L, 1985, NEUROTOXICOLOGY, V6, P81; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; de Groot DMG, 2001, J APPL TOXICOL, V21, pS57, DOI 10.1002/jat.812; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DUFFY FH, 1979, TOXICOL APPL PHARM, V47, P161, DOI 10.1016/0041-008X(79)90083-8; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Filliat P, 2002, DRUG CHEM TOXICOL, V25, P9, DOI 10.1081/DCT-100108469; Gazzaley AH, 1996, P NATL ACAD SCI USA, V93, P3121, DOI 10.1073/pnas.93.7.3121; Gray GC, 1999, AM J EPIDEMIOL, V150, P532; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hatta K, 1996, LANCET, V347, P1343, DOI 10.1016/S0140-6736(96)90998-8; Hof PR, 2002, BRAIN RES, V928, P175, DOI 10.1016/S0006-8993(01)03345-5; Huh JW, 2003, J NEUROTRAUM, V20, P975, DOI 10.1089/089771503770195821; HYMOWITZ N, 1990, NEUROTOXICOL TERATOL, V12, P47, DOI 10.1016/0892-0362(90)90112-P; Inada K, 2003, NEUROSCI RES, V45, P473, DOI 10.1016/S0168-0102(03)00012-9; Iqbal U, 2004, BEHAV BRAIN RES, V150, P117, DOI 10.1016/S0166-4328(03)00246-8; Isaksson J, 2001, ACTA NEUROPATHOL, V102, P246; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Johnson EA, 2004, J NEUROTRAUM, V21, P1183, DOI 10.1089/neu.2004.21.1183; Kawada T, 2005, PERCEPT MOTOR SKILL, V100, P1121, DOI 10.2466/pms.100.3c.1121-1126; Kawana N, 2001, Mil Med, V166, P23; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Kreutz MR, 1998, J NEUROSCI, V18, P8278; LALLEMENT G, 1994, NEUROREPORT, V5, P2265, DOI 10.1097/00001756-199411000-00015; LALLEMENT G, 1991, NEUROTOXICOLOGY, V12, P655; LALLEMENT G, 1994, NEUROREPORT, V5, P425, DOI 10.1097/00001756-199401120-00013; LALLEMENT G, 1992, NEUROSCI LETT, V139, P104, DOI 10.1016/0304-3940(92)90868-8; LEVIN HS, 1976, CLIN TOXICOL, V9, P391, DOI 10.3109/15563657608988138; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Luthi-Carter R, 2003, NEUROBIOL DIS, V14, P624, DOI 10.1016/j.nbd.2003.08.024; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Mathern GW, 1996, NEUROREPORT, V7, P1029, DOI 10.1097/00001756-199604100-00015; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; McCauley L A, 2001, Int J Occup Environ Health, V7, P79; McDonough JH, 1997, NEUROSCI BIOBEHAV R, V21, P559, DOI 10.1016/S0149-7634(96)00050-4; MCDONOUGH JH, 1993, NEUROSCI BIOBEHAV R, V17, P203, DOI 10.1016/S0149-7634(05)80151-4; Mikuni N, 1998, NEUROSCI LETT, V255, P25, DOI 10.1016/S0304-3940(98)00704-6; Mikuni N, 1999, NEUROSCI LETT, V267, P165, DOI 10.1016/S0304-3940(99)00355-9; Mishizen-Eberz AJ, 2004, NEUROBIOL DIS, V15, P80, DOI 10.1016/j.nbd.2003.09.016; Miyaki K, 2005, J OCCUP HEALTH, V47, P299, DOI 10.1539/joh.47.299; MORITA H, 1995, LANCET, V346, P290; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Munirathinam S, 2004, J NEUROSCI RES, V77, P739, DOI 10.1002/jnr.20209; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nishiwaki Y, 2001, ENVIRON HEALTH PERSP, V109, P1169, DOI 10.2307/3454865; Nold JB, 2001, TOXICOL PATHOL, V29, P585, DOI 10.1080/019262301317226393; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Ohtani T, 2004, PSYCHIAT CLIN NEUROS, V58, P624, DOI 10.1111/j.1440-1819.2004.01313.x; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Phillips LL, 1998, HIPPOCAMPUS, V8, P390, DOI 10.1002/(SICI)1098-1063(1998)8:4<390::AID-HIPO7>3.3.CO;2-9; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; PIEHL F, 1995, EUR J NEUROSCI, V7, P2101, DOI 10.1111/j.1460-9568.1995.tb00632.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; RUSSELL RW, 1986, NEUROTOXICOL TERATOL, V8, P675; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SHIH TM, 1990, PSYCHOPHARMACOLOGY, V101, P489, DOI 10.1007/BF02244227; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; SINGH AK, 1987, ENVIRON RES, V43, P342, DOI 10.1016/S0013-9351(87)80034-8; SIPOS M, 2002, US ARMY MED DEFENSE, P525; Soundarapandian MM, 2005, MOL NEUROBIOL, V32, P145, DOI 10.1385/MN:32:2:145; SPARENBORG S, 1992, NEUROPHARMACOLOGY, V31, P357, DOI 10.1016/0028-3908(92)90068-Z; Sutcu R, 2005, INT J NEUROSCI, V115, P305, DOI 10.1080/00207450590519012; Temerowski M, 2005, NEUROTOXICOL TERATOL, V27, P279, DOI 10.1016/j.ntt.2004.12.004; Thompson S., 2005, PHARM MD ARMY MED RE, P1; Tortarolo M, 2006, J NEUROSCI RES, V83, P134, DOI 10.1002/jnr.20715; WAFFORD KA, 1993, NEUROREPORT, V4, P1347, DOI 10.1097/00001756-199309150-00015; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; Wood SJ, 2001, J APPL TOXICOL, V21, pS83, DOI 10.1002/jat.817	85	7	7	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X			NEUROTOXICOLOGY	Neurotoxicology	JAN	2008	29	1					73	80		10.1016/j.neuro.2007.09.002			8	Neurosciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	262ZO	WOS:000253187600008	17942156				2022-02-06	
J	Lesperance, K; Martin, MJ; Beekley, AC; Steele, SR				Lesperance, Kelly; Martin, Matthew J.; Beekley, Alec C.; Steele, Scott R.			The significance of penetrating gluteal injuries: An analysis of the operation Iraqi freedom experience	JOURNAL OF SURGICAL EDUCATION			English	Article						penetrating injuries; gluteal; OIF; rectal trauma	EXTRAPERITONEAL RECTAL INJURIES; SUPERIOR GLUTEAL; GUNSHOT WOUNDS; MANAGEMENT; TRAUMA; PRINCIPLES; COLOSTOMY; PATIENT; REGION; ARTERY	BACKGROUND: Although penetrating gluteal injuries rarely are life-threatening, the risk for concomitant injury to regional anatomic structures warrants additional evaluation. We analyzed factors affecting the management and outcomes of these injuries. METHODS: Retrospective analysis of prospectively collected data from the 31 st Combat Support Hospital during Operation Iraqi Freedom over a 16 month period. RESULTS: From 3442 patients, 115 patients (3.3%) suffered penetrating gluteal injuries. They were predominately male (98%) with a mean injury severity score of 13. Mortality was 6% (n = 7). Primary mechanisms of injury were improvised explosive devices (41%) and gunshot Wounds (59%). Associated injuries were present in 57% of patients [orthopedic (35%), abdominal (29%), rectal (25%), vascular (21%), genitourinary (14%), pulmonary (11%), sphincter (9%)]. Overall, 76% required Surgical management, with 14% developing postoperative complications. In total, 27 patients (24%) required stoma placement. Gunshot wounds were associated with through and through injuries (43% vs 6%, p < 0.01), rectal injury (35% vs 11%, p < 0.05), and stoma placement (32% vs 11%, P < 0.05). Blast injuries were associated with a higher mean transfusion requirement (11 vs 6 units, p < 0.05), increased length of stay (14 vs 9 days, p < 0.05), and traumatic brain injury (24% vs 6%, p < 0.05). Independent predictors of a need for stoma placement were gunshot wounds (odds ratio = 10, p < 0.05) and injury severity score greater than 20 (odds ratio = 27, p < 0.01). CONCLUSIONS: Penetrating gluteal injuries are associated with significant damage to local structures. Gunshot wounds carry a higher risk of injury to the rectum and stoma placement, whereas blast injuries are associated with less local injury and more multisystem trauma.	[Lesperance, Kelly; Martin, Matthew J.; Beekley, Alec C.; Steele, Scott R.] Madigan Army Med Ctr, Dept Surg, Ft Lewis, WA USA		Steele, SR (corresponding author), 9606 Piperhill Dr SE, Olympia, WA 98513 USA.	docsteele@hotmail.com	Martin, Matthew/B-2676-2014	Martin, Matthew/0000-0002-9169-9069			Arthurs Z, 2006, AM J SURG, V191, P604, DOI 10.1016/j.amjsurg.2006.02.009; Belley G, 1997, J TRAUMA, V43, P703, DOI 10.1097/00005373-199710000-00026; BOSTICK PJ, 1993, J NATL MED ASSOC, V85, P460; BURCH JM, 1989, ANN SURG, V209, P600, DOI 10.1097/00000658-198905000-00013; DIGIACOMO JC, 1994, J TRAUMA, V37, P622, DOI 10.1097/00005373-199410000-00016; GILROY D, 1992, J TRAUMA, V32, P294, DOI 10.1097/00005373-199203000-00005; Gonzalez RP, 2006, J TRAUMA, V61, P815, DOI 10.1097/01.ta.0000239497.96387.9d; Haut ER, 2004, DIS COLON RECTUM, V47, P1526, DOI 10.1007/s10350-004-0605-0; IVATURY RR, 1982, J TRAUMA, V22, P706, DOI 10.1097/00005373-198208000-00011; Kudsk KA, 2003, WORLD J SURG, V27, P895, DOI 10.1007/s00268-003-6719-z; Leaphart CL, 2006, J PEDIATR SURG, V41, P700, DOI 10.1016/j.jpedsurg.2005.12.012; Liu Xin-sheng, 2006, Chin J Traumatol, V9, P56; Lunsjo K, 2006, J TRAUMA, V60, P1145, DOI 10.1097/01.ta.0000197615.31553.1e; Makrin V, 2001, J TRAUMA, V50, P707, DOI 10.1097/00005373-200104000-00018; MAMODE N, 1994, BRIT J SURG, V81, P203, DOI 10.1002/bjs.1800810214; MERCER DW, 1992, ARCH SURG-CHICAGO, V127, P407; Pons F, 1997, ANN UROL, V31, P294; Porter JM, 2001, AM SURGEON, V67, P438; Schaffzin DM, 2004, DIS COLON RECTUM, V47, P1745, DOI 10.1007/s10350-004-0633-9; Shatnawi NJ, 2006, ASIAN J SURG, V29, P11, DOI 10.1016/S1015-9584(09)60286-4; SMITH K, 1976, J TRAUMA, V16, P273, DOI 10.1097/00005373-197604000-00004; Steele R, 2007, ANN EMERG MED, V50, P1, DOI 10.1016/j.annemergmed.2006.09.007; VITALE GC, 1983, AM SURGEON, V49, P159; Vukic Z, 2000, MIL MED, V165, P237, DOI 10.1093/milmed/165.3.237	24	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1931-7204			J SURG EDUC	J. Surg. Educ.	JAN-FEB	2008	65	1					61	66		10.1016/j.jsurg.2007.08.004			6	Education, Scientific Disciplines; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Education & Educational Research; Surgery	339IB	WOS:000258570200008	18308283				2022-02-06	
J	Persinger, MA; Tiller, SG				Persinger, Michael A.; Tiller, Sandra G.			Case report: A prototypical spontaneous 'sensed presence' of a sentient being and concomitant electroencephalographic activity in the clinical laboratory	NEUROCASE			English	Article						Seizures; Electroencephalography; The sensed presence; Closed head injury; Theta activity	COMPLEX MAGNETIC-FIELDS; BRAIN INJURY; PROFILES; SELF	The sensed presence of a 'Sentient Being' has been hypothesized to be the transient awareness of the right hemispheric equivalent of the left hemispheric sense of self. When the clinical context is supportive for the expression of anomalous cognition, the experience is reported frequently by patients who display complex partial epileptic-like symptoms and signs following a mild closed head injury. This article describes a patient with a history of presences subsequent to a 'mild' closed head injury who reported strong experiences during an electroencephalographic screening within a very quiet and darkened setting at the end of a day of neuropsychological assessments. The right-sided presence was preceded by the sensation of an 'electric shock' through the right hand and then both hands. Whole body 'icy coldness' and then vibrations 'moved' through her entire body. The experiences were concomitant with paroxysmal irregular 4-5-Hz activity over the temporal lobes. This case illustrates that many sensed presences might be similar to 'epileptic auras' for patients who also display elevated complex partial epileptic-like experiences following closed head injuries and that close attention to typically ignored electroencephalographic 'transients' may be helpful indicators.	[Persinger, Michael A.; Tiller, Sandra G.] Laurentian Univ, Neuropsychol Lab, Behav Neurosci Program, Sudbury, ON P3E 2C6, Canada		Persinger, MA (corresponding author), Laurentian Univ, Neuropsychol Lab, Behav Neurosci Program, Sudbury, ON P3E 2C6, Canada.	mpersinger@laurentian.ca					ARDILA A, 1988, EPILEPSIA, V29, P188, DOI 10.1111/j.1528-1157.1988.tb04417.x; ARZY A, 2006, NATURE, V443, P3; GLOOR P, 1993, BRAIN, V116, P1249, DOI 10.1093/brain/116.5.1249; Landtblom AM, 2006, EPILEPSY BEHAV, V9, P186, DOI 10.1016/j.yebeh.2006.04.023; PERSINGER MA, 1993, PERCEPT MOTOR SKILL, V76, P915, DOI 10.2466/pms.1993.76.3.915; PERSINGER MA, 1984, PERCEPT MOTOR SKILL, V58, P127, DOI 10.2466/PMS.58.1.127-133; Persinger MA, 2003, J PSYCHOL, V137, P5, DOI 10.1080/00223980309600595; Persinger MA, 2002, J NERV MENT DIS, V190, P533, DOI 10.1097/00005053-200208000-00006; PERSINGER MA, 1992, BRAIN COGNITION, V20, P217, DOI 10.1016/0278-2626(92)90016-F; Persinger MA, 2001, J NEUROPSYCH CLIN N, V13, P515, DOI 10.1176/appi.neuropsych.13.4.515; Persinger MA, 1995, PERCEPT MOTOR SKILL, V81, P1283, DOI 10.2466/pms.1995.81.3f.1283; PERSINGER MA, 1993, J CLIN PSYCHOL, V49, P33, DOI 10.1002/1097-4679(199301)49:1<33::AID-JCLP2270490106>3.0.CO;2-H; Persinger MA, 2000, PERCEPT MOTOR SKILL, V90, P659, DOI 10.2466/PMS.90.2.659-674; PERSINGER MA, 1994, PSYCHOL REP, V75, P1059, DOI 10.2466/pr0.1994.75.3.1059; PERSINGER MA, 1993, PSYCHOL REP, V72, P1059, DOI 10.2466/pr0.1993.72.3c.1059; ROBERTS RJ, 1992, EPILEPSY RES, V13, P167, DOI 10.1016/0920-1211(92)90073-3	16	7	7	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1355-4794			NEUROCASE	Neurocase		2008	14	5					425	430		10.1080/13554790802406172			6	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	368FM	WOS:000260607000006	18821169				2022-02-06	
J	Safaz, I; Alaca, R; Bozlar, U; Yasar, E				Safaz, Ismail; Alaca, Ridvan; Bozlar, Ugur; Yasar, Evren			Bilateral sciatic nerve entrapment due to heterotopic ossification in a traumatic brain-injured patient	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						traumatic brain injury; heterotopic ossification; sciatic nerve entrapment	COMPRESSION; SECONDARY	We report a 22-yr-old man who was admitted to our inpatient rehabilitation center 17 mos after a traumatic brain injury (TBI). He was also diagnosed to have bilateral sciatic nerve entrapment attributable to hip beterotopic ossification (HO). Presenting the first report of a sciatic nerve entrapment secondary to a HO in TBI, we herein discuss the concurrence of a lower-motor nerve problem in a patient with an upper-motor nerve injury.	[Safaz, Ismail; Alaca, Ridvan; Yasar, Evren] Turkish Armed Forces Rehabil Ctr, Ankara, Turkey; [Alaca, Ridvan] Gulhane Mil Med Acad, Dept Phys Med & Rehabil, Ankara, Turkey; [Bozlar, Ugur] Gulhane Mil Med Acad, Dept Radiol, Ankara, Turkey		Safaz, I (corresponding author), TSK Rehabil Bakim Merkezi Lojmanlari, V-3-17 Bilkent, Ankara, Turkey.			BOZLAR, UGUR/0000-0002-2233-2079			Abayev B, 2005, NEUROLOGIST, V11, P184, DOI 10.1097/01.nrl.0000160557.86676.63; Chan KT, 2005, AM J PHYS MED REHAB, V84, P145, DOI 10.1097/01.PHM.0000151939.59660.B1; Chua H. C., 1997, SMJ, V38, P447; CITTAPIETROLUNGO TJ, 1992, ARCH PHYS MED REHAB, V73, P258; FITZSIMMONS AS, 1993, ARCH PHYS MED REHAB, V74, P770, DOI 10.1016/0003-9993(93)90042-9; Laborde A, 2005, RHEUMATOLOGY, V44, P110, DOI 10.1093/rheumatology/keh255; REINSTEIN L, 1983, ARCH PHYS MED REHAB, V64, P65	7	7	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JAN	2008	87	1					65	67		10.1097/PHM.0b013e31815b5b4d			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	248OC	WOS:000252162200010	18158431				2022-02-06	
J	Tamura, A; Nakahira, Y; Iwamoto, M; Watanabe, I; Miki, K; Hayashi, S; Kitagawa, Y; Yasuki, T				Tamura, Atsutaka; Nakahira, Yuko; Iwamoto, Masami; Watanabe, Isao; Miki, Kazuo; Hayashi, Shigeki; Kitagawa, Yuichi; Yasuki, Tsuyoshi			Analysis of traumatic brain injury due to primary head contact during vehicle-to-pedestrian impact	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						traumatic brain injury; vehicle-to-pedestrian impact; traction force; cervical spinal cord; brainstem; diffuse axonal injury	INTRACRANIAL-PRESSURE; MODEL; MOTION; RECONSTRUCTION; BIOMECHANICS; ACCIDENTS; SEVERITY; FALLS	We developed a 50th-percentile American male pedestrian model including a detailed brain, and the mechanical responses and kinematic biofidelity predicted by this model were validated against the available cadaveric test data. Vehicle-to-pedestrian impact simulations were then performed to investigate a potential mechanism for traumatic brain injury resulting from a lateral blunt impact to the head. Due to inertia of the brain mass, it was found that the average traction force produced in the cervical spinal cord exceeded 50 N in the impact involving a sport utility vehicle and 25 N in the impact involving a sedan, when the striking vehicle was travelling at 40 km/h. This inertial loading may play a key role in a brainstem, or upper-cervical-cord, lesion occurring before head strike. Results of this study suggest that close attention should be paid to pedestrian kinematics during free flight even before the head makes primary contact with the striking vehicle.	[Tamura, Atsutaka; Nakahira, Yuko; Iwamoto, Masami; Watanabe, Isao; Miki, Kazuo] Toyota Cent Res & Dev Labs Inc, Biomech Lab, Nagakute, Aichi 48011, Japan; [Hayashi, Shigeki; Kitagawa, Yuichi; Yasuki, Tsuyoshi] Toyota Motor Co Ltd, Adv CAE Div, Toyota, Japan		Tamura, A (corresponding author), Toyota Cent Res & Dev Labs Inc, Biomech Lab, 41-1 Aza Yokomichi, Nagakute, Aichi 48011, Japan.	a-tamura@mosk.tytlabs.co.jp					Aimedieu P, 2004, J NEUROSURG, V100, P111, DOI 10.3171/jns.2004.100.1.0111; Anderson R, 2003, INT J VEHICLE DES, V32, P1, DOI 10.1504/IJVD.2003.003233; Anderson R, 2005, P 19 INT TECHN C ENH; Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; BANDAK FA, 1994, P 38 STAPP CAR CRASH, P145; Crandall JR, 2006, INT J CRASHWORTHINES, V11, P529, DOI 10.1533/ijcr.2006.0146; Crandall JR, 2002, BRIT MED J, V324, P1145, DOI 10.1136/bmj.324.7346.1145; Deck C., 2004, P 2004 INT IRCOBI C, P79; DiMaggio Charles, 2006, Int J Inj Contr Saf Promot, V13, P95, DOI 10.1080/17457300500310038; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Fildes B, 2004, P IRCOBI C GRAZ AUST, P167; Fredriksson R, 2006, P INT IRCOBI C BIOM, P253; Gunji Hirobumi, 2002, Leg Med (Tokyo), V4, P84, DOI 10.1016/S1344-6223(02)00012-3; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hasegawa J, 2003, P 18 INT TECHN C ENH; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Ishikawa H., 2005, P 19 INT TECHN C ENH; Kam C., 2005, 2005011875 SAE, DOI 10.4271/2005-01-1875; Kerrigan J, 2005, P INT C BIOM IMP IRC, P159; Kerrigan J, 2005, P 19 INT TECHN C ENH; KING AI, 2002, P 4 WORLD C BIOM CAL; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; KONDO T, 1995, SCI JUSTICE, V35, P197, DOI 10.1016/S1355-0306(95)72661-2; Lefler DE, 2004, ACCIDENT ANAL PREV, V36, P295, DOI 10.1016/S0001-4575(03)00007-1; Marguilies SS, 1992, P INT IRCOBI C BIOM, P213; Meissner M, 2006, 2006010462 SAE; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Okamoto Y, 2006, P 2006 INT IRCOBI C, P265; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pohlemann T, 2001, P 2001 INT IRCOBI IN; Roudsari BS, 2004, INJURY PREV, V10, P154, DOI 10.1136/ip.2003.003814; Simms CK, 2006, INT J CRASHWORTHINES, V11, P345, DOI 10.1533/ijcr.2005.0109; Smith JP, 2003, AM ECON REV, V93, P315, DOI 10.1257/000282803321947263; TAMURA A, 2006, P IRCOBI C MADR SPAI, P361; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Tamura A., 2006, J BIOMECH SCI ENG, V1, P304; Yang J., 2005, INT J VEH SAF, V1, P100, DOI [10.1504/IJVS.2005.007540, 10.1504/ijvs.2005.007540]; Yoganandan Narayan, 2004, Traffic Inj Prev, V5, P368, DOI 10.1080/15389580490510336; Zhang L, 2001, Stapp Car Crash J, V45, P369	43	7	7	1	8	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1358-8265			INT J CRASHWORTHINES	Int. J. Crashworthiness		2008	13	4					375	385		10.1080/13588260802030497			11	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	323UC	WOS:000257472900003					2022-02-06	
J	Wallace, SE; Evans, K; Arnold, T; Hux, K				Wallace, Sarah E.; Evans, Kelli; Arnold, Taylor; Hux, Karen			Functional brain injury rehabilitation: Survivor experiences reported by families and professionals	BRAIN INJURY			English	Article						traumatic brain injury; community based rehabilitation; outcome; family	RATING-SCALE; DISABILITY; MODEL; SELF	Primary objective: The researchers investigated rehabilitation experiences of brain injury (BI) survivors participating in a functional programme. Research design: The researchers used a phenomenological approach involving the collection of artifacts and the analysis of focus group discussions through horizontalizing statements, creating meaning units and clustering codes. Methods and procedures: Focus groups including staff members and survivors' relatives reported perceptions about the programme and survivors' experiences; programme artifacts (e.g. survivors' schedules, website information) provided additional information. Survivors verified focus group responses and an analysis using five assessment measures served to validate positive functional changes among programme participants. Main outcomes: Three general categories of themes emerged: components of functional therapy, programme/culture features supporting functional therapy and family members' and survivors' reactions to a functional programme. Sub-categories and themes provided details about issues central to functional BI treatment. Conclusions: The findings suggest that functional therapy programmes: (a) address family and survivors' goals, (b) occur in the community or real world, (c) are implemented by people in survivors' environments, (d) are collaborative, (e) focus on a positive culture, (f) build on basic skills, (g) allow exploration of discharge options, (h) preserve survivors' privacy and dignity and (i) recognize difficulties associated with transitioning from acute to post-acute rehabilitation.	[Wallace, Sarah E.; Evans, Kelli; Arnold, Taylor; Hux, Karen] Univ Nebraska, Barkley Mem Ctr, Lincoln, NE 68583 USA		Wallace, SE (corresponding author), Univ Nebraska, Barkley Mem Ctr, 318K, Lincoln, NE 68583 USA.	sarahliz511@yahoo.com	Hux, Karen/AAQ-2078-2020	Wallace, Sarah E./0000-0003-4085-9250			Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Creswell JW., 1998, QUAL INQ; Crisp R., 1993, DISABIL HANDICAP SOC, V8, P393, DOI DOI 10.1080/02674649366780371; JOHNSTON MV, 1992, J HEAD TRAUMA REHAB, V7, P68; JORDAN L, 2004, DIS STUD ORG C HELD; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; MALEC JF, 2005, RASCH MEASUREMENT HL; Miles M.B., 1994, QUALITATIVE DATA ANA, V2nd; Moustakas C.E., 1994, PHENOMENOLOGICAL RES; OLIVER M, 1990, IND SOC MOD DIS JOIN; PERSINGER MA, 1993, PSYCHOL REP, V72, P1059, DOI 10.2466/pr0.1993.72.3c.1059; *QUAL LIV INC, 2004, RECR REHAB; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P510, DOI 10.1097/00001199-200212000-00003; Seelman KD, 2000, TECHNOLOGY DISABILIT, V12, P77; Siminski P, 2003, DISABIL SOC, V18, P707, DOI 10.1080/0968759032000119479; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; World Health Organization, 2007, INT CLASS FUNCT DIS; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002	22	7	7	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2007	21	13-14					1371	1384		10.1080/02699050701785088			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	253AA	WOS:000252488200005	18066939				2022-02-06	
J	Romeiro, RR; Romano-Silva, MA; De Marco, L; Teixeira, AL; Correa, H				Romeiro, Ricardo R.; Romano-Silva, Marco A.; De Marco, Luiz; Teixeira, Antonio L., Jr.; Correa, Humberto			Can variation in aquaporin 4 gene be associated with different outcomes in traumatic brain edema?	NEUROSCIENCE LETTERS			English	Article						head trauma; brain edema; aquaporin 4	MIGRATION	In traumatic brain injury (TBI), cerebral edema and hemorrhage are factors involved in the determination of the clinical presentation and outcome. The aquaporin 4 (AQP4) water channel is abundant in mammalian brain and there is a growing body of evidence suggesting that this protein plays a major role in the control of water flow within the central nervous system. Previous studies examined the influence of genetic variants in cerebral edema of TBI. However, to our knowledge, there are no previous studies of molecular variations of the AQP4 gene and its association with TBL. Thus, we sought to investigate if the clinical presentation and outcome of TBI could be influenced by the presence of mutations on exon 4 of the AQP4 gene. One hundred and two patients were enrolled in this study. A neurologist assessed the clinical severity at admission according to the GCS followed by a brain computer tomography (CT) scan. Then, DNA was extracted from blood cells and exon 4 of the AQP4 gene amplified by the polymerase chain reaction and directly sequenced. On discharge, GOS was assigned by a neurologist blind to the CGS on admission. We did not find any variation in exon 4 of the AQP4 gene in our considerable large sample. Despite this negative result, there is a strong biological rationale for the involvement of AQP4 gene in brain edema regulation and, as consequence, in TBI. Therefore, further studies should be performed, including the assessment of the other three exons of the AQP4 gene. (c) 2007 Elsevier Ireland Ltd. All rights reserved.	Univ Fed Minas Gerais, Fac Med, Dept Mental Hlth, BR-30130100 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Hosp Joao XXIII, BR-30130100 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Dept Pharmacol, BR-30130100 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Dept Internal Med, BR-30130100 Belo Horizonte, MG, Brazil		Correa, H (corresponding author), Univ Fed Minas Gerais, Fac Med, Dept Mental Hlth, Av Alfredo Baleno 190, BR-30130100 Belo Horizonte, MG, Brazil.	correa@task.com.br	Correa, Humberto/B-6497-2009; Romano-Silva, Marco Aurelio/T-8321-2019; Teixeira, Antonio L/N-3315-2014; DE MARCO, LUIZ/H-6275-2012; Romano-Silva, Marco Aurelio/A-1790-2008	Correa, Humberto/0000-0003-4327-6413; Teixeira, Antonio L/0000-0002-9621-5422; DE MARCO, LUIZ/0000-0003-2535-7439; Romano-Silva, Marco Aurelio/0000-0002-6558-4639			Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Gunnarson E, 2004, NEUROSCIENCE, V129, P947, DOI 10.1016/j.neuroscience.2004.08.022; Hadjigeorgiou GM, 2005, NEUROLOGY, V65, P1077, DOI 10.1212/01.wnl.0000178890.93795.0e; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460	9	7	8	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	OCT 16	2007	426	2					133	134		10.1016/j.neulet.2007.09.004			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225EP	WOS:000250500200013	17890008				2022-02-06	
J	Hughes, J; Orange, JB				Hughes, Julie; Orange, J. B.			Mapping Functional Communication Measurements for Traumatic Brain Injury to the WHO-ICF	CANADIAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY AND AUDIOLOGY			English	Article						WHO-ICF; traumatic brain injury; functional communication; adults		Traditional impairment-based cognitive communication assessments do not adequately capture the complex functional communication problems of individuals with traumatic brain injury (TBI). There are three objectives of this paper. The first objective is to review the World Health Organization's International Classification of Functioning and Disability's (ICF) conceptual framework. The second objective is to describe the use of the ICF to conceptualize the functional communication abilities of individuals with TBI. The third objective is to discuss findings from a mapping analysis of three functional communication measures to the components of the ICF. The three measures include the American Speech-Language Hearing Association Functional Assessment of Communicative Skills (ASHA FACS) (Frattali, Thompson, Holland, Wohl, & Ferketic, 1995), the Communication Activities of Daily Living (CADL-2) (Holland, Frattali, & Fromm, 1999), and the Functional Assessment of Verbal Reasoning and Executive Skills (FAVRES) (MacDonald, 1998). The findings from the mapping are reported and their relevance to clinical practice is discussed. Finally, suggestions are provided regarding the use of the WHO-ICF framework by speech-language pathologists when they determine which functional communication activities are important to individuals with TBI, and which measurement tools most accurately reflect the functional communication abilities of individuals with TBI.	[Hughes, Julie] Univ Western Ontario, Fac Hlth Sci Hlth & Rehabil Sci, London, ON, Canada; [Orange, J. B.] Univ Western Ontario, Fac Hlth Sci, Sch Commuicat Disorders & Sci Hlth & Rehabil Sci, London, ON, Canada		Hughes, J (corresponding author), Parkwood Hosp, St Josephs Hlth Care London, 801 Commissioners Rd East, London, ON, Canada.			Orange, JB/0000-0002-2632-3049			Adamovich B. B., 1992, SCALES COGNITIVE ABI; American Speech-Language-Hearing Association, 1990, ADV REP FUNCT COMM M; American Speech-Language-Hearing Association, 2001, SCOP PRACT SPEECH LA; Beukelman D., 1991, COMMUNICATION DISORD, P1; Body R., 1999, BRAIN DAM B; CASLPO, 2002, PREF PRACT GUID COGN; Davidson B., 2002, NEUROGENIC COMMUNICA, P19; Eadie TL, 2003, AM J SPEECH-LANG PAT, V12, P189, DOI 10.1044/1058-0360(2003/065); Frattali C., 1995, AMERICAN SPEECH LANG; GILLIS R, 1996, TRAUMATIC BRAIN INJU; Gioa GA, 2000, BEHAV RATING INVENTO; Holland A., 1999, COMMUNICATION ACTIVI; Kertesz A., 1982, W APHASIA BATTERY; Larkins B., 2000, NEUROGENIC COMMUNICA, P206; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; MacDonald S., 1998, FUNCTIONAL ASSESSMEN; Ontario Brain Injury Association (OBIA), 2001, INF ACQ BRAIN INJ ES; Orange, 2005, ADV SPEECH LANGUAGE, V7, P187, DOI [DOI 10.1080/14417040500337062, https://doi.org/10.1080/14417040500337062]; Ostensjo S, 2006, DISABIL REHABIL, V28, P489, DOI 10.1080/09638280500212013; Sohlberg M., 2001, COGNITIVE REHABILITA; State University of New York at Buffalo, 1993, GUID US UN DAT SET M; Statistics Canada, 2006, CAN COMM HLTH SURV C, P623; Threats T, 2004, ADV SPEECH LANGUAGE, V6, P53, DOI DOI 10.1080/14417040410001669426; Threats T. T., 2003, CONCEPTUAL FRAMEWORK; Threats TT, 2002, J MED SPEECH-LANG PA, V10, pXVII; Turkstra L., 2005, J MED SPEECH-LANG PA, V13, P9; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; WHO, 2001, INT CLASS CAT FUNCT; Worrall L, 2002, J COMMUN DISORD, V35, P107, DOI 10.1016/S0021-9924(02)00060-6; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P744	31	7	7	0	0	CANADIAN ASSOC SPEECH-LANGUAGE PATHOLOGISTS & AUDIOLOGISTS	OTTAWA	920-1 NICHOLAS ST, OTTAWA, ONTARIO K1N 7B7, CANADA	1913-2018			CAN J SPEECH-LANG PA	Can. J. Speech-Lang. Pathol. Audiol.	FAL	2007	31	3					134	143					10	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V6G5J	WOS:000420263400005					2022-02-06	
J	Ulmer, S; Schulz, E; Moeller, B; Krause, UR; Nabavi, A; Mehdorn, HM; Jansen, O				Ulmer, S.; Schulz, E.; Moeller, B.; Krause, U. R.; Nabavi, A.; Mehdorn, H. M.; Jansen, O.			Radiation dose of the lens in trans-sphenoidal pituitary surgery: Pros and cons of a conventional setup using fluoroscopic guidance and CT-based neuronavigation	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article; Proceedings Paper	56th Annual Meeting of the German-Society-of-Neurosurgery	MAY 07-11, 2005	Strasbourg, GERMANY	German Soc Neurosurg			X-RAYS; BRAIN; COMPLICATIONS; RADIOTHERAPY; IRRADIATION; TOLERANCE; EXPOSURE; SYSTEM; CANCER; INJURY	BACKGROUND AND PURPOSE: We determined the radiation dose in patients' lenses during pituitary surgery with either conventional fluoroscopy or CT-guided neuronavigation. MATERIALS AND METHODS: Thermoluminescent dosimeters (TLD-100H) were attached to the lenses of an anthropomorphic Alderson-Rando head phantom. Simulation of the conventional setup of continuous fluoroscopy (61 kV peak, 2.01 mAs) with collimation and automatic exposure control was used with 1 TLD being removed every 5 seconds, followed by another experiment with I being removed every 30 seconds. For CT-guided neuronavigation, a spiral of 3-mm-thick sections without gap was performed (140 kV, 220 mA). Patients' charts (n = 87) were reviewed in terms of radiation exposure and perioperative complications, RESULTS: Radiation dose is distance-dependent (P <.002), with an exposure-time-dependent linear increase (R-2 = 99.27, P <.0001) close to the primary beam only. The radiation dose of the CT (mean, 39.39 mGy) was fivefold higher compared with the maximal time of 3 minutes (8 mGy) reached in our patients by using the conventional setup. CT offers more detailed 3D anatomy available at any time intraoperatively. Tolerance doses needed to develop cataracts were not reached, and perioperative complications occurred without significant differences (Mann-Whitney U test, P =.39) using either method. Continuous use of fluoroscopy reached the mean value of CT after 14.33 minutes. CONCLUSION: Neuronavigation provides better anatomic information and avoids repetitive exposure and accumulation to the staff, with the disadvantage of an increased radiation exposure to the patient causing at least no acute harm, Long-term effects are hard to prove but cannot be neglected either.	Univ Hosp Schleswig Holstein, Dept Neurosurg, Neuroradiol Sect, D-24105 Kiel, Germany; Univ Hosp Schleswig Holstein, Dept Neurol, Kiel, Germany; Univ Hosp Schleswig Holstein, Dept Radiol & Nucl Med, Lubeck, Germany		Ulmer, S (corresponding author), Univ Hosp Schleswig Holstein, Dept Neurosurg, Neuroradiol Sect, Schittenhelmstr 10, D-24105 Kiel, Germany.	ulmer@email.com	Jansen, Olav/D-2547-2010; Nabavi, Arya/E-5200-2010; Mehdorn, Maximilian/D-2495-2010				ARISTIZABAL SA, 1979, INT J RADIAT ONCOL, V5, P349, DOI 10.1016/0360-3016(79)91215-X; Berrington A, 2001, BRIT J RADIOL, V74, P507, DOI 10.1259/bjr.74.882.740507; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; BROWN GC, 1982, OPHTHALMOLOGY, V89, P1489; *COMM BIOL EFF ION, 2006, HLTH RISKS EXP LOW L, V7; Danesh-Meyer HV, 2004, CLIN EXP OPHTHALMOL, V32, P333, DOI 10.1111/j.1442-9071.2004.00825.x; DEEG HJ, 1984, INT J RADIAT ONCOL, V10, P957, DOI 10.1016/0360-3016(84)90163-9; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y; Fahlbusch R, 2005, EUR J ENDOCRINOL, V153, P239, DOI 10.1530/eje.1.01970; Garrott H, 2004, CLIN EXP OPHTHALMOL, V32, P330, DOI 10.1111/j.1442-9071.2004.00824.x; GORDON KB, 1995, INT J RADIAT ONCOL, V31, P1123, DOI 10.1016/0360-3016(95)00062-4; Grunert P, 2003, NEUROSURG REV, V26, P73, DOI 10.1007/s10143-003-0262-0; HAMMER HM, 1983, T OPHTHAL SOC UK, V103, P208; Imanishi Y, 2005, EUR RADIOL, V15, P41, DOI 10.1007/s00330-004-2459-1; KATO A, 1991, J NEUROSURG, V74, P845, DOI 10.3171/jns.1991.74.5.0845; KLINE LB, 1985, OPHTHALMOLOGY, V92, P1118; Knehr S, 1999, INT J RADIAT BIOL, V75, P407, DOI 10.1080/095530099140320; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Nabavi A, 2001, NEUROSURGERY, V48, P787, DOI 10.1097/00006123-200104000-00019; NAKISSA N, 1983, CANCER, V51, P980, DOI 10.1002/1097-0142(19830315)51:6<980::AID-CNCR2820510603>3.0.CO;2-Y; Nikjoo H, 2002, RADIAT PROT DOSIM, V99, P77, DOI 10.1093/oxfordjournals.rpd.a006843; Nimsky C, 2000, NEUROSURGERY, V47, P1070, DOI 10.1097/00006123-200011000-00008; Parsons J T, 1996, Oncology (Williston Park), V10, P837; PARSONS JT, 1996, ONCOLOGY WILLISTON P, V10, P847; Pergolizzi RS, 2001, J MAGN RESON IMAGING, V13, P136, DOI 10.1002/1522-2586(200101)13:1<136::AID-JMRI1021>3.0.CO;2-8; PEZNER RD, 1981, INT J RADIAT ONCOL, V7, P397, DOI 10.1016/0360-3016(81)90115-2; Rehani MM, 2000, BRIT MED J, V320, P593, DOI 10.1136/bmj.320.7235.593; RON E, 1988, NEW ENGL J MED, V319, P1033, DOI 10.1056/NEJM198810203191601; RUBIN P, 1968, CLIN RADIATION PATHO; Sadetzki S, 2005, RADIAT RES, V163, P424, DOI 10.1667/RR3329; SHUKOVSK.LJ, 1972, RADIOLOGY, V104, P629, DOI 10.1148/104.3.629; Thornton FJ, 2003, ACAD RADIOL, V10, P379, DOI 10.1016/S1076-6332(03)80026-0; Vano E, 1998, BRIT J RADIOL, V71, P728, DOI 10.1259/bjr.71.847.9771383; WELBOURN RB, 1986, SURGERY, V100, P1185	34	7	7	0	3	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	SEP	2007	28	8					1559	1564		10.3174/ajnr.A0588			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	213DC	WOS:000249645300034	17846212	Green Published, hybrid			2022-02-06	
J	Yokota, H; Atsumi, T; Araki, T; Fuse, A; Sato, H; Kushimoto, S; Koido, Y; Kawai, M; Yamamoto, Y				Yokota, Hiroyuki; Atsumi, Takahiro; Araki, Takashi; Fuse, Akira; Sato, Hidetaka; Kushimoto, Shigeki; Koido, Yuichi; Kawai, Makoto; Yamamoto, Yasuhiro			Cerebral endothelial injury in elderly patients with severe head injury measured by serum thrombomodulin and von Willebrand factor	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						cerebral endothelial injury; head injury; thrombomodulin; von Willebrand factor; elderly patient	TRAUMATIC BRAIN-INJURY; VONWILLEBRAND-FACTOR; PREDICTING SURVIVAL; GERIATRIC TRAUMA; MORTALITY; COAGULOPATHY	Elevated serum levels of thrombomodulin (TM) and von Willebrand factor (vWf) are good indicators of injury and activation of cerebral endothelium in patients with severe simple head injury. The present study evaluated cerebral endothelial injury or activation as the serum levels of TM and vWf in elderly and younger patients with similar brain trauma, to evaluate the primary parenchymal injury of the brain. Patients with head injury were classified into the young group (16-30 years), the middle-aged group (31-65 years), and the elderly group (over 66 years). There was no difference in Glasgow Coma Scale on admission between the three groups. The serum levels of TM and vWf at 2 hours after injury were significantly higher in the elderly group than in the other groups. However, the serum levels of TM and vWf were not significantly different at 3 and 7 days after injury. Cerebral endothelial activation and injury were significantly higher in elderly patients just after head injury than in younger patients, which suggests that greater sensitivity to endothelial injury and activation may be important in the worse outcome after head injury in elderly patients compared with younger patients.	Main Hosp, Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo, Japan		Yokota, H (corresponding author), Main Hosp, Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo, Japan.						BARATHAM G, 1972, J NEUROL NEUROSUR PS, V35, P698, DOI 10.1136/jnnp.35.5.698; BOLLINGER O, 1891, BEITRAG WISSENSCHAFT, V2, P457; DEMARIA EJ, 1987, ANN SURG, V206, P738, DOI 10.1097/00000658-198712000-00009; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; HANDIN IR, 2000, HARRISONS, P745; Ikegami K, 1998, J TRAUMA, V44, P789, DOI 10.1097/00005373-199805000-00008; ISHII H, 1994, THROMBIN THROMBOMODU, P121; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; MELLION BT, 1992, COMPLICATIONS SEQUEL, P51; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; PELLICANE JV, 1992, J TRAUMA, V33, P440, DOI 10.1097/00005373-199209000-00018; Pondaag W, 1979, Acta Neurochir Suppl (Wien), V28, P98; RUGGERI ZM, 1993, FASEB J, V7, P308, DOI 10.1096/fasebj.7.2.8440408; SANDE JJ, 1981, J NEUROSURG, V55, P718; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TAKANO S, 1990, BLOOD, V76, P2024; Tornetta P, 1999, J TRAUMA, V46, P702, DOI 10.1097/00005373-199904000-00024; VERWEIJ CL, 1988, HAEMOSTASIS, V18, P224; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007; Yokota H, 2002, J NEUROTRAUM, V19, P1007, DOI 10.1089/089771502760341929; YOKOTA H, 1995, NEUROCHEMICAL MONITO, P98	28	7	11	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	SEP	2007	47	9					383	388		10.2176/nmc.47.383			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	213AR	WOS:000249638800001	17895610	Bronze			2022-02-06	
J	Miller, A; Panitch, H				Miller, Ariel; Panitch, Hillel			Therapeutic use of dextromethorphan: Key learnings from treatment of pseudobulbar affect	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article; Proceedings Paper	11th Symposium of the European-Charcot-Foundation	NOV 17-19, 2005	Lisbon, PORTUGAL	European Charcot Fdn		pseudobulbar effect; emotion; laughing; crying; explosive; multiple sclerosis; amyotrophic lateral sclerosis; neuroprotection	AMYOTROPHIC-LATERAL-SCLEROSIS; NMDA-RECEPTOR ANTAGONISTS; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; PATHOLOGICAL LAUGHTER; EMOTIONAL LABILITY; POOR METABOLIZERS; SIGMA-LIGANDS; EXTENSIVE METABOLIZERS; QUINIDINE TREATMENT	A varietv of neurological conditions and disease states are accompanied by pseudobulbar affect (PBA), an emotional disorder characterized by uncontrollable outbursts of laughing and crying. The causes of PBA are unclear but may involve lesions in neural circuits regulating the motor output of emotional expression. Several agents used in treating other psychiatric disorders have been applied in the treatment of PBA with some success but data are limited and these agents are associated with unpleasant side effects due to nonspecific activity in diffuse neural networks. Dextroimethorphan (DM), a widely used cough suppressant, acts at receptors in the brainstem and cerebellum, brain regions implicated in the regulation of emotional output. The combination of DM and quinidine (Q), an enzyme inhibitor that blocks DM metabolisin, has recently been tested in phase III clinical trials in patients with multiple sclerosis and amyotrophic lateral sclerosis and was both safe and effective in palliating PBA symptoms. In addition, clinical studies pertaining to the safety and efficacy of DM/Q in a variety of neurological disease states are ongoing, (C) 2007 Elsevier B.V. All rights reserved.	Technion Israel Inst Technol, Rappaport Fac Med, Res Inst, Ctr Multiple Sclerosis,Carmel Med Ctr, Haifa, Israel; Univ Vermont, Coll Med, Dept Neurol, Multiple Sclerosis Ctr, Burlington, VT 05401 USA		Miller, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Res Inst, Ctr Multiple Sclerosis,Carmel Med Ctr, Haifa, Israel.	millera@tx.technion.ac.il					ANDERSEN G, 1993, LANCET, V342, P837, DOI 10.1016/0140-6736(93)92696-Q; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Arciniegas D B, 2000, Semin Clin Neuropsychiatry, V5, P290, DOI 10.1053/scnp.2000.9554; Arciniegas DB, 2005, CNS SPECTRUMS, V10, P1, DOI 10.1017/S1092852900026602; Baldessarini R., 2001, PHARM BASIS THERAPEU, P447; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Ben Abraham R, 2002, CLIN J PAIN, V18, P282; Bittigau P, 1997, J CHILD NEUROL, V12, P471, DOI 10.1177/088307389701200802; BLACK KJ, 1994, AM J PSYCHIAT, V151, P456; Blin O, 1996, CLIN NEUROPHARMACOL, V19, P189, DOI 10.1097/00002826-199619020-00009; BOKESCH PM, 1994, ANESTHESIOLOGY, V81, P470, DOI 10.1097/00000542-199408000-00026; BRINN R, 1986, BRIT J CLIN PHARMACO, V22, P194, DOI 10.1111/j.1365-2125.1986.tb05250.x; BROLY F, 1989, BRIT J CLIN PHARMACO, V28, P29, DOI 10.1111/j.1365-2125.1989.tb03502.x; Brooks BR, 2004, NEUROLOGY, V63, P1364; BROSEN K, 1987, PHARMACOL TOXICOL, V60, P312, DOI 10.1111/j.1600-0773.1987.tb01758.x; Burns A, 1999, INT J GERIATR PSYCH, V14, P681, DOI 10.1002/(SICI)1099-1166(199908)14:8<681::AID-GPS49>3.3.CO;2-Q; CECCALDI M, 1994, EUR NEUROL, V34, P36, DOI 10.1159/000117005; CHAPMAN AG, 1989, EUR J PHARMACOL, V166, P201, DOI 10.1016/0014-2999(89)90060-5; Chase TN, 2000, J NEUROL, V247, P36, DOI 10.1007/PL00007759; CHOI DW, 1987, J PHARMACOL EXP THER, V242, P713; Dark FL, 1996, AUST NZ J PSYCHIAT, V30, P472, DOI 10.3109/00048679609065020; Darwin C., 1965, EXPRESS EMOT MAN; DECOSTER MA, 1995, BRAIN RES, V671, P45, DOI 10.1016/0006-8993(94)01294-R; Desmeules JA, 1999, J PHARMACOL EXP THER, V288, P607; Ebert B, 1998, BIOCHEM PHARMACOL, V56, P553, DOI 10.1016/S0006-2952(98)00088-4; ELNASR MS, 1990, EUR J PHARMACOL, V185, P19, DOI 10.1016/0014-2999(90)90206-L; Feinstein A, 1997, ARCH NEUROL-CHICAGO, V54, P1116, DOI 10.1001/archneur.1997.00550210050012; GOLDING EM, 1995, MOL CHEM NEUROPATHOL, V24, P137, DOI 10.1007/BF02962139; Gredal O, 1997, ACTA NEUROL SCAND, V96, P8; HARVEY PD, 1989, J CLIN PSYCHOL, V45, P786, DOI 10.1002/1097-4679(198909)45:5<786::AID-JCLP2270450515>3.0.CO;2-P; Heiskanen T, 2002, PAIN, V96, P261, DOI 10.1016/S0304-3959(01)00455-9; HOUSE A, 1989, BMJ-BRIT MED J, V298, P991, DOI 10.1136/bmj.298.6679.991; INABA T, 1986, BRIT J CLIN PHARMACO, V22, P199, DOI 10.1111/j.1365-2125.1986.tb05251.x; IRONSIDE R, 1956, BRAIN, V79, P589, DOI 10.1093/brain/79.4.589; Kim JS, 2000, NEUROLOGY, V54, P1805, DOI 10.1212/WNL.54.9.1805; Kim JS, 1997, STROKE, V28, P2321; KLEIN M, 1989, J PHARMACOL EXP THER, V251, P207; LAUTERBACH EC, 1991, J CLIN PSYCHOPHARM, V11, P392, DOI 10.1097/00004714-199112000-00021; LEEMANN T, 1986, EUR J CLIN PHARMACOL, V29, P739, DOI 10.1007/BF00615971; LIEBERMAN A, 1977, ARCH NEUROL-CHICAGO, V34, P717, DOI 10.1001/archneur.1977.00500230087017; LIPTON SA, 1993, TRENDS NEUROSCI, V16, P527, DOI 10.1016/0166-2236(93)90198-U; Liu YX, 2003, J PHARMACOL EXP THER, V305, P212, DOI 10.1124/jpet.102.043166; LUHMANN HJ, 1994, NEUROSCI LETT, V178, P171, DOI 10.1016/0304-3940(94)90317-4; Maurice T, 1997, PROG NEURO-PSYCHOPH, V21, P69, DOI 10.1016/S0278-5846(96)00160-1; Maurice T, 2001, BRAIN RES REV, V37, P116, DOI 10.1016/S0165-0173(01)00112-6; MCQUAY HJ, 1994, PAIN, V59, P127, DOI 10.1016/0304-3959(94)90056-6; MIKUS G, 1986, EUR J CLIN PHARMACOL, V31, P69, DOI 10.1007/BF00870989; Miller A, 2006, J NEUROL SCI, V245, P153, DOI 10.1016/j.jns.2005.09.018; MONYER H, 1988, BRAIN RES, V446, P144, DOI 10.1016/0006-8993(88)91304-2; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; MORRIS PLP, 1993, AUST NZ J PSYCHIAT, V27, P601, DOI 10.3109/00048679309075822; Muller U, 1999, BRAIN INJURY, V13, P805, DOI 10.1080/026990599121197; MUSACCHIO JM, 1989, LIFE SCI, V45, P1721, DOI 10.1016/0024-3205(89)90510-9; Newsom-Davis IC, 1999, J NEUROL SCI, V169, P22, DOI 10.1016/S0022-510X(99)00211-7; Okuda DT, 2005, MOVEMENT DISORD, V20, P1389, DOI 10.1002/mds.20607; OLNEY JW, 1978, NATURE, V271, P557, DOI 10.1038/271557a0; Palmer GC, 2001, CURR DRUG TARGETS, V2, P241, DOI 10.2174/1389450013348335; Panitch HS, 2006, ANN NEUROL, V59, P780, DOI 10.1002/ana.20828; Parsons CG, 1998, DRUG NEWS PERSPECT, V11, P523, DOI 10.1358/dnp.1998.11.9.863689; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; Poeck K, 1969, Ger Med Mon, V14, P394; Poeck K., 1969, HDB CLIN NEUROLOGY, P343; Pollock BG, 1998, AM J PSYCHIAT, V155, P1110, DOI 10.1176/ajp.155.8.1110; Pope LE, 2004, J CLIN PHARMACOL, V44, P1132, DOI 10.1177/0091270004269521; PRINCE DA, 1988, NEUROSCI LETT, V85, P291, DOI 10.1016/0304-3940(88)90581-2; RADEK RJ, 1992, NEUROSCI LETT, V139, P191, DOI 10.1016/0304-3940(92)90549-M; Robertson GM, 1890, J MENT SCI, V36, P338; ROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81; ROBINSON RG, 1983, COMPR PSYCHIAT, V24, P555, DOI 10.1016/0010-440X(83)90024-X; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; RODEN DM, 1996, GOODMAN GILMANS PHAR, P839; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; Sang CN, 2002, ANESTHESIOLOGY, V96, P1053, DOI 10.1097/00000542-200205000-00005; Sang CN, 2000, J PAIN SYMPTOM MANAG, V19, pS21; Sato T, 2002, AM J PSYCHIAT, V159, P968, DOI 10.1176/appi.ajp.159.6.968; SCHIFFER R, 2005, REV PSEUDOBULBAR AFF; SCHIFFER RB, 1985, NEW ENGL J MED, V312, P1480, DOI 10.1056/NEJM198506063122303; Smith RA, 2004, MULT SCLER J, V10, P679, DOI 10.1191/1352458504ms1106oa; STARKSTEIN SE, 1988, ARCH GEN PSYCHIAT, V45, P247; STARKSTEIN SE, 1989, BRIT J PSYCHIAT, V154, P170, DOI 10.1192/bjp.154.2.170; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; STEINBERG GK, 1988, STROKE, V19, P1112, DOI 10.1161/01.STR.19.9.1112; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Tortella F C, 1989, NIDA Res Monogr, V95, P548; TORTELLA FC, 1989, BRAIN RES, V482, P179, DOI 10.1016/0006-8993(89)90558-1; TORTELLA FC, 1989, TRENDS PHARMACOL SCI, V10, P501, DOI 10.1016/0165-6147(89)90050-3; UDAKA F, 1984, ARCH NEUROL-CHICAGO, V41, P1095, DOI 10.1001/archneur.1984.04050210093023; VETTICADEN SJ, 1989, PHARMACEUT RES, V6, P13, DOI 10.1023/A:1015835215945; Vinik Aaron I., 1999, American Journal of Medicine, V107, p17S; WALKER FO, 1989, CLIN NEUROPHARMACOL, V12, P322, DOI 10.1097/00002826-198908000-00010; Weinbroum AA, 2000, CAN J ANAESTH, V47, P585, DOI 10.1007/BF03018952; WILLIAMS NA, 1988, PHARM RES-DORDR, V5, P193, DOI 10.1023/A:1015925225766; Wilson SAK, 1924, J NEUROL PSYCHOPATHO, V4, P299; YAMAMOTO H, 1995, J NEUROSCI, V15, P731; ZHANG Y, 1992, CLIN PHARMACOL THER, V51, P647, DOI 10.1038/clpt.1992.77	95	7	7	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	AUG 15	2007	259	1-2			SI		67	73		10.1016/j.jns.2006.06.030			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	198HK	WOS:000248617400013	17433820				2022-02-06	
J	Haberg, A; Qu, H; Hjelstuen, MH; Sonnewald, U				Haberg, A.; Qu, H.; Hjelstuen, M. H.; Sonnewald, U.			Effect of the pyrrolopyrimidine lipid peroxidation inhibitor U-101033E on neuronal and astrocytic metabolism and infarct volume in rats with transient middle cerebral artery occlusion	NEUROCHEMISTRY INTERNATIONAL			English	Article; Proceedings Paper	Symposium on Excitotoxicity in Neurologic Disease held at the 37th Annual Meeting of the American-Society-for-Neurochemistry	MAR 11-15, 2006	Portland, OR	Amer Soc Neurochem		neurons; Astrocytes; mitochondria; ischemia; reperfusion; glucose; acetate; lactate; MCAO; diffusion weighted imaging	TRAUMATIC BRAIN-INJURY; ALPHA-KETOGLUTARATE DEHYDROGENASE; ANTIOXIDANT U-101033E; MITOCHONDRIAL DYSFUNCTION; NEUROPROTECTIVE EFFICACY; PYRUVATE-DEHYDROGENASE; MAGNETIC-RESONANCE; OXIDATIVE STRESS; PENETRATING ANTIOXIDANTS; BARRIER PERMEABILITY	The aim of the present study was to assess the effect of post ictal administration of the pyrrolopyrimidine lipid peroxidation inhibitor, U-101033E, on infarct volume and neuronal and astrocytic metabolism in rats with transient middle cerebral artery occlusion (MCAO). Rats were subjected to 120 min of MCAO followed by 140 min of reperfusion and randomly assigned to control (n = 17) or U-101033E treatment (n = 16). Drug infusion started 5 min after MCAO and lasted 220 min with a 15 min interruption during the reperfusion procedure. Sixteen rats underwent diffusion weighted imaging 260 min after ictus, from which the apparent diffusion coefficient (ADC) was determined. Seventeen rats received an iv bolus injection of [1-C-13] glucose and [1,2-C-13]acetate 245 min after ictus. Tissue extracts from two brain regions representing penumbra and ischemic core were analyzed with C-13 NMRS and HPLC. U-101033E did not affect the volume of ischemic tissue estimated from the ADC maps. In the penumbra, U-101033E specifically decreased mitochondrial pyruvate metabolism via both pyruvate dehydrogenase and pyruvate carboxylase pathways. Thus, U-101033E impaired both neuronal and astrocytic mitochondrial pyruvate metabolism. At the same time anaerobic glucose usage was increased, leading to increased lactate labeling and content. Also alanine labeling was increased. The data do not support lactate as an important substrate for neuronal mitochondria in ischemia-reperfusion. A similar pattern of reduced mitochondrial pyruvate metabolism and increased cytosolic pyruvate metabolism was found in the irreversibly damaged ischemic core. The present study highlights the importance of other outcome measures than ischemic tissue volume for evaluation of drug efficacy in animal models, which in turn could increase the likelihood of success in clinical trials. (C) 2006 Elsevier Ltd. All rights reserved.	Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, NTNU, N-7034 Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Neurosci, NTNU, N-7034 Trondheim, Norway		Haberg, A (corresponding author), St Olavs Hosp, MR Ctr, Dept Circulat & Med Imaging, N-7006 Trondheim, Norway.	asta.haberg@ntnu.no					ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Bogaert YE, 2000, EXP NEUROL, V161, P115, DOI 10.1006/exnr.1999.7250; BOGAERT YE, 1994, FREE RADICAL BIO MED, V16, P811, DOI 10.1016/0891-5849(94)90197-X; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; BUNDY GL, 1995, J MED CHEM, V38, P4161, DOI 10.1021/jm00021a004; Camacho A, 2006, ARCH MED RES, V37, P11, DOI 10.1016/j.arcmed.2005.05.014; Chtistophe M, 2006, CURR PHARM DESIGN, V12, P739, DOI 10.2174/138161206775474242; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DELZOPPO GJ, 1991, STROKE, V22, P1276, DOI 10.1161/01.STR.22.10.1276; Demougeot C, 2004, J NEUROCHEM, V90, P776, DOI 10.1111/j.1471-4159.2004.02583.x; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; DUGAN LL, 1995, FREE RADICAL RES, V23, P27, DOI 10.3109/10715769509064016; Engelhard K, 2000, ANAESTHESIST, V49, P816, DOI 10.1007/s001010070054; Farooqui AA, 1998, CELL MOL NEUROBIOL, V18, P599, DOI 10.1023/A:1020261600498; FOLBERGROVA J, 1995, P NATL ACAD SCI USA, V92, P5057, DOI 10.1073/pnas.92.11.5057; GARCIA JH, 1994, AM J PATHOL, V145, P728; GEDDES JW, 1984, J NEUROCHEM, V42, P16, DOI 10.1111/j.1471-4159.1984.tb09691.x; Haberg A, 2006, NEUROCHEM INT, V48, P531, DOI 10.1016/j.neuint.2005.12.025; Haberg A, 2001, J CEREBR BLOOD F MET, V21, P1451, DOI 10.1097/00004647-200112000-00010; Haberg A, 1998, J CEREBR BLOOD F MET, V18, P1223, DOI 10.1097/00004647-199811000-00008; Hall ED, 1996, ACT NEUR S, V66, P107; Hall ED, 1997, J PHARMACOL EXP THER, V281, P895; HILLERED L, 1989, J NEUROSCI RES, V24, P247, DOI 10.1002/jnr.490240216; Karlsson J, 2002, BRAIN RES, V955, P268, DOI 10.1016/S0006-8993(02)03601-6; Keller JN, 1998, J NEUROSCI, V18, P687; Kvamme E, 2000, NEUROCHEM RES, V25, P1407, DOI 10.1023/A:1007668801570; Lauderback CM, 2000, BBA-MOL BASIS DIS, V1501, P149, DOI 10.1016/S0925-4439(00)00015-6; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MAXWELL L, 1992, MICROVASC RES, V43, P255, DOI 10.1016/0026-2862(92)90023-I; MULLER TB, 1995, STROKE, V26, P451, DOI 10.1161/01.STR.26.3.451; MULLER TB, 1995, STROKE, V26, P1453, DOI 10.1161/01.STR.26.8.1453; Murakami K, 1998, J NEUROSCI, V18, P205; Murin R, 2001, GEN PHYSIOL BIOPHYS, V20, P431; Nakai A, 1997, NEUROBIOL DIS, V4, P288, DOI 10.1006/nbdi.1997.0146; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Oz G, 2004, J NEUROSCI, V24, P11273, DOI 10.1523/JNEUROSCI.3564-04.2004; PATEL MS, 1974, J NEUROCHEM, V22, P717, DOI 10.1111/j.1471-4159.1974.tb04285.x; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; Qu H, 2000, DEV NEUROSCI-BASEL, V22, P429, DOI 10.1159/000017472; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; Rohn TT, 1998, BIOCHEM PHARMACOL, V56, P1371, DOI 10.1016/S0006-2952(98)00266-4; Schmid-Elsaesser R, 2000, EXP BRAIN RES, V130, P60, DOI 10.1007/s002210050006; Schmid-Elsaesser R, 1999, BRAIN RES, V816, P471, DOI 10.1016/S0006-8993(98)01197-4; Schmid-Elsaesser R, 1997, ACT NEUR S, V70, P176; SchmidElsaesser R, 1997, STROKE, V28, P2018, DOI 10.1161/01.STR.28.10.2018; Schurr A, 1997, BRAIN RES, V774, P221, DOI 10.1016/S0006-8993(97)81708-8; Schurr A, 1997, J NEUROCHEM, V69, P423; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; Sonnewald U, 1996, J NEUROCHEM, V67, P1711; SONNEWALD U, 1991, NEUROSCI LETT, V128, P235, DOI 10.1016/0304-3940(91)90268-X; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; *TIRL INT STEER CO, 2000, STROKE, V32, P2257; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; VANDENBERG CJ, 1973, METABOLIC COMPARTMEN, P137; Wang YY, 2006, J MINIM INVAS GYN, V13, P1, DOI 10.1016/j.jmig.2005.08.012; Waniewski RA, 1998, J NEUROSCI, V18, P5225, DOI 10.1523/JNEUROSCI.18-14-05225.1998; Ward BJ, 1997, MICROVASC RES, V53, P179, DOI 10.1006/mvre.1996.1997; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Xiong Y, 1997, J NEUROTRAUM, V14, P907, DOI 10.1089/neu.1997.14.907; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; YU ACH, 1983, J NEUROCHEM, V41, P1484, DOI 10.1111/j.1471-4159.1983.tb00849.x; Zaidan E, 1998, J NEUROCHEM, V70, P233	65	7	7	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUN	2007	50	7-8			SI		932	940		10.1016/j.neuint.2006.12.005			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	195UH	WOS:000248436900007	17241701				2022-02-06	
J	Pavlovskaya, M; Groswasser, Z; Keren, O; Mordvinov, E; Hochstein, S				Pavlovskaya, Marina; Groswasser, Zeev; Keren, Ofer; Mordvinov, Eugene; Hochstein, Shaul			Hemispheric visual atentional imbalance in patients with traumatic brain injury	BRAIN AND COGNITION			English	Article						attention; traumatic brain injury (TBI); neglect; asymmetry	CLOSED-HEAD-INJURY; CLINICAL CT-SCAN; SELECTIVE ATTENTION; VISUOSPATIAL ATTENTION; SUSTAINED ATTENTION; PATTERN-RECOGNITION; UNILATERAL NEGLECT; SPATIAL ATTENTION; NEURAL SYSTEMS; REACTION-TIME	We find a spatially asymmetric allocation of attention in patients with traumatic brain injury (TBI) despite the lack of obvious asymmetry in neurological indicators. Identification performance was measured for simple spatial patterns presented briefly to a locus 5 degrees into the left or right hemifield, after precuing attention to the same (ipsilateral) or opposite (cross-hemifield) side. Though the cue was nonpredictive of target location overall, performance was significantly slower for cross than for ipsilateral trials in both patients and controls. We tested 21 TBI patients without overt focal brain damage and nine control subjects. Only patients demonstrated significantly worse performance for left side presentation in the ipsilateral condition. Furthermore, in the cross-hemifield condition, the left-right difference seen in TBI patients was significantly larger-reflecting a failure in producing a leftward attention shift. Again no significant difference was found in controls. These hemifield effects suggest an asymmetry in the ability of TBI patients in shifting attention to the left hemifield, whether from central fixation or from a cue in the contra-lateral hemifield. The results support basic hypotheses regarding visual attention: Attentional control may be asymmetric and attention may be a distributed, rather than localized cortical function. (C) 2006 Elsevier Inc. All rights reserved.	Loewenstein Hosp & Rehabil Ctr, Dept Neurophysiol, IL-43100 Raanana, Israel; Loewenstein Hosp & Rehabil Ctr, Dept Traumat Brain Injury, IL-43100 Raanana, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, Jerusalem, Israel; Hebrew Univ Jerusalem, Neural Computat Ctr, Jerusalem, Israel; Charles E Smith Lab Collaborat Res Psychobiol, Jerusalem, Israel		Pavlovskaya, M (corresponding author), Loewenstein Hosp & Rehabil Ctr, Dept Neurophysiol, 278 Ahuza St, IL-43100 Raanana, Israel.	marinap@netvision.net.il					Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Ahissar M, 2001, PSYCHOL SCI, V12, P56, DOI 10.1111/1467-9280.00310; Alvarez JA, 2004, DEV NEUROPSYCHOL, V26, P627, DOI 10.1207/s15326942dn2602_6; Audet T, 2000, BRAIN COGNITION, V43, P17; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; BENDER MB, 1952, DISORDERS PERCEPTINO; Berlucchi G, 1997, NEUROPSYCHOLOGIA, V35, P941, DOI 10.1016/S0028-3932(97)00022-5; BISIACH E, 1988, HDB NEUROPSYCHOLOGY, P195; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; CARTER CS, 1995, BIOL PSYCHIAT, V37, P789, DOI 10.1016/0006-3223(94)00217-Q; CHEAL ML, 1994, Q J EXP PSYCHOL-A, V47, P699, DOI 10.1080/14640749408401134; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; CORBETTA M, 1993, J NEUROSCI, V13, P1202; CREMONAMETEYARD SL, 1992, NEUROPSYCHOLOGIA, V30, P123, DOI 10.1016/0028-3932(92)90022-E; CREMONAMETEYARD SL, 1994, BRAIN INJURY, V8, P541, DOI 10.3109/02699059409151006; DESIMONE R, 1990, Society for Neuroscience Abstracts, V16, P621; Duncan J, 1999, J EXP PSYCHOL GEN, V128, P450, DOI 10.1037/0096-3445.128.4.450; Duncan J, 1998, PHILOS T ROY SOC B, V353, P1307, DOI 10.1098/rstb.1998.0285; Duncan J., 2004, COGNITIVE NEUROSCIEN, P105; Godefroy O, 1996, BRAIN, V119, P191, DOI 10.1093/brain/119.1.191; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Heilman KM, 1993, CLIN NEUROPSYCHOLOGY, P279; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Jonides J., 1981, ATTENTION PERFORM, V11, P187; Kajs-Wyllie Marylyn, 2002, J Neurosci Nurs, V34, P303; Karnath HO, 2003, NEUROREPORT, V14, P437, DOI 10.1097/01.wnr.0000059778.23521.88; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Leibovitch FS, 1998, NEUROLOGY, V50, P901, DOI 10.1212/WNL.50.4.901; LOKEN WJ, 1995, NEUROPSYCHOLOGY, V9, P592, DOI 10.1037/0894-4105.9.4.592; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MELAMED S, 1985, SCAND J REHABIL MED, P16; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Mounts JRW, 1999, PERCEPT PSYCHOPHYS, V61, P322, DOI 10.3758/BF03206891; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; Napolitano E, 2005, MED SCI MONITOR, V11, pRA212; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PAVLOVSKAYA M, 1992, OPHTHAL PHYSL OPT, V12, P165, DOI 10.1111/j.1475-1313.1992.tb00282.x; Pavlovskaya M, 2002, J COGNITIVE NEUROSCI, V14, P745, DOI 10.1162/08989290260138645; Pavlovskaya M, 2001, SPATIAL VISION, V14, P151, DOI 10.1163/156856801300202913; Pavlovskaya M, 1997, J COGNITIVE NEUROSCI, V9, P824, DOI 10.1162/jocn.1997.9.6.824; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Posner M. I., 1984, ATTENTION PERFORM, P551; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1982, PHILOS T ROY SOC B, V298, P187, DOI 10.1098/rstb.1982.0081; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; POSNER MI, 1987, NEUROPSYCHOLOGIA, V25, P135, DOI 10.1016/0028-3932(87)90049-2; SAGI D, 1985, Spatial Vision, V1, P141, DOI 10.1163/156856885X00152; Schendel KL, 2001, PERCEPT PSYCHOPHYS, V63, P577, DOI 10.3758/BF03194423; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Siddall ORM, 2005, ANN PHARMACOTHER, V39, P1309, DOI 10.1345/aph.1E637; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; VALLAR G, 1994, J NEUROL NEUROSUR PS, V57, P464, DOI 10.1136/jnnp.57.4.464; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Vallar G, 2001, NEUROIMAGE, V14, pS52, DOI 10.1006/nimg.2001.0822; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; Vandenberghe R., 1997, Society for Neuroscience Abstracts, V23, P300; Vandenberghe R, 1996, BRAIN, V119, P1263, DOI 10.1093/brain/119.4.1263; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V22, P54, DOI 10.3758/BF03206080; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98	74	7	7	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626	1090-2147		BRAIN COGNITION	Brain Cogn.	JUN	2007	64	1					21	29		10.1016/j.bandc.2006.10.003			9	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	198HD	WOS:000248616700003	17182160				2022-02-06	
J	Orban, JC; Ichai, C				Orban, J.-C.; Ichai, C.			Hierarchical strategy for treating elevated intracranial pressure in severe traumatic brain injury	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						cerebral ischaemia; intracranial pressure; multimodal monitoring; osmotherapy; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; HYPERTONIC SALINE; BLOOD-FLOW; 20-PERCENT MANNITOL; HEAD-INJURY; MANAGEMENT; HYPERVENTILATION; HYPERTENSION; HYPOTHERMIA; THERAPY	The objective of the treatment of intracranial hypertension is to decrease intracranial pressure (ICP) while maintaining cerebral blood flow (CBF). Despite numerous treatments, none of them associates total efficiency and security. Systemic secondary cerebral injuries, which are responsible for cerebral ischemia, lead us to administer non specific treatments in order to optimize CBF and cerebral oxygenation. Thus, the goals are: 1) to maintain cerebral perfusion pressure >= 70 mmHg; 2) to control metabolic status by preventing hyperglycaemia, anaemia and hyperthermia; 3) to maintain normoxia and normocapnia (hypercapnia increases ICP and hypocapnia decreases CBF). Beside the neurosurgical evacuation of extra- and intraparenchymatous haematomas, osmotherapy and cerebrospinal fluid (CSF) evacuation are the two specific treatments of intracranial hypertension. Osmotherapy consists in an administration of a hypertonic solution which induces a decrease in cerebral water and finally in ICP. Mannitol (20%), which is the reference, associates osmotic and rheologic effects, and decreases CSF production too. Recent data conduct us to administer larger doses, between 0.7 and 1 g/kg in 15 minutes. Hypertonic saline solution associates osmotic effects and plasma volume loading. Thus, this solution is particularly appropriate in severe head injury with arterial hypotension. CBF evacuation decreases rapidly ICP without any major side-effect. Until now, there is no proof of a superior efficiency of a treatment for intracranial hypertension compared to another. Considering their mechanism of action, all of them are efficient but potentially dangerous too. Indeed, the choice between treatments depends on data which are issued from the multimodal monitoring. General non specific treatments are always necessary. Specific treatments are indicated if ICP is above 20-25 mmHg. Maintaining cerebral perfusion pressure represents the first therapeutic goal. If intracranial hypertension persists, evacuation of CBF or osmotherapy may be advocated. In case of refractory intracranial hypertension, it may be useful to deepen neurosedation. Controlled hypocapnia and barbiturates remain a third line therapy providing to monitor and maintain an appropriate CBF and cerebral oxygenation. Controlled hypothermia and decompressive craniectomy must be individually discussed. (c) 2007 Elsevier Masson SAS. Tous droits reserves.	Hop St Roche, Serv Reanimat Medicochirurg, F-06006 Nice 01, France		Ichai, C (corresponding author), Hop St Roche, Serv Reanimat Medicochirurg, 5 Rue Pierre Devoluy, F-06006 Nice 01, France.	ichai@unice.fr					Albanese J, 2004, ANN FR ANESTH, V23, P528, DOI 10.1016/j.annfar.2004.01.010; ANAES S, 1999, ANN FR ANESTH, V18, P108; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BERGER S, 1994, ACT NEUR S, V60, P494; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; FISHMAN RA, 1975, NEW ENGL J MED, V293, P706, DOI 10.1056/NEJM197510022931407; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Marion DW, 2004, CRIT CARE MED, V32, pS43, DOI 10.1097/01.CCM.0000110731.69637.16; MARMAROU A, 1994, ACTA NEUROCHIR, P421; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Paczynski RP, 1997, CRIT CARE CLIN, V13, P105, DOI 10.1016/S0749-0704(05)70298-0; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Ropper Allan H., 1993, P11; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHIERHOUT G, 2000, COCHRANE DB SYST REV; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P521; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF	33	7	9	0	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	MAY	2007	26	5					440	444		10.1016/j.annfar.2007.03.001			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	184XV	WOS:000247676800006	17434712				2022-02-06	
J	Kagerbauer, SM; Rothoerl, RD; Brawanski, A				Kagerbauer, S. M.; Rothoerl, R. D.; Brawanski, A.			Pituitary dysfunction after aneurysmal subarachnoid hemorrhage	NEUROLOGICAL RESEARCH			English	Article						aneurysmal SAH; pituitary dysfunction; hypopituitarism; hyponatremia	BRAIN NATRIURETIC PEPTIDE; NEUROENDOCRINE DYSFUNCTION; STIMULATION TEST; SEPTIC SHOCK; HYPONATREMIA; INJURY; HYPOPITUITARISM; CORTICOTROPIN; PREVALENCE; DEFICIENCY	Patients recovering from aneurysmal SAH often complain about weakness, fatigue and impaired cognitive skills. Pituitary dysfunction might be one possible reason for these complaints, as in patients with traumatic brain injury, hypopituitarism is known to be a common complication. There are only a few studies dealing with this problem in SAH patients, but these studies suggest that pituitary disturbances are very frequent after aneurysmal SAH. But anterior pituitary lobe disturbances might not be the only one responsible for some complaints or complications in patients suffering from aneurysmal SAH. Hyponatremia in the early state after SAH could be a hint for posterior pituitary lobe dysfunction.	Univ Regensburg, Dept Neurosurg, D-93042 Regensburg, Germany		Kagerbauer, SM (corresponding author), Univ Regensburg, Dept Neurosurg, Franz Josef Str Allee 11, D-93042 Regensburg, Germany.	simone.kagerbauer@klinik.uni-regensburg.de		Kagerbauer, Simone/0000-0002-0139-4422			AIMARETTI G, 2004, CLIN ENDOCINOL, V62, P525; Ambrosi B, 1998, EUR J ENDOCRINOL, V139, P575, DOI 10.1530/eje.0.1390575; Asa Sylvia L., 1995, P3; AUERNHAMMER C, 2004, PRAXISBUCH ENDOKRINO; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; BJERRE P, 1986, NEUROSURGERY, V19, P1012, DOI 10.1227/00006123-198612000-00018; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Dimopoulou I, 2004, INTENS CARE MED, V30, P1216, DOI 10.1007/s00134-004-2297-2; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Espiner EA, 2002, CLIN ENDOCRINOL, V56, P629, DOI 10.1046/j.1365-2265.2002.01285.x; FERNANDEZREAL JM, 1994, CLIN INVESTIGATOR, V72, P302; Fukui S, 2004, J CLIN NEUROSCI, V11, P606, DOI 10.1016/j.jocn.2003.02.016; GORCZYCA W, 1987, NEUROSURGERY, V20, P369, DOI 10.1227/00006123-198703000-00003; HUTTER BO, 1995, BRIT J NEUROSURG, V9, P465, DOI 10.1080/02688699550041106; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khurana VG, 2004, NEUROSURGERY, V55, P69, DOI 10.1227/01.NEU.0000126877.10254.4C; Kleindienst A, 2004, ACTA NEUROL SCAND, V109, P361, DOI 10.1046/j.1600-0404.2003.00245.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2003, J NEUROL NEUROSUR PS, V74, P1133, DOI 10.1136/jnnp.74.8.1133; Kurokawa Y, 1996, SURG NEUROL, V46, P500, DOI 10.1016/S0090-3019(96)00034-1; LASZLO FA, 1995, ACTA NEUROCHIR, V133, P122, DOI 10.1007/BF01420062; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Mangieri P, 2003, ARQ NEURO-PSIQUIAT, V61, P14, DOI 10.1590/S0004-282X2003000100003; McGirt MJ, 2004, NEUROSURGERY, V54, P1369, DOI 10.1227/01.NEU.0000125016.37332.50; MOOREEDE MC, 1983, NEW ENGL J MED, V309, P469, DOI 10.1056/NEJM198308253090806; Nguyen BN, 2001, BRAIN INJURY, V15, P975, DOI 10.1080/02699050110063459; Ogawasara K, 1998, NEUROL SURG TOKYO, V26, P501; Okuchi K, 1996, ACTA NEUROCHIR, V138, P951, DOI 10.1007/BF01411284; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P772, DOI 10.1136/jnnp.72.6.772; ROTHWELL PM, 1991, LANCET, V337, P582, DOI 10.1016/0140-6736(91)91641-7; Sanada S, 1977, No Shinkei Geka, V5, P519; Savaridas T, 2004, INTENS CARE MED, V30, P1479, DOI 10.1007/s00134-004-2306-5; Segatore M, 1993, J Neurosci Nurs, V25, P92; Sviri GE, 2000, STROKE, V31, P118, DOI 10.1161/01.STR.31.1.118; Tomida M, 1998, STROKE, V29, P1584, DOI 10.1161/01.STR.29.8.1584; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; Woo MH, 1997, ANN PHARMACOTHER, V31, P637; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011	43	7	7	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	APR	2007	29	3					283	288		10.1179/016164107X165633			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	165JJ	WOS:000246301100012	17509228				2022-02-06	
J	Body, R				Body, Richard			Decision making and somatic markers in conversation after traumatic brain injury	APHASIOLOGY			English	Article; Proceedings Paper	Stirling Discourse Colloquium	OCT, 2004	Univ Stirling, Stirling, SCOTLAND		Univ Stirling		CLOSED-HEAD-INJURY; PRAGMATIC LANGUAGE-SKILLS; PREFRONTAL CORTEX; GAMBLING TASK; DISCOURSE ABILITIES; BEHAVIORAL-CHANGES; EMOTION; HYPOTHESIS; IMPAIRMENT; DEFICITS	Background: Social decision making has been investigated in a range of client groups, resulting in the identification of the ventromedial prefrontal cortex (VMPC) as a significant structure in social decision making and the formulation of the somatic marker hypothesis (Damasio, 1994) to explain some of the mechanisms involved. The vulnerability of the VMPC following traumatic brain injury (TBI) suggests a potential degree of overlap between decision-making research and behaviour observed following TBI. Despite this, relatively little awareness of these concepts is evident in research on TBI in general and on communication after TBI in particular. Aims: To review the literature on decision making and the mechanisms thought to mediate it. To examine the potential application of decision-making theory to conversational behaviour following TBI. Main Contribution: The article will highlight the potential role of decision making in conversation, together with the mechanisms that support it, thereby raising awareness among clinicians and researchers of a potentially important contributor to communication after TBI. Conclusions: Social decision making and the somatic marker hypothesis are important constructs for our understanding of behaviours associated with TBI, including conversation.	Univ Sheffield, Dept Human Commun Sci, Sheffield S10 2TA, S Yorkshire, England		Body, R (corresponding author), Univ Sheffield, Dept Human Commun Sci, 31 Claremont Crescent, Sheffield S10 2TA, S Yorkshire, England.	r.body@sheffield.ac.uk	Body, Richard/C-2736-2010	Body, Richard/0000-0001-9089-8130			ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Bar-On R, 2003, BRAIN, V126, P1790, DOI 10.1093/brain/awg177; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 2005, TRENDS COGN SCI, V9, P159, DOI 10.1016/j.tics.2005.02.002; Bechara A, 1998, J NEUROSCI, V18, P428; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Body R, 1996, BRAIN INJURY, V10, P311, DOI 10.1080/026990596124485; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Body R., 1999, BRAIN DAM B; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Brown Gillian., 1983, DISCOURSE ANAL; Cavedini P, 2002, NEUROPSYCHOLOGIA, V40, P205, DOI 10.1016/S0028-3932(01)00077-X; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; CHANNONS, 2005, BRAIN LANG, V93, P123; Clark Herbert H., 1996, USING LANGUAGE; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; COURVILLE J, 1937, PATHOLOGY CENTRAL NE; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; DAMASIO AR, 1994, DESCARTER ERROR EMOT; DENESRAJ V, 1994, J PERS SOC PSYCHOL, V66, P819, DOI 10.1037/0022-3514.66.5.819; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Evans CEY, 2004, BRAIN COGNITION, V54, P240, DOI 10.1016/j.bandc.2004.02.022; Fein G, 2004, ALCOHOL CLIN EXP RES, V28, P1487, DOI 10.1097/01.ALC.0000141642.39065.9B; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Friedland D, 1998, BRAIN INJURY, V12, P1, DOI 10.1080/026990598122818; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; GOODWIN C, 1990, ANNU REV ANTHROPOL, V19, P283, DOI 10.1146/annurev.an.19.100190.001435; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; JOHNSON R, 2002, HEAD INJURY REHABILI, P159; Kleeberg J, 2004, ANN NEUROL, V56, P787, DOI 10.1002/ana.20277; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Lieberman MD, 2000, PSYCHOL BULL, V126, P109, DOI 10.1037/0033-2909.126.1.109; Macmillan M, 2000, ODD KIND FAME STORIE; Maguire EA, 1999, BRAIN, V122, P1839, DOI 10.1093/brain/122.10.1839; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; McDonald S., 2005, BRAIN IMPAIR, V6, P58, DOI [DOI 10.1375/BRIM.6.1.56.65481, 10.1375/brim.6.1.56.65481]; McDonald S., 1999, BRAIN DAM B; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Monterosso J, 2001, ADDICTION, V96, P1825, DOI 10.1046/j.1360-0443.2001.9612182512.x; O'Driscoll K, 1998, BRIT MED J, V317, P1673, DOI 10.1136/bmj.317.7174.1673a; Pearce S, 1998, BRAIN COGNITION, V38, P150, DOI 10.1006/brcg.1998.1018; Perkins M, 2002, INVESTIGATIONS IN CLINICAL PHONETICS AND LINGUISTICS, P1; Perkins M. R., 1995, CASE STUDIES CLIN LI, P293; Rahman S, 2001, TRENDS COGN SCI, V5, P271, DOI 10.1016/S1364-6613(00)01650-8; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Ritter LM, 2004, SCHIZOPHR RES, V68, P65, DOI 10.1016/S0920-9964(03)00086-0; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Shurman B, 2005, SCHIZOPHR RES, V72, P215, DOI 10.1016/j.schres.2004.03.020; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Toplak ME, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-8; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Turnbull OH, 2005, BRAIN COGNITION, V57, P244, DOI 10.1016/j.bandc.2004.08.053; Whitlow CT, 2004, DRUG ALCOHOL DEPEN, V76, P107, DOI 10.1016/j.drugalcdep.2004.04.009; Ylvisaker M., 1998, COLLABORATIVE BRAIN; [No title captured]	86	7	7	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	MAR-APR	2007	21	3-4					394	408		10.1080/02687030600911450			15	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	142VN	WOS:000244678800009					2022-02-06	
J	Kaptigau, WM; Ke, L; Rosenfeld, JV				Kaptigau, W. Matui; Ke, Liu; Rosenfeld, J. V.			Open depressed and penetrating skull fractures in Port Moresby General Hospital from 2003 to 2005	PAPUA NEW GUINEA MEDICAL JOURNAL			English	Article								Background: Open wounds to the head with skull bone depression pose the potential for serious injuries to the brain parenchyma and an increased risk of infection. The treatment of these injuries aims to repair the breached dura as well as remove any nidus for infection. Open wounds to the head due to bullets pose special problems and have a high fatality rate. Aim: To review the presentation, management and outcome of depressed and penetrating open fractures of the skull in Port Moresby. Method: All cases seen from 2003 to 2005 were included. All were managed without a CT (computed tomography) scan. Their Glasgow Outcome Scale (GOS) was documented on discharge. Results: There were 340 traumatic brain injury (TBI) cases over a period of 3 years between 2003 and 2005 managed by the Neurosurgery Unit of Port Moresby General Hospital. The open depressed and penetrating skull fractures seen in these cases numbered 46 (14%), of which 42 were males and 4 females. The weapons most commonly used were blunt objects (16), knives (11), guns (6) and axes (4). Gunshots contributed to 4 of the 7 deaths. 4 out of the 7 deaths were due to primary brain injury and 3 were due to infection. Conclusion: Open depressed fractures and penetrating injuries form a small but significant group in the management of head injuries. The use of blunt objects, firearms and arrows coupled with increasing urban violence is responsible for most of these injuries. The outcome of patients admitted who are fully conscious is expected to be good. They can be managed by prompt debridement of the wound, elevation of the fracture and removal of fragments as appropriate. However, the mortality rate is high in those with a Glasgow Coma Score of 8 or less on admission, a finding indicative of the severity of brain injury beneath the wound.			Kaptigau, WM (corresponding author), Port Moresby Gen Hosp, Dept Surg, Free Mail Bag,NCD 111, Boroko, Papua N Guinea.		Rosenfeld, Jeffrey V/B-7249-2011				BRAAKMAN R, 1972, J NEUROL NEUROSUR PS, V35, P395, DOI 10.1136/jnnp.35.3.395; JENNETT B, 1972, J NEUROSURG, V36, P333, DOI 10.3171/jns.1972.36.3.0333; JENNETT B, 1974, J NEUROSURG, V41, P208, DOI 10.3171/jns.1974.41.2.0208; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; Mathew P. K., 1996, Papua New Guinea Medical Journal, V39, P117; OH S, 1983, ACTA NEUROCHIR, V68, P111, DOI 10.1007/BF01406207; Olson S, 2004, J CLIN NEUROSCI, V11, P1, DOI 10.1016/j.jocn.2003.03.002; SHAFFREY ME, 1992, J NEUROTRAUM, V9, pS279; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; VANDENHEEVER CM, 1989, J NEUROSURG, V71, P186, DOI 10.3171/jns.1989.71.2.0186; Watters David A. K., 1996, Papua New Guinea Medical Journal, V39, P93	11	7	7	0	2	MEDICAL SOC PAPUA NEW GUINEA	GOTOKA EHP	PO BOX 60, GOTOKA EHP, PAPUA N GUINEA	0031-1480			PAPUA NEW GUINEA MED	Papua N. Guinea Med. J.	MAR-JUN	2007	50	1-2					58	63					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V90KQ	WOS:000206111600010	19354013				2022-02-06	
J	Kohta, M; Minami, H; Tanaka, K; Kuwamura, K; Kondoh, T; Kohmura, E				Kohta, Masaaki; Minami, Hiroaki; Tanaka, Kazuhiro; Kuwamura, Keiichi; Kondoh, Takeshi; Kohmura, Eiji			Delayed onset massive oedema and deterioration in traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						head injury; cerebral vasospasm; brain contusion; delayed deterioration; brain oedema	TRANSCRANIAL DOPPLER ULTRASOUND; CEREBRAL BLOOD-FLOW; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; ANGIOGRAPHIC FINDINGS; VASOSPASM; AUTOREGULATION; SPASM; PRESSURE	A 52-year-old man fell from standing and a computed tomography (CT) scan revealed traumatic intracerebral haematoma and subarachnoid haemorrhage in the temporal cortex. He was treated without surgery and discharged. On day 30 after the accident, he had no neurological deficit. On day 37 he complained of headache and urinary incontinence, and on day 39 he was hospitalized due to progressive neurological deterioration (reduced conciousness, dilated pupils, and left herniplegia). A CT scan revealed a diffuse low-density in the right cerebral hemisphere with marked midline shift. Emergency decompressive craniectomy and right temporal lobectomy were performed. Angiography after surgery revealed moderate vasospasm in the right middle and anterior cerebral arteries. The patient remained severely disabled. Delayed onset neurological deterioration can be caused by brain oedema and vasospasm after traumatic brain injury, despite an intervening period of improvement. (c) 2006 Elsevier Ltd. All rights reserved.	Kobe Univ, Grad Sch Med, Dept Neurosurg, Chuo Ku, Kobe, Hyogo 6500017, Japan; Awaji Hosp, Dept Neurosurg, Sumoto, Japan		Kondoh, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Neurosurg, Chuo Ku, Kusunoki Cho 7-5-2, Kobe, Hyogo 6500017, Japan.	tkondo@med.kobe-u.ac.jpb		Kohta, Masaaki/0000-0001-5936-7163			Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; CHAN KH, 1992, NEUROSURGERY, V30, P697; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; FREIDENFELT H, 1963, ACTA RADIOL DIAGN, V1, P278, DOI 10.1177/028418516300100221; Gebel JM, 2002, STROKE, V33, P2636, DOI 10.1161/01.STR.0000035283.34109.EA; GOMEZ CR, 1991, SURG NEUROL, V35, P30, DOI 10.1016/0090-3019(91)90198-I; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Lang EW, 2003, J CLIN NEUROSCI, V10, P670, DOI 10.1016/S0967-5868(03)00197-8; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Mayer SA, 1998, STROKE, V29, P1791, DOI 10.1161/01.STR.29.9.1791; PASQUALIN A, 1984, NEUROSURGERY, V15, P855, DOI 10.1227/00006123-198412000-00015; Powers WJ, 2001, NEUROLOGY, V57, P18, DOI 10.1212/WNL.57.1.18; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; VARDIMAN AB, 1995, AM J NEURORADIOL, V16, P319; Wojner-Alexander AW, 2005, NEUROLOGY, V64, P1354, DOI 10.1212/01.WNL.0000158284.41705.A5; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Yamada K, 1998, NEUROSURGERY, V43, P153, DOI 10.1097/00006123-199807000-00101; Zubkov AY, 1999, J NEUROTRAUM, V16, P763, DOI 10.1089/neu.1999.16.763	22	7	8	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	FEB	2007	14	2					167	170		10.1016/j.jocn.2006.01.042			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124SE	WOS:000243389400015	17161292				2022-02-06	
J	Najeb, Y; Essadki, B; Latifi, M; Fikry, T				Najeb, Y.; Essadki, B.; Latifi, M.; Fikry, T.			Bipolar dislocation of the foreann	CHIRURGIE DE LA MAIN			English	Article						elbow dislocation; perilunate dislocation; wrist; scaphoid fracture	PERILUNATE DISLOCATION; ELBOW	The authors report the case of a 23 year old patient, who presented the following combination of injuries after a fall, namely a divergent dislocation of the elbow, a fracture of the radial head, a fracture of the ulna and a perilunate dislocation with scaphoid fracture. The entire injury thus represented a bipolar dislocation of the forearm. The emergency management consisted of a closed reduction of the elbow together with osteosynthesis of the ulna, internal fixation of the scaphoid with a compression screw, and scaphocapitate K wiring. After 26 months, the function of the elbow was satisfactory, and the range of motion of the wrist was from 50 degrees of flexion to 40 degrees of extension. Satisfactory healing of the scaphoid was observed. This combination of injuries has only rarely been reported in the literature. (c) 2006 Elsevier Masson SAS. Tons droits reserves	[Najeb, Y.; Essadki, B.; Latifi, M.; Fikry, T.] CHU Marrakech, Serv Traumatol Orthopedie, Marrakech, Morocco		Najeb, Y (corresponding author), CHU Marrakech, Serv Traumatol Orthopedie, Marrakech, Morocco.	yousseffiajeb@hotmail.com		najeb, youssef/0000-0001-9475-7191			CHEN WS, 1994, J TRAUMA, V37, P504, DOI 10.1097/00005373-199409000-00029; DODD CAF, 1987, J TRAUMA, V27, P1307; HERZBERG G, 1993, HAND SURG AM, V18, P768; KERR CD, 1995, J TRAUMA, V38, P941, DOI 10.1097/00005373-199506000-00022; Masmejean E, 2001, REV CHIR ORTHOP, V87, P499; ROSSON J W, 1987, Journal of the Royal College of Surgeons of Edinburgh, V32, P122; VANCE RM, 1980, J BONE JOINT SURG AM, V62, P271, DOI 10.2106/00004623-198062020-00014	7	7	8	0	1	ELSEVIER	BRIDGEWATER	685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA	1297-3203	1769-6666		CHIR MAIN	Chir. Main.	FEB	2007	26	1					62	64		10.1016/j.main.2006.09.003			3	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	273OP	WOS:000253941300013	17418775				2022-02-06	
J	Dawson, KS; Batchelor, J; Meares, S; Chapman, J; Marosszeky, JE				Dawson, Katie S.; Batchelor, Jennifer; Meares, Susanne; Chapman, Jennifer; Marosszeky, Jeno E.			Applicability of neural reserve theory in mild traumatic brain injury	BRAIN INJURY			English	Article						brain reserve capacity; cognitive reserve; minor brain injury	CLOSED-HEAD INJURY; POSTTRAUMATIC AMNESIA; COGNITIVE RESERVE; INTELLIGENCE; DEMENTIA; ASSOCIATION; PREDICTORS; EDUCATION; RECOVERY; VALIDITY	Objective: The aim of the current study was to examine whether neural reserve influenced the duration of post-traumatic amnesia ( PTA) following mild traumatic brain injury ( MTBI). Method: The relationship between duration of PTA and both IQ and education was examined in a group of 59 MTBI patients. In addition, the effects of factors that could potentially diminish neural reserve, namely pre-injury hazardous alcohol consumption, pre-injury marijuana use, previous neurological damage, age and post-injury emotional distress on PTA duration were analysed. Results: Significant, negative associations between PTA duration and both IQ and education were revealed. None of the other variables that were examined were significantly related to PTA duration. Conclusion: The findings were interpreted as providing preliminary evidence to suggest that reference to neural reserve may help explain between-subject variability in acute response to MTBI.	Macquarie Univ, Dept Psychol, Sydney, NSW 2112, Australia; Westmead Hosp, Dept Rehabil Med, Sydney, NSW, Australia		Batchelor, J (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW 2112, Australia.	jenny.batchelor@psy.mq.edu.au		Meares, Susanne/0000-0002-3859-9974; Batchelor, Jennifer/0000-0003-4438-4993			Ahmed S, 2000, BRAIN INJURY, V14, P765; Alexander GE, 1997, AM J PSYCHIAT, V154, P165; BABOR TF, 2001, AUDIT ALCOHOL USE DI; BARONA A, 1986, INT J CLIN NEUROPSYC, V8, P169; Basso MR, 2000, J CLIN EXP NEUROPSYC, V22, P208, DOI 10.1076/1380-3395(200004)22:2;1-1;FT208; Bigler ED, 2007, COGNITIVE RESERVE TH, P85; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; DAVIS C, 2001, DISS ABSTR INT B, V62, P3395; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; Fein G, 2004, ALCOHOL, V32, P63, DOI 10.1016/j.alcohol.2003.10.003; Feinstein A, 2000, BRAIN COGNITION, V44, P78; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Glatt SL, 1996, NEUROEPIDEMIOLOGY, V15, P20, DOI 10.1159/000109885; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; JACOBS B, 1993, NEUROPSYCHOLOGY, V7, P273; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; KELSER S, 2003, APPL NEUROPSYCHOL, V10, P153; LOVIBOND SH, 1995, MANUAL DEPRESSION AN; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; MATARAZZO JD, 1972, WESCHLERS MEASUREMEN; MCALLISTER T, 2005, 25 ANN M NAT AC NEUR; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Nebes RD, 2005, NEUROLOGY, V65, P1487, DOI 10.1212/01.wnl.0000183152.16690.26; O'Jile JR, 2006, ARCH CLIN NEUROPSYCH, V21, P293, DOI 10.1016/j.acn.2006.03.003; Piccinelli M, 1997, BRIT MED J, V314, P420, DOI 10.1136/bmj.314.7078.420; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Richards M, 2007, COGNITIVE RESERVE TH, P36; ROPACKI M, 2000, DISS ABSTR INT B, V61, P3860; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; RUTTER M, 1985, J CHILD PSYCHOL PSYC, V26, P683, DOI 10.1111/j.1469-7610.1985.tb00584.x; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Stapert S, 2006, BRAIN INJURY, V20, P161, DOI 10.1080/02699050500442949; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Stern Y, 2007, COGNITIVE RESERVE TH; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Wickett JC, 2000, PERS INDIV DIFFER, V29, P1095, DOI 10.1016/S0191-8869(99)00258-5; WILLERMAN L, 1991, INTELLIGENCE, V15, P223, DOI 10.1016/0160-2896(91)90031-8; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	50	7	7	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	9					943	949		10.1080/02699050701553171			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	202ZA	WOS:000248942600006	17729047				2022-02-06	
J	Kanakura, H; Taniguch, T				Kanakura, Hiroko; Taniguch, Takumi			The antiinflammatory effects of propofol in endotoxemic rats during moderate and mild hypothermia	JOURNAL OF ANESTHESIA			English	Article						propofol; endotoxemia; hemodynamics; hypothermia; cytokine	TUMOR-NECROSIS-FACTOR; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; CARDIAC-ARREST; SHOCK; INTERLEUKIN-1; RESPONSES; CYTOKINE; SEPSIS; FLOW	Purpose. We previously found that propofol attenuated the mortality rate and inflammatory responses during endotoxemia in rats; however, whether propofol retains its antiinflammatory effects during hypothermia has not been determined. We investigated the effects of propofol on endotoxemic rats subjected to moderate or mild hypothermia. Methods. Male Wistar rats (n = 88) were anesthetized intraperitoneally with pentobarbital sodium and assigned to one of two protocols: one representing moderate hypothermia (30 degrees-32 degrees C) and the other representing mild hypotherima (33 degrees-35 degrees C). Each protocol included four equal-sized groups: group A, Escherichia coli endotoxin (15mg(.)kg(-1), i.v.) and normothermia; group B, propofol (10mg(.)kg(-1.)h(-1), i.v.) and normothermia after endotoxin injection; group C, endotoxin (15mg(.)kg(-1), i.v.) and hypothermia; and group D, propofol (10mg(.)kg(-1.)h(-1), i.v.) and hypothermia after endotoxin injection. Rats then were warmed or cooled to maintain rectal temperatures as above for 6 It. The mortality rate was assessed up to 6h after endotoxin injection. In addition, we assessed hemodynamics, acid-base status, and plasma cytokine concentrations. Results. Endotoxemic rats developed hypotension and metabolic acidosis as well as increased plasma cytokine concentrations. Mortality rates 6h after endotoxin injection were 70%, 40%, 10%, and 0% for groups A-D, respectively, at moderate hypothermia. Propofol administration to endotoxemic rats with hypothermia, whether moderate or mild, also attenuated the high mortality rate, metabolic acidosis, and elevation of cytokines, but these effects were not superior to those of hypothermia alone. Conclusion. During hypothermia, propofol administration does not have additive beneficial antiinflammatory effects.	[Taniguch, Takumi] Kanazawa Univ, Grad Sch Med Sci, Dept Emergency & Crit Care Med, Kanazawa, Ishikawa 9208641, Japan; [Kanakura, Hiroko] Kanazawa Univ, Grad Sch Med Sci, Dept Anesthesiol & Intens Care Med, Kanazawa, Ishikawa 9208641, Japan		Taniguch, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Emergency & Crit Care Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.						Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; DAMAS P, 1989, CRIT CARE MED, V17, P975, DOI 10.1097/00003246-198910000-00001; Gordon BR, 2005, J INFECT DIS, V191, P1515, DOI 10.1086/428908; Hayashi S, 2005, ACT NEUR S, V95, P269; Heine J, 1996, BRIT J ANAESTH, V77, P387, DOI 10.1093/bja/77.3.387; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kahveci FS, 2001, SURG NEUROL, V56, P206, DOI 10.1016/S0090-3019(01)00555-9; LESLIE K, 1995, ANESTH ANALG, V80, P1007, DOI 10.1097/00000539-199505000-00027; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARTY C, 1994, CRIT CARE MED, V22, P673, DOI 10.1097/00003246-199404000-00025; Mikawa K, 1998, ANESTH ANALG, V87, P695, DOI 10.1097/00000539-199809000-00039; NATANSON C, 1989, J EXP MED, V169, P823, DOI 10.1084/jem.169.3.823; Peters CE, 2001, ANESTHESIOLOGY, V94, P313, DOI 10.1097/00000542-200102000-00022; Takemoto Yasuhiro, 2005, J Anesth, V19, P40, DOI 10.1007/s00540-004-0267-z; Taniguchi T, 2000, CRIT CARE MED, V28, P1101, DOI 10.1097/00003246-200004000-00032; Taniguchi T, 2002, CRIT CARE MED, V30, P904, DOI 10.1097/00003246-200204000-00032; WAKABAYASHI G, 1991, J CLIN INVEST, V87, P1925, DOI 10.1172/JCI115218	18	7	8	0	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.		2007	21	3					354	360		10.1007/s00540-007-0533-y			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	310LN	WOS:000256531200011	17680188				2022-02-06	
J	Lescot, T; Pereira, AR; Abdennour, L; Sanchez-Pena, P; Naccache, L; Coriat, P; Puybasset, L				Lescot, Thomas; Pereira, Ana Rosa; Abdennour, Lamine; Sanchez-Pena, Paola; Naccache, Lionel; Coriat, Pierre; Puybasset, Louis			Effect of loxapine on electrical brain activity, intracranial pressure, and middle cerebral artery flow velocity in traumatic brain-injured patients	NEUROCRITICAL CARE			English	Article						traumatic brain injury; delirium; loxapine; agitation; antipsychotics; continuous electroencephalogram monitoring; intracranial pressure	ATYPICAL ANTIPSYCHOTICS; DROPERIDOL; OLANZAPINE; MORTALITY; DELIRIUM	Introduction Delirium is a frequent complication of traumatic brain injury, especially during the weaning period. Antipsychotic drugs are often used in this case. Loxapine is a tricyclic antipsychotic drug with sedating properties. The effects of intravenous loxapine on EEG as well as on systemic and cerebral hemodynamics after traumatic brain injury are unknown. Methods Seven sedated and mechanically ventilated traumatic brain injured patients were studied 11 +/- 5 days after trauma. They were on continuous perfusion of sufentanil and midazolam. Left and right spectral edge frequency (SEFI, SEFr) of continuous EEG recording, intracranial pressure (ICP), mean flow velocity of the middle cerebral artery (MFVMCA) and mean arterial pressure (MAP) were simultaneously recorded and digitalized before and after loxapine infusion (10 mg, in 10 min of continuous infusion). Results Loxapine induced no significant change on MAP, MFV. On the contrary, it decreased ICP and both SEFI, SEFr. ETCO2 and the dose of vasopressors were not altered during the study period. Conclusion 10 mg of loxapine administered intravenously over 10 min decreased brain electrical activity. There is a concomitant reduction in ICP without any significant change in cerebral blood flow velocity. The use of intravenous loxapine to control agitation is not accompanied by deleterious hemodynamic or systemic effects in ICU's traumatic brain injured patients.	Grp Hosp Pitie Salpetriere, Dept Anesthesie & Reanimatol, F-75013 Paris, France; Univ Paris 06, Grp Hosp Pitie Salpetriere, Dept Anesthesiol & Crit Care, Assistance Publ Hop Paris AP HP, Paris, France; Univ Paris 06, Grp Hosp Pitie Salpetriere, Dept Clin Neurophysiol, Assistance Publ Hop Paris AP HP, Paris, France		Puybasset, L (corresponding author), Grp Hosp Pitie Salpetriere, Dept Anesthesie & Reanimatol, 47 Blvd Hop, F-75013 Paris, France.	louis.puybasset@psl.aphp.fr		naccache, lionel/0000-0002-2874-1009			BARTHEL JS, 1995, GASTROINTEST ENDOSC, V42, P45, DOI 10.1016/S0016-5107(95)70242-3; Centorrino F, 2002, AM J PSYCHIAT, V159, P109, DOI 10.1176/appi.ajp.159.1.109; Elovic EP, 2003, J HEAD TRAUMA REHAB, V18, P177, DOI 10.1097/00001199-200303000-00008; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; FENTON M, 2000, COCHRANE DB SYST REV; Flacker JM, 1999, J GERONTOL A-BIOL, V54, pB239, DOI 10.1093/gerona/54.6.B239; Kapur S, 1998, AM J PSYCHIAT, V155, P921, DOI 10.1176/ajp.155.7.921; Krieger D, 2003, NEUROREHABILITATION, V18, P205; Lescot T, 2005, INTENS CARE MED, V31, P1042, DOI 10.1007/s00134-005-2709-y; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Milbrandt EB, 2005, CRIT CARE MED, V33, P226, DOI 10.1097/01.CCM.0000150743.16005.9A; Nakayama M, 2003, ANESTH ANALG, V96, P765, DOI 10.1213/01.ANE.0000048517.98692.53; Rosati DL, 2002, AM J PHYS MED REHAB, V81, P90, DOI 10.1097/00002060-200202000-00003; Yamada K, 2004, BRAIN TOPOGR, V16, P281	14	7	7	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2007	7	2					124	127		10.1007/s12028-007-0051-7			4	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	214MJ	WOS:000249741700005	17846719				2022-02-06	
J	Luther, MS; Krewer, C; Muller, F; Koenig, E				Luther, Marianne S.; Krewer, Carmen; Mueller, Friedemann; Koenig, Eberhard			Orthostatic circulatory disorders in early neurorehabilitation: A case report and management overview	BRAIN INJURY			English	Article						rehabilitation; postural syncope; minimally conscious state; spinal cord injury	SPINAL-CORD-INJURY; FUNCTIONAL ELECTRIC-STIMULATION; BED REST; HYPOTENSION; RESPONSES	Orthostatic circulatory disorders are a common problem in the mobilization of patients with severe neurological diseases such as paraplegia, the vegetative state or the minimally conscious state. They create difficulties when mobilizing the patient out of bed. Although their incidence has not been clearly established and the severity and length of symptoms differ greatly, a relevant number of the patients in a rehabilitation unit is affected. Rehabilitation specialists should therefore be aware of these disorders and the therapeutic alternatives available. This case study reports on a 45-year-old patient who repeatedly suffered from orthostatic hypotension after a severe traumatic brain injury. The pathogenesis and predisposing factors of orthostatic dysfunction in severely disabled neurological patients as well as therapeutic efforts are subsequently reviewed.	Neurol Klin Bad Aibling, D-83043 Bad Aibling, Germany		Luther, MS (corresponding author), Neurol Klin Bad Aibling, Kolbermoorerstr 72, D-83043 Bad Aibling, Germany.	mluther@schoen-kliniken.de	Krewer, Carmen/H-2845-2019	Krewer, Carmen/0000-0002-4153-0791			*AM AC NEUR CONS C, 1996, J NEUROL SCI, V144, P218; Balocchi R, 2000, METHOD INFORM MED, V39, P157; Bisharat N, 2002, PACE, V25, P372, DOI 10.1046/j.1460-9592.2002.00372.x; Capaldi LM, 2005, AGE AGEING, V34, P86, DOI 10.1093/ageing/afh241; Chao CY, 2005, ARCH PHYS MED REHAB, V86, P1427, DOI 10.1016/j.apmr.2004.12.033; Convertino VA, 1997, MED SCI SPORT EXER, V29, P191, DOI 10.1097/00005768-199702000-00005; Czell David, 2004, J Neuroeng Rehabil, V1, P4, DOI 10.1186/1743-0003-1-4; Diehl RR, 1999, NERVENARZT, V70, P1044, DOI 10.1007/s001150050538; Do D, 2000, J NEUROL NEUROSUR PS, V69, P832, DOI 10.1136/jnnp.69.6.832; Faghri PD, 2001, ARCH PHYS MED REHAB, V82, P1587, DOI 10.1053/apmr.2001.25984; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Illman A, 2000, SPINAL CORD, V38, P741, DOI 10.1038/sj.sc.3101089; Kibisa Raimundas, 2006, Medicina (Kaunas), V42, P932; Kong KH, 2003, ARCH PHYS MED REHAB, V84, P559, DOI 10.1053/apmr.2003.50040; Maury M, 1998, SPINAL CORD, V36, P87, DOI 10.1038/sj.sc.3100587; Mukand J, 2001, ARCH PHYS MED REHAB, V82, P694, DOI 10.1053/apmr.2001.22350; Muraki S, 2000, EUR J APPL PHYSIOL, V81, P271, DOI 10.1007/s004210050042; Oldenburg O, 2002, CURR OPIN PHARMACOL, V2, P740, DOI 10.1016/S1471-4892(02)00213-8; SENARD JM, 1991, EUR J CLIN PHARMACOL, V41, P593, DOI 10.1007/BF00314991; SOCHART DH, 1999, J BONE JOINT SURG, V700, pB81; Topp Robert, 2002, AACN Clin Issues, V13, P263, DOI 10.1097/00044067-200205000-00011; Welch R, 1970, Nurs Clin North Am, V5, P621	23	7	8	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	7					763	767		10.1080/02699050701481639			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	192LX	WOS:000248204400012	17653950				2022-02-06	
J	Manville, J; Laurer, HL; Steudel, WI; Mautes, AEM				Manville, Jerome; Laurer, Helmut L.; Steudel, Wolf-Ingo; Mautes, Angelika E. M.			Changes in cortical and subcortical energy metabolism after repetitive and single controlled cortical impact injury in the mouse	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						repetitive; ATP; glucose; lactate; controlled cortical impact injury; mouse	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; REGIONAL ENERGY; RATS; LESION	In the present investigation we examined regional ATP, glucose, and lactate content in the cortical and subcortical region, in a mouse model of controlled cortcal impact (CCI) injury In serial tissue sections, bioluminescence imaging of ATP, glucose, and lactate was performed 1 h after a single CCI injury or sham surgery and 15 min, 1, 24, and 48 h after the induction of a second CCI injury 24 h later or sham surgery. Bioluminescence images were analyzed by computer-assisted densitometry at the lesion site, at the contralateral site, and in a subcortical region. After repetitive CCI injury, the cortical ATP content decreased bilaterally at 15 min and 1 h, and reached a significant minimum at 24 h, as compared with sham. At 48 h the ATP content bilaterally reached base level again. No significant changes in ATP were found in the subcortical region. After repetitive CCI injury, the lactate content increased bilaterally, reached a significant level at 15 min at the trauma site, and bilaterally reached a significant maximum at 1 h. Thereafter, lactate content decreased below base level without reaching significance and reached baseline again at 48 h. In the ipsilateral subcortical region, lactate content increased transiently above the baseline at 1 h and decreased to a significant minimum at 24 and 48 h. No significant changes were found in the contralateral subcortical area. No significant differences between glucose content in sham animals and the cortical and subcortical area could be measured over time; the subcortical glucose content was bilaterally lower than cortical content at all time points and reached a significant minimum bilaterally at 48 h after repetitive CCI injury compared with cortical glucose content. Single CCI injury did not affect ATP, glucose, and lactate contents at any time point. Repetitive CCI injury caused a more severe depression in cerebral metabolism at early time points after trauma compared with a single CCI injury and indicates that lactate might be an early indicator of post-traumatic metabolic disruption.	Univ Saarland, Sch Med, Neurosurg Res Lab, D-66421 Homburg, Germany; Univ Saarland, Sch Med, Dept Neurosurg, D-66421 Homburg, Germany; Geothe Univ Hosp, Dept Trauma Surg, Frankfurt, Germany		Mautes, AEM (corresponding author), Univ Saarland, Sch Med, Neurosurg Res Lab, D-66421 Homburg, Germany.	unvamau@uniklinikum-saarland.de					Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Mautes AEM, 2001, J MOL NEUROSCI, V16, P33, DOI 10.1385/JMN:16:1:33; Plesnila N, 2003, NEUROSCI LETT, V345, P85, DOI 10.1016/S0304-3940(03)00396-3; PONTEN U, 1973, J NEUROCHEM, V21, P1127, DOI 10.1111/j.1471-4159.1973.tb07567.x; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; SOOD SC, 1980, ACTA NEUROCHIR, V53, P47, DOI 10.1007/BF02074520; SUTTON RL, 1994, ACTA NEUROCHIR, P446; WAGNER KR, 1985, J NEUROSURG, V63, P88, DOI 10.3171/jns.1985.63.1.0088; Weinzierl MR, 2002, J MOL NEUROSCI, V18, P247, DOI 10.1385/JMN:18:3:247; Woertgen C, 2001, J NEUROTRAUM, V18, P569, DOI 10.1089/089771501300227378	14	7	7	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.		2007	31	2					95	100		10.1385/JMN/31:02:95			6	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	144MM	WOS:000244800300001	17478883				2022-02-06	
J	Patrick, PD; Mabry, JL; Gurka, MJ; Buck, ML; Boatwright, E; Blackman, JA				Patrick, Peter D.; Mabry, Jennifer L.; Gurka, Matthew J.; Buck, Marcia L.; Boatwright, Evelyn; Blackman, James A.			MRI patterns in prolonged low response states following traumatic brain injury in children and adolescents	BRAIN INJURY			English	Article						TBI; MRI; vegetative state; coma; minimally conscious	VEGETATIVE STATE; HEAD-INJURY; YOUNG-ADULTS; COMA; PROGNOSIS; LESION	Objectives: To explore the relationship between location and pattern of brain injury identified on MRI and prolonged low response state in children post-traumatic brain injury (TBI). Methods: This observational study compared 15 children who spontaneously recovered within 30 days post-TBI to 17 who remained in a prolonged low response state. Results: 92.9% of children with brain stem injury were in the low response group. The predicted probability was 0.81 for brain stem injury alone, increasing to 0.95 with a regional pattern of injury to the brain stem, basal ganglia, and thalamus. Conclusions: Low response state in children post-TBI is strongly correlated with two distinctive regions of injury: the brain stem alone, and an injury pattern to the brain stem, basal ganglia, and thalamus. This study demonstrates the need for large-scale clinical studies using MRI as a tool for outcome assessment in children and adolescents following severe TBI.	Univ Virginia, Kluge Childrens Rehabil Ctr, Dept Pediat, Charlottesville, VA 22901 USA; Univ Virginia, Inst Res, Charlottesville, VA 22901 USA; Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA		Patrick, PD (corresponding author), Univ Virginia, Kluge Childrens Rehabil Ctr, Dept Pediat, 2270 Ivy Rd, Charlottesville, VA 22901 USA.	pdp2n@virignia.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD039631] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5R24HD039631] Funding Source: Medline		ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Ashwal Stephen, 2002, Semin Pediatr Neurol, V9, P19, DOI 10.1053/spen.2002.30334; Augustine G., 2001, NEUROSCIENCE; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Bolton C. F., 1998, COMA IMPAIRED CONSCI; Christophe C, 2002, AM J NEURORADIOL, V23, P716; Efron B., 1979, ANN STAT, V17, P1; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Hagen C., 1972, LEVELS COGNITIVE FUN; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kingsley R. E., 2000, CONCISE TEXT NEUROSC; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; SAS Institute Inc, 2002, SAS STAT US GUID VER; Shewmon DA, 2000, J CLIN NEUROPHYSIOL, V17, P457, DOI 10.1097/00004691-200009000-00004; Stokes ME, 2000, CATEGORICAL DATA ANA; Trubel HK, 2003, CURR OPIN PEDIATR, V15, P283, DOI 10.1097/00008480-200306000-00010; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Woischneck D, 2003, CHILD NERV SYST, V19, P174, DOI 10.1007/s00381-002-0703-z; Zanchetti, 1959, ARCH ITAL BIOL, V97, P33; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	26	7	7	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2007	21	1					63	68		10.1080/02699050601111401			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	141FQ	WOS:000244564600008	17364521				2022-02-06	
J	Shapcott, EJB; Bloom, GA; Johnston, KM; Loughead, TM; Delaney, JS				Shapcott, Erin J. B.; Bloom, Gordon A.; Johnston, Karen M.; Loughead, Todd M.; Delaney, J. Scott			The effects of explanatory style on concussion outcomes in sport	NEUROREHABILITATION			English	Article						concussion; explanatory style; sport psychology	RISK FACTOR; AGREEMENT STATEMENT; SELF-ESTEEM; HEAD-INJURY; GAY MEN; OPTIMISM; ILLNESS; DEPRESSION; PESSIMISM; STRESS	Individuals with an optimistic explanatory style have generally been linked with improved mental and physical health across a variety of chronic and serious conditions. The purpose of the current study was to examine the effects of explanatory style on recovery time and number of sport-related concussions suffered in the last 12 months. University varsity athletes (n=170) suffering from at least one concussion over the last 12 months from six contact or collision team sports completed both the ttributional Style Questionnaire and the Sport History Questionnaire. The results indicated that athletes with an optimistic explanatory style took longer to recover than athletes with a pessimistic or average explanatory style. More specifically, optimistic athletes who suffered a complex concussion (requiring more than 7 days to recover) took significantly longer to return to play. However, the results showed that explanatory style did not influence whether an athlete suffered subsequent concussions. Overall, the current results can be used to better understand the psychology of concussions, as well as concussion prevention efforts and management strategies.	McGill Univ, Dept Kinesiol & Hlth Educ, Montreal, PQ H2W 1S4, Canada; Univ Toronto, Toronto, ON, Canada; Univ Windsor, Windsor, ON N9B 3P4, Canada		Bloom, GA (corresponding author), McGill Univ, Dept Kinesiol & Hlth Educ, 475 Pine Ave W, Montreal, PQ H2W 1S4, Canada.	gordon.bloom@mcgill.ca					ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; CARVER CS, 1987, COGNITIVE THER RES, V11, P449, DOI 10.1007/BF01175355; CARVER CS, 1993, J PERS SOC PSYCHOL, V65, P375, DOI 10.1037/0022-3514.65.2.375; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; CARVER CS, 1979, J PERS SOC PSYCHOL, V37, P1186, DOI 10.1037/0022-3514.37.7.1186; Cohen F, 1999, BRAIN BEHAV IMMUN, V13, P155, DOI 10.1006/brbi.1998.0531; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Ford IW, 2000, J SPORT SCI, V18, P301, DOI 10.1080/026404100402368; Fournier M, 2002, BRIT J HEALTH PSYCH, V7, P409, DOI 10.1348/135910702320645390; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Isaacowitz DM, 2005, J RES PERS, V39, P224, DOI 10.1016/j.jrp.2004.02.003; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Kontos AP, 2004, J APPL SPORT PSYCHOL, V16, P220, DOI 10.1080/10413200490485568; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; LIN EH, 1990, BEHAV RES THER, V28, P243, DOI 10.1016/0005-7967(90)90007-6; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; MARSHALL GN, 1992, J PERS SOC PSYCHOL, V62, P1067, DOI 10.1037/0022-3514.62.6.1067; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; PETERSON C, 1984, PSYCHOL REV, V91, P347, DOI 10.1037/0033-295X.91.3.347; Peterson C, 2000, AM PSYCHOL, V55, P44, DOI 10.1037/0003-066X.55.1.44; PETERSON C, 1982, COGNITIVE THER RES, V6, P287, DOI 10.1007/BF01173577; PETERSON C, 1987, J PERS, V55, P237, DOI 10.1111/j.1467-6494.1987.tb00436.x; PETERSON C, 1988, J PERS SOC PSYCHOL, V55, P23, DOI 10.1037/0022-3514.55.1.23; Peterson C, 2001, COGNITIVE THER RES, V25, P633, DOI 10.1023/A:1012945120821; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Reed GM, 1999, HEALTH PSYCHOL, V18, P354, DOI 10.1037/0278-6133.18.4.354; REED GM, 1994, HEALTH PSYCHOL, V13, P299, DOI 10.1037/0278-6133.13.4.299; SCHEIER MF, 1989, J PERS SOC PSYCHOL, V57, P1024, DOI 10.1037/0022-3514.57.6.1024; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Spencer SM, 1996, PERS SOC PSYCHOL B, V22, P354, DOI 10.1177/0146167296224003; Symister P, 2003, HEALTH PSYCHOL, V22, P123, DOI 10.1037/0278-6133.22.2.123; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; WENGLERT L, 1995, PERS INDIV DIFFER, V18, P653, DOI 10.1016/0191-8869(94)00193-V; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596	41	7	8	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2007	22	3					161	167					7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	216NM	WOS:000249884800002	17917166				2022-02-06	
J	Spearman, RC; Stamm, BH; Tivis, LJ				Spearman, Russell C.; Stamm, B. Hudnall; Tivis, Laura J.			Traumatic brain injury state planning grant: Preparing for change in a rural state	BRAIN INJURY			English	Article						traumatic brain injury; rural; state planning grant	VOCATIONAL-REHABILITATION; NEEDS; SERVICES; PEOPLE; TBI	Purpose: The overarching purpose of this work was to generate a framework on which to build a traumatic brain injury (TBI) system-support action plan for individuals with a TBI living in a rural state. Methods: Four research questions were posed aimed at describing rural service/support needs and service satisfaction among persons with a TBI, as well as rural service/support availability as defined by providers. One hundred and ninety-four providers/agencies and 250 individuals/family members completed one of two versions (provider/agency, individual/family member) of a Needs and Resources Assessment. Results: Data analyses indicated that the majority of individual respondents lived at an impoverished income level and lived with a TBI for similar to 12 years. Quality of life was perceived as significantly lower after the TBI than before. Employment decreased significantly following a TBI. Reasons for unemployment included a perceived inability to work, problems regarding proper accommodation and/or perceptions regarding being chosen as suitable job candidates. Conclusions: Provider data confirmed that many important services are rarely available or specific to TBIs. Basic assistance with employment, cognitive training and occupational therapy were among those most needed. Paradoxically, a high proportion of individuals reported feeling satisfied with most services. Applications of these data along with recommendations for other rural states are described.	Idaho State Univ, Inst Rural Hlth, Pocatello, ID 83209 USA		Spearman, RC (corresponding author), Idaho State Univ, Boise Ctr, Inst Rural Hlth, 12301 W Explorer Dr,102, Boise, ID 83713 USA.	spearuss@isu.edu	Stamm, Beth Hudnall/AAK-2544-2020	Stamm, Beth Hudnall/0000-0003-4187-8701			*BUR HLTH POL VIT, 1999, ID VIT STAT 1999 ANN; *CDC, 2006, WHAT CAUS TBP; *CDCP, 2001, INJ FACT BOOK 2001 2, P110; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA, P1; Coetzer B R, 2002, Aust J Rural Health, V10, P229, DOI 10.1046/j.1440-1584.2002.00425.x; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; *DVBIC, 2006, BLAST INJ; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; GORDON CJ, 1985, METACOGNITION COGNIT, V2, P1; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; *ID EM MED SYST, 2001, COMM ID TRAUM ADV CO; *IDAH DEP TRANSP, 2005, ID TRAFF COLL 2005; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Langlois J. A., 2006, TRAUMATIC BRAIN INJU, P1; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; *MISS HEAD INJ ADV, 2004, MISS 2004 TRAUM BRA; *NAT I NEUR DIS ST, 2006, TRAUM BRAIN INJ HOP; *NOD, 2004, NOD HARR SURV 2004 L; O'Neill JH, 2004, ARCH PHYS MED REHAB, V85, pS68, DOI 10.1016/j.apmr.2003.08.114; Schootman M, 1999, BRAIN INJURY, V13, P995; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Thurman DJ, 2001, HEAD TRAUMA, P327; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; *US DEP HHS, 2005, HIGHL HLTH WORKF PRO; 2006, BRAIN MATTERS; [No title captured], DOI DOI 10.1037/10489-011	28	7	7	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	8					837	849		10.1080/02699050701426857			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	202YZ	WOS:000248942400005	17676441				2022-02-06	
J	Ashki, N; Hayes, KC; Shi, RY				Ashki, Negin; Hayes, Keith C.; Shi, Riyi			Nitric oxide reversibly impairs axonal conduction in guinea pig spinal cord	JOURNAL OF NEUROTRAUMA			English	Article						axons; conduction; guinea pig; nitric oxide; spinal cord injury	TRAUMATIC BRAIN-INJURY; SLOW SODIUM INACTIVATION; CNS WHITE-MATTER; IN-VITRO; NA+ CHANNELS; HALF-LIFE; SYNTHASE; RAT; NERVE; NEURONS	Increased expression of the inducible and neuronal isoforms of nitric oxide synthase (NOS), and elevated concentrations of nitric oxide (NO) metabolites, are present within the central nervous system (CNS) following neurotrauma and are implicated in the pathogenesis of the accompanying neurologic deficits. We tested the hypothesis that elevated extracellular concentrations of NO introduced by the donor Spermine NONOate, induce reversible axonal conduction deficits in neurons of the guinea pig spinal cord. The compound action potential (CAP) and compound membrane potential (CMP) of excised ventral cord white matter were recorded before, during, and after bathing the tissue (30 min) in varying concentrations (0.25-3.0 mM) of Spermine NONOate. The principal results were a rapid onset, dose-dependent, reduction in amplitude of the CAP (p < 0.05) accompanied by depolarization of the CMP during NO exposure. These effects were largely reversible on washout, at low concentration of the donor (0.5 mM), but were only partially reversed at higher concentrations. Changes in the electrophysiological properties were not evident when the donor had been a priori depleted of NO. The results extend previous reports that NO induces reversible axonal conduction deficits. They provide new evidence of dissociation of the effects of NO on CAP and CMP during washout, and after prolonged exposure to the donor. They add support to the emerging concept that immune-mediated axonal conduction failure contributes to reversible neurologic deficits following neurotrauma and aid in understanding clinical phenomena such as spinal shock and neurologic recovery.	Lawson Hlth Res Inst, London, ON N6C 5J1, Canada; Univ Western Ontario, Neurosci Program, London, ON, Canada; Purdue Univ, Dept Basic Med Sci, Inst Appl Neurol, W Lafayette, IN 47907 USA		Hayes, KC (corresponding author), Lawson Hlth Res Inst, 801 Commissioners Rd E, London, ON N6C 5J1, Canada.	kchayes@uwo.ca					Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Bao F, 2002, NEUROSCIENCE, V115, P839, DOI 10.1016/S0306-4522(02)00506-7; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; Brown GC, 2003, MOL NEUROBIOL, V27, P325, DOI 10.1385/MN:27:3:325; Calabrese V, 2000, NEUROCHEM RES, V25, P1315, DOI 10.1023/A:1007604414773; Chatzipanteli K, 2002, J NEUROTRAUM, V19, P639, DOI 10.1089/089771502753754109; Davies AL, 2006, J NEUROTRAUM, V23, P1261, DOI 10.1089/neu.2006.23.1261; DECARVALHO AC, 1986, AM PHYSL SOC, pC99; Diaz-Ruiz A, 2004, NEUROSCI LETT, V357, P49, DOI 10.1016/j.neulet.2003.12.042; Dietz V, 2004, ACT NEUR S, V89, P95; Ditunno JF, 2004, SPINAL CORD, V42, P383, DOI 10.1038/sj.sc.3101603; Fisher CG, 2005, SPINE, V30, P2200, DOI 10.1097/01.brs.0000181058.06412.a9; Garthwaite G, 2002, NEUROSCIENCE, V109, P145, DOI 10.1016/S0306-4522(01)00447-X; GATTI RM, 1994, FEBS LETT, V348, P287, DOI 10.1016/0014-5793(94)00625-3; Hakim TS, 1996, PHYSIOL MEAS, V17, P267, DOI 10.1088/0967-3334/17/4/004; Hayes KC, 1997, J NEUROTRAUM, V14, P235, DOI 10.1089/neu.1997.14.235; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; HOGG N, 1992, BIOCHEM J, V281, P419, DOI 10.1042/bj2810419; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Isaksson J, 2005, SPINAL CORD, V43, P167, DOI 10.1038/sj.sc.3101672; Kapoor R, 1999, ANN NY ACAD SCI, V893, P304, DOI 10.1111/j.1749-6632.1999.tb07843.x; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Kirshblum S, 2004, ARCH PHYS MED REHAB, V85, P1811, DOI 10.1016/j.apmr.2004.03.015; Koller H, 1997, PROG NEUROBIOL, V52, P1, DOI 10.1016/S0301-0082(96)00065-2; Kroncke KD, 1997, NITRIC OXIDE-BIOL CH, V1, P107, DOI 10.1006/niox.1997.0118; Kwak EK, 2005, J KOREAN MED SCI, V20, P663, DOI 10.3346/jkms.2005.20.4.663; Lancaster JR, 1996, METHOD ENZYMOL, V268, P31; Laurent M, 1996, BIOCHEM J, V314, P109, DOI 10.1042/bj3140109; Li Z, 1998, NEURON, V20, P1039, DOI 10.1016/S0896-6273(00)80484-5; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lu J, 2003, NEUROSCI LETT, V339, P147, DOI 10.1016/S0304-3940(03)00003-X; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; Matsuyama Y, 1998, J SPINAL DISORD, V11, P248; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Nakahara S, 2002, J NEUROTRAUM, V19, P1467, DOI 10.1089/089771502320914697; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Rejdak K, 2004, NEUROLOGY, V63, P1439; Renganathan M, 2002, J NEUROPHYSIOL, V87, P761, DOI 10.1152/jn.00369.2001; Rose MR, 1998, BRIT MED J, V316, P1104, DOI 10.1136/bmj.316.7138.1104; Satake K, 2000, MOL BRAIN RES, V85, P114, DOI 10.1016/S0169-328X(00)00253-9; Sato T, 1995, BRAIN RES, V704, P117, DOI 10.1016/0006-8993(95)01165-X; Schmidt K, 1997, N-S ARCH PHARMACOL, V355, P457, DOI 10.1007/PL00004969; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi R, 2000, NEUROSCIENCE, V98, P157, DOI 10.1016/S0306-4522(00)00096-8; SHRAGER P, 1977, J GEN PHYSIOL, V69, P183, DOI 10.1085/jgp.69.2.183; Shrager P, 1998, J NEUROPHYSIOL, V79, P529, DOI 10.1152/jn.1998.79.2.529; SIMMONS ML, 1992, J NEUROCHEM, V59, P897, DOI 10.1111/j.1471-4159.1992.tb08328.x; STARKUS JG, 1978, AM J PHYSIOL, V235, pC238, DOI 10.1152/ajpcell.1978.235.5.C238; Steiner L, 1997, DIABETOLOGIA, V40, P150, DOI 10.1007/s001250050656; STYS PK, 1992, J NEUROSCI, V12, P430; Stys PK, 1998, NEUROSCIENCE, V82, P21; Takeuchi A, 1998, EUR J NEUROSCI, V10, P1613, DOI 10.1046/j.1460-9568.1998.00168.x; Trudrung P, 2000, NEUROSCI LETT, V287, P125, DOI 10.1016/S0304-3940(00)01145-9; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wang XK, 2000, DRUG NEWS PERSPECT, V13, P133, DOI 10.1358/dnp.2000.13.3.657283; Waxman SG, 2001, NEUROLOGY, V56, P1621, DOI 10.1212/WNL.56.12.1621; WINK DA, 1993, CHEM RES TOXICOL, V6, P23, DOI 10.1021/tx00031a003; WOOD J, 1994, NEUROPHARMACOLOGY, V33, P1235, DOI 10.1016/0028-3908(94)90022-1; WU W, 1994, NEUROSCIENCE, V61, P719, DOI 10.1016/0306-4522(94)90394-8; Yamada K, 1997, J NEUROCHEM, V68, P1234; ZIELASEK J, 1992, CELL IMMUNOL, V141, P111, DOI 10.1016/0008-8749(92)90131-8	63	7	7	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2006	23	12					1779	1793		10.1089/neu.2006.23.1779			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	120AP	WOS:000243056100006	17184188				2022-02-06	
J	Getchell, ML; Li, H; Vaishnav, RA; Borders, AS; Witta, J; Subhedar, N; de Villiers, W; Stromberg, AJ; Getchell, TV				Getchell, M. L.; Li, H.; Vaishnav, R. A.; Borders, A. S.; Witta, J.; Subhedar, N.; de Villiers, W.; Stromberg, A. J.; Getchell, T. V.			Temporal gene expression profiles of target-ablated olfactory epithelium in mice with disrupted expression of scavenger receptor A: impact on macrophages	PHYSIOLOGICAL GENOMICS			English	Article						neurogenesis; microarray; phagocytosis; chemokines; cytokines; dendritic cells	LEUKEMIA INHIBITORY FACTOR; MESSENGER-RNA-EXPRESSION; TRAUMATIC BRAIN-INJURY; FALSE DISCOVERY RATE; APOPTOTIC CELLS; MOUSE EMBRYOS; ADHESION; PHAGOCYTOSIS; RECOGNITION; CLEARANCE	Target ablation [removal of the olfactory bulb (OBX)] induces apoptotic death of olfactory sensory neurons (OSNs) and an immune response in which activation and recruitment of macrophages (m phi s) into the olfactory epithelium (OE) occupy a central role. M phi s phagocytose apoptotic neurons and secrete cytokines/growth factors that regulate subsequent progenitor cell proliferation and neurogenesis. Scavenger receptor A (SR-A) is a pattern recognition receptor that mediates binding of m phi s to apoptotic cells and other relevant immune response functions. The aim of this study was to determine the impact of the absence of SR-A on the immune response to OBX. The immune response to OBX was evaluated in mice in which functional expression of the m phi scavenger receptor (MSR) was eliminated by gene disruption (MSR-/-) and wild-type (wt) mice of the same genetic background. OBX induced significant apoptotic death of mature OSNs in the two strains. However, subsequent m phi infiltration and activation and progenitor cell proliferation were significantly reduced in MSR-/- vs. wt mice. Gene expression profiling at short intervals after OBX demonstrated significant differences in temporal patterns of expression of several gene categories, including immune response genes. Many immune response genes that showed different temporal patterns of expression are related to m phi function, including cytokine and chemokine secretion, phagocytosis, and m phi maturation and activation. These studies suggest that impairment of the immune response to OBX in the OE of MSR-/- mice most likely resulted from decreased m phi adhesion and subsequent reduced infiltration and activation, with a resultant decrease in neurogenesis.	Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Univ Kentucky, Coll Med, Dept Stat, Lexington, KY 40536 USA; Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA; Univ Kentucky, Coll Med, Dept Internal Med, Lexington, KY 40536 USA		Getchell, ML (corresponding author), Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, 800 So Limestone St, Lexington, KY 40536 USA.	mgetch@uky.ed	Vaishnav, Radhika/AAN-4556-2021		NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG016824] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1P20-RR-16481-01] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG-16824] Funding Source: Medline		Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Babaev VR, 2000, ARTERIOSCL THROM VAS, V20, P2593, DOI 10.1161/01.ATV.20.12.2593; BANDTLOW CE, 1990, J CELL BIOL, V111, P1701, DOI 10.1083/jcb.111.4.1701; Baroody FM, 1991, SMELL TASTE HLTH DIS, P529; BELL MD, 1994, J NEUROCYTOL, V23, P605, DOI 10.1007/BF01191555; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bornemann KD, 2001, AM J PATHOL, V158, P63, DOI 10.1016/S0002-9440(10)63945-4; BRIELAND JK, 1995, AM J RESP CELL MOL, V12, P104, DOI 10.1165/ajrcmb.12.1.7811465; Carter LA, 2004, J NEUROSCI, V24, P5670, DOI 10.1523/JNEUROSCI.0330-04.2004; Chen L, 2003, MOL VIS, V9, P151; Christie RH, 1996, AM J PATHOL, V148, P399; Cowan CM, 2001, J NEUROSCI, V21, P7099, DOI 10.1523/JNEUROSCI.21-18-07099.2001; Daugherty A, 2001, J LIPID RES, V42, P1049; de Almeida CJG, 2005, CELL MOL LIFE SCI, V62, P1532, DOI 10.1007/s00018-005-4511-y; Fadeel B, 2003, CELL MOL LIFE SCI, V60, P2575, DOI 10.1007/s00018-003-3145-1; Fadok VA, 2003, CURR BIOL, V13, pR655, DOI 10.1016/S0960-9822(03)00575-X; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Farbman AI, 1992, CELL BIOL OLFACTION; Ferguson TA, 2005, IMMUNOL RES, V32, P99, DOI 10.1385/IR:32:1-3:099; FRASER I, 1993, NATURE, V364, P343, DOI 10.1038/364343a0; FREEMAN TC, 1998, MGI DIRECT DATA SUBM, P1; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Getchell ML, 2003, NEUROBIOL AGING, V24, P663, DOI 10.1016/S0197-4580(02)00195-1; GETCHELL ML, 1991, ANAT REC, V231, P358, DOI 10.1002/ar.1092310310; Getchell TV, 2005, J NEUROSCI RES, V80, P309, DOI 10.1002/jnr.20411; Getchell TV, 2002, J NEUROSCI RES, V70, P784, DOI 10.1002/jnr.10432; Getchell TV, 2002, J NEUROSCI RES, V67, P246, DOI 10.1002/jnr.10090; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Gowen BB, 2001, J LEUKOCYTE BIOL, V69, P575; Graff CL, 2005, J PHARM SCI-US, V94, P1187, DOI 10.1002/jps.20318; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Guermonprez P, 2005, SPRINGER SEMIN IMMUN, V26, P257, DOI 10.1007/s00281-004-0176-0; Harkness KA, 2003, J NEUROIMMUNOL, V142, P1, DOI 10.1016/S0165-5728(03)00251-0; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Jafek BW, 2002, CHEM SENSES, V27, P623, DOI 10.1093/chemse/27.7.623; JAFEK BW, 1983, LARYNGOSCOPE, V93, P1576, DOI 10.1288/00005537-198312000-00011; Kern RC, 2004, LARYNGOSCOPE, V114, P279, DOI 10.1097/00005537-200402000-00018; Kern RC, 2000, LARYNGOSCOPE, V110, P1071, DOI 10.1097/00005537-200007000-00001; Kim Chang H., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P343, DOI 10.2174/1568008043339712; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Kofler S, 2005, CLIN SCI, V108, P205, DOI 10.1042/CS20040174; Komohara Y, 2005, DEV DYNAM, V232, P67, DOI 10.1002/dvdy.20206; Kosswig N, 2003, J BIOL CHEM, V278, P34219, DOI 10.1074/jbc.M303465200; Kruessel JS, 1997, J REPROD IMMUNOL, V34, P103, DOI 10.1016/S0165-0378(97)00030-2; Kuhlow CJ, 2003, GLIA, V44, P76, DOI 10.1002/glia.10273; Kwong K, 2004, PHYSIOL GENOMICS, V20, P73, DOI 10.1152/physiolgenomics.00187.2004; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Liu L, 2005, J NEUROCHEM, V92, P546, DOI 10.1111/j.1471-4159.2004.02909.x; LOURY MC, 1991, SMELL TASTE HLTH DIS, P515; Maderna P, 2003, BBA-MOL BASIS DIS, V1639, P141, DOI 10.1016/j.bbadis.2003.09.004; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; MELLERT TK, 1992, OTOLARYNG HEAD NECK, V106, P181, DOI 10.1177/019459989210600221; Mukhopadhyay S, 2004, IMMUNOBIOLOGY, V209, P39, DOI 10.1016/j.imbio.2004.02.004; Murphy N, 2005, EMBED SYST PROGRAM, V18, P15; Naba I, 2000, EXP NEUROL, V166, P83, DOI 10.1006/exnr.2000.7495; Nan B, 2001, J COMP NEUROL, V435, P60, DOI 10.1002/cne.1193; Nicoletti A, 1999, EUR J IMMUNOL, V29, P512, DOI 10.1002/(SICI)1521-4141(199902)29:02<512::AID-IMMU512>3.0.CO;2-Y; Peretto P, 2002, J COMP NEUROL, V451, P267, DOI 10.1002/cne.10343; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI13903; Post SR, 2002, J LIPID RES, V43, P1829, DOI 10.1194/jlr.M200231-JLR200; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Shetty RS, 2005, MOL CELL NEUROSCI, V30, P90, DOI 10.1016/j.mcn.2005.06.003; Skoberne M, 2005, CURR TOP MICROBIOL, V289, P259; Srivastava RAK, 2003, J NEUROL SCI, V210, P11, DOI 10.1016/S0022-510X(03)00006-6; Steinman RM, 2001, MT SINAI J MED, V68, P160; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; SUZUKI Y, 1995, EXP NEUROL, V136, P225, DOI 10.1006/exnr.1995.1099; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Terpstra V, 1997, P NATL ACAD SCI USA, V94, P8127, DOI 10.1073/pnas.94.15.8127; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Witta J, 2003, J NEUROTRAUM, V20, P523, DOI 10.1089/089771503767168456; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Wu Q, 2000, J NEUROSCI, V20, P2609; Yokota T, 1998, EXP CELL RES, V239, P16, DOI 10.1006/excr.1997.3876	81	7	9	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1094-8341	1531-2267		PHYSIOL GENOMICS	Physiol. Genomics	NOV 27	2006	27	3					245	263		10.1152/physiolgenomics.00261.2005			19	Cell Biology; Genetics & Heredity; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Genetics & Heredity; Physiology	109WK	WOS:000242340100006	16882882				2022-02-06	
J	Johnson, VE; Murray, L; Raghupathi, R; Stewart, J; Nicoll, JAR; MacKinnon, MA; McIntosh, TK; Graham, DI				Johnson, V. E.; Murray, L.; Raghupathi, R.; Stewart, J.; Nicoll, J. A. R.; MacKinnon, M. -A.; McIntosh, T. K.; Graham, D. I.			No evidence for the presence of apolipoprotein epsilon-4, interleukin-1 alpha allele 2 and interleukin-1 beta allele 2 cause an increase in programmed cell death following traumatic brain injury in humans	CLINICAL NEUROPATHOLOGY			English	Article						head injury; apolipoprotein E; interleukin 1; genetics; programmed cell death	SPINAL-CORD-INJURY; CEREBRAL AMYLOID ANGIOPATHY; FATAL HEAD-INJURY; ALZHEIMERS-DISEASE; DNA FRAGMENTATION; IN-SITU; E POLYMORPHISM; RISK-FACTORS; APOPTOSIS; RATS	Background: Brain injury after trauma is an important cause of mortality and morbidity in society. There is evidence in both man and laboratory animals that in addition to necrosis, cell loss may occur as a result of programmed cell death (PCD). The cellular and molecular responses after head injury are partly influenced by genetic polymorphisms of apolipoprotein E and the proinflammatory cytokine IL-1. Aim: The principal aim of this study was to determine whether the presence of the ApoE epsilon(4), IL-1(alpha 2) or IL-I beta(2) allele types influenced the amounts of PCD after head injury compared with controls. Methods: Paraffin sections from the hippocampus of 38 patients (32 M : 6 F, aged 15-75, mean 38 years, survival 7-576 hours; mean 36 hours) who died after a head injury were stained by Tunel histochemistry and quantified, and genotyping was undertaken by PCR "blind" to clinical detail. Results: There were more Tunel+ cells (neurons and glia) after head injury than in controls with statistically increased numbers in all sectors of the hippocampus including the dentate fascia. However, there was no correlation between ApoE epsilon(4), IL-1 alpha allele 2 and IL-1 beta allele 2 and the amount of Tunel positivity. Conclusion: Given that both the ApoE and IL-1 influence outcome after various forms of acute brain injury, further work will be required to determine the mechanism underlying this relationship.	Univ Glasgow, Acad Unit Neuropathol, Glasgow, Lanark, Scotland; Univ Glasgow, Acad Unit Med & Therapeut, Glasgow, Lanark, Scotland; Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA USA; Univ Southampton, Div Clin Neurosci, Southampton, Hants, England		Graham, DI (corresponding author), So Gen Hosp, Dept Neuropathol, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.	d.graham@clinmed.gla.ac.uk	Nicoll, James/I-9253-2017	Nicoll, James/0000-0002-9444-7246	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5-P05-NS008803-30] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, P01NS008803] Funding Source: NIH RePORTER		Abe Y, 1999, J NEUROTRAUM, V16, P945, DOI 10.1089/neu.1999.16.945; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Bernstein MS, 2002, ARTERIOSCL THROM VAS, V22, P133, DOI 10.1161/hq0102.101819; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; CharriautMarlangue C, 1996, TRENDS NEUROSCI, V19, P109, DOI 10.1016/S0166-2236(96)80039-7; Conti AC, 1998, J NEUROSCI, V18, P5663; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Fan Lei, 1995, Molecular Brain Research, V30, P125, DOI 10.1016/0169-328X(94)00287-O; Fowler J, 2002, CLIN NEUROPATHOL, V21, P156; FREIDLANDER RM, 1996, J EXP MED, V184, P717; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Greenberg SM, 1996, STROKE, V27, P1333, DOI 10.1161/01.STR.27.8.1333; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Hartman RE, 2002, J NEUROSCI, V22, P10083; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; HOLZMAN DM, 2004, J MOL NEUROSCI, V23, P247; HOWARD CV, 1998, UNBIASED STEREOLOGY, P75; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KRAUS JF, 1995, NEW YORK, P22; Lawrence CB, 1998, EUR J NEUROSCI, V10, P1188, DOI 10.1046/j.1460-9568.1998.00136.x; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; LUIGI ME, 2000, ANN NEUROL, V47, P361; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; Mochizuki H, 1996, J NEUROL SCI, V137, P120, DOI 10.1016/0022-510X(95)00336-Z; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, P28; NICKLIN MJH, 1994, GENOMICS, V19, P382, DOI 10.1006/geno.1994.1076; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.3.CO;2-7; Nicoll JAR, 1997, ANN NEUROL, V41, P716, DOI 10.1002/ana.410410607; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; PETITO CK, 1995, J NEUROPATH EXP NEUR, V54, P761, DOI 10.1097/00005072-199511000-00002; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; RINK A, 1995, AM J PATHOL, V147, P1575; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schiefermeier M, 2000, STROKE, V31, P2068, DOI 10.1161/01.STR.31.9.2068; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; Sheng JG, 1998, J NEUROPATH EXP NEUR, V57, P323, DOI 10.1097/00005072-199804000-00003; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Wang XK, 1997, STROKE, V28, P155, DOI 10.1161/01.STR.28.1.155; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; WILSON S, 1999, J NEUROTRAUM, V10, P1001; 1934, J PSYCHOL NEUROL LPZ, V46, P113	57	7	8	0	1	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0722-5091			CLIN NEUROPATHOL	Clin. Neuropathol.	NOV-DEC	2006	25	6					255	264					10	Clinical Neurology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	115CQ	WOS:000242712800001	17140155				2022-02-06	
J	Schmitter-Edgecombe, M; Langill, M				Schmitter-Edgecombe, Maureen; Langill, Michelle			Costs of a predictable switch between simple cognitive tasks following severe closed-head injury	NEUROPSYCHOLOGY			English	Article						closed-head injury; traumatic brain injury; executive functions; task switching; set shifting	TRAUMATIC BRAIN-INJURY; DIVIDED ATTENTION; EXECUTIVE CONTROL; SET RECONFIGURATION; PREFRONTAL CORTEX; PERFORMANCE; MEMORY; COMPONENTS; MECHANISMS; FLUENCY	The authors used a predictable, externally cued task-switching paradigm to investigate executive control in a severe closed-head injury (CHI) population. Eighteen individuals with severe CHI and 18 controls switched between classifying whether a digit was odd or even and whether a letter was a consonant or vowel on every 4th trial. The target stimuli appeared in a circle divided into 8 equivalent parts. Presentation of the stimuli rotated clockwise. Participants performed the switching task at both a short (200 ms) and a long (1,000 Ins) preparatory interval. Although the participants with CHI exhibited slower response times and greater switch costs, similar to controls, additional preparatory time reduced the switch costs, and the switch costs were limited to the 1st trial in the run. These findings indicate that participants with severe CHI were able to take advantage of time to prepare for the task switch, and the executive control processes involved in the switch costs were completed before the 1st trial of the run ended.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, POB 644820, Pullman, WA 99164 USA.	schmitter-e@wsu.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS047690-02, R01 NS47690-01, R01 NS047690-01, R01 NS047690] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER		ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Allport A, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P35; Allport D.A., 1999, ATTENTION SPACE ACTI, P273; Altmann EM, 2004, PSYCHOL SCI, V15, P616, DOI 10.1111/j.0956-7976.2004.00729.x; Baddeley A, 2001, J EXP PSYCHOL GEN, V130, P641, DOI 10.1037//0096-3445.130.4.641; Baddeley A.D., 1986, WORKING MEMORY; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Benton A., 1976, MULTILINGUAL APHASIA; Brouwer W, 2001, BRAIN COGNITION, V46, P54, DOI 10.1016/S0278-2626(01)80033-6; *CEDR CORP, 1999, SUPERLAB PRO BETA VE; Cepeda NJ, 2001, DEV PSYCHOL, V37, P715, DOI 10.1037/0012-1649.37.5.715; De Jong R, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P357; Delis DC, 1987, CALIFORNIA VERBAL LE; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Gansler DA, 1996, BRAIN COGNITION, V30, P194, DOI 10.1006/brcg.1996.0012; German D. J., 1990, TEST ADOLESCENT ADUL; Golden J. C., 1978, STROOP COLOR WORD TE; Gopher D, 2000, J EXP PSYCHOL GEN, V129, P308, DOI 10.1037/0096-3445.129.3.308; Goschke T, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P331; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Heaton RK, 1981, MANUAL WISCONSIN CAR; Jersild AT, 1927, ARCH PSYCHOL, V14; Karayanidis F, 2003, PSYCHOPHYSIOLOGY, V40, P329, DOI 10.1111/1469-8986.00037; Keele SW, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P627; Koch I, 2003, PSYCHON B REV, V10, P488, DOI 10.3758/BF03196511; Kray J, 2000, PSYCHOL AGING, V15, P126, DOI 10.1037//0882-7974.15.1.126; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; LOFTUS GR, 1978, MEM COGNITION, V6, P312, DOI 10.3758/BF03197461; LOGAN GD, 1985, ACTA PSYCHOL, V60, P193, DOI 10.1016/0001-6918(85)90055-1; Mayr U, 2001, EUR J COGN PSYCHOL, V13, P47, DOI 10.1080/09541440042000214; Mayr U, 2000, J EXP PSYCHOL LEARN, V26, P1124, DOI 10.1037/0278-7393.26.5.1124; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Meiran N, 2001, EUR J COGN PSYCHOL, V13, P165, DOI 10.1080/09541440042000269; Meiran N, 1996, J EXP PSYCHOL LEARN, V22, P1423, DOI 10.1037/0278-7393.22.6.1423; Meiran N, 2001, J GERONTOL B-PSYCHOL, V56, pP88, DOI 10.1093/geronb/56.2.P88; Milan EG, 2005, ACTA PSYCHOL, V118, P319, DOI 10.1016/j.actpsy.2004.10.015; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Monsell S, 2003, MEM COGNITION, V31, P327, DOI 10.3758/BF03194391; Nieuwenhuis S, 2002, PSYCHON B REV, V9, P86, DOI 10.3758/BF03196259; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ridderinkhof KR, 2002, BRAIN COGNITION, V49, P382, DOI 10.1006/brcg.2001.1506; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rogers RD, 1998, BRAIN, V121, P815, DOI 10.1093/brain/121.5.815; Rubinstein JS, 2001, J EXP PSYCHOL HUMAN, V27, P763, DOI 10.1037//0096-1523.27.4.763; Rushworth MFS, 2005, EXP PSYCHOL, V52, P83, DOI 10.1027/1618-3169.52.2.83; Saeki E, 2004, MEMORY, V12, P257, DOI 10.1080/09658210244000649; Schmitter-Edgecombe M, 2005, BRAIN LANG, V94, P331, DOI 10.1016/j.bandl.2005.01.007; Schmitter-Edgecombe M, 2000, NEUROPSYCHOLOGY, V14, P559; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Smith A., 1991, SYMBOL DIGIT MODALIT; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Sohn MH, 2001, J EXP PSYCHOL GEN, V130, P764, DOI 10.1037//0096-3445.130.4.764; SPECTOR A, 1976, AM J PSYCHOL, V89, P669, DOI 10.2307/1421465; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; STRAYER DL, 1994, PSYCHOL AGING, V9, P589, DOI 10.1037/0882-7974.9.4.589; Swainson R, 2003, J COGNITIVE NEUROSCI, V15, P785, DOI 10.1162/089892903322370717; Sylvester CYC, 2003, NEUROPSYCHOLOGIA, V41, P357, DOI 10.1016/S0028-3932(02)00167-7; TEASDALE G, 1974, LANCET, V2, P81; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Van Asselen M, 2000, PSYCHOL BELG, V40, P259; Van Zomeren A. H., 1981, REACTION TIME ATTENT; VILKKI J, 1994, NEUROPSYCHOLOGIA, V32, P1257, DOI 10.1016/0028-3932(94)90107-4; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003; Zachary R., 1991, SHIPLEY I LIVING SCA; ZACHARY RA, 1985, J CLIN PSYCHOL, V41, P532, DOI 10.1002/1097-4679(198507)41:4<532::AID-JCLP2270410414>3.0.CO;2-D	72	7	7	0	10	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	NOV	2006	20	6					675	684		10.1037/0894-4105.20.6.675			10	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	101SO	WOS:000241761000006	17100512	Green Accepted			2022-02-06	
J	Tracy, S; Schinco, MA; Griffen, MM; Kerwin, AJ; Devin, T; Tepas, JJ				Tracy, Susanne; Schinco, Miren A.; Griffen, Margaret M.; Kerwin, Andrew J.; Devin, Terry; Tepas, Joseph J.			Urgent airway intervention: Does outcome change with personnel performing the procedure?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	35th Annnual Meeting of the Western-Trauma-Association	FEB 27-MAR 05, 2005	Jackson Hole, WY	Western Trauma Assoc		prehospital endotracheal intubation; trauma center endotracheal intubation; pneumonia; nosocomial pneumonia; resistant organisms; length of hospital and ICU stay	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; FIELD	Background: Recent studies indicate that prehospital endotracheal intubation (PHEI) is associated with increased septic morbidity. Because the decision to intubate in the field is considered a life-sustaining mandate we analyzed our experience to validate these reports and to compare field intubation to that done in more controlled circumstances on patient arrival at the trauma center. Methods: The registry of our Level I trauma center was queried from January 2002 through December 2003 for patients who required emergent El and had a hospital stay > 2 days. Patients were stratified by site of El into PHEI and trauma center intubation (TCEI). Demographic data (age, gender, Glasgow Comma Scale, Injury Severity Score) as well as outcome measures (incidence of pneumonia [PNA], Intensive Care Unit length of stay [ICU LOS], hospital length of stay [hospital LOS], and mortality) were compared between groups. Results were subjected to chi(2) or unpaired t test, accepting p < 0.05 as significant. Results: The 628 patients requiring EI consisted of 271 in PHEI and 357 in TCEL. When comparing these groups, PHEI were more severely injured (lower Glasgow Comma Scale score and higher Injury Severity Score), but had no other differences in demographics or in measured outcome variables. Within these groups, patients who developed PNA were comparable. They demonstrated similar time of onset of PNA after injury and had similar incidence of resistant organisms (46%). Conclusions: These data demonstrate no increased risk of PNA for urgent prehospital intubation. Moreover, the onset of PNA and the similar bacteriology is reflective of injury severity and not of additional infectious risk posed by these prehospital lifesaving maneuvers.	Univ Florida, Hlth Sci Ctr, Dept Surg, Div Trauma & Crit Care, Jacksonville, FL 32209 USA		Schinco, MA (corresponding author), 655 W 8th St, Jacksonville, FL 32209 USA.	miren.schinco@jax.ufl.edu					Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Ochs M, 2002, ANN EMERG MED, V40, P159, DOI 10.1067/mem.2002.126397; POSTE JC, 2004, AIR MED J, V4, P36; Slater EA, 1998, J TRAUMA, V45, P588, DOI 10.1097/00005373-199809000-00031; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3	8	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2006	61	5					1162	1165		10.1097/01.ta.0000243887.90697.06			4	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	105TB	WOS:000242054100022	17099523				2022-02-06	
J	Allen, DN; Knatz, DT; Mayfield, J				Allen, Daniel N.; Knatz, Danielle T.; Mayfield, Joan			Validity of the Children's Category Test-Level 1 in a clinical sample with heterogeneous forms of brain dysfunction	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						children; traumatic brain injury; Attention-Deficit/Hyperactivity Disorder; neuropsychology; cognitive; category test; Woodcock-Johnson	LATENT STRUCTURE	Validity of the Children's Category Test-Level 1 (CCT-1) was evaluated in 123 children with various forms of brain dysfunction. Confirmatory factor analyses indicated that the CCT-1 is composed of two factors. The first factor was composed of subtests II and III, and was named "Conceptual Discrimination", while the second was composed of subtests IV and V, and was named "Conceptual Memory". Both factors were more highly correlated with mathematical achievement than with reading or writing achievement. Comparisons between traumatic brain injury (TBI) and Attention-Deficit/Hyperactivity Disorder (ADHD) groups indicated that the Conceptual Discrimination factor was more sensitive to TBI than the Conceptual Memory factor. Also, the total error composite T-score was not particularly sensitive to ADHD. Findings indicate that the composite T-score should be interpreted with caution because it does not appear sensitive to milder forms of brain dysfunction and because the CCT- I is a multidimensional procedure. (c) 2006 Published by Elsevier Ltd on behalf of National Academy of Neuropsychology.	Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA; Our Childrens House, Dallas, TX USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, Box 455030,4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Alexander AI, 2005, ARCH CLIN NEUROPSYCH, V20, P587, DOI 10.1016/j.acn.2004.12.005; Allen DN, 1999, J CLIN EXP NEUROPSYC, V21, P237, DOI 10.1076/jcen.21.2.237.926; ALLEN DN, 2006, QUANTIFIED PROCESS A; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BOLL T, 1993, CHILDRENS CATEGORY T; Choca JP, 1997, NEUROPSYCHOL REV, V7, P61, DOI 10.1023/B:NERV.0000005944.98635.16; Donders J, 1999, J CLIN EXP NEUROPSYC, V21, P279; Donders J, 2001, PSYCHOL ASSESSMENT, V13, P592, DOI 10.1037/1040-3590.13.4.592; Halstead NC, 1943, ARCH NEURO PSYCHIATR, V49, P489; Halstead WC, 1947, BRAIN INTELLIGENCE Q; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; Johnstone B, 1997, PSYCHOL ASSESSMENT, V9, P28, DOI 10.1037/1040-3590.9.1.28; KELLY MD, 1992, ARCH CLIN NEUROPSYCH, V7, P415, DOI 10.1016/0887-6177(92)90154-F; KLONOFF H, 1969, DEV MED CHILD NEUROL, V11, P198; Livingston RB, 1996, PERCEPT MOTOR SKILL, V83, P851, DOI 10.2466/pms.1996.83.3.851; Moore BA, 2004, ARCH CLIN NEUROPSYCH, V19, P1, DOI 10.1016/S0887-6177(02)00171-3; Nesbit-Greene K, 2002, J CLIN EXP NEUROPSYC, V24, P194, DOI 10.1076/jcen.24.2.194.996; REED HBC, 1965, J CONSULT PSYCHOL, V29, P247, DOI 10.1037/h0022145; REEDER KP, 1992, ARCH CLIN NEUROPSYCH, V7, P53, DOI 10.1016/0887-6177(92)90018-I; TEASDALE G, 1974, LANCET, V2, P81	20	7	7	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	OCT	2006	21	7					711	720		10.1016/j.acn.2006.08.003			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	112JR	WOS:000242522400012	17071362	Bronze			2022-02-06	
J	Gallagher, R; Drance, E; Higginbotham, S				Gallagher, Romayne; Drance, Elisabeth; Higginbotham, Susan			Finding the person behind the pain: Chronic pain management in a patient with traumatic brain injury	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article							OLDER-ADULTS	Chronic pain is common after a traumatic brain injury. Cognitive impairment post injury may be a consequence of the brain injury alone, or in combination with pain, clinical depression, and psychological and emotional factors. We present a case of a severely cognitively impaired person post-traumatic brain injury, whose behavior included social withdrawal, irritability, and agitation around direct care-which was unresponsive to psychotropic intervention or care delivery strategies. The introduction of an opioid made a significant improvement in the cognition and quality of life of the individual. This case suggests that clinicians should consider a trial of opioid analgesics in individuals with brain injury who have significant cognitive impairment in association with other behaviors suggestive of depression and pain.	Providence Hlth Care, Div Residential Care, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, Dept Family Practice, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada		Gallagher, R (corresponding author), Providence Hlth Care, Div Residential Care, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	rgallagher@providencehealth.bc.ca					Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Arnow BA, 2006, PSYCHOSOM MED, V68, P262, DOI 10.1097/01.psy.0000204851.15499.fc; Bonica JJ, 2001, BONICAS MANAGEMENT P, P196; Dean M, 2004, J PAIN SYMPTOM MANAG, V28, P497, DOI 10.1016/j.jpainsymman.2004.02.021; Ferrell B, 2002, J AM GERIATR SOC, V50, pS205, DOI 10.1046/j.1532-5415.50.6s.1.x; Hart Robert P, 2003, Curr Pain Headache Rep, V7, P116, DOI 10.1007/s11916-003-0021-5; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Herr K, 2006, J PAIN SYMPTOM MANAG, V31, P170, DOI 10.1016/j.jpainsymman.2005.07.001; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Martelli MF, 2004, J HEAD TRAUMA REHAB, V19, P10, DOI 10.1097/00001199-200401000-00003; Unutzer J, 2004, J AM GERIATR SOC, V52, P1916, DOI 10.1111/j.1532-5415.2004.52519.x; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Walker WC, 2004, J HEAD TRAUMA REHAB, V19, P72, DOI 10.1097/00001199-200401000-00007; Weiner DK, 2006, PAIN MED, V7, P60, DOI 10.1111/j.1526-4637.2006.00091.x; Wiech K, 2005, NEUROIMAGE, V27, P59, DOI 10.1016/j.neuroimage.2005.03.044	15	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	SEP	2006	7	7					432	434		10.1016/j.jamda.2006.04.010			3	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	090CX	WOS:000240929300006	16979087				2022-02-06	
J	Lange, RT; Chelune, GJ; Tulsky, DS				Lange, Rael T.; Chelune, Gordon J.; Tulsky, David S.			Development of WAIS-III general ability index minus WMS-III memory discrepancy scores	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	23rd Annual Meeting of the National-Academy-of-Neuropsychology	2003	Dallas, TX	Natl Acad Neuropsychol			TRAUMATIC BRAIN INJURY; INTELLIGENCE; SCALE; SAMPLE; IQ	Analysis of the discrepancy between intellectual functioning and memory ability has received some support as a useful means for evaluating memory impairment. In recent additions to Wechlser scale interpretation, the WAIS-III General Ability Index (GAI) and the WMS-III Delayed Memory Index (DMI) were developed. The purpose of this investigation is to develop base rate data for GAI-IMI, GAI-GMI, and GAI-DMI discrepancy scores using data from the WAIS-III/WMS-III standardization sample (weighted N = 1250). Base rate tables were developed using the predicted-difference method and two simple-difference methods (i.e., stratified and non-stratified). These tables provide valuable data for clinical reference purposes to determine the frequency of GAI-IMI, GAI-GMI, and GAI-DMI discrepancy scores in the WAIS-III/WMS-III standardization sample.	Riverview Hosp, Dept Res, Coquitlam, BC V3C 4J2, Canada; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Kessler Med Rehabil Res & Educ Co, W Orange, NJ 07052 USA		Lange, RT (corresponding author), Riverview Hosp, Dept Res, Room 124 ADMIN Bldg,2601 Lougheed Highway, Coquitlam, BC V3C 4J2, Canada.	rlange@bcmhs.bc.ca		Tulsky, David/0000-0002-4335-4509			BORNSTEIN RA, 1989, PSYCHOL ASSESSMENT J, V1, P203; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hawkins KA, 2001, J INT NEUROPSYCH SOC, V7, P875, DOI 10.1017/S1355617701777119; Iverson GL, 2000, J CLIN EXP NEUROPSYC, V22, P191, DOI 10.1076/1380-3395(200004)22:2;1-1;FT191; IVERSON GL, 2000, AM PSYCH AS ANN C; IVERSON GL, 2001, AM J FORENSIC PSYCH, V19, P5; Larrabee GJ, 2004, J CLIN EXP NEUROPSYC, V26, P706, DOI 10.1080/13803390490504380; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Milner B, 1975, Adv Neurol, V8, P299; OSCARBERMAN M, 1993, CLIN NEUROPSYCHOL, V7, P281, DOI 10.1080/13854049308401899; PRIGATANO GP, 1978, J CLIN PSYCHOL, V34, P816, DOI 10.1002/1097-4679(197810)34:4<816::AID-JCLP2270340402>3.0.CO;2-Q; PRIGATANO GP, 1974, J CLIN PSYCHOL, V42, P318; *PSYCH CORP, 2002, WAIS 3 WMS 3 TECHN M; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; *PSYCH CORP, 2001, WAIS 3 WMS 3 WAIT 2; QUADFASEL AF, 1955, EPILEPSIA, V4, P80, DOI 10.1111/j.1528-1157.1955.tb03176.x; SENIOR G, 2001, NAT AC NEUR ANN C NO; SOLOMON GS, 1986, J CLIN PSYCHOL, V42, P318, DOI 10.1002/1097-4679(198603)42:2<318::AID-JCLP2270420217>3.0.CO;2-3; Tulsky DS, 2000, PSYCHOL ASSESSMENT, V12, P253, DOI [10.1037/1040-3590.12.3.253, 10.1037//1040-3590.12.3.253]; Tulsky DS, 2004, J CLIN EXP NEUROPSYC, V26, P563, DOI 10.1080/13803390490490782; Tulsky DS, 2001, PSYCHOL ASSESSMENT, V13, P566, DOI 10.1037/1040-3590.13.4.566; Tulsky DS., 2003, CLIN INTERPRETATION, P93, DOI [10.1016/B978-012703570-3/50007-9, DOI 10.1016/B978-012703570-3/50007-9]; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1945, WECHSLER MEMORY SCAL; ZAIDEL D, 1974, BRAIN, V97, P263, DOI 10.1093/brain/97.1.263	31	7	7	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	SEP	2006	20	3					382	395		10.1080/13854040590967586			14	Psychology, Clinical; Clinical Neurology; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	071MT	WOS:000239607000003	16895854				2022-02-06	
J	Zafonte, RD				Zafonte, Ross D.			Update on biotechnology for TBI rehabilitation - A look at the future	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	2nd Federal Interagency Conference on Traumatic Brain Injury	MAR 10, 2006	Bethesda, MD			biotechnology; devices; traumatic brain injury	STIMULATION; NEURONS; GENDER; STROKE	The purpose of this review article is to discuss the novel dynamics in the area of traumatic brain injury medicine and how rapid changes in biotechnology will influence the lives of persons with traumatic brain injury. This article will focus on biomaterials, devices, cellular therapy, conventional therapy, and person-specific therapy that will be part of the future care plans for those who treat persons with traumatic brain injury.	UPMC, Hlth Syst, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA		Zafonte, RD (corresponding author), UPMC, Hlth Syst, Dept Phys Med & Rehabil, 3471 5th Ave,Suite 201, Pittsburgh, PA 15213 USA.	zafonterd@upmc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042678] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1U01HD42678-02] Funding Source: Medline		Brewer BR, 2005, IEEE T NEUR SYS REH, V13, P1, DOI 10.1109/TNSRE.2005.843443; Brown JA, 2006, NEUROSURGERY, V58, P464, DOI 10.1227/01.NEU.0000197100.63931.04; Cooper RA, 2005, ASSIST TECHNOL, V17, P159, DOI 10.1080/10400435.2005.10132105; Floel A, 2006, COGN BEHAV NEUROL, V19, P1, DOI 10.1097/00146965-200603000-00001; Hayman MW, 2005, J BIOCHEM BIOPH METH, V62, P231, DOI 10.1016/j.jbbm.2004.12.001; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Loeb GE, 2001, MED ENG PHYS, V23, P9, DOI 10.1016/S1350-4533(01)00011-X; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Milbrandt EB, 2005, CRIT CARE MED, V33, P226, DOI 10.1097/01.CCM.0000150743.16005.9A; Ochoa Juan B, 2004, Nutr Clin Pract, V19, P216, DOI 10.1177/0115426504019003216; Silva GA, 2006, NAT REV NEUROSCI, V7, P65, DOI 10.1038/nrn1827; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Weber DJ, 2004, CAN J PHYSIOL PHARM, V82, P784, DOI 10.1139/Y04-078; ZAFONTE R, 2005, ARCH PHYS MED REHAB, V86, P9	16	7	7	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2006	21	5					403	407		10.1097/00001199-200609000-00005			5	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	084JM	WOS:000240529200005	16983226				2022-02-06	
J	Fourcade, O; Fuzier, R; Daboussi, A; Gigaud, K; Tremoulet, M; Samii, K				Fourcade, O.; Fuzier, R.; Daboussi, A.; Gigaud, K.; Tremoulet, M.; Samii, K.			Decompressive craniectomy and intracranial hypertension	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article; Proceedings Paper	27th Conference of the Association-de-Neuroanesthesie-Reanimation-de-Langue-Francaise	NOV 17-18, 2005	Toulouse, FRANCE	Assoc Neuroanesthesie Reanimat Langue Francaise		decompressive craniectomy; intracranial hypertension; prognosis; head trauma	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; MANAGEMENT; PRESSURE; CHILDREN	Decompressive craniectomy was purposed for the treatment of refractory intracranial hypertension after head injury. This review discusses results obtained by this surgery in severe head trauma. Several studies have confirmed a reduction in intracranial pressure secondary to decompressive craniectomy. Mortality decreased and the proportion of good outcome of the survivors increased. These results have not been confirmed prospectively, and indications have to be clarified. The positive effects of decompressive craniectomy compared to barbiturate or hypocapnia in the "second tier therapy" in refractory intracranial hypertension could be interesting to evaluate. (c) 2006 Elsevier SAS. Tous droits reserves.	Univ Toulouse 3, CHU Toulouse, Dept Anesthesie Reanimat, Hop Purpan, F-31059 Toulouse 09, France; CHU Toulouse, Hop Purpan, Serv Neurochirurg, F-31059 Toulouse, France		Fourcade, O (corresponding author), Univ Toulouse 3, CHU Toulouse, Dept Anesthesie Reanimat, Hop Purpan, Pl Dr Baylac, F-31059 Toulouse 09, France.	fourcade.o@chu-toulouse.fr					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Arjona A, 2004, REV NEUROLOGIA, V38, P145, DOI 10.33588/rn.3802.2003327; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Guerra WKW, 1999, INTENS CARE MED, V25, P1327; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kunze E, 1998, ACT NEUR S, V71, P16; MAAS AIR, 1996, YB INTENSIVE CARE EM, P707; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Stefini R, 1999, NEUROSURGERY, V45, P626, DOI 10.1097/00006123-199909000-00038; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; VAHEDI K, 2005, ENCY MED, DOI UNSP 17-046-D-15; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; Yamaura A, 1977, No Shinkei Geka, V5, P345; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	27	7	7	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.	AUG	2006	25	8					858	862		10.1016/j.annfar.2006.03.015			5	Anesthesiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	087OH	WOS:000240751200012	16675190				2022-02-06	
J	Frontczak-Baniewicz, M; Gordon-Krajcer, W; Walski, M				Frontczak-Baniewicz, Malgorzata; Gordon-Krajcer, Wanda; Walski, Michal			The immature endothelial cell in new vessel formation following surgical injury in rat brain	NEUROENDOCRINOLOGY LETTERS			English	Article						neovascularization; endothelial-like cell; ultrastructural studies	BLOOD-VESSELS; CEREBRAL-CORTEX; EXPRESSION; PRECURSORS; FLK-1; PROLIFERATION; PROGENITORS; POPULATION; BIOLOGY; VEGF	OBJECTIVES: We investigated neovascularization in the cerebral cortex of the adult rat after surgical brain injury by ultrastructural, immunocytochemical and immunochemical means. Previously we described endothelial-like cell that participates in new vessel formation on plasma proteins that served as a provisional matrix in the region immediately adjacent to the traumatic injury. In the present study we describe new vessel formation in the multistep process with the alterations in endothelial-like cell immunophenotype. METHOD: The observations were conducted from 2 to7 days after induction of cortical trauma. Traumatic injury was induced in the fronto-temporal region of cerebral cortex. RESULTS: We show that endothelial-like cell Could not Successfully terminate its development without the presence of pericyte and astrocyte. New formed blood vessels were accompanied by fibroblast and lipofibroblast cells differentiated probably from common progenitor. MAIN FINDINGS: Our result Suggests that endothelial-like cell is committed endothelial cell between progenitor endothelial cell and terminally differentiated endothelium stage. Therefore, we propose that out of endothelial stern cells present in blood at different stages of morphogenetic differentiation and specifically arrested in "check points" of development trauma mobilize the group of the most differentiated progenitors. These may contribute to new vessel formation. CONCLUSION: Our model should be useful for the characterization of endothelial commitment and endothelial cell differentiation after brain injury.	Polish Acad Sci, Med Res Ctr, Dept Cell Ultrastruct, PL-02106 Warsaw, Poland; Polish Acad Sci, Med Res Ctr, Dept Neurochem, PL-02106 Warsaw, Poland		Frontczak-Baniewicz, M (corresponding author), Polish Acad Sci, Med Res Ctr, Dept Cell Ultrastruct, 5 Pawinskiego St, PL-02106 Warsaw, Poland.	gosia@cmdik.pan.pl					Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Caprioli A, 1998, P NATL ACAD SCI USA, V95, P1641, DOI 10.1073/pnas.95.4.1641; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cho SK, 2001, BLOOD, V98, P3635, DOI 10.1182/blood.V98.13.3635; Cobbs CS, 1998, NEUROSCI LETT, V249, P79, DOI 10.1016/S0304-3940(98)00377-2; Frontczak-Baniewicz M, 2003, ACTA NEUROBIOL EXP, V63, P65; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hungerford JE, 1999, J VASC RES, V36, P2, DOI 10.1159/000025622; Isner JM, 2000, J INVASIVE CARDIOL, V12, p14A; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kabrun N, 1997, DEVELOPMENT, V124, P2039; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lennmyr F, 1998, J NEUROPATH EXP NEUR, V57, P874, DOI 10.1097/00005072-199809000-00009; Luttun A, 2002, TRENDS CARDIOVAS MED, V12, P88, DOI 10.1016/S1050-1738(01)00152-9; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Rafii S, 2000, J CLIN INVEST, V105, P17, DOI 10.1172/JCI8774; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Robert B, 1996, AM J PHYSIOL-RENAL, V271, pF744, DOI 10.1152/ajprenal.1996.271.3.F744; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; Torday JS, 2003, PEDIATR PATHOL MOL M, V22, P189, DOI 10.1080/15227950390178407; Walski M, 2003, ACTA NEUROBIOL EXP, V63, P77; Weinstein BM, 1999, DEV DYNAM, V215, P2, DOI 10.1002/(SICI)1097-0177(199905)215:1<2::AID-DVDY2>3.0.CO;2-U; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568	31	7	10	0	3	MAGHIRA & MAAS PUBLICATIONS	MUNSBACH	MAGHIRA & MAAS S A R L, 6C, RUE GABRIEL LIPPMANN, L-5365 MUNSBACH, LUXEMBOURG	0172-780X	2354-4716		NEUROENDOCRINOL LETT	Neuroendocrinol. Lett.	AUG	2006	27	4					539	546					8	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	119ST	WOS:000243034300021	16891988				2022-02-06	
J	Deininger, MH; Meyermann, R; Schluesener, HJ				Deininger, Martin H.; Meyermann, Richard; Schluesener, Hermann J.			Endostatin/collagen XVIII accumulates in patients with traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						endostatin/collagen XVIII; NO signaling cascade; traumatic brain injury	ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; FACTOR EXPRESSION; MICROGLIAL CELLS; TUMOR-GROWTH; ANGIOGENESIS; APOPTOSIS; VEGF; RAT; LOCALIZATION	In patients with traumatic brain injury (TBI), hypoperfusion contributes to ongoing and expanding areas of neuronal damage long after the initial trauma has ceased. In order to evaluate whether the antiangiogenic protein endostatin may play a role in this process, we analyzed its spatial distribution in brains of 18 patients with TBI. We observed an increase of endostatin/collagen XVIII+ macrophages/microglial cells but not astrocytes up to day 14 and a consequent decrease to day 16 post-TBI. In addition, paracellular endostatin/collagen XVIII deposits were detected. In vitro experiments revealed that microglial endostatin release is induced predominantly by hypoxia and, to a lesser extent, by reactive oxygen intermediates. Common NO synthase inhibitor pharmacotherapy with aminoguanidine and L-NAME completely abolished endostatin release from microglial cells, raising hopes of altering endostatin release in vivo.	Univ Freiburg, Sch Med, Dept Neurosurg, Freiburg, Germany; Univ Tubingen, Sch Med, Brain Res Inst, Tubingen, Germany		Deininger, MH (corresponding author), Univ Freiburg, Sch Med, Dept Neurosurg, Freiburg, Germany.	deining@nz.ukl.uni-freiburg.de					Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chua CC, 1998, FREE RADICAL BIO MED, V25, P891, DOI 10.1016/S0891-5849(98)00115-4; Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721; Dixelius J, 2000, BLOOD, V95, P3403, DOI 10.1182/blood.V95.11.3403.011k07_3403_3411; Feelisch M, 1998, N-S ARCH PHARMACOL, V358, P113, DOI 10.1007/PL00005231; Ferrari D, 1996, J IMMUNOL, V156, P1531; Hall ED, 1999, ANN NY ACAD SCI, V890, P462, DOI 10.1111/j.1749-6632.1999.tb08025.x; Kuroki M, 1996, J CLIN INVEST, V98, P1667, DOI 10.1172/JCI118962; Mates JM, 2000, INT J BIOCHEM CELL B, V32, P157, DOI 10.1016/S1357-2725(99)00088-6; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Miller MJS, 1996, INFLAMM RES, V45, P272, DOI 10.1007/BF02280990; Miosge N, 1999, FASEB J, V13, P1743, DOI 10.1096/fasebj.13.13.1743; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nag S, 2002, J NEUROPATH EXP NEUR, V61, P778, DOI 10.1093/jnen/61.9.778; Nilsson BO, 1999, INFLAMM RES, V48, P509, DOI 10.1007/s000110050495; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Papavassiliou E, 1997, J NEUROSCI RES, V49, P451, DOI 10.1002/(SICI)1097-4547(19970815)49:4<451::AID-JNR6>3.0.CO;2-7; Schluesener HJ, 1997, GLIA, V20, P365, DOI 10.1002/(SICI)1098-1136(199708)20:4<365::AID-GLIA8>3.0.CO;2-4; Shichiri M, 2001, FASEB J, V15, P1044, DOI 10.1096/fj.99-1083com; Standker L, 1997, FEBS LETT, V420, P129, DOI 10.1016/S0014-5793(97)01503-2; Strik HM, 2001, CANCER, V91, P1013, DOI 10.1002/1097-0142(20010301)91:5<1013::AID-CNCR1092>3.0.CO;2-Q; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; TETSUKA T, 1995, AM J PHYSIOL-CELL PH, V269, pC55, DOI 10.1152/ajpcell.1995.269.1.C55; TUDER RM, 1995, J CLIN INVEST, V95, P1798, DOI 10.1172/JCI117858; Urbich C, 2002, FASEB J, V16, P706, DOI 10.1096/fj.01-0637fje; Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414	30	7	10	0	0	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2006	23	7					1103	1110		10.1089/neu.2006.23.1103			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	069UG	WOS:000239473200006	16866623				2022-02-06	
J	Kerr, JH				Kerr, John H.			Examining the Bertuzzi-Moore NHL ice hockey incident: Crossing the line between sanctioned and unsanctioned violence in sport	AGGRESSION AND VIOLENT BEHAVIOR			English	Article						violence in sport; ice hockey; reversal theory	AGGRESSION	This paper examines sanctioned and unsanctioned aggression and violence in sport. It focuses on a recent notorious violent incident in a National Hockey League (NHL) game between the Vancouver Canucks and the Colorado Avalanche. The incident involved Vancouver's Todd Bertuzzi and Colorado's Steve Moore. Bertuzzi was the aggressor, and Moore suffered a fracture to the C3 and C4 vertebrae at the base of his neck, a concussion, and various cuts to his face. Bertuzzi was suspended, fined, and faced a criminal trial and possible jail sentence. The Bertuzzi-Moore incident is examined in detail and attempts to clarify why, even in a sport where "fist-fighting" is considered to be part of the game by players, coaches, and officials, this particular act crossed the line between sanctioned and unsanctioned violence in sport. It will also address various aspects of the incident, including legal aspects and speculate as to the why Bertuzzi, an athlete known for his highly competitive physical approach to the game, would, apparently "out of character", commit an unsanctioned violent act. Reversal theory, an innovative general theory in psychology is used to explain the motivation behind such sudden violent behavior. Possibilities for eliminating unsanctioned violence from ice hockey are considered. (c) 2005 Elsevier Ltd. All rights reserved.	Kokushikan Univ, Fac Hlth & Sport Sci, Tama Ku, Tokyo 2068515, Japan		Kerr, JH (corresponding author), Kokushikan Univ, Fac Hlth & Sport Sci, Tama Ku, 7-3-1 Nagayama, Tokyo 2068515, Japan.	kerr@kokushikan.ac.jp					Apter M.J., 2001, MOTIVATIONAL STYLES; APTER MJ, 1997, 8 INT C REV THEOR U; Apter MJ., 1982, EXPERIENCE MOTIVATIO; Atyeo D., 1979, BLOOD GUTS VIOLENCE; COLBURN K, 1985, CAN J SOCIOL, V10, P153; COLBURN K, 1989, DEVIANT BEHAV; Dryden K, 2004, GLOBE MAIL      0327, pA19; Dryden Ken, 1983, GAME; HALL N, 2004, VANCOUVER SUN   0827, pA1; HASSMEN P, 1995, SPORT PSYCHOL, V9, P297, DOI 10.1123/tsp.9.3.297; HEADS I, 1992, TRUE BLUE STORY NSW; Hutchins B., 1997, International Review for the Sociology of Sport, V32, P161, DOI 10.1177/101269097032002004; James M, 1997, CRIM LAW REV, P41; KERR G, 2004, GLOBE MAIL      0311, pS2; KERR G, 2004, GLOBE MAIL      0311, pA1; Kerr J., 2004, RETHINKING AGGRESSIO; Kerr J.H., 1997, MOTIVATION EMOTION S; Kerr JH, 1999, SPORT PSYCHOL, V13, P83, DOI 10.1123/tsp.13.1.83; MAKI A, 2004, GLOBE MAIL      0311, pS1; Maxwell JP, 2004, PSYCHOL SPORT EXERC, V5, P279, DOI 10.1016/S1469-0292(03)00007-4; MORRIS J, 2004, GLOBE MAIL      0327, pS2; MULGREW I, 2004, VANCOUVER SUN   0312, pA5; NAYLOR D, 2004, GLOBE MAIL, pS3; PAP E, 2004, VANCOUVER SUN   0301, P1; Robinson D. W., 1987, J SPORT BEHAVIOR, V10, P137; Russell G. W., 1993, SOCIAL PSYCHOL SPORT; Smith M, 1983, VIOLENCE SPORT; Wilson GV, 1999, PERS INDIV DIFFER, V27, P85, DOI 10.1016/S0191-8869(98)00226-8; YOUNG K, 1993, SOCIOL SPORT J, V10, P373, DOI 10.1123/ssj.10.4.373; 2005, VANCOUVER SUN   0218, pG1; 2004, JAPAN TIMES     0626, P24; 2004, GLOBE MAIL      0311, pA16	32	7	7	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-1789			AGGRESS VIOLENT BEH	Aggress. Violent Behav.	JUL-AUG	2006	11	4					313	322		10.1016/j.avb.2005.07.010			10	Criminology & Penology; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Criminology & Penology; Psychology	060JB	WOS:000238797400001					2022-02-06	
J	Pereira, PMG; Oliveira, E; Insausti, R				Goncalves Pereira, P. M.; Oliveira, E.; Insausti, R.			Quantitative volumetric analysis of the hippocampus, amygdala and entorhinal cortex: Normative database for the adult Portuguese population	REVISTA DE NEUROLOGIA			Spanish	Article						amygdala; entorhinal cortex; hippocarnpus; magnetic resonance imaging; normative database; Portuguese population; volumetry	TEMPORAL-LOBE EPILEPSY; MILD COGNITIVE IMPAIRMENT; EARLY ALZHEIMERS-DISEASE; TRAUMATIC BRAIN INJURY; WHITE-MATTER CHANGES; MINI-MENTAL STATE; TOTAL GRAY-MATTER; MRI VOLUMETRY; TEMPOROPOLAR CORTICES; AGE	Introduction. Atrophy of the hippocampus, amygdala and entorhinal cortex can be found in neurodegenerative diseases, head trauma and epilepsy and are expressed by means of volume reductions. The ability to detect these changes quantitatively depends on accurate comparisons with normative databases. Aim. To present standard magnetic resonance imaging (MRI) volumes of the mesio-temporal lobe structures and an objective statistical methodology for contrasting pathological states. Subjects and methods. Volumes of the right and left hippocampi, amygdalae and entorhinal cortex were measured from MRI in 34 right-handed healthy volunteers, aged 19-52 years. Data were normalized for the individual variation in total intracranial volume. Reproducibility was confirmed by intra/inter-observer tests. The statistical analyses included asymmetry comparisons, correlations between volumes and tests to assess the influence of age, gender and general morphometry (body mass index and height). For each volume, we further defined a normative interval by means of 99% confidence ellipses, accordingly to Hotteling's method. Results. Right-left asymmetry in the volumes of the hippocampus and entorhinal cortex was a normal finding. Structures located in the right hemisphere were larger than the left by a small but statistically significant amount. No asymmetry was found in the amygdala. There was no correlation in-between these volumes. Gender differences were exclusively noted in the absolute amygdala volumes (male > female) but were eliminated by the normalization procedure. No effect of age or morphometry was seen in the absolute or normalized volumes (except for a milder correlation between hippocampal volumes and height). Confidence ellipses were built for every structure and provided a precise reading of the data. Particularly, it allowed for a clear distinction of pathological asymmetries and bilateral cases. Conclusion. These normative volumes serve as a reference for the assessment of pathologic groups within similar age-range. The use of a single graphic representation simplifies the clinical interpretation and enhances the precision of the results.	Hosp Pedro Hispano, Dept Imagiol, P-4454509 Matosinhos, Portugal; Univ Beira Interior, Fac Ciencias Salud, Covilha, Portugal; Escuela Super Tecnol Salud, Inst Politecn Oporto, Oporto, Portugal; Univ Castilla La Mancha, Fac Med, Lab Neuroanat Humana, Albacete, Spain		Pereira, PMG (corresponding author), Hosp Pedro Hispano, Dept Imagiol, Rua Dr Eduardo Torres, P-4454509 Matosinhos, Portugal.	pmgp@ipp.estsp.pt		Goncalves Pereira, Pedro M./0000-0002-5369-489X			Achten E, 1998, NEURORADIOLOGY, V40, P558, DOI 10.1007/s002340050644; Amaral D. G., 1987, HDB PHYSL NERVOUS SY, VV, P211; Amaral D.G., 1990, HUMAN NERVOUS SYSTEM, P711, DOI [10.1016/B978-0-12-547625-6.50026-X, DOI 10.1016/B978-0-12-547625-6.50026-X]; ARMSTRONG E, 1990, HUMAN NERVOUS SYSTEM, P711; Barkovich AJ, 1997, EPILEPSIA, V38, P1255; Bernasconi N, 1999, NEUROLOGY, V52, P1870, DOI 10.1212/WNL.52.9.1870; Bernasconi N, 2003, BRAIN, V126, P462, DOI 10.1093/brain/awg034; BHATIA S, 1993, NEUROLOGY, V43, P2006, DOI 10.1212/WNL.43.10.2006; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brierley B, 2002, BRAIN RES REV, V39, P84, DOI 10.1016/S0165-0173(02)00160-1; Callen DJA, 2001, NEUROLOGY, V57, P1669, DOI 10.1212/WNL.57.9.1669; Calmon G, 2000, MAGN RESON IMAGING, V18, P439, DOI 10.1016/S0730-725X(99)00118-6; CASCINO GD, 1991, ANN NEUROL, V30, P31, DOI 10.1002/ana.410300107; CENDES F, 1994, BRAIN, V117, P739, DOI 10.1093/brain/117.4.739; CENDES F, 1993, NEUROLOGY, V43, P719, DOI 10.1212/WNL.43.4.719; Coffey C.E, 1994, TXB GERIATRIC NEUROP, P159; Coffey CE, 1998, ARCH NEUROL-CHICAGO, V55, P169, DOI 10.1001/archneur.55.2.169; Convit A, 1997, NEUROBIOL AGING, V18, P131, DOI 10.1016/S0197-4580(97)00001-8; Convit A, 1999, PSYCHIAT RES-NEUROIM, V90, P113, DOI 10.1016/S0925-4927(99)00007-4; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Dade LA, 2004, NEUROIMAGE, V22, P1492, DOI 10.1016/j.neuroimage.2004.03.023; DASILVA FHL, 1999, HDB CLIN NEUROLOGY 1, P39; Du AT, 2001, J NEUROL NEUROSUR PS, V71, P441, DOI 10.1136/jnnp.71.4.441; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Duvernoy HM., 1998, HUMAN HIPPOCAMPUS FU; Eritaia J, 2000, MAGN RESON MED, V44, P973, DOI 10.1002/1522-2594(200012)44:6<973::AID-MRM21>3.0.CO;2-H; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; FREE SL, 1995, AM J NEURORADIOL, V16, P637; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Ge YL, 2002, AM J NEURORADIOL, V23, P1334; Gloor P., 1997, TEMPORAL LOBE LIMBIC; GONCALVESPEREIR.PM, 2005, MAGMA MAGNETIC RESON, V18, P19; Gur RE, 2000, ARCH GEN PSYCHIAT, V57, P769, DOI 10.1001/archpsyc.57.8.769; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.1093/biomet/28.3-4.321; Insausti R, 1998, AM J NEURORADIOL, V19, P659; INSAUSTI R, 1993, HIPPOCAMPUS, V3, P19; JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; JACK CR, 1992, NEUROLOGY, V42, P183, DOI 10.1212/WNL.42.1.183; JACK CR, 1995, MAGN RESON IMAGING, V13, P1057, DOI 10.1016/0730-725X(95)02013-J; Juottonen K, 1998, NEUROBIOL AGING, V19, P15, DOI 10.1016/S0197-4580(98)00007-4; Jutila L, 2001, AM J NEURORADIOL, V22, P1490; Kalus P, 2005, NEUROIMAGE, V24, P1122, DOI 10.1016/j.neuroimage.2004.10.007; Kalviainen R, 1998, NEUROLOGY, V50, P1377, DOI 10.1212/WNL.50.5.1377; Kalviainen R, 1997, EPILEPSY RES, V28, P39, DOI 10.1016/S0920-1211(97)00029-6; Kantarci K, 2002, DEMENT GERIATR COGN, V14, P198, DOI 10.1159/000066021; KILLIANY RJ, 1993, ARCH NEUROL-CHICAGO, V50, P949, DOI 10.1001/archneur.1993.00540090052010; Kolmogorov A. N., 1933, GIORNALE I ITALIANO, V4, P83; Kopelman MD, 2002, BRAIN, V125, P2152, DOI 10.1093/brain/awf229; Laakso MP, 1995, NEUROREPORT, V6, P2414, DOI 10.1097/00001756-199511270-00032; Lange N, 1997, PSYCHIAT RES-NEUROIM, V74, P1, DOI 10.1016/S0925-4927(96)03054-5; Lemieux L, 1999, MAGN RESON MED, V42, P127; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Mouton PR, 1998, NEUROBIOL AGING, V19, P371, DOI 10.1016/S0197-4580(98)00080-3; Mu QW, 1999, AM J NEURORADIOL, V20, P207; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Pereira PMG, 2005, AM J NEURORADIOL, V26, P319; Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464; Roberts N, 2000, BRIT J RADIOL, V73, P679, DOI 10.1259/bjr.73.871.11089458; SA MJ, 1999, ACTA STEREOL, V18, P161; SAKAMOTO AC, 2001, EPILEPSY SURG, P532; Salmenpera T, 2000, SEIZURE-EUR J EPILEP, V9, P208, DOI 10.1053/seiz.1999.0373; Salmenpera T, 2005, NEUROLOGY, V64, P62, DOI 10.1212/01.WNL.0000148643.36513.2A; Salmenpera T, 2001, EPILEPSY RES, V46, P69, DOI 10.1016/S0920-1211(01)00258-3; Salmenpera T, 2000, EPILEPSY RES, V40, P155, DOI 10.1016/S0920-1211(00)00121-2; Schuff N, 2001, ALZHEIMER'S DISEASE, P229, DOI 10.1002/0470846453.ch21; SOININEN HS, 1994, NEUROLOGY, V44, P1660, DOI 10.1212/WNL.44.9.1660; SORVARI H, 1995, J COMP NEUROL, V360, P185, DOI 10.1002/cne.903600202; Szentkuti A, 2004, J NEUROL, V251, P1345, DOI 10.1007/s00415-004-0540-y; TAMRAZ JC, 2000, ATLAS REGIONAL ANATO, P161; VANHOESEN GW, 1995, MAGN RESON IMAGING, V13, P1047, DOI 10.1016/0730-725X(95)02012-I; VanPaesschen W, 1997, ANN NEUROL, V41, P41, DOI 10.1002/ana.410410109; Wang DM, 2002, MAGN RESON IMAGING, V20, P27, DOI 10.1016/S0730-725X(02)00466-6; WATSON C, 1992, NEUROLOGY, V42, P1743, DOI 10.1212/WNL.42.9.1743; Wu CC, 2002, NEUROLOGY, V59, P383, DOI 10.1212/WNL.59.3.383	78	7	10	0	2	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	JUN 16	2006	42	12					713	722		10.33588/rn.4212.2005352			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	055IK	WOS:000238443300003	16775796				2022-02-06	
J	Noetzel, MJ				Noetzel, Michael J.			Perinatal trauma and cerebral palsy	CLINICS IN PERINATOLOGY			English	Article							NEONATAL SUBGALEAL HEMATOMA; EPIDURAL HEMATOMA; INTRACRANIAL HEMORRHAGE; SUBDURAL HEMATOMAS; VACUUM; NEWBORN; OUTCOMES; FORCEPS; INJURY	In this article "perinatal trauma" is restricted to injuries that are sustained by the infant during the labor and delivery primarily as a result of mechanical factors, with the understanding that even under optimal circumstances, the process of birth is traumatic. Mechanical insults to the perinatal brain may result in primarily a hypoxic or ischemic injury to the cerebral tissues; those conditions are not discussed in this article. Although there are multiple types of perinatal trauma, this article is restricted mainly to those types that impact upon the subsequent development of cerebral palsy, although when applicable, other adverse developmental outcomes are mentioned.	St Louis Childrens Hosp, Dept Neurol, St Louis, MO 63110 USA		Noetzel, MJ (corresponding author), St Louis Childrens Hosp, Dept Neurol, Room 12E25,1 Childrens Pl, St Louis, MO 63110 USA.	noetzelm@neuro.wustl.edu					Akiyama Y, 2001, CHILD NERV SYST, V17, P290, DOI 10.1007/s003810000408; Amar AP, 2003, NEUROSURGERY, V52, P1470, DOI 10.1227/01.NEU.0000065180.07961.54; Chadwick LM, 1996, J PAEDIATR CHILD H, V32, P228, DOI 10.1111/j.1440-1754.1996.tb01559.x; Duckett S., 1995, PEDIAT NEUROPATHOLOG, P243; Gardella C, 2001, AM J OBSTET GYNECOL, V185, P896, DOI 10.1067/mob.2001.117309; GOVAERT P, 1992, ARCH DIS CHILD-FETAL, V67, P840, DOI 10.1136/adc.67.7_Spec_No.840; Guilcher GMT, 2005, HAEMOPHILIA, V11, P411, DOI 10.1111/j.1365-2516.2005.01102.x; Hanigan WC, 1995, CHILD NERV SYST, V11, P698, DOI 10.1007/BF00262235; HANIGAN WC, 1990, PEDIATRICS, V85, P534; HARWOODNASH DC, 1971, RADIOLOGY, V101, P151, DOI 10.1148/101.1.151; HAYASHI T, 1987, CHILD NERV SYST, V3, P23, DOI 10.1007/BF00707189; Heyman R, 2005, NEUROSURGERY, V57, P924, DOI 10.1227/01.NEU.0000180026.73246.bf; Kumar M, 2004, AM J PERINAT, V21, P15, DOI 10.1038/sj.jp.7211063; Martin Joyce A, 2005, Natl Vital Stat Rep, V54, P1; McKinstry RC, 2002, NEUROLOGY, V59, P824, DOI 10.1212/WNL.59.6.824; Perrin RG, 1997, NEUROSURGERY, V40, P1190, DOI 10.1097/00006123-199706000-00016; Stephens RP, 1997, PEDIATRICS, V99, P619, DOI 10.1542/peds.99.4.619; TAKAGI T, 1978, CHILD BRAIN, V4, P306; Towner D, 1999, NEW ENGL J MED, V341, P1709, DOI 10.1056/NEJM199912023412301; Vachharajani A, 2002, AM J PERINAT, V19, P401, DOI 10.1055/s-2002-36837; Vinchon M, 2005, CHILD NERV SYST, V21, P1042, DOI 10.1007/s00381-004-1131-z; VOLPE JJ, 2001, NEUROLOGY NEWBORN, P397; Volpe JJ, 2001, NEUROLOGY NEWBORN, P813; WELCH K, 1986, DEV MED CHILD NEUROL, V28, P156; Wen SW, 2001, AM J EPIDEMIOL, V153, P103, DOI 10.1093/aje/153.2.103; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9	26	7	8	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0095-5108	1557-9840		CLIN PERINATOL	Clin. Perinatol.	JUN	2006	33	2					355	+		10.1016/j.clp.2006.03.003			13	Obstetrics & Gynecology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Pediatrics	062PI	WOS:000238956600009	16765729				2022-02-06	
J	Bennett, P; Fawcett, L				Bennett, Philippa; Fawcett, Louise			Trauma injuries sustained by female footballers	TRAUMA-ENGLAND			English	Article						ACL; ankle; concussion; female; injury; soccer		Soccer is becoming the leading sport for women worldwide with 21 million females registered with the Federation Internationale de Football Association (FIFA). It is now the top female sport in England with 131 678 registered players and 9600 registered clubs. Several studies have looked at the injury rates amongst female players. Some injuries have been highlighted as more common in women. This article looks at the epidemiology of injuries in women's soccer and in particular anterior cruciate ligament injuries, ankle injuries and concussion. It will discuss the diagnosis and management needed for these injuries in female soccer players. With this increasing popularity, clinicians will see more female players sustaining trauma through playing soccer. Early and appropriate management of these injuries is essential if women are to continue to enjoy soccer at a recreational level and succeed at a competitive level, perhaps with a podium finish in 2012.	[Bennett, Philippa; Fawcett, Louise] Football Assoc, London W1D FA, England		Bennett, P (corresponding author), London House, Norfolk PE33 0BY, England.	pippa.Bennett@thefa.com					ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; Bjordal JM, 1997, AM J SPORT MED, V25, P341, DOI 10.1177/036354659702500312; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; ENGSTROM B, 1991, AM J SPORT MED, V19, P372, DOI 10.1177/036354659101900408; Faude O, 2005, AM J SPORT MED, V33, P1694, DOI 10.1177/0363546505275011; Feller J, 2004, BRIT J SPORT MED, V38, P383, DOI 10.1136/bjsm.2004.013300; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Giza E, 2005, BRIT J SPORT MED, V39, P212, DOI 10.1136/bjsm.2004.011973; Giza E, 2003, AM J SPORT MED, V31, P550, DOI 10.1177/03635465030310041201; GRAY J, 1985, INT J SPORTS MED, V6, P314, DOI 10.1055/s-2008-1025861; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Hawkins RD, 2001, BRIT J SPORT MED, V35, P43, DOI 10.1136/bjsm.35.1.43; Heyworth J, 2003, BRIT J SPORT MED, V37, P194, DOI 10.1136/bjsm.37.3.194; HUTCHINSON MR, 1995, SPORTS MED, V19, P288, DOI 10.2165/00007256-199519040-00006; Li G, 1999, J BIOMECH, V32, P395, DOI 10.1016/S0021-9290(98)00181-X; Lohmander LS, 2004, ARTHRITIS RHEUM-US, V50, P3145, DOI 10.1002/art.20589; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Myklebust G, 2003, CLIN J SPORT MED, V13, P71, DOI 10.1097/00042752-200303000-00002; Ostenberg A, 2000, SCAND J MED SCI SPOR, V10, P279, DOI 10.1034/j.1600-0838.2000.010005279.x; Pandy MG, 1997, J BIOMECH, V30, P1015, DOI 10.1016/S0021-9290(97)00070-5; Shelbourne KD, 1998, AM J SPORT MED, V26, P402, DOI 10.1177/03635465980260031001; Soderman K, 2001, SCAND J MED SCI SPOR, V11, P299, DOI 10.1034/j.1600-0838.2001.110508.x; SOURYAL TO, 1993, AM J SPORT MED, V21, P535, DOI 10.1177/036354659302100410; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; Stone A, 2006, COMMUNICATION; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; vanDijk CN, 1996, J BONE JOINT SURG BR, V78B, P958, DOI 10.1302/0301-620X78B6.1283; Wojtys EM, 2002, AM J SPORT MED, V30, P182, DOI 10.1177/03635465020300020601; Woods C, 2003, BRIT J SPORT MED, V37, P233, DOI 10.1136/bjsm.37.3.233; ZELISKO JA, 1982, AM J SPORT MED, V10, P297, DOI 10.1177/036354658201000507	30	7	7	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma	APR	2006	8	2					69	76		10.1177/1460408606072682			8	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V3B5L	WOS:000218105600001					2022-02-06	
J	Meyer, S; Gottschling, S; Baghai, A; Polcher, T; Strittmatter, M; Gortner, L				Meyer, S; Gottschling, S; Baghai, A; Polcher, T; Strittmatter, M; Gortner, L			The role of S100B-protein in neonatology, pediatric intensive care, and pediatrics	KLINISCHE PADIATRIE			German	Article						S100B protein; neuromonitoring; asphyxia; brain injury; outcome; children	BRAIN-SPECIFIC PROTEINS; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; AMINO-ACID-SEQUENCE; MINOR HEAD-INJURY; S-100 PROTEIN; S100B PROTEIN; CEREBROSPINAL-FLUID; CARDIOPULMONARY BYPASS; S100-BETA PROTEIN; CARDIAC-SURGERY	During the last years neuromonitoring with various biochemical markers such as S100B protein has been introduced into the clinical settings of neonatal and pediatric intensive care. Several investigations have been undertaken to correlate S100B protein concentrations to the diagnosis and prognosis of neonates and children with severe cerebral disorders. This articles gives a review on the current knowledge, indications and limitations on the use of S100B protein after non-traumatic and traumatic brain injury in neonates and children.	Univ Saarlandes Kliniken, Klin Allgemeine Padiat & Neonatol, D-66421 Homburg, Germany		Meyer, S (corresponding author), Univ Saarlandes Kliniken, Klin Allgemeine Padiat & Neonatol, Kirrbergerstr Gebaude 9, D-66421 Homburg, Germany.	sascha.meyer@uniklinik-saarland.de					Akhtar Javed I, 2003, Pediatr Crit Care Med, V4, P322; Ali MS, 2000, BRIT J ANAESTH, V85, P287, DOI 10.1093/bja/85.2.287; Anderson RE, 2000, ANN THORAC SURG, V69, P847, DOI 10.1016/S0003-4975(99)01526-X; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Beems T, 2003, ACTA NEUROCHIR, V145, P37, DOI 10.1007/s00701-002-1019-1; Berger Rachel, 2003, Pediatr Crit Care Med, V4, P391, DOI 10.1097/01.PCC.0000075324.45784.8A; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Blennow M, 2001, ACTA PAEDIATR, V90, P1171, DOI 10.1080/080352501317061594; Buonocore G, 2004, CLIN PERINATOL, V31, P107, DOI 10.1016/j.clp.2004.03.008; de Vries J, 2001, J NEUROL NEUROSUR PS, V71, P671, DOI 10.1136/jnnp.71.5.671; Dennery PA, 2003, ARCH PEDIAT ADOL MED, V157, P1151, DOI 10.1001/archpedi.157.12.1151; DONATO R, 1986, CELL CALCIUM, V7, P123, DOI 10.1016/0143-4160(86)90017-5; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Gazzolo D, 2004, CRIT CARE MED, V32, P131, DOI 10.1097/01.CCM.0000104116.91462.CD; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Gazzolo D, 2002, CRIT CARE MED, V30, P1356, DOI 10.1097/00003246-200206000-00037; Gazzolo D, 2002, PEDIATR RES, V51, P215, DOI 10.1203/00006450-200202000-00015; Gazzolo D, 2001, CLIN CHEM, V47, P954; Gazzolo D, 1999, J NEUROL SCI, V170, P32, DOI 10.1016/S0022-510X(99)00194-X; Herrmann M, 2003, RESTOR NEUROL NEUROS, V21, P177; HOWARD A, 1992, BIOCHEM BIOPH RES CO, V185, P663, DOI 10.1016/0006-291X(92)91676-H; Infante JR, 2003, J PHYSIOL BIOCHEM, V59, P255, DOI 10.1007/BF03179882; Infante JR, 2000, TUMOR BIOL, V21, P38, DOI 10.1159/000030109; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; ISOBE T, 1981, EUR J BIOCHEM, V115, P469; ISOBE T, 1981, EUR J BIOCHEM, V116, P79, DOI 10.1111/j.1432-1033.1981.tb05303.x; ISOBE T, 1978, EUR J BIOCHEM, V89, P379, DOI 10.1111/j.1432-1033.1978.tb12539.x; Jensen E, 2000, PAEDIATR ANAESTH, V10, P297, DOI 10.1046/j.1460-9592.2000.00522.x; Lamers KJB, 2003, BRAIN RES BULL, V61, P261, DOI 10.1016/S0361-9230(03)00089-3; Lardner D, 2004, PEDIATR ANESTH, V14, P495, DOI 10.1111/j.1460-9592.2004.01230.x; Leviton A, 2002, ACTA PAEDIATR, V91, P9, DOI 10.1080/080352502753457851; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; MARKS A, 1990, BIOESSAYS, V12, P381, DOI 10.1002/bies.950120806; McAdory BS, 1998, BRAIN RES, V813, P211, DOI 10.1016/S0006-8993(98)01014-2; Michetti F, 2002, CLIN CHEM, V48, P2097; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Nagdyman N, 2003, PEDIATR RES, V54, P270, DOI 10.1203/01.PDR.0000072518.98189.A0; Nagdyman N, 2001, PEDIATR RES, V49, P502, DOI 10.1203/00006450-200104000-00011; Ozatik MA, 2002, PERFUSION-UK, V17, P335, DOI 10.1191/0267659102pf597oa; Park ES, 2004, BRAIN DEV-JPN, V26, P190, DOI 10.1016/S0387-7604(03)00126-8; Park ES, 2000, YONSEI MED J, V41, P328, DOI 10.3349/ymj.2000.41.3.328; Portela LVC, 2002, CLIN CHEM, V48, P950; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Schulpis KH, 2004, CLIN BIOCHEM, V37, P76, DOI 10.1016/j.clinbiochem.2003.08.002; SHAABAN AM, 2004, ANAESTHESIA, V59, P20; Snyder-Ramos SA, 2004, ANAESTHESIA, V59, P344, DOI 10.1111/j.1365-2044.2004.03663.x; Snyder-Ramos SA, 2003, RESTOR NEUROL NEUROS, V21, P123; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Spinella Philip C, 2004, Pediatr Crit Care Med, V5, P53, DOI 10.1097/01.PCC.0000102221.98378.7D; Unertl K, 1997, ANAESTHESIST, V46, P471, DOI 10.1007/s001010050426; van Passel R, 2001, Eur J Paediatr Neurol, V5, P15, DOI 10.1053/ejpn.2001.0399; Wainwright MS, 2004, ANN NEUROL, V56, P61, DOI 10.1002/ana.20142; Whitelaw A, 2001, ARCH DIS CHILD-FETAL, V84, pF90, DOI 10.1136/fn.84.2.F90; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	60	7	9	0	5	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0300-8630	1439-3824		KLIN PADIATR	Klinische Padiatr.	MAR-APR	2006	218	2					49	56		10.1055/s-2005-836607			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	025NP	WOS:000236273400001	16506102				2022-02-06	
J	Petersen, C; Scherwath, A; Kruithoff, E; Koch, U				Petersen, C; Scherwath, A; Kruithoff, E; Koch, U			Post-acute service utilisation and parental satisfaction with health care services after mild traumatic brain injury in children and adolescents	BRAIN INJURY			English	Article						traumatic brain injury; health care services; utilisation; satisfaction	UK	The objectives of this study were to describe and analyse the current aftercare practise following define TBI in four German cities. A retrospective, cross-sectional design was chosen in order to investigate the research questions. Methods and procedures included a questionnaire mailed to parents whose children were admitted with TBI to one of seven collaborating hospitals. A total of 564 parents participated in the study. The results indicate that aftercare services were rarely utilised. Furthermore, it was found that the behaviour of the physician in charge had a great impact on parental satisfaction with healthcare services. In conclusion, the findings described in this article underline the need to improve communication between acute and post-acute services.	Univ Hamburg Eppendorf, Inst & Policlin Med Psychol, Ctr Psychosocial Med, Med Ctr, D-20246 Hamburg, Germany		Petersen, C (corresponding author), Univ Hamburg Eppendorf, Inst & Policlin Med Psychol, Ctr Psychosocial Med, Med Ctr, Martinistr 52,S 35, D-20246 Hamburg, Germany.	copeters@uke.uni-hamburg.de	Scherwath, Angela/Q-4197-2016; Koch, Uwe/A-5825-2009	Scherwath, Angela/0000-0002-7338-5218			*BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; Emanuelson I, 2003, INT J REHABIL RES, V26, P257, DOI 10.1097/00004356-200312000-00002; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Klonoff H, 1995, TRAUMATIC HEAD INJUR, P219; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Parmelee D X, 1989, Psychiatr Med, V7, P11; Phillips VL, 2004, J HEAD TRAUMA REHAB, V19, P217, DOI 10.1097/00001199-200405000-00003; RICHARDT HH, 1999, TAGUNGSBERICHT KURAT; SCHMIDT S, TESTING IMPROVING CH; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; WILLER B, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P18; World Health Organization, 1992, ICD 10 CLASSIFICATIO	15	7	8	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2006	20	3					321	326		10.1080/02699050500488108			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	021GT	WOS:000235972400011	16537273				2022-02-06	
J	Singh, M; Vaishya, S; Gupta, S; Mehta, VS				Singh, M; Vaishya, S; Gupta, S; Mehta, VS			Economics of head injuries	NEUROLOGY INDIA			English	Article						head injury; neurotrauma; cost analysis; economics	TRAUMA; COSTS	Head injuries account for significant proportion of neurosurgical admissions and bed occupancy. Patients with head injuries also consume significant proportions of neurosurgical resources. A prospective 6-month study has been carried out to evaluate the expenditure incurred on head injury patients in a modern neurosurgical center equipped with state of the art infrastructure. Costing areas included wages / salaries of health care personnel, cost of medicines / surgical items / crystalloids, general store items, stationary, all investigation charges, equipment cost, overhead building cost, maintenance cost, electricity and water charges and cost of medical gases, air conditioning and operation theatre expenses. Expenditure in each area was calculated and apportioned to each bed. The statistical analysis was done using X-2 test. The cost of stay in ward was found to be Rs. 1062 / bed / day and in neurosurgical ICU Rs. 3082 / bed / day. The operation theatre cost for each surgery was Rs. 11948. The cost of hospital stay per day for minor, moderate and severe head injury group was found to be Rs. 1921, Rs. 2569 and Rs. 2713 respectively. The patients who developed complications, the cost of stay per day in the hospital were Rs. 2867. In the operative group, the cost of hospital stay per day was Rs. 3804. The total expenditure in minor head injury was Rs. 7800 per patient, in moderate head injury was Rs. 22172 per patient whereas in severe head injury, it was found to be Rs. 3285 per patient. Patients who underwent surgery, the total cost incurred was Rs. 33100 per operated patient.	All India Inst Med Sci, Ctr Neurosci, Dept Neurosurg, New Delhi 110029, India		Singh, M (corresponding author), All India Inst Med Sci, Ctr Neurosci, Dept Neurosurg, New Delhi 110029, India.	mehta_vs@rediffmail.com					Berkowitz Monroe, 1993, Journal of Emergency Medicine, V11, P63; GRABOW JD, 1984, AM J PUBLIC HEALTH, V74, P710, DOI 10.2105/AJPH.74.7.710; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Havill JH, 1998, NEW ZEAL MED J, V111, P161; MARKERT AV, 1993, POLSKI TYGODNIK LEKA, V48, P389; MCGIBONY JR, 1967, PRINCIPLES HOSP ADM; MENDELOW AD, 1989, BRAIN INJURY, V3, P283; METHALER JM, 1996, ARCH PHYS MED REHAB, V77, P1; MULLER A, 1980, AM J PUBLIC HEALTH, V70, P586, DOI 10.2105/AJPH.70.6.586; SAYWELL RM, 1989, J AM GERIATR SOC, V37, P625, DOI 10.1111/j.1532-5415.1989.tb01253.x; 1962, MUDALIAR COMMITTEE; 1987, TATA CONSULTANCY SER	12	7	7	0	0	NEUROL SOC INDIA	CHANDIGARH	C/O J S CHOPRA, PGIMER, DEPT NEUROLOGY, CHANDIGARH 160 012, INDIA	0028-3886			NEUROL INDIA	Neurol. India	MAR	2006	54	1					78	80					3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	045VG	WOS:000237770100021	16679650				2022-02-06	
J	Gruber, M; Wiesner, G; Burger, R; Lindner, R				Gruber, M; Wiesner, G; Burger, R; Lindner, R			The salicylate trapping method: Is oxidation of salicylic acid solution oxygen and time dependent and metal catalysed?	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						salicylate trapping method; 2,5-DHBA; 2,3-DHBA; hyperoxia; oxygen; metal catalysis	HYDROXYL RADICAL GENERATION; TRAUMATIC BRAIN-INJURY; EPIDURAL MASS LESION; ELECTROCHEMICAL DETECTION; LIQUID-CHROMATOGRAPHY; REPRODUCIBLE MODEL; LIPID-PEROXIDATION; RAT STRIATUM; MICRODIALYSIS; METABOLISM	For a microdialytic trapping method we systematically investigated changes in concentrations of 2,5-dihydroxy-benzoic acid (2,5-DHBA) and 2,3-dihydroxy-benzoic acid (2,3-DHBA) in freshly prepared solutions of salicylic acid (SA). The solvent was 0.9% saline exposed to different atmospheric concentrations of oxygen (0, 21, and 100%). The solutions were treated by freezing-thawing and an ultrasonic bath in presence and absence of aluminium foil. Without aluminium the concentrations of 2,5-DHBA and 2,3-DHBA kept constant over an observed period of 160 min on different levels from below 20 ng/ml to about 100 ng/ml. In presence of aluminium the concentrations increased to maximum 307 ng/ml after 160 min. Ultrasonic irradiation amplified this effect to maximum 341 ng/ml. HPLC/ECD processing and quantitative analysis of dihydroxy-benzoic acids (DHBAs) in microdialysis may be artificially influenced by varying oxygen environment and metal catalysis. (c) 2005 Elsevier B.V. All rights reserved.	Univ Regensburg, Dept Anaesthesiol, D-93053 Regensburg, Germany; German Heart Ctr Munich, Inst Anasthesiol, D-80636 Munich, Germany; Univ Regensburg, Dept Neurosurg, D-93053 Regensburg, Germany		Gruber, M (corresponding author), Univ Regensburg, Dept Anaesthesiol, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	Michael.Gruber@klinik.uni-regensburg.de	Gruber, Michael/A-5342-2012	Gruber, Michael/0000-0002-5509-9760			Adibhatla RM, 2003, ANTIOXID REDOX SIGN, V5, P647, DOI 10.1089/152308603770310329; ALTHAUS JS, 1993, MOL CHEM NEUROPATHOL, V20, P147, DOI 10.1007/BF02815368; Alves OL, 2004, CURR PHARM DESIGN, V10, P2163, DOI 10.2174/1381612043384187; Bendszus M, 2002, J NEUROSURG, V97, P1419, DOI 10.3171/jns.2002.97.6.1419; BOISVERT DP, 1991, J CEREB BLOOD FLOW M, V11, P637; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Burger R, 2002, J NEUROSURG, V97, P1410, DOI 10.3171/jns.2002.97.6.1410; Cambonie G, 2000, J NEUROSCI RES, V62, P84, DOI 10.1002/1097-4547(20001001)62:1<84::AID-JNR9>3.3.CO;2-L; Cheng FC, 2002, J CHROMATOGR B, V781, P481, DOI 10.1016/S1570-0232(02)00620-7; CHIUEH CC, 1992, FREE RADICAL BIO MED, V13, P581, DOI 10.1016/0891-5849(92)90151-6; Doppenberg EMR, 1998, J NEUROTRAUM, V15, P337, DOI 10.1089/neu.1998.15.337; FLOYD RA, 1984, J BIOCHEM BIOPH METH, V10, P221, DOI 10.1016/0165-022X(84)90042-3; Freed AL, 2001, J NEUROSCI METH, V109, P23, DOI 10.1016/S0165-0270(01)00397-1; GROOTVELD M, 1986, BIOCHEM J, V237, P499, DOI 10.1042/bj2370499; Hara S, 2004, BRAIN RES, V1016, P281, DOI 10.1016/j.brainres.2004.05.047; Hirata T, 1996, RES COMMUN MOL PATH, V93, P187; INGELMANSUNDBERG M, 1991, BIOCHEM J, V276, P753, DOI 10.1042/bj2760753; Lang K, 1996, COLLECT CZECH CHEM C, V61, P1729, DOI 10.1135/cccc19961729; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Obata T, 1999, J PHYSIOL-PARIS, V93, P213, DOI 10.1016/S0928-4257(99)80153-3; Obata T, 1999, BRAIN RES, V817, P206, DOI 10.1016/S0006-8993(98)01225-6; OTURAN MA, 1992, NEW J CHEM, V16, P705; SteMarie L, 1996, ANAL BIOCHEM, V241, P67, DOI 10.1006/abio.1996.0379; Stenken JA, 2001, ANAL BIOCHEM, V290, P314, DOI 10.1006/abio.2000.4985; Vitrac H, 2005, FREE RADICAL RES, V39, P519, DOI 10.1080/10715760500092543; XIE CX, 1995, NEUROTOXICOLOGY, V16, P489	27	7	7	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232			J CHROMATOGR B	J. Chromatogr. B	FEB 2	2006	831	1-2					320	323		10.1016/j.jchromb.2005.11.017			4	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	011JG	WOS:000235263800044	16324892				2022-02-06	
J	Chang, YC; Tsai, JC; Tseng, FY				Chang, YC; Tsai, JC; Tseng, FY			Neuropsychiatric disturbances and hypopituitarism after traumatic brain injury in an elderly man	JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION			English	Article						hypopituitarism; neuropsychiatric symptoms; traumatic brain injury	SEVERE HEAD TRAUMA; NEUROENDOCRINE DYSFUNCTION; AGE; PREVALENCE	Neuropsychiatric or cognitive disturbances are common complications after traumatic brain injury. They are commonly regarded as irreversible sequelae of organic brain injuries. We report a case of hypopituitarism in a 77-year-old man who presented with long-term neuropsychiatric disturbances, including cognitive impairment, disturbed sleep patterns, personality change, loss of affect, and visual and auditory hallucinations after a traumatic subdural hemorrhage. The treatment response to hormone replacement therapy was nearly complete. Hypopituitarism is rarely considered in patients who sustain traumatic brain injury and the neuro psychiatric manifestations of posttraumatic hypopituitarism have rarely been reported. This case highlights the importance of hypopituitarism as a potential reversible cause of neuro psychiatric disturbances after traumatic brain injury.	Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan; Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei, Taiwan		Tseng, FY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, 7 Chung Shan S Rd, Taipei 100, Taiwan.	fytseng@ha.mc.ntu.edu.tw	Chang, Yi-cheng/O-1334-2018	Chang, Yi-cheng/0000-0002-8077-5011; Tseng, Fen-Yu/0000-0003-1571-5255; TSAI, JUI-CHANG/0000-0003-2723-6841			Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; BARRECA T, 1980, J CLIN ENDOCR METAB, V51, P1279, DOI 10.1210/jcem-51-6-1279; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BISTRITZER T, 1981, AM J DIS CHILD, V135, P966, DOI 10.1001/archpedi.1981.02130340070022; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; Childers MK, 1998, BRAIN INJURY, V12, P517, DOI 10.1080/026990598122476; Chuang CC, 1998, GERONTOLOGY, V44, P162, DOI 10.1159/000022002; CLARK JDA, 1988, CLIN ENDOCRINOL, V29, P153, DOI 10.1111/j.1365-2265.1988.tb00257.x; DANIEL PM, 1959, LANCET, V2, P927; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Dimopoulou I, 2004, INTENS CARE MED, V30, P298, DOI 10.1007/s00134-003-2058-7; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; Frieboes RM, 1999, J NEUROPSYCH CLIN N, V11, P354, DOI 10.1176/jnp.11.3.354; GRAY A, 1991, J CLIN ENDOCR METAB, V73, P1016, DOI 10.1210/jcem-73-5-1016; IRANMANESH A, 1991, J CLIN ENDOCR METAB, V73, P1081, DOI 10.1210/jcem-73-5-1081; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; LEIGH H, 1984, ADV INTERNAL MED, V29, P413; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; MARIOTTI S, 1995, ENDOCR REV, V16, P686, DOI 10.1210/er.16.6.686; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Springer J, 2001, LANCET, V357, P1848, DOI 10.1016/S0140-6736(00)04953-9; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; Vaninetti S, 2000, EUR J ENDOCRINOL, V142, P144, DOI 10.1530/eje.0.1420144; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340	26	7	7	2	3	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	0929-6646	1876-0821		J FORMOS MED ASSOC	J. Formos. Med. Assoc.	FEB	2006	105	2					172	176		10.1016/S0929-6646(09)60341-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014PZ	WOS:000235493600012	16477340	Bronze			2022-02-06	
J	Turner, AP; Kivlahan, DR; Rimmele, CT; Bombardier, CH				Turner, AP; Kivlahan, DR; Rimmele, CT; Bombardier, CH			Does preinjury alcohol use or blood alcohol level influence cognitive functioning after traumatic brain injury?	REHABILITATION PSYCHOLOGY			English	Article						alcohol; traumatic brain injury; cognition; rehabilitation; BAL	DISORDERS IDENTIFICATION TEST; SPINAL-CORD-INJURY; SUBSTANCE-ABUSE; NATURAL-HISTORY; SELF-REPORTS; INTOXICATION; DRINKING; VALIDITY; ETHANOL; STATE	Objective: To examine the relations among preinjury alcohol use patterns and admission blood alcohol level (BAL) and postinjury cognitive functioning among individuals with recent TBI. Design: Cohort survey with chart review and follow-up cognitive assessment. Setting: Acute inpatient rehabilitation program in a Level I trauma center. Participants: 124 consecutive initial admissions meeting inclusion criteria. Measures: Admission BAL, preinjury alcohol consumption, consequences, and symptoms of dependence, as well as initial injury severity and subsequent cognitive functioning. Results: Higher BAL at hospital admission was related to greater initial injury severity (lower Glasgow Coma Scale score). Preinjury alcohol consumption and admission BAL were not consistently related to any postinjury assessment of cognition. Conclusion: Alcohol use at the time of injury may exacerbate the initial severity of TBI. Cognitive functioning soon after injury does not appear to be related to any preinjury drinking behavior.	VA Puget Sound Hlth Care Syst, Rehabil Care Serv, Seattle, WA 98108 USA; Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; VA Puget Cound Hlth Care Syst, Seattle, WA USA; Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA		Turner, AP (corresponding author), VA Puget Sound Hlth Care Syst, Rehabil Care Serv, S-117,1660 S Columbian Way, Seattle, WA 98108 USA.	aaron.turner@med.va.gov	Turner, Aaron/A-7902-2009; Bombardier, Charles H./AAZ-3260-2021	Turner, Aaron/0000-0001-6897-8003; Bombardier, Charles H./0000-0003-4758-6283			Allen JP, 2001, PREV MED, V33, P428, DOI 10.1006/pmed.2001.0910; Babor TF, 2000, J STUD ALCOHOL, V61, P55, DOI 10.15288/jsa.2000.61.55; BABOR TF, 1990, BEHAV ASSESS, V12, P5; Babor TF, 2001, AUDIT ALCOHOL USE DI; BOMARDIER CH, 2000, HDB REHABILITATION P, P399; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 1997, ARCH PHYS MED REHAB, V78, P592, DOI 10.1016/S0003-9993(97)90424-X; Bombardier CH, 1997, REHABIL PSYCHOL, V42, P259; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; Cohen J., 2013, STAT POWER ANAL BEHA; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Gentilello LM, 1999, J TRAUMA, V47, P1131, DOI 10.1097/00005373-199912000-00027; *I MED, 1990, BROAD BAS TREATM AL; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Karzmark P, 1997, ASSESSMENT, V4, P1; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MAISTO SA, 1990, BEHAV ASSESS, V12, P117; Marcotte TD, 1997, J CLIN EXP NEUROPSYC, V19, P386, DOI 10.1080/01688639708403867; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; MEYERS J, 1995, MEYERS SCORING SYSTE; Miller WR, 1997, J CLIN PSYCHOL, V53, P263, DOI 10.1002/(SICI)1097-4679(199704)53:3<263::AID-JCLP10>3.0.CO;2-G; MILLER WR, 1984, MANUAL COMPREHENSIVE; Parsons OA, 1998, J STUD ALCOHOL, V59, P180, DOI 10.15288/jsa.1998.59.180; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Rey A., 1964, EXAMEN CLIN PSYCHOL; ROEHRICH L, 1993, J CONSULT CLIN PSYCH, V61, P812, DOI 10.1037/0022-006X.61.5.812; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; Schmidt M., 1996, REY AUDITORY VERBAL; SCHWAMM LH, 1987, ANN INTERN MED, V107, P486, DOI 10.7326/0003-4819-107-4-486; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Tate PS, 1999, BRAIN INJURY, V13, P767; TEASDALE G, 1974, LANCET, V2, P81; Turner AP, 2003, ARCH PHYS MED REHAB, V84, P358, DOI 10.1053/apmr.2003.50107; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Wechsler D, 1987, MEMORY SCALE REVISED; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x; YAMAKAMI I, 1995, J NEUROSURG, V82, P813, DOI 10.3171/jns.1995.82.5.0813; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zink BJ, 1998, ACAD EMERG MED, V5, P9, DOI 10.1111/j.1553-2712.1998.tb02568.x; [No title captured], DOI DOI 10.1037/0894-4105.7.3.296	49	7	7	0	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2006	51	1					78	86		10.1037/0090-5550.51.1.78			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	022FH	WOS:000236040000011					2022-02-06	
J	Hesseling, RJ; Steinbuch, M; Veldpaus, FE; Klisch, T				Hesseling, RJ; Steinbuch, M; Veldpaus, FE; Klisch, T			Feedback control of occupant motion during a crash	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						adaptive/active restraint systems; safety belt; air bag; feedback control; loop shaping; identification		Passive in-vehicle safety systems such as the air bag and the belt restrain the occupant during a crash. However, often their behavior is not optimal In terms of occupant injuries. This paper discusses an approach to design an ideal restraint system. The problem is formulated as a feedback tracking problem with the objective to force the controlled variables, i.e., the acceleration of the head and the chest of the occupant, to follow a priori defined reference signals by simultaneous manipulation of the belt and the air bag. The reference signals have to reflect minimal injuries to the head, the chest, and the neck. More or less realistic numerical models of a crash test are far too complex to be used in control design processes. Therefore, a strategy is presented to derive simple, linear MIMO models. These models approximate the local dynamic behavior of the complex model and are suitable for control design. Analysis of the interactions in these simple models makes it plausible that the control design problem can be split into two separate tracking problems. Next, stabilizing low order controllers are designed using these models, and implemented in the closed loop system with the realistic numerical model. Results are presented, suggesting that feedback control with low order controllers is extremely effective as a basis for ideal restraint systems. Reductions of the adopted injury measures of at least 40% in comparison with the uncontrolled restraint system are achieved.	Tech Univ Eindhoven, NL-5600 MB Eindhoven, Netherlands; Bayer Motorenwerke AG, Adv Safety Engn, D-08788 Munich, Germany		Steinbuch, M (corresponding author), Tech Univ Eindhoven, POB 513, NL-5600 MB Eindhoven, Netherlands.	M.Steinbuch@tue.nl	Steinbuch, Maarten/I-2013-2012	Steinbuch, Maarten/0000-0002-1469-1696			Azimzadeh F, 2001, COMPUT CHEM ENG, V25, P15, DOI 10.1016/S0098-1354(00)00629-3; Bandura A, 2002, EUR PSYCHOL, V7, P2, DOI 10.1027//1016-9040.7.1.2; BENDJELLAL F, 1997, P 41 STAPP CAR CRASH; BIRCH S, 2000, AUTOMOT ENG INT, V108, P75, DOI DOI 10.1027//1016-9040.7.1.2; BOSGRA OH, 2004, LECT NOTES TU EINDHO; BOSTROM O, 2000, P 2000 INT IRCOBI C; Boverie S, 2003, CONTROL ENG PRACT, V11, P1413, DOI 10.1016/S0967-0661(03)00137-0; BREED DS, 2001, P 17 INT TECHN C ENH; BRISTOL EH, 1966, IEEE T AUTOMAT CONTR, VAC11, P133, DOI 10.1109/TAC.1966.1098266; Clute G., 2001, P 17 INT TECHN C ENH; COOPER J, 2004, P AIRB 2004 KARLSR F; COPPERTHITE C, 1998, Patent No. 5851027; De Schutter B, 2000, J COMPUT APPL MATH, V121, P331, DOI 10.1016/S0377-0427(00)00341-1; DESOER CA, 1980, IEEE T CIRCUITS SYST, V27, P104, DOI 10.1109/TCS.1980.1084787; Driels M., 1996, LINEAR CONTROL SYSTE; GALER FM, 1997, INT J CRASHWORTHINES, V2, P153; GANDHI UN, 1995, INT J IMPACT ENG, V16, P95, DOI 10.1016/0734-743X(94)E0029-U; GRANDFILS T, 2001, P 3 EUR MADYMO US C; Grewal M. S., 2001, KALMAN FILTERING THE; HEITPLATZ F, P 17 INT TECHN C ENH; Hesseling RJ, 2003, 42ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-6, PROCEEDINGS, P2780; HESSELING RJ, 2001, P 3 INT C CONTR THEO; HESSELING RJ, 2002, P 4 AS CONTR C SING; HESSELING RJ, 2004, THESIS TU EINDHOVEN; HUSSEY B, 1997, Patent No. 0763451; JOHANNESSEN HG, 1995, P 39 ANN M AAAM CHIC; KALLIERIS D, 1995, P 39 STAPP CAR CRASH; Kamal M.M., 1970, 700414 SAE; KARLOW JP, 2000, Patent No. 6019392; KENT R, 2001, P 2001 INT RES C BIO; KENT R, 2003, P 47 ANN M AAAM LISB; Ljung L., 1999, SYSTEM IDENTIFICATIO, V2nd; LOBDELL TE, 1972, S HUM IMP RESP GM LA; MCCARTHY MG, 2001, P 17 INT TECHN C ENH; MUSER M, 2000, P 2000 INT IRCOBI C; NEATHERY RF, 1972, 730982 SAE; *NHTSA, 2001, DOTHS809474 NHTSA US; *NHTSA, 1999, NHTSA99496237; NIEBOER JJ, 1988, P 32 STAPP CAR CRASH; PRASAD P, 1985, P 10 INT TECHN C EXP; Rugh WJ, 2000, AUTOMATICA, V36, P1401, DOI 10.1016/S0005-1098(00)00058-3; SCHMIDT H, 2002, THESIS ROYAL I TECHN; SMITH KJ, 1995, P AM CONTR C SEATTL; SMITHSON A, 2001, Patent No. 6196589; Steinbuch M, 1998, EUR J CONTROL, V4, P278, DOI 10.1016/S0947-3580(98)70121-9; *TNO AUT, 1999, MADYMO VERS 5 4 MAN; *TNO AUT, 1999, MADYMO VERS 5 4 MAMM; Van Overschee P., 1996, SUBSPACE IDENTIFICAT; VANDENBOOM TJJ, 2004, LECT NOTES DUTCH I S; VANDITZHUIJZEN G, P 2002 IEEE INT C CO; VANHELMONT JB, 1990, P APPL MULT SYST TEC; VANPOPPEL JA, 2002, Patent No. 6384518; VANSCHIE C, 2003, COMMUNICATION; WINKLER G, 2002, Patent No. 10959956; WISMANS JSH, 1994, LECT NOTES TECHNISCH	55	7	7	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness		2006	11	1					81	96		10.1533/ijcr.2005.0387			16	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	032TG	WOS:000236797000007					2022-02-06	
J	Kumar, A; Singh, H; Sharma, KC				Kumar, Arun; Singh, Hukum; Sharma, Karam Chand			Penetrating head injury from a pedestal fan rotor blade in a child - An unusual case	PEDIATRIC NEUROSURGERY			English	Article						penetrating head injury; pedestal fan rotor blade injury; unusual case, pedestal fan rotor blade injury	TRAUMATIC BRAIN INJURY; CRANIOCEREBRAL INJURY; GUNSHOT WOUNDS; EPIDEMIOLOGY; ADOLESCENTS; PREVENTION; SCANS	Penetrating head injuries in children constitute only a small part of the total number of traumatic head injuries seen in casualty. A number of household articles have been described to cause penetrating injuries, apart from gunshot and pellet injuries. We describe, for the first time, an unusual case of penetrating injury due to the rotor blade of pedestal fan used very commonly in the Indian subcontinent. Copyright (c) 2006 S. Karger AG, Basel.	Vardhman Mahavir Med Coll, Dept Pediat Surg, New Delhi, India; Vardhman Mahavir Med Coll, Dept Neurosurg, New Delhi, India; Safdarjang Hosp, New Delhi, India		Kumar, A (corresponding author), 9-18,2nd Floor,S Patel Nagar, New Delhi 110008, India.	krishnarun@yahoo.com					[Anonymous], 1994, JAMA-J AM MED ASSOC, V271, P495; Ardill W, 2003, SURG NEUROL, V60, P120, DOI 10.1016/S0090-3019(03)00158-7; Bhatjiwale MG, 2001, BRIT J NEUROSURG, V15, P256, DOI 10.1080/02688690120057709; Browning JG, 2005, EMERG MED J, V22, P33, DOI 10.1136/emj.2004.016196; DOMINGO Z, 1994, PEDIATR NEUROSURG, V21, P45, DOI 10.1159/000120813; DUJOVNY M, 1975, J TRAUMA, V15, P981, DOI 10.1097/00005373-197511000-00007; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Geller E, 1997, PEDIATR RADIOL, V27, P790, DOI 10.1007/s002470050234; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; HOLLERMAN JJ, 1990, AM J ROENTGENOL, V155, P685, DOI 10.2214/ajr.155.4.2119095; KELLY DF, 1996, NEUROLOGICAL SURG, P1618; Koestler J, 2001, J EMERG MED, V21, P145, DOI 10.1016/S0736-4679(01)00363-8; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; LEVY ML, 1993, NEUROSURGERY, V33, P1018; Lopez F, 2000, CHILD NERV SYST, V16, P117, DOI 10.1007/s003810050025; Martinez-Lage JF, 2001, PEDIATR SURG INT, V17, P657, DOI 10.1007/s003830100018; MCMICKEN DB, 1986, ANN EMERG MED, V15, P274, DOI 10.1016/S0196-0644(86)80565-0; Pabuscu Y, 2003, COMPUT MED IMAG GRAP, V27, P397, DOI 10.1016/S0895-6111(03)00015-6; REGEV E, 1990, INJURY, V21, P414, DOI 10.1016/0020-1383(90)90138-K; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; SOTIROPOULOS SV, 1990, AM J DIS CHILD, V144, P980, DOI 10.1001/archpedi.1990.02150330040018; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Tan MH, 2003, INJURY, V34, P950, DOI 10.1016/S0020-1383(02)00167-5; TAY JS, 1987, PEDIATRICS, V79, P261; Taylor AG, 1997, J NEUROSURG, V87, P512, DOI 10.3171/jns.1997.87.4.0512	26	7	7	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.		2006	42	6					391	394		10.1159/000095572			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	120CO	WOS:000243061400010	17047422				2022-02-06	
J	McAuliffe, MJ; Ward, EC				McAuliffe, Megan J.; Ward, Elizabeth C.			The use of electropalatography in the assessment and treatment of acquired motor speech disorders in adults: Current knowledge and future directions	NEUROREHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; TONGUE-PALATE CONTACT; PARKINSONS-DISEASE; DYSARTHRIA; EPG; THERAPY; COARTICULATION; PATTERNS; CHILDREN; APRAXIA	Electropalatography (EPG) has been employed to measure speech articulation since the mid-1970s. This technique has predominately been used in experimental phonetic research and in the diagnosis and treatment of articulation disorders in children. However, there is a growing body of research employing EPG to diagnose and treat articulatory impairment associated with acquired motor speech disorder (MSD) in adults. The purpose of this paper was to (1) review the findings of studies pertaining to the assessment and treatment of MSDs in adults using EPG, (2) highlight current methodologies employed, and (3) discuss the potential limitations of EPG in the assessment and treatment of MSDs and examine directions for future applied research and treatment studies.	Univ Canterbury, Dept Commun Disorders, Christchurch 8002, New Zealand; Univ Queensland, Div Speech Pathol, Brisbane, Qld, Australia		McAuliffe, MJ (corresponding author), Univ Canterbury, Dept Commun Disorders, Locked Bag 4800, Christchurch 8002, New Zealand.	megan.mcauliffe@canterbury.ac.nz	Ward, Elizabeth/F-9652-2010	Ward, Elizabeth/0000-0002-2680-8978; McAuliffe, Megan/0000-0003-3827-2215			BARRY RM, 1993, CLIN LINGUIST PHONET, V7, P275, DOI 10.1080/02699209308985567; BARRY RM, 1989, CLIN LINGUIST PHONET, V3, P81, DOI 10.3109/02699208908985273; BARRY RM, 1995, CLIN LINGUIST PHONET, V9, P311, DOI 10.3109/02699209508985339; BARRY RM, 1992, ROYAL COLL SPEECH LA, P6; BARRY RM, 1995, CASE STUDIES CLIN LI, P181; BUTCHER A, 1989, CLIN LINGUIST PHONET, V3, P39, DOI 10.3109/02699208908985269; Carter P, 2004, CLIN LINGUIST PHONET, V18, P359, DOI 10.1080/02699200410001703637; CHENERY HJ, 1998, DYSARTHRIA PHYSL APP, P36; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; Duffy, 2005, MOTOR SPEECH DISORDE; EDWARDS S, 1989, CLIN LINGUIST PHONET, V3, P111, DOI 10.3109/02699208908985275; FARNETANI E, 1991, QUADERNI CTR STUDIO, V10, P117; GIBBON F, 1993, CLIN LINGUIST PHONET, V7, P247, DOI 10.1080/02699209308985565; Gibbon F, 2000, J MED SPEECH-LANG PA, V8, P239; Gibbon FE, 1999, J SPEECH LANG HEAR R, V42, P382, DOI 10.1044/jslhr.4202.382; GOLDSTEIN P, 1994, CLIN LINGUIST PHONET, V8, P201, DOI 10.3109/02699209408985307; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; Goozee JV, 2003, J MED SPEECH-LANG PA, V11, P115; HARDCASTLE W, 1989, CLIN LINGUIST PHONET, V3, P1, DOI 10.3109/02699208908985268; Hardcastle W. J., 1992, INTELLIGIBILITY SPEE, P287; HARDCASTLE WJ, 1991, J PHONETICS, V19, P251, DOI 10.1016/S0095-4470(19)30343-2; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HARDCASTLE WJ, 1985, BRIT J DISORD COMMUN, V20, P249; HARDCASTLE WJ, 1986, CULTIVATED AUSTR FES, P417; HARTELIUS L, 2001, SPEECH MOTOR CONTROL, P192; HOWARD S, 1995, EUR J DISORDER COMM, V30, P246; INGRAM J, 1990, P 3 AUSTR INT C SPEE; Kent R. D., 1997, NEW PHONOLOGIES DEV, P247; KURUVILLA MS, 2005, CANT C COMM DIS CHRI; McAuliffe M J, 2001, Logoped Phoniatr Vocol, V26, P165, DOI 10.1080/14015430152928357; McAuliffe MJ, 2006, CLIN LINGUIST PHONET, V20, P1, DOI 10.1080/02699200400001044; McAuliffe MJ, 2006, CLIN LINGUIST PHONET, V20, P19, DOI 10.1080/0269-9200400001069; McAuliffe MJ, 2005, J MED SPEECH-LANG PA, V13, P149; MCAULIFFE MJ, 2005, CANT C COMM DIS CHRI; McFarland DH, 1996, J ACOUST SOC AM, V100, P1093, DOI 10.1121/1.416286; Murdoch BE, 2000, J MED SPEECH-LANG PA, V8, P359; SCOTT D, 2004, GPG USER MANUAL; SONIES BC, 1997, CLIN MANAGEMENT SENS, P177; Southwood MH, 1997, CLIN LINGUIST PHONET, V11, P179, DOI 10.3109/02699209708985190; Stone BM, 1997, J GLACIOL, V43, P11, DOI 10.3189/S002214300000277X; Terband H, 2004, SPEECH MOTOR CONTROL, P389; WASHINO K, 1981, CURRENT ISSUES NEURO, V6, P125; Weismer G, 1999, J ACOUST SOC AM, V105, P2882, DOI 10.1121/1.426902; Wood S., 2000, ACQUIRED NEUROGENIC, P203; [No title captured]	45	7	7	0	13	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2006	21	3					189	203					15	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	120KV	WOS:000243084500002	17167188				2022-02-06	
J	Scherer, MJ; Bodine, C				Scherer, Marcia J.; Bodine, Cathy			Technology for improving cognitive function: Report on a workshop sponsored by the U.S. Interagency Committee on Disability Research	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Assessment; disability; Alzheimer's disease; intellectual disability; traumatic brain injury; stroke; assistive technology; disability statistics; biomedical engineering		The U.S. federal Interagency Committee on Disability Research (ICDR) and its Subcommittee on Technology (IST) sponsored a state of the art workshop on ''Technology for Improving Cognitive Function,'' from 29-30 June 2006 in Washington, D.C. This paper summarizes the content of the keynote and panel presentations.	[Scherer, Marcia J.] Inst Matching Person & Technol Inc, 486 Lake Rd, Webster, NY 14580 USA; [Bodine, Cathy] Univ Colorado, Hlth Sci Ctr, Dept Phys Med Rehabil, Denver, CO USA		Scherer, MJ (corresponding author), Inst Matching Person & Technol Inc, 486 Lake Rd, Webster, NY 14580 USA.	IMPT97@aol.com		Scherer, Marcia/0000-0001-8374-6526			U.S. federal Interagency Committee on Disability Research (ICDR) Subcommittee on Technology (IST), 2006, TECHN IMPR COGN FUNC	1	7	7	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2006	1	4					257	261		10.1080/17483100600982977			5	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V06DJ	WOS:000213920600006	19260173				2022-02-06	
J	Tsai, SH; Chen, WL; Yang, CM; Lu, LH; Chiang, MF; Chi, LJ; Chiu, WT				Tsai, Shin-Han; Chen, Wan-Lin; Yang, Che-Ming; Lu, Li-Hua; Chiang, Ming-Fu; Chi, Long-Jin; Chiu, Wen-Ta			Emergency air medical services for patients with head injury	SURGICAL NEUROLOGY			English	Article						head injury; emergency air medical services; ventilator; remote island	CRITICALLY ILL PATIENTS; TRAUMATIC BRAIN-INJURY; AMBULANCE; TRANSPORT; TAIWAN	Background: Patients suffering head injury in remote islands of Taiwan, which have a shortage of manpower and facilities, depend on EAMS for prompt and definitive treatment. Emergency air medical services are becoming an increasingly important issue in improving the quality of primary care and avoiding medicolegal problems. The purpose of this study was to investigate the characteristics of patients with head injury and use of EAMS. Methods: We reviewed all patients, especially head injury victims transported by air ambulance from a remote island, Kinmen (400 km from Taiwan Main Island), from January 2001 to December 2003. Data were collected with regard to demographics, disease classification, mechanism of injury, severity of head injury, ventilator use, and mortality rate. Results: A total of 215 patients were transferred, of whom 57 (27%) had head injury. The mean age of patients was 48.6 +/- 23.8 years. Males accounted for 72% of the cases (male/female ratio, 2.6: 1). Motor-vehicle accidents were the most common mechanism of injury (68%). There were 21 (37%), 20 (35%), and 16 (28%) patients in the minor, moderate, and severe head-injury groups, respectively. Nineteen patients (33%) received mechanical ventilation. The overall mortality rate was 14% (8/57). In the severe head-injury group, the mortality rate was 44% (7/16). Conclusions: The higher incidence of head injury (26.5%) in EAMS than in ground transportation (19.8%) suggests that preflight assessment and in-flight management of patients conducted by an experienced escort team following guidelines for head injury in EAMS are a very important issue. (c) 2006 Elsevier Inc. All rights reserved.	Taipei Med Univ, Inst Injury Prevent & Control, Taipei 110, Taiwan; Taipei Med Univ, Dept Neurosurg, Taipei 110, Taiwan; Taipei Med Univ, Dept Emergency & Crit Care Med, Taipei 110, Taiwan; Wan Fang Med Ctr, Taipei 110, Taiwan; Taipei City Hosp Renal Branch, Div Neurosurg, Taipei 106, Taiwan; Taipei Med Univ, Inst Hlth Care Adm, Taipei 110, Taiwan; Tongs Taichung Metro Harbor Hosp, Dept Emergency Med, Taichung 435, Taiwan; Mackay Mem Hosp, Dept Neurosurg, Taipei 104, Taiwan; Int SOS, Taipei 104, Taiwan		Chiu, WT (corresponding author), Taipei Med Univ, Inst Injury Prevent & Control, Taipei 110, Taiwan.	wtchiu@tmu.edu.tw					Arfken CL, 1998, J TRAUMA, V45, P785, DOI 10.1097/00005373-199810000-00031; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Beninati William, 2002, Respir Care Clin N Am, V8, P51, DOI 10.1016/S1078-5337(02)00016-3; Chiu WT, 2003, J TRAUMA, V55, P391, DOI 10.1097/01.TA.0000079368.15678.6D; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Deakin C D, 2001, Curr Opin Anaesthesiol, V14, P191, DOI 10.1097/00001503-200104000-00011; Dewhurst AT, 2001, ANAESTHESIA, V56, P882, DOI 10.1046/j.1365-2044.2001.02059-2.x; Duke GJ, 2001, MED J AUSTRALIA, V174, P122, DOI 10.5694/j.1326-5377.2001.tb143182.x; Gebremichael M, 2000, CRIT CARE MED, V28, P79, DOI 10.1097/00003246-200001000-00013; Hargarten S W, 1993, Air Med J, V12, P398, DOI 10.1016/S1067-991X(05)80171-3; Hung C C, 1991, J Formos Med Assoc, V90, P1227; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; JASTREMSKI MS, 1993, CRIT CARE MED, V21, P931; Koppenberg Joachim, 2002, Curr Opin Anaesthesiol, V15, P211, DOI 10.1097/00001503-200204000-00011; MULROONEY P, 1994, BR J HOSP MED, V45, P209; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; Thomas Stephen H, 2003, Curr Opin Anaesthesiol, V16, P153, DOI 10.1097/00001503-200304000-00008; TSAI SH, 2003, J EMERG CRIT CARE ME, V14, P99; WIJINGAARDEN M, 1996, J TRAUMA, V41, P26; Young JS, 1998, AM SURGEON, V64, P88	21	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.		2006	66			2			S32	S36		10.1016/j.surneu.2006.06.051			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	107OW	WOS:000242181900007	17071253				2022-02-06	
J	Peets, AD; Berthiaume, LR; Bagshaw, SM; Federico, P; Doig, CJ; Zygun, DA				Peets, AD; Berthiaume, LR; Bagshaw, SM; Federico, P; Doig, CJ; Zygun, DA			Prolonged refractory status epilepticus following acute traumatic brain injury: a case report of excellent neurological recovery	CRITICAL CARE			English	Article							CONVULSIVE STATUS-EPILEPTICUS; GENERALIZED STATUS EPILEPTICUS; TERM MORTALITY; RISK-FACTORS; SEIZURES; PREDICTORS; MANAGEMENT; PROGNOSIS; EPISODE; IMPACT	Introduction Refractory status epilepticus (RSE) secondary to traumatic brain injury (TBI) may be under-recognized and is associated with significant morbidity and mortality. Methods This case report describes a 20 year old previously healthy woman who suffered a severe TBI as a result of a motor vehicle collision and subsequently developed RSE. Pharmacological coma, physiological support and continuous electroencephalography (cEEG) were undertaken. Results Following 25 days of pharmacological coma, electrographic and clinical seizures subsided and the patient has made an excellent cognitive recovery. Conclusion With early identification, aggressive physiological support, appropriate monitoring, including cEEG, and an adequate length of treatment, young trauma patients with no previous seizure history and limited structural damage to the brain can have excellent neurological recovery from prolonged RSE.	Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; Univ Calgary, Dept Crit Care, Calgary, AB, Canada; Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; Univ Calgary, Dept Neurosci, Calgary, AB, Canada; Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada		Zygun, DA (corresponding author), Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada.	david.zygun@calgaryhealthregion.ca	Doig, Christopher/AAC-7949-2020	Doig, Christopher/0000-0002-8576-9139			Afsar N, 2003, SEIZURE-EUR J EPILEP, V12, P23, DOI 10.1016/S1059131102001437; Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; AMINOFF MJ, 1980, AM J MED, V69, P657, DOI 10.1016/0002-9343(80)90415-5; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; BARRY E, 1993, NEUROLOGY, V43, P1473, DOI 10.1212/WNL.43.8.1473; Bleck TP, 2005, CURR OPIN CRIT CARE, V11, P117, DOI 10.1097/01.ccx.0000157079.72999.87; BLECK TP, 1993, CRIT CARE MED, V21, P955, DOI 10.1097/00003246-199307000-00004; Bramstedt KA, 2004, EPILEPSY BEHAV, V5, P752, DOI 10.1016/j.yebeh.2004.05.007; Chin RFM, 2004, EUR J NEUROL, V11, P800, DOI 10.1111/j.1468-1331.2004.00943.x; Claassen J, 2002, EPILEPSIA, V43, P146, DOI 10.1046/j.1528-1157.2002.28501.x; Claassen J, 2002, NEUROLOGY, V58, P139, DOI 10.1212/WNL.58.1.139; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Garzon E, 2003, SEIZURE-EUR J EPILEP, V12, P337, DOI 10.1016/S1059-1311(02)00324-2; Holtkamp M, 2005, J NEUROL NEUROSUR PS, V76, P534, DOI 10.1136/jnnp.2004.041947; JAGODA A, 1993, ANN EMERG MED, V22, P1337, DOI 10.1016/S0196-0644(05)80120-9; Logroscino G, 2002, NEUROLOGY, V58, P537, DOI 10.1212/WNL.58.4.537; Logroscino G, 1997, EPILEPSIA, V38, P1344, DOI 10.1111/j.1528-1157.1997.tb00073.x; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; LOWENSTEIN DH, 1993, NEUROLOGY, V43, P483, DOI 10.1212/WNL.43.3_Part_1.483; Ma XP, 2001, EPILEPSY RES, V46, P33, DOI 10.1016/S0920-1211(01)00252-2; Marik PE, 2004, CHEST, V126, P582, DOI 10.1378/chest.126.2.582; Mayer SA, 2002, ARCH NEUROL-CHICAGO, V59, P205, DOI 10.1001/archneur.59.2.205; MIRSKI MA, 1995, CRIT CARE MED, V23, P400, DOI 10.1097/00003246-199502000-00028; Nishie Makoto, 2003, Rinsho Shinkeigaku, V43, P422; SCHOLTES FB, 1994, EPILEPSIA, V35, P1104, DOI 10.1111/j.1528-1157.1994.tb02562.x; Skaff PT, 2001, NEUROLOGY, V57, P1336, DOI 10.1212/WNL.57.7.1336; TANGANELLI P, 1991, EUR NEUROL, V31, P413, DOI 10.1159/000116706; TOWNE AR, 1994, EPILEPSIA, V35, P27, DOI 10.1111/j.1528-1157.1994.tb02908.x; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Waterhouse EJ, 1999, EPILEPSIA, V40, P752, DOI 10.1111/j.1528-1157.1999.tb00774.x; MANAGEMENT PROGNOS 2	33	7	7	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	DEC	2005	9	6					R725	R728		10.1186/cc3884			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014XR	WOS:000235514400021	16280070	gold, Green Published			2022-02-06	
J	Nybo, T; Sainio, M; Muller, K				Nybo, T; Sainio, M; Muller, K			Middle age cognition and vocational outcome of childhood brain injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						childhood TBI; follow-up; middle age; cognition; vocational outcome	HEAD-INJURY; SHORT-TERM; FOLLOW-UP; TBI; SEQUELAE; MODERATE; SCALE	Objectives - In this almost four-decade follow-up we studied the cognitive performance of a cohort of 22 traumatic brain injury (TBI) patients in relation to vocational outcome. The patients had suffered a moderate to severe TBI in traffic accidents as preschoolers. Methods - The neuropsychological assessment included the Profile of Mood States questionnaire and the Neurobehavioral Rating Scale. The cognitive performance of full-time working patients was compared with that of those not working. Results - Full-time working patients had significantly better intellectual performance than the patients not at work. Memory performance was partly defective in both groups but neither group had subjective memory complaints. All patients working full time lived in a marital relationship and had less neurobehavioral problems than the patients not at work. Conclusions - Good intellectual capacity, verbal memory, and marital status were connected with a positive outcome. We suggest that as late as in middle age in spite of moderate to severe childhood TBI, it is still possible for a subgroup of patients to live a normal productive life.	Finnish Inst Occupat Hlth, Brain & Work Res Ctr, Helsinki, Finland		Nybo, T (corresponding author), Finnish Inst Occupat Hlth, Brain & Work Res Ctr, Topeliuksenkatu 41 A, Helsinki, Finland.	taina.nybo@ttl.fi		Sainio, Markku/0000-0002-3145-1301			Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Asikainen I, 1999, EUR J NEUROL, V6, P179, DOI 10.1111/j.1468-1331.1999.tb00011.x; Benton AL, 1974, REVISED VISUAL RETEN; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; Clifton GL, 1993, NEUROSURGERY, V33, P8; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Hoofien D, 2001, BRAIN INJURY, V15, P189; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; MCNAIR DM, 1981, EDITS MANUAL PROFILE; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Nybo T, 1999, BRAIN INJURY, V13, P759; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Wechsler D, 1987, MEMORY SCALE REVISED; WECHSLER D, 1981, MANUAL WECHLER ADUL; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	23	7	7	0	2	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	NOV	2005	112	5					338	342		10.1111/j.1600-0404.2005.00489.x			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	972ZH	WOS:000232491900011	16218918				2022-02-06	
J	Ucar, T; Ozkaya, G; Demir, N; Gurer, I; Akyuz, M; Onal, MZ				Ucar, T; Ozkaya, G; Demir, N; Gurer, I; Akyuz, M; Onal, MZ			The effects of environmental light-dark changes on experimental mild traumatic brain injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						brain injury; experimental; melatonin; light-dark changes	ACCELERATES RECOVERY; MELATONIN PROTECTS; SPECTRAL-ANALYSIS; NITRIC-OXIDE; HEAD-INJURY; REPERFUSION; ISCHEMIA; NEGLECT; DAMAGE; MODEL	Objectives - The aim of this study was to investigate the effects of environmental light-dark changes on the outcome of mild traumatic brain injury (MTBI) using an experimental rodent model. The functions of endogenous and exogenous melatonin on the outcome of injury were also investigated Methods - Mild traumatic brain injury was experimentally induced in 56 male Sprague-Dawley rats using a weight-drop device. Animals were divided into four groups of 14 each as follows: (i) sham-operated (trauma only, normal day-night cycle), (ii) treated with melatonin (trauma + melatonin, normal day-night cycle), (iii) darkness-induced (trauma + 48 h constant dark), and (iv) treated with melatonin and darkness-induced (trauma + 48 h constant dark + melatonin). Melatonin (50 mg/kg) was administered, intraperitoneally, immediately after trauma. EEG recordings were taken at three time periods (pretrauma, immediately after trauma, and 48 h after trauma). Motor functions were tested pretrauma, 24 and 48 h post-trauma. Serum melatonin levels were determined pretrauma and 48 h post-trauma. Tissue samples from right frontal area were taken 48 h after trauma for light and electron microscopic examinations. Conclusion - Following MTBI light deprivation alone and light deprivation in combination with exogenously administered melatonin indicated significant neuroprotective effects. Although there may be other important pathways, darkness-induced elevation in endogenous melatonin secretion appears to play an important role in this neuroprotective outcome.	Univ Akdeniz, Sch Med, Dept Neurosurg, TR-07070 Antalya, Turkey; Univ Akdeniz, Sch Phys Educ & Sports, Antalya, Turkey; Univ Akdeniz, Sch Med, Dept Histol, Antalya, Turkey; Univ Akdeniz, Sch Med, Dept Pathol, Antalya, Turkey; Univ Akdeniz, Sch Med, Dept Neurol, Antalya, Turkey		Ucar, T (corresponding author), Univ Akdeniz, Sch Med, Dept Neurosurg, TR-07070 Antalya, Turkey.	tucar@akdeniz.edu.tr	Gurer, Inanc Elif/C-3042-2016; Ozkaya, Y. Gul/F-5320-2011	Ozkaya, Y. Gul/0000-0002-4887-8379			ACUNACASTROVIEJO D, 1995, J PINEAL RES, V19, P57; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ALFOLDI P, 1990, PFLUG ARCH EUR J PHY, V417, P398, DOI 10.1007/BF00370659; Arendt J, 1998, THERAPIE, V53, P479; ATTENBURROW MEJ, 1995, PSYCHOPHARMACOLOGY, V121, P503, DOI 10.1007/BF02246501; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Burcham KJ, 1998, BEHAV BRAIN RES, V90, P187, DOI 10.1016/S0166-4328(97)00100-9; Cagnacci A, 1996, J PINEAL RES, V21, P200, DOI 10.1111/j.1600-079X.1996.tb00287.x; Cardinali DP, 1997, J PINEAL RES, V23, P32, DOI 10.1111/j.1600-079X.1997.tb00332.x; CORWIN JV, 1993, BEHAV BRAIN RES, V56, P187, DOI 10.1016/0166-4328(93)90038-R; CORWIN JV, 1991, SOC NEUR ABSTR, V21, P175; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; Dave, 1998, J Cardiovasc Pharmacol Ther, V3, P153, DOI 10.1177/107424849800300208; Fiorina P, 1999, SCAND J IMMUNOL, V50, P228; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gorgulu AK, 2001, NEUROSURGERY, V49, P1434; Guerrero JM, 1997, J PINEAL RES, V23, P24, DOI 10.1111/j.1600-079X.1997.tb00331.x; Hashimoto S, 1996, AM J PHYSIOL-REG I, V270, pR1073, DOI 10.1152/ajpregu.1996.270.5.R1073; Huether G, 1998, J PINEAL RES, V24, P146, DOI 10.1111/j.1600-079X.1998.tb00527.x; Kabuto H, 1998, EPILEPSIA, V39, P237, DOI 10.1111/j.1528-1157.1998.tb01367.x; Kaptanoglu E, 2000, J NEUROSURG, V93, P77, DOI 10.3171/spi.2000.93.1.0077; Kilic E, 1999, J CEREBR BLOOD F MET, V19, P511, DOI 10.1097/00004647-199905000-00005; Lagneux C, 2000, LIFE SCI, V66, P503, DOI 10.1016/S0024-3205(99)00620-7; Levin HS., 1996, NEUROTRAUMA, P755; Ling X, 1999, ACTA PHARMACOL SIN, V20, P409; Lipartiti M, 1996, ADV EXP MED BIOL, V398, P315; Mahle CD, 1997, J BIOL RHYTHM, V12, P690, DOI 10.1177/074873049701200626; MAKAROV AY, 1977, ZH NEVROPATOL PSIKH, V77, P1814; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; MORCOL T, 1996, 5 ANN S BIOL RHYTHMS; MORCOL T, 1996, ANN NEUR SOC M WASH; Munoz-Hoyos A, 1998, J CHILD NEUROL, V13, P501, DOI 10.1177/088307389801301007; Nowak JZ, 1998, PHARM WORLD SCI, V20, P18, DOI 10.1023/A:1008688724058; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Parsons LC, 1997, J NEUROTRAUM, V14, P549, DOI 10.1089/neu.1997.14.549; Pevet P, 1998, THERAPIE, V53, P411; REIMER W, 1995, BRAIN INJURY, V9, P55, DOI 10.3109/02699059509004572; Reiter R, 1997, LIFE SCI, V60, P2255, DOI 10.1016/S0024-3205(97)00030-1; Reiter RJ, 1999, BIOL SIGNAL RECEPT, V8, P56; Ricker JH, 2000, J HEAD TRAUMA REHAB, V15, P859, DOI 10.1097/00001199-200004000-00007; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Sewerynek E, 1996, HEPATO-GASTROENTEROL, V43, P898; Skaper SD, 1999, ANN NY ACAD SCI, V890, P107, DOI 10.1111/j.1749-6632.1999.tb07985.x; Srinivasan Venkatramanujan, 1997, Indian Journal of Physiology and Pharmacology, V41, P309; Tan DX, 1998, J PINEAL RES, V25, P184, DOI 10.1111/j.1600-079X.1998.tb00558.x; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Vargo JM, 1999, J TRAUMA, V47, P265, DOI 10.1097/00005373-199908000-00008; Vargo JM, 1998, BEHAV NEUROSCI, V112, P387, DOI 10.1037/0735-7044.112.2.387; Wakatsuki A, 2000, J PINEAL RES, V28, P172; Wakatsuki A, 1999, J PINEAL RES, V26, P147, DOI 10.1111/j.1600-079X.1999.tb00576.x; Watanabe M, 1999, EXP NEUROL, V160, P133, DOI 10.1006/exnr.1999.7208; WEINBERG U, 1979, J CLIN ENDOCR METAB, V48, P114, DOI 10.1210/jcem-48-1-114; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2	54	7	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	SEP	2005	112	3					163	172		10.1111/j.1600-0404.2005.00463.x			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	952RK	WOS:000231023000005	16097958				2022-02-06	
J	Charalambous, C; Dunning, J; Omorphos, S; Cleanthous, S; Begum, P; Mackway-Jones, K				Charalambous, C; Dunning, J; Omorphos, S; Cleanthous, S; Begum, P; Mackway-Jones, K			A maximally sensitive clinical decision rule to reduce the need for radiography in mandibular trauma	ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND			English	Article						mandible; fractures; diagnosis; cohort studies	OTTAWA ANKLE RULES; FRACTURES; DIAGNOSIS; INJURY; HEAD	INTRODUCTON To identify clinical symptoms and signs that exclude the presence of mandibular fracture in patients presenting with mandibular trauma and thus devise a clinical decision rule that will rule out the need for radiography in some patients. PATIENTS AND METHODS A prospective study was conducted of consecutive patients with a possible diagnosis of mandibular fracture who attended a city-centre emergency department between July 2000 and December 2001. Clinical symptoms and signs were recorded for each patient using a preclesigned proforma. Radiographic evaluation of a suspected mandibular fracture consisted of lateral-oblique and postero-anterior mandibular views. The presence of a fracture was based on the interpretation of the X-rays by a radiologist who was blinded to the clinical probability of a fracture. Data were initially analysed using the chi-square test. Recursive partitioning was then performed to create a maximally sensitive decision tree. RESULTS 280 patients were included in the study, 65 of whom had a mandibular fracture. A maximally sensitive decision rule was found that identified 5 parameters (malocclusion, trismus, broken teeth, pain with mouth closed, step deformity) whose absence excluded mandibular fracture. This rule has a sensitivity of 100% and specificity of 39% in identifying patients with mandibular fracture. If applied to our patient cohort, this rule would have saved 83 radiographs without missing any fractures. CONCLUSIONS A simple decision rule is presented that can be used to exclude the need for radiography in a subset of patients with mandibular trauma.	Manchester Royal Infirm, Dept Accident & Emergency, Manchester M13 9WL, Lancs, England		Dunning, J (corresponding author), Manchester Royal Infirm, Dept Accident & Emergency, Oxford Rd, Manchester M13 9WL, Lancs, England.	joeldunning@doctors.org.uk					Alonso Leonardo L., 1995, Journal of Emergency Medicine, V13, P297, DOI 10.1016/0736-4679(95)00006-V; Bachmann LM, 2003, BMJ-BRIT MED J, V326, P417, DOI 10.1136/bmj.326.7386.417; Breiman L., 1984, CLASSIFICATION REGRE; BUSUITO MJ, 1986, J TRAUMA, V26, P826, DOI 10.1097/00005373-198609000-00008; CHAYRA GA, 1986, J ORAL MAXIL SURG, V44, P677, DOI 10.1016/0278-2391(86)90034-0; Dart RG, 1999, ANN EMERG MED, V33, P283, DOI 10.1016/S0196-0644(99)70364-1; DIMITROULIS G, 1990, BR DENT J, V170, P300; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P120, DOI 10.1016/0030-4220(85)90002-7; Heyworth J, 2003, BRIT MED J, V326, P405, DOI 10.1136/bmj.326.7386.405; JAMES RB, 1981, J ORAL SURG, V39, P275; JOHNSTON CC, 1980, ANN EMERG MED, V9, P415, DOI 10.1016/S0196-0644(80)80154-5; LANGDON JD, 1982, BRIT J HOSP MED, V28, P589; MOILANEN A, 1982, INT J ORAL MAXILLOF, V11, P299, DOI 10.1016/S0300-9785(82)80029-X; OLSON RA, 1982, J ORAL MAXIL SURG, V40, P23, DOI 10.1016/S0278-2391(82)80011-6; Schwab RA, 1998, AM J EMERG MED, V16, P304, DOI 10.1016/S0735-6757(98)90108-5; STEINBERG D, 1997, CART CLASSIFICATION; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; VETTER JD, 1991, INT J ORAL MAX SURG, V20, P214, DOI 10.1016/S0901-5027(05)80177-8; WILLIAMS J, 1992, ANN EMERG MED, V21, P719, DOI 10.1016/S0196-0644(05)82786-6	20	7	8	0	0	ROYAL COLL SURGEONS ENGLAND	LONDON	35-43 LINCOLN'S INN FIELDS, LONDON WC2A 3PN, ENGLAND	0035-8843	1478-7083		ANN ROY COLL SURG	Ann. R. Coll. Surg. Engl.	JUL	2005	87	4					259	263		10.1308/1478708051810			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	951JO	WOS:000230926500010	16053686	Green Published			2022-02-06	
J	Donders, J; Giroux, A				Donders, J; Giroux, A			Discrepancies between the California Verbal Learning Test: Children's Version and the Children's Category Test after pediatric traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						children; TBI; learning; problem solving	EXECUTIVE FUNCTION; HEAD-INJURY; WISC-III; PERFORMANCE; COMPONENTS; FREQUENCY; TERM	One hundred 9-16-year-old children with traumatic brain injury (TBI) completed the California Verbal Learning Test-Children's Version (CVLT-C) and the Children's Category Test (CCT) within I year after injury. Performance contrasts between these two instruments that were unusually large (> 16 T score points) were about as common in this clinical sample as in the standardization sample of both instruments. However, relatively poor performance on the CVLT-C as compared to the CCT was associated with prolonged coma and lower scores on the Processing Speed index of the Wechsler Intelligence Scale for Children-Third Edition. It is concluded that a relative weakness on the CVLT-C is more likely to reflect cerebral compromise after pediatric TBI than is a relative weakness on the CCT.	Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; Hope Coll, Holland, MI 49423 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					BOLL T, 1993, CHILDRENS CATEGORY T; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Delis DC., 1994, CALIFORNIA VERBAL LE; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 1998, J INT NEUROPSYCH SOC, V4, P242, DOI 10.1017/S1355617798002422; DONDERS J, 1998, HDB PEDIAT PSYCHOL P, V2, P155; Harrell FE Jr, 2017, REGRESSION MODELING; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; Kramer JH, 1997, NEUROPSYCHOLOGY, V11, P577, DOI 10.1037/0894-4105.11.4.577; Levin HS, 2000, J CLIN EXP NEUROPSYC, V22, P1, DOI 10.1076/1380-3395(200002)22:1;1-8;FT001; Lowther JL, 2004, ARCH CLIN NEUROPSYCH, V19, P105, DOI 10.1016/S0887-6177(02)00222-6; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Millis SR, 2003, CHILD NEUROPSYCHOL, V9, P221, DOI 10.1076/chin.9.3.221.16455; Nesbit-Greene K, 2002, J CLIN EXP NEUROPSYC, V24, P194, DOI 10.1076/jcen.24.2.194.996; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Schinka JA, 1998, PSYCHOL ASSESSMENT, V10, P171, DOI 10.1037/1040-3590.10.2.171; Shum D, 2000, BRAIN COGNITION, V44, P59; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	27	7	7	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2005	11	4					386	391		10.1017/S1355617705050435			6	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	948UY	WOS:000230742400005	16209418				2022-02-06	
J	Loh, EWL; Goozee, JV; Murdoch, BE				Loh, EWL; Goozee, JV; Murdoch, BE			Kinematic analysis of jaw function in children following traumatic brain injury	BRAIN INJURY			English	Article						jaw; kinematics; speech; children; traumatic brain injury	SPEECH MOTOR CONTROL; MOVEMENTS; ADULTS; LIP; VARIABILITY; ADOLESCENTS; CHILDHOOD; FORCE	Primary objective: To investigate jaw movements in children following traumatic brain injury (TBI) during speech using electromagnetic articulography (EMA). Methods and procedures: Jaw movements of two non-dysarthric children ( aged 12.75 and 13.08 years) who had sustained a TBI were recorded using the AG-100 EMA system (Carstens Medizineletronik) during word-initial consonant productions. Mean quantitative kinematic parameters and coefficient of variation ( variability) values were calculated and individually compared to the mean values obtained by a group of six control children ( mean age 12.57 years, SD 1.52). Main outcomes and results: The two children with TBI exhibited word-initial consonant jaw movement durations that were comparable to the control children, with sub-clinical reductions in speed being offset by reduced distances. Differences were observed between the two children in jaw kinematic variability, with one child exhibiting increased variability, while the other child demonstrated reduced or comparable variability compared to the control group. Conclusions: Possible sub-clinical impairments of jaw movement for speech were exhibited by two children who had sustained a TBI, providing insight into the consequences of TBI on speech motor control development.	Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia		Goozee, JV (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia.	j.goozee@uq.edu.au	Murdoch, Bruce E/C-1397-2012				ACKERMANN H, 1995, FOLIA PHONIATR LOGO, V47, P15, DOI 10.1159/000266338; Brown J.R., 1975, MOTOR SPEECH DISORDE; BRUNER JS, 1973, CHILD DEV, V44, P1; Cahill LM, 2002, BRAIN INJURY, V16, P415, DOI 10.1080/02699050110119871; Cahill LM, 2000, J MED SPEECH-LANG PA, V8, P347; CAHILL LM, 2001, TRAUMATIC BRAIN INJU, P121; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; Conwit RA, 1999, CLIN NEUROPHYSIOL, V110, P1270, DOI 10.1016/S1388-2457(99)00054-1; Eguchi S, 1969, Acta Otolaryngol Suppl, V257, P1; Enderby P, 1983, FRENCHAY DYSARTHRIA; FISHER H, 1971, FISHERLOGEMANN TEST; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; Green JR, 2002, J SPEECH LANG HEAR R, V45, P66, DOI 10.1044/1092-4388(2002/005); Hayden D A, 1994, Clin Commun Disord, V4, P162; HINTON VA, 1992, J SPEECH HEAR RES, V35, P245, DOI 10.1044/jshr.3502.245; Kelso JS, 1995, DYNAMIC PATTERNS SEL; KENT RD, 1980, J PHONETICS, V8, P157, DOI 10.1016/S0095-4470(19)31460-3; KENT RD, 1976, J SPEECH HEAR RES, V19, P420; KUEHN DP, 1980, J ACOUST SOC AM, V67, P1825, DOI 10.1121/1.384264; MCHENRY MA, 1994, J SPEECH HEAR RES, V37, P1271, DOI 10.1044/jshr.3706.1271; MUNHALL KG, 1989, ACQUIRED APRAXIA SPE, P64; Murdoch BE, 2003, BRAIN INJURY, V17, P79, DOI 10.1080/0269905021000010203; MURODCH BE, 1990, ACQUIRED SPEECH LANG; NITTROUER S, 1993, J SPEECH HEAR RES, V36, P959, DOI 10.1044/jshr.3605.959; RUSIEWICZ HL, 2002, AM SPEECH LANG HEAR; Schmidt RA., 1991, MOTOR LEARNING PERFO; SHARKEY SG, 1985, J SPEECH HEAR RES, V28, P8, DOI 10.1044/jshr.2801.08; Smith A, 1998, J SPEECH LANG HEAR R, V41, P18, DOI 10.1044/jslhr.4101.18; Stierwalt JAG, 1996, DISORDERS MOTOR SPEE, P241; Theodoros D G, 1998, Pediatr Rehabil, V2, P107; THOMPSON EC, 1997, J MED SPEECH-LANG PA, V5, P191; TINGLEY BM, 1975, CHILD DEV, V46, P186; van Lieshout PHHM, 2002, J SPEECH LANG HEAR R, V45, P5, DOI 10.1044/1092-4388(2002/001); WALKER JF, 1992, J SPEECH HEAR RES, V35, P4, DOI 10.1044/jshr.3501.04; Walsh B, 2002, J SPEECH LANG HEAR R, V45, P1119, DOI 10.1044/1092-4388(2002/090); WEISS CE, 1978, WEISS COMPREHENSIVE; [No title captured]	37	7	7	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2005	19	7					529	538		10.1080/02699050400025083			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	933IQ	WOS:000229622500007	16136690				2022-02-06	
J	Ries, M; Marks, W				Ries, M; Marks, W			Selective attention deficits following severe closed head injury: The role of inhibitory processes	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; closed head injury; attention; inhibition; negative priming	MEMORY; MECHANISMS; IMPLICIT; REPETITION; AMNESIA; TASKS	Heightened distractibility following severe closed head injury (sCHI) may result from a deficit in selective attention. The integrity of inhibitory processes involved in selective attention was assessed through use of a negative priming paradigm, allowing dissociation of inhibitory and episodic retrieval processes. In this task, inhibitory processes are elicited under intact stimulus conditions, whereas episodic retrieval is elicited when target stimuli are degraded. Despite inconsistent evidence of inhibitory deficits following sCHI in the literature, long-term survivors of sCHI showed no negative priming under intact stimulus conditions, providing evidence of compromised inhibitory processing. The sCHI participants' demonstration of negative priming when target stimuli were degraded provides evidence that automatic retrieval processes are intact following sCHI, results that are consistent with prior findings.	Univ Memphis, Dept Psychol, Memphis, TN 38152 USA		Ries, M (corresponding author), Univ Wisconsin, Sch Med, Vet Adm Hosp, Geriatr Res Educ & Clin Ctr 11G, 2500 Overlook Terrace, Madison, WI 53705 USA.	mlr@medicine.wisc.edu					BEGG I, 1987, J EXP PSYCHOL LEARN, V13, P553, DOI 10.1037/0278-7393.13.4.553; BROWN AS, 1991, J EXP PSYCHOL LEARN, V17, P514, DOI 10.1037/0278-7393.17.3.514; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; ENGLE RW, 1995, PSYCHOL SCI, V6, P122, DOI 10.1111/j.1467-9280.1995.tb00318.x; HASHER L, 1991, J EXP PSYCHOL LEARN, V17, P163, DOI 10.1037/0278-7393.17.1.163; HUNT RR, 1980, J EXP PSYCHOL GEN, V109, P49, DOI 10.1037/0096-3445.109.1.49; Kane MJ, 1997, J EXP PSYCHOL HUMAN, V23, P632, DOI 10.1037/0096-1523.23.3.632; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MATESANZ R, 1996, TRANSPLANT NEWSLETTE, V1, P1; MAY CP, 1995, PSYCHOL BULL, V118, P35, DOI 10.1037/0033-2909.118.1.35; MCDANIEL MA, 1986, J EXP PSYCHOL LEARN, V12, P54, DOI 10.1037/0278-7393.12.1.54; McDowall J, 1996, NEW ZEAL J PSYCHOL, V25, P2; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MCNAMARA TP, 2003, HDB PSYCHOL EXPT PSY, P447; Neely J., 1991, BASIC PROCESSES READ; NEILL WT, 1992, J EXP PSYCHOL LEARN, V18, P993, DOI 10.1037/0278-7393.18.5.993; NEILL WT, 1977, J EXP PSYCHOL HUMAN, V3, P444, DOI 10.1037/0096-1523.3.3.444; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; Pashler H.E., 1999, PSYCHOL ATTENTION; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SCHMITTEREDGECO.ME, 1992, J CLIN EXP NEUROPSYC, V14, P728; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; Simpson A, 2000, NEUROPSYCHOLOGY, V14, P310, DOI 10.1037//0894-4105.14.2.310; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Stuss DT, 1999, NEUROPSYCHOLOGIA, V37, P1005, DOI 10.1016/S0028-3932(98)00158-4; TIPPER SP, 1989, J EXP CHILD PSYCHOL, V48, P353, DOI 10.1016/0022-0965(89)90047-7; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P591, DOI 10.1080/14640748508400921; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Vakil E, 1996, NEUROPSY NEUROPSY BE, V9, P171; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; WHITTLESEA BWA, 1990, J MEM LANG, V29, P546, DOI 10.1016/0749-596X(90)90051-Z; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Whyte J, 1998, J INT NEUROPSYCH SOC, V4, P127, DOI 10.1017/S1355617798001271; [No title captured]	38	7	7	0	6	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2005	19	4					476	483		10.1037/0894-4105.19.4.476			8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	951BC	WOS:000230902800008	16060822				2022-02-06	
J	Schlosser, HG; Unterberg, A; Clarke, A				Schlosser, HG; Unterberg, A; Clarke, A			Using video-oculography for galvanic evoked vestibulo-ocular monitoring in comatose patients	JOURNAL OF NEUROSCIENCE METHODS			English	Article						galvanic stimulation; vestibulo-ocular monitoring; video-oculography; eye tracker; post-traumatic injury; prognosis; outcome; neuromonitoring; comatose patients; severe brain injury; eye movements; brain death; brainstern monitoring	STIMULATION; REFLEX	Binocular eye movement responses to galvanic vestibular stimulation were measured in comatose patients. Healthy persons have been demonstrated to show a consistent and reproducible relationship between eye movement and galvanic vestibular stimulation. Any pathology of the vestibular integrating structures (brainstem and to some degree the cerebellum and cortex) is assumed to influence this response pathognomonically. A monitoring facility was designed to record eye movements during galvanic labyrinth polarization (GaLa) in order to examine the vestibular response in comatose patients. GaLa was applied by means of two pairs of electrodes attached between the mastoid and interscapular region. A custom-built, battery-driven current-source stimulator served to generate sinusoidal stimuli that could be applied either unilaterally or simultaneously and independently to the left and right labyrinths. The resultant binocular eye movements were recorded using a Chronos Eye Tracker and the digital image sequences stored for subsequent analysis. Repeated testing was performed in five comatose patients with a Glasgow Coma Score of 3, who were intubated and ventilated (subarachnoid hemorrhage (n = 3), traumatic injury (it = 2)). The observed ocular movements varied. In four cases ocular movements in response to GaLa were observed, while one patient showed neither spontaneous nor galvanic-induced eye movements. The latter was diagnosed as brain-dead 2 days after testing. In contrast, the patients who showed ocular movements synchronous with galvanic stimulation left the intensive care unit (ICU) for rehabilitation. These data indicate that it is possible to assess brain function in comatose patients by evaluating the vestibulo-ocular response to galvanic stimulation. The designed monitoring facility can be used on the ICU ward without disconnection of other monitoring equipment. (c) 2004 Elsevier B.V. All rights reserved.	Univ Med Berlin, Dept Neurosurg, Charite Campus Virchow Clin, Berlin, Germany; Univ Heidelberg, Med Ctr, Dept Neurosurg, Heidelberg, Germany; Univ Med Berlin, Vestibular Res Lab, Berlin, Germany		Schlosser, HG (corresponding author), Univ Med Berlin, Dept Neurosurg, Charite Campus Virchow Clin, Berlin, Germany.	hans-georg.schlosser@charite.de					Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Buettner U W, 1992, Baillieres Clin Neurol, V1, P289; BUETTNER UW, 1989, ARCH NEUROL-CHICAGO, V46, P561, DOI 10.1001/archneur.1989.00520410095030; Clarke AH, 2002, BEHAV RES METH INS C, V34, P549, DOI 10.3758/BF03195484; GRUESSER O-J, 1990, Journal of Physiology (Cambridge), V430, P537; JENNETT B, 1975, LANCET, V1, P480; MUELLERJENSEN A, 1987, J NEUROL NEUROSUR PS, V50, P389, DOI 10.1136/jnnp.50.4.389; Quarck G, 1998, NEUROPHYSIOL CLIN, V28, P413, DOI 10.1016/S0987-7053(99)80025-2; Schlosser HG, 2001, NEUROREPORT, V12, P1443, DOI 10.1097/00001756-200105250-00029; SCHLOSSER HG, 1999, REAKTION ENZELNER NE, P44; TOGLIA JU, 1981, ANN NEUROL, V9, P294, DOI 10.1002/ana.410090314	11	7	7	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	JUN 30	2005	145	1-2					127	131		10.1016/j.jneumeth.2004.12.004			5	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	936OY	WOS:000229866500011	15922031				2022-02-06	
J	Mussack, T; Huber, SM; Ladurner, R; Hummel, T; Mutschler, W				Mussack, T; Huber, SM; Ladurner, R; Hummel, T; Mutschler, W			Bilateral decompressive craniectomy due to intracranial hypertension during acute posttraumatic liver dysfunction	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						cerebral edema; intracranial hypertension; bilateral decompressive craniectomy; acute liver dysfunction; liver trauma	TRAUMATIC BRAIN-INJURY; CEREBRAL EDEMA; THERAPEUTIC HYPOTHERMIA; MANAGEMENT; FAILURE; HYPERVENTILATION; PRESSURE; TRIAL; CARE		Klinikum Univ Munchen, Dept Surg Innenstadt, D-80336 Munich, Germany		Mussack, T (corresponding author), Klinikum Univ Munchen, Dept Surg Innenstadt, Nussbaumstr 20, D-80336 Munich, Germany.	Tlomas.Mussack@med.uni-muenchen.de					Bagley RS, 1996, AM J VET RES, V57, P116; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CANALESE J, 1982, GUT, V23, P625, DOI 10.1136/gut.23.7.625; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; EDE RJ, 1986, J HEPATOL, V2, P43, DOI 10.1016/S0168-8278(86)80007-1; FORBES A, 1989, HEPATOLOGY, V10, P306, DOI 10.1002/hep.1840100309; GAAB MR, 1990, ACT NEUR S, V51, P326; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Harbrecht BG, 2001, AM SURGEON, V67, P122; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; Jalan R, 2002, METAB BRAIN DIS, V17, P437, DOI 10.1023/A:1021930506853; Jalan R, 2003, SEMIN LIVER DIS, V23, P271; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; Jalan R, 2001, HEPATOLOGY, V34, P50, DOI 10.1053/jhep.2001.25386; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; OGRADY JG, 1993, LANCET, V342, P273; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Plevris JN, 1998, ALIMENT PHARM THERAP, V12, P405; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Rahman T, 2001, INTENS CARE MED, V27, P467, DOI 10.1007/s001340100873; Regel G, 1996, WORLD J SURG, V20, P422, DOI 10.1007/s002689900067; Rise IR, 1998, J NEUROSURG, V89, P454, DOI 10.3171/jns.1998.89.3.0454; ROHRER MJ, 1992, CRIT CARE MED, V20, P1402, DOI 10.1097/00003246-199210000-00007; Schiodt FV, 1999, LIVER TRANSPLANT SUR, V5, P29, DOI 10.1002/lt.500050102; Schneider GH, 2002, ACT NEUR S, V81, P77; Strauss GI, 2001, GASTROENTEROLOGY, V121, P1109, DOI 10.1053/gast.2001.29310; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P537; WENDON JA, 1992, HEPATOLOGY, V15, P1067, DOI 10.1002/hep.1840150616; WILLIAMS R, 1991, DIGEST DIS SCI, V36, P820, DOI 10.1007/BF01311243	37	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2005	58	5					1061	1065		10.1097/01.TA.0000171989.63817.8c			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	932PU	WOS:000229566600037	15920425				2022-02-06	
J	Saad, DF; Crawford, GI; Wulkan, ML				Saad, DF; Crawford, GI; Wulkan, ML			Cerebral venous thrombosis after closed head injury in a child	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article									Emory Univ, Div Pediat Surg, Sch Med, Atlanta, GA 30322 USA; Grady Mem Hosp, Dept Surg, Atlanta, GA USA		Wulkan, ML (corresponding author), Emory Univ, Div Pediat Surg, Sch Med, 2015 Uppergate Dr,NE, Atlanta, GA 30322 USA.	mark.wulkan@oz.ped.emory.edu						0	7	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2005	58	5					1066	1067		10.1097/01.TA.0000162726.74081.F3			2	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	932PU	WOS:000229566600038	15920426				2022-02-06	
J	Glenn, MB; Wroblewski, B				Glenn, MB; Wroblewski, B			Twenty years of pharmacology	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anticonvulsants; antidepressants; antipsychotic drugs; antispasticity drugs; pharmacology; traumatic brain injury	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED-TRIAL; DOUBLE-BLIND; BOTULINUM TOXIN; ATYPICAL ANTIPSYCHOTICS; POSTTRAUMATIC SEIZURES; INTRATHECAL BACLOFEN; BEHAVIORAL SYMPTOMS; ALZHEIMERS-DISEASE	During the past 20 years in pharmacology, a number of innovations have appeared that have resulted in significant changes in the drugs available for people with traumatic brain injury. Among the anticonvulsants, antidepressants, and antipsychotics, new drugs have appeared with fewer cognitive side effects. In these classes of drugs, as well as among central nervous system stimulants, once-daily or other sustained-release preparations have been introduced that make it considerably more likely that the patient will take his or her medication, with smaller fluctuations in drug levels as well. New drugs have also resulted in a greater number of medications for the clinician to choose from. The overall effect has been a dramatic change in pharmacology that has benefited people with traumatic brain injury.	Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA 02114 USA; Harvard Univ, Spaulding Rehabil Hosp, Outpatient Program, Boston, MA 02114 USA; Harvard Univ, Spaulding Rehabil Hosp, Community Brain Injury Rehabil Program, Boston, MA 02114 USA; NeighborCare, Woburn, MA USA		Glenn, MB (corresponding author), Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA 02114 USA.	mglenn@partners.com					Agosti RM, 1996, J HEAD TRAUMA REHAB, V11, P100, DOI 10.1097/00001199-199608000-00016; Banovac K, 2000, J Spinal Cord Med, V23, P40; Bergin AM, 2002, NEUROL CLIN, V20, P1163; Blount PJ, 2002, J HEAD TRAUMA REHAB, V17, P314, DOI 10.1097/00001199-200208000-00005; BORGSTEIN J, 1993, J HEAD TRAUMA REHAB, V8, P103; Brashear A, 2004, ARCH PHYS MED REHAB, V85, P705, DOI 10.1016/j.apmr.2003.08.077; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Burke WJ, 2002, J CLIN PSYCHIAT, V63, P331, DOI 10.4088/JCP.v63n0410; CARDENAS DD, 1987, J HEAD TRAUMA REHAB, V2, P43; Casey DE, 2004, J CLIN PSYCHIAT, V65, P4; CASSIDY JW, 1994, J HEAD TRAUMA REHAB, V9, P43, DOI 10.1097/00001199-199409000-00005; CASSIDY JW, 1991, J HEAD TRAUMA REHAB, V6, P81; Coffey RJ, 2002, ARCH PHYS MED REHAB, V83, P735, DOI 10.1053/apmr.2002.32820; COWELL LC, 1995, J HEAD TRAUMA REHAB, V10, P91, DOI 10.1097/00001199-199512000-00018; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; De Deyn PP, 1999, NEUROLOGY, V53, P946, DOI 10.1212/WNL.53.5.946; Elovic E, 1996, J HEAD TRAUMA REHAB, V11, P89, DOI 10.1097/00001199-199606000-00013; Elovic E, 2000, J HEAD TRAUMA REHAB, V15, P1068, DOI 10.1097/00001199-200008000-00009; Elovic EP, 2003, J HEAD TRAUMA REHAB, V18, P177, DOI 10.1097/00001199-200303000-00008; Elovic EP, 2001, J HEAD TRAUMA REHAB, V16, P603, DOI 10.1097/00001199-200112000-00008; Glendinning C., 1991, DISABILITY HANDICAP, V6, P3; Glenn MB, 1996, J HEAD TRAUMA REHAB, V11, P96, DOI 10.1097/00001199-199604000-00009; Glenn MB, 1997, J HEAD TRAUMA REHAB, V12, P40, DOI 10.1097/00001199-199712000-00005; GLENN MB, 1993, J HEAD TRAUMA REHAB, V8, P97; GLENN MB, 1986, J HEAD TRAUMA REHAB, V1, P73; GLENN MB, 1986, J HEAD TRAUMA REHAB, V1, P72; GLENN MB, 1989, J HEAD TRAUMA REHAB, V4, P85; Goldstein BJ, 1998, J PSYCHOPHARMACOL, V12, pS55, DOI 10.1177/0269881198012003041; Gorman JM, 1999, J CLIN PSYCHIAT, V60, P9; Herrmann N, 2004, AM J PSYCHIAT, V161, P1113, DOI 10.1176/appi.ajp.161.6.1113; Hoch DB, 2003, J HEAD TRAUMA REHAB, V18, P383, DOI 10.1097/00001199-200307000-00009; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; JOSEPH AB, 1995, J HEAD TRAUMA REHAB, V10, P90, DOI 10.1097/00001199-199504000-00010; Kaplan MS, 1997, J HEAD TRAUMA REHAB, V12, P93, DOI 10.1097/00001199-199710000-00009; Katz IR, 1999, J CLIN PSYCHIAT, V60, P107, DOI 10.4088/JCP.v60n0207; Lexell J, 2003, J HEAD TRAUMA REHAB, V18, P196, DOI 10.1097/00001199-200303000-00009; Lindenmayer JP, 2000, J CLIN PSYCHIAT, V61, P123, DOI 10.4088/JCP.v61n0207; Marshall JWB, 2003, BRAIN RES, V972, P119, DOI 10.1016/S0006-8993(03)02511-3; Martin R, 1999, NEUROLOGY, V52, P321, DOI 10.1212/WNL.52.2.321; McDowell SK, 1996, J HEAD TRAUMA REHAB, V11, P89, DOI 10.1097/00001199-199612000-00011; MCEVOY K, 2003, AHFS DRUG INFORMATIO, P2313; MCEVOY K, 2003, AHFS DRUG INFORMATIO, P2154; MCEVOY K, 2003, AHFS DRUG INFORMATIO, P2414; Meythaler JM, 1997, J HEAD TRAUMA REHAB, V12, P87, DOI 10.1097/00001199-199702000-00012; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Mintzer J, 2001, INT J GERIATR PSYCH, V16, pS71, DOI 10.1002/1099-1166(200112)16:1+<::AID-GPS568>3.0.CO;2-M; Pigott TA, 2003, J CLIN PSYCHIAT, V64, P1048, DOI 10.4088/JCP.v64n0910; Quitkin FM, 2001, J CLIN PSYCHIAT, V62, P358, DOI 10.4088/JCP.v62n0509; *RISP, 2003, RISP RISP PRESCR INF; *SERZ, 2002, SERZ PRESCR INF; Solomon PR, 2002, JAMA-J AM MED ASSOC, V288, P835, DOI 10.1001/jama.288.7.835; Street JS, 2000, ARCH GEN PSYCHIAT, V57, P968, DOI 10.1001/archpsyc.57.10.968; Tariot PN, 2000, CLIN THER, V22, P1068, DOI 10.1016/S0149-2918(00)80085-5; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Thase ME, 1998, J CLIN PSYCHIAT, V59, P502, DOI 10.4088/JCP.v59n1002; Thaxton L, 2002, J HEAD TRAUMA REHAB, V17, P335, DOI 10.1097/00001199-200208000-00007; Wallen MA, 2004, ARCH PHYS MED REHAB, V85, P192, DOI 10.1016/j.apmr.2003.05.008; *WELLB, 2002, WELLB PRESCR INF; Wernicke JF, 2002, J CLIN PSYCHIAT, V63, P50; Whitlock JA, 1999, J HEAD TRAUMA REHAB, V14, P424, DOI 10.1097/00001199-199908000-00010; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Zafonte RD, 2001, J HEAD TRAUMA REHAB, V16, P519, DOI 10.1097/00001199-200110000-00012; ZASLER ND, 1995, J HEAD TRAUMA REHAB, V10, P101, DOI 10.1097/00001199-199508000-00010; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; ZIPR, 2001, ZIPR GEOD PRESCR INF; 2003, MED LETT, V45, P11	68	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2005	20	1					51	61		10.1097/00001199-200501000-00006			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	894AT	WOS:000226762900005	15668570				2022-02-06	
J	Hein, G; Schubert, T; von Cramon, DY				Hein, G; Schubert, T; von Cramon, DY			Closed head injury and perceptual processing in dual-task situations	EXPERIMENTAL BRAIN RESEARCH			English	Article						closed-head injury; Parkinson's disease; psychological refractory period paradigm; perceptual processing; cross modal interference	TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; PARKINSONS-DISEASE; ATTENTIONAL CONTROL; PREFRONTAL CORTEX; VISUAL ONSETS; PERFORMANCE; INTERFERENCE; DEFICITS; DISTRACTIBILITY	Using a classical psychological refractory period (PRP) paradigm we investigated whether increased interference between dual-task input processes is one possible source of dual-task deficits in patients with closed-head injury (CHI). Patients and age-matched controls were asked to give speeded motor reactions to an auditory and a visual stimulus. The perceptual difficulty of the visual stimulus was manipulated by varying its intensity. The results of Experiment 1 showed that CHI patients suffer from increased interference between dual-task input processes, which is related to the salience of the visual stimulus. A second experiment indicated that this input interference may be specific to brain damage following CHI. It is not evident in other groups of neurological patients like Parkinson's disease patients. We conclude that the non-interfering processing of input stages in dual-tasks requires cognitive control. A decline in the control of input processes should be considered as one source of dual-task deficits in CHI patients.	MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England; Humboldt Univ, Dept Psychol, D-12489 Berlin, Germany; Univ Leipzig, Day Clin Cognit Neurol, D-04103 Leipzig, Germany		Hein, G (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 2EF, England.	grit.hein@mrc-cbu.cam.ac.uk		Schubert, Torsten/0000-0002-6514-6145			Arnell KM, 1999, J EXP PSYCHOL HUMAN, V25, P630, DOI 10.1037/0096-1523.25.3.630; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; BENECKE R, 1986, BRAIN, V109, P739, DOI 10.1093/brain/109.4.739; Brass M, 2003, NEUROPSYCHOLOGY, V17, P265, DOI 10.1037/0894-4105.17.2.265; BROWN RG, 1990, TRENDS NEUROSCI, V13, P21, DOI 10.1016/0166-2236(90)90058-I; DALRYMPLEALFORD JC, 1994, J NEUROL NEUROSUR PS, V57, P360, DOI 10.1136/jnnp.57.3.360; DEJONG R, 1993, J EXP PSYCHOL HUMAN, V19, P965, DOI 10.1037/0096-1523.19.5.965; Dell'Acqua R, 2003, EXP BRAIN RES, V152, P29, DOI 10.1007/s00221-003-1512-7; Dell'Acqua R, 2001, EXP BRAIN RES, V136, P364, DOI 10.1007/s002210000586; Donk M, 2001, PERCEPT PSYCHOPHYS, V63, P891, DOI 10.3758/BF03194445; Fahn S., 1987, RECENT DEV PARKINSON, V153 163, P293, DOI DOI 10.2490/JJRMC.47.791; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fournet N, 1996, J NEUROL NEUROSUR PS, V60, P313, DOI 10.1136/jnnp.60.3.313; Gellatly A, 1999, J EXP PSYCHOL HUMAN, V25, P1609, DOI 10.1037/0096-1523.25.6.1609; HEIN G, 2004, IN PRESS PSYCHOL AGI; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HORSTINK MWIM, 1990, J NEUROL NEUROSUR PS, V53, P685, DOI 10.1136/jnnp.53.8.685; Hsieh S, 2000, PERCEPT MOTOR SKILL, V91, P893, DOI 10.2466/PMS.91.7.893-902; Jahanshahi M, 2000, NEUROIMAGE, V12, P713, DOI 10.1006/nimg.2000.0647; Jolicoeur P, 1999, PSYCHON B REV, V6, P87, DOI 10.3758/BF03210813; Kaipio ML, 1999, NEUROREPORT, V10, P2125, DOI 10.1097/00001756-199907130-00024; Kaipio ML, 2000, NEUROREPORT, V11, P1463; Kim MS, 1999, PERCEPT PSYCHOPHYS, V61, P1009, DOI 10.3758/BF03207609; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Lewis SJG, 2003, NEUROPSYCHOLOGIA, V41, P645, DOI 10.1016/S0028-3932(02)00257-9; Luck SJ, 1998, PSYCHOL SCI, V9, P223, DOI 10.1111/1467-9280.00043; MALAPANI C, 1994, NEUROLOGY, V44, P319, DOI 10.1212/WNL.44.2.319; MCCANN RS, 1992, J EXP PSYCHOL HUMAN, V18, P471, DOI 10.1037/0096-1523.18.2.471; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; MILLER J, 1989, PERCEPT PSYCHOPHYS, V45, P567, DOI 10.3758/BF03208064; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; PASHLER H, 1989, Q J EXP PSYCHOL-A, V41, P19, DOI 10.1080/14640748908402351; Pollux PMJ, 2002, J CLIN EXP NEUROPSYC, V24, P1046, DOI 10.1076/jcen.24.8.1046.8374; Polo MD, 2002, NEUROPSYCHOLOGIA, V40, P2350, DOI 10.1016/S0028-3932(02)00127-6; Richardson JTE., 2000, CLIN NEUROPSYCHOLOGI; Robertson C, 1996, NEUROPSYCHOLOGIA, V34, P1069, DOI 10.1016/0028-3932(96)00031-0; Saint-Cyr JA, 2002, J NEUROSURG, V97, P1152, DOI 10.3171/jns.2002.97.5.1152; Schubert T, 2003, COGNITIVE BRAIN RES, V17, P733, DOI 10.1016/S0926-6410(03)00198-8; Schubert T., 1999, J EXPT PSYCHOL HUMAN, V25, P1; SCHWEICKERT R, 1983, J EXP PSYCHOL LEARN, V9, P353, DOI 10.1037/0278-7393.9.3.353; Solbakk AK, 1999, PSYCHOPHYSIOLOGY, V36, P802; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V49, P83, DOI 10.3758/BF03211619; THEEUWES J, 1994, PERCEPTION, V23, P429, DOI 10.1068/p230429; Werheid K, 2002, ARCH CLIN NEUROPSYCH, V17, P547, DOI 10.1016/S0887-6177(01)00134-2; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013; Wrightson P, 1999, MILD HEAD INJURY GUI; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P812, DOI 10.1037/0096-1523.16.4.812; YANTIS S, 1993, J EXP PSYCHOL HUMAN, V19, P676, DOI 10.1037/0096-1523.19.3.676	54	7	7	0	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	JAN	2005	160	2					223	234		10.1007/s00221-004-2006-y			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	876CE	WOS:000225472500009	15338087				2022-02-06	
J	McCaffrey, RJ; Yantz, CL				McCaffrey, RJ; Yantz, CL			"Cognitive Impairment Associated with Toxigenic Fungal Exposure": A critique and critical analysis	APPLIED NEUROPSYCHOLOGY			English	Article						Daubert; toxic tort; mold	INDOOR MOLD; HEAD-INJURY; STACHYBOTRYS	Recently Gordon et al. (2004) reported the results of a study relating exposure to toxigenic fungi to cognitive impairment. A number of methodological problems limit the utility of this study, including the authors' not examining a number of potential confounding variables, use of a mild traumatic brain injury group as a comparison, and problematic statistical analyses increasing the Type I error rate. Based on these limitations, the authors' conclusion that mold-exposed people have more cognitive and physical symptoms than normal controls is questionable at best. This critique describes some of the problems with the methodology employed and the related difficulty in drawing conclusions from their work.	SUNY Albany, Dept Psychol Social Sci, Albany, NY 12222 USA		McCaffrey, RJ (corresponding author), SUNY Albany, Dept Psychol Social Sci, 1400 Washington Ave, Albany, NY 12222 USA.	rm188@albany.edu					Aaron LA, 2001, ANN INTERN MED, V134, P868, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00011; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Gordon WA, 2004, APPL NEUROPSYCHOL, V11, P65, DOI 10.1207/s15324826an1102_1; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Greiffenstein MF, 2003, CLIN NEUROPSYCHOL, V17, P561, DOI 10.1076/clin.17.4.561.27937; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; IVERSON GL, 2001, J FORENSIC NEUROPSYC, V2, P19, DOI DOI 10.1300/J151v02n01_02; Iverson Grant L., 2005, Brain Injury, V19, P15; Kilburn KH, 2003, ARCH ENVIRON HEALTH, V58, P390; Kuhn DM, 2003, CLIN MICROBIOL REV, V16, P144, DOI 10.1128/CMR.16.1.144-172.2003; Lees-Haley PR, 2003, PSYCHOL REP, V93, P561, DOI 10.2466/PR0.93.6.561-584; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Reynolds CR, 1999, CLIN NEUROPSYCHOL, V13, P386, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT386; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Victor TL, 2004, PROF PSYCHOL-RES PR, V35, P373, DOI 10.1037/0735-7028.35.4.373; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594	21	7	7	0	1	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2005	12	3					134	137		10.1207/S15324826AN1203_2			4	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	965OR	WOS:000231960500002	16131339				2022-02-06	
J	Pittella, JEH; Gusmao, S				Pittella, JEH; Gusmao, S			Cleft cavum of the septum pellucidum in victims of fatal road traffic accidents: a distinct type of cavum associated with severe diffuse axonal injury	SURGICAL NEUROLOGY			English	Article						cavum of the septum pellucidum; head injury; road traffic accident; diffuse axonal injury	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; BOXERS; DAMAGE; VERGAE; HUMANS; MYELIN; SIGN	Background: The cavum Of the Septum pellucidum (CSP) is a small cavity constantly present in fetuses and newborns, of variable frequency among necropsied adults and with a high frequency in professional boxers. Method: A pathologic study was conducted on brains of 626 patients without a history of head trauma (group 1) autopsied consecutively from a general hospital and of 120 random victims of fatal road traffic accidents (group 2). Results: In group 1, 237 (37.9%) cases of CSP were observed, virtually all in a triangular or trapezoidal shape. In group 2, 65 (54.2%) cases of CSP were observed, 50 (76.9%) in triangular or trapezoidal shape and 15 (23.1%) in cleft shape. Cleft CSP was always associated with severe diffuse axonal injury (grades 2 and 3). Conclusion: Although described in boxers, the CSP has not been reported in other types of head injury. The largest frequency of CSP found in fatal victims of head trauma, particularly in patients with severe diffuse axonal lesion (grades 2 and 3), when compared with the individuals without a history of head trauma, suggests that the high-intensity angular acceleration of the head causes complementary and independent displacement of the 2 cerebral hemispheres and dislocation of one of the leaves of the septum pellucidum on the other. This could result in separation of the 2 leaves and formation of CSP, usually in cleft shape.	Univ Fed Minas Gerais, Sch Med, Dept Pathol & Forens Med, Lab Neuropathol, BR-30130100 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Sch Med, Dept Surg, BR-30130100 Belo Horizonte, MG, Brazil		Pittella, JEH (corresponding author), Rua Otoni 712-304, BR-30150270 Belo Horizonte, MG, Brazil.	pittella@medicina.ufmg.br	Pittella, Jose Eymard Homem/F-3191-2013	Pittella, Jose Eymard Homem/0000-0002-6244-9781			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; BOGDANOFF B, 1989, NEUROLOGY, V39, P991, DOI 10.1212/WNL.39.7.991; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CROMPTON R, 1971, LANCET, V3, P669; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; GRAHMANN H, 1957, PSYCHIAT NEUROL BASE, V30, P285; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; HUGHES RA, 1955, ARCH NEURO PSYCHIATR, V74, P259, DOI 10.1001/archneurpsyc.1955.02330150025004; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; KASTE M, 1982, LANCET, V2, P1186; LAMPERT PW, 1984, JAMA-J AM MED ASSOC, V251, P2676, DOI 10.1001/jama.251.20.2676; LARROCHE JC, 1961, BIOL NEONATORUM, V3, P193; MAWDSLEY C, 1963, LANCET, V2, P795; NEUBUERGER KT, 1959, ARCH NEURO PSYCHIATR, V81, P403, DOI 10.1001/archneurpsyc.1959.02340160001001; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OTERUELO FT, 1986, ANAT ANZEIGER, V162, P271; Pittella JEH, 2003, J FORENSIC SCI, V48, P626; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; RAKIC P, 1968, J COMP NEUROL, V132, P45, DOI 10.1002/cne.901320103; SHAW CM, 1969, BRAIN, V92, P213, DOI 10.1093/brain/92.1.213; SPILLANE J D, 1962, Br Med J, V2, P1205; STRICH SJ, 1968, J NEUROL NEUROSUR PS, V31, P110, DOI 10.1136/jnnp.31.2.110; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; Unterharnscheidt F, 1995, Rev Neurol, V23, P1027; VANWAGENEN WP, 1934, AM J CANCER, V20, P539; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52; [No title captured]	39	7	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.		2005	63			1			30	35		10.1016/j.surneu.2004.09.012			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	898FB	WOS:000227060500006					2022-02-06	
J	Shirhan, M; Moochhala, SM; Yang, KLS; Sng, J; Ng, KC; Mok, P; Lu, J				Shirhan, M; Moochhala, SM; Yang, KLS; Sng, J; Ng, KC; Mok, P; Lu, J			Preservation of neurological functions by nitric oxide synthase inhibitors in conscious rats following delayed hemorrhagic shock	LIFE SCIENCES			English	Article						iNOS inhibitor; behavior; constant volume pressure; irreversible hemorrhagic shock	TRAUMATIC BRAIN INJURY; CEREBRAL-ISCHEMIA; L-ARGININE; AMINOGUANIDINE; PATHOPHYSIOLOGY; CELLS	Excessive production of nitric oxide (NO) as result of inducible nitric oxide synthase (iNOS) induction has been implicated in the pathophysiology of hemorrhagic shock. Our aim was to study the effects of NOS inhibitors, aminoguanidine (AG) and N-G-nitro-L-arginine methyl ester (L-NAME), on survival rate, mean arterial blood pressure (MABP), temporal evolution of infarct volume, nitric oxide (NO) production and neurological deficit in a model of delayed hemorrhagic shock (DHS) in conscious rats. Our results showed that the NOS inhibitors significantly improved survival rate, MABP, and attenuated brain NO overproduction 24, 48 h and 72 h after DHS. AG reduced brain infarct volume and improved the neurological performance evaluated by the rotameric and grip strength tests while L-NAME did not show protective effect in rats following DHS. These findings suggest that NO formation via iNOS activation may contribute to organ damage and that the selective iNOS inhibitor, AG, may be of interest as a therapeutic agent for neurological recovery following DHS. (C) 2004 Elsevier Inc. All rights reserved.	DSO Natl labs, Def Med & Environm Res Inst, Singapore 117510, Singapore; Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore		Moochhala, SM (corresponding author), DSO Natl labs, Def Med Res Inst, 27 Med Dr,Level 12 Gen Off, Singapore 117510, Singapore.	nmiv19@nus.edu.sg		MOOCHHALA, SHABBIR/0000-0003-4521-3192			Bazzani C, 1997, LIFE SCI, V61, P1889, DOI 10.1016/S0024-3205(97)00828-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cash D, 2001, BRAIN RES, V905, P91, DOI 10.1016/S0006-8993(01)02508-2; CHI OZ, 1993, BRAIN RES, V630, P214; Cobbs CS, 1997, BRAIN RES, V751, P336, DOI 10.1016/S0006-8993(96)01429-1; DALKARA T, 1994, BRAIN PATHOL, V4, P49; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Higuchi Y, 1998, EUR J PHARMACOL, V342, P47, DOI 10.1016/S0014-2999(97)01524-0; Hua TC, 1999, SHOCK, V11, P51, DOI 10.1097/00024382-199901000-00008; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; JANIGRO D, 1994, CIRC RES, V75, P528, DOI 10.1161/01.RES.75.3.528; Kawase M, 1996, BRAIN RES, V738, P319, DOI 10.1016/S0006-8993(96)00924-9; Kline JA, 1999, SHOCK, V12, P454, DOI 10.1097/00024382-199912000-00007; KOBARI M, 1994, BRAIN RES, V667, P255, DOI 10.1016/0006-8993(94)91503-2; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; Liaudet L, 2000, CRIT CARE MED, V28, pN37, DOI 10.1097/00003246-200004001-00005; Lu PP, 1999, SHOCK, V12, P222, DOI 10.1097/00024382-199909000-00009; MONCADA S, 1991, PHARMACOL REV, V43, P109; Ng KC, 2003, NEUROPHARMACOLOGY, V44, P244, DOI 10.1016/S0028-3908(02)00368-4; SULLIVAN SJ, 1994, BRAIN INJURY, V8, P613, DOI 10.3109/02699059409151014; SZABO C, 1994, SHOCK, V2, P145, DOI 10.1097/00024382-199408000-00011; Szabo C, 1995, New Horiz, V3, P2; VIKTOROV IV, 2000, VESTNIK RAMN, V4, P5; Wei G, 1999, BBA-MOL BASIS DIS, V1455, P23, DOI 10.1016/S0925-4439(99)00051-4; Yao YM, 1996, AM J PHYSIOL-HEART C, V270, pH1616, DOI 10.1152/ajpheart.1996.270.5.H1616; Zhang FY, 1996, STROKE, V27, P317, DOI 10.1161/01.STR.27.2.317; Zingarelli B, 1997, EUR J PHARMACOL, V338, P55, DOI 10.1016/S0014-2999(97)01325-3	27	7	8	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	DEC 24	2004	76	6					661	670		10.1016/j.lfs.2004.07.015			10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	886YJ	WOS:000226268700006	15567191				2022-02-06	
J	Kover, F; Schwarcz, A; Pal, J; Bogner, P; Vajna, T; Vadon, G; Doczi, T				Kover, F; Schwarcz, A; Pal, J; Bogner, P; Vajna, T; Vadon, G; Doczi, T			Fast method for longitudinal relaxation time and water content mapping of the human brain on a clinical MR scanner	ACTA NEUROCHIRURGICA			English	Article						MRI; oedema; T-1; water content; quantification	IN-VIVO; MULTIPLE-SCLEROSIS; T1 VALUES; T-1; EDEMA; QUANTIFICATION; INVIVO; MODEL; FIELD; IRON	Background. Longitudinal relaxation time (T-1) map generation from human brain slices renders possible the in vivo follow-up of the changes in T-1 values during the course of several pathologies such as stroke, multiple sclerosis, traumatic brain injury etc. T-1 values can be converted to water contents, thus brain oedema reducing therapy can be non-invasively evaluated. The purpose of the study was to work out a fast and simple MRI method to obtain T-1 and water maps of the human brain. Method. The T-1 values of Gadolinium solutions with different concentrations were determined by means of MRI methods at a clinical MR scanner operating at 1 Tesla. In order to validate these measurements, T-1 values of the same Gadolinium solutions were also quantified with a relaxometer operating at the same field strength. T-1 and water maps from the brains of healthy volunteers were obtained with an inversion prepared spoiled gradient echo sequence (turbo-FLASH). Findings. The T-1 values of Gadolinium solutions measured with the relaxometer showed a strong correlation (r>0.999) with those determined with MRI sequences on the whole body scanner. The fastest MRI method to produce T-1 and consequent water maps from human brain was the inversion prepared turbo-FLASH sequence. Conclusions. The implemented turbo-FLASH method can produce T-1 and water map of a single virtual brain slice within 2 minutes. However, brain tissue containing haemorrhage should be excluded from the measurement due to the large influence of excessive haemoglobin concentration on longitudinal relaxation. The proposed method is available on most of the MR scanners, thus T-1 and water mapping of human brain can be routinely performed.	Univ Pecs, Dept Neurosurg, H-7624 Pecs, Hungary; Pecs Diagnost Inst, Pecs, Hungary; Hungarian Acad Sci, Neurosurg Res Grp, Pecs, Hungary; Univ Kapisvar, Inst Diagnost Imaging & Radiat Oncol, Kaposvar, Hungary		Schwarcz, A (corresponding author), Univ Pecs, Dept Neurosurg, Ret Utca 2, H-7624 Pecs, Hungary.	attila.schwarcz@aok.pte.hu	Doczi, Tamas/C-5750-2009; Pal, Jozsef/C-4073-2009; Pal, Jozsef/I-3416-2013	Pal, Jozsef/0000-0001-6468-6409			BLUML S, 1993, MAGN RESON MED, V30, P289, DOI 10.1002/mrm.1910300304; BREGER RK, 1986, MAGNET RESON MED, V3, P649, DOI 10.1002/mrm.1910030502; CHRISTIANSEN P, 1994, MAGN RESON IMAGING, V12, P1237, DOI 10.1016/0730-725X(94)90088-9; Clare S, 2001, MAGNET RESON MED, V45, P630, DOI 10.1002/mrm.1085; DEICHMANN R, 1992, J MAGN RESON, V96, P608, DOI 10.1016/0022-2364(92)90347-A; Deichmann R, 1999, MAGNET RESON MED, V42, P206, DOI 10.1002/(SICI)1522-2594(199907)42:1<206::AID-MRM28>3.0.CO;2-Q; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Fatouros PP, 1999, J NEUROSURG, V90, P109, DOI 10.3171/jns.1999.90.1.0109; FATOUROS PP, 1991, MAGNET RESON MED, V17, P402, DOI 10.1002/mrm.1910170212; GOWLAND P, 1993, MAGNET RESON MED, V30, P351, DOI 10.1002/mrm.1910300312; HANICKE W, 1988, J MAGN RESON, V77, P64, DOI 10.1016/0022-2364(88)90032-7; LARSSON HBW, 1989, MAGNET RESON MED, V11, P337, DOI 10.1002/mrm.1910110308; LIANG ZP, 2000, PRINCIPLES MAGNETIC, P223; Lin WL, 1997, MAGNET RESON MED, V38, P303, DOI 10.1002/mrm.1910380221; Lin WL, 2000, J CEREBR BLOOD F MET, V20, P37, DOI 10.1097/00004647-200001000-00007; MACDONALD HL, 1986, BRIT J RADIOL, V59, P355, DOI 10.1259/0007-1285-59-700-355; Ogg RJ, 1998, MAGNET RESON MED, V40, P749, DOI 10.1002/mrm.1910400516; PENN RD, 1980, NEUROSURGERY, V6, P249, DOI 10.1227/00006123-198003000-00004; Scheyer LE, 2001, AATCC REV, V1, P45; Schwarcz A, 2002, ACTA NEUROCHIR, V144, P811, DOI 10.1007/s00701-002-0935-4; Schwarcz A, 2001, MAGN RESON MED, V46, P1246, DOI 10.1002/mrm.1324; Truyen L, 1996, NEUROLOGY, V47, P1469, DOI 10.1212/WNL.47.6.1469; Venkatesan R, 2000, MAGNET RESON MED, V43, P146, DOI 10.1002/(SICI)1522-2594(200001)43:1<146::AID-MRM18>3.0.CO;2-L; Vymazal J, 1996, MAGN RESON MED, V35, P56, DOI 10.1002/mrm.1910350108	24	7	7	0	6	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	DEC	2004	146	12					1341	1346		10.1007/s00701-004-0370-9			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	873SX	WOS:000225302400021	15449146				2022-02-06	
J	Ozgurtas, T; Kahraman, S				Ozgurtas, T; Kahraman, S			State of the art of new data on the role of magnesium in brain injury: clinical interest of measurements of total and ionized magnesium	MAGNESIUM RESEARCH			English	Article						brain injury; magnesium	INTRACELLULAR FREE MAGNESIUM; VASCULAR SMOOTH-MUSCLE; CLOSED-HEAD INJURY; NITRIC-OXIDE; CELL-DEATH; CEREBRAL-ISCHEMIA; HIPPOCAMPAL SLICES; BIOENERGETIC STATE; LIPID-PEROXIDATION; NMDA RESPONSES	Despite many research studies on traumatic brain injury, few markers have been applicable to diagnose trauma at tissue concentration. Today, the importance of the magnesium ion in posttramnatic homeostasis of brain is a well-known reality. Magnesium concentration affects a number of secondary injury factors including neurotransmitter release, ion changes, oxidative stress, protein synthesis, and energy metabolism. There are many experimental and clinical studies relating to magnesium status in brain injury. It was considered by some authors that only the total form of magnesium should be measured in brain injury. However, recent studies point out that measurement of the ionized form also aids in the intervention of patients with brain trauma. This review aims to explain the role of magnesium in brain injury and to assess the real status of magnesium through pertinent tests.	Gulhane Mil Med Acad, Dept Neurosurg, TR-06018 Ankara, Turkey; Gulhane Mil Med Acad, Dept Biochem & Clin Biochem, TR-06018 Ankara, Turkey		Kahraman, S (corresponding author), Gulhane Mil Med Acad, Dept Neurosurg, TR-06018 Ankara, Turkey.	skahraman@gata.edu.tr	OZGURTAS, TANER/X-4768-2019; Kahraman, Serdar/K-4658-2019	Kahraman, Serdar/0000-0003-2489-3854			ALBERS GW, 1995, STROKE, V26, P254, DOI 10.1161/01.STR.26.2.254; Altura BM, 1995, CELL MOL BIOL RES, V41, P347; Altura BM, 1997, BBA-MOL CELL RES, V1358, P1, DOI 10.1016/S0167-4889(97)00077-3; ALTURA BM, 1994, ALCOHOL CLIN EXP RES, V18, P1057, DOI 10.1111/j.1530-0277.1994.tb00082.x; ALTURA BM, 1995, ALCOHOL, V12, P433, DOI 10.1016/0741-8329(95)00026-N; ALTURA BT, 1994, SCAND J CLIN LAB INV, V54, P21, DOI 10.3109/00365519409095208; ALTURA BT, 1980, NEUROSCI LETT, V20, P323, DOI 10.1016/0304-3940(80)90168-8; ALTURA BT, 1980, MED HYPOTHESES, V6, P753, DOI 10.1016/0306-9877(80)90093-6; ALTURA BT, 1994, SCAND J CLIN LAB INV, V54, P83, DOI 10.3109/00365519409095214; ALVAREZLEEFMANS FJ, 1987, CAN J PHYSIOL PHARM, V65, P915, DOI 10.1139/y87-147; Bara M., 1984, MAGNESIUM, V3, P212; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; Barros LF, 2002, BIOL RES, V35, P209; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BERGER R, 1991, J DEV PHYSIOL, V16, P9; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cheng FC, 1999, J CHROMATOGR B, V723, P31, DOI 10.1016/S0378-4347(98)00532-5; Chiolero R, 1994, New Horiz, V2, P432; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; COMBS DJ, 1990, STROKE, V21, P936, DOI 10.1161/01.STR.21.6.936; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; DAVIES KJA, 1987, J BIOL CHEM, V262, P8220; Durlach J, 2002, MAGNESIUM RES, V15, P203; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; FleckensteinGrun G, 1997, MAGNESIUM RES, V10, P101; FLINK EB, 1981, ARCH INTERN MED, V141, P441, DOI 10.1001/archinte.141.4.441; Garnier Y, 2002, J SOC GYNECOL INVEST, V9, P86, DOI 10.1016/S1071-5576(01)00161-7; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GOLDING EM, 1994, BRAIN RES, V668, P46, DOI 10.1016/0006-8993(94)90509-6; GUNTHER T, 1995, MOL CELL BIOCHEM, V144, P141, DOI 10.1007/BF00944393; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; HAMADA Y, 1994, PEDIATR RES, V35, P10, DOI 10.1203/00006450-199401000-00003; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Heath DL, 1998, SCAND J CLIN LAB INV, V58, P161, DOI 10.1080/00365519850186751; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; HELFAER MA, 1994, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1994, P297; HENROTTE JG, 1985, J AM COLL NUTR, V4, P165, DOI 10.1080/07315724.1985.10720073; Hoane MR, 1998, BRAIN RES BULL, V45, P45, DOI 10.1016/S0361-9230(97)00288-8; Huijgen HJ, 1999, CLIN CHEM LAB MED, V37, P465, DOI 10.1515/CCLM.1999.075; ISERI LT, 1984, AM HEART J, V108, P188, DOI 10.1016/0002-8703(84)90572-6; JOBORN H, 1985, CLIN ENDOCRINOL, V23, P219, DOI 10.1111/j.1365-2265.1985.tb00217.x; Kahraman S, 2003, CLIN CHIM ACTA, V334, P211, DOI 10.1016/S0009-8981(03)00235-3; KING LR, 1965, SURG GYNECOL OBSTETR, V120, P761; KING LR, 1973, ANN SURG, V177, P126, DOI 10.1097/00000658-197301000-00022; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lin JY, 2002, LIFE SCI, V71, P803, DOI 10.1016/S0024-3205(02)01738-1; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; Morrill GA, 1997, FEBS LETT, V408, P191, DOI 10.1016/S0014-5793(97)00420-1; NELSON KB, 1995, PEDIATRICS, V95, P263; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; PAOLETTI P, 1995, NEURON, V15, P1109, DOI 10.1016/0896-6273(95)90099-3; Regan RF, 1998, J NEUROCHEM, V70, P77; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; RUBIN H, 1976, J CELL PHYSIOL, V89, P613, DOI 10.1002/jcp.1040890418; Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2; SCHANNE FAX, 1993, BIOCHIM BIOPHYS ACTA, V1158, P257, DOI 10.1016/0304-4165(93)90023-2; SEELIG MS, 1994, J AM COLL NUTR, V13, P429; Siegel GJ, 1999, MOL CELLULAR MED ASP; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Suzuki M, 1997, GEN PHARMACOL, V28, P119, DOI 10.1016/S0306-3623(96)00148-6; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Taylor CT, 1999, PHARM RES-DORDR, V16, P1498, DOI 10.1023/A:1011936016833; THURMAN DJ, 2001, HEAD TRAUMA THERAPEU, P75; *US DHHS, 1999, TRAUM BRAIN INJ US R; VANINGEN HE, 1994, CLIN CHEM, V40, P52; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; VINK R, 1988, BRAIN RES, V460, P184, DOI 10.1016/0006-8993(88)91221-8; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1990, J NEUROSCI, V10, P3524; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1909, AM J PHYSIOL, V261, P1527; VINK R, 1991, MG2PLUS EXCITABLE ME, P125; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Yang ZW, 2000, PFLUG ARCH EUR J PHY, V439, P240, DOI 10.1007/s004240050935; YOUNG W, 1992, J NEUROTRAUM, V9, pS9	91	7	7	0	1	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	0953-1424	1952-4021		MAGNESIUM RES	Magnes. Res.	DEC	2004	17	4					327	334					8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	889TM	WOS:000226465500009	15726908				2022-02-06	
J	Holdnack, JA; Lissner, D; Bowden, SC; McCarthy, KAL				Holdnack, JA; Lissner, D; Bowden, SC; McCarthy, KAL			Utilising the WAIS-III/WMS-III in clinical practice: Update of research and issues relevant to Australian normative research	AUSTRALIAN PSYCHOLOGIST			English	Article							WECHSLER MEMORY SCALE; CONFIRMATORY FACTOR-ANALYSIS; ADULT INTELLIGENCE SCALE; WMS-III; CROSS-VALIDATION; REVISED SCORES; SAMPLE; EDITION; MUNNS; IQ	The latest versions of the Wechsler Adult Intelligence Scale (WAIS) and Wechsler Memory Scale (WMS) offer some decided advantages over the previous versions. This article discusses the research on the updated versions of the tests with reference to the continuity of construct validity across versions. In addition, there have been some concerns reported about the use of the WAIS-III and WMS-III in Australia due to the absence of local norms. These issues are discussed with reference to data collected in various countries including published factor-analytic research. Other evidence reviewed includes studies on malingering and the effects of clinical conditions such as traumatic brain injury on intellectual and memory performance. These studies support the utility and validity of the WAIS-III and WMS-III in the evaluation of diverse clinical conditions. The recently updated technical manual includes additional data such as discrepancy base rates, and reviews additional recent research utilising the WAIS-III and WMS-III.	Psychol Corp, San Antonio, TX USA; Psychol Corp Australia & New Zealand, Sydney, NSW, Australia; Univ Melbourne, Parkville, Vic 3052, Australia; Univ Newcastle, Callaghan, NSW, Australia		Holdnack, JA (corresponding author), Psychol Corp, 5 Rose Hill Dr, Bear, DE 19701 USA.	James_Holdnack@Harcourt.com	Bowden, Stephen C/C-3726-2012				Arnau RC, 2000, ASSESSMENT, V7, P237, DOI 10.1177/107319110000700304; Bowden SC, 1999, PSYCHOL ASSESSMENT, V11, P339, DOI 10.1037/1040-3590.11.3.339; Bowden SC, 2001, CLIN NEUROPSYCHOL, V15, P69, DOI 10.1076/clin.15.1.69.1910; BOWDEN SC, 2003, AUSTR PSYCH SOC COLL; BOWDEN SC, IN PRESS INTELLIGENC; Carstairs JR, 2000, AUST PSYCHOL, V35, P36, DOI 10.1080/00050060008257466; Caruso JC, 1999, PSYCHOL ASSESSMENT, V11, P198, DOI 10.1037/1040-3590.11.2.198; Cohen M.J., 1997, CHILDRENS MEMORY SCA; CRAWFORD JR, 1995, BRIT J CLIN PSYCHOL, V34, P237, DOI 10.1111/j.2044-8260.1995.tb01458.x; CRAWFORD JR, 1990, BRIT J CLIN PSYCHOL, V29, P105, DOI 10.1111/j.2044-8260.1990.tb00854.x; Doss RC, 2000, CLIN NEUROPSYCHOL, V14, P468, DOI 10.1076/clin.14.4.468.7195; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; FLYNN JR, 1984, PSYCHOL BULL, V95, P29, DOI 10.1037/0033-2909.95.1.29; HOLDNACK JA, 2003, 31 ANN M INT NEUR SO; Hunter, 2002, AUSTR J ED DEV PSYCH, V2, P49; Kalechstein AD, 1998, CLIN NEUROPSYCHOL, V12, P339, DOI 10.1076/clin.12.3.339.1991; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; Leach L., 2000, KAPLAN BAYCREST NEUR; MATARAZZO JD, 1990, AM PSYCHOL, V45, P999, DOI 10.1037/0003-066X.45.9.999; MATARAZZO JD, 1988, J CLIN PSYCHOL, V44, P940, DOI 10.1002/1097-4679(198811)44:6<940::AID-JCLP2270440615>3.0.CO;2-A; McLean JE., 1990, PSYCHOL ASSESSMENT J, V2, P289, DOI [10.1037/1040-3590.2.3.289, DOI 10.1037/1040-3590.2.3.289]; Millis SR, 1999, J CLIN EXP NEUROPSYC, V21, P87, DOI 10.1076/jcen.21.1.87.937; Price LR, 2002, J CLIN EXP NEUROPSYC, V24, P574, DOI 10.1076/jcen.24.5.574.1013; *PSYCH CORP, 2001, WECHSL TEST AD READ; *PSYCH CORP AUSTR, 1997, UNPUB AUSTR NORM PRO; Ryan JJ, 2001, ARCH CLIN NEUROPSYCH, V16, P151, DOI 10.1016/S0887-6177(99)00061-X; Saklofske DH, 2000, PSYCHOL ASSESSMENT, V12, P436, DOI 10.1037/1040-3590.12.4.436; SENIOR G, 2001, 21 ANN C NAT AC NEUR; Shores EA, 2000, AUST PSYCHOL, V35, P41, DOI 10.1080/00050060008257467; SOPER HV, 1988, J CLIN EXP NEUROPSYC, V10, P255, DOI 10.1080/01688638808408240; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; Tulsky D., 2003, CLIN INTERPRETATION, P147; Tulsky DS, 2003, PSYCHOL ASSESSMENT, V15, P149, DOI 10.1037/1040-3590.15.2.149; Wechsler D., 2002, WAIS 3 WMS 3 TECHNIC; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1997, WAIS 3 WMS 3 TECHNIC; Zhu JJ, 2000, CLIN NEUROPSYCHOL, V14, P461, DOI 10.1076/clin.14.4.461.7197	38	7	8	0	13	AUSTRALIAN PSYCHOLOGICAL SOC	CARLTON	1 GRATTAN STREET, CARLTON, VICTORIA 3053, AUSTRALIA	0005-0067			AUST PSYCHOL	Aust. Psychol.	NOV	2004	39	3					220	227		10.1080/00050060412331295072			8	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	877HT	WOS:000225559500007					2022-02-06	
J	Kis, M; Saunders, F; ten Hove, MW; Leslie, JR				Kis, M; Saunders, F; ten Hove, MW; Leslie, JR			Rotational acceleration measurements - Evaluating helmet protection	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							MINOR HEAD-INJURY; PROFESSIONAL FOOTBALL; CONCUSSION; IMPACTS; SEQUELAE	Purpose: Current helmet testing standards do not address the rotational components of an impact to the head. We describe a new testing paradigm used to measure the rotational acceleration of a headform and a protective helmet following an impact to the head in the horizontal plane. This impact simulation allows for the testing of currently available head protection devices in conditions thought to be important for the generation of cerebral concussion. The degree to which a particular helmet dampens rotational acceleration, and thus protects against concussion, can be assessed. Methods: Our testing device consists of a pneumatic piston that provides a measured impact to a standard headform. Four different helmets were tested using the described paradigm. Results: Acceleration curves for each helmet and the corresponding headform are presented. Conclusions: Clear differences in rotational acceleration were demonstrated. Possible avenues of further investigation are discussed.	Dalhousie Univ, Dept Neurosurg, Halifax, NS, Canada; Queens Univ, Dept Neurosurg, Kingston, ON, Canada; Queens Univ, Dept Neuroophthalmol, Kingston, ON, Canada; Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada		Saunders, F (corresponding author), 95 King St E, Kingston, ON K7L 2Z7, Canada.			TEN HOVE, MARTIN/0000-0002-0781-9305			BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; CANTU RC, 1996, BRIT J SPORT MED, V30, P189; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gurdjian E S, 1972, Clin Neurosurg, V19, P1; Halstead PD, 2001, J ATHL TRAINING, V36, P322; HALSTEAD PD, 1998, SAFETY ICE HOCKEY, P93; HAYES RL, 1989, MILD HEAD INJURY, P54; HENDERSON M, 1995, MOT ACC AUTH NEW S W; Holbourn AHS, 1943, LANCET, V2, P438; McCrory P, 2001, CLIN J SPORT MED, V11, P190, DOI 10.1097/00042752-200107000-00010; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; SYMONDS C, 1962, LANCET, V1, P1	23	7	7	0	15	CANADIAN J NEUROL SCI INC	CALGARY	PO BOX 4220, STATION C EDITORIAL & SUBSCRIPTION SERV, CALGARY, AB T2T 5N1, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	NOV	2004	31	4					499	503		10.1017/S031716710000370X			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	873ZF	WOS:000225319900012	15595255	Bronze			2022-02-06	
J	Pontius, AA; Wieser, HG				Pontius, AA; Wieser, HG			Can memories kindle nonconvulsive behavioral seizures in humans? Case report exemplifying the "limbic psychotic trigger reaction"	EPILEPSY & BEHAVIOR			English	Article						human behavioral seizures; limbic kindling; limbic psychotic trigger reaction; fire setting; limbic "paleo-consciousness"; olfaction; memory revival; animal models; olfactory habituation; priming	TEMPORAL-LOBE EPILEPSY; NONEPILEPTIC SEIZURES; QUESTIONABLE ASPECTS; FRONTAL-LOBE; HOMICIDE; SCHIZOPHRENIA; STIMULATION; DYSFUNCTION; AGGRESSION; VIOLENCE	We present three hypotheses-(1) the limbic psychotic trigger reaction (LPTR) is a form of nonconvulsive behavioral seizures (NCBS), (2) kindling may occur in the LPTR, and (3) kindling may occur with memory stimuli-and report a case that may exemplify a LPTR kindled by memory and triggered by light and smell. The LPTR has a primate model, in which NCBS are kindled by intermittent exposure to actual subthreshold stimuli. In humans, we propose that such triggering stimuli can be revived by memory alone. Thus, individualized stimuli can trigger partial limbic seizures or seizure-like bizarre episodes with a transient loss of frontal control functions. We present a case of paroxysmal episodes of out-of-character, bizarre, unplanned nonvoluntary acts that Occurred with flat affect and without drive motivation (e.g., "fire setting"). Implicated is a transient state of limbic "paleo-consciousness" with preserved memory, autonomic arousal, and first-time brief psychosis (e.g., olfactory, visual hallucinations and depersonalization with olfactory attributes). As in kindled primates, LPTR patients do not show a consistent pattern of morphological brain abnormality; half have had an abnormal electroencephalogram, computed tomography scan, or magnetic resonance image at some time during their lives, and half (including the new patient) have had closed head injuries. (C) 2004 Elsevier Inc. All rights reserved.	Univ Zurich Hosp, Neurol Clin, Dept Epileptol & Electroencephalog, CH-8091 Zurich, Switzerland; Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA		Wieser, HG (corresponding author), Univ Zurich Hosp, Neurol Clin, Dept Epileptol & Electroencephalog, CH-8091 Zurich, Switzerland.	hgwepi@neurol.unizh.ch					Abubakr A, 2003, EPILEPSY BEHAV, V4, P241, DOI 10.1016/S1525-5050(03)00082-9; BEAR D, 1987, INTEGRATIVE PSYCHIAT, V5, P125; CAIN D P, 1992, P539; CLORE GL, 1992, CONSTRUCTION OF SOCIAL JUDGMENTS, P133; COLLINS RC, 1987, HDB PHYSL 2, V5, P811; CROMIE WJ, 2002, HARV U GAZ, V47, P1; DELGADOESCUETA AV, 1981, NEW ENGL J MED, V305, P711, DOI 10.1056/NEJM198109173051231; EBERT U, 1999, NEUROFORUM, V3, P76; Farias ST, 2003, EPILEPSY BEHAV, V4, P424, DOI 10.1016/S1525-5050(03)00143-4; GLOOR P, 1982, ANN NEUROL, V12, P129, DOI 10.1002/ana.410120203; GODDARD GV, 1967, NATURE, V214, P1020, DOI 10.1038/2141020a0; GODDARD GV, 1986, LIMBIC SYSTEM FUNCTI, P95; Grant Jon E, 2004, Ann Clin Psychiatry, V16, P27, DOI 10.1080/10401230490281366; Halgren E, 1982, Hum Neurobiol, V1, P251; Halgren E, 1991, Adv Neurol, V55, P385; HEATH RG, 1955, AM J PSYCHIAT, V111, P862, DOI 10.1176/ajp.111.11.862; Holden C, 2001, SCIENCE, V292, P1039; Iriarte J, 2003, EPILEPSY BEHAV, V4, P354, DOI 10.1016/S1525-5050(03)00113-6; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kanner AM, 2003, EPILEPSY BEHAV, V4, P360, DOI 10.1016/S1525-5050(03)00114-8; Kanner AM, 2001, EPILEPSY BEHAV, V2, P170, DOI 10.1006/ebeh.2001.0192; Kuyk J, 2003, EPILEPSY BEHAV, V4, P13, DOI 10.1016/S1525-5050(02)00683-2; Kuzma John M, 2004, Curr Psychiatry Rep, V6, P58, DOI 10.1007/s11920-004-0040-x; LEIS AA, 1992, NEUROLOGY, V42, P95, DOI 10.1212/WNL.42.1.95; LELLIOTT PT, 1991, ACTA NEUROL SCAND, V83, P129, DOI 10.1111/j.1600-0404.1991.tb04661.x; MacLean P.D., 1990, TRIUNE BRAIN EVOLUTI; McCarley RW, 1999, EUR ARCH PSY CLIN N, V249, P69; Mokleby K, 2002, EPILEPSIA, V43, P193, DOI 10.1046/j.1528-1157.2002.20901.x; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; Panksepp J, 2003, BRAIN COGNITION, V52, P4, DOI 10.1016/S0278-2626(03)00003-4; PONITUS AA, 1976, ADOLESCENCE, V11, P509; Pontius A. A., 2002, EVOLUTIONARY NEUROET, P167; PONTIUS AA, 1980, J NERV MENT DIS, V168, P111, DOI 10.1097/00005053-198002000-00008; PONTIUS AA, 1987, INTEGRATIVE PSYCHIAT, V5, P116; Pontius AA, 1997, AGGRESS VIOLENT BEH, V2, P125, DOI 10.1016/S1359-1789(96)00002-X; Pontius AA, 1996, B AM ACAD PSYCH LAW, V24, P125; PONTIUS AA, 1981, J FORENSIC SCI, V26, P123; Pontius AA, 2000, AGGRESS VIOLENT BEH, V5, P423, DOI 10.1016/S1359-1789(98)00041-X; Pontius AA, 2004, AGGRESS VIOLENT BEH, V9, P503, DOI 10.1016/S1359-1789(03)00046-6; Pontius AA, 2003, AGGRESS VIOLENT BEH, V8, P547, DOI 10.1016/S1359-1789(02)00099-X; Pontius AA, 1999, PERCEPT MOTOR SKILL, V88, P970, DOI 10.2466/PMS.88.3.970-982; PONTIUS AA, 1995, PSYCHOL REP, V76, P55, DOI 10.2466/pr0.1995.76.1.55; Pontius AA, 2001, INT J OFFENDER THER, V45, P515, DOI 10.1177/0306624X01454010; Pontius AA, 2001, J DEV PHYS DISABIL, V13, P191, DOI 10.1023/A:1016617526205; PONTIUS AA, 1993, PSYCHOL REP, V73, P615, DOI 10.2466/pr0.1993.73.2.615; Pontius AA, 2003, AGGRESS VIOLENT BEH, V8, P245, DOI 10.1016/S1359-1789(01)00069-6; PONTIUS AA, 2002, CLIN CASE STUD, V1, P341; Pontius Anneliese A., 1993, Integrative Psychiatry, V9, P151; POST RM, 1975, LANCET, V1, P409; PROUST MA, 1954, RECH TEMPS PERDU; Prueter C, 2002, EPILEPSIA, V43, P188, DOI 10.1046/j.1528-1157.2002.45900.x; RACINE RJ, 1980, NEUROSURGERY, V3, P324; Reuber M, 2002, EPILEPSIA, V43, P1013, DOI 10.1046/j.1528-1157.2002.52301.x; SCHACTER DL, 1996, SEARCHING MEMORY; Scheepers M, 2003, CURR OPIN NEUROL, V16, P183, DOI 10.1097/00019052-200304000-00011; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; SRAMKA M, 1983, NEUROSURGICAL TREATM, P651; STRIPLING JS, 1990, KINDLING, V4, P45; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043; Wada JA, 1998, ADV BEHAV BIOL, V48, P1; WADA JA, 1978, LIMBIC MECHANISMS, P369; WADA JA, 1990, KINDLING, V4, P383; WAXMAN SG, 1975, ARCH GEN PSYCHIAT, V32, P1580; Wieser H G, 1998, Adv Neurol, V75, P69; WIESER HG, 1983, NEUROSCI BIOBEHAV R, V7, P427, DOI 10.1016/0149-7634(83)90050-7; WIESER HG, 1989, EPILEPTIC FOCUS, P113; Wieser HG., 1983, ELECTROCLINICAL FEAT; [No title captured]	68	7	7	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	OCT	2004	5	5					775	783		10.1016/j.yebeh.2004.05.013			9	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	857UO	WOS:000224144300026	15380135				2022-02-06	
J	Sutter, FKP				Sutter, FKP			Ocular injuries caused by plastic bullet shotguns in Switzerland	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						blunt ocular injury; blindness; plastic bullets; rubber bullets; sub-tethal weapons; ballistics; baton rounds; riot control	RUBBER	Five patients with blunt ocular trauma due to hard plastic shotguns used by police forces during riots presented to the Ophthalmology Department of University Hospital in Zurich, Switzerland, between December 2000 and May 2001. All five eyes suffered ocular concussion. Three of five eyes presented with severe damage to the anterior segment of the eye, two of these eyes showed combined involvement of the anterior and posterior segments. Two patients completely recovered visual acuity in the injured eye, two reached a final visual acuity of 6/12 and in one case the injured eye was legally blinded. Three of the patients claimed to have been uninvolved bystanders at the riots. The theoretical probability of hitting the head/neck area or one of the two eyes for each shot fired at a person from different operational distances is calculated and ophthalmological and technical aspects of this special type of plastic bullet shotgun used in Switzerland are discussed. (C) 2004 Elsevier Ltd. All rights reserved.	Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland		Sutter, FKP (corresponding author), Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland.	sutter-adler@gmx.ch					BALOURIS CA, 1990, LANCET, V335, P415, DOI 10.1016/0140-6736(90)90252-Z; COHEN MA, 1985, S AFR MED J, V68, P849; METRESS EK, 1987, INT J HEALTH SERV, V17, P333, DOI 10.2190/08GN-WR79-X908-8YE0; Missliwetz J, 1991, Beitr Gerichtl Med, V49, P361; RITCHIE AJ, 1992, INJURY, V23, P265, DOI 10.1016/S0020-1383(05)80013-0; ROCKE L, 1983, LANCET, V1, P919; SHAW J, 1972, BRIT MED J, V4, P764, DOI 10.1136/bmj.4.5843.764; SHERIDAN SM, 1983, BRIT J ORAL SURG, V21, P259, DOI 10.1016/0007-117X(83)90014-8; WHITLOCK RIH, 1981, ANN ROY COLL SURG, V63, P31; YELLIN A, 1992, J THORAC CARDIOV SUR, V103, P381; 1997, GESCHAFTSPRUFUNGSKOM, P144	11	7	7	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	OCT	2004	35	10					963	967		10.1016/j.injury.2003.11.020			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	858BC	WOS:000224164100002	15351657				2022-02-06	
J	Jorger, G; Thielemann, F				Jorger, G; Thielemann, F			Traumatic vertebral artery dissection in 8 years old boy	UNFALLCHIRURG			German	Article						dissection; vertebral artery; blunt trauma; ischemia; MRI	INTERNAL CAROTID-ARTERY; ISCHEMIC STROKE; YOUNG-ADULTS; EPIDEMIOLOGY; DIAGNOSIS; INJURIES; BRAIN	Dissections of extracranial brain supplying arteries are a common cause of ischemic strokes in young patients. Accidents are often accountable for that. We report the case of an 8 year old boy with traumatic vertebral dissection after he was bumped while playing football. He developed an ischemia on both sides of the thalamus which was caused by a bilateral system of the vertebral artery. He showed motor eye and progressive neuropsychological deficits. The CT and MRI scan confirmed the diagnosis. The symptoms ameliorated under anticoagulation treatment with intravenous heparin. At the end of the hospital stay, neuropsychological deficits persisted. Doppler ultrasound showed recanalization of the vertebral artery. Further treatment consisted of anticoagulation with marcumar for 6 months.			Jorger, G (corresponding author), Ludwigstr 7, D-78073 Bad Durrheim, Germany.	goetz.joerger@gmx.de					Bartels E, 1996, ULTRASCHALL MED, V17, P55, DOI 10.1055/s-2007-1003147; BERLIT P, 1991, FORTSCHR NEUROL PSYC, V59, P322, DOI 10.1055/s-2007-1000706; Bertram M, 1999, DEUT MED WOCHENSCHR, V124, P273, DOI 10.1055/s-2007-1024294; Biousse V, 1998, AM J OPHTHALMOL, V126, P565, DOI 10.1016/S0002-9394(98)00136-6; BLECIC S, 1995, CURR OPIN NEUROL, V8, P30, DOI 10.1097/00019052-199502000-00006; BOGOUSSLAVSKY J, 1992, NEUROL CLIN, V10, P113, DOI 10.1016/S0733-8619(18)30236-6; Brandt T, 1998, ANN NEUROL, V44, P281, DOI 10.1002/ana.410440224; BUI LN, 1993, STROKE, V24, P126, DOI 10.1161/01.STR.24.1.126; CAPLAN LR, 1985, STROKE, V16, P1030, DOI 10.1161/01.STR.16.6.1030; DIZINGER HG, 1985, DEUT MED WOCHENSCHR, V110, P1759, DOI 10.1055/s-2008-1069082; Ganesan V, 2002, NEUROLOGY, V59, P1552, DOI 10.1212/01.WNL.0000033092.87560.1A; GRAU AJ, 1997, STROKE, V28, P88; HART RG, 1983, STROKE, V14, P110, DOI 10.1161/01.STR.14.1.110; Hasan I, 2002, PEDIATR NEUROSURG, V37, P168, DOI 10.1159/000065391; Heckmann JG, 2000, DEUT MED WOCHENSCHR, V125, P1333, DOI 10.1055/s-2000-8070; Koch S, 2001, J NEUROIMAGING, V11, P63, DOI 10.1111/j.1552-6569.2001.tb00013.x; KRIEGER D, 1990, DEUT MED WOCHENSCHR, V115, P580, DOI 10.1055/s-2008-1065050; Kristensen B, 1997, STROKE, V28, P1702, DOI 10.1161/01.STR.28.9.1702; LASKE A, 1990, SCHWEIZ MED WSCHR, V120, P1050; Leclerc X, 1996, STROKE, V27, P461, DOI 10.1161/01.STR.27.3.461; Leys D, 1997, EUR NEUROL, V37, P3, DOI 10.1159/000117396; MAXEINER H, 1989, Z RECHTSMED, V102, P191; Oelerich M, 1999, EUR RADIOL, V9, P1385, DOI 10.1007/s003300050853; PERCHERON G, 1976, REV NEUROL, V132, P309; STEINKE W, 1994, STROKE, V25, P998, DOI 10.1161/01.STR.25.5.998; Sturzenegger M, 1996, Ther Umsch, V53, P544; WEBSTER MWI, 1988, LANCET, V2, P11; WEKSLER BB, 1995, CURR OPIN NEUROL, V8, P38, DOI 10.1097/00019052-199502000-00007; WURM G, 1995, CHIRURG, V66, P916	29	7	7	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	SEP	2004	107	9					803	806		10.1007/s00113-004-0797-8			4	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	862PF	WOS:000224502400009	15235781				2022-02-06	
J	Mendez, DR; Cherian, L; Robertson, CS				Mendez, DR; Cherian, L; Robertson, CS			Laser Doppler flow and brain tissue PO2 after cortical impact injury complicated by secondary ischemia in rats treated with arginine	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Academic-Emergency-Medicine	MAY 05-08, 2001	ATLANTA, GA	Soc Acad Emergency Med		traumatic brain injury; neurotrauma; cerebral blood flow; brain tissue PO2; arginine; L-arginine	CEREBRAL-BLOOD-FLOW; SUBDURAL-HEMATOMA; HEAD-INJURY; HYPERCAPNIA; POPULATION	Background: Traumatic brain injury (TBI) makes the brain susceptible to secondary insults such as ischemia. This study tested the hypothesis that L-arginine would increase regional CBF (rCBF) and brain tissue po(2) (PbtO(2)) at the injury site. Methods: A secondary insult model was employed in rodents. rCBF was measured with laser doppler flowmetry (LDF) and PbtO(2) with a po(2) catheter at the impact site. Animals were randomized to receive L-arginine, D-arginine or saline intravenously, 5 minutes after impact. Results: In animals who received L-arginine, the percentage rCBF from baseline (%CBF) was higher at the impact site after impact (p < 0.001), during bilateral carotid occulation (BCO) (p = 0.001) and during reperfusion (p = 0.032). In contrast, PbtO2 was not significantly increased throughout the experiment for the L-arginine group. Conclusions: Administration of L-arginine increased rCBF in the injured brain tissue, and resulted in better preservation of CBF during BCO than D-arginine and saline.	Baylor Coll Med, Dept Pediat Emergency Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Mendez, DR (corresponding author), Baylor Coll Med, Dept Pediat Emergency Med, 6621 Fannin St,Room A210, Houston, TX 77030 USA.	drmendez@texaschildrenshospital.org			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline		ADAMS JH, 1983, ACTA NEUROCHIR, V32, pS15; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; CHERIAN L, 1996, J NEUROTRAUM, V57, P717; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Golding EM, 2000, J CEREBR BLOOD F MET, V20, P820, DOI 10.1097/00004647-200005000-00008; IADECOLA C, 1994, AM J PHYSIOL, V266, pR546, DOI 10.1152/ajpregu.1994.266.2.R546; IADECOLA C, 1992, P NATL ACAD SCI USA, V89, P3913, DOI 10.1073/pnas.89.9.3913; Jones SC, 1999, AM J PHYSIOL-HEART C, V276, pH1253, DOI 10.1152/ajpheart.1999.276.4.H1253; Jones Suzanne R., 1993, Endangered Species Update, V10, P1; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; KRAUS JF, 1987, PEDIATRICS, V79, P501; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; MACRAE IM, 1993, J CEREBR BLOOD F MET, V13, P276, DOI 10.1038/jcbfm.1993.34; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; MICHAUD LJ, 1994, PEDIATR CLIN N AM, V75, P553; MULLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439; *NAT RES COUNC, 1985, INJ AM CONT PUBL HLT, P791; OKIYAMA K, 1994, J NEUROTRAUM, V11, P83, DOI 10.1089/neu.1994.11.83; PIEK J, 1992, J NEUROSURG, V33, P403; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; SALVANT JB, 1993, NEUROSURGERY, V33, P387; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; WADA K, 1997, J NEUROTRAUM, V14, P760; WALD S, 1991, Journal of Trauma, V31, P1041, DOI 10.1097/00005373-199107000-00102; Wang QO, 1998, BRAIN RES, V793, P187, DOI 10.1016/S0006-8993(98)00173-5	36	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2004	57	2					244	250		10.1097/01.TA.0000103983.22362.67			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	859YG	WOS:000224303700008	15345968				2022-02-06	
J	Pittella, JEH; Gusmao, SND				Pittella, JEH; Gusmao, SND			The conformation of the brain plays an important role in the distribution of diffuse axonal injury in fatal road traffic accident	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						diffuse axonal injury; head injury; road traffic accident; biomechanics	AMYLOID PRECURSOR PROTEIN; CLOSED-HEAD-INJURY; CEREBRAL CONCUSSION; DAMAGE; TRAUMA; IMPACT; HUMANS; STATE	Objective: A study was made of the brain lesions in 120 random victims of fatal road traffic accidents to determine the frequency and topographic distribution of diffuse axonal damage (DAI) in relation to the midline brain structures. Method: The identification of axons was carried out with a mouse antibody anti-neurofilament proteins 70-, 160-, and 210-kD. Results: DAI was identified in 96 (80%) brains and classified as Grade 1 in 21.9%, as Grade 2 in 51%, and as Grade 3 in 27.1% of the patients. In spite of the diffuse distribution that is characteristic of DAI, damage occurred preferentially in the interhemispheric formations (corpus callosum and fornix) and rostral portion of the brainstem, usually to one side of the midline. Conclusion: From a mechanical point of view, the interhemispheric formations and the rostral portion of the brainstem act as fixating structures for the cerebral hemispheres during rotational acceleration of the head. It is known that the motion of the cerebral hemispheres is delayed at the points of fixation, where greater stress would be produced, particularly on the side subjected to greater displacement. The frequent involvement by DAI of deep, center-medial brain structures, usually to one side of the midline, supports the mechanism proposed above.	Univ Fed Minas Gerais, Sch Med, Neuropathol Lab, Dept Pathol & Forens Med, Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Sch Med, Dept Neurol & Psychiat, Belo Horizonte, MG, Brazil		Pittella, JEH (corresponding author), Rua Otoni 712-304, BR-30150270 Belo Horizonte, MG, Brazil.	pittella@medicina.ufmg.br	Pittella, Jose Eymard Homem/F-3191-2013	Pittella, Jose Eymard Homem/0000-0002-6244-9781			AbouHamden A, 1997, J NEUROTRAUM, V14, P699, DOI 10.1089/neu.1997.14.699; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Adams JH, 1992, GREENFIELDS NEUROPAT, P106; ADAMS JH, 1984, GREENFIELDS NEUROPAT, P85; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; CROMPTON MR, 1971, LANCET, V1, P669; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Graham DI, 1997, GREENFIELDS NEUROPAT, P197; GRCEVIC N, 1988, SCAND J REHABIL MED, P25; Holbourn AHS, 1944, J NEUROSURG, V1, P190, DOI 10.3171/jns.1944.1.3.0190; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Ironside JW, 2002, GREENFIELDS NEUROPAT, P193; JENNETT B, 1972, LANCET, V1, P734; Kernohan JW, 1929, ARCH NEURO PSYCHIATR, V21, P274, DOI 10.1001/archneurpsyc.1929.02210200030004; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MILLER JD, 1984, GREENFIELDS NEUROPAT, P53; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; Ommaya A K, 1966, Ann R Coll Surg Engl, V39, P317; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OMMAYA AK, 1966, HEAD INJURY, P260; Pittella JEH, 2003, J FORENSIC SCI, V48, P626; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; ROSENBLUM WI, 1981, NEUROSURGERY, V9, P613, DOI 10.1227/00006123-198112000-00001; RUSSELL DS, 1971, PATHOLOGY TUMOURS NE, P273; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; STRICH SJ, 1961, LANCET, V2, P443; TEASDALE G, 1974, LANCET, V2, P81; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; [No title captured]	40	7	10	0	1	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	JUN	2004	62	2B					406	413		10.1590/S0004-282X2004000300007			8	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	835XA	WOS:000222517600007	15273836	Green Submitted, Green Published, gold			2022-02-06	
J	Tubbs, RS; Wellons, JC; Blount, JP; Oakes, WJ				Tubbs, RS; Wellons, JC; Blount, JP; Oakes, WJ			Left-sided vagus nerve stimulation decreases intracranial pressure without resultant bradycardia in the pig: a potential therapeutic modality for humans	CHILDS NERVOUS SYSTEM			English	Article						peripheral nerve; trauma; head injury	CEREBRAL-BLOOD-FLOW; VAGAL-STIMULATION; INCREASES; SEIZURES; MODEL	Introduction. The medical literature is lacking in data regarding intracranial pressure in an animal model with concomitant vagus nerve and spinal cord stimulation. Methods. Ten pigs were anesthetized and placed in the supine position and an intracranial pressure monitor was inserted. Each study animal had a small laminectomy performed in the lumbar region and the left vagus nerve exposed within the carotid sheath. Intracranial pressure was monitored for 3 h in all animals. Eight animals at the end of 3 h of monitoring underwent vagus nerve stimulation and or spinal cord stimulation. Study and control animals had their intracranial pressure monitored for an additional 1 and 2 h respectively. Results. Following vagus nerve stimulation, all animals had significant (p<0.05) decreases in their intracranial pressure with a lasting effect of 15-35 min (mean 18.5 min). No significant change in blood pressure was noted during stimulation of the vagus nerve. After spinal cord stimulation all animals responded with acute increases in their intracranial pressure (p<0.05). Conclusions. Left vagus nerve stimulation reliably decreases intracranial pressure in the pig. The mechanism of this action remains unclear and does not appear to be due to resultant bradycardia. Conversely, stimulation of the upper lumbar spinal cord increases intracranial pressure with simultaneous increases in heart rate. Following additional studies and with close observation of cerebral perfusion pressure, we believe that left vagus nerve stimulation may represent a novel adjunctive therapy for decreasing elevated intracranial pressure in posttraumatic human patients with head injuries. Additionally, according to this animal data, minimizing spinal cord stimulation should be considered in the acute setting following head injury so as to minimize iatrogenic elevation of intracranial pressure.	Childrens Hosp, Birmingham, AL 35233 USA; Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA		Tubbs, RS (corresponding author), Childrens Hosp, 1600 7th Ave S ACC 400, Birmingham, AL 35233 USA.	richard.tubbs@ccc.uab.edu		Blount, Jeffrey/0000-0001-6244-4879			Bakay RAE, 1996, NEUROSURGERY, V39, P430; Ebel H, 2001, MINIM INVAS NEUROSUR, V44, P50, DOI 10.1055/s-2001-13583; GARNETT ES, 1992, PACE, V15, P1579, DOI 10.1111/j.1540-8159.1992.tb02936.x; Hagl C, 2002, EUR J CARDIO-THORAC, V22, P510, DOI 10.1016/S1010-7940(02)00380-9; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P729; HAMMOND EJ, 1992, EPILEPSIA, V33, P1013, DOI 10.1111/j.1528-1157.1992.tb01752.x; HAMMOND EJ, 1992, BRAIN RES, V583, P300, DOI 10.1016/S0006-8993(10)80038-1; Handforth A, 1998, NEUROLOGY, V51, P48, DOI 10.1212/WNL.51.1.48; Henry Thomas R., 1997, Epilepsia, V38, P144; JOSEPHS LG, 1994, J TRAUMA, V36, P815, DOI 10.1097/00005373-199406000-00011; KAMATH MV, 1992, PACE, V15, P1581, DOI 10.1111/j.1540-8159.1992.tb02937.x; LOCKARD JS, 1990, EPILEPSIA, V31, pS20, DOI 10.1111/j.1528-1157.1990.tb05844.x; MCLACHLAN RS, 1993, EPILEPSIA, V34, P918, DOI 10.1111/j.1528-1157.1993.tb02112.x; MEYER GA, 1970, J NEUROSURG, V33, P662, DOI 10.3171/jns.1970.33.6.0662; NARITOKU DK, 1992, PACE, V15, P1572, DOI 10.1111/j.1540-8159.1992.tb02935.x; PENRY JK, 1990, EPILEPSIA S2, V31, P40; PETTOROSSI VE, 1978, EUR NEUROL, V17, P216, DOI 10.1159/000114948; RAKSIN PB, 2003, NEUROSURG FOCUS, V14, P1; RUTECKI P, 1990, EPILEPSIA, V31, pS1, DOI 10.1111/j.1528-1157.1990.tb05843.x; SALINSKY MC, 1993, EPILEPSIA, V34, P299, DOI 10.1111/j.1528-1157.1993.tb02415.x; UPTON ARM, 1992, PACE, V15, P1543, DOI 10.1111/j.1540-8159.1992.tb02932.x; WALLIS DE, 1987, J ELECTROCARDIOL, V20, P154, DOI 10.1016/S0022-0736(87)80105-X	22	7	8	1	4	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	MAY	2004	20	5					309	312		10.1007/s00381-004-0947-x			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	825BX	WOS:000221732100003	15083332				2022-02-06	
J	Constantinidou, F; Kreimer, L				Constantinidou, F; Kreimer, L			Feature description and categorization of common objects after traumatic brain injury: The effects of a multi-trial paradigm	BRAIN AND LANGUAGE			English	Article						TBI; categorization; feature description; verbal learning; working memory; recall; object description	STIMULUS MODALITY; PERFORMANCE; ATTENTION	This study investigated the ability to describe and categorize common objects following brain injury. Thirteen subjects with moderate to severe traumatic brain injury (TBI) and 13 noninjured controls participated in this project. The project consisted of 3 parts: 1. A spontaneous condition, 2. A training session, and 3. An application condition. During the spontaneous condition, subjects were asked to describe common objects. Following the spontaneous condition, subjects participated in a multi-trial training session to learn 8 perceptual features. The protocol concluded with an application condition where subjects were asked to apply all 8 features to describe additional objects. Overall, noninjured subjects provided more features than the group with TBI. However, subjects with TBI benefited from the training session, as they were able to learn more features across the repeated trials. Furthermore, both groups performed better during the application condition compared to the spontaneous description of objects. The results indicate that the multi-trial training session was effective in teaching subjects the 8 perceptual features. (C) 2003 Elsevier Inc. All rights reserved.	Miami Univ, Dept Speech Pathol & Audiol, Oxford, OH 45056 USA; St Elizabeth Hosp, Edgewood, KY USA		Constantinidou, F (corresponding author), Miami Univ, Dept Speech Pathol & Audiol, 2 Bachelor Hall, Oxford, OH 45056 USA.	constaf@muohio.edu		Constantinidou, Fofi/0000-0002-7928-8363			Amazeen EL, 1996, J EXP PSYCHOL HUMAN, V22, P213, DOI 10.1037/0096-1523.22.1.213; BUTTERS MA, 1993, J CLIN EXP NEUROPSYC, V15, P219, DOI 10.1080/01688639308402559; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Constantinidou F, 1999, J MED SPEECH-LANG PA, V7, P283; Constantinidou F, 1996, J GEN PSYCHOL, V123, P173, DOI 10.1080/00221309.1996.9921270; CONSTANTINIDOU F, 1995, J HEAD TRAUMA REHAB, V10, P90, DOI 10.1097/00001199-199508000-00009; Constantinidou F., 1998, HEARSAY, V12, P20; CONSTANTINIDOU F, IN PRESS TRAUMATIC B; Delis D.C., 2000, CALIFORNIA VERBAL LE; Eimer M, 1997, BIOL PSYCHOL, V44, P143, DOI 10.1016/S0301-0511(96)05217-9; FARAH MJ, 1991, J EXP PSYCHOL GEN, V120, P339, DOI 10.1037/0096-3445.120.4.339; Gazzaniga, 1979, HDB BEHAVIORAL NEURO, V2, P3; GAZZANIGA MS, 1998, COGNITIVE NEUROSCIEN; GENTILINI M, 1989, MILD HEAD INJURY, P163; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; LEVIN HS, 1992, SCAND J REHABIL MED, P14; LEZAK MD, 1995, NEUROPSYCHOLOCICAL A; LODGEMILLER KA, 1993, J MED SPEECH-LANG PA, V1, P133; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MONTGOMERY GK, 1995, BRAIN INJURY, V9, P453, DOI 10.3109/02699059509008205; Shimamura Arthur P., 1995, P803; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Zeno S., 1995, ED WORLD FREQUENCY G	29	7	7	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	APR	2004	89	1					216	225		10.1016/S0093-934X(03)00399-7			10	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	804FK	WOS:000220284400024	15010253				2022-02-06	
J	Reichard, RR; White, CL; Hogan, RN; Hladik, CL; Dolinak, D				Reichard, RR; White, CL; Hogan, RN; Hladik, CL; Dolinak, D			beta-amyloid precursor protein immunohistochemistry in the evaluation of pediatric traumatic optic nerve injury	OPHTHALMOLOGY			English	Article; Proceedings Paper	78th Annual Meeting of the American-Association-of-Neuropathologists	JUN 20-23, 2002	DENVER, CO	Amer Assoc Neuropathol			AXONAL INJURY; HEAD-INJURY; INFANTS; DAMAGE; AUTOPSIES; CHILDREN	Objective: The pathologic markers of nonaccidental injury (NAI) of the central nervous system (CNS) of infants and young children include subdural, subarachnoid, and retinal hemorrhages. Immunohistochemical staining for P-amyloid precursor protein (pAPP) has been used to investigate traumatic axonal injury of the brain, brain stem, and spinal cord injuries, and has potential as an additional indicator of traumatic head injury. A single study has reported that PAPP immunostaining of the optic nerve in CNS NAI reveals axonal damage. The purpose of our study was to explore further the utility of OAPP immunostaining of optic nerves for the detection of traumatic axonal injury. Methods: We used hematoxylin-eosin and PAPP immunostaining to evaluate the eyes and optic nerves in 18 cases of CNS nonaccidental blunt force head injury, 4 cases of homicidal blunt force abdominal injury (BFAI), 1 homicidal suffocation, 1 case of sudden infant death syndrome, 1 near-drowning, 1 overlay (clinical history: "found under sleeping mother in bed"), 1 motor vehicle accident, and 6 natural deaths in children ! 5 years of age. Results: Evaluation of the cases of CNS NAI revealed 17 of 18 (94%) with subdural hemorrhage; 15 of 18 (83%), subarachnoid hemorrhage; 17 of 18 (94%), retinal hemorrhage; 16 of 18 (88%), perioptic nerve hemorrhage; and 6 of 18 (33%), optic nerve PAPP immunoreactive axonal swellings. The only nontraumatic case that demonstrated PAPP immunoreactive axonal swellings was the near-drowning. No cases of BFAI, suffocation, overlay, or natural deaths revealed any retinal or perioptic nerve hemorrhage or significant optic nerve PAPP immunoreactivity. Global hypoxic-ischemic injury was present in 21 cases, of which 19 had evidence of brain swelling, and 7 demonstrated PAPP immunoreactive axonal swellings. Conclusions: These findings confirm the presence of optic nerve axonal injury in some cases of fatal pediatric CNS NAI. (C) 2004 by the American Academy of Ophthalmology.	Univ Texas, SW Med Sch, Dept Pathol, Neuropathol Lab, Dallas, TX 75230 USA; Univ Texas, SW Med Sch, Dept Pathol, Immunohistochem Lab, Dallas, TX 75230 USA; Univ Texas, SW Med Sch, Dept Ophthalmol, Dallas, TX 75230 USA; SW Inst Forens Sci, Dallas, TX USA		Reichard, RR (corresponding author), Univ New Mexico, Off Med Investigator, MSC11 6030,1, Albuquerque, NM 87131 USA.	Ross@ud.net	White, Charles L/AAJ-1858-2021	White, Charles L/0000-0002-3870-2804			Anderson RH, 2001, CARDIOL YOUNG, V11, P1, DOI 10.1017/S1047951100012348; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Foster BS, 1997, ARCH OPHTHALMOL-CHIC, V115, P623, DOI 10.1001/archopht.1997.01100150625008; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Gentleman SM, 1999, NEUROPATH APPL NEURO, V25, P41; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; Gleckman AM, 2000, ARCH PATHOL LAB MED, V124, P251; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hoyert DL, 2001, PEDIATRICS, V108, P1241, DOI 10.1542/peds.108.6.1241; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; MCLEOD D, 1980, BRIT J OPHTHALMOL, V64, P247, DOI 10.1136/bjo.64.4.247; MORIN PJ, 1993, J NEUROCHEM, V61, P464; Reichard RR, 2003, J NEUROPATH EXP NEUR, V62, P237, DOI 10.1093/jnen/62.3.237; Reichard RR, 2003, J NEUROTRAUM, V20, P347, DOI 10.1089/089771503765172309; TSO MOM, 1977, ARCH OPHTHALMOL-CHIC, V95, P1448, DOI 10.1001/archopht.1977.04450080158022	17	7	9	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	APR	2004	111	4					822	827		10.1016/j.ophtha.2003.07.016			6	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Ophthalmology	809BX	WOS:000220613300030	15051219				2022-02-06	
J	Elovic, EP				Elovic, EP			Anterior pituitary dysfunction after traumatic brain injury, Part II	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							PREVALENCE; SECONDARY		Kessler Med Rehabil Res & Educ Corp, TBI Res Lab, W Orange, NJ 07052 USA		Elovic, EP (corresponding author), Kessler Med Rehabil Res & Educ Corp, TBI Res Lab, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	eelovic@kmrrec.org					Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BHASIN S, 2003, WILLIAMS TXB ENDOCRI, P771; Citron JT, 1996, J UROLOGY, V155, P529, DOI 10.1016/S0022-5347(01)66441-3; GRIFFINJE, 2003, WILLIAMS TXB ENDOCRI, P709; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Larsen P.R., 2003, WILLIAMS TXB ENDOCRI, P331; LARSEN PR, 2003, WILLIAMS TXB ENDOCRI, P423; Larsen PR, 2003, WILLIAMS TXB ENDOCRI, P491, DOI 10.1097/00060793-200106000-00001; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Melmed S, 2003, WILLIAMS TXB ENDOCRI, P177	10	7	8	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2004	19	2					184	187		10.1097/00001199-200403000-00010			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	809NR	WOS:000220643900010	15247828				2022-02-06	
J	Sanchez, CM; Suarez, MA; Nebra, A; Gutierrez, I; Guallart, A; Millaste, A				Sanchez, CM; Suarez, MA; Nebra, A; Gutierrez, I; Guallart, A; Millaste, A			Early activation of coagulation and fibrinolysis in traumatic brain injury and spontaneous intracerebral hemorrhage: a comparative study	NEUROLOGIA			Spanish	Article						thrombin-antithrombin III complex; D-dimer; 1+2 thrombin fragment; cerebral hemorrhage; head injury	DISSEMINATED INTRAVASCULAR COAGULATION; SEVERE HEAD-INJURY; TISSUE FACTOR; COAGULOPATHY; AGE; HYPERCOAGULABILITY; PROCOAGULANT; FAILURE; STROKE; SCALE	Introduction. Traumatic brain injury (TBI) and spontaneous intracerebral hemorrhage (SIH) are associated with acute brain injury. Both increase intracranial pressure because of hemorrhages which activate the coagulation system. The relationship between acute brain injury and coagulation activation can be explained by the tissue factor release from the damaged brain to the circulation. This problem has been addressed in several studies, though detailed investigations are lacking mainly in SIR Objective. To study the activation of hemostasis in a group of patients with TBI and with SIH. Patients and methods. Prospective observational study. Seventy-five intensive care patients were divided in two groups. The first group (n = 45) included TBI and the second (n = 30) SIH. There were 40 healthy persons as a control group. Thrombin-antithrombin M complex, D-dimer and 1 + 2 thrombin fragment levels were measured. Results. All the studied markers were significantly higher in the two patient groups. Thrombin-antithrombin III complex-dimer were significantly higher in TBI. We have and D confirmed a relationship between higher levels of markers and The injury severity, measured with the Glasgow coma scale. Conclusions. Acute brain injury secondary to TBI and SIH activates coagulation system and fibrinolysis early. This activation attempts to achieve a hemostasia status. The activation is more intense in patients with low Glasgow coma scores on admission.	Hosp Obispo Polanco, Unidad Cuidados Intensivos, Teruel, Spain; Hosp Clin Univ Lozano Biesa, Serv Med Intens, Zaragoza, Spain		Sanchez, CM (corresponding author), Juan Salvador 3,4 D, Teruel 44002, Spain.	cmsp@wanadoo.es					BACH R, 1981, J BIOL CHEM, V256, P8324; BREDBACKA S, 1994, J NEUROSURG ANESTH, V6, P75; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; FRANKE CL, 1992, CEREBROVASC DIS, V2, P365, DOI 10.1159/000109044; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; HURSTING MJ, 1993, CLIN CHEM, V39, P683; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; LANDI G, 1987, NEUROLOGY, V37, P1667, DOI 10.1212/WNL.37.10.1667; Lee KR, 1996, ACTA NEUROCHIR, V138, P396, DOI 10.1007/BF01420301; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lowe GDO, 1997, BRIT J HAEMATOL, V97, P775, DOI 10.1046/j.1365-2141.1997.1222936.x; Marshall LF, 1991, J NEUROSURG S, V75, P14; MCGEHEE WG, 1968, SURG CLIN N AM, V48, P1247; MULLERBERGHAUS G, 1989, SEMIN THROMB HEMOST, V15, P58, DOI 10.1055/s-2007-1002690; NEMERSON Y, 1995, THROMB HAEMOSTASIS, V74, P180; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; SORENSEN JV, 1993, SCAND J CLIN LAB INV, V53, P659, DOI 10.3109/00365519309092568; SUZUKI M, 1994, THROMB HAEMOSTASIS, V71, P155; Takahashi H, 1997, J NEUROSURG, V86, P768, DOI 10.3171/jns.1997.86.5.0768; Takahashi H, 2000, J TRAUMA, V49, P86, DOI 10.1097/00005373-200007000-00013; TAKAHASHI H, 1996, NO TO SHINKEI, V48, P1009; TEASDALE G, 1974, LANCET, V2, P81; ten Cate H, 1993, New Horiz, V1, P312; VANWERSCH JWJ, 1993, EUR J CLIN CHEM CLIN, V31, P575; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003; VECHT CJ, 1975, J NEUROL NEUROSUR PS, V38, P567, DOI 10.1136/jnnp.38.6.567	30	7	12	0	3	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0213-4853	1578-1968		NEUROLOGIA	Neurologia	MAR	2004	19	2					44	52					9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	808AI	WOS:000220541600002	14986179				2022-02-06	
J	Borges, N; Cerejo, A; Santos, A; Sarmento, A; Azevedo, I				Borges, N; Cerejo, A; Santos, A; Sarmento, A; Azevedo, I			Changes in rat cerebral mitochondrial succinate dehydrogenase activity after brain trauma	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						brain trauma; mitochondria; morphology; peroxysome; TTC	CULTURED HIPPOCAMPAL-NEURONS; LIPID-PEROXIDATION; INJURY; MODEL; QUANTIFICATION; DISRUPTION; METABOLISM; DENDRITES; MOVEMENT; ISCHEMIA	The objective of this study was to evaluate 2,3,5-triphenyltetrazolium chloride (TTC) staining in the brain tissue of rats submitted to a closed head traumatic injury, in comparison to control rats not submitted to trauma. The closed head, weight drop trauma model described by Marmarou et al. (1994) was used. Animals were all sacrificed 24 h after trauma. Staining of cerebral coronal slices using TTC, coupled to image analysis software, was used to measure the level of staining. An ultrastructural study of the brain region underneath the impact zone, as well as from the correspondent region of control rats, was also done. The TTC image analysis revealed a significant decrease in the percentage of white area, in traumatized rats (mean +/- SEM 23.93% +/- 2.26, n = 4 for control, 12.13% +/- 1.72, n = 9 for traumatized rats, p < .05). The ultrastructural analysis revealed that the number of axons showing at least one mitochondrion was significantly higher in the trauma group (mean &PLUSMN; SEM 49.3%, n = 4 rats, 75 photographs, 2443 axons) than in control groups (23%, n = 3 rats, 30 photographs, 6220 axons, (p < .001). Another difference observed was the larger mitochondrial size in the axons of traumatized rats (mean diameter +/- SEM 0.520 +/- 0.003 pin) compared to the controlled rats (0.368 +/- 0.006 mum; p < .001). The ultrastructural observation of the traumatized brain revealed a significantly higher number of peroxisomes per photograph (mean number &PLUSMN; SEM 10.58 &PLUSMN; 1.18, n = 75) compared to the control group (0.19 &PLUSMN; 0.08, n = 30, p < .001). The results indicate an increase of mitochondrial and peroxysomal relative mass, with a higher succinate dehydrogenase activity, 24 h after the induction of traumatic brain injury.	Fac Med, Inst Pharmacol & Therapeut, Oporto, Portugal; Fac Med, Serv Bioquim, Oporto, Portugal		Borges, N (corresponding author), Univ Porto, Fac Ciencias Nutr & Alimentacao, Rua Dr Roberto Frias, P-4200465 Oporto, Portugal.		Borges, Nuno/K-7051-2013; Cerejo, Antonio/AAT-7863-2020; Sarmento, Antonio/M-5235-2013	Cerejo, Antonio/0000-0001-9136-873X; Borges, Nuno/0000-0001-6357-0615; Sarmento, Antonio/0000-0001-5269-7231; Santos, Alejandro/0000-0003-0706-5301			AZEVEDO I, 1981, BLOOD VESSELS, V18, P110; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BOSE B, 1988, STROKE, V19, P28, DOI 10.1161/01.STR.19.1.28; Castejon OJ, 2000, BRAIN INJURY, V14, P303; COHADON F, 1991, J NEUROL SCI, V103, pS27; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; HEINEL LA, 1994, BRAIN RES BULL, V34, P137, DOI 10.1016/0361-9230(94)90010-8; Hsiang JNK, 1997, ACTA NEUROCHIR, V139, P464, DOI 10.1007/BF01808884; KARNOVASKY MORRIS J., 1967, J CELL BIOL, V35, P213, DOI 10.1083/jcb.35.1.213; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kraus J, 1996, NEUROTRAUMA, P13; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Ligon LA, 2000, J COMP NEUROL, V427, P340, DOI 10.1002/1096-9861(20001120)427:3<340::AID-CNE2>3.0.CO;2-Y; Ligon LA, 2000, J COMP NEUROL, V427, P351, DOI 10.1002/1096-9861(20001120)427:3<351::AID-CNE3>3.0.CO;2-R; LISZCZAK TM, 1984, ACTA NEUROPATHOL, V65, P150, DOI 10.1007/BF00690469; Maciel EN, 2001, J NEUROCHEM, V79, P1237, DOI 10.1046/j.1471-4159.2001.00670.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McDonald RPA, 1999, NEUROREPORT, V10, P1875, DOI 10.1097/00001756-199906230-00014; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; Regner A, 2001, J NEUROTRAUM, V18, P783, DOI 10.1089/089771501316919148; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067	30	7	9	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	FEB	2004	114	2					217	227		10.1080/00207450490249419			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	769RH	WOS:000188663200007	14702209				2022-02-06	
J	Ondrejcak, T; Vanicky, I; Galik, J				Ondrejcak, T; Vanicky, I; Galik, J			Ischemic preconditioning does not improve neurological recovery after spinal cord compression injury in the rat	BRAIN RESEARCH			English	Article						trauma; ischemic preconditioning; spinal cord; rat	WHITE-MATTER; NEURONAL DAMAGE; REPERFUSION INJURY; CEREBRAL-ISCHEMIA; AORTIC OCCLUSION; SECONDARY INJURY; BRAIN-INJURY; BLOOD-FLOW; CELL-DEATH; TOLERANCE	Ischemic preconditioning (IPC) has been defined as the endogenous cellular protective mechanism evoked by brief ischemic periods. IPC renders the tissue of the central nervous system more resistant to subsequent lethal ischemic insults, and similar protective effect of IPC has been observed after experimental traumatic brain injury. Spinal cord trauma differs from cerebral trauma in that the secondary processes are damaging mostly the white matter. In the present study, we have tested the hypothesis that a transient non-lethal ischemic insult would improve outcomes after subsequent traumatic spinal cord injury (SCI). In the IPC group, 5-min spinal cord ischemia has been induced by aortic occlusion combined with hypotension. Forty-eight hours after IPC, moderate spinal cord injury has been induced by epidural balloon inflation at T8 level. Control group underwent identical surgical procedures without ischemia followed by SCI after 48 h. During the 4-week survival, locomotor performance of all rats was repeatedly tested and evaluated according to BBB scale. After 4 weeks, the animals were perfusion-fixed for histopathology, and morphometric analyses were performed in order to quantify the extent of the spinal cord lesion. All animals were completely paraplegic after SCI, and showed partial neurological recovery during their survival period. No significant differences were detected either in neurological scores or in morphometric measurements after 4 weeks, survival. These results indicate that in contrary to cerebral trauma, IPC does not improve the outcome after SCI. (C) 2003 Elsevier BV All rights reserved.	Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia; Iowa State Univ, Coll Vet Med, Ames, IA USA		Ondrejcak, T (corresponding author), Slovak Acad Sci, Inst Neurobiol, Soltesovej 4, Kosice 04001, Slovakia.		Vanicky, Ivo/ABB-2298-2021; Galik, Jan/I-2324-2016	Galik, Jan/0000-0001-9581-9585			Abraham VS, 2000, ANN THORAC SURG, V69, P475, DOI 10.1016/S0003-4975(99)01301-6; AKI T, 1984, SPINE, V9, P800, DOI 10.1097/00007632-198411000-00006; Barone FC, 1998, STROKE, V29, P1937, DOI 10.1161/01.STR.29.9.1937; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; de Haan P, 2000, J THORAC CARDIOV SUR, V120, P513, DOI 10.1067/mtc.2000.106836; Deng WB, 2003, P NATL ACAD SCI USA, V100, P6801, DOI 10.1073/pnas.1136624100; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Fan T, 1999, SURG NEUROL, V52, P299, DOI 10.1016/S0090-3019(99)00082-8; Fitch MT, 1999, J NEUROSCI, V19, P8182; GLAZIER SS, 1994, J CEREBR BLOOD F MET, V14, P545, DOI 10.1038/jcbfm.1994.68; Gottlieb M, 2000, J CEREBR BLOOD F MET, V20, P678, DOI 10.1097/00004647-200004000-00005; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Ishida T, 1997, SHOCK, V8, P86, DOI 10.1097/00024382-199708000-00003; Ito T, 1997, ACTA NEUROPATHOL, V93, P13; Jarmundowicz W, 1997, Neurol Neurochir Pol, V31, P1167; KATO H, 1991, BRAIN RES, V553, P238, DOI 10.1016/0006-8993(91)90831-F; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; KIRINO T, 1991, J CEREBR BLOOD F MET, V11, P299, DOI 10.1038/jcbfm.1991.62; KITAGAWA K, 1991, BRAIN RES, V561, P203, DOI 10.1016/0006-8993(91)91596-S; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; Lee HT, 1996, J SURG RES, V63, P29, DOI 10.1006/jsre.1996.0217; LIU Y, 1992, BRAIN RES, V586, P121, DOI 10.1016/0006-8993(92)91380-W; MARSALA M, 1994, J CEREBR BLOOD F MET, V14, P604, DOI 10.1038/jcbfm.1994.75; Masada T, 2001, J CEREBR BLOOD F MET, V21, P22, DOI 10.1097/00004647-200101000-00004; Matsuyama K, 1997, ANN THORAC SURG, V63, P1315, DOI 10.1016/S0003-4975(97)00104-5; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; McCallion K, 2000, SHOCK, V14, P429, DOI 10.1097/00024382-200014040-00002; Munyao N, 1998, NEUROREPORT, V9, P321, DOI 10.1097/00001756-199801260-00026; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Perez-Pinzon MA, 1999, NEUROREPORT, V10, P2951, DOI 10.1097/00001756-199909290-00014; PerezPinzon MA, 1996, NEUROSCIENCE, V75, P687; PerezPinzon MA, 1997, J CEREBR BLOOD F MET, V17, P175, DOI 10.1097/00004647-199702000-00007; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; SCHURR A, 1987, FEBS LETT, V224, P4, DOI 10.1016/0014-5793(87)80411-8; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; Taira Y, 1996, STROKE, V27, P1850, DOI 10.1161/01.STR.27.10.1850; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tekkok SB, 2001, J NEUROSCI, V21, P4237, DOI 10.1523/JNEUROSCI.21-12-04237.2001; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Warden P, 2001, EXP NEUROL, V168, P213, DOI 10.1006/exnr.2000.7622; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; Zhang C, 2002, INVEST OPHTH VIS SCI, V43, P3059; Zvara DA, 1999, ANN THORAC SURG, V68, P874, DOI 10.1016/S0003-4975(99)00559-7	47	7	10	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JAN 9	2004	995	2					267	273		10.1016/j.brainres.2003.10.009			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	760XV	WOS:000187861300014	14672817				2022-02-06	
J	di Bartolomeo, S; Sanson, G; Nardi, G; Michelutto, V; Scian, F				di Bartolomeo, Stefano; Sanson, Gianfranco; Nardi, Giuseppe; Michelutto, Vanni; Scian, Franca			Inadequate ventilation of patients with severe brain injury: a possible drawback to prehospital advanced trauma care?	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Brain; carbon dioxide; injury; intubation; prehospital; trauma; ventilation	BLOOD-GASES	Objectives: To assess the appropriateness of arterial carbon dioxide tension control in a group of 92 patients with traumatic brain injury who, despite receiving advanced prehospital care, showed no improved outcome in comparison with a group homogeneous but for a lower level of prehospital care. Methods: A retrospective registration of the early in-hospital arterial carbon dioxide tension of the patients intubated and ventilated on scene. Patients were excluded if the arterial carbon dioxide tension did not reflect prehospital ventilation or its alteration might have been intentional or unavoidable. Results: Arterial carbon dioxide tension was normal (35-45mmHg) in only six of the 16 suitable cases (37.5%), was elevated (> 45mmHg) in three cases (18.75%), low (25-35mmHg) in five cases (31.25%), and extremely low (< 25mmHg) in two cases (12.5%). Conclusion: Potentially dangerous alterations in capnia occurred in the majority of patients analysed. The possible consequences and causes are discussed. Further studies are needed to assess the consequences of any deviation from ideal standards, and to set realistic standards of arterial carbon dioxide tension control during prehospital ventilation. (c) 2003 Lippincott Williams & Wilkins.	[di Bartolomeo, Stefano] Az Osp SM Misericordia, Anaesthesia & Intens Care, I-33100 Udine, Italy; [Sanson, Gianfranco] Osped Cattinara, Pronto Soccorso, I-34100 Trieste, Italy; [Nardi, Giuseppe] Osped S Camillo Forlanini, Shock & Trauma Unit, I-00147 Rome, Italy; [Michelutto, Vanni] Osp SM Misericordia, Anaesthesia & Intens Care, I-33100 Udine, Italy; [Scian, Franca] Osped SM Angeli, Serv Anestesia, I-33080 Pordenone, Italy		di Bartolomeo, S (corresponding author), Azienda Osped SMd Misericordia, Serv Anesthesia & Intens Care 2, Piazza SM Misericordia, I-33100 Udine, Italy.	dibartolomeo.stefano@aoud.sanita.fvg.it	Di Bartolomeo, Stefano/K-1695-2016	Di Bartolomeo, Stefano/0000-0002-3468-9358; Sanson, Gianfranco/0000-0001-8319-635X			Bullock R, 1995, GUIDELINES MANAGEMEN; Bullock RM, 2000, J NEUROTRAUM, V17, P513; Davey A L, 2001, Air Med J, V20, P27, DOI 10.1067/mmj.2001.116993; David JS, 1999, ANN FR ANESTH, V18, P398, DOI 10.1016/S0750-7658(99)80087-2; Di Bartolomeo S, 2001, ARCH SURG-CHICAGO, V136, P1293, DOI 10.1001/archsurg.136.11.1293; GERVAIS HW, 1987, CRIT CARE MED, V15, P761, DOI 10.1097/00003246-198708000-00010; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; PFENNINGER EG, 1991, ACTA ANAESTH SCAND, V35, P148, DOI 10.1111/j.1399-6576.1991.tb03263.x; Rhoades Carol, 2002, Air Med J, V21, P43, DOI 10.1016/S1067-991X(02)70085-0; Thomas SH, 2002, J TRAUMA, V52, P47, DOI 10.1097/00005373-200201000-00010; Wayne M A, 2001, Prehosp Emerg Care, V5, P73, DOI 10.1080/10903120190940371; Weiland S, PREHOSPITAL EARLY HO	12	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	DEC	2003	10	4					268	271		10.1097/01.mej.0000103466.32882.7b			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	V40ZX	WOS:000209517600005	14676502				2022-02-06	
J	Dvir, Z; Penso-Zabludowski, E				Dvir, Z; Penso-Zabludowski, E			The effects of protocol and test situation on maximal vs. submaximal cervical motion: medicolegal implications	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						cervical spine; motion; protocol; effort; feigning	ACUTE WHIPLASH INJURY; PAIN	The objectives of this study were to examine the influence of the measurement protocol on the range and consistency of cervical motion (CM) in maximal vs. feigned limitation of CM, to explore some cognitive aspects of the feigning performance and to assess the effect of imagined pain vs. financial gain as a stimulus for the submaximal performance. The directions of flexion, extension, right and left rotation and right and left lateral flexion were measured in 26 normal subjects. Four protocols were compared: performance of CM with eyes open vs. eyes closed and testing at either a repetitive (within direction) or random (among directions) order. In each direction three measurements were recorded. Subjects were initially asked to move the head maximally, they were then presented with a vignette describing a fictitious accident involving the neck and were told to feign CM limitation in order to achieve unlawful compensation. In the third part, subjects were instructed to limit CM due to an imagined severe pain applying the repetitive order-eyes open paradigm only. Maximal CM paradigms were associated with significantly larger range (p=0.0000) and higher consistency (p=0.0000) compared the feigning paradigms. The eyes open-repetitive order protocol best separated between maximal and feigned performance. It was also indicated that the majority of subjects used the sensation of tension in the neck region as a cue for feigning while attempting to be as consistent as possible. Compared to feigning motivated by financial gain, limitation due to imagined pain resulted in significantly greater CM reductions and lesser consistency. The findings suggest that while feigning of motion impairment is probably based on somato-sensory input, the preferred CM testing protocol should consist of within direction repetitive movements with eyes open.	Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, IL-69978 Tel Aviv, Israel		Dvir, Z (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, IL-69978 Tel Aviv, Israel.	zdvir@post.tau.ac.il					Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Castro WHM, 2001, INT J LEGAL MED, V114, P316, DOI 10.1007/s004140000193; Dall'Alba PT, 2001, SPINE, V26, P2090, DOI 10.1097/00007632-200110010-00009; DOEGE TC, 1993, GUIDES EVALUATION PE, P116; Dvir Z, 2000, CLIN BIOMECH, V15, P658, DOI 10.1016/S0268-0033(00)00033-4; Dvir Z, 2001, SPINE, V26, P1680, DOI 10.1097/00007632-200108010-00010; DVIR Z, 2004, UNPUB CLIN J PAIN; Dvir Zeevi, 2002, Physiother Res Int, V7, P136, DOI 10.1002/pri.250; DVORAK J, 1992, SPINE, V17, pS393, DOI 10.1097/00007632-199210001-00009; HAINES F, 1999, P 1 WORLD C WHIPL AS, P90; Kasch H, 2001, SPINE, V26, P1246, DOI 10.1097/00007632-200106010-00014; Kasch H, 2001, NEUROLOGY, V56, P1637, DOI 10.1212/WNL.56.12.1637; Osterbauer P J, 1996, J Manipulative Physiol Ther, V19, P231; POLATIN PB, 1992, HDB PAIN ASSESSMENT, P32; Trott PH, 1996, CLIN BIOMECH, V11, P201, DOI 10.1016/0268-0033(95)00072-0	15	7	7	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	DEC	2003	117	6					350	355		10.1007/s00414-003-0402-7			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	746YZ	WOS:000186777800006	14574591				2022-02-06	
J	Bell, KR; Esselman, P; Garner, MD; Doctor, J; Bombardier, C; Johnson, K; Temkin, N; Dikmen, S				Bell, KR; Esselman, P; Garner, MD; Doctor, J; Bombardier, C; Johnson, K; Temkin, N; Dikmen, S			The use of a World Wide Web-based consultation site to provide support to telephone staff in a traumatic brain injury demonstration project	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; delivery of health care; rehabilitation; telecommunications; telemedicine	HEALTH INFORMATION; INTERNET; TECHNOLOGY; DISTANCE	Objectives: Distance from expertise in traumatic brain injury (TBI) is often an impediment to appropriate TBI care from local health care providers, especially in rural areas. To overcome this barrier to care and to support a randomized, controlled trial of telephone follow-up after discharge from acute rehabilitation, we demonstrated the use of a confidential consultation Web site to provide expert recommendations and advice to front-line telephone staff at a different site. Conclusions: This use of Internet communication proved convenient to all users, improved client confidence, and served as an excellent training tool to less experienced staff. In addition, use of a Web-based consultation method provided for archiving of all discussions for later review.	Univ Washington, Dept Rehabil Med, Sch Social Work, Seattle, WA 98195 USA; Univ Washington, Dept Med Educ & Med Informat, Sch Social Work, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg & Biostat, Sch Social Work, Seattle, WA 98195 USA		Bell, KR (corresponding author), Univ Washington, Dept Rehabil Med, Sch Social Work, Box 356490,1959 Pacific Ave, Seattle, WA 98195 USA.	krbell@u.washington.edu	Bombardier, Charles H./AAZ-3260-2021	Bombardier, Charles H./0000-0003-4758-6283; Bell, Kathleen/0000-0002-0928-2046			Balas EA, 1997, JAMA-J AM MED ASSOC, V278, P152, DOI 10.1001/jama.278.2.152; Berland GK, 2001, JAMA-J AM MED ASSOC, V285, P2612, DOI 10.1001/jama.285.20.2612; Capner M, 2000, J TELEMED TELECARE, V6, P311, DOI 10.1258/1357633001935969; Cunningham JA, 2000, J STUD ALCOHOL, V61, P794, DOI 10.15288/jsa.2000.61.794; Gray J, 1998, J AM MED INFORM ASSN, P351; Gustafson DH, 1999, AM J PREV MED, V16, P1, DOI 10.1016/S0749-3797(98)00108-1; Liss HJ, 2002, REHABIL PSYCHOL, V47, P8, DOI 10.1037/0090-5550.47.1.8; Lissman TL, 2001, PSYCHIAT SERV, V52, P1046, DOI 10.1176/appi.ps.52.8.1046; McKay HG, 2002, REHABIL PSYCHOL, V47, P31, DOI 10.1037/0090-5550.47.1.31; Spatz MA, 2000, B MED LIBR ASSOC, V88, P382; Tate DF, 2001, JAMA-J AM MED ASSOC, V285, P1172, DOI 10.1001/jama.285.9.1172; Welch PG, 2000, MIL MED, V165, P189, DOI 10.1093/milmed/165.3.189	12	7	7	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2003	18	6					504	511		10.1097/00001199-200311000-00004			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	747MX	WOS:000186809200004	14707880				2022-02-06	
J	Rinecker, M; Plesnila, N; Baethmann, A; Stoffel, M				Rinecker, M; Plesnila, N; Baethmann, A; Stoffel, M			Secondary growth of a cortical necrosis: effect of NOS inhibition by aminoguanidine post insult	ACTA NEUROCHIRURGICA			English	Article						aminoguanidine; brain injury; lesion growth; nitric oxide	NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN INJURY; COLD INJURY; RAT; LESION; EDEMA; EXPRESSION; BARRIER; SYSTEM; VOLUME	Background. A cortical tissue necrosis from a focal freezing injury expands to 140% of its initial volume within 24 hrs in rats. Previous studies of our laboratory have shown that administration of the NOS inhibitor aminoguanidine (AG) prior to trauma attenuates this process of secondary brain damage. Objective of the present study was to analyse whether this agent is also protective when treatment commences after the insult. Method. A highly standardized freezing lesion was induced in the brain cortex of 30 anaesthetized rats. The animals were divided into three experimental groups. Animals of group I (sham-5 min, n=10) were sacrificed 5 min after trauma for quantitative histomorphometric assessment of the primary cortical lesion. Animals of group II (sham-24 h, n=10) received isotonic saline (16.7 ml/kg b.w., i.p.) at 15 min and 8 hrs after trauma. In the treatment group (group III, AG-24 h, n=10), AG was administered (100 mg/kg b.w.) also at 15 min and 8 hrs after trauma. 24 hrs later - the time point of maximal lesion spread - the animals of group II and III were sacrificed for quantification of the secondary lesion growth. Findings. The focal freezing injury produced a cortical necrosis volume of 6.07+/-1.04 mm(3) immediately after trauma (group I). After sham treatment, the necrosis expanded to 8.39+/-1.57 mm(3) within 24 hrs (group II) corresponding to a lesion growth of 138% compared to the primary necrosis (p<0.01 vs. group I). In animals treated with AG after the trauma (group III), the volume of necrosis was significantly attenuated at 24 hrs to 6.77+/-0.87 mm(3) representing an expansion of the lesion to only 112% (p<0.05 vs. group II). Thus, AG was inhibiting the secondary growth of necrosis by no less than 69%. Interpretation. The findings demonstrate that AG retains its neuroprotective potential against secondary brain damage from trauma even when administration begins after trauma.	Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany; Univ Munich, Klinikum Grosshadern, Inst Surg Res, D-8000 Munich, Germany		Stoffel, M (corresponding author), Univ Bonn, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.	michael.stoffel@ukb.uni-bonn.de	Plesnila, Nikolaus/T-7522-2019				BAETHMANN A, 1988, CRIT CARE MED, V16, P972, DOI 10.1097/00003246-198810000-00008; Dogan A, 1999, J NEUROSURG, V90, P1078, DOI 10.3171/jns.1999.90.6.1078; EGGERT HR, 1985, NEUROSURGERY, V16, P443, DOI 10.1227/00006123-198504000-00001; ERISKAT J, 1994, ACTA NEUROCHIR, P425; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Gorlach C, 2000, PFLUG ARCH EUR J PHY, V440, P309; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; Knerlich F, 1999, MOL BRAIN RES, V68, P73, DOI 10.1016/S0169-328X(99)00064-9; KOENIG H, 1989, J NEUROCHEM, V52, P101, DOI 10.1111/j.1471-4159.1989.tb10903.x; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; LINDSBERG PJ, 1991, J CEREBR BLOOD F MET, V11, P88, DOI 10.1038/jcbfm.1991.10; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Nilsson BO, 1999, INFLAMM RES, V48, P509, DOI 10.1007/s000110050495; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Southan GJ, 1996, BRIT J PHARMACOL, V117, P619, DOI 10.1111/j.1476-5381.1996.tb15236.x; Stoffel M, 2002, NEUROSCI LETT, V324, P201, DOI 10.1016/S0304-3940(02)00196-9; Stoffel M, 2001, J NEUROTRAUM, V18, P425, DOI 10.1089/089771501750171010; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; UYLINGS HBM, 1986, J NEUROSCI METH, V18, P19, DOI 10.1016/0165-0270(86)90111-1; VONHOF S, 1997, THESIS L MAXIMILIANS; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WYRWICH W, 1997, THESIS L MAXIMILIANS	23	7	7	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2003	145	11					977	981		10.1007/s00701-003-0131-1			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	745JV	WOS:000186686300016	14628203				2022-02-06	
J	Shima, H; Fujisawa, H; Suehiro, E; Uetsuka, S; Maekawa, T; Suzuki, M				Shima, H; Fujisawa, H; Suehiro, E; Uetsuka, S; Maekawa, T; Suzuki, M			Mild hypothermia inhibits exogenous glutamate-induced increases in nitric oxide synthesis	JOURNAL OF NEUROTRAUMA			English	Article						glutamate neurotoxicity; hypothermia; microdialysis; nitrate; nitric oxide; nitrite	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; CORTICAL EXTRACELLULAR LEVELS; EXCITATORY AMINO-ACIDS; IN-VIVO MICRODIALYSIS; RAT-BRAIN; THERAPEUTIC HYPOTHERMIA; SYNTHASE INHIBITION; ARTERY OCCLUSION; CONTUSION TRAUMA	The purpose of this study was to investigate changes in nitric oxide (NO) synthesis induced by exogenous glutamate perfusion into the cerebral cortex, and the effects of mild hypothermia on this glutamate-induced NO synthesis. Glutamate-induced cortical lesions were produced by perfusion of 0.5 M glutamate solution via a microdialysis probe, and the extracellular concentrations of NO end-products (nitrite and nitrate) were measured by microdialysis in normothermic (37degreesC) and hypothermic (32degreesC) rats. The levels of NO end-products in the normothermia group were elevated markedly by glutamate perfusion, and this change was completely attenuated by the induction of hypothermia. The glutamate-induced increases were also attenuated markedly by both Nomega-nitro-L-arginine methyl ester (L-NAME) and 7-nitroindazole (7-NI). These results suggest that the perfusion of exogenous glutamate into the cortex induces NO synthesis, that is derived primarily from the activity of neuronal NO synthase. These results also demonstrate that hypothermia prevents this glutamate-induced increase in NO, suggesting that the protection afforded by the hypothermic condition is most likely linked to its inhibition of the glutamate-induced NO synthesis.	Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan; Yamaguchi Univ, Sch Med, Dept Crit Care Med, Ube, Yamaguchi 7558505, Japan		Suzuki, M (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosurg, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.		Suehiro, Eiichi/I-5852-2019				BABBEDGE RC, 1993, BRIT J PHARMACOL, V110, P225, DOI 10.1111/j.1476-5381.1993.tb13796.x; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BULLOCK R, 1993, GLUTAMATE TRANSMITTE, V36, P113; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUTCHER SP, 1990, STROKE, V21, P1727, DOI 10.1161/01.STR.21.12.1727; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DAWSON VL, 1993, J NEUROSCI, V13, P2651; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FUJISAWA H, 1993, BRAIN RES, V629, P73, DOI 10.1016/0006-8993(93)90483-4; Fujisawa H, 1996, J NEUROTRAUM, V13, P245, DOI 10.1089/neu.1996.13.245; Fujisawa H, 1999, J NEUROTRAUM, V16, P1083, DOI 10.1089/neu.1999.16.1083; FUJISAWA H, 2000, NEUROTRAUMA RES, V12, P14; FUJISAWA H, 1995, NEUROCHEMICAL MONITO, P36; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GRAHAM SH, 1990, NEUROSCI LETT, V110, P124, DOI 10.1016/0304-3940(90)90799-F; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; KADER A, 1994, NEUROSURGERY, V35, P272, DOI 10.1227/00006123-199408000-00013; Kamii H, 1996, J CEREBR BLOOD F MET, V16, P1153, DOI 10.1097/00004647-199611000-00009; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kirsch JR, 1997, STROKE, V28, P2259, DOI 10.1161/01.STR.28.11.2259; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; KUMURA E, 1994, J CEREBR BLOOD F MET, V14, P487, DOI 10.1038/jcbfm.1994.60; Lancelot E, 1998, NEUROSCI LETT, V242, P131, DOI 10.1016/S0304-3940(98)00095-0; Landolt H, 1998, J CLIN NEUROSCI, V5, P193, DOI 10.1016/S0967-5868(98)90037-6; LUO D, 1993, NEUROSCIENCE, V57, P897, DOI 10.1016/0306-4522(93)90035-E; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MOORE PK, 1993, BRIT J PHARMACOL, V110, P219, DOI 10.1111/j.1476-5381.1993.tb13795.x; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OHTA K, 1994, NEUROSCI LETT, V176, P165, DOI 10.1016/0304-3940(94)90073-6; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Regli L, 1996, J CEREBR BLOOD F MET, V16, P988, DOI 10.1097/00004647-199609000-00024; Sakamoto KI, 1997, J NEUROTRAUM, V14, P349, DOI 10.1089/neu.1997.14.349; Shibata M, 1996, BRAIN RES, V734, P86, DOI 10.1016/0006-8993(96)00617-8; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Suehiro E, 1999, J NEUROTRAUM, V16, P285, DOI 10.1089/neu.1999.16.285; Uetsuka S, 2002, J NEUROTRAUM, V19, P1105, DOI 10.1089/089771502760342009; Yamada K, 1997, J NEUROCHEM, V68, P1234; Yasuda H, 2001, EPILEPSIA, V42, P13, DOI 10.1046/j.1528-1157.2001.083032.x; YOSHIDA T, 1994, J CEREBR BLOOD F MET, V14, P924, DOI 10.1038/jcbfm.1994.123; YOSHIDA T, 1995, NEUROSCI LETT, V194, P214, DOI 10.1016/0304-3940(95)11752-I; ZHANG ZG, 1995, J CEREB BLOOD FLOW S, V15, pS90	47	7	8	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2003	20	11					1179	1187		10.1089/089771503770802862			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	747BE	WOS:000186784600003	14651805				2022-02-06	
J	Asthagiri, AR; Dumont, AS; Sheehan, JM				Asthagiri, AR; Dumont, AS; Sheehan, JM			Acute and long-term management of sports-related closed head injuries	CLINICS IN SPORTS MEDICINE			English	Article							NECK INJURIES; CONCUSSION; RETURN	Neurological complications afflicting athletes have been recognized since antiquity. Only more recently have both acute, and more important, long-term ramifications of athletic closed head injuries been more clearly defined. Consequently, closed head injuries sustained by athletes at all levels are becoming increasingly recognized, diagnosed, and managed appropriately through a multidisciplinary network of professionals, beginning on the field and extending through rehabilitation and long-term follow-up. This article addresses the acute and long-term management of athletic closed head injuries. The discussion includes historical evolution of injury management, epidemiology, pathophysiology/biomechanics, and classification schemes that provide a rational basis for the clinical evaluation and management of closed head injuries incurred in sports.	Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Div Neurosurg, Hershey, PA 17033 USA; Univ Virginia, Sch Med, Dept Neurol Surg, Charlottesville, VA 22908 USA		Sheehan, JM (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Div Neurosurg, 500 Univ Dr, Hershey, PA 17033 USA.	jsheehan@psu.edu					*AM COLL SURG, 1993, ADV TRAUM LIF SUPP M; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BAILES EB, 2001, NEUROLOGICAL SPORTS, P2; BAILES JE, 1991, NEUROSURGERY, V29, P491, DOI 10.1227/00006123-199110000-00001; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Barth JT, 1989, MILD HEAD INJURY, P257; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cantu RC, 1997, CLIN SPORT MED, V16, P531, DOI 10.1016/S0278-5919(05)70038-7; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Clarke KS, 1998, CLIN SPORT MED, V17, P1, DOI 10.1016/S0278-5919(05)70056-9; *CO MED SOC, 1991, REP SPORTS MED COMM; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colorado Medical Society School and Sports Medicine Committee, 1990, COLO MED, V87, P4; Harmon KG, 1999, AM FAM PHYSICIAN, V60, P887; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; JORDAN SE, 1996, ACTA NEUROL SCAND, V80, P150; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; MASTER JT, 1998, NEUROLOGY, V51, P791; MASTER JT, 1999, JAMA-J AM MED ASSOC, V282, P971; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; Meek T D, 1970, Tex Med, V66, P58; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Proctor MR, 2000, CLIN SPORT MED, V19, P693, DOI 10.1016/S0278-5919(05)70233-7; Tegner Y, 1996, BRIT J SPORT MED, V30, P251, DOI 10.1136/bjsm.30.3.251; THORNDIKE A, 1952, NEW ENGL J MED, V247, P554, DOI 10.1056/NEJM195210092471504; Warren WL, 1998, CLIN SPORT MED, V17, P13, DOI 10.1016/S0278-5919(05)70057-0; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401	38	7	8	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JUL	2003	22	3					559	+		10.1016/S0278-5919(02)00111-4			19	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	692LT	WOS:000183663100011	12852686				2022-02-06	
J	Hohlrieder, M; Hinterhoelzl, J; Ulmer, H; Lang, C; Hackl, W; Kampfl, A; Benzer, A; Schmutzhard, E; Gassner, R				Hohlrieder, M; Hinterhoelzl, J; Ulmer, H; Lang, C; Hackl, W; Kampfl, A; Benzer, A; Schmutzhard, E; Gassner, R			Traumatic intracranial hemorrhages in facial fracture patients: review of 2,195 patients	INTENSIVE CARE MEDICINE			English	Article						head trauma; facial fracture; intracranial hemorrhage; predictor; risk factor	MINOR HEAD-INJURY; COMPUTED TOMOGRAPHIC SCANS; EMERGENCY-DEPARTMENT; CLINICAL PREDICTORS; SKULL FRACTURE; COMA SCORE; HEMATOMA; MANAGEMENT; CHILDREN; RULE	Objective. Patients sustaining facial fractures are at risk for accompanying traumatic intracranial hematomas, which are a major cause of morbidity and mortality. Prompt recognition is crucial in improving patient survival and recovery. This study examined which simple clinical signs identify facial fracture patients at risk for intracranial hemorrhage before the performance of computed tomography. Design and methods. Retrospective study of 2,195 patients with facial fractures during a period of 7 years. By means of univariate and multivariate analysis clinical features potentially predictive for (a) intracranial hemorrhage and (b) surgery for intracranial hemorrhage were identified. Setting. Critical care units of anesthesiology and neurology, general traumatology, and oral and maxillofacial surgery in a level I trauma university hospital. Results. Seizures (OR 22.1) and vomiting/nausea (OR 20.2) were the strongest independent predictors of intracranial bleeding in facial fracture patients. For intracranial hemorrhages requiring surgical intervention closed head injuries (OR 9.75) and cranial vault fractures (OR 5.0) were the most significant risk factors. However, among those patients without vomiting/nausea and without seizures and without closed head injury (n=1,628), 20 patients (1.2%) suffered intracranial hemorrhage, and six (0.37%) of them required surgical intervention. Conclusions. Simple clinical symptoms, such as seizures, vomiting/nausea, history of a closed head injury or cranial vault fractures are strong predictors for intracranial hemorrhage in facial fracture patients. The early consideration of such important indicators allows us to detect patients at elevated risk of an intracranial hematoma requiring surgical intervention.	Univ Innsbruck, Dept Anesthesiol & Crit Care Med, A-6020 Innsbruck, Austria; Univ Innsbruck, Dept Neurol, Intens Care Unit, A-6020 Innsbruck, Austria; Univ Innsbruck, Dept Biostat, A-6020 Innsbruck, Austria; Univ Innsbruck, Dept Traumatol, A-6020 Innsbruck, Austria; Univ Innsbruck, Dept Oral & Maxillofacial Surg, A-6020 Innsbruck, Austria; Univ Pittsburgh, Dept Oral & Maxillofacial Surg, Pittsburgh, PA 15261 USA		Hohlrieder, M (corresponding author), Univ Innsbruck, Dept Anesthesiol & Crit Care Med, Anichstr 35, A-6020 Innsbruck, Austria.	matthias.hohlrieder@uibk.ac.at	Ulmer, Hanno/S-6615-2019	Ulmer, Hanno/0000-0001-5911-1002; Schmutzhard, Erich/0000-0003-3295-7491			ADEKEYE EO, 1980, J ORAL SURG, V38, P355; Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; Arienta C, 1997, SURG NEUROL, V48, P213, DOI 10.1016/S0090-3019(97)00019-0; BONADIO WA, 1989, AM J DIS CHILD, V143, P194, DOI 10.1001/archpedi.1989.02150140084025; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; CHAN KH, 1990, J NEUROSURG, V72, P189, DOI 10.3171/jns.1990.72.2.0189; Claassen J, 2001, CRIT CARE MED, V29, P494, DOI 10.1097/00003246-200103000-00005; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Egol A, 1999, CRIT CARE MED, V27, P633; GALBRAITH S, 1976, BMJ-BRIT MED J, V1, P1438, DOI 10.1136/bmj.1.6023.1438; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Hackl W, 2001, J TRAUMA, V50, P41, DOI 10.1097/00005373-200101000-00007; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; HAUG RH, 1994, J ORAL MAXIL SURG, V52, P729, DOI 10.1016/0278-2391(94)90488-X; Heard C, 2002, CRIT CARE MED, V30, P1403, DOI 10.1097/00003246-200206000-00059; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; Herrera EJ, 2000, CHILD NERV SYST, V16, P585, DOI 10.1007/s003810000340; HUELKE DF, 1983, J ORAL MAXIL SURG, V41, P241, DOI 10.1016/0278-2391(83)90266-5; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Maggi G, 1998, J Neurosurg Sci, V42, P95; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; MCCABE JB, 1984, AM J EMERG MED, V2, P333, DOI 10.1016/0735-6757(84)90130-X; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; MOHANTY SK, 1991, J TRAUMA, V31, P801, DOI 10.1097/00005373-199106000-00010; MORGAN B D G, 1972, British Journal of Plastic Surgery, V25, P147, DOI 10.1016/S0007-1226(72)80037-7; OLSON RA, 1982, J ORAL MAXIL SURG, V40, P23, DOI 10.1016/S0278-2391(82)80011-6; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; RAMUNDO ML, 1995, PEDIATR EMERG CARE, V11, P1, DOI 10.1097/00006565-199502000-00001; RIVARA F, 1987, PEDIATRICS, V80, P579; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; STEIN SC, 1993, ANN EMERG MED, V22, P1193, DOI 10.1016/S0196-0644(05)80989-8; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stiell IG, 2001, ANN EMERG MED, V38, P160, DOI 10.1067/mem.2001.116796; Stiell IG, 2001, ANN EMERG MED, V38, P317, DOI 10.1067/mem.2001.116795; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TAHERI PA, 1993, ARCH SURG-CHICAGO, V128, P289; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; Teasdale GM, 2000, INTENS CARE MED, V26, P153, DOI 10.1007/s001340050037; Tung TC, 2000, J TRAUMA, V49, P420, DOI 10.1097/00005373-200009000-00006; TURVEY TA, 1977, J ORAL SURG, V35, P887; Woisetschlager C, 2000, INTENS CARE MED, V26, P1561, DOI 10.1007/s001340000663	48	7	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	JUL	2003	29	7					1095	1100		10.1007/s00134-003-1804-1			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	698ZD	WOS:000184030000011	12768238				2022-02-06	
J	Marshall, RC; Karow, CM; Morelli, CA; Iden, KK; Dixon, J				Marshall, RC; Karow, CM; Morelli, CA; Iden, KK; Dixon, J			Problem-solving by traumatically brain injured and neurologically intact subjects on an adaptation of the twenty questions test	BRAIN INJURY			English	Article							FRONTAL-LOBE DAMAGE; INTERROGATIVE STRATEGIES; ASKING STRATEGIES; OLD-AGE; ADULTS; ALCOHOLICS; CHILDREN; DEFICITS; TASK; CLASSIFICATION	Primary objective: RAPS (Rapid Assessment of Problem-Solving) is a clinical measure for assessing verbal problem-solving in hard-to-test patients or those that may not be able to tolerate a longer, more detailed assessment. The design of the test is based on Mosher and Hornsby's Twenty Question test, but RAPS contains several modifications to facilitate its use with brain-injured individuals. This study used RAPS to compare the verbal problem-solving ability of subjects that were neurologically intact and subjects that bad chronic traumatic brain injuries. Methods and Procedures: Twenty-one adults that were neurologically intact (NI) and 21 adults that had incurred a traumatic brain injury (TBI) matched for age, gender and education took part in the study. Before being tested with RAPS, participants signed an IRB-approved consent form and completed a battery of neurocognitive measures. RAPS entailed the solving of three verbal problems. Each problem involved an array of 32 pictures of common objects (e.g. football) arranged in a 4 x 8 grid. The subjects were instructed to ask yes/no questions to determine which picture the examiner was 'thinking of'. Three scores were computed for each problem solved: number of questions asked, percentage of constraint-seeking questions, and question-asking efficiency scores for the first four questions. Outcomes: No learning effects across the problems were found for any of the RAPS measures. Scores were averaged across the three problems to determine group effects. Groups of TBI and NI subjects did not differ significantly in the number of questions asked in solving RAPS problems. Members of the NI group asked significantly more constraint-seeking questions (e.g. Is it an animal?) than those in the TBI group, and the subjects that had incurred brain injuries did more guessing than the NI group. Over 70% of the time, guessing took place after the semantic category containing the target picture was known to the subject. Guesses took the form of pseudo-constraint questions (e.g. Is it the animal with a long neck?) rather than frank guesses (e.g. Is it the giraffe?). These trends were seen for both groups. Question-asking efficiency scores, computed for the first four questions of each problem, reflected the amount of information gained by the subjects' questions. It was anticipated that subjects' questioning strategies would target larger rather than smaller number of pictures and systematically reduce the number of total pictures under consideration. Question-asking efficiency scores were significantly higher for the group of NI subjects. Both groups increased question-asking efficiency scores across the first four questions, and there was no significant group x question interaction. Further analysis of the question-asking efficiency scores revealed that questions from the group of NI subjects tended to target multiple categories of pictures and larger single semantic categories of pictures on the 32-item problem-solving board, whereas those from the group of TBI subjects often targeted smaller categories or portions of categories. Conclusions: Two meta-cognitive functions, planning and strategy shifting, appeared to explain most of the differences in the verbal problem-solving performance between the groups. Both groups, however, demonstrated a range of abilities on RAPS. Until a larger normative database for RAPS is available, it behooves clinicians using the test to analyse results on an individual basis, to consider the subject's pre-morbid problem-solving ability and to weigh those factors associated with brain injury that could affect RAPS performance.	Univ Kentucky, Dept Rehabil Sci, Lexington, KY 40536 USA; Univ Kentucky, Div Commun Disorders, Lexington, KY 40536 USA; Univ Rhode Isl, Dept Commun Disorders, Kingston, RI 02881 USA; Univ Florida, Gainesville, FL USA; Dept Vet Affairs Med Ctr, Providence, RI USA		Marshall, RC (corresponding author), Univ Kentucky, Dept Rehabil Sci, Room 110 B,Hlth Sci Bldg,900 S Limestone, Lexington, KY 40536 USA.						BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BARTON JA, 1988, J EDUC PSYCHOL, V80, P184, DOI 10.1037/0022-0663.80.2.184; BORYS SV, 1979, AM J MENT DEF, V84, P280; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Channon S, 1999, NEUROPSYCHOLOGIA, V37, P757, DOI 10.1016/S0028-3932(98)00138-9; CORNELIUS SW, 1987, PSYCHOL AGING, V2, P144, DOI 10.1037/0882-7974.2.2.144; DENNEY DR, 1975, J EXP CHILD PSYCHOL, V19, P476, DOI 10.1016/0022-0965(75)90077-6; DENNEY DR, 1973, DEV PSYCHOL, V8, P202, DOI 10.1037/h0034144; DENNEY DR, 1973, DEV PSYCHOL, V9, P275, DOI 10.1037/h0035092; DENNEY DR, 1972, CHILD DEV, V43, P820; DENNEY NW, 1982, J GERONTOL, V37, P190, DOI 10.1093/geronj/37.2.190; DENNEY NW, 1974, DEV PSYCHOL, V10, P458, DOI 10.1037/h0036444; DENNEY NW, 1985, INT J AGING HUM DEV, V21, P161, DOI 10.2190/A3J2-75L4-01C3-W81W; DENNEY NW, 1974, CHILD DEV, V45, P1108; DENNEY NW, 1981, J GERONTOL, V36, P323, DOI 10.1093/geronj/36.3.323; Dimitrov M, 1996, CORTEX, V32, P357, DOI 10.1016/S0010-9452(96)80057-8; GILLIS R, 1996, TRAUMATIC BRAIN INJU; GOLDMAN RS, 1988, J STUD ALCOHOL, V49, P142, DOI 10.15288/jsa.1988.49.142; GOLDSTEIN FC, 1991, BRAIN COGNITION, V17, P23, DOI 10.1016/0278-2626(91)90063-E; Goodglass H, 1983, ASSESSMENT APHASIA R; Grant D. A., 1993, WISCONSIN CARD SORTI; HARTLEY AA, 1983, J GERONTOL, V38, P72, DOI 10.1093/geronj/38.1.72; Kaplan E, 1983, BOSTON NAMING TEST; KESLER MS, 1976, HUM DEV, V19, P310, DOI 10.1159/000271537; LAINE M, 1982, DRUG ALCOHOL DEPEN, V10, P235, DOI 10.1016/0376-8716(82)90017-5; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; MARSHALL RC, CONV AM SPEECH LANG; MARSHALL RC, UNPUB J HEAD TRAUMA; MARSHALL RC, 1996, CLIN APHASIOLOGY, V24, P181; Merbitz CT, 2000, BEHAV INTERVENT, V15, P169, DOI 10.1002/1099-078X(200007/09)15:3<169::AID-BIN54>3.0.CO;2-5; Mosher F.A., 1966, STUDIES COGNITIVE GR, P86; O'Reilly MF, 2000, J VOCAT REHABIL, V14, P187; Rath JF, 2000, J HEAD TRAUMA REHAB, V15, P724, DOI 10.1097/00001199-200002000-00010; Raven J, COLOURED PROGR MATRI; ROSS D, 1986, ROSS INFORMATION PRO; SAARNIO P, 1993, ALCOHOL ALCOHOLISM, V28, P585; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SIEGLER RS, 1977, CHILD DEV, V48, P395, DOI 10.1111/j.1467-8624.1977.tb01176.x; SIMON HA, 1975, COGNITIVE PSYCHOL, V7, P268, DOI 10.1016/0010-0285(75)90012-2; VILKKI J, 1988, CORTEX, V24, P119, DOI 10.1016/S0010-9452(88)80020-0; Wechsler D, 1987, MEMORY SCALE REVISED; YORKSTON KM, 1980, J SPEECH HEAR DISORD, V45, P27, DOI 10.1044/jshd.4501.27	45	7	7	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2003	17	7					589	608		10.1080/0269905031000088496			20	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	690HG	WOS:000183541900005	12775271				2022-02-06	
J	Okonkwo, DO; Stone, JR				Okonkwo, DO; Stone, JR			Basic science of closed head injuries and spinal cord injuries	CLINICS IN SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN INJURY; CONTROLLED CORTICAL IMPACT; MODERATE FLUID-PERCUSSION; EXCITATORY AMINO-ACIDS; CENTRAL-NERVOUS-SYSTEM; CYTOCHROME-C RELEASE; CYCLOSPORINE-A; LIPID-PEROXIDATION; CLINICAL-TRIALS; POSTTRAUMATIC HYPOTHERMIA	Traumatic injury to the central nervous system is frequently associated with athletics. Although traumatic brain injuries are far more common among athletes, spinal cord injuries comprise a devastating component of sports-related CNS injury. Trends with respect to head and spinal cord injuries vary by sport, but the pathological mechanisms by which central nervous system injury occurs are common throughout multiple types of athletic competition. This article is a broad-based review of primary injury mechanisms in traumatic brain injury and spinal cord injury. We detail a subset of secondary injury mechanisms in traumatic brain injury and spinal cord injury, with attention to experimental therapeutic strategies targeting specific injury cascades. Each section concludes with a survey of experimental models currently employed in traumatic brain injury and spinal cord injury research.	Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA; Univ Virginia, Dept Neurol Surg, Charlottesville, VA 22908 USA		Okonkwo, DO (corresponding author), Univ Virginia, Dept Neurosci, POB 800212, Charlottesville, VA 22908 USA.						Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Attar A, 1998, NEUROL RES, V20, P353, DOI 10.1080/01616412.1998.11740531; Attar A, 2001, NEUROL RES, V23, P843, DOI 10.1179/016164101101199289; Barami K, 2000, NEUROSURGERY, V47, P691; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Bozbuga M, 1998, NEUROSURG REV, V21, P36, DOI 10.1007/BF01111483; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Buki A, 2000, J NEUROSCI, V20, P2825; Carlock KS, 1997, CLIN IMAG, V21, P411; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; CLIFTON G L, 1989, Journal of Neurotrauma, V6, P71, DOI 10.1089/neu.1989.6.71; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; CLIFTON GL, 1995, J NEUROTRAUM, V12, P923, DOI 10.1089/neu.1995.12.923; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; Dimar JR, 2000, SPINE, V25, P2294, DOI 10.1097/00007632-200009150-00006; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; DOPPENBERG EMR, 1997, ANN NY ACAD SCI, V825, P305; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GOETZ T, 1988, Journal of Neurotrauma, V5, P139, DOI 10.1089/neu.1988.5.139; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; HALL ED, 1993, RES P ARNMD, V71, P81; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoffmann C, 2000, CURR MED CHEM, V7, P1113, DOI 10.2174/0929867003374282; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kaufmann WE, 1997, PROSTAG OTH LIPID M, V54, P601, DOI 10.1016/S0090-6980(97)00128-7; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; Koc RK, 1999, SPINAL CORD, V37, P29, DOI 10.1038/sj.sc.3100732; KONTOS HA, 1989, CHEM-BIOL INTERACT, V72, P229, DOI 10.1016/0009-2797(89)90001-X; Kuida K, 2000, INT J BIOCHEM CELL B, V32, P121, DOI 10.1016/S1357-2725(99)00024-2; Lapchak PA, 2001, STROKE, V32, P1220, DOI 10.1161/01.STR.32.5.1220; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Maihofner C, 2000, NEUROSCIENCE, V101, P1093, DOI 10.1016/S0306-4522(00)00361-4; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL RJ, 1995, EUR J ANAESTH, V12, P5; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Movsesyan VA, 2001, EXP NEUROL, V167, P366, DOI 10.1006/exnr.2000.7567; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NIDA TY, 1995, J NEUROTRAUM, V12, P77, DOI 10.1089/neu.1995.12.77; Nishio S, 1997, ACT NEUR S, V70, P84; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; OSENBACH RK, 1989, PEDIATR NEUROSCI, V15, P168, DOI 10.1159/000120464; PANG D, 1989, J TRAUMA, V29, P654, DOI 10.1097/00005373-198905000-00021; PANG D, 1982, J NEUROSURG, V57, P114, DOI 10.3171/jns.1982.57.1.0114; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Resnick DK, 1998, J NEUROTRAUM, V15, P1005, DOI 10.1089/neu.1998.15.1005; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Robertson GS, 2000, BRAIN PATHOL, V10, P283, DOI 10.1111/j.1750-3639.2000.tb00262.x; SANADA T, 1993, J NEUROTRAUM, V10, P65, DOI 10.1089/neu.1993.10.65; SAUL TG, 1996, NEUROTRAUMA; Saunders NR, 1998, J NEUROSCI, V18, P339; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schwab JM, 2000, J NEUROIMMUNOL, V111, P122, DOI 10.1016/S0165-5728(00)00372-6; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Stein DG, 1991, J NEUROTRAUM, V8, P281, DOI 10.1089/neu.1991.8.281; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Taoka Y, 1997, J NEUROSURG, V86, P1007, DOI 10.3171/jns.1997.86.6.1007; TATOR CH, 2002, PRINCIPLES SPINAL SU, P2847; TATOR CH, 2002, NEUROSURGERY, P2847; Tymianski M, 1996, NEUROSURGERY, V38, P1176; WEBER ED, 1977, BRAIN RES, V125, P241, DOI 10.1016/0006-8993(77)90618-7; WEI EP, 1986, AM J PHYSIOL, V251, pH693, DOI 10.1152/ajpheart.1986.251.4.H693; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Xiong Y, 1997, J NEUROTRAUM, V14, P907, DOI 10.1089/neu.1997.14.907; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Yin XM, 2000, CELL RES, V10, P161, DOI 10.1038/sj.cr.7290045; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Yu CG, 2000, J NEUROSURG, V93, P85, DOI 10.3171/spi.2000.93.1.0085; Yu WR, 1999, ACTA NEUROPATHOL, V98, P15, DOI 10.1007/s004010051046; Yu WR, 2000, ACTA NEUROPATHOL, V100, P546, DOI 10.1007/s004010000206	95	7	7	0	7	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0278-5919			CLIN SPORT MED	Clin. Sports Med.	JUL	2003	22	3					467	+		10.1016/S0278-5919(02)00107-2			16	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	692LT	WOS:000183663100005	12852680				2022-02-06	
J	Albert, T; Yelnik, A				Albert, T; Yelnik, A			Physiotherapy for spasticity	NEUROCHIRURGIE			French	Article; Proceedings Paper	53rd Annual Congress of the Societe-de-Neurochirurgie-de-Langue-Francaise	MAY 09-12, 2003	TOZEUR, TUNISIA	Soc Neurochirurg Langue Francaise		spasticity; physiotherapy	BODY-WEIGHT SUPPORT; ELECTRICAL NERVE-STIMULATION; SPINAL-CORD INJURY; POSTSTROKE PARETIC ARM; HEMIPLEGIC PATIENTS; STROKE PATIENTS; HEMIPARETIC SUBJECTS; MOTOR FUNCTION; H-REFLEX; WALKING	The aims of physiotherapy techniques used for the treatment of spasticity are to favor sensorimotor recovery and gesture relearning and to lead to an optimal independence in daily life activities. For stroke and head injury patients, there are several techniques sometimes based on opposing principles. The concept of Bobath tries to inhibit the spastic paralysis and the associated reactions to improve the voluntary motricity of limbs with the ultimate goal of enabling exercises in a functional situation, sometimes after a very long period of therapy. On the contrary, according to the concept of Brunnstom, the goal of exercise is to strengthen the spastic paralysis and the associated reactions to enable the upright position and walking as soon as possible. This technique is especially used in very severe deficiencies where the aim is to avoid the bedridden situation. Three active principles can be identified for neurological rehabilitation. 1) Muscle tendon stretching on a regular basis inhibits short-term spasticity aid avoids hypoextensibilty and long-term muscular contracture. 2) Reinforcement of muscular contraction is proposed to the patient as soon as voluntary mechanical control is sufficient. 3) Relearning of prehension, body balance,, and locomotion is achieved by repeated acts which mimic daily life activities as close as possible. Early walking for subjects with hemiplegia and incomplete paraplegia can be performed with partial weight bearing. It is now established that this technique allows to obtain improved walking without increasing spasticity. Electrical stimulation is not used routinely by rehabilitation teams. It allows to reduce the spasticity of antagonist muscles working against stimulated muscles. It participates in improving the strength of contraction of weak muscles notably in subjects with incomplete paraplegia. Finally, it can be used to improve or replace a functional command (lifting the foot during walking, for example). Nevertheless, electrical stimulation cannot replace basic rehabilitation exercises.	Ctr Med Phys & Readapt Coubert, F-77257 Brie Comte Robert, France; GH Lariboisiere Fernand Widal, Serv Med Phys & Readaptat, Paris, France		Albert, T (corresponding author), Ctr Med Phys & Readapt Coubert, F-77257 Brie Comte Robert, France.	alain.velnik@lrb.ap-hop-paris.fr	yelnik, alain/B-6832-2016				Barbeau H, 1998, ANN NY ACAD SCI, V860, P377, DOI 10.1111/j.1749-6632.1998.tb09063.x; BASMAJIAN JV, 1987, ARCH PHYS MED REHAB, V68, P267; BOBATH B, HEMIPLEGIE ADULTE; Burridge JH, 1997, CLIN REHABIL, V11, P201, DOI 10.1177/026921559701100303; Burridge JH, 2000, J NEUROL NEUROSUR PS, V69, P353, DOI 10.1136/jnnp.69.3.353; CAREY JR, 1990, ARCH PHYS MED REHAB, V71, P888; CARR J, 2000, MOVEMENT SCI; Dodd KJ, 2002, ARCH PHYS MED REHAB, V83, P1157, DOI 10.1053/apmr.2002.34286; EDWARDS S, 1998, SPASTICITY REHAB; EDZARD E, 1990, STROKE, V21, P1081; ENGARDT M, 1995, ARCH PHYS MED REHAB, V76, P419, DOI 10.1016/S0003-9993(95)80570-2; Field-Fote EC, 2001, ARCH PHYS MED REHAB, V82, P818, DOI 10.1053/apmr.2001.23752; FUNG J, 1994, J NEUROPHYSIOL, V72, P2090, DOI 10.1152/jn.1994.72.5.2090; Goulet C, 1996, SCAND J REHABIL MED, V28, P169; GRANAT MH, 1993, PARAPLEGIA, V31, P207, DOI 10.1038/sc.1993.39; HALSTEAD LS, 1993, PARAPLEGIA, V31, P715, DOI 10.1038/sc.1993.113; HAN JS, 1994, CHINESE MED J-PEKING, V107, P6; Harvey LA, 2000, ARCH PHYS MED REHAB, V81, P1340, DOI 10.1053/apmr.2000.9168; Harvey LA, 2002, SPINAL CORD, V40, P1, DOI 10.1038/sj.sc.3101241; Hesse S, 1999, ARCH PHYS MED REHAB, V80, P421, DOI 10.1016/S0003-9993(99)90279-4; HUICHAN CWY, 1993, CAN J NEUROL SCI, V20, P97, DOI 10.1017/S0317167100047636; LEE KH, 1976, ARCH PHYS MED REHAB, V57, P311; LEVIN MF, 1992, ELECTROEN CLIN NEURO, V85, P131, DOI 10.1016/0168-5597(92)90079-Q; LOGIGIAN MK, 1983, ARCH PHYS MED REHAB, V64, P364; LORD JP, 1986, ARCH PHYS MED REHAB, V67, P88, DOI 10.1016/0003-9993(86)90108-5; Nilsson L, 2001, CLIN REHABIL, V15, P515, DOI 10.1191/026921501680425234; Nuyens GE, 2002, ARCH PHYS MED REHAB, V83, P930, DOI 10.1053/apmr.2002.33233; POTISK KP, 1995, SCAND J REHABIL MED, V27, P169; ROBINSON CJ, 1988, ARCH PHYS MED REHAB, V69, P862; Rossignol S, 2000, CURR OPIN NEUROBIOL, V10, P708, DOI 10.1016/S0959-4388(00)00151-3; Rouleaud S., 2000, Annales de Readaptation et de Medecine Physique, V43, P279, DOI 10.1016/S0168-6054(00)80003-3; Schmit BD, 2000, ARCH PHYS MED REHAB, V81, P269; SEIB TP, 1994, ARCH PHYS MED REHAB, V75, P746; Sharp SA, 1997, ARCH PHYS MED REHAB, V78, P1231, DOI 10.1016/S0003-9993(97)90337-3; Skold C, 2002, J REHABIL MED, V34, P25, DOI 10.1080/165019702317242677; Sonde L, 1998, SCAND J REHABIL MED, V30, P95; Sonde L, 2000, CLIN REHABIL, V14, P14, DOI 10.1191/026921500673534278; STEFANOVSKA A, 1988, SCAND J REHABIL MED, P115; THOUMIE P, 1995, PARAPLEGIA, V33, P647, DOI 10.1038/sc.1995.136; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; VISINTIN M, 1989, CAN J NEUROL SCI, V16, P315, DOI 10.1017/S0317167100029152; Wang RY, 2000, J REHABIL RES DEV, V37, P73; Weingarden HP, 1998, AM J PHYS MED REHAB, V77, P276, DOI 10.1097/00002060-199807000-00002; WERNIG A, 1995, EUR J NEUROSCI, V7, P823, DOI 10.1111/j.1460-9568.1995.tb00686.x; Yu Y, 1993, Zhonghua Yi Xue Za Zhi, V73, P593	45	7	8	1	19	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	MAY	2003	49	2-3	2				239	246					8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Surgery	679JM	WOS:000182917100012	12746698				2022-02-06	
J	Cahill, LM; Murdoch, BE; Theodoros, DG				Cahill, LM; Murdoch, BE; Theodoros, DG			Perceptual and instrumental analysis of laryngeal function after traumatic brain injury in childhood	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; dysarthria; instrumental assessment; laryngeal function; traumatic brain injury	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; CHILDREN; REORGANIZATION; DISORDERS; VOICE	Objective: To investigate laryngeal function and phonatory disturbance in children with traumatic brain injury (TBI), using both perceptual and instrumental techniques. Design and participants: The performance of 16 individuals with moderate to severe TBI acquired in childhood and 16 nonneurologicatly impaired control subjects was compared on a battery of perceptual (Frenchay Dysarthria Assessment, speech sample analysis) and instrumental (Aerophone II, laryngograph) assessments. Results and conclusions: As a group, the children with TBI demonstrated normal, or only minimally impaired laryngeal function, when compared with the control group, which contrasts with the significant laryngeal impairment noted in adults after TBI. Several reasons for the different findings in relation to laryngeal function in adults and children after TBI are postulated: (1) differing types of injury usually incurred by adults and children may result in a relatively decreased degree of neurologic impairment in these children, (2) differences in recovery potential between adults and children, and (3) the pediatric larynx is still developing, hence it may be better able to compensate for any impairment incurred.	Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld, Australia; Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia		Cahill, LM (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, St Lucia, Qld 4072, Australia.		Cahill, Louise/C-7919-2012; Theodoros, Deborah/F-1362-2010; Murdoch, Bruce E/C-1397-2012	Cahill, Louise/0000-0003-3662-896X			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Aronson A. E, 1990, CLIN VOICE DISORDERS; Baken RJ, 1987, CLIN MEASUREMENT SPE; BASSICH CJ, 1986, J SPEECH HEAR DISORD, V51, P125, DOI 10.1044/jshd.5102.125; BENNETT S, 1983, J SPEECH HEAR RES, V26, P137, DOI 10.1044/jshr.2601.137; BLAUSTEIN S, 1983, J COMMUN DISORD, V16, P157, DOI 10.1016/0021-9924(83)90046-1; Brown J.R., 1975, MOTOR SPEECH DISORDE; Cahill LM, 2002, BRAIN INJURY, V16, P415, DOI 10.1080/02699050110119871; Cahill LM, 2000, J MED SPEECH-LANG PA, V8, P347; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; CHILDERS DG, 1985, LANGUAGE FUNCTION PH; Chugani HT, 1996, BRAIN DEV-JPN, V18, P347, DOI 10.1016/0387-7604(96)00032-0; COLTON R, 1996, VOICE PROBLEMS PHYSL; COLTON RH, 1990, J VOICE, V4, P10, DOI 10.1016/S0892-1997(05)80077-3; Costeff H, 1985, Scand J Rehabil Med Suppl, V12, P10; CRAFT AW, 1972, BMJ-BRIT MED J, V4, P200, DOI 10.1136/bmj.4.5834.200; DANIELWHITNEY B, 1989, RECENT ADV CLIN DYSA; Enderby P, 1983, FRENCHAY DYSARTHRIA; FEX S, 1992, J VOICE, V6, P155, DOI 10.1016/S0892-1997(05)80130-4; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GLAZE LE, 1988, J VOICE, V4, P312; Goozee JV, 1998, INT J LANG COMM DIS, V33, P221; HANSON DG, 1991, OTOLARYNG CLIN N AM, V24, P1035; HARTMAN DE, 1984, ANN OTO RHINOL LARYN, V93, P57, DOI 10.1177/000348948409300114; HERTZPANNIER L, 1999, J NEURORADIOLOGY, V9, P203; HOLLIEN H, 1967, SPEECH MONOGR, V34, P80; HORII Y, 1983, J COMMUN DISORD, V16, P257, DOI 10.1016/0021-9924(83)90010-2; KENT RD, 1989, J SPEECH HEAR DISORD, V54, P482, DOI 10.1044/jshd.5404.482; Levin HS., 1982, NEUROBEHAVIORAL CONS; McHenry M, 2000, LARYNGOSCOPE, V110, P1157, DOI 10.1097/00005537-200007000-00017; MCHENRY MA, 1994, J MED SPEECH-LANG PA, V2, P59; MCHENRY MA, 1996, DISORDERS MOTOR SPEE; MICHEL JF, 1966, LANG SPEECH, V9, P46, DOI 10.1177/002383096600900104; Mira M. P., 1992, TRAUMATIC BRAIN INJU; MURDOCH BE, 1994, EUR J DISORDER COMM, V29, P379; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; Murdoch BE, 1998, DYSARTHRIA PHYSL APP; NETSELL R, 1979, ARCH PHYS MED REHAB, V60, P502; Ramig LO, 1992, INTELLIGIBILITY SPEE; Stathopoulos ET, 1997, J SPEECH LANG HEAR R, V40, P595, DOI 10.1044/jslhr.4003.595; Theodoros D G, 1998, Pediatr Rehabil, V2, P107; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1994, BRAIN INJURY, V8, P667, DOI 10.3109/02699059409151021; Titze IR., 1994, PRINCIPLES VOICE PRO; VOGEL M, 1982, FOLIA PHONIATR, V34, P150, DOI 10.1159/000265644; VONCRAMON D, 1981, NEUROPSYCHOLOGIA, V19, P801, DOI 10.1016/0028-3932(81)90092-0; Wilson DK., 1979, VOICE PROBLEMS CHILD; WORKINGER M S, 1992, Brain Injury, V6, P183, DOI 10.3109/02699059209029657; Yorkston KM., 1999, MANAGEMENT MOTOR SPE; [No title captured]	51	7	8	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2003	18	3					268	283		10.1097/00001199-200305000-00005			16	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	682HM	WOS:000183085700005	12802169				2022-02-06	
J	Fuchs, S; Lewis, RJ				Fuchs, S; Lewis, RJ			Tools for the measurement of outcome after minor head injury in children: Summary from the Ambulatory Pediatric Association/EMSC outcomes research conference	ACADEMIC EMERGENCY MEDICINE			English	Article						pediatrics; outcomes; minor/mild head injury	FUNCTIONAL INDEPENDENCE MEASURE; TRAUMATIC BRAIN INJURY; INTENSIVE-CARE UNIT; SEVERITY; WEEFIM	This article summarizes discussions held during a conference on outcomes research in emergency medical services for children. It provides detailed information on existing outcome measures for pediatric minor head injury. Benefits and/or limitations in their applicability for use in pediatric emergency medicine and pediatric minor head injury research are highlighted.	Childrens Mem Hosp, Div Pediat Emergency Med, Chicago, IL 60614 USA; Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60614 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Emergency Med, Los Angeles, CA 90024 USA; Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA		Fuchs, S (corresponding author), Childrens Mem Hosp, Div Pediat Emergency Med, 2300 Childrens Plaza,Box 62, Chicago, IL 60614 USA.						AITKEN ME, 2000, P NAT C CHILDH EM BA; Amling J K, 1990, J Neurosci Nurs, V22, P13; Bergman DA, 1999, PEDIATRICS, V104, P1407; BRUINICKS RH, 2002, SCALES INDEPENDENT B; Choi SC, 1998, J NEUROTRAUM, V15, P771, DOI 10.1089/neu.1998.15.771; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; DONDERS J, 1993, J CLIN PSYCHOL, V49, P255, DOI 10.1002/1097-4679(199303)49:2<255::AID-JCLP2270490220>3.0.CO;2-Q; EICHELBERGER MR, 1990, EMSC ASSESSMENT BATT; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Gedeit R, 2001, Pediatr Rev, V22, P118, DOI 10.1542/pir.22-4-118; GENSEMER IB, 1989, ANN EMERG MED, V18, P9, DOI 10.1016/S0196-0644(89)80303-8; Gioia G.A., 2000, BRIEF BEHAV RATING I; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; HILL B, ADAPTIVE MALADAPTIVE; Langlois JA, 2001, TRAUMATIC BRAIN INJU; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; McCarthy ML, 2002, AMBUL PEDIATR, V2, P337, DOI 10.1367/1539-4409(2002)002<0337:CHSITP>2.0.CO;2; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; OKADA PJ, 1995, ARCH PEDIAT ADOLESC, V149, P65; OKADA PJ, 1997, AMB CHILD HLTH, V3, P205; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; SPLAINGARD ML, 1989, ARCH PHYS MED REHAB, V70, P318; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; vanderSluis CK, 1997, J TRAUMA, V43, P501, DOI 10.1097/00005373-199709000-00019; VARNI JW, 1998, PEDSQL 4 0 MEASUREME; Ware JE., 1996, CHQ USERS MANUAL; Wechsler D, 1967, MANUAL WECHSLER PRES; Weiss H., 1997, CHILD ADOLESCENT EME; Wright J, 2000, J HEAD TRAUMA REHAB, V15, P734, DOI 10.1097/00001199-200002000-00011	33	7	7	0	0	HANLEY & BELFUS INC	PHILADELPHIA	210 S 13TH ST, PHILADELPHIA, PA 19107 USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	APR	2003	10	4					368	375		10.1197/aemj.10.4.368			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	663FL	WOS:000181995500013	12670852				2022-02-06	
J	Thees, C; Scheufler, KM; Nadstawek, J; Zentner, J; Lehnert, A; Hoeft, A				Thees, C; Scheufler, KM; Nadstawek, J; Zentner, J; Lehnert, A; Hoeft, A			Monitoring of cerebral perfusion pressure during intracranial hypertension: a sufficient parameter of adequate cerebral perfusion and oxygenation?	INTENSIVE CARE MEDICINE			English	Article						intracranial hypertension; cerebral perfusion pressure; cerebral oxygenation; near-infrared reflexion spectroscopy	TRAUMATIC BRAIN INJURY; CRITICAL CLOSING PRESSURE; BLOOD-VOLUME; HEAD-INJURY; AUTOREGULATION; MANAGEMENT; FLOW; SPECTROSCOPY; CIRCULATION; METABOLISM	Objective: A cerebral perfusion pressure (CPP) oriented treatment is a widely accepted standard for patients with intracranial hypertension. In an animal model of controlled intracranial hypertension we investigated whether CPP is a reliable parameter of sufficient cerebral perfusion and oxygenation. Using near-infrared reflexion spectroscopy the effect of decreasing CPP due to increasing intracranial pressure (ICP) on cerebral tissue oxygenation was studied. Methods: Ten rabbits were subjected to artificially elevated ICP using the cisterna-magna infusion technique. Regional cerebral O-2 saturation of hemoglobin (tiSO(2)), regional tissue concentration of hemoglobin (tiHb), and CPP were recorded continuously. CPP was investigated with respect to tiSO(2) Electrocortical activity was simultaneously recorded by two-channel EEG to determine the onset of ischemia. Results: Reduced CPP due to increased ICP led to a continuous decrease in tiSO(2). There was progressive suppression of EEG frequency and amplitude with decreasing CPP in all animals. Onset of EEG-silence due to elevated ICP was observed in a wide range of CPP-values between 9 and 42 mmHg. At the same time tiSO(2) varied merely between 0 and 5%. Conclusions Regarding the EEG effects due to increased ICP (EEG silence), CPP values showed a wide interindividual variability, in contrast to tiSO(2). In our animal model the sole calculation of CPP did not reflect adequate cerebral perfusion.	Univ Bonn, Dept Anesthesia & Intens Care Med, D-3105 Bonn, Germany; Univ Bonn, Dept Neurosurg, D-5300 Bonn, Germany		Thees, C (corresponding author), Univ Bonn, Dept Anesthesia & Intens Care Med, Sigmund Freud Str 25, D-3105 Bonn, Germany.						BARZO P, 1991, NEUROSURGERY, V28, P821, DOI 10.1227/00006123-199106000-00006; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BURTON AC, 1951, AM J PHYSIOL, V164, P319, DOI 10.1152/ajplegacy.1951.164.2.319; CUNITZ G, 1995, ANAESTHESIST, V44, P369, DOI 10.1007/s001010050166; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dawson SL, 1999, J APPL PHYSIOL, V86, P675, DOI 10.1152/jappl.1999.86.2.675; Dinkel M, 1998, ANASTH INTENSIVMED, V39, P399; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; GRUBB RL, 1973, ARCH NEUROL-CHICAGO, V28, P38, DOI 10.1001/archneur.1973.00490190056006; LAMMERTSMA AA, 1984, J CEREBR BLOOD F MET, V4, P317, DOI 10.1038/jcbfm.1984.47; LANGFITT TW, 1965, NEUROLOGY, V15, P622, DOI 10.1212/WNL.15.7.622; MARSHALL LF, 1975, J NEUROSURG, V43, P308, DOI 10.3171/jns.1975.43.3.0308; Mascia L, 2000, INTENS CARE MED, V26, P202, DOI 10.1007/s001340050046; NAKAGAWA Y, 1974, J NEUROSURG, V41, P427, DOI 10.3171/jns.1974.41.4.0427; PERMUTT S, 1963, J APPL PHYSIOL, V18, P924, DOI 10.1152/jappl.1963.18.5.924; PHELPS ME, 1979, J NUCL MED, V20, P328; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; Reinstrup P, 2001, ANESTHESIOLOGY, V95, P1079, DOI 10.1097/00000542-200111000-00009; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Steinberg F, 1997, ADV EXP MED BIOL, V428, P69; Steinberg F, 1997, ADV EXP MED BIOL, V428, P553; Ter Minassian A, 2002, CRIT CARE MED, V30, P1616, DOI 10.1097/00003246-200207000-00036; Thees C, 2002, ANESTHESIOLOGY, V96, P595, DOI 10.1097/00000542-200203000-00014; Weyland A, 2000, J NEUROSURG ANESTH, V12, P210, DOI 10.1097/00008506-200007000-00002; WYATT JS, 1990, J APPL PHYSIOL, V68, P1086	28	7	7	0	1	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	MAR	2003	29	3					386	390		10.1007/s00134-002-1625-7			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZQ	WOS:000182095500008	12541158				2022-02-06	
J	Jones, PA; Minns, RA; Lo, TYM; Andrews, PJD; Taylor, GS; Ali, S				Jones, PA; Minns, RA; Lo, TYM; Andrews, PJD; Taylor, GS; Ali, S			Graphical display of variability and inter-relationships of pressure signals in children with traumatic brain injury	PHYSIOLOGICAL MEASUREMENT			English	Article						children; head injury; intracranial pressure; cerebral perfusion pressure; variability; pattern recognition	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; SECONDARY INSULTS; INTRACRANIAL HYPERTENSION; YOUNG-CHILDREN; SURVIVAL; INFANTS	A prospective observational study was undertaken to examine time series ICU data of pressure variables (mean arterial pressure (MAP), intracranial pressure (ICP) and cerebral perfusion pressure (CPP)) and relate their variability (SD) to outcome, together with simple graphical displays which could be useful at the ICU bedspace. Forty-three children (aged <1-15 years) were admitted to the intensive care unit for Regional Neurosurgical Service, Edinburgh, following traumatic brain injury (TBI). The standard deviations from 221291 validated pressure data measurements (representing three variables) were calculated for the duration of ICP monitoring (and in 48 h epochs from the time of injury). Data were displayed on polygraphs, and several well-defined 'patterns' were described. The standard deviations of MAP, ICP and CPP for the total duration of monitoring were found to be significantly related to survival (p = 0.003, <0.001 and 0.005, respectively), while the SD of ICP alone was strongly related to global recovery (p = 0.008) in the first 48 h post-injury. Patterns in 104 epochs (each of 48 h) were identified. Ninety-two were of the type I (MAP > CPP > ICP) pattern and 12 were of the non-type I pattern. Glasgow Outcome Scale scores at 12 months were significantly related to the dichotomized pattern type (Fisher's exact test p < 0.001 for both alive versus dead and independent versus dependent outcomes). Only one patient with type I pattern died in this series. While variability of ICP during the first 48 h post-injury is predictive of the outcome, the pattern behaviour of three pressure signals gives useful outcome prediction information throughout monitoring. These displays may help interpret some of the plethora of data produced at the bedside.	Univ Edinburgh, Dept Child Life & Hlth, Edinburgh EH9 1UW, Midlothian, Scotland; Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; Western Gen Hosp, Dept Clin & Surg Serv, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Edinburgh, Sch Med, Dept Med Stat, Edinburgh EH8 9AG, Midlothian, Scotland; Kuala Lumpur Hosp, Inst Paediat, Kuala Lumpur 50586, Malaysia		Jones, PA (corresponding author), Univ Edinburgh, Dept Child Life & Hlth, 20 Sylvan Pl, Edinburgh EH9 1UW, Midlothian, Scotland.	Robert.Minns@ed.ac.uk					Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Chambers IR, 2000, BRIT J NEUROSURG, V14, P424; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; CORTBUS F, 1994, ACTA NEUROCHIR, V130, P117, DOI 10.1007/BF01405511; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; GAAB M R, 1986, Neurological Research, V8, P44; Griffith R L, 1979, Adv Neurol, V22, P51; HOWELLS TP, 2002, THESIS U EDINBURGH; Jackson S, 2000, ACTA NEUROCHIR SUPPL, V76, P453; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; JONES PA, 2003, IN PRESS BR J NEUROS; MARMAROU A, 1991, J NEUROSURG, V75, pS21, DOI 10.3171/sup.1991.75.1s.0s21; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; McQuatt A, 1999, LECT NOTES ARTIF INT, V1620, P336; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, FJ NEUROSURG, V54, P289; MILLER JD, 1992, J NEUROTRAUMA S1, V9, P317; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; SKLAR FH, 1980, J NEUROSURG, V53, P166, DOI 10.3171/jns.1980.53.2.0166; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; TEASDALE GM, 1974, LANCET, V1, P290	23	7	7	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334			PHYSIOL MEAS	Physiol. Meas.	FEB	2003	24	1					201	211	PII S0967-3334(03)55605-2	10.1088/0967-3334/24/1/315			11	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering; Physiology	652FG	WOS:000181368700015	12636197				2022-02-06	
J	Zalish, M; Lavie, V				Zalish, M; Lavie, V			Dexanabinol (HU-211) has a beneficial effect on axonal sprouting and survival after rat optic nerve crush injury	VISION RESEARCH			English	Article						dexanabinol; degeneration; regeneration; optic nerve; NMDA receptor antagonist	CLOSED-HEAD INJURY; NMDA ANTAGONIST; RECEPTOR; BRAIN; REGENERATION; ISCHEMIA; RABBIT; INDUCE; ALPHA; TERM	Dexanabinol (HU-211) is a synthetic non-psychotropic cannabinoid and a non-competitive NMDA-receptor antagonist. The beneficial effect of dexanabinol on prevention of degeneration and promotion of regeneration was studied on the crush-injured rat optic nerve model. Sprague-Dawley rats were subjected to a calibrated crush injury of the optic nerve and treated with a single intraperitoneal injection of dexanabinol (7 mg/kg), its vehicle only or were untreated. Transmission electron microscopic analysis of the excised optic nerves was performed after 30 days. In the dexanabinol treated rats, the site of injury was traversed by unmyelinated and thinly myelinated axons, possibly indicative of regenerative growth. No such growth was detectable in the controls. Viable axons were found 0.5 mm distal to the site of injury in 6 of 8 dexanabinol treated rats, but in only I of 10 rats in the control groups. These results have clinical implications for the prevention of secondary degeneration and promotion of regeneration after injuries to the central nervous system. (C) 2002 Elsevier Science Ltd. All rights reserved.	Kaplan Med Ctr, Dept Ophthalmol, IL-76100 Rehovot, Israel; Pharmos Ltd, Dept Pharmacol, IL-76326 Rehovot, Israel		Zalish, M (corresponding author), Kaplan Med Ctr, Eye Dept, IL-76100 Rehovot, Israel.						Baird DH, 1996, J NEUROSCI, V16, P2642; BARILAN A, 1995, INVESIGATIVE OPHTHAL, V36, P935; BARJOSEPH A, 1994, MOL CHEM NEUROPATHOL, V23, P125, DOI 10.1007/BF02815406; BELAYEV L, 1995, MOL CHEM NEUROPATHOL, V25, P19, DOI 10.1007/BF02815084; BELAYEV L, 1995, STROKE, V26, P2313, DOI 10.1161/01.STR.26.12.2313; BIEGON A, 1995, NEUROL RES, V17, P1275; DUVDEVANI R, 1990, RESTOR NEUROL NEUROS, V2, P31, DOI 10.3233/RNN-1990-2104; EITAN S, 1994, SCIENCE, V264, P1764, DOI 10.1126/science.7911602; ESHHAR N, 1993, NEUROREPORT, V5, P237, DOI 10.1097/00001756-199312000-00013; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; HADANI M, 1984, P NATL ACAD SCI-BIOL, V81, P7965, DOI 10.1073/pnas.81.24.7965; KACHALSKY SG, 2000, SOC NEUR ABSTR, V26, P1125; LAVIE V, 1990, J COMP NEUROL, V298, P293, DOI 10.1002/cne.902980304; McKinney RA, 1999, P NATL ACAD SCI USA, V96, P11631, DOI 10.1073/pnas.96.20.11631; MURRAY M, 1982, J COMP NEUROL, V209, P352, DOI 10.1002/cne.902090405; NADLER V, 1993, BRAIN RES, V622, P79, DOI 10.1016/0006-8993(93)90804-V; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; NADLER V, 1993, NEUROSCI LETT, V159, P1; Pan WH, 1997, NEUROSCI BIOBEHAV R, V21, P603, DOI 10.1016/S0149-7634(96)00047-4; RICHARDSON PM, 1982, J NEUROCYTOL, V11, P949, DOI 10.1007/BF01148310; SCHWARTZ M, 1991, BRAIN RES, V545, P334, DOI 10.1016/0006-8993(91)91309-O; SCHWARTZ M, 1985, SCIENCE, V228, P600, DOI 10.1126/science.3983646; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Yoles E, 1996, J NEUROTRAUM, V13, P49, DOI 10.1089/neu.1996.13.49	26	7	10	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989			VISION RES	Vision Res.	FEB	2003	43	3					237	242	PII S0042-6989(02)00494-7	10.1016/S0042-6989(02)00494-7			6	Neurosciences; Ophthalmology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology; Psychology	641TQ	WOS:000180762900002	12535983				2022-02-06	
J	Khan, OH; Enno, T; Del Bigio, MR				Khan, OH; Enno, T; Del Bigio, MR			Tacrolimus and cyclosporine A are of no benefit to young rats with kaolin-induced hydrocephalus	PEDIATRIC NEUROSURGERY			English	Article						axon; behavior; calcineurin; calpain; cerebral ventricle; FK506; neuroprotection	TRAUMATIC BRAIN-INJURY; WHITE-MATTER CHANGES; CALPAIN INHIBITORS; PERMEABILITY TRANSITION; CEREBRAL-ISCHEMIA; NERVOUS-SYSTEM; AXONAL INJURY; FK506; DAMAGE; NEUROPROTECTION	Hydrocephalus causes damage to periventricular axons. Tacrolimus, cyclosporine A (CsA) and calpain inhibitors have been shown to protect axons in rat models of acute traumatic brain injury. We hypothesized that these agents would ameliorate the axon damage and behavioral effects in experimental hydrocephalus. Hydrocephalus was induced in 3-week-old rats by injection of kaolin into the cisterna magna. Tests of cognitive and motor function were performed on a weekly basis. In a blinded and randomized manner, tacrolimus (FK506; 3.6 mg/kg body weight) or CsA ( 10 mg/kg) was administered once daily by subcutaneous injection for 2 weeks, beginning 2 weeks after induction of hydrocephalus. In a separate experiment, calpain inhibitor I ( 10 mg/kg/day) was administered by continuous subcutaneous infusion. The brains were subjected to histopathological and biochemical analyses after 2 weeks of treatment. There was no statistically significant protection in regard to behavior, brain structure or brain composition in any of the experiments. However, there was biochemical and histological evidence of renal injury following chronic tacrolimus and CsA administration. Calcineurin inhibition does not offer significant protection in this rat model of hydrocephalus. Copyright (C) 2003 S. Karger AG, Basel.	Univ Manitoba, Dept Pathol, Winnipeg, MB R3E 0W3, Canada; Manitoba Inst Child Hlth, Winnipeg, MB, Canada		Del Bigio, MR (corresponding author), Univ Manitoba, Dept Pathol, 770 Bannatyne Ave, Winnipeg, MB R3E 0W3, Canada.	delbigi@cc.umanitoba.ca		Del Bigio, Marc/0000-0001-8366-0394			Araki T, 1997, J NEURAL TRANSM, V104, P259, DOI 10.1007/BF01273186; Bavetta S, 1999, EXP NEUROL, V158, P382, DOI 10.1006/exnr.1999.7119; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Campbell G, 1999, NEUROREPORT, V10, P3955, DOI 10.1097/00001756-199912160-00042; Del Bigio MR, 2002, NEUROSURGERY, V51, P460, DOI 10.1097/00006123-200208000-00029; Del Bigio MR, 2001, J NEUROSURG, V94, P788, DOI 10.3171/jns.2001.94.5.0788; Del Bigio MR, 2000, J NEUROPATH EXP NEUR, V59, P946, DOI 10.1093/jnen/59.11.946; DelBigio MR, 1997, J NEUROPATH EXP NEUR, V56, P1053, DOI 10.1097/00005072-199709000-00010; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; Donkor IO, 2000, CURR MED CHEM, V7, P1171, DOI 10.2174/0929867003374129; Drake M, 1996, ACTA PHYSIOL SCAND, V158, P155, DOI 10.1046/j.1365-201X.1996.535298000.x; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Khan OH, 2003, PEDIATR RES, V53, P970, DOI 10.1203/01.PDR.0000061561.42921.5B; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Koedel U, 2000, J INFECT DIS, V182, P1437, DOI 10.1086/315877; Li PA, 1998, NEUROSCI LETT, V247, P17, DOI 10.1016/S0304-3940(98)00266-3; Liu XD, 2002, ACTA PHARMACOL SIN, V23, P225; McAllister JP, 1998, NEUROSURG CLIN N AM, V9, P73; Mollison KW, 1998, TOXICOLOGY, V125, P169, DOI 10.1016/S0300-483X(97)00167-4; Moser VC, 1997, NEUROTOXICOLOGY, V18, P929; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; RAMI A, 1993, BRAIN RES, V609, P67, DOI 10.1016/0006-8993(93)90856-I; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Shibazaki Y, 2001, BRAIN RES, V892, P351, DOI 10.1016/S0006-8993(00)03271-6; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Snyder SH, 1998, NEURON, V21, P283, DOI 10.1016/S0896-6273(00)80538-3; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Uchino H, 2002, NEUROBIOL DIS, V10, P219, DOI 10.1006/nbdi.2002.0514; Vachon P, 2002, BRAIN RES, V943, P1, DOI 10.1016/S0006-8993(02)02413-7; Wakita H, 1998, BRAIN RES, V792, P105, DOI 10.1016/S0006-8993(98)00126-7; WAKITA H, 1995, STROKE, V26, P1415, DOI 10.1161/01.STR.26.8.1415; WANG KKW, 1994, TRENDS PHARMACOL SCI, V15, P412, DOI 10.1016/0165-6147(94)90090-6; Wells GJ, 1998, EXPERT OPIN THER PAT, V8, P1707, DOI 10.1517/13543776.8.12.1707; Wijdicks EFM, 2001, LIVER TRANSPLANT, V7, P937, DOI 10.1053/jlts.2001.27475	34	7	8	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2003	39	6					309	313		10.1159/000075259			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	765CL	WOS:000188249500005	14734865				2022-02-06	
J	Mauritz, W; Rusnak, M; Janciak, I				Mauritz, W; Rusnak, M; Janciak, I		Traumatic Brain Injury Study Team	Implementing scientific evidence-based guidelines: Case study of severe traumatic brain injuries	CLINICAL RESEARCH AND REGULATORY AFFAIRS			English	Article							HEAD-INJURY; MANAGEMENT; CARE	Research has proven that all brain damage does not occur at the moment of trauma, but rather evolves over the ensuing hours and days after the initial injury, due to brain swelling. In most cases, this secondary damage can be controlled using scientific, evidence-based treatment guidelines. The US based Brain Trauma Foundation developed those guidelines in 1995. Trauma is the most frequent cause of death between the 1st and the 40th year of life in Austria. The program targets an issue of quality of care improvement in the hospital setting. The program started with six regional ones. Consequently, the program will be extended to more trauma centers later on. Representatives of all participating centers were trained at the spot (within the hospitals) in details of documentation (hardware and software). The Internet based database is used to monitor the compliance with the Guidelines and the outcomes of treatment. The data collected will be analyzed and will provide basic epidemiological and quality of care information.	Int Gesell Erforsch Hirntraumata, A-1010 Vienna, Austria		Rusnak, M (corresponding author), Int Gesell Erforsch Hirntraumata, Fischhof 3, A-1010 Vienna, Austria.	mrusnak@igeh.org	Rusnak, Martin/K-9349-2016	Rusnak, Martin/0000-0003-3321-1042			Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; BULLOCK R, 1996, GUIDELINES MANAGEMEN; FREUDENSCHUSS B, 1999, ACTA CHIRURGICA S156, V31, P2; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; Ng I., 1998, Annals Academy of Medicine Singapore, V27, P332; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Vitaz TW, 2001, J TRAUMA, V51, P369, DOI 10.1097/00005373-200108000-00025	10	7	7	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1060-1333	1532-2521		CLIN RES REGUL AFF	Clin. Res. Regul. Affairs		2003	20	1					81	87		10.1081/CRP-120018744			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	661NA	WOS:000181895600009					2022-02-06	
J	Newman, H; Reems, JA; Rigley, TH; Bravo, D; Strong, DM				Newman, H; Reems, JA; Rigley, TH; Bravo, D; Strong, DM			Donor age and gender are the strongest predictors of marrow recovery from cadaveric vertebral bodies	CELL TRANSPLANTATION			English	Article						organ donor marrow; vertebral bodies; stem cells	TOTAL LYMPHOID IRRADIATION; BONE-MARROW; TRANSPLANTATION TOLERANCE; GRAFT ACCEPTANCE; CELL-MIGRATION; CHIMERISM; ALLOGRAFTS; PRIMATES	The purpose of this retrospective analysis was to determine whether there were donor factors that were useful for predicting the yield of nucleated cells from marrow derived from cadaveric vertebral bodies. An analysis of 132 donors over a 6-year period was performed. The average number of vertebral bodies procured from each donor was 10.2 +/- 1.6 (range 5-14). The total number of nucleated cells recovered per donor ranged from 24 x 10(9) to 160 x 10(9) with an average recovery of 69 +/- 28 x 10(9) cells. The cell viability of the recovered cells was >95%. The average age of the donors was 33 +/- 14 years (mean +/- SD; range 12-65) with an average weight of 169 +/- 41 lb (range 82-308 lb). Males comprised 68% of the donor population. The average number of days from admission to death was 1.9 +/- 1.7 with a range of 1-11.4 days and the interval between asystole and procurement averaged 3.1 +/- 2.3 h (range (0.1-14.7 h). The majority of donors died from head trauma due to an intracranial bleed, gunshot wound, or closed head injury. Regression analysis of the data indicated that the total nucleated cell yield tended to decrease with increasing time between hospital admission and death. The data also indicated that in general female donors yielded lower cell numbers independent of age and male donors under 30 years of age yielded the highest number of cells.	Puget Sound Blood Ctr, NW Tissue Ctr, Seattle, WA 98104 USA; Univ Washington, Div Med, Dept Hematol, Seattle, WA 98195 USA; Univ Washington, Div Med, Dept Surg, Seattle, WA 98195 USA; Univ Washington, Div Med, Dept Orthopaed, Seattle, WA 98195 USA		Reems, JA (corresponding author), Puget Sound Blood Ctr, NW Tissue Ctr, 921 Terry Ave, Seattle, WA 98104 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [F32DK009266] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK09266] Funding Source: Medline		BARBER WH, 1991, TRANSPLANTATION, V51, P70, DOI 10.1097/00007890-199101000-00011; BARBER WH, 1989, TRANSPLANTATION, V47, P593; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Ciancio G, 2001, TRANSPLANTATION, V71, P827, DOI 10.1097/00007890-200104150-00002; FERREBEE JW, 1959, BLOOD, V14, P140, DOI 10.1182/blood.V14.2.140.140; MUGISHIMA H, 1985, BLOOD, V65, P392; MYBURGH JA, 1980, TRANSPLANTATION, V29, P405, DOI 10.1097/00007890-198005000-00012; Nitta Y, 2001, TRANSPL P, V33, P110, DOI 10.1016/S0041-1345(00)01929-1; RAPPAPORT FT, 1979, ANN SURG, V190, P461; RAY RN, 1964, BLOOD, V17, P97; ROLLES K, 1994, LANCET, V343, P263, DOI 10.1016/S0140-6736(94)91113-4; Shapiro R, 2001, TRANSPLANT P, V33, P1134, DOI 10.1016/S0041-1345(00)02461-1; SHARP TG, 1984, J IMMUNOL METHODS, V69, P187, DOI 10.1016/0022-1759(84)90317-X; SLAVIN S, 1978, J EXP MED, V147, P700, DOI 10.1084/jem.147.3.700; STARZL TE, 1993, HEPATOLOGY, V17, P1127; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; SYKES M, 1988, IMMUNOL TODAY, V9, P23, DOI 10.1016/0167-5699(88)91352-7	17	7	7	0	1	COGNIZANT COMMUNICATION CORP	ELMSFORD	3 HARTSDALE ROAD, ELMSFORD, NY 10523-3701 USA	0963-6897			CELL TRANSPLANT	Cell Transplant.		2003	12	1					83	90		10.3727/000000003783985133			8	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	663WN	WOS:000182029700010	12693668				2022-02-06	
J	De Kort, AC; Rulkens, MP; Ijzerman, MJ; Maathuis, CGB				De Kort, AC; Rulkens, MP; Ijzerman, MJ; Maathuis, CGB			The Come Back Programme: a rehabilitation programme for patients with brain injury with psychosocial problems despite previous rehabilitation	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						brain injury; employment; independent living; psychosocial functioning; rehabilitation programme	RANDOMIZED CONTROLLED TRIAL; ROUTINE FOLLOW-UP; HEAD-INJURY; MODERATE; EPIDEMIOLOGY	In 1994 the Come Back Programme (CBP) started in the rehabilitation centre, Groot Klimmendaal, in Arnhem, The Netherlands. The CBP is a rehabilitation programme for (young) adults with brain injury (BI) having problems with their psychosocial functioning despite having undergone a rehabilitation programme previously. The main goal of the CBP is to regain maximal independence in psychosocial functioning. The objectives of the study were to assess problems experienced after BI, despite having undergone a rehabilitation programme previously, and whether the CBP can improve psychosocial functioning. The study was retrospective, through investigating medical records and via a structured questionnaire sent to patients who participated in the CBP between 1994 and 1998 (n = 25). Follow-up was at least I year after the CBP. There was an 80% response (n=20). The mean age at BI was 22 years. The patients had severe BI (mean duration of coma 4.7 weeks) and 17 had traumatic BI. Prior to the CBP negative consequences were seen on independence of living, employability, relationships and contact with friends. No or little effect was seen on contact with family and leisure activities. After the CBP, positive effects were found on employability and independence of living but not on premorbid levels. The effect on the other aspects were absent or not clear. Most patients wanted support at follow-up. The authors concluded that the CBP had a positive effect on independence of living and employability. A 'second' rehabilitation programme can be useful if psychosocial problems are present. Long-lasting support and structural control seem necessary and are recommended.	Rehabil Ctr Het Roessingh, NL-7522 AH Enschede, Netherlands; Rehabil Ctr Groot Klimmendaal, Arnhem, Netherlands; Roessingh Res & Dev, Enschede, Netherlands		De Kort, AC (corresponding author), Rehabil Ctr Het Roessingh, Roessinghbleekweg 33, NL-7522 AH Enschede, Netherlands.		IJzerman, Maarten J/Q-8963-2016; IJzerman, Maarten/AAB-6894-2020	IJzerman, Maarten J/0000-0001-5788-5805; IJzerman, Maarten/0000-0001-5788-5805			ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; GROET E, 1997, MEDISCH CONTACT, V6, P191; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; NYSTROM SA, 1992, SCANDINAVIAN J REH S, V26, P163; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; SAHGAL V, 1989, SCAND J REHABIL MED, V21, P71; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; vanBalen HGG, 1996, DISABIL REHABIL, V18, P181, DOI 10.3109/09638289609166298; VANBALEN HGG, 1996, CLIN REHABIL, V10, P259; VANBALEN HGG, 1993, TIJDSCHRIFT KINDERRE, V3, P7; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9	20	7	7	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	2002	25	4					271	278		10.1097/00004356-200212000-00004			8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	631EU	WOS:000180155800004	12451302				2022-02-06	
J	Schatz, P; Hillary, FG; Moelter, ST; Chute, DL				Schatz, P; Hillary, FG; Moelter, ST; Chute, DL			Retrospective assessment of rehabilitation outcome after traumatic brain injury: Development and utility of the Functional Independence Level	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						functional outcome; level of independence; traumatic brain injury; rehabilitation; retrospective archival research	DISABILITY RATING-SCALE; TERM FOLLOW-UP; HEAD-INJURY; COMMUNITY INTEGRATION; RECOVERY; COMA; VALIDATION; STABILITY; PROGNOSIS; SEVERITY	To develop a measure suitable for retrospective analysis of qualitative brain injury outcome data, the Functional Independence Level (FIL), and document its reliability, validity, and utility Design: Retrospective analysis of existing records, with inclusion based on availability of records, and quantitative or qualitative documentation of functional status at a minimum of 1.5 years after injury. Setting: Statewide acute and postacute rehabilitation facilities, as part of a State Head Injury Program. Participants: A total of 338 individuals, with documented moderate to severe traumatic brain injury; primarily males ages 16 to 45. Main Outcome Measures: Disability Rating Scale (DRS) at discharge from primary rehabilitation, Living Situation and Functional independence Level coded from information in postacute rehabilitation reports, at an average of approximately 6 years after injury. Results: Inter-rater reliability coefficients for FIL ratings extracted from rehabilitation records, and between retrospective and in vivo assessments were highly significant. DRS scores at discharge from primary rehabilitation predicted a significant amount of variance in FIL scores at an average of 5 years after injury, and DRS scores remained a stable and significant predictor of FIL scores as the time period between discharge from rehabilitation and outcome ratings increased to 10 years after injury. FIL ratings were significantly lower for individuals living in residential facilities than those living with their families, as compared to living alone. Conclusions: The FIL is a reliable and useful tool for retrospective and prospective assessments of rehabilitation outcome. Gains made during primary rehabilitation by people with severe traumatic brain injury are generally maintained at long-term follow up. Retrospective ratings using the DRS and FIL can help guide postacute rehabilitation planning within state or regional head injury programs.	St Josephs Univ, Philadelphia, PA 19131 USA; Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA; Univ Sci Philadelphia, Philadelphia, PA USA; Drexel Univ, Philadelphia, PA 19104 USA		Schatz, P (corresponding author), St Josephs Univ, Post Hall 222,560 City Ave, Philadelphia, PA 19131 USA.		Hillary, Frank/AAN-8622-2021	Schatz, Philip/0000-0002-6222-6545			*AL TRAUM BRAIN IN, 1998, EMS ALASKA, V21, P6; *AR TBI SCI SURV P, 1994, ANN REP TRAUM BRAIN; Ashley MJ, 1997, BRAIN INJURY, V11, P677; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; BOND MR, 1990, REHABILITATION ADULT, P59; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Gardner W, 1999, ARCH CLIN NEUROPSYCH, V14, P779; GIBBS LI, 1996, MMWR-MORBID MORTAL W, V45, P796; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; GORDNER RL, 1998, REHABILITATION PERSO; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRANGER CV, 1994, AM J PHYS MED REHAB, V73, P51, DOI 10.1097/00002060-199473010-00012; Hagen C., 1972, LEVELS COGNITIVE FUN; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hillary F, 2001, ARCH CLIN NEUROPSYCH, V16, P171, DOI 10.1016/S0887-6177(00)00050-0; IMES C, 1983, COGNITIVE REHABILITA, V1, P11; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; JENNETT B, 1990, REHABILITATION ADULT, P3; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kraus JF, 1993, HEAD INJURY, P1; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; *MINN DEP HLTH INJ, 1996, TRAUM BRAIN SPIN COR; MOELTER S, 1999, ARCH CLIN NEUROPSYCH, V14, P615; MOLITOR AJ, 1990, HLTH REPORTER, V11, P1; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosenthal R, 1991, ESSENTIALS BEHAV RES, V2nd; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Schatz P, 1996, ARCH CLIN NEUROPSYCH, V11, P444; Schatz P, 2001, NEUROREHABILITATION, V16, P281; SCHATZ P, 1995, PREDICTING LEVEL IND; SEGAL ME, 1995, AM J PHYS MED REHAB, V74, P276, DOI 10.1097/00002060-199507000-00004; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; Stevens JP., 1996, APPL MULTIVARIATE ST; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WHYTE J, 1998, REHABILITATION MED P, P1191; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WINGATE SJ, 1999, DISS ABSTR INT, V59, P6082; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	57	7	7	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	2002	17	6					510	525		10.1097/00001199-200212000-00003			16	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	617NN	WOS:000179367900003	12802242				2022-02-06	
J	Downey, D; Mraz, R; Knott, J; Knutson, C; Holte, L; Van Dyke, D				Downey, D; Mraz, R; Knott, J; Knutson, C; Holte, L; Van Dyke, D			Diagnosis and evaluation of children who are not talking	INFANTS & YOUNG CHILDREN			English	Article						articulation disorders; autism; communication disorders; hearing loss; mental retardation; speech and language delay	LANGUAGE DISORDERS; SPEECH; BEHAVIOR	"My child is not talking" is a concern voiced by many parents and families. Possible etiologies for developmental language disorders and articulation disorders are many: mental retardation, craniological disorders, cerebral palsy, autism, traumatic brain injury, hearing loss, sometimes there will be a single etiology: however, most times there are multiple etiologies, mild in nature, that come together to produce speeds and language delay. As health care providers, therapists, and educators it is essential that we assist the child's family in finding answers to their questions. We are wise to seek the advice of an interdisciplinary team of professionals to determine whether the child's communication abilities are developing normally or whether professional intervention is needed. It has been well documented that early diagnosis and treatment for speech and language problems greatly improve the child's overall prognosis, and can often prevent the development of additional disorders in the areas of behavior, learning, reading and social development.	Univ Iowa Hlth Care, Ctr Disabil & Dev, Div Dev Disabil, Iowa City, IA USA		Downey, D (corresponding author), Univ Iowa Hlth Care, Ctr Disabil & Dev, Div Dev Disabil, Iowa City, IA USA.						*AM SPEECH HEAR AS, INTR AUGM ALT COMM; *AM SPEECH HEAR AS, DEV APR SPEECH; *AM SPEECH HEAR AS, LANG LIT DEV; *AM SPEECH HEAR AS, DYS; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P65; Barlow JA, 1999, J SPEECH LANG HEAR R, V42, P1482, DOI 10.1044/jslhr.4206.1482; Bauer S, 1995, Pediatr Rev, V16, P130, DOI 10.1542/pir.16-4-130; Bauer S, 1995, Pediatr Rev, V16, P168, DOI 10.1542/pir.16-5-168; BESS FH, 1986, EAR HEARING, V7, P3, DOI 10.1097/00003446-198602000-00003; BILLEAUD FP, 1998, COMMUNICATION DISORD; BLACKMAN JA, 1996, DISORDERS DEV LEARNI, P186; Bloom L., 1978, LANGUAGE DEV LANGUAG; CHEN D, 1999, ESSENTIAL ELEMENTS E; Chiocca E M, 1998, Pediatr Nurs, V24, P43; COPLAN J, 1995, BEHAV DEV PEDIAT, P195; Curry CJ, 1997, AM J MED GENET, V72, P468, DOI 10.1002/(SICI)1096-8628(19971112)72:4<468::AID-AJMG18>3.0.CO;2-P; Darley F. L., 1978, DIAGNOSTIC METHODS S; DAVIS JM, 1986, J SPEECH HEAR DISORD, V51, P53, DOI 10.1044/jshd.5101.53; Fisher E, 1999, INFANT YOUNG CHILD, V11, P1, DOI 10.1097/00001163-199901000-00004; FRAZER C, 2001, BRIGHT FUTURES CASE; GENESEE F, 1989, J CHILD LANG, V16, P161, DOI 10.1017/S0305000900013490; GERBER SE, 1990, PREVENTION ETIOLOGY; Gibbon FE, 1999, J SPEECH LANG HEAR R, V42, P382, DOI 10.1044/jslhr.4202.382; Hall PK, 1993, DEV APRAXIA SPEECH T; HAMAGUCHI PM, 1995, CHILDHOOD SPEECH LAN; HARDING E, 1986, BILINGUAL FAMILY HDB; Hardy J.C., 1996, DISORDERS DEV LEARNI, P262; HODSON B, 1997, PERSPECTIVES APPL PH; Karchmer MA, 1999, AM ANN DEAF, V144, P68; KELLY DP, 1999, DEV BEHAV PEDIAT, P621; KENNA M, 2000, NELSON TXB PEDIAT, P1941; Kent RD, 2000, J SPEECH LANG HEAR R, V43, P1275, DOI 10.1044/jslhr.4305.1275; Kent RD, 2000, J COMMUN DISORD, V33, P391, DOI 10.1016/S0021-9924(00)00023-X; KNIGHT JR, 2001, BRIGHT FUTURES CASE; LEES J, 1996, CHILDREN LANGUAGE DI, P8; MARTIN KI, 1997, DOES MY CHILD HAVE S; McLaughlin B, 1995, FOSTERING 2 LANGUAGE; Meisels SJ, 2000, HDB EARLY CHILDHOOD, V2; Moeller MP, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e43; NORTHERN JL, 1989, STUDY GUIDE HDB SPEE; PALMER FB, 1995, BEHAV DEV PEDIAT HDB, P88; Rapin I, 1997, NEW ENGL J MED, V337, P97, DOI 10.1056/NEJM199707103370206; ROSMAN NP, 1995, AUTISM BEHAV DEV PED, P73; ROSSETTI LM, 1996, COMMUNICATION INTERV; ROSSETTI LM, 1990, INFANT TODDLER LANGU; SCHWARTZ S, 1996, NEW LANGUAGE TOYS TE; Shinnar S, 2001, PEDIATR NEUROL, V24, P183, DOI 10.1016/S0887-8994(00)00266-6; SILVA PA, 1987, DEV MED CHILD NEUROL, V29, P630; Sowell T., 1997, LATE TALKING CHILDRE; STARK RE, 1995, TREATMENT OPTIONS EA; Stein MT, 2001, PEDIATRICS, V107, P910; TEELE DW, 1990, J INFECT DIS, V162, P685, DOI 10.1093/infdis/162.3.685; Templin M. C., 1957, CERTAIN LANGUAGE SKI; Toppelberg CO, 2000, J AM ACAD CHILD PSY, V39, P143, DOI 10.1097/00004583-200002000-00011; VANDYKE DC, 1984, AM FAM PHYSICIAN, V29, P257; WIDEN J, 2000, EAR HEARING, P471; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161	57	7	7	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0896-3746	1550-5081		INFANT YOUNG CHILD	Infants Young Child.	OCT	2002	15	2					38	48		10.1097/00001163-200210000-00006			11	Education, Special; Psychology, Developmental; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Psychology; Rehabilitation	596QY	WOS:000178177800005					2022-02-06	
J	Greenwood, R				Greenwood, R			Head injury for neurologists	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							TRAUMATIC BRAIN-INJURY; RECOVERY		UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England		Greenwood, R (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	richard.greenwood@homerton.nhs.uk					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; Deb S, 1999, AM J PSYCHIAT, V156, P374; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Graham DI, 1997, GREENFIELDS NEUROPAT, P197; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; JEANETT B, 1975, EPILEPSY NONMISSILE; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jennett B, 1981, MANAGEMENT HEAD INJU; LISHMAN A, 1998, ORGANIC PSYCHIAT; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	21	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	SEP	2002	73			1			I8	I16					9	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	589WB	WOS:000177783400003	12185256				2022-02-06	
J	Orient-Lopez, F; Terre-Boliart, R; Bernabeu-Guitart, M; Ramon-Rona, S; Perez-Miras, A				Orient-Lopez, F; Terre-Boliart, R; Bernabeu-Guitart, M; Ramon-Rona, S; Perez-Miras, A			The usefulness of dopaminergic drugs in traumatic brain injury	REVISTA DE NEUROLOGIA			Spanish	Article						amantidine; bromocriptine; dopaminergic agents; head injury; neuropsychological deficit; rehabilitation; treatment	FRONTAL-LOBE DYSFUNCTION; DOUBLE-BLIND; PARKINSONIAN-PATIENTS; AMANTADINE; BROMOCRIPTINE; PATIENT; AGONIST; ANTIDEPRESSANT; ROPINIROLE; MANAGEMENT	Objective. To review the bibliography indexed in MEDLINE so as to assess and/or compare the usefulness and indications of dopaminergic drugs in both cognitive and motor disorders due to head injuries (traumatic brain injury). Development. Lesions due to head injuries cause both focal and diffuse cerebral damage which lead to neuropsychological and motor deficit. It is clear that motor alterations cause major physical disability, but neuropsychological alterations affect cognitive behaviour and emotional aspects which are very disabling and seriously affect both the patient and his family and also his return to social, family and working life. There is a wide range of drugs available to assist in the improvement or recovery of the patient. Some of the most important of these drugs are the dopaminergic agents, due to the importance of dopamine for proper frontal cerebral are a function. Conclusions. This study confirms the indications for the use of dopaminergeric drugs when trying to improve or accelerate recovery from cognitive deficits inpatients with traumatic cerebral damage. However, it is important to note that, in view of the complexity of cognitive function and the mechanisms of their recovery, it will be necessary to make randomized, double-blind, prospective studies with a control group (if possible) so as to determine the real part played by these drugs in the recovery process of patients with traumatic brain damage.	Inst Guttmann, Unidad Dano Cerebral, E-08027 Barcelona, Spain			metges@guttmann.com					ACTON G, 1989, BRIT J CLIN PHARMACO, V28, P435, DOI 10.1111/j.1365-2125.1989.tb03524.x; Adler CH, 1997, NEUROLOGY, V49, P393, DOI 10.1212/WNL.49.2.393; Bascunana H, 2000, REV NEUROLOGIA, V30, P1044, DOI 10.33588/rn.3011.99480; Becker PM, 1998, NEUROLOGY, V51, P1221, DOI 10.1212/WNL.51.4.1221; COPE DN, 1996, MED REHABILITATION T, P573; DOBKIN BH, 1993, ANN NEUROL, V33, P313, DOI 10.1002/ana.410330315; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Jungerman T, 1999, J CLIN PSYCHOPHARM, V19, P522, DOI 10.1097/00004714-199912000-00006; Karli DC, 1999, BRAIN INJURY, V13, P63, DOI 10.1080/026990599121908; KORNHUBER J, 1994, J NEURAL TRANSM-SUPP, P91; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Kuzel MD, 1999, AM J HEALTH-SYST PH, V56, P217, DOI 10.1093/ajhp/56.3.217; LEONCARRION J, 1998, NOTICIAS MED, V3686, P32; Maj J, 1997, J NEURAL TRANSM, V104, P525, DOI 10.1007/BF01277669; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MULLER U, 1994, PROG NEURO-PSYCHOPH, V18, P1103, DOI 10.1016/0278-5846(94)90114-7; Munoz-Cespedes JM, 2001, REV NEUROLOGIA, V32, P351, DOI 10.33588/rn.3204.2000456; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; ODELL MW, 1996, MED REHABILITATION T, P103; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; Rajput AH, 1997, NEUROLOGY, V49, P1066, DOI 10.1212/WNL.49.4.1066; Rinne UK, 1998, NEUROLOGY, V51, P1309, DOI 10.1212/WNL.51.5.1309; Schneider WN, 1999, BRAIN INJURY, V13, P863; Shiller AD, 1999, BRAIN INJURY, V13, P715; SITLANDMARKEN PA, 1990, J CLIN PSYCHIAT, V51, P68; Suarez JI, 2001, REV NEUROLOGIA, V32, P289, DOI 10.33588/rn.3203.2000518; TERRE R, 2002, IN PRESS REHABILITAC; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; WHITE RJ, 1992, NEW ENGL J MED, V327, P1507; Wilkinson R, 1999, BRAIN INJURY, V13, P1025; Zafonte RD, 2000, J HEAD TRAUMA REHAB, V15, P1179, DOI 10.1097/00001199-200010000-00014; Zafonte RD, 1998, BRAIN INJURY, V12, P617	35	7	8	0	0	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	AUG 16	2002	35	4					362	366		10.33588/rn.3504.2001457			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	595RM	WOS:000178122600014	12235569				2022-02-06	
J	Labelle, J; Swaine, BR				Labelle, J; Swaine, BR			Reliability associated with the abstraction of data from medical records for inclusion in an information system for persons with a traumatic brain injury	BRAIN INJURY			English	Article							INTEROBSERVER VARIABILITY; DATA-COLLECTION; HIGH AGREEMENT; LOW KAPPA; REGISTRY; REHABILITATION; ORGANIZATION; COMORBIDITY; PARADOXES; SERVICES	Objective: This article presents the intra- and inter-rater reliability associated with the extraction, from medical rehabilitation charts, of data to be included in a head injury information system currently under development. Methods: A data collection form was developed to facilitate and standardize the data extraction. Two clinicians extracted information pertaining to 231 variables of the system from 15 charts of persons receiving rehabilitation services following a head injury. Results: Average percentage agreement was high and did not vary from one category of variables to the other (84-88%). Substantial intra-rater agreement (k = 0.66) and moderate inter-rater agreement (k = 0.56) were found to be associated with the extraction of the variables studied. Conclusions: The results suggest that clinicians using standardized procedures can reliably extract important data pertaining to personal history, impairments, and disabilities relating to sensorimotor function. Some potential sources of error are identified and recommendations are presented.	Ctr Interdisciplinaire Rech Readaptat, Inst Readaptat, Montreal, PQ H3S 2J4, Canada; Univ Montreal, Fac Med, Ecole Readaptat, Montreal, PQ H3C 3J7, Canada		Swaine, BR (corresponding author), Ctr Interdisciplinaire Rech Readaptat, Inst Readaptat, 6300 Darlington, Montreal, PQ H3S 2J4, Canada.	bonnie.swaine@umontreal.ca					AARONSON LS, 1994, RES NURS HEALTH, V17, P67, DOI 10.1002/nur.4770170110; Aegerter P, 1998, REV EPIDEMIOL SANTE, V46, P226; Allison J J, 2000, Jt Comm J Qual Improv, V26, P115; BEARD CM, 1992, J CLIN EPIDEMIOL, V45, P1013; Blackmer J, 1999, BRAIN INJURY, V13, P627; Booth J L, 1997, Aust Health Rev, V20, P84; BOYD NF, 1979, J CHRON DIS, V32, P327, DOI 10.1016/0021-9681(79)90088-2; Chen LM, 1999, CRIT CARE MED, V27, P1999, DOI 10.1097/00003246-199909000-00046; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; DENISEANNUNZIAT.D, 1998, J REHABIL OUTCOMES M, V2, P12; Edouard L, 1996, BRIT J OBSTET GYNAEC, V103, P891, DOI 10.1111/j.1471-0528.1996.tb09908.x; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Fleiss JL, 1978, APPLIED PSYCHOL MEAS, V2, P113, DOI [10.1177/014662167800200111, DOI 10.1177/014662167800200111]; Forbes SA, 1997, ARCH PHYS MED REHAB, V78, P1112, DOI 10.1016/S0003-9993(97)90137-4; Fougeyrollas P, 1998, INT J REHABIL RES, V21, P127, DOI 10.1097/00004356-199806000-00002; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; HALL KM, 1997, ARCH PHYSICAL MED RE, V787, pS5; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; HORWITZ RI, 1984, J CHRON DIS, V37, P825, DOI 10.1016/0021-9681(84)90015-8; JOHNSON DJ, 1994, SPECTROSCOPY, V9, P27; JOHNSTON MV, 1991, AM J PHYS MED REHAB, V70, P40, DOI 10.1097/00002060-199102000-00008; Kashner TM, 1998, MED CARE, V36, P1324, DOI 10.1097/00005650-199809000-00005; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; King M, 1996, NEW ZEAL MED J, V109, P207; LABELLE J, 2001, THESIS U MONTREAL; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lanska MJ, 1996, PEDIATR NEUROL, V15, P120, DOI 10.1016/0887-8994(96)00155-5; Liu MG, 1997, ARCH PHYS MED REHAB, V78, P166, DOI 10.1016/S0003-9993(97)90259-8; MAGEE LA, 1994, REPROD TOXICOL, V8, P419, DOI 10.1016/0890-6238(94)90082-5; Malats N, 1995, REV EPIDEMIOL SANTE, V43, P533; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; McLellan BA, 1997, J TRAUMA, V42, P763, DOI 10.1097/00005373-199705000-00001; Owen JL, 1999, J TRAUMA, V46, P1100, DOI 10.1097/00005373-199906000-00025; PEPIN M, 2000, EBIS C P PAR FRANC; Rawson NSB, 1997, SOC PSYCH PSYCH EPID, V32, P191, DOI 10.1007/BF00788238; RUBIN HR, 1992, JAMA-J AM MED ASSOC, V267, P2349, DOI 10.1001/jama.267.17.2349; *SPSS SCI, 1998, MAN SPSS BAS 7 5; Stange KC, 1998, MED CARE, V36, P851, DOI 10.1097/00005650-199806000-00009; TRUELLE JL, 1992, SCAND J REHABIL MED, P115; VANIER M, 1992, SYSTEME EVALUATION G; Volk T, 1997, J THORAC CARDIOV SUR, V114, P903, DOI 10.1016/S0022-5223(97)70003-5; vonKoss Krowchuk H, 1995, J Nurs Meas, V3, P3; Wu L, 1997, EVAL HEALTH PROF, V20, P146, DOI 10.1177/016327879702000203	45	7	7	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2002	16	8					713	727		10.1080/02699050110119880			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	583GP	WOS:000177399100007	12167196				2022-02-06	
J	Tateno, A; Murata, Y; Robinson, RG				Tateno, A; Murata, Y; Robinson, RG			Comparison of cognitive impairment associated with major depression following stroke versus traumatic brain injury	PSYCHOSOMATICS			English	Article							INTELLECTUAL IMPAIRMENT; POSTSTROKE DEPRESSION; MOOD DISORDER; HEAD-INJURY; COMMUNITY; DEMENTIA	Several studies have reported an association between cognitive impairment and major depression following stroke but failed to find a similar association among patients with traumatic brain injury (TBI). This study examined the hypothesis that age differences between stroke and TBI patients would account for the differences in the effect of major depression on cognitive function. We examined subjects' cognitive function using the Mini-Mental State Examination and compared findings among patients with stroke or TBI. Results indicated that stroke patients with major depression (N = 73) were significantly older and more cognitively impaired than similar TBI patients (N = 35), even after matching patients for lesion volume and years of education. After matching for age, however, there was no association of major depression with cognitive impairment in this relatively young stroke population. These findings support the hypothesis that age, presumably related to physiological response to brain injury accounts for differences in the effect of major depression on cognitive function between stroke and TBI patients.	Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; Nippon Med Coll, Dept Neuropsychiat, Tokyo 113, Japan		Robinson, RG (corresponding author), Univ Iowa, Coll Med, Dept Psychiat, 200 Hawkins Dr,2887 JPP, Iowa City, IA 52242 USA.		crona, malin/B-7085-2012; Robinson, Robert/AAF-6191-2021		NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH052879, R01MH040355, R01MH053592] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH-53592, MH-52879, MH-40355, MH-00163] Funding Source: Medline		American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Andersen G, 1996, ACTA PSYCHIAT SCAND, V94, P272, DOI 10.1111/j.1600-0447.1996.tb09860.x; BOLLAWILSON K, 1989, AM J PSYCHIAT, V146, P627; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BURVILL PW, 1995, BRIT J PSYCHIAT, V166, P320, DOI 10.1192/bjp.166.3.320; DOWNHILL JE, 1994, J NERV MENT DIS, V182, P425, DOI 10.1097/00005053-199408000-00001; EASTWOOD MR, 1989, BRIT J PSYCHIAT, V154, P195, DOI 10.1192/bjp.154.2.195; EBRAHIM S, 1987, BRIT J PSYCHIAT, V151, P52, DOI 10.1192/bjp.151.1.52; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HOUSE A, 1990, PSYCHOL MED, V20, P805, DOI 10.1017/S0033291700036497; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORM AF, 1986, AUST NZ J PSYCHIAT, V20, P11, DOI 10.3109/00048678609158860; Kauhanen ML, 1999, STROKE, V30, P1875, DOI 10.1161/01.STR.30.9.1875; Murata Y, 2000, AM J GERIAT PSYCHIAT, V8, P310, DOI 10.1176/appi.ajgp.8.4.310; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; ROBINSON RG, 1986, BRIT J PSYCHIAT, V148, P541, DOI 10.1192/bjp.148.5.541; Robinson RG, 2000, AM J PSYCHIAT, V157, P351, DOI 10.1176/appi.ajp.157.3.351; ROBINSON RG, 1982, STROKE, V13, P635, DOI 10.1161/01.STR.13.5.635; RUTHERFORD WH, 1977, LANCET, V1, P1; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; SINYOR D, 1986, BRAIN, V109, P539; STARKSTEIN SE, 1987, BRAIN, V110, P1045, DOI 10.1093/brain/110.4.1045; TAYLOR CA, 1994, TRP NEUROPSYCHIAT AS, P81; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; WADE DT, 1987, BRIT J PSYCHIAT, V151, P200, DOI 10.1192/bjp.151.2.200; Wing J. K., 1974, MEASUREMENT CLASSIFI	29	7	8	0	7	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	JUL-AUG	2002	43	4					295	301		10.1176/appi.psy.43.4.295			7	Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	585EH	WOS:000177510900004	12189255				2022-02-06	
J	Jabbari, B; Rokhorenko, O; Khajavi, K; Mena, H				Jabbari, B; Rokhorenko, O; Khajavi, K; Mena, H			Intractable epilepsy and mild brain injury: incidence, pathology and surgical outcome	BRAIN INJURY			English	Article							HEAD-INJURY; SEIZURES	Objective: To study the role of mild brain injury in intractable epilepsy. Methods: The medical charts of 86 patients who underwent surgery for intractable epilepsy were reviewed in regard to the history of mild brain injury, pathology and surgical outcome. Results: Nine of 86 patients had a previous history of mild brain injury (10.4%) compared to 2.5% of 80 age and sex matched controls. Six of nine patients had non-neoplastic and three had neoplastic lesions. Post-surgical outcome was excellent in eight of nine patients (Engel class IA). Conclusions: The incidence of mild brain injury was 4-times higher in patients with intractable epilepsy compared to asymptomatic controls. The pathology was variable but in four of nine patients it was compatible with the described pathology in traumatic brain injury. Both groups, with or without brain injury, had good surgical outcome (88% versus 70%).	Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; Walter Reed Army Med Ctr, Dept Neurol, Washington, DC 20307 USA; Walter Reed Army Med Ctr, Neurosurg Serv, Washington, DC 20307 USA; Armed Forces Inst Pathol, Dept Neuropathol, Washington, DC 20306 USA		Jabbari, B (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.						ANNEGERS JF, 1979, NEUROSURGERY, V4, P203, DOI 10.1227/00006123-197903000-00001; CAVENESS WF, 1963, J NEUROSURG, V20, P570, DOI 10.3171/jns.1963.20.7.0570; DUCKETT S, 1993, MINOR HEAD TRAUMA, P5; EARLE KM, 1953, AMA ARCH NEUROL PSY, V69, P27, DOI 10.1001/archneurpsyc.1953.02320250033003; Engel Jerome Jr., 1993, P609; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; HOCHBERG F, 1984, NEUROLOGY, V34, P1511, DOI 10.1212/WNL.34.11.1511; Inskip PD, 1998, CANCER CAUSE CONTROL, V9, P109, DOI 10.1023/A:1008861722901; JENNETT B, 1975, EPILEPSY NONMISSIBLE; MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; MATHERN GW, 1995, BRAIN, V118, P105, DOI 10.1093/brain/118.1.105; PEREZDIAZ C, 1985, SURG NEUROL, V24, P81; PRESTOMARTIN S, 1988, INT J EPIDEMIOL, V27, P579; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rosenthal M, 1987, REHABIL PSYCHOL, P37; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; [No title captured]; 2000, J HEAD TRAUMA REHABI, V15, P750	20	7	7	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2002	16	6					463	467		10.1080/02699050110102086			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	569RK	WOS:000176615800001	12119082				2022-02-06	
J	Kumaraswamy, N; Naziah, A; Abdullah, J; Mmed, ARA; Abdullah, MR; Ghazaime, G				Kumaraswamy, N; Naziah, A; Abdullah, J; Mmed, ARA; Abdullah, MR; Ghazaime, G			Outcome of children with traumatic brain injury in rural Malaysia	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						brain; children; CT variable; Malaysia; outcome; prehospital; trauma	CLOSED-HEAD-INJURY; COMA SCALE; RECOVERY; COHORT; ADOLESCENTS; SEQUELAE; TOMOGRAPHY; PREDICTION; MANAGEMENT; CHILDHOOD	Malaysia had the second highest crude accident rate in the world until 1998. Most children who were involved in these road traffic accidents required intensive neurosurgical care management. We report a prospective study on 36 paediatric neurotrauma patients in rural North East West Malaysia who underwent uniform intensive therapy and were subsequently followed up over a period of 2 years. The modified paediatric Glasgow Coma Scale with support of the revised Wechlser Intelligence Scale for children was used to test the outcome of these children over a period of two years. All patients were managed aggressively in our intensive care as well as our high dependency units. Our results indicate that improvement in outcome is seen after a six month period. Midline shift, duration of coma and duration of transport were found to be significant variables associated with bad outcome. Other variables i.e. age, sex, Glasgow Coma Scale on admission and on site, and lesions of the dominant lobe were not found to be associated with good outcome in these patients. (C) 2002 Elsevier Science Ltd. All rights reserved.	Hosp Univ Sci Malaysia, Dept Neurosci, Kubang Kerian 16150, Kelantan, Malaysia; Hosp Univ Sci Malaysia, Div Psychiat, Dept Psychiat, Kubang Kerian 16150, Kelantan, Malaysia; Hosp Univ Sci Malaysia, Dept Radiol, Kubang Kerian 16150, Kelantan, Malaysia; Hosp Univ Sci Malaysia, Dept Community Med, Kubang Kerian 16150, Kelantan, Malaysia; Hosp Univ Sci Malaysia, Dept Anesthesiol & Intens Care, Kubang Kerian 16150, Kelantan, Malaysia		Abdullah, J (corresponding author), Hosp Univ Sci Malaysia, Dept Neurosci, Kubang Kerian 16150, Kelantan, Malaysia.		Abdullah, J/C-2828-2011	Abdullah, J/0000-0002-0258-7410			ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Azian AA, 2001, ACTA NEUROCHIR, V143, P711, DOI 10.1007/s007010170051; BLACK P, 1971, P INT S HEAD INJ ED, P131; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; HEISKANEN O, 1974, DEV MED CHILD NEUROL, V16, P11; HJERN B, 1962, ARCH DIS CHILD, V37, P113, DOI 10.1136/adc.37.192.113; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; JENNETT B, 1975, LANCET, V2, P480; KAISER G, 1984, NEUROPEDIATRICS, V15, P68, DOI 10.1055/s-2008-1052344; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; LEVIN HS, 1979, CHILD BRAIN, V5, P281; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; NAUGHTON JA, 1991, P INT S ED CHURCH LI, P106; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Ong LC, 1998, J PAEDIATR CHILD H, V34, P363, DOI 10.1046/j.1440-1754.1998.00239.x; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; Rudolf J, 1998, CEREBROVASC DIS, V8, P166, DOI 10.1159/000015843; SCOTTJUPP R, 1992, ARCH DIS CHILD, V67, P222, DOI 10.1136/adc.67.2.222; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; STAVER SL, 1976, ARCH PHYS MED REHAB, V57, P201; TEASDALE G, 1975, LANCET, V1, P480; TOMPKINS CA, 1990, BRAIN COGNITION, V13, P86, DOI 10.1016/0278-2626(90)90042-M; VISVANATHAN R, 1994, AUST NZ J SURG, V64, P527, DOI 10.1111/j.1445-2197.1994.tb02278.x; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; WOSSON DE, 1992, J TRAUMA, V33, P252; Yorkston KM, 1997, ARCH PHYS MED REHAB, V78, P1096, DOI 10.1016/S0003-9993(97)90134-9	43	7	8	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2002	9	3					251	255		10.1054/jocn.2001.1047			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582JR	WOS:000177347600006	12093129				2022-02-06	
J	Willcox, N; Oakley, P				Willcox, N; Oakley, P			Survival with an arterial pH of 6.57 following major trauma with exsanguinating haemorrhage associated with traumatic amputation	RESUSCITATION			English	Article						arterial pH; major traumas; exsanguinating haemorrhage	HEAD-INJURED PATIENTS; MILD HYPOTHERMIA; METABOLIC-ACIDOSIS; CIRCULATORY SHOCK; HEMORRHAGIC-SHOCK; MAXIMAL EXERCISE; LACTIC-ACIDOSIS; CARDIAC-ARREST; LACTATE; BLOOD	We report the survival of a multiply injured patient with exanguinating haemorrhage and an arterial pH of 6.5. following a road vehicle crash. The previously healthy 38 years old male driver veered off the motorway and collided with a tree. The ambulance arrived at the scene 9 min after being called by an eyewitness and, following rapid extrication from the wreckage; the patient arrived in hospital 27 min later (with a GCS of 6). and was immediately intubated. The patient had suffered near-complete amputation of the left leg at upper femoral shaft level. along with multiple distal fractures and open wounds. He also sustained a head injury and closed displaced fractures of left radius and ulna. The patient received 21 of crystalloids in the pre-hospital phase, Once in hospital the haemorrhage was controlled with a pressure dressing and intra-venous fluids were kept to a minimum until he was taken promptly to theatre. His initial arterial blood sample revealed a pH of 6.57, pCo(2) of 9.18 kPa, apO(2) of 70.11 kPa and a base excess of -27.5 mmol l(-1). The co-oximeter Hb was 5.8 g dl(-1). Haemorrhage was controlled in theatre where he was transfused a total of 30 U of blood, 1 pack of platelets, 12 U of fresh frozen plasma, 3.5 1 of crystalloids and 1.5 1 of colloid. Sodium bicarbonate was administered three times. He subsequently remained ventilated in intensive care unit (ICU). Over the following week he survived sepsis, disseminated intravascular coagulation and myoglobinuria (with transient renal failure) attributable to rhabdomyolysis secondary to muscle necrosis. He later underwent diversion colostomy and disarticulating amputation of the left femur after several debridements. After 6 weeks on ICU he made an excellent recovery will full return of his mental abilities, In this case, the serial arterial blood samples obtained were reliable. The lactic acidosis observed was the result of profound tissue hypo-perfusion and its rate of clearance seems to have greater prognostic value than its peak or initial value. Several factors may have contributed to the patient's survival: rapid retrieval from the scene, early intubation with excellent subsequent oxygenation (thus avoiding the dangerous combination of hypoxia and acidosis with synergistic influence on cardiac depression) and limited initial fluid resuscitation in the emergency department with prompt surgical intervention and vigorous restoration of organ perfusion after surgical haemostasis. Immediate operative haemostasis, coupled with restricted fluid administration beforehand and vigorous restoration of organ perfusion afterwards is now replacing the old resuscitation paradigm. Perhaps this shift in practice has helped this patient to survive. (C) 2002 Published by Elsevier Science Ireland Ltd.	N Staffordshire Hosp, Trauma Res Dept, Stoke On Trent ST4 7LN, Staffs, England		Willcox, N (corresponding author), N Staffordshire Hosp, Trauma Res Dept, Princes Rd, Stoke On Trent ST4 7LN, Staffs, England.						BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; FALK JL, 1985, ACUTE CARE, V11, P212; HERMANSEN L, 1972, J APPL PHYSIOL, V32, P304, DOI 10.1152/jappl.1972.32.3.304; HULSMANN WC, 1990, CELL BIOL INT REP, V14, P311, DOI 10.1016/0309-1651(90)91200-N; Ishikawa K, 2000, J TRAUMA, V49, P912, DOI 10.1097/00005373-200011000-00020; KOSTER R, 1992, RESUSCITATION, V24, P143, DOI 10.1016/0300-9572(92)90020-D; Krause KR, 2000, AM SURGEON, V66, P348; MANIKIS P, 1995, AM J EMERG MED, V13, P619, DOI 10.1016/0735-6757(95)90043-8; MIZOCK BA, 1992, CRIT CARE MED, V20, P80, DOI 10.1097/00003246-199201000-00020; Mizushima Y, 2000, J TRAUMA, V48, P58, DOI 10.1097/00005373-200001000-00010; Opdahl H, 1997, CRIT CARE MED, V25, P1431, DOI 10.1097/00003246-199708000-00035; ORCHARD CH, 1994, CARDIOVASC RES, V28, P1312, DOI 10.1093/cvr/28.9.1312; ORRINGER CE, 1977, NEW ENGL J MED, V297, P796, DOI 10.1056/NEJM197710132971502; OSNES JB, 1972, J APPL PHYSIOL, V32, P59, DOI 10.1152/jappl.1972.32.1.59; PERETZ DI, 1965, ANN NY ACAD SCI, V119, P1133, DOI 10.1111/j.1749-6632.1965.tb47467.x; Refsum HE, 1997, CRIT CARE MED, V25, P1497, DOI 10.1097/00003246-199709000-00016; Roberts I, 2001, LANCET, V357, P385, DOI 10.1016/S0140-6736(00)03653-9; ROBERTSON R, 1995, AM J SURG, V170, P691, DOI 10.1016/S0002-9610(99)80043-9; ROBERTSON R, 1995, AM J SURG, V170, P694; Shapiro MB, 2000, J TRAUMA, V49, P969, DOI 10.1097/00005373-200011000-00033; SHEFFIELD CW, 1994, ACTA ANAESTH SCAND, V38, P201, DOI 10.1111/j.1399-6576.1994.tb03873.x; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; VINCENT JL, 1983, CRIT CARE MED, V11, P449, DOI 10.1097/00003246-198306000-00012; Warner OJ, 2001, RESUSCITATION, V49, P213; WASSERMAN K, 1986, FASEB J, V45, P2904; WEIL MH, 1970, CIRCULATION, V41, P989, DOI 10.1161/01.CIR.41.6.989; ZHOU HZ, 1993, MAGN RESON MED, V29, P94, DOI 10.1002/mrm.1910290116	29	7	7	0	2	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0300-9572			RESUSCITATION	Resuscitation	MAY	2002	53	2					217	221	PII S0300-9572(02)00020-5	10.1016/S0300-9572(02)00020-5			5	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	559TC	WOS:000176040600013	12009226				2022-02-06	
J	Aoki, A; Mori, K; Maeda, M				Aoki, A; Mori, K; Maeda, M			Adequate cerebral perfusion pressure during rewarming to prevent ischemic deterioration after therapeutic hypothermia	NEUROLOGICAL RESEARCH			English	Article						hypothermia; cerebral perfusion pressure; rewarming; cerebral ischemia; misery perfusion; glutamate	SEVERE HEAD-INJURY; TRAUMATIC BRAIN INJURY; NITRIC-OXIDE SYNTHESIS; MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; INTRACRANIAL HYPERTENSION; CARDIOPULMONARY BYPASS; DIALYSIS ELECTRODE; GLUTAMATE RELEASE; METABOLIC-RATE	Ischemic deterioration during rewarming is one of the most notable clinical complications after successful therapeutic cerebral hypothermia, but the mechanism is not completely understood. Hypothermia may cause vasoconstriction and relative ischemia, especially with insufficient cerebral perfusion pressure (CPP). Various parameters were evaluated to determine the critical CPP threshold to avoid ischemia during rewarming. Cat experimental head injury was induced by inflating an epidural rubber balloon, and intracranial pressure was maintained at 30 mmHg. During rewarming after cerebral hypothermia, CPP was maintained at greater than or equal to120 mmHg (n = 16), 90 mmHg (n = 11), 60 mmHg (n = 11), and 40 mmHg (n = 4) by controlling the blood pressure. Cerebral blood flow, cerebral metabolic rate for oxygen, arteriovenous difference of oxygen (AVDO(2)), cerebral venous oxygen saturation (ScvO(2)), and extracellular glutamate concentrations were monitored by glutamate oxidase electrode. After rewarming, the cerebral metabolic parameters were almost restored to the pre-injury level in animals with CPP of more than 90 mmHg. However, in the animals with CPP = 60 mmHg, all parameters significantly deteriorated and indicated misery perfusion; ScvO(2) was low (29.5 +/- 1.1%), AVDO(2) was significantly high (9.9 +/- 0.8 ml 100 g(-1) min(-1)) (one-way analysis of variance, p < 0.05), and electron microscopic features showed subcellular ischemic change. Extracellular glutamate significantly increased during the rewarming period only in the CPP = 40 mmHg group. CPP less than 60 mmHg during rewarming causes secondary ischemic insult, which might indicate continuation of cerebral vasoconstriction in hypothermia. CPP higher than 90 mmHg is required to avoid the potential risk of relative ischemia after hypothermia.	Juntendo Univ, Izunagaoka Hosp, Dept Neurosurg, Shizuoka 4102295, Japan; Juntendo Casualty Ctr, Shizuoka, Japan		Aoki, A (corresponding author), Juntendo Univ, Izunagaoka Hosp, Dept Neurosurg, 1129 Nagaoka,Izunagaoka Cho, Shizuoka 4102295, Japan.						Asai S, 1998, NEUROREPORT, V9, P3863, DOI 10.1097/00001756-199812010-00018; Asai S, 1996, NEUROREPORT, V7, P1092, DOI 10.1097/00001756-199604100-00028; Asai S, 2000, BRAIN RES, V864, P60, DOI 10.1016/S0006-8993(00)02151-X; ASTRUP J, 1982, J NEUROSURG, V56, P482, DOI 10.3171/jns.1982.56.4.0482; BAKER AJ, 1991, STROKE, V22, P666, DOI 10.1161/01.STR.22.5.666; Bauer R, 2000, CRIT CARE MED, V28, P1128, DOI 10.1097/00003246-200004000-00036; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Bernard SA, 1999, CRIT CARE, V3, P167, DOI 10.1186/cc371; Biestro A, 1998, ACT NEUR S, V71, P5; Bouma G J, 1995, New Horiz, V3, P384; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHOPP M, 1989, J CEREBR BLOOD F MET, V9, P141, DOI 10.1038/jcbfm.1989.21; CLASEN RA, 1968, ARCH NEUROL-CHICAGO, V19, P472, DOI 10.1001/archneur.1968.00480050042004; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1995, J NEUROTRAUM, V12, P923, DOI 10.1089/neu.1995.12.923; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; EHRMANTRAUT WR, 1956, AMA ARCH INT MED; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Enomoto S, 1996, ANESTHESIOLOGY, V84, P1392, DOI 10.1097/00000542-199606000-00016; Fujisawa H, 1999, J NEUROTRAUM, V16, P1083, DOI 10.1089/neu.1999.16.1083; HAGERDAL M, 1975, J NEUROCHEM, V24, P311, DOI 10.1111/j.1471-4159.1975.tb11881.x; Irikura K, 1998, J CEREBR BLOOD F MET, V18, P1294, DOI 10.1097/00004647-199812000-00003; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KADER A, 1994, NEUROSURGERY, V35, P272, DOI 10.1227/00006123-199408000-00013; LEI BP, 1994, STROKE, V25, P147, DOI 10.1161/01.STR.25.1.147; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MICHENFELDER JD, 1968, ANESTHESIOLOGY, V29, P1107, DOI 10.1097/00000542-196811000-00005; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MITANI A, 1991, BRAIN RES, V562, P159, DOI 10.1016/0006-8993(91)91201-B; Mori K, 1999, NEUROL RES, V21, P585, DOI 10.1080/01616412.1999.11740981; MUIZELAAR JP, 1994, CAN J NEUROL SCI, V21, P1; Nakashima K, 1996, STROKE, V27, P913, DOI 10.1161/01.STR.27.5.913; Nemoto EM, 1996, J NEUROSURG ANESTH, V8, P52, DOI 10.1097/00008506-199601000-00012; OGURA K, 1991, J NEUROSURG, V75, P433, DOI 10.3171/jns.1991.75.3.0433; Pasztor E, 1973, STROKE, V4, P556, DOI 10.1161/01.STR.4.4.556; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; REULER JB, 1978, ANN INTERN MED, V89, P519, DOI 10.7326/0003-4819-89-4-519; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; SEDZIMIR CB, 1959, J NEUROSURG, V16, P407, DOI 10.3171/jns.1959.16.4.0407; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; TSUBOKAWA T, 1992, CRIT REV NEUROSURG, V2, P210; van der Linden J, 1989, Eur J Cardiothorac Surg, V3, P209, DOI 10.1016/1010-7940(89)90068-7; VANDAM LD, 1959, NEW ENGL J MED, V261, P595, DOI 10.1056/NEJM195909172611206; VANDAM LD, 1959, NEW ENGL J MED, V261, P546, DOI 10.1056/NEJM195909102611106; VERHAEGEN MJJ, 1993, STROKE, V24, P407, DOI 10.1161/01.STR.24.3.407; WOOD JH, 1987, CEREBRAL BLOOD FLOW, P75; WOODCOCK TE, 1987, ANESTHESIOLOGY, V67, P218, DOI 10.1097/00000542-198708000-00011; YAMASHITA K, 1991, STROKE, V22, P1574, DOI 10.1161/01.STR.22.12.1574	58	7	8	0	1	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	APR	2002	24	3					271	280		10.1179/016164102101199909			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	535NH	WOS:000174650200009	11958421				2022-02-06	
J	Braun, H; Schulz, S; Hollt, V				Braun, H; Schulz, S; Hollt, V			Expression changes of somatostatin receptor subtypes sst2A, sst2B, sst3 and sst4 after a cortical contusion trauma in rats	BRAIN RESEARCH			English	Article						neurotrauma; somatostatin receptor subtype; neuronal degeneration; regeneration; expression pattern; astrocyte	CENTRAL-NERVOUS-SYSTEM; MOLECULAR-CLONING; DENTATE GYRUS; 2 ISOFORMS; BRAIN; SECRETION; PROLIFERATION; NEUROGENESIS; CORTISTATIN; PEPTIDE	The neuropeptide somatostatin acts as a neuromodulator in the CNS in a predominantly inhibitory manner. In this study, an ipsilateral cortical and hippocampal damage in the brain of adult rats was induced by a cortical contusion trauma in order to examine subsequent changes of expression of different somatostatin receptor subtypes (sst). By using subtype specific antibodies we found a clear decline of expression level for sst2A, sst2B, sst3 and sst4 subtypes in the pyramidal cell layer of the ipsilateral hippocampus. Nissl staining revealed that this decline of expression level is due to cell death of sst expressing neurons within the first 48 h after trauma. Additionally we found a progressive infiltration of sst4 positive cells into regions of cortical and hippocampal. damage. The number of these cells increases striking within the first 3 days after trauma and it seems that their morphology changes from a round to an astrocyte-like shape. Moreover, sst4 and sst2A positive cells accumulate in the ipsilateral ependym and pyramidal-like cells expressing sst4 were found beneath the damaged CA3 pyramidal layer. Taken together, after trauma we found deterioration of sst positive neurons and an additional activation of sst4 and sst2A expressing cells the final fate of which has to be elucidated further. (C) 2002 Published by Elsevier Science B.V.	Otto Von Guericke Univ, Inst Pharmakol & Toxikol, D-39120 Magdeburg, Germany		Hollt, V (corresponding author), Otto Von Guericke Univ, Inst Pharmakol & Toxikol, Leipziger Str 44, D-39120 Magdeburg, Germany.		Schulz, Stefan/A-6928-2017	Schulz, Stefan/0000-0002-5997-8885			Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; Braun H, 1998, BRAIN RES, V803, P54, DOI 10.1016/S0006-8993(98)00609-X; BRAUN H, 2002, IN PRESS J NEUROTRAU; BRUNO JF, 1992, P NATL ACAD SCI USA, V89, P11151, DOI 10.1073/pnas.89.23.11151; BURGUS R, 1973, P NATL ACAD SCI USA, V70, P684, DOI 10.1073/pnas.70.3.684; deLecea L, 1997, J NEUROSCI, V17, P5868; DOLLINGER HC, 1976, HORM METAB RES, V8, P74, DOI 10.1055/s-0028-1093677; DOLLINGER HC, 1976, Z GASTROENTEROL VERH, V10, P56; EPELBAUM J, 1986, PROG NEUROBIOL, V27, P63, DOI 10.1016/0301-0082(86)90012-2; Fukusumi S, 1997, BIOCHEM BIOPH RES CO, V232, P157, DOI 10.1006/bbrc.1997.6252; Gillies G, 1997, TRENDS PHARMACOL SCI, V18, P87, DOI 10.1016/S0165-6147(96)01032-2; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Hailer NP, 1999, EUR J NEUROSCI, V11, P3359, DOI 10.1046/j.1460-9568.1999.00808.x; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; KLUXEN FW, 1992, P NATL ACAD SCI USA, V89, P4618, DOI 10.1073/pnas.89.10.4618; Liu JL, 1998, J NEUROSCI, V18, P7768; MEYERHOF W, 1992, P NATL ACAD SCI USA, V89, P10267, DOI 10.1073/pnas.89.21.10267; OCARROLL AM, 1992, MOL PHARMACOL, V42, P939; RAPTIS S, 1975, DIGESTION, V13, P15, DOI 10.1159/000197691; ROHRER L, 1993, P NATL ACAD SCI USA, V90, P4196, DOI 10.1073/pnas.90.9.4196; Schreff M, 2000, J NEUROSCI, V20, P3785, DOI 10.1523/JNEUROSCI.20-10-03785.2000; Schulz S, 2000, J PHYSIOLOGY-PARIS, V94, P259, DOI 10.1016/S0928-4257(00)00212-6; Schulz S, 1998, NEUROSCI LETT, V257, P37, DOI 10.1016/S0304-3940(98)00803-9; SORENSEN KV, 1981, NEUROENDOCRINOLOGY, V32, P335, DOI 10.1159/000123183; VANETTI M, 1992, FEBS LETT, V311, P290, DOI 10.1016/0014-5793(92)81122-3; VANETTI M, 1993, FEBS LETT, V331, P260, DOI 10.1016/0014-5793(93)80349-Y; YAMADA Y, 1992, MOL ENDOCRINOL, V6, P2136, DOI 10.1210/me.6.12.2136; YASUDA K, 1992, J BIOL CHEM, V267, P20422	29	7	7	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAR 15	2002	930	1-2					191	199	PII S0006-8993(01)03322-4	10.1016/S0006-8993(01)03322-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534ME	WOS:000174589500021	11879809				2022-02-06	
J	Reuter, D; Brownstein, D				Reuter, D; Brownstein, D			Common emergent pediatric neurologic problems	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article							SEIZURE RECURRENCE; STATUS EPILEPTICUS; COMPUTED-TOMOGRAPHY; INTRACRANIAL INJURY; FEBRILE SEIZURES; SKULL FRACTURE; RISK-FACTORS; HEAD-INJURY; CHILDREN; INFANTS	Although there are a variety of neurologic disease processes that the emergency physician should be aware of, the most common of these include seizures, closed head injury, headache, and syncope. This article discusses the classification, epidemiology, presentation, evaluation, and management of these common diseases.	Childrens Hosp & Reg Med Ctr, Emergency Serv CH04, Dept Emergency Sci, Seattle, WA 98105 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA		Brownstein, D (corresponding author), Childrens Hosp & Reg Med Ctr, Emergency Serv CH04, Dept Emergency Sci, 4800 Sandpoint Way,NE, Seattle, WA 98105 USA.						Bergman DA, 1996, PEDIATRICS, V97, P769; Bleck TP, 1999, EPILEPSIA, V40, pS59, DOI 10.1111/j.1528-1157.1999.tb00880.x; BLECK TP, 1999, EPILEPSIA S1, V40, P64; Braunwald E, 1992, HEART DIS TXB CARDIO, V4th; Burton LJ, 1997, PEDIATR EMERG CARE, V13, P1, DOI 10.1097/00006565-199702000-00001; CHAMBERLAIN JM, 1988, AM J DIS CHILD, V142, P1073, DOI 10.1001/archpedi.1988.02150100067028; Chamberlain JM, 1997, PEDIATR EMERG CARE, V13, P92, DOI 10.1097/00006565-199704000-00002; Cheung DS, 1999, EMERG MED CLIN N AM, V17, P9, DOI 10.1016/S0733-8627(05)70044-4; DAVIES RL, 1995, PEDIATRICS, V95, P345; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Feit L R, 1996, Adv Pediatr, V43, P469; Forsyth R, 1999, Pediatr Rev, V20, P39, DOI 10.1542/pir.20-2-39; FUCHS SM, 1997, PEDIAT EMERGENCY MED, P1009; GREEN SM, 1993, PEDIATRICS, V92, P527; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; Hamalainen ML, 1997, NEUROLOGY, V48, P103, DOI 10.1212/WNL.48.1.103; Hannon D W, 1993, Curr Probl Pediatr, V23, P358, DOI 10.1016/0045-9380(93)90031-7; Harrison AM, 1997, PEDIATR EMERG CARE, V13, P420, DOI 10.1097/00006565-199712000-00019; HAUSER WA, 1982, NEW ENGL J MED, V307, P522, DOI 10.1056/NEJM198208263070903; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hirtz D, 2000, NEUROLOGY, V55, P616, DOI 10.1212/WNL.55.5.616; JAFFE M, 1981, PEDIATRICS, V67, P729; JOFFE A, 1983, AM J DIS CHILD, V137, P1153, DOI 10.1001/archpedi.1983.02140380013005; KUDENCHUK PJ, 1985, MOD CONC CARDIOV DIS, V54, P25; LALKOUL R, 1997, ARCH DIS CHILD, V76, P445; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; LOMBROSO CT, 1967, PEDIATRICS, V39, P563; Lowenstein DH, 1998, WESTERN J MED, V168, P263; MACDONALD JT, 1994, HEADACHE, V34, P581, DOI 10.1111/j.1526-4610.1994.hed3410581.x; NELSON KB, 1978, PEDIATRICS, V61, P720; NELSON KB, 1976, NEW ENGL J MED, V295, P1029, DOI 10.1056/NEJM197611042951901; NIENABER CA, 1990, J AM COLL CARDIOL, V15, P948, DOI 10.1016/0735-1097(90)90222-B; OFFRINGA M, 1994, J PEDIATR-US, V124, P574, DOI 10.1016/S0022-3476(05)83136-1; PARTY MS, 2000, ARCH DIS CHILD, V83, P415; PRATT J L, 1989, Pediatric Emergency Care, V5, P80, DOI 10.1097/00006565-198906000-00002; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Quayle KS, 1999, PEDIATR CLIN N AM, V46, P1189, DOI 10.1016/S0031-3955(05)70182-6; Redillas C, 2000, HEADACHE, V40, P83, DOI 10.1046/j.1526-4610.2000.00014.x; RIVERA R, 1993, CRIT CARE MED, V21, P991, DOI 10.1097/00003246-199307000-00011; Roberts Mont R., 1995, Emergency Medicine Clinics of North America, V13, P489; ROSS BA, 1990, LEARNING CTR HIGHLIG, V5, P7; Rothner AD, 1999, CHILD ADOL PSYCH CL, V8, P727; SAPIRE DW, 1985, INT J CARDIOL, V9, P211, DOI 10.1016/0167-5273(85)90200-1; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; Scott RC, 1999, LANCET, V353, P623, DOI 10.1016/S0140-6736(98)06425-3; SCOTT WA, 1991, PEDIATR ANN, V20, P350, DOI 10.3928/0090-4481-19910701-08; Shane SA, 1997, PEDIATR EMERG CARE, V13, P198, DOI 10.1097/00006565-199706000-00006; Shinnar S, 1996, PEDIATRICS, V98, P216; Shugerman RP, 1996, PEDIATRICS, V97, P664; Silberstein SD, 2000, CURR OPIN NEUROL, V13, P277, DOI 10.1097/00019052-200006000-00008; Stecker MM, 1998, EPILEPSIA, V39, P18, DOI 10.1111/j.1528-1157.1998.tb01269.x; Teach SJ, 1999, PEDIATR EMERG CARE, V15, P9, DOI 10.1097/00006565-199902000-00003; TRAINOR JL, 1999, CLIN PEDIAT EMERGENC, V1, P13; van Stuijvenberg M, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.5.e51; VERITY CM, 1991, BMJ-BRIT MED J, V303, P1373, DOI 10.1136/bmj.303.6814.1373; Vining Eileen P. G., 1994, Emergency Medicine Clinics of North America, V12, P973; Ward TN, 2000, POSTGRAD MED, V108, P121, DOI 10.3810/pgm.2000.09.1.1209; Warden CR, 1997, ANN EMERG MED, V29, P518, DOI 10.1016/S0196-0644(97)70226-9	61	7	8	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	FEB	2002	20	1					155	+		10.1016/S0733-8627(03)00056-7			23	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	519PP	WOS:000173734900009	11826632				2022-02-06	
J	Baethmann, A; Wirth, A; Schlesinger-Raab, A				Baethmann, A; Wirth, A; Schlesinger-Raab, A		Study Grp BMBF Res Consortium Neur	Prospective system analysis of the pre- and early hospital care in severe head injury in Bavaria at a population-based level	EUROPEAN SURGICAL RESEARCH			English	Article						traumatic brain injury; pre- and early clinical patient management; system analysis			Klinikum Univ Munich, Inst Surg Res, D-81366 Munich, Germany		Baethmann, A (corresponding author), Klinikum Univ Munich, Inst Surg Res, D-81366 Munich, Germany.						ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; JENNETT B, 1975, LANCET, V1, P480; LEHR D, 1997, CRITICAL CARE, V42, pS71; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; WIRTH A, 2002, IN PRESS ACTA NEUR S; 1999, STERBEFALLE 1999 AUS, V4	8	7	7	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-312X			EUR SURG RES	Eur. Surg. Res.	JAN-APR	2002	34	1-2					42	46		10.1159/000048886			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	535QQ	WOS:000174655900008	11867900	Green Published			2022-02-06	
J	Fligor, BJ; Cox, LC; Nesathurai, S				Fligor, BJ; Cox, LC; Nesathurai, S			Subjective hearing loss and history of traumatic brain injury exhibits abnormal brainstem auditory evoked response: A case report	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; case report; evoked potentials, auditory, brain stem; rehabilitation		A 30-year-old woman presented with long-standing subjective unilateral auditory difficulties 13 years after sustaining closed head trauma. The battery of audiologic tests indicated normal hearing, but brainstem auditory evoked response (BAER) tests revealed abnormal neurogenic potentials in the symptomatic ear. The discrepancy between a normal pure tone audiogram and abnormal BAERs suggests that a site of neurologic injury could be causing the patient's problem with auditory perception. Imaging studies with gadolinium enhancement, however, did not document any abnormalities in the brainstem. Our present findings and previously published literature help identify the specific site of a neurologic deficit when routine audiologic tests and imaging studies detect no significant abnormality.	Boston Univ, Sargent Coll Allied Hlth & Rehabil Sci, Boston, MA 02215 USA; Boston Med Ctr, Boston, MA USA; Boston Univ, Sch Med, Boston, MA 02118 USA		Cox, LC (corresponding author), 720 Harrison Ave,Ste 601, Boston, MA 02118 USA.						Fenton GW, 1996, CLIN ELECTROENCEPHAL, V27, P174; GREEN DS, 1994, HDB CLIN AUDIOLOGY, P176; HALL JW, 1992, HDB AUDITORY EVOKED, P653; Moller A., 1994, PRINCIPLES APPL AUDI, P23; THORNTON AR, 1978, J SPEECH HEAR RES, V21, P507, DOI 10.1044/jshr.2103.507; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514	6	7	10	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2002	83	1					141	143		10.1053/apmr.2002.26813			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	509JU	WOS:000173145300022	11782845				2022-02-06	
J	Leon-Carrion, J				Leon-Carrion, J			Dementia due to head trauma: An obscure name for a clear neurocognitive syndrome	NEUROREHABILITATION			English	Article						dementia; brain injury; post-concussional disorder; neurobehavioral disorder; neuropsychiatric disorder; neuropsychological assessment	COMA DATA-BANK; ALZHEIMERS-DISEASE; BRAIN INJURY; SUBCORTICAL DEMENTIA; RISK; ROTTERDAM; SEQUELAE	This paper questions the DSM IV TR criteria for Dementia Due to Head Trauma (DDHT). We studied 20 consecutive traumatic brain injury (TBI) patients and checked them for this criteria. We found the diagnosis criteria to be oversensitive and lacking in specificity, consequently raising the possibility for all subjects who have sustained severe TBI to be diagnosed with dementia. A careful analysis of data and literature showed that nearly half of these patients were able to return to work after undergoing an intensive and holistic rehabilitation program, indicating a reversal of the "dementia''. Severe head injury produces a set of multiple cognitive deficits that shouldn't be considered dementia. The term "Severe Neurocognitive Disorder'' is suggested for use instead of DDHT for the cognitive deterioration of severe TBI patients.	Univ Seville, Dept Expt Psychol, Human Neuropsychol Lab, Seville 41005, Spain		Leon-Carrion, J (corresponding author), Univ Seville, Dept Expt Psychol, Human Neuropsychol Lab, San Francisco Javier S-N, Seville 41005, Spain.						ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ALBERT ML, 1974, J NEUROL NEUROSUR PS, V37, P121, DOI 10.1136/jnnp.37.2.121; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V3, P22; BARROSOMARTIN JM, 1999, REV ESPANOLA NEUROPS, V1, P3; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BENDIXEN BH, 1996, CATASTROPHIC BRAIN I; BENTON AL, 1963, BENTON VISUAL RETENT; BERESFORD HR, 1996, CATASTROPHIC BRAIN I; BRADSHAW JR, 1983, BRIT MED J, V286, P277, DOI 10.1136/bmj.286.6361.277; BRETELER MMB, 1992, NEUROEPIDEMIOLOGY, V11, P23, DOI 10.1159/000110957; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Christensen AL., 1974, LURIAS NEUROPSYCHOLO; CHUI HC, 1990, GERIATRIC REHABILITA, P389; CLARFIELD AM, 1988, ANN INTERN MED, V109, P476, DOI 10.7326/0003-4819-109-6-476; CLINTON J, 1991, NEUROPATH APPL NEURO, V17, P69, DOI 10.1111/j.1365-2990.1991.tb00695.x; Cotman CW, 1996, NEUROBIOL AGING, V17, P723; Cummings J, 1985, CLIN NEUROPSYCHIATRY; CUMMINGS JL, 1984, ARCH NEUROL-CHICAGO, V41, P874, DOI 10.1001/archneur.1984.04050190080019; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; FISHER NR, 1987, J NEUROL NEUROSUR PS, V50, P488, DOI 10.1136/jnnp.50.4.488; FREEMON FR, 1976, ARCH NEUROL-CHICAGO, V33, P658, DOI 10.1001/archneur.1976.00500090064013; GOLDBERG MR, 1995, CLIN CANCER RES, V1, P57; Goodglass H, 1983, ASSESSMENT APHASIA R; Graham DI, 1996, ACT NEUR S, V66, P96; Gronwall D., 1989, ASSESSMENT BEHAV CON, P19; GUALTIERI T, 1997, BRAIN INJURY, V5, P219; HART S, 1990, NEUROPSYCHOLOGY DEME; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Ingvar D H, 1975, Ciba Found Symp, P97; ISAACS B, 1983, LANCET, V1, P187; KAMPEN DL, 1989, ASSESSMENT BEHAV CON, P49; LARSON EB, 1984, ANN INTERN MED, V100, P417, DOI 10.7326/0003-4819-100-3-417; LeBlanc JM, 2000, J HEAD TRAUMA REHAB, V15, P1022, DOI 10.1097/00001199-200008000-00005; Leon-Carrion J, 1998, NEUROREHABILITATION, V11, P129, DOI 10.1016/S1053-8135(98)00017-1; Leon-Carrion J, 2000, NEUROREHABILITATION, V14, P33; LeonCarrion J, 1996, INT J NEUROSCI, V85, P231, DOI 10.3109/00207459608986685; LEONCARRION J, 2000, REV ESPANOLA NEUROPS, V2, P92; LEONCARRION J, 1999, BRAIN INJURY SOURCES, V2, P16; LEONCARRION J, 1994, SEVILLE NEUROPSYCHOL; LEONCARRION J, UNPUB ARE FRONTAL NE; LEONCARRION J, 1997, NEUROPSYCHOLOGICAL R; LEONCARRION J, 1999, REV ESPANOLA NEUROPS, V1, P19; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Lishman W. A., 1987, ORGANIC PSYCHIAT PSY; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; MARSDEN CD, 1972, BMJ-BRIT MED J, V2, P249, DOI 10.1136/bmj.2.5808.249; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Marshall LF, 1991, J NEUROSURG S, V75, P14; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; Mateer C. A., 1997, NEUROPSYCHOL REHABIL, P285; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; MOLLOY DW, 1991, DEMENTIA COMMUNICATI; OSIMANI A, 1991, DEMENTIA COMMUNICATI; PERINO C, 2000, BRAIN INJURY SOURCES, V4, P26; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, J NEUROL NEUROSUR PS, V17, P69; ROBERTS GW, 1991, LANCET, V338, P422; Ruff R. M., 1991, J NEUROSURG, V75, P550; SMITH JS, 1981, LANCET, V1, P824; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; WHEMAN P, 1990, ARCH PHYS MED REHAB, V71, P1047; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554	69	7	7	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2002	17	2					115	122	UNSP nre00153.sgm				8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	563AX	WOS:000176232200004	12082238				2022-02-06	
J	Parker, RS				Parker, RS			Recommendations for the revision of DSM-IV diagnostic categories for co-morbid posttraumatic stress disorder and traumatic brain injury	NEUROREHABILITATION			English	Article						traumatic brain injury; concussion; posttraumatic stress disorder; DSM-IV; loss of consciousness; dissociation; minor traumatic brain injury	MILD HEAD-INJURY; IMPLICIT MEMORY; CHILDREN; DEPRESSION; DISTRESS; AMNESIA	The definitions in the Diagnostic and Statistical Manual-4th Ed.-TR [5] relating to posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) after mechanical accidents do not reflect the range of dysfunctions, the significance of patient differences, and fluctuating intensity, direction, and symptoms with increasing time since an injury. The considerable overlapping of symptoms is not considered at all, nor is concussion given a diagnosis. Some anatomical and physiological considerations for these frequently comorbid conditions are specified to increase diagnostic precision, or call attention to unavoidable ambiguities. The current definitions lead to diagnostic error since there are many that are based upon symptoms that are not trauma related although they resemble those of TBI. A Taxonomy of Neurobehavioral Disorders draws attention to a wide range of physiological and behavioral functions, with implications for more accurate recognition of symptoms, diagnosis, and treatment. Persistent posttraumatic disorders, more complex than PTSD, exist, due to the effects of unhealed tissues, impairment, and the social consequences of impairment and rejection. There are recommendations for the improvement of the definitions of PTSD and traumatic brain injury when both may be co-morbid after a mechanical injury.	NYU, Sch Med, Dept Neurol, New York, NY 10016 USA		Parker, RS (corresponding author), 50 W 96TH St 9C, New York, NY 10025 USA.	rsp2@nyu.edu					ABUJUDEH HH, 1997, NUCL MED COMMUN, V20, P505; Alarcon RD, 1997, AUST NZ J PSYCHIAT, V31, P159, DOI 10.3109/00048679709073815; American Psychiatric Association, 2000, DIAGN STAT MAN, V4th ed; BERNE RM, 1998, PHYSIOLOGY; BLACKWOOD D, 2000, ENCY STRESS, V2, P212; BLANCHARD EB, 1997, AFTER CRASH; Bowman ML, 1999, CAN J PSYCHIAT, V44, P21, DOI 10.1177/070674379904400103; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Burke R. J., 1996, HDB STRESS MED HLTH, P101; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Chrousos GP, 1998, ANN NY ACAD SCI, V851, P311, DOI 10.1111/j.1749-6632.1998.tb09006.x; COOPER GL, 1996, HDB STRESS MED HLTH; CROVITZ HF, 1992, CORTEX, V28, P509, DOI 10.1016/S0010-9452(13)80160-8; Curle CE, 1996, BRIT J CLIN PSYCHOL, V35, P297, DOI 10.1111/j.2044-8260.1996.tb01183.x; DEKOSKY ST, 1998, SEMIN CLIN NEUROPSYC, V3, P176; Elliott ML, 1996, BRAIN INJURY, V10, P703, DOI 10.1080/026990596123972; EMORY LE, 1995, J HEAD TRAUMA REHAB, V10, P47; EPSTEIN FM, 1987, HEAD INJURY, P391; Feeny NC, 2000, J TRAUMA STRESS, V13, P489, DOI 10.1023/A:1007789409330; Frohman, 1995, ENDOCRINOL METAB, P555; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Gennarelli TA, 1993, HEAD INJURY, P137; GUGGENHEIM FG, 2000, COMPREHENSIVE TXB PS, P1504; HANSENGRANT SM, 1998, TXB PSYCHOPHARMACOLO, P171; HENDRICK EB, 1968, J TRAUM, V8, P547; Holaday M, 2000, J PERS ASSESS, V75, P143, DOI 10.1207/S15327752JPA7501_10; Hornstein N. L, 2000, COMPREHENSIVE TXB PS, P2902; HUBBARD JR, 1998, HDB STRESS MED ORGAN; KAUFMAN AS, INTELLIGENT TESTING; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; Krikorian R, 1998, J NEUROPSYCH CLIN N, V10, P359, DOI 10.1176/jnp.10.3.359; Kronfol Z, 2000, AM J PSYCHIAT, V157, P683, DOI 10.1176/appi.ajp.157.5.683; LIAU LM, 1996, NEUROLOGICAL SURG, P1549; LOMBARDI G, 1994, ANN NY ACAD SCI, V741, P216; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; MIDDELBOE T, 1992, J PERS DISORD, V6, P246, DOI 10.1521/pedi.1992.6.3.246; Miller MC, 1999, APPL ORGANOMET CHEM, V13, P9, DOI 10.1002/(SICI)1099-0739(199901)13:1<9::AID-AOC818>3.0.CO;2-#; Mirza KAH, 1998, BRIT J PSYCHIAT, V172, P443, DOI 10.1192/bjp.172.5.443; Molitch ME., 1995, ENDOCRINOL METAB, P221; Narayan RK, 1996, NEUROTRAUMA; OBRIEN SL, 1998, TRAUMATIC EVENTS MEN; Ommaya, 1997, Semin Clin Neuropsychiatry, V2, P163; PARKER R, 1995, J NEUROL ORTH MED S, V16, P118; PARKER R, 1990, TRAUMATIC BRAIN INJU; PARKER RS, 1994, SEMIN NEUROL, V14, P67, DOI 10.1055/s-2008-1041061; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Parker RS, 1996, J CLIN PSYCHOL, V52, P32, DOI 10.1002/(SICI)1097-4679(199601)52:1<32::AID-JCLP5>3.3.CO;2-1; PARKER RS, 1983, SELF IMAGE PSYCHODYN; PARKER RS, 1995, J COGNITIVE REHABILI, V13, P14; PARKER RS, 2001, CONCUSSIVE BRAIN TRA; Putnam F.W., 2000, COMPREHENSIVE TXB PS, V1, P1552; Salzman SK, 1994, NEUROBIOLOGY CENTRAL; SCHACTER DL, 1993, ANNU REV NEUROSCI, V16, P159, DOI 10.1146/annurev.ne.16.030193.001111; SCHACTER DL, 1991, AWARENESS DEFICIT BR, P127; Schreuder BJN, 2000, J TRAUMA STRESS, V13, P453, DOI 10.1023/A:1007733324351; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; STEINBERG M, 2000, COMPREHENSIVE TXB PS, P1544; Steinberg M., 2000, COMPREHENSIVE TXB PS, P1564; TUCKER DM, 1998, ANN NY ACAD SCI, V643, P134; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Von Wild K, 2001, BRAIN INJURY, V15, P273; Wagner AW, 2000, J TRAUMA STRESS, V13, P41, DOI 10.1023/A:1007716813407; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; WELKER WI, 1976, EVOLUTION BRAIN BEHA, P251; Wong C. M., 2000, ENCY STRESS, V1, P1; [No title captured]	67	7	8	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2002	17	2					131	143	UNSP nre00155.sgm				13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	563AX	WOS:000176232200006	12082240				2022-02-06	
J	Balogh, A; Wedekind, C; Klug, N				Balogh, A; Wedekind, C; Klug, N			Does wave VI of BAEP pertain to the prognosis of coma?	NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY			English	Article						median nerve evoked somatosensory potential brainstem auditory evoked potential; wave VI; prognosis; coma	AUDITORY-EVOKED-POTENTIALS; SEVERE HEAD-INJURY; BRAIN-STEM; RESPONSES; LESIONS	Objectives - The significance of brainstem auditory evoked potential (BAEP) wave VI for the outcome of comatose patients was assessed and compared to the prognostic impact of median nerve evoked somatosensory potential (MSEP) recording. Patients and methods - One hundred sixteen patients in a comatose state due to traumatic brain injury (n = 57) and to intracerebral hemorrhage or tumours (n = 59) were investigated prospectively. Outcome was assessed 3 months after the onset of coma using Glasgow Outcome Score (GOS). Standard BAEP and MSEP recordings were obtained within 24 h after coma onset. The frequency of findings was correlated with outcome by means of non-parametric statistical analysis. Additionally, 27 healthy volunteers were studied to confirm the constant presence of wave VI in normal BAEP. Results - In healthy controls, wave VI was present in 53/54 ears stimulated. Outcome correlation analysis revealed a significantly (p < 0.01) higher frequency of abnormal wave VI in patients with unfavourable outcome (GOS 1-3) irrespective of the underlying pathology. Similarly, abnormal MSEP findings were significantly more frequent in this outcome group. Diagnostic sensitivity for an unfavourable outcome was low for both parameters, whereas specificity and positive predictive value of abnormal wave VI as well as of abnormal MSEP were equally high. Conclusion - Abnormal BAEP wave VI bears prognostic information in comatose patients. (C) 2001 Editions scientifiques et medicales Elsevier SAS.	Univ Cologne, Dept Neurosurg, D-50924 Cologne, Germany		Wedekind, C (corresponding author), Univ Cologne, Dept Neurosurg, D-50924 Cologne, Germany.	DrChrWedekind@web.de					CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; Chiappa K.H., 1997, EVOKED POTENTIALS CL; CHIAPPA KH, 1979, ARCH NEUROL-CHICAGO, V36, P81, DOI 10.1001/archneur.1979.00500380051005; DEWEERD AW, 1985, ACTA NEUROL SCAND, V72, P489; FACCO E, 1985, ELECTROEN CLIN NEURO, V62, P332, DOI 10.1016/0168-5597(85)90041-3; Facco E, 2000, INTENS CARE MED, V26, P998, DOI 10.1007/s001340051294; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Fischer C, 1982, Adv Neurol, V32, P177; Garcia-Larrea L., 1993, Neurophysiologie Clinique, V23, P141; HARSLEM R, 1987, ELECTROENCEPHALOGR L, V66, P64; HASHIMOTO I, 1981, BRAIN, V104, P841, DOI 10.1093/brain/104.4.841; HUGHES JR, 1980, ELECTROEN CLIN NEURO, V48, P357, DOI 10.1016/0013-4694(80)90272-2; HUGHES JR, 1988, ELECTROEN CLIN NEURO, V71, P367, DOI 10.1016/0168-5597(88)90039-1; JENNETT B, 1975, LANCET, V1, P480; KARNAZE DS, 1982, NEUROLOGY, V32, P299, DOI 10.1212/WNL.32.3.299; Kimura J, 1989, ELECTRODIAGNOSIS DIS; KITAMOTO I, 1991, BRAIN DEV-JPN, V13, P326, DOI 10.1016/S0387-7604(12)80127-6; KRIEGER D, 1993, CRIT CARE MED, V21, P1944, DOI 10.1097/00003246-199312000-00024; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; LUTSCHG J, 1983, AM J DIS CHILD, V137, P421; MAURER K, 1985, ELECTROEN CLIN NEURO, V62, P135, DOI 10.1016/0168-5597(85)90025-5; PohlmannEden B, 1997, INTENS CARE MED, V23, P301, DOI 10.1007/s001340050332; Sachs, 1997, ANGEW STAT; SCHERG M, 1985, ELECTROENCEPHALOGR C, V62, P277; Wedekind C, 1999, J TRAUMA, V47, P44, DOI 10.1097/00005373-199907000-00010	26	7	7	1	4	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0987-7053	1769-7131		NEUROPHYSIOL CLIN	Neurophysiol. Clin.-Clin. Neurophysiol.	DEC	2001	31	6					406	411		10.1016/S0987-7053(01)00277-5			6	Clinical Neurology; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	513PD	WOS:000173386200006	11810990				2022-02-06	
J	Rouge-Maillart, C; Tracqui, A; Tortel, MC; Pessaux, P; Penneau, M; Ludes, B				Rouge-Maillart, C; Tracqui, A; Tortel, MC; Pessaux, P; Penneau, M; Ludes, B			Fatal blunt pancreatic trauma secondary to assault and battery: a case report	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						blunt abdominal trauma; pancreatic injury; violence; diagnosis	ABDOMINAL-TRAUMA; CHILD-ABUSE; INJURIES; DIAGNOSIS	The authors report on an fatal case of closed trauma of the pancreas in a context of violence. A 55-yearold man was found unconscious on the sidewalk and died a short time after being taken to the hospital. He had been hit with several punches to the face and abdomen 6 h before. The post-mortem examination showed numerous bruises over the whole body, a haemoperitoneum, a fissuration of the spleen and a massive peripancreatic haemorrhage associated with a complete dilaceration of the pancreas head. Histological examination of the pancreas revealed a massive necrosis associated with a subtotal disappearance of the acini, numerous sites of cytosteatonecrosis and a large haemorrhagic suffusion of the peripancreatic tissue. This case illustrates the possibilities of pancreatic injuries induced by blunt force aimed at the abdomen in a context of violence. Even if this occurs as an isolated injury it can result in rapid death because of the particular type of pancreatic fracture which is frequently involved. In postmortem situations, the pancreas should be systematically checked at necropsy and a histological examination should be carried out at the slightest doubt of a pancreatic lesion or suspicion of blunt force abdominal injuries.	Univ Hosp Angers, Emergency Dept, Unity Forens Med, F-49100 Angers, France; Fac Med Strasbourg, Inst Forens Med, Strasbourg, France		Rouge-Maillart, C (corresponding author), Univ Hosp Angers, Emergency Dept, Unity Forens Med, F-49100 Angers, France.	p.maillart@unimedia.fr	LUDES, Bertrand/AAB-6309-2022				Asensio JA, 1997, AM J SURG, V174, P54, DOI 10.1016/S0002-9610(97)00029-9; CARREL T, 1990, J CHIR-PARIS, V127, P438; COOPER A, 1988, J TRAUMA, V28, P1483, DOI 10.1097/00005373-198810000-00015; CRAIG MH, 1995, AM SURGEON, V61, P125; DAVIS JJ, 1976, ANN SURG, V183, P672, DOI 10.1097/00000658-197606000-00009; Errougani A, 1997, J CHIR-PARIS, V134, P9; FABIAN TC, 1990, ANN SURG, V211, P724, DOI 10.1097/00000658-199006000-00011; GIANELLO P, 1984, ACTA CHIR BELG, V84, P170; GOINS WA, 1990, ANN SURG, V212, P60, DOI 10.1097/00000658-199007000-00009; GONZALES TA, 1951, JAMA-J AM MED ASSOC, V146, P1506, DOI 10.1001/jama.1951.03670160048012; GRAHAM JM, 1978, AM J SURG, V136, P744, DOI 10.1016/0002-9610(78)90349-5; HIGASHITANI K, 2001, IN PRESS INT J LEGAL; Karger B, 2000, INT J LEGAL MED, V113, P84, DOI 10.1007/PL00007714; KARL HW, 1977, AM J SURG, V134, P549, DOI 10.1016/0002-9610(77)90431-7; NORTHRUP WF, 1972, SURGERY, V71, P27; Prevot J, 1993, Chirurgie, V119, P469; SIMS EH, 1984, J TRAUMA, V24, P125, DOI 10.1097/00005373-198402000-00006; SMEGO DR, 1985, J TRAUMA, V25, P771, DOI 10.1097/00005373-198508000-00007; SMITH SD, 1988, J PEDIATR SURG, V23, P610, DOI 10.1016/S0022-3468(88)80628-6; Timberlake GA, 1997, AM SURGEON, V63, P282; TOLIA V, 1990, CLIN PEDIATR, V29, P667, DOI 10.1177/000992289002901110; TOULOUKI.RJ, 1968, PEDIATRICS, V42, P642; Vock R, 2001, INT J LEGAL MED, V114, P244, DOI 10.1007/s004140000191; WISNER DH, 1990, ARCH SURG-CHICAGO, V125, P1109	24	7	7	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	DEC	2001	115	3					162	164		10.1007/s004140100235			3	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	543FZ	WOS:000175091900007	11775019				2022-02-06	
J	Ye, X; Hong, L; Chen, BD; Peterson, PL; Lee, CP				Ye, X; Hong, L; Chen, BD; Peterson, PL; Lee, CP			Appearance of shortened Bcl-2 and Bax proteins and lack of evidence for apoptosis in rat forebrain after severe experimental traumatic brain injury	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						N-acetylcysteine; apoptosis; Bax; Bcl-2; cytochrome c; oxygen reactive species; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; CYTOCHROME-C; MITOCHONDRIAL DYSFUNCTION; CELL-DEATH; DNA FRAGMENTATION; EXPRESSION; CLEAVAGE; NEURONS; ACTIVATION; MEMBRANE	To investigate whether apoptosis plays a role in traumatic brain injury (TBI), we examined the expression of Bcl-2 and Bax proteins and the release of mitochondrial cytochrome c in rat brains using Western blot analysis. Bcl-2 at the predicted 26 kDa was not detected in controls and TBI groups. However, at 1 h post-TBI, a shortened Bcl-2 protein with a molecular size of similar to 14.5 kDa was detected in the injured hemisphere (R). At 4 and 12 h post TBI, an additional bcl-2 band (similar to 10 kDa) was detected in R. Both bands disappeared at 14 days postinjury. The predicted 21-kDa band of Bax was detected in both controls and TBI animals. In addition, two shortened Bax proteins (similar to 18 kDa) were detected after TBI. The time course of appearance was similar to that of Bcl-2 described above. In the present study, neither cytochrome c release from mitochondria nor DNA fragmentation was detected in the forebrains of sham and TBI groups. Treatment of animals with an antioxidant N-acetylcysteine administered ip greatly diminished the levels of shortened Bcl-2 and Bax proteins. These findings suggest that the induction of shortened Bcl-2 and Bax proteins in rat brains may be associated with reactive oxygen species generated after TBI. (C) 2001 Academic Press.	Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA		Ye, X (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, 540 E Canfield St, Detroit, MI 48201 USA.	yexiong@med.wayne.edu		Xiong, Ye/0000-0001-9770-6031			Adachi S, 1997, J BIOL CHEM, V272, P21878, DOI 10.1074/jbc.272.35.21878; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; CHEN J, 1995, NEUROREPORT, V6, P394, DOI 10.1097/00001756-199501000-00040; Chen J, 1996, J NEUROCHEM, V67, P64; Chen J, 1997, J CEREBR BLOOD F MET, V17, P2, DOI 10.1097/00004647-199701000-00002; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Ding M, 1999, CARCINOGENESIS, V20, P663, DOI 10.1093/carcin/20.4.663; Ferrer I, 1997, ACTA NEUROPATHOL, V94, P583, DOI 10.1007/s004010050753; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Gillardon F, 1996, MOL BRAIN RES, V40, P254, DOI 10.1016/0169-328X(96)00059-9; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Hampton MB, 1998, ANN NY ACAD SCI, V854, P328, DOI 10.1111/j.1749-6632.1998.tb09913.x; HERON A, 1993, J NEUROCHEM, V61, P1973, DOI 10.1111/j.1471-4159.1993.tb09843.x; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; LINNIK MD, 1993, STROKE, V24, P2002, DOI 10.1161/01.STR.24.12.2002; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MONAGHAN P, 1992, J HISTOCHEM CYTOCHEM, V40, P1819, DOI 10.1177/40.12.1453000; MYERS KM, 1995, J NEUROCHEM, V65, P2432; Perez-Pinzon MA, 1999, J CEREBR BLOOD F MET, V19, P39, DOI 10.1097/00004647-199901000-00004; RINK A, 1995, AM J PATHOL, V147, P1575; Skulachev VP, 1998, FEBS LETT, V423, P275, DOI 10.1016/S0014-5793(98)00061-1; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; Tang DG, 1998, BIOCHEM BIOPH RES CO, V242, P380, DOI 10.1006/bbrc.1997.7969; Terui Y, 1998, EXP HEMATOL, V26, P236; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Wood DE, 2000, EXP CELL RES, V256, P375, DOI 10.1006/excr.2000.4859; Wood DE, 1999, J BIOL CHEM, V274, P8309, DOI 10.1074/jbc.274.12.8309; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zhivotovsky B, 1998, NATURE, V391, P449, DOI 10.1038/35060	39	7	11	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	AUG 17	2001	286	2					401	405		10.1006/bbrc.2001.5396			5	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	465TN	WOS:000170606200028	11500052				2022-02-06	
J	Ho, C; Coimbra, R; Hoyt, DB; Chan, TC				Ho, C; Coimbra, R; Hoyt, DB; Chan, TC			Severe traumatic brain injury from unmotorized scooter	JOURNAL OF EMERGENCY MEDICINE			English	Article						scooter; head injury; trauma; injury prevention		The popularity and use of unmotorized, footpropelled scooters has risen dramatically in the last few years. Increasing reports of traumatic injuries from these scooters have paralleled their commercial sales and success in this country and worldwide. We report a case of a previously healthy 48-year-oId woman who suffered a severe traumatic brain injury while riding one of these scooters, resulting in a devastating neurologic outcome and permanent vegetative state. This case emphasizes the importance of public awareness regarding the potential dangers and the need for appropriate precautions and protective gear when riding these recreational devices. (C) 2001 Elsevier Science Inc.	Univ Calif San Diego, Med Ctr, Dept Emergency Med, San Diego, CA 92130 USA; Univ Calif San Diego, Med Ctr, Dept Surg, Div Trauma, San Diego, CA 92130 USA		Ho, C (corresponding author), Univ Calif San Diego, Med Ctr, Dept Emergency Med, 200 W Arbor Dr 8676, San Diego, CA 92130 USA.		Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851			DEWAN SK, 2000, NY TIMES        0519, V25, pB1; ORECKLIN M, 2000, TIME            0605, V155, P55; Powell EC, 1996, PEDIATR EMERG CARE, V12, P259, DOI 10.1097/00006565-199608000-00006; Sorensen L, 1996, SCAND J MED SCI SPOR, V6, P281; *US CONS PROD SAF, 2000, SCOOT INJ; Ward J D, 1995, New Horiz, V3, P539; WilliamsAvery RM, 1996, ACCIDENT ANAL PREV, V28, P779, DOI 10.1016/S0001-4575(96)00040-1	7	7	7	1	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0736-4679			J EMERG MED	J. Emerg. Med.	AUG	2001	21	2					133	136		10.1016/S0736-4679(01)00356-0			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	460UQ	WOS:000170327300004	11489401				2022-02-06	
J	Schuhmann, MU; Rickels, E; Rosahl, SK; Schneekloth, CG; Samii, M				Schuhmann, MU; Rickels, E; Rosahl, SK; Schneekloth, CG; Samii, M			Acute care in neurosurgery: quantity, quality, and challenges	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						neurosurgery; acute care; budget; education	SUBARACHNOID HEMORRHAGE; FATALITY RATES; STROKE	Objective-Part of the daily routine in neurosurgery is the treatment of emergency room admissions, and acute cases from other departments or from outside hospitals. This acute care is not normally included in performance figures or budget management, nor analysed scientifically in respect of quantity and quality of care provided by neurosurgeons. Method-Over a 1 year period, all acute care cases managed by two neurosurgical on call teams in a large northern German city, were recorded prospectively on a day by day basis. A large database of 1819 entries was created and analysed using descriptive statistics. Results-The minimum incidence of patients requiring neurosurgical acute care was estimated to be 75-115/100 000 inhabitants/year. This corresponds to a mean of about 6/day. Only 30% of patients came directly via the emergency room. The fate of 70% of patients depended initially on the "neurosurgical qualification" of primary care doctors and here deficits existed. Although most intracerebral and subarachnoid haemorrhages were managed with the participation of neurosurgeons, they were not involved in the management of most mild and moderate traumatic brain injuries. Within 1 year the additional workload from acute care amounted to 1000 unplanned admissions, 900 acute imaging procedures, and almost 400 emergency operations. Conclusion-The current policy in public health, which includes cuts in resources, transport facilities, and manpower, is not compatible with the demonstrated extent of acute neurosurgical care. In addition to routine elective work, many extra admissions, evening or night time surgery, and imaging procedures have to be accomplished. An education programme for generalists is required to improve overall patient outcome. These conclusions hold special importance if health authorities wish to not only maintain present standards but aim to improve existing deficits.	Med Hsch Hannover, Neurochirurg Klin, D-30625 Hannover, Germany; Krankenhaus Nordstadt, Neurochirurg Klin, D-30167 Hannover, Germany; Int Neurosci Inst, D-30625 Hannover, Germany		Schuhmann, MU (corresponding author), Med Hsch Hannover, Neurochirurg Klin, Carl Neuberg Str 1, D-30625 Hannover, Germany.						BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; BRODERICK JP, 1993, J NEUROSURG, V78, P188, DOI 10.3171/jns.1993.78.2.0188; CHYATTE D, 1994, J NEUROSURG, V81, P525, DOI 10.3171/jns.1994.81.4.0525; Crimmins DW, 2000, J NEUROL NEUROSUR PS, V68, P8, DOI 10.1136/jnnp.68.1.8; CUPPLES PA, 1997, BRIT MED J, V314, P351; Francel P, 1996, NEUROLOGICAL SURG; HARMSEN P, 1992, STROKE, V23, P1410, DOI 10.1161/01.STR.23.10.1410; HERMAN B, 1982, STROKE, V13, P629, DOI 10.1161/01.STR.13.5.629; KELLY DF, 1995, OPERATIVE NEUROSURGI, P47; Kraus J, 2000, HEAD INJURY, P1; Linn FHH, 1996, STROKE, V27, P625, DOI 10.1161/01.STR.27.4.625; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; TEASDALE G, 1974, LANCET, V2, P81; 1996, NIEDERSACHSICHES LAN	15	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	AUG	2001	71	2					182	187		10.1136/jnnp.71.2.182			6	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	456WH	WOS:000170105400009	11459889	Green Published, Bronze			2022-02-06	
J	Correia, S; Faust, D; Doty, RL				Correia, S; Faust, D; Doty, RL			A re-examination of the rate of vocational dysfunction among patients with anosmia and mild to moderate closed head injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						anosmia; closed head injury; vocational dysfunction	OLFACTORY DYSFUNCTION; TRAUMA	This study sought to verify two earlier reports that up to 93% df patients with closed head injury (CHI) and anosmia are vocationally dysfunctional due to executive impairments associated with orbitofrontal damage. Participants were 11 men and 4 women identified from a pool of 60 potential subjects referred for evaluation of trauma-related chemosensory dysfunction at the University of Pennsylvania Smell and Taste Center from 1988 to 1994. These 15 subjects met four criteria: (i) willingness to complete a brief semi-structured interview concerning their pre- and post-CHI work history; (ii) age < 60 years; (iii) evidence of mild to moderate CHI; and (iv) scores on the University of Pennsylvania Smell Identification Test indicative of anosmia or severe microsmia and non-malingering. In contrast to the earlier reports, only 7% of the subjects were vocationally dysfunctional. This study calls into question previous reports suggesting that anosmia is a reliable predictor of post CHI vocational outcome. (C) 2001 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Univ Rhode Isl, Dept Psychol, Kingston, RI 02882 USA; Univ Penn, Med Ctr, Ctr Smell & Taste, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA		Correia, S (corresponding author), Butler Hosp, Dept Psychol, Providence, RI 02906 USA.		Doty, Richard L/G-1602-2013; Doty, Richard L/B-7623-2012				BROWN JW, 1985, CLIN NEUROPSYCHOLOGY, V1, P27; COSTANZO RM, 1992, SCI OLFACTION, P546; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; DIKMEN SS, 1989, MILD HEAD INJURY, P229; Doty R. L., 1992, J HEAD TRAUMA, V7, P47; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; GRONWALL D, 1974, LANCET, V2, P605; Jennett B, 1981, MANAGEMENT HEAD INJU; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P174; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; MALLOY PF, 1994, J NEUROPSYCH CLIN N, V6, P399; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P1; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P29; RICHARDSON JTE, 1990, CLIN NEUROPSYCHOL, P229; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; VANZOMEREN AH, 1990, HEAD INJURY HDB CLIN, V13; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171	26	7	7	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUL	2001	16	5					477	488		10.1016/S0887-6177(00)00059-7			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	443HK	WOS:000169335600004	14590161	Bronze			2022-02-06	
J	Hensley, PL; Reeve, A				Hensley, PL; Reeve, A			A case of antidepressant-induced akathisia in a patient with traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article									Univ New Mexico, Hlth Sci Ctr, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA		Hensley, PL (corresponding author), Univ New Mexico, Hlth Sci Ctr, Sch Med, Dept Psychiat, 2400 Tucker NE 4th Floor, Albuquerque, NM 87131 USA.						ADLER LA, 1995, BIOL PSYCHIAT, V37, P336, DOI 10.1016/0006-3223(94)00158-Y; *AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P744; Ayd FJ, 1995, LEXICON PSYCHIAT NEU, P15; HOAKEN PCS, 1995, CAN J PSYCHIAT, V40, P51, DOI 10.1177/070674379504000118; Leo RJ, 1996, J CLIN PSYCHIAT, V57, P449, DOI 10.4088/JCP.v57n1002	5	7	7	0	1	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	2001	16	3					302	305		10.1097/00001199-200106000-00009			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	442YY	WOS:000169313600009	11346452				2022-02-06	
J	Pontius, AA				Pontius, AA			Two bankrobbers with "antisocial" and "schizoid/avoidant" personality disorders, comorbid with partial seizures: Temporal lobe epilepsy and limbic psychotic trigger reaction, respectively	JOURNAL OF DEVELOPMENTAL AND PHYSICAL DISABILITIES			English	Article						antisocial and schizoid/avoidant personality disorders; diagnostic overshadowing; partial temporo-limbic seizures; atavistic regression; criminality; childhood head injury	DEVELOPMENTAL-DISABILITIES; PSYCHIATRIC-DISORDERS; QUESTIONABLE ASPECTS; HOMICIDE	"Diagnostic overshadowing" is illustrated by, two cases of unplanned, motiveless bank robbery, initially merely attributed to "antisocoial" or "schizoid/ avoidant" (loner) personality disorder, respectively. Both disorders, however, were comorbid with their potentially unobservable counterparts, with brief partial seizures, supported by both men's abnormal scalp-EEG's, their symptomatology with psychosis, and their histories of closed head injury in childhood. Such injuries are known to render particularly the temporo-limbic brain system susceptible to Inter partial seizure: Mr. A. had temporal lobe epilepsy (TLE) with stereotypic auditory command hallucinations and clouding of consciousness. (His past "antisocial" aggressive behavior might also have reflected TLE-related inter-ictal events.) Mr. B. had the symptomatology proposed as limbic psychotic trigger reaction (LPTR). Mr. B, a social loner, typically ruminated on past intermittent moderate stresses, a specific precondition of seizure kindling ultimately, elicited by a specific stimulus, resembling his past hurts. As is typical for LPTR, Mr B. had no clouding of consciousness and no amnesia for his atavistically regressive acts, committed with pat affect, nausea, and fleeting delusions of grandeur (being gifted like Rembrandt).	Harvard Univ, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA		Pontius, AA (corresponding author), Waldschmidt St 6, D-60316 Frankfurt, Germany.						American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BEAR D, 1987, INTEGRATIVE PSYCHIAT, V5, P125; DEVINSKY O, 1988, NEUROLOGY, V38, P1347, DOI 10.1212/WNL.38.9.1347; GESCHWIND N, 1984, SCIENCE, V224, P243; GODDARD GV, 1967, NATURE, V214, P1020, DOI 10.1038/2141020a0; GODDARD GV, 1986, LIMBIC SYSTEM FUNCTI, P95; HEATH RG, 1955, AM J PSYCHIAT, V111, P862, DOI 10.1176/ajp.111.11.862; Luiselli JK, 1998, J DEV PHYS DISABIL, V10, P315, DOI 10.1023/A:1021898203845; PONTIUS AA, 1987, INTEGRATIVE PSYCHIAT, V5, P116; Pontius AA, 1997, AGGRESS VIOLENT BEH, V2, P125, DOI 10.1016/S1359-1789(96)00002-X; Pontius AA, 1996, B AM ACAD PSYCH LAW, V24, P125; Pontius AA, 2000, AGGRESS VIOLENT BEH, V5, P423, DOI 10.1016/S1359-1789(98)00041-X; Pontius Anneliese A., 1993, Integrative Psychiatry, V9, P151; REISS S, 1983, AM J MENT DEF, V87, P396; SRAMKA M, 1983, NEUROSURGICAL TREATM, P651; Sturmey P, 1998, J DEV PHYS DISABIL, V10, P317, DOI 10.1023/A:1021850420684; WADA JA, 1978, LIMBIC MECHANISMS, P369; WEINBERGER DR, 1984, J PSYCHIAT RES, V18, P477, DOI 10.1016/0022-3956(84)90035-9	18	7	7	0	3	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1056-263X			J DEV PHYS DISABIL	J. Dev. Phys. Disabil.	JUN	2001	13	2					191	197		10.1023/A:1016617526205			7	Education, Special; Psychology, Developmental; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Psychology; Rehabilitation	434VX	WOS:000168837500007					2022-02-06	
J	Sun, JG; Kim, YJ; Hewett, J; Johnson, JC; Farmer, J; Gibler, M				Sun, JG; Kim, YJ; Hewett, J; Johnson, JC; Farmer, J; Gibler, M			Evaluation of traffic injury prevention programs using counting process approaches	JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION			English	Article						counting processes; traffic convictions; traffic injury prevention program; traumatic brain injury	RECURRENT EVENT RESPONSES	Traumatic brain injury (TBI) is among the most devastating of injuries leading to death and disability among young people today. The major cause of TBI is motor vehicle crashes. One way to reduce the rates of such crashes and thus TBI is through prevention programs. This article analyzes a study conducted for assessing a 1-day educational traffic injury prevention program for young traffic offenders with speeding violations. The obtained data include information about traffic convictions for speeding violations on a group of 16- to 23-year-old drivers. A common method for analyzing such studies is to use simple two-sample rank tests on summary statistics. But this approach ignores the detailed conviction process information and can assess only the long-term overall effect of the program. In this article, we treat the data as recurrent event data and apply a novel approach based on counting processes to evaluate the program. Our approach makes use of the information ignored by the rank tests and allows the assessment of both short- and long-term effects of the program. The analysis results indicate that the prevention program has an effect for a short period and suggest that a long-term effect could be gained if the program is repeated.	Univ Missouri, Dept Stat, Columbia, MO 65211 USA; Kirksville Coll Osteopath Med, Off Res Support, Kirksville, MO 63501 USA; Univ Missouri, Sch Med, Dept Phys Med & Rehabil, Columbia, MO 65212 USA		Sun, JG (corresponding author), Univ Missouri, Dept Stat, Columbia, MO 65211 USA.			Johnson, Jane/0000-0002-8825-5926			Andersen PK, 1993, STAT MODELS BASED CO; BRESLOW N, 1974, BIOMETRICS, V30, P89, DOI 10.2307/2529620; Breslow N. E., 1972, J ROYAL STAT SOC SER, V34, P216; Cook RJ, 1996, BIOMETRICS, V52, P557, DOI 10.2307/2532895; Cook RJ, 1996, BIOMETRICS, V52, P1311, DOI 10.2307/2532846; ENGLANDER J, 1993, J HEAD TRAUMA REHAB, V8, P101, DOI DOI 10.1097/00001199-199308020-00011; Farmer J, 2000, BRAIN INJURY, V14, P109, DOI 10.1080/026990500120772; FRANK RG, 1992, AM PSYCHOL, V47, P1045, DOI 10.1037/0003-066X.47.8.1045; GELLER ES, 1990, SOCIAL INFLUENCE PRO; GOLDSTEIN FC, 1990, TRAUMATIC BRAIN INJU; Hingson R., 1993, PROMOTING HLTH ADOLE; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI, V1st; KIM HM, 1994, STAT MED, V13, P2141, DOI 10.1002/sim.4780131921; LAWLESS JF, 1995, TECHNOMETRICS, V37, P158, DOI 10.2307/1269617; Lefkopoulou M, 1995, Lifetime Data Anal, V1, P73, DOI 10.1007/BF00985259; LIN DY, 1994, STAT MED, V13, P2233, DOI 10.1002/sim.4780132105; PETERSON L, 1995, HDB PEDIAT PSYCHOL; SUN J, 1995, STAT SINICA, V5, P279; Sun JG, 1997, CAN J STAT, V25, P101, DOI 10.2307/3315360.n; Wang MC, 1999, J AM STAT ASSOC, V94, P146, DOI 10.2307/2669690; WANG W, 1999, J AM STAT ASSOC, V94, P111	21	7	7	1	1	AMER STATISTICAL ASSOC	ALEXANDRIA	732 N WASHINGTON ST, ALEXANDRIA, VA 22314-1943 USA	0162-1459	1537-274X		J AM STAT ASSOC	J. Am. Stat. Assoc.	JUN	2001	96	454					469	475		10.1198/016214501753168181			7	Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	437HN	WOS:000168986400011					2022-02-06	
J	Al Naami, MY; Sadik, AA; Adam, MA				Al Naami, MY; Sadik, AA; Adam, MA			Evaluation of trauma registry data in Asir region	SAUDI MEDICAL JOURNAL			English	Article						trauma registry; mass casualty event	SAUDI-ARABIA; LIFE-SUPPORT; RESUSCITATION; MORTALITY; DISASTER; CARE	Objective: To analyze and report trauma registry data; to assess the validity, reliability, and feasibility of the trauma registry; and to discuss lessons learned from this event. Methods: A pre-designed trauma registry data was used for all injured patients admitted to Asir Central hospital after being involved in a major motor vehicle accident. A survey team registered and analyzed the trauma registry data using the statistics software SPSS for windows. Results: Eighty-five patients were admitted to the hospital with different injuries. All victims were males with a mean age of 27 years. Injuries were dominated by musculo-skeletal trauma followed by neurotrauma, thoracic, and abdominal trauma respectively. Pre-hospital data was deficient and most of the hospital in-patient's information was taken from the nurse's notes. Standard elements of the trauma registry were found essential for optimal trauma care. Morbidity was related mainly to neurological trauma. Mortality was related to head injury followed by thoracic and abdominal injuries. Conclusion: Trauma registry was valid, reliable, and feasible. A national trauma registry program should be established. Trauma registry, prehospital care, and disaster planning and management should be integral parts of a regionalized trauma care system. Successful trauma care systems have shown significant reductions in morbidity and mortality from trauma.	King Fahad Natl Guard Hosp, Dept Surg, Riyadh 11426, Saudi Arabia		Al Naami, MY (corresponding author), King Fahad Natl Guard Hosp, Dept Surg, POB 22490, Riyadh 11426, Saudi Arabia.						AHLBERG A, 1994, INJURY, V25, P97, DOI 10.1016/0020-1383(94)90110-4; Ali J, 1997, J TRAUMA, V42, P786, DOI 10.1097/00005373-199705000-00006; *AM COLL SURG COMM, 1993, RES OPT CAR INJ PAT; American College of Surgeons Committee on Trauma, 1997, ADV TRAUM LIF SUPP D; Blackwell Thomas H., 1993, Emergency Medicine Clinics of North America, V11, P1; BORDER JR, 1983, J TRAUMA, V23, P708, DOI 10.1097/00005373-198308000-00005; Boulanger BR, 1999, SURG CLIN N AM, V79, P1297, DOI 10.1016/S0039-6109(05)70079-7; CHAMPION H, TRAUMA SURG CRITICAL; FELICIANO DV, 1991, TRAUMA, P81; Galvin M E, 1991, J Emerg Nurs, V17, p44A; Henry S, 1999, SURG CLIN N AM, V79, P1259, DOI 10.1016/S0039-6109(05)70076-1; JACOBS LM, 1984, J TRAUMA, V24, P8, DOI 10.1097/00005373-198401000-00002; KAHN RH, 1997, ANN SAUDI MED, V17, P444; KLEIN JS, 1991, SURG CLIN N AM, V71, P257; KRANTZ BE, 1993, TRAUMA, P123; Lewis C. Phuli, 1996, Emergency Medicine Clinics of North America, V14, P439, DOI 10.1016/S0733-8627(05)70261-3; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; MATTOX KL, 1982, J TRAUMA, V22, P934, DOI 10.1097/00005373-198211000-00008; MULLINS RJ, 1996, TRAUMA, P159; RENZ BM, 1995, J TRAUMA, V38, P250; SHANKS NJ, 1994, PUBLIC HEALTH, V108, P27, DOI 10.1016/S0033-3506(05)80032-0; SILFRIDGE J, 1986, TRAUMA CARE SYSTEMS, P65; SMITH JP, 1985, J TRAUMA, V25, P65, DOI 10.1097/00005373-198501000-00011; Streiner D.L., 1989, HLTH MEASUREMENT SCA; TERRACINA A, 1994, PARKLAND TRAUMA HDB, P7; VELANOVICH V, 1989, SURGERY, V105, P65; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; Williams HR, 1997, INJURY, V28, P165, DOI 10.1016/S0020-1383(96)00194-5; WISNER D, 1993, ABDOMINAL TRAUMA, P1	29	7	7	0	0	SAUDI MED J	RIYADH	ARMED FORCES HOSPITAL, PO BOX 7897,, RIYADH 11159, SAUDI ARABIA	0379-5284			SAUDI MED J	Saudi Med. J.	MAY	2001	22	5					438	443					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442GN	WOS:000169277000011	11376388				2022-02-06	
J	Rowlands, A				Rowlands, A			Ability or disability? Strengths-based practice in the area of traumatic brain injury	FAMILIES IN SOCIETY-THE JOURNAL OF CONTEMPORARY HUMAN SERVICES			English	Article							HEAD-INJURY; FAMILY; COMMUNITY	Strengths-based approaches to working with individuals with traumatic brain Injury are rare. Perhaps this is partly because of severe cognitive Impairment but medicalized approaches that highlight deficits are also influential. The article describes circles of Support an community-based intervention based that works from a position of strength. This article argues that circles of Support fall clearly into strengths-based approaches, as supported by reference to the work of Saleebey, de Shazer, and McKnight, as well as literature on empowerment approaches to disability. Selected findings of a 3-year evaluation study illustrate the included conceptual arguments.	Univ Newcastle, Dept Social Work, Newcastle, NSW 2308, Australia		Rowlands, A (corresponding author), Univ Newcastle, Dept Social Work, Univ Dr, Newcastle, NSW 2308, Australia.						ADAMS N, 1996, AUSTR NZ J FAMILY TH, V17, P75; BOGDAN R, 1989, SOC PROBL, V36, P135, DOI 10.1525/sp.1989.36.2.03a00030; BOGDAN R, 1987, J SOC POLICY, V16, P34; BOND MR, 1984, CLOSED HEAD INJURY P, P148; Condeluci A., 1996, DIFFERENCE; CONDELUCI A, 1987, J HEAD TRAUMA REHAB, V2, P49; Condeluci A., 1995, INTERDEPENDENCE ROUT; Condes-Lara M, 1998, EUR J PAIN, V2, P15, DOI 10.1016/S1090-3801(98)90042-8; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; De Shazer S, 1988, CLUES INVESTIGATING; de Shazer S., 1991, PUTTING DIFFERENCE W; De Shazer S, 1985, KEYS SOLUTION BRIEF; ELSASS L, 1991, THESIS TROBE U MELBO; FALVEY M, 1994, ALL MY LIFES CIRCLE; FOREST M, 1994, INCLUSION PAPERS STR, P40; GOLD D, 1995, THESIS SYRACUSE U NE; Handy C, 1989, THE AGE OF UNREASON; Hill H, 1999, BRAIN INJURY, V13, P839, DOI 10.1080/026990599121043; HILL H, 1997, DULWICH CTR NEWSLETT, V4, P36; IFE J, 1997, 25 AUSTR ASS SOC WOR; Kosciulek JF, 1997, BRAIN INJURY, V11, P821, DOI 10.1080/026990597123034; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; MCKNIGHT J, 1999, SOCIAL WORK PROCESSE, P429; MCKNIGHT J, 1999, SOCIAL WORK PROCESSE, P476; McKnight J., 1995, CARELESS SOC; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; OBRIEN J, 1993, FRIENDSHIPS COMMUNIT, P9; OBRIEN P, 1997, HUMAN SERVICES PARTN, P64; Oliver M., 1996, UNDERSTANDING DISABI; Olver JH, 1995, CURR OPIN NEUROL, V8, P443, DOI 10.1097/00019052-199512000-00008; PEARPOINT J, 1992, PIANO BUILDING JUDIT; PERLESZ A, 1992, AUSTR NZ J FAMILY TH, V13, P145, DOI DOI 10.1002/J.1467-8438.1992.TB00910.X; Perlesz A., 1999, AUSTR NZ J FAMILY TH, V20, P11, DOI DOI 10.1111/J.0814-723X.1999.00089.X; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; PRIGITANO GP, 1988, 13 ANN C AUSTR SOC S; Racino J. A., 1994, J HEAD TRAUMA REHAB, V9, P35; RESNICK C, 1993, SOC WORK HEALTH CARE, V18, P49, DOI 10.1300/J010v18n02_03; Richards T, 1995, COMPUTER AIDED QUALI, P80; ROWLANDS A, 1999, THESIS U NEWCASTLE N; ROWLANDS A, 1995, 12 WORLD C INT FED P; Saleebey D, 1996, SOC WORK, V41, P296; Saleebey D., 1999, SOCIAL WORK PROCESSE, P14; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; SHARDLOW S, 1998, SOCIAL WORK THEMES I, P23; Strauss A., 1990, BASICS QUALITATIVE R; Strauss AL, 1987, QUALITATIVE ANAL SOC, DOI DOI 10.1017/CBO9780511557842; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; UDITSKY B, 1993, FRIENDSHIPS COMMUNIT, P85; Wertheimer A., 1995, CIRCLES SUPPORT BUIL; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Willer B., 1990, CANADIAN J REHABILIT, V3, P167; WILLER BS, 1993, CIRCLES SUPPORT INDI; Williams J.M., 1991, HEAD INJURY FAMILY M, P299; ZEIGLER E, 1989, COGNITIVE REHABILITA, V7, P34; [No title captured]	58	7	7	0	2	FAMILY SERVICE AMER	MILWAUKEE	11700 WEST LAKE PARK DRIVE, MILWAUKEE, WI 53224 USA	1044-3894			FAM SOC-J CONTEMP H	Fam. Soc.-J. Contemp. Hum. Serv.	MAY-JUN	2001	82	3					273	286		10.1606/1044-3894.201			14	Family Studies; Social Work	Social Science Citation Index (SSCI)	Family Studies; Social Work	438GT	WOS:000169045800009					2022-02-06	
J	Baulieu, F; Fournier, P; Baulieu, JL; Dalonneau, M; Chiaroni, P; Eder, V				Baulieu, F; Fournier, P; Baulieu, JL; Dalonneau, M; Chiaroni, P; Eder, V			Technetium-99m ECD single photon emission computed tomography in brain trauma: Comparison of early scintigraphic findings with long-term neuropsychological outcome	JOURNAL OF NEUROIMAGING			English	Article						brain injury; single photon emission computed tomography; technetium-99m (Tc-99m) ECD; neuropsychology	CLOSED-HEAD-INJURY; HM-PAO-SPECT; MILD; CT; PERFORMANCE; PERFUSION; MEMORY; MRI	Objective. The aim of this study was to assess the prognostic value of early brain scintigraphy in head injury in relation to long-term neuropsychological behavior. Twenty-four patients underwent technetium-99m (Tc-99m) ethyl cysteinate dimer single photon emission computed tomography (SPECT) within 1 month of the trauma. Scintigraphic abnormalities were evaluated both visually and semiquantitatively using the brain-to-cerebellum ratio method. The clinical neuropsychological investigation was conducted to evaluate abnormalities related to motor deficit, frontal behavior, and memory and language disorders. All patients had abnormalities on SPECT scan. One year after trauma, 14 patients (58%) had neuropsychological sequelae. The brain-to-cerebellum ratios in the left basal ganglia and brain stem were significantly decreased in patients with memory disorders (P =.03 and P =.02, respectively). Moreover, SPECT visual analysis indicated that low uptake in the basal ganglia, thalamus, and brain stem was associated with subsequent motor deficit, frontal behavior, and language and memory disorders. The authors conclude that brain SPECT can be valuable in predicting the neuropsychological behavior of survivors of severe head injury.	Bretonneau Univ Hosp, Dept Nucl Med, Tours, France; Trousseau Univ Hosp, Dept Neurol, Tours, France; Trousseau Univ Hosp, Dept Nucl Med, Tours, France		Baulieu, JL (corresponding author), CHU Trousseau, F-37044 Tours, France.	fbaulieu@med.univtours.fr					Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Alavi A, 1989, J Neuropsychiatry Clin Neurosci, V1, pS45; ALAVI A, 1987, J CEREB BLOOD FLO S1, V7, pS646; ALEXANDER MP, 1982, PSYCHIAT ASPECTS NEU, P219; BAVETTA S, 1994, NUCL MED COMMUN, V15, P961, DOI 10.1097/00006231-199412000-00007; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; CHANG LT, 1978, IEEE T NUCL SCI, V25, P638, DOI 10.1109/TNS.1978.4329385; DORDAIN M, 1983, ACTA NEUROL BELG, V83, P5; GENTRY LR, 1994, RADIOLOGY, V191, P1; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; GRAY BG, 1992, J NUCL MED, V33, P52; Heaton PDRK., 1993, WISCONSIN CARD SORTI; ICHISE M, 1994, J NUCL MED, V35, P217; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LOUFTI I, 1995, INVEST RADIOL, V30, P588; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; PRAYER L, 1993, ACTA RADIOL, V34, P593; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Wiedmann KD, 1989, NEUROPSYCHOLOGY, V3, P267, DOI 10.1037//0894-4105.3.4.267; WILSON JTL, 1997, SPECT NEUROLOGY PSYC, P423; Yamaki T, 1996, J NUCL MED, V37, P1166	28	7	8	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	APR	2001	11	2					112	120		10.1111/j.1552-6569.2001.tb00020.x			9	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	455FT	WOS:000170017400003	11296579				2022-02-06	
J	Sinnakaruppan, I; Williams, DM				Sinnakaruppan, I; Williams, DM			Head injury and family carers: a critical appraisal of case management programmes in the community	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						carers; community; education; family; head injury; training	TRAUMATIC BRAIN-INJURY; CAREGIVER BURDEN; INTERVENTION; DISTRESS; SURVIVORS	The objective of this review was to identify the available support systems for family carers of head-injured people within the community. The following databases were searched: MEDLINE, EMBASE PSYCHIATRY, CINAHL and PSYCHLIT (years 1987-1999). Only seven papers were identified. Programmes varied from behavioural to cognitive interventions to help carers adjust to particular problem behaviours in their injured relatives. All programmes were professionally led. Most of the data presented was on primary caregivers related to the head-injured person. Only one study used standard assessment tools. The remainder used a variety of methods including self-report measures and interviews. All interventions were reported as beneficial to carers. Overall these studies were found to be limited by biased sampling, nonstandardized outcome measures using subjective methodologies and a lack of control samples. Most studies did not reveal pertinent information regarding the degree and type of head injury or rehabilitation history. There is an outstanding requirement for large randomized controlled studies using standardized methodologies to identify efficacious carer programmes.	Ayrshire Cent Hosp, Douglas Grant Rehabil Ctr, Dept Psychol, Irvine KA12 8SS, Ayr, Scotland		Sinnakaruppan, I (corresponding author), Ayrshire Cent Hosp, Douglas Grant Rehabil Ctr, Dept Psychol, Irvine KA12 8SS, Ayr, Scotland.						ACORN S, 1993, J ADV NURS, V18, P39, DOI 10.1046/j.1365-2648.1993.18010039.x; ACORN S, 1995, J ADV NURS, V21, P872, DOI 10.1046/j.1365-2648.1995.21050872.x; Acorn S., 1993, CANADIAN J REHABILIT, V7, P149; BOWEN A, 1998, CLIN REHABIL, V12, P178; Buckwalter KC, 1999, ARCH PSYCHIAT NURS, V13, P80, DOI 10.1016/S0883-9417(99)80024-7; Campbell C H, 1988, Rehabil Nurs, V13, P320; Carnevale GJ, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199602000-00005; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Flanagan DAJ, 1998, BRIT J CLIN PSYCHOL, V37, P431, DOI 10.1111/j.2044-8260.1998.tb01400.x; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; GRANINGER W, 1992, CLIN INFECT DIS, V15, P49, DOI 10.1093/clinids/15.1.49; HALEY WE, 1989, GERONTOLOGIST, V29, P478, DOI 10.1093/geront/29.4.478; HAMMELL KRW, 1994, INT J REHABIL RES, V17, P319; HICKEY AM, 1992, IRISH MED J, V84, P109; Holland D, 1998, BRAIN INJURY, V12, P993, DOI 10.1080/026990598121918; Hornung WP, 1999, EUR ARCH PSY CLIN N, V249, P162, DOI 10.1007/s004060050082; Horowitz R., 1998, FAMILIES SYSTEMS HLT, V16, P71; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JALOWIEC A, 1987, UNPUB JALOWIEC COPIN; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; KAUSAR R, 1996, CLIN REHABIL, V10, P159; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kolakowsky-Hayner SA, 1999, NEUROREHABILITATION, V13, P27; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; MCDOWELL I, 1987, MEASURING HLTH GUIDE; MCGUIRE BE, 1990, CLIN REHABIL, V4, P319, DOI DOI 10.1177/026921559000400412; MURPHY M, 1999, BRIT J OCCUPATIONAL, V62, P436; Rosenberg M., 1965, SOC ADOLESCENT SELF; Semlyen JK, 1998, J NEUROL REHABIL, V12, P53; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742; Wenden FJ, 1998, CLIN REHABIL, V12, P53, DOI 10.1191/026921598675567949; Wilkins SS, 1999, PSYCHIATR SERV, V50, P747, DOI 10.1176/ps.50.6.747; Williams J., 1990, J HEAD TRAUMA REHAB, V5, P9, DOI [https://doi.org/10.1097/00001199-199003000-00004, DOI 10.1097/00001199-199003000-00004]; WOOD V, 1969, J GERONTOL, V24, P465, DOI 10.1093/geronj/24.4.465; Zanetti O, 1998, ARCH GERONTOL GERIAT, P531	36	7	7	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	MAR	2001	24	1					35	42		10.1097/00004356-200103000-00005			8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	414XJ	WOS:000167691200005	11302462				2022-02-06	
J	Suarez, JI				Suarez, JI			Management of closed head injury	REVISTA DE NEUROLOGIA			Spanish	Article						brain metabolism; cerebral edema; cerebral perfusion pressure; head injury; intracranial pressure	TRAUMATIC BRAIN INJURY; PRESSURE; MORTALITY; NUTRITION	Objective. To review current concepts regarding the management of severe closed head injury and determine the possible causes of brain damage in these patients. Development. Severe closed head injury causes a high rate of mortality and disability in developed countries. The diagnosis and management of these patients has progressed in recent years, from the availability of brain scanning to varied therapeutic methods based on brain metabolism and intracranial dynamics. We have reviewed the different neuropathological processes in relation to closed head injury and emphasized the importance of recognition a,ld control of the secondary lesions, which may have disastrous consequences for the patient. After clinical evaluation and early cardiorespiratory stabilization, the patients are taken to a critical care unit for continuous monitoring of the intracranial pressure, cerebral perfusion pressure and cerebral extraction of oxygen. We have discussed several therapeutic interventions taking into account the values obtained by continuous monitoring of these patients. As well as traditional measures (hyperventilation, manitol and barbiturate coma), there are other possibilities for treatment of these patients such as hypothermia, hypertonic saline solutions and neuroprotector agents. Conclusions. All patients with closed head injuries should be evaluated and treated as emergencies, and admitted to a critical cave unit to avoid secondary lesions such as hypoxemia arterial hypotension and cerebral enema. Treatment should be aimed at maintenance of the intracranial pressure and cerebral perfusion within normal limits and also maintenance satisfactory jugular saturation.	Univ Hosp Cleveland, Cleveland, OH USA; Case Western Reserve Univ, Cleveland, OH USA			jis4@po.cwru.edu					CRUZ J, 1998, NEUROLOGIC NEUROSURG, P405; Graham D.I., 1996, NEUROTRAUMA, P43; GUTMAN MB, 1992, J NEUROSURG, V77, P9, DOI 10.3171/jns.1992.77.1.0009; GUYTON AC, 1986, TXB MED PHYSL, P206; KLATZO I, 1979, RECENT ADV NEUROPATH, P27; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; Kraus J, 1996, NEUROTRAUMA, P13; Lang E W, 1994, Neurosurg Clin N Am, V5, P573; Letarte PB, 1999, SURG CLIN N AM, V79, P1449, DOI 10.1016/S0039-6109(05)70087-6; Lindenberg R, 1971, PATHOLOGY NERVOUS SY, V2, P1705; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Polderman KH, 2000, CRIT CARE MED, V28, P2022, DOI 10.1097/00003246-200006000-00057; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Ritter A M, 1994, Neurosurg Clin N Am, V5, P633; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosner Michael J., 1993, P57; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Stover JF, 1999, CRIT CARE MED, V27, P2252, DOI 10.1097/00003246-199910000-00031; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Suarez JI, 1999, REV NEUROLOGIA, V29, P1337, DOI 10.33588/rn.2912.99354; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; TEASDALE G, 1974, LANCET, V2, P81; VAZQUEZBARQUERO A, 1992, EUR J EPIDEMIOL, V8, P832, DOI 10.1007/BF00145328; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419; WHITE RJ, 1992, NEW ENGL J MED, V327, P1507; [No title captured]	32	7	9	0	0	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	FEB 1	2001	32	3					289	295		10.33588/rn.3203.2000518			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	420LY	WOS:000168007500022	11310289				2022-02-06	
J	Geiger, JD; Newsted, J; Drongowski, RA; Lelli, JL				Geiger, JD; Newsted, J; Drongowski, RA; Lelli, JL			Car surfing: An underreported mechanism of serious injury in children and adolescents	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	31st Annual Meeting of the American-Pediatric-Surgical-Association	MAY 25-29, 2000	ORLANDO, FLORIDA	Amer Pediat Surg Assoc				Background: Car surfing, in which participants stand on top of a moving vehicle as though it were a surfboard, has been reported as a cause of traumatic injury in only 5 cases in the literature. Over the last 8 years, however, the authors have treated 26 children, primarily adolescents, for injuries resulting from car surfing. This report describes the injuries and outcomes of this potentially underreported mechanism of injury. Methods: Medical records of 26 patients treated for car surfing injuries between 1991 and 1999 were reviewed. Demographics, hospital course, and type and severity of injuries were analyzed. Results: Eighteen boys (69%) and 8 girls (31%) with an average age of 15.7 +/- 3.4 years (range, 6 to 22) have presented with injuries related to car surfing. All patients had fallen from the hood, roof, or trunk of a moving motor vehicle, the majority falling from the hood (n = 13; 50%). injury severity was evaluated using the injury Severity Scores (ISS; 12.4 +/- 6.5), Revised Trauma Score (RTS; 7.5 +/- 1.1) and Glasgow Coma Score (GCS; 13.5 +/- 3.2). Injury severity was equivalent between boys and girls (P > .05), Central nervous system injuries predominated, with closed head injuries occurring in 22 (85%) and loss of consciousness in 10 (39%). Skull fractures occurred in 11 (42%) and intracranial bleeding in 9 (35%). Long-term cognitive rehabilitation was necessary in 22 (85%) patients. Th ree patients (12%) had spinal column fractures, with 2 (8%) suffering permanent paralysis. Two extremity (8%) and 3 (11.7%) pelvic fractures occurred. Most patients (73%) suffered significant skin and soft tissue injuries. Two patients (8%) presented with solid visceral injuries, and 1 child died. Conclusions: Car surfing is an extremely high-risk behavior in children and adolescents that leads to significant morbidity, long-term disability, and is potentially fatal. The incidence of car surfing may be greater than has been reported previously; therefore, prevention programs aimed at discouraging this high-risk behavior in children and adolescents should be considered. J Pediatr Surg 36:232-234. Copyright (C) 2001 by W.B. Saunders Company.	Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA; Childrens Mercy Hosp, St Vincent Mercy Med Ctr, Toledo, OH USA		Geiger, JD (corresponding author), Univ Michigan, CS Mott Childrens Hosp, F3970,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.						HOOFT PJ, 1994, INT J LEGAL MED, V106, P328, DOI 10.1007/BF01224781; KOHR RM, 1992, J FORENSIC SCI, V37, P1693; KROUSE MA, 1991, AM ACAD FORENSIC SCI, P30; Peterson T, 1999, ANN EMERG MED, V33, P192, DOI 10.1016/S0196-0644(99)70393-8	4	7	8	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0022-3468			J PEDIATR SURG	J. Pediatr. Surg.	JAN	2001	36	1					232	234		10.1053/jpsu.2001.20061			3	Pediatrics; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	388KW	WOS:000166180500044	11150472				2022-02-06	
J	Maskin, B; Gammella, D; Solari, L; Videta, W; Barboza, MF; Geliz, L; Rondina, C				Maskin, B; Gammella, D; Solari, L; Videta, W; Barboza, MF; Geliz, L; Rondina, C			Early release of the antinflammatory cytokine IL-10 in traumatic brain injury.	MEDICINA-BUENOS AIRES			Spanish	Article; Proceedings Paper	13th Annual Congress of the European-Society-of-Intensive-Care-Medicine	OCT 01-04, 2000	ROME, ITALY	Euopean Soc Intens Care Med		cytokine; interleukin-10; inmmunodepression; traumatic brain injury	NECROSIS-FACTOR-ALPHA; HEMORRHAGIC-SHOCK; INTERLEUKIN-10; PREDICTION; PNEUMONIA; PATTERNS	Early release of the antinflammatory cytokine IL-10 in traumatic brain injury. It has been reported that upwards of 50% of patients who survive an initial brain traumatic insult subsequently die due to infection and multiple organ failure. A paralysis of cell-mediated immunity following trauma, partially induced by antiinflammatory cytokine release, appears to be responsible for the increased susceptibility to infections. We determined the plasma levels of the anti-inflammatory cytokine IL-10 and the pro-inflamatory TNF-alpha in 15 patients admitted with severe traumatic brain injury (TBI). None of the patients had received glucocorticoid or catecholamine treatment. Thirteen volunteers served as controls. At study entry the IL-10 plasma levels were significantly higher than in controls: 41.8 (17.3-265.4) pg/mL vs. 2.2 (1.4-2.7) pg/mL, p < 0.001 (Mann-Whitney test). There was no difference between the first (at study entry) and second sample (4 hours later) (Wilcoxon test). TNF-alpha plasma levels were similar in patients and controls at study entry and 4 hours later. We conclude that severe TBI patients present an early response, with a significant increase of IL-10 plasma levels. These results could partially explain the immunodepression following TBI.	Hosp A Posadas, Unidad Terapia Intens, Buenos Aires, DF, Argentina; Lab Hosp A Posadas, Buenos Aires, DF, Argentina; Hosp C Alvarez, Unidad Terapia Intens, Rosario, Santa Fe, Argentina		Maskin, B (corresponding author), Camargo 120, RA-1414 Buenos Aires, DF, Argentina.	Bermask@datamarkets.com.ar					ASADULLAH K, 1995, CRIT CARE MED, V23, P1976, DOI 10.1097/00003246-199512000-00006; AYALA A, 1991, AM J PHYSIOL, V260, pR167, DOI 10.1152/ajpregu.1991.260.1.R167; CABEZAS FM, 2000, TRAUMATISMO ENCEFALO, P224; Calandra T, 2000, UPD INT CAR, V31, P67; Chiolero R, 1994, New Horiz, V2, P432; *CONS C COMM, 1992, CRIT CARE MED, V208, P64; DE WMR, 1991, J EXP MED, V174, P1209; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Fuchs AC, 1996, J CLIN IMMUNOL, V16, P291, DOI 10.1007/BF01541395; GORIS RJA, 1993, HOST DEFENSE DYSFUNC, P161; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; KEANE RM, 1983, SURG GYNECOL OBSTET, V156, P163; LEVY EM, 1984, CLIN IMMUNOL IMMUNOP, V32, P224, DOI 10.1016/0090-1229(84)90123-5; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; MEDURI GU, 1995, CLIN CHEST MED, V16, P61; MILLERGRAZIANO CL, 1991, J CLIN IMMUNOL, V11, P95, DOI 10.1007/BF00917745; RODRIGUEZ JL, 1991, J TRAUMA, V31, P907, DOI 10.1097/00005373-199107000-00005; ROTHWELL PM, 1995, CRIT CARE MED, V23, P78, DOI 10.1097/00003246-199501000-00015; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; STEPHAN RN, 1993, PATHOPHYSIOLOGY SHOC, P131; vanderPoll T, 1996, J CLIN INVEST, V97, P713, DOI 10.1172/JCI118469; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808	22	7	8	0	0	MEDICINA (BUENOS AIRES)	BUENOS AIRES	DONATO ALVAREZ 3150, 1427 BUENOS AIRES, ARGENTINA	0025-7680	1669-9106		MEDICINA-BUENOS AIRE	Med.-Buenos Aires		2001	61	5					573	576					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	488WW	WOS:000171960700010	11721324				2022-02-06	
J	Stern, BH				Stern, BH			Admissibility of neuropsychological testimony after Daubert and Kumho	NEUROREHABILITATION			English	Article								Neuropsychological testing has been used in court cases ail over the United States, as testimony to provide evidence of whether or not a person has a traumatic brain injury. It has, however, been scrutinized for its admissibility in court, but recognized for objectivity in successfully documenting and proving deficits in people with traumatic brain injuries. The trial court is used as a gatekeeper, and may chose to perform assessments of the tests themselves, for validity of sensitivity, specificity, reliability and validity in determining whether a neuropsychological Lest may be used as testimony in a court case.	Stark & Stark, Princeton, NJ 08543 USA		Stern, BH (corresponding author), Stark & Stark, POB 5315, Princeton, NJ 08543 USA.						BARTH JT, 1991, NEUROPSYCHOL REV, V2, P256; FAUST D, 1988, SCIENCE, V241, P31, DOI 10.1126/science.3291114; FAUST D, 1988, COPING PSYCHIAT PS S, V1; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P150; MATARAZZO JD, 1990, PSYCHOLOGIST, V999, P1013; Reed JE, 1996, BEHAV SCI LAW, V14, P315, DOI 10.1002/(SICI)1099-0798(199622)14:3<315::AID-BSL242>3.0.CO;2-X; REITAN RM, 1997, AM TRIAL LAWY ASS M, P1; SBORDONE RJ, 1996, ECOLOGICAL VALIDITY, pR14; SILVER JM, 1994, AM PSYCHIAT PRESS TX, P527; SILVER JM, 1997, J NEUROPSYCHIAT, V102, P107; SILVER JM, 1997, NEUROPSYCHIATRY TRAU, P105; STRUB RL, 1993, MENTAL STATUS EXAMIN; 1976, NEUROLOGY, V47, P598	13	7	7	1	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2001	16	2			SI		93	101					9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	480HE	WOS:000171455300005	11568467				2022-02-06	
J	Saper, JR				Saper, JR			Posttraumatic headache - A neurobehavioral disorder	ARCHIVES OF NEUROLOGY			English	Article							TRAUMATIC BRAIN INJURY; INDUCED AXONAL INJURY; NEUROPSYCHOLOGICAL DEFICITS; TECHNETIUM-99M-HMPAO SPECT; RADIOFREQUENCY NEUROTOMY; COMPUTED-TOMOGRAPHY; LEGAL SETTLEMENT; MILD; PATHOPHYSIOLOGY; PATHOBIOLOGY		Michigan Head Pain & Neurol Inst, Ann Arbor, MI 48104 USA		Saper, JR (corresponding author), Michigan Head Pain & Neurol Inst, 3120 Profess Dr, Ann Arbor, MI 48104 USA.						Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bogduk N, 1997, HEADACHE, P369; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; FIELDS HF, 1997, HEADACHE, P38; FISHER CM, 1982, NEUROLOGY, V32, P667, DOI 10.1212/WNL.32.6.667; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gean A D, 1995, New Horiz, V3, P549; GENNARELLI TA, 1985, TRAUMA CENTRAL NERVO, P169; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Gilkey SJ, 1997, HEADACHE, V37, P583, DOI 10.1046/j.1526-4610.1997.3709583.x; Goadsby P. J., 1997, HEADACHE, P5; GRAY BG, 1992, J NUCL MED, V33, P52; GRONWALL D, 1974, LANCET, V2, P605; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; ICHISE M, 1994, J NUCL MED, V35, P217; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Lord SM, 1996, NEW ENGL J MED, V335, P1721, DOI 10.1056/NEJM199612053352302; Masdeu J C, 1994, J Neuroimaging, V4, P177; MASDEU JC, 1995, J NEUROIMAGING, V5, pS53; McIntosh T K, 1986, NIDA Res Monogr, V75, P527; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MENDELSON G, 1982, MED J AUSTRALIA, V2, P132, DOI 10.5694/j.1326-5377.1982.tb124267.x; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; OMMAYA AK, 1968, JAMA-J AM MED ASSOC, V204, P275; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Otte A, 1997, J NEUROL NEUROSUR PS, V63, P368, DOI 10.1136/jnnp.63.3.368; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; RASKIN NH, 1987, HEADACHE, V27, P416, DOI 10.1111/j.1526-4610.1987.hed2708416.x; REEVES TM, 1995, EXP BRAIN RES, V106, P248; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; SAPER JR, 1999, HDB HEADACHE MANAGEM; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Wallis BJ, 1997, PAIN, V73, P15, DOI 10.1016/S0304-3959(97)00060-2; WEILLER C, 1995, NAT MED, V1, P858; YOUNG WB, 1997, HEADACHE, P253	50	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0003-9942			ARCH NEUROL-CHICAGO	Arch. Neurol.	DEC	2000	57	12					1776	1778		10.1001/archneur.57.12.1776			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	382EQ	WOS:000165810400016	11115246				2022-02-06	
J	Beaumont, A; Marmarou, C; Marmarou, A				Beaumont, A; Marmarou, C; Marmarou, A			The effects of human corticotrophin releasing factor on motor and cognitive deficits after impact acceleration injury	NEUROLOGICAL RESEARCH			English	Article						traumatic brain injury; Impact Acceleration Model; human corticotrophin releasing factor; motor deficits; cognitive deficits; neuroprotection	TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; LOCUS-COERULEUS; RATING-SCALE; RATS; EDEMA; MANAGEMENT; EXPERIENCE; PEPTIDES; PROTEIN	Corticotrophin releasing factor has been shown in several models of tissue injury to be an effective treatment for edema. In a previous study we demonstrated this ability in two models of traumatic brain injury (TBI). The aim of this study was to assess whether human corticotrophin releasing factor (hCRF) could additionally improve motor and cognitive deficits. Adult male Sprague-Dawley rats were randomised into five groups and injured with the Impact Acceleration Model of TBI. Groups I and II received sham injury followed by treatment with either drug vehicle or 100 mug kg(-1) hCRF respectively. Group III was injured with no treatment; Group IV animals were injured and treated with 50 mug kg(-1) hCRF and Group V were injured and treated with 100 mug kg(-1) hCRF. Animals were assessed both before and after injury with a battery of standardised neuropsychological tests including the Morris Water Maze, the Beam Walk Test, the Beam Balance Test and the Inclined Plane Test. Both 50 mug kg(-1) and 100 mug kg(-1) hCRF caused significant improvements in motor and cognitive functioning, confirming that in addition to edema-reducing properties, human corticotrophin releasing factor is also capable of improving motor and cognitive functioning Given the beneficial experimental effects of this compound, hCRF may be a useful clinical treatment, which requires formal evaluation.	Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Physiol, Richmond, VA 23298 USA		Marmarou, A (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, POB 980508,MCV Stn,Sanger Hall,Room 8004,1101 E M, Richmond, VA 23298 USA.		Beaumont, Andrew/AAJ-7457-2020				Beaumont A, 1998, ACT NEUR S, V71, P149; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BEHAN DP, 1995, FRONT NEUROENDOCRIN, V16, P362, DOI 10.1006/frne.1995.1013; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; KIANG JG, 1987, J PHARMACOL EXP THER, V243, P517; Lehnert H, 1998, NEUROCHEM RES, V23, P1039, DOI 10.1023/A:1020751817723; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; ORTH DN, 1992, ENDOCR REV, V13, P164, DOI 10.1210/er.13.2.164; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Roe SY, 1998, EUR J NEUROSCI, V10, P553, DOI 10.1046/j.1460-9568.1998.00064.x; SERDA SM, 1992, PHARMACOL RES, V26, P85, DOI 10.1016/1043-6618(92)90708-J; TJUAVEJV J, 1996, CANCER RES, V56, P1352; VALENTINO RJ, 1993, ANN NY ACAD SCI, V697, P173, DOI 10.1111/j.1749-6632.1993.tb49931.x; Villalona-Calero MA, 1998, ANN ONCOL, V9, P71, DOI 10.1023/A:1008251426425; WEI ET, 1987, EUR J PHARMACOL, V140, P63, DOI 10.1016/0014-2999(87)90634-0; WEI ET, 1989, EUR J PHARMACOL, V168, P81, DOI 10.1016/0014-2999(89)90635-3; WEI ET, 1991, REGUL PEPTIDES, V33, P93, DOI 10.1016/0167-0115(91)90205-U; WEI ET, 1986, J PHARMACOL EXP THER, V238, P783; Wu HC, 1997, NEUROSCIENCE, V78, P147, DOI 10.1016/S0306-4522(96)00533-7	32	7	8	0	2	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	OCT	2000	22	7					665	673					9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	373LH	WOS:000165290600003	11091970				2022-02-06	
J	Elster, EL				Elster, EL			Upper cervical chiropractic management of a patient with Parkinson's disease: A case report	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						cervical spine; chiropractic; Parkinson's disease; trauma; thermography	MIDDLE CEREBRAL-ARTERY; CLOSED-HEAD INJURY; MULTIPLE-SCLEROSIS; BLOOD-FLOW; TRAUMA; ISCHEMIA; PAIN	Objective: To discuss the use of upper cervical chiropractic management in managing a single patient with Parkinson's disease and to describe the clinical picture of the disease. Clinical Features: A 60-year-old man was diagnosed with Parkinson's disease at age 53 after a twitch developed in his left fifth finger. He later developed rigidity in his left leg, body tremor, slurring of speech, and memory loss among other findings. Intervention and Outcome: This subject was managed with upper cervical chiropractic care for 9 months. Analysis of precision upper cervical radiographs determined upper cervical misalignment. Neurophysiology was monitored with paraspinal digital infrared imaging. This patient was placed on a specially designed knee-chest table For adjustment, which was delivered by hand to the first cervical vertebrae, according to radiographic findings. Evaluation of Parkinson's symptoms occurred by doctor's observation, the patient's subjective description of symptoms, and use of the Unified Parkinson's Disease Rating Scale. Reevaluations demonstrated a marked improvement in both subjective and objective findings. Conclusion: Upper cervical chiropractic care aided by cervical radiographs and thermal imaging had a successful outcome for a patient with Parkinson's disease. Further investigation into upper cervical injury as a contributing factor to Parkinson's disease should be considered.			Elster, EL (corresponding author), 4880 Riverbend Rd, Boulder, CO 80301 USA.		Elster, Eric A/G-2332-2010; Elster, Eric/ABG-6091-2021				*AM AC FAM PHYS, 1993, COMP AAFP POS SEL HL, P67; AMALU W, 1993, PRECISION MULTIVECTO, P64; AMALU W, 1993, PRECISION RADIOLOGY, P65; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Christie B, 1996, BRIT MED J, V313, P1228, DOI 10.1136/bmj.313.7067.1228; Clark R. P., 1984, RECENT ADV MED THERM, P5, DOI 10.1007/978-1-4684-7697-2_2; COOTE JH, 1978, NEUROBIOLOGIC MECHAN, P91; DENSLOW J, 1987, AM J PHYSIOL, V150, P229; DIAKOW PRP, 1988, J MANIP PHYSIOL THER, V11, P114; Doder M, 1999, J NEUROL NEUROSUR PS, V66, P380, DOI 10.1136/jnnp.66.3.380; DRUMMOND PD, 1984, NEUROLOGY, V34, P1292, DOI 10.1212/WNL.34.10.1292; ECKER A, 1984, PSYCHIAT ANN, V14, P787, DOI 10.3928/0048-5713-19841101-08; FACTOR SA, 1991, MOVEMENT DISORD, V6, P225, DOI 10.1002/mds.870060306; FACTOR SA, 1988, MOVEMENT DISORD, V3, P30, DOI 10.1002/mds.870030105; Fahn S., 1987, RECENT DEV PARKINSON, P153; FELDMAN F, 1984, SKELETAL RADIOL, V12, P235, DOI 10.1007/BF00349505; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; FOLETTI G, 1995, PRESSE MED, V24, P1121; GALLAGHER JP, 1987, ACTA NEUROL SCAND, V75, P145, DOI 10.1111/j.1600-0404.1987.tb07909.x; Gardner E, 1969, Acta Anat Suppl (Basel), V56, P203; GAUTHERIE M, 1980, CANCER, V45, P51, DOI 10.1002/1097-0142(19800101)45:1<51::AID-CNCR2820450110>3.0.CO;2-L; GOETZ CG, 1992, NEUROL CLIN, V10, P907, DOI 10.1016/S0733-8619(18)30187-7; Goldberg G., 1986, THERMOLOGY, V1, P207; Guidice M A, 1987, Brain Inj, V1, P61; HEISS WD, 1976, ARCH NEUROL-CHICAGO, V33, P813, DOI 10.1001/archneur.1976.00500120017003; HENDLER N, 1982, PSYCHOSOMATICS, V23, P283; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; *INT THERM SOC, 1993, CLIN NEUR PAR THERM, P67; Jacques S, 1976, Surg Neurol, V5, P143; KORR IM, 1975, OSTEOPATHIC MED CLIN, P183; KURLAND LT, 1994, ANN NEUROL, V36, pS33, DOI 10.1002/ana.410360711; LEE MC, 1979, ARCH NEUROL-CHICAGO, V36, P1; Lees AJ, 1997, REV NEUROL-FRANCE, V153, P541; MATHEW RJ, 1984, BRIT J PSYCHIAT, V144, P529, DOI 10.1192/bjp.144.5.529; MATHEW RJ, 1980, LANCET, V1, P1308; *NAT PARK FDN INC, 1996, PARK FACTS; PALMER BJ, 1934, SUBLUXATION SPECIFIC, P862; Roski R, 1978, Surg Neurol, V10, P267; Seidler A, 1996, NEUROLOGY, V46, P1275, DOI 10.1212/WNL.46.5.1275; SOINI IH, 1985, EUR J RADIOL, V5, P281; SWERDLOW B, 1986, THERMOLOGY, V2, P1620; THOMAS D, 1990, BRIT J RHEUMATOL, V29, P268; UEMATSU S, 1988, J NEUROSURG, V69, P552, DOI 10.3171/jns.1988.69.4.0552; Uematsu S., 1985, THERMOLOGY, V1, P4; Weinstein S. A., 1986, POSTGRAD MED, P44; WEINSTEIN SA, 1987, CLIN J PAIN, V3, P107; WOOD EH, 1965, RADIOLOGY, V85, P270, DOI 10.1148/85.2.270; WYKE B, 1981, CLIN RHEUM DIS, V7, P223; ZELLNER J, 1986, J BONE JOINT SURG, V10, P558	49	7	7	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	OCT	2000	23	8					573	577		10.1067/mmt.2000.109673			5	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	371NW	WOS:000165185900009	11050615				2022-02-06	
J	Gourlay, D; Lun, KC; Liya, G				Gourlay, D; Lun, KC; Liya, G			Virtual reality and telemedicine for home health care	COMPUTERS & GRAPHICS-UK			English	Article						virtual reality; telemedicine; cognitive rehabilitation; traumatic brain injury		The rapid increase in the numbers of old people in society and the corresponding strain on medical resources will result in greater importance being placed on home health care. Advances in communications technologies will enable the old and disabled to receive health care ill the comfort and safety of their homes, eliminating costly and potentially hazardous journeys to hospital. We have developed a prototype networked virtual system to aid the cognitive and motor rehabilitation of patients suffering from conditions such as traumatic brain injury, stroke and Parkinsons disease. Our virtual kitchen aids the retraining of patients in important daily living skills such as meal preparation tasks. (C) 2000 Elsevier Science Ltd. All rights reserved.	Natl Univ Singapore, Dept Community Occupat & Family Med, Med Informat Program, Singapore 119260, Singapore		Gourlay, D (corresponding author), Natl Univ Singapore, Dept Community Occupat & Family Med, Med Informat Program, Singapore 119260, Singapore.	douglas@mip.nus.edu.sg					ANDREWS TK, 1995, P 2 TIDE C AMST, P276; Carlin AS, 1997, BEHAV RES THER, V35, P153, DOI 10.1016/S0005-7967(96)00085-X; Finkelstein J, 1998, ST HEAL T, V52, P272; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; KENNEDY RS, 1995, WORKSH SIM INT VIRT; KRAUS J, 1994, NEUROPSYCHIATRY TRAU; PUGNETTI L, 1995, MED MEETS VIRT REAL; Rizzo AA, 1997, ST HEAL T, V44, P123; Rose FF, 1998, VIRTUAL ENV CLIN PSY; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Stanney K, 1998, INT J HUM-COMPUT INT, V10, P135, DOI 10.1207/s15327590ijhc1002_3; Strickland D, 1997, ST HEAL T, V44, P81; WARNER D, 1996, E SHERMAN WEBUMETARY	13	7	8	1	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0097-8493	1873-7684		COMPUT GRAPH-UK	Comput. Graph.-UK	OCT	2000	24	5					695	699		10.1016/S0097-8493(00)00072-8			5	Computer Science, Software Engineering	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science	372VR	WOS:000165255200005					2022-02-06	
J	Israelian, MK; Novack, TA; Glen, ET; Alderson, AL				Israelian, MK; Novack, TA; Glen, ET; Alderson, AL			Changes in orientation during acute rehabilitation after traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article								Objective: To examine the profile of scores on a measure of orientation in a sample of patients with traumatic brain injury (TBI) during acute rehabilitation as a means of (a) assessing the extent of neural compromise, (b) assessing recovery of functioning, and (c) determining the relative difficulty of different indicators of orientation. Design: Repeated measures. Setting: Acute rehabilitation hospital. Participants: Forty-three patients with severe TBI interviewed daily throughout rehabilitation. Measures: The Orientation Log (O-Log) is a 10-item measure of orientation to place, time, and situation. Items are scored 0-3 on the basis of whether they are recalled spontaneously (3), with cueing (2), via recognition (1), or not at all (0). Results: O-Log score was correlated with severity of TBI. Return of orientation followed a consistent trajectory, with initial gains preceding a plateau effect. Patients had relatively more difficulty orienting to hospital name and date than to year, month, and city. Conclusions: The O-Log is sensitive to the severity of TBI. Progress in orientation, on average, occurs at a similar rate across patients, including those who present as severely disoriented, although those with severe disorientation may not achieve orientation by rehabilitation discharge.	Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL USA		Novack, TA (corresponding author), Spain Rehabil Ctr, 1717 6th Ave S, Birmingham, AL 35233 USA.						DANIEL WF, 1987, CORTEX, V23, P169, DOI 10.1016/S0010-9452(87)80030-8; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jennett B, 1981, MANAGEMENT HEAD INJU; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1986, NEUROTRAUMA TREATMEN, P89	7	7	7	0	1	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2000	45	3					284	291		10.1037/0090-5550.45.3.284			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	338BZ	WOS:000088399400005					2022-02-06	
J	Pape, HC; Rice, J; Wolfram, K; Gansslen, A; Pohlemann, T; Krettek, C				Pape, HC; Rice, J; Wolfram, K; Gansslen, A; Pohlemann, T; Krettek, C			Hip dislocation in patients with multiple injuries - A followup investigation	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							FRACTURE-DISLOCATION; TRAUMA	The combination of traumatic hip dislocation and multiple trauma have not been well documented in the medical literature to date. The role of surgery therefore has not been well defined in these patients. During a 12-year period, 29 consecutive patients with 31 traumatic hip dislocations with concomitant Injury Severity Scores exceeding 18 points were treated at the authors' institution. An initial satisfactory closed reduction was achieved in 23 patients, two patients had failed reductions, and four patients had noncongruous reductions. Open surgical procedures were done on these patients and on 10 additional patients who had associated acetabular or femoral head fractures. Overall, seven patients from the group died including two patients who had surgical procedures. From 17 living patients who did not require surgery for failed or noncongruous reductions, 13 patients were available for followup at a mean of 8 years after their injury. The clinical results at this followup were excellent in three hips, good in seven hips, and fair in four hips. The radiologic results, however, showed that five patients had early (Grades I and II according to Matta) hip degeneration and seven patients had Grade II (according to Ficat) avascular necrosis of the femoral head. These changes were not clinically significant at this followup and it is proposed that these results justify a policy of active treatment of traumatic hip dislocation in patients with multitrauma.	Hannover Med Sch, Dept Trauma Surg, D-30625 Hannover, Germany; Monash Univ, Melbourne, Vic 3004, Australia		Pape, HC (corresponding author), Hannover Med Sch, Dept Trauma Surg, D-30625 Hannover, Germany.			Pape, Hans-Christoph/0000-0002-2059-4980; Krettek, Christian/0000-0001-9807-0020			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; DAUBIGNE RM, 1990, REV CHIR ORTHOP, V76, P371; DREINHOFER KE, 1994, J BONE JOINT SURG BR, V76B, P6, DOI 10.1302/0301-620X.76B1.8300683; EPSTEIN HC, 1974, J BONE JOINT SURG AM, VA 56, P1103, DOI 10.2106/00004623-197456060-00001; EPSTEIN HC, 1985, CLIN ORTHOP RELAT R, P9; FICAT RP, 1985, J BONE JOINT SURG BR, V67, P3, DOI 10.1302/0301-620X.67B1.3155745; JACOB JR, 1987, CLIN ORTHOP RELAT R, P249; JASKULKA RA, 1991, J BONE JOINT SURG BR, V73, P465, DOI 10.1302/0301-620X.73B3.1670451; Matta J M, 1986, Instr Course Lect, V35, P382; Pape HC, 1999, J TRAUMA, V46, P58, DOI 10.1097/00005373-199901000-00010; PAPE HC, IN PRESS J OTHOP TRA; PIETRAFESA CA, 1983, JAMA-J AM MED ASSOC, V249, P3342; PIPKIN G, 1957, J BONE JOINT SURG AM, V39, P1027, DOI 10.2106/00004623-195739050-00004; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; ROSENTHAL RE, 1979, J TRAUMA, V19, P572, DOI 10.1097/00005373-197908000-00005; STEWART MJ, 1954, J BONE JOINT SURG AM, V36-A, P315, DOI 10.2106/00004623-195436020-00010; TRONZO RG, 1973, SURG HIP JOINT, P451; UPADHYAY SS, 1981, J BONE JOINT SURG BR, V63, P548, DOI 10.1302/0301-620X.63B4.7298682; YANG RS, 1991, CLIN ORTHOP RELAT R, P218	20	7	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	AUG	2000		377					99	105					7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	340WM	WOS:000088559100015	10943190				2022-02-06	
J	Burg, JS; Williams, R; Burright, RG; Donovick, PJ				Burg, JS; Williams, R; Burright, RG; Donovick, PJ			Psychiatric treatment outcome following traumatic brain injury	BRAIN INJURY			English	Article							HEAD-INJURY; BEHAVIORAL SEQUELAE; DEPRESSION	The relationship between self-reported history of traumatic brain injury (TBI) and psychiatric treatment outcome was investigated. TBI was hypothesized to be frequent, associated with cognitive deficits on neuropsychological testing, and less amenable to standard psychiatric treatment. Subjects were 42 psychiatric patients with a self-reported history of TBI and 25 psychiatric patients with no TBI history. Subjects received approximately 2 weeks of inpatient psychiatric treatment. Subjects received neuropsychological testing and completed the Brief Symptom Inventory weekly. TBI was frequent (66% of subjects); multiple injuries were common. Neuropsychological performance was generally average in both groups with few group differences. Subjects, on average, reported significantly decreased psychiatric symptoms on discharge. However, the TBI group appeared to improve less than the control group; group status was a significant predictor of treatment outcome. Implications of results for assessment and treatment of psychiatric disorders in patients with a history of TBI are discussed.	Northwestern Univ, Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; Binghamton Univ, Binghamton, NY USA; United Hlth Serv Hosp, Johnson City, NY USA; SUNY Coll Potsdam, Potsdam, NY 13676 USA		Burg, JS (corresponding author), Northwestern Univ, Sch Med, Dept Psychiat & Behav Sci, 222 E Super St,4th Floor, Chicago, IL 60611 USA.						BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Burg JS, 1996, J CLIN PSYCHOL MED S, V3, P243, DOI 10.1007/BF01993910; BURG JS, 1994, J INT NEUROPSYCH SOC, V1, P372; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; DELIS D, 1987, CALIFORNIA VERBAL LE; DERAGOTIS LR, 1993, BSI BRIEF INVENTORY; DIKEMAN S, 1977, ANN NEUROL, V2, P492; DIKEMAN S, 1986, J NEUROL NEUROSUR PS, V49, P1227; Donovick PJ, 1996, J CLIN PSYCHOL MED S, V3, P131, DOI 10.1007/BF01996133; DRUMMOND LM, 1988, BRIT J PSYCHIAT, V153, P839, DOI 10.1192/bjp.153.6.839; Gronwall D, 1989, MILD HEAD INJURY, P153; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KALSBEEK WD, 1980, J NEUROSURGERY S, V53, P19; KAUGMAN AS, 1990, KAUFMAN BRIEF INTELL; Kraus Jess F., 1994, P3; KWENTUS JA, 1985, PSYCHOSOMATICS, V26, P8, DOI 10.1016/S0033-3182(85)72900-3; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Levin H.S., 1989, MILD HEAD INJURY; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Levin HS., 1982, NEUROBEHAVIORAL CONS; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; Max JE, 1997, BRAIN INJURY, V11, P699; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; O'Shanick G J, 1986, Adv Psychosom Med, V16, P173; POPPELREUTER W, 1983, PSYCHISCHEN SCHADIGU; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; RANDOLPH C, 1994, CLIN NEUROPSYCHOL, V8, P99, DOI 10.1080/13854049408401547; SEGALOWITZ SJ, 1993, ANN M INT NEUR SOC G; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; Spreen O, 1991, COMPENDIUM NEUROPSYC; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Wechsler D., 1981, WAIS R MANUAL WECHSL; WEINSTEIN GS, 1981, J CLIN PSYCHIAT, V42, P120; WEPMAN JM, 1973, AUDITORY DISCRIMINAT; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8	41	7	7	0	0	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2000	14	6					513	533					21	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	325WN	WOS:000087699600003	10887886				2022-02-06	
J	McNaughton, H; Wadsworth, K				McNaughton, H; Wadsworth, K			Assessing the accuracy of hospital admission and discharge diagnosis of traumatic brain injury in a New Zealand hospital	NEW ZEALAND MEDICAL JOURNAL			English	Article							HEAD-INJURY; ALCOHOL-INTOXICATION; MANAGEMENT	Aims, To investigate the accuracy of admission and discharge coding of traumatic brain injury (TBI) in a New Zealand hospital. Method. Prospective study of all patients over fifteen years of age admitted to Hutt Hospital over a six-month period with an actual or potential diagnosis suggesting TBI. Results. During the six month period of study, 65 patients with the diagnosis of TBI were admitted to Hurt Hospital. Of these, 21 (32.3%) met the criteria for diagnosis of TBI ('Definite TBI'). A further eighteen patients, not admitted with a diagnosis of TBI, met the TBI criteria. Only 14/39;(35.9%) of 'Definite TBI' cases were identified at both admission and discharge. Discharge diagnosis of TBI identified correctly 26/39 (66.7%) of definite cases, with 34/60 (56.7%) cases with a discharge diagnosis of TBI not meeting our criteria for the diagnosis of TBI. Six out of 39 'Definite TBI' cases (15.4%) were not identified by either admission or discharge diagnosis. Thirty of the 65 patients (46.2%) admitted to hospital with the diagnosis of TBI showed clinical evidence of having taken alcohol,although only 12 had blood alcohol concentration measured. Conclusions. The admission and discharge diagnoses of TBI were not accurate when compared to a standard definition of TBI. For hospital discharge data to have any value, agreement on an operational diagnosis of TBI needs to be made, which should include measurement of the blood-alcohol concentration. A. suggestion for a diagnostic strategy is presented, along with ICD-10-AM codes that could be used to improve the current situation.	Wellington Sch Med, Rehabil Teaching & Res Unit, Wellington, New Zealand		McNaughton, H (corresponding author), Wellington Sch Med, Rehabil Teaching & Res Unit, POB 7343, Wellington, New Zealand.	harrym@wnmeds.ac.nz	McNaughton, Harry/AAC-6556-2020				ABERNETHY D, 1998, MENTOR ELECT HDB RES; Arienta C, 1997, SURG NEUROL, V48, P213, DOI 10.1016/S0090-3019(97)00019-0; BRIGGS M, 1984, BRIT MED J, V288, P983; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; MILLIMAN JF, 1990, RES PERS H, V2, P21; *NAT CTR CLASS HLT, 1998, ICD10AM NAT CTR CLAS; *PRIV COMM, 1994, HLTH INF PROV COD; RUTHERFORD WH, 1977, LANCET, V1, P1021; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; *TRAUM BRAIN INJ M, 1996, 1 TRAUM BRAIN INJ MO	15	7	7	0	3	NEW ZEALAND MEDICAL ASSOC	CHRISTCHURCH	C/O BRENNAN EDWARDES, DEPT SURGERY, CHRISTCHURCH HOSPITAL, PO BOX 4345, CHRISTCHURCH, 00000, NEW ZEALAND	0028-8446	1175-8716		NEW ZEAL MED J	N. Z. Med. J.	MAY 26	2000	113	1110					184	186					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	319GU	WOS:000087333800004	10917079				2022-02-06	
J	Payne, HC				Payne, HC			Traumatic brain injury, depression and cannabis use - assessing their effects on a cognitive performance	BRAIN INJURY			English	Article							CHRONIC MARIHUANA USE; HEAD-INJURY; MEMORY; ANXIETY	Patient RB is presented as a demonstration of the need for a more thorough understanding of the interactions of patient variables. RB had a history of traumatic brain injury along with current mood disorder and cannabis use. It was unclear initially whether or not his cognitive impairment was a permanent result of the brain injury, or a temporary effect of his mood and/or drug use. The literature offers few guidelines or precedents for understanding such complex cases or suggesting at which level it may be most appropriate to intervene. The impact of cannabis use in this individual appeared to have a detrimental effect on his mood. Treating RB's mood disorder resulted in larger cognitive gains than would have been anticipated in the literature. Specific neuropsychological tests are identified as being particularly sensitive to the cognitive changes in mood disorders.	Clandough Hosp, Acad Ctr, Univ Dept Geriatr Med, Memory Team, Penarth CF64 2XX, S Glam, Wales		Payne, HC (corresponding author), Clandough Hosp, Acad Ctr, Univ Dept Geriatr Med, Memory Team, Penarth CF64 2XX, S Glam, Wales.						Beck A.T, 1976, COGNITIVE THERAPY EM; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1987, BECK DEPRESSION INVE; BENSON DF, 1985, PSYCHIAT ASPECTS NEU; BENSON FD, 1973, BRIT J PSYCHIAT, V123, P555, DOI 10.1192/bjp.123.5.555; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bernstein D., 1973, PROGR RELAXATION TRA; Bleuler E., 1951, TXB PSYCHIAT; BOAG A, 1996, BEHAV ASSESSMENT DYS; BOND MR, 1990, REHABILITATION ADULT, P74; BOND MR, 1984, CLOSED HEAD INJURY, P272; BORG J, 1975, PSYCHOPHARMACOLOGIA, V42, P211, DOI 10.1007/BF00421258; BRAFF DL, 1981, AM J PSYCHIAT, V138, P613; BRAND N, 1987, PSYCHOL MED, V17, P145, DOI 10.1017/S0033291700013040; BROOKS N, 1989, ASSESSMENT BEHAV CON, V7, P283; BRUST JCM, 1993, NEUROLOGICAL ASPECTS; CAINE ED, 1986, NEUROPSYCHOLOGICAL A, P83; CARLIN AS, 1977, INT J ADDICT, V12, P617, DOI 10.3109/10826087709022166; CARLIN AS, 1992, FORENSIC NEUROPSYCHO, P99; CORWIN J, 1941, CLIN NEUROPSYCHOL, V7, P3; COUGHLAN AK, 1984, BRIT J PSYCHIAT, V145, P164, DOI 10.1192/bjp.145.2.164; DIMOND SJ, 1976, NATURE, V261, P690, DOI 10.1038/261690a0; Fennell M., 1989, COGNITIVE BEHAV THER; Gainotti G, 1972, Cortex, V8, P41; GLASS CS, 1986, J CONSULT CLIN PSYCH, V54, P261; GLASS R M, 1978, Psychopharmacology Bulletin, V14, P10; GRAF P, 1985, J EXPT PSYCHOL LEARN, V14, P758; Gronwall D, 1974, PSYCHOL EFFECTS CONC; Gualtieri T, 1990, J HEAD TRAUMA REHAB, V5, P32; Hamsher K., 1989, MULTILINGUAL APHASIA; Heaton R.K., 1981, WISCONSIN CARD SORTI; HEILMAN KM, 1993, CLIN NEUROPSYCHOLOGY, P551; HENRY GM, 1973, AM J PSYCHIAT, V130, P966, DOI 10.1176/ajp.130.9.966; HIRSCHENFANG S, 1960, J CLIN PSYCHOL, V16, P351, DOI 10.1002/1097-4679(196007)16:3<351::AID-JCLP2270160339>3.0.CO;2-X; JASTAK J, 1949, J ABNORM SOC PSYCH, V44, P367, DOI 10.1037/h0062679; KOLANSKY H, 1972, J AMER MED ASSOC, V222, P35, DOI 10.1001/jama.222.1.35; KRAEPLIN E, 1915, CLINPSYCHIAT; KREUTZER JS, 1991, J HEAD TRAUMA REHAB, V6, P12; MASSMAN PJ, 1992, J CLIN EXPT NEUROPSY, V14, P729; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; NAHAS GG, 1984, NEW YORK STATE J MED, V84, P599; Nelson H.E., 1982, NATL ADULT READING T; Novaco RW., 1975, ANGER CONTROL DEV EV; PRIGIANTO G, 1987, NEUROBEHAVIOURAL REC, P205; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; ROSENTHAL M, 1990, REHABILITATION ADULT, P181; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; Sander AM, 1997, J HEAD TRAUMA REHAB, V12, P28, DOI 10.1097/00001199-199710000-00004; Shum DHK, 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; Spreen O, 1991, COMPENDIUM NEUROPSYC; STERNBERG DE, 1976, ARCH GEN PSYCHIAT, V33, P219; TELLIER A, 1990, J CONSULT CLIN PSYCH, V58, P531; WALSH K, 1987, NEUROPSYCHOLOGY; Wechsler D, 1987, MANUAL WECHSLER MEMO; Wechsler D, 1981, WECHSLER ADULT INTEL; WERT RC, 1986, INT J ADDICT, V21, P629, DOI 10.3109/10826088609027382; WEST LJ, 1970, PSYCHOTOMIMETIC DRUG; WILLIAMS M, 1978, ADV PSYCHOL ASSESS, P410; [No title captured]	59	7	7	1	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2000	14	5					479	489		10.1080/026990500120583			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	316MQ	WOS:000087171500009	10834343				2022-02-06	
J	Castejon, OJ; Castejon, HV				Castejon, OJ; Castejon, HV			Oligodendroglial cell behaviour in traumatic oedematous human cerebral cortex: a light and electron microscopic study	BRAIN INJURY			English	Article							MULTIPLE SYSTEM ATROPHY; HUMAN-BRAIN; MATURE OLIGODENDROCYTES; RAT OLIGODENDROCYTES; OPTIC NERVES; STAB WOUNDS; IN-VITRO; PROLIFERATION; DEGENERATION; INCLUSIONS	Cortical biopsies of 12 patients with traumatic brain injuries have been used in the present study to examine oligodendroglial cell changes and reactivity. The samples were processed for light and transmission electron microscopy. Four main types of oligodendrocyte populations have been found: resting or unreactive oligodendrocytes, reactive oligodendrocytes, anoxic-ischaemic oligodendroglial cells and hyperthrophic phagocytic oligodendrocytes. The unreactive or resting oligodendrocyte type exhibited a fusiform or elongated shape, a clear or dense band of scarce perikaryal cytoplasm and a nucleus with peripheral heterorocromatin masses. Clear or dense reactive oligodendrocytes showed increased amount of perikaryal citoplasm, dilated endoplasmic reticulum and nuclear envelope, numerous clear, oedematous mitochondria and dense bodies. These oligodendrocytes appeared associated with degenerated myelinated axons. Anoxic-ischaemic oligodendrocytes showed lacunar enlargement of endoplasmic reticulum, dilated Golgi complex and enlargement and disassembly of nuclear envelope. They appeared also in contact with degenerated myelinated axons. Hypertrophic phagocytic oligodendrocytes were observed engulfing the associated degenerated myelinated axons, invading the myelin sheath, separating the myelin lamellae and exerting myelinolitic effects. Oligodendroglialpseudopodic expansions were observed phagocyting the axoplasmic matrix and leaving a huge vacuolar axoplasmic space. The vasogenic and cytotoxic components of traumatic brain oedema are discussed in relation with the oligodendroglial cell changes and reactivity.	Univ Zulia, Fac Med, Inst Invest Biol, LUZ, Maracaibo, Venezuela		Castejon, OJ (corresponding author), Univ Zulia, Fac Med, Inst Invest Biol, LUZ, Apdo 526, Maracaibo, Venezuela.						ALALI SYA, 1984, HISTOCHEM J, V16, P165, DOI 10.1007/BF01003547; Amat JA, 1998, GLIA, V22, P64, DOI 10.1002/(SICI)1098-1136(199801)22:1<64::AID-GLIA6>3.0.CO;2-8; ARAI N, 1991, Brain and Nerve (Tokyo), V43, P857; Arima K, 1997, ACTA NEUROPATHOL, V93, P558, DOI 10.1007/s004010050652; ASOU H, 1994, BRAIN RES BULL, V35, P359, DOI 10.1016/0361-9230(94)90114-7; BALENTINE JD, 1977, J NEUROPATH EXP NEUR, V36, P897, DOI 10.1097/00005072-197711000-00002; BARBARESE E, 1995, J CELL SCI, V108, P2781; BJARTMAR C, 1994, GLIA, V11, P235, DOI 10.1002/glia.440110304; Bourne, 1972, STRUCTURE FUNCTION N, VV, P39; BRESNAHAN JC, 1996, SOC NEUR ABSTR, V2, P1185; Butt AM, 1996, NEUROPATH APPL NEURO, V22, P540, DOI 10.1111/j.1365-2990.1996.tb01133.x; Castejon OJ, 1997, BRAIN INJURY, V11, P363, DOI 10.1080/026990597123520; Castejon OJ, 1998, BRAIN INJURY, V12, P409, DOI 10.1080/026990598122539; CASTEJON OJ, 1985, J SUBMICR CYTOL PATH, V17, P703; Choi Byung Ho, 1993, Yonsei Medical Journal, V34, P1; COLONNIER M, 1964, J ANAT, V98, P47; COSTA C, 1992, REV NEUROL, V148, P274; COSTA C, 1993, CURR OPIN NEUROL, V6, P865, DOI 10.1097/00019052-199312000-00007; DYER CA, 1995, DEV NEUROSCI-BASEL, V17, P53, DOI 10.1159/000111273; El Hachimi KH, 1998, EXP NEUROL, V154, P23, DOI 10.1006/exnr.1998.6894; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; FRIEDMAN B, 1989, GLIA, V2, P380, DOI 10.1002/glia.440020510; Fruttiger M, 1999, DEVELOPMENT, V126, P457; IKEDA K, 1995, NEUROSCI LETT, V194, P133, DOI 10.1016/0304-3940(95)11713-7; INNOUE M, 1997, ACTA NEUROPATHOL, V93, P585; IRWING RS, 1996, NEUROSCI LETT, V213, P189; ISACSON O, 1992, EXP NEUROL, V117, P151, DOI 10.1016/0014-4886(92)90123-8; KAGANOVSKAYA E A, 1981, Arkhiv Anatomii Gistologii i Embriologii, V81, P22; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; Keilhoff G, 1998, ACTA HISTOCHEM, V100, P409, DOI 10.1016/S0065-1281(98)80037-8; Kimelberg Harold K., 1995, P919; Kozhura V. L., 1994, ANESTEZIOL REANIMAT, V3, P24; LUDWIN SK, 1984, NATURE, V308, P274, DOI 10.1038/308274a0; Mandai K, 1997, NEUROSCIENCE, V77, P849, DOI 10.1016/S0306-4522(97)00517-4; Marmarou A, 1963, ACTA NEUROCHIRUGIA S, V57, P160; McDonald JW, 1998, NEUROREPORT, V9, P2757, DOI 10.1097/00001756-199808240-00014; MONTEIRO RAF, 1995, ARCH HISTOL CYTOL, V58, P417, DOI 10.1679/aohc.58.417; Nillson P, 1963, CEREBR BLOOD FLOW ME, V13, P183; Norton WT, 1999, NEUROCHEM RES, V24, P213, DOI 10.1023/A:1022505903312; OZAWA H, 1994, BRAIN DEV-JPN, V16, P92, DOI 10.1016/0387-7604(94)90041-8; PERSSON L, 1976, VIRCHOWS ARCH B, V22, P21; Peters A, 1996, J COMP NEUROL, V371, P153, DOI 10.1002/(SICI)1096-9861(19960715)371:1<153::AID-CNE9>3.0.CO;2-2; REYNOLDS R, 1987, NEUROCHEM RES, V12, P885, DOI 10.1007/BF00966310; Schmidt C, 1997, GLIA, V20, P284; Sluga E, 1967, BRAIN EDEMA, P223; Staub F, 1994, Anasthesiol Intensivmed Notfallmed Schmerzther, V29, P203, DOI 10.1055/s-2007-996719; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; TANI EIICHI, 1965, ACTS NEUROLPATHOL, V4, P604; VAUGHN JE, 1970, J COMP NEUROL, V140, P207, DOI 10.1002/cne.901400205; VICK RS, 1992, J NEUROTRAUM, V9, pS93; WATANABE I, 1976, ACTA NEUROPATHOL, V18, P1; WEBB A, 1995, J CELL SCI, V108, P2747; WOLLMANN RL, 1981, J NEUROSCI RES, V6, P757, DOI 10.1002/jnr.490060610; XIE DC, 1995, J NEUROCYTOL, V24, P435, DOI 10.1007/BF01181605	54	7	7	0	0	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2000	14	4					303	317					15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	302UE	WOS:000086383400001	10815839				2022-02-06	
J	Trudeau, N; Poulin-Dubois, D; Joanette, Y				Trudeau, N; Poulin-Dubois, D; Joanette, Y			Language development following brain injury in early childhood: a longitudinal case study	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						traumatic brain injury; child; case study; language acquisition	EARLY LEXICAL DEVELOPMENT; CLOSED HEAD-INJURY; CHILDREN; ADOLESCENTS; ACQUISITION; DISCOURSE; INFANTS; APHASIA; WORDS	The present longitudinal case study was designed to investigate the possibility that a traumatic brain injury (TBI) occurring during the second year of life, while significant lexical and grammatical competencies are emerging, could have an impact on subsequent language development. Thus, the language development of a very young girl (BL) who suffered a TBI at the age of 17 months was monitored for 6 months following the injury. Different procedures were used to measure her lexical and grammatical development: monthly parental checklists, fret-play sessions and word-learning tasks. BL's results were compared with two control groups (n = 5 and 9) matched for age and gender. Overall, the results are consistent with the classical view of acquired language disorders in children: despite an initial decrease in the use of her premorbid vocabulary, BL showed no durable significant impairment on any measure of lexical or grammatical development.	Dalhousie Univ, Sch Human Commun Disorders, Halifax, NS B3H 1R2, Canada; Concordia Univ, Ctr Res Human Dev, Montreal, PQ, Canada; Univ Montreal, Ctr Rech, Inst Geriatr, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Ecole Orthophonie & Audiol, Montreal, PQ H3C 3J7, Canada		Trudeau, N (corresponding author), Dalhousie Univ, Sch Human Commun Disorders, 5599 Fenwick St, Halifax, NS B3H 1R2, Canada.	ntrudeau@is.dal.ca		Trudeau, Natacha/0000-0002-1495-0205; Joanette, Yves/0000-0001-9212-1827			ALAJOUANINE T, 1965, BRAIN, V88, P653, DOI 10.1093/brain/88.4.653; Bates E, 1997, DEV NEUROPSYCHOL, V13, P275, DOI 10.1080/87565649709540682; BATES E, 1994, J CHILD LANG, V21, P85, DOI 10.1017/S0305000900008680; Bates E., 1993, MACARTHUR COMMUNICAT; Bayley N., 1969, MANUAL BAYLEY SCALES; Bloom L., 1978, LANGUAGE DEV LANGUAG; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; Brown R., 1973, 1 LANGUAGE; CHAPMAN SB, 1995, J HEAD TRAUMA REHAB, V10, P36, DOI 10.1097/00001199-199510000-00006; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FELDMAN HM, 1992, BRAIN LANG, V42, P89, DOI 10.1016/0093-934X(92)90058-M; FENSON L, 1994, MONOGR SOC RES CHILD, V59, pR5; FRANK I, 1996, UNPUB INVENTAIRE MAC; FROSCHEL E, 1918, KINDERSPRACHE APHASI; GOLINKOFF RM, 1994, J CHILD LANG, V21, P125, DOI 10.1017/S0305000900008692; HECAEN H, 1976, BRAIN LANG, V3, P114, DOI 10.1016/0093-934X(76)90009-2; IMAI M, 1994, COGNITIVE DEV, V9, P45, DOI 10.1016/0885-2014(94)90019-1; JORDAN F M, 1990, Brain Injury, V4, P27; JORDAN F M, 1990, Brain Injury, V4, P147, DOI 10.3109/02699059009026159; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; JORDAN FM, 1993, APHASIOLOGY, V7, P503, DOI 10.1080/02687039308248626; Lenneberg E.H., 1967, BIOL FDN LANGUAGE; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; MARCHMAN VA, 1991, APPL PSYCHOLINGUIST, V12, P1, DOI 10.1017/S0142716400009358; Markman E. M., 1989, CATEGORISATION NAMIN; MARKMAN EM, 1984, COGNITIVE PSYCHOL, V16, P1, DOI 10.1016/0010-0285(84)90002-1; MERVIS CB, 1994, CHILD DEV, V65, P1646, DOI 10.2307/1131285; PAQUIER P, 1993, APHASIOLOGY, V7, P421, DOI 10.1080/02687039308248618; Poulin-Dubois D, 1999, BRIT J DEV PSYCHOL, V17, P21, DOI 10.1348/026151099165131; POULINDUBOIS D, 1995, J CHILD LANG, V22, P325, DOI 10.1017/S0305000900009818; Shallice T., 1988, NEUROPSYCHOLOGY MENT; TEASDALE G, 1974, LANCET, V2, P81; Templin M., 1957, MONOGRAPH, V26; THAL DJ, 1991, BRAIN LANG, V40, P491, DOI 10.1016/0093-934X(91)90145-Q; Trudeau N., 1999, REV ORTHOPHONIE AUDI, P61; VARGHAKHADEM F, 1985, BRAIN, V108, P677, DOI 10.1093/brain/108.3.677; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48; [No title captured]	40	7	7	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	APR-JUN	2000	35	2					227	249					23	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	304PE	WOS:000086492000004	10912253				2022-02-06	
J	Farmer, J; Gibler, M; Kavanaugh, R; Johnson, J				Farmer, J; Gibler, M; Kavanaugh, R; Johnson, J			Preventing traumatic brain injury: an innovative approach to outcomes assessment	BRAIN INJURY			English	Article								The purpose of this study was to investigate the usefulness of the state traffic violations database as an outcome measure for the Young Traffic Offenders Programme, a 1-day educational injury prevention programme for young people with speeding offences. The database provided a fine-grained, cumulative record of each driver's traffic offences and sanctions applied. A comparison of 92 programme participants and 87 non-treated individuals showed no significant between-group difference in rate of convictions after the target programme date, but each group declined significantly in rate of convictions over time. Younger males and individuals with a higher number of convictions initially were more likely to have higher conviction rates after the target date. These findings underscore the need to improve prevention programmes and highlight the potential usefulness of existing public datasets for outcome evaluation.	Univ Missouri, Dept Phys Med & Rehabil, Sch Med, Columbia, MO 65212 USA; Univ Missouri, Sch Med, Biostat Grp, Columbia, MO 65212 USA		Farmer, J (corresponding author), Univ Missouri, Dept Phys Med & Rehabil, Sch Med, DC 046-00,1 Hosp Dr, Columbia, MO 65212 USA.			Johnson, Jane/0000-0002-8825-5926			Diggle PJ, 1994, ANAL LONGITUDINAL DA; ENGLANDER J, 1993, J HEAD TRAUMA REHAB, V8, P101, DOI DOI 10.1097/00001199-199308020-00011; FRANK RG, 1992, AM PSYCHOL, V47, P1045, DOI 10.1037/0003-066X.47.8.1045; GELLER ES, 1990, SOCIAL INFLUENCE PRO; GOLDSTEIN FC, 1990, TRAUMATIC BRAIN INJU; Hingson R., 1993, PROMOTING HLTH ADOLE; JESSOR R, 1987, ALCOHOL DRUGS DRIV, V3, P1, DOI DOI 10.1111/J.1360-0443.1987.TB01490.X; LEWIS CC, 1988, ALCOHOL DRUGS DRIVIN, V4, P1; PETERSON L, 1995, HDB PEDIAT PSYCHOL; STRUCKMANJOHNSON DL, 1989, ACCIDENT ANAL PREV, V21, P203, DOI 10.1016/0001-4575(89)90011-0; *US DEP TRANSP, 1991, FAT ACC REP SYST; WILLIAMS AF, 1994, ALCOHOL DRUGS DRIVIN, V10, P197	12	7	7	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	2000	14	2					109	115		10.1080/026990500120772			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	281GW	WOS:000085151000001	10695567				2022-02-06	
J	Hecimovic, I; Dmitrovic, B; Kurbel, S; Blagus, G; Vranes, J; Rukovanjski, M				Hecimovic, I; Dmitrovic, B; Kurbel, S; Blagus, G; Vranes, J; Rukovanjski, M			Intracranial infection after missile brain wound: 15 war cases	ZENTRALBLATT FUR NEUROCHIRURGIE			English	Article						head injuries; brain injuries; gunshot wound; surgical infection; brain abscess	PENETRATING CRANIOCEREBRAL INJURIES; IRAN-IRAQ WAR; LEBANESE CONFLICT; HEAD WOUNDS; MANAGEMENT; VIETNAM	Objectives: The present study describes 15 cases of intracranial infections developed in a group of in patients with missile brain wound (MBW), during the war in Croatia in the region of East Slavonia. Method: The retrospective study included 88 MBW casualties. There were 11 females and 77 males aged 2-80 years. The projectile penetration of the cranial dura was confirmed and the presence of intracranially retained foreign bodies was evaluated with computerized tomography (CT) in all the patients. The wounded were treated according to the modern recommendations of neurotrauma care. However, we extracted only accessible bone/metallic fragments during intracranial debridement. All intracranial infections were documented by cultures, CT, surgery or autopy. The mean follow-up period of wounded with intracranial infections was 2.4 years (range, 10 days to 7 years). Results: Intracranial infection developed in 14 patients (17%) as "early intracranial infections". Among 14/15 cases, infection developed within the first 8 weeks, and in 1 case 5 months after wounding. We recorded 4 cases of isolated bacterial meningitis, whereas in 9 cases brain abscess had developed. In 6 cases brain abscess was associated with concomitant meningitis and epidural empyema. Local cerebritis developed in one case, as well as subdural empyema with the concomitant meningitis in one case. There were 8 deaths in total of 15 cases. Glasgow Outcome Score 3 was observed in 2 and good outcome in 5/15 cases. The infectious organisms were isolated in 8 cases. Gram-positive bacteria were found in 12 different specimens. Gram-negative bacteria were found in 9 specimens. The most frequently isolated organism was Staphylococcus aureus. beta-hemolytic streptococcal and clostridial infections were not observed. Among the 15 patients with intracranial infection, just one did not have intracranially retained bone and/or metallic fragments. However, among the 73 head injuries without intracranial infections only 10 did not have retained fragments. CSF fistula and/or dehiscence developed in 13/15 patients with intracranial infection. In 67/73 wounded without intracranial infections, wound complications were not registered. Conclusion: The liberal use of post-contrast CT of the brain within the first 2 months after injury, especially if performed early in the clinical course, can lead to a prompt diagnosis of most of "early intracranial infections". The surgical procedures in order to prevent wound CSF fistula/dehiscence development are absolutely necessary. The immediate scalp and dural wound repair in case of wound complications are absolutely indicated and if needed, the procedures can be repeated. However, it seems that retained fragments are not responsible for an increased rate of intracranial infection.	Univ Hosp Osijek, Sch Med, Div Neurosurg, Osijek 31000, Croatia; Univ Hosp Osijek, Sch Med, Dept Pathol, Osijek 31000, Croatia; Univ Hosp Osijek, Sch Med, Dept Oncol, Osijek 31000, Croatia; Univ Zagreb, Sch Med, Dept Microbiol & Parasitol, Zagreb 41000, Croatia				Dmitrovic, Branko/AAP-4365-2020	Dmitrovic, Branko/0000-0002-5797-8013			AARABI B, 1987, NEUROSURGERY, V20, P610, DOI 10.1227/00006123-198704000-00018; AARABI B, 1989, NEUROSURGERY, V25, P923, DOI 10.1227/00006123-198912000-00011; AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; ABOLNIK IZ, 1990, NEUROSURGERY, V3, P3299; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CAREY ME, 1971, J NEUROSURG, V34, P145, DOI 10.3171/jns.1971.34.2part1.0145; CAREY ME, 1974, J NEUROSURG, V41, P542, DOI 10.3171/jns.1974.41.5.0542; COOPER PR, 1987, HEAD INJURY, P257; DREW JH, 1954, J NEUROSURG, V11, P386, DOI 10.3171/jns.1954.11.4.0386; ECKER AD, 1946, J NEUROSURG, V3, P1, DOI 10.3171/jns.1946.3.1.0001; Gonul E, 1997, NEUROSURG REV, V20, P177, DOI 10.1007/BF01105561; HAGAN RE, 1971, J NEUROSURG, V34, P132, DOI 10.3171/jns.1971.34.2part1.0132; HAMMON WM, 1971, J NEUROSURG, V34, P142, DOI 10.3171/jns.1971.34.2part1.0142; HECIMOVIC I, 1997, CLIN NEUROLOGY NE S1, V99, P201; Jankovic Stipan, 1997, Acta Medica Croatica, V51, P233; JENNETT B, 1975, LANCET, V1, P480; MERTENS HG, 1974, HDB CLIN NEUROLOGY 1, V16, P209; MYERS PW, 1989, J NEUROSURG, V70, pA319; PENCEK TL, 1986, J NEUROSURG, V64, P813, DOI 10.3171/jns.1986.64.5.0813; ROSENWASSER RH, 1991, SURG CLIN N AM, V71, P305; SABA MI, 1988, OPERATIVE NEUROSURGI, P37; Scap M, 1991, Lijec Vjesn, V113, P289; TAHA JM, 1991, NEUROSURGERY, V29, P380, DOI 10.1227/00006123-199109000-00007; TAHA JM, 1991, NEUROSURGERY, V29, P864, DOI 10.1227/00006123-199112000-00010; VRANKOVIC D, 1992, NEUROCHIRURGIA, V35, P150; VRANKOVIC D, 1993, RECENT ADVANCES IN NEUROTRAUMATOLOGY, P341; Vrankovic D, 1996, J Neurosurg Sci, V40, P107; WANNAMAKER GT, 1958, J NEUROSURG, V15, P512, DOI 10.3171/jns.1958.15.5.0512; WEAVER TA, 1946, J NEUROSURG, V3, P148, DOI 10.3171/jns.1946.3.2.0148	30	7	8	0	8	JOHANN AMBROSIUS BARTH VERLAG	HEIDELBERG	IM WEIHER 10, D-69121 HEIDELBERG, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.		2000	61	2					95	102		10.1055/s-2000-8266			8	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	346YD	WOS:000088897900005	10986758				2022-02-06	
J	Hoofien, D; Vakil, E; Gilboa, A				Hoofien, D; Vakil, E; Gilboa, A			Criterion validation of premorbid intelligence estimation in persons with traumatic brain injury: "Hold/don't hold'' versus "best performance'' procedures	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							WAIS-R; ABILITY; INDEX	The goal of the present study was to validate previously suggested regression equations for the estimation of premorbid ability against a real premorbid intellectual criterion. Fifty-four patients with traumatic brain injuries, for whom a premorbid military Primary Psychometric Rating (PPR) was available, participated in the study. Two prediction procedures were validated: (a) "BEST-10'', which generates a predicted score from the highest observed score of 10 WAIS-R subtests, according to the "best performance'' estimation principle. (b) "BEST-2'', which generates the predicted score from the higher of two subtests considered a priori resistant to neurological damage according to the "hold/don't hold'' principle. The two procedures showed similar correlation with the premorbid criterion. However, the BEST-10 method provided a more accurate estimation, generating a non-significant 2-point underestimation. The results support the application of previously proposed equations for estimating premorbid intelligence, and suggest that the use of the best performance principle is preferable as compared to the hold/don't hold principle.	Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; Natl Inst Rehabilitat Brain Injured, Tel Aviv, Israel; Bar Ilan Univ, Ramat Gan, Israel		Hoofien, D (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, Mt Scopus, IL-91905 Jerusalem, Israel.			Gilboa, Asaf/0000-0002-4530-7490			BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Crawford J.R., 1992, HDB NEUROPSYCHOLOGIC, P21; CRAWFORD JR, 1989, PERS INDIV DIFFER, V10, P793, DOI 10.1016/0191-8869(89)90126-8; Crocker L., 1986, INTRO CLASSICAL MODE, P217; DAVIDSON M, 1999, IN PRESS AM J PSYCHI; GAL R, 1986, PORTRAIT ISRAELI SOL, P76; HOFFIEN D, 1993, FINAL REPORT COMPREH; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MORTENSEN EL, 1991, J CLIN EXP NEUROPSYC, V13, P361, DOI 10.1080/01688639108401050; OLEARY UM, 1991, J CLIN PSYCHOL, V47, P277, DOI 10.1002/1097-4679(199103)47:2<277::AID-JCLP2270470215>3.0.CO;2-I; REEB M, 1976, J APPL PSYCHOL, V61, P253, DOI 10.1037/0021-9010.61.3.253; Schmand B, 1998, J CLIN EXP NEUROPSYC, V20, P42, DOI 10.1076/jcen.20.1.42.1485; SCHUERGER JM, 1989, J CLIN PSYCHOL, V45, P294, DOI 10.1002/1097-4679(198903)45:2<294::AID-JCLP2270450218>3.0.CO;2-N; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; SWIERCINSKY DP, 1978, PSYCHOL REP, V42, P601, DOI 10.2466/pr0.1978.42.2.601; VAKIL E, 1994, J CLIN PSYCHOL, V50, P240, DOI 10.1002/1097-4679(199403)50:2<240::AID-JCLP2270500215>3.0.CO;2-5; VANDERPLOEG RD, 1995, ARCH CLIN NEUROPSYCH, V10, P225, DOI 10.1016/0887-6177(94)00042-O; Vanderploeg RD, 1996, PSYCHOL ASSESSMENT, V8, P404, DOI 10.1037/1040-3590.8.4.404; VANDERPLOEG RD, 1994, CLIN GUIDE NEUROPSYC; Wechsler D., 1958, MEASUREMENT APPRAISA; Wechsler D, 1987, MANUAL WECHSLER MEMO; Wechsler D, 1981, WECHSLER ADULT INTEL; WILSON RS, 1978, J CONSULT CLIN PSYCH, V46, P1554, DOI 10.1037/0022-006X.46.6.1554	24	7	8	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2000	22	3					305	315		10.1076/1380-3395(200006)22:3;1-V;FT305			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	327UB	WOS:000087811000001	10855039				2022-02-06	
J	Constantinidou, F				Constantinidou, F			The effects of stimulus modality on interference and recognition performance following brain injury	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							CLOSED-HEAD-INJURY; MODERATE; MEMORY	This study investigated the effects of stimulus modality on recall after interference and recognition performance of 31 patients with moderate-to-severe closed head injury (CHI) and 31 normal participants. A multi-trial free recall paradigm incorporating three modality conditions (auditory, visual, and simultaneous auditory plus visual) was implemented. The presence of an interference list resulted in a significantly greater decline in word recall performance for the participants with CHI than for the normal participants. Visual presentation of information was the most resistant to interference compared to auditory presentation or auditory plus visual presentation. Recognition performance was superior to free recall. Furthermore, visually presented information (with or without simultaneous auditory presentation of names) resulted in better recognition performance than auditory presentation alone. Finally, there were no group differences in the use of intrusion words and repetitions during this multi-trial free recall paradigm.	Miami Univ, Dept Commun, Oxford, OH 45056 USA		Constantinidou, F (corresponding author), Miami Univ, Dept Commun, 2 Bachelor Hall, Oxford, OH 45056 USA.			Constantinidou, Fofi/0000-0002-7928-8363			AGRESTI AA, 1987, DISS ABSTR INT, V47, P3097; ARNETT JA, 1986, PSYCHOL REP, V59, P315, DOI 10.2466/pr0.1986.59.1.315; BROOKS D N, 1975, Cortex, V11, P329; Constantinidou F, 1996, J GEN PSYCHOL, V123, P173, DOI 10.1080/00221309.1996.9921270; CONSTANTINIDOU F, 1995, J HEAD TRAUMA REHAB, V10, P90, DOI 10.1097/00001199-199508000-00009; CONSTANTINIDOU F, 1989, THESIS S ILLINOIS U; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; DELIS D, 1987, CALIFORNIA VERBAL LE; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; ELBERT M, 1980, CONSTRASTS PICTURE F; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; GENTILINI M, 1989, MILD HEAD INJURY, P163; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; Hagen C., 1972, REHABILITATION HEAD; Levin H. S., 1989, J EXP PSYCHOL, V12, P95; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MCCAFFREY RJ, 1987, INT J CLIN NEUROPSYC, V9, P171; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; ODONNELL JP, 1988, J GEN PSYCHOL, V115, P335; PAIVIO A, 1976, IMAGERY VERBAL PROCE; Paivio A., 1971, IMAGERY VERBAL PROCE; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; SPIKMAN JM, 1995, J CLIN EXP NEUROPSYC, V17, P29, DOI 10.1080/13803399508406578; Squire LR., 1987, MEMORY BRAIN; Thorndike E. L., 1944, TEACHERS BOOK 30000; VENTRY IM, 1986, EVALUATING RES SPEEC; Zechmeister E. B., 1982, HUMAN MEMORY INTRO R; [No title captured]	34	7	7	0	0	SINGULAR PUBLISHING GROUP INC	SAN DIEGO	401 WEST A ST, STE 325, SAN DIEGO, CA 92101-7904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	DEC	1999	7	4					283	295					13	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	264LL	WOS:000084183700005					2022-02-06	
J	Jong, CN; Zafonte, RD; Millis, SR; Yavuzer, G				Jong, CN; Zafonte, RD; Millis, SR; Yavuzer, G			The effect of cocaine on traumatic brain injury outcome: a preliminary evaluation	BRAIN INJURY			English	Article							HEAD-INJURY; NEUROPSYCHOLOGICAL DEFICITS; ABUSERS; ALCOHOL; PATTERNS; MEMORY	The effect of acute cocaine use on the functional and neuropsychological outcome of persons with traumatic brain injury, (TBI) was examined by comparing persons with TBI who tested positive for cocaine at the time of admission with persons with negative drug and alcohol screens. Subjects were matched for age, admission GCS score, level of education, and aetiology of injury (closed vs penetrating head injury). Dependent measures were: the Disability Rating Scale, the Functional Independence Measure, and selected neuropsychological tests. No group differences were found in DRS, FIM, FIM subsets, or FIM change. However, the cocaine group scored significantly lower than the no-drugs group on the Rey Auditory Verbal Learning Test, but did not differ on any of the other neuropsychological tests.	Wayne State Univ, Rehabil Inst Michigan, Detroit, MI 48201 USA		Zafonte, RD (corresponding author), Wayne State Univ, Rehabil Inst Michigan, 261 Mack Blvd, Detroit, MI 48201 USA.						ARDILA A, 1991, INT J NEUROSCI, V57, P73, DOI 10.3109/00207459109150348; BAUER LO, 1994, ADDICT BEHAV, V19, P599, DOI 10.1016/0306-4603(94)90015-9; BEATTY WW, 1995, DRUG ALCOHOL DEPEN, V37, P247, DOI 10.1016/0376-8716(94)01072-S; Benton A., 1994, CONTRIBUTIONS NEUROP; BENTON AL, 1994, MULTILINGUA APHASIA; BERRY J, 1993, DRUG ALCOHOL DEPEN, V32, P231, DOI 10.1016/0376-8716(93)90087-7; Easton C, 1996, PROG NEURO-PSYCHOPH, V20, P969, DOI 10.1016/0278-5846(96)00077-2; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hoff AL, 1996, PSYCHIAT RES, V60, P167, DOI 10.1016/0165-1781(96)02758-8; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LINDENBAUM GA, 1989, J TRAUMA, V29, P1654, DOI 10.1097/00005373-198912000-00012; MANSCHRECK TC, 1990, COMPR PSYCHIAT, V31, P369, DOI 10.1016/0010-440X(90)90045-T; Mena I, 1994, NIDA Res Monogr, V138, P161; MENA I, 1989, CLIN NUCL MED, V14, P1412; MITTENBERG W, 1993, ARCH CLIN NEUROPSYCH, V8, P477, DOI 10.1016/0887-6177(93)90048-6; MUIR JK, 1995, J NEUROTRAUM, V12, P87, DOI 10.1089/neu.1995.12.87; MUIR JK, 1995, AM J PHYSIOL-HEART C, V268, pH68, DOI 10.1152/ajpheart.1995.268.1.H68; MUIR JK, 1992, J NEUROTRAUM, V9, P394; OMALLEY S, 1992, AM J DRUG ALCOHOL AB, V18, P131, DOI 10.3109/00952999208992826; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Robinson JE, 1999, J INT NEUROPSYCH SOC, V5, P10, DOI 10.1017/S1355617799511028; ROSELLI M, 1996, J CLIN EXP NEUROPSYC, V18, P122; Schmidt M., 1996, REY AUDITORY VERBAL; *STAT U NEW YORK B, 1990, GUID US UN DAT SET M; STRICKLAND TL, 1993, J NEUROPSYCH CLIN N, V5, P419; VOLKOW ND, 1988, BRIT J PSYCHIAT, V152, P641, DOI 10.1192/bjp.152.5.641; Volkow ND, 1997, ANN NY ACAD SCI, V820, P41, DOI 10.1111/j.1749-6632.1997.tb46188.x; Wechsler D, 1987, MEMORY SCALE REVISED	32	7	7	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	1999	13	12					1017	1023					7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	264UJ	WOS:000084200600007	10628506				2022-02-06	
J	Sakai, F; Amaha, K				Sakai, F; Amaha, K			The effects of hypothermia on a cloned human brain glutamate transporter (hGLT-1) expressed in Chinese hamster ovary cells: [H-3]L-glutamate uptake study	ANESTHESIA AND ANALGESIA			English	Article; Proceedings Paper	44th Annual Meeting of the Japan-Society-of-Anesthesiology	APR 23-25, 1997	NIIGATA, JAPAN	Japan Soc anesthesiol			RAT HIPPOCAMPUS; AMINO-ACIDS; RELEASE; GLT-1; NEUROTRANSMITTER; TEMPERATURE; CALCIUM; ASSAY	Hypothermia provides neuroprotection that inhibits increases in extracellular glutamate concentration during ischemia; however, the effect of hypothermia on the glutamate transporter is uncertain. A human glial glutamate transporter (hGLT-1) cDNA, isolated by screening a cDNA, library was cloned and stably transfected into Chinese hamster ovary cells. We assessed the effects of temperature on transporter activity in [H-3]L-glutamate flux experiments at 23, 32 and 37 degrees C. Hypothermia of 23 degrees C and 32 degrees C decreased [H-3]L-glutamate uptake at 60 min, to 76.7% +/- 7.3% (P < 0.05, n = 5) and 70.7% +/- 7.5% (P < 0.05, n = 5) of uptake at 37 degrees C, respectively. Reversed uptake of preloaded [H-3]L-glutamate via hGLT-1 was not observed at any temperature. The specific uptakes (Q(10) values) for 37 degrees C to 32 degrees C and 32 degrees C to 23 degrees C at 30 min were 3.48 and 2.37, whereas they were 2.17 and 0.91, respectively, for 60 min. These changes suggest that hypothermia attenuates uptake of extracellular glutamate via hGLT-1. in a temperature- and time-dependent manner. Implications: Under certain pathologic renditions, including cerebral ischemia and traumatic brain injury, glutamate neurotoxicity may initially be propagated by hypothermia due to relative failure of glutamate uptake via Human Glial Glutamate Transporter before a subsequent recovery of uptake.	Tokyo Med & Dent Univ, Dept Anesthesiol & Crit Care Med, Bunkyo Ku, Tokyo 1138519, Japan		Sakai, F (corresponding author), Tokyo Med & Dent Univ, Dept Anesthesiol & Crit Care Med, Bunkyo Ku, 5-45 Yushima 1-chome, Tokyo 1138519, Japan.						ANDERSON KJ, 1993, BRAIN RES, V622, P93, DOI 10.1016/0006-8993(93)90806-X; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Bergles DE, 1998, J NEUROSCI, V18, P7709; BICKLER PE, 1994, ANESTHESIOLOGY, V81, P1461, DOI 10.1097/00000542-199412000-00022; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dirig DM, 1997, J NEUROSCI, V17, P4406; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRUNEWALD M, 1995, J BIOL CHEM, V270, P17017, DOI 10.1074/jbc.270.28.17017; HILLE G, 1992, IONIC CHANNELS EXCIT; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716; KIMURA JE, 1979, J PHYSIOL-LONDON, V289, P479, DOI 10.1113/jphysiol.1979.sp012748; Levy LM, 1998, FEBS LETT, V422, P339, DOI 10.1016/S0014-5793(98)00036-2; MANFRAS BJ, 1994, BBA-BIOMEMBRANES, V1195, P185, DOI 10.1016/0005-2736(94)90026-4; Mennerick S, 1998, J NEUROSCI, V18, P4490; Miller C., 1987, NEUROMODULATION BIOC, P39; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Schlag BD, 1998, MOL PHARMACOL, V53, P355, DOI 10.1124/mol.53.3.355; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TORP R, 1995, EXP BRAIN RES, V103, P51	25	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	DEC	1999	89	6					1546	1550		10.1097/00000539-199912000-00044			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	260ZB	WOS:000083982400044	10589646				2022-02-06	
J	Metzl, JD				Metzl, JD			Sports-specific concerns in the young athlete: Football	PEDIATRIC EMERGENCY CARE			English	Article						football; sports medicine; adolescent; concussion; heat illness; shoulder injury	CONCUSSION; DIAGNOSIS; INJURIES	There are over 1.5 million males playing American football at all levels in the United States. American football is the most common participant sport among high-school-aged males. Owing to its high rate of injury per exposure hour, American football injuries are commonly treated in the emergency department during the autumn sports season. This article will review the history, epidemiology, and specific injury patterns seen in American football, with a focus on head and shoulder injuries.	Cornell Univ, Hosp Special Surg, Coll Med, Dept Pediat,Div Sports Med, New York, NY 10021 USA		Metzl, JD (corresponding author), Cornell Univ, Hosp Special Surg, Coll Med, Dept Pediat,Div Sports Med, 535 E 70th St, New York, NY 10021 USA.						*AM AC ORTH SOC SP, AOSSM HELM REM GUID; ARCIERO RA, 1999, ORTHOPAEDIC KNOWLEDG, V2, P165; BRONSTEIN RD, 1995, J MUSCULOSKELETAL ME, P14; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; CANTU RC, 1995, CLIN SPORT MED, V14, P517; DELEE JC, 1992, AM J SPORTS MED, V20, P570; GARRICK JG, 1978, PEDIATRICS, V61, P465, DOI 10.1542/peds.61.3.465; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GOLDBERG B, 1984, PHYSICIAN SPORTSMED, V12, P122; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Metzl JD, 1998, CLIN SPORT MED, V17, P663, DOI 10.1016/S0278-5919(05)70110-1; MORIARTY J, 1998, MANUAL SPORTS MED, P95; QUINCY R, 1999, US OL COMM SPORTS ME; REIDER B, 1996, SPORTS MED SCH AGED, P613; ROBEY JM, 1971, J AMER MED ASSOC, V217, P184, DOI 10.1001/jama.217.2.184; Sandor RP, 1997, PHYSICIAN SPORTSMED, V25, P35, DOI 10.3810/psm.1997.06.1400	17	7	7	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	OCT	1999	15	5					363	367		10.1097/00006565-199910000-00018			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	245GT	WOS:000083098600019	10532673				2022-02-06	
J	Flyte, MDG; Perchard, MF				Flyte, MDG; Perchard, MF			The prediction of car driver size and position to enhance safety in crashes	ERGONOMICS			English	Article						car drivers; anthropometric characteristics; safety; occupant protection		The positions which car drivers adopt when driving will depend on their anthropometric characteristics, the range and type of adjustment available from the vehicle package and their preferred driving posture. The design and testing of systems to protect occupants in car crashes assumes that the size and position of the driver is 'normal' or 'average', although there is some accommodation for adjustability. If, however, the occupant protection system had information on the driver's chosen seat position, on whether the driver was particularly large or small and on whether the driver was sitting close to or further from the steering wheel, in a crash the system could tailor its performance and enhance the protection offered. This study investigated whether it was possible to predict the physical characteristics of the driver and the driver's position in relation to the steering wheel, from data that could be collected by sensors in the seat and seat mounting. In order to do this, anthropometric characteristics of drivers and their usual seated position in their own vehicle were measured and analyses were undertaken to identify whether there were any relationships between the driver-related and the vehicle-related measures. The results showed that it was possible to predict drivers' head and chest positions relative to injury-producing features of the vehicle such as the steering wheel (and hence the airbag) and to predict some physical dimensions of drivers.	Loughborough Univ Technol, Dept Human Sci, Vehicle Safety Res Grp, Loughborough LE11 3TU, Leics, England; N Middlesex Hosp, London N18 1QX, England		Flyte, MDG (corresponding author), Loughborough Univ Technol, Dept Human Sci, Vehicle Safety Res Grp, Loughborough LE11 3TU, Leics, England.						AIBE T, 1982, P 9 INT TECHN C ENH, V1, P231; BREED DS, 1994, 940527 SAE; Evans L., 1991, TRAFFIC SAFETY DRIVE; FLYTE MDG, 1997, J CRASHWORTHINESS, V2, P153; GALER MD, 1993, P C462 2 ROAD TRANSP, P17; GALER MD, 1994, P 14 INT TECHN C ENH, V1, P491; GRAFTON AJ, 1995, P INT C BIOM IMP BRU, P311; HARMS PL, 1991, P 13 INT TECHN C ENH, V1, P121; HASLEGRAVE CM, 1980, ERGONOMICS, V23, P437, DOI 10.1080/00140138008924759; Lehto M. R., 1993, AUTOMOTIVE ERGONOMIC, P141; MILLER JH, 1996, 960662 SAE; PARKIN S, 1993, P 37 ANN M ASS ADV A; Pheasant S, 1997, BODYSPACE ANTHROPOME; SMITH BW, 1994, P 14 INT TECHN C ENH, V1, P570; VANVOORHIES KL, 1996, P 15 INT TECHN C ENH, V1, P465; [No title captured]	16	7	7	0	4	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0014-0139			ERGONOMICS	Ergonomics	SEP	1999	42	9					1149	1166		10.1080/001401399185045			18	Engineering, Industrial; Ergonomics; Psychology, Applied; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Psychology	236AY	WOS:000082577100002					2022-02-06	
J	Maxeiner, H; Spies, C; Irnich, B; Brock, M				Maxeiner, H; Spies, C; Irnich, B; Brock, M			Rupture of several parasagittal bridging veins without subdural bleeding	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							TRAUMATIC BRAIN INJURY; EDEMA		Free Univ Berlin, Med Sch Benjamin Franklin, Inst Legal Med, D-14195 Berlin, Germany; Free Univ Berlin, Med Sch Benjamin Franklin, Dept Anesthesiol, D-14195 Berlin, Germany; Free Univ Berlin, Med Sch Benjamin Franklin, Dept Neurosurg, D-14195 Berlin, Germany		Maxeiner, H (corresponding author), Free Univ Berlin, Med Sch Benjamin Franklin, Inst Legal Med, Hittorfstr 18, D-14195 Berlin, Germany.						Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, ACT NEUR S, V70, P119; BULLOCK R, 1993, SCHWEIZ MED WSCHR, V123, P449; Bullock R., 1997, SCI FDN TRAUMA, P101; DOERR W, 1993, SPEZIELLE PATHOLOG A, V6; FREYTAG E, 1963, ARCH PATHOL, V75, P402; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, V1, P197; GRANDE PO, 1997, J TRAUMA, V42, P23; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KRAULAND W, 1982, VERLETZUNGEN INTRAKR; Krauland W., 1961, ZWANGLOSE ABHANDLUNG; LEESTMA JE, 1989, FORENSIC NEUROPATHOL; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Maxeiner H, 1997, FORENSIC SCI INT, V89, P103, DOI 10.1016/S0379-0738(97)00124-2; Maxeiner H., 1998, RECHTSMEDIZIN, V9, P14; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; UNTERBERG AW, 1997, J TRAUMA S, V42, P32; Voigt G E, 1968, Dtsch Z Gesamte Gerichtl Med, V64, P9, DOI 10.1007/BF00585127	22	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	1999	47	3					606	610		10.1097/00005373-199909000-00039			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	236PL	WOS:000082607700042	10498329				2022-02-06	
J	Mulhall, LE; Williams, IM; Abel, LA				Mulhall, LE; Williams, IM; Abel, LA			Bedside tests of saccades after head injury	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article						antisaccades; eye movements; memory-guided saccades; self-paced saccades; traumatic brain injury	CORTICAL CONTROL; EYE-MOVEMENTS; BASAL GANGLIA; VALIDATION; SYSTEM; PET	Objectives: To compare the techniques of bedside and infrared oculographic tests of saccades and to compare the results of birth tests in control subjects and in patients with traumatic brain injuries (TBI). Materials and Methods: The authors elicited single memory-guided saccades, antisaccades, and self-paced saccades in 19 TBI subjects and 26 age-matched control subjects at the bedside. Taped instructions were used to ensure that the timing and sequence of each stimulus (index finger flexion) were the same in all subjects and as close as possible to those used in both the current and previous laboratory studies. Results: Self-paced saccade rate was significantly decreased in patients with TBI. The increased error rate in single memory guided saccades and antisaccades was not statistically significant. Conclusion: The authors concluded that the bedside saccade tests have limited Value in patients with TBI because of the range of results and large overlap of the distributions of these two groups. The number of parameters that can be measured is limited. Bedside saccade tests are easier than infrared oculographic tests because the target remains visible.	Monash Univ, Alfred Hosp, Dept Med, Neuroophthalmol Lab, Melbourne, Vic 3181, Australia; La Trobe Univ, Sch Orthopt, Melbourne, Vic, Australia		Mulhall, LE (corresponding author), 15 Collins St, Melbourne, Vic 3000, Australia.		Abel, Larry/D-9915-2012	Abel, Larry/0000-0002-2393-0644			ADAMS JH, 1990, HDB CLIN NEUROLOGY, V57, P43; ANDERSON TJ, 1994, BRAIN, V117, P1073, DOI 10.1093/brain/117.5.1073; CURRIE J, 1991, ARCH NEUROL-CHICAGO, V48, P644, DOI 10.1001/archneur.1991.00530180102024; DEJONG JD, 1971, EXP NEUROL, V32, P58, DOI 10.1016/0014-4886(71)90165-8; GENTRY LR, 1991, MAGNETIC RESONANCE I, P439; GUITTON D, 1985, EXP BRAIN RES, V58, P455; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; PETIT L, 1993, J NEUROPHYSIOL, V69, P1009, DOI 10.1152/jn.1993.69.4.1009; PIERROTDESEILLIGNY C, 1991, EXP BRAIN RES, V83, P607; PIERROTDESEILLIGNY C, 1991, NEURO-OPHTHALMOLOGY, V11, P63, DOI 10.3109/01658109108997298; POSNER MI, 1984, J NEUROSCI, V4, P1863; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SHARPE JA, 1986, ADAPTIVE PROCESSES V, P239; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Tusa R J, 1989, Bull Soc Belge Ophtalmol, V237, P67; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2; WURTZ RH, 1986, PROG BRAIN RES, V64, P175	17	7	7	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1070-8022			J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	SEP	1999	19	3					160	165					6	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	306YU	WOS:000086626900002	10494943				2022-02-06	
J	Robin, DA; Max, JE; Stierwalt, JAG; Guenzer, LC; Lindgren, SD				Robin, DA; Max, JE; Stierwalt, JAG; Guenzer, LC; Lindgren, SD			Sustained attention in children and adolescents with traumatic brain injury	APHASIOLOGY			English	Article							CLOSED-HEAD INJURY	We studied sustained attention in 64 subjects, 49 of whom had suffered a traumatic brain injury (TBI) and 15 who served as orthopedic controls. Subjects were required to respond to the appearance or disappearance of a star on a computer monitor, embedded in 250 stars. Results showed that subjects with TBI had lower accuracy than controls and a significant vigilance decrement. Severe TBI resulted in much greater attentional deficits, than mild injuries.	Univ Iowa, Dept Speech Pathol & Audiol, Natl Ctr Voice & Speech, Iowa City, IA 52242 USA; Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; SW Missouri State Univ, Dept Commun Disorders, Springfield, MO 65802 USA; No Illinois Univ, De Kalb, IL 60115 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA		Robin, DA (corresponding author), Univ Iowa, Dept Speech Pathol & Audiol, Natl Ctr Voice & Speech, 120B WJSHC, Iowa City, IA 52242 USA.		Robin, Donald/F-2109-2010				BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; LODGEMILLER KA, 1993, J MED SPEECH-LANG PA, V1, P133; LOKEN WJ, 1995, NEUROPSYCHOLOGY, V9, P592, DOI 10.1037/0894-4105.9.4.592; Lustig AP, 1998, J MED SPEECH-LANG PA, V6, P13; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rizzo M, 1996, BRAIN, V119, P951, DOI 10.1093/brain/119.3.951; RIZZO M, 1990, NEUROLOGY, V40, P447, DOI 10.1212/WNL.40.3_Part_1.447; STIERWALT JAG, 1997, CLIN APH C JUN BIGF; TEASDALE G, 1974, LANCET, V2, P81; Timmermans SR, 1991, COGNITIVE REHABILITA, V9, P26; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357	12	7	7	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology	SEP-NOV	1999	13	9-11					701	708		10.1080/026870399401812			8	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	248MM	WOS:000083279200008					2022-02-06	
J	Mignon, F; Qanadli, SD; Sissakian, JF; Bruckert, F; Mesurolle, B; Coggia, M; Lacombe, P				Mignon, F; Qanadli, SD; Sissakian, JF; Bruckert, F; Mesurolle, B; Coggia, M; Lacombe, P			Post-traumatic dissection of the cervical ICA with false aneurysm formation : helical CT and angiographic findings in one case	JOURNAL DE RADIOLOGIE			French	Article						dissection; trauma; aneurysm; artery, internal carotid; CT, helical; angiography; vascular surgical procedures	INTERNAL CAROTID-ARTERY; ANGIOGRAPHY	A 20-year-old man presented with mild intracranial bleeding, a Horner's syndrome, and left neck swelling following head injury. Following noncontrast CT of the brain, a contrast-enhanced helical CT was performed through the neck that showed a hematoma in the poststyloid space (carotid sheath) with irregular diameter of the ICA. Selective digital subtraction angiography confirmed the presence of left cervical ICA dissection with pseudoaneurysm formation. The aneurysm was resected and an end-to-end anastomosis was done using an inverted saphenous graft. Histology confirmed a diagnosis of traumatic ICA dissection with pseudoaneurysm formation and there was no evidence of pre-existing pathology. Helical CT is a simple, widely available, and relatively non-invasive imaging technique that correlates well with angiography. It should be considered in the evaluation of patients with suspected cervical ICA dissection.	Hop Ambroise Pare, Serv Radiol, F-92204 Boulogne, France		Mignon, F (corresponding author), Hop Ambroise Pare, Serv Radiol, Ave Charles De Gaulle, F-92204 Boulogne, France.			QANADLI, Salah Dine/0000-0003-1330-660X			Bousson V, 1998, J RADIOL, V79, P723; Candon E, 1996, NEUROSURGERY, V39, P863, DOI 10.1097/00006123-199610000-00047; CORMIER JM, 1995, ANN VASC SURG, V9, P500, DOI 10.1007/BF02143868; Egelhof T, 1996, RADIOLOGE, V36, P850, DOI 10.1007/s001170050150; Hubaut JJ, 1997, ANN VASC SURG, V11, P634, DOI 10.1007/s100169900103; KLINKERT A, 1995, J RADIOL, V8, P491; Leys D, 1997, EUR NEUROL, V37, P3, DOI 10.1159/000117396; Matsuura JH, 1997, J ENDOVASC SURG, V4, P339, DOI 10.1583/1074-6218(1997)004<0339:TCADAP>2.0.CO;2; Pica RA, 1996, AM J NEURORADIOL, V17, P86; Raptis S, 1996, EUR J VASC ENDOVASC, V11, P148, DOI 10.1016/S1078-5884(96)80043-8; STURZENEGGER M, 1995, NEUROLOGY, V45, P691, DOI 10.1212/WNL.45.4.691; WURM G, 1995, CHIRURG, V66, P916	12	7	7	0	1	MASSON EDITEUR	PARIS 06	120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE	0221-0363			J RADIOL	J. Radiol.	JUN	1999	80	6					585	587					3	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	210TW	WOS:000081121600012	10417892				2022-02-06	
J	Kay, JB; Warschausky, S				Kay, JB; Warschausky, S			WISC-III index growth curve characteristics following traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							HEAD-INJURY; CHILDREN; RECOVERY; PATTERNS; SEVERITY; COHORT	Previous studies have replicated the four-factor structure of the WISC-III in children with traumatic brain injury (TBI) and demonstrated the sensitivity of WISC-III indexes to severity of injury. This archival study examined the growth curve characteristics of the indexes following traumatic brain injury. The primary hypothesis was that there is systematic variability in the components (e.g., slope) of the curves. Subjects included 40 children with documented loss of consciousness, age at injury 9.3 years (SD = 2.6), 68% severe TBI, evaluated with a full WISC-III a minimum of three times post-injury. Growth curve analyses with hierarchical linear modeling, conducted with factor scores recalculated as non-age-standardized z scores, indicated that although the intercept was reliable and could be predicted by injury characteristics, there was little systematic variation in index growth rates. Findings suggest that WISC-III indexes are of limited utility as repeated measures of recovery following TBI.	Univ Michigan, Med Ctr, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Warschausky, S (corresponding author), Univ Michigan, Med Ctr, Dept Phys Med & Rehabil, Box 0050, Ann Arbor, MI 48109 USA.						BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BROOKS DN, 1984, J CLIN NEUROPSYCHOL, V6, P71, DOI 10.1080/01688638408401198; Bryk, 1992, HIERARCHICAL LINEAR; BRYK AS, 1987, PSYCHOL BULL, V101, P147, DOI 10.1037/0033-2909.101.1.147; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; DILLER L, 1987, REHABILITATION OUTCO, P209; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 1996, CHILD NEUROPSYCHOL, V2, P227, DOI 10.1080/09297049608402255; Donders J, 1997, ASSESSMENT, V4, P107, DOI 10.1177/107319119700400114; Donders J, 1996, CHILD NEUROPSYCHOL, V2, P185, DOI 10.1080/09297049608402251; DONDERS J, 1993, CLIN NEUROPSYCHOL, V7, P430, DOI 10.1080/13854049308401533; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fletcher JM, 1995, HDB PEDIAT PSYCHOL, P362; Fletcher JM, 1987, NEUROBEHAVIORAL RECO, P279; FRANCIS DJ, 1991, J CONSULT CLIN PSYCH, V59, P27, DOI 10.1037/0022-006X.59.1.27; FRANCIS DJ, 1993, FRAMES REFERENCE ASS, P29; FRNACIS DJ, 1995, ANN M INT NEUR SOC S; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Kaufman, 1994, INTELLIGENT TESTING; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; SHAYWITZ BA, 1995, TRAUMATIC HEAD INJUR, P271; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; WARD JD, 1995, TRAUMATIC HEAD INJUR, P258; Wechsler D., 1989, WECHSLER PRESCHOOL P; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Zwaagstra R, 1996, J CLIN EXP NEUROPSYC, V18, P383, DOI 10.1080/01688639608408995; [No title captured]	31	7	8	0	3	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	1999	21	2					186	199		10.1076/jcen.21.2.186.927			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	226CL	WOS:000082002700004	10425516				2022-02-06	
J	Kiris, T; Gorgulu, A; Unal, F; Turkoglu, U; Cobanoglu, S; Ekuklu, G				Kiris, T; Gorgulu, A; Unal, F; Turkoglu, U; Cobanoglu, S; Ekuklu, G			Superoxide dismutase activity and the effect of N-methly-D-aspartate antagonists on lipid peroxidation in the early phase of cold injury	RESEARCH IN EXPERIMENTAL MEDICINE			English	Article						cold injury; lipid peroxidation; MK-801; NMDA antagonist; superoxide dismutase	SPINAL-CORD INJURY; VASOGENIC BRAIN EDEMA; OXYGEN FREE-RADICALS; AMINO-ACID RELEASE; NEUROLOGICAL DISORDERS; ISCHEMIA; EXCITOTOXICITY; INVOLVEMENT; GLUTAMATE; RECEPTORS	Free radicals, lipid peroxidation and excitatory amino acids have been implicated in the secondary mechanisms of traumatic brain injury. We used the cold injury model in rats to assess the endogenous activity of the protective enzyme superoxide dismutase (SOD) and the lipid peroxidation level in the contused tissue at an early phase of injury. Furthermore, we treated the rats with two different N-methyl-D-aspartate receptor antagonists, namely MK-801 and CPP, and evaluated their effect on lipid peroxidation in the contused tissue. Rats were divided into four groups: sham, control, treatment 1 and treatment 2 groups (n = 16 for each group). Thirty and 60 min after craniectomy or injury, tissue samples were removed. SOD activity didn't change in this period. However, lipid peroxidation in terms of malondialdehyde (MDA) amount showed a significant increase at 60 min. Fifteen minutes after injury, MK-801 (1 mg/kg), CPP (10 mg/kg) or saline (1 ml) were applied intraperitoneally in treatment 1, treatment 2 and the control groups, Treatment with MK-801 attenuated MDA levels, whereas treatment with CPP did not. The protective effect of MK-801 achieved statistical significance. These results demonstrate that SOD activity does not change in the Parry period of cold injury. Moreover, these results show that lipid peroxidation increases after 60 min of cold injury, and treatment with MK-801 15 min after injury can prevent this elevation.	Trakya Univ, Sch Med, Dept Neurosurg, TR-22030 Edirne, Turkey; Istanbul Univ, Sch Med, Dept Biochem, TR-34390 Istanbul, Turkey; Trakya Univ, Sch Med, Dept Publ Hlth, TR-22030 Edirne, Turkey; Istanbul Univ, Sch Med, Dept Neurosurg, TR-34390 Istanbul, Turkey		Kiris, T (corresponding author), Atakoy 5 Kisim D8 Blok Daire 8, TR-34750 Istanbul, Turkey.	talatk@hotmail.com	Kiris, Talat/AAP-4665-2020	Kiris, Talat/0000-0002-2985-3758			ANDO Y, 1989, BRAIN RES, V477, P286, DOI 10.1016/0006-8993(89)91416-9; AVERET N, 1990, NEUROCHEM RES, V15, P791, DOI 10.1007/BF00968556; BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; BARUT S, 1993, NEUROSURG REV, V16, P53, DOI 10.1007/BF00308614; BULLOCK R, 1990, J CEREBR BLOOD F MET, V10, P668, DOI 10.1038/jcbfm.1990.120; CHAN PH, 1983, BRAIN RES, V277, P329, DOI 10.1016/0006-8993(83)90941-1; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; FADEN AI, 1987, CLIN NEUROPHARMACOL, V10, P193, DOI 10.1097/00002826-198706000-00001; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; Faden AI, 1988, J NEUROTRAUM, V5, P33, DOI 10.1089/neu.1988.5.33; FAROOQUI AA, 1994, INT REV NEUROBIOL, V36, P267, DOI 10.1016/S0074-7742(08)60306-2; FAROOQUI AA, 1991, BRAIN RES REV, V16, P171, DOI 10.1016/0165-0173(91)90004-R; FUKUHARA T, 1994, NEUROSURGERY, V35, P924, DOI 10.1227/00006123-199411000-00018; HALL ED, 1986, J NEUROSURG, V64, P951, DOI 10.3171/jns.1986.64.6.0951; IKEDA Y, 1990, NEUROSURGERY, V27, P1; IKEDA Y, 1989, NEUROSURGERY, V24, P679, DOI 10.1227/00006123-198905000-00004; IZGI N, 1990, TURKISH NEUROSURGERY, V1, P119; JANSSEN L, 1989, SPINE, V14, P23, DOI 10.1097/00007632-198901000-00005; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KUCHIWAKI H, 1994, ACTA NEUROCHIR, P62; LIN SZ, 1994, ACTA NEUROCHIR, P528; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MYLROIE AA, 1986, TOXICOL APPL PHARM, V82, P512, DOI 10.1016/0041-008X(86)90286-3; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OURY TD, 1993, J BIOL CHEM, V268, P15394; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PELLEGRINIGIAMPIETRO DE, 1990, J NEUROSCI, V10, P1035, DOI 10.1523/jneurosci.10-03-01035.1990; Qian H, 1997, NEUROCHEM RES, V22, P1231, DOI 10.1023/A:1021980929422; SHAPIRA Y, 1989, Neurological Research, V11, P169; SIESJO BK, 1991, FUND CLIN PHARMACOL, V5, P755, DOI 10.1111/j.1472-8206.1991.tb00765.x; TANAKA H, 1994, ACTA NEUROCHIR, P524; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; YU ACH, 1986, J NEUROCHEM, V47, P1181	35	7	8	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0300-9130			RES EXP MED	Res. Exp. Med.	APR	1999	198	6					341	347		10.1007/s004330050116			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	196UG	WOS:000080325500005	10369089				2022-02-06	
J	Wozniak, RJ; Coelho, CA; Duffy, RJ; Liles, BZ				Wozniak, RJ; Coelho, CA; Duffy, RJ; Liles, BZ			Intonation unit analysis of conversational discourse in closed head injury	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; LANGUAGE; DEFICITS; SKILLS; ADULTS	This study employed a modification of the intonation unit analysis for conversational discourse developed by Mentis and Prutting. The percentage of total intonation units produced within separate ideational categories was calculated for groups of closed head-injured and normal control subjects as well as the examiner. No significant differences were found between subject groups or the examiner's performance within the two groups. However, significant differences were noted between the examiner's production of intonation units and the performances of both subject groups. Findings suggest the manner in which samples of conversation were elicited may have constrained the context, thereby masking potential differences between groups.	Univ Connecticut, Dept Commun Sci, Storrs, CT 06269 USA		Coelho, CA (corresponding author), Univ Connecticut, Dept Commun Sci, U-85, Storrs, CT 06269 USA.						ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; BOLES L, 1993, ANN CONV AM SPEECH L; BRINTON B, 1984, J SPEECH HEAR RES, V27, P350, DOI 10.1044/jshr.2703.350; Chafe Wallace, 1994, DISCOURSE CONSCIOUSN; Chafe Wallace, 1987, TYPOLOGICAL STUDIES, V11, P21; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Cruttenden A., 1986, INTONATION; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; GAJAR A, 1984, J APPL BEHAV ANAL, V17, P353, DOI 10.1901/jaba.1984.17-353; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giles G M, 1988, Brain Inj, V2, P75, DOI 10.3109/02699058809150933; HAGEN C, 1980, REHABILITATION HEAD, P8; Halliday M. A. K., 1985, INTRO FUNCTIONAL GRA; Hartley L. L, 1995, COGNITIVE COMMUNICAT; HOLLINGSHEAD A, 1972, UNPUB 4 FACTOR INDEX; Kertesz A., 1982, W APHASIA BATTERY; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MATTIS S, 1976, GERIATRIC PSYCHIAT, P148; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; MILTON SB, 1988, J HEAD TRAUMA REHAB, V3, P1; Pang D, 1985, HEAD INJURY REHABILI, P3; Prigatano G. P., 1985, LANG SCI, V7, P217, DOI [10.1016/S0388-0001(85)80020-6, DOI 10.1016/S0388-0001(85)80020-6]; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; UZZELL BP, 1988, ARCH NEUROL-CHICAGO, V45, P420, DOI 10.1001/archneur.1988.00520280066017	29	7	7	2	4	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	1999	13	3					191	203		10.1080/026990599121700			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	175LL	WOS:000079095900003	10081600				2022-02-06	
J	Al Moutaery, K; Morais, C; Biary, N; Al Deeb, S; Tariq, M				Al Moutaery, K; Morais, C; Biary, N; Al Deeb, S; Tariq, M			Effect of acrylamide on neurological recovery following spinal cord injury in rats	ACTA NEUROCHIRURGICA			English	Article						spinal cord injury; acrylamide; oxidative stress	PERIPHERAL-NERVE; TISSUE-DAMAGE; BLOOD-FLOW; BRAIN; TRAUMA; NEUROTOXICITY; COMPRESSION; MECHANISMS; DEGENERATION; METABOLISM	Acrylamide (ACR) is a cumulative neurotoxin which causes axonal degeneration in animals and man. Industrial workers exposed to ACR have been reported to suffer from a variety of central and peripheral neuropathological symptoms including numbness of hands and feet, skin peeling and muscular weakness of legs. These reports suggest that the body burden of ACR may be a risk factor in recovery patterns following neurotrauma. The present study was designed to assess the effect of ACR on neurological recovery following spinal cord injury (SCI) in rats. Male Sprague-Dawley rats weighing 200-230 g were anaesthetised with chloral hydrate and laminectomy was performed at T 7-8 level leaving the dura intact. A compression plate (2.2 x 5.0 mm) loaded with a weight of 35 g was placed on the exposed cord for 5 minutes. Animals were divided into seven groups of eight rats each. The animals in Group 1 served as control whereas rats in Group 2 underwent laminectomy alone (sham). The rats in Group 3 to 6 were subjected to SCI as mentioned above. Animals in Groups 4, 5 and 6 also received ACR in the doses of 10 mg/kg, 20 mg/kg and 40 mg/kg, i.p., respectively in addition to SCI, whereas the rats in Group 7 received ACR alone at a dose of 40 mg/kg body weight. The first dose of ACR was given 30 minutes before SCI, followed by daily administration of drug for 7 days. Post traumatic neurological recovery was recorded daily for 10 days using a modified Tarlov score, inclined plane test and sensory and vocal score. Electrophysiological changes were assessed using somatosensory and corticomotor evoked potentials. The animals were sacrificed at different time intervals and the injured site of the spinal cord was analysed for lipid hydroperoxides (LPH), conjugated dienes (CD) and glutathione (GSH). Neuropathological changes in the spinal cord were assessed using light microscopy. The rats exposed to compression injury alone showed a maximum neurological deficit at 24 hr and then a gradual recovery was observed over a period of 10 days. The rats treated with ACR along with SCI showed poor or no recovery over a period of 10 days. Our electrophysiological and histopathological studies also confirmed that concomitant exposure to ACR produces a significant deleterious effect on the recovery from SCI. SCI induced increase in oxidative stress (increase in LPH and CD and decrease in GSH) is also exacerbated by ACR suggesting a role of free radicals. The results of this study suggest that increased body burden of ACR may retard the recovery from neurotrauma or even lead to permanent disability.	Armed Forces Hosp, FRSC Res Ctr, Riyadh 11159, Saudi Arabia; Armed Forces Hosp, Dept Neurosurg, Riyadh, Saudi Arabia		Tariq, M (corresponding author), Armed Forces Hosp, FRSC Res Ctr, POB 7897,W-912, Riyadh 11159, Saudi Arabia.		Morais, Christudas/G-4412-2010				ABOUDONIA MB, 1993, J TOXICOL ENV HEALTH, V39, P447, DOI 10.1080/15287399309531764; ANDERSON DK, 1980, J NEUROSURG, V53, P375, DOI 10.3171/jns.1980.53.3.0375; AULD RB, 1967, CAN MED ASSOC J, V96, P652; BALENTINE JD, 1978, LAB INVEST, V39, P236; BALENTINE JD, 1985, NEUROLOGICAL SURG TR, P285; BANIK NL, 1982, NEUROCHEM RES, V7, P1465, DOI 10.1007/BF00965089; BASKIN DS, 1987, NEUROSURGERY, V20, P871, DOI 10.1227/00006123-198706000-00009; BEISWANGER CM, 1993, TOXICOL APPL PHARM, V118, P233, DOI 10.1006/taap.1993.1029; BLACK P, 1986, NEUROSURGERY, V19, P752, DOI 10.1227/00006123-198611000-00006; BLUMENTHAL GM, 1995, FUND APPL TOXICOL, V27, P149, DOI 10.1006/faat.1995.1118; BRAUGHLER JM, 1983, J NEUROSURG, V59, P256, DOI 10.3171/jns.1983.59.2.0256; Buege J A, 1978, Methods Enzymol, V52, P302; CLENDENON NR, 1978, NEUROLOGY, V28, P78, DOI 10.1212/WNL.28.1.78; CLENDENON NR, 1978, J NEUROSURG, V49, P563, DOI 10.3171/jns.1978.49.4.0563; Crofton KM, 1996, TOXICOL APPL PHARM, V139, P163, DOI 10.1006/taap.1996.0155; DAVIS LN, 1976, INVESTIGATION SELECT, P1; DEARFIELD KL, 1988, MUTAT RES, V195, P145; DEGRANDCHAMP RL, 1990, NEUROPATH APPL NEURO, V16, P239, DOI 10.1111/j.1365-2990.1990.tb01160.x; DELAMARTER RB, 1995, J BONE JOINT SURG AM, V77A, P1042, DOI 10.2106/00004623-199507000-00010; DEMEDIUK P, 1985, P NATL ACAD SCI USA, V82, P7071, DOI 10.1073/pnas.82.20.7071; DIXIT R, 1980, CHEM-BIOL INTERACT, V32, P353, DOI 10.1016/0009-2797(80)90103-9; EDWARDS PM, 1975, BIOCHEM PHARMACOL, V24, P1277, DOI 10.1016/0006-2952(75)90336-6; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; FULLERTON PM, 1966, BRIT J IND MED, V23, P210, DOI 10.1136/oem.23.3.210; FULLERTON PM, 1969, J NEUROL NEUROSUR PS, V32, P186, DOI 10.1136/jnnp.32.3.186; GARLAND TO, 1967, BMJ-BRIT MED J, V4, P134, DOI 10.1136/bmj.4.5572.134; HANDELMAN GJ, 1988, LIPIDS, V23, P598, DOI 10.1007/BF02535604; HOLTZ A, 1989, SURG NEUROL, V31, P350, DOI 10.1016/0090-3019(89)90066-9; HOLTZ A, 1990, NEUROSURGERY, V26, P952, DOI 10.1227/00006123-199006000-00005; HOWLAND RD, 1981, TOXICOL APPL PHARM, V60, P324, DOI 10.1016/0041-008X(91)90235-7; IIZUKA H, 1987, J NEUROSURG, V66, P595, DOI 10.3171/jns.1987.66.4.0595; ILDAN F, 1995, NEUROSURG REV, V18, P35, DOI 10.1007/BF00416476; ISAAC L, 1995, SURG NEUROL, V43, P484, DOI 10.1016/0090-3019(95)80094-W; JACOBSEN J, 1983, EARLY DOSE DEPENDENT, V40, P447; KIRSCH JR, 1979, STROKE, V10, P288, DOI 10.1161/01.STR.10.3.288; KUPERMAN AS, 1958, J PHARMACOL EXP THER, V123, P180; LEHNING EJ, 1994, J TOXICOL ENV HEALTH, V42, P331, DOI 10.1080/15287399409531883; LOPACHIN RM, 1994, NEUROTOXICOLOGY, V15, P247; MANGINO MJ, 1991, AM J PHYSIOL, V261, pF841, DOI 10.1152/ajprenal.1991.261.5.F841; MATERSON CH, 1995, TOXICOL APPL PHARM, V133, P73; MATERSON CH, 1995, TOXICOL APPL PHARM, V131, P119; MATSUOKA M, 1993, ENVIRON RES, V61, P37, DOI 10.1006/enrs.1993.1047; MILLER MS, 1984, J NEUROCHEM, V43, P1401, DOI 10.1111/j.1471-4159.1984.tb05400.x; NYSTROM B, 1988, ACTA NEUROL SCAND, V78, P460, DOI 10.1111/j.1600-0404.1988.tb03688.x; REAGAN KE, 1994, NEUROCHEM INT, V25, P133, DOI 10.1016/0197-0186(94)90032-9; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; SABRI MI, 1989, BRAIN RES, V483, P1, DOI 10.1016/0006-8993(89)90028-0; SAGER PR, 1988, TOXICOLOGY, V49, P479, DOI 10.1016/0300-483X(88)90034-0; SCHECHTER L, 1994, J AM COLL TOXICOL, V13, P261, DOI 10.3109/10915819409140598; SRIVASTAVA P, 1984, TOXICOL LETT, V22, P211; TANDRUP T, 1992, NEUROPATH APPL NEURO, V18, P250, DOI 10.1111/j.1365-2990.1992.tb00787.x; Tariq M, 1998, J NEUROTRAUM, V15, P239, DOI 10.1089/neu.1998.15.239; TARIQ M, 1997, P 11 INT C NEUR SURG; TARLOV IM, 1954, ANN ARCH NEUROL PSYC, V71, P275; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; TATOR CH, 1979, CAN J SURG, V22, P575; TILSON HA, 1979, TOXICOL APPL PHARM, V47, P253, DOI 10.1016/0041-008X(79)90319-3; *US EPA, 1981, LEV 1 EC EV ACR; VINK R, 1989, ANN NEUROL, V25, P26, DOI 10.1002/ana.410250105; WALLACE MC, 1986, NEUROSURGERY, V18, P433	60	7	7	1	5	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1999	141	9					989	999		10.1007/s007010050406			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	241FB	WOS:000082871100027	10526081				2022-02-06	
J	Cameron, KL; Yunker, CA; Austin, MC				Cameron, KL; Yunker, CA; Austin, MC			A standardized protocol for the initial evaluation and documentation of mild brain injury	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; sideline; neurologic	GUIDELINES; CONCUSSION; RETURN; SPORTS	Objective: To present a protocol for the initial assessment and documentation of mild brain injury, a protocol that is used within the Department of Physical Education at the United States Military Academy. Background: Recently, much attention has been given to the assessment and management of mild brain injury by the sports medicine community. Although the classification of and management strategies for mild brain injury have been well disputed, most experts agree on the essentials of the sideline or initial evaluation. According to leading experts, if an athlete has experienced an episode of mild brain injury, the initial signs and symptoms, as well as the course of those signs and symptoms, should be documented. Description: Although many athletic training texts formerly discussed techniques for evaluating an episode of mild brain injury, few present an objective protocol to follow. Our protocol includes 3 components. The first component is the initial evaluation, which incorporates serial observations during the first 20 minutes after injury, with neurologic checks every 5 minutes. The second component includes a take-home sheet for athletes not referred to a physician for further evaluation. The third part of the protocol is a 24-hour postinjury follow-up examination for any signs or symptoms of postconcussion syndrome. Finally, we present the indications for referral to a physician for further evaluation. Clinical Advantages/Recommendations : Using a standard protocol to guide evaluation and to document the initial course of signs and symptoms after mild brain injury allows the sports medicine staff to make better management decisions. In addition, patient instructions and the course of follow-up evaluations can be improved if a standard protocol is employed. Our protocol has been developed to meet the needs both of athletes who are exposed to mild brain injury on a daily basis and of the certified athletic trainers who initially evaluate them; the protocol can be adapted to the individual needs of each athletic training setting.	US Mil Acad, Dept Phys Educ, W Point, NY 10996 USA; Univ Nebraska, Omaha, NE 68182 USA		Cameron, KL (corresponding author), US Mil Acad, Dept Phys Educ, W Point, NY 10996 USA.			Cameron, Kenneth/0000-0002-6276-4482			*AM AC ORTH SURG, 1991, ATHL TRAIN SPORTS ME, P496; ARNHEIM DD, 1997, MODERN PRINCIPLES AT, P713; BOOHER JM, 1994, ATHLETIC INJURY ASSE, P270; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; GUSKIEWICZ KM, 1998, SPORTS REL CONC NERV; HOTZ GA, 1998, SPORTS REL CONC NERV; HOUGH D, 1994, P MILD BRAIN INJ SPO, P31; JORDAN B, 1994, P MILD BRAIN INJ SPO, P43; Kelly JP, 1997, NEUROLOGY, V48, P581; LANDRY G, 1994, P MILD BRAIN INJ SPO, P47; LEVIN H, 1994, P MILD BRAIN INJ SPO, P53; MALEC JF, 1994, P MILD BRAIN INJ SPO, P62; MCCREA MA, 1998, SPORTS REL CONC NERV; *NAT ATHL TRAIN AS, 1994, P MILD BRAIN INJ SPO, P2; PERRIN DH, 1994, P MILD BRAIN INJ SPO, P81; Putukian M, 1996, PHYSICIAN SPORTSMED, V24, P25, DOI 10.3810/psm.1996.11.1283; RICE SG, 1995, SPORTS MED PRIMARY C, V12, pS9; Roos R, 1996, PHYSICIAN SPORTSMED, V24, P67, DOI 10.3810/psm.1996.10.1327; ROY S, 1983, SPORTS MED PREVENTIO, P141; SAAL JA, 1987, PHYS MED REHABIL, V1, P649; SEWARD JM, 1997, ATHL THER TODAY, V6, P11; SZYMANSKI HV, 1992, INT J PSYCHIAT MED, V22, P357, DOI 10.2190/XARA-B1EF-J2HC-VAE0; TORG JR, 1991, ATHLETIC INJURIES HE, P229; WARD AB, 1992, ARCH EMERG MED, P314; WARREN D, 1989, Pediatric Emergency Care, V5, P83, DOI 10.1097/00006565-198906000-00003	26	7	7	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	JAN-MAR	1999	34	1					34	42					9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	178QV	WOS:000079278200010	16558546				2022-02-06	
J	Gualtieri, CT; Johnson, LG				Gualtieri, CT; Johnson, LG			Traumatic brain injury: Special issues in psychiatric assessment	NEUROREHABILITATION			English	Article						neuropsychiatric assessment; brain injury; depression; electrical injury	POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD-INJURY; GENERAL-ANESTHESIA; LIGHTNING INJURIES; AWARENESS; RECOVERY; SEQUELAE; HISTORY; MEMORY; MANIA	This article addresses selected problems encountered in assessing individuals who have sustained traumatic brain injuries(tbi). Neuropsychiatric assessment, neuropsychological assessment, and psychiatric responses to tbi are discussed. Two less commonly encountered diagnoses (post-traumatic stress disorder and electrical injury) are also addressed.	N Carolina Neuropsychiat, Chapel Hill, NC 27514 USA		Gualtieri, CT (corresponding author), N Carolina Neuropsychiat, 1829 E Franklin St,Bldg 400,Franklin Sq, Chapel Hill, NC 27514 USA.						Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; Bailey AR, 1997, ANAESTHESIA, V52, P460, DOI 10.1111/j.1365-2044.1997.133-az0134.x; BAKER EL, 1985, J OCCUP ENVIRON MED, V27, P206; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck AT, 1990, BECK ANXIETY INVENTO; BENPORATH YS, 1995, SAGE PUBLI ATIONS, P1; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Bonebakker AE, 1996, MEM COGNITION, V24, P766, DOI 10.3758/BF03201101; Carleton S C, 1995, Cardiol Clin, V13, P263; Cheng P T, 1994, Changgeng Yi Xue Za Zhi, V17, P220; CHERINGTON M, 1995, WESTERN J MED, V162, P413; CHERINGTON M, 1993, NEURO, V43; CUMMINGS JL, 1984, AM J PSYCHIAT, V141, P1084; DANIEL M, 1985, INT J CLIN NEUROPSYC, V7, P102; DEROGATIXS LR, 1996, SYMPTOM CHECKLIST 90; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FEENEY DM, 1988, PHARM APPROACHES TRE, P121; FLORHENRY P, 1980, ADV BIOL PSYCHIAT, V4, P21; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gass CS, 1997, ARCH CLIN NEUROPSYCH, V12, P199, DOI 10.1016/S0887-6177(96)00032-7; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GRANT I, 1987, NEUROBEHAVIORAL RECO, P232; GRUBE BJ, 1992, ELECT TRAUMA PATHOPH, P133; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; Gualtieri C. T., 1990, NEUROPSYCHIATRY BEHA; GUALTIERI CT, 1995, NEUROPSY NEUROPSY BE, V8, P127; GUALTIERI CT, 1999, DRUG TREATMENT NEURO; Halstead WC, 1947, BRAIN INTELLIGENCE Q; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; HOOSHMAND H, 1989, CLIN ELECTROENCEPHAL, V20, P111, DOI 10.1177/155005948902000208; Hopewell C. A., 1983, CLIN NEUROPSYCHOLOGY, V5, P61; Jumbelic MI, 1995, SEMIN NEUROL, V15, P342, DOI 10.1055/s-2008-1041042; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; KleinschmidtDeMasters BK, 1995, SEMIN NEUROL, V15, P323, DOI 10.1055/s-2008-1041039; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Levin H., 1987, HEAD INJURY, P442; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; MILLER L, 1993, PSYCHOTHERAPY BRAIN; Nordstrom O, 1997, ACTA ANAESTH SCAND, V41, P978, DOI 10.1111/j.1399-6576.1997.tb04823.x; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; PANSE F, 1970, HDB CLIN NEUROLOGY, V7, P344; Ranta SOV, 1998, ANESTH ANALG, V86, P1084, DOI 10.1097/00000539-199805000-00035; REGIER DA, 1988, ARCH GEN PSYCHIAT, V45, P977; Rey A., 1964, EXAMEN CLIN PSYCHOL; ROBINSON RG, 1983, STROKE, V14, P736, DOI 10.1161/01.STR.14.5.736; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; ROSS ED, 1981, ARCH NEUROL-CHICAGO, V38, P561, DOI 10.1001/archneur.1981.00510090055006; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SCHWAMM L, 1998, ANN INTERN MED, V107, P491; Schwender D, 1998, BRIT J ANAESTH, V80, P133, DOI 10.1093/bja/80.2.133; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Smith T L, 1998, CRNA, V9, P44; SOLEM L, 1977, J TRAUMA, V17, P487, DOI 10.1097/00005373-197707000-00001; STARKSTEIN SE, 1988, ARCH GEN PSYCHIAT, V45, P247; STARKSTEIN SE, 1988, J NERV MENT DIS, V176, P87, DOI 10.1097/00005053-198802000-00004; Strub R, 1985, MENTAL STATUS EXAMIN; tenDuis HJ, 1995, SEMIN NEUROL, V15, P381; Tosch P, 1988, J Neurosci Nurs, V20, P223; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; vanderKolk BA, 1997, J CLIN PSYCHIAT, V58, P16; VARGHESE G, 1986, PARAPLEGIA, V24, P159, DOI 10.1038/sc.1986.21; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; VAUHKONEN K, 1959, ACTA PSYCHIAT NEUR S, V137, P90; Von Monakow C, 1969, BRAIN BEHAVIOR, P27; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; WILKINSON C, 1978, AM J SURG, V136, P693, DOI 10.1016/0002-9610(78)90337-9	77	7	7	0	1	IOS PRESS	AMSTERDAM	VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		1999	13	2					103	115					13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	253HF	WOS:000083550400005					2022-02-06	
S	Kerr, ME; Kraus, M; Marion, D; Kamboh, I		Eke, A; Delpy, DT		Kerr, ME; Kraus, M; Marion, D; Kamboh, I			Evaluation of apolipoprotein E genotypes on cerebral blood flow and metabolism following traumatic brain injury	OXYGEN TRANSPORT TO TISSUE XXI	ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY		English	Article; Proceedings Paper	26th Annual Meeting of the International-Society-on-Oxygen-Transport-to-Tissue (ISOTT 98)	AUG 23-28, 1998	BUDAPEST, HUNGARY	Int Soc Oxygen Transport Tissue, Alliance Pharmaceut, Hemox Therapeut, Radiometer Copenhagen, Berlex Biosic			ALZHEIMERS-DISEASE; HEAD-INJURY; BETA; APOE		Univ Pittsburgh, Pittsburgh, PA 15261 USA		Kerr, ME (corresponding author), Univ Pittsburgh, 360 Victoria Bldg,3500 Victoria St, Pittsburgh, PA 15261 USA.						BENVENISTE EN, 1994, J IMMUNOL, V153, P5210; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; GOETTING MG, 1990, CRIT CARE MED, V18, P1220, DOI 10.1097/00003246-199011000-00006; Graham DI, 1996, ACT NEUR S, V66, P96; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; KAMBOH MI, 1995, ATHEROSCLEROSIS, V112, P145, DOI 10.1016/0021-9150(94)05409-C; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; Nicoll J. A. R., 1996, V777, P271; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1975, STROKE, V6, P245, DOI 10.1161/01.STR.6.3.245; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; YANKNER BA, 1991, NEW ENGL J MED, V325, P1849; ZURNARELLI E, 1996, NEUROREPORT, V8, P45	17	7	7	0	0	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0065-2598		0-306-46281-8	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		1999	471						117	124					8	Cell Biology; Hematology; Medicine, Research & Experimental; Physiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Hematology; Research & Experimental Medicine; Physiology	BP58J	WOS:000085570200014	10659138				2022-02-06	
J	Nassehi, A				Nassehi, A			The paradox of visibility. Towards an epistemological concussion of sociology	SOZIALE WELT-ZEITSCHRIFT FUR SOZIALWISSENSCHAFTLICHE FORSCHUNG UND PRAXIS			German	Article								Today, the specific yield of cultural studies and social sciences is not to make us feel secure, to describe the order of the world, or to offer guidance on how to live our Byes. On the contrary, social sciences break up common securities and unmask order as a result instead of a prerequisite of culture and society. The article tries to illustrate this situation of epistemological insecurity with three epistemological siblings: postcolonial migrants, human clones, and transsexuals. Each of these represents the problem of representation in its own way and can thus serve as a touchstone of the social sciences. The article concludes by drawing some consequences for sociology, which has to learn that it does not only describe its objects but also helps to form them.	LMU Munchen, Inst Soziol, D-80801 Munich, Germany		Nassehi, A (corresponding author), LMU Munchen, Inst Soziol, Konradstr 6, D-80801 Munich, Germany.						Adorno T. W, 1979, SOZIOLOGISCHE SCHRIF; Bauman Z., 1995, MODERNE AMBIVALENZ; BHABA H, 1994, LOCATION CULTURE; Derrida Jacques, 1988, RANDGANGE PHILOS, P29; Foucault M, 1976, GEBURT KLIN ARCHAOLO; Foucault Michel, 1974, ORDNUNG DISKURSES; Garfinkel Harold., 1967, STUDIES ETHNOMETHODO; GOFFMAN E, 1996, ARRANGEMENT GESCHLEC; Habermas J., 1998, POSTNATIONALE KONSTE, P248; Habermas Jurgen, 1985, PHILOSOPHISCHEN DISK, P104; Haraway Donna J., 1995, NEUERFINDUNG NATUR P; HIRSCHAUER S, 1989, Z SOZIOL, V18, P100; Hirschauer S, 1993, SOZIALE KONSTRUKTION; Kessler SJ, 1978, GENDER ETHNOMETHODOL; Lindemann G., 1994, DENKACHSEN THEORETIS, P115; Lindemann Gesa, 1993, PARADOXE GESCHLECHT; Luhmann N., 1997, GESELLSCHAFT GESELLS; Nassehi A, 1998, SOZ WELT, V49, P151; NASSEHI A., 1992, KRITIK THEORIE SOZIA, P43; NASSEHI A, 2000, UNPUB KLASSISCHE GES; NASSEHI A, 1999, BEITRAGE SOZIOLOGIE; Nietzsche F, 1980, SAMTLICHE WERKE KRIT, V1, P873; SAID E, 1997, BEITRAGE ANGLOAMERIK, P81; West C, 1991, SOCIAL CONSTRUCTION, P13	24	7	7	0	4	VERLAG OTTO SCHWARTZ & CO	GOTTINGEN	ANNASTRABE 7, D-37075 GOTTINGEN, GERMANY	0038-6073			SOZ WELT	Sozial Welt-Zeit. Sozialwiss. Forsch. Praxis		1999	50	4					349	+					14	Sociology	Social Science Citation Index (SSCI)	Sociology	297NT	WOS:000086089500002					2022-02-06	
J	Parente, R; Kolakowsky-Hayner, S; Krug, K; Wilk, C				Parente, R; Kolakowsky-Hayner, S; Krug, K; Wilk, C			Retraining working memory after traumatic brain injury	NEUROREHABILITATION			English	Article						working memory; traumatic brain injury; cognitive rehabilitation	SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; COMPREHENSION; DEMENTIA; SYSTEM	The function of working memory has not been investigated in a brain injured population. There are no generally accepted measures of working memory. The degree to which these measures correlate with Ether measures of learning and performance is unclear. The results of several analyses indicated that working memory is a state of active processing that is more than memory span. The two measures of working memory used in this study predicted conventional measures of verbal and visual learning, and retention. They also predicted several different measures of academic skill. The results of a pilot study showed that various therapy activities could improve functioning in working memory.	Towson State Univ, Towson, MD 21252 USA; Med Coll Virginia, Richmond, VA 23298 USA		Parente, R (corresponding author), 1212 Brokview Rd, Towson, MD 21286 USA.		Krug, Kathrin Barbara/ABA-5087-2020; Kolakowsky-Hayner, Stephanie A./I-9858-2019; Parente, Frederick/W-2570-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Parente, Frederick/0000-0002-2784-3433			Atkinson RC, 1968, PSYCHOL LEARNING MOT, V2; BADDELEY A, 1985, J MEM LANG, V24, P119, DOI 10.1016/0749-596X(85)90019-1; Baddeley A.D., 1986, WORKING MEMORY; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; COCHRAN KF, 1987, J RES PERS, V21, P197, DOI 10.1016/0092-6566(87)90007-9; COWAN N, 1988, PSYCHOL BULL, V104, P163, DOI 10.1037/0033-2909.104.2.163; Cowan N, 1996, TOP LANG DISORD, V17, P1, DOI 10.1097/00011363-199611000-00003; CROWDER RG, 1993, MEM COGNITION, V21, P142, DOI 10.3758/BF03202725; DANEMAN M, 1986, J MEM LANG, V25, P1, DOI 10.1016/0749-596X(86)90018-5; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; ENGLE RW, 1992, J EXP PSYCHOL LEARN, V18, P972, DOI 10.1037/0278-7393.18.5.972; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; MARTIN RC, 1987, BRAIN LANG, V32, P159, DOI 10.1016/0093-934X(87)90122-2; MASSON MEJ, 1983, J EDUC PSYCHOL, V75, P314, DOI 10.1037/0022-0663.75.2.314; Montgomery J., 1995, J SPEECH HEAR RES, V38, P177; MORRIS RG, 1986, COGNITIVE NEUROPSYCH, V3, P77, DOI 10.1080/02643298608252670; MORRIS RG, 1984, COGNITIVE NEUROPSYCH, V1, P143, DOI 10.1080/02643298408252019; PARENTE R., 1996, RETRAINING COGNITION; PARENTE R, 1998, COGNITIVE TECHNOLOGY, V3, P33; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; SALAME P, 1982, J VERB LEARN VERB BE, V21, P150, DOI 10.1016/S0022-5371(82)90521-7	21	7	7	0	7	IOS PRESS	AMSTERDAM	VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		1999	13	3					157	163					7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	289YL	WOS:000085649500005					2022-02-06	
S	Robertson, IH		Gopher, D; Koriat, A		Robertson, IH			Theory-driven neuropsychological rehabilitation: The role of attention and competition in recovery of function after brain damage	ATTENTION AND PERFORMANCE XVII: COGNITIVE REGULATION OF PERFORMANCE: INTERACTION OF THEORY AND APPLICATION	Attention and Performance		English	Article; Proceedings Paper	17th International Symposium on Attention and Performance	JUL 07-12, 1996	BEIT OREN, ISRAEL				MASSIVE CORTICAL REORGANIZATION; UNILATERAL LEFT NEGLECT; ADULT SQUIRREL-MONKEYS; PRIMARY MOTOR CORTEX; VISUAL NEGLECT; SUSTAINED ATTENTION; MOVEMENT REPRESENTATIONS; VESTIBULAR STIMULATION; SOMATOSENSORY CORTEX; SELECTIVE ATTENTION	Recovery of function following brain damage is still inadequately understood. Compensatory processes are important, but recent research suggests that plastic reorganization of damaged circuits may also occur under certain circumstances. The degree and nature of such reorganization depends in part on behavioral and cognitive factors, it is argued; these factors can influence underlying neural recovery through network pattern completion based on Hebbian learning. Such a view implies the need for adequate theories of neuropsychological function to determine the optimum inputs that will both maximize completion and minimize competitive inhibition and faulty completion. Unpatterned input that does not conform to the underlying neuropsychological structure may lead to activation of neural systems that inhibit function in the damaged network. It is argued that frontal lobe-based attentional circuits play a crucial role in recovery through providing patterned input to lesioned networks. The heuristic value of this approach to understanding recovery of function is tested against a number of experiments on unilateral neglect and functional recovery following stroke and traumatic brain injury.	MRC, Appl Psychol Unit, London W1N 4AL, England		Robertson, IH (corresponding author), MRC, Appl Psychol Unit, London W1N 4AL, England.	ian.robertson@mrc-apu.cam.ac.uk					ARMSTRONGJAMES M, 1983, J PHYSIOL-LONDON, V335, P427, DOI 10.1113/jphysiol.1983.sp014542; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BLANCGARIN J, 1994, NEUROPSYCHOL REHABIL, V4, P359, DOI 10.1080/09602019408401606; BOTTINI G, 1994, EXP BRAIN RES, V99, P164; BOTTINI G, 1995, NATURE, V376, P778, DOI 10.1038/376778a0; BOYESON MG, 1992, PHARMACOL BIOCHEM BE, V43, P771, DOI 10.1016/0091-3057(92)90407-7; BOYESON MG, 1989, J NEUROL REHABIL, V3, P35; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; CAPPA S, 1987, NEUROPSYCHOLOGIA, V25, P775, DOI 10.1016/0028-3932(87)90115-1; COHEN LG, 1991, BRAIN, V114, P615, DOI 10.1093/brain/114.1.615; COTMAN CW, 1982, ANNU REV PSYCHOL, V33, P371, DOI 10.1146/annurev.ps.33.020182.002103; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DREVETS WC, 1995, NATURE, V373, P249, DOI 10.1038/373249a0; FEENEY DM, 1993, J NEURAL TRANSP PLAS, V4, P199, DOI 10.1155/NP.1993.199; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FEENEY DM, 1985, PHYSIOL PSYCHOL, V13, P197; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; GOODALE MA, 1990, CAN J PSYCHOL, V44, P180, DOI 10.1037/h0084245; GOODALE MA, 1973, EXP BRAIN RES, V17, P75; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; GRONWALL D, 1974, LANCET, V2, P1452; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HIER DB, 1983, NEUROLOGY, V33, P345, DOI 10.1212/WNL.33.3.345; IMAMURA K, 1988, NEUROSCI LETT, V88, P57, DOI 10.1016/0304-3940(88)90315-1; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; KASAMATSU T, 1976, SCIENCE, V194, P206, DOI 10.1126/science.959850; KOLB B, 1992, J NEUROSCI, V12, P2321; LADAVAS E, 1994, NEUROPSYCHOLOGIA, V32, P1195, DOI 10.1016/0028-3932(94)90102-3; Luria A.R., 1975, HDB CLIN NEUROLOGY, P368; Luria AR, 1963, RESTORATION FUNCTION; LYNCH JC, 1989, J NEUROPHYSIOL, V61, P74, DOI 10.1152/jn.1989.61.1.74; Manly T, 1997, NEUROCASE, V3, P19, DOI 10.1080/13554799708404031; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MEICHENBAUM DH, 1971, J ABNORM PSYCHOL, V77, P115, DOI 10.1037/h0030773; MEYER PM, 1963, J COMP PHYSIOL PSYCH, V56, P397, DOI 10.1037/h0047822; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MURRE JM, UNPUB SELF REPAIRING; Najenson T, 1980, Int Rehabil Med, V2, P17; NOVACK TA, 1987, ARCH PHYS MED REHAB, V68, P729; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; OKE A, 1978, SCIENCE, V200, P1411, DOI 10.1126/science.663623; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1993, ATTENTION SELECTION, P390; PURVES D, 1987, TRENDS NEUROSCI, V10, P398, DOI 10.1016/0166-2236(87)90005-1; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; RAMACHANDRAN VS, 1992, NEUROREPORT, V3, P583, DOI 10.1097/00001756-199207000-00009; Reason J., 1993, ATTENTION SELECTION, P406; RIZZOLATTI G, 1990, REV NEUROL, V146, P626; RIZZOLATTI G, 1987, NEUROPHYSIOLOGICAL N, P289; ROBERTSON I, 1992, INT J NEUROSCI, V62, P45; Robertson IH, 1997, NEUROPSYCHOLOGY, V11, P290, DOI 10.1037/0894-4105.11.2.290; ROBERTSON IH, 1993, NEUROPSYCHOLOGIA, V31, P293, DOI 10.1016/0028-3932(93)90093-F; ROBERTSON IH, 1992, J NEUROL NEUROSUR PS, V55, P799, DOI 10.1136/jnnp.55.9.799; ROBERTSON IH, 1992, NEUROPSYCHOLOGIA, V30, P553, DOI 10.1016/0028-3932(92)90058-T; ROBERTSON IH, 1994, NEUROPSYCHOLOGIA, V32, P1, DOI 10.1016/0028-3932(94)90064-7; ROBERTSON IH, 1995, J CLIN EXP NEUROPSYC, V17, P416, DOI 10.1080/01688639508405133; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P1527, DOI 10.1016/S0028-3932(97)00084-5; Robertson IH, 1998, NEUROPSYCHOL REHABIL, V8, P19, DOI 10.1080/713755556; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Robertson IH, 1995, NEUROREPORT, V7, P246, DOI 10.1097/00001756-199512000-00059; ROBERTSON IH, 1993, UNILATRAL NEGLECT CL; ROBERTSON IH, IN PRESS REHABILITAT; Schwartz M. F., 1993, J HEAD TRAUMA REHAB, V8, P59, DOI [10.1097/00001199-199303000-00007, DOI 10.1097/00001199-199303000-00007]; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; STONE SP, 1991, J NEUROL NEUROSUR PS, V54, P345, DOI 10.1136/jnnp.54.4.345; STONE SP, 1992, J NEUROL NEUROSUR PS, V55, P431, DOI 10.1136/jnnp.55.6.431; SUTTON RL, 1989, BEHAV NEUROSCI, V103, P837, DOI 10.1037/0735-7044.103.4.837; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; VALLAR G, 1993, BRAIN, V116, P71, DOI 10.1093/brain/116.1.71; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; WALKERBATSON D, 1992, RESTOR NEUROL NEUROS, V4, P47, DOI 10.3233/RNN-1992-4106; WALL JT, 1985, SYNAPTIC PLASTICITY, P231; WALLACE SF, 1990, J COMP NEUROL, V296, P222, DOI 10.1002/cne.902960204; WATSON M, 1984, BRAIN RES, V296, P129, DOI 10.1016/0006-8993(84)90518-3; WHISHAW IQ, 1986, BEHAV NEURAL BIOL, V46, P285, DOI 10.1016/S0163-1047(86)90233-5; WILL B, 1992, ADV EXP MED BIOL, V325, P79; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; [No title captured]	83	7	7	0	5	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142 USA	1047-0387		0-262-07188-6	ATTENTION PERFORM			1999	17						677	696					20	Behavioral Sciences; Psychology, Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychology	BM97X	WOS:000080333800024					2022-02-06	
J	Ellis, K; Speed, J; Balbierz, JM				Ellis, K; Speed, J; Balbierz, JM			Post-craniectomy intracranial hypotension: potential impact on rehabilitation	BRAIN INJURY			English	Article							PRESSURE HEADACHE; FLUID PRESSURE	More aggressive neurosurgical management of intractably elevated intracranial pressure has resulted in increased survival of severely brain injured patients, many of whom are transferred for inpatient rehabilitation status post-craniectomy. Positional headache due to intracranial hypotension has been described in the literature, but is rarely reported as a complicating factor for patients receiving rehabilitation therapies. Low cerebrospinal fluid (CSF) pressure symptoms include postural headache, vertigo, nausea, vomiting, visual symptoms, auditory symptoms, and rarely cognitive changes. This report describes a patient who sustained a severe traumatic brain injury requiring craniectomy for management of increased intracranial pressure who subsequently developed intracranial hypotension. One month post-craniectomy, she developed postural headaches with cognitive and functional decline, which significantly impaired her rehabilitation. Aggressive efforts at conservative management including hydration and empiric blood patch were unsuccessful. Once the bone flap was replaced, she made rapid and dramatic functional gains, with total resolution of headache. This paper hypothesizes that the mechanism of low CSF pressure after extensive craniectomy is related to loss of hydrostatic pressure following removal of the skull vault. Ln rehabilitation of severely brain injured patients with craniectomies, it is important to recognize and appropriately treat this syndrome to avoid compromising patient care and prolonging hospitalization.	Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT USA		Speed, J (corresponding author), 50 N Med Dr, Salt Lake City, UT 84132 USA.						BAKER CC, 1983, MINN MED, V66, P325; BELL WE, 1960, NEUROLOGY, V10, P512, DOI 10.1212/WNL.10.5.512; FISHMAN RA, 1994, NEUROLOGY, V44, P1981, DOI 10.1212/WNL.44.10.1981-a; GAUKROGER PB, 1987, PAIN, V29, P119, DOI 10.1016/0304-3959(87)90185-0; GORMLEY JB, 1960, ANESTHESIOLOGY, V21, P565; JACOBS MB, 1991, WESTERN J MED, V155, P178; KOSMORSKY GS, 1995, J NEURO-OPHTHALMOL, V15, P79; LYONS MK, 1990, MAYO CLIN PROC, V65, P684, DOI 10.1016/S0025-6196(12)65131-3; MARCELIS J, 1990, HEADACHE, V30, P192, DOI 10.1111/j.1526-4610.1990.hed3004192.x; MOKRI B, 1996, AM J PHYSICAL MED RE, V75, P158; PANNULLO SC, 1993, NEUROLOGY, V43, P919, DOI 10.1212/WNL.43.5.919; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RANDO TA, 1992, NEUROLOGY, V42, P481, DOI 10.1212/WNL.42.3.481; RASKIN NH, 1990, HEADACHE, V30, P197, DOI 10.1111/j.1526-4610.1990.hed3004197.x; RENOWDEN SA, 1995, J NEUROL NEUROSUR PS, V59, P511, DOI 10.1136/jnnp.59.5.511; VANDAM LD, 1956, JAMA-J AM MED ASSOC, V161, P586, DOI 10.1001/jama.1956.02970070018005	16	7	7	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1998	12	10					895	899		10.1080/026990598122115			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	121FR	WOS:000076003100008	9783087				2022-02-06	
J	Wright, SC				Wright, SC			Case report: Postconcussion syndrome after minor head injury	AVIATION SPACE AND ENVIRONMENTAL MEDICINE			English	Article							CONCUSSION	A 31-yr-old flight medic struck the top of his head while loading a patient onto an ambulance. He sustained a momentary alteration of sensorium but otherwise seemed fine. Approximately 1 week after the incident, he experienced the onset of headaches and disabling vertigo that persisted over the next 2 mo, gradually decreasing in severity with time. Although not deemed significant at the time of injury, a mild head injury can result in postconcussion syndrome, a collection cf neurologic symptoms that can persist for some time before resolving. This case emphasizes the need for a period of observation after head trauma before clearing aviators for flying duties.	36th Med Evacuat Battal, Ft Hood, TX USA		Wright, SC (corresponding author), 1513 Chardonnay, Harker Hts, TX 76548 USA.						ALVES W, 1993, J HEAD TRAUMA REHAB, V8, P45; DOZEMA D, 1991, ANN EMERG MED, V20, P1281; Evans R W, 1987, Tex Med, V83, P49; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MANDEL S, 1989, POSTGRAD MED, V85, P213; McClelland RJ, 1996, J PSYCHOSOM RES, V40, P563, DOI 10.1016/0022-3999(95)00616-8	10	7	7	0	1	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	0095-6562			AVIAT SPACE ENVIR MD	Aviat. Space Environ. Med.	OCT	1998	69	10					999	1000					2	Public, Environmental & Occupational Health; Medicine, General & Internal; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine; Sport Sciences	123KY	WOS:000076125400013	9773904				2022-02-06	
J	Bakshi, A; Mahapatra, AK				Bakshi, A; Mahapatra, AK			Basilar artery vasospasm after severe head injury: A preliminary transcranial Doppler ultrasound study	NATIONAL MEDICAL JOURNAL OF INDIA			English	Article							CEREBRAL BLOOD-FLOW; VELOCITY; HYPEREMIA; SPASM	Background. Post traumatic vasospasm after severe head injury is now a well known entity. However, all studies available in the literature have evaluated only the anterior cerebral circulation. We evaluated the incidence of basilar artery vasospasm in patients with severe head injury. Methods, Basilar artery mean blood flow velocity was measured in 16 patients with severe closed head injury (Glasgow Coma Scale 8 or less) using transcranial Doppler ultrasonography. Ten normal subjects also underwent the same investigation. The patients' age ranged From 5 to 65 years. The study group included 13 males and 3 females. All patients underwent serial CT scans. In 10 patients the blood flow velocity was measured within 72 hours of the injury and in the remaining 6 it was done within 4 days to 3 weeks after the injury. Results. The basilar artery could be insonated easily in all the patients. The depth of insonation ranged from 65-85 mm in adults and 50-60 mm in children (n = 2). The mean blood flow velocity in severely head-injured patients was 47.4 cm/second which was significantly higher than the normal value of 42 cm/second (p < 0.008). Eight of the 14 adults (57%) had a mean blood flow velocity higher than the control value. In 7 (50%) of these the velocity was higher than 60 cm/second. Seven of these 8 patients with a high blood flow velocity had evidence of diffuse brain injury on CT scan. Six of them had effacement of the basal cisterns as a result of diffuse brain oedema. Among the remaining 8 patients who had contusion and haematoma on CT scan, only 2 had a high blood flow velocity in the basilar artery, Conclusion. Basilar artery blood how velocity is higher in patients with severe head injury. Patients with diffuse brain injury have a particularly high velocity. Thus, it may be an easy method to assess the severity of head injury. The temporal profile of basilar artery vasospasm needs to be established in severely head-injured patients to assess its clinical utility.	All India Inst Med Sci, Dept Neurosurg, New Delhi 110029, India		Mahapatra, AK (corresponding author), All India Inst Med Sci, Dept Neurosurg, New Delhi 110029, India.						CHAN KH, 1992, NEUROSURGERY, V30, P697; GUPTA R, 1995, ACTA NEUROCHIR, V137, P74, DOI 10.1007/BF02188785; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; HENNERICI M, 1987, SURG NEUROL, V27, P439, DOI 10.1016/0090-3019(87)90251-5; MARSHALL LF, 1978, J NEUROSURG, V48, P560, DOI 10.3171/jns.1978.48.4.0560; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; Otis S, 1996, NEUROSONOLOGY, P113; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; SHIOGAI T, 1992, STROKE, V23, P462; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; ZURYNSKI YA, 1995, J NEUROL SCI, V134, P33, DOI 10.1016/0022-510X(95)00172-9	12	7	8	0	1	ALL INDIA INST MEDICAL SCIENCES	NEW DELHI	ANSARI NAGAR, NEW DELHI 110 029, INDIA	0970-258X			NATL MED J INDIA	Natl. Med. J. India	SEP-OCT	1998	11	5					220	221					2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222PY	WOS:000081795000006	10997169				2022-02-06	
J	Cools, C; Manders, E				Cools, C; Manders, E			Analysis of language and communication function in traumatic brain injured patients	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						communication; language disorder; traumatic brain injury	ADULTS		UZ Leuven, Dept ENT Head & Neck Surg, B-3000 Louvain, Belgium		Cools, C (corresponding author), UZ Leuven, Dept ENT Head & Neck Surg, Kapucijnenvoer 7, B-3000 Louvain, Belgium.						Blomert L, 1995, AMSTERDAM NIJMEGEN T; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; COOLS C, 1997, COGNITIEVE TAALSTOOR; De Renzi E., 1979, AUDITORY COMPREHENSI; Goodglass H, 1983, ASSESSMENT APHASIA R; Hagen C, 1984, LANGUAGE DISORDERS A, P245; JORDAN LS, 1985, LANGUAGE SPEECH HEAR, V16, P227; KENNEDY MRT, 1991, COMMUNICATION DISORD, P123; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; MANDERS E, 1996, AL DOENDE SPREEKT ME; MARQUARDT TP, 1990, TRAUMATIC BRAIN INJU, P191; MCDONALD S, 1995, BRAIN INJURY, V9, P225; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Penn C, 1988, Brain Inj, V2, P3, DOI 10.3109/02699058809150928; PONSFORD J, 1995, TRAUMATIC BRAIN INJU, P1; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; TURKSTRA LLS, 1995, BRAIN INJURY, V10, P329	17	7	8	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	SEP	1998	21	3					323	329		10.1097/00004356-199809000-00007			7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	134PU	WOS:000076752400007	9812260				2022-02-06	
J	Davis, KL; Jenkins, LW; DeWitt, DS; Prough, DS				Davis, KL; Jenkins, LW; DeWitt, DS; Prough, DS			Mild traumatic brain injury does not modify the cerebral blood flow profile of secondary forebrain ischemia in Wistar rats	JOURNAL OF NEUROTRAUMA			English	Article						blood flow; brain; cerebral ischemia; hippocampus; rats; traumatic brain injury	LASER-DOPPLER FLOWMETRY; SEVERE HEAD-INJURY; INCOMPLETE ISCHEMIA; HYDROGEN CLEARANCE; HYPOPERFUSION; METABOLISM; CATS; MICROCIRCULATION; HIPPOCAMPUS; THRESHOLDS	The rat hippocampus is hypersensitive to secondary cerebral ischemia after mild traumatic brain injury (TBI), An unconfirmed assumption in previous studies of mild TBI followed by forebrain ischemia has been that antecedent TBI did not alter cerebral blood flow (CBF) dynamics in response to secondary ischemia, Using laser Doppler flowmetry (LDF), relative changes in regional hippocampal CA1 blood flow (hCBF) were recorded continuously to quantitatively characterize hCBF before, during, and after 6 min of forebrain ischemia in either normal or mildly traumatized rats. Two experimental groups of fasted male Wistar rats were compared. Group 1 (n = 6) rats were given 6 minutes of transient forebrain ischemia using bilateral carotid clamping and hemorrhagic hypotension. Group 2 (n = 6) rats were subjected to mild (0.8 atm) fluid percussion TBI followed 1 h after trauma by 6 min of transient forebrain ischemia, The laser Doppler flow probe was inserted stereotactically to measure CA1 blood flow. The electroencephalogram (EEG) was continuously recorded. During the forebrain ischemic insult there were no intergroup differences in the magnitude or duration of the decrease in CBF in CA1, In both groups, CBF returned to preischemic values within one minute of reperfusion but traumatized rats had no initial hyperemia, There were no intergroup differences in the CBF threshold when the EEG became isoelectric. These data suggest that the ischemic insult was comparable either with or without antecedent TBI in this model. This confirms that this model of TBI followed by forebrain ischemia is well suited for evaluating changes in the sensitivity of CA1 neurons to cerebral ischemia rather than assessing differences in relative ischemia.	Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA		Jenkins, LW (corresponding author), Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.		Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035365] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35365] Funding Source: Medline		ADAMS JH, 1985, CENTRAL NERVOUS SYST, P65; ANDERSEN BJ, 1988, J NEUROSURG, V68, P601, DOI 10.3171/jns.1988.68.4.0601; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DeWitt D S, 1995, New Horiz, V3, P376; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DIRNAGL U, 1994, STROKE, V25, P1028, DOI 10.1161/01.STR.25.5.1028; Fabricius M, 1996, J CEREBR BLOOD F MET, V16, P156, DOI 10.1097/00004647-199601000-00018; FUKUDA O, 1995, NEUROSURGERY, V36, P358, DOI 10.1227/00006123-199502000-00016; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; GIONET TX, 1992, BRAIN RES, V586, P188, DOI 10.1016/0006-8993(92)91626-P; HABERL RL, 1989, AM J PHYSIOL, V256, pH1247, DOI 10.1152/ajpheart.1989.256.4.H1247; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENKINS LW, 1989, CONT ISSUES NEUROLOG, V1, P47; KAGSTROM E, 1983, J CEREBR BLOOD F MET, V3, P183, DOI 10.1038/jcbfm.1983.25; Kramer MS, 1996, NEUROSURGERY, V38, P355, DOI 10.1097/00006123-199602000-00024; KUROIWA T, 1992, STROKE, V23, P1349, DOI 10.1161/01.STR.23.9.1349; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Long JB, 1996, J NEUROTRAUM, V13, P149, DOI 10.1089/neu.1996.13.149; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; RICHARDS HK, 1995, AM J PHYSIOL-HEART C, V268, pH213, DOI 10.1152/ajpheart.1995.268.1.H213; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; SKARPHEDINSSON JO, 1988, ACTA PHYSIOL SCAND, V134, P133, DOI 10.1111/j.1748-1716.1988.tb08469.x; SMITH ML, 1983, J CEREBR BLOOD F MET, V3, P543, DOI 10.1038/jcbfm.1983.83; THEILEN H, 1993, AM J PHYSIOL, V265, pH642, DOI 10.1152/ajpheart.1993.265.2.H642; Vaagenes P, 1996, CRIT CARE MED, V24, pS57; VERHAEGEN M, 1994, ANESTHESIOLOGY, V81, P965, DOI 10.1097/00000542-199410000-00024; Vink R, 1996, J NEUROCHEM, V66, P2477; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YOSHINO A, 1992, J CEREBR BLOOD F MET, V12, P996, DOI 10.1038/jcbfm.1992.137; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	43	7	7	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	1998	15	8					615	625		10.1089/neu.1998.15.615			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	111KP	WOS:000075436500005	9726260				2022-02-06	
J	Ong, LC; Chandran, V; Zasmani, S; Lye, MS				Ong, LC; Chandran, V; Zasmani, S; Lye, MS			Outcome of closed head injury in Malaysian children: Neurocognitive and behavioural sequelae	JOURNAL OF PAEDIATRICS AND CHILD HEALTH			English	Article						children; head injury; neurobehavioural outcome	TRAUMATIC BRAIN INJURY; ADOLESCENTS; COMA; RECOVERY; MEMORY; SCALE; MILD	Objective: To compare the neurobehavioural outcome of children aged 6-12 years with severe closed head injury [sCHI] (coma > 24 h), mild-to-moderate head injury [mCHI] (coma < 6 h) and orthopaedic controls. Methods: Twenty-nine children in each group, matched for age, sex and ethnicity, were assessed using the Glasgow Outcome Scale (GOS), Weschler Intelligence Scale for Children (WISC-III), Movement Assessment Battery for Children (Movement ABC), Wide Range Assessment of Learning and Memory (WRAML) and a standardised neurological examination 6 months post-injury. Parental reporting of pre- and post-injury behaviour was documented using the Child Behaviour Checklist (CBCL). Results: Seven (24.1%) children with sCHI and three (10.3%) orthopaedic controls had residual motor deficits. Three (10.3%) children with sCHI and none in the other groups faced problems with independent ambulation. Twenty-seven (93.1%) of those with sCHI and all children in the other groups had GOS scores of good recovery or moderate disability. Twenty-two (81.5%) sCHI, five (18.5%) mCHI and one (3.7%) orthopaedic control reported a deterioration in school performance. MANOVAS identified a significant injury group effect for performance skills (P = 0.007), verbal skills (P = 0.002), memory and learning (P = 0.001) and motor skills (P = 0.001). Repeated measures ANOVA for pre- and post-injury CBCL scores showed significant differences related to somatic complaints (P = 0.004), problems of socialising (P = 0.003), delinquency (P = 0.004), aggressiveness (P = 0.010), thought (P < 0.001) and attention (P < 0.001). Post-hoc univariate analysis showed the significant differences were between that of the sCHI children and the other two groups. Conclusion: Although most sCHI children seemed to have made good physical recovery, there were cognitive, motor, memory and learning difficulties and behavioural problems concomitant with a deterioration in school performance compared with those with lesser or no head injury. This highlights the need for better integrated rehabilitation services to enable a gradual return into mainstream school.	Univ Kebangsaan Malaysia, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia; Univ Kebangsaan Malaysia, Fac Med, Dept Psychiat, Kuala Lumpur, Malaysia; Inst Med Res, Dept Epidemiol Res, Kuala Lumpur 50588, Malaysia		Ong, LC (corresponding author), Hosp Univ Kebangsaan Malaysia, Dept Paediat, Kuala Lumpur 56000, Malaysia.		Ong, Lai Choo/G-6439-2011	Ong, Lai Choo/0000-0003-3903-9343			Achenbach TM, 1991, MANUAL CHILD BEHAV C; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BASSON MD, 1991, J TRAUMA, V31, P1363, DOI 10.1097/00005373-199110000-00008; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; FARMER MY, 1987, PEDIATR NEUROSCI, V13, P304, DOI 10.1159/000120348; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JENNETT B, 1975, LANCET, V1, P480; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1979, CHILD BRAIN, V5, P281; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; MICHAUD LJ, 1993, ARCH PHYS MED REHAB, V74, P368; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; PELCO L, 1992, Brain Injury, V6, P29, DOI 10.3109/02699059209008119; RUIJS MBM, 1994, CLIN NEUROL NEUROSUR, V96, P273, DOI 10.1016/0303-8467(94)90114-7; SATTLER JM, 1990, ASSESSMENT CHILDREN, P136; SCOTTJUPP R, 1992, ARCH DIS CHILD, V67, P222, DOI 10.1136/adc.67.2.222; SHESLOW AW, 1990, WIDE RANGE ASSESSMEN; Sugden, 1992, MOVEMENT ASSESSMENT; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; WESSON DE, 1992, J TRAUMA, V33, P252, DOI 10.1097/00005373-199208000-00015	31	7	7	2	5	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1034-4810			J PAEDIATR CHILD H	J. Paediatr. Child Health	AUG	1998	34	4					363	368		10.1046/j.1440-1754.1998.00239.x			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	104CR	WOS:000074995400014	9727180				2022-02-06	
J	Webb, D				Webb, D			A 'revenge' on modern times: Notes on Traumatic Brain Injury	SOCIOLOGY-THE JOURNAL OF THE BRITISH SOCIOLOGICAL ASSOCIATION			English	Article						disability; mind; modernity; Traumatic Brain Injury		Traumatic Brain Injury (TBI) results from cerebral damage caused by a blow to the head, for example in a road traffic accident. The frequency of TBI means that it has been characterised as the silent epidemic of modern times. The majority of those who are head-injured are young men. This paper argues that the social reaction to head injury is testament to the latent eugenicist and mentalist suppositions within modernity. The brain-damaged person cannot readily overcome disability with the assistance of the technological aids available to those whose handicapping condition is physical. The consequences that head injury has for the mind and for the 'self' entail the special sequestration of those who are head-injured from modernity's concerns with reflexivity and with the paramount cultural and material importance of the mind, whatever is said about the sociological significance of 'body matters'. Because TBI brings in its wake the liminality of being 'neither here nor there', of young men who become once again 'children', the implications for family dynamics are both distinctive and profound. The 'future', around which much of modernity revolves, is denied to those whose catastrophe arose from these same modern times.	Nottingham Trent Univ, Dept Social Sci, Crime & Social Res Unit, Nottingham NG1 4BU, England		Webb, D (corresponding author), Nottingham Trent Univ, Dept Social Sci, Crime & Social Res Unit, Burton St, Nottingham NG1 4BU, England.						Bauman Z., 1991, MODERNITY HOLOCAUST; BROCK MD, 1995, LIVING HEAD INJURY; BROOKS N, 1984, CLOSED HEAD INJURY P; Crisp R., 1993, DISABIL HANDICAP SOC, V8, P393, DOI DOI 10.1080/02674649366780371; Donzelot Jacques, 1980, POLICING FAMILIES; Fox N., 1993, POSTMODERNISM SOCIOL; Frank A. W., 1990, THEOR CULT SOC, V7, P131, DOI DOI 10.1177/026327690007001007; Giddens A., 1990, MODERNITY SELF IDENT; GOFFMAN I, 1973, STIGMA; Hand JE, 1994, DISABIL SOC, V9, P167, DOI 10.1080/09687599466780201; HIGHAM P, 1996, ASSESSING LONG TERM; HUBERT J, 1995, LIFE HEAD INJURY; Illich I, 1975, MED NEMESIS EXPROPRI; Kreutzer JS, 1990, COMMUNITY INTEGRATIO; MCMILLAN T, 1991, REHABILITATION PROGR; MELLOR PA, 1993, SOCIOLOGY, V27, P411, DOI 10.1177/0038038593027003005; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Oliver M., 1990, POLITICS DISABLEMENT; PFEIFFER D, 1994, DISABIL SOC, V9, P481, DOI 10.1080/09687599466780471; Popper KR., 1977, SELF ITS BRAIN ARGUM; Proctor R., 1988, RACIAL HYGIENE MED N; ROSE S, 1992, MAKING MEMORY; SHAKESPEARE T, 1994, DISABIL SOC, V9, P283, DOI 10.1080/09687599466780341; SHAKESPEARE T, 1995, CRIT SOC POLICY, V44, P22, DOI DOI 10.1177/026101839501504402; SHILLING C, 1991, SOCIOLOGY, V25, P653, DOI 10.1177/0038038591025004006; STONE SD, 1995, DISABIL SOC, V10, P413, DOI 10.1080/09687599550023426; Thomas F, 1987, POLITICS MENTAL HAND; Turner B., 1992, REGULATING BODIES; VOYSEY M, 1975, CONSTANT BURDEN RECO; Weeks J., 1981, SEX POLITICS SOC REG	30	7	7	1	8	BRITISH SOCIOLOGICAL ASSOC	DURHAM	UNIT 3G, MOUNTJOY RESEARCH CTR, STOCKTON RD, DURHAM, DURHAM, ENGLAND DH1 3UR	0038-0385			SOCIOLOGY	Sociol.-J. Brit. Sociol. Assoc.	AUG	1998	32	3					541	555		10.1177/0038038598032003008			15	Sociology	Social Science Citation Index (SSCI)	Sociology	109ZZ	WOS:000075356000007					2022-02-06	
J	Cornford, EM; Hyman, S; Cornford, ME; Damian, RT; Raleigh, MJ				Cornford, EM; Hyman, S; Cornford, ME; Damian, RT; Raleigh, MJ			A single glucose transporter configuration in normal primate brain endothelium: Comparison with resected human brain	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						baboon; blood-brain barrier; electron microscopy; Glut1 glucose transporter; quantitative immunogold; rhesus monkey; squirrel and vervet monkeys	CHOROID-PLEXUS; BARRIER; LOCALIZATION; PROTEIN; FAMILY; RAT; IMMUNOGOLD; EXPRESSION; GLUT-1	Cellular distribution of the Glut1 glucose transporter in normal primate brains was analyzed by immunogold electron microscopy. Two configurations of endothelial Glut1 glucose transporter (high and low density capillaries) have been found in resections of traumatically injured and epileptogenic human brain; the objective of the present study was to ascertain whether these same 2 capillary populations, expressing high and low glucose transporter densities, were the common configuration in normal brain. The relative numbers of Glut1 glucose transporter-associated gold particles on luminal and abluminal endothelial cell membranes were determined within the cerebral cortex of several normal, nonhuman primates. Low Glut1 densities were seen in brain endothelia of both the rhesus and squirrel monkey cortex, with slightly greater quantities of Glut1 in vervet monkey cortices. The Glut1 transporter was most highly expressed in the baboon cortex, approaching the concentrations seen in human brains. In the rhesus, squirrel, and vervet monkeys, Glut1 concentrations were greater on the abluminal than luminal capillary membranes. In contrast, mean luminal membrane Glut1 concentrations were greater in baboons, resembling the distribution seen in the human brain. Brain regional differences in transporter concentration were seen in comparing membrane densities in the baboon cortex (similar to 15 Glut1-gold particles per mu meter), hippocampus (similar to 12 Glut1 gold particles per mu meter), cerebellum (similar to 6 Glut1-gold particles per mu meter), and retinal microvasculature (similar to 20 Glut1-gold particles per mu meter). We conclude that a single, uniform Glut1 distribution characterizes brain capillaries of normal nonhuman primates, and hypothesize that the presence of high and low density glucose transporter endothelial cells (seen in human traumatic injury and seizure resections) represents a pathologic response to brain insult.	Vet Adm W Los Angeles Med Ctr, SW Reg VA Epilepsy Ctr W127B, Res Serv, Los Angeles, CA 90073 USA; Vet Adm W Los Angeles Med Ctr, SW Reg VA Epilepsy Ctr W127B, Neurol Serv, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; Harbor UCLA Med Ctr, Dept Pathol, Los Angeles, CA 90059 USA; Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA		Cornford, EM (corresponding author), Vet Adm W Los Angeles Med Ctr, SW Reg VA Epilepsy Ctr W127B, Res Serv, Los Angeles, CA 90073 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 25554] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS025554] Funding Source: NIH RePORTER		BALDWIN SA, 1989, METHOD ENZYMOL, V174, P39; BELL GI, 1993, J BIOL CHEM, V268, P19161; BOADO RJ, 1990, BIOCHEM BIOPH RES CO, V166, P174, DOI 10.1016/0006-291X(90)91927-K; Bolz S, 1996, CELL TISSUE RES, V284, P355, DOI 10.1007/s004410050596; BRAUN LD, 1985, J NEUROCHEM, V44, P911, DOI 10.1111/j.1471-4159.1985.tb12903.x; Chen M. G., 1988, Tropical Diseases Bulletin, V85, pR1; Cornford EM, 1998, J NEUROPATH EXP NEUR, V57, P404, DOI 10.1097/00005072-199805000-00004; CORNFORD EM, 1994, J CEREBR BLOOD F MET, V14, P106, DOI 10.1038/jcbfm.1994.15; Cornford EM, 1998, J CEREBR BLOOD F MET, V18, P26, DOI 10.1097/00004647-199801000-00003; Cornford EM, 1996, J NEUROTRAUM, V13, P523, DOI 10.1089/neu.1996.13.523; CORNFORD EM, 1993, J CEREB BLOOD FLOW M, V663, P7; CRANE PD, 1978, STROKE, V9, P12, DOI 10.1161/01.STR.9.1.12; DICK APK, 1986, J NEUROCHEM, V46, P1406, DOI 10.1111/j.1471-4159.1986.tb01755.x; DICK APK, 1984, P NATL ACAD SCI-BIOL, V81, P7233, DOI 10.1073/pnas.81.22.7233; DWYER KJ, 1993, ENDOCRINOLOGY, V132, P558, DOI 10.1210/en.132.2.558; FARRELL CL, 1991, P NATL ACAD SCI USA, V88, P5779, DOI 10.1073/pnas.88.13.5779; GERHART DZ, 1989, J NEUROSCI RES, V22, P464, DOI 10.1002/jnr.490220413; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; HARIK SI, 1990, J NEUROSCI, V10, P3862, DOI 10.1523/JNEUROSCI.10-12-03862.1990; HARRIS DS, 1992, P NATL ACAD SCI USA, V89, P7556, DOI 10.1073/pnas.89.16.7556; HASPEL HC, 1988, J BIOL CHEM, V263, P398; JAMES DE, 1995, NEWS PHYSIOL SCI, V10, P67, DOI 10.1152/physiologyonline.1995.10.2.67; KALARIA RN, 1988, ANN NEUROL, V24, P757, DOI 10.1002/ana.410240610; KENNEDY C, 1978, ANN NEUROL, V4, P293, DOI 10.1002/ana.410040402; KUHL DE, 1980, ANN NEUROL, V8, P47, DOI 10.1002/ana.410080108; Kumagai AK, 1996, BRAIN RES, V706, P313, DOI 10.1016/0006-8993(95)01335-0; KUMAGAI AK, 1994, BBA-BIOMEMBRANES, V1193, P24, DOI 10.1016/0005-2736(94)90328-X; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; REIVICH M, 1979, CIRC RES, V44, P127, DOI 10.1161/01.RES.44.1.127; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; TAKATA K, 1991, J HISTOCHEM CYTOCHEM, V39, P287, DOI 10.1177/39.3.1993828; Takata K, 1996, J ELECTRON MICROSC, V45, P275, DOI 10.1093/oxfordjournals.jmicro.a023443; THORENS B, 1990, AM J PHYSIOL, V259, pC296; WERTHEIMER E, 1991, P NATL ACAD SCI USA, V88, P2525, DOI 10.1073/pnas.88.6.2525; WIDNELL CC, 1990, FASEB J, V4, P1634, DOI 10.1096/fasebj.4.6.2156742	36	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JUL	1998	57	7					699	713		10.1097/00005072-199807000-00007			15	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	105GP	WOS:000075064600007	9690674	Bronze			2022-02-06	
J	Landy, PJB				Landy, PJB			Neurological sequelae of minor head and neck injuries	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article							WHIPLASH; REAPPRAISAL; STRESS; PAIN	The objective was to determine why some people who are involved in minor motor vehicle accidents, without loss of consciousness, have persisting headaches and neckache, and to suggest management of these symptoms. Between 1954 and 1994, over 4400 cases were referred for medico-legal opinions. A group has been selected for discussion. During the period 1954-1966, 414 cases following closed head injuries were seen with varying periods of post traumatic nmr resin (PTA) from nil to greater than 72 h. The average time between the accident and the examination was 21 months. The shortest period was 3 months and the longest 7 years. The age at the time of the accident varied from 2.5 to 72 years. The largest group fell between the ages of 20 and 40 years. The main complaints were headache, giddiness, loss of concentration and poor memory. 380 were reviewed by questionnaire after settlement of the case. 112 cases of extension/flexion injuries of the neck were seen between 1985 and 1989 and their symptoms and resolution were compared with 50 cases seen over the same period following significant head or neck injury. The results showed that the more severe the head or neck injury, the less likely were the cases to suffer symptoms of post-traumatic headaches or persisting neck symptoms. 112 conclusion, while 70% of minor head and neck injuries settle within a few weeks of a motor vehicle accident, about 30% continue to complain of headaches and/or neck pain. Tire prolonged management, extensive physiotherapy and slow court settlement lend to excessive introspection and prolongation of symptoms. (C) 1998 Elsevier Science Ltd. All rights reserved.			Landy, PJB (corresponding author), 201 Wickham Terr, Brisbane, Qld 4000, Australia.						BARNSLEY L, 1994, NEW ENGL J MED, V330, P1047, DOI 10.1056/NEJM199404143301504; BERRY H, 1985, PSYCHOL ASPECTS WHIP, P1716; BOGDUK N, 1988, SPINE, V13, P610; DEANS GT, 1987, INJURY, V18, P10, DOI 10.1016/0020-1383(87)90375-5; Erichsen JE, 1882, CONCUSSION SPINE NER; FORDYCE WE, 1973, POSTGRAD MED, V53, P123, DOI 10.1080/00325481.1973.11713462; GRIFFIN JQC, 1993, C ROYAL AUSTR NZ COL; HELZER JE, 1987, NEW ENGL J MED, V317, P1630, DOI 10.1056/NEJM198712243172604; HIRSCH SA, 1988, ORTHOP CLIN N AM, V19, P791; HOHL M, 1974, J BONE JOINT SURG AM, VA 56, P1675, DOI 10.2106/00004623-197456080-00018; JACOME DE, 1987, CLIN ELECTROENCEPHAL, V18, P41; KELLY R, 1981, J ROY SOC MED, V74, P275, DOI 10.1177/014107688107400407; KENNEDY F, 1946, COMPENSATION MED, V1, P19; MENDLESON G, 1982, MED J AUSTRALIA, V11, P132; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PEARCE JMS, 1989, J NEUROL NEUROSUR PS, V52, P1329, DOI 10.1136/jnnp.52.12.1329; RADANOV BP, 1991, LANCET, V338, P712, DOI 10.1016/0140-6736(91)91441-V; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SCHUTT CH, 1968, J AMER MED ASSOC, V206, P2689, DOI 10.1001/jama.206.12.2689; SEVERY J, 1955, CANADIAN SERVICES ME, V11, P729; SYMONDS C, 1962, LANCET, P1; TORRES F, 1961, ARCH NEUROL-CHICAGO, V5, P28, DOI 10.1001/archneur.1961.00450130030005; TYRER SP, 1986, BRIT MED J, V292, P1, DOI 10.1136/bmj.292.6512.1; WALKER E, 1981, NEUROSURGERY, V9, P228; 1991, LANCET	27	7	8	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	APR	1998	29	3					199	206		10.1016/S0020-1383(97)00178-2			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	ZT817	WOS:000074130600006	9709421				2022-02-06	
J	LaPier, TLK; Sirotnak, N; Alexander, K				LaPier, TLK; Sirotnak, N; Alexander, K			Aerobic exercise for a patient with chronic multisystem impairments	PHYSICAL THERAPY			English	Article						exercise; heterotopic ossification; traumatic brain injury	MAXIMAL OXYGEN-UPTAKE; LEG EXERCISE; LOWER BODY; ARM; RESPONSES; INJURIES; WORK	Many patients with long-term disabilities have inactive lifestyles that put them at risk for chronic diseases and secondary disabilities. The purpose of this case report is to illustrate the process of aerobic exercise prescription for a patient with chronic multisystem impairments. The patient was a 43-year-old man who incurred a traumatic brain injury and multiple fractures in a motorcycle accident 15 years previously. He subsequently developed heterotopic ossification around the right hip. In addition, the patient had a history of smoking. We chose a "nontraditional" mode of exercise for the patient that we believed would be safe and; effective and would accommodate his neurologic and orthopedic impairments. The mode of exercise used was an apparatus in which the upper and lower extremities alternately flexed and extended in a nonreciprocal fashion. The patient attended 12 exercise sessions over a 1-month period, during which he demonstrated acute and chronic physiological responses appropriate for the exercise stimulus.	Idaho State Univ, Dept Phys Therapy, Pocatello, ID 83209 USA		LaPier, TLK (corresponding author), Idaho State Univ, Dept Phys Therapy, Campus Box 8002, Pocatello, ID 83209 USA.	lapitany@isu.edu					American College of Sports Medicine, 1995, GUID EX TEST PRESCR; ARRINGTON ED, 1995, ORTHOP CLIN N AM, V26, P411; ASTRAND I, 1968, J APPL PHYSIOL, V25, P528, DOI 10.1152/jappl.1968.25.5.528; ASTRAND PO, 1965, J APPL PHYSIOL, V20, P253, DOI 10.1152/jappl.1965.20.2.253; BACHYNSKICOLE M, 1985, OCCUPATIONAL THERAPY, V5, P859; BERGH U, 1976, J APPL PHYSIOL, V41, P191, DOI 10.1152/jappl.1976.41.2.191; BEVEGARD BS, 1966, J APPL PHYSIOL, V21, P123, DOI 10.1152/jappl.1966.21.1.123; BJURO T, 1975, SCAND J REHABIL MED, V7, P106; BRINKMANN JR, 1979, PHYS THER, V59, P859, DOI 10.1093/ptj/59.7.859; CRYIAX J, 1978, TXB ORTHOPAEDIC MED, V1; Duncan PW, 1987, STROKE REHABILITATIO; FITZSIMMONS AS, 1993, ARCH PHYS MED REHAB, V74, P770, DOI 10.1016/0003-9993(93)90042-9; GUTIN B, 1988, ARCH PHYS MED REHAB, V69, P510; Hakki A. H., 1983, CARDIOVASCULATURE RE, V4, P997; HOSKINS TA, 1975, ARCH PHYS MED REHAB, V56, P544; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; King JL, 1989, J CARDIOPULM REHABIL, V9, P237; LANDIN S, 1977, CLIN SCI MOL MED, V53, P257, DOI 10.1042/cs0530257; MCARDLE W, 1996, EXERCISE PHYSL; MODY BS, 1994, J BONE JOINT SURG BR, V76B, P607, DOI 10.1302/0301-620X.76B4.8027150; OLGIATI R, 1988, ARCH PHYS MED REHAB, V69, P846; POTEMPA K, 1995, STROKE, V26, P101, DOI 10.1161/01.STR.26.1.101; RAGNARSSON KT, 1988, CLIN ORTHOP RELAT R, P53; RICHARDSON JK, 1994, CLIN ORTHOPEDIC PHYS; Rowell LB, 1993, HUMAN CARDIOVASCULAR; RYAN JB, 1991, AM J SPORT MED, V19, P299, DOI 10.1177/036354659101900316; SAWKA MN, 1982, AVIAT SPACE ENVIR MD, V53, P354; SCHMITT D, 1995, THESIS IDAHO STATE U; SECHER NH, 1977, ACTA PHYSIOL SCAND, V100, P288, DOI 10.1111/j.1748-1716.1977.tb05952.x; SECHER NH, 1974, J APPL PHYSIOL, V36, P515, DOI 10.1152/jappl.1974.36.5.515; TONER MM, 1983, J APPL PHYSIOL, V54, P1403, DOI 10.1152/jappl.1983.54.5.1403; Vitale AE, 1997, BRAIN INJURY, V11, P67, DOI 10.1080/026990597123827; Wolman RL, 1994, CLIN REHABIL, V8, P253	34	7	7	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	APR	1998	78	4					417	424		10.1093/ptj/78.4.417			8	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	ZG376	WOS:000072995400007	9555924	Bronze			2022-02-06	
J	Bell, KR; Sandel, ME				Bell, KR; Sandel, ME			Brain injury rehabilitation. 4. Postacute rehabilitation and community integration	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							CENTRAL-NERVOUS-SYSTEM; SEVERE HEAD-INJURY; 2-YEAR FOLLOW-UP; SUBSTANCE-ABUSE; ALCOHOL-INTOXICATION; DEPRESSION; BEHAVIOR; WORK	This self-directed learning module highlights new advances in this topic area. It is part of the chapter on brain injury rehabilitation in the Self-Directed Physiatric Education Program for practitioners and trainees in physical medicine and rehabilitation. This article discusses behavioral and affective disorders, the neurophysiologic basis for and rehabilitation of cognitive skills, effects of alcohol and illegal substances on outcome after traumatic brain injury (TBI), family dynamics after TBI, disorders of sexuality, return-to-work issues, and present models for TBI rehabilitation. New advances covered in this article include treatment of depression and mania, pragmatic skills therapy, effects of acute and chronic alcohol use on pathophysiology of TBI, profile of sexual dysfunction, and review of federal legislation pertaining to TBI. (C) 1998 by the American Academy of Physical Medicine and Rehabilitation.	Univ Washington, Sch Med, Seattle, WA 98195 USA; Kaiser Fdn Rehabil Ctr, Vallejo, CA 94589 USA		Bell, KR (corresponding author), Univ Washington, Sch Med, Seattle, WA 98195 USA.			Bell, Kathleen/0000-0002-0928-2046			BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; BANJA JD, 1992, J HEAD TRAUMA REHAB, V7, P46; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Bergquist TF, 1994, J HEAD TRAUMA REHAB, V9, P50, DOI 10.1097/00001199-199412000-00007; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Bryant ET, 1993, J HEAD TRAUMA REHAB, V8, P15; CASSEL JC, 1995, NEUROSCIENCE, V69, P1, DOI 10.1016/0306-4522(95)00241-A; CASSIDY JW, 1994, J HEAD TRAUMA REHAB, V9, P43, DOI 10.1097/00001199-199409000-00005; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; Elliott ML, 1996, BRAIN INJURY, V10, P703, DOI 10.1080/026990596123972; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Florian V, 1991, Int Disabil Stud, V13, P150; FRASER RT, 1994, TOP LANG DISORD, V15, P55, DOI 10.1097/00011363-199411000-00006; FULLER MG, 1994, J NEUROPSYCH CLIN N, V6, P143; GOODALL P, 1994, J HEAD TRAUMA REHAB, V9, P61; GOULIAEV AH, 1994, BRAIN RES REV, V19, P180, DOI 10.1016/0165-0173(94)90011-6; GUALTIERI T, 1909, BRAIN INJURY, V5, P219; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HOLMAN RB, 1994, ADDICTION, V89, P1435, DOI 10.1111/j.1360-0443.1994.tb03740.x; JOHNSTON MV, 1992, J HEAD TRAUMA REHAB, V7, P68; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; JOSEPH AB, 1995, J HEAD TRAUMA REHAB, V10, P90, DOI 10.1097/00001199-199504000-00010; KELLY DF, 1995, J NEUROTRAUM, V12, P883, DOI 10.1089/neu.1995.12.883; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; MCENTEE WJ, 1993, PSYCHOPHARMACOLOGY, V111, P391, DOI 10.1007/BF02253527; Miller L., 1994, J COGNITIVE REHABILI, V12, P12; MOORE D, 1994, J SOC BEHAV PERS, V9, P369; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; PESSAR LF, 1993, BRAIN INJURY, V7, P231, DOI 10.3109/02699059309029675; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; SANDEL ME, 1996, MED REHABILITATION T, P557; SANDEL ME, IN PRESS REHABIL MED; SCHACTER DL, 1992, P NATL ACAD SCI USA, V89, P11113, DOI 10.1073/pnas.89.23.11113; SERGENT J, 1994, TRENDS NEUROSCI, V17, P221, DOI 10.1016/0166-2236(94)90002-7; SILVER JM, 1994, J HEAD TRAUMA REHAB, V9, P61, DOI 10.1097/00001199-199409000-00006; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; WAGSTAFF AJ, 1994, DRUG AGING, V4, P510, DOI 10.2165/00002512-199404060-00006; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x; WROBLEWSKI BA, 1994, J HEAD TRAUMA REHAB, V9, P19, DOI 10.1097/00001199-199409000-00004	58	7	7	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	1998	79	3		1			S21	S25		10.1016/S0003-9993(98)90116-2			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	ZC421	WOS:000072576300005					2022-02-06	
J	Paolin, A; Rodriguez, G; Betetto, M; Simini, G				Paolin, A; Rodriguez, G; Betetto, M; Simini, G			Cerebral hemodynamic response to CO2 otter severe head injury: Clinical and prognostic implications	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						cerebrovascular reactivity; cerebral blood flow; carbon dioxide; head injury; Glasgow coma scale; posttraumatic coma; outcome	TRAUMATIC BRAIN-LESIONS; BLOOD-FLOW; CARBON-DIOXIDE; COMATOSE PATIENTS; ACUTE PHASE; HYPERVENTILATION; PRESSURE; VASOREACTIVITY; CIRCULATION; REACTIVITY	Objective: To study the cerebrovascular reactivity to CO2 after severe head injury to establish the clinical and prognostic relevance of CO2 reactivity. Methods: Cerebrovascular reactivity to CO2 was studied in 20 patients with severe head injuries at 3.0 +/- 1.8 days after trauma onset. Two cerebral blood flow studies were performed to measure CO2 reactivity: the first study in a condition of normocapnia and the second study in a condition of relative hypocapnia. Results: Global reactivity was superimposable to that found in awake, normocapnic subjects and did not correlate with age and Glasgoff Coma Scale score but was dependent on the type of brain lesion. Moreover, reactivity correlated with outcome in patients studied after the first 3 days after trauma. Conclusions: Our data suggest that cerebrovascular reactivity is (a) almost preserved after a severe head injury; (b) significantly influenced by type of brain lesion; (c) prognostically relevant only in patients studied after the first 3 days after trauma.	S Maria Battuti Hosp, Anaesthesia & Crit Care Dept, I-31100 Treviso, Italy; Univ Hosp Genova, Neurophysiopathol Dept, Genova, Italy; Univ Hosp Genova, Ctr Cerebral Neurophysiol, Natl Res Council, Genova, Italy		Paolin, A (corresponding author), S Maria Battuti Hosp, Anaesthesia & Crit Care Dept, I-31100 Treviso, Italy.						COLD GE, 1989, ACTA NEUROCHIR, V96, P100, DOI 10.1007/BF01456166; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P359, DOI 10.1111/j.1399-6576.1977.tb01232.x; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P222; DARBY JM, 1988, NEUROSURGERY, V23, P84, DOI 10.1227/00006123-198807000-00014; DEUTSCH G, 1987, J CEREBR BLOOD F MET, V7, P29, DOI 10.1038/jcbfm.1987.5; ENEVOLDSEN EM, 1977, J NEUROSURG, V47, P699, DOI 10.3171/jns.1977.47.5.0699; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GREENBERG JH, 1978, CIRC RES, V43, P324, DOI 10.1161/01.RES.43.2.324; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; HEISS WD, 1976, ARCH NEUROL-CHICAGO, V33, P813, DOI 10.1001/archneur.1976.00500120017003; HOYER S, 1972, EUR NEUROL, V8, P174, DOI 10.1159/000114574; INGVAR DH, 1979, ACTA NEUROL SCAND, V60, P12, DOI 10.1111/j.1600-0404.1979.tb02947.x; JAGGI JL, 1987, CEREBRAL BLOOD FLOW, P189; JENNETT B, 1975, LANCET, V1, P480; MAMO H, 1983, ARCH NEUROL-CHICAGO, V40, P626, DOI 10.1001/archneur.1983.04050090062010; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MAXIMILIAN VA, 1980, STROKE, V11, P342, DOI 10.1161/01.STR.11.4.342; MCHENRY LC, 1965, ARCH NEUROL-CHICAGO, V12, P270, DOI 10.1001/archneur.1965.00460270046006; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1983, FUNCTIONAL RADIONUCL, P145; Olesen J, 1971, STROKE, V2, P519, DOI 10.1161/01.STR.2.6.519; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Pistolese GR, 1972, STROKE, V3, P456, DOI 10.1161/01.STR.3.4.456; RISBERG J, 1975, STROKE, V6, P142, DOI 10.1161/01.STR.6.2.142; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SAUNDERS ML, 1979, J NEUROSURG, V51, P18, DOI 10.3171/jns.1979.51.1.0018; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; STOYKA WW, 1974, CAN ANAESTH SOC J, V21, P205, DOI 10.1007/BF03013113; TEASDALE G, 1974, LANCET, V2, P81; WEI EP, 1977, CIRCULATION      S43, V56, P111; YOSHIHARA M, 1995, J NEUROSURG, V82, P386, DOI 10.3171/jns.1995.82.3.0386	39	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	1998	44	3					495	500		10.1097/00005373-199803000-00012			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	ZD780	WOS:000072723100014	9529177				2022-02-06	
J	Dobkin, BH				Dobkin, BH			Experimental brain injury and repair	CURRENT OPINION IN NEUROLOGY			English	Article							FOCAL CEREBRAL-ISCHEMIA; ADULT SQUIRREL-MONKEYS; PRIMARY MOTOR CORTEX; CLOSED-HEAD INJURY; GROWTH-FACTOR; MOVEMENT REPRESENTATIONS; RODENT MODELS; RAT; RECOVERY; DAMAGE	Strategies for neurological rehabilitation after brain injury have an increasingly scientific basis, which is being built upon animal models that examine the short- and long-term consequences of an injury and that test training paradigms, drugs and biologic interventions. Damage is associated with neuronal and network changes that can be manipulated to improve outcomes. Adjustments in the synaptic strength between the neuronal assemblies that represent behaviors are a key mechanism by which motor learning and functional gains evolve. Although practice aids adaptations, early overuse of cells adjacent to the site of injury might lead to a greater focal injury. The search for relevant models for rehabilitative interventions in terms of cellular and systems alterations, physiology, anatomy, impairments, and measurable behaviors continues. (C) Rapid Science Publishers.	Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90095 USA		Dobkin, BH (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurol, 300 UCLA Med Plaza, Los Angeles, CA 90095 USA.	bdobkin@mcpo.medctr.ucla.edu					Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Brecknell JE, 1996, NEUROSCIENCE, V74, P775, DOI 10.1016/0306-4522(96)00167-4; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Dettmers C, 1997, CEREBROVASC DIS, V7, P187, DOI 10.1159/000108190; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; DIXON C, 1996, NEUOTRAUMA, P137; Dobkin BH, 1996, NEUROLOGIST, V2, P239; Donoghue JP, 1997, CEREB CORTEX, V7, P97, DOI 10.1093/cercor/7.2.97; Faden AI, 1996, JAMA-J AM MED ASSOC, V276, P569, DOI 10.1001/jama.276.7.569; FISHER M, 1995, J CEREBR BLOOD F MET, V15, P953, DOI 10.1038/jcbfm.1995.121; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; Goldstein LB, 1997, CURR OPIN NEUROL, V10, P52, DOI 10.1097/00019052-199702000-00011; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; HALLETT M, 1995, ANN NEUROL, V38, P4, DOI 10.1002/ana.410380104; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Huntley GW, 1997, CEREB CORTEX, V7, P143, DOI 10.1093/cercor/7.2.143; JENKINS IH, 1994, J NEUROSCI, V14, P3775; JONES TA, 1994, J NEUROSCI, V14, P2140; Jones TA, 1996, BRAIN RES, V733, P142, DOI 10.1016/S0006-8993(96)00792-5; Jorgensen OS, 1997, EXP NEUROL, V144, P326, DOI 10.1006/exnr.1996.6372; KARNI A, 1995, NATURE, V377, P155; KASS J, 1997, NEUROSCIENTIST, V3, P123; KOZLOWSKI D, 1996, 26 M SOC NEUR, V22, P1905; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Lee VM, 1996, STROKE, V27, P2110, DOI 10.1161/01.STR.27.11.2110; Marchal G, 1996, STROKE, V27, P599, DOI 10.1161/01.STR.27.4.599; Mattsson B, 1997, STROKE, V28, P1225, DOI 10.1161/01.STR.28.6.1225; MCAULEY MA, 1995, CEREBROVAS BRAIN MET, V7, P153; Napieralski JA, 1996, J COMP NEUROL, V373, P484; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/0006-8993(96)00273-9; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; SANES JN, 1995, SCIENCE, V268, P1775, DOI 10.1126/science.7792606; Schmanke TD, 1996, J NEUROTRAUM, V13, P293, DOI 10.1089/neu.1996.13.293; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Seil FJ, 1997, CURR OPIN NEUROL, V10, P49; Sinclair SR, 1996, NEUROREPORT, V7, P2547, DOI 10.1097/00001756-199611040-00029; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; SUTTON RL, 1989, BEHAV NEUROSCI, V103, P837, DOI 10.1037/0735-7044.103.4.837; Witte OW, 1997, ADV NEUROL, V73, P207; [No title captured]	48	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1350-7540			CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	1997	10	6					493	497		10.1097/00019052-199712000-00010			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YQ035	WOS:000071340900010	9425563				2022-02-06	
J	Rosenberg, LJ; Lucas, JH				Rosenberg, LJ; Lucas, JH			The effects of ciliary neurotrophic factor on murine spinal cord neurons subjected to dendrite transection injury	BRAIN RESEARCH			English	Article						axotomy; cell death; ciliary neurotrophic factor; cytokine; neuronal cell culture; spinal cord injury; trophic factor	TRAUMATIC BRAIN INJURY; MOTOR-NEURONS; CELL-DEATH; C-FOS; ULTRASTRUCTURAL-CHANGES; FACTOR PREVENTS; CNTF RECEPTOR; MOTONEURONS; EXPRESSION; CULTURE	Ciliary neurotrophic factor (CNTF) has been found to increase neuronal survival during development and after axotomy. The present study tested the effects of CNTF on lesioned and uninjured mouse spinal cord (SC) neurons grown in tissue culture. An initial toxicity study found that a 24-72 h exposure of SC cultures to concentrations of CNTF above 1000 ng/ml caused stress and death of unlesioned neurons and glia. Pre-selected SC neurons were then subjected to transection of a primary dendrite 100 mu m from the edge of the perikaryon (approximate to 50% average survival at 24 h). Application of CNTF at concentrations ranging from 0.5 to 1000 ng/ml immediately after Iesioning had no statistically significant effects on SC neuron survival 24 h after dendrotomy. Separation of control (no CNTF) and CNTF-treated cells into groups of putative alpha-motor (multipolar with somal diameters greater than or equal to 25 mu m) and non-or-motor neurons (< 25 mu m somal diameters) also failed to reveal any significant differences in survival. The lack of protection by CNTF of lesioned SC neurons in mature (21-28 DIV) cultures may reflect a loss of sensitivity to CNTF that occurs with development. Alternatively, protection by CNTF may require co-factors or factors that are released from target or other cells after injury but that are not present in SC cultures. (C) 1997 Elsevier Science B.V.	Ohio State Univ, Dept Physiol, Columbus, OH 43210 USA		Lucas, JH (corresponding author), Ohio State Univ, Dept Physiol, Hamilton Hall,Room 404,1645 Neil Ave, Columbus, OH 43210 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029683] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS29683-04-08] Funding Source: Medline		APFEL SC, 1993, BRAIN RES, V605, P1; ARAWAKA Y, 1990, J NEUROSCI, V10, P3507; BARBIN G, 1984, J NEUROCHEM, V43, P1469; CLATTERBUCK RE, 1994, J COMP NEUROL, V342, P45, DOI 10.1002/cne.903420106; COFFER P, 1995, ONCOGENE, V10, P985; CURTIS R, 1993, NATURE, V365, P253, DOI 10.1038/365253a0; Davis S, 1993, Curr Opin Neurobiol, V3, P20, DOI 10.1016/0959-4388(93)90030-3; DIETRICH WD, 1996, J NEUROTRAUM, V13, P3009; DRAGUNOW M, 1990, EXP NEUROL, V107, P236, DOI 10.1016/0014-4886(90)90141-E; EMERY DG, 1987, EXP BRAIN RES, V67, P41, DOI 10.1007/BF00269451; FORGER NG, 1993, J NEUROSCI, V13, P4720; FRIEDMAN B, 1992, NEURON, V9, P295, DOI 10.1016/0896-6273(92)90168-D; GROSS GW, 1983, J NEUROSCI, V3, P1979; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; KATO AC, 1994, EXP NEUROL, V130, P196, DOI 10.1006/exnr.1994.1198; KORSCHING S, 1993, J NEUROSCI, V13, P2739; Lucas J H, 1985, Cent Nerv Syst Trauma, V2, P231; LUCAS JH, 1994, J NEUROTRAUM, V11, P35, DOI 10.1089/neu.1994.11.35; LUCAS JH, 1995, CRC S MEMBR, P353; MAGAL E, 1991, DEV BRAIN RES, V63, P141, DOI 10.1016/0165-3806(91)90074-S; MANTHORPE M, 1985, P77; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; Oyesiku NM, 1996, J COMP NEUROL, V364, P68, DOI 10.1002/(SICI)1096-9861(19960101)364:1<68::AID-CNE6>3.0.CO;2-Q; Peters A, 1976, FINE STRUCTURE NERVO, P406; Phillips H.J., 1973, TISSUE CULTURE METHO, P406, DOI [10.1016/b978-0-12-427150-0.50101-7, DOI 10.1016/B978-0-12-427150-0.50101-7]; PHILLIPS LL, 1992, J NEUROTRAUM, V9, P323, DOI 10.1089/neu.1992.9.323; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; Raghupathi R., 1996, Society for Neuroscience Abstracts, V22, P21; RANSOM BR, 1977, J NEUROPHYSIOL, V40, P1132, DOI 10.1152/jn.1977.40.5.1132; RINK A, 1995, AM J PATHOL, V147, P1575; Rosenberg LJ, 1996, J NEUROTRAUM, V13, P417, DOI 10.1089/neu.1996.13.417; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SNIDER WD, 1989, ANN NEUROL, V26, P489, DOI 10.1002/ana.410260402; STAHL N, 1994, J NEUROBIOL, V25, P1454, DOI 10.1002/neu.480251111; VEJSADA R, 1995, EUR J NEUROSCI, V7, P108, DOI 10.1111/j.1460-9568.1995.tb01025.x; Wewetzer K, 1990, Neuroreport, V1, P203, DOI 10.1097/00001756-199011000-00007; YIN QW, 1994, J NEUROSCI, V14, P7629	40	7	10	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	NOV 14	1997	775	1-2					209	213		10.1016/S0006-8993(97)00954-2			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YM275	WOS:000071047300025	9439846				2022-02-06	
J	Ellwanger, J; Rosenfeld, JP; Sweet, JJ				Ellwanger, J; Rosenfeld, JP; Sweet, JJ			P300 event-related brain potential as an index of recognition response to autobiographical and recently learned information in closed-head-injury patients	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	34th Annual Meeting of the Society-for-Psychophysiological-Research	OCT 06-09, 1994	ATLANTA, GA	Soc Psychophysiol Res			DETECTING SIMULATED AMNESIA; AUDITORY ODDBALL TASK	Fourteen patients who sustained a closed-head injury had their P300 (P3) measured in a visual recognition paradigm to test the use of P3 as an index of recognition in this population. Subjects participated in recognition tests for both autobiographical information (their birthday) and for a word list learned immediately before testing while event-related potentials were recorded. Within-subjects rests were used to determine that the P3 amplitude in response to oddball items (the subject's birthday and the studied word list) was larger than the P3 in response to non-oddball items for 9 of 11 subjects in the autobiographical condition, and 6 of 12 subjects in the word-list condition. Averaged P3s to oddball items were also larger than P3s to non-oddball items in standard group tests (p < .001), suggesting this difference can be used as an index of recognition in closed-head-injury patients.	Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; Evanston Hosp, Evanston, IL USA		Rosenfeld, JP (corresponding author), Northwestern Univ, Dept Psychol, 20209 Sheridan Rd, Evanston, IL 60208 USA.						DEACON D, 1991, ELECTROEN CLIN NEURO, V78, P133, DOI 10.1016/0013-4694(91)90113-I; Ellwanger J, 1996, INT J PSYCHOPHYSIOL, V23, P9, DOI 10.1016/0167-8760(96)00035-9; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; ROSENFELD JP, 1995, INT J PSYCHOPHYSIOL, V19, P1, DOI 10.1016/0167-8760(94)00057-L; Rosenfeld JP, 1996, CLIN NEUROPSYCHOL, V10, P163, DOI 10.1080/13854049608406678; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; Warrington E, 1984, RECOGNITION MEMORY T, V1	8	7	7	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	1997	11	4					428	432		10.1080/13854049708400473			5	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology; Neurosciences & Neurology	136GW	WOS:000076851900011					2022-02-06	
J	Baylis, GC; Bayliss, LL				Baylis, GC; Bayliss, LL			Deficit in figure-ground segmentation following closed head injury	NEUROPSYCHOLOGIA			English	Article						visual parsing; attention	VISUAL-ATTENTION; OBJECTS; ORGANIZATION; PERCEPTION; NEGLECT	Patient CB showed a severe impairment in figure-ground segmentation following a closed head injury. Unlike normal subjects, CB was unable to parse smaller and brighter parts of stimuli as figure. Moreover, she did not show the normal effect that symmetrical regions are seen as figure, although she was able to make overt judgments of symmetry. Since she was able to attend normally to isolated objects, CB demonstrates a dissociation between figure-ground segmentation and subsequent processes of attention. Despite her severe impairment in figure-ground segmentation, CB showed normal 'parallel' single feature visual search. This suggests that figure-ground segmentation is dissociable from 'preattentive' processes such as visual search. (C) 1997 Elsevier Science Ltd.	PRESBYTERIAN COLL,CLINTON,SC 29325		Baylis, GC (corresponding author), UNIV S CAROLINA,DEPT PSYCHOL,COLUMBIA,SC 29208, USA.			BAYLIS, Gordon/0000-0002-4223-9074	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29NS027296] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29 NS27296] Funding Source: Medline		BAYLIS GC, 1994, J EXP PSYCHOL HUMAN, V20, P208, DOI 10.1037/0096-1523.20.1.208; BAYLIS GC, 1995, J EXP PSYCHOL HUMAN, V21, P1323, DOI 10.1037/0096-1523.21.6.1323; BAYLIS GC, 1993, J EXP PSYCHOL HUMAN, V19, P451, DOI 10.1037/0096-1523.19.3.451; BAYLIS GC, 1992, PERCEPT PSYCHOPHYS, V51, P145, DOI 10.3758/BF03212239; BAYLIS GC, 1997, COGNITIVE NEUROSCIEN; BAYLIS GC, 1995, CURRENT DIRECTIONS P, V4, P201; DRIVER J, 1992, NATURE, V360, P73, DOI 10.1038/360073a0; DRIVER J, 1989, J EXP PSYCHOL HUMAN, V15, P448, DOI 10.1037/0096-1523.15.3.448; DRIVER J, 1995, CURRENT DIRECTIONS P, V4, P140; DRIVER J, IN PRESS COGNITIVE P; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GRABOWECKY M, 1993, J COGNITIVE NEUROSCI, V5, P288, DOI 10.1162/jocn.1993.5.3.288; JULSEZ B, 1984, DYNAMIC ASPECTS NEOC, P585; KARTSOUNIS LD, 1991, NEUROPSYCHOLOGIA, V29, P969, DOI 10.1016/0028-3932(91)90061-C; MACK A, 1992, COGNITIVE PSYCHOL, V24, P475, DOI 10.1016/0010-0285(92)90016-U; Rock I., 1984, PERCEPTION; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201, DOI 10.1080/02724988843000104; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WILKINSON L., 1990, SYSTAT SYSTEM STAT	20	7	7	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia	AUG	1997	35	8					1133	1138		10.1016/S0028-3932(97)00013-4			6	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	XM391	WOS:A1997XM39100009	9256378				2022-02-06	
J	Christensen, LV; McKay, DC				Christensen, LV; McKay, DC			Reflex jaw motions and jaw stiffness pertaining to whiplash injury of the neck	CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE			English	Article							SKELETAL-MUSCLE CONTRACTIONS; TEMPOROMANDIBULAR-JOINT; EXTENSION-FLEXION; PATHO-PHYSIOLOGY; PHYSICS; HUMANS; HEAD	Because a so-called mandibular whiplash injury requires the absence of short-latency jaw-closing reflexes in order to explain the postulated mechanism of injury (excessive jaw opening), the authors studied the presence and absence and, more importantly, the kinematics (duration, displacement, velocity, acceleration) of monosynaptic and, possibly, polysynaptic myotatic (stretch) reflexes in the jaw elevator muscles. In six healthy adults jaw jerk maneuvers were elicited through a brisk tap on the chin, and surface electromyography identified elevator reflexes while translational electrognathography identified the kinematics of the reflexes, The maneuvers were done while maintaining the rest position (3% MVC) and moderate clenching of the teeth (30% MVC). Electromyography was also used to identify phasic elevator excitations during a passive brisk neck extension maneuver, A sudden and unexpected elongation of the jaw elevators released autogenic reflex responses that, in conjunction with augmented tissue elasticity (stiffness), elevated the mandible into centric occlusion within approximately 150 milliseconds. In 86% of trials, the responses occurred regardless of the prevailing resting and clenching contractile activities. There was no evidence of a depressor force that consistently would and could anchor the mandible in a position of extreme or moderate depression, the theoretical linchpin of the mandibular whiplash injury. It was concluded that the mandibular locomotor system is very efficient in maintaining the rest and intercuspal positions of the mandible. This study found no evidence corroborating the mechanism claimed to release a so-called mandibular whiplash injury.									BAKKE M, 1993, SCAND J DENT RES, V101, P314; BERZIN F, 1995, J ORAL REHABIL, V22, P463, DOI 10.1111/j.1365-2842.1995.tb00802.x; CAILLIET R, 1981, NECK ARM PAIN, P73; CARR AB, 1991, J ORAL REHABIL, V18, P143, DOI 10.1111/j.1365-2842.1991.tb00041.x; Christensen L V, 1989, Swed Dent J Suppl, V60, P1; CHRISTENSEN LV, 1990, J ORAL REHABIL, V17, P473, DOI 10.1111/j.1365-2842.1990.tb01418.x; CHRISTENSEN LV, 1995, J ORAL REHABIL, V22, P521, DOI 10.1111/j.1365-2842.1995.tb01198.x; CHRISTENSEN LV, 1986, J ORAL REHABIL, V13, P451, DOI 10.1111/j.1365-2842.1986.tb01307.x; CHRISTENSEN LV, 1986, J ORAL REHABIL, V13, P463, DOI 10.1111/j.1365-2842.1986.tb01308.x; CHRISTENSEN LV, 1992, J ORAL REHABIL, V19, P615, DOI 10.1111/j.1365-2842.1992.tb01491.x; CHRISTENSEN LV, 1992, J ORAL REHABIL, V19, P471, DOI 10.1111/j.1365-2842.1992.tb01111.x; Christensen LV, 1996, J ORAL REHABIL, V23, P638; Christensen LV, 1996, J ORAL REHABIL, V23, P424, DOI 10.1111/j.1365-2842.1996.tb00874.x; CHRISTENSEN LV, 1991, J ORAL REHABIL, V18, P15, DOI 10.1111/j.1365-2842.1991.tb00026.x; CHRISTENSEN LV, 1996, J CRANIOMANDIB PRACT, V14, P240; DELAAT A, 1985, THESIS CATHOLIC U LE, P15; DONEGAN SJ, 1990, J ORAL REHABIL, V17, P509, DOI 10.1111/j.1365-2842.1990.tb01422.x; DUNN JJ, 1995, TEMPOROMANDIBULAR DI, P13; Ferrario VF, 1996, J ORAL REHABIL, V23, P401, DOI 10.1111/j.1365-2842.1996.tb00871.x; GIBBS CH, 1982, ADV OCCLUSION, P2; GOLDMAN DT, 1986, NBS PUBL, V330; GRANIT R, 1955, RECEPTORS SENSORY PE, P191; HELLSING G, 1978, THESSI CAROLINE I SC, P9; HOWARD RP, 1991, J ORAL MAXIL SURG, V49, P1210, DOI 10.1016/0278-2391(91)90418-L; HOWARD RP, 1995, J ORAL MAXIL SURG, V53, P256, DOI 10.1016/0278-2391(95)90220-1; KAWAMURA Y., 1957, MED JOUR OSAKA UNIV, V8, P247; Kossioni AE, 1995, ARCH ORAL BIOL, V40, P1143, DOI 10.1016/0003-9969(95)00080-1; LUND J P, 1991, Critical Reviews in Oral Biology and Medicine, V2, P33; LUNDBERG M, 1963, ACTA RADIOL S, V220, P7; MANNHEIMER J, 1989, Clinical Preventive Dentistry, V11, P29; McConnell W. E., 1995, 952724 SAE, P215; Michler L, 1987, J Craniomandib Disord, V1, P97; MOHAMED SE, 1985, J ORAL REHABIL, V12, P355, DOI 10.1111/j.1365-2842.1985.tb01290.x; OKESON JP, 1996, OROFACIAL PAIN GUIDE, P8; OSHAUGHNESSY T, 1994, SYNOPSIS; OTTENHOFF FAM, 1992, J NEUROPHYSIOL, V67, P75, DOI 10.1152/jn.1992.67.1.75; OTTENHOFF FAM, 1992, J NEUROPHYSIOL, V68, P933, DOI 10.1152/jn.1992.68.3.933; RUGH JD, 1982, BEHAVIORAL ASPECTS D, P179; SCHNEIDER K, 1989, J DENT RES, V68, P1360, DOI 10.1177/00220345890680091401; STEIGERWALD DP, 1992, WHIPLASH TEMPOROMAND, P1; TIMMER LM, 1967, THESIS U GRONINGEN, P20; TURKER KS, 1989, ELECTROMYOGRAPHY JAW, P237; WEINBERG S, 1987, J ORAL MAXIL SURG, V45, P653, DOI 10.1016/0278-2391(87)90302-8; WIDMALM SE, 1982, J ORAL REHABIL, V9, P479, DOI 10.1111/j.1365-2842.1982.tb01037.x; WIDMALM SE, 1988, J ORAL REHABIL, V15, P3, DOI 10.1111/j.1365-2842.1988.tb00142.x; WIDMALM SE, 1976, ACTA ODONTOL SCAND S, V72, P1; WIDMER CG, 1987, ARCH ORAL BIOL, V32, P135, DOI 10.1016/0003-9969(87)90057-4; ZAR JH, 1984, BIOSTAT ANAL, P206; [No title captured]	49	7	7	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0886-9634	2151-0903		CRANIO	Cranio-J. Craniomandib. Sleep Pract.	JUL	1997	15	3					242	260		10.1080/08869634.1997.11746018			19	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	XL688	WOS:A1997XL68800012	9586504				2022-02-06	
J	Souter, MJ; Andrews, PJD; Piper, IR; Miller, JD				Souter, MJ; Andrews, PJD; Piper, IR; Miller, JD			Effects of alfentanil on cerebral haemodynamics in an experimental model of traumatic brain injury	BRITISH JOURNAL OF ANAESTHESIA			English	Article; Proceedings Paper	Meeting of the Anaesthesia-Research-Society	JUL 01-02, 1994	ABERDEEN, SCOTLAND	Anaesthesia Res Soc		analgesics opioid, alfentanil; brain, injury; brain, blood flow; brain, intracranial pressure; rat	INTRACRANIAL-PRESSURE; SUFENTANIL; FENTANYL; FLOW; RAT	Alfentanil is reported to increase intracranial pressure (ICP) after neurotrauma. A direct cerebral vasodilator effect has been postulated. We studied 17 Sprague-Dawley rats allocated to one of three groups. Animals were anaesthetized and their lungs ventilated, and arterial pressure, ICP and/or regional cerebral blood flow (CBF) measurements were undertaken. Group 1 (n=6) received a severe closed head injury while group 2 (n=5) received no injury. ICP and mean arterial pressure (MAP) were measured before, during and after rapid infusion of alfentanil 250, 500 and 750 mu g kg(-1). CBF was measured by hydrogen clearance before rapid infusions and at 30-min intervals after starting a subsequent slow infusion of alfentanil 500 mu g kg(-1) h(-1). Group 3 (n=6) underwent CBF measurement only, for comparison with those of groups 1 and 2. They received an injury but no alfentanil. ICP or MAP values did not differ significantly between groups 1 and 2. Rapid i.v. doses of alfentanil produced increases in ICP and reductions in MAP. ICP changes were consistent with a drug effect (P<0.001) but were small. Reductions in MAP were significant (P<0.05) and preceded changes in ICP. CBF values were similar and unaffected by slow alfentanil infusion in groups 1 and 2, and did not differ significantly between groups 1 and 3. We conclude that alfentanil did not appear to exert a direct effect on the cerebral circulation. Changes in ICP after rapid infusion were secondary to reductions in SAP. Slow infusion did not cause such changes.			Souter, MJ (corresponding author), UNIV EDINBURGH,WESTERN GEN HOSP,DEPT CLIN NEUROSCI,CREWE RD S,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.		Souter, Michael/ABE-1890-2020				ASGEIRSSON B, 1994, INTENS CARE MED, V20, P567, DOI 10.1007/BF01705723; HANOWELL LH, 1993, J NEUROSURG ANESTH, V5, P31; HARGREAVES DM, 1992, ANAESTHESIA, V47, P1008, DOI 10.1111/j.1365-2044.1992.tb03225.x; HERRICK IA, 1991, ANESTH ANALG, V72, P359; Hoffmann P, 1987, Eur J Anaesthesiol Suppl, V1, P71; KISSIN I, 1991, ANESTHESIOLOGY, V75, P813, DOI 10.1097/00000542-199111000-00013; KOFKE WA, 1992, ANESTH ANALG, V75, P953; MARKOVITZ BP, 1992, ANESTHESIOLOGY, V76, P71, DOI 10.1097/00000542-199201000-00011; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marx W, 1989, J Neurosurg Anesthesiol, V1, P3, DOI 10.1097/00008506-198903000-00002; MAYBERG TS, 1993, ANESTHESIOLOGY, V78, P288, DOI 10.1097/00000542-199302000-00012; MONITTO CL, 1993, ANESTH ANALG, V76, P985; MOSS E, 1992, ANAESTHESIA, V47, P134, DOI 10.1111/j.1365-2044.1992.tb02011.x; PAZTOR E, 1973, STROKE, V4, P556; PIPER IR, 1993, J NEUROTRAUMA S1, V10, pS62; SCHREGEL W, 1992, ANAESTHESIST, V41, P21; YANG PK, 1992, ANESTHESIOLOGY, V77, P153, DOI 10.1097/00000542-199207000-00022; YANG PK, 1993, ANESTHESIOLOGY, V79, P635	18	7	7	0	0	PROF SCI PUBL	LONDON	TAVISTOCK HOUSE EAST, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0007-0912			BRIT J ANAESTH	Br. J. Anaesth.	JUL	1997	79	1					97	102		10.1093/bja/79.1.97			6	Anesthesiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	XM546	WOS:A1997XM54600018	9301396	Bronze			2022-02-06	
J	Tanaka, K; Ogawa, N; Asanuma, M; Kondo, Y				Tanaka, K; Ogawa, N; Asanuma, M; Kondo, Y			Thyrotropin releasing hormone prevents abnormalities of cortical acetylcholine and monoamines in mice following head injury	REGULATORY PEPTIDES			English	Article						cerebral cortex; acetylcholine; norepinephrine; dopamine; TRH; head injury; mice	CHOLINERGIC MECHANISMS; BRAIN INJURY; TRH; ANALOG; RAT; INVOLVEMENT; BEHAVIOR; RECOVERY; DENTATE	We investigated the effects of thyrotropin releasing hormone (TRH) on changes in cortical concentrations of acetylcholine (ACh) and monoamines produced by concussion in mice. Concussion was induced by dropping a metal rod on the head, and the concentration of ACh, norepinephrine (NE), dopamine (DA) and serotonin (5-HT) in the cerebral cortex were measured by HPLC. We also examined the arousal effects of 0.5 mg/kg of TRH and 0.015 mg/kg of L-pyro-2-aminoadipyl-histidyl-thiazolidine-4-carboxamide (MK-771), a TRH analogue, injected intraperitoneally 10 min before concussion, on neurotransmitter concentrations. Mice were sacrificed at 25 (representing the righting reflex time) and 210 s (representing spontaneous movement time). At 25 s after concussion, the concentration of ACh was significantly higher than in control mice, but pretreatment with TRH and MK-771 prevented the rise in ACh. In contrast, head injury significantly reduced NE concentration. TRH and MK-771 also prevented the fall in NE. Concussion did not change cortical concentrations of DA and 5-HT. Our results suggest that disturbances of consciousness produced by concussion may be due to increased ACh and diminished NE in the cerebral cortex. Our findings also suggest that the arousal effects of TRH on concussion-induced disturbances of consciousness are due to normalization of cortical cholinergic and noradrenergic neuronal systems. (C) 1997 Elsevier Science B.V.	OKAYAMA UNIV,SCH MED,DEPT NEUROSCI,INST MOL & CELLULAR MED,OKAYAMA 700,JAPAN; SAITAMA MED SCH,DEPT PHYSIOL,MOROYAMA,SAITAMA 35004,JAPAN								Adams JH, 1975, HDB CLIN NEUROLOGY, V23, P35; BROWN M, 1975, ENDOCRINOLOGY, V96, P1333, DOI 10.1210/endo-96-5-1333; COOPER JR, 1991, BIOCH BASIS NEUROPHA, P454; DAIL WG, 1981, BRAIN RES, V211, P79, DOI 10.1016/0006-8993(81)90068-8; Faden AI, 1996, PHARMACOL TOXICOL, V78, P12, DOI 10.1111/j.1600-0773.1996.tb00173.x; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FEENEY DM, 1985, PHYSIOL PSYCHOL, V13, P197; Ganong WF, 1995, REV MED PHYSL, V17th, P781; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; HENNIES HH, 1982, BIOCHEM PHARMACOL, V31, P2430, DOI 10.1016/0006-2952(82)90541-X; HORST WD, 1974, LIFE SCI, V15, P1073; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; ITO Y, 1993, J PHARMACOL EXP THER, V268, P255; LYNCH MA, 1986, NEUROPHARMACOLOGY, V25, P493, DOI 10.1016/0028-3908(86)90173-5; MANAKA S, 1977, IGAKU NO AYUMI, V102, P867; Markianos M, 1996, ACTA NEUROCHIR, V138, P57, DOI 10.1007/BF01411725; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; METCALF G, 1974, NATURE, V252, P310, DOI 10.1038/252310a0; MIYAMOTO M, 1982, PHARMACOL BIOCHEM BE, V17, P797, DOI 10.1016/0091-3057(82)90363-X; MIYAMOTO M, 1977, EUR J PHARMACOL, V44, P143, DOI 10.1016/0014-2999(77)90100-5; NAGAI Y, 1980, J PHARMACOBIO-DYNAM, V3, P500, DOI 10.1248/bpb1978.3.500; OGAWA N, 1994, BRAIN RES, V633, P167, DOI 10.1016/0006-8993(94)91536-9; OGAWA N, 1982, IRCS MED SCI-BIOCHEM, V10, P512; OGAWA N, 1986, TRH SPINOCEREBELLAR, P25; OKA M, 1989, ARZNEIMITTEL-FORSCH, V39-1, P297; OKUDA C, 1987, LIFE SCI, V40, P1293, DOI 10.1016/0024-3205(87)90586-8; POPOLI P, 1989, EUR J PHARMACOL, V173, P211, DOI 10.1016/0014-2999(89)90523-2; PUIL E, 1990, BRIT J PHARMACOL, V101, P61, DOI 10.1111/j.1476-5381.1990.tb12089.x; RASTOGI RB, 1981, EUR J PHARMACOL, V73, P307, DOI 10.1016/0014-2999(81)90231-4; SANO K, 1979, ADV NEUROL SCI, V23, P184; Sasaki M, 1987, No To Shinkei, V39, P983; SCHMIDT DE, 1977, COMMUN PSYCHOPHARMAC, V1, P469; STANTON PK, 1989, EXP BRAIN RES, V77, P517; SYMONDS C, 1962, LANCET, V1, P1; TANAKA K, 1992, REGUL PEPTIDES, V38, P129, DOI 10.1016/0167-0115(92)90051-U; Tandian D, 1990, J NEUROTRAUM, V9, P174; TRABUCCHI M, 1975, PHARMACOL RES COMMUN, V7, P81, DOI 10.1016/S0031-6989(75)80032-4; WEI E, 1975, NATURE, V253, P739, DOI 10.1038/253739a0; WEISS HR, 1988, EUR J PHARMACOL, V148, P107, DOI 10.1016/0014-2999(88)90459-1; YARBROUGH GG, 1978, EUR J PHARMACOL, V48, P19, DOI 10.1016/0014-2999(78)90040-7	40	7	7	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-0115			REGUL PEPTIDES	Regul. Pept.	JUN 18	1997	70	2-3					173	178		10.1016/S0167-0115(97)01013-6			6	Endocrinology & Metabolism; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Physiology	XQ996	WOS:A1997XQ99600012	9272630				2022-02-06	
J	Dohrmann, GJ; Rubin, JM				Dohrmann, GJ; Rubin, JM			Neurotraumatology: Ultrasonic evaluation of the central nervous system	NEUROLOGICAL RESEARCH			English	Article						neurotrauma; ultrasound; neurosonology; brain; spinal cord	HEMORRHAGE	In this study we describe the technique of intraoperative ultrasound imaging of brain and spinal cord in trauma patients. The images are shown and their interpretation is discussed. This intraoperative imaging allows for localization of hematomas, bone fragments and indriven foreign bodies (i.e., pieces of plastic, glass, metal, etc.). Disc material and bone fragments deep to the spinal cord can be localized with this technique. Real-time ultrasound can be used to guide instruments within the brain and, thereby, provide dynamic guidance for removal of bone fragments and foreign bodies dynamically. In summary, intraoperative real-time ultrasonic imaging is of use to the neurosurgeon in the treatment of the neurotrauma patient.	UNIV MICHIGAN,MED CTR,DEPT RADIOL,ANN ARBOR,MI 48109		Dohrmann, GJ (corresponding author), UNIV CHICAGO,MED CTR,SECT NEUROSURG MC3026,5841 S MARYLAND AVE,CHICAGO,IL 60637, USA.						CHANDLER WF, 1984, CLIN NEUROSURG, V31, P550; DOHRMANN GJ, 1981, SURG NEUROL, V16, P362, DOI 10.1016/0090-3019(81)90279-2; DOHRMANN GJ, 1995, NEUROSURGERY, P575; DOHRMANN GJ, 1996, NEUROSONOLOGY, P417; ENZMANN DR, 1981, AM J NEURORADIOL, V2, P517; KOIVUKANGUS J, 1984, ACTA U OULUENSIS D, V115, P1; LILLEHEI KO, 1984, NEUROSURGERY, V14, P48, DOI 10.1227/00006123-198401000-00010; RUBIN JM, 1983, RADIOLOGY, V148, P519, DOI 10.1148/radiology.148.2.6867352; RUBIN JM, 1982, SURG NEUROL, V18, P143, DOI 10.1016/0090-3019(82)90375-5; RUBIN JM, 1990, ULTRASOUND NEUROSURG	10	7	8	0	1	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897	0161-6412			NEUROL RES	Neurol. Res.	JUN	1997	19	3					317	322		10.1080/01616412.1997.11740819			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XC468	WOS:A1997XC46800018	9192386				2022-02-06	
J	Woischneck, D; Firsching, R; Ruckert, N; Hussein, S; Heissler, H; Aumuller, E; Dietz, H				Woischneck, D; Firsching, R; Ruckert, N; Hussein, S; Heissler, H; Aumuller, E; Dietz, H			Clinical predictors of the psychosocial long term outcome after brain injury	NEUROLOGICAL RESEARCH			English	Article						brain injury; outcome; quality of life; cranial computerized tomography	SEVERE HEAD-INJURY	The correlation of clinical with psychological and social data is ail attempt to find predictors of the definite long term outcome after brain injury. 34 patients were reexamined 3 to 8 years after the accident using a number of psychological tests. Additionally, life duality was defined and evaluated. Only patients with an initial Glasgow Coma Scale-Score of 3-12, an intracranial traumatic lesion on computertomography and age 16-65 years at the time of accident were included in this study. Patients exhibited a uniform pattern of disturbances in psychosocial long term outcome. These disturbances were compared with initial clinical data: memory, attention and learning were significantly correlated with the duration of coma and the presence of additional extracerebral injuries. From the initial computerized tomography, the findings 'compression of basal cisterns' and 'intracerebral contusion' showed to be predictors of the cerebral function. Late social status and behavior, defined as quality of life, were clearly related with initial clinical findings. In conclusion, there are early clinical predictors of the long term social and psychological outcome after brain injury.	HANNOVER MED SCH, NEUROCHIRURG KLIN, HANNOVER, GERMANY		Woischneck, D (corresponding author), OTTO VON GUERICKE UNIV, FAK MED, NEUROCHIRURG KLIN, LEIPZIGERSTR 44, D-39120 MAGDEBURG, GERMANY.						Athiappan S., 1993, Annals Academy of Medicine Singapore, V22, P452; BOWERS SA, 1980, NEUROSURGERY, V6, P237; BRUCE DA, 1978, CRIT CARE MED, V6, P254, DOI 10.1097/00003246-197807000-00006; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; COULDWELL WT, 1996, J NEUROSURG, V84, P29; DONGEN KJ, 1983, J NEUROSURG, V59, P951; FORMISANO R, 1991, ACTA NEUROCHIR, V109, P1, DOI 10.1007/BF01405688; Frowein R A, 1988, Acta Neurochir Suppl (Wien), V44, P70; GODERSKY JC, 1990, ACT NEUR S, V51, P311; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; JENETT B, 1975, LANCET, V1, P480; KATZ DL, 1994, ARCH NEUROL-CHICAGO, V51, P663; LEZAK DL, 1983, NEUROPSYCHOLOGICAL A, P421; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; QUATTROCCHI KB, 1991, SURG NEUROL, V35, P183, DOI 10.1016/0090-3019(91)90069-L; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613	17	7	7	0	3	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897	0161-6412			NEUROL RES	Neurol. Res.	JUN	1997	19	3					305	310		10.1080/01616412.1997.11740817			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XC468	WOS:A1997XC46800016	9192384				2022-02-06	
J	Davis, CH; Fardanesh, L; Rubner, D; Wanlass, RL; McDonald, CM				Davis, CH; Fardanesh, L; Rubner, D; Wanlass, RL; McDonald, CM			Profiles of functional recovery in fifty traumatically brain-injured patients after acute rehabilitation	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Functional Independence Measure (FIM(TM)); Davis Functional Status Measure; traumatic brain injury; rehabilitation		Research to demonstrate the efficacy of head injury rehabilitation is important at a time when cost-containment efforts are intensifying. A useful tool that would predict the functional improvement during hospitalization and length of stay (LOS) of persons with traumatic brain injury would be of benefit to patients and their families, insurance carriers, and rehabilitation specialists. This study examines functional improvements made by 50 traumatic brain-injured patients admitted to the rehabilitation unit at the University of California, Davis, Medical Center (UCDMC) as measured by the UCDMC Davis Functional Status Measure (DFSM), which was adapted from the Functional Independence Measure (FIMTM). Th, DFSM incorporates additional items to provide a more thorough measure of skills to be rehabilitated. The purpose of this study was to compare scores and profiles on the DFSM items obtained by patients with LOS greater than and less than and equal to the median rehabilitation LOS (23 days). Relationships were explored among admission DFSM scores, LOS for rehabilitation, discharge destination, and functional outcome. Results indicate that patients admitted to the rehabilitation unit attained a similar profile or level of function by discharge, regardless of admission Glasgow Coma Scale scores or admission DFSM scores. There were no significant differences in admission Glasgow Coma Scale score, age, acute LOS, or discharge disposition between the LOS groups. There was a significant difference in median admission DFSM score in 26 of 31 categories between the LOS groups. There was a significant difference in median DFSM change (admission to discharge) in 24 of 31 categories between the LOS groups. The admission DFSM total score was inversely proportional to the length of stay, with a correlation coefficient of 0.78. DFSM change and admission to discharge was linearly correlated with LOS (R = 0.66). The DFSM documents functional outcome and measures gains during inpatient rehabilitation. The DFSM profile is helpful in predicting the LOS needed to achieve those gains.			Davis, CH (corresponding author), UNIV CALIF DAVIS,MED CTR,DEPT PHYS MED & REHABIL,2315 STOCKTON BLVD,ROOM G503,SACRAMENTO,CA 95817, USA.			McDonald, Craig/0000-0002-8779-3220			BUNCH WH, 1994, AM J PHYS MED REHAB, V73, P40, DOI 10.1097/00002060-199473010-00010; COOK L, 1994, ARCH PHYS MED REHAB, V75, P390, DOI 10.1016/0003-9993(94)90160-0; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; GRANGER CV, 1992, AM J PHYS MED REHAB, V71, P108, DOI 10.1097/00002060-199204000-00009; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; Heinemann AW, 1990, J NEUROL REHABIL, V4, P27; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; JOHNSTON MV, 1994, AM J PHYS MED REHAB, V73, P296, DOI 10.1097/00002060-199407000-00014; LAUGHLIN J, 1992, REHABIL MANAGEME DEC, P57; MALKMUS D, 1980, REHABILITATION HEAD; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; Racino J. A., 1994, J HEAD TRAUMA REHAB, V9, P35; SAHGAL V, 1989, SCAND J REHABIL MED, V21, P71	14	7	7	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY-JUN	1997	76	3					213	218		10.1097/00002060-199705000-00011			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	XG430	WOS:A1997XG43000010	9207707				2022-02-06	
J	Savitz, MH				Savitz, MH			Another look at ventriculosubgaleal shunting procedures	MOUNT SINAI JOURNAL OF MEDICINE			English	Article						closed head injury; Cushing's triad; intracranial pressure; cerebral contusion; hydrocephalus	HEAD TRAUMA	Ventriculosubgaleal shunts were available at the turn of the century as a treatment for hydrocephalus. Almost 80 years later, Ferret and Graf advocated such shunting for the temporary decompression of ventricles enlarged by tumors or by hydrocephalus. The use of a subgaleal shunt in acute head trauma was first published in 1983. No direct measurement of intracranial pressure was attempted in 30 cases. Evidence by computed tomography of compressed ventricles and cerebral contusion correlated well with elevated pressure. When the Camino intracranial pressure monitor became available, the device was inserted before placement of the shunt to assess the appropriateness and efficacy of the method in 21 patients. An additional 22 cases of intraventricular hemorrhage with acute hydrocephalus were treated over a 17-year period. The simple method of shunting into the subgaleal space has broad application for the temporary relief of increased intracranial pressure or high-pressure hydrocephalus.	NYACK HOSP,DEPT SURG,DIV NEUROSURG,ROCKLAND,NY; GOOD SAMARITAN HOSP,ROCKLAND,NY								DAVIDOFF LM, 1929, ARCH SURG-CHICAGO, V18, P1737; DRABKIN AJ, 1980, ACTA NEUROCHIR WIEN, V55, P107; PERRET GE, 1977, J NEUROSURG, V47, P590, DOI 10.3171/jns.1977.47.4.0590; SAVITZ MH, 1983, CRIT CARE MED, V11, P290, DOI 10.1097/00003246-198304000-00009; SAVITZ MH, IN PRESS J NEUROL OR; SAVITZ MH, 1991, J NEUROL ORTH MED S, V12, P205; TABADDOR K, 1982, SURG NEUROL, V18, P212, DOI 10.1016/0090-3019(82)90395-0; VENES J, 1980, CHILD BRAIN, V7, P236	8	7	7	1	1	MOUNT SINAI HOSPITAL	NEW YORK	BOX 1094 ONE GUSTAVE L LEVY PLACE ATTN: CIRCULATION ASST, NEW YORK, NY 10029-6574	0027-2507			MT SINAI J MED	Mt. Sinai J. Med.	MAY	1997	64	3					189	193					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WX203	WOS:A1997WX20300009	9145668				2022-02-06	
J	Maeshima, S; Uematsu, Y; Ozaki, F; Fujita, K; Nakai, K; Itakura, T; Komai, N				Maeshima, S; Uematsu, Y; Ozaki, F; Fujita, K; Nakai, K; Itakura, T; Komai, N			Impairment of short-term memory in left hemispheric traumatic brain injuries	BRAIN INJURY			English	Article							CONDUCTION APHASIA	We report on two patients with traumatic lesions in the temporal and parietal lobes who demonstrated disturbances of short-term memory (STM) following improvement on the aphasia. Patient 1 was a 66-year-old right-handed man who presented to our hospital with a cerebral contusion. One admission we observed a Wernicke's aphasia with paraphasic jargon in this patient that resolved within 8 weeks. Patient 2 was a 35-year-old right-handed woman, with an acute subdural haematoma and a cerebral contusion, who underwent craniotomy and evacuation of the haematoma. In this patient we noted a transient Wernicke's aphasia following the operation that improved within 3 months. Linguistically, the aphasia observed in each of these two patients was not a typical conduction aphasia because of the absence of paraphasia, and impairment of comprehension was unclear despite a decrease in performance on repetition tasks. Both verbal and non-verbal tasks suggested an impairment in STM. These findings suggest that involvement of the left hemisphere may cause disturbances in both verbal and non-verbal STM.			Maeshima, S (corresponding author), WAKAYAMA MED COLL,DEPT NEUROL SURG,27 NANABAN CHO,WAKAYAMA 640,JAPAN.			Maeshima, Shinichiro/0000-0002-0808-3432			CERMAK LS, 1976, BRAIN LANG, V3, P16, DOI 10.1016/0093-934X(76)90002-X; DUBOIS J, 1964, NEUROPSYCHOLOGIA, V2, P9, DOI 10.1016/0028-3932(64)90029-6; GORDON WP, 1983, NEUROPSYCHOLOGIA, V21, P325, DOI 10.1016/0028-3932(83)90019-2; HEILMAN KM, 1976, BRAIN LANG, V3, P201, DOI 10.1016/0093-934X(76)90017-1; HIGO K, 1985, HIGHER BRAIN FUNCTIO, V5, P33; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; SAMUELS I, 1971, PHYSIOL BEHAV, V6, P447, DOI 10.1016/0031-9384(71)90181-8; SHALLICE T, 1977, BRAIN LANG, V4, P479, DOI 10.1016/0093-934X(77)90040-2; SHALLICE T, 1970, Q J EXP PSYCHOL, V22, P261, DOI 10.1080/00335557043000203; VALLAR G, 1984, COGNITIVE NEUROPSYCH, V1, P121, DOI 10.1080/02643298408252018; WARRINGTON EK, 1969, BRAIN, V92, P885, DOI 10.1093/brain/92.4.885	11	7	7	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	APR	1997	11	4					279	286					8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WQ736	WOS:A1997WQ73600005	9134202				2022-02-06	
J	Brooker, AE				Brooker, AE			Performance on the Wechsler Memory Scale-Revised for patients with mild traumatic brain injury and mild dementia	PERCEPTUAL AND MOTOR SKILLS			English	Article								The purpose of this study was to delineate significant differences among mild traumatic brain-injured and early onset mild dementia patients examined using the Wechsler Memory Scale-Revised subtests. In comparison to 12 mild traumatic brain-injured patients, 11 mild dementia patients scored significantly lower on Verbal Paired Associates I and II, Visual Reproduction I and II, and Visual Paired Associates I. Raw score summaries for the Wechsler Memory Scale-Revised indicated significantly lower scores on Verbal Memory, Visual Memory, and the over-all composite General Memory for mild dementia patients in comparison to individuals who sustained a mild traumatic brain injury. Despite equivalent scores on Attention/Concentration, the dementia group did not show significantly lowered delay in memory recall by comparison with mild closed-head injured patients. The study recommends replication with much larger sample sizes to validate the results.									ALBERT MS, 1988, GERIATRIC NEUROPSYCH, P33; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BOYER CL, 1991, AM PSYCH CONV SAN FR; CROSSEN JR, 1988, CLIN NEUROPSYCHOL, V2, P393; GOODWIN DM, 1989, DICT NEUROPSYCHOLOGY, P79; Heaton RK, 1991, COMPREHENSIVE NORMS; HUPPERT FA, 1986, BRIT MED BULL, V42, P11, DOI 10.1093/oxfordjournals.bmb.a072089; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LORING DW, 1989, CLIN NEUROPSYCHOL, V3, P59, DOI DOI 10.1080/13854048908404077; Mateer CA, 1990, COGNITIVE REHABILITA, P68; MATEER CA, 1992, REHABILITATION POSTC, P143; MATTIS S, 1976, DEMENTIA RATING SCAL, P77; NIEMANN H, 1989, THESIS U VICTORIA BR; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Ruff R. M., 1989, J HEAD TRAUMA REHAB, V4, P20, DOI [10.1097/00001199-198909000-00006, DOI 10.1097/00001199-198909000-00006]; SOHLBERG MM, 1989, J CLIN EXPT NEUROPSY, V2, P871; TERRY RD, 1983, ANN NEUROL, V14, P497, DOI 10.1002/ana.410140502; TWUM M, 1994, J CLIN EXP NEUROPSYC, V16, P630, DOI 10.1080/01688639408402674; WEBER M, 1989, J HEAD TRAUMA REHABI, V5, P73; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; ZEC R, 1991, 1991 AM PSYCH CONV S	23	7	7	0	3	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	FEB	1997	84	1					131	138					8	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	WK483	WOS:A1997WK48300024	9132701				2022-02-06	
J	Hoffmann, RG; Tremont, G; Scott, JG; Adams, RL; Mittenberg, W				Hoffmann, RG; Tremont, G; Scott, JG; Adams, RL; Mittenberg, W			Cross-validation of predicted Wechsler memory scale - revised scores in a normative sample of 25- to 34-year-old patients	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article								Equations for prorating Wechsler Memory Scale-Revised General Memory (GM) and Delayed Recall (DR) index scores (Woodward Be Axelrod, 1995) were confirmed in the Mittenberg Burton, Darrow, and Thompson (1992) normative WMS-R sample of 50 subjects between the ages of 25 and 34, and confirmed in a separate clinical sample of 30 patients with closed head injury who were age, education, and gender matched with 30 subjects from that normative sample. Predicted GM and DR index scores fell within 6 points of the obtained scores for 98% of the the Mittenberg et al. (1992) sample and 93% to 100% of the marched head injury and normative samples, despite statistically significant differences between these groups in obtained GM, DR, and percent retention of LM I and II and VR I and II. Sir points is well within the standard error of measurement of these index scores. These findings confirm the earlier cross-validation results reported by Axelrod, Putnam, Woodward, and Adams (1996) in a mixed sample of traumatic brain injury and other neurological insult, and suggest that this method of estimating weighted score sums for WMS-R General Memory and Delayed Recall indices may be safely used in normative samples of patients in this age range as well as neurologically compromised patients without significantly impacting index score accuracy. (C) 1997 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	BROWN UNIV,PROVIDENCE,RI 02912; UNIV OKLAHOMA,CTR HLTH SCI,NORMAN,OK 73019; NOVA SE UNIV,FT LAUDERDALE,FL 33314		Hoffmann, RG (corresponding author), UNIV MINNESOTA,DEPT BEHAV SCI,10 UNIV DR,DULUTH,MN 55812, USA.						Axelrod BN, 1996, PSYCHOL ASSESSMENT, V8, P73; BLACK FW, 1973, PSYCHOL REP, V33, P919, DOI 10.2466/pr0.1973.33.3.919; LARRABEE GJ, 1983, J CLIN NEUROPSYCHOL, V5, P159, DOI 10.1080/01688638308401162; Mittenberg W., 1992, PSYCHOL ASSESSMENT, V4, P363; *NAT I NEUR DIS ST, 1989, INT HEAD INJ TASK FO; NAUGLE RI, 1993, ARCH CLIN NEUROPSYCH, V8, P381, DOI 10.1016/0887-6177(93)90002-I; PRIGATANO GP, 1978, J CLIN PSYCHOL, V34, P816, DOI 10.1002/1097-4679(197810)34:4<816::AID-JCLP2270340402>3.0.CO;2-Q; RUSSELL EW, 1975, J CONSULT CLIN PSYCH, V43, P800, DOI 10.1037/0022-006X.43.6.800; SKILBECK C E, 1980, Journal of Clinical Neuropsychology, V2, P293, DOI 10.1080/01688638008403801; Wechsler D, 1987, MEMORY SCALE REVISED; WILLIAMSON DJ, 1996, NEUROPSYCHOLOGY CLIN, P10; Woodard JL, 1995, PSYCHOL ASSESSMENT, V7, P445; WOODARD JL, 1993, J CLIN EXP NEUROPSYC, V15, P968, DOI 10.1080/01688639308402611; [No title captured]	14	7	7	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1997	12	7					677	682					6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	YB885	WOS:A1997YB88500007	14590661				2022-02-06	
J	Silver, JM; Rattok, J; Anderson, K				Silver, JM; Rattok, J; Anderson, K			Post-traumatic stress disorder and traumatic brain injury	NEUROCASE			English	Article						post-traumatic stress disorder; traumatic amnesia		The co-existence of post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) has rarely been reported. It has been hypothesized that this co-morbidity is unusual since amnesia for the traumatic event would be protective against the development of PTSD. In this paper, we present seven individuals who developed the full syndrome of PTSD after TBI. We discuss the clinical features that are characteristic of PTSD and not commonly found in those individuals who have TBI without PTSD. We believe that this comorbidity is not uncommon, and can be detected with a thorough psychiatric evaluation.	COLUMBIA UNIV,DEPT PSYCHIAT,NEW YORK,NY; LONG ISL JEWISH MED CTR,MANHASSET,NY								American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Blake D., 1995, CLIN ADM PTSD SCALE; BORNSTEIN RA, 1988, NEUROSURGERY, V23, P622, DOI 10.1227/00006123-198811000-00013; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1015; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Epstein Richard S., 1994, P285; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; First MB, 1995, STRUCTURED CLIN INTE; Hammaiberg M., 1992, PSYCHOL ASSESSMENT, V4, P67, DOI [10.1037/1040-3590.4.1.67, DOI 10.1037/1040-3590.4.1.67]; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kraus Jess F., 1994, P3; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Parker RS, 1996, J CLIN PSYCHOL, V52, P32, DOI 10.1002/(SICI)1097-4679(199601)52:1<32::AID-JCLP5>3.3.CO;2-1; RATTOK J, 1996, P J HEAD TRAUM REH, V11, P95; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SILVER JM, 1997, IN PRESS TXB NEUROPS; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; 1996, HARV MENTAL HLTH LET, V12, P1	25	7	7	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD, ENGLAND OX2 6DP	1355-4794			NEUROCASE	Neurocase		1997	3	2					151	157		10.1080/13554799708404048			7	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	XL491	WOS:A1997XL49100008					2022-02-06	
J	Lill, H; Sangmeister, M; Hillrichs, B; Lange, K; Echtermeyer, V				Lill, H; Sangmeister, M; Hillrichs, B; Lange, K; Echtermeyer, V			Bilateral luxatio erecta of the shoulder joint - A rare injury. Management and therapy of a patient with multiple trauma	UNFALLCHIRURG			German	Article						luxatio erecta humeri; bilateral; treatment strategy	DISLOCATION	The case of a 36-year-old male patient is reported who fell from 20 m, sustaining injuries to the abdomen and pelvis and fractures of both arms and the left leg as well as erect dislocation of both shoulders (luxatio erecta humeri). The injury on the right was subcoracoid, that on the left subglenoid - a compound dislocation of the humerus head through the axilla. Based on this case and the pertinent literature, the pathophysiology, diagnosis and treatment of this rare injury are discussed. After immediate closed reduction, soft tissue damage, fractures or neurovascular lesions should be operated on as soon as possible.			Lill, H (corresponding author), KLINIKUM MINDEN,UNFALLCHIRURG KLIN,FRIEDRICHSTR 17,D-32427 MINDEN,GERMANY.						BOURGEON R, 1950, Afr Fr Chir, V6, P223; DAVIDS JR, 1990, CLIN ORTHOP RELAT R, V252, P144; DOWNEY EF, 1983, AM J ROENTGENOL, V140, P1207, DOI 10.2214/ajr.140.6.1207; FERY A, 1987, INT ORTHOP, V11, P9; KOBIENIA G, 1976, AKTUEL TRAUMATOL, V6, P227; LANGFRITZ H U, 1956, Monatsschr Unfallheilkd Versicherungsmed, V59, P367; LASKIN S, 1971, CLIN ORTHOPAEDICS, V80, P126; LEVEL A, 1981, J TRAUMA, V21, P323, DOI 10.1097/00005373-198104000-00011; Mallon W J, 1990, J Orthop Trauma, V4, P19; Middeldorpf M, 1859, CLIN EUROPENNE, V2, P12; Murrard J, 1920, REV ORTHOP, V7, P423; NEWMAN KJH, 1993, INJURY, V24, P684, DOI 10.1016/0020-1383(93)90323-X; PEIRO A, 1975, INJURY, V6, P294, DOI 10.1016/0020-1383(75)90176-X; Rockwood C., 1991, FRACTURES ADULTS; SARKAR MR, 1989, UNFALLCHIRURG, V92, P17	15	7	7	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	OCT	1996	99	10					801	805		10.1007/s001130050058			5	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	VQ372	WOS:A1996VQ37200013	9005570				2022-02-06	
J	DellaCorte, F; Clemente, A; Mignani, V; Rollo, M				DellaCorte, F; Clemente, A; Mignani, V; Rollo, M			Diagnosis of traumatic carotid-cavernous sinus fistula by monitoring venous oxygen saturation in the jugular bulb: Report of two cases	NEUROSURGERY			English	Article						acute bead injury; carotid-cavernous sinus fistula; jugular vein	SEVERE BRAIN INJURY; CEREBRAL OXYGENATION	OBJECTIVE AND IMPORTANCE: A traumatic carotid-cavernous sinus fistula (CCF) Is rarely diagnosed early and may sometimes be missed until clinical signs and symptoms appear. The continuous monitoring of cerebral venous oxygen saturation may reveal the presence of a CCF by means of a fiberoptic catheter that records very high oxygen saturation values when positioned in the jugular bulb. CLINICAL PRESENTATION: We report two cases of early diagnosis of CCFs unexpectedly revealed by monitoring the jugular bulb for venous oxygen saturation values that approximated arterial saturation values. One case was diagnosed on Day 3 after admission, and the other was diagnosed shortly after cannulation of the ipsilateral jugular bulb. INTERVENTION: Confirmation of the diagnosis of CCF was obtained by angiography. Intravascular treatment was performed in one case. CONCLUSION: These cases add another diagnostic role to cerebral venous oxygen saturation monitoring. When high cerebral venous oxygen saturation values rapidly or abruptly reach arterial oxygen saturation, the presence of a CCF must be considered and confirmed by arterial angiography.	UNIV CATTOLICA SACRO CUORE, SCH MED, INST ANESTHESIOL & INTENS CARE, I-00168 ROME, ITALY; UNIV CATTOLICA SACRO CUORE, SCH MED, INST RADIOL, I-00168 ROME, ITALY				Della Corte, Francesco/ABI-7646-2020	Della Corte, Francesco/0000-0003-1736-2318			ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; Cruz J, 1988, Acta Neurochir Suppl (Wien), V42, P35; CRUZ J, 1991, NEUROSURGERY, V29, P743, DOI 10.1227/00006123-199111000-00017; CRUZ J, 1993, CRIT CARE MED, V21, P1225, DOI 10.1097/00003246-199308000-00025; DEARDEN NM, 1993, ACTA NEUROCHIR, P91; GARLICK R, 1987, SCAND J CLIN LAB INV, V47, P47; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; TAKENOSHITA Y, 1990, J CRANIO MAXILL SURG, V18, P41, DOI 10.1016/S1010-5182(05)80602-X; [No title captured]	11	7	7	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	1996	39	2					390	392					3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UY523	WOS:A1996UY52300073	8832679				2022-02-06	
J	Peter, KS; Hsu, JD; Keenan, MAE; Romansky, SG				Peter, KS; Hsu, JD; Keenan, MAE; Romansky, SG			Histology and intramuscular pressure in spastic muscle	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						compartment pressures; denervation; histology muscle biopsy; reinnervation; spasticity		A prospective study was performed to delineate the pathologic processes occurring in the degradation of muscle function with the onset of spasticity. Sixteen adult patients with spasticity secondary to traumatic brain injury (TBI) were evaluated clinically and histologically. Short-term patients showed even distribution of mild, moderate, and severe spasticity, while moderate spasticity predominated in the chronic group. Motor control was predominately selective with pattern overlay in both groups. Muscles with spasticity of less than 6 months duration showed nonspecific histologic changes. Muscles with spasticity of duration longer than 1 year demonstrated neurogenic atrophy, some also showed signs of denervation followed by reinnervation. No evidence of compartment syndrome was found in the spastic muscles studied. Transient high elevation of intramuscular pressure was noted in some patients during muscle stretch or activity. Muscles that become spastic following TBI demonstrate neurogenic degeneration, generally apparent greater than 1 year after the injury. Prior to this, spastic muscles demonstrate nonspecific atrophic changes.	UNIV SO CALIF,RANCHO LOS AMIGOS MED CTR,DEPT SURG,DOWNEY,CA 90242; ALBERT EINSTEIN MED CTR,DEPT ORTHOPAED SURG,PHILADELPHIA,PA; TEMPLE UNIV,DEPT ORTHOPAED SURG,PHILADELPHIA,PA 19122; LONG BEACH MEM MED CTR,DEPT PATHOL,LONG BEACH,CA; UNIV SO CALIF,DEPT ORTHOPAED SURG,LOS ANGELES,CA		Peter, KS (corresponding author), PARK NICOLLET MED CTR,DEPT ORTHOPAED SURG,6490 EXCELSIOR BLVD,SUITE 400E,MINNEAPOLIS,MN 55426, USA.		Keenan, Mary Ann/ABB-1551-2020				BAUMANN JU, 1979, CLIN ORTHOPAEDICS, V145, P292; BROOKE MH, 1969, NEUROLOGY, V19, P378, DOI 10.1212/WNL.19.4.378; BROOKE MH, 1969, NEUROLOGY, V19, P221, DOI 10.1212/WNL.19.3.221; CASTLE ME, 1979, CLIN ORTHOPAEDICS, V142, P223; DEGIROLAMI U, 1982, AM J PATHOL, V2, P235; Dubowitz V, 1973, MUSCLE BIOPSY MODERN, V1st; GARLAND DE, 1983, PHYS THER, V63, P2004, DOI 10.1093/ptj/63.12.2004; HUFSCHMIDT A, 1985, J NEUROL NEUROSUR PS, V48, P676, DOI 10.1136/jnnp.48.7.676; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; MUBAREK SJ, 1981, COMPARTMENT SYNDROME; RORABECK CH, 1981, J TRAUMA, V21, P446; SCELSI R, 1984, ACTA NEUROPATHOL, V62, P324, DOI 10.1007/BF00687615; SCELSI R, 1986, PARAPLEGIA, V24, P250, DOI 10.1038/sc.1986.35; SLAGER UT, 1985, CLIN ORTHOPAEDICS, V199, P159; SYLVEST O, 1959, Acta Rheumatol Scand, V5, P216; YOUNG RR, 1987, CLIN ORTHOP RELAT R, V219, P50; [No title captured]; [No title captured]	18	7	7	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1996	11	4					1	7		10.1097/00001199-199608000-00003			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VA386	WOS:A1996VA38600003					2022-02-06	
J	Queen, SA; Feeney, DM				Queen, SA; Feeney, DM			Temporally changing patterns of hippocampal cerebral glucose utilization following sensorimotor cortical contusion in rats	BRAIN RESEARCH			English	Article						cortical contusion traumatic brain injury; hippocampal CA3 region; cerebral glucose metabolism	HYPOGLYCEMIC BRAIN-DAMAGE; KAINIC ACID; BLOOD-FLOW; PYRAMIDAL CELLS; PATHOLOGICAL ALTERATIONS; SELECTIVE VULNERABILITY; NEOCORTICAL ABLATIONS; 2-DEOXYGLUCOSE UPTAKE; METABOLIC CHANGES; BASAL GANGLIA	Unilateral sensorimotor cortical contusion significantly decreased ipsilateral hippocampal cerebral metabolic rates of glucose utilization (CMR(glu)) compared to sham controls at 2 and 16 days post injury. In contrast, hippocampal CMR(glu) was transiently increased at 6 days post injury. Both the increased and decreased CMR(glu) were predominantly localized to the hippocampal CA3 subfield ipsilateral to injury and were significantly different from sham controls in the dorsal but not ventral hippocampal formation.	UNIV NEW MEXICO,DEPT PSYCHOL,ALBUQUERQUE,NM 87131		Queen, SA (corresponding author), UNIV NEW MEXICO,SCH MED,HLTH SCI CTR,DEPT PHARMACOL,915 STANFORD DR NE,ALBUQUERQUE,NM 87131, USA.						AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; AUER RN, 1985, ACTA NEUROPATHOL, V67, P13, DOI 10.1007/BF00688120; BECK T, 1995, STROKE, V26, P1107, DOI 10.1161/01.STR.26.6.1107; BECK T, 1990, J CEREBR BLOOD F MET, V10, P542, DOI 10.1038/jcbfm.1990.96; BECK T, 1987, AM J PHYSIOL, V252, pH504, DOI 10.1152/ajpheart.1987.252.3.H504; BENARI Y, 1981, NEUROSCIENCE, V6, P1361, DOI 10.1016/0306-4522(81)90193-7; CHASTAIN JE, 1987, EUR J PHARMACOL, V142, P215, DOI 10.1016/0014-2999(87)90110-5; CHEN MJ, 1988, NEUR ABSTR, V14, P996; COOPER RM, 1984, EXP NEUROL, V83, P134, DOI 10.1016/0014-4886(84)90052-9; COOPER RM, 1984, EXP NEUROL, V86, P261, DOI 10.1016/0014-4886(84)90185-7; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DAIL WG, 1981, BRAIN RES, V211, P79, DOI 10.1016/0006-8993(81)90068-8; DAUTH GW, 1984, ANN NEUROL, V17, P431; DIEMER NH, 1987, CEREBROVASC DIS, P53; DIETRICH WD, 1986, J CEREBR BLOOD F MET, V6, P195, DOI 10.1038/jcbfm.1986.32; EVANS MC, 1984, BRAIN RES, V297, P235, DOI 10.1016/0006-8993(84)90565-1; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FEENEY DM, 1988, PHARM APPROACHES TRE, P121; FEENEY DM, 1989, J NEUROTRAUM, V6, P209; FEENEY DM, 1994, NEUR ABSTR, V20, P197; GILMAN S, 1987, ANN NEUROL, V22, P370, DOI 10.1002/ana.410220314; GINSBERG MD, 1989, J CEREBR BLOOD F MET, V9, P329, DOI 10.1038/jcbfm.1989.51; HOSOKAWA S, 1985, BRAIN RES, V343, P8, DOI 10.1016/0006-8993(85)91152-7; INGLIS F, 1992, J NEUROTRAUM, V9, P75, DOI 10.1089/neu.1992.9.75; JORGENSEN MB, 1990, J CEREBR BLOOD F MET, V10, P243, DOI 10.1038/jcbfm.1990.41; JORGENSEN MB, 1993, EXP NEUROL, V120, P70, DOI 10.1006/exnr.1993.1041; KIRINO T, 1990, BRAIN RES, V510, P17, DOI 10.1016/0006-8993(90)90722-N; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Konig J. F. R., 1963, RAT BRAIN STEREOTAXI; KROBERT KA, 1992, J NEUROTRAUM, V9, P64; LANDIS DMD, 1994, ANNU REV NEUROSCI, V17, P133, DOI 10.1146/annurev.ne.17.030194.001025; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MIES G, 1990, J CEREBR BLOOD F MET, V10, P638, DOI 10.1038/jcbfm.1990.116; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; NEDERGAARD M, 1988, J CEREBR BLOOD F MET, V8, P100, DOI 10.1038/jcbfm.1988.13; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; RISCHKE KR, 1991, J CEREB BLOOD FLOW M, V11, P106; RISCHKE R, 1992, PHARMACOLOGY, V45, P142, DOI 10.1159/000138992; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; SHIBUYA M, 1987, J NEURAL TRANSM, V68, P271, DOI 10.1007/BF02098503; SHIMOYAMA I, 1988, ANN NEUROL, V24, P718, DOI 10.1002/ana.410240605; SHIRAISHI K, 1989, J CEREBR BLOOD F MET, V9, P765, DOI 10.1038/jcbfm.1989.110; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; SORG O, 1991, BRAIN RES, V563, P227, DOI 10.1016/0006-8993(91)91538-C; SUTHERLAND RJ, 1993, J NEUROTRAUMA, V10, pS162; TANAKA S, 1990, NEUROSCIENCE, V36, P339, DOI 10.1016/0306-4522(90)90430-C; TREMBLAY E, 1983, NEUROSCIENCE, V8, P299, DOI 10.1016/0306-4522(83)90068-4; WEISEND M P, 1989, Society for Neuroscience Abstracts, V15, P69; WEISEND MP, 1994, J NEUROSURG, V80, P120, DOI 10.3171/jns.1994.80.1.0120; YAO H, 1995, J CEREBR BLOOD F MET, V15, P398, DOI 10.1038/jcbfm.1995.50; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	53	7	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUN 17	1996	724	2					246	250		10.1016/0006-8993(96)00308-3			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UW579	WOS:A1996UW57900012	8828575				2022-02-06	
J	Parkinson, D				Parkinson, D			Evaluating cerebral concussion	SURGICAL NEUROLOGY			English	Article						concussion; coma; acceleration; reversible; transmitters		Years ago we developed a rat model that was consistently comatose for 1-2 seconds following 50 G acceleration of the head. Motor normalcy returned in about 10 seconds, and normal memory in an hour. There were immediate electroencephalogram and transmitter changes. All these returned to normal within an hour following 1 or 20 such concussions. We could find no light or electron microscopic changes. Halothane anesthesia precludes measurement of coma and introduces distortion of metabolite findings. To date our findings indicate concussion at this level is completely reversible.	UNIV MANITOBA,DEPT ANAT,WINNIPEG,MB,CANADA								Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; ESCHUN G, 1992, SURG NEUROL, V37, P101, DOI 10.1016/0090-3019(92)90184-O; FROWEIN RA, 1977, ACTA NEUROCHIR WIEN, V34, P5; LOMBARD CHARLES F., 1951, JOUR AVIATION MED, V22, P109; PARKINSON D, 1992, MED HYPOTHESES, V37, P37, DOI 10.1016/0306-9877(92)90010-A; PARKINSON D, 1983, SURG NEUROL, V20, P456, DOI 10.1016/0090-3019(83)90027-7; PARKINSON D, 1981, SURG NEUROL, V16, P347, DOI 10.1016/0090-3019(81)90272-X; PARKINSON D, 1982, CLIN NEUR, V29, P131; PARKINSON D, 1988, SURG NEUROL, V30, P102, DOI 10.1016/0090-3019(88)90094-8; PARKINSON D, 1977, MAYO CLIN PROC, V52, P492; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; PUDENZ RH, 1946, J NEUROSURG, V3, P387; WEST M, 1981, BRAIN RES, V225, P271, DOI 10.1016/0006-8993(81)90835-0; 1966, CLIN NEUROSURG, V12, P345	14	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0090-3019			SURG NEUROL	Surg. Neurol.	MAY	1996	45	5					459	462		10.1016/0090-3019(95)00210-3			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UG769	WOS:A1996UG76900015	8629247				2022-02-06	
J	Mizobata, Y; Hiraide, A; Katayama, M; Sugimoto, H; Yoshioka, T; Sugimoto, T				Mizobata, Y; Hiraide, A; Katayama, M; Sugimoto, H; Yoshioka, T; Sugimoto, T			Oxidation of D(-)3-hydroxybutyrate administered to rats with extensive burns	SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY			English	Article						3-hydroxybutyrate; glucose; oxidation; thermal injury; (CO2)-C-14	KETONE-BODY METABOLISM; INSULIN RESISTANCE; MAMMALIAN-TISSUES; LIPID-SYNTHESIS; BODIES; ACETOACETATE; GLUCOSE; BRAIN; D(-)-3-HYDROXYBUTYRATE; D-3-HYDROXYBUTYRATE	Although the suppressive effect of 3-hydroxybutyrate (3-OHB) on post-traumatic protein catabolism in traumatized patients is well documented, the oxidation of exogenously administered 3-OHB during catabolic stress has not been investigated, The present study was designed to evaluate, using radioactive isotopes, total body oxidation in rats with and without burn stress to which 3-OHB had been exogenously administered, in comparison with total body oxidation in such rats that had received glucose, The rats were divided into four groups, based on whether or not a 30% full-thickness burn was inflicted, and the type of infusate they received after the burn, namely, 3-OHB or glucose, The total exhaled CO2 was collected for 6h after the infusion was commenced, and (CO2)-C-14 was assayed in a liquid scintillation spectrometer, Oxidation of the infusate was calculated from the percentage of exhaled (CO2)-C-14 derived from the infused substrates, The plasma concentration of 3-OHB was significantly increased after the infusion in both the burned and non-burned rats, The total exhaled (CO2)-C-14 from the rats infused with glucose decreased from 48.2 +/- 2.4% to 40.8 +/- 3.7% (means +/- SD, P < 0.001) after thermal injury, However, the total exhaled (CO2)-C-14 from the rats infused with 3-OHB appeared sooner, and there was no difference in the total expired (CO2)-C-14 derived from 3-OHB between the burned and non-burned rats, at 68.1 +/- 2.7% vs 66.4 +/- 3.4%, respectively, These findings suggest that even under conditions of burn stress, 3-OHB can be oxidized normally if the plasma concentration of 3-OHB is elevated by exogenous administration.	OSAKA UNIV,SCH MED,DEPT TRAUMATOL,SUITA,OSAKA 565,JAPAN								ABBOTT WC, 1985, JPEN-PARENTER ENTER, V9, P153, DOI 10.1177/0148607185009002153; BATES MW, 1968, BIOCHEM J, V110, P655, DOI 10.1042/bj1100655; BATES MW, 1972, AM J PHYSIOL, V222, P462, DOI 10.1152/ajplegacy.1972.222.2.462; BAXTER C R, 1987, Comprehensive Therapy, V13, P36; BERGMAN EN, 1963, AM J PHYSIOL, V205, P658, DOI 10.1152/ajplegacy.1963.205.4.658; BEYLOT M, 1989, AM J PHYSIOL, V257, pE665, DOI 10.1152/ajpendo.1989.257.5.E665; BIRKHAHN RH, 1981, JPEN-PARENTER ENTER, V5, P24, DOI 10.1177/014860718100500124; BIRKHAHN RH, 1988, J SURG RES, V44, P160, DOI 10.1016/0022-4804(88)90044-3; BIRKHAHN RH, 1981, J TRAUMA, V21, P513, DOI 10.1097/00005373-198107000-00002; BIRKHAHN RH, 1986, J NUTR, V116, P851, DOI 10.1093/jn/116.5.851; BLACK PR, 1982, ANN SURG, V196, P420, DOI 10.1097/00000658-198210000-00005; CAAMANO GJ, 1990, NEUROCHEM RES, V15, P529, DOI 10.1007/BF00966212; FERY F, 1983, AM J PHYSIOL, V245, pE318, DOI 10.1152/ajpendo.1983.245.4.E318; FERY F, 1986, AM J PHYSIOL, V250, pE495, DOI 10.1152/ajpendo.1986.250.5.E495; Goodwin C W, 1985, Crit Care Clin, V1, P97; HARANO Y, 1983, CLIN CHIM ACTA, V134, P327, DOI 10.1016/0009-8981(83)90371-6; HARDING JE, 1992, AM J OBSTET GYNECOL, V166, P671, DOI 10.1016/0002-9378(92)91696-8; HASEGAWA J, 1982, J FERMENT TECHNOL, V60, P501; Hawkins R.A., 1971, ADV ENZYME REGUL, V9, P387, DOI DOI 10.1016/S0065-2571(71)80055-9; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; HIRAIDE A, 1991, SURGERY, V109, P176; HIRAIDE A, 1991, EUR SURG RES, V23, P250, DOI 10.1159/000129160; MANKTELOW A, 1986, J TRAUMA, V26, P143, DOI 10.1097/00005373-198602000-00008; NEUFELD HA, 1976, METABOLISM, V25, P877, DOI 10.1016/0026-0495(76)90120-7; NEUFELD HA, 1980, ENDOCRINOLOGY, V107, P596, DOI 10.1210/endo-107-2-596; OWEN OE, 1973, BIOCHEM J, V134, P499, DOI 10.1042/bj1340499; OWEN OE, 1973, J CLIN INVEST, V52, P2606, DOI 10.1172/JCI107453; PAGE MA, 1971, BIOCHEM J, V121, P49, DOI 10.1042/bj1210049; PASULKA PS, 1987, SURG CLIN N AM, V67, P109; PATEL MS, 1977, J NEUROCHEM, V28, P109, DOI 10.1111/j.1471-4159.1977.tb07715.x; RICH AJ, 1990, P NUTR SOC, V49, P361, DOI 10.1079/PNS19900042; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; ROMANOSKY AJ, 1983, CIRC SHOCK, V11, P311; RUDERMAN NB, 1973, AM J PHYSIOL, V224, P1391, DOI 10.1152/ajplegacy.1973.224.6.1391; SMITH R, 1975, LANCET, V4, P7897; SULTAN AMN, 1990, MOL CELL BIOCHEM, V93, P107; VARY TC, 1986, J TRAUMA, V26, P419, DOI 10.1097/00005373-198605000-00002; VIRKAMAKI A, 1992, J CLIN ENDOCR METAB, V74, P673, DOI 10.1210/jc.74.3.673; WANNEMACHER RW, 1979, J CLIN INVEST, V64, P1565, DOI 10.1172/JCI109617; WEBBER RJ, 1977, J BIOL CHEM, V252, P5222; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041; Wilmore D W, 1974, Clin Plast Surg, V1, P603; WOLFE RR, 1977, AM J PHYSIOL, V233, pE80, DOI 10.1152/ajpendo.1977.233.2.E80; WOLFE RR, 1979, METABOLISM, V28, P1031, DOI 10.1016/0026-0495(79)90007-6; WOLFE RR, 1987, J TRAUMA, V18, P800	45	7	7	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0941-1291			SURG TODAY	Surg. Today-Jpn. J. Surg.		1996	26	3					173	178		10.1007/BF00311502			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UA641	WOS:A1996UA64100005	8845609				2022-02-06	
J	LOUTFI, ISSA; SINGH, A				LOUTFI, ISSA; SINGH, A			COMPARISON OF QUANTITATIVE METHODS FOR BRAIN SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY ANALYSIS IN HEAD TRAUMA AND STROKE	INVESTIGATIVE RADIOLOGY			English	Article						SPECT; BRAIN; PERFUSION; QUANTITATION	CEREBRAL BLOOD-FLOW; HMPAO-SPECT; QUANTIFICATION	RATIONALE AND OBJECTIVES. In this study, three semi-automated (SA) methods for brain single photon emission computed tomography (SPECT) analysis were evaluated and compared with a quantitative manual (QM) method that allowed precise demarcation of telencephalic and cerebellar regions of interest. METHODS. Twenty patients with traumatic brain injury or stroke were imaged by SPECT after injection of 30 mCi (1110 MBq) of Tc-99m HMPAO. The SA methods included: 1) SA left-to-right ratio method, which generated uptake ratios in 4 pairs of symmetric brain sectors in each slice; 2) adjusted scale method, which displayed each slice according to a linear 10-color scale; and 3) SA brain-to-cerebellum ratio method, which exhibited a color scale indicating 5% change in the ratio. RESULTS. The concordance with QM method was 85% for the adjusted scale method and 80% for the SA left-to-right ratio method. A combination of the Adjusted Scale Method and SA left-to-right ratio method yielded concordant results with the QM method in 95% of patients, Brain-to-cerebellum ratio method gave inconsistent findings because of variable cerebellar activity. CONCLUSIONS. Semi-automated methods reliably evaluated relative brain perfusion in most patients. Whereas the adjusted scale method had the best correlation with the QM method, a combination of the adjusted scale method and SA left-to-right ratio method was the most useful for routine analysis of brain perfusion, Semi-automated brain-to-cerebellum ratio method was found to be the least useful because of variability of cerebellum uptake, particularly when the brain uptake was higher than the cerebellum, The QM method allowed precise and most accurate delineation of regions of interest for quantitation of relative brain perfusion but required considerable operator input and knowledge of brain anatomy.	UNIV MISSOURI, HOSP & CLIN, DEPT RADIOL, DIV NUCL MED, COLUMBIA, MO 65212 USA								ANDERSEN AR, 1988, J CEREBR BLOOD F MET, V8, pS69, DOI 10.1038/jcbfm.1988.35; BUDINGER TF, 1978, J NUCL MED, V19, P309; CLAUS JJ, 1994, EUR J NUCL MED, V21, P1044, DOI 10.1007/BF00181058; FRIEDMAN PJ, 1993, SCAND J REHABIL MED, V25, P99; HOLMAN BL, 1992, J NUCL MED, V33, P1888; HOUSTON AS, 1994, J NUCL MED, V35, P239; JACOBS A, 1993, NUCL MED COMMUN, V14, P702, DOI 10.1097/00006231-199308000-00011; Janicek M J, 1992, J Nucl Biol Med, V36, P319; JOHNSON KA, 1993, J NUCL MED, V34, P2044; LAMOUREUX G, 1990, J NUCL MED, V31, P1862; LEGIDO A, 1993, J CHILD NEUROL, V8, P227, DOI 10.1177/088307389300800304; LEWIS SW, 1992, PSYCHOL MED, V22, P27, DOI 10.1017/S0033291700032694; MARKUS HS, 1993, NUCL MED COMMUN, V14, P628, DOI 10.1097/00006231-199308000-00002; MIGNECO O, 1994, COMPUT MED IMAG GRAP, V18, P413, DOI 10.1016/0895-6111(94)90078-7; NEIRINCKX RD, 1987, J NUCL MED, V28, P191; NICKEL O, 1989, EUR J NUCL MED, V15, P1; STAPLETON SJ, 1994, J NUCL MED, V35, P1547; SYED GMS, 1992, NUCL MED COMMUN, V13, P811, DOI 10.1097/00006231-199211000-00007; Todd-Pokropek Andrew E., 1992, Brain Topography, V5, P119, DOI 10.1007/BF01129039	19	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0020-9996	1536-0210		INVEST RADIOL	Invest. Radiol.	OCT	1995	30	10					588	594		10.1097/00004424-199510000-00004			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	TC029	WOS:A1995TC02900004	8557498				2022-02-06	
J	WHITSON, JS; KAMPFL, A; ZHAO, X; HAYES, RL				WHITSON, JS; KAMPFL, A; ZHAO, X; HAYES, RL			TIME-COURSE OF NEUROFILAMENT PROTEIN LOSS FOLLOWING DEPOLARIZATION-INDUCED INJURY IN CNS CULTURE	NEUROSCIENCE LETTERS			English	Article						DEPOLARIZATION; NEUROFILAMENT PROTEINS; POTASSIUM; CYTOSKELETON; TRAUMA; ISCHEMIA	MICROTUBULE-ASSOCIATED PROTEIN-2; TRAUMATIC BRAIN INJURY; CORTICAL CELL-CULTURE; RAT-BRAIN; HIPPOCAMPAL NEUROARCHITECTURE; FOREBRAIN ISCHEMIA; CEREBRAL-ISCHEMIA; CALPAIN-I; GLUTAMATE; ANTIBODIES	In septo-hippocampal cell cultures, brief potassium depolarization produces calcium-dependent decreases in neurofilament proteins and loss of fine neuritic processes within 24 h. It is not known whether neurons later exhibit delayed degeneration and die, live with enduring neurofilament loss, or restore neurofilament protein levels. Therefore, we exposed septohippocampal cultures to 6 min potassium depolarization (60 mM) with 2.8-11.8 mM extracellular Ca2+ and evaluated immunoreactivity for low, medium and heavy neurofilament proteins, neuronal number, and neuronal morphology for 10 days. Neuronal number remained unchanged; neurofilament protein levels recovered to between 31% and 99% of control levels, and fine neuritic processes reappeared.	UNIV TEXAS,HLTH SCI CTR,DEPT NEUROSURG,HOUSTON,TX 77030						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031998] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS 31998] Funding Source: Medline		BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; BRION JP, 1994, NEUROSCIENCE, V63, P895, DOI 10.1016/0306-4522(94)90533-9; CHOI DW, 1987, J NEUROSCI, V7, P357; CORK LC, 1986, J NEUROPATH EXP NEUR, V45, P56, DOI 10.1097/00005072-198601000-00005; DIETZEL I, 1986, ADV NEUROL, V44, P619; DIEZGUERRA FJ, 1995, EUR J BIOCHEM, V227, P68, DOI 10.1111/j.1432-1033.1995.tb20360.x; FORNO LS, 1986, NEUROSCI LETT, V64, P253, DOI 10.1016/0304-3940(86)90337-X; FRANKLIN JL, 1992, TRENDS NEUROSCI, V12, P501; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Grisar T M, 1986, Adv Neurol, V44, P1045; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; KAKU Y, 1993, J CEREBR BLOOD F MET, V13, P402, DOI 10.1038/jcbfm.1993.54; KAMPFL AW, IN PRESS EUR J NEURO; KATAYAMA Y, 1991, BRAIN RES, V558, P136, DOI 10.1016/0006-8993(91)90730-J; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; Liem RKH, 1993, CURR OPIN CELL BIOL, V5, P12, DOI 10.1016/S0955-0674(05)80003-1; MATTSON MP, 1988, J NEUROSCI RES, V21, P447, DOI 10.1002/jnr.490210236; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MATTSON MP, 1989, BRAIN RES, V478, P337, DOI 10.1016/0006-8993(89)91514-X; NAKAMURA M, 1992, EXP BRAIN RES, V89, P31; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NIXON RA, 1992, CELL MOTIL CYTOSKEL, V22, P81, DOI 10.1002/cm.970220202; OGATA N, 1989, J NEUROSURG, V70, P103, DOI 10.3171/jns.1989.70.1.0103; PERLMUTTER LS, 1988, SYNAPSE, V2, P79, DOI 10.1002/syn.890020111; POLTORAK M, 1988, BRAIN RES, V475, P328, DOI 10.1016/0006-8993(88)90621-X; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; POSMANTUR R, 1995, J NEUROTRAUM, V12, P136; POSMANTUR R, UNPUB J NEUROPATHOL; RIEDERER BM, 1992, J NEUROCHEM, V58, P649, DOI 10.1111/j.1471-4159.1992.tb09767.x; SHAW G, 1986, EUR J CELL BIOL, V42, P1; SIMAN R, 1985, BRAIN RES, V347, P399, DOI 10.1016/0006-8993(85)90208-2; SONG DK, 1994, J NEUROSCI RES, V39, P474, DOI 10.1002/jnr.490390414; Sternberger L. A., 1986, IMMUNOHISTOCHEMISTRY; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; STERNBERGER NH, 1985, P NATL ACAD SCI USA, V82, P4274, DOI 10.1073/pnas.82.12.4274; SZATKOWSKI M, 1994, TRENDS NEUROSCI, V17, P359, DOI 10.1016/0166-2236(94)90040-X; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TRONCOSO JC, 1984, BRAIN RES, V364, P295; WANG S, 1994, J NEUROCHEM, V62, P739; WHITSON JS, IN PRESS BRAIN RES	43	7	7	0	0	ELSEVIER SCI PUBL IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	SEP 8	1995	197	2					159	163		10.1016/0304-3940(95)11921-I			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RW406	WOS:A1995RW40600019	8552284				2022-02-06	
J	NAGARAJ, N; ELGAZZAR, AH; FERNANDEZULLOA, M				NAGARAJ, N; ELGAZZAR, AH; FERNANDEZULLOA, M			HETEROTOPIC OSSIFICATION MIMICKING INFECTION - SCINTIGRAPHIC EVALUATION	CLINICAL NUCLEAR MEDICINE			English	Article							BONE	Heterotopic ossification is a disorder of unknown etiology characterized by bone formation in the mesenchymal tissues, It occurs most commonly in patients who have had traumatic brain injury, spinal cord injury, or joint trauma or surgery.	UNIV CINCINNATI,MED CTR,DEPT RADIOL,EL SAENGER RADIOISOTOPE LAB,CINCINNATI,OH 45267								BROSSLER EC, 1987, AJR, V168, P931; CARDOCI G, 1992, NUCL MED COMMUN, V113, P440; FREED JH, 1982, PARAPLEGIA, V20, P208, DOI 10.1038/sc.1982.39; GARLAND DE, 1989, CLIN ORTHOP RELAT R, V242, P169; GARLAND DE, 1991, CLIN ORTHOPAEDICS, V263, P13; KEWELRAMONI LS, 1977, AM J PHYS MED, V56, P99; ORZEL JA, 1985, J NUCL MED, V26, P125; Spencer R P, 1992, Nucl Med Commun, V13, P897, DOI 10.1097/00006231-199212000-00008; SZIKLAS JJ, 1985, CLIN NUCL MED, V10, P376, DOI 10.1097/00003072-198505000-00017; TANAKA T, 1977, RADIOLOGY, V123, P217, DOI 10.1148/123.1.217	10	7	7	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQUARE, PHILADELPHIA, PA 19106	0363-9762			CLIN NUCL MED	Clin. Nucl. Med.	SEP	1995	20	9					763	766		10.1097/00003072-199509000-00001			4	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	RV437	WOS:A1995RV43700001	8521649				2022-02-06	
J	FINSET, A; KROGSTAD, JM; HANSEN, H; BERSTAD, J; HAARBERG, D; KRISTANSEN, G; SAETHER, K; WANG, MD				FINSET, A; KROGSTAD, JM; HANSEN, H; BERSTAD, J; HAARBERG, D; KRISTANSEN, G; SAETHER, K; WANG, MD			TEAM DEVELOPMENT AND MEMORY TRAINING IN TRAUMATIC BRAIN INJURY REHABILITATION - 2 BIRDS WITH ONE STONE	BRAIN INJURY			English	Article							INTERDISCIPLINARY	The need for developing team cooperation procedures when treating patients with traumatic brain injury (TBI) is stated. One approach in promoting team cooperation is to combine team development with a specific training programme. A memory training programme used in a subacute TBI rehabilitation unit is described. A combination of a team development procedure and memory training programme was performed in the unit. A questionnaire to assess team members' attitudes to team cooperation was administered before and after team development, and memory training procedures were implemented. The post-training questionnaire administration indicated a more positive perception among team members of how the team functioned. The efficacy of memory training showed variable results. The programme described may illustrate the advantages of combining a specific treatment programme with efforts to promote team development.	SUNNAAS REHABIL HOSP, N-1450 NESODDTANGEN, NORWAY		FINSET, A (corresponding author), UNIV OSLO, DEPT BEHAV SCI MED, POB 1111 BLINDERN, N-0317 OSLO, NORWAY.						BENEDICT RHB, 1989, CLIN PSYCHOL REV, V9, P605; Conder R, 1988, Brain Inj, V2, P365, DOI 10.3109/02699058809150909; DIHLE AK, 1991, ERGOTERAPEUTEN, V1, P6; DILLER L, 1990, ARCH PHYS MED REHAB, V71, P275; FINSET A, 1992, SCAND J REHABIL MED, P25; FINSET A, 1993, MAR INT BRAIN INJ FO; FINSET A, 1990, COGNITIVE REHABILITA, P99; GJONE G, 1972, SCANDINAVIAN J REHAB, V4, P2; GLISKY EL, 1986, J HEAD TRAUMA REHAB, V1, P54, DOI DOI 10.1097/00001199-198609000-00009; Koning-Haanstra M., 1990, TRAUMATIC BRAIN INJU, P145; KROGSTAD JM, 1992, SCANDINAVIAN J REH S, V26, P86; MELVIN JL, 1980, ARCH PHYS MED REHAB, V61, P379; MELVIN JL, 1989, ARCH PHYS MED REHAB, V70, P273; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Wilson BA, 1984, CLIN MANAGEMENT MEMO; ZENCIUS A, 1991, Brain Injury, V5, P321, DOI 10.3109/02699059109008102	16	7	8	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	1995	9	5					495	507		10.3109/02699059509008209			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	RJ331	WOS:A1995RJ33100008	7550221				2022-02-06	
J	MYSIW, WJ; JACKSON, RD				MYSIW, WJ; JACKSON, RD			DIFFERENTIAL-DIAGNOSIS OF AGITATION FOLLOWING BRAIN INJURY	NEUROREHABILITATION			English	Article						BRAIN INJURY; AGITATION; DIAGNOSIS	CLOSED HEAD-INJURY	Posttraumatic agitation is perhaps the most dramatic behavioral consequence of severe traumatic brain injury. The mechanism for this behavior remains to be determined. The development of effective management strategies has been hampered at least in part by the lack of a consensus definition for posttraumatic agitation. The diagnosis of posttraumatic agitation is a diagnosis of exclusion. Concurrent neurologic or medical decline during the recovery from an acute traumatic brain injury may precipitate delirium, which has many clinical features that overlap with posttraumatic agitation. Hence, the differential diagnosis of posttraumatic agitation includes all medical and neurologic etiologies for transient declines in consciousness and cognition.	OHIO STATE UNIV,DEPT MED,DIV ENDOCRINOL & METAB,COLUMBUS,OH 43210		MYSIW, WJ (corresponding author), OHIO STATE UNIV,DEPT PHYS MED & REHABIL,DODD HALL,480 W 9TH AVE,COLUMBUS,OH 43210, USA.		Mysiw, Walter/E-3724-2011				American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BELL RM, 1988, J TRAUMA, V28, P923, DOI 10.1097/00005373-198807000-00004; BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; CHANDLER NC, 1988, BRAIN INJURY, V2, P309; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; HALE MS, 1982, J NERV MENT DIS, V170, P362, DOI 10.1097/00005053-198206000-00006; HORN LJ, 1992, REHABILITATION POSTC; HORN LJ, 1988, J HEAD TRAUMA REHABI, V3, P86; JACKSON RD, 1989, ARCH PHYS MED REHAB, V70, P33; KAPLAN HI, 1993, KAPLAN SADOCKS SYNOP, P338; KAPLAN HI, 1993, KAPLAN SADOCKS SYNOP, P300; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LIPOWSKI ZJ, 1985, HDB CLIN NEUROLOGY, V2, P523; MALKMUS D, 1979, REHABILITATION HEAD; MOSS R, 1987, GERIATRICS, V42, P35; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; MYSIW WJ, MED REHABILITATION T; OREILLY MJ, 1979, AM J MED, V66, P463; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; Rowland Todd R., 1992, Archives of Physical Medicine and Rehabilitation, V73, P963; SACHDEV P, 1991, J NERV MENT DIS, V179, P381, DOI 10.1097/00005053-199107000-00001; SANDEL ME, 1994, NOV ANN M AM AC PHYS; VINCENT FM, 1986, NEUROSURGERY, V18, P190, DOI 10.1227/00006123-198602000-00013; Whyte J, 1993, REHABILITATION MED P, P825; Zasler N., 1993, J HEAD TRAUMA REHAB, V8, P13, DOI 10.1097/00001199-199309000-00004; ZEIGLER MG, 1990, CRIT CARE MED, V18, P253; 1986, JAMA-J AM MED ASSOC, V256, P744	30	7	7	0	1	ELSEVIER SCI PUBL IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	JUL	1995	5	3					197	204		10.1016/1053-8135(95)00117-Q			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RP776	WOS:A1995RP77600002	24525534				2022-02-06	
J	JALC, P; MARSALA, J; JALCOVA, H				JALC, P; MARSALA, J; JALCOVA, H			POSTISCHEMIC REPERFUSION CAUSES A MASSIVE CALCIUM OVERLOAD IN THE MYELINATED SPINAL-CORD FIBERS	MOLECULAR AND CHEMICAL NEUROPATHOLOGY			English	Article; Proceedings Paper	6th International Symposium on New Frontiers in the Biochemistry and Biophysics of Stroke, Neurotrauma, and Other Neurological Diseases	AUG 16-19, 1993	MARTIN, SLOVAKIA			SPINAL CORD; ISCHEMIA; MYELINATED AXONS; CALCIUM ACCUMULATION; ISCHEMIA-REPERFUSION INJURY	TRANSITORY TRAUMATIC PARAPLEGIA; MONKEY MACACA-MULATTA; AXOPLASMIC-TRANSPORT; MAMMALIAN NERVE; WHITE MATTER; ISCHEMIA; INJURY; BRAIN; REOXYGENATION; VULNERABILITY	The visualization of Ca binding in the myelinated axons of lumbosacral segments of rabbit was done at the electron microscopic level using the spinal cord ischemia model. To assess the calcium accumulation, the binding agent pyroantimonate was used. Nonsignificant Ca2+ binding was found in the myelinated axons after 40 min of ischemia followed immediately by perfusion fixation. A high concentration of calcium pyroantimonate deposits, seen as electron dense particles, was detected in the myelin interlamellar clefts and axoplasm. The paranodal region was the most affected site.	INST EXPTL PHYS, KOSICE 04011, SLOVAKIA		JALC, P (corresponding author), SLOVAK ACAD SCI, INST NEUROBIOL, VYSTAVBY 1, KOSICE 04011, SLOVAKIA.						BALENTINE JD, 1978, LAB INVEST, V39, P254; BALENTINE JD, 1980, FED PROC, V39, P416; BALENTINE JD, 1977, ANN NEUROL, V2, P520, DOI 10.1002/ana.410020612; Banik N L, 1985, Cent Nerv Syst Trauma, V2, P99; BLACK JA, 1990, TRENDS NEUROSCI, V13, P48, DOI 10.1016/0166-2236(90)90068-L; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; BRESNAHAN JC, 1978, J NEUROL SCI, V37, P59, DOI 10.1016/0022-510X(78)90228-9; BRESNAHAN JC, 1976, J NEUROL SCI, V28, P521, DOI 10.1016/0022-510X(76)90122-2; CHAN SY, 1980, J PHYSIOL-LONDON, V301, P477, DOI 10.1113/jphysiol.1980.sp013219; DANIELISOVA V, 1990, NEUROLOGY, V40, P1125, DOI 10.1212/WNL.40.7.1125; DEGROOT H, 1989, FREE RADICAL BIO MED, V6, P541, DOI 10.1016/0891-5849(89)90047-6; DOHRMANN GJ, 1971, J NEUROSURG, V35, P263, DOI 10.3171/jns.1971.35.3.0263; DUCKER T B, 1969, Surgical Forum (Chicago), V20, P428; FERCAKOVA A, 1992, BRAIN RES, V593, P159, DOI 10.1016/0006-8993(92)91304-W; Fercakova A, 1994, J Hirnforsch, V35, P295; FOLLIS F, 1993, J CEREBR BLOOD F MET, V13, P170, DOI 10.1038/jcbfm.1993.20; GOODKIN R, 1969, Surgical Forum (Chicago), V20, P430; GRAY PTA, 1985, TRENDS NEUROSCI, V8, P411, DOI 10.1016/0166-2236(85)90144-4; GRIFFITHS IR, 1983, J NEUROL SCI, V58, P335, DOI 10.1016/0022-510X(83)90093-X; HARRIS RJ, 1981, J CEREBR BLOOD F MET, V1, P203, DOI 10.1038/jcbfm.1981.21; HOSSMANN KA, 1977, STROKE, V8, P77, DOI 10.1161/01.STR.8.1.77; HOSSMANN KA, 1970, Z NEUROL, V198, P33, DOI 10.1007/BF00316134; Jalc P, 1989, Neirofiziologiia, V21, P267; JALC P, 1993, FUNCT DEV MORPH, V3, P43; Kakulas B A, 1984, Cent Nerv Syst Trauma, V1, P117; KRAUSE GS, 1988, CRIT CARE MED, V16, P714, DOI 10.1097/00003246-198807000-00015; KUMAR K, 1987, ACTA NEUROPATHOL, V73, P393, DOI 10.1007/BF00688266; MARSALA J, 1994, MICROSC RES TECHNIQ, V28, P226, DOI 10.1002/jemt.1070280307; MARSALA J, 1989, NEUROSCI LETT, V106, P83, DOI 10.1016/0304-3940(89)90206-1; MARSALA J, 1991, NEUROSCIENCE, V45, P479, DOI 10.1016/0306-4522(91)90243-H; MARSALA J, 1992, NEUROSCI LETT, V146, P121, DOI 10.1016/0304-3940(92)90058-F; MARSALA M, 1992, RESTOR NEUROL NEUROS, V3, P283, DOI 10.3233/RNN-1992-3601; MARSALA M, 1989, EXP NEUROL, V105, P93, DOI 10.1016/0014-4886(89)90176-3; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; OCHS S, 1984, NEUROCHEM RES, V9, P823, DOI 10.1007/BF00965669; OCHS S, 1972, SCIENCE, V176, P252, DOI 10.1126/science.176.4032.252; OCHS S, 1977, NATURE, V270, P748, DOI 10.1038/270748a0; ORENDACOVA J, 1991, NEUROSCI LETT, V128, P143, DOI 10.1016/0304-3940(91)90247-Q; RASMUSSEN H, 1977, PHYSIOL REV, V57, P421, DOI 10.1152/physrev.1977.57.3.421; ROSENTHAL RE, 1986, ANN EMERG MED, V15, P1360, DOI 10.1016/S0196-0644(86)80627-8; SATRAN R, 1988, Stroke, V19, P529; SCHLAEPFER WW, 1985, J NEUROCHEM, V44, P502, DOI 10.1111/j.1471-4159.1985.tb05442.x; SIEMKOWICZ E, 1981, STROKE, V12, P236, DOI 10.1161/01.STR.12.2.236; SIESJO BK, 1988, CRIT CARE MED, V16, P954, DOI 10.1097/00003246-198810000-00006; SIMPSON RK, 1990, NEUROCHEM RES, V15, P635, DOI 10.1007/BF00973755; SLOCUM RD, 1982, J HISTOCHEM CYTOCHEM, V30, P617, DOI 10.1177/30.7.6179981; WAGNER FC, 1971, J NEUROSURG, V35, P272, DOI 10.3171/jns.1971.35.3.0272; WALLACE MC, 1989, SURG NEUROL, V27, P207; WAXMAN SG, 1991, TRENDS NEUROSCI, V14, P461, DOI 10.1016/0166-2236(91)90046-W; WAXMAN SG, 1990, ANN NEUROL, V28, P335, DOI 10.1002/ana.410280306; ZIVIN JA, 1980, STROKE, V11, P200, DOI 10.1161/01.STR.11.2.200	51	7	7	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1044-7393			MOL CHEM NEUROPATHOL	Mol. Chem. Neuropathol.	JUN-AUG	1995	25	2-3					143	153		10.1007/BF02960909			11	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pathology	RU433	WOS:A1995RU43300008	8534317				2022-02-06	
J	LEE, EJ; CHIO, CC; CHEN, HH				LEE, EJ; CHIO, CC; CHEN, HH			AGGRESSIVE TEMPORAL LOBECTOMY FOR UNCAL HERNIATION IN TRAUMATIC SUBDURAL-HEMATOMA	JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION			English	Article						UNCAL HERNIATION; TEMPORAL LOBECTOMY; SUBTEMPORAL DECOMPRESSION; SUBDURAL HEMATOMA; HEAD TRAUMA	SEVERE HEAD-INJURY; MANAGEMENT; DECOMPRESSION	Over a period of 28 months, 29 patients who sustained uncal herniation originating from fronto-temporal acute subdural hematoma with major contusion and swelling of the temporal lobe were treated surgically. These 29 patients were divided into two groups according to whether or not they underwent aggressive temporal resection in two study periods. During the initial 16 months, from February 1991 to June 1992, 16 of the 29 (group A) underwent classic surgery (subtemporal decompression for evacuation of the hematoma and debridement of the contused brain). In the 12 months from July 1992 to June 1993, the remaining 13 patients (group B) underwent an aggressive temporal lobectomy in addition to the aforementioned procedures, including 10 complete temporal lobectomies and three anterior temporal lobectomies. In group A, there were nine operative deaths, with a mortality of 56%, and the mean Glasgow Outcome Scale (GOS) score was 2.2 +/- 0.4 (mean +/- SEM) after 24 to 36 months of follow-up. In group B, one patient died after operation, and the mean GOS score was 4.0 +/- 0.4 in a follow-up period of 12 to 24 months. Compared with group A, group B showed a better survival rate and more favorable functional outcome. Favorable recovery in group B was noted only after a complete temporal lobectomy (good in seven and moderate disability in three). The three patients who underwent an anterior temporal lobectomy had unfavorable recoveries (two vegetative states and one death). This study supports the theory that aggressive decompression through a complete temporal lobectomy can significantly improve the unfavorable outcome of classic surgery in patients with traumatic uncal herniation accompanying severe temporal contusion and swelling.	NATL CHENG KUNG UNIV, MED CTR, DEPT SURG, DIV NEUROSURG, TAINAN 70101, TAIWAN								BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BRICOLO A, 1977, J NEUROSURG, V47, P680, DOI 10.3171/jns.1977.47.5.0680; CIRICILLO SF, 1992, J TRAUMA, V33, P899, DOI 10.1097/00005373-199212000-00018; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; FELL DA, 1975, J NEUROSURG, V42, P37, DOI 10.3171/jns.1975.42.1.0037; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; GUTTERMAN P, 1970, J NEUROSURG, V32, P330, DOI 10.3171/jns.1970.32.3.0330; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; JAMIESON KG, 1972, J NEUROSURG, V37, P137, DOI 10.3171/jns.1972.37.2.0137; JENNETT B, 1975, LANCET, V1, P480; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; MARSHALL LF, 1983, NEUROSURGERY, V13, P412, DOI 10.1227/00006123-198310000-00011; Meyer A, 1920, ARCH NEURO PSYCHIATR, V4, P387, DOI 10.1001/archneurpsyc.1920.02180220036003; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Miller JD, 1988, OPERATIVE NEUROSURGI, V1, P33; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; MUNRO D, 1952, NEW ENGL J MED, V247, P699, DOI 10.1056/NEJM195211062471901; NUSSBAUM ES, 1991, NEUROSURGERY, V29, P62, DOI 10.1227/00006123-199107000-00010; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; RICHARDS T, 1974, SURGERY, V75, P253; SARABIA R, 1988, ACTA NEUROCHIR SUPP, V42, P50; SELLING JM, 1981, J NEUROSURG, V55, P516; TALALLA A, 1971, J TRAUM, V11, P771, DOI 10.1097/00005373-197109000-00008; Tseng S H, 1992, J Formos Med Assoc, V91, P24; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; XU BN, 1993, NEUROSURGERY, V32, P289, DOI 10.1227/00006123-199302000-00019	29	7	10	0	0	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	0929-6646	1876-0821		J FORMOS MED ASSOC	J. Formos. Med. Assoc.	JUN	1995	94	6					341	345					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RK413	WOS:A1995RK41300010	7549554				2022-02-06	
J	BLOSSER, J; DEPOMPEI, R				BLOSSER, J; DEPOMPEI, R			FOSTERING EFFECTIVE FAMILY INVOLVEMENT THROUGH MENTORING	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						FAMILY INVOLVEMENT; MENTORING; PROTEGE; TRAUMATIC BRAIN INJURY		Mentoring has been used successfully by leaders in business and education organizations to facilitate professional training and development of employees who show promise. Many of the principles and practices used in these mentoring programs can be applied to families of individuals with traumatic brain injury (TBI). This article defines mentoring, explores several commonly used mentoring practices, and shows how these practices can be used to develop specific skills of family members. Suggestions are offered for encouraging and implementing a mentoring orientation in treatment programs for individuals with TBI. Through mentoring processes, professionals can increase the inclusion and involvement of families in planning and treatment.			BLOSSER, J (corresponding author), UNIV AKRON,SCH COMMUN DISORDERS,CTR SPEECH & HEARING,AKRON,OH 44325, USA.						ALLEMAN E, 1982, MENTORING BEHAVIORAL; ASHMORE L, 1992, COMMUNICOLOGIEST, V17, P9; JOWERS L, 1990, REV RES NURSING ED; KOVACH T, 1992, ASHA, V29, P47; KOVACH T, 1992, ASHA, V29, P33; KRAM KE, 1983, ACAD MANAGE J, V26, P608, DOI 10.2307/255910; PHILLIPSJONES LL, 1982, MENTORS PROTEGEES; STEPHENS I, 1991, COMMUNICOLOGIST, V16, P3; 1992, COMMUNICOLOGIST, V17, P8	9	7	7	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1995	10	2					46	56		10.1097/00001199-199504000-00006			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QR039	WOS:A1995QR03900006					2022-02-06	
J	HULL, BL				HULL, BL			FEMALE REPRODUCTIVE SURGERY	VETERINARY CLINICS OF NORTH AMERICA-FOOD ANIMAL PRACTICE			English	Article								Unlike the situation in the equine species, in which both rectovaginal fistulas and rectovaginal lacerations occur with about equal frequency, rectovaginal injuries in the bovine almost always are lacerations. The only time rectovaginal fistulas occur in the bovine is, rarely, as a congenital problem associated with atresia ani or when the repair of a rectovaginal laceration fails. This distribution frequency has to do with the different causes in the two species. In the mare, the forceful, if not violent, abdominal press during parturition may cause the foal's foot to tear through the rectovaginal shelf. If the live fetus then retracts its limb, a fistula remains. If the hoof lies within the rectum during subsequent abdominal presses, however, the tear may proceed caudally through the anal sphincter, resulting in a rectovaginal laceration.(13,2) In the cow, these lacerations almost invariably are caused by inappropriate human intervention during assisted delivery of the fetus. Injudicious traction before the vagina has had sufficient time and stimulus to dilate predisposes the vaginal wall to injury. An unassisted delivery seldom results in this type of injury. Lacerations tend to occur when the calvarium of the fetal head forcefully stretch the dorsal commissure of the vulva. If the tear is only mucosal, it is said to be a first-degree perineal laceration and is of little consequence. Second-degree lacerations involve deeper perivaginal tissues and often result in protrusion of fat through the tear. In third-degree perineal lacerations, the pressure exerted by the fetal head initiates a tear that proceeds both dorsally and cranially through the perineal body, anal sphincter, and a variable distance up the rectovaginal shelf.(7) If the veterinarian realizes that a tear is about to occur during an assisted delivery, it always is wise to perform an episiotomy to direct the area of tension relief away from the rectovaginal shelf. The need for such an incision often does not become apparent until the fetal head is presented at the vestibule. Sometimes, gentle stretching of the vulvar lips over the fetal crown eventually provides sufficient stretching to facilitate extraction, but this may be time consuming. In many cases, further delay may result in death of the calf. If the veterinarian decides to perform an episiotomy, it is important to realize that the aim of this controlled incision is to minimize the amount of tissue trauma, thereby maximizing the chances of the cow maintaining sound vulvar conformation. If an epidural anesthesia already has been administered, the perineal area will be desensitized. If not, an injection of local anesthetic agent into the stretched tissue probably will be ineffective and does not appear to be warranted. Ln our experience, the animals show little or no reaction to a sharp scalpel incision over the taut vulvar lips. The incision then is extended dorsolaterally until tension on the fetal head is reduced and fetal extraction can proceed safely. Following delivery, the episiotomy site should be infiltrated with local anesthetic agent and closed. A modified vertical mattress pattern using nonabsorbable suture ensures optimal healing. Failure to close an episiotomy may lead to a pneumovagina. Antibiotic administration is optional, but may reduce the possibility of abscessation. If the veterinarian does not perform an episiotomy and a third-degree rectovaginal laceration occurs, it may be closed immediately with some success. These injuries, however, cannot be closed with any degree of success in the post-trauma period (day 1 through day 30 or 60). In the first 30 to 60 days after the tear occurs, the tissues are swollen, edematous, and necrotic. These swollen tissues will not hold sutures very well and, because they are infected, secondary dehiscence is common. Unless the veterinarian is present when the laceration occurs and can suture it immediately, it therefore is prudent to treat the cow medically until healing is complete. Once the necrosis and swelling have subsided, the scar tissue around the laceration can be dissected and good surgical apposition achieved. Dietary management, applied in the equine species to create softer feces, usually is not indicated because cattle feces already are sufficiently soft to allow free passage.			HULL, BL (corresponding author), OHIO STATE UNIV,COLL VET MED,DEPT VET CLIN SCI,FOOD ANIM SECT,601 VERNON L THARP ST,COLUMBUS,OH 43210, USA.							0	7	7	0	10	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0749-0720			VET CLIN N AM-FOOD A	Vet. Clin. N. Am.-Food Anim. Pract.	MAR	1995	11	1					37	53					17	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	QQ658	WOS:A1995QQ65800004	7796335				2022-02-06	
J	STEIN, DG; GLASIER, MM				STEIN, DG; GLASIER, MM			SOME PRACTICAL AND THEORETICAL ISSUES CONCERNING FETAL BRAIN-TISSUE GRAFTS AS THERAPY FOR BRAIN DYSFUNCTIONS	BEHAVIORAL AND BRAIN SCIENCES			English	Article						BRAIN DAMAGE; DEGENERATIVE DISORDERS; FUNCTIONAL RECOVERY; GRAFTING INTO CNS; NEURAL TRANSPLANTS; NEUROLOGY; PARKINSONS DISEASE; PLASTICITY	ADRENAL CHROMAFFIN CELLS; CENTRAL-NERVOUS-SYSTEM; SEVERE PARKINSONS-DISEASE; ADULT-RAT BRAIN; DOPAMINE NEURONS; CAUDATE-NUCLEUS; GROWTH-FACTOR; LEARNING IMPAIRMENTS; BEHAVIORAL RECOVERY; HIPPOCAMPAL-NEURONS	Grafts of embryonic neural tissue into the brains of adult patients are currently being used to treat Parkinson's disease and are under serious consideration as therapy for a variety of other degenerative and traumatic disorders. This target article evaluates the use of transplants to promote recovery from brain injury and highlights the kinds of questions and problems that must be addressed before this form of therapy is routinely applied. It has been argued that neural transplantation can promote functional recovery through the replacement of damaged nerve cells, the reestablishment of specific nerve pathways lost as a result of injury, the release of specific neurotransmitters, or the production of factors that promote neuronal growth. The latter two mechanisms, which need not rely on anatomical connections to the host brain, are open to examination for nonsurgical, less intrusive therapeutic use. Certain subjective judgments used to select patients who will receive grafts and in assessment of the outcome of graft therapy make it difficult to evaluate the procedure. In addition, little long-term assessment of transplant efficacy and effect has been done in nonhuman primates. Carefully controlled human studies, with multiple testing paradigms, are also needed to establish the efficacy of transplant therapy.			STEIN, DG (corresponding author), RUTGERS STATE UNIV,INST ANIM BEHAV,BRAIN RES & CNS PLAST LAB,NEWARK,NJ 07102, USA.		Stein, Donald/AAJ-5139-2020				AHLSKOG JE, 1990, MAYO CLIN PROC, V65, P305, DOI 10.1016/S0025-6196(12)62532-4; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; BACKLUND EO, 1985, NEURAL GRAFTING MAMM, P551; BANKIEWICZ KS, 1991, J NEUROSURG, V74, P97, DOI 10.3171/jns.1991.74.1.0097; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; BRUNDIN P, 1989, EXP BRAIN RES, V75, P195; BUZSAKI G, 1989, EXP NEUROL, V105, P10, DOI 10.1016/0014-4886(89)90167-2; CARMICHAEL SW, 1988, NEW ENGL J MED, V318, P254; CASSEL JC, 1992, NEUROSCI LETT, V138, P32, DOI 10.1016/0304-3940(92)90465-J; CASSEL JC, 1992, BRAIN RES, V585, P243, DOI 10.1016/0006-8993(92)91213-X; CASSEL JC, 1992, RESTOR NEUROL NEUROS, V4, P65, DOI 10.3233/RNN-1992-4201; CLARKE DJ, 1990, EXP NEUROL, V107, P11, DOI 10.1016/0014-4886(90)90059-2; COLLIER TJ, 1988, BRAIN RES, V448, P77, DOI 10.1016/0006-8993(88)91103-1; COLLIER TJ, 1985, HOMEOSTATIC FUNCTION; Cooper I., 1969, INVOLUNTARY MOVEMENT; COOPER I, 1956, NEUROSURGICAL ALLEVI; Cooper IS, 1961, PARKINSONISM ITS MED; COTMAN CW, 1984, NEURAL GRAFTING MAMM, P169; COTMAN CW, 1988, PROG BRAIN RES, V78, P311; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; DALRYMPLEALFORD JC, 1988, EXP BRAIN RES, V69, P545; DECKER MW, 1991, SYNAPSE, V7, P151, DOI 10.1002/syn.890070209; DOERING LC, 1992, EXP NEUROL, V118, P253, DOI 10.1016/0014-4886(92)90182-P; DUNBAR GL, 1988, PHARM APPROACHES TRE, P195; DUNNETT SB, 1982, BRAIN RES, V251, P335, DOI 10.1016/0006-8993(82)90751-X; DUNNETT SB, 1985, NEUROSCIENCE, V16, P787, DOI 10.1016/0306-4522(85)90094-6; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FINE A, 1990, BRAIN RES REV, V15, P121, DOI 10.1016/0165-0173(90)90014-F; FORNO LS, 1991, ACTA NEUROPATHOL, V81, P691, DOI 10.1007/BF00296383; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; FREED WJ, 1990, SCIENCE, V250, P1434; FREED WJ, 1991, RESTOR NEUROL NEUROS, V3, P109, DOI 10.3233/RNN-1991-3301; FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0; FREED WJ, 1990, EXP NEUROL, V110, P139, DOI 10.1016/0014-4886(90)90026-O; GAGE FH, 1984, SCIENCE, V225, P533, DOI 10.1126/science.6539949; GAGE FH, 1993, NATURE, V361, P405, DOI 10.1038/361405a0; GOETZ CG, 1993, NEUROLOGY, V43, P1; GOULD E, 1990, J NEUROSCI, V10, P996; GREELY HT, 1989, NEW ENGL J MED, V320, P1093, DOI 10.1056/NEJM198904203201624; HAHN HJ, 1992, PHARMACOL TOXICOL, V70, P188, DOI 10.1111/j.1600-0773.1992.tb00454.x; HANSEN JT, 1990, NEURAL TRANSPLANTATI, P573; HART T, 1978, BRAIN RES BULL, V3, P245, DOI 10.1016/0361-9230(78)90122-3; HEUSCHLING P, 1988, DEV BRAIN RES, V38, P9, DOI 10.1016/0165-3806(88)90081-8; HICKEY WF, 1987, P NATL ACAD SCI USA, V84, P2082, DOI 10.1073/pnas.84.7.2082; HIRSCH EC, 1990, ANN NEUROL, V27, P676, DOI 10.1002/ana.410270615; HODGES H, 1990, NEURAL TRANSPLANTATI, P347; HOFFER BJ, 1992, EXP NEUROL, V118, P243, DOI 10.1016/0014-4886(92)90181-O; HORELLOU P, 1990, NEURON, V5, P393, DOI 10.1016/0896-6273(90)90078-T; HURTIG H, 1989, ANN NEUROL, V25, P607, DOI 10.1002/ana.410250613; IKEGAMI S, 1989, NEUROSCI LETT, V101, P17, DOI 10.1016/0304-3940(89)90433-3; JAGER WAD, 1970, ARCH NEUROL-CHICAGO, V23, P528; JANKOVIC J, 1989, NEUROLOGY, V39, P1227, DOI 10.1212/WNL.39.9.1227; KESSLAK JP, 1986, EXP NEUROL, V92, P377, DOI 10.1016/0014-4886(86)90089-0; KORDOWER JH, 1991, ANN NEUROL, V29, P405, DOI 10.1002/ana.410290411; KORDOWER JH, 1990, J NEUROSURG, V73, P418, DOI 10.3171/jns.1990.73.3.0418; KREUGER BA, 1991, ENDOCRINOLOGY, V129, P2647; LABBE R, 1983, SCIENCE, V217, P470; LANDAU WM, 1990, NEUROLOGY, V40, P733, DOI 10.1212/WNL.40.5.733; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LINDVALL O, 1989, ARCH NEUROL-CHICAGO, V46, P615, DOI 10.1001/archneur.1989.00520420033021; LOPEZLOZANO JJ, 1990, TRANSPL P, V22, P2243; LOY R, 1990, SCIENCE, V208, P1282; MADRAZO I, 1990, TRANSPLANTATION, V49, P1026, DOI 10.1097/00007890-199005000-00047; MADRAZO I, 1988, NEW ENGL J MED, V318, P51; MADRAZO I, 1987, NEW ENGL J MED, V316, P831, DOI 10.1056/NEJM198704023161402; MAHADIK SP, 1988, DRUG DEVELOP RES, V15, P337, DOI 10.1002/ddr.430150402; MATTSON MP, 1990, INT J DEV NEUROSCI, V8, P399, DOI 10.1016/0736-5748(90)90073-B; MUDRICK LA, 1989, EXP BRAIN RES, V76, P333; MUFSON EJ, 1986, BRAIN RES, V401, P162; NAINI AB, 1991, ARCH NEUROL-CHICAGO, V48, P813; NAPARSTEK Y, 1984, NATURE, V310, P241, DOI 10.1038/310241a0; NEUHAUS RJ, 1989, NATIONAL REV, V41, P1213; NICOLAS MK, 1988, TRANSPLANTATION MAMM, P249; Nieto-Sampedro M, 1988, PHARM APPROACHES TRE, P301; NIETOSAMPEDRO M, 1984, P NATL ACAD SCI-BIOL, V81, P6250, DOI 10.1073/pnas.81.19.6250; NIETOSAMPEDRO M, 1983, J NEUROSCI, V3, P2219; NILSSON OG, 1987, EXP BRAIN RES, V67, P195, DOI 10.1007/BF00269466; NILSSON OG, 1990, BRAIN RES, V515, P193, DOI 10.1016/0006-8993(90)90596-4; NOZUE T, 1993, TRANSPLANTATION, V55, P346, DOI 10.1097/00007890-199302000-00022; OLSON L, 1991, ARCH NEUROL-CHICAGO, V48, P373, DOI 10.1001/archneur.1991.00530160037011; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; PETERSON DI, 1989, NEUROLOGY, V39, P235, DOI 10.1212/WNL.39.2.235; Pollack I F, 1990, Restor Neurol Neurosci, V1, P347, DOI 10.3233/RNN-1990-1506; POLLACK IF, 1990, EXP NEUROL, V108, P114, DOI 10.1016/0014-4886(90)90017-M; POLTORAK M, 1989, EXP NEUROL, V103, P222, DOI 10.1016/0014-4886(89)90046-0; PORTERASANCHEZ A, 1987, NEUROPLASTICITY NEW, P9; PRZEDBORSKI S, 1991, BRAIN RES, V550, P231, DOI 10.1016/0006-8993(91)91323-S; RAO K, 1988, PROG BRAIN RES, V78, P281; REDMOND DE, 1993, MOL CELLULAR APPROAC, P325; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; ROOF RL, 1993, BRAIN RES, V407, P333; Sabel B., 1988, PHARM APPROACHES TRE; SAWLE GV, 1992, ANN NEUROL, V31, P166, DOI 10.1002/ana.410310207; SEGAL M, 1989, BRAIN RES, V500, P139, DOI 10.1016/0006-8993(89)90307-7; SELLAL F, 1992, NEUROLOGY, V42, P255, DOI 10.1212/WNL.42.1.255; SILANI V, 1990, ANN NEUROL, V27, P341, DOI 10.1002/ana.410270323; SLADEK JR, 1988, PROG BRAIN RES, V78, P497; SLOAN DJ, 1991, TRENDS NEUROSCI, V14, P341, DOI 10.1016/0166-2236(91)90159-R; SOTELO C, 1987, ANN NY ACAD SCI, V495, P242, DOI 10.1111/j.1749-6632.1987.tb23679.x; SOTELO C, 1987, NEUROSCIENCE, V20, P1, DOI 10.1016/0306-4522(87)90002-9; SOTELO C, 1991, TRENDS NEUROSCI, V14, P350, DOI 10.1016/0166-2236(91)90161-M; SPENCER DD, 1992, NEW ENGL J MED, V327, P1541, DOI 10.1056/NEJM199211263272201; STEECECOLLIER K, 1990, EXP NEUROL, V110, P201, DOI 10.1016/0014-4886(90)90031-M; STEIN DG, 1985, BEHAV NEURAL BIOL, V44, P266, DOI 10.1016/S0163-1047(85)90282-1; STEIN DG, 1985, NEUROBIOL AGING, V6, P157, DOI 10.1016/0197-4580(85)90036-3; STEIN DG, 1987, ANN NY ACAD SCI, V495, P444, DOI 10.1111/j.1749-6632.1987.tb23693.x; STEIN DG, 1988, BRAIN INJURY RECOVER, P249; STODDARD SL, 1989, EXP NEUROL, V104, P218, DOI 10.1016/0014-4886(89)90032-0; TAYLOR JR, 1990, NEURAL TRANSPLANTATI, P573; WANHUA AY, 1982, BRAIN RES, V238, P404; WATERS C, 1990, MOVEMENT DISORD, V5, P248, DOI 10.1002/mds.870050312; WIDNER H, 1988, BRAIN RES REV, V13, P287, DOI 10.1016/0165-0173(88)90010-0; WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203; WILL B, 1989, NEURONAL GRAFTING AL, P189; WILL B, 1988, PHARM APPROACHES TRE, P339; WOODRUFF ML, 1990, PROG BRAIN RES, V82, P367; YONG VW, 1989, J NEUROL SCI, V94, P51, DOI 10.1016/0022-510X(89)90217-7	118	7	8	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211	0140-525X			BEHAV BRAIN SCI	Behav. Brain Sci.	MAR	1995	18	1					36	45		10.1017/S0140525X00037250			10	Psychology, Biological; Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences; Neurosciences & Neurology	QY120	WOS:A1995QY12000004					2022-02-06	
J	HOTZ, G; HELMESTABROOKS, N				HOTZ, G; HELMESTABROOKS, N			PERSEVERATION .2. A STUDY OF PERSEVERATION IN CLOSED-HEAD INJURY	BRAIN INJURY			English	Article							DEMENTIA; DISEASE	This study examines the nature and extent of perseveration in 15 individuals with closed-head injury (CHI) by (a) identifying and describing the types of perseveration that occurred on verbal and non-verbal tasks, (b) examining the possible underlying neuropsychological mechanisms of perseverative behaviour and (c) exploring neuroanatomical correlates of perseveration. Performance of the 15 CHI patients was compared with 15 neurologically normal subjects matched for sex, age, handedness and educational level. The CHI subjects produced significantly more perseverations than did normals, and 'recurrent' perseveration was the most frequently occurring type. A test of verbal learning elicited the greatest number of recurrent perseverations. Overall test performance of the CHI group suggested that memory dysfunction and impaired attention were most likely responsible for perseverative errors. CT scan analyses showed that the three most perseverative CHI subjects evidenced left temporal lobe damage.	UNIV MIAMI, SCH MED, DEPT NEUROL, DIV NEUROREHABIL, MIAMI, FL USA; BOSTON UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02118 USA; UNIV ARIZONA, NATL CTR NEUROGEN COMMUN DISORDERS, TUCSON, AZ USA						NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC 1409, DC 00081] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [P01DC000081, P50DC000081, P60DC001409] Funding Source: NIH RePORTER		ADAMOVICH BB, 1985, COGNITIVE REHABILITA; ALBERT ML, 1986, CORTEX, V22, P103, DOI 10.1016/S0010-9452(86)80035-1; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; ALLISON RS, 1966, BRIT MED J, V2, P1027, DOI 10.1136/bmj.2.5521.1027; Auerbach S., 1986, J HEAD TRAUMA REHAB, V3, P1; BAYLES KA, 1991, J COGNITIVE NEUROSCI, V3, P166, DOI 10.1162/jocn.1991.3.2.166; BAYLES KA, 1985, BRAIN LANG, V25, P102, DOI 10.1016/0093-934X(85)90123-3; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Bilder R M, 1987, Arch Clin Neuropsychol, V2, P195, DOI 10.1016/0887-6177(87)90009-6; BUCKINGHAM HW, 1985, CURRENT PERSPECTIVES, P113; Delis DC, 1987, CALIFORNIA VERBAL LE; FREEMAN T, 1966, BRIT J PSYCHIAT, V112, P27, DOI 10.1192/bjp.112.482.27; FULD PA, 1982, ANN NEUROL, V11, P155, DOI 10.1002/ana.410110208; HAGAN C, 1979, REHABILITATION HEAD, P87; Helm-Estabrooks N, 1991, BRIEF TEST HEAD INJU; HELMESTABROOKS N, 1987, ARCH NEUROL-CHICAGO, V44, P1253, DOI 10.1001/archneur.1987.00520240035008; HELMESTABROOKS N, 1990, APHASIA DIAGNOSTIC P; HELMICK JW, 1976, J COMMUN DISORD, V9, P143, DOI 10.1016/0021-9924(76)90006-X; HUDSON AJ, 1968, BRAIN, V91, P571, DOI 10.1093/brain/91.3.571; JENNETT B, 1975, LANCET, V1, P480; Kaplan E., 1991, WAIS R NEUROPSYCHOLO; LEES AJ, 1983, BRAIN, V106, P257, DOI 10.1093/brain/106.2.257; LEVIN HS, 1985, CENTRAL NERVOUS SYST, P281; LURIA AR, 1965, BRAIN, V88, P1, DOI 10.1093/brain/88.1.1; MIRSKY AF, 1978, ED BRAIN, P33; NISSEN M, 1986, J HEAD TRAUMA REHAB, V1, P13; PIETRO MJS, 1986, BRAIN LANG, V29, P1, DOI 10.1016/0093-934X(86)90030-1; SANDSON J, 1984, NEUROPSYCHOLOGIA, V22, P715, DOI 10.1016/0028-3932(84)90098-8; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; [No title captured]; [No title captured]	32	7	7	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB-MAR	1995	9	2					161	172		10.3109/02699059509008189			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	QN628	WOS:A1995QN62800005	7787836				2022-02-06	
J	JOHNSTONE, B; PINKOWSKI, M; FARMER, J; HAGGLUND, KJ				JOHNSTONE, B; PINKOWSKI, M; FARMER, J; HAGGLUND, KJ			NEUROBEHAVIORAL DEFICITS, ADOLESCENT TRAUMATIC BRAIN INJURY, AND TRANSITION TO COLLEGE	JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS			English	Article						ADOLESCENCE; TRAUMATIC BRAIN INJURY; MODERATOR VARIABLES; NEUROPSYCHOLOGY	HEAD-INJURY; CHILDREN; SYMPTOMS	Outcome following traumatic brain injury (TBI) has been frequently evaluated for adults, although there has been minimal research on adolescents with TBI. It has been argued that TBI sequelae may be more difficult for adolescents to adjust to given developmental changes in physical (puberty), interpersonal (self-concept), and environmental domains (transition to college). In addition, it is commonly acknowledged that moderator variables such as psychiatric history, family functioning, substance use, and sexuality impact functional outcome following TBI, although it is often difficult to objectively evaluate these variables. The current study examined relationships among TBI-related deficits, moderator variables, and academic outcomes for sh adolescents transitioning to college. The findings suggest that it may not be appropriate to predict functional outcome based solely on objective neuropsychological results. However, moderator variables appear to have a more direct relationship with outcome depending on the moderator variable and the individual.			JOHNSTONE, B (corresponding author), UNIV MISSOURI,SCH MED,DEPT PM&R,501 RUSK REHABIL CTR,1 HOSP DR,COLUMBIA,MO 65212, USA.		Hagglund, Kristofer/AAD-9871-2020	Johnstone, Brick/0000-0001-8845-9649; Hagglund, Kristofer/0000-0001-7748-7492			BASS DA, 1990, AUST J ECOL, V15, P227, DOI 10.1111/j.1442-9993.1990.tb01531.x; BROOKS DN, 1987, NEUROBEHAVIORAL RECO, P55; DENNIS M, 1988, MASTER LECT SERIES C, P89; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; EWINGCOBBS L, 1987, J LEARN DISABIL, V20, P526, DOI 10.1177/002221948702000904; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; TAKANISHI R, AM PSYCHOL, V48, P85; WOOD F, 1984, INT J PSYCHIAT MED, V14, P277; Worthington J, 1989, Rehabil Nurs, V14, P118	10	7	7	0	0	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	1068-9583			J CLIN PSYCHOL MED S	J. Clin. Psychol. Med. Settings	DEC	1994	1	4					375	386		10.1007/BF01991080			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	RK317	WOS:A1994RK31700009	24225863				2022-02-06	
J	NATIV, A; LAZARUS, JAC; NATIV, J; JOSEPH, J				NATIV, A; LAZARUS, JAC; NATIV, J; JOSEPH, J			POTENTIALS ASSOCIATED WITH THE GO/NO-GO PARADIGM IN TRAUMATIC BRAIN INJURY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							TRIGGERED FINGER MOVEMENT; COLOR DISCRIMINATION; HAND MOVEMENT	Surface event-related potentials associated with visually triggered movements (Go) and the inhibition of planned movements (No-Go) were examined in seven healthy subjects and five postacute traumatic brain injured (TBI) subjects. Analysis showed that the cortical potential P1-N1 was similarly affected by condition in both the control and TBI groups. Although TBI subjects showed smaller P1-N1 amplitudes (Go = 2.91uV; No-Go = 3.95uV; p < .03) relative to control subjects (Go = 4.82uV; No-Go = 6.03uV; p < .03), both groups showed larger amplitudes in the No-Go condition. A bipolar lead (C3'-C3'') over the sensorimotor cortex showed a reversal of polarity between Go and No-Go conditions which was synchronized with the EMG activity in all control subjects, This signal reversal and timing of potentials was absent in four of the five TBI subjects' waveforms, suggesting difficulty in sensorimotor processes associated with movement control. In addition, TBI subjects displayed a number of atypical stimulus-locked waveforms, which are discussed relative to the specific functional impairments of individual subjects. The results highlight the potential usefulness of such paradigms as the Go/No-Go procedure in the analyses of electroencephalographic waveforms and of the effects of TBI.	UNIV WISCONSIN,DEPT KINESIOL,MADISON,WI 53706; UNIV WATERLOO,DEPT KINESIOL,WATERLOO N2L 3G1,ON,CANADA; NEUROMUSCULAR GAIN,TORONTO,ON,CANADA; NICOLET BIOMED INC,MADISON,WI								BACHYRITA P, 1993, REHABILITATION MED P, P381; BARRETT G, 1987, ELECTROENCEPHALOGR C, V63, P340; CHISHOLM RC, 1988, INT J NEUROSCI, V42, P131, DOI 10.3109/00207458808985768; GEMBA DH, 1989, NEUROSCI LETT, V101, P263, DOI 10.1016/0304-3940(89)90543-0; LANG W, 1990, EXP BRAIN RES, V79, P504; NATIV A, 1992, INT J NEUROSCI, V66, P107, DOI 10.3109/00207459208999795; NATIV A, 1991, PHYS THER, V71, P48, DOI 10.1093/ptj/71.1.48; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; SASAKI K, 1986, EXP BRAIN RES, V64, P603, DOI 10.1007/BF00340499; THICKBROOM GW, 1985, ELECTROEN CLIN NEURO, V62, P209, DOI 10.1016/0168-5597(85)90016-4	10	7	7	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	1994	75	12					1322	1326					5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	PX233	WOS:A1994PX23300008	7993171				2022-02-06	
J	REEDER, KP; LOGUE, PE				REEDER, KP; LOGUE, PE			THE EFFECTS OF TRAUMATIC BRAIN INJURIES ON INFORMATION-PROCESSING	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							CEREBRAL BLOOD-FLOW; HEAD-INJURY; MEMORY	Many individuals experience memory impairment subsequent to traumatic brain injuries (TBI). These memory deficits may result from general impairment of information processing rather than damage to memory critical neurological systems. The investigators examined learning time and recall errors for easy and hard word pairs in a distraction and no-distraction condition to examine learning patterns. Although results indicated that individuals with and without TBI generally showed the same learning and retrieval patterns, individuals with TBI did so in an accentuated manner. This suggests that attentional deficits associated with TBI are not responsible for subsequent memory deficits.			REEDER, KP (corresponding author), DUKE UNIV,MED CTR,DEPT PSYCHIAT,DURHAM,NC 27710, USA.						AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BADDELEY A, 1987, NEUROBEHAVIORAL RECO, P296; Baddeley A.D., 1987, WORKING MEMORY; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BUTTERS N, 1985, CLIN NEUROPSYCHOLOGY, P403; CUSUMANO S, 1992, ELECTROEN CLIN NEURO, V84, P499, DOI 10.1016/0168-5597(92)90039-E; ERICKSON KR, 1990, WESTERN J MED, V152, P159; GENARELLI T, 1982, HEAD INJURY, P83; GENTRY LR, 1987, AJNR AM J NEURORADIO, V9, P101; GLISKY EL, 1986, J HEAD TRAUMA REHAB, V1, P54, DOI DOI 10.1097/00001199-198609000-00009; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Hasher L, 1988, PSYCHOL LEARNING MOT, P193, DOI DOI 10.1016/S0079-7421(08)60041-9; HOVDA DA, 1992, J NEUROTRAUMA S1, V9, P47; Kahneman D., 1973, ATTENTION EFFORT; MILNER B, 1966, AMNESIA, P109; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Parasuraman R, 1984, VARIETIES ATTENTION; PRIBRAM K H, 1973, P293; REEDER KP, IN PRESS ARCH CLIN N; REITAN RM, 1985, HALSTEAD REITAN NURU; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; TROST HA, 1992, ACTA NEUROCHIR, V116, P33, DOI 10.1007/BF01541250; Zarkovic K, 1991, Neurol Croat, V40, P129; [No title captured]; [No title captured]	28	7	7	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV-DEC	1994	9	6					491	500		10.1016/0887-6177(94)90040-X			10	Psychology, Clinical; Psychology	Social Science Citation Index (SSCI)	Psychology	PT254	WOS:A1994PT25400003	14590998				2022-02-06	
J	CLARK, LW				CLARK, LW			COMMUNICATION DISORDERS - WHAT TO LOOK FOR, AND WHEN TO REFER	GERIATRICS			English	Article								Communication impairments, with or without a swallowing disorder, are common among older adults. Aphasia, which is usually caused by a focal lesion, can affect spoken and written language, auditory comprehension, and reading ability but by itself does not affect intellectual and cognitive abilities. A cognitive-communicative impairment is related to underlying cognitive deficits in memory, attention, or visual perception and is seen with traumatic brain injury and nontreatable dementia. Voice and speech impairments such as dysarthria and apraxia of speech may lead to self-imposed social isolation and depression. Dysphagia may accompany a communication disorder or exist independently. As a primary care physician, your in-office workup can help diagnose a communication disorder and identify candidates for referral to an otolaryngologist and/or speech language pathologist.	HUNTER MT SINAI,GERIATR EDUC CTR,NEW YORK,NY		CLARK, LW (corresponding author), CUNY HUNTER COLL,SCH OPTOMETRY,COMMUN SCI PROGRAM,NEW YORK,NY 10021, USA.						BUEKELMAN DR, 1991, COMMUNICATION DISORD; CLARK L, 1993, COMMUNICATION DISORD; SELLERS D, 1983, LEGAL ASPECTS APHASI; 1988, ASHA, V3, P80	4	7	7	0	4	ADVANSTAR COMMUNICATIONS	DULUTH	131 W FIRST ST, DULUTH, MN 55802	0016-867X			GERIATRICS	Geriatrics	JUN	1994	49	6					51	55					5	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	NT074	WOS:A1994NT07400006	8005459				2022-02-06	
J	SCHNEIDER, GH; UNTERBERG, A; LANKSCH, WR				SCHNEIDER, GH; UNTERBERG, A; LANKSCH, WR			21-AMINOSTEROID U-74389F REDUCES VASOGENIC BRAIN EDEMA	ACTA NEUROCHIRURGICA			English	Article						COLD INJURY; BRAIN SWELLING; CEREBRAL EDEMA; LAZAROIDS; RATS	RADICALS; ISCHEMIA; U74006F	21-Aminosteroids have been shown to attenuate neuronal damage and to improve neurological outcome after experimental ischemia. The aim of this study was to determine whether brain edema induced by a cryogenic injury can be influenced by the 21-aminosteroid U-74389F. A cortical freezing lesion was applied to the right parietal region of Sprague-Dawley rats under ketamine-xylazine anesthesia. Systemic blood pressure was monitored in the peritraumatic period. Four different doses of U-74389F (A-D) were studied for their effect on post-traumatic brain swelling and edema. Respective control groups received only the solvent, citric acid buffer. (A) 3 mg/kg b.w. i.p. (total dose) 30 min before, 1 and 12 h; post trauma (p.t.); (B) 9 mg/kg b.w. i.v. 30 min before, 1 and 12 h p.t.; (C) 25 mg/kg b.w. i.v. 30 min before, 1, 6, and 12 h p.t.; (D) 50 mg/kg b.w. i.v. 15 min before, 15 and 30 min as well as 1, 2,6, and 12 h p.t. 24 h after trauma, brains were removed and hemispheric swelling and water content were determined from the difference between wet and dry weight. Application of the 21-aminosteroid U-74389F moderately reduced post-traumatic brain swelling in all treatment groups: (A) 5%, (B) 9%, (C) 12%, and (D) 14%. In parallel with this, the increase in water content of the traumatized hemisphere was marginally lowered by U-74389F in all groups; in (C) e.g. from 1.9 +/- 0.1% to 1.7 +/- 0.1%, p = 0.07. These two findings taken together indicate that the 21-aminosteroid U-74389F moderately reduces post-traumatic swelling and edema.			SCHNEIDER, GH (corresponding author), FREE UNIV BERLIN, RUDOLF VIRCHOW MED CTR, DEPT NEUROSURG, AUGUSTENBURGER PL 1, D-13353 BERLIN, GERMANY.						Anderson D K, 1985, Cent Nerv Syst Trauma, V2, P257; HALL ED, 1988, BRAIN RES, V451, P350, DOI 10.1016/0006-8993(88)90782-2; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; KOGURE K, 1982, NEUROCHEM RES, V7, P437, DOI 10.1007/BF00965496; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; PERKINS WJ, 1991, STROKE, V22, P902, DOI 10.1161/01.STR.22.7.902; REUELEN HJ, 1972, STEROIDS BRAIN OEDEM; SUZUKI O, 1974, EXPERIENTIA, V30, P248, DOI 10.1007/BF01934807; UNTERBERG A, 1988, ACTA NEUROPATHOL, V76, P238, DOI 10.1007/BF00687770; UNTERBERG A, 1990, ACT NEUR S, V51, P104; WAHL M, 1988, J CEREBR BLOOD F MET, V8, P621, DOI 10.1038/jcbfm.1988.109; ZUCCARELLO M, 1989, STROKE, V20, P367, DOI 10.1161/01.STR.20.3.367	13	7	7	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1994				60			516	518					3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NX226	WOS:A1994NX22600141	7976635				2022-02-06	
